seq_id,uniprot_id,protein_names,gene_names,length,function_cc,subcellular_location_cc,tissue_specificity,involvement_in_disease,doug_name,nucleus,cytoplasm,mitochondria,er,golgi,lysosome,secreted,endosome,plasma_membrane,junction,peroxisome,membrane,cilium,cytoskeleton,lnc_rna,ribosomal,transcription_factor,gene_symbol,entrez_gene_id_pete,uni_gene_id_pete,ensembl_id_pete,tigrid_pete,go_pete,description_pete,genomic_coordinates_pete,cytoband_pete,gene_name_pete,pete_list
344_SEPT9_10801,Q9UHD8,septin-9 (mll septin-like fusion protein msf-a) (mll septin-like fusion protein) (ovarian/breast septin) (ov/br septin) (septin d1),SEPTIN9 KIAA0991 MSF SEPT9,586,"function: filament-forming cytoskeletal gtpase (by similarity). may play a role in cytokinesis (potential). may play a role in the internalization of 2 intracellular microbial pathogens, listeria monocytogenes and shigella flexneri. {eco:0000250, eco:0000305}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:17546647, eco:0000269|pubmed:17922164}. note=in an epithelial cell line, concentrates at cell-cell contact areas. after tgf-beta1 treatment and induction of epithelial to mesenchymal transition, colocalizes partly with actin stress fibers. during bacterial infection, displays a collar shape structure next to actin at the pole of invading bacteria.","TISSUE SPECIFICITY: Widely expressed. Isoforms are differentially expressed in testes, kidney, liver heart, spleen, brain, peripheral blood leukocytes, skeletal muscle and kidney. Specific isoforms appear to demonstrate tissue specificity. Isoform 5 is the most highly expressed in fetal tissue. Isoform 1 is detected in all tissues except the brain and thymus, while isoform 2, isoform 3, and isoform 4 are detected at low levels in approximately half of the fetal tissues. {ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329, ECO:0000269|PubMed:11593400, ECO:0000269|PubMed:15915442}.","DISEASE: Note=A chromosomal aberration involving SEPTIN9/MSF is found in therapy-related acute myeloid leukemia (t-AML). Translocation t(11;17)(q23;q25) with KMT2A/MLL1. {ECO:0000269|PubMed:10339604}.; DISEASE: Hereditary neuralgic amyotrophy (HNA) [MIM:162100]: Autosomal dominant form of recurrent focal neuropathy characterized clinically by acute, recurrent episodes of brachial plexus neuropathy with muscle weakness and atrophy preceded by severe pain in the affected arm. HNA is triggered by environmental factors such as infection or parturition. {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:18492087, ECO:0000269|PubMed:19451530}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,SEPTIN9,10801,NA,NA,NA,NA,NA,NA,NA,NA,NA
797_MARCH6_10299,O60337,e3 ubiquitin-protein ligase march6 (ec 2.3.2.27) (doa10 homolog) (membrane-associated ring finger protein 6) (membrane-associated ring-ch protein vi) (march-vi) (protein teb-4) (ring finger protein 176) (ring-type e3 ubiquitin transferase march6),MARCH6 KIAA0597 RNF176 TEB4,910,"function: e3 ubiquitin-protein ligase that promotes 'lys-48'-linked ubiquitination of target proteins, leading to their proteasomal degradation (pubmed:15673284). promotes ubiquitination of dio2, leading to its degradation (pubmed:19651899). promotes ubiquitination of sqle, leading to its degradation (pubmed:24449766). e3 ubiquitin ligases accept ubiquitin from an e2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. may cooperate with ube2g1 (pubmed:15673284). {eco:0000269|pubmed:15673284, eco:0000269|pubmed:19651899, eco:0000269|pubmed:24449766}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:15673284}; multi-pass membrane protein {eco:0000269|pubmed:15673284}.,TISSUE SPECIFICITY: Present in brain (at protein level). {ECO:0000269|PubMed:15673284}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MARCHF6,10299,NA,NA,NA,NA,NA,NA,NA,NA,NA
960_SEPT2_4735,Q15019,septin-2 (neural precursor cell expressed developmentally down-regulated protein 5) (nedd-5),SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2,361,"function: filament-forming cytoskeletal gtpase. forms a filamentous structure with septin12, septin6, septin2 and probably septin4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (pubmed:25588830). required for normal organization of the actin cytoskeleton. plays a role in the biogenesis of polarized columnar-shaped epithelium by maintaining polyglutamylated microtubules, thus facilitating efficient vesicle transport, and by impeding map4 binding to tubulin. required for the progression through mitosis. forms a scaffold at the midplane of the mitotic splindle required to maintain cenpe localization at kinetochores and consequently chromosome congression. during anaphase, may be required for chromosome segregation and spindle elongation. plays a role in ciliogenesis and collective cell movements. in cilia, required for the integrity of the diffusion barrier at the base of the primary cilium that prevents diffusion of transmembrane proteins between the cilia and plasma membranes: probably acts by regulating the assembly of the tectonic-like complex (also named b9 complex) by localizing tmem231 protein. may play a role in the internalization of 2 intracellular microbial pathogens, listeria monocytogenes and shigella flexneri. {eco:0000269|pubmed:15774761, eco:0000269|pubmed:17803907, eco:0000269|pubmed:18209106, eco:0000269|pubmed:19145258, eco:0000305|pubmed:25588830}.","subcellular location: cytoplasm {eco:0000269|pubmed:15774761}. cytoplasm, cytoskeleton {eco:0000269|pubmed:15774761}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:15774761}. chromosome, centromere, kinetochore {eco:0000269|pubmed:15774761}. cleavage furrow {eco:0000269|pubmed:15774761}. midbody {eco:0000269|pubmed:15774761}. cytoplasm, cell cortex {eco:0000269|pubmed:15774761}. cell projection, cilium membrane {eco:0000250}. cell projection, cilium, flagellum {eco:0000269|pubmed:25588830}. note=in metaphase cells, localized within the microtubule spindle. at the metaphase plate, in close apposition to the kinetochores of the congressed chromosomes. in cells undergoing cytokinesis, localized to the midbody, the ingressing cleavage furrow, and the central spindle. during bacterial infection, displays a collar shape structure next to actin at the pole of invading bacteria. in epithelial cells, colocalizes with polyglutamylated tubulin around the trans-golgi network, as well as juxatnuclear and proximal golgi apparatus. localizes at the base of the cilia near the morphological distinction between the cilia and plasma membranes. found in the sperm annulus (pubmed:25588830). {eco:0000269|pubmed:25588830}.","TISSUE SPECIFICITY: Widely expressed. Up-regulated in liver cancer. {ECO:0000269|PubMed:15915442, ECO:0000269|PubMed:19165576}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,SEPTIN2,4735,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT12,P19388,"dna-directed rna polymerases i, ii, and iii subunit rpabc1 (rna polymerases i, ii, and iii subunit abc1) (dna-directed rna polymerase ii 23 kda polypeptide) (dna-directed rna polymerase ii subunit e) (rpb5 homolog) (xap4)",POLR2E,210,subcellular location: nucleus {eco:0000269|pubmed:9852112}.,NA,NA,NA,polymerase (RNA) II (DNA directed) polypeptide E (POLR2E),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,POL2RE,5434,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT14,Q9NZN5,rho guanine nucleotide exchange factor 12 (leukemia-associated rhogef),ARHGEF12 KIAA0382 LARG,1544,subcellular location: cytoplasm {eco:0000305}. membrane {eco:0000305}. note=translocated to the membrane upon stimulation. {eco:0000305}.,tissue specificity: ubiquitously expressed. isoform 2 is found in jejunum and testis.,DISEASE: Note=A chromosomal aberration involving ARHGEF12 may be a cause of acute leukemia. Translocation t(11;11)(q23;23) with KMT2A/MLL1. {ECO:0000269|PubMed:10681437}.,NA,Rho guanine nucleotide exchange factor 12 (ARHGEF12),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARHGEF12,23365,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT2,P35609,alpha-actinin-2 (alpha-actinin skeletal muscle isoform 2) (f-actin cross-linking protein),ACTN2,894,"subcellular location: cytoplasm, myofibril, sarcomere, z line {eco:0000269|pubmed:11171996, eco:0000269|pubmed:19932097}. note=colocalizes with myoz1 and flnc at the z-lines of skeletal muscle.",tissue specificity: expressed in both skeletal and cardiac muscle.,"DISEASE: Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20022194, ECO:0000269|PubMed:25173926}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:14567970, ECO:0000269|PubMed:25224718}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,actinin alpha 2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ACTN2,88,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT20,Q9UNZ2,nsfl1 cofactor p47 (ubx domain-containing protein 2c) (p97 cofactor p47),NSFL1C UBXN2C,370,"subcellular location: nucleus {eco:0000250|uniprotkb:o35987}. golgi apparatus, golgi stack {eco:0000250|uniprotkb:o35987}. chromosome {eco:0000250|uniprotkb:o35987}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000250|uniprotkb:o35987}. note=predominantly nuclear in interphase cells. bound to the axial elements of sex chromosomes in pachytene spermatocytes. a small proportion of the protein is cytoplasmic, associated with golgi stacks. localizes to centrosome during mitotic prophase and metaphase. {eco:0000250|uniprotkb:o35987}.",NA,NA,NA,NSFL1 (p97) cofactor (p47) NSFL1C,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,NSFL1C,55968,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT26,P35749,"myosin-11 (myosin heavy chain 11) (myosin heavy chain, smooth muscle isoform) (smmhc)",MYH11 KIAA0866,1972,subcellular location: melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. thick filaments of the myofibrils.,"tissue specificity: smooth muscle; expressed in the umbilical artery, bladder, esophagus and trachea. isoform 1 is mostly found in slowly contracting tonic muscles. {eco:0000269|pubmed:16000639}.","DISEASE: Note=A chromosomal aberration involving MYH11 is found in acute myeloid leukemia of M4EO subtype. Pericentric inversion inv(16)(p13;q22). The inversion produces a fusion protein consisting of the 165 N-terminal residues of CBF-beta (PEPB2) and the tail region of MYH11.; DISEASE: Aortic aneurysm, familial thoracic 4 (AAT4) [MIM:132900]: A disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. {ECO:0000269|PubMed:16444274}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Myosin heavy chain 11 (MYH11),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MYH11,4629,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT28,A0A024R7P5,"similar to laminin receptor 1, isoform cra_a",LOC388524 hCG_20807,199,subcellular location: cytoplasm {eco:0000256|saas:saas01080644}.,NA,NA,NA,Similar to lamanin receptor 1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,RPSAP58,388524,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT3,Q99743,neuronal pas domain-containing protein 2 (neuronal pas2) (basic-helix-loop-helix-pas protein mop4) (class e basic helix-loop-helix protein 9) (bhlhe9) (member of pas protein 4) (pas domain-containing protein 4),NPAS2 BHLHE9 MOP4 PASD4,824,"subcellular location: nucleus {eco:0000255|prosite-prorule:pru00981, eco:0000269|pubmed:14645221}.",NA,NA,NA,neuronal PAS domain protein 2 (NPAS2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,NPAS2,4862,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT5,P49771,fms-related tyrosine kinase 3 ligand (flt3 ligand) (flt3l) (sl cytokine),FLT3LG,235,subcellular location: isoform 1: cell membrane; single-pass type i membrane protein.; subcellular location: isoform 2: secreted.,NA,NA,NA,fms-related tyrosine kinase 3 ligand,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FLT3LG,2323,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT6,Q13368,maguk p55 subfamily member 3 (discs large homolog 3) (protein mpp3),MPP3 DLG3,585,NA,NA,NA,NA,"membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,MPP5,64398,NA,NA,NA,NA,NA,NA,NA,NA,NA
ADT9,Q15714,tsc22 domain family protein 1 (cerebral protein 2) (regulatory protein tsc-22) (tgfb-stimulated clone 22 homolog) (transforming growth factor beta-1-induced transcript 4 protein),TSC22D1 KIAA1994 TGFB1I4 TSC22 hucep-2,1073,subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,tissue specificity: widely expressed in fetal and adult tissues.,NA,NA,"TSC22 domain family, member 1 (TSC22D1)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TSC22D1,8848,NA,NA,NA,NA,NA,NA,NA,NA,NA
ANO1_AS1_T062911_G014510_1_447_1019_573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
ANO1_AS1_T062911_G014510_2_398_895_498,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
BOLA3_AS1_T191973_G044207_1_1427_1822_396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CALML3_AS1.5_T036343_G008259_1_479_1162_684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CALML3_AS1.5_T036343_G008259_2_385_1059_675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT101.1_T018833_G004234_1_60_443_384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT101.1_T018833_G004234_2_3525_3788_264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1111_T352722_G083290_1_456_1667_1212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1111_T352722_G083290_2_589_1626_1038,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1144.1_T359193_G084753_1_929_1768_840,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1144.1_T359193_G084753_2_1180_1539_360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1144.2_T359194_G084753_1_929_1768_840,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1144.2_T359194_G084753_2_1180_1539_360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1367_T060449_G014057_1_30_1331_1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1367_T060449_G014057_2_532_807_276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1378.2_T062242_G014366_1_2018_2641_624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1378.2_T062242_G014366_2_321_602_282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1449.1_T070828_G016390_1_238_720_483,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1449.1_T070828_G016390_2_401_652_252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1452.1_T071276_G016478_1_93_788_696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1452.1_T071276_G016478_2_2995_3228_234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1454_T071522_G016513_1_1122_1892_771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1454_T071522_G016513_2_208_708_501,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT151.3_T027960_G006287_1_2942_3769_828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT151.3_T027960_G006287_2_15387_15731_345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1571_T086563_G020094_1_281_976_696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1571_T086563_G020094_2_2344_2601_258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1651_T102861_G024234_1_1199_1891_693,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1651_T102861_G024234_2_3561_3842_282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1686_T107057_G025268_1_5122_5934_813,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1686_T107057_G025268_2_4537_5037_501,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1852.2_T132489_G031083_1_3501_3875_375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1852.2_T132489_G031083_2_524_799_276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1881.1_T137363_G032189_1_2163_2987_825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1881.1_T137363_G032189_2_3118_3387_270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1917.2_T144453_G033626_1_2303_2959_657,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1917.2_T144453_G033626_2_1532_2110_579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1941.1_T148927_G034563_1_3496_4026_531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1941.1_T148927_G034563_2_4305_4745_441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1942_T149369_G034642_1_6407_7270_864,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1942_T149369_G034642_2_6951_7271_321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1968.2_T153055_G035480_1_1286_1960_675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT1968.2_T153055_G035480_2_2275_2736_462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.1_T227650_G052508_1_19198_20361_1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.1_T227650_G052508_2_19310_20443_1134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.3_T227648_G052508_1_18572_19735_1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.3_T227648_G052508_2_18684_19817_1134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.4_T227647_G052508_1_13832_14995_1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT2217.4_T227647_G052508_2_13944_15077_1134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT239_T189457_G043567_1_3047_3727_681,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT239_T189457_G043567_2_1778_2185_408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT297_T196839_G045377_1_2510_3112_603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT297_T196839_G045377_2_1163_1555_393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT306.5_T198267_G045736_1_5067_5474_408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT306.5_T198267_G045736_2_4738_5097_360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT446.1_T250066_G057497_1_562_1254_693,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT446.1_T250066_G057497_2_4427_4768_342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT505.1_T259126_G059652_1_37_678_642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT505.1_T259126_G059652_2_3064_3537_474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT505.2_T259129_G059652_1_31_672_642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT505.2_T259129_G059652_2_3044_3517_474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT583_T271074_G062826_1_2272_2871_600,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT583_T271074_G062826_2_704_1135_432,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT625.2_T275901_G064124_1_899_2041_1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT625.2_T275901_G064124_2_2580_3158_579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT634.1_T277460_G064362_1_1422_2105_684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT634.1_T277460_G064362_2_111_689_579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT634.2_T277464_G064362_1_1098_1781_684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT634.2_T277464_G064362_2_3025_3492_468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT668.2_T283555_G066082_1_5822_6478_657,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT668.2_T283555_G066082_2_6783_7376_594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT721_T289517_G067689_1_1083_1535_453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT721_T289517_G067689_2_860_1204_345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT86_T016624_G003715_1_534_1100_567,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT86_T016624_G003715_2_1073_1276_204,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT989_T334872_G078524_1_319_849_531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAT989_T334872_G078524_2_50_364_315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA1,P43355,melanoma-associated antigen 1 (antigen mz2-e) (cancer/testis antigen 1.1) (ct1.1) (mage-1 antigen),MAGEA1 MAGE1 MAGE1A,309,subcellular location: cytoplasm. nucleus.,"tissue specificity: expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes. never expressed in kidney tumors, leukemias and lymphomas.",NA,NA,Mage A1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MAGEA1,4100,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA10,O60829,p antigen family member 4 (page-4) (g antigen family c member 1) (page-1),PAGE4 GAGEC1 JM27,102,"subcellular location: cytoplasm {eco:0000269|pubmed:12489849, eco:0000269|pubmed:24559171, eco:0000269|pubmed:25374899}. nucleus {eco:0000269|pubmed:24559171}. mitochondrion {eco:0000269|pubmed:25374899}. note=translocates to mitochondria in response to stress. {eco:0000269|pubmed:25374899}.","tissue specificity: expressed at basal lvels in the adult normal prostate gland but is highly up-regulated in the fetal prostate and prostate cancer cells (pubmed:12489849, pubmed:25374899, pubmed:24559171, pubmed:24263171). preferentially expressed in normal male and female reproductive tissues, testis, fallopian tube, uterus, and placenta, as well as in testicular cancer, uterine cancer, cervical cancer and kidney cancer (pubmed:9724777, pubmed:12489849). {eco:0000269|pubmed:12489849, eco:0000269|pubmed:24263171, eco:0000269|pubmed:24559171, eco:0000269|pubmed:25374899, eco:0000269|pubmed:9724777}.",NA,NA,Page 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PAGE4,9506,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA11,Q9UBF1,melanoma-associated antigen c2 (cancer/testis antigen 10) (ct10) (hepatocellular carcinoma-associated antigen 587) (mage-c2 antigen) (mage-e1 antigen),MAGEC2 HCA587 MAGEE1,373,"subcellular location: cytoplasm {eco:0000269|pubmed:12920247}. nucleus {eco:0000269|pubmed:12920247}. note=nuclear in germ cells. cytoplasmic in well-differentiated hepatocellular carcinoma, nuclear in moderately- and poorly-differentiated hepatocellular carcinoma.","tissue specificity: not expressed in normal tissues, except in germ cells in the seminiferous tubules and in purkinje cells of the cerebellum. expressed in various tumors, including melanoma, lymphoma, as well as pancreatic cancer, mammary gland cancer, non-small cell lung cancer and liver cancer. in hepatocellular carcinoma, there is an inverse correlation between tumor differentiation and protein expression, i.e. the lower the differentiation, the higher percentage of expression. {eco:0000269|pubmed:12097419, eco:0000269|pubmed:12920247}.",NA,NA,Mage E1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MAGEC2,51438,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA12,Q9NY87,sperm protein associated with the nucleus on the x chromosome c (cancer/testis antigen 11.3) (ct11.3) (cancer/testis-associated protein ctp11) (nuclear-associated protein span-xc) (spanx-c) (spanx family member c),SPANXC,97,subcellular location: cytoplasm {eco:0000269|pubmed:10626816}. nucleus {eco:0000269|pubmed:10626816}. note=associated with nuclear craters.,"tissue specificity: detected in testis, melanoma and bladder carcinoma. {eco:0000269|pubmed:10626816, eco:0000269|pubmed:12758128}.",NA,NA,Span XC,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SPANXC,64663,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA13,Q9UNA0,a disintegrin and metalloproteinase with thrombospondin motifs 5 (adam-ts 5) (adam-ts5) (adamts-5) (ec 3.4.24.-) (a disintegrin and metalloproteinase with thrombospondin motifs 11) (adam-ts 11) (adamts-11) (admp-2) (aggrecanase-2),ADAMTS5 ADAMTS11 ADMP2,930,"subcellular location: secreted, extracellular space, extracellular matrix {eco:0000269|pubmed:18992360}.","tissue specificity: expressed at low level in placenta primarily but also detected in heart and brain, cervix, uterus, bladder, esophagus, rib cartilage, chondroblastoma, fibrous tissue and a joint capsule from an arthritic patient.",NA,NA,Adam 2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ADAMTS5,11096,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA14,Q9UI38,probable threonine protease prss50 (ec 3.4.25.-) (cancer/testis antigen 20) (serine protease 50) (testis-specific protease-like protein 50),PRSS50 CT20 TSP50,385,subcellular location: endoplasmic reticulum {eco:0000305|pubmed:17283160}. note=may also localize to cytoplasmic membranes.,tissue specificity: testis specific. differentially expressed in some breast cancer tissues.,NA,NA,TSP 50,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRSS50,29122,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA15,Q8NEN9,pdz domain-containing protein 8 (sarcoma antigen ny-sar-84/ny-sar-104),PDZD8 PDZK8,1154,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:29097544}; single-pass membrane protein {eco:0000255}. note=localizes at mitochondria-endoplasmic reticulum contact sites. {eco:0000269|pubmed:29097544}.,NA,NA,NA,NY-SAR 35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FMR1NB,158521,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA16,Q969F0,fetal and adult testis-expressed transcript protein (cancer/testis antigen 43) (ct43) (tumor antigen bj-hcc-2),FATE1 FATE,183,"subcellular location: mitochondrion {eco:0000269|pubmed:26567849, eco:0000269|pubmed:27402544}. mitochondrion outer membrane {eco:0000269|pubmed:27402544}. endoplasmic reticulum membrane {eco:0000269|pubmed:27402544}; single-pass membrane protein {eco:0000305}; cytoplasmic side {eco:0000305|pubmed:27402544}. note=localized to specific membrane structures termed mitochondria-associated membranes (mams) which connect the endoplasmic reticulum (er) and the mitochondria. also associated with the outer surface of mitochondria at sites that are not in close contact with the er. {eco:0000269|pubmed:27402544}.","tissue specificity: testis-specific in fetus (aged from 6 to 11 weeks). in adult, expressed predominantly in testis, with some expression in lung, heart, kidney, adrenal gland and whole brain (pubmed:11694338). highly expressed in certain types of cancer tissues such as hepatocellular carcinoma, colon and gastric cancer. weakly expressed in normal pancreas (pubmed:12865919). {eco:0000269|pubmed:11694338, eco:0000269|pubmed:12865919}.",NA,NA,Fate 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FATE1,89885,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA17,O60829,p antigen family member 4 (page-4) (g antigen family c member 1) (page-1),PAGE4 GAGEC1 JM27,102,"subcellular location: cytoplasm {eco:0000269|pubmed:12489849, eco:0000269|pubmed:24559171, eco:0000269|pubmed:25374899}. nucleus {eco:0000269|pubmed:24559171}. mitochondrion {eco:0000269|pubmed:25374899}. note=translocates to mitochondria in response to stress. {eco:0000269|pubmed:25374899}.","tissue specificity: expressed at basal lvels in the adult normal prostate gland but is highly up-regulated in the fetal prostate and prostate cancer cells (pubmed:12489849, pubmed:25374899, pubmed:24559171, pubmed:24263171). preferentially expressed in normal male and female reproductive tissues, testis, fallopian tube, uterus, and placenta, as well as in testicular cancer, uterine cancer, cervical cancer and kidney cancer (pubmed:9724777, pubmed:12489849). {eco:0000269|pubmed:12489849, eco:0000269|pubmed:24263171, eco:0000269|pubmed:24559171, eco:0000269|pubmed:25374899, eco:0000269|pubmed:9724777}.",NA,NA,Page 5,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PAGE5,90737,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA18,Q13136,liprin-alpha-1 (lar-interacting protein 1) (lip-1) (protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (ptprf-interacting protein alpha-1),PPFIA1 LIP1,1202,subcellular location: cytoplasm {eco:0000269|pubmed:7796809}. note=colocalizes with ptprf at the ends of focal adhesions most proximal to the cell nucleus.,"tissue specificity: ubiquitous. {eco:0000269|pubmed:7796809, eco:0000269|pubmed:9624153}.",NA,NA,Lip1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LIAS,11019,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA19,Q15506,sperm surface protein sp17 (cancer/testis antigen 22) (ct22) (sp17-1) (sperm autoantigenic protein 17) (sperm protein 17),SPA17 SP17,151,subcellular location: membrane {eco:0000305}; peripheral membrane protein {eco:0000305}.,tissue specificity: testis and sperm specific.,NA,NA,SPA17,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SPA17,53340,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA2,Q16385,"protein ssx2 (cancer/testis antigen 5.2) (ct5.2) (synovial sarcoma, x breakpoint 2) (tumor antigen hom-mel-40)",SSX2 SSX2A; SSX2B,188,subcellular location: nucleus.,"tissue specificity: expressed at high level in the testis. expressed at low level in thyroid. not detected in tonsil, colon, lung, spleen, prostate, kidney, striated and smooth muscles. detected in rhabdomyosarcoma and fibrosarcoma cell lines. not detected in mesenchymal and epithelial cell lines.","DISEASE: Note=A chromosomal aberration involving SSX2 may be a cause of synovial sarcoma. Translocation t(X;18)(p11.2;q11.2). The translocation is specifically found in more than 80% of synovial sarcoma. The fusion products SSXT-SSX1 or SSXT-SSX2 are probably responsible for transforming activity. Heterogeneity in the position of the breakpoint can occur (low frequency). {ECO:0000269|PubMed:7539744, ECO:0000269|PubMed:7951320}.",NA,SSX-2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SSX2,6757,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA20,B2R9W4,"cdna, flj94585, highly similar to homo sapiens melanoma antigen, family a, 8 (magea8), mrna",NA,318,NA,NA,NA,NA,Mage A8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,MAGEA8,4107,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA21,P43366,melanoma-associated antigen b1 (cancer/testis antigen 3.1) (ct3.1) (dss-ahc critical interval mage superfamily 10) (dam10) (mage-b1 antigen) (mage-xp antigen),MAGEB1 MAGEL1 MAGEXP,347,NA,tissue specificity: expressed only in testis.,NA,NA,Mage B1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MAGEB1,4112,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA22,O15479,melanoma-associated antigen b2 (cancer/testis antigen 3.2) (ct3.2) (dss-ahc critical interval mage superfamily 6) (dam6) (mage xp-2 antigen) (mage-b2 antigen),MAGEB2,319,NA,"tissue specificity: expressed in testis and placenta, and in a significant fraction of tumors of various histologic types.",NA,NA,Mage B2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MAGEB2,4113,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA23,P43358,melanoma-associated antigen 4 (cancer/testis antigen 1.4) (ct1.4) (mage-4 antigen) (mage-41 antigen) (mage-x2 antigen),MAGEA4 MAGE4,317,NA,"tissue specificity: expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes and placenta.",NA,NA,Mage A4,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MAGEA4,4103,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA24,Q16384,"protein ssx1 (cancer/testis antigen 5.1) (ct5.1) (synovial sarcoma, x breakpoint 1)",SSX1,188,NA,"tissue specificity: expressed at high level in the testis. expressed at low level in thyroid. not detected in tonsil, colon, lung, spleen, prostate, kidney, striated and smooth muscles. detected in rhabdomyosarcoma and fibrosarcoma cell lines. not detected in mesenchymal and epithelial cell lines.",DISEASE: Note=A chromosomal aberration involving SSX1 may be a cause of synovial sarcoma. Translocation t(X;18)(p11.2;q11.2). The translocation is specifically found in more than 80% of synovial sarcoma. The fusion products SSXT-SSX1 or SSXT-SSX2 are probably responsible for transforming activity. Heterogeneity in the position of the breakpoint can occur (low frequency). {ECO:0000269|PubMed:7539744}.,NA,SSX-1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,SSX1,6756,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA25,Q13065,g antigen 1 (gage-1) (antigen mz2-f) (cancer/testis antigen 4.1) (ct4.1),GAGE1,117,NA,"tissue specificity: expressed in a variety of tumor tissues but not in normal tissues, except testis.",NA,NA,Gage 2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,GAGE2C,2574,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA26,Q13065,melanoma-associated antigen d2 (11b6) (breast cancer-associated gene 1 protein) (bcg-1) (hepatocellular carcinoma-associated protein jcl-1) (mage-d2 antigen),MAGED2 BCG1,606,NA,"tissue specificity: widely expressed. in the developing and adult kidney, expressed in the thick ascending limb of the loop of henle and the distal convoluted tubules outside the loop. {eco:0000269|pubmed:11856887, eco:0000269|pubmed:27120771}.","DISEASE: Bartter syndrome 5, antenatal, transient (BARTS5) [MIM:300971]: An X-linked recessive form of Bartter syndrome, a disorder characterized by impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and varying degrees of hypercalciuria. BARTS5 is an antenatal form beginning in utero with marked fetal polyuria that leads to polyhydramnios and premature delivery. It is characterized by severe but transient symptoms that can resolve with age. {ECO:0000269|PubMed:27120771}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Gage 4,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,GAGE4,2576,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA27,Q9UNF1,melanoma-associated antigen d2 (11b6) (breast cancer-associated gene 1 protein) (bcg-1) (hepatocellular carcinoma-associated protein jcl-1) (mage-d2 antigen),MAGED2 BCG1,606,NA,"tissue specificity: widely expressed. in the developing and adult kidney, expressed in the thick ascending limb of the loop of henle and the distal convoluted tubules outside the loop. {eco:0000269|pubmed:11856887, eco:0000269|pubmed:27120771}.","DISEASE: Bartter syndrome 5, antenatal, transient (BARTS5) [MIM:300971]: An X-linked recessive form of Bartter syndrome, a disorder characterized by impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and varying degrees of hypercalciuria. BARTS5 is an antenatal form beginning in utero with marked fetal polyuria that leads to polyhydramnios and premature delivery. It is characterized by severe but transient symptoms that can resolve with age. {ECO:0000269|PubMed:27120771}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Mage A3,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MAGEA3,4102,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA28,Q9UHG2,prosaas (proprotein convertase subtilisin/kexin type 1 inhibitor) (proprotein convertase 1 inhibitor) (pro-saas) [cleaved into: kep; big saas (b-saas); little saas (l-saas) (n-prosaas); big pen-len (b-pen-len) (saas ct(1-49)); pen; little len (l-len); big len (b-len) (saas ct(25-40))],PCSK1N,260,"subcellular location: secreted {eco:0000250|uniprotkb:q9qxv0}. golgi apparatus, trans-golgi network {eco:0000250|uniprotkb:q9qxv0}. note=a n-terminal processed peptide, probably big saas or little saas, is accumulated in cytoplasmic protein tau deposits in frontotemporal dementia and parkinsonism linked to chromosome 17 (pick disease), alzheimer disease and amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 (guam disease). {eco:0000269|pubmed:12914799, eco:0000269|pubmed:14746899}.",tissue specificity: expressed in brain and pancreas. {eco:0000269|pubmed:10632593}.,NA,NA,CT-1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRM2,5620,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA3,P78358,cancer/testis antigen 1 (autoimmunogenic cancer/testis antigen ny-eso-1) (cancer/testis antigen 6.1) (ct6.1) (l antigen family member 2) (lage-2),CTAG1A CTAG CTAG1 ESO1 LAGE2 LAGE2A; CTAG1B LAGE2B,180,subcellular location: cytoplasm {eco:0000269|pubmed:12065688}.,"tissue specificity: expressed in testis and ovary and in a wide variety of cancers. detected in uterine myometrium. expressed from 18 weeks until birth in human fetal testis. in the adult testis, is strongly expressed in spermatogonia and in primary spermatocytes, but not in post-meiotic cells or in testicular somatic cells (at protein level). {eco:0000269|pubmed:12065688}.",NA,NA,Ny-ESO1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTAG1B,1485,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA4,O94888,ubx domain-containing protein 7,UBXN7 KIAA0794 UBXD7,489,subcellular location: nucleus {eco:0000269|pubmed:22537386}.,NA,NA,NA,Gage 7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GAGE7,2579,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA5,O60224,protein ssx4 (cancer/testis antigen 5.4) (ct5.4),SSX4 SSX4A; SSX4B,188,NA,NA,NA,NA,SSX-4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,SSX4,6759,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA6,Q9GZY0,nuclear rna export factor 2 (cancer/testis antigen 39) (ct39) (tap-like protein 2) (tapl-2),NXF2 TAPL2; NXF2B,626,"subcellular location: nucleus, nucleoplasm. cytoplasm. note=localized in the nucleoplasm and at the nuclear envelope. shuttles between the nucleus and the cytoplasm.",tissue specificity: expressed almost exclusively in testis. also expressed in several cancers. {eco:0000269|pubmed:12704671}.,NA,NA,NXF-2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NXF2,56001,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA7,Q9ULW0,targeting protein for xklp2 (differentially expressed in cancerous and non-cancerous lung cells 2) (dil-2) (hepatocellular carcinoma-associated antigen 519) (hepatocellular carcinoma-associated antigen 90) (protein fls353) (restricted expression proliferation-associated protein 100) (p100),TPX2 C20orf1 C20orf2 DIL2 HCA519,747,"subcellular location: nucleus {eco:0000269|pubmed:19208764}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:18663142, eco:0000269|pubmed:19208764}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:18663142, eco:0000269|pubmed:19208764}. note=during mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during s and g2, it is diffusely distributed throughout the nucleus. is released from the nucleus in apoptotic cells and is detected on apoptotic microtubules. {eco:0000269|pubmed:19208764}.",tissue specificity: expressed in lung carcinoma cell lines but not in normal lung tissues.,NA,NA,TPX 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CRISP2,7180,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA8,Q9HD64,x antigen family member 1 (xage-1) (cancer/testis antigen 12.1) (ct12.1) (g antigen family d member 2),XAGE1A GAGED2 XAGE1; XAGE1B; XAGE1C; XAGE1D; XAGE1E,81,NA,"tissue specificity: in normal tissues, highly expressed in testis. expressed also in many different types of cancers: highly expressed in breast cancer, prostate cancer and many types of lung cancers, including squamous cell carcinoma, small cell carcinoma, non-small cell carcinoma, and adenocarcinoma, as well as in ewing's cell lines, in some ewing's sarcoma patient samples, and in one of one alveolar rhabdomyosarcoma patient sample. {eco:0000269|pubmed:12479262, eco:0000269|pubmed:17335148}.",NA,NA,Xage 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,XAGE1A,653220,NA,NA,NA,NA,NA,NA,NA,NA,NA
CTA9,Q14657,ekc/keops complex subunit lage3 (l antigen family member 3) (protein eso-3) (protein itba2),LAGE3 DXS9879E ESO3 ITBA2,143,"subcellular location: cytoplasm {eco:0000269|pubmed:28805828}. nucleus {eco:0000269|pubmed:22912744, eco:0000269|pubmed:27903914, eco:0000269|pubmed:28805828}.","tissue specificity: ubiquitous. {eco:0000269|pubmed:12384295, eco:0000269|pubmed:8786131}.","DISEASE: Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006]: A form of Galloway-Mowat syndrome, a severe renal-neurological disease characterized by early-onset nephrotic syndrome associated with microcephaly, central nervous system abnormalities, developmental delays, and a propensity for seizures. Brain anomalies include gyration defects ranging from lissencephaly to pachygyria and polymicrogyria, and cerebellar hypoplasia. Most patients show facial dysmorphism characterized by a small, narrow forehead, large/floppy ears, deep-set eyes, hypertelorism and micrognathia. Additional variable features are visual impairment and arachnodactyly. Most patients die in early childhood. {ECO:0000269|PubMed:28805828}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Lage 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTAG2,30848,NA,NA,NA,NA,NA,NA,NA,NA,NA
FAM83H_AS1.1_T353730_G083462_1_965_1774_810,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FAM83H_AS1.1_T353730_G083462_2_769_1248_480,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FAM83H_AS1.5_T353728_G083462_1_2453_3277_825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FAM83H_AS1.5_T353728_G083462_2_5957_6766_810,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FBXL19_AS1_T130509_G030577_1_4499_4918_420,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FBXL19_AS1_T130509_G030577_2_595_960_366,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FGD5_AS1.2_T238556_G054780_1_2671_2889_219,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
FGD5_AS1.2_T238556_G054780_2_2946_3134_189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00086_T380530_G090147_1_2221_2550_330,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00086_T380530_G090147_2_1384_1710_327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00087_T380486_G090134_1_1429_1728_300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00087_T380486_G090134_2_2141_2407_267,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00675.1_T141810_G033025_1_309_497_189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00675.1_T141810_G033025_2_188_358_171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00675.4_T141809_G033025_1_1138_1524_387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LINC00675.4_T141809_G033025_2_421_750_330,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
MAFG_AS1.1_T156740_G036152_1_2503_3105_603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
MAFG_AS1.1_T156740_G036152_2_116_637_522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
MIR205HG.2_T029617_G006597_1_387_779_393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA10,P01619,immunoglobulin kappa variable 3-20 (ig kappa chain v-iii region b6) (ig kappa chain v-iii region gol) (ig kappa chain v-iii region hah) (ig kappa chain v-iii region hic) (ig kappa chain v-iii region iarc/bl41) (ig kappa chain v-iii region ng9) (ig kappa chain v-iii region sie) (ig kappa chain v-iii region ti) (ig kappa chain v-iii region wol),IGKV3-20,116,"subcellular location: secreted {eco:0000303|pubmed:20176268, eco:0000303|pubmed:22158414}. cell membrane {eco:0000303|pubmed:20176268, eco:0000303|pubmed:22158414}.",NA,NA,NA,Immunoglobulin Kappa J region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,RBPJ,3516,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA11,O60664,perilipin-3 (47 kda mannose 6-phosphate receptor-binding protein) (47 kda mpr-binding protein) (cargo selection protein tip47) (mannose-6-phosphate receptor-binding protein 1) (placental protein 17) (pp17),PLIN3 M6PRBP1 TIP47,434,"subcellular location: cytoplasm {eco:0000269|pubmed:15545278, eco:0000269|pubmed:26357594, eco:0000269|pubmed:9590177}. endosome membrane {eco:0000305}; peripheral membrane protein {eco:0000305}; cytoplasmic side {eco:0000305}. lipid droplet {eco:0000305}. note=membrane associated on endosomes. detected in the envelope and the core of lipid bodies and in lipid sails. {eco:0000305}.",NA,NA,NA,Mannose-6-phosphate receptor binding protein 1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PLIN3,10226,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA13,Q9H4A3,serine/threonine-protein kinase wnk1 (ec 2.7.11.1) (erythrocyte 65 kda protein) (p65) (kinase deficient protein) (protein kinase lysine-deficient 1) (protein kinase with no lysine 1) (hwnk1),WNK1 HSN2 KDP KIAA0344 PRKWNK1,2382,subcellular location: cytoplasm {eco:0000269|pubmed:10660600}.,"tissue specificity: widely expressed, with highest levels observed in the testis, heart, kidney and skeletal muscle. isoform 3 is kidney-specific and specifically expressed in the distal convoluted tubule (dct) and connecting tubule (cnt) of the nephron. {eco:0000269|pubmed:10660600, eco:0000269|pubmed:11571656, eco:0000269|pubmed:14645531, eco:0000269|pubmed:22701532}.","DISEASE: Pseudohypoaldosteronism 2C (PHA2C) [MIM:614492]: An autosomal dominant disorder characterized by severe hypertension, hyperkalemia, hyperchloremia, mild hyperchloremic metabolic acidosis in some cases, and correction of physiologic abnormalities by thiazide diuretics. {ECO:0000269|PubMed:11498583}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neuropathy, hereditary sensory and autonomic, 2A (HSAN2A) [MIM:201300]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN2A is an autosomal recessive disorder characterized by impairment of pain, temperature and touch sensation, onset of symptoms in infancy or early childhood, occurrence of distal extremity pathologies (paronychia, whitlows, ulcers, and Charcot joints), frequent amputations, sensory loss that affects all modalities of sensation (lower and upper limbs and perhaps the trunk as well), absence or diminution of tendon reflexes (usually in all limbs), minimal autonomic dysfunction, absence of sensory nerve action potentials, and virtual absence of myelinated fibers with decreased numbers of unmyelinated fibers in sural nerves. {ECO:0000269|PubMed:15060842, ECO:0000269|PubMed:15911806, ECO:0000269|PubMed:18521183}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,WNK lysine deficient protein kinase 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,WNK1,65125,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA14,Q86UV5,ubiquitin carboxyl-terminal hydrolase 48 (ec 3.4.19.12) (deubiquitinating enzyme 48) (ubiquitin thioesterase 48) (ubiquitin-specific peptidase 48) (ubiquitin-specific protease 48) (ubiquitin-specific-processing protease 48),USP48 USP31,1035,subcellular location: cytoplasm {eco:0000269|pubmed:16214042}. nucleus {eco:0000269|pubmed:16214042}.,"tissue specificity: widely expressed. {eco:0000269|pubmed:14715245, eco:0000269|pubmed:15354349, eco:0000269|pubmed:16214042}.",NA,NA,Ubiquitin specific peptidase 31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,USP31,57478,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA19,Q15435,protein phosphatase 1 regulatory subunit 7 (protein phosphatase 1 regulatory subunit 22),PPP1R7 SDS22,360,subcellular location: nucleus {eco:0000250}.,tissue specificity: widely expressed. {eco:0000269|pubmed:7498485}.,NA,NA,"Protein phosphotase 3, regulatory subunit 7",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PP3R1,5534,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA22,O15031,plexin-b2 (mm1),PLXNB2 KIAA0315,1838,subcellular location: cell membrane {eco:0000269|pubmed:12533544}; single-pass type i membrane protein {eco:0000255}.,NA,NA,NA,Plexin B2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PLXNB2,23654,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA27,P68104,elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor tu) (ef-tu) (eukaryotic elongation factor 1 a-1) (eef1a-1) (leukocyte receptor cluster member 7),EEF1A1 EEF1A EF1A LENG7,462,"subcellular location: cytoplasm {eco:0000269|pubmed:19158340, eco:0000269|pubmed:8650580}. nucleus {eco:0000269|pubmed:17177976, eco:0000269|pubmed:8650580}. nucleus, nucleolus {eco:0000269|pubmed:8650580}. cell membrane {eco:0000269|pubmed:26497934}. note=colocalizes with dlc1 at actin-rich regions in the cell periphery (pubmed:19158340). translocates together with zpr1 from the cytoplasm to the nucleus and nucleolus after treatment with mitogens (pubmed:8650580). localization at the cell membrane depends on eef1a1 phosphorylation status and the presence of ppp1r16b (pubmed:26497934). {eco:0000269|pubmed:19158340, eco:0000269|pubmed:26497934, eco:0000269|pubmed:8650580}.","tissue specificity: brain, placenta, lung, liver, kidney, pancreas but barely detectable in heart and skeletal muscle.",NA,NA,Eukaryotic translation elongation factor 1 alpha 1,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EEF1A1,1915,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA29,Q14149,morc family cw-type zinc finger protein 3 (nuclear matrix protein 2) (zinc finger cw-type coiled-coil domain protein 3),MORC3 KIAA0136 NXP2 ZCWCC3,939,"subcellular location: nucleus, nucleoplasm {eco:0000269|pubmed:11927593, eco:0000269|pubmed:17332504}. nucleus matrix {eco:0000269|pubmed:11927593, eco:0000269|pubmed:20501696}. nucleus, pml body {eco:0000269|pubmed:17332504}. note=also found in pml-independent nuclear bodies. localization to nuclear bodies is atp-dependent. {eco:0000269|pubmed:20501696}.","tissue specificity: expressed in heart, placenta, skeletal muscle, brain, pancreas, lung, liver, but not kidney. {eco:0000269|pubmed:11927593}.",NA,NA,"Zinc-finger protein, CW type with coiled-coil domain 3",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MORC3,23515,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA6,P29144,tripeptidyl-peptidase 2 (tpp-2) (ec 3.4.14.10) (tripeptidyl aminopeptidase) (tripeptidyl-peptidase ii) (tpp-ii),TPP2,1249,subcellular location: cytoplasm {eco:0000269|pubmed:19747897}. nucleus {eco:0000269|pubmed:19747897}. note=translocates to the nucleus in responce to gamma-irradiation.,NA,NA,NA,Tripeptidyl peptidase II,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TPP2,7174,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCA7,Q9Y5R2,matrix metalloproteinase-24 (mmp-24) (ec 3.4.24.-) (membrane-type matrix metalloproteinase 5) (mt-mmp 5) (mtmmp5) (membrane-type-5 matrix metalloproteinase) (mt5-mmp) (mt5mmp) [cleaved into: processed matrix metalloproteinase-24],MMP24 MT5MMP,645,"subcellular location: matrix metalloproteinase-24: cell membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}. golgi apparatus, trans-golgi network membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}. note=recycled back to the plasma membrane through the trans-golgi network via interaction with apba3. {eco:0000250}.; subcellular location: processed matrix metalloproteinase-24: secreted, extracellular space, extracellular matrix {eco:0000250}. note=also shed from cell surface as soluble proteinase, by a proteolytic cleavage. {eco:0000250}.","tissue specificity: predominantly expressed in brain, kidney, pancreas and lung. overexpressed in a series of brain tumors, including astrocytomas and glioblastomas. {eco:0000269|pubmed:10363975}.",NA,NA,Matrix metallopeptidase 24,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MMP24,10893,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCAT1_T351126_G082910_1_3108_3569_462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PCAT1_T351126_G082910_2_1371_1655_285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.1_T230582_G053084_1_496_2364_1869,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.1_T230582_G053084_2_4907_5623_717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.3_T230574_G053084_1_1598_3466_1869,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.3_T230574_G053084_2_6009_6725_717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.4_T230577_G053084_1_1393_2109_717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.4_T230577_G053084_2_3913_4350_438,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.5_T230585_G053084_1_588_2456_1869,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.5_T230585_G053084_2_4999_5715_717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.7_T230583_G053084_1_519_2387_1869,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT104.7_T230583_G053084_2_4930_5646_717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT105.1_T088591_G020554_1_2942_3247_306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT105.1_T088591_G020554_2_1954_2223_270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT11.3_T317393_G074313_1_1665_2435_771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT11.3_T317393_G074313_2_1181_1723_543,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT116_T182782_G041985_1_685_1521_837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT116_T182782_G041985_2_2888_3328_441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT134_T229254_G052821_1_4848_5438_591,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT134_T229254_G052821_2_1505_2056_552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT139_T035222_G008006_1_1922_2554_633,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT139_T035222_G008006_2_2852_3289_438,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT182_T137385_G032197_1_4841_5419_579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT182_T137385_G032197_2_5188_5577_390,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT188.2_T382727_G090657_1_4263_4976_714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT188.2_T382727_G090657_2_1887_2474_588,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT191_T211082_G048869_1_5688_6299_612,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT191_T211082_G048869_2_6825_7370_546,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT193_T143309_G033348_1_7398_8183_786,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT193_T143309_G033348_2_5577_6215_639,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT236_T273012_G063396_1_1305_2057_753,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT236_T273012_G063396_2_1244_1561_318,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT274_T052636_G012194_1_1430_2524_1095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT274_T052636_G012194_2_1581_1985_405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT28.1_T183157_G042036_1_3585_4718_1134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT28.1_T183157_G042036_2_4136_5131_996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT28.4_T183159_G042036_1_1382_2515_1134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT28.4_T183159_G042036_2_1933_2928_996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT297_T126437_G029520_1_1983_2522_540,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT297_T126437_G029520_2_3734_4096_363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT3.1_T183162_G042038_1_6945_7547_603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT3.1_T183162_G042038_2_7615_8046_432,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT41_T315818_G074087_1_5955_6662_708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT41_T315818_G074087_2_4464_4820_357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT67_T183175_G042042_1_16548_18869_2322,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT67_T183175_G042042_2_16882_18090_1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO10,P40121,macrophage-capping protein (actin regulatory protein cap-g),CAPG AFCP MCP,348,"subcellular location: nucleus {eco:0000269|pubmed:17081065, eco:0000269|pubmed:18266911}. cytoplasm {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. cell projection, lamellipodium {eco:0000250|uniprotkb:p24452}. cell projection, ruffle {eco:0000250|uniprotkb:p24452}. note=in macrophages, may be predominantly cytoplasmic. nuclear localization was observed in fibroblasts. in macrophages, present at the membrane-cytoplasm interface. in activated macrophages, concentrated in the ruffles of the leading lamellipodia. {eco:0000250|uniprotkb:p24452}.",tissue specificity: macrophages and macrophage-like cells.,NA,NA,Macrophage capping protein gelsolin-like (CAPG),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CAPG,822,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO11,P23280,carbonic anhydrase 6 (ec 4.2.1.1) (carbonate dehydratase vi) (carbonic anhydrase vi) (ca-vi) (salivary carbonic anhydrase) (secreted carbonic anhydrase),CA6,308,subcellular location: secreted.,tissue specificity: major constituent of saliva.,NA,NA,Carbonic anhydrase IV,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CA4,762,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO14,Q02224,centromere-associated protein e (centromere protein e) (cenp-e) (kinesin-7) (kinesin-related protein cenpe),CENPE,2701,"subcellular location: chromosome, centromere, kinetochore {eco:0000269|pubmed:17535814, eco:0000269|pubmed:18374647, eco:0000269|pubmed:18460473, eco:0000269|pubmed:25395579, eco:0000269|pubmed:25918224, eco:0000269|pubmed:9763420}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:9763420}. chromosome, centromere {eco:0000269|pubmed:26321640}. note=associates with kinetochores during congression (as early as prometaphase), relocates to the spindle midzone at anaphase, and is quantitatively discarded at the end of the cell division (by similarity). recruited to the kinetochore in a sept7, cenpq and trappc12-dependent manner (pubmed:18460473, pubmed:25918224, pubmed:25395579). recruited to the pericentromeric/centromeric regions of the chromosome in a ctcf-dependent manner (pubmed:26321640). {eco:0000250|uniprotkb:q6rt24, eco:0000269|pubmed:18460473, eco:0000269|pubmed:25395579, eco:0000269|pubmed:25918224, eco:0000269|pubmed:26321640}.",NA,"DISEASE: Microcephaly 13, primary, autosomal recessive (MCPH13) [MIM:616051]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. {ECO:0000269|PubMed:24748105}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Centromere protein E,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CENPE,1062,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO16,Q9ULV8,e3 ubiquitin-protein ligase cbl-c (ec 2.3.2.27) (ring finger protein 57) (ring-type e3 ubiquitin transferase cbl-c) (sh3-binding protein cbl-3) (sh3-binding protein cbl-c) (signal transduction protein cbl-c),CBLC CBL3 RNF57,474,NA,tissue specificity: ubiquitous. {eco:0000269|pubmed:10362357}.,NA,NA,Cas-Br-M ecotropic retroviral transforming sequence c (CBLC),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,CBLC,23624,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO18,Q12802,a-kinase anchor protein 13 (akap-13) (akap-lbc) (breast cancer nuclear receptor-binding auxiliary protein) (guanine nucleotide exchange factor lbc) (human thyroid-anchoring protein 31) (lymphoid blast crisis oncogene) (lbc oncogene) (non-oncogenic rho gtpase-specific gtp exchange factor) (protein kinase a-anchoring protein 13) (prka13) (p47),AKAP13 BRX HT31 LBC,2813,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:11546812, eco:0000269|pubmed:9891067}. cytoplasm {eco:0000269|pubmed:9627117}. cytoplasm, cell cortex {eco:0000269|pubmed:11546812}. nucleus {eco:0000269|pubmed:9627117}. membrane {eco:0000269|pubmed:11696353, eco:0000269|pubmed:9891067}; peripheral membrane protein {eco:0000269|pubmed:11696353, eco:0000305|pubmed:9891067}. note=colocalizes with the actin cytoskeleton at the cell cortex. {eco:0000269|pubmed:11546812}.","tissue specificity: detected in mammary gland (pubmed:9627117). detected in heart (at protein level) (pubmed:11546812). expressed as a 5.3 kb transcript in hematopoietic cells, skeletal muscle, lung, heart, estrogen-responsive reproductive tissues, including breast ductal epithelium. also found in testis and breast cancer cell lines. predominantly expressed as a 10 kb transcript in the heart and at lower levels in the lung, placenta, kidney, pancreas, skeletal muscle and liver. transcripts of between 6-9 kb are also expressed in myeloid and lymphoid lineages, a variety of epithelial tissues, and in skeletal muscle. {eco:0000269|pubmed:11546812, eco:0000269|pubmed:9627117, eco:0000269|pubmed:9891067}.",NA,NA,Protein kinase A anchor protein 13/lymphoid blast crisis oncogene/breast cancer nuclear receptor-binding auxiliary protein (BRX),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AKAP13,11214,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO23,Q7Z7E8,ubiquitin-conjugating enzyme e2 q1 (ec 2.3.2.23) (e2 ubiquitin-conjugating enzyme q1) (protein nice-5) (ubiquitin carrier protein q1) (ubiquitin-protein ligase q1),UBE2Q1 NICE5 UBE2Q PRO3094,422,"subcellular location: nucleus {eco:0000250|uniprotkb:q7tss2}. cell projection, filopodium {eco:0000250|uniprotkb:q7tss2}. cytoplasm, cytosol {eco:0000250|uniprotkb:q7tss2}.",tissue specificity: widely expressed. {eco:0000269|pubmed:11230159}.,NA,NA,NICE5,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBE2Q1,55585,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO25,Q9NP31,sh2 domain-containing protein 2a (sh2 domain-containing adapter protein) (t cell-specific adapter protein) (tsad) (vegf receptor-associated protein),SH2D2A SCAP TSAD VRAP,389,subcellular location: cytoplasm.,"tissue specificity: expression limited to tissues of the immune system and, in particular, activated t-cells. expressed in peripheral blood leukocytes, thymus and spleen. much lower expression or undetectable, in brain, placenta, skeletal muscle, prostate, testis, ovary, small intestine, and colon. expressed at low levels in unstimulated t-cells, but not expressed in normal resting or activated b-cells. according to pubmed:10692392, expression is not restricted to activated t-cells, but strongly expressed in blood cell lineages, the endothelium and other cell and tissue types, such as heart, lung, and liver.",NA,NA,SH2 domain containing adaptor protein,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SH2B1,25970,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO29,O75521,"enoyl-coa delta isomerase 2, mitochondrial (ec 5.3.3.8) (drs-1) (delta(3),delta(2)-enoyl-coa isomerase) (d3,d2-enoyl-coa isomerase) (diazepam-binding inhibitor-related protein 1) (dbi-related protein 1) (dodecenoyl-coa isomerase) (hepatocellular carcinoma-associated antigen 88) (peroxisomal 3,2-trans-enoyl-coa isomerase) (peci) (renal carcinoma antigen ny-ren-1)",ECI2 DRS1 HCA88 PECI,394,subcellular location: isoform 1: mitochondrion {eco:0000250}.; subcellular location: isoform 2: peroxisome matrix.,"tissue specificity: abundant in heart, skeletal muscle and liver. expressed in cd34(+) t-cells and cd34(+) bone marrow cells. {eco:0000269|pubmed:15217832}.",NA,NA,"Peroxisomal D3,D2 enoyl CoA isomerase/Hepatocellular carcimona-associated antigen 64",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ECI2,10455,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO3,P05067,amyloid-beta precursor protein (app) (abpp) (appi) (alzheimer disease amyloid protein) (amyloid precursor protein) (amyloid-beta a4 protein) (cerebral vascular amyloid peptide) (cvap) (prea4) (protease nexin-ii) (pn-ii) [cleaved into: n-app; soluble app-alpha (s-app-alpha); soluble app-beta (s-app-beta); c99 (beta-secretase c-terminal fragment) (beta-ctf); amyloid-beta protein 42 (abeta42) (beta-app42); amyloid-beta protein 40 (abeta40) (beta-app40); c83 (alpha-secretase c-terminal fragment) (alpha-ctf); p3(42); p3(40); c80; gamma-secretase c-terminal fragment 59 (amyloid intracellular domain 59) (aicd-59) (aid(59)) (gamma-ctf(59)); gamma-secretase c-terminal fragment 57 (amyloid intracellular domain 57) (aicd-57) (aid(57)) (gamma-ctf(57)); gamma-secretase c-terminal fragment 50 (amyloid intracellular domain 50) (aicd-50) (aid(50)) (gamma-ctf(50)); c31],APP A4 AD1,770,"subcellular location: cell membrane {eco:0000269|pubmed:10383380, eco:0000269|pubmed:20580937, eco:0000269|pubmed:2649245, eco:0000305|pubmed:25122912}; single-pass type i membrane protein {eco:0000269|pubmed:30630874, eco:0000305|pubmed:10383380, eco:0000305|pubmed:25122912}. membrane {eco:0000269|pubmed:2900137, eco:0000305|pubmed:22584060}; single-pass type i membrane protein {eco:0000269|pubmed:2900137, eco:0000269|pubmed:30630874, eco:0000305|pubmed:22584060}. perikaryon {eco:0000269|pubmed:10341243}. cell projection, growth cone {eco:0000269|pubmed:10341243}. membrane, clathrin-coated pit {eco:0000269|pubmed:20580937}. early endosome {eco:0000269|pubmed:20580937}. cytoplasmic vesicle {eco:0000269|pubmed:20580937, eco:0000269|pubmed:25122912}. note=cell surface protein that rapidly becomes internalized via clathrin-coated pits. only a minor proportion is present at the cell membrane; most of the protein is present in intracellular vesicles (pubmed:20580937). during maturation, the immature app (n-glycosylated in the endoplasmic reticulum) moves to the golgi complex where complete maturation occurs (o-glycosylated and sulfated). after alpha-secretase cleavage, soluble app is released into the extracellular space and the c-terminal is internalized to endosomes and lysosomes. some app accumulates in secretory transport vesicles leaving the late golgi compartment and returns to the cell surface. app sorts to the basolateral surface in epithelial cells. during neuronal differentiation, the thr-743 phosphorylated form is located mainly in growth cones, moderately in neurites and sparingly in the cell body (pubmed:10341243). casein kinase phosphorylation can occur either at the cell surface or within a post-golgi compartment. associates with gpc1 in perinuclear compartments. colocalizes with sorl1 in a vesicular pattern in cytoplasm and perinuclear regions. {eco:0000269|pubmed:10341243, eco:0000269|pubmed:20580937}.; subcellular location: soluble app-beta: secreted {eco:0000269|pubmed:10656250, eco:0000269|pubmed:2649245}.; subcellular location: amyloid-beta protein 42: cell surface. note=associates with fpr2 at the cell surface and the complex is then rapidly internalized. {eco:0000269|pubmed:11689470}.; subcellular location: gamma-secretase c-terminal fragment 59: nucleus {eco:0000269|pubmed:11544248}. cytoplasm {eco:0000269|pubmed:11544248}. note=located to both the cytoplasm and nuclei of neurons. it can be translocated to the nucleus through association with apbb1 (fe65) (pubmed:11544248). in dopaminergic neurons, the phosphorylated thr-743 form is localized to the nucleus (by similarity). {eco:0000250|uniprotkb:p12023, eco:0000269|pubmed:11544248}.","tissue specificity: expressed in the brain and in cerebrospinal fluid (at protein level) (pubmed:2649245). expressed in all fetal tissues examined with highest levels in brain, kidney, heart and spleen. weak expression in liver. in adult brain, highest expression found in the frontal lobe of the cortex and in the anterior perisylvian cortex-opercular gyri. moderate expression in the cerebellar cortex, the posterior perisylvian cortex-opercular gyri and the temporal associated cortex. weak expression found in the striate, extra-striate and motor cortices. expressed in cerebrospinal fluid, and plasma. isoform app695 is the predominant form in neuronal tissue, isoform app751 and isoform app770 are widely expressed in non-neuronal cells. isoform app751 is the most abundant form in t-lymphocytes. appican is expressed in astrocytes. {eco:0000269|pubmed:12859342, eco:0000269|pubmed:1406936, eco:0000269|pubmed:2649245}.","DISEASE: Alzheimer disease 1 (AD1) [MIM:104300]: A familial early-onset form of Alzheimer disease. It can be associated with cerebral amyloid angiopathy. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:10097173, ECO:0000269|PubMed:10631141, ECO:0000269|PubMed:10656250, ECO:0000269|PubMed:10665499, ECO:0000269|PubMed:10677483, ECO:0000269|PubMed:10867787, ECO:0000269|PubMed:11063718, ECO:0000269|PubMed:11311152, ECO:0000269|PubMed:11528419, ECO:0000269|PubMed:12034808, ECO:0000269|PubMed:1302033, ECO:0000269|PubMed:1303239, ECO:0000269|PubMed:1303275, ECO:0000269|PubMed:1415269, ECO:0000269|PubMed:1465129, ECO:0000269|PubMed:15201367, ECO:0000269|PubMed:15365148, ECO:0000269|PubMed:15668448, ECO:0000269|PubMed:1671712, ECO:0000269|PubMed:1678058, ECO:0000269|PubMed:1908231, ECO:0000269|PubMed:1925564, ECO:0000269|PubMed:1944558, ECO:0000269|PubMed:8267572, ECO:0000269|PubMed:8290042, ECO:0000269|PubMed:8476439, ECO:0000269|PubMed:8577393, ECO:0000269|PubMed:8886002, ECO:0000269|PubMed:9328472, ECO:0000269|PubMed:9754958}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714]: A hereditary localized amyloidosis due to amyloid-beta A4 peptide(s) deposition in the cerebral vessels. The principal clinical characteristics are recurrent cerebral and cerebellar hemorrhages, recurrent strokes, cerebral ischemia, cerebral infarction, and progressive mental deterioration. Patients develop cerebral hemorrhage because of the severe cerebral amyloid angiopathy. Parenchymal amyloid deposits are rare and largely in the form of pre-amyloid lesions or diffuse plaque-like structures. They are Congo red negative and lack the dense amyloid cores commonly present in Alzheimer disease. Some affected individuals manifest progressive aphasic dementia, leukoencephalopathy, and occipital calcifications. {ECO:0000269|PubMed:11409420, ECO:0000269|PubMed:12654973, ECO:0000269|PubMed:16178030, ECO:0000269|PubMed:20697050, ECO:0000269|PubMed:2111584}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Amyloid Beta (4) precursor protein,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,APP,351,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO30,Q9HCK8,chromodomain-helicase-dna-binding protein 8 (chd-8) (ec 3.6.4.12) (atp-dependent helicase chd8) (helicase with snf2 domain 1),CHD8 HELSNF1 KIAA1564,2581,"subcellular location: nucleus {eco:0000255|hamap-rule:mf_03071, eco:0000269|pubmed:18378692, eco:0000269|pubmed:20453063}. note=localizes to the promoter regions of several ctnnb1-responsive genes. also present at known ctcf target sites. {eco:0000255|hamap-rule:mf_03071}.",NA,"DISEASE: Autism 18 (AUTS18) [MIM:615032]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:23160955, ECO:0000269|PubMed:26637798}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,Helicase with SNF2 domain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CHD8,57680,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO31,Q9UNE7,e3 ubiquitin-protein ligase chip (ec 2.3.2.27) (antigen ny-co-7) (cll-associated antigen kw-8) (carboxy terminus of hsp70-interacting protein) (ring-type e3 ubiquitin transferase chip) (stip1 homology and u box-containing protein 1),STUB1 CHIP PP1131,303,"subcellular location: cytoplasm {eco:0000269|pubmed:10330192, eco:0000269|pubmed:17369820, eco:0000269|pubmed:23973223}. nucleus {eco:0000269|pubmed:23973223}. note=translocates to the nucleus in response to inflammatory signals in regulatory t-cells (treg). {eco:0000269|pubmed:23973223}.","tissue specificity: expressed in differentiated myotubes (at protein level) (pubmed:17369820). highly expressed in skeletal muscle, heart, pancreas, brain and placenta (pubmed:10330192, pubmed:11435423). detected in kidney, liver and lung (pubmed:10330192, pubmed:11435423). {eco:0000269|pubmed:10330192, eco:0000269|pubmed:11435423, eco:0000269|pubmed:17369820}.","DISEASE: Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR16 is characterized by truncal and limb ataxia resulting in gait instability. Additionally, patients may show dysarthria, nystagmus, spasticity of the lower limbs, and mild peripheral sensory neuropathy. {ECO:0000269|PubMed:24113144, ECO:0000269|PubMed:24312598, ECO:0000269|PubMed:24719489, ECO:0000269|PubMed:24742043, ECO:0000269|PubMed:25258038}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia 48 (SCA48) [MIM:618093]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA48 is an autosomal dominant neurodegenerative disease characterized by onset in mid-adulthood of progressive cognitive decline and gait ataxia, and vermian and hemispheric cerebellar atrophy. {ECO:0000269|PubMed:30381368}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NY-CO-7/STUB1/CLL-associated antigen KW-8,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,STUB1,10273,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO37,Q9BXL7,caspase recruitment domain-containing protein 11 (card-containing maguk protein 1) (carma 1),CARD11 CARMA1,1154,subcellular location: cytoplasm {eco:0000269|pubmed:17287217}. membrane raft {eco:0000269|pubmed:17287217}. note=colocalized with dpp4 in membrane rafts. {eco:0000269|pubmed:17287217}.,"tissue specificity: detected in adult peripheral blood leukocytes, thymus, spleen and liver. also found in promyelocytic leukemia hl-60 cells, chronic myelogenous leukemia k-562 cells, burkitt's lymphoma raji cells and colorectal adenocarcinoma sw480 cells. not detected in helas3, molt-4, a-549 and g431 cells. {eco:0000269|pubmed:11278692}.","DISEASE: B-cell expansion with NFKB and T-cell anergy (BENTA) [MIM:616452]: An autosomal dominant condition characterized by onset in infancy of splenomegaly and polyclonal expansion of B cells, resulting in peripheral lymphocytosis. Affected individuals also show mild immune dysfunction, including some defective antibody responses and T-cell anergy. There may be a predisposition to the development of B-cell malignancy. {ECO:0000269|PubMed:23129749, ECO:0000269|PubMed:28628108}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 11 A (IMD11A) [MIM:615206]: An autosomal recessive primary immunodeficiency characterized by normal numbers of T and B-lymphocytes, but defective intracellular signaling. There is a block in B-cell differentiation with increased numbers of transitional B-cells and hypogammaglobulinemia, as well as decreased numbers of regulatory T-cells and defects in T-cell function. {ECO:0000269|PubMed:23374270, ECO:0000269|PubMed:23561803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638]: An autosomal dominant disorder of immune dysfunction characterized by onset of moderate to severe atopic dermatitis in early childhood. Some patients may have recurrent infections and other variable immune abnormalities. Laboratory studies show defects in T-cell activation, increased IgE, and eosinophilia. {ECO:0000269|PubMed:28628108}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,Caspase domain recruitment (CARD11),FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CARD11,84433,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO38,P15311,ezrin (cytovillin) (villin-2) (p81),EZR VIL2,586,"subcellular location: apical cell membrane {eco:0000269|pubmed:18046454}; peripheral membrane protein {eco:0000269|pubmed:18046454}; cytoplasmic side {eco:0000269|pubmed:18046454}. cell projection {eco:0000269|pubmed:18046454}. cell projection, microvillus membrane {eco:0000269|pubmed:18046454}; peripheral membrane protein {eco:0000269|pubmed:18046454}; cytoplasmic side {eco:0000269|pubmed:18046454}. cell projection, ruffle membrane {eco:0000269|pubmed:18046454}; peripheral membrane protein {eco:0000269|pubmed:18046454}; cytoplasmic side {eco:0000269|pubmed:18046454}. cytoplasm, cell cortex {eco:0000269|pubmed:18046454}. cytoplasm, cytoskeleton {eco:0000269|pubmed:18046454}. cell projection, microvillus {eco:0000250|uniprotkb:p26040}. note=localization to the apical membrane of parietal cells depends on the interaction with mpp5. localizes to cell extensions and peripheral processes of astrocytes (by similarity). microvillar peripheral membrane protein (cytoplasmic side). {eco:0000250|uniprotkb:p31977}.","tissue specificity: expressed in cerebral cortex, basal ganglia, hippocampus, hypophysis, and optic nerve. weakly expressed in brain stem and diencephalon. stronger expression was detected in gray matter of frontal lobe compared to white matter (at protein level). component of the microvilli of intestinal epithelial cells. preferentially expressed in astrocytes of hippocampus, frontal cortex, thalamus, parahippocampal cortex, amygdala, insula, and corpus callosum. not detected in neurons in most tissues studied. {eco:0000269|pubmed:15797715}.",NA,NA,Cytovillin 2,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EZR,7430,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRO40,Q92791,endoplasmic reticulum protein sc65 (leprecan-like protein 4) (nucleolar autoantigen no55) (prolyl 3-hydroxylase family member 4) (synaptonemal complex protein sc65),P3H4 LEPREL4 NOL55 SC65,437,subcellular location: endoplasmic reticulum {eco:0000269|pubmed:23959653}.,"tissue specificity: detected in fibroblasts (at protein level) (pubmed:23959653). detected in spleen, prostate, testis, ovary, colon, pancreas, kidney, placenta and heart (pubmed:10952778). {eco:0000269|pubmed:10952778, eco:0000269|pubmed:23959653}.",NA,NA,Nucleolar autoantigen / MAD-Pro-34,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,P3H4,10609,NA,NA,NA,NA,NA,NA,NA,NA,NA
SPATA41_T123512_G029083_1_801_1718_918,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SPATA41_T123512_G029083_2_2954_3229_276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
BOLA3_AS1_T191973_G044207_2_402_665_264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
MIR205HG.2_T029617_G006597_2_1325_1552_228,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT282_T344692_G081083_1_3008_3415_408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
PRCAT282_T344692_G081083_2_2771_2995_225,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
1_HSPA1A_3303,P0DMV8,heat shock 70 kda protein 1a (heat shock 70 kda protein 1) (hsp70-1) (hsp70.1),HSPA1A HSP72 HSPA1 HSX70,641,"function: molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. this is achieved through cycles of atp binding, atp hydrolysis and adp release, mediated by co-chaperones. the co-chaperones have been shown to not only regulate different steps of the atpase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. the affinity for polypeptides is regulated by its nucleotide bound state. in the atp-bound form, it has a low affinity for substrate proteins. however, upon hydrolysis of the atp to adp, it undergoes a conformational change that increases its affinity for substrate proteins. it goes through repeated cycles of atp hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. the co-chaperones are of three types: j-domain co-chaperones such as hsp40s (stimulate atpase hydrolysis by hsp70), the nucleotide exchange factors (nef) such as bag1/2/3 (facilitate conversion of hsp70 from the adp-bound to the atp-bound state thereby promoting substrate release), and the tpr domain chaperones such as hopx and stub1 (pubmed:24012426, pubmed:26865365, pubmed:24318877). maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones hopx and stub1. during the early stress response, the acetylated form binds to hopx which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase stub1 that promotes ubiquitin-mediated protein degradation (pubmed:27708256). regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (pubmed:27137183). enhances stub1-mediated smad3 ubiquitination and degradation and facilitates stub1-mediated inhibition of tgf-beta signaling (pubmed:24613385). essential for stub1-mediated ubiquitination and degradation of foxp3 in regulatory t-cells (treg) during inflammation (pubmed:23973223). negatively regulates heat shock-induced hsf1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (pubmed:9499401). {eco:0000269|pubmed:22528486, eco:0000269|pubmed:23973223, eco:0000269|pubmed:24318877, eco:0000269|pubmed:24613385, eco:0000269|pubmed:27137183, eco:0000269|pubmed:27708256, eco:0000269|pubmed:9499401, eco:0000303|pubmed:24012426, eco:0000303|pubmed:26865365}.; function: (microbial infection) in case of rotavirus a infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {eco:0000269|pubmed:16537599}.","subcellular location: cytoplasm {eco:0000269|pubmed:17289661}. nucleus {eco:0000269|pubmed:27137183}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:27137183}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,HSPA1A,3303,Hs.274402,ENST00000375651,THC2597004,NA,"Homo sapiens heat shock 70kDa protein 1A (HSPA1A), mRNA [NM_005345]",chr6:31785491-31785550,hs|6p21.33,heat shock 70kDa protein 1A,TRUE
10_RPS28_6234,P62857,40s ribosomal protein s28 (small ribosomal subunit protein es28),RPS28,69,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:q6qat1}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q6qat1, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Diamond-Blackfan anemia 15, with mandibulofacial dysostosis (DBA15) [MIM:606164]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:24942156}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS28,6234,Hs.728794,ENST00000417088,THC2470104,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S28 (RPS28), mRNA [NM_001031]",chr19:8387194-8387253,hs|19p13.2,ribosomal protein S28,TRUE
100_AKAP17A_8227,Q02040,"a-kinase anchor protein 17a (akap-17a) (721p) (b-lymphocyte antigen) (protein xe7) (protein kinase a-anchoring protein 17a) (prka17a) (splicing factor, arginine/serine-rich 17a)",AKAP17A CXYorf3 DXYS155E SFRS17A XE7,695,"function: splice factor regulating alternative splice site selection for certain mrna precursors. mediates regulation of pre-mrna splicing in a pka-dependent manner. {eco:0000269|pubmed:16982639, eco:0000269|pubmed:19840947}.","subcellular location: nucleus speckle {eco:0000269|pubmed:16982639, eco:0000269|pubmed:19840947}.","TISSUE SPECIFICITY: Widely expressed. Found in heart, brain, lung, liver, skeletal muscle, kidney and pancreas. Expressed in activated B-cells and placenta. Expressed in all cell lines tested including Jurkat-TAg, U-937 and HEK293 cells. {ECO:0000269|PubMed:19840947}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AKAP17A,8227,Hs.522572,ENST00000474361,THC2495503,"GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005575(cellular_component)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006397(mRNA processing)|GO:0007165(signal transduction)|GO:0008380(RNA splicing)|GO:0016607(nuclear speck)|GO:0042113(B cell activation)","Homo sapiens A kinase (PRKA) anchor protein 17A (AKAP17A), transcript variant 1, mRNA [NM_005088]",chrY:1671323-1671382,hs|Yp11.32,A kinase (PRKA) anchor protein 17A,TRUE
1000_H2AFY_9555,O75367,core histone macro-h2a.1 (histone macroh2a1) (mh2a1) (histone h2a.y) (h2a/y) (medulloblastoma antigen mu-mb-50.205),H2AFY MACROH2A1,372,"function: variant histone h2a which replaces conventional h2a in a subset of nucleosomes where it represses transcription (pubmed:12718888, pubmed:15621527, pubmed:16428466). nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. involved in stable x chromosome inactivation (pubmed:15897469). inhibits the binding of transcription factors, including nf-kappa-b, and interferes with the activity of remodeling swi/snf complexes (pubmed:12718888, pubmed:16428466). inhibits histone acetylation by ep300 and recruits class i hdacs, which induces a hypoacetylated state of chromatin (pubmed:16428466, pubmed:16107708). {eco:0000269|pubmed:12718888, eco:0000269|pubmed:15621527, eco:0000269|pubmed:15897469, eco:0000269|pubmed:16107708, eco:0000269|pubmed:16428466}.; function: isoform 1: binds adp-ribose and o-acetyl-adp-ribose, and may be involved in adp-ribose-mediated chromatin modulation (pubmed:15902274). increases the expression of genes involved in redox metabolism, including sod3 (pubmed:23022728). {eco:0000269|pubmed:15902274, eco:0000269|pubmed:23022728}.; function: isoform 2: represses sod3 gene expression. {eco:0000269|pubmed:23022728}.","subcellular location: nucleus {eco:0000269|pubmed:15621527, eco:0000269|pubmed:15897469, eco:0000269|pubmed:9634239}. chromosome {eco:0000269|pubmed:15621527, eco:0000269|pubmed:15897469, eco:0000269|pubmed:9634239}. note=enriched in inactive x chromosome chromatin and in senescence-associated heterochromatin. {eco:0000269|pubmed:15621527, eco:0000269|pubmed:15897469, eco:0000269|pubmed:9634239}.",TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9714746}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,H2AFY,9555,Hs.420272,ENST00000506671,THC2557036,GO:0000786(nucleosome)|GO:0000793(condensed chromosome)|GO:0001740(Barr body)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0005634(nucleus)|GO:0006334(nucleosome assembly)|GO:0007549(dosage compensation)|GO:0016568(chromatin modification),"Homo sapiens H2A histone family, member Y (H2AFY), transcript variant 3, mRNA [NM_138610]",chr5:134670784-134670725,hs|5q31.1,"H2A histone family, member Y",TRUE
1001_ITPK1_3705,Q13572,"inositol-tetrakisphosphate 1-kinase (ec 2.7.1.134) (inositol 1,3,4-trisphosphate 5/6-kinase) (inositol-triphosphate 5/6-kinase) (ins(1,3,4)p(3) 5/6-kinase) (ec 2.7.1.159)",ITPK1,414,"function: kinase that can phosphorylate various inositol polyphosphate such as ins(3,4,5,6)p4 or ins(1,3,4)p3. phosphorylates ins(3,4,5,6)p4 at position 1 to form ins(1,3,4,5,6)p5. this reaction is thought to have regulatory importance, since ins(3,4,5,6)p4 is an inhibitor of plasma membrane ca(2+)-activated cl(-) channels, while ins(1,3,4,5,6)p5 is not. also phosphorylates ins(1,3,4)p3 on o-5 and o-6 to form ins(1,3,4,6)p4, an essential molecule in the hexakisphosphate (insp6) pathway. also acts as an inositol polyphosphate phosphatase that dephosphorylate ins(1,3,4,5)p4 and ins(1,3,4,6)p4 to ins(1,3,4)p3, and ins(1,3,4,5,6)p5 to ins(3,4,5,6)p4. may also act as an isomerase that interconverts the inositol tetrakisphosphate isomers ins(1,3,4,5)p4 and ins(1,3,4,6)p4 in the presence of adp and magnesium. probably acts as the rate-limiting enzyme of the insp6 pathway. modifies tnf-alpha-induced apoptosis by interfering with the activation of tnfrsf1a-associated death domain (pubmed:11909533, pubmed:12925536, pubmed:17616525). plays an important role in mlkl-mediated necroptosis. produces highly phosphorylated inositol phosphates such as inositolhexakisphosphate (insp6) which bind to mlkl mediating the release of an n-terminal auto-inhibitory region leading to its activation. essential for activated phospho-mlkl to oligomerize and localize to the cell membrane during necroptosis (pubmed:17616525). {eco:0000269|pubmed:11909533, eco:0000269|pubmed:12925536, eco:0000269|pubmed:17616525}.",NA,"TISSUE SPECIFICITY: Expressed in brain > heart > skeletal muscle = kidney = pancreas = liver = placenta > lung. In brain, it is expressed in cerebellum, cerebral cortex, medulla, spinal cord, occipital lobe, frontal lobe, temporal lobe and putamen. {ECO:0000269|PubMed:8662638}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ITPK1,3705,Hs.308122,ENST00000267615,THC2467777,GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0003824(catalytic activity)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0007165(signal transduction)|GO:0007596(blood coagulation)|GO:0008152(metabolic process)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0016787(hydrolase activity)|GO:0016853(isomerase activity)|GO:0016874(ligase activity)|GO:0032957(inositol trisphosphate metabolic process)|GO:0047325(inositol tetrakisphosphate 1-kinase activity),"Homo sapiens inositol-tetrakisphosphate 1-kinase (ITPK1), transcript variant 1, mRNA [NM_014216]",chr14:93406366-93406307,hs|14q32.12,inositol-tetrakisphosphate 1-kinase,TRUE
1002_PTPN11_5781,Q06124,tyrosine-protein phosphatase non-receptor type 11 (ec 3.1.3.48) (protein-tyrosine phosphatase 1d) (ptp-1d) (protein-tyrosine phosphatase 2c) (ptp-2c) (sh-ptp2) (shp-2) (shp2) (sh-ptp3),PTPN11 PTP2C SHPTP2,597,"function: acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. positively regulates mapk signal transduction pathway (pubmed:28074573). dephosphorylates gab1, arhgap35 and egfr (pubmed:28074573). dephosphorylates rock2 at 'tyr-722' resulting in stimulatation of its rhoa binding activity. dephosphorylates cdc73 (pubmed:26742426). {eco:0000269|pubmed:10655584, eco:0000269|pubmed:18559669, eco:0000269|pubmed:18829466, eco:0000269|pubmed:26742426, eco:0000269|pubmed:28074573}.",subcellular location: cytoplasm {eco:0000269|pubmed:26742426}. nucleus {eco:0000269|pubmed:26742426}.,"TISSUE SPECIFICITY: Widely expressed, with highest levels in heart, brain, and skeletal muscle. {ECO:0000269|PubMed:1280823, ECO:0000269|PubMed:7681589, ECO:0000269|PubMed:8216283}.","DISEASE: LEOPARD syndrome 1 (LPRD1) [MIM:151100]: A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness. {ECO:0000269|PubMed:12058348, ECO:0000269|PubMed:14961557, ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15389709, ECO:0000269|PubMed:15520399, ECO:0000269|PubMed:15690106, ECO:0000269|PubMed:16679933, ECO:0000269|PubMed:16733669, ECO:0000269|PubMed:24891296, ECO:0000269|PubMed:26742426}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 1 (NS1) [MIM:163950]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS1 develop multiple giant cell lesions of the jaw or other bony or soft tissues, which are classified as pigmented villonodular synovitis (PVNS) when occurring in the jaw or joints. {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12325025, ECO:0000269|PubMed:12529711, ECO:0000269|PubMed:12634870, ECO:0000269|PubMed:12717436, ECO:0000269|PubMed:12739139, ECO:0000269|PubMed:12960218, ECO:0000269|PubMed:15384080, ECO:0000269|PubMed:15889278, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:19020799, ECO:0000269|PubMed:24891296, ECO:0000269|PubMed:28074573}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in PTPN11 account for more than 50% of the cases.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:12717436, ECO:0000269|PubMed:26742426}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Metachondromatosis (MC) [MIM:156250]: A skeletal disorder with radiologic features of both multiple exostoses and Ollier disease, characterized by the presence of exostoses, commonly of the bones of the hands and feet, and enchondromas of the metaphyses of long bones and iliac crest. {ECO:0000269|PubMed:20577567}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PTPN11,5781,Hs.506852,ENST00000351677,THC2632196,GO:0004725(protein tyrosine phosphatase activity)|GO:0004726(non-membrane spanning protein tyrosine phosphatase activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0008286(insulin receptor signaling pathway)|GO:0008543(fibroblast growth factor receptor signaling pathway)|GO:0016787(hydrolase activity)|GO:0019221(cytokine-mediated signaling pathway)|GO:0030168(platelet activation)|GO:0031295(T cell costimulation)|GO:0033628(regulation of cell adhesion mediated by integrin)|GO:0034329(cell junction assembly)|GO:0035335(peptidyl-tyrosine dephosphorylation)|GO:0048013(ephrin receptor signaling pathway)|GO:0050900(leukocyte migration)|GO:0060333(interferon-gamma-mediated signaling pathway)|GO:0060334(regulation of interferon-gamma-mediated signaling pathway)|GO:0060337(type I interferon-mediated signaling pathway)|GO:0060338(regulation of type I interferon-mediated signaling pathway),"Homo sapiens protein tyrosine phosphatase, non-receptor type 11 (PTPN11), mRNA [NM_002834]",chr12:112947581-112947640,hs|12q24.13,"protein tyrosine phosphatase, non-receptor type 11",TRUE
1003_EIF3J_8669,O75822,eukaryotic translation initiation factor 3 subunit j (eif3j) (eukaryotic translation initiation factor 3 subunit 1) (eif-3-alpha) (eif3 p35),EIF3J EIF3S1 PRO0391,258,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation. the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03009}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3J,8669,Hs.404056,ENST00000261868,THC2494965,GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit J (EIF3J), mRNA [NM_003758]",chr15:44854101-44854160,hs|15q21.1,"eukaryotic translation initiation factor 3, subunit J",TRUE
1004_TRIP12_9320,Q14669,e3 ubiquitin-protein ligase trip12 (ec 2.3.2.26) (e3 ubiquitin-protein ligase for arf) (ulf) (hect-type e3 ubiquitin transferase trip12) (thyroid receptor-interacting protein 12) (tr-interacting protein 12) (trip-12),TRIP12 KIAA0045 ULF,1992,"function: e3 ubiquitin-protein ligase involved in ubiquitin fusion degradation (ufd) pathway and regulation of dna repair (pubmed:19028681, pubmed:22884692). part of the ubiquitin fusion degradation (ufd) pathway, a process that mediates ubiquitination of protein at their n-terminus, regardless of the presence of lysine residues in target proteins (pubmed:19028681). acts as a key regulator of dna damage response by acting as a suppressor of rnf168, an e3 ubiquitin-protein ligase that promotes accumulation of 'lys-63'-linked histone h2a and h2ax at dna damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes (pubmed:22884692). in normal cells, mediates ubiquitination and degradation of isoform p19arf/arf of cdkn2a, a lysine-less tumor suppressor required for p53/tp53 activation under oncogenic stress (pubmed:20208519). in cancer cells, however, isoform p19arf/arf and trip12 are located in different cell compartments, preventing isoform p19arf/arf ubiquitination and degradation (pubmed:20208519). does not mediate ubiquitination of isoform p16-ink4a of cdkn2a (pubmed:20208519). also catalyzes ubiquitination of nae1 and smarce1, leading to their degradation (pubmed:18627766). ubiquitination and degradation of target proteins is regulated by interaction with proteins such as myc, tradd or smarcc1, which disrupt the interaction between trip12 and target proteins (pubmed:20829358). mediates ubiquitination of asxl1: following binding to n(6)-methyladenosine methylated dna, asxl1 is ubiquitinated by trip12, leading to its degradation and subsequent inactivation of the pr-dub complex (pubmed:30982744). {eco:0000269|pubmed:18627766, eco:0000269|pubmed:19028681, eco:0000269|pubmed:20208519, eco:0000269|pubmed:20829358, eco:0000269|pubmed:22884692, eco:0000269|pubmed:30982744}.","subcellular location: nucleus, nucleoplasm {eco:0000269|pubmed:20208519}.",NA,"DISEASE: Mental retardation, autosomal dominant 49 (MRD49) [MIM:617752]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:27848077, ECO:0000269|PubMed:28251352}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRIP12,9320,Hs.591633,ENST00000283943,THC2502771,GO:0000502(proteasome complex)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005488(binding)|GO:0005575(cellular_component)|GO:0005622(intracellular)|GO:0006464(protein modification process)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0046966(thyroid hormone receptor binding),"Homo sapiens thyroid hormone receptor interactor 12 (TRIP12), mRNA [NM_004238]",chr2:230631997-230631938,hs|2q36.3,thyroid hormone receptor interactor 12,TRUE
1006_YEATS2_55689,Q9ULM3,yeats domain-containing protein 2,YEATS2 KIAA1197,1422,"function: chromatin reader component of the atac complex, a complex with histone acetyltransferase activity on histones h3 and h4. yeats2 specifically recognizes and binds histone h3 crotonylated at 'lys-27' (h3k27cr) (pubmed:27103431). crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (pubmed:27103431). {eco:0000269|pubmed:18838386, eco:0000269|pubmed:19103755, eco:0000269|pubmed:27103431}.","subcellular location: nucleus {eco:0000305|pubmed:18838386, eco:0000305|pubmed:19103755}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YEATS2,55689,Hs.632575,ENST00000472593,THC2499320,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex)|GO:0017025(TBP-class protein binding)|GO:0043966(histone H3 acetylation)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens YEATS domain containing 2 (YEATS2), mRNA [NM_018023]",chr3:183530319-183530378,hs|3q27.1,YEATS domain containing 2,TRUE
1007_SEL1L3_23231,Q68CR1,protein sel-1 homolog 3 (suppressor of lin-12-like protein 3) (sel-1l3),SEL1L3 KIAA0746,1132,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,SEL1L3,23231,Hs.479384,ENST00000513416,THC2620863,GO:0005488(binding)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens sel-1 suppressor of lin-12-like 3 (C. elegans) (SEL1L3), mRNA [NM_015187]",chr4:25749158-25749099,hs|4p15.2,sel-1 suppressor of lin-12-like 3 (C. elegans),TRUE
1008_IDH1_3417,O75874,isocitrate dehydrogenase [nadp] cytoplasmic (idh) (ec 1.1.1.42) (cytosolic nadp-isocitrate dehydrogenase) (idp) (nadp(+)-specific icdh) (oxalosuccinate decarboxylase),IDH1 PICD,414,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:10521434}. peroxisome {eco:0000269|pubmed:10521434}.",NA,"DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:19117336, ECO:0000269|PubMed:19935646}. Note=The gene represented in this entry is involved in disease pathogenesis. Mutations affecting Arg-132 are tissue-specific, and suggest that this residue plays a unique role in the development of high-grade gliomas. Mutations of Arg-132 to Cys, His, Leu or Ser abolish magnesium binding and abolish the conversion of isocitrate to alpha-ketoglutarate. Instead, alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate. Elevated levels of R(-)-2-hydroxyglutarate are correlated with an elevated risk of malignant brain tumors. {ECO:0000269|PubMed:19935646}.; DISEASE: Note=Genetic variations are associated with cartilaginous tumors such as enchondroma or chondrosarcoma. Mutations of Arg-132 to Cys, Gly or His abolish the conversion of isocitrate to alpha-ketoglutarate. Instead, alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate. {ECO:0000269|PubMed:26161668}.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,IDH1,3417,Hs.593422,ENST00000415913,THC2568143,"GO:0000287(magnesium ion binding)|GO:0004450(isocitrate dehydrogenase (NADP+) activity)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005777(peroxisome)|GO:0005782(peroxisomal matrix)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006097(glyoxylate cycle)|GO:0006099(tricarboxylic acid cycle)|GO:0006102(isocitrate metabolic process)|GO:0006103(2-oxoglutarate metabolic process)|GO:0006740(NADPH regeneration)|GO:0006749(glutathione metabolic process)|GO:0006979(response to oxidative stress)|GO:0016491(oxidoreductase activity)|GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)|GO:0042803(protein homodimerization activity)|GO:0044255(cellular lipid metabolic process)|GO:0051287(NAD binding)","Homo sapiens isocitrate dehydrogenase 1 (NADP+), soluble (IDH1), mRNA [NM_005896]",chr2:209101385-209101326,hs|2q34,"isocitrate dehydrogenase 1 (NADP+), soluble",TRUE
1009_TMEM85_51234,Q5J8M3,er membrane protein complex subunit 4 (cell proliferation-inducing gene 17 protein) (transmembrane protein 85),EMC4 TMEM85 HSPC184 PIG17,183,function: may mediate anti-apoptotic activity.,subcellular location: membrane {eco:0000269|pubmed:22119785}; multi-pass membrane protein {eco:0000269|pubmed:22119785}.,TISSUE SPECIFICITY: Isoform 1 is expressed in brain and heart. Isoform 2 is expressed in heart. {ECO:0000269|PubMed:18586032}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM85,51234,Hs.250905,ENST00000249209,NP1195548,GO:0006915(apoptosis)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 85 (TMEM85), mRNA [NM_016454]",chr15:34522139-34522198,hs|15q14,transmembrane protein 85,TRUE
101_HSPH1_10808,Q92598,heat shock protein 105 kda (antigen ny-co-25) (heat shock 110 kda protein),HSPH1 HSP105 HSP110 KIAA0201,858,"function: acts as a nucleotide-exchange factor (nef) for chaperone proteins hspa1a and hspa1b, promoting the release of adp from hspa1a/b thereby triggering client/substrate protein release (pubmed:24318877). prevents the aggregation of denatured proteins in cells under severe stress, on which the atp levels decrease markedly. inhibits hspa8/hsc70 atpase and chaperone activities (by similarity). {eco:0000250|uniprotkb:q60446, eco:0000250|uniprotkb:q61699, eco:0000269|pubmed:24318877}.",subcellular location: cytoplasm {eco:0000269|pubmed:9931472}.,"TISSUE SPECIFICITY: Highly expressed in testis. Present at lower levels in most brain regions, except cerebellum. Overexpressed in cancer cells. {ECO:0000269|PubMed:10865058, ECO:0000269|PubMed:16232202}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSPH1,10808,Hs.36927,ENST00000320027,THC2470174,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005874(microtubule)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0043014(alpha-tubulin binding)|GO:0045345(positive regulation of MHC class I biosynthetic process)|GO:0051085(chaperone mediated protein folding requiring cofactor)|GO:0051135(positive regulation of NK T cell activation),"Homo sapiens heat shock 105kDa/110kDa protein 1 (HSPH1), mRNA [NM_006644]",chr13:31710855-31710796,hs|13q12.3,heat shock 105kDa/110kDa protein 1,TRUE
1010_LDLR_3949,P01130,low-density lipoprotein receptor (ldl receptor),LDLR,860,"function: binds ldl, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. in order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. {eco:0000269|pubmed:3005267, eco:0000269|pubmed:6091915}.; function: (microbial infection) acts as a receptor for hepatitis c virus in hepatocytes, but not through a direct interaction with viral proteins. {eco:0000269|pubmed:10535997, eco:0000269|pubmed:12615904}.; function: (microbial infection) acts as a receptor for vesicular stomatitis virus. {eco:0000269|pubmed:23589850}.; function: (microbial infection) in case of hiv-1 infection, may function as a receptor for extracellular tat in neurons, mediating its internalization in uninfected cells. {eco:0000269|pubmed:11100124}.","subcellular location: cell membrane {eco:0000269|pubmed:17461796, eco:0000269|pubmed:19520913}; single-pass type i membrane protein {eco:0000250|uniprotkb:p01131}. membrane, clathrin-coated pit {eco:0000303|pubmed:6091915}. golgi apparatus {eco:0000269|pubmed:17461796}. early endosome {eco:0000269|pubmed:17461796}. late endosome {eco:0000269|pubmed:17461796}. lysosome {eco:0000269|pubmed:17461796}. note=rapidly endocytosed upon ligand binding. {eco:0000269|pubmed:3104336}.",NA,"DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: A common autosomal dominant disorder characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. The disorder occurs in 2 clinical forms: a mild form that becomes evident in the fourth or fifth decade in individuals carrying heterozygous LDLR mutations; a more severe form that usually manifests in the first two decades of life in individuals with homozygous LDLR mutations. {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:22509010, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:25378237, ECO:0000269|PubMed:25545329, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.71}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LDLR,3949,Hs.213289,ENST00000252444,THC2470337,GO:0004872(receptor activity)|GO:0005041(low-density lipoprotein receptor activity)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005764(lysosome)|GO:0005769(early endosome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0005901(caveola)|GO:0005905(coated pit)|GO:0006629(lipid metabolic process)|GO:0006810(transport)|GO:0006869(lipid transport)|GO:0006897(endocytosis)|GO:0006898(receptor-mediated endocytosis)|GO:0007568(aging)|GO:0008202(steroid metabolic process)|GO:0008203(cholesterol metabolic process)|GO:0009725(response to hormone stimulus)|GO:0009897(external side of plasma membrane)|GO:0010008(endosome membrane)|GO:0030169(low-density lipoprotein particle binding)|GO:0030229(very-low-density lipoprotein particle receptor activity)|GO:0030299(intestinal cholesterol absorption)|GO:0030301(cholesterol transport)|GO:0030669(clathrin-coated endocytic vesicle membrane)|GO:0032355(response to estradiol stimulus)|GO:0033762(response to glucagon stimulus)|GO:0034362(low-density lipoprotein particle)|GO:0034383(low-density lipoprotein particle clearance)|GO:0042157(lipoprotein metabolic process)|GO:0042159(lipoprotein catabolic process)|GO:0042632(cholesterol homeostasis)|GO:0044419(interspecies interaction between organisms)|GO:0055038(recycling endosome membrane),"Homo sapiens low density lipoprotein receptor (LDLR), transcript variant 1, mRNA [NM_000527]",chr19:11244293-11244352,hs|19p13.2,low density lipoprotein receptor,TRUE
1011_FAM129B_64855,Q96TA1,protein niban 2 (meg-3) (melanoma invasion by erk) (minerva) (niban-like protein 1) (protein fam129b),NIBAN2 C9orf88 FAM129B,746,"function: may play a role in apoptosis suppression. may promote melanoma cell invasion in vitro. {eco:0000269|pubmed:19362540, eco:0000269|pubmed:21148485}.","subcellular location: cytoplasm, cytosol. cell junction, adherens junction. membrane {eco:0000305}; lipid-anchor {eco:0000305}. note=in exponentially growing cells, exclusively cytoplasmic. cell membrane localization is observed when cells reach confluency and during telophase. in melanoma cells, targeting to the plasma membrane may be impaired by c-terminal phosphorylation.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM129B,64855,Hs.522401,NA,NA,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005912(adherens junction)|GO:0030054(cell junction)|GO:0043066(negative regulation of apoptosis),"Homo sapiens MEG3 (MEG3) mRNA, complete cds. [AF151783]",chr9:130267727-130267668,hs|9q33.3,"family with sequence similarity 129, member B",TRUE
1012_MAP3K5_4217,Q99683,mitogen-activated protein kinase kinase kinase 5 (ec 2.7.11.25) (apoptosis signal-regulating kinase 1) (ask-1) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5),MAP3K5 ASK1 MAPKKK5 MEKK5,1374,"function: serine/threonine kinase which acts as an essential component of the map kinase signal transduction pathway. plays an important role in the cascades of cellular responses evoked by changes in the environment. mediates signaling for determination of cell fate such as differentiation and survival. plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. map3k5/ask1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (tnf) or lipopolysaccharide (lps). once activated, acts as an upstream activator of the mkk/jnk signal transduction cascade and the p38 mapk signal transduction cascade through the phosphorylation and activation of several map kinase kinases like map2k4/sek1, map2k3/mkk3, map2k6/mkk6 and map2k7/mkk7. these map2ks in turn activate p38 mapks and c-jun n-terminal kinases (jnks). both p38 mapk and jnks control the transcription factors activator protein-1 (ap-1). {eco:0000269|pubmed:10411906, eco:0000269|pubmed:10688666, eco:0000269|pubmed:10849426, eco:0000269|pubmed:11029458, eco:0000269|pubmed:11154276, eco:0000269|pubmed:11689443, eco:0000269|pubmed:11920685, eco:0000269|pubmed:12697749, eco:0000269|pubmed:14688258, eco:0000269|pubmed:14749717, eco:0000269|pubmed:15023544, eco:0000269|pubmed:16129676, eco:0000269|pubmed:17220297, eco:0000269|pubmed:23102700, eco:0000269|pubmed:8940179, eco:0000269|pubmed:8974401, eco:0000269|pubmed:9564042, eco:0000269|pubmed:9774977}.",subcellular location: cytoplasm. endoplasmic reticulum. note=interaction with 14-3-3 proteins alters the distribution of map3k5/ask1 and restricts it to the perinuclear endoplasmic reticulum region.,TISSUE SPECIFICITY: Abundantly expressed in heart and pancreas.,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,MAP3K5,4217,Hs.186486,ENST00000359015,THC2462723,GO:0000165(MAPKKK cascade)|GO:0000166(nucleotide binding)|GO:0000186(activation of MAPKK activity)|GO:0000287(magnesium ion binding)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0004709(MAP kinase kinase kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006919(activation of caspase activity)|GO:0007254(JNK cascade)|GO:0007257(activation of JUN kinase activity)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0008631(induction of apoptosis by oxidative stress)|GO:0008656(caspase activator activity)|GO:0010421(hydrogen peroxide-mediated programmed cell death)|GO:0019903(protein phosphatase binding)|GO:0042803(protein homodimerization activity)|GO:0043065(positive regulation of apoptosis)|GO:0043280(positive regulation of caspase activity)|GO:0044419(interspecies interaction between organisms)|GO:0070301(cellular response to hydrogen peroxide),"Homo sapiens mitogen-activated protein kinase kinase kinase 5 (MAP3K5), mRNA [NM_005923]",chr6:136878408-136878349,hs|6q23.3,mitogen-activated protein kinase kinase kinase 5,TRUE
1013_NEFH_4744,P12036,neurofilament heavy polypeptide (nf-h) (200 kda neurofilament protein) (neurofilament triplet h protein),NEFH KIAA0845 NFH,1026,"function: neurofilaments usually contain three intermediate filament proteins: l, m, and h which are involved in the maintenance of neuronal caliber. nf-h has an important function in mature axons that is not subserved by the two smaller nf proteins.",subcellular location: cytoplasm {eco:0000269|pubmed:27040688}.,NA,"DISEASE: Amyotrophic lateral sclerosis (ALS) [MIM:105400]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:7849698}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2CC (CMT2CC) [MIM:616924]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:27040688}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEFH,4744,Hs.198760,ENST00000310624,NP1158150,GO:0000226(microtubule cytoskeleton organization)|GO:0003674(molecular_function)|GO:0005739(mitochondrion)|GO:0005883(neurofilament)|GO:0007399(nervous system development)|GO:0008219(cell death)|GO:0030424(axon)|GO:0045104(intermediate filament cytoskeleton organization),"Homo sapiens neurofilament, heavy polypeptide (NEFH), mRNA [NM_021076]",chr22:29887194-29887253,hs|22q12.2,"neurofilament, heavy polypeptide",TRUE
1014_RAP1B_5908,P61224,ras-related protein rap-1b (gtp-binding protein smg p21b),RAP1B OK/SW-cl.11,184,"function: gtp-binding protein that possesses intrinsic gtpase activity. contributes to the polarizing activity of krit1 and cdh5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. required for the localization of phosphorylated prkcz, pard3 and tiam1 to the cell junction. plays a role in the establishment of basal endothelial barrier function. {eco:0000269|pubmed:18660803, eco:0000269|pubmed:20332120, eco:0000269|pubmed:21840392}.","subcellular location: cell membrane. cytoplasm, cytosol. cell junction. note=may shuttle between plasma membrane and cytosol. presence of krit1 and cdh5 is required for its localization to the cell junction.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAP1B,5908,Hs.369920,ENST00000393436,THC2498739,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0006112(energy reserve metabolic process)|GO:0006184(GTP catabolic process)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0007596(blood coagulation)|GO:0008283(cell proliferation)|GO:0016020(membrane)|GO:0019003(GDP binding)|GO:0050796(regulation of insulin secretion)|GO:2000114(regulation of establishment of cell polarity),"Homo sapiens RAP1B, member of RAS oncogene family (RAP1B), transcript variant 1, mRNA [NM_015646]",chr12:69054229-69054288,hs|12q15,"RAP1B, member of RAS oncogene family",TRUE
1015_MCCC1_56922,Q96RQ3,"methylcrotonoyl-coa carboxylase subunit alpha, mitochondrial (mccase subunit alpha) (ec 6.4.1.4) (3-methylcrotonyl-coa carboxylase 1) (3-methylcrotonyl-coa carboxylase biotin-containing subunit) (3-methylcrotonyl-coa:carbon dioxide ligase subunit alpha)",MCCC1 MCCA,725,"function: biotin-attachment subunit of the 3-methylcrotonyl-coa carboxylase, an enzyme that catalyzes the conversion of 3-methylcrotonyl-coa to 3-methylglutaconyl-coa, a critical step for leucine and isovaleric acid catabolism. {eco:0000269|pubmed:17360195}.",subcellular location: mitochondrion matrix {eco:0000269|pubmed:16023992}.,NA,"DISEASE: 3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]: An autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency. {ECO:0000269|PubMed:11170888, ECO:0000269|PubMed:11181649, ECO:0000269|PubMed:11406611, ECO:0000269|PubMed:16010683, ECO:0000269|PubMed:17968484, ECO:0000269|PubMed:21071250, ECO:0000269|PubMed:22150417, ECO:0000269|PubMed:22264772, ECO:0000269|PubMed:22642865, ECO:0000269|PubMed:25382614, ECO:0000269|PubMed:27601257, ECO:0000269|Ref.6}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MCCC1,56922,Hs.47649,ENST00000497830,THC2607681,GO:0000166(nucleotide binding)|GO:0004075(biotin carboxylase activity)|GO:0004485(methylcrotonoyl-CoA carboxylase activity)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006552(leucine catabolic process)|GO:0006768(biotin metabolic process)|GO:0009083(branched chain family amino acid catabolic process)|GO:0009374(biotin binding)|GO:0016874(ligase activity)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0046872(metal ion binding),"Homo sapiens methylcrotonoyl-CoA carboxylase 1 (alpha) (MCCC1), nuclear gene encoding mitochondrial protein, mRNA [NM_020166]",chr3:182733114-182733055,hs|3q27.1,methylcrotonoyl-CoA carboxylase 1 (alpha),TRUE
1017_MT1E_4493,P04732,metallothionein-1e (mt-1e) (metallothionein-ie) (mt-ie),MT1E,61,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT1E,4493,Hs.534330,ENST00000330439,THC2497960,GO:0005507(copper ion binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0045926(negative regulation of growth)|GO:0046870(cadmium ion binding)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0071276(cellular response to cadmium ion)|GO:0071294(cellular response to zinc ion),"Homo sapiens metallothionein 1E (MT1E), mRNA [NM_175617]",chr16:56660853-56660912,hs|16q12.2,metallothionein 1E,TRUE
1018_KRT8_3856,P05787,"keratin, type ii cytoskeletal 8 (cytokeratin-8) (ck-8) (keratin-8) (k8) (type-ii keratin kb8)",KRT8 CYK8,483,"function: together with krt19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. {eco:0000269|pubmed:16000376}.","subcellular location: cytoplasm {eco:0000269|pubmed:10973561, eco:0000269|pubmed:19188445}. nucleus, nucleoplasm {eco:0000250}. nucleus matrix {eco:0000250}.","TISSUE SPECIFICITY: Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma membrane in structures that contain dystrophin and spectrin. Expressed in gingival mucosa and hard palate of the oral cavity. {ECO:0000269|PubMed:10973561, ECO:0000269|PubMed:16000376}.","DISEASE: Cirrhosis (CIRRH) [MIM:215600]: A liver disease characterized by severe panlobular liver-cell swelling with Mallory body formation, prominent pericellular fibrosis, and marked deposits of copper. Clinical features include abdomen swelling, jaundice and pulmonary hypertension. {ECO:0000269|PubMed:12724528}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KRT8,3856,Hs.533782,ENST00000550170,THC2514651,GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005882(intermediate filament)|GO:0007010(cytoskeleton organization)|GO:0016363(nuclear matrix)|GO:0044419(interspecies interaction between organisms)|GO:0045095(keratin filament),"Homo sapiens keratin 8 (KRT8), mRNA [NM_002273]",chr12:53291085-53291026,hs|12q13.13,keratin 8,TRUE
1019_PEA15_8682,Q15121,astrocytic phosphoprotein pea-15 (15 kda phosphoprotein enriched in astrocytes) (phosphoprotein enriched in diabetes) (ped),PEA15,130,"function: blocks ras-mediated inhibition of integrin activation and modulates the erk map kinase cascade. inhibits rps6ka3 activities by retaining it in the cytoplasm (by similarity). inhibits both tnfrsf6- and tnfrsf1a-mediated casp8 activity and apoptosis. regulates glucose transport by controlling both the content of slc2a1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of slc2a4 from the cell interior to the surface. {eco:0000250, eco:0000269|pubmed:10442631, eco:0000269|pubmed:9670003}.",subcellular location: cytoplasm. note=associated with microtubules.,"TISSUE SPECIFICITY: Ubiquitously expressed. Most abundant in tissues such as heart, brain, muscle and adipose tissue which utilize glucose as an energy source. Lower expression in glucose-producing tissues. Higher levels of expression are found in tissues from individuals with type 2 diabetes than in controls. {ECO:0000269|PubMed:9670003}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PEA15,8682,Hs.517216,ENST00000368076,THC2501738,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005875(microtubule associated complex)|GO:0006810(transport)|GO:0006916(anti-apoptosis)|GO:0008643(carbohydrate transport)|GO:0042981(regulation of apoptosis)|GO:0043278(response to morphine)|GO:0046325(negative regulation of glucose import),"Homo sapiens phosphoprotein enriched in astrocytes 15 (PEA15), mRNA [NM_003768]",chr1:160184975-160185034,hs|1q23.2,phosphoprotein enriched in astrocytes 15,TRUE
102_LAPTM4A_9741,Q15012,lysosomal-associated transmembrane protein 4a (golgi 4-transmembrane-spanning transporter mtp),LAPTM4A KIAA0108 LAPTM4 MBNT MTRP UNQ1846/PRO3574,233,function: may function in the transport of nucleosides and/or nucleoside derivatives between the cytosol and the lumen of an intracellular membrane-bound compartment. {eco:0000250}.,subcellular location: endomembrane system {eco:0000305}; multi-pass membrane protein {eco:0000305}. note=may reside in an intracellular membrane-bound compartment. {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LAPTM4A,9741,Hs.467807,ENST00000175091,THC2778844,GO:0005794(Golgi apparatus)|GO:0006810(transport)|GO:0012505(endomembrane system)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens lysosomal protein transmembrane 4 alpha (LAPTM4A), mRNA [NM_014713]",chr2:20232535-20232476,hs|2p24.1,lysosomal protein transmembrane 4 alpha,TRUE
1020_NDUFA3_4696,O95167,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (complex i-b9) (ci-b9) (nadh-ubiquinone oxidoreductase b9 subunit),NDUFA3,84,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA3,4696,Hs.198269,ENST00000484103,THC2490320,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa (NDUFA3), mRNA [NM_004542]",chr19:54609251-54609310,hs|19q13.42,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa",TRUE
1022_TXNDC5_81567,Q8NBS9,thioredoxin domain-containing protein 5 (endoplasmic reticulum resident protein 46) (er protein 46) (erp46) (thioredoxin-like protein p46),TXNDC5 TLP46 UNQ364/PRO700,432,function: possesses thioredoxin activity. has been shown to reduce insulin disulfide bonds. also complements protein disulfide-isomerase deficiency in yeast (by similarity). {eco:0000250}.,subcellular location: endoplasmic reticulum lumen {eco:0000255|prosite-prorule:pru10138}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TXNDC5,81567,Hs.150837,ENST00000439343,THC2483613,GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0006662(glycerol ether metabolic process)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006916(anti-apoptosis)|GO:0009055(electron carrier activity)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0016044(cellular membrane organization)|GO:0016853(isomerase activity)|GO:0043202(lysosomal lumen)|GO:0045454(cell redox homeostasis),"Homo sapiens thioredoxin domain containing 5 (endoplasmic reticulum) (TXNDC5), transcript variant 1, mRNA [NM_030810]",chr6:7882079-7882020,hs|6p24.3,thioredoxin domain containing 5 (endoplasmic reticulum),TRUE
1023_STRA13_201254,O14503,class e basic helix-loop-helix protein 40 (bhlhe40) (class b basic helix-loop-helix protein 2) (bhlhb2) (differentially expressed in chondrocytes protein 1) (dec1) (enhancer-of-split and hairy-related protein 2) (sharp-2) (stimulated by retinoic acid gene 13 protein),BHLHE40 BHLHB2 DEC1 SHARP2 STRA13,412,"function: transcriptional repressor involved in the regulation of the circadian rhythm by negatively regulating the activity of the clock genes and clock-controlled genes (pubmed:12397359, pubmed:18411297). acts as the negative limb of a novel autoregulatory feedback loop (dec loop) which differs from the one formed by the per and cry transcriptional repressors (per/cry loop) (pubmed:14672706). both these loops are interlocked as it represses the expression of per1/2 and in turn is repressed by per1/2 and cry1/2 (pubmed:15193144). represses the activity of the circadian transcriptional activator: clock-arntl/bmal1|arntl2/bmal2 heterodimer by competing for the binding to e-box elements (5'-cacgtg-3') found within the promoters of its target genes (pubmed:15560782). negatively regulates its own expression and the expression of dbp and bhlhe41/dec2 (pubmed:14672706). acts as a corepressor of rxr and the rxr-lxr heterodimers and represses the ligand-induced rxra and nr1h3/lxra transactivation activity (pubmed:19786558). may be involved in the regulation of chondrocyte differentiation via the camp pathway (pubmed:19786558). represses the transcription of nr0b2 and attentuates the transactivation of nr0b2 by the clock-arntl/bmal1 complex (pubmed:28797635). drives the circadian rhythm of blood pressure through transcriptional repression of atp1b1 in the cardiovascular system (pubmed:30012868). {eco:0000269|pubmed:12397359, eco:0000269|pubmed:14672706, eco:0000269|pubmed:15193144, eco:0000269|pubmed:15560782, eco:0000269|pubmed:18411297, eco:0000269|pubmed:19786558, eco:0000269|pubmed:28797635, eco:0000269|pubmed:30012868}.","subcellular location: cytoplasm {eco:0000269|pubmed:21829689}. nucleus {eco:0000269|pubmed:11278694, eco:0000269|pubmed:21829689, eco:0000269|pubmed:28797635}. note=predominantly localized in the nucleus (pubmed:11278694). {eco:0000269|pubmed:11278694}.","TISSUE SPECIFICITY: Expressed in cartilage, spleen, intestine, lung, and to a lesser extent in heart, brain, liver, muscle and stomach.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,STRA13,201254,Hs.37616,ENST00000392359,THC2634741,"GO:0000712(resolution of meiotic recombination intermediates)|GO:0000775(chromosome, centromeric region)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006281(DNA repair)|GO:0031297(replication fork processing)|GO:0031398(positive regulation of protein ubiquitination)|GO:0043240(Fanconi anaemia nuclear complex)|GO:0071821(FANCM-MHF complex)","Homo sapiens stimulated by retinoic acid 13 homolog (mouse) (STRA13), mRNA [NM_144998]",chr17:79976695-79976636,hs|17q25.3,stimulated by retinoic acid 13 homolog (mouse),TRUE
1024_NPEPPS_9520,P55786,puromycin-sensitive aminopeptidase (psa) (ec 3.4.11.14) (cytosol alanyl aminopeptidase) (aap-s),NPEPPS PSA,919,"function: aminopeptidase with broad substrate specificity for several peptides. involved in proteolytic events essential for cell growth and viability. may act as regulator of neuropeptide activity. plays a role in the antigen-processing pathway for mhc class i molecules. involved in the n-terminal trimming of cytotoxic t-cell epitope precursors. digests the poly-q peptides found in many cellular proteins. digests tau from normal brain more efficiently than tau from alzheimer disease brain. {eco:0000269|pubmed:10978616, eco:0000269|pubmed:11062501, eco:0000269|pubmed:17154549, eco:0000269|pubmed:17318184, eco:0000269|pubmed:19917696}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:10978616}. nucleus {eco:0000305}.","TISSUE SPECIFICITY: Detected in liver, epithelium of renal tubules, epithelium of small and large intestine, gastric epithelial cells, and alveoli of the lung (at protein level). {ECO:0000269|PubMed:10978616}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NPEPPS,9520,Hs.443837,ENST00000544660,THC2470309,GO:0000209(protein polyubiquitination)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0004177(aminopeptidase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)|GO:0071456(cellular response to hypoxia),"Homo sapiens aminopeptidase puromycin sensitive (NPEPPS), mRNA [NM_006310]",chr17:45699415-45699474,hs|17q21.32,aminopeptidase puromycin sensitive,TRUE
1025_YIPF6_286451,Q96EC8,protein yipf6 (yip1 family member 6),YIPF6,236,function: may be required for stable yipf1 and yipf2 protein expression. {eco:0000269|pubmed:28286305}.,"subcellular location: golgi apparatus membrane {eco:0000269|pubmed:27999994}; multi-pass membrane protein {eco:0000305}. note=evenly distributed between cis- and trans-golgi apparatus (pubmed:27999994). mainly localizes within medial-/trans-golgi and trans-golgi network (tgn), while less so within cis-golgi (pubmed:28286305). {eco:0000269|pubmed:27999994, eco:0000269|pubmed:28286305}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,YIPF6,286451,Hs.82719,ENST00000374643,THC2464562,GO:0005783(endoplasmic reticulum)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens Yip1 domain family, member 6 (YIPF6), transcript variant A, mRNA [NM_173834]",chrX:67742695-67742754,hs|Xq12,"Yip1 domain family, member 6",TRUE
1026_CLIP1_6249,P30622,cap-gly domain-containing linker protein 1 (cytoplasmic linker protein 1) (cytoplasmic linker protein 170 alpha-2) (clip-170) (reed-sternberg intermediate filament-associated protein) (restin),CLIP1 CYLN1 RSN,1438,"function: binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. promotes microtubule growth and microtubule bundling. links cytoplasmic vesicles to microtubules and thereby plays an important role in intracellular vesicle trafficking. plays a role macropinocytosis and endosome trafficking. {eco:0000269|pubmed:12433698, eco:0000269|pubmed:17563362, eco:0000269|pubmed:17889670}.","subcellular location: cytoplasm {eco:0000305}. cytoplasm, cytoskeleton {eco:0000269|pubmed:17889670, eco:0000269|pubmed:21646404}. cytoplasmic vesicle membrane {eco:0000269|pubmed:12433698}; peripheral membrane protein; cytoplasmic side. cell projection, ruffle {eco:0000269|pubmed:12433698}. note=localizes to microtubule plus ends (pubmed:21646404, pubmed:17889670). localizes preferentially to the ends of tyrosinated microtubules (by similarity). accumulates in plasma membrane regions with ruffling and protrusions. associates with the membranes of intermediate macropinocytic vesicles (pubmed:12433698). {eco:0000250|uniprotkb:q922j3, eco:0000269|pubmed:12433698, eco:0000269|pubmed:17889670, eco:0000269|pubmed:21646404}.","TISSUE SPECIFICITY: Detected in dendritic cells (at protein level). Highly expressed in the Reed-Sternberg cells of Hodgkin disease. {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:1600942}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CLIP1,6249,Hs.524809,ENST00000392458,THC2466244,GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0000776(kinetochore)|GO:0003676(nucleic acid binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005874(microtubule)|GO:0005881(cytoplasmic microtubule)|GO:0005882(intermediate filament)|GO:0007067(mitosis)|GO:0008017(microtubule binding)|GO:0008270(zinc ion binding)|GO:0015630(microtubule cytoskeleton)|GO:0031116(positive regulation of microtubule polymerization)|GO:0042803(protein homodimerization activity)|GO:0046872(metal ion binding)|GO:0051010(microtubule plus-end binding),"Homo sapiens CAP-GLY domain containing linker protein 1 (CLIP1), transcript variant 1, mRNA [NM_002956]",chr12:122756161-122756102,hs|12q24.31,CAP-GLY domain containing linker protein 1,TRUE
1027_SRSF7_6432,Q16629,"serine/arginine-rich splicing factor 7 (splicing factor 9g8) (splicing factor, arginine/serine-rich 7)",SRSF7 SFRS7,238,"function: required for pre-mrna splicing. can also modulate alternative splicing in vitro. represses the splicing of mapt/tau exon 10. may function as export adapter involved in mrna nuclear export such as of histone h2a. binds mrna which is thought to be transferred to the nxf1-nxt1 heterodimer for export (tap/nxf1 pathway); enhances nxf1-nxt1 rna-binding activity. rna-binding is semi-sequence specific. {eco:0000269|pubmed:11336712, eco:0000269|pubmed:12667464, eco:0000269|pubmed:15009664, eco:0000269|pubmed:18364396}.",subcellular location: nucleus {eco:0000269|pubmed:11336712}. cytoplasm {eco:0000269|pubmed:11336712}.,"TISSUE SPECIFICITY: Brain, liver, kidney and lung.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF7,6432,Hs.309090,ENST00000415527,THC2550857,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0031124(mRNA 3'-end processing)|GO:0046872(metal ion binding)|GO:0048025(negative regulation of nuclear mRNA splicing, via spliceosome)","Homo sapiens serine/arginine-rich splicing factor 7 (SRSF7), transcript variant 1, mRNA [NM_001031684]",chr2:38975263-38975204,hs|2p22.1,serine/arginine-rich splicing factor 7,TRUE
1028_UBE2Z_65264,Q9H832,ubiquitin-conjugating enzyme e2 z (ec 2.3.2.23) (e2 ubiquitin-conjugating enzyme z) (uba6-specific e2 conjugating enzyme 1) (use1) (ubiquitin carrier protein z) (ubiquitin-protein ligase z),UBE2Z HOYS7,354,"function: catalyzes the covalent attachment of ubiquitin to other proteins (by similarity). specific substrate for uba6, not charged with ubiquitin by ube1. may be involved in apoptosis regulation. {eco:0000255|prosite-prorule:pru00388, eco:0000269|pubmed:17464193, eco:0000269|pubmed:17597759}.",subcellular location: cytoplasm {eco:0000269|pubmed:17160626}. nucleus {eco:0000269|pubmed:17160626}.,"TISSUE SPECIFICITY: Widely expressed. Highly in placenta, pancreas, spleen and testis. {ECO:0000269|PubMed:17160626, ECO:0000269|PubMed:17597759}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBE2Z,65264,Hs.514297,ENST00000513342,THC2468879,GO:0000166(nucleotide binding)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006915(apoptosis)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity),"Homo sapiens ubiquitin-conjugating enzyme E2Z (UBE2Z), mRNA [NM_023079]",chr17:47006292-47006351,hs|17q21.32,ubiquitin-conjugating enzyme E2Z,TRUE
1029_MRPL53_116540,Q96EL3,"39s ribosomal protein l53, mitochondrial (l53mt) (mrp-l53) (mitochondrial large ribosomal subunit protein ml53)",MRPL53,112,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPL53,116540,Hs.534527,ENST00000468875,THC2462914,GO:0005739(mitochondrion)|GO:0005840(ribosome),"Homo sapiens mitochondrial ribosomal protein L53 (MRPL53), nuclear gene encoding mitochondrial protein, mRNA [NM_053050]",chr2:74699266-74699207,hs|2p13.1,mitochondrial ribosomal protein L53,TRUE
103_RPS25_6230,P62851,40s ribosomal protein s25 (small ribosomal subunit protein es25),RPS25,125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS25,6230,Hs.512676,ENST00000540179,THC2517571,GO:0000028(ribosomal small subunit assembly)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S25 (RPS25), mRNA [NM_001028]",chr11:118886633-118886574,hs|11q23.3,ribosomal protein S25,TRUE
1030_ABHD11_83451,Q8NFV4,protein abhd11 (ec 3.-.-.-) (alpha/beta hydrolase domain-containing protein 11) (abhydrolase domain-containing protein 11) (williams-beuren syndrome chromosomal region 21 protein),ABHD11 WBSCR21 PP1226,315,NA,NA,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:12073013}.,"DISEASE: Note=ABHD11 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,ABHD11,83451,Hs.647045,ENST00000462381,THC2615021,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005739(mitochondrion)|GO:0008150(biological_process)|GO:0016787(hydrolase activity),"Homo sapiens abhydrolase domain containing 11 (ABHD11), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_148912]",chr7:73151670-73151611,hs|7q11.23,abhydrolase domain containing 11,TRUE
1031_SOCS7_30837,O14512,"suppressor of cytokine signaling 7 (socs-7) (nck, ash and phospholipase c gamma-binding protein) (nck-associated protein 4) (nap-4)",SOCS7 NAP4 SOCS6,581,"function: regulates signaling cascades probably through protein ubiquitination and/or sequestration. functions in insulin signaling and glucose homeostasis through irs1 ubiquitination and subsequent proteasomal degradation. inhibits also prolactin, growth hormone and leptin signaling by preventing stat3 and stat5 activation, sequestering them in the cytoplasm and reducing their binding to dna. may be a substrate recognition component of a scf-like e3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (by similarity). {eco:0000250, eco:0000269|pubmed:15677474, eco:0000269|pubmed:16127460}.","subcellular location: cytoplasm. cell membrane; peripheral membrane protein; cytoplasmic side. nucleus. note=mostly cytoplasmic, but shuttles between the cytoplasm and the nucleus. rapidly relocalizes to the nucleus after uv irradiation. cytoplasmic location depends upon sept7 presence.",TISSUE SPECIFICITY: Expressed in brain and leukocytes. Also in fetal lung fibroblasts and fetal brain. {ECO:0000269|PubMed:9344857}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SOCS7,30837,Hs.514132,NA,THC2527406,GO:0005515(protein binding)|GO:0005575(cellular_component)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0008150(biological_process)|GO:0008286(insulin receptor signaling pathway)|GO:0009968(negative regulation of signal transduction)|GO:0016567(protein ubiquitination)|GO:0017124(SH3 domain binding)|GO:0035556(intracellular signal transduction)|GO:0040008(regulation of growth)|GO:0045444(fat cell differentiation),"Homo sapiens suppressor of cytokine signaling 7 (SOCS7), mRNA [NM_014598]",chr17:36561724-36561783,hs|17q12,suppressor of cytokine signaling 7,TRUE
1032_C1orf9_51430,Q9UBS9,sun domain-containing ossification factor (membrane protein ch1) (protein osteopotentia homolog) (sun-like protein 1),SUCO C1orf9 CH1 OPT SLP1,1254,function: required for bone modeling during late embryogenesis. regulates type i collagen synthesis in osteoblasts during their postnatal maturation (by similarity). {eco:0000250}.,subcellular location: rough endoplasmic reticulum membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in pancreas and testis and to a lower extent in prostate, ovary, heart, thymus, small intestine and spleen. {ECO:0000269|PubMed:10673381}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C1orf9,51430,Hs.626306,ENST00000367723,THC2481620,GO:0001503(ossification)|GO:0005783(endoplasmic reticulum)|GO:0007275(multicellular organismal development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030867(rough endoplasmic reticulum membrane),"Homo sapiens chromosome 1 open reading frame 9 (C1orf9), transcript variant 2, mRNA [NM_016227]",chr1:172580756-172580815,hs|1q24.3,chromosome 1 open reading frame 9,TRUE
1033_PCBD1_5092,P61457,pterin-4-alpha-carbinolamine dehydratase (phs) (ec 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (dimerization cofactor of hepatocyte nuclear factor 1-alpha) (dcoh) (dimerization cofactor of hnf1) (phenylalanine hydroxylase-stimulating protein) (pterin carbinolamine dehydratase) (pcd),PCBD1 DCOH PCBD,104,function: involved in tetrahydrobiopterin biosynthesis. seems to both prevent the formation of 7-pterins and accelerate the formation of quinonoid-bh2. coactivator for hnf1a-dependent transcription. regulates the dimerization of homeodomain protein hnf1a and enhances its transcriptional activity.,subcellular location: cytoplasm. nucleus. note=cytoplasmic and/or nuclear.,NA,"DISEASE: Hyperphenylalaninemia, BH4-deficient, D (HPABH4D) [MIM:264070]: An autosomal recessive disease characterized by primapterinuria, a variant form of hyperphenylalaninemia defined by increased excretion of 7-substituted pterins in the urine. Patients with primapterinuria show an increased ratio of neopterin to biopterin in the urine, excretion of subnormal levels of biopterins, and normal levels of biogenic amines in cerebrospinal fluid. Neurologic signs are mild, present in the neonatal period only, and include hypotonia, delayed motor development and tremor. {ECO:0000269|PubMed:8352282, ECO:0000269|PubMed:9760199}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PCBD1,5092,Hs.3192,ENST00000299299,THC2467725,"GO:0003713(transcription coactivator activity)|GO:0004505(phenylalanine 4-monooxygenase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006559(L-phenylalanine catabolic process)|GO:0006729(tetrahydrobiopterin biosynthetic process)|GO:0008124(4-alpha-hydroxytetrahydrobiopterin dehydratase activity)|GO:0016829(lyase activity)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042802(identical protein binding)|GO:0043496(regulation of protein homodimerization activity)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0051289(protein homotetramerization)|GO:0051291(protein heterooligomerization)","Homo sapiens pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), mRNA [NM_000281]",chr10:72643511-72643452,hs|10q22.1,pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha,TRUE
1034_OCIAD2_132299,Q56VL3,ocia domain-containing protein 2 (ovarian carcinoma immunoreactive antigen-like protein),OCIAD2,154,NA,subcellular location: endosome {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,OCIAD2,132299,Hs.95835,ENST00000381464,THC2461806,GO:0005768(endosome),"Homo sapiens OCIA domain containing 2 (OCIAD2), transcript variant 1, mRNA [NM_001014446]",chr4:48887525-48887466,hs|4p11,OCIA domain containing 2,TRUE
1035_RAB35_11021,Q15286,ras-related protein rab-35 (gtp-binding protein ray) (ras-related protein rab-1c),RAB35 RAB1C RAY,201,"function: the small gtpases rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. rabs cycle between an inactive gdp-bound form and an active gtp-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. that rab is involved in the process of endocytosis and is an essential rate-limiting regulator of the fast recycling pathway back to the plasma membrane. during cytokinesis, required for the postfurrowing terminal steps, namely for intercellular bridge stability and abscission, possibly by controlling phosphatidylinositol 4,5-bis phosphate (pip2) and sept2 localization at the intercellular bridge. may indirectly regulate neurite outgrowth. together with tbc1d13 may be involved in regulation of insulin-induced glucose transporter slc2a4/glut4 translocation to the plasma membrane in adipocytes. {eco:0000250|uniprotkb:q6phn9, eco:0000269|pubmed:16950109, eco:0000269|pubmed:21951725}.","subcellular location: cell membrane {eco:0000269|pubmed:16950109, eco:0000269|pubmed:21951725}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}. membrane, clathrin-coated pit {eco:0000269|pubmed:16950109}. cytoplasmic vesicle, clathrin-coated vesicle {eco:0000269|pubmed:16950109}. endosome {eco:0000269|pubmed:16950109, eco:0000269|pubmed:21951725}. melanosome {eco:0000269|pubmed:17081065}. note=present on sorting endosomes and recycling endosome tubules (pubmed:16950109). tends to be enriched in pip2-positive cell membrane domains (pubmed:16950109). during mitosis, associated with the plasma membrane and present at the ingressing furrow during early cytokinesis as well as at the intercellular bridge later during cytokinesis (pubmed:16950109). identified in stage i to stage iv melanosomes (pubmed:17081065). {eco:0000269|pubmed:16950109, eco:0000269|pubmed:17081065}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAB35,11021,Hs.524788,ENST00000229340,THC2556752,"GO:0000166(nucleotide binding)|GO:0000910(cytokinesis)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005546(phosphatidylinositol-4,5-bisphosphate binding)|GO:0005739(mitochondrion)|GO:0005768(endosome)|GO:0005886(plasma membrane)|GO:0005905(coated pit)|GO:0006184(GTP catabolic process)|GO:0007264(small GTPase mediated signal transduction)|GO:0008104(protein localization)|GO:0015031(protein transport)|GO:0016197(endosome transport)|GO:0031253(cell projection membrane)|GO:0031410(cytoplasmic vesicle)|GO:0042470(melanosome)|GO:0045171(intercellular bridge)|GO:0045334(clathrin-coated endocytic vesicle)","Homo sapiens RAB35, member RAS oncogene family (RAB35), transcript variant 1, mRNA [NM_006861]",chr12:120533027-120532968,hs|12q24.23,"RAB35, member RAS oncogene family",TRUE
1036_WWC1_23286,Q8IX03,protein kibra (hbeag-binding protein 3) (kidney and brain protein) (kibra) (ww domain-containing protein 1),WWC1 KIAA0869,1113,"function: probable regulator of the hippo/swh (sav/wts/hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. along with nf2 can synergistically induce the phosphorylation of lats1 and lats2 and can probably function in the regulation of the hippo/swh (sav/wts/hpo) signaling pathway. acts as a transcriptional coactivator of esr1 which plays an essential role in dynll1-mediated esr1 transactivation. regulates collagen-stimulated activation of the erk/mapk cascade. modulates directional migration of podocytes. acts as a substrate for prkcz. plays a role in cognition and memory performance. {eco:0000269|pubmed:15081397, eco:0000269|pubmed:16684779, eco:0000269|pubmed:18190796, eco:0000269|pubmed:18596123, eco:0000269|pubmed:18672031, eco:0000269|pubmed:20159598, eco:0000269|pubmed:23778582}.","subcellular location: cytoplasm. cytoplasm, perinuclear region. nucleus. cell projection, ruffle membrane. note=colocalizes with prkcz in the perinuclear region.","TISSUE SPECIFICITY: Expressed in mammary epithelial cells and breast cancer cell lines. Found in the luminal epithelium surrounding the ducts in the normal breast. In the brain, expressed in somatodendritic compartment of neurons in the cortex and hippocampus and in the cerebellum it is found in the Purkinje cells and some granule cells (at protein level). Detected in brain, heart, colon and kidney. In the kidney, expressed in glomerular podocytes, in some tubules and in the collecting duct. {ECO:0000269|PubMed:12559952, ECO:0000269|PubMed:18190796, ECO:0000269|PubMed:18596123, ECO:0000269|PubMed:18672031}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,WWC1,23286,Hs.484047,ENST00000518204,THC2600555,"GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016477(cell migration)|GO:0032587(ruffle membrane)|GO:0035330(regulation of hippo signaling cascade)|GO:0042995(cell projection)|GO:0043410(positive regulation of MAPKKK cascade)|GO:0048471(perinuclear region of cytoplasm)","Homo sapiens WW and C2 domain containing 1 (WWC1), transcript variant 3, mRNA [NM_015238]",chr5:167896127-167896186,hs|5q34,WW and C2 domain containing 1,TRUE
1037_SUZ12_23512,Q15022,polycomb protein suz12 (chromatin precipitated e2f target 9 protein) (chet 9 protein) (joined to jazf1 protein) (suppressor of zeste 12 protein homolog),SUZ12 CHET9 JJAZ1 KIAA0160,739,"function: polycomb group (pcg) protein. component of the prc2/eed-ezh2 complex, which methylates 'lys-9' (h3k9me) and 'lys-27' (h3k27me) of histone h3, leading to transcriptional repression of the affected target gene. the prc2/eed-ezh2 complex may also serve as a recruiting platform for dna methyltransferases, thereby linking two epigenetic repression systems. genes repressed by the prc2/eed-ezh2 complex include hoxc8, hoxa9, myt1 and cdkn2a. {eco:0000269|pubmed:15225548, eco:0000269|pubmed:15231737, eco:0000269|pubmed:15385962, eco:0000269|pubmed:16618801, eco:0000269|pubmed:17344414, eco:0000269|pubmed:18285464, eco:0000269|pubmed:28229514}.",subcellular location: nucleus {eco:0000269|pubmed:15231737}.,"TISSUE SPECIFICITY: Overexpressed in breast and colon cancer. {ECO:0000269|PubMed:15231737, ECO:0000269|PubMed:15684044}.","DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; DISEASE: Note=Defects in EED are associated with Weaver syndrome (WVS): A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand. {ECO:0000269|PubMed:28229514}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SUZ12,23512,Hs.730786,ENST00000322652,THC2519335,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001739(sex chromatin)|GO:0003682(chromatin binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0008284(positive regulation of cell proliferation)|GO:0016568(chromatin modification)|GO:0016571(histone methylation)|GO:0016574(histone ubiquitination)|GO:0035064(methylated histone residue binding)|GO:0035098(ESC/E(Z) complex)|GO:0042054(histone methyltransferase activity)|GO:0045596(negative regulation of cell differentiation)|GO:0046872(metal ion binding)","Homo sapiens suppressor of zeste 12 homolog (Drosophila) (SUZ12), mRNA [NM_015355]",chr17:30327536-30327595,hs|17q11.2,suppressor of zeste 12 homolog (Drosophila),TRUE
1038_ZNHIT1_10467,O43257,zinc finger hit domain-containing protein 1 (cyclin-g1-binding protein 1) (zinc finger protein subfamily 4a member 1) (p18 hamlet),ZNHIT1 CGBP1 ZNFN4A1,154,"function: seems to play a role in p53-mediated apoptosis induction (pubmed:17380123). binds to nr1d2 and relieves it of its inhibitory effect on the transcription of apoc3 without affecting its dna-binding activity (pubmed:17892483). {eco:0000269|pubmed:17380123, eco:0000269|pubmed:17892483}.",subcellular location: nucleus {eco:0000269|pubmed:17892483}.,"TISSUE SPECIFICITY: Expressed abundantly in liver, but weakly in skeletal muscle, ovary and small intestine. {ECO:0000269|PubMed:17892483}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNHIT1,10467,Hs.211079,ENST00000485387,THC2492130,GO:0005515(protein binding)|GO:0046872(metal ion binding),"Homo sapiens zinc finger, HIT-type containing 1 (ZNHIT1), mRNA [NM_006349]",chr7:100867339-100867398,hs|7q22.1,"zinc finger, HIT-type containing 1",TRUE
1039_ABAT_18,P80404,"4-aminobutyrate aminotransferase, mitochondrial (ec 2.6.1.19) ((s)-3-amino-2-methylpropionate transaminase) (ec 2.6.1.22) (gaba aminotransferase) (gaba-at) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba-t) (l-aibat)",ABAT GABAT,500,"function: catalyzes the conversion of gamma-aminobutyrate and l-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively. can also convert delta-aminovalerate and beta-alanine.",subcellular location: mitochondrion matrix.,TISSUE SPECIFICITY: Liver > pancreas > brain > kidney > heart > placenta.,"DISEASE: GABA transaminase deficiency (GABATD) [MIM:613163]: An enzymatic deficiency resulting in psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. {ECO:0000269|PubMed:10407778}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ABAT,18,Hs.336768,ENST00000396600,THC2608590,GO:0001666(response to hypoxia)|GO:0003867(4-aminobutyrate transaminase activity)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0007268(synaptic transmission)|GO:0007269(neurotransmitter secretion)|GO:0007610(behavior)|GO:0007620(copulation)|GO:0007626(locomotory behavior)|GO:0009450(gamma-aminobutyric acid catabolic process)|GO:0010039(response to iron ion)|GO:0016740(transferase activity)|GO:0019717(synaptosome)|GO:0030170(pyridoxal phosphate binding)|GO:0032144(4-aminobutyrate transaminase complex)|GO:0032145(succinate-semialdehyde dehydrogenase binding)|GO:0035094(response to nicotine)|GO:0042135(neurotransmitter catabolic process)|GO:0042493(response to drug)|GO:0042803(protein homodimerization activity)|GO:0045471(response to ethanol)|GO:0045776(negative regulation of blood pressure)|GO:0047298((S)-3-amino-2-methylpropionate transaminase activity)|GO:0048148(behavioral response to cocaine),"Homo sapiens 4-aminobutyrate aminotransferase (ABAT), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_000663]",chr16:8878328-8878387,hs|16p13.2,4-aminobutyrate aminotransferase,TRUE
104_RPL23_9349,P62829,60s ribosomal protein l23 (60s ribosomal protein l17) (large ribosomal subunit protein ul14),RPL23,140,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL23,9349,Hs.406300,ENST00000245857,THC2580634,GO:0003735(structural constituent of ribosome)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006610(ribosomal protein import into nucleus)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L23 (RPL23), mRNA [NM_000978]",chr17:37006423-37006364,hs|17q12,ribosomal protein L23,TRUE
1040_DIAPH1_1729,O60610,protein diaphanous homolog 1 (diaphanous-related formin-1) (drf1),DIAPH1 DIAP1,1272,"function: actin nucleation and elongation factor required for the assembly of f-actin structures, such as actin cables and stress fibers (by similarity). binds to the barbed end of the actin filament and slows down actin polymerization and depolymerization (by similarity). required for cytokinesis, and transcriptional activation of the serum response factor (by similarity). dfr proteins couple rho and src tyrosine kinase during signaling and the regulation of actin dynamics (by similarity). functions as a scaffold protein for mapre1 and apc to stabilize microtubules and promote cell migration (by similarity). has neurite outgrowth promoting activity. acts in a rho-dependent manner to recruit pfy1 to the membrane (by similarity). in hear cells, it may play a role in the regulation of actin polymerization in hair cells (pubmed:20937854, pubmed:21834987, pubmed:26912466). the memo1-rhoa-diaph1 signaling pathway plays an important role in erbb2-dependent stabilization of microtubules at the cell cortex (pubmed:20937854, pubmed:21834987). it controls the localization of apc and clasp2 to the cell membrane, via the regulation of gsk3b activity (pubmed:20937854, pubmed:21834987). in turn, membrane-bound apc allows the localization of the macf1 to the cell membrane, which is required for microtubule capture and stabilization (pubmed:20937854, pubmed:21834987). plays a role in the regulation of cell morphology and cytoskeletal organization. required in the control of cell shape (pubmed:20937854, pubmed:21834987). plays a role in brain development (pubmed:24781755). also acts as an actin nucleation and elongation factor in the nucleus by promoting nuclear actin polymerization inside the nucleus to drive serum-dependent srf-mrtfa activity (by similarity). {eco:0000250|uniprotkb:o08808, eco:0000269|pubmed:20937854, eco:0000269|pubmed:21834987, eco:0000269|pubmed:24781755, eco:0000269|pubmed:26912466}.","subcellular location: cell membrane {eco:0000250|uniprotkb:o08808}. cell projection, ruffle membrane {eco:0000250|uniprotkb:o08808}. cytoplasm, cytoskeleton {eco:0000269|pubmed:24781755}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:24781755}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:24781755}. cytoplasm {eco:0000250|uniprotkb:o08808}. nucleus {eco:0000250|uniprotkb:o08808}. note=membrane ruffles, especially at the tip of ruffles, of motile cells. {eco:0000250|uniprotkb:o08808}.","TISSUE SPECIFICITY: Expressed in brain, heart, placenta, lung, kidney, pancreas, liver, skeletal muscle and cochlea. Expressed in platelets (PubMed:26912466). {ECO:0000269|PubMed:26912466}.","DISEASE: Deafness, autosomal dominant, 1 (DFNA1) [MIM:124900]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Patients may have mild thrombocytopenia and enlarged platelets, although most of DFNA1 affected individuals do not have significant bleeding tendencies. {ECO:0000269|PubMed:22938506, ECO:0000269|PubMed:26912466, ECO:0000269|PubMed:27808407, ECO:0000269|PubMed:9360932}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, cortical blindness, and microcephaly syndrome (SCBMS) [MIM:616632]: A severe autosomal recessive neurodevelopmental disorder characterized by microcephaly, early-onset seizures, severely delayed psychomotor development, short stature, and cortical blindness. {ECO:0000269|PubMed:24781755, ECO:0000269|PubMed:26463574}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,DIAPH1,1729,Hs.529451,ENST00000253811,THC2468692,GO:0003779(actin binding)|GO:0005102(receptor binding)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0007010(cytoskeleton organization)|GO:0007605(sensory perception of sound)|GO:0008360(regulation of cell shape)|GO:0016043(cellular component organization)|GO:0017048(Rho GTPase binding)|GO:0030036(actin cytoskeleton organization)|GO:0030041(actin filament polymerization)|GO:0032587(ruffle membrane)|GO:0032886(regulation of microtubule-based process)|GO:0042995(cell projection),"Homo sapiens diaphanous homolog 1 (Drosophila) (DIAPH1), transcript variant 1, mRNA [NM_005219]",chr5:140894648-140894589,hs|5q31.3,diaphanous homolog 1 (Drosophila),TRUE
1041_MLL_4297,Q03164,histone-lysine n-methyltransferase 2a (lysine n-methyltransferase 2a) (ec 2.1.1.43) (all-1) (cxxc-type zinc finger protein 7) (myeloid/lymphoid or mixed-lineage leukemia) (myeloid/lymphoid or mixed-lineage leukemia protein 1) (trithorax-like protein) (zinc finger protein hrx) [cleaved into: mll cleavage product n320 (n-terminal cleavage product of 320 kda) (p320); mll cleavage product c180 (c-terminal cleavage product of 180 kda) (p180)],KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1,3969,"function: histone methyltransferase that plays an essential role in early development and hematopoiesis. catalytic subunit of the mll1/mll complex, a multiprotein complex that mediates both methylation of 'lys-4' of histone h3 (h3k4me) complex and acetylation of 'lys-16' of histone h4 (h4k16ac). in the mll1/mll complex, it specifically mediates h3k4me, a specific tag for epigenetic transcriptional activation (pubmed:12453419, pubmed:20677832, pubmed:26886794). has weak methyltransferase activity by itself, and requires other component of the mll1/mll complex to obtain full methyltransferase activity (pubmed:19187761, pubmed:26886794). has no activity toward histone h3 phosphorylated on 'thr-3', less activity toward h3 dimethylated on 'arg-8' or 'lys-9', while it has higher activity toward h3 acetylated on 'lys-9'. binds to unmethylated cpg elements in the promoter of target genes and helps maintain them in the nonmethylated state (pubmed:20010842). required for transcriptional activation of hoxa9 (pubmed:12453419, pubmed:20677832, pubmed:20010842). promotes ppp1r15a-induced apoptosis. plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the clock-arntl/bmal1 heterodimer. establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'lys-4' of histone h3 (h3k4me) and this histone modification directs the circadian acetylation at h3k9 and h3k14 allowing the recruitment of clock-arntl/bmal1 to chromatin (by similarity). {eco:0000250|uniprotkb:p55200, eco:0000269|pubmed:10490642, eco:0000269|pubmed:12453419, eco:0000269|pubmed:15960975, eco:0000269|pubmed:19187761, eco:0000269|pubmed:19556245, eco:0000269|pubmed:20010842, eco:0000269|pubmed:21220120, eco:0000269|pubmed:26886794, eco:0000305|pubmed:20677832}.",subcellular location: nucleus {eco:0000269|pubmed:12482972}.; subcellular location: mll cleavage product n320: nucleus.; subcellular location: mll cleavage product c180: nucleus. note=localizes to a diffuse nuclear pattern when not associated with mll cleavage product n320.,"TISSUE SPECIFICITY: Heart, lung, brain and T- and B-lymphocytes.","DISEASE: Wiedemann-Steiner syndrome (WDSTS) [MIM:605130]: A syndrome characterized by hairy elbows (hypertrichosis cubiti), intellectual disability, a distinctive facial appearance, and short stature. Facial characteristics include long eyelashes, thick or arched eyebrows with a lateral flare, and downslanting and vertically narrow palpebral fissures. {ECO:0000269|PubMed:22795537}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Chromosomal aberrations involving KMT2A are a cause of acute leukemias. Translocation t(1;11)(q21;q23) with MLLT11/AF1Q; translocation t(3;11)(p21;q23) with NCKIPSD/AF3p21; translocation t(3,11)(q25,q23) with GMPS; translocation t(4;11)(q21;q23) with AFF1/MLLT2/AF4; insertion ins(5;11)(q31;q13q23) with AFF4/AF5Q31; translocation t(5;11)(q12;q23) with AF5-alpha/CENPK; translocation t(6;11)(q27;q23) with AFDN; translocation t(9;11)(p22;q23) with MLLT3/AF9; translocation t(10;11)(p11.2;q23) with ABI1; translocation t(10;11)(p12;q23) with MLLT10/AF10; t(11;15)(q23;q14) with KNL1 and ZFYVE19; translocation t(11;17)(q23;q21) with MLLT6/AF17; translocation t(11;19)(q23;p13.3) with ELL; translocation t(11;19)(q23;p13.3) with MLLT1/ENL; translocation t(11;19)(q23;p23) with GAS7; translocation t(X;11)(q13;q23) with FOXO4/AFX1. Translocation t(3;11)(q28;q23) with LPP. Translocation t(10;11)(q22;q23) with TET1. Translocation t(9;11)(q34;q23) with DAB2IP. Translocation t(4;11)(p12;q23) with FRYL. Fusion proteins KMT2A-MLLT1, KMT2A-MLLT3 and KMT2A-ELL interact with PPP1R15A and, on the contrary to unfused KMT2A, inhibit PPP1R15A-induced apoptosis. Fusion protein KMT2A-MLLT3 interacts with MEN1 and PSIP1 (PubMed:22936661, PubMed:25305204). {ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:22936661, ECO:0000269|PubMed:25305204}.; DISEASE: Note=A chromosomal aberration involving KMT2A may be a cause of chronic neutrophilic leukemia. Translocation t(4;11)(q21;q23) with SEPT11. {ECO:0000269|PubMed:10490642}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MLL,4297,Hs.258855,NA,NP288430,"GO:0003677(DNA binding)|GO:0003680(AT DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006461(protein complex assembly)|GO:0006915(apoptosis)|GO:0008168(methyltransferase activity)|GO:0008270(zinc ion binding)|GO:0016568(chromatin modification)|GO:0016740(transferase activity)|GO:0035097(histone methyltransferase complex)|GO:0035162(embryonic hemopoiesis)|GO:0042800(histone methyltransferase activity (H3-K4 specific))|GO:0042802(identical protein binding)|GO:0042803(protein homodimerization activity)|GO:0043984(histone H4-K16 acetylation)|GO:0044212(transcription regulatory region DNA binding)|GO:0045322(unmethylated CpG binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0051568(histone H3-K4 methylation)|GO:0070577(histone acetyl-lysine binding)|GO:0071339(MLL1 complex)","Homo sapiens clone 1370-39 MLL protein mRNA, partial cds. [AF272382]",chr11:118350890-118350949,hs|11q23.3,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)",TRUE
1042_PTP4A2_8073,Q12974,protein tyrosine phosphatase type iva 2 (ec 3.1.3.48) (hu-pp-1) (ov-1) (ptp(caaxii)) (protein-tyrosine phosphatase 4a2) (protein-tyrosine phosphatase of regenerating liver 2) (prl-2),PTP4A2 PRL2 PTPCAAX2 BM-008,167,function: protein tyrosine phosphatase which stimulates progression from g1 into s phase during mitosis. promotes tumors. inhibits geranylgeranyl transferase type ii activity by blocking the association between rabggta and rabggtb. {eco:0000269|pubmed:14643450}.,subcellular location: cell membrane. early endosome. cytoplasm.,"TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in skeletal muscle, heart and thymus. Overexpressed in prostate tumor tissue. {ECO:0000269|PubMed:10940933, ECO:0000269|PubMed:11734337, ECO:0000269|PubMed:8661118}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PTP4A2,8073,Hs.470477,ENST00000489313,THC2533390,GO:0004727(prenylated protein tyrosine phosphatase activity)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0005886(plasma membrane)|GO:0008138(protein tyrosine/serine/threonine phosphatase activity)|GO:0016787(hydrolase activity),"Homo sapiens protein tyrosine phosphatase type IVA, member 2 (PTP4A2), transcript variant 1, mRNA [NM_080391]",chr1:32374398-32374339,hs|1p35.2,"protein tyrosine phosphatase type IVA, member 2",TRUE
1043_LEPROT_54741,O15243,leptin receptor gene-related protein (endospanin-1) (leptin receptor overlapping transcript protein) (ob-r gene-related protein) (ob-rgrp),LEPROT LEPR OBR,131,"function: negatively regulates leptin receptor (lepr) cell surface expression, and thus decreases response to leptin. negatively regulates growth hormone (gh) receptor cell surface expression in liver. may play a role in liver resistance to gh during periods of reduced nutrient availability. {eco:0000269|pubmed:18042720, eco:0000269|pubmed:19907080}.",subcellular location: golgi apparatus membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}. endosome membrane {eco:0000250}.,"TISSUE SPECIFICITY: Expressed at the highest levels in heart and placenta and at a lesser extent in lung, liver, skeletal muscle, kidney and pancreas.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LEPROT,54741,Hs.23581,ENST00000371065,THC2466421,GO:0000139(Golgi membrane)|GO:0003674(molecular_function)|GO:0005768(endosome)|GO:0005794(Golgi apparatus)|GO:0005887(integral to plasma membrane)|GO:0008150(biological_process)|GO:0010008(endosome membrane)|GO:0016020(membrane),"Homo sapiens leptin receptor overlapping transcript (LEPROT), transcript variant 1, mRNA [NM_017526]",chr1:65898052-65898111,hs|1p31.3,leptin receptor overlapping transcript,TRUE
1044_ZFP36L2_678,P47974,"mrna decay activator protein zfp36l2 (butyrate response factor 2) (egf-response factor 2) (erf-2) (tpa-induced sequence 11d) (zinc finger protein 36, c3h1 type-like 2) (zfp36-like 2)",ZFP36L2 BRF2 ERF2 RNF162C TIS11D,494,"function: zinc-finger rna-binding protein that destabilizes several cytoplasmic au-rich element (are)-containing mrna transcripts by promoting their poly(a) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (pubmed:25106868, pubmed:14981510). acts as a 3'-untranslated region (utr) are mrna-binding adapter protein to communicate signaling events to the mrna decay machinery (pubmed:25106868). functions by recruiting the ccr4-not deadenylase complex and probably other components of the cytoplasmic rna decay machinery to the bound are-containing mrnas, and hence promotes are-mediated mrna deadenylation and decay processes (pubmed:25106868). binds to 3'-utr are of numerous mrnas (pubmed:20506496, pubmed:25106868, pubmed:14981510). promotes are-containing mrna decay of the low-density lipoprotein (ldl) receptor (ldlr) mrna in response to phorbol 12-myristate 13-acetate (pma) treatment in a p38 mapk-dependent manner (pubmed:25106868). positively regulates early adipogenesis by promoting are-mediated mrna decay of immediate early genes (iegs). plays a role in mature peripheral neuron integrity by promoting are-containing mrna decay of the transcriptional repressor rest mrna. plays a role in ovulation and oocyte meiotic maturation by promoting are-mediated mrna decay of the luteinizing hormone receptor lhcgr mrna. acts as a negative regulator of erythroid cell differentiation: promotes glucocorticoid-induced self-renewal of erythroid cells by binding mrnas that are induced or highly expressed during terminal erythroid differentiation and promotes their degradation, preventing erythroid cell differentiation. in association with zfp36l1 maintains quiescence on developing b lymphocytes by promoting are-mediated decay of several mrnas encoding cell cycle regulators that help b cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (vdj) recombination process and functional immune cell formation. together with zfp36l1 is also necessary for thymocyte development and prevention of t-cell acute lymphoblastic leukemia (t-all) transformation by promoting are-mediated mrna decay of the oncogenic transcription factor notch1 mrna. {eco:0000250|uniprotkb:p23949, eco:0000269|pubmed:14981510, eco:0000269|pubmed:20506496, eco:0000269|pubmed:25106868}.",subcellular location: nucleus {eco:0000250|uniprotkb:p23949}. cytoplasm {eco:0000250|uniprotkb:p23949}. note=shuttles between the nucleus and the cytoplasm in a xpo1/crm1-dependent manner. {eco:0000250|uniprotkb:p23949}.,"TISSUE SPECIFICITY: Expressed mainly in the basal epidermal layer, weakly in the suprabasal epidermal layers (PubMed:27182009). Expressed in epidermal keratinocytes (at protein level) (PubMed:27182009). {ECO:0000269|PubMed:27182009}.",DISEASE: Note=Defects in ZFP36L2 may be a cause of leukemias. Frameshift mutations disrupting ZFP36L2 have been found in a patient with acute myeloid leukemia (PubMed:21109922). {ECO:0000269|PubMed:21109922}.,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,ZFP36L2,678,Hs.503093,ENST00000282388,THC2485818,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0008283(cell proliferation)|GO:0043488(regulation of mRNA stability)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 36, C3H type-like 2 (ZFP36L2), mRNA [NM_006887]",chr2:43451215-43451156,hs|2p21,"zinc finger protein 36, C3H type-like 2",TRUE
1045_STRBP_55342,Q96SI9,spermatid perinuclear rna-binding protein,STRBP SPNR,672,function: involved in spermatogenesis and sperm function. plays a role in regulation of cell growth. binds to double-stranded dna and rna. binds most efficiently to poly(i:c) rna than to poly(di:dc) dna. binds also to single-stranded poly(g) rna. binds non-specifically to the mrna prm1 3'-utr and adenovirus va rna (by similarity). {eco:0000250}.,subcellular location: cytoplasm {eco:0000250}. note=microtubule-associated that localizes to the manchette in developing spermatids. {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,STRBP,55342,Hs.694157,ENST00000407982,THC2647703,GO:0003677(DNA binding)|GO:0003725(double-stranded RNA binding)|GO:0003727(single-stranded RNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006928(cellular component movement)|GO:0007275(multicellular organismal development)|GO:0007283(spermatogenesis)|GO:0007286(spermatid development)|GO:0007638(mechanosensory behavior)|GO:0015630(microtubule cytoskeleton)|GO:0030154(cell differentiation),"Homo sapiens spermatid perinuclear RNA binding protein (STRBP), transcript variant 1, mRNA [NM_018387]",chr9:125887911-125887852,hs|9q33.3,spermatid perinuclear RNA binding protein,TRUE
1046_SRRT_51593,Q9BXP5,serrate rna effector molecule homolog (arsenite-resistance protein 2),SRRT ARS2 ASR2,876,"function: acts as a mediator between the cap-binding complex (cbc) and the primary micrornas (mirnas) processing machinery during cell proliferation. contributes to the stability and delivery of capped primary mirna transcripts to the primary mirna processing complex containing dgcr8 and drosha, thereby playing a role in rna-mediated gene silencing (rnai) by mirnas. binds capped rnas (m7gpppg-capped rna); however interaction is probably mediated via its interaction with ncbp1/cbp80 component of the cbc complex. involved in cell cycle progression at s phase. does not directly confer arsenite resistance but rather modulates arsenic sensitivity. independently of its activity on mirnas, necessary and sufficient to promote neural stem cell self-renewal. does so by directly binding sox2 promoter and positively regulating its transcription (by similarity). {eco:0000250, eco:0000269|pubmed:19632182}.","subcellular location: nucleus, nucleoplasm {eco:0000250}. cytoplasm {eco:0000250}. note=predominantly nuclear. shuttles between the nucleus and the cytoplasm in a crm1-dependent way (by similarity). {eco:0000250}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:18086880}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRRT,51593,Hs.111801,ENST00000388793,THC2467955,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0008283(cell proliferation)|GO:0031047(gene silencing by RNA)|GO:0031053(primary miRNA processing)|GO:0046685(response to arsenic-containing substance),"Homo sapiens serrate RNA effector molecule homolog (Arabidopsis) (SRRT), transcript variant 1, mRNA [NM_015908]",chr7:100486219-100486278,hs|7q22.1,serrate RNA effector molecule homolog (Arabidopsis),TRUE
1047_C4orf34_201895,Q96QK8,small integral membrane protein 14,SMIM14 C4orf34,99,NA,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:24499674}; single-pass membrane protein {eco:0000269|pubmed:24499674}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C4orf34,201895,Hs.576320,ENST00000512441,THC2461238,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 4 open reading frame 34 (C4orf34), mRNA [NM_174921]",chr4:39553321-39553262,hs|4p14,chromosome 4 open reading frame 34,TRUE
1048_TSPYL4_23270,Q9UJ04,testis-specific y-encoded-like protein 4 (tspy-like protein 4),TSPYL4 KIAA0721,414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,TSPYL4,23270,Hs.284141,ENST00000420283,THC2611476,GO:0005634(nucleus)|GO:0006334(nucleosome assembly),"Homo sapiens TSPY-like 4 (TSPYL4), mRNA [NM_021648]",chr6:116571248-116571189,hs|6q22.1,TSPY-like 4,TRUE
1049_ABLIM1_3983,O14639,actin-binding lim protein 1 (ablim-1) (actin-binding lim protein family member 1) (actin-binding double zinc finger protein) (limab1) (limatin),ABLIM1 ABLIM KIAA0059 LIMAB1,778,"function: may act as scaffold protein (by similarity). may play a role in the development of the retina. has been suggested to play a role in axon guidance. {eco:0000250, eco:0000269|pubmed:9245787}.","subcellular location: cytoplasm {eco:0000250}. cytoplasm, cytoskeleton {eco:0000250}. note=associated with the cytoskeleton. {eco:0000250}.","TISSUE SPECIFICITY: Detected in liver, heart, skeletal muscle, brain and retina, where it is concentrated in the inner segment and in the outer plexiform layers. {ECO:0000269|PubMed:9245787}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ABLIM1,3983,Hs.438236,ENST00000369267,THC2610804,GO:0003779(actin binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0007010(cytoskeleton organization)|GO:0007411(axon guidance)|GO:0007601(visual perception)|GO:0008270(zinc ion binding)|GO:0009887(organ morphogenesis)|GO:0015629(actin cytoskeleton)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding),"Homo sapiens actin binding LIM protein 1 (ABLIM1), transcript variant 3, mRNA [NM_001003408]",chr10:116190950-116190891,hs|10q25.3,actin binding LIM protein 1,TRUE
105_HIST2H2AA4_723790,Q6FI13,histone h2a type 2-a (histone h2a.2) (histone h2a/o),HIST2H2AA3 H2AFO HIST2H2AA; HIST2H2AA4,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST2H2AA4,723790,Hs.731339,ENST00000369159,THC2462331,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 2, H2aa4 (HIST2H2AA4), mRNA [NM_001040874]",chr1:149823105-149823161,hs|1q21.2,"histone cluster 2, H2aa4",TRUE
1050_PRCP_5547,P42785,lysosomal pro-x carboxypeptidase (ec 3.4.16.2) (angiotensinase c) (lysosomal carboxypeptidase c) (proline carboxypeptidase) (prolylcarboxypeptidase) (prcp),PRCP PCP,496,"function: cleaves c-terminal amino acids linked to proline in peptides such as angiotensin ii, iii and des-arg9-bradykinin. this cleavage occurs at acidic ph, but enzymatic activity is retained with some substrates at neutral ph.",subcellular location: lysosome.,"TISSUE SPECIFICITY: Highest levels in placenta, lung and liver. Also present in heart, brain, pancreas and kidney.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRCP,5547,Hs.523936,ENST00000532709,NP1147551,"GO:0004185(serine-type carboxypeptidase activity)|GO:0005515(protein binding)|GO:0005764(lysosome)|GO:0005886(plasma membrane)|GO:0006508(proteolysis)|GO:0007596(blood coagulation)|GO:0007597(blood coagulation, intrinsic pathway)|GO:0008233(peptidase activity)|GO:0008236(serine-type peptidase activity)","Homo sapiens prolylcarboxypeptidase (angiotensinase C) (PRCP), transcript variant 2, mRNA [NM_199418]",chr11:82535525-82535466,hs|11q14.1,prolylcarboxypeptidase (angiotensinase C),TRUE
1051_TRA2B_6434,P62995,"transformer-2 protein homolog beta (tra-2 beta) (tra2-beta) (htra2-beta) (splicing factor, arginine/serine-rich 10) (transformer-2 protein homolog b)",TRA2B SFRS10,288,"function: sequence-specific rna-binding protein which participates in the control of pre-mrna splicing. can either activate or suppress exon inclusion. acts additively with rbmx to promote exon 7 inclusion of the survival motor neuron smn2. activates the splicing of mapt/tau exon 10. alters pre-mrna splicing patterns by antagonizing the effects of splicing regulators, like rbmx. binds to the ag-rich se2 domain in the smn exon 7 rna. binds to pre-mrna. {eco:0000269|pubmed:12165565, eco:0000269|pubmed:12761049, eco:0000269|pubmed:15009664, eco:0000269|pubmed:9546399}.","subcellular location: nucleus {eco:0000269|pubmed:9212162, eco:0000269|pubmed:9546399}.","TISSUE SPECIFICITY: Highest expression in heart, skeletal muscle and pancreas. Less abundant in kidney, placenta and brain. Lowest expression in kidney and liver. {ECO:0000269|PubMed:9790768}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRA2B,6434,Hs.533122,ENST00000342294,THC2546917,"GO:0000166(nucleotide binding)|GO:0000375(RNA splicing, via transesterification reactions)|GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0048026(positive regulation of nuclear mRNA splicing, via spliceosome)",transformer 2 beta homolog (Drosophila) [Source:HGNC Symbol;Acc:10781] [ENST00000342294],chr3:185649620-185649561,hs|3q27.2,transformer 2 beta homolog (Drosophila),TRUE
1052_ARL6IP4_51329,Q66PJ3,adp-ribosylation factor-like protein 6-interacting protein 4 (arl-6-interacting protein 4) (aip-4) (hsp-975) (hsvi-binding protein) (sr-15) (srp25) (sr-25) (splicing factor srrp37),ARL6IP4,421,"function: involved in modulating alternative pre-mrna splicing with either 5' distal site activation or preferential use of 3' proximal site. in case of infection by herpes simplex virus (hsvi), may act as a splicing inhibitor of hsvi pre-mrna. {eco:0000269|pubmed:19582790}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:19582790}. nucleus speckle {eco:0000269|pubmed:19582790}.","TISSUE SPECIFICITY: Isoforms 3 and 7 were identified in brain, pancreas, prostate, and testis, but little or no message could be detected in other tissues. {ECO:0000269|PubMed:19582790}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARL6IP4,51329,Hs.103561,ENST00000539576,NP434144,GO:0005634(nucleus)|GO:0008380(RNA splicing),"Homo sapiens ADP-ribosylation-like factor 6 interacting protein 4 (ARL6IP4), transcript variant 4, mRNA [NM_001002252]",chr12:123467393-123467452,hs|12q24.31,ADP-ribosylation-like factor 6 interacting protein 4,TRUE
1053_FAM127A_8933,A6ZKI3,retrotransposon gag-like protein 8c (mammalian retrotransposon derived protein 8c),RTL8C CXX1 FAM127A MAR8 MAR8C MART8,113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM127A,8933,Hs.522789,ENST00000257013,THC2762807,NA,"Homo sapiens family with sequence similarity 127, member A (FAM127A), mRNA [NM_001078171]",chrX:134167390-134167449,hs|Xq26.3,"family with sequence similarity 127, member A",TRUE
1054_GLOD4_51031,Q9HC38,glyoxalase domain-containing protein 4,GLOD4 C17orf25 CGI-150 My027,313,NA,subcellular location: mitochondrion {eco:0000305|pubmed:12897971}.,"TISSUE SPECIFICITY: Expressed in heart, brain, liver, kidney, pancreas and placenta. Not expressed in skeletal muscle and lung. {ECO:0000269|PubMed:11642406}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,GLOD4,51031,Hs.279061,ENST00000397393,NP239909,GO:0005739(mitochondrion),"Homo sapiens glyoxalase domain containing 4 (GLOD4), mRNA [NM_016080]",chr17:662753-662694,hs|17p13.3,glyoxalase domain containing 4,TRUE
1055_KIAA0146_23514,Q14159,dna repair-scaffolding protein (scaffolding protein involved in dna repair),SPIDR KIAA0146,915,"function: plays a role in dna double-strand break (dbs) repair via homologous recombination (hr). serves as a scaffolding protein that helps to promote the recruitment of dna-processing enzymes like the helicase blm and recombinase rad51 to site of dna damage, and hence contributes to maintain genomic integrity. {eco:0000269|pubmed:23509288, eco:0000269|pubmed:23754376}.","subcellular location: nucleus {eco:0000269|pubmed:23509288}. note=together with blm, is redistributed in discrete nuclear dna damage-induced foci following hydroxyurea (hu) or camptothecin (cpt) treatment.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KIAA0146,23514,Hs.381058,ENST00000297423,THC2511949,NA,"Homo sapiens KIAA0146 (KIAA0146), mRNA [NM_001080394]",chr8:48648093-48648152,hs|8q11.21,KIAA0146,TRUE
1056_KIAA0355_9710,O15063,uncharacterized protein kiaa0355,KIAA0355,1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,KIAA0355,9710,Hs.330073,ENST00000299505,THC2495260,NA,"Homo sapiens KIAA0355 (KIAA0355), mRNA [NM_014686]",chr19:34846363-34846422,hs|19q13.11,KIAA0355,TRUE
1057_SRRM1_10250,Q8IYB3,serine/arginine repetitive matrix protein 1 (sr-related nuclear matrix protein of 160 kda) (srm160) (ser/arg-related nuclear matrix protein),SRRM1 SRM160,904,"function: part of pre- and post-splicing multiprotein mrnp complexes. involved in numerous pre-mrna processing events. promotes constitutive and exonic splicing enhancer (ese)-dependent splicing activation by bridging together sequence-specific (sr family proteins, sfrs4, sfrs5 and tra2b/sfrs10) and basal snrnp (snrp70 and snrpa1) factors of the spliceosome. stimulates mrna 3'-end cleavage independently of the formation of an exon junction complex. binds both pre-mrna and spliced mrna 20-25 nt upstream of exon-exon junctions. binds rna and dna with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {eco:0000269|pubmed:10339552, eco:0000269|pubmed:10668804, eco:0000269|pubmed:11739730, eco:0000269|pubmed:12600940, eco:0000269|pubmed:12944400, eco:0000269|pubmed:9531537}.","subcellular location: nucleus matrix {eco:0000269|pubmed:12624182, eco:0000269|pubmed:9531537}. nucleus speckle {eco:0000269|pubmed:11546874, eco:0000269|pubmed:9531537}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRRM1,10250,Hs.18192,ENST00000374389,THC2469516,"GO:0000375(RNA splicing, via transesterification reactions)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006406(mRNA export from nucleus)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016363(nuclear matrix)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens serine/arginine repetitive matrix 1 (SRRM1), mRNA [NM_005839]",chr1:24999475-24999534,hs|1p36.11,serine/arginine repetitive matrix 1,TRUE
1058_SLC25A3_5250,Q00325,"phosphate carrier protein, mitochondrial (phosphate transport protein) (ptp) (solute carrier family 25 member 3)",SLC25A3 PHC OK/SW-cl.48,362,function: transport of phosphate groups from the cytosol to the mitochondrial matrix. phosphate is cotransported with h(+). may play a role regulation of the mitochondrial permeability transition pore (mptp).,subcellular location: mitochondrion inner membrane; multi-pass membrane protein.,NA,"DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC25A3,5250,Hs.290404,ENST00000549338,THC2542538,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005887(integral to plasma membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0006810(transport)|GO:0015293(symporter activity)|GO:0015320(phosphate carrier activity)|GO:0016020(membrane),"Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 (SLC25A3), nuclear gene encoding mitochondrial protein, transcript variant 3, mRNA [NM_213611]",chr12:98995317-98995376,hs|12q23.1,"solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3",TRUE
1059_NEMF_9147,O60524,nuclear export mediator factor nemf (antigen ny-co-1) (serologically defined colon cancer antigen 1),NEMF SDCCAG1,1076,"function: component of the ribosome quality control complex (rqc), a ribosome-associated complex that mediates ubiquitination and extraction of incompletely synthesized nascent chains for proteasomal degradation. nemf is responsible for selective recognition of stalled 60s subunits by recognizing an exposed, nascent chain-conjugated trna moiety. nemf is important for the stable association of ltn1 to the complex (pubmed:25578875). may indirectly play a role in nuclear export (pubmed:16103875). {eco:0000269|pubmed:16103875, eco:0000269|pubmed:25578875}.",subcellular location: nucleus {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in brain, heart, liver, lung, spleen, and skeletal muscle. Also expressed at lower levels in stomach and testis. {ECO:0000269|PubMed:16103875}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEMF,9147,Hs.655964,ENST00000556882,THC2523454,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm),"Homo sapiens nuclear export mediator factor (NEMF), mRNA [NM_004713]",chr14:50295934-50295875,hs|14q21.3,nuclear export mediator factor,TRUE
106_RPLP2_6181,P05387,60s acidic ribosomal protein p2 (large ribosomal subunit protein p2) (renal carcinoma antigen ny-ren-44),RPLP2 D11S2243E RPP2,115,function: plays an important role in the elongation step of protein synthesis.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPLP2,6181,Hs.437594,ENST00000321153,THC2500756,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein, large, P2 (RPLP2), mRNA [NM_001004]",chr11:812818-812877,hs|11p15.5,"ribosomal protein, large, P2",TRUE
1060_CNP_1267,P23582,c-type natriuretic peptide [cleaved into: cnp-22; cnp-29; cnp-53],NPPC CNP2,126,"function: hormone which plays a role in endochondral ossification through regulation of cartilaginous growth plate chondrocytes proliferation and differentiation. may also be vasoactive and natriuretic. specifically binds and stimulates the cgmp production of the npr2 receptor. binds the clearance receptor npr3 (by similarity). {eco:0000250, eco:0000269|pubmed:1672777}.",subcellular location: secreted.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CNP,1267,Hs.273621,ENST00000393892,THC2465228,"GO:0000226(microtubule cytoskeleton organization)|GO:0004113(2',3'-cyclic-nucleotide 3'-phosphodiesterase activity)|GO:0005524(ATP binding)|GO:0005615(extracellular space)|GO:0005622(intracellular)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0007268(synaptic transmission)|GO:0007409(axonogenesis)|GO:0008344(adult locomotory behavior)|GO:0009214(cyclic nucleotide catabolic process)|GO:0009636(response to toxin)|GO:0016070(RNA metabolic process)|GO:0016301(kinase activity)|GO:0016787(hydrolase activity)|GO:0042470(melanosome)|GO:0048471(perinuclear region of cytoplasm)","Homo sapiens 2',3'-cyclic nucleotide 3' phosphodiesterase (CNP), mRNA [NM_033133]",chr17:40127069-40127128,hs|17q21.2,"2',3'-cyclic nucleotide 3' phosphodiesterase",TRUE
1061_GMNN_51053,O75496,geminin,GMNN,209,"function: inhibits dna replication by preventing the incorporation of mcm complex into pre-replication complex (pre-rc). it is degraded during the mitotic phase of the cell cycle. its destruction at the metaphase-anaphase transition permits replication in the succeeding cell cycle.; function: inhibits the transcriptional activity of a subset of hox proteins, enrolling them in cell proliferative control.",subcellular location: cytoplasm. nucleus. note=mainly cytoplasmic but can be relocalized to the nucleus.,NA,"DISEASE: Meier-Gorlin syndrome 6 (MGORS6) [MIM:616835]: A form of Meier-Gorlin syndrome, a syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:26637980}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GMNN,51053,Hs.234896,ENST00000356509,THC2462447,"GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006461(protein complex assembly)|GO:0008156(negative regulation of DNA replication)|GO:0009887(organ morphogenesis)|GO:0042826(histone deacetylase binding)|GO:0045786(negative regulation of cell cycle)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0070491(repressing transcription factor binding)","Homo sapiens geminin, DNA replication inhibitor (GMNN), transcript variant 1, mRNA [NM_015895]",chr6:24786108-24786167,hs|6p22.3,"geminin, DNA replication inhibitor",TRUE
1062_BCLAF1_9774,Q9NYF8,bcl-2-associated transcription factor 1 (btf) (bclaf1 and thrap3 family member 1),BCLAF1 BTF KIAA0164,920,function: death-promoting transcriptional repressor. may be involved in cyclin-d1/ccnd1 mrna stability through the snarp complex which associates with both the 3'end of the ccnd1 gene and its mrna. {eco:0000269|pubmed:18794151}.,"subcellular location: cytoplasm. nucleus. nucleus speckle {eco:0000269|pubmed:24100041}. nucleus, nucleoplasm {eco:0000269|pubmed:24100041}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BCLAF1,9774,Hs.486542,ENST00000527613,THC2519361,"GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006917(induction of apoptosis)|GO:0043065(positive regulation of apoptosis)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens BCL2-associated transcription factor 1 (BCLAF1), transcript variant 1, mRNA [NM_014739]",chr6:136579829-136579770,hs|6q23.3,BCL2-associated transcription factor 1,TRUE
1063_ITGAV_3685,P06756,integrin alpha-v (vitronectin receptor) (vitronectin receptor subunit alpha) (cd antigen cd51) [cleaved into: integrin alpha-v heavy chain; integrin alpha-v light chain],ITGAV MSK8 VNRA VTNR,1048,"function: the alpha-v (itgav) integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vwf. they recognize the sequence r-g-d in a wide array of ligands. itgav:itgb3 binds to fractalkine (cx3cl1) and may act as its coreceptor in cx3cr1-dependent fractalkine signaling (pubmed:23125415). itgav:itgb3 binds to nrg1 (via egf domain) and this binding is essential for nrg1-erbb signaling (pubmed:20682778). itgav:itgb3 binds to fgf1 and this binding is essential for fgf1 signaling (pubmed:18441324). itgav:itgb3 binds to fgf2 and this binding is essential for fgf2 signaling (pubmed:28302677). itgav:itgb3 binds to igf1 and this binding is essential for igf1 signaling (pubmed:19578119). itgav:itgb3 binds to igf2 and this binding is essential for igf2 signaling (pubmed:28873464). itgav:itgb3 binds to il1b and this binding is essential for il1b signaling (pubmed:29030430). itgav:itgb3 binds to pla2g2a via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (pubmed:18635536, pubmed:25398877). itgav:itgb3 and itgav:itgb6 act as a receptor for fibrillin-1 (fbn1) and mediate r-g-d-dependent cell adhesion to fbn1 (pubmed:12807887, pubmed:17158881). integrin alpha-v/beta-6 or alpha-v/beta-8 (itgav:itgb6 or itgav:itgb8) mediates r-g-d-dependent release of transforming growth factor beta-1 (tgf-beta-1) from regulatory latency-associated peptide (lap), thereby playing a key role in tgf-beta-1 activation (pubmed:15184403, pubmed:22278742, pubmed:28117447). {eco:0000269|pubmed:12807887, eco:0000269|pubmed:15184403, eco:0000269|pubmed:17158881, eco:0000269|pubmed:18441324, eco:0000269|pubmed:18635536, eco:0000269|pubmed:19578119, eco:0000269|pubmed:20682778, eco:0000269|pubmed:22278742, eco:0000269|pubmed:23125415, eco:0000269|pubmed:25398877, eco:0000269|pubmed:28117447, eco:0000269|pubmed:28302677, eco:0000269|pubmed:28873464, eco:0000269|pubmed:29030430}.; function: (microbial infection) integrin itgav:itgb5 acts as a receptor for adenovirus type c. {eco:0000269|pubmed:20615244}.; function: (microbial infection) integrin itgav:itgb5 and itgav:itgb3 act as receptors for coxsackievirus a9 and b1. {eco:0000269|pubmed:15194773, eco:0000269|pubmed:7519807, eco:0000269|pubmed:9426447}.; function: (microbial infection) integrin itgav:itgb3 acts as a receptor for herpes virus 8/hhv-8. {eco:0000269|pubmed:18045938}.; function: (microbial infection) integrin itgav:itgb6 acts as a receptor for herpes simplex 1/hhv-1. {eco:0000269|pubmed:24367260}.; function: (microbial infection) integrin itgav:itgb3 acts as a receptor for human parechovirus 1. {eco:0000269|pubmed:11160695}.; function: (microbial infection) integrin itgav:itgb3 acts as a receptor for west nile virus. {eco:0000269|pubmed:23658209}.; function: (microbial infection) in case of hiv-1 infection, the interaction with extracellular viral tat protein seems to enhance angiogenesis in kaposi's sarcoma lesions. {eco:0000269|pubmed:10397733}.","subcellular location: cell membrane; single-pass type i membrane protein. cell junction, focal adhesion {eco:0000269|pubmed:17158881}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ITGAV,3685,Hs.436873,ENST00000374907,THC2544883,GO:0001525(angiogenesis)|GO:0001568(blood vessel development)|GO:0001846(opsonin binding)|GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion)|GO:0007160(cell-matrix adhesion)|GO:0007229(integrin-mediated signaling pathway)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0008284(positive regulation of cell proliferation)|GO:0008305(integrin complex)|GO:0009897(external side of plasma membrane)|GO:0009986(cell surface)|GO:0010745(negative regulation of macrophage derived foam cell differentiation)|GO:0010888(negative regulation of lipid storage)|GO:0016020(membrane)|GO:0030335(positive regulation of cell migration)|GO:0031994(insulin-like growth factor I binding)|GO:0032369(negative regulation of lipid transport)|GO:0033690(positive regulation of osteoblast proliferation)|GO:0035635(entry of bacterium into host cell)|GO:0043066(negative regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0045715(negative regulation of low-density lipoprotein particle receptor biosynthetic process)|GO:0045785(positive regulation of cell adhesion)|GO:0046718(entry of virus into host cell)|GO:0050431(transforming growth factor beta binding)|GO:0050748(negative regulation of lipoprotein metabolic process)|GO:0050764(regulation of phagocytosis)|GO:0050900(leukocyte migration)|GO:0052066(entry of symbiont into host cell by promotion of host phagocytosis)|GO:0070371(ERK1 and ERK2 cascade)|GO:0097024(protein kinase C alpha binding)|GO:2000425(regulation of apoptotic cell clearance),"Homo sapiens integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV), transcript variant 1, mRNA [NM_002210]",chr2:187545295-187545354,hs|2q32.1,"integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)",TRUE
1064_TMEM184B_25829,Q9Y519,transmembrane protein 184b (putative mapk-activating protein fm08),TMEM184B C22orf5 PSEC0108,407,function: may activate the map kinase signaling pathway. {eco:0000269|pubmed:12761501}.,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM184B,25829,Hs.182626,ENST00000361684,THC2600214,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 184B (TMEM184B), transcript variant 1, mRNA [NM_012264]",chr22:38615432-38615373,hs|22q13.1,transmembrane protein 184B,TRUE
1065_COX5A_9377,P20674,"cytochrome c oxidase subunit 5a, mitochondrial (cytochrome c oxidase polypeptide va)",COX5A,150,"function: this is the heme a-containing chain of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane.,NA,"DISEASE: Note=Mitochondrial complex IV deficiency is a rare condition caused by mutation in COX5A that lead to pulmonary arterial hypertension (PAH), failure to thrive and lactic acidemia. {ECO:0000269|PubMed:28247525}.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX5A,9377,Hs.401903,ENST00000322347,THC2468165,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0009055(electron carrier activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0046872(metal ion binding),"Homo sapiens cytochrome c oxidase subunit Va (COX5A), nuclear gene encoding mitochondrial protein, mRNA [NM_004255]",chr15:75212695-75212636,hs|15q24.2,cytochrome c oxidase subunit Va,TRUE
1066_PDPK1_5170,O15530,3-phosphoinositide-dependent protein kinase 1 (hpdk1) (ec 2.7.11.1),PDPK1 PDK1,556,"function: serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the agc family of protein kinases. its targets include: protein kinase b (pkb/akt1, pkb/akt2, pkb/akt3), p70 ribosomal protein s6 kinase (rps6kb1), p90 ribosomal protein s6 kinase (rps6ka1, rps6ka2 and rps6ka3), cyclic amp-dependent protein kinase (prkaca), protein kinase c (prkcd and prkcz), serum and glucocorticoid-inducible kinase (sgk1, sgk2 and sgk3), p21-activated kinase-1 (pak1), protein kinase pkn (pkn1 and pkn2). plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to pkb/akt1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. negatively regulates the tgf-beta-induced signaling by: modulating the association of smad3 and smad7 with tgf-beta receptor, phosphorylating smad2, smad3, smad4 and smad7, preventing the nuclear translocation of smad3 and smad4 and the translocation of smad7 from the nucleus to the cytoplasm in response to tgf-beta. activates pparg transcriptional activity and promotes adipocyte differentiation. activates the nf-kappa-b pathway via phosphorylation of ikkb. the tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin ii. controls proliferation, survival, and growth of developing pancreatic cells. participates in the regulation of ca(2+) entry and ca(2+)-activated k(+) channels of mast cells. essential for the motility of vascular endothelial cells (ecs) and is involved in the regulation of their chemotaxis. plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-t cells and mediating notch-induced cell growth and proliferative responses. provides negative feedback inhibition to toll-like receptor-mediated nf-kappa-b activation in macrophages. isoform 3 is catalytically inactive. {eco:0000269|pubmed:10226025, eco:0000269|pubmed:10480933, eco:0000269|pubmed:10995762, eco:0000269|pubmed:12167717, eco:0000269|pubmed:14585963, eco:0000269|pubmed:14604990, eco:0000269|pubmed:16207722, eco:0000269|pubmed:16251192, eco:0000269|pubmed:17327236, eco:0000269|pubmed:17371830, eco:0000269|pubmed:18835241, eco:0000269|pubmed:9094314, eco:0000269|pubmed:9445476, eco:0000269|pubmed:9707564, eco:0000269|pubmed:9768361}.","subcellular location: cytoplasm. nucleus. cell membrane; peripheral membrane protein. cell junction, focal adhesion. note=tyrosine phosphorylation seems to occur only at the cell membrane. translocates to the cell membrane following insulin stimulation by a mechanism that involves binding to grb14 and insr. src and hsp90 promote its localization to the cell membrane. its nuclear localization is dependent on its association with ptpn6 and its phosphorylation at ser-396. restricted to the nucleus in neuronal cells while in non-neuronal cells it is found in the cytoplasm. the ser-241 phosphorylated form is distributed along the perinuclear region in neuronal cells while in non-neuronal cells it is found in both the nucleus and the cytoplasm. igf1 transiently increases phosphorylation at ser-241 of neuronal pdpk1, resulting in its translocation to other cellular compartments. the tyrosine-phosphorylated form colocalizes with ptk2b in focal adhesions after angiotensin ii stimulation.","TISSUE SPECIFICITY: Appears to be expressed ubiquitously. The Tyr-9 phosphorylated form is markedly increased in diseased tissue compared with normal tissue from lung, liver, colon and breast. {ECO:0000269|PubMed:18024423}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PDPK1,5170,Hs.459691,ENST00000354836,NP1156956,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0004676(3-phosphoinositide-dependent protein kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006468(protein phosphorylation)|GO:0006469(negative regulation of protein kinase activity)|GO:0007268(synaptic transmission)|GO:0007596(blood coagulation)|GO:0008286(insulin receptor signaling pathway)|GO:0008543(fibroblast growth factor receptor signaling pathway)|GO:0016301(kinase activity)|GO:0016310(phosphorylation)|GO:0018107(peptidyl-threonine phosphorylation)|GO:0030036(actin cytoskeleton organization)|GO:0030168(platelet activation)|GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway)|GO:0031295(T cell costimulation)|GO:0032148(activation of protein kinase B activity)|GO:0032869(cellular response to insulin stimulus)|GO:0035556(intracellular signal transduction)|GO:0046777(protein autophosphorylation)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0050852(T cell receptor signaling pathway)|GO:0090004(positive regulation of establishment of protein localization in plasma membrane),"Homo sapiens 3-phosphoinositide dependent protein kinase-1 (PDPK1), transcript variant 1, mRNA [NM_002613]",chr16:2645846-2647177,hs|16p13.3,3-phosphoinositide dependent protein kinase-1,TRUE
1067_C12orf57_113246,Q99622,protein c10,C12orf57 C10,126,"function: in brain, may be required for corpus callosum development. {eco:0000269|pubmed:23453666}.",subcellular location: cytoplasm {eco:0000269|pubmed:23453666}.,"TISSUE SPECIFICITY: Ubiquitously expressed, with higher expression in lung and fetal brain. {ECO:0000269|PubMed:23453666}.","DISEASE: Temtamy syndrome (TEMTYS) [MIM:218340]: A mental retardation/multiple congenital anomaly syndrome characterized by variable craniofacial dysmorphism, ocular coloboma, seizures, and brain abnormalities, including abnormalities of the corpus callosum and thalamus. {ECO:0000269|PubMed:23453665, ECO:0000269|PubMed:23453666, ECO:0000269|PubMed:23633300}. Note=The disease is caused by mutations affecting the gene represented in this entry. A variant resulting in a GUG start codon may be able to produce some protein because of a consensus Kozak sequence, although less efficiently than the wild type. This would explain the phenotypic variability observed.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C12orf57,113246,Hs.405913,ENST00000540506,THC2465842,NA,"Homo sapiens chromosome 12 open reading frame 57 (C12orf57), mRNA [NM_138425]",chr12:7055087-7055146,hs|12p13.31,chromosome 12 open reading frame 57,TRUE
1068_NDUFAB1_4706,O14561,"acyl carrier protein, mitochondrial (acp) (ci-sdap) (nadh-ubiquinone oxidoreductase 9.6 kda subunit)",NDUFAB1,156,"function: carrier of the growing fatty acid chain in fatty acid biosynthesis (by similarity). accessory and non-catalytic subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), which functions in the transfer of electrons from nadh to the respiratory chain (pubmed:27626371). {eco:0000250|uniprotkb:p52505, eco:0000269|pubmed:27626371}.","subcellular location: mitochondrion {eco:0000269|pubmed:12611891, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFAB1,4706,Hs.189716,ENST00000484769,THC2734212,"GO:0000036(acyl carrier activity)|GO:0005504(fatty acid binding)|GO:0005509(calcium ion binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0005759(mitochondrial matrix)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006633(fatty acid biosynthetic process)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0022904(respiratory electron transport chain)|GO:0031177(phosphopantetheine binding)|GO:0031966(mitochondrial membrane)|GO:0048037(cofactor binding)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa (NDUFAB1), nuclear gene encoding mitochondrial protein, mRNA [NM_005003]",chr16:23596691-23593672,hs|16p12.2,"NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa",TRUE
1069_PTRH2_51651,Q9Y3E5,"peptidyl-trna hydrolase 2, mitochondrial (pth 2) (ec 3.1.1.29) (bcl-2 inhibitor of transcription 1)",PTRH2 BIT1 PTH2 CGI-147,179,"function: the natural substrate for this enzyme may be peptidyl-trnas which drop off the ribosome during protein synthesis. {eco:0000250}.; function: promotes caspase-independent apoptosis by regulating the function of two transcriptional regulators, aes and tle1. {eco:0000269|pubmed:15006356}.",subcellular location: mitochondrion.,NA,"DISEASE: Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset (IMNEPD) [MIM:616263]: A progressive multisystem disease characterized by a variety of neurologic, endocrine, and, in some patients, pancreatic features. Variable clinical symptoms include global developmental delay, hypotonia, hearing loss, ataxia, hyporeflexia, facial dysmorphism, hypothyroidism, and pancreatic insufficiency. {ECO:0000269|PubMed:25558065, ECO:0000269|PubMed:25574476}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PTRH2,51651,Hs.12677,ENST00000537860,THC2492055,GO:0004045(aminoacyl-tRNA hydrolase activity)|GO:0005739(mitochondrion)|GO:0006915(apoptosis)|GO:0016787(hydrolase activity),"Homo sapiens peptidyl-tRNA hydrolase 2 (PTRH2), nuclear gene encoding mitochondrial protein, mRNA [NM_016077]",chr17:57774800-57774741,hs|17q23.1,peptidyl-tRNA hydrolase 2,TRUE
107_RPS27_6232,P42677,40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1) (small ribosomal subunit protein es27),RPS27 MPS1,84,"function: component of the small ribosomal subunit (pubmed:8706699). required for proper rrna processing and maturation of 18s rrnas (pubmed:25424902). {eco:0000269|pubmed:25424902, eco:0000305|pubmed:8706699}.",NA,TISSUE SPECIFICITY: Expressed in a wide variety of actively proliferating cells and tumor tissues.,"DISEASE: Diamond-Blackfan anemia 17 (DBA17) [MIM:617409]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:25424902}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPS27,6232,Hs.546291,ENST00000493224,THC2596064,GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0003677(DNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008270(zinc ion binding)|GO:0008283(cell proliferation)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0046872(metal ion binding),"Homo sapiens ribosomal protein S27 (RPS27), mRNA [NM_001030]",chr1:153964124-153964571,hs|1q21.3,ribosomal protein S27,TRUE
1070_MGST1_4257,P10620,microsomal glutathione s-transferase 1 (microsomal gst-1) (ec 2.5.1.18) (microsomal gst-i),MGST1 GST12 MGST,155,function: conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. has a wide substrate specificity.,subcellular location: microsome {eco:0000250}. mitochondrion outer membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. endoplasmic reticulum membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,TISSUE SPECIFICITY: Highly expressed in liver.,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MGST1,4257,Hs.389700,ENST00000539708,THC2625515,GO:0004364(glutathione transferase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005743(mitochondrial inner membrane)|GO:0005778(peroxisomal membrane)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006749(glutathione metabolic process)|GO:0006805(xenobiotic metabolic process)|GO:0010243(response to organic nitrogen)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0032496(response to lipopolysaccharide)|GO:0033327(Leydig cell differentiation)|GO:0042493(response to drug)|GO:0042803(protein homodimerization activity)|GO:0043295(glutathione binding)|GO:0045177(apical part of cell)|GO:0070207(protein homotrimerization),"Homo sapiens microsomal glutathione S-transferase 1 (MGST1), transcript variant 1c, mRNA [NM_145791]",chr12:16516907-16516966,hs|12p12.3,microsomal glutathione S-transferase 1,TRUE
1071_NRBP2_340371,Q9NSY0,nuclear receptor-binding protein 2 (transformation-related gene 16 protein) (trg-16),NRBP2 PP9320 TRG16,501,function: may regulate apoptosis of neural progenitor cells during their differentiation. {eco:0000250}.,subcellular location: cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NRBP2,340371,Hs.521926,ENST00000327830,THC2462678,"GO:0000166(nucleotide binding)|GO:0004672(protein kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006468(protein phosphorylation)|GO:0007399(nervous system development)|GO:0016772(transferase activity, transferring phosphorus-containing groups)|GO:0030182(neuron differentiation)|GO:0043524(negative regulation of neuron apoptosis)","Homo sapiens nuclear receptor binding protein 2 (NRBP2), mRNA [NM_178564]",chr8:144916291-144916232,hs|8q24.3,nuclear receptor binding protein 2,TRUE
1072_CTSB_1508,P07858,cathepsin b (ec 3.4.22.1) (app secretase) (apps) (cathepsin b1) [cleaved into: cathepsin b light chain; cathepsin b heavy chain],CTSB CPSB,339,"function: thiol protease which is believed to participate in intracellular degradation and turnover of proteins (pubmed:12220505). cleaves matrix extracellular phosphoglycoprotein mepe (pubmed:12220505). has also been implicated in tumor invasion and metastasis (pubmed:3972105). {eco:0000269|pubmed:12220505, eco:0000269|pubmed:3972105}.","subcellular location: lysosome {eco:0000269|pubmed:16733801}. melanosome {eco:0000269|pubmed:17081065}. secreted, extracellular space {eco:0000250|uniprotkb:a1e295}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000269|pubmed:17081065}.",TISSUE SPECIFICITY: Expressed in the stratum spinosum of the epidermis. Weak expression is detected in the stratum granulosum. {ECO:0000269|PubMed:28457472}.,"DISEASE: Keratolytic winter erythema (KWE) [MIM:148370]: An autosomal dominant genodermatosis characterized by recurrent episodes of palmoplantar erythema and epidermal peeling presenting seasonal variation. KWE manifests during childhood. Skin lesions may spread to the dorsum of hands and feet and to the interdigital spaces. Lower legs, knees and thighs may also be involved. A less common finding is a slowly migratory, annular erythema that is seen mostly on the extremities. Between flares, the skin can appear unremarkable. Itching can occur, and hyperhidrosis, associated with a pungent odor, is invariably present. Formation of vesicles is rare, whereas keratolysis that causes the formation of dry blisters is regularly seen. Cold weather, moisture, febrile diseases, and physical and mental stress can trigger exacerbations. In severely affected individuals, skin manifestations persist unremittingly. Penetrance of the disease is high, but expressivity is variable, even within the same family. {ECO:0000269|PubMed:28457472}. Note=The gene represented in this entry is involved in disease pathogenesis. Tandem duplications in a non-coding genomic region containing an active enhancer element for CTSB result in CTSB abnormal expression with pathological consequences. {ECO:0000269|PubMed:28457472}.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTSB,1508,Hs.520898,ENST00000415599,THC2465648,GO:0004197(cysteine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005622(intracellular)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005764(lysosome)|GO:0005901(caveola)|GO:0006508(proteolysis)|GO:0006914(autophagy)|GO:0007519(skeletal muscle tissue development)|GO:0008233(peptidase activity)|GO:0009611(response to wounding)|GO:0009612(response to mechanical stimulus)|GO:0009749(response to glucose stimulus)|GO:0009897(external side of plasma membrane)|GO:0014070(response to organic cyclic compound)|GO:0014075(response to amine stimulus)|GO:0016324(apical plasma membrane)|GO:0030984(kininogen binding)|GO:0042277(peptide binding)|GO:0042383(sarcolemma)|GO:0042470(melanosome)|GO:0042981(regulation of apoptosis)|GO:0043434(response to peptide hormone stimulus)|GO:0045471(response to ethanol)|GO:0048471(perinuclear region of cytoplasm)|GO:0050790(regulation of catalytic activity)|GO:0060548(negative regulation of cell death)|GO:0070670(response to interleukin-4),"Homo sapiens cathepsin B (CTSB), transcript variant 2, mRNA [NM_147780]",chr8:11701936-11701877,hs|8p23.1,cathepsin B,TRUE
1073_GLTSCR1_29998,Q9NZM4,brd4-interacting chromatin-remodeling complex-associated protein (glioma tumor suppressor candidate region gene 1 protein),BICRA GLTSCR1,1560,"function: component of swi/snf chromatin remodeling subcomplex gbaf that carries out key enzymatic activities, changing chromatin structure by altering dna-histone contacts within a nucleosome in an atp-dependent manner (pubmed:29374058). may play a role in brd4-mediated gene transcription (pubmed:21555454). {eco:0000269|pubmed:21555454, eco:0000269|pubmed:29374058}.",NA,"TISSUE SPECIFICITY: Expressed at moderate levels in heart, brain, placenta, skeletal muscle, and pancreas, and at lower levels in lung, liver and kidney. {ECO:0000269|PubMed:10708517}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GLTSCR1,29998,Hs.97244,NA,THC2472635,GO:0005515(protein binding),"Homo sapiens glioma tumor suppressor candidate region protein 1 (GLTSCR1) mRNA, complete cds. [AF182077]",chr19:48206224-48206285,hs|19q13.33,glioma tumor suppressor candidate region gene 1,TRUE
1074_LTA4H_4048,P09960,leukotriene a-4 hydrolase (lta-4 hydrolase) (ec 3.3.2.6) (leukotriene a(4) hydrolase),LTA4H LTA4,611,"function: epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene b4. has also aminopeptidase activity. {eco:0000269|pubmed:11917124, eco:0000269|pubmed:12207002, eco:0000269|pubmed:15078870, eco:0000269|pubmed:18804029, eco:0000269|pubmed:1897988, eco:0000269|pubmed:1975494, eco:0000269|pubmed:2244921}.",subcellular location: cytoplasm.,"TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LTA4H,4048,Hs.524648,ENST00000413268,NP1161372,GO:0004177(aminopeptidase activity)|GO:0004301(epoxide hydrolase activity)|GO:0004463(leukotriene-A4 hydrolase activity)|GO:0005488(binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0006692(prostanoid metabolic process)|GO:0006954(inflammatory response)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0008270(zinc ion binding)|GO:0010043(response to zinc ion)|GO:0019370(leukotriene biosynthetic process)|GO:0043171(peptide catabolic process)|GO:0043434(response to peptide hormone stimulus)|GO:0046872(metal ion binding)|GO:0060509(Type I pneumocyte differentiation),"Homo sapiens leukotriene A4 hydrolase (LTA4H), mRNA [NM_000895]",chr12:96394826-96394767,hs|12q23.1,leukotriene A4 hydrolase,TRUE
1075_WIPI2_26100,Q9Y4P8,wd repeat domain phosphoinositide-interacting protein 2 (wipi-2) (wipi49-like protein 2),WIPI2 CGI-50,454,"function: component of the autophagy machinery that controls the major intracellular degradation process by which cytoplasmic materials are packaged into autophagosomes and delivered to lysosomes for degradation (pubmed:20505359, pubmed:28561066). involved in an early step of the formation of preautophagosomal structures (pubmed:20505359, pubmed:28561066). binds and is activated by phosphatidylinositol 3-phosphate (ptdins3p) forming on membranes of the endoplasmic reticulum upon activation of the upstream ulk1 and pi3 kinases (pubmed:28561066). once activated, wipi2 recruits at phagophore assembly sites the atg12-atg5-atg16l1 complex that directly controls the elongation of the nascent autophagosomal membrane (pubmed:20505359, pubmed:28561066). {eco:0000269|pubmed:20505359, eco:0000269|pubmed:28561066, eco:0000269|pubmed:30968111}.; function: isoform 4: recruits the atg12-atg5-atg16l1 complex to omegasomes and preautophagosomal structures, resulting in atg8 family proteins lipidation and starvation-induced autophagy. isoform 4 is also required for autophagic clearance of pathogenic bacteria. isoform 4 binds the membrane surrounding salmonella and recruits the atg12-5-16l1 complex, initiating lc3 conjugation, autophagosomal membrane formation, and engulfment of salmonella. {eco:0000269|pubmed:24954904}.","subcellular location: preautophagosomal structure membrane {eco:0000269|pubmed:20505359, eco:0000269|pubmed:21564513, eco:0000269|pubmed:22456507, eco:0000269|pubmed:23916833, eco:0000269|pubmed:28561066}; peripheral membrane protein {eco:0000269|pubmed:20505359, eco:0000269|pubmed:21564513, eco:0000269|pubmed:22456507}; cytoplasmic side {eco:0000269|pubmed:20505359, eco:0000269|pubmed:21564513, eco:0000269|pubmed:22456507}. note=localizes to omegasomes membranes which are endoplasmic reticulum connected structures at the origin of preautophagosomal structures. enriched at preautophagosomal structure membranes in response to ptdins3p. {eco:0000269|pubmed:24954904}.","TISSUE SPECIFICITY: Ubiquitously expressed (at protein level). Highly expressed in heart, skeletal muscle and pancreas. Expression is down-regulated in pancreatic and in kidney tumors. {ECO:0000269|PubMed:15602573, ECO:0000269|PubMed:20505359}.","DISEASE: Intellectual developmental disorder with short stature and variable skeletal anomalies (IDDSSA) [MIM:618453]: An autosomal recessive disorder characterized by severe mental retardation, speech and language impairment, developmental delay, and cardiac, thyroid and skeletal abnormalities. Skeletal features include short stature, camptodactyly, fifth finger clinodactyly, thumb hypoplasia, overlapping toes, and kyphosis or lumbar vertebral abnormalities. {ECO:0000269|PubMed:30968111}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,WIPI2,26100,Hs.122363,ENST00000484262,THC2470669,"GO:0000045(autophagic vacuole assembly)|GO:0000046(autophagic vacuole fusion)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005776(autophagic vacuole)|GO:0005829(cytosol)|GO:0006914(autophagy)|GO:0032266(phosphatidylinositol-3-phosphate binding)|GO:0034045(pre-autophagosomal structure membrane)|GO:0043234(protein complex)|GO:0070772(PAS complex)|GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","Homo sapiens WD repeat domain, phosphoinositide interacting 2 (WIPI2), transcript variant 1, mRNA [NM_015610]",chr7:5270616-5270675,hs|7p22.1,"WD repeat domain, phosphoinositide interacting 2",TRUE
1076_TANC1_85461,Q9C0D5,"protein tanc1 (tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)",TANC1 KIAA1728,1861,function: may be a scaffold component in the postsynaptic density. {eco:0000250}.,"subcellular location: cell junction, synapse, postsynaptic density {eco:0000250}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TANC1,85461,Hs.61590,ENST00000454300,NP1156811,GO:0005488(binding)|GO:0005886(plasma membrane)|GO:0014069(postsynaptic density)|GO:0030054(cell junction)|GO:0045202(synapse)|GO:0045211(postsynaptic membrane),"Homo sapiens tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 (TANC1), transcript variant 1, mRNA [NM_033394]",chr2:160089090-160089149,hs|2q24.2,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1",TRUE
1077_NPM1_4869,P06748,nucleophosmin (npm) (nucleolar phosphoprotein b23) (nucleolar protein no38) (numatrin),NPM1 NPM,294,"function: involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/tp53 and arf. binds ribosome presumably to drive ribosome nuclear export. associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. acts as a chaperonin for the core histones h3, h2b and h4. stimulates apex1 endonuclease activity on apurinic/apyrimidinic (ap) double-stranded dna but inhibits apex1 endonuclease activity on ap single-stranded rna. may exert a control of apex1 endonuclease activity within nucleoli devoted to repair ap on rdna and the removal of oxidized rrna molecules. in concert with brca2, regulates centrosome duplication. regulates centriole duplication: phosphorylation by plk2 is able to trigger centriole replication. negatively regulates the activation of eif2ak2/pkr and suppresses apoptosis through inhibition of eif2ak2/pkr autophosphorylation. antagonizes the inhibitory effect of atf5 on cell proliferation and relieves atf5-induced g2/m blockade (pubmed:22528486). in complex with myc enhances the transcription of myc target genes (pubmed:25956029). {eco:0000269|pubmed:12882984, eco:0000269|pubmed:16107701, eco:0000269|pubmed:17015463, eco:0000269|pubmed:18809582, eco:0000269|pubmed:19188445, eco:0000269|pubmed:20352051, eco:0000269|pubmed:21084279, eco:0000269|pubmed:22002061, eco:0000269|pubmed:22528486, eco:0000269|pubmed:25956029}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:19208757, eco:0000269|pubmed:22528486, eco:0000269|pubmed:25818168, eco:0000269|pubmed:25956029}. nucleus, nucleoplasm {eco:0000269|pubmed:25818168}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. note=generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. has been found in the cytoplasm in patients with primary acute myelogenous leukemia (aml), but not with secondary aml. can shuttle between cytoplasm and nucleus. co- localizes with the methylated form of rps10 in the granular component (gc) region of the nucleolus. colocalized with nucleolin and apex1 in nucleoli. isoform 1 of nek2 is required for its localization to the centrosome during mitosis.",NA,"DISEASE: Note=A chromosomal aberration involving NPM1 is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with ALK. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated. {ECO:0000269|PubMed:8122112, ECO:0000269|PubMed:8633037}.; DISEASE: Note=A chromosomal aberration involving NPM1 is found in a form of acute promyelocytic leukemia. Translocation t(5;17)(q32;q11) with RARA. {ECO:0000269|PubMed:8562957}.; DISEASE: Note=A chromosomal aberration involving NPM1 is a cause of myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34) with MLF1. {ECO:0000269|PubMed:8570204}.; DISEASE: Note=Defects in NPM1 are associated with acute myelogenous leukemia (AML). Mutations in exon 12 affecting the C-terminus of the protein are associated with an aberrant cytoplasmic location. {ECO:0000269|PubMed:15659725}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NPM1,4869,Hs.557550,ENST00000517671,THC2557816,GO:0003676(nucleic acid binding)|GO:0003713(transcription coactivator activity)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005856(cytoskeleton)|GO:0006281(DNA repair)|GO:0006334(nucleosome assembly)|GO:0006886(intracellular protein transport)|GO:0006913(nucleocytoplasmic transport)|GO:0006916(anti-apoptosis)|GO:0006950(response to stress)|GO:0007098(centrosome cycle)|GO:0007165(signal transduction)|GO:0007569(cell aging)|GO:0008104(protein localization)|GO:0008285(negative regulation of cell proliferation)|GO:0010826(negative regulation of centrosome duplication)|GO:0030529(ribonucleoprotein complex)|GO:0030957(Tat protein binding)|GO:0031616(spindle pole centrosome)|GO:0032071(regulation of endodeoxyribonuclease activity)|GO:0034080(CenH3-containing nucleosome assembly at centromere)|GO:0042255(ribosome assembly)|GO:0042393(histone binding)|GO:0042803(protein homodimerization activity)|GO:0043023(ribosomal large subunit binding)|GO:0043024(ribosomal small subunit binding)|GO:0044419(interspecies interaction between organisms)|GO:0046982(protein heterodimerization activity)|GO:0051059(NF-kappaB binding)|GO:0051082(unfolded protein binding)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051259(protein oligomerization)|GO:0060699(regulation of endoribonuclease activity),"Homo sapiens nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1), transcript variant 1, mRNA [NM_002520]",chr5:170837789-170837848,hs|5q35.1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",TRUE
1078_EEF1G_1937,P26641,elongation factor 1-gamma (ef-1-gamma) (eef-1b gamma),EEF1G EF1G PRO1608,437,function: probably plays a role in anchoring the complex to other cellular components.,NA,"TISSUE SPECIFICITY: Highly expressed in pancreatic tumor tissue and to a lesser extent in normal kidney, intestine, pancreas, stomach, lung, brain, spleen and liver.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EEF1G,1937,Hs.144835,ENST00000496634,THC2530226,GO:0003746(translation elongation factor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005853(eukaryotic translation elongation factor 1 complex)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0009615(response to virus)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation elongation factor 1 gamma (EEF1G), mRNA [NM_001404]",chr11:62327560-62327270,hs|11q12.3,eukaryotic translation elongation factor 1 gamma,TRUE
1079_IST1_9798,P53990,ist1 homolog (hist1) (putative mapk-activating protein pm28),IST1 KIAA0174,364,"function: escrt-iii-like protein involved in specific functions of the escrt machinery. is required for efficient abscission during cytokinesis, but not for hiv-1 budding. the involvement in the mvb pathway is not established. involved in recruiting vps4a and/or vps4b to the midbody of dividing cells (pubmed:19129479, pubmed:19129480). during late anaphase, involved in nuclear envelope reassembly and mitotic spindle disassembly together with the escrt-iii complex: ist1 acts by mediating the recruitment of spast to the nuclear membrane, leading to microtubule severing (pubmed:26040712). regulates early endosomal tubulation together with the escrt-iii complex by mediating the recruitment of spast (pubmed:23897888). {eco:0000269|pubmed:19129479, eco:0000269|pubmed:19129480, eco:0000269|pubmed:23897888, eco:0000269|pubmed:26040712}.","subcellular location: cytoplasmic vesicle {eco:0000269|pubmed:19129479, eco:0000269|pubmed:19129480}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:20719964}. midbody {eco:0000269|pubmed:20719964}. nucleus envelope {eco:0000269|pubmed:26040712}. note=localizes to centrosome and midbody of dividing cells (pubmed:19129480, pubmed:19129479, pubmed:20719964). colocalized with spart to the ends of flemming bodies during cytokinesis (pubmed:20719964). localizes to the nuclear envelope during late anaphase (pubmed:26040712). {eco:0000269|pubmed:19129479, eco:0000269|pubmed:19129480, eco:0000269|pubmed:20719964, eco:0000269|pubmed:26040712}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,IST1,9798,Hs.232194,ENST00000439924,THC2494929,GO:0005515(protein binding)|GO:0005793(ER-Golgi intermediate compartment)|GO:0007049(cell cycle)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0051301(cell division),"Homo sapiens increased sodium tolerance 1 homolog (yeast) (IST1), mRNA [NM_014761]",chr16:71962464-71962838,hs|16q22.2,increased sodium tolerance 1 homolog (yeast),TRUE
108_RPS12_6206,P25398,40s ribosomal protein s12 (small ribosomal subunit protein es12),RPS12,132,NA,subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS12,6206,Hs.546289,ENST00000484616,THC2465754,GO:0003674(molecular_function)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S12 (RPS12), mRNA [NM_001016]",chr6:133138639-133138698,hs|6q23.2,ribosomal protein S12,TRUE
1080_IRX4_50805,P78413,iroquois-class homeodomain protein irx-4 (homeodomain protein irxa3) (iroquois homeobox protein 4),IRX4 IRXA3,519,function: likely to be an important mediator of ventricular differentiation during cardiac development.,subcellular location: nucleus {eco:0000305}.,TISSUE SPECIFICITY: Predominantly expressed in cardiac ventricles.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IRX4,50805,Hs.196927,ENST00000505790,THC2478120,GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0007507(heart development)|GO:0043565(sequence-specific DNA binding)|GO:0048561(establishment of organ orientation),"Homo sapiens iroquois homeobox 4 (IRX4), mRNA [NM_016358]",chr5:1877555-1877533,hs|5p15.33,iroquois homeobox 4,TRUE
1081_DDX3Y_8653,O15523,"atp-dependent rna helicase ddx3y (ec 3.6.4.13) (dead box protein 3, y-chromosomal)",DDX3Y DBY,660,function: probable atp-dependent rna helicase. may play a role in spermatogenesis.,subcellular location: cytoplasm {eco:0000269|pubmed:15383328}. nucleus {eco:0000269|pubmed:15383328}. note=shuttles between the nucleus and the cytoplasm in an xpo1-dependent manner.,TISSUE SPECIFICITY: Testis-specific. Expressed predominantly in spermatogonia. {ECO:0000269|PubMed:15294876}.,DISEASE: Note=DDX3Y is located in the 'azoospermia factor a' (AZFa) region on chromosome Y which is deleted in Sertoli cell-only syndrome. This is an infertility disorder in which no germ cells are visible in seminiferous tubules leading to azoospermia.,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDX3Y,8653,Hs.99120,NA,NA,GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0004386(helicase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0008026(ATP-dependent helicase activity)|GO:0016787(hydrolase activity),"Homo sapiens dead box, Y isoform (DBY) mRNA, alternative transcript 2, complete cds. [AF000984]",chrY:15032080-15032140,hs|Yq11.21,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked",TRUE
1082_MCM7_4176,P33993,dna replication licensing factor mcm7 (ec 3.6.4.12) (cdc47 homolog) (p1.1-mcm3),MCM7 CDC47 MCM2,719,"function: acts as component of the mcm2-7 complex (mcm complex) which is the putative replicative helicase essential for 'once per cell cycle' dna replication initiation and elongation in eukaryotic cells. the active atpase sites in the mcm2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the atp-binding site of the walker a box of the adjacent subunit. the six atpase active sites, however, are likely to contribute differentially to the complex helicase activity. required for s-phase checkpoint activation upon uv-induced damage. {eco:0000269|pubmed:15210935, eco:0000269|pubmed:15538388, eco:0000269|pubmed:9305914}.",subcellular location: nucleus {eco:0000250}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MCM7,4176,Hs.438720,ENST00000303887,NP840387,GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000785(chromatin)|GO:0003677(DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0004003(ATP-dependent DNA helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006260(DNA replication)|GO:0006268(DNA unwinding involved in replication)|GO:0006270(DNA-dependent DNA replication initiation)|GO:0006271(DNA strand elongation involved in DNA replication)|GO:0006974(response to DNA damage stimulus)|GO:0008283(cell proliferation)|GO:0016787(hydrolase activity)|GO:0042325(regulation of phosphorylation)|GO:0042555(MCM complex),"Homo sapiens minichromosome maintenance complex component 7 (MCM7), transcript variant 2, mRNA [NM_182776]",chr7:99690579-99690520,hs|7q22.1,minichromosome maintenance complex component 7,TRUE
1083_LAMC1_3915,P11047,laminin subunit gamma-1 (laminin b2 chain) (laminin-1 subunit gamma) (laminin-10 subunit gamma) (laminin-11 subunit gamma) (laminin-2 subunit gamma) (laminin-3 subunit gamma) (laminin-4 subunit gamma) (laminin-6 subunit gamma) (laminin-7 subunit gamma) (laminin-8 subunit gamma) (laminin-9 subunit gamma) (s-laminin subunit gamma) (s-lam gamma),LAMC1 LAMB2,1609,"function: binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.","subcellular location: secreted, extracellular space, extracellular matrix, basement membrane.",TISSUE SPECIFICITY: Found in the basement membranes (major component).,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LAMC1,3915,Hs.609663,ENST00000258341,THC2538877,GO:0005201(extracellular matrix structural constituent)|GO:0005576(extracellular region)|GO:0005604(basement membrane)|GO:0005606(laminin-1 complex)|GO:0005615(extracellular space)|GO:0006461(protein complex assembly)|GO:0007155(cell adhesion)|GO:0007411(axon guidance)|GO:0007492(endoderm development)|GO:0016477(cell migration)|GO:0022617(extracellular matrix disassembly)|GO:0031012(extracellular matrix)|GO:0031581(hemidesmosome assembly)|GO:0034446(substrate adhesion-dependent cell spreading)|GO:0043259(laminin-10 complex)|GO:0043260(laminin-11 complex)|GO:0050679(positive regulation of epithelial cell proliferation),"Homo sapiens laminin, gamma 1 (formerly LAMB2) (LAMC1), mRNA [NM_002293]",chr1:183114406-183114465,hs|1q25.3,"laminin, gamma 1 (formerly LAMB2)",TRUE
1084_RAB10_10890,P61026,ras-related protein rab-10,RAB10,200,"function: the small gtpases rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes (pubmed:21248164). rabs cycle between an inactive gdp-bound form and an active gtp-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (pubmed:21248164). that rab is mainly involved in the biosynthetic transport of proteins from the golgi to the plasma membrane (pubmed:21248164). regulates, for instance, slc2a4/glut4 glucose transporter-enriched vesicles delivery to the plasma membrane (by similarity). in parallel, it regulates the transport of tlr4, a toll-like receptor to the plasma membrane and therefore may be important for innate immune response (by similarity). plays also a specific role in asymmetric protein transport to the plasma membrane (pubmed:16641372). in neurons, it is involved in axonogenesis through regulation of vesicular membrane trafficking toward the axonal plasma membrane (by similarity). in epithelial cells, it regulates transport from the golgi to the basolateral membrane (pubmed:16641372). may play a role in the basolateral recycling pathway and in phagosome maturation (by similarity). may play a role in endoplasmic reticulum dynamics and morphology controlling tubulation along microtubules and tubules fusion (pubmed:23263280). together with lrrk2, rab8a, and rilpl1, it regulates ciliogenesis (pubmed:30398148). when phosphorylated by lrrk2 on thr-73, binds rilpl1 and inhibits ciliogenesis (pubmed:30398148). {eco:0000250|uniprotkb:p24409, eco:0000250|uniprotkb:p61027, eco:0000269|pubmed:16641372, eco:0000269|pubmed:21248164, eco:0000269|pubmed:23263280, eco:0000269|pubmed:30398148}.","subcellular location: cytoplasmic vesicle membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}. golgi apparatus membrane {eco:0000269|pubmed:23263280}. golgi apparatus, trans-golgi network membrane {eco:0000250|uniprotkb:p24409}. endosome membrane {eco:0000269|pubmed:16641372}. recycling endosome membrane {eco:0000250|uniprotkb:p24409}. cytoplasmic vesicle, phagosome membrane {eco:0000250|uniprotkb:p24409}. cytoplasm, cytoskeleton, cilium basal body {eco:0000269|pubmed:20576682, eco:0000269|pubmed:30398148}. endoplasmic reticulum membrane {eco:0000269|pubmed:23263280}. cytoplasm, perinuclear region {eco:0000269|pubmed:29212815}. note=associates with slc2a4/glut4 storage vesicles (pubmed:22908308). localizes to the base of the cilium when phosphorylated by lrrk2 on thr-73 (pubmed:20576682, pubmed:30398148). transiently associates with phagosomes (by similarity). localizes to the endoplasmic reticulum at domains of new tubule growth (pubmed:23263280). {eco:0000250|uniprotkb:p24409, eco:0000269|pubmed:20576682, eco:0000269|pubmed:22908308, eco:0000269|pubmed:23263280, eco:0000269|pubmed:30398148}.","TISSUE SPECIFICITY: Expressed in the hippocampus (PubMed:29562525). Expressed in neutrophils (at protein level) (PubMed:29127255). {ECO:0000269|PubMed:29127255, ECO:0000269|PubMed:29562525}.",NA,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,RAB10,10890,Hs.467960,ENST00000264710,THC2465504,GO:0000166(nucleotide binding)|GO:0005525(GTP binding)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0007264(small GTPase mediated signal transduction)|GO:0015031(protein transport),"Homo sapiens RAB10, member RAS oncogene family (RAB10), mRNA [NM_016131]",chr2:26359998-26360057,hs|2p23.3,"RAB10, member RAS oncogene family",TRUE
1085_FAM117B_150864,Q6P1L5,protein fam117b (amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein),FAM117B ALS2CR13,589,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM117B,150864,Hs.471130,ENST00000303116,THC2629531,NA,"Homo sapiens family with sequence similarity 117, member B (FAM117B), mRNA [NM_173511]",chr2:203634375-203634434,hs|2q33.2,"family with sequence similarity 117, member B",TRUE
1086_RBPJ_3516,Q06330,recombining binding protein suppressor of hairless (cbf-1) (j kappa-recombination signal-binding protein) (rbp-j kappa) (rbp-j) (rbp-jk) (renal carcinoma antigen ny-ren-30),RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH,500,"function: transcriptional regulator that plays a central role in notch signaling, a signaling pathway involved in cell-cell communication that regulates a broad spectrum of cell-fate determinations. acts as a transcriptional repressor when it is not associated with notch proteins. when associated with some nicd product of notch proteins (notch intracellular domain), it acts as a transcriptional activator that activates transcription of notch target genes. probably represses or activates transcription via the recruitment of chromatin remodeling complexes containing histone deacetylase or histone acetylase proteins, respectively. specifically binds to the immunoglobulin kappa-type j segment recombination signal sequence. binds specifically to methylated dna (pubmed:21991380). binds to the oxygen responsive element of cox4i2 and activates its transcription under hypoxia conditions (4% oxygen) (pubmed:23303788). negatively regulates the phagocyte oxidative burst in response to bacterial infection by repressing transcription of nadph oxidase subunits (by similarity). {eco:0000250|uniprotkb:p31266, eco:0000269|pubmed:21991380, eco:0000269|pubmed:23303788}.","subcellular location: nucleus. cytoplasm. note=mainly nuclear, upon interaction with rita/c12orf52, translocates to the cytoplasm, down-regulating the notch signaling pathway.",NA,"DISEASE: Adams-Oliver syndrome 3 (AOS3) [MIM:614814]: An autosomal dominant form of Adams-Oliver syndrome, a disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. AOS3 patients manifest characteristic vertex scalp defects and terminal limb defects, but without congenital heart defects, other associated defects, or immune defects. {ECO:0000269|PubMed:22883147}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBPJ,3516,Hs.479396,ENST00000505727,THC2619416,"GO:0000150(recombinase activity)|GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006310(DNA recombination)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007221(positive regulation of transcription of Notch receptor target)|GO:0010467(gene expression)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens recombination signal binding protein for immunoglobulin kappa J region (RBPJ), transcript variant 4, mRNA [NM_203284]",chr4:26432686-26432745,hs|4p15.2,recombination signal binding protein for immunoglobulin kappa J region,TRUE
1087_GORASP2_26003,Q9H8Y8,golgi reassembly-stacking protein 2 (grs2) (golgi phosphoprotein 6) (golph6) (golgi reassembly-stacking protein of 55 kda) (grasp55) (p59),GORASP2 GOLPH6,452,"function: plays a role in the assembly and membrane stacking of the golgi cisternae, and in the process by which golgi stacks reform after breakdown during mitosis and meiosis (pubmed:10487747, pubmed:21515684, pubmed:22523075). may regulate the intracellular transport and presentation of a defined set of transmembrane proteins, such as transmembrane tgfa (pubmed:11101516). required for normal acrosome formation during spermiogenesis and normal male fertility, probably by promoting colocalization of jam2 and jam3 at contact sites between germ cells and sertoli cells (by similarity). mediates er stress-induced unconventional (er/golgi-independent) trafficking of core-glycosylated cftr to cell membrane (pubmed:21884936, pubmed:27062250, pubmed:28067262). {eco:0000250|uniprotkb:q99jx3, eco:0000269|pubmed:10487747, eco:0000269|pubmed:11101516, eco:0000269|pubmed:21515684, eco:0000269|pubmed:21884936, eco:0000269|pubmed:22523075, eco:0000269|pubmed:27062250, eco:0000269|pubmed:28067262}.","subcellular location: golgi apparatus membrane {eco:0000269|pubmed:10487747, eco:0000269|pubmed:11101516, eco:0000269|pubmed:27062250}; lipid-anchor {eco:0000269|pubmed:11101516}. endoplasmic reticulum membrane {eco:0000269|pubmed:27062250}. golgi apparatus {eco:0000269|pubmed:28067262}. note=detected in the intermediate golgi, membrane-associated (by similarity). er stress triggers its relocalization from golgi to er membrane (pubmed:27062250, pubmed:28067262). {eco:0000250|uniprotkb:q9r064, eco:0000269|pubmed:27062250, eco:0000269|pubmed:28067262}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GORASP2,26003,Hs.431317,ENST00000486498,THC2465486,GO:0000139(Golgi membrane)|GO:0005794(Golgi apparatus)|GO:0005797(Golgi medial cisterna)|GO:0006996(organelle organization)|GO:0007030(Golgi organization)|GO:0016020(membrane),"Homo sapiens golgi reassembly stacking protein 2, 55kDa (GORASP2), transcript variant 1, mRNA [NM_015530]",chr2:171823014-171823073,hs|2q31.1,"golgi reassembly stacking protein 2, 55kDa",TRUE
1088_PPIA_5478,P62937,"peptidyl-prolyl cis-trans isomerase a (ppiase a) (ec 5.2.1.8) (cyclophilin a) (cyclosporin a-binding protein) (rotamase a) [cleaved into: peptidyl-prolyl cis-trans isomerase a, n-terminally processed]",PPIA CYPA,165,function: ppiases accelerate the folding of proteins. it catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. {eco:0000269|pubmed:20676357}.,"subcellular location: cytoplasm {eco:0000269|pubmed:16527992}. secreted {eco:0000269|pubmed:16527992}. note=secretion occurs in response to oxidative stress in vascular smooth muscle through a vesicular secretory pathway that involves actin remodeling and myosin ii activation, and mediates erk1/2 activation.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PPIA,5478,Hs.356331,ENST00000415933,THC2566146,GO:0002576(platelet degranulation)|GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006278(RNA-dependent DNA replication)|GO:0006457(protein folding)|GO:0007596(blood coagulation)|GO:0016032(viral reproduction)|GO:0016853(isomerase activity)|GO:0019047(provirus integration)|GO:0019059(initiation of viral infection)|GO:0019061(uncoating of virus)|GO:0030168(platelet activation)|GO:0030260(entry into host cell)|GO:0042277(peptide binding)|GO:0044419(interspecies interaction between organisms)|GO:0045069(regulation of viral genome replication)|GO:0046790(virion binding)|GO:0050900(leukocyte migration)|GO:0051082(unfolded protein binding),"Homo sapiens peptidylprolyl isomerase A (cyclophilin A) (PPIA), mRNA [NM_021130]",chr7:44841005-44841064,hs|7p13,peptidylprolyl isomerase A (cyclophilin A),TRUE
109_PPAP2A_8611,O14494,phospholipid phosphatase 1 (ec 3.1.3.4) (lipid phosphate phosphohydrolase 1) (pap2-alpha) (phosphatidate phosphohydrolase type 2a) (phosphatidic acid phosphatase 2a) (pap-2a) (pap2a),PLPP1 LPP1 PPAP2A,284,"function: broad-specificity phosphohydrolase that dephosphorylates exogenous bioactive glycerolipids and sphingolipids. catalyzes the conversion of phosphatidic acid (pa) to diacylglycerol (dg). pivotal regulator of lysophosphatidic acid (lpa) signaling in the cardiovascular system. major enzyme responsible of dephosphorylating lpa in platelets, which terminates signaling actions of lpa. may control circulating, and possibly also regulate localized, lpa levels resulting from platelet activation. it has little activity towards ceramide-1-phosphate (c-1-p) and sphingosine-1-phosphate (s-1-p). the relative catalytic efficiency is lpa > pa > s-1-p > c-1-p. it's down-regulation may contribute to the development of colon adenocarcinoma. {eco:0000269|pubmed:12909631}.",subcellular location: cell membrane; multi-pass membrane protein.,"TISSUE SPECIFICITY: Ubiquitously expressed with highest expression found in prostate. Isoform 1 is predominant in kidney, lung, placenta and liver. Isoform 2 is predominant in heart and pancreas. Found to be down-regulated in colon adenocarcinomas.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PPAP2A,8611,Hs.696231,ENST00000307259,THC2579307,GO:0005624(membrane fraction)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006629(lipid metabolic process)|GO:0006665(sphingolipid metabolic process)|GO:0007205(activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway)|GO:0008195(phosphatidate phosphatase activity)|GO:0008285(negative regulation of cell proliferation)|GO:0008354(germ cell migration)|GO:0016787(hydrolase activity)|GO:0019216(regulation of lipid metabolic process)|GO:0030518(steroid hormone receptor signaling pathway)|GO:0030521(androgen receptor signaling pathway)|GO:0046839(phospholipid dephosphorylation),"Homo sapiens phosphatidic acid phosphatase type 2A (PPAP2A), transcript variant 2, mRNA [NM_176895]",chr5:54721742-54721155,hs|5q11.2,phosphatidic acid phosphatase type 2A,TRUE
1090_TSPYL5_85453,Q86VY4,testis-specific y-encoded-like protein 5 (tspy-like protein 5),TSPYL5 KIAA1750,417,"function: involved in modulation of cell growth and cellular response to gamma radiation probably via regulation of the akt signaling pathway. involved in regulation of p53/tp53. suppresses p53/tp53 protein levels and promotes its ubiquitination; the function is dependent on usp7 and independent on mdm2. proposed to displace p53/tp53 from interaction with usp7. {eco:0000269|pubmed:20079711, eco:0000269|pubmed:21170034}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TSPYL5,85453,Hs.173094,ENST00000322128,THC2609202,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006334(nucleosome assembly)|GO:0008284(positive regulation of cell proliferation)|GO:0031398(positive regulation of protein ubiquitination)|GO:0040008(regulation of growth)|GO:0051897(positive regulation of protein kinase B signaling cascade)|GO:0071480(cellular response to gamma radiation),"Homo sapiens TSPY-like 5 (TSPYL5), mRNA [NM_033512]",chr8:98285844-98285785,hs|8q22.1,TSPY-like 5,TRUE
1091_RBBP6_5930,Q7Z6E9,e3 ubiquitin-protein ligase rbbp6 (ec 2.3.2.27) (proliferation potential-related protein) (protein p2p-r) (ring-type e3 ubiquitin transferase rbbp6) (retinoblastoma-binding q protein 1) (rbq-1) (retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),RBBP6 P2PR PACT RBQ1 My038,1792,"function: e3 ubiquitin-protein ligase which promotes ubiquitination of ybx1, leading to its degradation by the proteasome (pubmed:18851979). may play a role as a scaffold protein to promote the assembly of the p53/tp53-mdm2 complex, resulting in increase of mdm2-mediated ubiquitination and degradation of p53/tp53; may function as negative regulator of p53/tp53, leading to both apoptosis and cell growth (by similarity). regulates dna-replication and the stability of chromosomal common fragile sites (cfss) in a zbtb38- and mcm10-dependent manner. controls zbtb38 protein stability and abundance via ubiquitination and proteasomal degradation, and zbtb38 in turn negatively regulates the expression of mcm10 which plays an important role in dna-replication (pubmed:24726359). {eco:0000250|uniprotkb:p97868, eco:0000269|pubmed:18851979, eco:0000269|pubmed:24726359}.","subcellular location: nucleus, nucleolus. chromosome. cytoplasm, cytoskeleton, microtubule organizing center, centrosome. note=colocalizes with mitotic chromosomes. colocalizes with nek6 in the centrosome.","TISSUE SPECIFICITY: Highly expressed in the placenta and testis. Expressed at lower levels in the brain, heart, kidney, liver and lung. Overexpressed in esophageal cancer. {ECO:0000269|PubMed:15475430}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,RBBP6,5930,NA,NA,THC2478571,GO:0000151(ubiquitin ligase complex)|GO:0003676(nucleic acid binding)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005856(cytoskeleton)|GO:0008270(zinc ion binding)|GO:0016874(ligase activity)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0046872(metal ion binding),"Homo sapiens retinoblastoma binding protein 6, mRNA (cDNA clone IMAGE:6214974), with apparent retained intron. [BC051317]",chr16:24552220-24552279,hs|16p12.1,retinoblastoma binding protein 6,TRUE
1092_B2M_567,P61769,beta-2-microglobulin [cleaved into: beta-2-microglobulin form pi 5.3],B2M CDABP0092 HDCMA22P,119,"function: component of the class i major histocompatibility complex (mhc). involved in the presentation of peptide antigens to the immune system. exogenously applied m.tuberculosis esxa or esxa-esxb (or esxa expressed in host) binds b2m and decreases its export to the cell surface (total protein levels do not change), probably leading to defects in class i antigen presentation (pubmed:25356553). {eco:0000269|pubmed:25356553}.","subcellular location: secreted {eco:0000269|pubmed:1336137, eco:0000269|pubmed:7554280}. cell surface {eco:0000269|pubmed:25356553}. note=detected in serum and urine (pubmed:1336137, pubmed:7554280). {eco:0000269|pubmed:7554280, eco:0000269|ref.6}.; subcellular location: note=(microbial infection) in the presence of m.tuberculosis esxa-esxb complex decreased amounts of b2m are found on the cell surface (pubmed:25356553). {eco:0000269|pubmed:25356553}.",NA,"DISEASE: Immunodeficiency 43 (IMD43) [MIM:241600]: A disorder characterized by marked reduction in serum concentrations of immunoglobulins and albumin, and hypoproteinemia due to hypercatabolism. Patients may suffer from recurrent respiratory tract infections and severe skin disease. {ECO:0000269|PubMed:16549777}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyloidosis 8 (AMYL8) [MIM:105200]: A form of hereditary generalized amyloidosis. Clinical features include extensive visceral amyloid deposits, renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash. There is no involvement of the nervous system. {ECO:0000269|PubMed:22693999}. Note=The disease is caused by mutations affecting the gene represented in this entry. Apart from the presence of causative mutations, beta-2-microglobulin may adopt the fibrillar configuration of amyloid when its serum levels are persistently high. High beta(2)-microglobulin serum levels result in amyloidosis in patients on long-term hemodialysis (PubMed:7918443). In contrast to patients with dialysis-related amyloidosis, patients with hereditary amyloidosis have normal circulating concentrations of beta2-microglobulin (PubMed:22693999). {ECO:0000269|PubMed:22693999, ECO:0000269|PubMed:7918443}.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,B2M,567,Hs.534255,ENST00000396754,THC2593660,GO:0000139(Golgi membrane)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005788(endoplasmic reticulum lumen)|GO:0005886(plasma membrane)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016032(viral reproduction)|GO:0019221(cytokine-mediated signaling pathway)|GO:0031901(early endosome membrane)|GO:0042493(response to drug)|GO:0042612(MHC class I protein complex)|GO:0046686(response to cadmium ion)|GO:0050690(regulation of defense response to virus by virus)|GO:0050776(regulation of immune response)|GO:0060333(interferon-gamma-mediated signaling pathway),"Homo sapiens beta-2-microglobulin (B2M), mRNA [NM_004048]",chr15:45007773-45007832,hs|15q21.1,beta-2-microglobulin,TRUE
1093_EIF1AX_1964,P47813,"eukaryotic translation initiation factor 1a, x-chromosomal (eif-1a x isoform) (eukaryotic translation initiation factor 4c) (eif-4c)",EIF1AX EIF1A EIF4C,144,function: seems to be required for maximal rate of protein biosynthesis. enhances ribosome dissociation into subunits and stabilizes the binding of the initiator met-trna(i) to 40 s ribosomal subunits.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF1AX,1964,Hs.522590,ENST00000379607,THC2461811,"GO:0003743(translation initiation factor activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0008135(translation factor activity, nucleic acid binding)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process)","Homo sapiens eukaryotic translation initiation factor 1A, X-linked (EIF1AX), mRNA [NM_001412]",chrX:20142662-20142636,hs|Xp22.12,"eukaryotic translation initiation factor 1A, X-linked",TRUE
1094_IMPA1_3612,P29218,inositol monophosphatase 1 (imp 1) (impase 1) (ec 3.1.3.25) (d-galactose 1-phosphate phosphatase) (ec 3.1.3.94) (inositol-1(or 4)-monophosphatase 1) (lithium-sensitive myo-inositol monophosphatase a1),IMPA1 IMPA,277,"function: responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. has broad substrate specificity and can use myo-inositol monophosphates, myo-inositol 1,3-diphosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-phosphate, d-galactose 1-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-amp as substrates. {eco:0000269|pubmed:17068342, eco:0000269|pubmed:8718889, eco:0000269|pubmed:9462881}.",subcellular location: cytoplasm {eco:0000269|pubmed:17068342}.,NA,"DISEASE: Mental retardation, autosomal recessive 59 (MRT59) [MIM:617323]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT59 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:26416544}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IMPA1,3612,Hs.656694,ENST00000256108,THC2466293,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006661(phosphatidylinositol biosynthetic process)|GO:0006796(phosphate metabolic process)|GO:0007165(signal transduction)|GO:0008934(inositol-1(or 4)-monophosphatase activity)|GO:0010226(response to lithium ion)|GO:0016787(hydrolase activity)|GO:0030424(axon)|GO:0042803(protein homodimerization activity)|GO:0043025(neuronal cell body)|GO:0046855(inositol phosphate dephosphorylation)|GO:0046872(metal ion binding),"Homo sapiens inositol(myo)-1(or 4)-monophosphatase 1 (IMPA1), transcript variant 1, mRNA [NM_005536]",chr8:82570477-82570418,hs|8q21.13,inositol(myo)-1(or 4)-monophosphatase 1,TRUE
1095_NDUFA7_4701,O95182,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (complex i-b14.5a) (ci-b14.5a) (nadh-ubiquinone oxidoreductase subunit b14.5a),NDUFA7,113,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA7,4701,Hs.333427,ENST00000301457,THC2540471,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0042773(ATP synthesis coupled electron transport)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa (NDUFA7), nuclear gene encoding mitochondrial protein, mRNA [NM_005001]",chr19:8376334-8376275,hs|19p13.2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa",TRUE
1096_ANKHD1_54882,Q8IWZ3,ankyrin repeat and kh domain-containing protein 1 (hiv-1 vpr-binding ankyrin repeat protein) (multiple ankyrin repeats single kh domain) (hmask),ANKHD1 KIAA1085 MASK VBARP PP2500,2542,function: may play a role as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells. isoform 2 may possess an antiapoptotic effect and protect cells during normal cell survival through its regulation of caspases. {eco:0000269|pubmed:16098192}.,"subcellular location: cytoplasm {eco:0000269|pubmed:16098192, eco:0000269|pubmed:16956752}.","TISSUE SPECIFICITY: Ubiquitous with high expression in cervix, spleen and brain. Expressed in hematopoietic cells with increased expression in leukemia cells. Isoform 2 is highly expressed in spleen with almost no expression in muscle and brain. {ECO:0000269|PubMed:14557257, ECO:0000269|PubMed:16098192, ECO:0000269|PubMed:16956752}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ANKHD1,54882,Hs.594084,ENST00000536646,THC2649878,GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm),"Homo sapiens ankyrin repeat and KH domain containing 1 (ANKHD1), transcript variant 1, mRNA [NM_017747]",chr5:139893010-139903655,hs|5q31.3,ankyrin repeat and KH domain containing 1,TRUE
1097_CCDC28A_25901,Q8IWP9,coiled-coil domain-containing protein 28a (ccrl1ap),CCDC28A C6orf80,274,NA,NA,NA,DISEASE: Note=A chromosomal aberration involving CCDC28A has been identified in acute leukemias. Translocation t(6;11)(q24.1;p15.5) with NUP98. The chimeric transcript is an in-frame fusion of NUP98 exon 13 to CCDC28A exon 2. Ectopic expression of NUP98-CCDC28A in mouse promotes the proliferative capacity and self-renewal potential of hematopoietic progenitors and rapidly induced fatal myeloproliferative neoplasms and defects in the differentiation of the erythro-megakaryocytic lineage. {ECO:0000269|PubMed:16028218}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,CCDC28A,25901,Hs.412019,ENST00000026464,THC2615073,NA,"Homo sapiens coiled-coil domain containing 28A (CCDC28A), mRNA [NM_015439]",chr6:139114248-139114307,hs|6q24.1,coiled-coil domain containing 28A,TRUE
1098_ARGLU1_55082,Q9NWB6,arginine and glutamate-rich protein 1,ARGLU1,273,function: required for the estrogen-dependent expression of esr1 target genes. can act in cooperation with med1. {eco:0000269|pubmed:21454576}.,"subcellular location: nucleus {eco:0000269|pubmed:21454576}. note=recruited, in an estrogen-dependent manner, to esr1 target gene promoters. colocalizes with med1.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARGLU1,55082,Hs.508644,ENST00000375926,THC2583670,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens arginine and glutamate rich 1 (ARGLU1), mRNA [NM_018011]",chr13:107209409-107196463,hs|13q33.3,arginine and glutamate rich 1,TRUE
1099_WDR90_197335,Q96KV7,wd repeat-containing protein 90,WDR90 C16orf15 C16orf16 C16orf17 C16orf18 C16orf19 KIAA1924,1748,function: required for efficient primary cilium formation. {eco:0000269|pubmed:28781053}.,"subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {eco:0000269|pubmed:28781053}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,WDR90,197335,Hs.511903,ENST00000547407,THC2607026,NA,"Homo sapiens WD repeat domain 90 (WDR90), mRNA [NM_145294]",chr16:717721-717780,hs|16p13.3,WD repeat domain 90,TRUE
11_MGC10814_84757,Q9BSM7,mgc10814 protein,MGC10814,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,MGC10814,84757,Hs.679519,NA,NA,NA,"Homo sapiens hypothetical protein MGC10814, mRNA (cDNA clone MGC:10814 IMAGE:3613095), complete cds. [BC004943]",chr19:18992197-18992138,hs|19p13.11,uncharacterized protein MGC10814,TRUE
110_AMD1_262,P17707,s-adenosylmethionine decarboxylase proenzyme (adometdc) (samdc) (ec 4.1.1.50) [cleaved into: s-adenosylmethionine decarboxylase alpha chain; s-adenosylmethionine decarboxylase beta chain],AMD1 AMD,334,"function: essential for biosynthesis of the polyamines spermidine and spermine. promotes maintenance and self-renewal of embryonic stem cells, by maintaining spermine levels. {eco:0000250|uniprotkb:p0dmn7}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,AMD1,262,Hs.159118,ENST00000451850,THC2576997,GO:0004014(adenosylmethionine decarboxylase activity)|GO:0005829(cytosol)|GO:0006595(polyamine metabolic process)|GO:0006597(spermine biosynthetic process)|GO:0008295(spermidine biosynthetic process)|GO:0016829(lyase activity)|GO:0034641(cellular nitrogen compound metabolic process),"Homo sapiens adenosylmethionine decarboxylase 1 (AMD1), transcript variant 1, mRNA [NM_001634]",chr6:111214701-111214760,hs|6q21,adenosylmethionine decarboxylase 1,TRUE
1100_KIAA0494_9813,O75071,ef-hand calcium-binding domain-containing protein 14,EFCAB14 KIAA0494,495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,KIAA0494,9813,Hs.592859,ENST00000371933,THC2502894,GO:0005509(calcium ion binding),"Homo sapiens KIAA0494 (KIAA0494), mRNA [NM_014774]",chr1:47141088-47141029,hs|1p33,KIAA0494,TRUE
1101_ID1_3397,P41134,dna-binding protein inhibitor id-1 (class b basic helix-loop-helix protein 24) (bhlhb24) (inhibitor of dna binding 1) (inhibitor of differentiation 1),ID1 BHLHB24 ID,155,"function: transcriptional regulator (lacking a basic dna binding domain) which negatively regulates the basic helix-loop-helix (bhlh) transcription factors by forming heterodimers and inhibiting their dna binding and transcriptional activity. implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. inhibits skeletal muscle and cardiac myocyte differentiation. regulates the circadian clock by repressing the transcriptional activator activity of the clock-arntl/bmal1 heterodimer (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000250}. nucleus.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,ID1,3397,Hs.504609,ENST00000376105,THC2587723,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001525(angiogenesis)|GO:0001886(endothelial cell morphogenesis)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006915(apoptosis)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0007275(multicellular organismal development)|GO:0010621(negative regulation of transcription by transcription factor localization)|GO:0030509(BMP signaling pathway)|GO:0031648(protein destabilization)|GO:0032963(collagen metabolic process)|GO:0043392(negative regulation of DNA binding)|GO:0043408(regulation of MAPKKK cascade)|GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity)|GO:0043534(blood vessel endothelial cell migration)|GO:0045668(negative regulation of osteoblast differentiation)|GO:0045765(regulation of angiogenesis)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046677(response to antibiotic)|GO:0048514(blood vessel morphogenesis)|GO:0060425(lung morphogenesis)|GO:0060426(lung vasculature development)","Homo sapiens inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1), transcript variant 1, mRNA [NM_002165]",chr20:30194158-30194217,hs|20q11.21,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",TRUE
1102_BRD1_23774,O95696,bromodomain-containing protein 1 (br140-like protein) (bromodomain and phd finger-containing protein 2),BRD1 BRL BRPF2,1058,"function: component of the moz/morf complex which has a histone h3 acetyltransferase activity. {eco:0000269|pubmed:16387653, eco:0000269|pubmed:21880731}.",subcellular location: nucleus {eco:0000269|pubmed:21880731}.,TISSUE SPECIFICITY: Highly expressed in testis.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BRD1,23774,Hs.127950,ENST00000457780,NP1473492,GO:0005634(nucleus)|GO:0008270(zinc ion binding)|GO:0016568(chromatin modification)|GO:0043966(histone H3 acetylation)|GO:0046872(metal ion binding)|GO:0070776(MOZ/MORF histone acetyltransferase complex),"Homo sapiens bromodomain containing 1 (BRD1), mRNA [NM_014577]",chr22:50167024-50166965,hs|22q13.33,bromodomain containing 1,TRUE
1103_USO1_8615,O60763,general vesicular transport factor p115 (protein uso1 homolog) (transcytosis-associated protein) (tap) (vesicle-docking protein),USO1 VDP,962,function: general vesicular transport factor required for intercisternal transport in the golgi stack; it is required for transcytotic fusion and/or subsequent binding of the vesicles to the target membrane. may well act as a vesicular anchor by interacting with the target membrane and holding the vesicular and target membranes in proximity. {eco:0000250|uniprotkb:p41542}.,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:19454686, eco:0000269|pubmed:9478999}. golgi apparatus membrane {eco:0000269|pubmed:19454686, eco:0000269|pubmed:9478999}; peripheral membrane protein {eco:0000269|pubmed:19454686, eco:0000269|pubmed:9478999}. note=recycles between the cytosol and the golgi apparatus during interphase. during interphase, the phosphorylated form is found exclusively in cytosol; the unphosphorylated form is associated with golgi apparatus membranes. {eco:0000269|pubmed:19454686, eco:0000269|pubmed:9478999}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,USO1,8615,Hs.292689,ENST00000264904,THC2760832,GO:0000139(Golgi membrane)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0008565(protein transporter activity)|GO:0016020(membrane)|GO:0048280(vesicle fusion with Golgi apparatus),"Homo sapiens USO1 vesicle docking protein homolog (yeast) (USO1), mRNA [NM_003715]",chr4:76734902-76734961,hs|4q21.1,USO1 vesicle docking protein homolog (yeast),TRUE
1104_CHMP3_51652,Q9Y3E7,charged multivesicular body protein 3 (chromatin-modifying protein 3) (neuroendocrine differentiation factor) (vacuolar protein sorting-associated protein 24) (hvps24),CHMP3 CGI149 NEDF VPS24 CGI-149,222,"function: probable core component of the endosomal sorting required for transport complex iii (escrt-iii) which is involved in multivesicular bodies (mvbs) formation and sorting of endosomal cargo proteins into mvbs. mvbs contain intraluminal vesicles (ilvs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. the mvb pathway appears to require the sequential function of escrt-o, -i,-ii and -iii complexes. escrt-iii proteins mostly dissociate from the invaginating membrane before the ilv is released. the escrt machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (hiv-1 and other lentiviruses). escrt-iii proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the aaa atpase vps4. selectively binds to phosphatidylinositol 3,5-bisphosphate ptdins(3,5)p2 and ptdins(3,4)p2 in preference to other phosphoinositides tested. involved in late stages of cytokinesis. plays a role in endosomal sorting/trafficking of egf receptor. isoform 2 prevents stress-mediated cell death and accumulation of reactive oxygen species when expressed in yeast cells. {eco:0000269|pubmed:14505570, eco:0000269|pubmed:15707591, eco:0000269|pubmed:16740483, eco:0000269|pubmed:17331679, eco:0000269|pubmed:18076377}.","subcellular location: cytoplasm, cytosol. membrane; lipid-anchor. endosome. late endosome membrane {eco:0000305}. note=localizes to the midbody of dividing cells.","TISSUE SPECIFICITY: Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:15632132}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CHMP3,51652,Hs.591582,ENST00000263856,THC2493800,"GO:0000910(cytokinesis)|GO:0005515(protein binding)|GO:0005546(phosphatidylinositol-4,5-bisphosphate binding)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0005829(cytosol)|GO:0007049(cell cycle)|GO:0008333(endosome to lysosome transport)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016197(endosome transport)|GO:0030496(midbody)|GO:0031902(late endosome membrane)|GO:0051036(regulation of endosome size)","Homo sapiens charged multivesicular body protein 3 (CHMP3), transcript variant 1, mRNA [NM_016079]",chr2:86730707-86730648,hs|2p11.2,charged multivesicular body protein 3,TRUE
1105_SGK1_6446,O00141,serine/threonine-protein kinase sgk1 (ec 2.7.11.1) (serum/glucocorticoid-regulated kinase 1),SGK1 SGK,431,"function: serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. plays an important role in cellular stress response. contributes to regulation of renal na(+) retention, renal k(+) elimination, salt appetite, gastric acid secretion, intestinal na(+)/h(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. up-regulates na(+) channels: scnn1a/enac, scn5a and asic1/accn2, k(+) channels: kcnj1/romk1, kcna1-5, kcnq1-5 and kcne1, epithelial ca(2+) channels: trpv5 and trpv6, chloride channels: bsnd, clcn2 and cftr, glutamate transporters: slc1a3/eaat1, slc1a2 /eaat2, slc1a1/eaat3, slc1a6/eaat4 and slc1a7/eaat5, amino acid transporters: slc1a5/asct2, slc38a1/sn1 and slc6a19, creatine transporter: slc6a8, na(+)/dicarboxylate cotransporter: slc13a2/nadc1, na(+)-dependent phosphate cotransporter: slc34a2/napi-2b, glutamate receptor: grik2/glur6. up-regulates carriers: slc9a3/nhe3, slc12a1/nkcc2, slc12a3/ncc, slc5a3/smit, slc2a1/glut1, slc5a1/sglt1 and slc15a2/pept2. regulates enzymes: gsk3a/b, pmm2 and na(+)/k(+) atpase, and transcription factors: ctnnb1 and nuclear factor nf-kappa-b. stimulates sodium transport into epithelial cells by enhancing the stability and expression of scnn1a/enac. this is achieved by phosphorylating the nedd4l ubiquitin e3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to scnn1a/enac and targeting it for degradation. regulates store-operated ca(+2) entry (soce) by stimulating orai1 and stim1. regulates kcnj1/romk1 directly via its phosphorylation or indirectly via increased interaction with slc9a3r2/nherf2. phosphorylates mdm2 and activates mdm2-dependent ubiquitination of p53/tp53. phosphorylates mapt/tau and mediates microtubule depolymerization and neurite formation in hippocampal neurons. phosphorylates slc2a4/glut4 and up-regulates its activity. phosphorylates apbb1/fe65 and promotes its localization to the nucleus. phosphorylates mapk1/erk2 and activates it by enhancing its interaction with map2k1/mek1 and map2k2/mek2. phosphorylates fbxw7 and plays an inhibitory role in the notch1 signaling. phosphorylates foxo1 resulting in its relocalization from the nucleus to the cytoplasm. phosphorylates foxo3, promoting its exit from the nucleus and interference with foxo3-dependent transcription. phosphorylates braf and map3k3/mekk3 and inhibits their activity. phosphorylates slc9a3/nhe3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. phosphorylates creb1. necessary for vascular remodeling during angiogenesis. sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. isoform 2 exhibited a greater effect on cell plasma membrane expression of scnn1a/enac and na(+) transport than isoform 1. {eco:0000269|pubmed:11154281, eco:0000269|pubmed:11410590, eco:0000269|pubmed:11696533, eco:0000269|pubmed:12397388, eco:0000269|pubmed:12590200, eco:0000269|pubmed:12634932, eco:0000269|pubmed:12650886, eco:0000269|pubmed:12761204, eco:0000269|pubmed:12911626, eco:0000269|pubmed:14623317, eco:0000269|pubmed:14706641, eco:0000269|pubmed:15040001, eco:0000269|pubmed:15044175, eco:0000269|pubmed:15234985, eco:0000269|pubmed:15319523, eco:0000269|pubmed:15496163, eco:0000269|pubmed:15733869, eco:0000269|pubmed:15737648, eco:0000269|pubmed:15845389, eco:0000269|pubmed:15888551, eco:0000269|pubmed:16036218, eco:0000269|pubmed:16443776, eco:0000269|pubmed:16982696, eco:0000269|pubmed:17382906, eco:0000269|pubmed:18005662, eco:0000269|pubmed:18304449, eco:0000269|pubmed:18753299, eco:0000269|pubmed:19447520, eco:0000269|pubmed:19756449, eco:0000269|pubmed:20511718, eco:0000269|pubmed:20730100, eco:0000269|pubmed:21865597}.","subcellular location: cytoplasm. nucleus. endoplasmic reticulum membrane. cell membrane. mitochondrion. note=the subcellular localization is controlled by the cell cycle, as well as by exposure to specific hormones and environmental stress stimuli. in proliferating cells, it shuttles between the nucleus and cytoplasm in synchrony with the cell cycle, and in serum/growth factor-stimulated cells it resides in the nucleus. in contrast, after exposure to environmental stress or treatment with glucocorticoids, it is detected in the cytoplasm and with certain stress conditions is associated with the mitochondria. in osmoregulation through the epithelial sodium channel, it can be localized to the cytoplasmic surface of the cell membrane. nuclear, upon phosphorylation.; subcellular location: isoform 2: cell membrane.","TISSUE SPECIFICITY: Expressed in most tissues with highest levels in the pancreas, followed by placenta, kidney and lung. Isoform 2 is strongly expressed in brain and pancreas, weaker in heart, placenta, lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.",NA,NA,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,SGK1,6446,Hs.510078,ENST00000367857,THC2495241,GO:0000166(nucleotide binding)|GO:0001558(regulation of cell growth)|GO:0004674(protein serine/threonine kinase activity)|GO:0005246(calcium channel regulator activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005886(plasma membrane)|GO:0006468(protein phosphorylation)|GO:0006814(sodium ion transport)|GO:0006950(response to stress)|GO:0007616(long-term memory)|GO:0008217(regulation of blood pressure)|GO:0015459(potassium channel regulator activity)|GO:0017080(sodium channel regulator activity)|GO:0017081(chloride channel regulator activity)|GO:0030334(regulation of cell migration)|GO:0032411(positive regulation of transporter activity)|GO:0042127(regulation of cell proliferation)|GO:0042981(regulation of apoptosis)|GO:0050790(regulation of catalytic activity)|GO:0051090(regulation of sequence-specific DNA binding transcription factor activity)|GO:0060453(regulation of gastric acid secretion)|GO:0070294(renal sodium ion absorption),"Homo sapiens serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 1, mRNA [NM_005627]",chr6:134490715-134490656,hs|6q23.2,serum/glucocorticoid regulated kinase 1,TRUE
1106_SLC22A23_63027,A1A5C7,solute carrier family 22 member 23,SLC22A23 C6orf85,686,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,SLC22A23,63027,Hs.713588,ENST00000436008,THC2467179,GO:0006811(ion transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022857(transmembrane transporter activity),"Homo sapiens solute carrier family 22, member 23 (SLC22A23), transcript variant 1, mRNA [NM_015482]",chr6:3269354-3269295,hs|6p25.2,"solute carrier family 22, member 23",TRUE
1107_ACAT1_38,P35610,sterol o-acyltransferase 1 (ec 2.3.1.26) (acyl-coenzyme a:cholesterol acyltransferase 1) (acat-1) (cholesterol acyltransferase 1),SOAT1 ACACT ACACT1 ACAT ACAT1 SOAT STAT,550,"function: catalyzes the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol. plays a role in lipoprotein assembly and dietary cholesterol absorption. in addition to its acyltransferase activity, it may act as a ligase.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:16154994}; multi-pass membrane protein {eco:0000269|pubmed:16154994}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ACAT1,38,Hs.232375,ENST00000533597,THC2464703,"GO:0001889(liver development)|GO:0003985(acetyl-CoA C-acetyltransferase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0007420(brain development)|GO:0009083(branched chain family amino acid catabolic process)|GO:0009725(response to hormone stimulus)|GO:0014070(response to organic cyclic compound)|GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups)|GO:0019899(enzyme binding)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042594(response to starvation)|GO:0042803(protein homodimerization activity)|GO:0043441(acetoacetic acid biosynthetic process)|GO:0044255(cellular lipid metabolic process)|GO:0046872(metal ion binding)|GO:0046950(cellular ketone body metabolic process)|GO:0046951(ketone body biosynthetic process)|GO:0046952(ketone body catabolic process)|GO:0050662(coenzyme binding)|GO:0051260(protein homooligomerization)|GO:0060612(adipose tissue development)|GO:0072229(metanephric proximal convoluted tubule development)","Homo sapiens acetyl-CoA acetyltransferase 1 (ACAT1), nuclear gene encoding mitochondrial protein, mRNA [NM_000019]",chr11:108018009-108018068,hs|11q22.3,acetyl-CoA acetyltransferase 1,TRUE
1108_CUX1_1523,P39880,homeobox protein cut-like 1 (ccaat displacement protein) (cdp) (homeobox protein cux-1),CUX1 CUTL1,1505,"function: transcription factor involved in the control of neuronal differentiation in the brain. regulates dendrite development and branching, and dendritic spine formation in cortical layers ii-iii. also involved in the control of synaptogenesis. in addition, it has probably a broad role in mammalian development as a repressor of developmentally regulated gene expression. may act by preventing binding of positively-activing ccaat factors to promoters. component of nf-munr repressor; binds to the matrix attachment regions (mars) (5' and 3') of the immunoglobulin heavy chain enhancer. represses t-cell receptor (tcr) beta enhancer function by binding to marbeta, an atc-rich dna sequence located upstream of the tcr beta enhancer. binds to the th enhancer; may require the basic helix-loop-helix protein tcf4 as a coactivator. {eco:0000250|uniprotkb:p53564}.",subcellular location: nucleus.,NA,"DISEASE: Global developmental delay with or without impaired intellectual development (GDDI) [MIM:618330]: An autosomal dominant disorder characterized by global developmental delay associated with mild-to-moderate intellectual disability, hypotonia and short stature in some patients. {ECO:0000269|PubMed:30014507}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,CUX1,1523,Hs.191482,ENST00000360264,THC2670539,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000139(Golgi membrane)|GO:0000301(retrograde transport, vesicle recycling within Golgi)|GO:0003682(chromatin binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006810(transport)|GO:0006891(intra-Golgi vesicle-mediated transport)|GO:0007275(multicellular organismal development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030173(integral to Golgi membrane)|GO:0030324(lung development)|GO:0030674(protein binding, bridging)|GO:0042491(auditory receptor cell differentiation)|GO:0043565(sequence-specific DNA binding)","Homo sapiens cut-like homeobox 1 (CUX1), transcript variant 1, mRNA [NM_181552]",chr7:101893025-101893084,hs|7q22.1,cut-like homeobox 1,TRUE
1109_PSMB6_5694,P28072,proteasome subunit beta type-6 (ec 3.4.25.1) (macropain delta chain) (multicatalytic endopeptidase complex delta chain) (proteasome delta chain) (proteasome subunit y),PSMB6 LMPY Y,239,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). within the 20s core complex, psmb6 displays a peptidylglutamyl-hydrolizing activity also termed postacidic or caspase-like activity, meaning that the peptides bond hydrolysis occurs directly after acidic residues. {eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.",subcellular location: cytoplasm {eco:0000269|pubmed:12181345}. nucleus {eco:0000269|pubmed:12181345}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMB6,5694,Hs.77060,ENST00000270586,THC2705405,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0004175(endopeptidase activity)|GO:0004298(threonine-type endopeptidase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, beta type, 6 (PSMB6), mRNA [NM_002798]",chr17:4701404-4701589,hs|17p13.2,"proteasome (prosome, macropain) subunit, beta type, 6",TRUE
111_GDF15_9518,Q99988,growth/differentiation factor 15 (gdf-15) (macrophage inhibitory cytokine 1) (mic-1) (nsaid-activated gene 1 protein) (nag-1) (nsaid-regulated gene 1 protein) (nrg-1) (placental tgf-beta) (placental bone morphogenetic protein) (prostate differentiation factor),GDF15 MIC1 PDF PLAB PTGFB,308,"function: regulates food intake, energy expenditure and body weight in response to metabolic and toxin-induced stresses (pubmed:28953886, pubmed:28846097, pubmed:28846098, pubmed:28846099, pubmed:23468844, pubmed:29046435). binds to its receptor, gfral, and activates gfral-expressing neurons localized in the area postrema and nucleus tractus solitarius of the brainstem (pubmed:28953886, pubmed:28846097, pubmed:28846098, pubmed:28846099). it then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which contitutes part of the 'emergency circuit' that shapes feeding responses to stressful conditions (pubmed:28953886). on hepatocytes, inhibits growth hormone signaling (by similarity). {eco:0000250|uniprotkb:q9z0j7, eco:0000269|pubmed:23468844, eco:0000269|pubmed:28846097, eco:0000269|pubmed:28846098, eco:0000269|pubmed:28846099, eco:0000269|pubmed:28953886, eco:0000269|pubmed:29046435}.","subcellular location: secreted {eco:0000269|pubmed:28572090, eco:0000269|pubmed:29046435}.","TISSUE SPECIFICITY: Highly expressed in placenta, with lower levels in prostate and colon and some expression in kidney (PubMed:9348093). Detected in plasma (at protein level) (PubMed:28572090, PubMed:29046435). {ECO:0000269|PubMed:28572090, ECO:0000269|PubMed:29046435, ECO:0000269|PubMed:9348093}.",DISEASE: Note=Plasma levels are increased in children with concomitant heart disease and failure to thrive but not in children with heart disease and normal body weight. {ECO:0000269|PubMed:28572090}.,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GDF15,9518,Hs.616962,ENST00000252809,THC2532749,GO:0005125(cytokine activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0007165(signal transduction)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0007267(cell-cell signaling)|GO:0008083(growth factor activity),"Homo sapiens growth differentiation factor 15 (GDF15), mRNA [NM_004864]",chr19:18499890-18499949,hs|19p13.11,growth differentiation factor 15,TRUE
1110_PGK1_5230,P00558,phosphoglycerate kinase 1 (ec 2.7.2.3) (cell migration-inducing gene 10 protein) (primer recognition protein 2) (prp 2),PGK1 PGKA MIG10 OK/SW-cl.110,417,"function: catalyzes one of the two atp producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (pubmed:30323285, pubmed:7391028). in addition to its role as a glycolytic enzyme, it seems that pgk-1 acts as a polymerase alpha cofactor protein (primer recognition protein) (pubmed:2324090). may play a role in sperm motility (pubmed:26677959). {eco:0000269|pubmed:2324090, eco:0000269|pubmed:26677959, eco:0000269|pubmed:30323285, eco:0000269|pubmed:7391028}.",subcellular location: cytoplasm.,TISSUE SPECIFICITY: Mainly expressed in spermatogonia. Localized on the principle piece in the sperm (at protein level). Expression significantly decreased in the testis of elderly men. {ECO:0000269|PubMed:26677959}.,"DISEASE: Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]: A condition with a highly variable clinical phenotype that includes hemolytic anemia, rhabdomyolysis, myopathy and neurologic involvement. Patients can express one or more of these manifestations. {ECO:0000269|PubMed:1547346, ECO:0000269|PubMed:1586722, ECO:0000269|PubMed:2001457, ECO:0000269|PubMed:6933565, ECO:0000269|PubMed:6941312, ECO:0000269|PubMed:8043870, ECO:0000269|PubMed:8615693, ECO:0000269|PubMed:8673469, ECO:0000269|PubMed:9744480}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PGK1,5230,Hs.78771,ENST00000537456,THC2585232,GO:0000166(nucleotide binding)|GO:0004618(phosphoglycerate kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006094(gluconeogenesis)|GO:0006096(glycolysis)|GO:0016310(phosphorylation)|GO:0016740(transferase activity),"Homo sapiens phosphoglycerate kinase 1 (PGK1), mRNA [NM_000291]",chrX:77381462-77381521,hs|Xq21.1,phosphoglycerate kinase 1,TRUE
1111_KLF6_1316,Q99612,krueppel-like factor 6 (b-cell-derived protein 1) (core promoter element-binding protein) (gc-rich sites-binding factor gbf) (proto-oncogene bcd1) (suppressor of tumorigenicity 12 protein) (transcription factor zf9),KLF6 BCD1 COPEB CPBP ST12,283,function: transcriptional activator (by similarity). binds a gc box motif. could play a role in b-cell growth and development. {eco:0000250}.,subcellular location: nucleus.,"TISSUE SPECIFICITY: Highly expressed in placenta followed by spleen, thymus, prostate, testis, small intestine and colon. Weakly expressed in pancreas, lung, liver, heart and skeletal muscle. Also expressed in fetal brain, spleen and thymus.","DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:15824733}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:11752579}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KLF6,1316,Hs.4055,ENST00000173785,THC2469498,"GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0019221(cytokine-mediated signaling pathway)|GO:0030183(B cell differentiation)|GO:0042060(wound healing)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding)","Homo sapiens Kruppel-like factor 6 (KLF6), transcript variant A, mRNA [NM_001300]",chr10:3821446-3821387,hs|10p15.1,Kruppel-like factor 6,TRUE
1112_TGOLN2_10618,O43493,trans-golgi network integral membrane protein 2 (trans-golgi network glycoprotein 46) (tgn38 homolog) (htgn46) (trans-golgi network glycoprotein 48) (htgn48) (trans-golgi network glycoprotein 51) (htgn51) (trans-golgi network protein 2),TGOLN2 TGN46 TGN51,437,function: may be involved in regulating membrane traffic to and from trans-golgi network.,"subcellular location: cell membrane; single-pass type i membrane protein. golgi apparatus, trans-golgi network membrane; single-pass type i membrane protein. note=primarily in trans-golgi network. cycles between the trans-golgi network and the cell surface returning via endosomes.",TISSUE SPECIFICITY: Isoform TGN46 is widely expressed. Isoform TGN51 is more abundant in fetal lung and kidney. Isoform TGN48 is barely expressed in embryonic kidney and promyelocytic cells.,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TGOLN2,10618,Hs.593382,ENST00000377386,THC2509094,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0005886(plasma membrane)|GO:0016021(integral to membrane)|GO:0030133(transport vesicle),"Homo sapiens trans-golgi network protein 2 (TGOLN2), transcript variant 1, mRNA [NM_006464]",chr2:85545401-85545342,hs|2p11.2,trans-golgi network protein 2,TRUE
1113_PTPLB_201562,Q6Y1H2,very-long-chain (3r)-3-hydroxyacyl-coa dehydratase 2 (ec 4.2.1.134) (3-hydroxyacyl-coa dehydratase 2) (hacd2) (protein-tyrosine phosphatase-like member b),HACD2 PTPLB,254,"function: catalyzes the third of the four reactions of the long-chain fatty acids elongation cycle. this endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/vlcfas per cycle. this enzyme catalyzes the dehydration of the 3-hydroxyacyl-coa intermediate into trans-2,3-enoyl-coa, within each cycle of fatty acid elongation. thereby, it participates in the production of vlcfas of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. {eco:0000269|pubmed:18554506}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:15024066, eco:0000269|pubmed:18554506}; multi-pass membrane protein {eco:0000269|pubmed:15024066, eco:0000269|pubmed:18554506}.","TISSUE SPECIFICITY: Highly expressed in testis, spleen, prostate, colon and heart, followed by moderate expression in thymus, ovary, small intestine, peripheral blood leukocytes, liver, skeletal muscle and pancreas. Weakly detected in kidney, placenta, brain and lung. {ECO:0000269|PubMed:15024066}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PTPLB,201562,Hs.705480,ENST00000383657,THC2491384,GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006633(fatty acid biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016829(lyase activity),"protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b [Source:HGNC Symbol;Acc:9640] [ENST00000383657]",chr3:123210797-123210738,hs|3q21.1,"protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b",TRUE
1114_STAG3L1_54441,P0CL83,putative stag3-like protein 1 (stromal antigen 3-like protein 1),STAG3L1,205,NA,subcellular location: nucleus {eco:0000255|prosite-prorule:pru00750}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,STAG3L1,54441,Hs.632310,ENST00000483309,THC2472382,GO:0005488(binding)|GO:0005634(nucleus),"Homo sapiens stromal antigen 3-like 1 (STAG3L1), non-coding RNA [NR_040583]",chr7:74996261-74996320,hs|7q11.23,stromal antigen 3-like 1,TRUE
1115_ZNF350_59348,Q9GZX5,zinc finger protein 350 (krab zinc finger protein zfqr) (zinc finger and brca1-interacting protein with a krab domain 1) (zinc finger protein zbrk1),ZNF350 ZBRK1,532,"function: transcriptional repressor. binds to a specific sequence, 5'-gggxxxcagxxxttt-3', within gadd45 intron 3. {eco:0000269|pubmed:11090615}.",subcellular location: nucleus. nucleus matrix. note=associated with the nuclear matrix.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11161714}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF350,59348,Hs.407694,ENST00000243644,THC2471069,"GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0016363(nuclear matrix)|GO:0017053(transcriptional repressor complex)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 350 (ZNF350), mRNA [NM_021632]",chr19:52467706-52467647,hs|19q13.41,zinc finger protein 350,TRUE
1116_CDKN1C_1028,P49918,cyclin-dependent kinase inhibitor 1c (cyclin-dependent kinase inhibitor p57) (p57kip2),CDKN1C KIP2,316,"function: potent tight-binding inhibitor of several g1 cyclin/cdk complexes (cyclin e-cdk2, cyclin d2-cdk4, and cyclin a-cdk2) and, to lesser extent, of the mitotic cyclin b-cdc2. negative regulator of cell proliferation. may play a role in maintenance of the non-proliferative state throughout life.",subcellular location: nucleus {eco:0000250}.,"TISSUE SPECIFICITY: Expressed in the heart, brain, lung, skeletal muscle, kidney, pancreas and testis. Expressed in the eye. High levels are seen in the placenta while low levels are seen in the liver. {ECO:0000269|PubMed:22634751}.","DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:10424811, ECO:0000269|PubMed:26077438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]: A rare condition characterized by intrauterine growth restriction, metaphyseal dysplasia, congenital adrenal hypoplasia, and genital anomalies. Patients with this condition may present shortly after birth with severe adrenal insufficiency, which can be life-threatening if not recognized early and commenced on steroid replacement therapy. Other reported features in this condition include, hypercalciuria and/or hypercalcemia, craniosynostosis, cleft palate, and scoliosis. {ECO:0000269|PubMed:22634751}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CDKN1C,1028,Hs.106070,ENST00000313407,THC2646038,"GO:0000079(regulation of cyclin-dependent protein kinase activity)|GO:0000080(G1 phase of mitotic cell cycle)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0004860(protein kinase inhibitor activity)|GO:0004861(cyclin-dependent protein kinase inhibitor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0008285(negative regulation of cell proliferation)|GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway)|GO:0033673(negative regulation of kinase activity)|GO:0042326(negative regulation of phosphorylation)|GO:0042551(neuron maturation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0050680(negative regulation of epithelial cell proliferation)","Homo sapiens cyclin-dependent kinase inhibitor 1C (p57, Kip2) (CDKN1C), transcript variant 1, mRNA [NM_000076]",chr11:2904962-2904903,hs|11p15.4,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",TRUE
1117_C1orf122_127687,Q6ZSJ8,uncharacterized protein c1orf122 (protein alaesm),C1orf122,110,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C1orf122,127687,Hs.532749,ENST00000525096,NP1460476,NA,"Homo sapiens chromosome 1 open reading frame 122 (C1orf122), transcript variant 1, mRNA [NM_198446]",chr1:38274918-38274977,hs|1p34.3,chromosome 1 open reading frame 122,TRUE
1118_SNHG12_85028,Q9BXW3,putative uncharacterized protein snhg12 (transformation-related gene 11 protein) (trg-11),SNHG12 C1orf79 PNAS-123 TRG11,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,SNHG12,85028,Hs.632377,NA,THC2511720,NA,"Homo sapiens small nucleolar RNA host gene 12 (non-protein coding) (SNHG12), non-coding RNA [NR_024127]",chr1:28906090-28905179,hs|1p35.3,small nucleolar RNA host gene 12 (non-protein coding),TRUE
1119_TMEM42_131616,Q69YG0,transmembrane protein 42,TMEM42,159,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TMEM42,131616,Hs.646856,ENST00000477126,THC2498567,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 42 (TMEM42), mRNA [NM_144638]",chr3:44907045-44907104,hs|3p21.31,transmembrane protein 42,TRUE
112_RPL19_6143,P84098,60s ribosomal protein l19 (large ribosomal subunit protein el19),RPL19,196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL19,6143,Hs.381061,ENST00000225430,THC2565463,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L19 (RPL19), mRNA [NM_000981]",chr17:37360880-37360939,hs|17q12,ribosomal protein L19,TRUE
1120_LAPTM4B_55353,Q86VI4,lysosomal-associated transmembrane protein 4b (lysosome-associated transmembrane protein 4-beta),LAPTM4B PSEC0001,317,"function: required for optimal lysosomal function (pubmed:21224396). blocks egf-stimulated egfr intraluminal sorting and degradation. conversely by binding with the phosphatidylinositol 4,5-bisphosphate, regulates its pip5k1c interaction, inhibits hgs ubiquitination and relieves laptm4b inhibition of egfr degradation (pubmed:25588945). recruits slc3a2 and slc7a5 (the leu transporter) to the lysosome, promoting entry of leucine and other essential amino acid (eaa) into the lysosome, stimulating activation of proton-transporting vacuolar (v)-atpase protein pump (v-atpase) and hence mtorc1 activation (pubmed:25998567). plays a role as negative regulator of tgfb1 production in regulatory t cells (pubmed:26126825). binds ceramide and facilitates its exit from late endosome in order to control cell death pathways (pubmed:26280656). {eco:0000269|pubmed:21224396, eco:0000269|pubmed:25588945, eco:0000269|pubmed:25998567, eco:0000269|pubmed:26126825, eco:0000269|pubmed:26280656}.","subcellular location: endomembrane system {eco:0000269|pubmed:12902989}; multi-pass membrane protein {eco:0000269|pubmed:12902989}. late endosome membrane {eco:0000269|pubmed:21224396, eco:0000269|pubmed:22096579, eco:0000269|pubmed:25588945}. cell membrane {eco:0000269|pubmed:22096579}. cell projection {eco:0000269|pubmed:22096579}. lysosome membrane {eco:0000269|pubmed:21224396, eco:0000269|pubmed:22096579}. endosome membrane. endosome, multivesicular body membrane {eco:0000269|pubmed:26280656}. endosome, multivesicular body lumen {eco:0000269|pubmed:26280656}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LAPTM4B,55353,Hs.492314,ENST00000378722,THC2678952,GO:0005515(protein binding)|GO:0006810(transport)|GO:0012505(endomembrane system)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens lysosomal protein transmembrane 4 beta (LAPTM4B), mRNA [NM_018407]",chr8:98864581-98864640,hs|8q22.1,lysosomal protein transmembrane 4 beta,TRUE
1121_RPL22L1_200916,Q6P5R6,60s ribosomal protein l22-like 1 (large ribosomal subunit protein el22-like 1),RPL22L1,122,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL22L1,200916,Hs.380933,ENST00000494771,THC2463114,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens ribosomal protein L22-like 1 (RPL22L1), mRNA [NM_001099645]",chr3:170584263-170584204,hs|3q26.2,ribosomal protein L22-like 1,TRUE
1122_NFIL3_4783,Q16649,nuclear factor interleukin-3-regulated protein (e4 promoter-binding protein 4) (interleukin-3 promoter transcriptional activator) (interleukin-3-binding protein 1) (transcriptional activator nf-il3a),NFIL3 E4BP4 IL3BP1,462,"function: acts as a transcriptional regulator that recognizes and binds to the sequence 5'-[ga]tta[ct]gtaa[ct]-3', a sequence present in many cellular and viral promoters. represses transcription from promoters with activating transcription factor (atf) sites. represses promoter activity in osteoblasts (by similarity). represses transcriptional activity of per1 (by similarity). represses transcriptional activity of per2 via the b-site on the promoter (by similarity). activates transcription from the interleukin-3 promoter in t-cells. competes for the same consensus-binding site with par dna-binding factors (dbp, hlf and tef) (by similarity). component of the circadian clock that acts as a negative regulator for the circadian expression of per2 oscillation in the cell-autonomous core clock (by similarity). protects pro-b cells from programmed cell death (by similarity). represses the transcription of cyp2a5 (by similarity). positively regulates the expression and activity of ces2 by antagonizing the repressive action of nr1d1 on ces2 (by similarity). {eco:0000250|uniprotkb:o08750, eco:0000269|pubmed:1620116, eco:0000269|pubmed:7565758, eco:0000269|pubmed:8836190}.",subcellular location: nucleus {eco:0000255|prosite-prorule:pru00978}.,"TISSUE SPECIFICITY: Expressed in bladder stomach, thyroid, spinal cord, lymph node, trachea, adrenal gland, bone marrow and muscle. {ECO:0000269|PubMed:10942106}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NFIL3,4783,Hs.79334,ENST00000297689,THC2641236,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003714(transcription corepressor activity)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006955(immune response)|GO:0007623(circadian rhythm)|GO:0043565(sequence-specific DNA binding)|GO:0046983(protein dimerization activity)","Homo sapiens nuclear factor, interleukin 3 regulated (NFIL3), mRNA [NM_005384]",chr9:94171459-94171400,hs|9q22.31,"nuclear factor, interleukin 3 regulated",TRUE
1123_H2AFV_94239,Q71UI9,histone h2a.v (h2a.f/z),H2AFV H2AV,128,"function: variant histone h2a which replaces conventional h2a in a subset of nucleosomes. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. may be involved in the formation of constitutive heterochromatin. may be required for chromosome segregation during cell division (by similarity). {eco:0000250}.",subcellular location: nucleus {eco:0000250}. chromosome {eco:0000250}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H2AFV,94239,Hs.488189,ENST00000381124,THC2468599,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens H2A histone family, member V (H2AFV), transcript variant 1, mRNA [NM_012412]",chr7:44873931-44873872,hs|7p13,"H2A histone family, member V",TRUE
1124_TIMM13_26517,Q9Y5L4,mitochondrial import inner membrane translocase subunit tim13,TIMM13 TIM13B TIMM13A TIMM13B,95,"function: mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. also required for the transfer of beta-barrel precursors from the tom complex to the sorting and assembly machinery (sam complex) of the outer membrane. acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. the timm8-timm13 complex mediates the import of proteins such as timm23, slc25a12/aralar1 and slc25a13/aralar2, while the predominant timm9-timm10 70 kda complex mediates the import of much more proteins. {eco:0000269|pubmed:11489896, eco:0000269|pubmed:15254020}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:11489896}; peripheral membrane protein {eco:0000269|pubmed:11489896}; intermembrane side {eco:0000269|pubmed:11489896}.,"TISSUE SPECIFICITY: Ubiquitous, with highest expression in heart, kidney, liver and skeletal muscle.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TIMM13,26517,Hs.75056,ENST00000215570,THC2467974,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006626(protein targeting to mitochondrion)|GO:0007605(sensory perception of sound)|GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0042719(mitochondrial intermembrane space protein transporter complex)|GO:0045039(protein import into mitochondrial inner membrane)|GO:0046872(metal ion binding)|GO:0072321(chaperone-mediated protein transport),"Homo sapiens translocase of inner mitochondrial membrane 13 homolog (yeast) (TIMM13), nuclear gene encoding mitochondrial protein, mRNA [NM_012458]",chr19:2426657-2426598,hs|19p13.3,translocase of inner mitochondrial membrane 13 homolog (yeast),TRUE
1125_IGF2_3481,P01344,insulin-like growth factor ii (igf-ii) (somatomedin-a) (t3m-11-derived growth factor) [cleaved into: insulin-like growth factor ii; insulin-like growth factor ii ala-25 del; preptin],IGF2 PP1446,180,"function: the insulin-like growth factors possess growth-promoting activity. major fetal growth hormone in mammals. plays a key role in regulating fetoplacental development. igf-ii is influenced by placental lactogen. also involved in tissue differentiation. positively regulates myogenic transcription factor myod1 function by facilitating the recruitment of transcriptional coactivators, thereby controlling muscle terminal differentiation (by similarity). in adults, involved in glucose metabolism in adipose tissue, skeletal muscle and liver (probable). acts as a ligand for integrin which is required for igf2 signaling (pubmed:28873464). {eco:0000250|uniprotkb:p09535, eco:0000269|pubmed:28873464, eco:0000305|pubmed:24593700}.; function: preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of mapk1 and mapk3. {eco:0000269|pubmed:16912056}.",subcellular location: secreted {eco:0000269|pubmed:16040806}.,"TISSUE SPECIFICITY: Expressed in heart, placenta, lung, liver, muscle, kidney, tongue, limb, eye and pancreas. {ECO:0000269|PubMed:16531418}.","DISEASE: Silver-Russell syndrome (SRS) [MIM:180860]: A clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations. The phenotypic expression changes during childhood and adolescence, with the facial features and asymmetry usually becoming more subtle with age. {ECO:0000269|PubMed:19066168}. Note=The gene represented in this entry is involved in disease pathogenesis. Most of the cases of Silver-Russell syndrome are caused by the epigenetic changes of DNA hypomethylation at the telomeric imprinting control region (ICR1) on chromosome 11p15, involving the H19 and IGF2 genes.; DISEASE: Growth restriction, severe, with distinctive facies (GRDF) [MIM:616489]: A disease characterized by severe prenatal and postnatal growth restriction, facial dysmorphism, and short stature in the presence of normal or slightly elevated growth hormone levels. {ECO:0000269|PubMed:26154720}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,IGF2,3481,Hs.272259,ENST00000381319,THC2465311,"GO:0001501(skeletal system development)|GO:0001503(ossification)|GO:0001934(positive regulation of protein phosphorylation)|GO:0005158(insulin receptor binding)|GO:0005159(insulin-like growth factor receptor binding)|GO:0005179(hormone activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006349(regulation of gene expression by genetic imprinting)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007275(multicellular organismal development)|GO:0008083(growth factor activity)|GO:0008284(positive regulation of cell proliferation)|GO:0008286(insulin receptor signaling pathway)|GO:0030546(receptor activator activity)|GO:0042104(positive regulation of activated T cell proliferation)|GO:0043085(positive regulation of catalytic activity)|GO:0043410(positive regulation of MAPKKK cascade)|GO:0043539(protein serine/threonine kinase activator activity)|GO:0045725(positive regulation of glycogen biosynthetic process)|GO:0045840(positive regulation of mitosis)|GO:0046628(positive regulation of insulin receptor signaling pathway)|GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)|GO:0051781(positive regulation of cell division)|GO:0051897(positive regulation of protein kinase B signaling cascade)|GO:0071902(positive regulation of protein serine/threonine kinase activity)|GO:2000273(positive regulation of receptor activity)|GO:2000467(positive regulation of glycogen (starch) synthase activity)","Homo sapiens insulin-like growth factor 2 (somatomedin A) (IGF2), transcript variant 1, mRNA [NM_000612]",chr11:2150453-2150394,hs|11p15.5,insulin-like growth factor 2 (somatomedin A),TRUE
1126_RAD23B_5887,P54727,uv excision repair protein rad23 homolog b (hr23b) (hhr23b) (xp-c repair-complementing complex 58 kda protein) (p58),RAD23B,409,"function: multiubiquitin chain receptor involved in modulation of proteasomal degradation. binds to polyubiquitin chains. proposed to be capable to bind simultaneously to the 26s proteasome and to polyubiquitinated substrates and to deliver ubiquitinated proteins to the proteasome. may play a role in endoplasmic reticulum-associated degradation (erad) of misfolded glycoproteins by association with pngase and delivering deglycosylated proteins to the proteasome.; function: involved in global genome nucleotide excision repair (gg-ner) by acting as component of the xpc complex. cooperatively with cetn2 appears to stabilize xpc. may protect xpc from proteasomal degradation.; function: the xpc complex is proposed to represent the first factor bound at the sites of dna damage and together with other core recognition factors, xpa, rpa and the tfiih complex, is part of the pre-incision (or initial recognition) complex. the xpc complex recognizes a wide spectrum of damaged dna characterized by distortions of the dna helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. the orientation of xpc complex binding appears to be crucial for inducing a productive ner. xpc complex is proposed to recognize and to interact with unpaired bases on the undamaged dna strand which is followed by recruitment of the tfiih complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the ner machinery. cyclobutane pyrimidine dimers (cpds) which are formed upon uv-induced dna damage esacpe detection by the xpc complex due to a low degree of structural perurbation. instead they are detected by the uv-ddb complex which in turn recruits and cooperates with the xpc complex in the respective dna repair. in vitro, the xpc:rad23b dimer is sufficient to initiate ner; it preferentially binds to cisplatin and uv-damaged double-stranded dna and also binds to a variety of chemically and structurally diverse dna adducts. xpc:rad23b contacts dna both 5' and 3' of a cisplatin lesion with a preference for the 5' side. xpc:rad23b induces a bend in dna upon binding. xpc:rad23b stimulates the activity of dna glycosylases tdg and smug1.","subcellular location: nucleus. cytoplasm. note=the intracellular distribution is cell cycle dependent. localized to the nucleus and the cytoplasm during g1 phase. nuclear levels decrease during s-phase; upon entering mitosis, relocalizes in the cytoplasm without association with chromatin.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RAD23B,5887,Hs.521640,ENST00000358015,THC2574925,"GO:0000502(proteasome complex)|GO:0000715(nucleotide-excision repair, DNA damage recognition)|GO:0000718(nucleotide-excision repair, DNA damage removal)|GO:0003684(damaged DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006281(DNA repair)|GO:0006289(nucleotide-excision repair)|GO:0006974(response to DNA damage stimulus)|GO:0007283(spermatogenesis)|GO:0031593(polyubiquitin binding)|GO:0032434(regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0071942(XPC complex)","Homo sapiens RAD23 homolog B (S. cerevisiae) (RAD23B), transcript variant 1, mRNA [NM_002874]",chr9:110092822-110092881,hs|9q31.2,RAD23 homolog B (S. cerevisiae),TRUE
1127_IGF1R_3480,P08069,insulin-like growth factor 1 receptor (ec 2.7.10.1) (insulin-like growth factor i receptor) (igf-i receptor) (cd antigen cd221) [cleaved into: insulin-like growth factor 1 receptor alpha chain; insulin-like growth factor 1 receptor beta chain],IGF1R,1367,"function: receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (igf1). binds igf1 with high affinity and igf2 and insulin (ins) with a lower affinity. the activated igf1r is involved in cell growth and survival control. igf1r is crucial for tumor transformation and survival of malignant cell. ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (irs1/2), shc and 14-3-3 proteins. phosphorylation of irss proteins lead to the activation of two main signaling pathways: the pi3k-akt/pkb pathway and the ras-mapk pathway. the result of activating the mapk pathway is increased cellular proliferation, whereas activating the pi3k pathway inhibits apoptosis and stimulates protein synthesis. phosphorylated irs1 can activate the 85 kda regulatory subunit of pi3k (pik3r1), leading to activation of several downstream substrates, including protein akt/pkb. akt phosphorylation, in turn, enhances protein synthesis through mtor activation and triggers the antiapoptotic effects of igfir through phosphorylation and inactivation of bad. in parallel to pi3k-driven signaling, recruitment of grb2/sos by phosphorylated irs1 or shc leads to recruitment of ras and activation of the ras-mapk pathway. in addition to these two main signaling pathways igf1r signals also through the janus kinase/signal transducer and activator of transcription pathway (jak/stat). phosphorylation of jak proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (stat) proteins. in particular activation of stat3, may be essential for the transforming activity of igf1r. the jak/stat pathway activates gene transcription and may be responsible for the transforming activity. jnk kinases can also be activated by the igf1r. igf1 exerts inhibiting activities on jnk activation via phosphorylation and inhibition of map3k5/ask1, which is able to directly associate with the igf1r.; function: when present in a hybrid receptor with insr, binds igf1. pubmed:12138094 shows that hybrid receptors composed of igf1r and insr isoform long are activated with a high affinity by igf1, with low affinity by igf2 and not significantly activated by insulin, and that hybrid receptors composed of igf1r and insr isoform short are activated by igf1, igf2 and insulin. in contrast, pubmed:16831875 shows that hybrid receptors composed of igf1r and insr isoform long and hybrid receptors composed of igf1r and insr isoform short have similar binding characteristics, both bind igf1 and have a low affinity for insulin.",subcellular location: cell membrane {eco:0000269|pubmed:17524361}; single-pass type i membrane protein {eco:0000269|pubmed:17524361}.,"TISSUE SPECIFICITY: Found as a hybrid receptor with INSR in muscle, heart, kidney, adipose tissue, skeletal muscle, hepatoma, fibroblasts, spleen and placenta (at protein level). Expressed in a variety of tissues. Overexpressed in tumors, including melanomas, cancers of the colon, pancreas prostate and kidney. {ECO:0000269|PubMed:12019176, ECO:0000269|PubMed:8247543, ECO:0000269|PubMed:9202395, ECO:0000269|PubMed:9355755}.","DISEASE: Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]: A disorder characterized by intrauterine growth retardation, poor postnatal growth and increased plasma IGF1 levels. {ECO:0000269|PubMed:14657428, ECO:0000269|PubMed:15928254, ECO:0000269|PubMed:25040157}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,IGF1R,3480,Hs.643120,ENST00000268035,THC2461723,GO:0000166(nucleotide binding)|GO:0004713(protein tyrosine kinase activity)|GO:0004872(receptor activity)|GO:0005010(insulin-like growth factor receptor activity)|GO:0005158(insulin receptor binding)|GO:0005515(protein binding)|GO:0005520(insulin-like growth factor binding)|GO:0005524(ATP binding)|GO:0005792(microsome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0005901(caveola)|GO:0006916(anti-apoptosis)|GO:0006955(immune response)|GO:0007165(signal transduction)|GO:0007409(axonogenesis)|GO:0007420(brain development)|GO:0008284(positive regulation of cell proliferation)|GO:0008286(insulin receptor signaling pathway)|GO:0009887(organ morphogenesis)|GO:0014065(phosphatidylinositol 3-kinase cascade)|GO:0016020(membrane)|GO:0030010(establishment of cell polarity)|GO:0030238(male sex determination)|GO:0030335(positive regulation of cell migration)|GO:0030879(mammary gland development)|GO:0031017(exocrine pancreas development)|GO:0031175(neuron projection development)|GO:0031994(insulin-like growth factor I binding)|GO:0032467(positive regulation of cytokinesis)|GO:0033197(response to vitamin E)|GO:0042802(identical protein binding)|GO:0043005(neuron projection)|GO:0043409(negative regulation of MAPKKK cascade)|GO:0043410(positive regulation of MAPKKK cascade)|GO:0043548(phosphatidylinositol 3-kinase binding)|GO:0043559(insulin binding)|GO:0043560(insulin receptor substrate binding)|GO:0045740(positive regulation of DNA replication)|GO:0045768(positive regulation of anti-apoptosis)|GO:0046777(protein autophosphorylation)|GO:0046872(metal ion binding)|GO:0048009(insulin-like growth factor receptor signaling pathway)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0051262(protein tetramerization)|GO:0051291(protein heterooligomerization)|GO:0051897(positive regulation of protein kinase B signaling cascade)|GO:0051898(negative regulation of protein kinase B signaling cascade)|GO:0060740(prostate gland epithelium morphogenesis)|GO:0090031(positive regulation of steroid hormone biosynthetic process),"Homo sapiens insulin-like growth factor 1 receptor (IGF1R), mRNA [NM_000875]",chr15:99507366-99507425,hs|15q26.3,insulin-like growth factor 1 receptor,TRUE
1128_C5orf15_56951,Q8NC54,keratinocyte-associated transmembrane protein 2,KCT2 C5orf15 HTGN29,265,NA,subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:12752121}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C5orf15,56951,Hs.730670,ENST00000231512,THC2469485,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 5 open reading frame 15 (C5orf15), mRNA [NM_020199]",chr5:133291476-133291417,hs|5q31.1,chromosome 5 open reading frame 15,TRUE
1129_EZH2_2146,Q15910,histone-lysine n-methyltransferase ezh2 (ec 2.1.1.43) (enx-1) (enhancer of zeste homolog 2) (lysine n-methyltransferase 6),EZH2 KMT6,746,"function: polycomb group (pcg) protein. catalytic subunit of the prc2/eed-ezh2 complex, which methylates 'lys-9' (h3k9me) and 'lys-27' (h3k27me) of histone h3, leading to transcriptional repression of the affected target gene. able to mono-, di- and trimethylate 'lys-27' of histone h3 to form h3k27me1, h3k27me2 and h3k27me3, respectively. displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into h3k27, h3k27me0 > h3k27me1 > h3k27me2 (pubmed:22323599, pubmed:30923826). compared to ezh1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming h3k27me3, which is required for embryonic stem cell identity and proper differentiation. the prc2/eed-ezh2 complex may also serve as a recruiting platform for dna methyltransferases, thereby linking two epigenetic repression systems. genes repressed by the prc2/eed-ezh2 complex include hoxc8, hoxa9, myt1, cdkn2a and retinoic acid target genes. ezh2 can also methylate non-histone proteins such as the transcription factor gata4 and the nuclear receptor rora. regulates the circadian clock via histone methylation at the promoter of the circadian genes. essential for the cry1/2-mediated repression of the transcriptional activation of per1/2 by the clock-arntl/bmal1 heterodimer; involved in the di and trimethylation of 'lys-27' of histone h3 on per1/2 promoters which is necessary for the cry1/2 proteins to inhibit transcription. {eco:0000269|pubmed:14532106, eco:0000269|pubmed:15225548, eco:0000269|pubmed:15231737, eco:0000269|pubmed:15385962, eco:0000269|pubmed:16179254, eco:0000269|pubmed:16357870, eco:0000269|pubmed:16618801, eco:0000269|pubmed:16717091, eco:0000269|pubmed:16936726, eco:0000269|pubmed:17210787, eco:0000269|pubmed:17344414, eco:0000269|pubmed:18285464, eco:0000269|pubmed:19026781, eco:0000269|pubmed:20935635, eco:0000269|pubmed:22323599, eco:0000269|pubmed:23063525, eco:0000269|pubmed:24474760, eco:0000269|pubmed:30923826}.","subcellular location: nucleus {eco:0000269|pubmed:12101246, eco:0000269|pubmed:14532106, eco:0000269|pubmed:15231737, eco:0000269|pubmed:9584199}.","TISSUE SPECIFICITY: Expressed in many tissues. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis. {ECO:0000269|PubMed:14532106}.","DISEASE: Weaver syndrome (WVS) [MIM:277590]: A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand. {ECO:0000269|PubMed:22177091, ECO:0000269|PubMed:22190405, ECO:0000269|PubMed:23239504, ECO:0000269|PubMed:26694085, ECO:0000269|PubMed:28229514}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,EZH2,2146,Hs.444082,ENST00000320356,THC2483741,"GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006325(chromatin organization)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008168(methyltransferase activity)|GO:0016568(chromatin modification)|GO:0016571(histone methylation)|GO:0016740(transferase activity)|GO:0018024(histone-lysine N-methyltransferase activity)|GO:0035098(ESC/E(Z) complex)|GO:0042054(histone methyltransferase activity)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048387(negative regulation of retinoic acid receptor signaling pathway)","Homo sapiens enhancer of zeste homolog 2 (Drosophila) (EZH2), transcript variant 1, mRNA [NM_004456]",chr7:148504580-148504521,hs|7q36.1,enhancer of zeste homolog 2 (Drosophila),TRUE
113_LOC648771_648771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC648771,648771,NA,ENST00000454660,NA,NA,"PREDICTED: Homo sapiens 60S ribosomal protein L12-like (LOC648771), miscRNA [XR_133285]",chr2:204055801-204055860,hs|2q33.2,60S ribosomal protein L12-like,TRUE
1130_RASSF3_283349,Q86WH2,ras association domain-containing protein 3,RASSF3,238,NA,"subcellular location: cytoplasm {eco:0000269|pubmed:15569673}. cytoplasm, cytoskeleton {eco:0000269|pubmed:15569673}. note=localized to microtubules in vascular endothelial cells.",TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11965544}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,RASSF3,283349,Hs.655521,ENST00000542104,THC2611977,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0005886(plasma membrane)|GO:0007165(signal transduction)|GO:0042802(identical protein binding),"Homo sapiens Ras association (RalGDS/AF-6) domain family member 3 (RASSF3), transcript variant 1, mRNA [NM_178169]",chr12:65091151-65091210,hs|12q14.2,Ras association (RalGDS/AF-6) domain family member 3,TRUE
1132_SH3RF1_57630,Q7Z6J0,e3 ubiquitin-protein ligase sh3rf1 (ec 2.3.2.27) (plenty of sh3s) (protein posh) (ring finger protein 142) (ring-type e3 ubiquitin transferase sh3rf1) (sh3 domain-containing ring finger protein 1) (sh3 multiple domains protein 2),SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2,888,"function: has e3 ubiquitin-protein ligase activity. in the absence of an external substrate, it can catalyze self-ubiquitination (pubmed:15659549, pubmed:20696164). stimulates ubiquitination of potassium channel kcnj1, enhancing it's dynamin-dependent and clathrin-independent endocytosis (pubmed:19710010). acts as a scaffold protein that coordinates with mapk8ip1/jip1 in organizing different components of the jnk pathway, including rac1 or rac2, map3k11/mlk3 or map3k7/tak1, map2k7/mkk7, mapk8/jnk1 and/or mapk9/jnk2 into a functional multiprotein complex to ensure the effective activation of the jnk signaling pathway. regulates the differentiation of cd4(+) and cd8(+) t-cells and promotes t-helper 1 (th1) cell differentiation. regulates the activation of mapk8/jnk1 and mapk9/jnk2 in cd4(+) t-cells and the activation of mapk8/jnk1 in cd8(+) t-cells. plays a crucial role in the migration of neocortical neurons in the developing brain. controls proper cortical neuronal migration and the formation of proximal cytoplasmic dilation in the leading process (pcdlp) in migratory neocortical neurons by regulating the proper localization of activated rac1 and f-actin assembly (by similarity). {eco:0000250|uniprotkb:q69zi1, eco:0000269|pubmed:15659549, eco:0000269|pubmed:19710010, eco:0000269|pubmed:20696164}.; function: (microbial infection) plays an essential role in the targeting of hiv-1 gag to the plasma membrane, this function is dependent on it's ring domain, and hence it's e3 ligase activity. {eco:0000269|pubmed:15659549}.","subcellular location: cytoplasm, perinuclear region {eco:0000250|uniprotkb:q71f54}. cell projection, lamellipodium {eco:0000250|uniprotkb:q69zi1}. golgi apparatus, trans-golgi network {eco:0000269|pubmed:15659549, eco:0000269|pubmed:17420289}. note=colocalizes, with akt2, in lamellipodia (by similarity). colocalizes, with herp1, in trans-golgi network. {eco:0000250|uniprotkb:q69zi1, eco:0000269|pubmed:17420289}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SH3RF1,57630,Hs.301804,ENST00000284637,THC2462298,GO:0005078(MAP-kinase scaffold activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006917(induction of apoptosis)|GO:0008270(zinc ion binding)|GO:0016874(ligase activity)|GO:0030027(lamellipodium)|GO:0043066(negative regulation of apoptosis)|GO:0043154(negative regulation of caspase activity)|GO:0046328(regulation of JNK cascade)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens SH3 domain containing ring finger 1 (SH3RF1), mRNA [NM_020870]",chr4:170015564-170015505,hs|4q32.3,SH3 domain containing ring finger 1,TRUE
1133_SMARCA1_6594,P28370,probable global transcription activator snf2l1 (ec 3.6.4.-) (atp-dependent helicase smarca1) (nucleosome-remodeling factor subunit snf2l) (swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a member 1),SMARCA1 SNF2L SNF2L1,1054,"function: energy-transducing component of nurf (nucleosome-remodeling factor) and cerf (cecr2-containing-remodeling factor) complexes. both complexes facilitate the perturbation of chromatin structure in an atp-dependent manner. potentiates neurite outgrowth. may be involved in brain development by regulating en-1 and en-2 expression. may be involved in the development of luteal cells. {eco:0000269|pubmed:14609955, eco:0000269|pubmed:15310751, eco:0000269|pubmed:15640247, eco:0000269|pubmed:16740656}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SMARCA1,6594,Hs.152292,ENST00000371122,NP518595,"GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0006338(chromatin remodeling)|GO:0006351(transcription, DNA-dependent)|GO:0007420(brain development)|GO:0008094(DNA-dependent ATPase activity)|GO:0016585(chromatin remodeling complex)|GO:0016589(NURF complex)|GO:0016787(hydrolase activity)|GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides)|GO:0030182(neuron differentiation)|GO:0031491(nucleosome binding)|GO:0043044(ATP-dependent chromatin remodeling)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (SMARCA1), transcript variant 1, mRNA [NM_003069]",chrX:128580725-128580666,hs|Xq25,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",TRUE
1134_C1QBP_708,Q07021,"complement component 1 q subcomponent-binding protein, mitochondrial (asf/sf2-associated protein p32) (glycoprotein gc1qbp) (c1qbp) (hyaluronan-binding protein 1) (mitochondrial matrix protein p32) (gc1q-r protein) (p33) (sf2ap32)",C1QBP GC1QBP HABP1 SF2P32,282,"function: is believed to be a multifunctional and multicompartmental protein involved in inflammation and infection processes, ribosome biogenesis, protein synthesis in mitochondria, regulation of apoptosis, transcriptional regulation and pre-mrna splicing. at the cell surface is thought to act as an endothelial receptor for plasma proteins of the complement and kallikrein-kinin cascades. putative receptor for c1q; specifically binds to the globular 'heads' of c1q thus inhibiting c1; may perform the receptor function through a complex with c1qr/cd93. in complex with cytokeratin-1/krt1 is a high affinity receptor for kininogen-1/hmwk. can also bind other plasma proteins, such as coagulation factor xii leading to its autoactivation. may function to bind initially fluid kininogen-1 to the cell membrane. the secreted form may enhance both extrinsic and intrinsic coagulation pathways. it is postulated that the cell surface form requires docking with transmembrane proteins for downstream signaling which might be specific for a cell-type or response. by acting as c1q receptor is involved in chemotaxis of immature dendritic cells and neutrophils and is proposed to signal through cd209/dc-sign on immature dendritic cells, through integrin alpha-4/beta-1 during trophoblast invasion of the decidua, and through integrin beta-1 during endothelial cell adhesion and spreading. signaling involved in inhibition of innate immune response is implicating the pi3k-akt/pkb pathway. required for protein synthesis in mitochondria (pubmed:28942965). in mitochondrial translation may be involved in formation of functional 55s mitoribosomes; the function seems to involve its rna-binding activity. may be involved in the nucleolar ribosome maturation process; the function may involve the exchange of fbl for rrp1 in the association with pre-ribosome particles. involved in regulation of rna splicing by inhibiting the rna-binding capacity of srsf1 and its phosphorylation. is required for the nuclear translocation of splicing factor u2af1l4. involved in regulation of cdkn2a- and hrk-mediated apoptosis. stabilizes mitochondrial cdkn2a isoform smarf. may be involved in regulation of foxc1 transcriptional activity and nfy/ccaat-binding factor complex-mediated transcription. may play a role in antibacterial defense as it can bind to cell surface hyaluronan and inhibit streptococcus pneumoniae hyaluronate lyase. may be involved in modulation of the immune response; ligation by hcv core protein is resulting in suppression of interleukin-12 production in monocyte-derived dendritic cells. involved in regulation of antiviral response by inhibiting ddx58- and ifih1-mediated signaling pathways probably involving its association with mavs after viral infection. {eco:0000269|pubmed:10022843, eco:0000269|pubmed:10479529, eco:0000269|pubmed:10722602, eco:0000269|pubmed:11086025, eco:0000269|pubmed:11859136, eco:0000269|pubmed:15243141, eco:0000269|pubmed:16140380, eco:0000269|pubmed:16177118, eco:0000269|pubmed:17881511, eco:0000269|pubmed:18676636, eco:0000269|pubmed:19004836, eco:0000269|pubmed:19164550, eco:0000269|pubmed:20810993, eco:0000269|pubmed:21536856, eco:0000269|pubmed:21544310, eco:0000269|pubmed:22700724, eco:0000269|pubmed:28942965, eco:0000269|pubmed:8662673, eco:0000269|pubmed:8710908, eco:0000269|pubmed:9461517}.; function: (microbial infection) involved in hiv-1 replication, presumably by contributing to splicing of viral rna. {eco:0000269|pubmed:12833064}.; function: (microbial infection) in infection processes acts as an attachment site for microbial proteins, including listeria monocytogenes internalin b (inlb) and staphylococcus aureus protein a. {eco:0000269|pubmed:10722602, eco:0000269|pubmed:10747014, eco:0000269|pubmed:12411480}.; function: (microbial infection) involved in replication of rubella virus. {eco:0000269|pubmed:12034482}.","subcellular location: mitochondrion matrix {eco:0000269|pubmed:15031724, eco:0000269|pubmed:17486078, eco:0000269|pubmed:19164550, eco:0000269|pubmed:9305894}. nucleus {eco:0000269|pubmed:18676636}. cell membrane {eco:0000269|pubmed:10747014, eco:0000269|pubmed:11493647, eco:0000269|pubmed:12574814, eco:0000269|pubmed:8195709, eco:0000269|pubmed:8662673, eco:0000269|pubmed:9191880, eco:0000269|pubmed:9233640}; peripheral membrane protein {eco:0000269|pubmed:12574814, eco:0000269|pubmed:8662673, eco:0000269|pubmed:9191880}; extracellular side. secreted. cytoplasm {eco:0000269|pubmed:11493647}. nucleus, nucleolus {eco:0000269|pubmed:21536856}. note=seems to be predominantly localized to mitochondria. secreted by activated lymphocytes.","TISSUE SPECIFICITY: Expressed on cell surface of peripheral blood cells (at protein level); Surface expression is reported for macrophages and monocyte-derived dendritic cells. {ECO:0000269|PubMed:12574814, ECO:0000269|PubMed:8662673}.","DISEASE: Combined oxidative phosphorylation deficiency 33 (COXPD33) [MIM:617713]: An autosomal recessive disorder caused by multiple mitochondrial respiratory chain defects and impaired mitochondrial energy metabolism. Clinical manifestations are highly variable. Affected infants present with cardiomyopathy accompanied by multisystemic features involving liver, kidney, and brain. Death in infancy is observed in some patients. Children and adults present with myopathy and progressive external ophthalmoplegia. {ECO:0000269|PubMed:28942965}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C1QBP,708,Hs.555866,ENST00000225698,THC2469874,"GO:0001849(complement component C1q binding)|GO:0005080(protein kinase C binding)|GO:0005515(protein binding)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0005886(plasma membrane)|GO:0006955(immune response)|GO:0007596(blood coagulation)|GO:0007597(blood coagulation, intrinsic pathway)|GO:0016020(membrane)|GO:0044419(interspecies interaction between organisms)","Homo sapiens complement component 1, q subcomponent binding protein (C1QBP), nuclear gene encoding mitochondrial protein, mRNA [NM_001212]",chr17:5336307-5336248,hs|17p13.2,"complement component 1, q subcomponent binding protein",TRUE
1135_ARMC2_84071,Q8NEN0,armadillo repeat-containing protein 2,ARMC2,867,function: required for sperm flagellum axoneme organization and function (by similarity). involved in axonemal central pair complex assembly and/or stability (by similarity). {eco:0000250|uniprotkb:q3ury6}.,NA,TISSUE SPECIFICITY: Expressed at higher level in testis. {ECO:0000269|PubMed:30686508}.,"DISEASE: Spermatogenic failure 38 (SPGF38) [MIM:618433]: An autosomal recessive infertility disorder characterized by asthenoteratozoospermia. Spermatozoa exhibit multiple morphologic abnormalities including short, absent, coiled, bent, or irregular-caliber flagella. {ECO:0000269|PubMed:30686508}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ARMC2,84071,Hs.645481,ENST00000368972,THC2474703,GO:0005488(binding),"Homo sapiens armadillo repeat containing 2 (ARMC2), mRNA [NM_032131]",chr6:109294735-109294794,hs|6q21,armadillo repeat containing 2,TRUE
1136_HPRT1_3251,P00492,hypoxanthine-guanine phosphoribosyltransferase (hgprt) (hgprtase) (ec 2.4.2.8),HPRT1 HPRT,218,"function: converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. plays a central role in the generation of purine nucleotides through the purine salvage pathway.",subcellular location: cytoplasm.,NA,"DISEASE: Lesch-Nyhan syndrome (LNS) [MIM:300322]: Characterized by complete lack of enzymatic activity that results in hyperuricemia, choreoathetosis, mental retardation, and compulsive self-mutilation. {ECO:0000269|PubMed:15571223, ECO:0000269|PubMed:17027311, ECO:0000269|PubMed:20544509, ECO:0000269|PubMed:2071157, ECO:0000269|PubMed:2246854, ECO:0000269|PubMed:2347587, ECO:0000269|PubMed:2358296, ECO:0000269|PubMed:24940672, ECO:0000269|PubMed:2572141, ECO:0000269|PubMed:2910902, ECO:0000269|PubMed:3265398, ECO:0000269|PubMed:3384338, ECO:0000269|PubMed:6853716, ECO:0000269|PubMed:7627191, ECO:0000269|PubMed:9452051}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gout HPRT-related (GOUT-HPRT) [MIM:300323]: Characterized by partial enzyme activity and hyperuricemia. {ECO:0000269|PubMed:15571223, ECO:0000269|PubMed:17027311, ECO:0000269|PubMed:20544509, ECO:0000269|PubMed:24940672, ECO:0000269|PubMed:2896620, ECO:0000269|PubMed:2909537, ECO:0000269|PubMed:3198771, ECO:0000269|PubMed:3358423, ECO:0000269|PubMed:6572373, ECO:0000269|PubMed:6706936, ECO:0000269|PubMed:6853490, ECO:0000269|PubMed:7987318}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HPRT1,3251,Hs.412707,ENST00000298556,THC2479985,"GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0001975(response to amphetamine)|GO:0004422(hypoxanthine phosphoribosyltransferase activity)|GO:0004614(phosphoglucomutase activity)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006144(purine base metabolic process)|GO:0006164(purine nucleotide biosynthetic process)|GO:0006166(purine ribonucleoside salvage)|GO:0006168(adenine salvage)|GO:0006178(guanine salvage)|GO:0007283(spermatogenesis)|GO:0007610(behavior)|GO:0007625(grooming behavior)|GO:0009116(nucleoside metabolic process)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0019255(glucose 1-phosphate metabolic process)|GO:0019835(cytolysis)|GO:0021756(striatum development)|GO:0021895(cerebral cortex neuron differentiation)|GO:0021954(central nervous system neuron development)|GO:0032263(GMP salvage)|GO:0032264(IMP salvage)|GO:0042803(protein homodimerization activity)|GO:0043101(purine-containing compound salvage)|GO:0043103(hypoxanthine salvage)|GO:0045964(positive regulation of dopamine metabolic process)|GO:0046038(GMP catabolic process)|GO:0046040(IMP metabolic process)|GO:0046083(adenine metabolic process)|GO:0046100(hypoxanthine metabolic process)|GO:0046651(lymphocyte proliferation)|GO:0048813(dendrite morphogenesis)|GO:0051289(protein homotetramerization)|GO:0052657(guanine phosphoribosyltransferase activity)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens hypoxanthine phosphoribosyltransferase 1 (HPRT1), mRNA [NM_000194]",chrX:133634514-133634573,hs|Xq26.3,hypoxanthine phosphoribosyltransferase 1,TRUE
1137_KAT6A_7994,Q92794,"histone acetyltransferase kat6a (ec 2.3.1.48) (moz, ybf2/sas3, sas2 and tip60 protein 3) (myst-3) (monocytic leukemia zinc finger protein) (runt-related transcription factor-binding protein 2) (zinc finger protein 220)",KAT6A MOZ MYST3 RUNXBP2 ZNF220,2004,"function: histone acetyltransferase that acetylates lysine residues in histone h3 and histone h4 (in vitro). component of the moz/morf complex which has a histone h3 acetyltransferase activity. may act as a transcriptional coactivator for runx1 and runx2. acetylates p53/tp53 at 'lys-120' and 'lys-382' and controls its transcriptional activity via association with pml. {eco:0000269|pubmed:11742995, eco:0000269|pubmed:11965546, eco:0000269|pubmed:12771199, eco:0000269|pubmed:16387653, eco:0000269|pubmed:17925393, eco:0000269|pubmed:23431171}.","subcellular location: nucleus. nucleus, nucleolus. nucleus, nucleoplasm. nucleus, pml body. note=recruited into pml body after dna damage.",NA,"DISEASE: Note=Chromosomal aberrations involving KAT6A may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with CREBBP (PubMed:8782817). Translocation t(8;22)(p11;q13) with EP300 (PubMed:10824998). KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription (PubMed:11742995). Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation (PubMed:12676584). {ECO:0000269|PubMed:10824998, ECO:0000269|PubMed:11742995, ECO:0000269|PubMed:12676584, ECO:0000269|PubMed:8782817}.; DISEASE: Note=A chromosomal aberration involving KAT6A is a cause of therapy-related myelodysplastic syndrome. Translocation t(2;8)(p23;p11.2) with ASXL2 generates a KAT6A-ASXL2 fusion protein. {ECO:0000269|Ref.3}.; DISEASE: Mental retardation, autosomal dominant 32 (MRD32) [MIM:616268]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD32 patients manifest intellectual disability, dysmorphic facial features, delayed psychomotor development, and lack of speech. {ECO:0000269|PubMed:25728775, ECO:0000269|PubMed:25728777}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KAT6A,7994,Hs.491577,ENST00000396930,THC2467531,"GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0003713(transcription coactivator activity)|GO:0004402(histone acetyltransferase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006323(DNA packaging)|GO:0006334(nucleosome assembly)|GO:0008134(transcription factor binding)|GO:0008270(zinc ion binding)|GO:0016407(acetyltransferase activity)|GO:0016568(chromatin modification)|GO:0016573(histone acetylation)|GO:0030099(myeloid cell differentiation)|GO:0043966(histone H3 acetylation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0070776(MOZ/MORF histone acetyltransferase complex)","Homo sapiens K(lysine) acetyltransferase 6A (KAT6A), transcript variant 3, mRNA [NM_006766]",chr8:41788575-41788516,hs|8p11.21,K(lysine) acetyltransferase 6A,TRUE
1138_SNRNP200_23020,O75643,u5 small nuclear ribonucleoprotein 200 kda helicase (ec 3.6.4.13) (activating signal cointegrator 1 complex subunit 3-like 1) (brr2 homolog) (u5 snrnp-specific 200 kda protein) (u5-200kd),SNRNP200 ASCC3L1 HELIC2 KIAA0788,2136,"function: plays role in pre-mrna splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (pubmed:28502770, pubmed:28781166, pubmed:29361316, pubmed:30315277, pubmed:29360106, pubmed:29301961, pubmed:30728453, pubmed:30705154). involved in spliceosome assembly, activation and disassembly. mediates changes in the dynamic network of rna-rna interactions in the spliceosome. catalyzes the atp-dependent unwinding of u4/u6 rna duplices, an essential step in the assembly of a catalytically active spliceosome. {eco:0000269|pubmed:16723661, eco:0000269|pubmed:23045696, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166, eco:0000269|pubmed:29301961, eco:0000269|pubmed:29360106, eco:0000269|pubmed:29361316, eco:0000269|pubmed:30315277, eco:0000269|pubmed:30705154, eco:0000269|pubmed:30728453, eco:0000269|pubmed:8670905, eco:0000269|pubmed:9539711}.","subcellular location: nucleus {eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166, eco:0000269|pubmed:29301961, eco:0000269|pubmed:29360106, eco:0000269|pubmed:29361316, eco:0000269|pubmed:30315277, eco:0000269|pubmed:30705154, eco:0000269|pubmed:30728453, eco:0000269|pubmed:9539711}.",TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:19878916}.,"DISEASE: Retinitis pigmentosa 33 (RP33) [MIM:610359]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:16723661, ECO:0000269|PubMed:19710410, ECO:0000269|PubMed:19878916, ECO:0000269|PubMed:21618346, ECO:0000269|PubMed:23029027, ECO:0000269|PubMed:23045696, ECO:0000269|PubMed:23887765, ECO:0000269|PubMed:24319334}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRNP200,23020,Hs.246112,ENST00000543553,THC2465423,"GO:0000166(nucleotide binding)|GO:0000354(cis assembly of pre-catalytic spliceosome)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003676(nucleic acid binding)|GO:0004386(helicase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005682(U5 snRNP)|GO:0005730(nucleolus)|GO:0008026(ATP-dependent helicase activity)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016787(hydrolase activity)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein 200kDa (U5) (SNRNP200), mRNA [NM_014014]",chr2:96940734-96940675,hs|2q11.2,small nuclear ribonucleoprotein 200kDa (U5),TRUE
1139_NDUFA2_4695,O43678,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (complex i-b8) (ci-b8) (nadh-ubiquinone oxidoreductase b8 subunit),NDUFA2,99,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 13 (MC1DN13) [MIM:618235]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN13 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:18513682}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA2,4695,Hs.534333,ENST00000502960,THC2536941,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0031966(mitochondrial membrane)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa (NDUFA2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_002488]",chr5:140026844-140025208,hs|5q31.3,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa",TRUE
114_SRRM2_23524,Q9UQ35,serine/arginine repetitive matrix protein 2 (300 kda nuclear matrix antigen) (serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kda) (sr-related nuclear matrix protein of 300 kda) (ser/arg-related nuclear matrix protein of 300 kda) (splicing coactivator subunit srm300) (tax-responsive enhancer element-binding protein 803) (taxreb803),SRRM2 KIAA0324 SRL300 SRM300 HSPC075,2752,"function: required for pre-mrna splicing as component of the spliceosome. {eco:0000269|pubmed:19854871, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961, eco:0000269|pubmed:29360106, eco:0000269|pubmed:29361316, eco:0000269|pubmed:30705154, eco:0000269|pubmed:9531537}.","subcellular location: nucleus {eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961, eco:0000269|pubmed:29360106, eco:0000269|pubmed:29361316, eco:0000269|pubmed:30705154}. nucleus speckle {eco:0000269|pubmed:9531537}.","TISSUE SPECIFICITY: Expressed in liver, placenta, and white blood cells. {ECO:0000269|PubMed:11004489}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRRM2,23524,Hs.433343,ENST00000301740,THC2562607,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0008380(RNA splicing)|GO:0015030(Cajal body)|GO:0016607(nuclear speck)|GO:0047485(protein N-terminus binding)|GO:0070742(C2H2 zinc finger domain binding)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens serine/arginine repetitive matrix 2 (SRRM2), mRNA [NM_016333]",chr16:2821188-2821247,hs|16p13.3,serine/arginine repetitive matrix 2,TRUE
1140_PODXL_5420,Q9NZ53,podocalyxin-like protein 2 (endoglycan),PODXL2 UNQ1861/PRO3742,605,"function: acts as a ligand for vascular selectins. mediates rapid rolling of leukocytes over vascular surfaces through high affinity divalent cation-dependent interactions with e-, p- and l-selectins. {eco:0000269|pubmed:18606703}.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in T-cells, B-cells and monocytes. Expression is higher on memory and germinal center cells than on naive B-cells (at protein level). Highly expressed in brain. Moderately expressed in pancreas, kidney and lymphoid node. Weakly expressed in liver. Detected in both endothelial cells and CD34+ bone marrow cells. {ECO:0000269|PubMed:10722749, ECO:0000269|PubMed:18606703}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PODXL,5420,Hs.16426,ENST00000541194,THC2604997,GO:0001726(ruffle)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0015629(actin cytoskeleton)|GO:0016324(apical plasma membrane)|GO:0016477(cell migration)|GO:0022408(negative regulation of cell-cell adhesion)|GO:0030027(lamellipodium)|GO:0030175(filopodium)|GO:0030335(positive regulation of cell migration)|GO:0031528(microvillus membrane)|GO:0032534(regulation of microvillus assembly)|GO:0033634(positive regulation of cell-cell adhesion mediated by integrin)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045121(membrane raft)|GO:0050900(leukocyte migration)|GO:0072175(epithelial tube formation),"Homo sapiens podocalyxin-like (PODXL), transcript variant 1, mRNA [NM_001018111]",chr7:131185194-131185135,hs|7q32.3,podocalyxin-like,TRUE
1141_EIF4A3_9775,P38919,"eukaryotic initiation factor 4a-iii (eif-4a-iii) (eif4a-iii) (ec 3.6.4.13) (atp-dependent rna helicase ddx48) (atp-dependent rna helicase eif4a-3) (dead box protein 48) (eukaryotic initiation factor 4a-like nuk-34) (eukaryotic translation initiation factor 4a isoform 3) (nuclear matrix protein 265) (nmp 265) (hnmp 265) [cleaved into: eukaryotic initiation factor 4a-iii, n-terminally processed]",EIF4A3 DDX48 KIAA0111,411,"function: atp-dependent rna helicase (pubmed:16170325). involved in pre-mrna splicing as component of the spliceosome (pubmed:11991638, pubmed:22961380, pubmed:28502770, pubmed:28076346, pubmed:29301961). core component of the splicing-dependent multiprotein exon junction complex (ejc) deposited at splice junctions on mrnas (pubmed:16209946, pubmed:16170325, pubmed:16314458, pubmed:16923391, pubmed:16931718, pubmed:19033377, pubmed:20479275). the ejc is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during ejc assembly or during subsequent mrna metabolism. the ejc marks the position of the exon-exon junction in the mature mrna for the gene expression machinery and the core components remain bound to spliced mrnas throughout all stages of mrna metabolism thereby influencing downstream processes including nuclear mrna export, subcellular mrna localization, translation efficiency and nonsense-mediated mrna decay (nmd). its rna-dependent atpase and rna-helicase activities are induced by casc3, but abolished in presence of the magoh-rbm8a heterodimer, thereby trapping the atp-bound ejc core onto spliced mrna in a stable conformation. the inhibition of atpase activity by the magoh-rbm8a heterodimer increases the rna-binding affinity of the ejc. involved in translational enhancement of spliced mrnas after formation of the 80s ribosome complex. binds spliced mrna in sequence-independent manner, 20-24 nucleotides upstream of mrna exon-exon junctions. shows higher affinity for single-stranded rna in an atp-bound core ejc complex than after the atp is hydrolyzed. involved in the splicing modulation of bcl2l1/bcl-x (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as bcl-x(s); the function is different from the established ejc assembly (pubmed:22203037). involved in craniofacial development (pubmed:24360810). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:15034551, eco:0000269|pubmed:16170325, eco:0000269|pubmed:16209946, eco:0000269|pubmed:16314458, eco:0000269|pubmed:16923391, eco:0000269|pubmed:16931718, eco:0000269|pubmed:17375189, eco:0000269|pubmed:19033377, eco:0000269|pubmed:19409878, eco:0000269|pubmed:20479275, eco:0000269|pubmed:22203037, eco:0000269|pubmed:22961380, eco:0000269|pubmed:24360810, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}.","subcellular location: nucleus {eco:0000269|pubmed:10623621, eco:0000269|pubmed:11991638, eco:0000269|pubmed:22961380, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}. nucleus speckle {eco:0000269|pubmed:10623621}. cytoplasm {eco:0000250|uniprotkb:q3b8q2}. note=nucleocytoplasmic shuttling protein. travels to the cytoplasm as part of the exon junction complex (ejc) bound to mrna. detected in dendritic layer as well as the nuclear and cytoplasmic (somatic) compartments of neurons. colocalizes with stau1 and fmr1 in dendrites (by similarity). {eco:0000250|uniprotkb:q3b8q2}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10623621}.,"DISEASE: Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305]: A syndrome characterized by a unique pattern of anomalies consisting of microstomia, micrognathia, abnormal fusion of mandible, cleft palate/Robin sequence, absence of central lower incisors, minor ears anomalies, hypoplastic first ray, abnormal tibiae, hypoplastic halluces, and clubfeet. Learning disability is also a common finding. {ECO:0000269|PubMed:24360810}. Note=The disease is caused by mutations affecting the gene represented in this entry. EIF4A3 mutations resulting in Richieri-Costa-Pereira syndrome include a repeat expansion of 18 or 20 nucleotides in the 5' untranslated region. Affected individuals have 14 to 16 repeats, while healthy individuals have 3 to 12 repeats (PubMed:24360810). {ECO:0000269|PubMed:24360810}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF4A3,9775,Hs.389649,ENST00000269349,THC2509236,"GO:0000166(nucleotide binding)|GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0004004(ATP-dependent RNA helicase activity)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006810(transport)|GO:0008143(poly(A) RNA binding)|GO:0008380(RNA splicing)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016607(nuclear speck)|GO:0016787(hydrolase activity)|GO:0017148(negative regulation of translation)|GO:0035145(exon-exon junction complex)|GO:0045727(positive regulation of translation)|GO:0051028(mRNA transport)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens eukaryotic translation initiation factor 4A3 (EIF4A3), mRNA [NM_014740]",chr17:78109220-78109161,hs|17q25.3,eukaryotic translation initiation factor 4A3,TRUE
1142_NOP56_10528,O00567,nucleolar protein 56 (nucleolar protein 5a),NOP56 NOL5A,594,"function: involved in the early to middle stages of 60s ribosomal subunit biogenesis. core component of box c/d small nucleolar ribonucleoprotein (snornp) particles. required for the biogenesis of box c/d snornas such u3, u8 and u14 snornas. {eco:0000269|pubmed:12777385, eco:0000269|pubmed:15574333}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:12429849, eco:0000269|pubmed:12777385, eco:0000269|pubmed:9372940}. cytoplasm {eco:0000250|uniprotkb:q9d6z1}. nucleus, nucleoplasm {eco:0000305|pubmed:15574333}.",NA,"DISEASE: Spinocerebellar ataxia 36 (SCA36) [MIM:614153]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA36 is characterized by complicated clinical features, with ataxia as the first symptom, followed by characteristic late-onset involvement of the motor neuron system. Ataxic symptoms, such as gait and truncal instability, ataxic dysarthria, and uncoordinated limbs, start in late forties to fifties. Characteristically, affected individuals exhibit tongue atrophy with fasciculation. Progression of motor neuron involvement is typically limited to the tongue and main proximal skeletal muscles in both upper and lower extremities. {ECO:0000269|PubMed:21683323}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by large hexanucleotide CGCCTG repeat expansions within intron 1. These expansions induce RNA foci and sequester the RNA-binding protein SRSF2. In addition, the transcription of MIR1292, a microRNA gene located just 19 bp 3' of the GGCCTG repeat, is significantly decreased.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NOP56,10528,Hs.376064,ENST00000329276,THC2508617,GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005732(small nucleolar ribonucleoprotein complex)|GO:0005737(cytoplasm)|GO:0006364(rRNA processing)|GO:0008219(cell death)|GO:0030515(snoRNA binding)|GO:0031428(box C/D snoRNP complex)|GO:0070761(pre-snoRNP complex),"Homo sapiens NOP56 ribonucleoprotein homolog (yeast) (NOP56), transcript variant 1, mRNA [NM_006392]",chr20:2638880-2638939,hs|20p13,NOP56 ribonucleoprotein homolog (yeast),TRUE
1143_PHF2_5253,O75151,lysine-specific demethylase phf2 (ec 1.14.11.-) (grc5) (phd finger protein 2),PHF2 CENP-35 KIAA0662,1096,"function: lysine demethylase that demethylates both histones and non-histone proteins. enzymatically inactive by itself, and becomes active following phosphorylation by pka: forms a complex with arid5b and mediates demethylation of methylated arid5b. demethylation of arid5b leads to target the phf2-arid5b complex to target promoters, where phf2 mediates demethylation of dimethylated 'lys-9' of histone h3 (h3k9me2), followed by transcription activation of target genes. the phf2-arid5b complex acts as a coactivator of hnf4a in liver. phf2 is recruited to trimethylated 'lys-4' of histone h3 (h3k4me3) at rdna promoters and promotes expression of rdna. {eco:0000269|pubmed:20129925, eco:0000269|pubmed:21167174, eco:0000269|pubmed:21532585}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:20129925}. chromosome, centromere, kinetochore {eco:0000269|pubmed:20813266}.","TISSUE SPECIFICITY: Widely expressed, including in liver (at protein level). {ECO:0000269|PubMed:21532585}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PHF2,5253,Hs.211441,ENST00000359246,NP841398,"GO:0001889(liver development)|GO:0003713(transcription coactivator activity)|GO:0005506(iron ion binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006482(protein demethylation)|GO:0008270(zinc ion binding)|GO:0016491(oxidoreductase activity)|GO:0016568(chromatin modification)|GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen)|GO:0032452(histone demethylase activity)|GO:0032454(histone demethylase activity (H3-K9 specific))|GO:0033169(histone H3-K9 demethylation)|GO:0035064(methylated histone residue binding)|GO:0046872(metal ion binding)|GO:0061188(negative regulation of chromatin silencing at rDNA)","Homo sapiens PHD finger protein 2 (PHF2), mRNA [NM_005392]",chr9:96441749-96441808,hs|9q22.31,PHD finger protein 2,TRUE
1144_ATP5I_521,P56385,"atp synthase subunit e, mitochondrial (atpase subunit e) (atp synthase membrane subunit e) [cleaved into: atp synthase subunit e, mitochondrial, n-terminally processed]",ATP5ME ATP5I ATP5K,69,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core, and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain. minor subunit located with subunit a in the membrane.",subcellular location: mitochondrion. mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5I,521,Hs.85539,ENST00000515202,THC2550897,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006811(ion transport)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E (ATP5I), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_007100]",chr4:667722-667153,hs|4p16.3,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E",TRUE
1145_PRR15L_79170,Q9BU68,proline-rich protein 15-like protein (protein atad4),PRR15L ATAD4,103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,PRR15L,79170,Hs.368260,ENST00000300557,THC2470376,NA,"Homo sapiens proline rich 15-like (PRR15L), mRNA [NM_024320]",chr17:46029448-46029389,hs|17q21.32,proline rich 15-like,TRUE
1146_SSBP1_6742,Q04837,"single-stranded dna-binding protein, mitochondrial (mt-ssb) (mtssb) (pwp1-interacting protein 17)",SSBP1 SSBP,148,function: this protein binds preferentially and cooperatively to ss-dna. probably involved in mitochondrial dna replication. associates with mitochondrial dna.,"subcellular location: mitochondrion {eco:0000269|pubmed:18063578}. mitochondrion matrix, mitochondrion nucleoid {eco:0000269|pubmed:18063578}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SSBP1,6742,Hs.490394,ENST00000467681,THC2510169,GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003697(single-stranded DNA binding)|GO:0005739(mitochondrion)|GO:0006260(DNA replication)|GO:0042645(mitochondrial nucleoid)|GO:0051096(positive regulation of helicase activity)|GO:0070584(mitochondrion morphogenesis),"Homo sapiens single-stranded DNA binding protein 1 (SSBP1), nuclear gene encoding mitochondrial protein, mRNA [NM_003143]",chr7:141445323-141445382,hs|7q34,single-stranded DNA binding protein 1,TRUE
1147_PPA1_5464,Q15181,inorganic pyrophosphatase (ec 3.6.1.1) (pyrophosphate phospho-hydrolase) (ppase),PPA1 IOPPP PP,289,NA,subcellular location: cytoplasm {eco:0000250}.,TISSUE SPECIFICITY: Expressed ubiquitously. {ECO:0000269|PubMed:10542310}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PPA1,5464,Hs.437403,ENST00000373232,THC2546616,GO:0000287(magnesium ion binding)|GO:0004427(inorganic diphosphatase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006796(phosphate metabolic process)|GO:0010467(gene expression)|GO:0016787(hydrolase activity)|GO:0071344(diphosphate metabolic process),"Homo sapiens pyrophosphatase (inorganic) 1 (PPA1), mRNA [NM_021129]",chr10:71962931-71962872,hs|10q22.1,pyrophosphatase (inorganic) 1,TRUE
1148_GMPR2_51292,Q9P2T1,gmp reductase 2 (gmpr 2) (ec 1.7.1.7) (guanosine 5'-monophosphate oxidoreductase 2) (guanosine monophosphate reductase 2),GMPR2,348,"function: catalyzes the irreversible nadph-dependent deamination of gmp to imp. it functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of g to a nucleotides, and in maintaining the intracellular balance of a and g nucleotides (pubmed:12009299, pubmed:12669231, pubmed:16359702, pubmed:22037469). plays a role in modulating cellular differentiation (pubmed:12669231). {eco:0000255|hamap-rule:mf_03195, eco:0000269|pubmed:12009299, eco:0000269|pubmed:12669231, eco:0000269|pubmed:16359702, eco:0000269|pubmed:22037469}.",NA,"TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle, kidney, brain, liver, prostate, spleen, placenta, testis and ovary. Low expression in colon, thymus and peripheral blood leukocytes. {ECO:0000269|PubMed:12009299, ECO:0000269|PubMed:12669231}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GMPR2,51292,Hs.368855,ENST00000456667,THC2492547,"GO:0003920(GMP reductase activity)|GO:0005829(cytosol)|GO:0006144(purine base metabolic process)|GO:0009117(nucleotide metabolic process)|GO:0016491(oxidoreductase activity)|GO:0043101(purine-containing compound salvage)|GO:0046872(metal ion binding)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens guanosine monophosphate reductase 2 (GMPR2), transcript variant 2, mRNA [NM_001002000]",chr14:24708342-24708401,hs|14q12,guanosine monophosphate reductase 2,TRUE
1149_ARF3_377,P61204,adp-ribosylation factor 3,ARF3,181,"function: gtp-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an adp-ribosyltransferase. involved in protein trafficking; may modulate vesicle budding and uncoating within the golgi apparatus.","subcellular location: golgi apparatus {eco:0000269|pubmed:17555535}. cytoplasm, perinuclear region {eco:0000269|pubmed:17555535}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARF3,377,NA,ENST00000398092,THC2583971,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006184(GTP catabolic process)|GO:0007264(small GTPase mediated signal transduction)|GO:0015031(protein transport)|GO:0016192(vesicle-mediated transport)|GO:0048471(perinuclear region of cytoplasm),ADP-ribosylation factor 3 [Source:HGNC Symbol;Acc:654] [ENST00000398092],chr12:49297471-49297412,hs|12q13.12,ADP-ribosylation factor 3,TRUE
115_HMGN2_3151,P05204,non-histone chromosomal protein hmg-17 (high mobility group nucleosome-binding domain-containing protein 2),HMGN2 HMG17,90,function: binds to the inner side of the nucleosomal dna thus altering the interaction between the dna and the histone octamer. may be involved in the process which maintains transcribable genes in a unique chromatin conformation (by similarity). {eco:0000250}.,subcellular location: nucleus {eco:0000269|pubmed:10739259}. cytoplasm {eco:0000269|pubmed:10739259}. note=cytoplasmic enrichment upon phosphorylation.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HMGN2,3151,Hs.181163,ENST00000361427,THC2570960,"GO:0000785(chromatin)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006325(chromatin organization)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens high mobility group nucleosomal binding domain 2 (HMGN2), mRNA [NM_005517]",chr1:26802354-26802413,hs|1p36.11,high mobility group nucleosomal binding domain 2,TRUE
1150_NME1_4830,P15531,nucleoside diphosphate kinase a (ndk a) (ndp kinase a) (ec 2.7.4.6) (granzyme a-activated dnase) (gaad) (metastasis inhibition factor nm23) (nm23-h1) (tumor metastatic process-associated protein),NME1 NDPKA NM23,152,"function: major role in the synthesis of nucleoside triphosphates other than atp. the atp gamma phosphate is transferred to the ndp beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. involved in cell proliferation, differentiation and development, signal transduction, g protein-coupled receptor endocytosis, and gene expression. required for neural development including neural patterning and cell fate determination. during gzma-mediated cell death, works in concert with trex1. nme1 nicks one strand of dna and trex1 removes bases from the free 3' end to enhance dna damage and prevent dna end reannealing and rapid repair. {eco:0000269|pubmed:12628186, eco:0000269|pubmed:16818237, eco:0000269|pubmed:8810265}.",subcellular location: cytoplasm {eco:0000269|pubmed:16442775}. nucleus {eco:0000269|pubmed:16442775}. note=cell-cycle dependent nuclear localization which can be induced by interaction with epstein-barr viral proteins or by degradation of the set complex by gzma.,"TISSUE SPECIFICITY: Isoform 1 is expressed in heart, brain, placenta, lung, liver, skeletal muscle, pancreas, spleen and thymus. Expressed in lung carcinoma cell lines but not in normal lung tissues. Isoform 2 is ubiquitously expressed and its expression is also related to tumor differentiation. {ECO:0000269|PubMed:10512675, ECO:0000269|PubMed:12601555, ECO:0000269|PubMed:16442775}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NME1,4830,Hs.463456,ENST00000013034,THC2504170,"GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0002762(negative regulation of myeloid leukocyte differentiation)|GO:0004536(deoxyribonuclease activity)|GO:0004550(nucleoside diphosphate kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005525(GTP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005882(intermediate filament)|GO:0006165(nucleoside diphosphate phosphorylation)|GO:0006183(GTP biosynthetic process)|GO:0006228(UTP biosynthetic process)|GO:0006241(CTP biosynthetic process)|GO:0006897(endocytosis)|GO:0007399(nervous system development)|GO:0008285(negative regulation of cell proliferation)|GO:0009117(nucleotide metabolic process)|GO:0015949(nucleobase, nucleoside and nucleotide interconversion)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0030154(cell differentiation)|GO:0042493(response to drug)|GO:0042802(identical protein binding)|GO:0042981(regulation of apoptosis)|GO:0043015(gamma-tubulin binding)|GO:0043388(positive regulation of DNA binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0050679(positive regulation of epithelial cell proliferation)|GO:0051591(response to cAMP)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 1, mRNA [NM_198175]",chr17:49238609-49239123,hs|17q21.33,"non-metastatic cells 1, protein (NM23A) expressed in",TRUE
1151_SAV1_60485,Q9H4B6,protein salvador homolog 1 (45 kda ww domain protein) (hww45),SAV1 WW45,383,"function: regulator of stk3/mst2 and stk4/mst1 in the hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. the core of this pathway is composed of a kinase cascade wherein stk3/mst2 and stk4/mst1, in complex with its regulatory protein sav1, phosphorylates and activates lats1/2 in complex with its regulatory protein mob1, which in turn phosphorylates and inactivates yap1 oncoprotein and wwtr1/taz. phosphorylation of yap1 by lats1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. sav1 is required for stk3/mst2 and stk4/mst1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. plays a role in centrosome disjunction by regulating the localization of nek2 to centrosomes, and its ability to phosphorylate crocc and cep250. in conjunction with stk3/mst2, activates the transcriptional activity of esr1 through the modulation of its phosphorylation. {eco:0000269|pubmed:16930133, eco:0000269|pubmed:19212654, eco:0000269|pubmed:21076410, eco:0000269|pubmed:21104395}.",subcellular location: nucleus {eco:0000269|pubmed:19212654}. cytoplasm {eco:0000269|pubmed:19212654}.,"TISSUE SPECIFICITY: Ubiquitously expressed in adult tissues with highest expression in the pancreas, aorta and interventricular septum and lowest expression in skeletal muscle. Expression was higher in fetal than in the adult heart. Expressed in various cell lines. {ECO:0000269|PubMed:19212654}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SAV1,60485,Hs.642842,ENST00000324679,THC2467223,GO:0001942(hair follicle development)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007165(signal transduction)|GO:0030216(keratinocyte differentiation)|GO:0035329(hippo signaling cascade)|GO:0043065(positive regulation of apoptosis)|GO:0050680(negative regulation of epithelial cell proliferation)|GO:0060487(lung epithelial cell differentiation)|GO:0060575(intestinal epithelial cell differentiation)|GO:2000036(regulation of stem cell maintenance),"Homo sapiens salvador homolog 1 (Drosophila) (SAV1), mRNA [NM_021818]",chr14:51100478-51100419,hs|14q22.1,salvador homolog 1 (Drosophila),TRUE
1152_HIST1H4L_8368,P62805,histone h4,H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4,103,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,"DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6. {ECO:0000269|PubMed:12414651}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H4L,8368,Hs.533295,ENST00000355981,THC2486688,NA,"Homo sapiens histone cluster 1, H4l (HIST1H4L), mRNA [NM_003546]",chr6:27841008-27840949,hs|6p22.1,"histone cluster 1, H4l",TRUE
1153_SELK_58515,Q9Y6D0,selenoprotein k (selk),SELENOK SELK HSPC030 HSPC297,94,"function: required for ca(2+) flux in immune cells and plays a role in t-cell proliferation and in t-cell and neutrophil migration (by similarity). involved in endoplasmic reticulum-associated degradation (erad) of soluble glycosylated proteins (pubmed:22016385). required for palmitoylation and cell surface expression of cd36 and involved in macrophage uptake of low-density lipoprotein and in foam cell formation (by similarity). together with zdhhc6, required for palmitoylation of itpr1 in immune cells, leading to regulate itpr1 stability and function (pubmed:25368151). plays a role in protection of cells from er stress-induced apoptosis (pubmed:20692228). protects cells from oxidative stress when overexpressed in cardiomyocytes (pubmed:16962588). {eco:0000250|uniprotkb:q9jlj1, eco:0000269|pubmed:16962588, eco:0000269|pubmed:20692228, eco:0000269|pubmed:22016385, eco:0000269|pubmed:25368151}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:16962588, eco:0000269|pubmed:21220695, eco:0000269|pubmed:22016385, eco:0000269|pubmed:25368151}; single-pass membrane protein {eco:0000255}. cell membrane {eco:0000269|pubmed:12775843}; single-pass membrane protein {eco:0000255}. note=probably mainly localized in the er. {eco:0000269|pubmed:21220695}.",TISSUE SPECIFICITY: Highly expressed in heart. {ECO:0000269|PubMed:16962588}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SELK,58515,Hs.58471,ENST00000488746,THC2536132,GO:0005783(endoplasmic reticulum)|GO:0006979(response to oxidative stress),"Homo sapiens selenoprotein K (SELK), mRNA [NM_021237]",chr3:53919421-53919362,hs|3p21.1,selenoprotein K,TRUE
1154_CAMLG_819,P49069,calcium signal-modulating cyclophilin ligand (caml),CAMLG CAML,296,function: likely involved in the mobilization of calcium as a result of the tcr/cd3 complex interaction. binds to cyclophilin b.,subcellular location: membrane; multi-pass membrane protein.,"TISSUE SPECIFICITY: Ubiquitous. Highest levels in brain, testis and ovary.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CAMLG,819,Hs.529846,ENST00000297156,NP097432,GO:0001881(receptor recycling)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0006952(defense response)|GO:0007165(signal transduction)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens calcium modulating ligand (CAMLG), mRNA [NM_001745]",chr5:134086572-134086631,hs|5q31.1,calcium modulating ligand,TRUE
1155_EIF5_1983,P55010,eukaryotic translation initiation factor 5 (eif-5),EIF5,431,function: catalyzes the hydrolysis of gtp bound to the 40s ribosomal initiation complex (40s.mrna.met-trna[f].eif-2.gtp) with the subsequent joining of a 60s ribosomal subunit resulting in the release of eif-2 and the guanine nucleotide. the subsequent joining of a 60s ribosomal subunit results in the formation of a functional 80s initiation complex (80s.mrna.met-trna[f]).,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF5,1983,Hs.433702,ENST00000216554,THC2511308,"GO:0000166(nucleotide binding)|GO:0003743(translation initiation factor activity)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006184(GTP catabolic process)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0008135(translation factor activity, nucleic acid binding)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0044267(cellular protein metabolic process)","Homo sapiens eukaryotic translation initiation factor 5 (EIF5), transcript variant 1, mRNA [NM_001969]",chr14:103809241-103809300,hs|14q32.32,eukaryotic translation initiation factor 5,TRUE
1156_PREPL_9581,Q4J6C6,prolyl endopeptidase-like (ec 3.4.21.-) (prolylendopeptidase-like),PREPL KIAA0436,727,"function: serine peptidase whose precise substrate specificity remains unclear (pubmed:16143824, pubmed:16385448, pubmed:28726805). does not cleave peptides after a arginine or lysine residue (pubmed:16143824). regulates trans-golgi network morphology and sorting by regulating the membrane binding of the ap-1 complex (pubmed:23321636). may play a role in the regulation of synaptic vesicle exocytosis (pubmed:24610330). {eco:0000269|pubmed:16143824, eco:0000269|pubmed:16385448, eco:0000269|pubmed:23321636, eco:0000269|pubmed:24610330, eco:0000269|pubmed:28726805}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:16385448, eco:0000269|pubmed:23485813}. golgi apparatus, trans-golgi network {eco:0000250|uniprotkb:q8c167}. cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q8c167}. golgi apparatus {eco:0000250|uniprotkb:q8c167}. nucleus {eco:0000269|pubmed:23485813}. note=co-localizes with ap-1 in the trans-golgi network (by similarity). co-localizes with map2 and actb on the cytoskeleton (by similarity). co-localizes with stx6 and gosr2 at the golgi apparatus (by similarity). {eco:0000250|uniprotkb:q8c167}.","TISSUE SPECIFICITY: Expressed in pyramidal neurons of the temporal cortex and neocortex (at protein level) (PubMed:23485813). Widely expressed (PubMed:15913950, PubMed:16385448). Expressed at higher level in brain, skeletal muscle, heart and kidney (PubMed:15913950, PubMed:16385448). Expressed at the endplates in the neuromuscular junction (PubMed:24610330). {ECO:0000269|PubMed:15913950, ECO:0000269|PubMed:16385448, ECO:0000269|PubMed:23485813, ECO:0000269|PubMed:24610330}.","DISEASE: Hypotonia-cystinuria syndrome (HCS) [MIM:606407]: Characterized generalized hypotonia at birth, nephrolithiasis, growth hormone deficiency, minor facial dysmorphism, failure to thrive, followed by hyperphagia and rapid weight gain in late childhood. {ECO:0000269|PubMed:16385448, ECO:0000269|PubMed:21686663, ECO:0000269|PubMed:23321636, ECO:0000269|PubMed:23485813, ECO:0000269|PubMed:28726805}. Note=The gene represented in this entry is involved in disease pathogenesis. Hypotonia-cystinuria syndrome is a contiguous gene syndrome caused by a homozygous deletion on chromosome 2p21 that disrupts the gene represented in this entry and SLC3A1 (PubMed:16385448, PubMed:21686663). A homozygous 77.4-kb deletion that disrupts the gene represented in this entry, SLC3A1 and CAMKMT, causes atypical hypotonia-cystinuria syndrome, characterized by mild to moderate mental retardation and respiratory chain complex IV deficiency (PubMed:21686663). Patient cells exhibit a larger trans-Golgi network and a reduced redistribution of AP-1 complex, which causes impairment in AP-1 mediated membrane-cytoplasm recycling and secretion (PubMed:23321636). {ECO:0000269|PubMed:16385448, ECO:0000269|PubMed:21686663, ECO:0000269|PubMed:23321636}.; DISEASE: Myasthenic syndrome, congenital, 22 (CMS22) [MIM:616224]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features include easy fatigability and muscle weakness. CMS22 is an autosomal recessive form characterized by neonatal hypotonia. {ECO:0000269|PubMed:24610330, ECO:0000269|PubMed:29483676}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,PREPL,9581,Hs.727511,ENST00000409936,THC2501130,GO:0004252(serine-type endopeptidase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0008233(peptidase activity),"Homo sapiens prolyl endopeptidase-like (PREPL), transcript variant 1, mRNA [NM_006036]",chr2:44545965-44545906,hs|2p21,prolyl endopeptidase-like,TRUE
1157_KRAS_3845,P01116,"gtpase kras (k-ras 2) (ki-ras) (c-k-ras) (c-ki-ras) [cleaved into: gtpase kras, n-terminally processed]",KRAS KRAS2 RASK2,189,"function: ras proteins bind gdp/gtp and possess intrinsic gtpase activity. plays an important role in the regulation of cell proliferation (pubmed:23698361, pubmed:22711838). plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (tsgs) in colorectal cancer (crc) cells in a znf304-dependent manner (pubmed:24623306). {eco:0000269|pubmed:22711838, eco:0000269|pubmed:23698361, eco:0000269|pubmed:24623306, eco:0000305}.","subcellular location: cell membrane {eco:0000269|pubmed:22431598, eco:0000269|pubmed:23698361}; lipid-anchor {eco:0000305|pubmed:23698361}; cytoplasmic side {eco:0000305|pubmed:23698361}. cytoplasm, cytosol {eco:0000269|pubmed:23698361}.",NA,"DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:17332249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:16773572, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:17468812, ECO:0000269|PubMed:19396835, ECO:0000269|PubMed:20949621}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. {ECO:0000269|PubMed:16247081}.; DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:20949621, ECO:0000269|PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRAS mutations are involved in cancer development. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:1553789, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:3627975, ECO:0000269|PubMed:6092920, ECO:0000269|PubMed:6695174, ECO:0000269|PubMed:7773929}.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KRAS,3845,Hs.505033,ENST00000311936,THC2465782,GO:0000165(MAPKKK cascade)|GO:0000166(nucleotide binding)|GO:0000186(activation of MAPKK activity)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005739(mitochondrion)|GO:0005886(plasma membrane)|GO:0007165(signal transduction)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007264(small GTPase mediated signal transduction)|GO:0007265(Ras protein signal transduction)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0008286(insulin receptor signaling pathway)|GO:0008321(Ral guanyl-nucleotide exchange factor activity)|GO:0019002(GMP binding)|GO:0019003(GDP binding)|GO:0019221(cytokine-mediated signaling pathway)|GO:0030275(LRR domain binding)|GO:0035176(social behavior)|GO:0043406(positive regulation of MAP kinase activity)|GO:0045121(membrane raft)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050900(leukocyte migration)|GO:0051000(positive regulation of nitric-oxide synthase activity)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051384(response to glucocorticoid stimulus)|GO:0051385(response to mineralocorticoid stimulus),"Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a, mRNA [NM_033360]",chr12:25358370-25358311,hs|12p12.1,v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,TRUE
1158_SEMA4C_54910,Q9C0C4,semaphorin-4c,SEMA4C KIAA1739 SEMAI UNQ5855/PRO34487,833,"function: cell surface receptor for plxnb2 that plays an important role in cell-cell signaling. plxnb2 binding promotes downstream activation of rhoa and phosphorylation of erbb2 at 'tyr-1248'. required for normal brain development, axon guidance and cell migration (by similarity). probable signaling receptor which may play a role in myogenic differentiation through activation of the stress-activated mapk cascade. {eco:0000250, eco:0000269|pubmed:17498836}.","subcellular location: cell junction, synapse, postsynaptic density membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}. cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEMA4C,54910,Hs.516220,ENST00000467747,THC2490793,GO:0004872(receptor activity)|GO:0005886(plasma membrane)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0014069(postsynaptic density)|GO:0016021(integral to membrane)|GO:0030054(cell junction)|GO:0030672(synaptic vesicle membrane)|GO:0031410(cytoplasmic vesicle)|GO:0032874(positive regulation of stress-activated MAPK cascade)|GO:0042692(muscle cell differentiation)|GO:0045202(synapse)|GO:0045211(postsynaptic membrane),"Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C (SEMA4C), mRNA [NM_017789]",chr2:97525582-97525523,hs|2q11.2,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C",TRUE
1159_PIP4K2B_8396,P78356,phosphatidylinositol 5-phosphate 4-kinase type-2 beta (ec 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (diphosphoinositide kinase 2-beta) (phosphatidylinositol 5-phosphate 4-kinase type ii beta) (pi(5)p 4-kinase type ii beta) (pip4kii-beta) (ptdins(5)p-4-kinase isoform 2-beta),PIP4K2B PIP5K2B,416,"function: participates in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. {eco:0000269|pubmed:9038203}.",subcellular location: endoplasmic reticulum membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. cell membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. nucleus {eco:0000269|pubmed:20583997}. cytoplasm {eco:0000269|pubmed:20583997}. note=associated with the plasma membrane and the endoplasmic reticulum. {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in brain, heart, pancreas, skeletal muscle and kidney. Detected at lower levels in placenta, lung and liver. {ECO:0000269|PubMed:9038203}.",NA,NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PIP4K2B,8396,Hs.730609,ENST00000269554,THC2586937,GO:0000166(nucleotide binding)|GO:0005057(receptor signaling protein activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005886(plasma membrane)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0016308(1-phosphatidylinositol-4-phosphate 5-kinase activity)|GO:0016309(1-phosphatidylinositol-5-phosphate 4-kinase activity)|GO:0016740(transferase activity),"Homo sapiens phosphatidylinositol-5-phosphate 4-kinase, type II, beta (PIP4K2B), mRNA [NM_003559]",chr17:36922033-36921974,hs|17q12,"phosphatidylinositol-5-phosphate 4-kinase, type II, beta",TRUE
116_TRIB1_10221,Q96RU8,tribbles homolog 1 (trb-1) (g-protein-coupled receptor-induced gene 2 protein) (gig-2) (skip1),TRIB1 C8FW GIG2 TRB1,372,"function: adapter protein involved in protein degradation by interacting with cop1 ubiquitin ligase (pubmed:27041596). the cop1-binding motif is masked by autoinhibitory interactions with the protein kinase domain (pubmed:26455797). serves to alter cop1 substrate specificity by directing the activity of cop1 toward cebpa (pubmed:27041596). binds selectively the recognition sequence of cebpa (pubmed:26455797). regulates myeloid cell differentiation by altering the expression of cebpa in a cop1-dependent manner (by similarity). controls macrophage, eosinophil and neutrophil differentiation via the cop1-binding domain (by similarity). interacts with mapk kinases and regulates activation of map kinases, but has no kinase activity (pubmed:15299019, pubmed:26455797). {eco:0000250|uniprotkb:q8k4k4, eco:0000269|pubmed:15299019, eco:0000269|pubmed:26455797, eco:0000305|pubmed:27041596}.",NA,"TISSUE SPECIFICITY: Expressed in most human tissues with the highest levels in skeletal muscle, thyroid gland, pancreas, peripheral blood leukocytes, and bone marrow. {ECO:0000269|PubMed:15299019}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TRIB1,10221,Hs.444947,ENST00000311922,THC2466660,"GO:0004672(protein kinase activity)|GO:0004860(protein kinase inhibitor activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006468(protein phosphorylation)|GO:0006469(negative regulation of protein kinase activity)|GO:0007254(JNK cascade)|GO:0008134(transcription factor binding)|GO:0014912(negative regulation of smooth muscle cell migration)|GO:0016772(transferase activity, transferring phosphorus-containing groups)|GO:0031434(mitogen-activated protein kinase kinase binding)|GO:0031625(ubiquitin protein ligase binding)|GO:0031665(negative regulation of lipopolysaccharide-mediated signaling pathway)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0032496(response to lipopolysaccharide)|GO:0043405(regulation of MAP kinase activity)|GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity)|GO:0048662(negative regulation of smooth muscle cell proliferation)|GO:0055106(ubiquitin-protein ligase regulator activity)","Homo sapiens tribbles homolog 1 (Drosophila) (TRIB1), mRNA [NM_025195]",chr8:126450454-126450513,hs|8q24.13,tribbles homolog 1 (Drosophila),TRUE
1160_CYFIP1_23191,Q7L576,cytoplasmic fmr1-interacting protein 1 (specifically rac1-associated protein 1) (sra-1) (p140sra-1),CYFIP1 KIAA0068,1253,"function: component of the cyfip1-eif4e-fmr1 complex which binds to the mrna cap and mediates translational repression. in the cyfip1-eif4e-fmr1 complex this subunit is an adapter between eif4e and fmr1. promotes the translation repression activity of fmr1 in brain probably by mediating its association with eif4e and mrna (by similarity). regulates formation of membrane ruffles and lamellipodia. plays a role in axon outgrowth. binds to f-actin but not to rna. part of the wave complex that regulates actin filament reorganization via its interaction with the arp2/3 complex. actin remodeling activity is regulated by rac1. regulator of epithelial morphogenesis. as component of the wave1 complex, required for bdnf-ntrk2 endocytic trafficking and signaling from early endosomes (by similarity). may act as an invasion suppressor in cancers. {eco:0000250|uniprotkb:q7tmb8, eco:0000269|pubmed:16260607, eco:0000269|pubmed:19524508, eco:0000269|pubmed:21107423, eco:0000269|pubmed:9417078}.","subcellular location: cytoplasm {eco:0000250|uniprotkb:q7tmb8}. cytoplasm, perinuclear region {eco:0000250|uniprotkb:q7tmb8}. cell projection, lamellipodium {eco:0000250|uniprotkb:q7tmb8}. cell projection, ruffle {eco:0000250|uniprotkb:q7tmb8}. cell junction, synapse, synaptosome {eco:0000250|uniprotkb:q7tmb8}. note=highly expressed in the perinuclear region (by similarity). enriched in synaptosomes (by similarity). also enriched in membrane ruffles and at the tips of lamellipodia (by similarity). {eco:0000250|uniprotkb:q7tmb8}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYFIP1,23191,Hs.26704,ENST00000412127,THC2631238,GO:0001726(ruffle)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005845(mRNA cap binding complex)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0008360(regulation of cell shape)|GO:0019717(synaptosome)|GO:0030027(lamellipodium)|GO:0030032(lamellipodium assembly)|GO:0030054(cell junction)|GO:0030154(cell differentiation)|GO:0031529(ruffle organization)|GO:0045202(synapse)|GO:0048365(Rac GTPase binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0048675(axon extension)|GO:0051015(actin filament binding),"Homo sapiens cytoplasmic FMR1 interacting protein 1 (CYFIP1), transcript variant 1, mRNA [NM_014608]",chr15:23003325-23003384,hs|15q11.2,cytoplasmic FMR1 interacting protein 1,TRUE
1161_LINC00116_205251,Q8NCU8,mitoregulin (small integral membrane protein 37),MTLN LINC00116 NCRNA00116 SMIM37,56,"function: positively regulates mitochondrial complex assembly and/or stability (by similarity). increases mitochondrial membrane potential and mitochondrial respiration rate awhile decreasing mitochondrial reactive oxygen species (pubmed:29949756). also increases mitochondrial calcium retention capacity (pubmed:29949756). {eco:0000250|uniprotkb:q8bt35, eco:0000269|pubmed:29949756}.",subcellular location: mitochondrion inner membrane {eco:0000250|uniprotkb:q8bt35}; single-pass membrane protein {eco:0000305}. note=preferentially binds to cardiolipin relative to other common cell membrane lipids. {eco:0000250|uniprotkb:q8bt35}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LINC00116,205251,Hs.128499,NA,THC2778897,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens long intergenic non-protein coding RNA 116 (LINC00116), non-coding RNA [NR_027063]",chr2:110969194-110969135,hs|2q13,long intergenic non-protein coding RNA 116,TRUE
1162_LIMS1_3987,P48059,lim and senescent cell antigen-like-containing domain protein 1 (particularly interesting new cys-his protein 1) (pinch-1) (renal carcinoma antigen ny-ren-48),LIMS1 PINCH PINCH1,325,"function: adapter protein in a cytoplasmic complex linking beta-integrins to the actin cytoskeleton, bridges the complex to cell surface receptor tyrosine kinases and growth factor receptors. involved in the regulation of cell survival, cell proliferation and cell differentiation.","subcellular location: cell junction, focal adhesion. cell membrane; peripheral membrane protein; cytoplasmic side.",TISSUE SPECIFICITY: Expressed in most tissues except in the brain.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LIMS1,3987,Hs.597715,ENST00000332345,THC2470725,"GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005925(focal adhesion)|GO:0007569(cell aging)|GO:0008270(zinc ion binding)|GO:0030054(cell junction)|GO:0034329(cell junction assembly)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0071560(cellular response to transforming growth factor beta stimulus)","Homo sapiens LIM and senescent cell antigen-like domains 1 (LIMS1), transcript variant 2, mRNA [NM_004987]",chr2:109300515-109300574,hs|2q12.3,LIM and senescent cell antigen-like domains 1,TRUE
1163_CARS2_79587,Q9HA77,"probable cysteine--trna ligase, mitochondrial (ec 6.1.1.16) (cysteinyl-trna synthetase) (cysrs)",CARS2 OK/SW-cl.10,564,NA,subcellular location: mitochondrion matrix {eco:0000250}.,NA,"DISEASE: Combined oxidative phosphorylation deficiency 27 (COXPD27) [MIM:616672]: An autosomal recessive mitochondrial disorder characterized by multiple mitochondrial respiratory-chain-complex deficiencies causing neurological regression, progressive cognitive decline, complex movement disorder, epileptic encephalopathy, progressive spastic tetraparesis, and progressive impairment of vision and hearing. {ECO:0000269|PubMed:25361775, ECO:0000269|PubMed:25787132}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,CARS2,79587,Hs.508725,ENST00000537802,THC2503844,GO:0000166(nucleotide binding)|GO:0004817(cysteine-tRNA ligase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0005829(cytosol)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006423(cysteinyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0016874(ligase activity)|GO:0046872(metal ion binding),"Homo sapiens cysteinyl-tRNA synthetase 2, mitochondrial (putative) (CARS2), nuclear gene encoding mitochondrial protein, mRNA [NM_024537]",chr13:111293837-111293778,hs|13q34,"cysteinyl-tRNA synthetase 2, mitochondrial (putative)",TRUE
1164_PTDSS1_9791,P48651,phosphatidylserine synthase 1 (pss-1) (ptdser synthase 1) (ec 2.7.8.29) (serine-exchange enzyme i),PTDSS1 KIAA0024 PSSA,473,"function: catalyzes a base-exchange reaction in which the polar head group of phosphatidylethanolamine (pe) or phosphatidylcholine (pc) is replaced by l-serine. in membranes, ptdss1 catalyzes mainly the conversion of phosphatidylcholine. also converts, in vitro and to a lesser extent, phosphatidylethanolamine.",subcellular location: endoplasmic reticulum membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}. note=highly enriched in the mitochondria-associated membrane (mam). {eco:0000250}.,NA,"DISEASE: Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]: A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PTDSS1,9791,Hs.292579,ENST00000455950,THC2469210,GO:0006659(phosphatidylserine biosynthetic process)|GO:0008654(phospholipid biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity),"Homo sapiens phosphatidylserine synthase 1 (PTDSS1), mRNA [NM_014754]",chr8:97346598-97346657,hs|8q22.1,phosphatidylserine synthase 1,TRUE
1165_ICT1_3396,Q14197,"peptidyl-trna hydrolase ict1, mitochondrial (ec 3.1.1.29) (39s ribosomal protein l58, mitochondrial) (mrp-l58) (digestion substraction 1) (ds-1) (immature colon carcinoma transcript 1 protein) (mitochondrial large ribosomal subunit protein ml62)",MRPL58 DS1 ICT1,206,"function: essential peptidyl-trna hydrolase component of the mitochondrial large ribosomal subunit. acts as a codon-independent translation release factor that has lost all stop codon specificity and directs the termination of translation in mitochondrion, possibly in case of abortive elongation. may be involved in the hydrolysis of peptidyl-trnas that have been prematurely terminated and thus in the recycling of stalled mitochondrial ribosomes. {eco:0000269|pubmed:20186120}.","subcellular location: mitochondrion {eco:0000269|pubmed:20186120, eco:0000269|pubmed:23908630, eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",TISSUE SPECIFICITY: Down-regulated during the in vitro differentiation of HT29-D4 colon carcinoma cells. {ECO:0000269|PubMed:8575443}.,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,ICT1,3396,Hs.407955,ENST00000301585,THC2464593,"GO:0004045(aminoacyl-tRNA hydrolase activity)|GO:0005739(mitochondrion)|GO:0005762(mitochondrial large ribosomal subunit)|GO:0016150(translation release factor activity, codon nonspecific)|GO:0016787(hydrolase activity)|GO:0070126(mitochondrial translational termination)","Homo sapiens immature colon carcinoma transcript 1 (ICT1), mRNA [NM_001545]",chr17:73017278-73017337,hs|17q25.1,immature colon carcinoma transcript 1,TRUE
1166_EBPL_84650,Q9BY08,emopamil-binding protein-like (emopamil-binding-related protein),EBPL EBRP ERP,206,function: does not possess sterol isomerase activity and does not bind sigma ligands. {eco:0000269|pubmed:12760743}.,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12760743}; multi-pass membrane protein {eco:0000269|pubmed:12760743}.,"TISSUE SPECIFICITY: Widely expressed with highest levels in liver, lung and kidney. {ECO:0000269|PubMed:12760743}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,EBPL,84650,Hs.433278,ENST00000378274,THC2490888,GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016125(sterol metabolic process)|GO:0047750(cholestenol delta-isomerase activity),"Homo sapiens emopamil binding protein-like (EBPL), mRNA [NM_032565]",chr13:50234979-50234920,hs|13q14.2,emopamil binding protein-like,TRUE
1167_BZW2_28969,Q9Y6E2,basic leucine zipper and w2 domain-containing protein 2,BZW2 HSPC028 MSTP017,419,function: may be involved in neuronal differentiation. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,BZW2,28969,Hs.487635,ENST00000436868,THC2557332,GO:0005488(binding)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0016070(RNA metabolic process)|GO:0030154(cell differentiation),"Homo sapiens basic leucine zipper and W2 domains 2 (BZW2), transcript variant 2, mRNA [NM_014038]",chr7:16746044-16746103,hs|7p21.1,basic leucine zipper and W2 domains 2,TRUE
1168_MT1X_4501,P80297,metallothionein-1x (mt-1x) (metallothionein-ix) (mt-ix),MT1X,61,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. may be involved in fam168a anti-apoptotic signaling (pubmed:23251525). {eco:0000269|pubmed:23251525}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT1X,4501,Hs.374950,ENST00000394485,THC2483725,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0010038(response to metal ion)|GO:0045926(negative regulation of growth)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0071276(cellular response to cadmium ion)|GO:0071294(cellular response to zinc ion),"Homo sapiens metallothionein 1X (MT1X), mRNA [NM_005952]",chr16:56717910-56717969,hs|16q13,metallothionein 1X,TRUE
1169_ILF2_3608,Q12905,interleukin enhancer-binding factor 2 (nuclear factor of activated t-cells 45 kda),ILF2 NF45 PRO3063,390,"function: appears to function predominantly as a heterodimeric complex with ilf3. this complex may regulate transcription of the il2 gene during t-cell activation. it can also promote the formation of stable dna-dependent protein kinase holoenzyme complexes on dna. essential for the efficient reshuttling of ilf3 (isoform 1 and isoform 2) into the nucleus. {eco:0000269|pubmed:10574923, eco:0000269|pubmed:11739746, eco:0000269|pubmed:21123651, eco:0000269|pubmed:9442054}.","subcellular location: nucleus, nucleolus. cytoplasm. nucleus. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ILF2,3608,Hs.75117,ENST00000480213,THC2596886,"GO:0003677(DNA binding)|GO:0003725(double-stranded RNA binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006351(transcription, DNA-dependent)|GO:0006955(immune response)|GO:0016740(transferase activity)|GO:0030529(ribonucleoprotein complex)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens interleukin enhancer binding factor 2, 45kDa (ILF2), mRNA [NM_004515]",chr1:153634727-153634668,hs|1q21.3,"interleukin enhancer binding factor 2, 45kDa",TRUE
117_DHX9_1660,Q08211,atp-dependent rna helicase a (ec 3.6.4.13) (deah box protein 9) (dexh-box helicase 9) (leukophysin) (lkp) (nuclear dna helicase ii) (ndh ii) (rna helicase a),DHX9 DDX9 LKP NDH2,1270,"function: multifunctional atp-dependent nucleic acid helicase that unwinds dna and rna in a 3' to 5' direction and that plays important roles in many processes, such as dna replication, transcriptional activation, post-transcriptional rna regulation, mrna translation and rna-mediated gene silencing (pubmed:9111062, pubmed:11416126, pubmed:12711669, pubmed:15355351, pubmed:16680162, pubmed:17531811, pubmed:20669935, pubmed:21561811, pubmed:24049074, pubmed:25062910, pubmed:24990949, pubmed:28221134). requires a 3'-single-stranded tail as entry site for acid nuclei unwinding activities as well as the binding and hydrolyzing of any of the four ribo- or deoxyribo-nucleotide triphosphates (ntps) (pubmed:1537828). unwinds numerous nucleic acid substrates such as double-stranded (ds) dna and rna, dna:rna hybrids, dna and rna forks composed of either partially complementary dna duplexes or dna:rna hybrids, respectively, and also dna and rna displacement loops (d- and r-loops), triplex-helical dna (h-dna) structure and dna and rna-based g-quadruplexes (pubmed:20669935, pubmed:21561811, pubmed:24049074). binds dsdna, single-stranded dna (ssdna), dsrna, ssrna and poly(a)-containing rna (pubmed:9111062, pubmed:10198287). binds also to circular dsdna or dsrna of either linear and/or circular forms and stimulates the relaxation of supercoiled dnas catalyzed by topoisomerase top2a (pubmed:12711669). plays a role in dna replication at origins of replication and cell cycle progression (pubmed:24990949). plays a role as a transcriptional coactivator acting as a bridging factor between polymerase ii holoenzyme and transcription factors or cofactors, such as brca1, crebbp, rela and smn1 (pubmed:11149922, pubmed:9323138, pubmed:9662397, pubmed:11038348, pubmed:11416126, pubmed:15355351, pubmed:28221134). binds to the cdkn2a promoter (pubmed:11038348). plays several roles in post-transcriptional regulation of gene expression (pubmed:28221134, pubmed:28355180). in cooperation with nup98, promotes pre-mrna alternative splicing activities of a subset of genes (pubmed:11402034, pubmed:16680162, pubmed:28221134, pubmed:28355180). as component of a large per complex, is involved in the negative regulation of 3' transcriptional termination of circadian target genes such as per1 and nr1d1 and the control of the circadian rhythms (by similarity). acts also as a nuclear resolvase that is able to bind and neutralize harmful massive secondary double-stranded rna structures formed by inverted-repeat alu retrotransposon elements that are inserted and transcribed as parts of genes during the process of gene transposition (pubmed:28355180). involved in the positive regulation of nuclear export of constitutive transport element (cte)-containing unspliced mrna (pubmed:9162007, pubmed:10924507, pubmed:11402034). component of the coding region determinant (crd)-mediated complex that promotes cytoplasmic myc mrna stability (pubmed:19029303). plays a role in mrna translation (pubmed:28355180). positively regulates translation of selected mrnas through its binding to post-transcriptional control element (pce) in the 5'-untranslated region (utr) (pubmed:16680162). involved with larp6 in the translation stimulation of type i collagen mrnas for co1a1 and co1a2 through binding of a specific stem-loop structure in their 5'-utrs (pubmed:22190748). stimulates lin28a-dependent mrna translation probably by facilitating ribonucleoprotein remodeling during the process of translation (pubmed:21247876). plays also a role as a small interfering (sirna)-loading factor involved in the rna-induced silencing complex (risc) loading complex (rlc) assembly, and hence functions in the risc-mediated gene silencing process (pubmed:17531811). binds preferentially to short double-stranded rna, such as those produced during rotavirus intestinal infection (pubmed:28636595). this interaction may mediate nlrp9 inflammasome activation and trigger inflammatory response, including il18 release and pyroptosis (pubmed:28636595). finally, mediates the attachment of heterogeneous nuclear ribonucleoproteins (hnrnps) to actin filaments in the nucleus (pubmed:11687588). {eco:0000250|uniprotkb:o70133, eco:0000269|pubmed:10198287, eco:0000269|pubmed:10924507, eco:0000269|pubmed:11038348, eco:0000269|pubmed:11149922, eco:0000269|pubmed:11402034, eco:0000269|pubmed:11416126, eco:0000269|pubmed:11687588, eco:0000269|pubmed:12711669, eco:0000269|pubmed:15355351, eco:0000269|pubmed:1537828, eco:0000269|pubmed:16680162, eco:0000269|pubmed:17531811, eco:0000269|pubmed:19029303, eco:0000269|pubmed:20669935, eco:0000269|pubmed:21247876, eco:0000269|pubmed:21561811, eco:0000269|pubmed:22190748, eco:0000269|pubmed:24049074, eco:0000269|pubmed:24990949, eco:0000269|pubmed:25062910, eco:0000269|pubmed:28221134, eco:0000269|pubmed:28355180, eco:0000269|pubmed:28636595, eco:0000269|pubmed:9111062, eco:0000269|pubmed:9162007, eco:0000269|pubmed:9323138, eco:0000269|pubmed:9662397}.; function: (microbial infection) plays a role in hiv-1 replication and virion infectivity (pubmed:11096080, pubmed:19229320, pubmed:25149208, pubmed:27107641). enhances hiv-1 transcription by facilitating the binding of rna polymerase ii holoenzyme to the proviral dna (pubmed:11096080, pubmed:25149208). binds (via drbm domain 2) to the hiv-1 tar rna and stimulates hiv-1 transcription of transactivation response element (tar)-containing mrnas (pubmed:9892698, pubmed:11096080). involved also in hiv-1 mrna splicing and transport (pubmed:25149208). positively regulates hiv-1 gag mrna translation, through its binding to post-transcriptional control element (pce) in the 5'-untranslated region (utr) (pubmed:16680162). binds (via drbm domains) to a hiv-1 double-stranded rna region of the primer binding site (pbs)-segment of the 5'-utr, and hence stimulates dhx9 incorporation into virions and virion infectivity (pubmed:27107641). plays also a role as a cytosolic viral myd88-dependent dna and rna sensors in plasmacytoid dendritic cells (pdcs), and hence induce antiviral innate immune responses (pubmed:20696886, pubmed:21957149). binds (via the ob-fold region) to viral single-stranded dna unmethylated c-phosphate-g (cpg) oligonucleotide (pubmed:20696886). {eco:0000269|pubmed:11096080, eco:0000269|pubmed:16680162, eco:0000269|pubmed:19229320, eco:0000269|pubmed:20696886, eco:0000269|pubmed:21957149, eco:0000269|pubmed:25149208, eco:0000269|pubmed:27107641, eco:0000269|pubmed:9892698}.","subcellular location: nucleus {eco:0000269|pubmed:10198287, eco:0000269|pubmed:10207077, eco:0000269|pubmed:11687588, eco:0000269|pubmed:16375861, eco:0000269|pubmed:17303075, eco:0000269|pubmed:9162007}. nucleus, nucleoplasm {eco:0000269|pubmed:28221134}. nucleus, nucleolus {eco:0000269|pubmed:12429849}. cytoplasm {eco:0000269|pubmed:10198287, eco:0000269|pubmed:10207077, eco:0000269|pubmed:16375861, eco:0000269|pubmed:17289661, eco:0000269|pubmed:19029303, eco:0000269|pubmed:20696886, eco:0000269|pubmed:8690889, eco:0000269|pubmed:9162007}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:17498979}. note=nucleoplasmic shuttling protein (pubmed:10198287, pubmed:16375861, pubmed:10207077, pubmed:9162007). its nuclear import involves the nucleocytoplasmic transport receptor importin alpha/importin beta receptor pathway in a ran-dependent manner (pubmed:16375861). in interphase, localizes in nuclear stress granules and at perichromatin fibrils and in cytoplasmic ribonucleoprotein granules (pubmed:10198287). colocalizes with wrn and h2afx at centrosomes in a microtubule-dependent manner following dna damaging agent treatment (pubmed:17498979). excluded from the mitotic nucleus as early as prophase and re-entered the nucleus at telophase (pubmed:10198287). recruited in diffuse and discrete intranuclear foci (glfg-body) in a nup98-dependent manner (pubmed:28221134). colocalizes with sp7 in the nucleus (pubmed:17303075). colocalizes with actb at nuclear actin filaments inside the nucleus or at the nuclear pore (pubmed:11687588). colocalizes with hnrnpc at nuclear ribonucleoprotein complex proteins in the nucleus (pubmed:11687588). localized in cytoplasmic mrnp granules containing untranslated mrnas (pubmed:17289661). {eco:0000269|pubmed:10198287, eco:0000269|pubmed:10207077, eco:0000269|pubmed:11687588, eco:0000269|pubmed:16375861, eco:0000269|pubmed:17289661, eco:0000269|pubmed:17303075, eco:0000269|pubmed:17498979, eco:0000269|pubmed:28221134, eco:0000269|pubmed:9162007}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,DHX9,1660,Hs.191518,ENST00000485081,THC2463666,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003724(RNA helicase activity)|GO:0003725(double-stranded RNA binding)|GO:0004003(ATP-dependent DNA helicase activity)|GO:0004004(ATP-dependent RNA helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016787(hydrolase activity)|GO:0030529(ribonucleoprotein complex)|GO:0034605(cellular response to heat)|GO:0070934(CRD-mediated mRNA stabilization)|GO:0070937(CRD-mediated mRNA stability complex)","Homo sapiens DEAH (Asp-Glu-Ala-His) box polypeptide 9 (DHX9), transcript variant 1, mRNA [NM_001357]",chr1:182856674-182856733,hs|1q25.3,DEAH (Asp-Glu-Ala-His) box polypeptide 9,TRUE
1170_MRPL43_84545,Q8N983,"39s ribosomal protein l43, mitochondrial (l43mt) (mrp-l43) (mitochondrial large ribosomal subunit protein ml43) (mitochondrial ribosomal protein bmrp36a)",MRPL43,215,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.","TISSUE SPECIFICITY: High relative levels in skeletal muscle and testis. Lower levels of expression in the heart, brain, placenta, lung, liver, kidney, pancreas, spleen, thymus, prostate, ovary, small intestine, colon and leukocytes. Expression is coregulated with TWNK. {ECO:0000269|PubMed:15509589}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPL43,84545,Hs.421848,ENST00000370234,THC2466403,GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein L43 (MRPL43), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_032112]",chr10:102746193-102746134,hs|10q24.31,mitochondrial ribosomal protein L43,TRUE
1171_SF3B1_23451,O75533,splicing factor 3b subunit 1 (pre-mrna-splicing factor sf3b 155 kda subunit) (sf3b155) (spliceosome-associated protein 155) (sap 155),SF3B1 SAP155,1304,"function: involved in pre-mrna splicing as a component of the splicing factor sf3b complex (pubmed:27720643). sf3b complex is required for 'a' complex assembly formed by the stable binding of u2 snrnp to the branchpoint sequence (bps) in pre-mrna. sequence independent binding of sf3a/sf3b complex upstream of the branch site is essential, it may anchor u2 snrnp to the pre-mrna (pubmed:12234937). together with other u2 snrnp complex components may also play a role in the selective processing of micrornas (mirnas) from the long primary mirna transcript, pri-mir-17-92 (by similarity). may also be involved in the assembly of the 'e' complex (pubmed:10882114). belongs also to the minor u12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mrna intron (pubmed:15146077). {eco:0000250|uniprotkb:q99nb9, eco:0000269|pubmed:10882114, eco:0000269|pubmed:12234937, eco:0000269|pubmed:15146077, eco:0000269|pubmed:27720643}.","subcellular location: nucleus {eco:0000269|pubmed:27720643, eco:0000269|pubmed:28541300}. nucleus speckle. note=during mitosis, transiently dispersed from the nuclear speckles to the cytoplasm.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SF3B1,23451,Hs.632554,ENST00000479532,THC2591913,"GO:0000375(RNA splicing, via transesterification reactions)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003682(chromatin binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005689(U12-type spliceosomal complex)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016607(nuclear speck)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens splicing factor 3b, subunit 1, 155kDa (SF3B1), transcript variant 1, mRNA [NM_012433]",chr2:198257125-198257066,hs|2q33.1,"splicing factor 3b, subunit 1, 155kDa",TRUE
1172_NDUFB11_54539,Q9NX14,"nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (complex i-esss) (ci-esss) (nadh-ubiquinone oxidoreductase esss subunit) (neuronal protein 17.3) (np17.3) (p17.3)",NDUFB11 UNQ111/PRO1064,153,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Linear skin defects with multiple congenital anomalies 3 (LSDMCA3) [MIM:300952]: A disorder characterized by dermal, ocular, neurological and cardiac abnormalities. LSDMCA3 clinical features include linear skin defects on face and neck at birth, lacrimal duct atresia, myopia, nystagmus, strabismus, cardiomyopathy, axial hypotonia, seizures, corpus callosum agenesis, and dilation of lateral ventricles. {ECO:0000269|PubMed:25772934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial complex I deficiency, nuclear type 30 (MC1DN30) [MIM:301021]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:26741492}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB11,54539,Hs.521969,ENST00000447793,THC2487822,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006810(transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain),"Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa (NDUFB11), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_019056]",chrX:47002105-47002046,hs|Xp11.23,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa",TRUE
1173_ATP1B1_481,P05026,sodium/potassium-transporting atpase subunit beta-1 (sodium/potassium-dependent atpase subunit beta-1),ATP1B1 ATP1B,303,"function: this is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of atp coupled with the exchange of na(+) and k(+) ions across the plasma membrane. the beta subunit regulates, through assembly of alpha/beta heterodimers, the number of sodium pumps transported to the plasma membrane. {eco:0000269|pubmed:19694409}.; function: involved in cell adhesion and establishing epithelial cell polarity. {eco:0000269|pubmed:19694409}.","subcellular location: cell membrane {eco:0000255}; single-pass type ii membrane protein {eco:0000255}. cell membrane, sarcolemma {eco:0000250|uniprotkb:p14094}. note=colocalizes with obscn at the intercalated disk and sarcolemma in cardiomyocytes. localizes in long striations at the level of z and m lines. {eco:0000250|uniprotkb:p14094}.",TISSUE SPECIFICITY: Found in most tissues.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP1B1,481,Hs.291196,ENST00000367816,THC2470205,GO:0001666(response to hypoxia)|GO:0005391(sodium:potassium-exchanging ATPase activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005890(sodium:potassium-exchanging ATPase complex)|GO:0005901(caveola)|GO:0006754(ATP biosynthetic process)|GO:0006810(transport)|GO:0006813(potassium ion transport)|GO:0006814(sodium ion transport)|GO:0007596(blood coagulation)|GO:0016021(integral to membrane)|GO:0016323(basolateral plasma membrane)|GO:0016324(apical plasma membrane)|GO:0034220(ion transmembrane transport)|GO:0050900(leukocyte migration)|GO:0055085(transmembrane transport),"Homo sapiens ATPase, Na+/K+ transporting, beta 1 polypeptide (ATP1B1), mRNA [NM_001677]",chr1:169101877-169101936,hs|1q24.2,"ATPase, Na+/K+ transporting, beta 1 polypeptide",TRUE
1174_GAS5_60674,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,GAS5,60674,Hs.531856,NA,THC2551504,NA,"Homo sapiens growth arrest-specific 5 (non-protein coding) (GAS5), non-coding RNA [NR_002578]",chr1:173833037-173833020,hs|1q25.1,growth arrest-specific 5 (non-protein coding),TRUE
1176_ZNHIT3_9326,Q15649,zinc finger hit domain-containing protein 3 (hnf-4a coactivator) (thyroid hormone receptor interactor 3) (thyroid receptor-interacting protein 3) (tr-interacting protein 3) (trip-3),ZNHIT3 TRIP3,155,NA,subcellular location: cytoplasm {eco:0000269|pubmed:28335020}. nucleus {eco:0000269|pubmed:28335020}.,NA,"DISEASE: PEHO syndrome (PEHO) [MIM:260565]: An autosomal recessive syndrome characterized by progressive encephalopathy, lack of psychomotor development, severe mental retardation, early onset epileptic seizures, optic nerve/cerebellar atrophy, pedal edema, and early death. {ECO:0000269|PubMed:28335020}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,ZNHIT3,9326,Hs.2210,ENST00000225410,THC2466012,"GO:0005622(intracellular)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0046966(thyroid hormone receptor binding)","Homo sapiens zinc finger, HIT-type containing 3 (ZNHIT3), mRNA [NM_004773]",chr17:34851427-34851486,hs|17q12,"zinc finger, HIT-type containing 3",TRUE
1177_C6orf106_64771,Q9H6K1,protein ilrun (inflammation and lipid regulator with uba-like and nbr1-like domains protein),ILRUN C6orf106,298,"function: negative regulator of innate antiviral response. blocks irf3-dependent cytokine production such as ifna, ifnb and tnf (pubmed:29802199). interacts with irf3 and inhibits irf3 recruitment to type i ifn promoter sequences while also reducing nuclear levels of the coactivators ep300 and crebbp (pubmed:29802199). {eco:0000269|pubmed:29802199}.","subcellular location: cytoplasm {eco:0000269|pubmed:25736925, eco:0000269|pubmed:29802199}. nucleus {eco:0000269|pubmed:29802199}.",TISSUE SPECIFICITY: Expressed in lung (at protein level). {ECO:0000269|PubMed:25736925}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C6orf106,64771,Hs.643498,ENST00000374023,THC2515406,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens chromosome 6 open reading frame 106 (C6orf106), transcript variant 1, mRNA [NM_024294]",chr6:34555166-34555107,hs|6p21.31,chromosome 6 open reading frame 106,TRUE
1178_C12orf51_283450,Q9Y4D8,probable e3 ubiquitin-protein ligase hectd4 (ec 2.3.2.26) (hect domain-containing protein 4) (hect-type e3 ubiquitin transferase hectd4),HECTD4 C12orf51 KIAA0614,3996,function: e3 ubiquitin-protein ligase which accepts ubiquitin from an e2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {eco:0000250}.,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C12orf51,283450,Hs.530943,ENST00000377560,THC2580566,GO:0004842(ubiquitin-protein ligase activity)|GO:0005622(intracellular)|GO:0006464(protein modification process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process),"Homo sapiens chromosome 12 open reading frame 51 (C12orf51), mRNA [NM_001109662]",chr12:112598483-112598424,hs|12q24.13,chromosome 12 open reading frame 51,TRUE
1179_CXXC5_51523,Q7LFL8,cxxc-type zinc finger protein 5 (cf5) (putative mapk-activating protein pm08) (putative nf-kappa-b-activating protein 102) (retinoid-inducible nuclear factor) (rinf),CXXC5 HSPC195 TCCCIA00297,322,"function: may indirectly participate in activation of the nf-kappa-b and mapk pathways. acts as a mediator of bmp4-mediated modulation of canonical wnt signaling activity in neural stem cells (by similarity). required for dna damage-induced atm phosphorylation, p53 activation and cell cycle arrest. involved in myelopoiesis. transcription factor. binds to the oxygen responsive element of cox4i2 and represses its transcription under hypoxia conditions (4% oxygen), as well as normoxia conditions (20% oxygen) (pubmed:23303788). may repress cox4i2 transactivation induced by chchd2 and rbpj (pubmed:23303788). binds preferentially to dna containing cytidine-phosphate-guanosine (cpg) dinucleotides over cph (h=a, t, and c), hemimethylated-cpg and hemimethylated-hydroxymethyl-cpg (pubmed:29276034). {eco:0000250|uniprotkb:q5xiq3, eco:0000269|pubmed:19182210, eco:0000269|pubmed:19557330, eco:0000269|pubmed:23303788, eco:0000269|pubmed:29276034}.","subcellular location: nucleus {eco:0000269|pubmed:19182210, eco:0000269|pubmed:19557330}. cytoplasm {eco:0000250|uniprotkb:q5xiq3}. note=colocalizes with dvl1 in large bodies localized just outside the nuclear membrane. {eco:0000250|uniprotkb:q5xiq3}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,CXXC5,51523,Hs.189119,ENST00000515038,THC2558507,GO:0003677(DNA binding)|GO:0004871(signal transducer activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007165(signal transduction)|GO:0008270(zinc ion binding)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0046872(metal ion binding),"Homo sapiens CXXC finger protein 5 (CXXC5), mRNA [NM_016463]",chr5:139062536-139062595,hs|5q31.2,CXXC finger protein 5,TRUE
118_RPS7_6201,P62081,40s ribosomal protein s7 (small ribosomal subunit protein es7),RPS7,194,function: required for rrna maturation. {eco:0000269|pubmed:19061985}.,"subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:20873783}. note=colocalizes with nek6 in the centrosome. {eco:0000269|pubmed:20873783}.",NA,"DISEASE: Diamond-Blackfan anemia 8 (DBA8) [MIM:612563]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:19061985}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,RPS7,6201,Hs.546287,ENST00000406376,THC2578871,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0005856(cytoskeleton)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0030686(90S preribosome)|GO:0031018(endocrine pancreas development)|GO:0032040(small-subunit processome)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S7 (RPS7), mRNA [NM_001011]",chr2:3627728-3627787,hs|2p25.3,ribosomal protein S7,TRUE
1180_ATP8B2_57198,P98198,phospholipid-transporting atpase id (ec 7.6.2.1) (atpase class i type 8b member 2) (p4-atpase flippase complex alpha subunit atp8b2),ATP8B2 ATPID KIAA1137,1209,function: catalytic component of a p4-atpase flippase complex which catalyzes the hydrolysis of atp coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (probable). {eco:0000305}.,"subcellular location: cell membrane {eco:0000269|pubmed:20947505, eco:0000269|pubmed:20961850}; multi-pass membrane protein {eco:0000255}. endoplasmic reticulum membrane {eco:0000269|pubmed:20961850}; multi-pass membrane protein {eco:0000255}. note=tmem30a, but not tmem30b, is required for its export from endoplasmic reticulum to the plasma membrane. {eco:0000269|pubmed:20961850}.","TISSUE SPECIFICITY: Isoform 3 is ubiquitous, with highest expression in aorta, cerebellum and uterus. {ECO:0000269|PubMed:12880872}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP8B2,57198,Hs.435700,ENST00000368489,THC2491275,"GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0004012(phospholipid-translocating ATPase activity)|GO:0005524(ATP binding)|GO:0005886(plasma membrane)|GO:0006200(ATP catabolic process)|GO:0006812(cation transport)|GO:0015662(ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism)|GO:0015914(phospholipid transport)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0016887(ATPase activity)|GO:0034220(ion transmembrane transport)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, class I, type 8B, member 2 (ATP8B2), transcript variant 1, mRNA [NM_020452]",chr1:154323478-154323537,hs|1q21.3,"ATPase, class I, type 8B, member 2",TRUE
1181_TM2D1_83941,Q9BX74,tm2 domain-containing protein 1 (amyloid-beta-binding protein) (hbbp),TM2D1 BBP,207,"function: may participate in amyloid-beta-induced apoptosis via its interaction with beta-app42. {eco:0000269|pubmed:11278849, eco:0000269|pubmed:12836168}.",subcellular location: membrane {eco:0000269|pubmed:11278849}; multi-pass membrane protein {eco:0000269|pubmed:11278849}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11278849}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TM2D1,83941,Hs.656790,ENST00000472357,THC2560074,GO:0001540(beta-amyloid binding)|GO:0004930(G-protein coupled receptor activity)|GO:0005887(integral to plasma membrane)|GO:0006915(apoptosis)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0016020(membrane),"Homo sapiens TM2 domain containing 1 (TM2D1), mRNA [NM_032027]",chr1:62146823-62146764,hs|1p31.3,TM2 domain containing 1,TRUE
1182_PHF10_55274,Q8WUB8,phd finger protein 10 (brg1-associated factor 45a) (baf45a) (xap135),PHF10 BAF45A,498,"function: involved in transcription activity regulation by chromatin remodeling. belongs to the neural progenitors-specific chromatin remodeling complex (npbaf complex) and is required for the proliferation of neural progenitors. during neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. the transition from proliferating neural stem/progenitor cells to post-mitotic neurons requires a switch in subunit composition of the npbaf and nbaf complexes. as neural progenitors exit mitosis and differentiate into neurons, npbaf complexes which contain actl6a/baf53a and phf10/baf45a, are exchanged for homologous alternative actl6b/baf53b and dpf1/baf45b or dpf3/baf45c subunits in neuron-specific complexes (nbaf). the npbaf complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. the nbaf complex along with crest plays a role regulating the activity of genes essential for dendrite growth (by similarity). {eco:0000250}.",subcellular location: nucleus {eco:0000250}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PHF10,55274,Hs.435933,ENST00000339209,THC2470766,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007399(nervous system development)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)|GO:0071564(npBAF complex)","Homo sapiens PHD finger protein 10 (PHF10), transcript variant 1, mRNA [NM_018288]",chr6:170104142-170104083,hs|6q27,PHD finger protein 10,TRUE
1183_MDK_4192,P21741,midkine (mk) (amphiregulin-associated protein) (arap) (midgestation and kidney protein) (neurite outgrowth-promoting factor 2) (neurite outgrowth-promoting protein),MDK MK1 NEGF2,143,"function: secreted protein that functions as cytokine and growth factor and mediates its signal through cell-surface proteoglycan and non-proteoglycan receptors (pubmed:18469519, pubmed:12573468, pubmed:12122009, pubmed:10212223, pubmed:24458438, pubmed:15466886, pubmed:12084985, pubmed:10772929). binds cell-surface proteoglycan receptors via their chondroitin sulfate (cs) groups (pubmed:12084985, pubmed:10212223). thereby regulates many processes like inflammatory response, cell proliferation, cell adhesion, cell growth, cell survival, tissue regeneration, cell differentiation and cell migration (pubmed:12573468, pubmed:12122009, pubmed:10212223, pubmed:10683378, pubmed:24458438, pubmed:22323540, pubmed:12084985, pubmed:15466886, pubmed:10772929). participates in inflammatory processes by exerting two different activities. firstly, mediates neutrophils and macrophages recruitment to the sites of inflammation both by direct action by cooperating namely with itgb2 via lrp1 and by inducing chemokine expression (pubmed:10683378, pubmed:24458438). this inflammation can be accompanied by epithelial cell survival and smooth muscle cell migration after renal and vessel damage, respectively (pubmed:10683378). secondly, suppresses the development of tolerogenic dendric cells thereby inhibiting the differentiation of regulatory t cells and also promote t cell expansion through nfat signaling and th1 cell differentiation (pubmed:22323540). promotes tissue regeneration after injury or trauma. after heart damage negatively regulates the recruitment of inflammatory cells and mediates cell survival through activation of anti-apoptotic signaling pathways via mapks and akt pathways through the activation of angiogenesis (by similarity). also facilitates liver regeneration as well as bone repair by recruiting macrophage at trauma site and by promoting cartilage development by facilitating chondrocyte differentiation (by similarity). plays a role in brain by promoting neural precursor cells survival and growth through interaction with heparan sulfate proteoglycans (by similarity). binds ptprz1 and promotes neuronal migration and embryonic neurons survival (pubmed:10212223). binds sdc3 or gpc2 and mediates neurite outgrowth and cell adhesion (pubmed:12084985, pubmed:1768439). binds chondroitin sulfate e and heparin leading to inhibition of neuronal cell adhesion induced by binding with gpc2 (pubmed:12084985). binds cspg5 and promotes elongation of oligodendroglial precursor-like cells (by similarity). also binds itga6:itgb1 complex; this interaction mediates mdk-induced neurite outgrowth (pubmed:15466886, pubmed:1768439). binds lrp1; promotes neuronal survival (pubmed:10772929). binds itga4:itgb1 complex; this interaction mediates mdk-induced osteoblast cells migration through pxn phosphorylation (pubmed:15466886). binds anaplastic lymphoma kinase (alk) which induces alk activation and subsequent phosphorylation of the insulin receptor substrate (irs1), followed by the activation of mitogen-activated protein kinase (mapk) and pi3-kinase, and the induction of cell proliferation (pubmed:12122009). promotes epithelial to mesenchymal transition through interaction with notch2 (pubmed:18469519). during arteriogenesis, plays a role in vascular endothelial cell proliferation by inducing vegfa expression and release which in turn induces nitric oxide synthase expression. moreover activates vasodilation through nitric oxide synthase activation (by similarity). negatively regulates bone formation in response to mechanical load by inhibiting wnt/beta-catenin signaling in osteoblasts (by similarity). in addition plays a role in hippocampal development, working memory, auditory response, early fetal adrenal gland development and the female reproductive system (by similarity). {eco:0000250|uniprotkb:p12025, eco:0000250|uniprotkb:q9r1s9, eco:0000269|pubmed:10212223, eco:0000269|pubmed:10683378, eco:0000269|pubmed:10772929, eco:0000269|pubmed:12084985, eco:0000269|pubmed:12122009, eco:0000269|pubmed:12573468, eco:0000269|pubmed:15466886, eco:0000269|pubmed:1768439, eco:0000269|pubmed:18469519, eco:0000269|pubmed:22323540, eco:0000269|pubmed:24458438}.",subcellular location: secreted.,TISSUE SPECIFICITY: Expressed in various tumor cell lines. In insulinoma tissue predominantly expressed in precancerous lesions. {ECO:0000269|PubMed:17379400}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MDK,4192,Hs.82045,ENST00000407067,NP1464770,"GO:0001662(behavioral fear response)|GO:0005576(extracellular region)|GO:0007165(signal transduction)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0007614(short-term memory)|GO:0008083(growth factor activity)|GO:0008201(heparin binding)|GO:0009611(response to wounding)|GO:0021542(dentate gyrus development)|GO:0021681(cerebellar granular layer development)|GO:0021987(cerebral cortex development)|GO:0030154(cell differentiation)|GO:0030325(adrenal gland development)|GO:0030421(defecation)|GO:0043526(neuroprotection)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0050795(regulation of behavior)|GO:0051781(positive regulation of cell division)","Homo sapiens midkine (neurite growth-promoting factor 2) (MDK), transcript variant 1, mRNA [NM_001012334]",chr11:46405231-46405290,hs|11p11.2,midkine (neurite growth-promoting factor 2),TRUE
1184_RIPK4_54101,P57078,receptor-interacting serine/threonine-protein kinase 4 (ec 2.7.11.1) (ankyrin repeat domain-containing protein 3) (pkc-delta-interacting protein kinase),RIPK4 ANKRD3 DIK,832,"function: involved in stratified epithelial development. it is a direct transcriptional target of tp63. plays a role in nf-kappa-b activation. {eco:0000269|pubmed:12446564, eco:0000269|pubmed:22197488}.",subcellular location: cytoplasm. membrane {eco:0000250}; peripheral membrane protein {eco:0000250}.,TISSUE SPECIFICITY: Expressed in hair follicles and skin. {ECO:0000269|PubMed:26129644}.,"DISEASE: Bartsocas-Papas syndrome (BPS) [MIM:263650]: An autosomal recessive disorder characterized by multiple popliteal pterygia leading to severe arthrogryposis, ankyloblepharon filiforme adnatum, filiform bands between the jaws, synostosis of the carpal/tarsal and phalangeal bones in the hands and feet, digital hypoplasia/aplasia, complete soft-tissue syndactyly, lack of nails, lack of scalp hair, eyebrows and eyelashes, blepharophimosis, cleft lip and/or palate, and hypoplastic external genitalia. Early lethality is common, although survival into childhood and beyond has been reported. {ECO:0000269|PubMed:22197488, ECO:0000269|PubMed:22197489}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: CHAND syndrome (CHANDS) [MIM:214350]: An autosomal recessive syndrome characterized by ankyloblepharon, sparse, curly and woolly hair, nail dysplasia, and oral frenula. {ECO:0000269|PubMed:23610050, ECO:0000269|PubMed:26129644}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RIPK4,54101,Hs.517310,ENST00000352483,THC2463473,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0004872(receptor activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0016020(membrane),"Homo sapiens receptor-interacting serine-threonine kinase 4 (RIPK4), mRNA [NM_020639]",chr21:43159692-43159633,hs|21q22.3,receptor-interacting serine-threonine kinase 4,TRUE
1185_ST6GAL1_6480,P15907,"beta-galactoside alpha-2,6-sialyltransferase 1 (alpha 2,6-st 1) (ec 2.4.99.1) (b-cell antigen cd75) (cmp-n-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (st6gal i) (st6gali) (sialyltransferase 1)",ST6GAL1 SIAT1,406,"function: transfers sialic acid from cmp-sialic acid to galactose-containing acceptor substrates. {eco:0000269|pubmed:21081508, eco:0000269|pubmed:23999306}.","subcellular location: golgi apparatus, golgi stack membrane {eco:0000269|pubmed:20378551}; single-pass type ii membrane protein {eco:0000305}. secreted. note=membrane-bound form in trans cisternae of golgi. secreted into the body fluid.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ST6GAL1,6480,Hs.207459,ENST00000470633,THC2528425,"GO:0000139(Golgi membrane)|GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity)|GO:0005576(extracellular region)|GO:0005794(Golgi apparatus)|GO:0006464(protein modification process)|GO:0006486(protein glycosylation)|GO:0006959(humoral immune response)|GO:0008373(sialyltransferase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0030173(integral to Golgi membrane)|GO:0032580(Golgi cisterna membrane)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)","Homo sapiens ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 (ST6GAL1), transcript variant 1, mRNA [NM_173216]",chr3:186796052-186796111,hs|3q27.3,"ST6 beta-galactosamide alpha-2,6-sialyltranferase 1",TRUE
1186_WDR1_9948,O75083,wd repeat-containing protein 1 (actin-interacting protein 1) (aip1) (nori-1),WDR1,606,"function: induces disassembly of actin filaments in conjunction with adf/cofilin family proteins (pubmed:15629458). enhances cofilin-mediated actin severing (by similarity). involved in cytokinesis. involved in chemotactic cell migration by restricting lamellipodial membrane protrusions (pubmed:18494608). involved in myocardium sarcomere organization. required for cardiomyocyte growth and maintenance (by similarity). involved in megakaryocyte maturation and platelet shedding. required for the establishment of planar cell polarity (pcp) during follicular epithelium development and for cell shape changes during pcp; the function seems to implicate cooperation with cfl1 and/or dstn/adf. involved in the generation/maintenance of cortical tension (by similarity). involved in assembly and maintenance of epithelial apical cell junctions and plays a role in the organization of the perijunctional actomyosin belt (pubmed:25792565). {eco:0000250|uniprotkb:o88342, eco:0000250|uniprotkb:q9w7f2, eco:0000269|pubmed:15629458, eco:0000269|pubmed:18494608, eco:0000269|pubmed:25792565}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q5rki0}. cell projection, podosome {eco:0000269|pubmed:22721921}. cell junction {eco:0000269|pubmed:25792565}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,WDR1,9948,Hs.128548,ENST00000382452,THC2514335,GO:0002576(platelet degranulation)|GO:0003779(actin binding)|GO:0005576(extracellular region)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0007596(blood coagulation)|GO:0007605(sensory perception of sound)|GO:0030168(platelet activation),"Homo sapiens WD repeat domain 1 (WDR1), transcript variant 1, mRNA [NM_017491]",chr4:10076351-10076292,hs|4p16.1,WD repeat domain 1,TRUE
1187_TDP2_51567,O95551,tyrosyl-dna phosphodiesterase 2 (tyr-dna phosphodiesterase 2) (htdp2) (ec 3.1.4.-) (5'-tyrosyl-dna phosphodiesterase) (5'-tyr-dna phosphodiesterase) (ets1-associated protein 2) (ets1-associated protein ii) (eapii) (traf and tnf receptor-associated protein) (tyrosyl-rna phosphodiesterase) (vpg unlinkase),TDP2 EAP2 TTRAP AD-022,362,"function: dna repair enzyme that can remove a variety of covalent adducts from dna through hydrolysis of a 5'-phosphodiester bond, giving rise to dna with a free 5' phosphate. catalyzes the hydrolysis of dead-end complexes between dna and the topoisomerase 2 (top2) active site tyrosine residue. the 5'-tyrosyl dna phosphodiesterase activity can enable the repair of top2-induced dna double-strand breaks/dsbs without the need for nuclease activity, creating a 'clean' dsb with 5'-phosphate termini that are ready for ligation (pubmed:27099339, pubmed:27060144). thereby, protects the transcription of many genes involved in neurological development and maintenance from the abortive activity of top2. hydrolyzes 5'-phosphoglycolates on protruding 5' ends on dsbs due to dna damage by radiation and free radicals. has preference for single-stranded dna or duplex dna with a 4 base pair overhang as substrate. acts as a regulator of ribosome biogenesis following stress. has also 3'-tyrosyl dna phosphodiesterase activity, but less efficiently and much slower than tdp1. constitutes the major if not only 5'-tyrosyl-dna phosphodiesterase in cells. also acts as an adapter by participating in the specific activation of map3k7/tak1 in response to tgf-beta: associates with components of the tgf-beta receptor-traf6-tak1 signaling module and promotes their ubiquitination dependent complex formation. involved in non-canonical tgf-beta induced signaling routes. may also act as a negative regulator of ets1 and may inhibit nf-kappa-b activation. {eco:0000269|pubmed:19794497, eco:0000269|pubmed:21030584, eco:0000269|pubmed:21921940, eco:0000269|pubmed:21980489, eco:0000269|pubmed:22405347, eco:0000269|pubmed:22822062, eco:0000269|pubmed:24658003, eco:0000269|pubmed:27060144, eco:0000269|pubmed:27099339}.; function: (microbial infection) also acts as a 5'-tyrosyl-rna phosphodiesterase following picornavirus infection: its activity is hijacked by picornavirus and acts by specifically cleaving the protein-rna covalent linkage generated during the viral genomic rna replication steps of a picornavirus infection, without impairing the integrity of viral rna. {eco:0000269|pubmed:22908287}.","subcellular location: nucleus {eco:0000269|pubmed:12743594}. nucleus, pml body {eco:0000269|pubmed:19794497, eco:0000269|pubmed:21921940}. nucleus, nucleolus {eco:0000269|pubmed:21921940}. cytoplasm. note=localizes to nucleolar cavities following stress; localization to nucleolus is dependent on pml protein. {eco:0000269|pubmed:21921940}.; subcellular location: cytoplasm {eco:0000269|pubmed:22908287}. note=(microbial infection) in case of infection by picornavirus, relocalizes to cytoplasmic sites distinct from those containing viral proteins associated with rna replication or encapsidation. {eco:0000269|pubmed:22908287}.","TISSUE SPECIFICITY: Widely expressed (PubMed:10764746). Highly expressed in various brain regions, including the frontal and occipital lobes, the hippocampus, the striatum and the cerebellum (PubMed:24658003). {ECO:0000269|PubMed:10764746, ECO:0000269|PubMed:24658003}.","DISEASE: Spinocerebellar ataxia, autosomal recessive, 23 (SCAR23) [MIM:616949]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia. {ECO:0000269|PubMed:24658003}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TDP2,51567,Hs.403010,ENST00000341060,THC2715505,GO:0000287(magnesium ion binding)|GO:0003714(transcription corepressor activity)|GO:0004518(nuclease activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006302(double-strand break repair)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0016605(PML body)|GO:0016787(hydrolase activity)|GO:0070260(5'-tyrosyl-DNA phosphodiesterase activity),"Homo sapiens tyrosyl-DNA phosphodiesterase 2 (TDP2), mRNA [NM_016614]",chr6:24650393-24650334,hs|6p22.3,tyrosyl-DNA phosphodiesterase 2,TRUE
1188_RIC8A_60626,Q9NPQ8,synembryn-a (protein ric-8a),RIC8A,531,"function: guanine nucleotide exchange factor (gef), which can activate some, but not all, g-alpha proteins. able to activate gnai1, gnao1 and gnaq, but not gnas by exchanging bound gdp for free gtp. involved in regulation of microtubule pulling forces during mitotic movement of chromosomes by stimulating g(i)-alpha protein, possibly leading to release g(i)-alpha-gtp and numa proteins from the numa-gpsm2-g(i)-alpha-gdp complex (by similarity). also acts as an activator for g(q)-alpha (gnaq) protein by enhancing the g(q)-coupled receptor-mediated erk activation. {eco:0000250, eco:0000269|pubmed:16629901}.",subcellular location: cytoplasm {eco:0000250}. cell membrane {eco:0000250}. note=colocalizes with ric8a in ca2 hippocampal neurons. colocalizes with gnai1 and rgs14 at the plasma membrane (by similarity). {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RIC8A,60626,Hs.592292,ENST00000325207,THC2525439,GO:0001701(in utero embryonic development)|GO:0001965(G-protein alpha-subunit binding)|GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005096(GTPase activator activity)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0008542(visual learning)|GO:0009416(response to light stimulus),"Homo sapiens resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) (RIC8A), mRNA [NM_021932]",chr11:215007-215066,hs|11p15.5,resistance to inhibitors of cholinesterase 8 homolog A (C. elegans),TRUE
1189_HDAC1_3065,Q13547,histone deacetylase 1 (hd1) (ec 3.5.1.98),HDAC1 RPD3L1,482,"function: responsible for the deacetylation of lysine residues on the n-terminal part of the core histones (h2a, h2b, h3 and h4). histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. histone deacetylases act via the formation of large multiprotein complexes. deacetylates sp proteins, sp1 and sp3, and regulates their function. component of the brg1-rb1-hdac1 complex, which negatively regulates the crest-mediated transcription in resting neurons. upon calcium stimulation, hdac1 is released from the complex and crebbp is recruited, which facilitates transcriptional activation. deacetylates tshz3 and regulates its transcriptional repressor activity. deacetylates 'lys-310' in rela and thereby inhibits the transcriptional activity of nf-kappa-b. deacetylates nr1d2 and abrogates the effect of kat5-mediated relieving of nr1d2 transcription repression activity. component of a rcor/gfi/kdm1a/hdac complex that suppresses, via histone deacetylase (hdac) recruitment, a number of genes implicated in multilineage blood cell development. involved in ciart-mediated transcriptional repression of the circadian transcriptional activator: clock-arntl/bmal1 heterodimer. required for the transcriptional repression of circadian target genes, such as per1, mediated by the large per complex or cry1 through histone deacetylation. {eco:0000269|pubmed:12837748, eco:0000269|pubmed:16478997, eco:0000269|pubmed:17000776, eco:0000269|pubmed:17704056, eco:0000269|pubmed:17996965, eco:0000269|pubmed:19081374, eco:0000269|pubmed:19343227}.",subcellular location: nucleus {eco:0000269|pubmed:10846170}.,"TISSUE SPECIFICITY: Ubiquitous, with higher levels in heart, pancreas and testis, and lower levels in kidney and brain.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HDAC1,3065,Hs.88556,ENST00000476391,THC2470011,"GO:0000118(histone deacetylase complex)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001047(core promoter binding)|GO:0001106(RNA polymerase II transcription corepressor activity)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0004407(histone deacetylase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006338(chromatin remodeling)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006476(protein deacetylation)|GO:0006916(anti-apoptosis)|GO:0007596(blood coagulation)|GO:0008134(transcription factor binding)|GO:0008284(positive regulation of cell proliferation)|GO:0009913(epidermal cell differentiation)|GO:0010832(negative regulation of myotube differentiation)|GO:0010870(positive regulation of receptor biosynthetic process)|GO:0016568(chromatin modification)|GO:0016575(histone deacetylation)|GO:0016580(Sin3 complex)|GO:0016581(NuRD complex)|GO:0016787(hydrolase activity)|GO:0019899(enzyme binding)|GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific))|GO:0033558(protein deacetylase activity)|GO:0033613(activating transcription factor binding)|GO:0034739(histone deacetylase activity (H3-K16 specific))|GO:0042475(odontogenesis of dentine-containing tooth)|GO:0042733(embryonic digit morphogenesis)|GO:0042826(histone deacetylase binding)|GO:0043066(negative regulation of apoptosis)|GO:0043922(negative regulation by host of viral transcription)|GO:0044419(interspecies interaction between organisms)|GO:0045786(negative regulation of cell cycle)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific))|GO:0046970(NAD-dependent histone deacetylase activity (H4-K16 specific))|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0060766(negative regulation of androgen receptor signaling pathway)|GO:0060789(hair follicle placode formation)|GO:0061029(eyelid development in camera-type eye)|GO:0061198(fungiform papilla formation)|GO:0070932(histone H3 deacetylation)|GO:0070933(histone H4 deacetylation)","Homo sapiens histone deacetylase 1 (HDAC1), mRNA [NM_004964]",chr1:32799037-32799096,hs|1p35.1,histone deacetylase 1,TRUE
119_RPS10_6204,P46783,40s ribosomal protein s10 (small ribosomal subunit protein es10),RPS10,165,function: component of the 40s ribosomal subunit.,"subcellular location: cytoplasm {eco:0000269|pubmed:20159986}. nucleus, nucleolus {eco:0000269|pubmed:20159986}. note=localized in the granular component (gc) region of the nucleolus. methylation is required for its localization in the gc region. colocalizes with nps1 in the gc region of the nucleolus.",NA,"DISEASE: Diamond-Blackfan anemia 9 (DBA9) [MIM:613308]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:20116044}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPS10,6204,Hs.645317,ENST00000494077,THC2594981,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S10 (RPS10), transcript variant 2, mRNA [NM_001014]",chr6:34385296-34385237,hs|6p21.31,ribosomal protein S10,TRUE
1190_HIST1H2AG_8969,P0C0S8,histone h2a type 1 (h2a.1) (histone h2a/ptl),H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2AG,8969,Hs.51011,ENST00000359193,THC2477745,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly)|GO:0019899(enzyme binding),"Homo sapiens histone cluster 1, H2ag (HIST1H2AG), mRNA [NM_021064]",chr6:27101157-27101216,hs|6p22.1,"histone cluster 1, H2ag",TRUE
1191_JUND_3727,P17535,transcription factor jun-d,JUND,347,function: transcription factor binding ap-1 sites. {eco:0000269|pubmed:9989505}.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,JUND,3727,NA,NA,THC2480324,GO:0000785(chromatin)|GO:0002076(osteoblast development)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0043565(sequence-specific DNA binding)|GO:0044212(transcription regulatory region DNA binding)|GO:0045669(positive regulation of osteoblast differentiation)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046983(protein dimerization activity)|GO:0071277(cellular response to calcium ion),Human junD mRNA. [X56681],chr19:18390814-18390756,hs|19p13.11,jun D proto-oncogene,TRUE
1192_CNKSR3_154043,Q6P9H4,connector enhancer of kinase suppressor of ras 3 (connector enhancer of ksr 3) (cnk homolog protein 3) (cnk3) (cnksr family member 3) (maguin-like protein),CNKSR3 MAGI1,555,function: involved in transepithelial sodium transport. regulates aldosterone-induced and epithelial sodium channel (enac)-mediated sodium transport through regulation of enac cell surface expression. acts as a scaffold protein coordinating the assembly of an enac-regulatory complex (erc). {eco:0000269|pubmed:22851176}.,subcellular location: cytoplasm {eco:0000269|pubmed:22851176}. apical cell membrane {eco:0000269|pubmed:22851176}; peripheral membrane protein {eco:0000269|pubmed:22851176}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CNKSR3,154043,Hs.16064,ENST00000367213,THC2470615,GO:0005737(cytoplasm)|GO:0009966(regulation of signal transduction)|GO:0010765(positive regulation of sodium ion transport)|GO:0016020(membrane)|GO:0033137(negative regulation of peptidyl-serine phosphorylation)|GO:0070373(negative regulation of ERK1 and ERK2 cascade),"Homo sapiens CNKSR family member 3 (CNKSR3), mRNA [NM_173515]",chr6:154726608-154726549,hs|6q25.2,CNKSR family member 3,TRUE
1193_HIST1H2BH_8345,Q93079,histone h2b type 1-h (histone h2b.j) (h2b/j),HIST1H2BH H2BFJ,126,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2BH,8345,Hs.247815,ENST00000356350,THC2506257,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 1, H2bh (HIST1H2BH), mRNA [NM_003524]",chr6:26252222-26252281,hs|6p22.2,"histone cluster 1, H2bh",TRUE
1194_ANXA1_301,P04083,annexin a1 (annexin i) (annexin-1) (calpactin ii) (calpactin-2) (chromobindin-9) (lipocortin i) (phospholipase a2 inhibitory protein) (p35),ANXA1 ANX1 LPC1,346,"function: plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. has anti-inflammatory activity (pubmed:8425544). plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (by similarity). promotes resolution of inflammation and wound healing (pubmed:25664854). functions at least in part by activating the formyl peptide receptors and downstream signaling cascades (pubmed:15187149, pubmed:25664854). promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors (pubmed:15187149). contributes to the adaptive immune response by enhancing signaling cascades that are triggered by t-cell activation, regulates differentiation and proliferation of activated t-cells (pubmed:17008549). promotes the differentiation of t-cells into th1 cells and negatively regulates differentiation into th2 cells (pubmed:17008549). has no effect on unstimulated t cells (pubmed:17008549). promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration (pubmed:15187149). negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton (pubmed:19625660). has high affinity for ca(2+) and can bind up to eight ca(2+) ions (by similarity). displays ca(2+)-dependent binding to phospholipid membranes (pubmed:2532504, pubmed:8557678). plays a role in the formation of phagocytic cups and phagosomes. plays a role in phagocytosis by mediating the ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton (by similarity). {eco:0000250|uniprotkb:p10107, eco:0000250|uniprotkb:p19619, eco:0000269|pubmed:15187149, eco:0000269|pubmed:17008549, eco:0000269|pubmed:19625660, eco:0000269|pubmed:2532504, eco:0000269|pubmed:25664854, eco:0000269|pubmed:2936963, eco:0000269|pubmed:8425544, eco:0000269|pubmed:8557678}.","subcellular location: nucleus {eco:0000269|pubmed:10772777, eco:0000269|pubmed:19625660}. cytoplasm {eco:0000269|pubmed:10772777, eco:0000269|pubmed:17008549, eco:0000269|pubmed:19625660}. cell projection, cilium {eco:0000250|uniprotkb:p46193}. cell membrane {eco:0000269|pubmed:10772777}. membrane {eco:0000269|pubmed:17008549, eco:0000269|pubmed:2532504, eco:0000269|pubmed:8557678}; peripheral membrane protein {eco:0000269|pubmed:2532504, eco:0000269|pubmed:8557678}. endosome membrane {eco:0000250|uniprotkb:p07150}; peripheral membrane protein {eco:0000250|uniprotkb:p07150}. basolateral cell membrane {eco:0000250|uniprotkb:p51662}. apical cell membrane {eco:0000250|uniprotkb:p10107}. lateral cell membrane {eco:0000250|uniprotkb:p10107}. secreted {eco:0000269|pubmed:17008549, eco:0000269|pubmed:19625660, eco:0000269|pubmed:25664854}. secreted, extracellular space {eco:0000269|pubmed:25664854}. cell membrane {eco:0000269|pubmed:10772777, eco:0000269|pubmed:19625660, eco:0000269|pubmed:25664854}; peripheral membrane protein {eco:0000269|pubmed:10772777, eco:0000269|pubmed:19625660, eco:0000269|pubmed:25664854}; extracellular side {eco:0000269|pubmed:10772777, eco:0000269|pubmed:19625660, eco:0000269|pubmed:25664854}. secreted, extracellular exosome {eco:0000269|pubmed:25664854}. cytoplasmic vesicle, secretory vesicle lumen {eco:0000269|pubmed:10772777}. cell projection, phagocytic cup {eco:0000250|uniprotkb:p10107}. early endosome {eco:0000250|uniprotkb:p19619}. cytoplasmic vesicle membrane {eco:0000250|uniprotkb:p19619}; peripheral membrane protein {eco:0000250|uniprotkb:p19619}. note=secreted, at least in part via exosomes and other secretory vesicles. detected in exosomes and other extracellular vesicles (pubmed:25664854). detected in gelatinase granules in resting neutrophils (pubmed:10772777). secretion is increased in response to wounding and inflammation (pubmed:25664854). secretion is increased upon t-cell activation (pubmed:17008549). neutrophil adhesion to endothelial cells stimulates secretion via gelatinase granules, but foreign particle phagocytosis has no effect (pubmed:10772777). colocalizes with actin fibers at phagocytic cups (by similarity). displays calcium-dependent binding to phospholipid membranes (pubmed:2532504, pubmed:8557678). {eco:0000250|uniprotkb:p10107, eco:0000269|pubmed:10772777, eco:0000269|pubmed:17008549, eco:0000269|pubmed:2532504, eco:0000269|pubmed:25664854, eco:0000269|pubmed:8557678}.","TISSUE SPECIFICITY: Detected in resting neutrophils (PubMed:10772777). Detected in peripheral blood T-cells (PubMed:17008549). Detected in extracellular vesicles in blood serum from patients with inflammatory bowel disease, but not in serum from healthy donors (PubMed:25664854). Detected in placenta (at protein level) (PubMed:2532504). Detected in liver. {ECO:0000269|PubMed:2532504, ECO:0000269|PubMed:2936963}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,ANXA1,301,Hs.494173,ENST00000376911,THC2563662,"GO:0001533(cornified envelope)|GO:0002674(negative regulation of acute inflammatory response)|GO:0003697(single-stranded DNA binding)|GO:0003727(single-stranded RNA binding)|GO:0004859(phospholipase inhibitor activity)|GO:0005102(receptor binding)|GO:0005198(structural molecule activity)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005543(phospholipid binding)|GO:0005544(calcium-dependent phospholipid binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005929(cilium)|GO:0006629(lipid metabolic process)|GO:0006916(anti-apoptosis)|GO:0006928(cellular component movement)|GO:0006954(inflammatory response)|GO:0007049(cell cycle)|GO:0007165(signal transduction)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0010165(response to X-ray)|GO:0014070(response to organic cyclic compound)|GO:0016323(basolateral plasma membrane)|GO:0018149(peptide cross-linking)|GO:0019834(phospholipase A2 inhibitor activity)|GO:0030073(insulin secretion)|GO:0030216(keratinocyte differentiation)|GO:0030674(protein binding, bridging)|GO:0031018(endocrine pancreas development)|GO:0031340(positive regulation of vesicle fusion)|GO:0031394(positive regulation of prostaglandin biosynthetic process)|GO:0031966(mitochondrial membrane)|GO:0032355(response to estradiol stimulus)|GO:0042063(gliogenesis)|GO:0042127(regulation of cell proliferation)|GO:0042383(sarcolemma)|GO:0042493(response to drug)|GO:0042803(protein homodimerization activity)|GO:0043065(positive regulation of apoptosis)|GO:0043066(negative regulation of apoptosis)|GO:0043234(protein complex)|GO:0043434(response to peptide hormone stimulus)|GO:0046632(alpha-beta T cell differentiation)|GO:0050482(arachidonic acid secretion)|GO:0050709(negative regulation of protein secretion)|GO:0051384(response to glucocorticoid stimulus)|GO:0060206(estrous cycle phase)|GO:0070301(cellular response to hydrogen peroxide)|GO:0070365(hepatocyte differentiation)|GO:0070555(response to interleukin-1)","Homo sapiens annexin A1 (ANXA1), mRNA [NM_000700]",chr9:75785002-75785061,hs|9q21.13,annexin A1,TRUE
1195_TMEM125_128218,Q96AQ2,transmembrane protein 125,TMEM125,219,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TMEM125,128218,Hs.104476,ENST00000432792,THC2464236,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 125 (TMEM125), mRNA [NM_144626]",chr1:43739605-43739664,hs|1p34.2,transmembrane protein 125,TRUE
1196_ZFP62_643836,Q8NB50,zinc finger protein 62 homolog (zfp-62),ZFP62,900,function: may play a role in differentiating skeletal muscle. {eco:0000250}.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZFP62,643836,Hs.509227,ENST00000359141,THC2498551,"GO:0003676(nucleic acid binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 62 homolog (mouse) (ZFP62), transcript variant 1, mRNA [NM_152283]",chr5:180274691-180274632,hs|5q35.3,zinc finger protein 62 homolog (mouse),TRUE
1197_GNAQ_2776,P50148,guanine nucleotide-binding protein g(q) subunit alpha (guanine nucleotide-binding protein alpha-q),GNAQ GAQ,359,function: guanine nucleotide-binding proteins (g proteins) are involved as modulators or transducers in various transmembrane signaling systems. regulates b-cell selection and survival and is required to prevent b-cell-dependent autoimmunity. regulates chemotaxis of bm-derived neutrophils and dendritic cells (in vitro) (by similarity). {eco:0000250}.,"subcellular location: nucleus {eco:0000250}. membrane {eco:0000250}. nucleus membrane {eco:0000250}. note=colocalizes with the adrenergic receptors, adren1a and adren1b, at the nuclear membrane of cardiac myocytes. {eco:0000250}.","TISSUE SPECIFICITY: Predominantly expressed in ovary, prostate, testis and colon. Down-regulated in the peripheral blood lymphocytes (PBLs) of rheumatoid arthritis patients (at protein level). {ECO:0000269|PubMed:21923740, ECO:0000269|PubMed:8664309}.","DISEASE: Capillary malformations, congenital (CMC) [MIM:163000]: A form of vascular malformations that are present from birth, tend to grow with the individual, do not regress spontaneously, and show normal rates of endothelial cell turnover. Capillary malformations are distinct from capillary hemangiomas, which are highly proliferative lesions that appear shortly after birth and show rapid growth, slow involution, and endothelial hypercellularity. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sturge-Weber syndrome (SWS) [MIM:185300]: A syndrome characterized by an intracranial vascular anomaly, leptomeningeal angiomatosis, most often involving the occipital and posterior parietal lobes. The most common features are facial cutaneous vascular malformations (port-wine stains), seizures, and glaucoma. Stasis results in ischemia underlying the leptomeningeal angiomatosis, leading to calcification and laminar cortical necrosis. The clinical course is highly variable and some children experience intractable seizures, mental retardation, and recurrent stroke-like episodes. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GNAQ,2776,Hs.269782,ENST00000286548,THC2492537,GO:0000166(nucleotide binding)|GO:0001501(skeletal system development)|GO:0001508(regulation of action potential)|GO:0001664(G-protein-coupled receptor binding)|GO:0003924(GTPase activity)|GO:0004629(phospholipase C activity)|GO:0004871(signal transducer activity)|GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005096(GTPase activator activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005834(heterotrimeric G-protein complex)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0006469(negative regulation of protein kinase activity)|GO:0006471(protein ADP-ribosylation)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007189(activation of adenylate cyclase activity by G-protein signaling pathway)|GO:0007202(activation of phospholipase C activity)|GO:0007215(glutamate signaling pathway)|GO:0007507(heart development)|GO:0007596(blood coagulation)|GO:0007610(behavior)|GO:0009791(post-embryonic development)|GO:0016322(neuron remodeling)|GO:0019001(guanyl nucleotide binding)|GO:0021884(forebrain neuron development)|GO:0030168(platelet activation)|GO:0031234(extrinsic to internal side of plasma membrane)|GO:0031683(G-protein beta/gamma-subunit complex binding)|GO:0035412(regulation of catenin import into nucleus)|GO:0042733(embryonic digit morphogenesis)|GO:0043547(positive regulation of GTPase activity)|GO:0045634(regulation of melanocyte differentiation)|GO:0046872(metal ion binding)|GO:0048066(developmental pigmentation)|GO:0050821(protein stabilization)|GO:0060158(activation of phospholipase C activity by dopamine receptor signaling pathway),"guanine nucleotide binding protein (G protein), q polypeptide [Source:HGNC Symbol;Acc:4390] [ENST00000286548]",chr9:80334250-80334191,hs|9q21.2,"guanine nucleotide binding protein (G protein), q polypeptide",TRUE
1198_FAM100B_283991,Q8IYN6,uba-like domain-containing protein 2,UBALD2 FAM100B,164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM100B,283991,Hs.644033,ENST00000327490,THC2599594,NA,"Homo sapiens family with sequence similarity 100, member B (FAM100B), mRNA [NM_182565]",chr17:74267309-74267368,hs|17q25.1,"family with sequence similarity 100, member B",TRUE
1199_PRKAR2A_5576,P13861,camp-dependent protein kinase type ii-alpha regulatory subunit,PRKAR2A PKR2 PRKAR2,404,"function: regulatory subunit of the camp-dependent protein kinases involved in camp signaling in cells. type ii regulatory chains mediate membrane association by binding to anchoring proteins, including the map2 kinase.",subcellular location: cytoplasm {eco:0000269|pubmed:21423175}. cell membrane {eco:0000269|pubmed:21423175}. note=colocalizes with pja2 in the cytoplasm and the cell membrane.,"TISSUE SPECIFICITY: Four types of regulatory chains are found: I-alpha, I-beta, II-alpha, and II-beta. Their expression varies among tissues and is in some cases constitutive and in others inducible.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PRKAR2A,5576,Hs.631923,ENST00000265563,THC2534552,GO:0000166(nucleotide binding)|GO:0001932(regulation of protein phosphorylation)|GO:0005624(membrane fraction)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005952(cAMP-dependent protein kinase complex)|GO:0006112(energy reserve metabolic process)|GO:0006833(water transport)|GO:0007165(signal transduction)|GO:0007202(activation of phospholipase C activity)|GO:0007596(blood coagulation)|GO:0008603(cAMP-dependent protein kinase regulator activity)|GO:0016301(kinase activity)|GO:0019904(protein domain specific binding)|GO:0030315(T-tubule)|GO:0030552(cAMP binding)|GO:0031625(ubiquitin protein ligase binding)|GO:0034199(activation of protein kinase A activity)|GO:0035556(intracellular signal transduction)|GO:0042803(protein homodimerization activity)|GO:0045859(regulation of protein kinase activity)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0048471(perinuclear region of cytoplasm)|GO:0050796(regulation of insulin secretion)|GO:0051291(protein heterooligomerization)|GO:0055085(transmembrane transport)|GO:0071377(cellular response to glucagon stimulus),"protein kinase, cAMP-dependent, regulatory, type II, alpha [Source:HGNC Symbol;Acc:9391] [ENST00000265563]",chr3:48784606-48784547,hs|3p21.31,"protein kinase, cAMP-dependent, regulatory, type II, alpha",TRUE
12_HSP90AA1_3320,P07900,heat shock protein hsp 90-alpha (heat shock 86 kda) (hsp 86) (hsp86) (lipopolysaccharide-associated protein 2) (lap-2) (lps-associated protein 2) (renal carcinoma antigen ny-ren-38),HSP90AA1 HSP90A HSPC1 HSPCA,732,"function: molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. undergoes a functional cycle that is linked to its atpase activity which is essential for its chaperone activity. this cycle probably induces conformational changes in the client proteins, thereby causing their activation. interacts dynamically with various co-chaperones that modulate its substrate recognition, atpase cycle and chaperone function (pubmed:11274138, pubmed:15577939, pubmed:15937123, pubmed:27353360, pubmed:29127155). engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself (pubmed:29127155). recruitment of atp and co-chaperone followed by client protein forms a functional chaperone. after the completion of the chaperoning process, properly folded client protein and co-chaperone leave hsp90 in an adp-bound partially open conformation and finally, adp is released from hsp90 which acquires an open conformation for the next cycle (pubmed:27295069, pubmed:26991466). apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. hsp90 and its co-chaperones modulate transcription at least at three different levels (pubmed:25973397). in the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues(pubmed:25973397). second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or dna methyl transferases, and thereby respond to the change in the environment (pubmed:25973397). third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (pubmed:25973397). binds bacterial lipopolysaccharide (lps) and mediates lps-induced inflammatory response, including tnf secretion by monocytes (pubmed:11276205). antagonizes stub1-mediated inhibition of tgf-beta signaling via inhibition of stub1-mediated smad3 ubiquitination and degradation (pubmed:24613385). {eco:0000269|pubmed:11274138, eco:0000269|pubmed:11276205, eco:0000269|pubmed:15577939, eco:0000269|pubmed:15937123, eco:0000269|pubmed:24613385, eco:0000269|pubmed:27353360, eco:0000269|pubmed:29127155, eco:0000303|pubmed:25973397, eco:0000303|pubmed:26991466, eco:0000303|pubmed:27295069}.",subcellular location: nucleus {eco:0000250|uniprotkb:p07901}. cytoplasm {eco:0000250|uniprotkb:p07901}. melanosome {eco:0000269|pubmed:17081065}. cell membrane {eco:0000269|pubmed:11276205}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,HSP90AA1,3320,Hs.525600,ENST00000440936,THC2593538,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000278(mitotic cell cycle)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006200(ATP catabolic process)|GO:0006457(protein folding)|GO:0006839(mitochondrial transport)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0007165(signal transduction)|GO:0007411(axon guidance)|GO:0016887(ATPase activity)|GO:0030235(nitric-oxide synthase regulator activity)|GO:0030911(TPR domain binding)|GO:0034619(cellular chaperone-mediated protein complex assembly)|GO:0042026(protein refolding)|GO:0042470(melanosome)|GO:0042802(identical protein binding)|GO:0042803(protein homodimerization activity)|GO:0045040(protein import into mitochondrial outer membrane)|GO:0045429(positive regulation of nitric oxide biosynthetic process)|GO:0046209(nitric oxide metabolic process)|GO:0050999(regulation of nitric-oxide synthase activity)|GO:0051082(unfolded protein binding),"Homo sapiens heat shock protein 90kDa alpha (cytosolic), class A member 1 (HSP90AA1), transcript variant 1, mRNA [NM_001017963]",chr14:102547125-102547072,hs|14q32.31,"heat shock protein 90kDa alpha (cytosolic), class A member 1",TRUE
120_NPIPL3_23117,Q92617,nuclear pore complex-interacting protein family member b3 (nuclear pore complex-interacting protein-like 3) (protein pps22-1),NPIPB3 KIAA0220 NPIPL3,1050,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NPIPL3,23117,Hs.632865,ENST00000319334,THC2583434,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens nuclear pore complex interacting protein-like 3 (NPIPL3), mRNA [NM_130464]",chr16:21415424-21415365,hs|16p12.2,nuclear pore complex interacting protein-like 3,TRUE
1200_C11orf96_387763,Q7Z7L8,uncharacterized protein c11orf96 (protein ag2 homolog),C11orf96 AG2,435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C11orf96,387763,Hs.714890,ENST00000528572,NA,NA,"Homo sapiens chromosome 11 open reading frame 96 (C11orf96), mRNA [NM_001145033]",chr11:43965338-43965397,hs|11p11.2,chromosome 11 open reading frame 96,TRUE
1201_UIMC1_51720,Q96RL1,brca1-a complex subunit rap80 (receptor-associated protein 80) (retinoid x receptor-interacting protein 110) (ubiquitin interaction motif-containing protein 1),UIMC1 RAP80 RXRIP110,719,"function: ubiquitin-binding protein (pubmed:24627472). specifically recognizes and binds 'lys-63'-linked ubiquitin (pubmed:19328070, ref.37). plays a central role in the brca1-a complex by specifically binding 'lys-63'-linked ubiquitinated histones h2a and h2ax at dna lesions sites, leading to target the brca1-bard1 heterodimer to sites of dna damage at double-strand breaks (dsbs). the brca1-a complex also possesses deubiquitinase activity that specifically removes 'lys-63'-linked ubiquitin on histones h2a and h2ax. also weakly binds monoubiquitin but with much less affinity than 'lys-63'-linked ubiquitin. may interact with monoubiquitinated histones h2a and h2b; the relevance of such results is however unclear in vivo. does not bind lys-48'-linked ubiquitin. may indirectly act as a transcriptional repressor by inhibiting the interaction of nr6a1 with the corepressor ncor1. {eco:0000269|pubmed:12080054, eco:0000269|pubmed:17525340, eco:0000269|pubmed:17525341, eco:0000269|pubmed:17525342, eco:0000269|pubmed:17621610, eco:0000269|pubmed:17643121, eco:0000269|pubmed:19015238, eco:0000269|pubmed:19202061, eco:0000269|pubmed:19261748, eco:0000269|pubmed:19328070, eco:0000269|pubmed:24627472, eco:0000269|ref.37}.","subcellular location: nucleus {eco:0000269|pubmed:12080054, eco:0000269|pubmed:17525340, eco:0000269|pubmed:17525341, eco:0000269|pubmed:17525342, eco:0000269|pubmed:17621610, eco:0000269|pubmed:17643121}. note=localizes at sites of dna damage at double-strand breaks (dsbs).","TISSUE SPECIFICITY: Expressed in testis, ovary, thymus and heart. Expressed in germ cells of the testis. {ECO:0000269|PubMed:12080054}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UIMC1,51720,Hs.232721,ENST00000510698,THC2603405,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006302(double-strand break repair)|GO:0010212(response to ionizing radiation)|GO:0016568(chromatin modification)|GO:0031572(G2/M transition DNA damage checkpoint)|GO:0042393(histone binding)|GO:0045739(positive regulation of DNA repair)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046965(retinoid X receptor binding)|GO:0070530(K63-linked polyubiquitin binding)|GO:0070531(BRCA1-A complex)|GO:0070537(histone H2A K63-linked deubiquitination)","Homo sapiens ubiquitin interaction motif containing 1 (UIMC1), transcript variant 2, mRNA [NM_016290]",chr5:176332000-176331981,hs|5q35.2,ubiquitin interaction motif containing 1,TRUE
1202_CTNNA1_1495,P35221,catenin alpha-1 (alpha e-catenin) (cadherin-associated protein) (renal carcinoma antigen ny-ren-13),CTNNA1,906,"function: associates with the cytoplasmic domain of a variety of cadherins. the association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. can associate with both e- and n-cadherins. originally believed to be a stable component of e-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. in contrast, cortical actin was found to be much more dynamic than e-cadherin/catenin complexes and ctnna1 was shown not to bind to f-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. the homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the arp2/3 complex for binding to actin filaments. may play a crucial role in cell differentiation. {eco:0000269|pubmed:25653389}.","subcellular location: isoform 1: cytoplasm, cytoskeleton. cell junction, adherens junction. cell membrane; peripheral membrane protein; cytoplasmic side. cell junction. note=found at cell-cell boundaries and probably at cell-matrix boundaries.; subcellular location: isoform 3: cell membrane {eco:0000269|pubmed:21708131}; peripheral membrane protein {eco:0000269|pubmed:21708131}; cytoplasmic side {eco:0000269|pubmed:21708131}.",TISSUE SPECIFICITY: Expressed ubiquitously in normal tissues.,"DISEASE: Note=Germline CTNNA1 truncating mutations have been detected in patients with hereditary diffuse gastric cancer (HDGC) and may play a role in disease susceptibility. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. {ECO:0000269|PubMed:23208944, ECO:0000269|PubMed:26182300}.; DISEASE: Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970]: A form of retinal patterned dystrophy, a heterogeneous group of macular disorders caused by abnormal accumulation of lipofuscin in the retinal pigment epithelium. Lipofuscin distribution can show various shapes that define different types of macular dystrophy, including reticular (fishnet-like) dystrophy, macroreticular (spider-shaped) dystrophy and butterfly-shaped pigment dystrophy. MDPT2 is an autosomal dominant form characterized by bilateral accumulation of pigment in the macular area that resembles the wings of a butterfly. {ECO:0000269|PubMed:26691986}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CTNNA1,1495,Hs.445981,ENST00000540387,THC2488421,GO:0001541(ovarian follicle development)|GO:0001669(acrosomal vesicle)|GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0005915(zonula adherens)|GO:0007155(cell adhesion)|GO:0007163(establishment or maintenance of cell polarity)|GO:0007406(negative regulation of neuroblast proliferation)|GO:0007568(aging)|GO:0008013(beta-catenin binding)|GO:0008584(male gonad development)|GO:0014070(response to organic cyclic compound)|GO:0015629(actin cytoskeleton)|GO:0016264(gap junction assembly)|GO:0016342(catenin complex)|GO:0017166(vinculin binding)|GO:0030027(lamellipodium)|GO:0031103(axon regeneration)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0042127(regulation of cell proliferation)|GO:0042475(odontogenesis of dentine-containing tooth)|GO:0042692(muscle cell differentiation)|GO:0043066(negative regulation of apoptosis)|GO:0043297(apical junction assembly)|GO:0043627(response to estrogen stimulus)|GO:0045216(cell-cell junction organization)|GO:0045295(gamma-catenin binding)|GO:0045296(cadherin binding)|GO:0045880(positive regulation of smoothened signaling pathway)|GO:0051015(actin filament binding)|GO:0051149(positive regulation of muscle cell differentiation)|GO:0071681(cellular response to indole-3-methanol),"Homo sapiens catenin (cadherin-associated protein), alpha 1, 102kDa (CTNNA1), mRNA [NM_001903]",chr5:138270387-138270446,hs|5q31.2,"catenin (cadherin-associated protein), alpha 1, 102kDa",TRUE
1203_SRSF1_6426,Q07955,"serine/arginine-rich splicing factor 1 (alternative-splicing factor 1) (asf-1) (splicing factor, arginine/serine-rich 1) (pre-mrna-splicing factor sf2, p33 subunit)",SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3,248,"function: plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. interacts with other spliceosomal components, via the rs domains, to form a bridge between the 5'- and 3'-splice site binding components, u1 snrnp and u2af. can stimulate binding of u1 snrnp to a 5'-splice site-containing pre-mrna. binds to purine-rich rna sequences, either the octamer, 5'-rgaagaac-3' (r=a or g) or the decamers, aggacagagc/aggacgaagc. binds preferentially to the 5'-cgaggcg-3' motif in vitro. three copies of the octamer constitute a powerful splicing enhancer in vitro, the asf/sf2 splicing enhancer (ase) which can specifically activate ase-dependent splicing. isoform asf-2 and isoform asf-3 act as splicing repressors. may function as export adapter involved in mrna nuclear export through the tap/nxf1 pathway. {eco:0000269|pubmed:8139654}.","subcellular location: cytoplasm {eco:0000269|pubmed:12215544, eco:0000269|pubmed:20308322, eco:0000269|pubmed:24449914, eco:0000269|pubmed:9420331}. nucleus speckle {eco:0000269|pubmed:12215544, eco:0000269|pubmed:20308322, eco:0000269|pubmed:24449914, eco:0000269|pubmed:9420331}. note=in nuclear speckles. shuttles between the nucleus and the cytoplasm (pubmed:12215544, pubmed:20308322, pubmed:9420331, pubmed:24449914). nuclear import is mediated via interaction with tnpo3 (pubmed:24449914). {eco:0000269|pubmed:12215544, eco:0000269|pubmed:20308322, eco:0000269|pubmed:24449914, eco:0000269|pubmed:9420331}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF1,6426,Hs.68714,ENST00000258962,THC2566139,"GO:0000166(nucleotide binding)|GO:0000395(nuclear mRNA 5'-splice site recognition)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0001701(in utero embryonic development)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006376(mRNA splice site selection)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0050733(RS domain binding)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens serine/arginine-rich splicing factor 1 (SRSF1), transcript variant 2, mRNA [NM_001078166]",chr17:56081291-56081232,hs|17q22,serine/arginine-rich splicing factor 1,TRUE
1204_TAF15_8148,Q16514,transcription initiation factor tfiid subunit 12 (transcription initiation factor tfiid 20/15 kda subunits) (tafii-20/tafii-15) (tafii20/tafii15),TAF12 TAF15 TAF2J TAFII20,161,"function: tafs are components of the transcription factor iid (tfiid) complex, pcaf histone acetylase complex and tbp-free tafii complex (tftc). tafs components-tiifd are essential for mediating regulation of rna polymerase transcription.","subcellular location: nucleus {eco:0000269|pubmed:11564863, eco:0000269|pubmed:9674425}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TAF15,8148,Hs.402752,ENST00000311979,THC2467967,"GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)","Homo sapiens TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa (TAF15), transcript variant 1, mRNA [NM_139215]",chr17:34173994-34174053,hs|17q12,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",TRUE
1205_HIST1H2AH_85235,Q96KK5,histone h2a type 1-h (histone h2a/s),HIST1H2AH HIST1H2AI,128,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2AH,85235,Hs.352225,ENST00000377459,THC2481866,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 1, H2ah (HIST1H2AH), mRNA [NM_080596]",chr6:27115246-27115305,hs|6p22.1,"histone cluster 1, H2ah",TRUE
1206_CHCHD1_118487,Q96BP2,"coiled-coil-helix-coiled-coil-helix domain-containing protein 1 (28s ribosomal protein s37, mitochondrial) (mrp-s37) (mitochondrial small ribosomal subunit protein ms37) (nuclear protein c2360)",CHCHD1 C10orf34 MRPS37,118,NA,subcellular location: mitochondrion {eco:0000269|pubmed:23908630}. nucleus {eco:0000269|pubmed:15177562}.,NA,NA,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,CHCHD1,118487,Hs.181174,ENST00000372837,THC2472285,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion),"Homo sapiens coiled-coil-helix-coiled-coil-helix domain containing 1 (CHCHD1), mRNA [NM_203298]",chr10:75542926-75542985,hs|10q22.2,coiled-coil-helix-coiled-coil-helix domain containing 1,TRUE
1207_PAFAH1B1_5048,P43034,platelet-activating factor acetylhydrolase ib subunit alpha (lissencephaly-1 protein) (lis-1) (paf acetylhydrolase 45 kda subunit) (paf-ah 45 kda subunit) (paf-ah alpha) (pafah alpha),PAFAH1B1 LIS1 MDCR MDS PAFAHA,410,"function: required for proper activation of rho gtpases and actin polymerization at the leading edge of locomoting cerebellar neurons and postmigratory hippocampal neurons in response to calcium influx triggered via nmda receptors. non-catalytic subunit of an acetylhydrolase complex which inactivates platelet-activating factor (paf) by removing the acetyl group at the sn-2 position (by similarity). positively regulates the activity of the minus-end directed microtubule motor protein dynein. may enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus end. required for several dynein- and microtubule-dependent processes such as the maintenance of golgi integrity, the peripheral transport of microtubule fragments and the coupling of the nucleus and centrosome. required during brain development for the proliferation of neuronal precursors and the migration of newly formed neurons from the ventricular/subventricular zone toward the cortical plate. neuronal migration involves a process called nucleokinesis, whereby migrating cells extend an anterior process into which the nucleus subsequently translocates. during nucleokinesis dynein at the nuclear surface may translocate the nucleus towards the centrosome by exerting force on centrosomal microtubules. may also play a role in other forms of cell locomotion including the migration of fibroblasts during wound healing. required for dynein recruitment to microtubule plus ends and bicd2-bound cargos (pubmed:22956769). {eco:0000250|uniprotkb:p63005, eco:0000269|pubmed:15173193, eco:0000269|pubmed:22956769}.","subcellular location: cytoplasm, cytoskeleton. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. cytoplasm, cytoskeleton, spindle {eco:0000255|hamap-rule:mf_03141}. nucleus membrane {eco:0000255|hamap-rule:mf_03141}. note=redistributes to axons during neuronal development. also localizes to the microtubules of the manchette in elongating spermatids and to the meiotic spindle in spermatocytes (by similarity). localizes to the plus end of microtubules and to the centrosome. may localize to the nuclear membrane. {eco:0000250}.",TISSUE SPECIFICITY: Fairly ubiquitous expression in both the frontal and occipital areas of the brain.,"DISEASE: Lissencephaly 1 (LIS1) [MIM:607432]: A classical lissencephaly. It is characterized by agyria or pachygyria and disorganization of the clear neuronal lamination of normal six-layered cortex. The cortex is abnormally thick and poorly organized with 4 primitive layers. Associated with enlarged and dysmorphic ventricles and often hypoplasia of the corpus callosum. {ECO:0000269|PubMed:11163258, ECO:0000269|PubMed:11502906, ECO:0000269|PubMed:15007136, ECO:0000269|PubMed:15173193, ECO:0000269|PubMed:9063735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Subcortical band heterotopia (SBH) [MIM:607432]: SBH is a mild brain malformation of the lissencephaly spectrum. It is characterized by bilateral and symmetric plates or bands of gray matter found in the central white matter between the cortex and cerebral ventricles, cerebral convolutions usually appearing normal. {ECO:0000269|PubMed:10441340, ECO:0000269|PubMed:14581661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miller-Dieker lissencephaly syndrome (MDLS) [MIM:247200]: A contiguous gene deletion syndrome of chromosome 17p13.3, characterized by classical lissencephaly and distinct facial features. Additional congenital malformations can be part of the condition. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,PAFAH1B1,5048,Hs.77318,ENST00000397195,THC2572120,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000087(M phase of mitotic cell cycle)|GO:0000132(establishment of mitotic spindle orientation)|GO:0000226(microtubule cytoskeleton organization)|GO:0000235(astral microtubule)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0000776(kinetochore)|GO:0001675(acrosome assembly)|GO:0001764(neuron migration)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005626(insoluble fraction)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005819(spindle)|GO:0005829(cytosol)|GO:0005871(kinesin complex)|GO:0005874(microtubule)|GO:0005875(microtubule associated complex)|GO:0005938(cell cortex)|GO:0006810(transport)|GO:0007017(microtubule-based process)|GO:0007097(nuclear migration)|GO:0007268(synaptic transmission)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0007405(neuroblast proliferation)|GO:0007611(learning or memory)|GO:0008017(microtubule binding)|GO:0008090(retrograde axon cargo transport)|GO:0008201(heparin binding)|GO:0008344(adult locomotory behavior)|GO:0010977(negative regulation of neuron projection development)|GO:0016020(membrane)|GO:0016042(lipid catabolic process)|GO:0017145(stem cell division)|GO:0019226(transmission of nerve impulse)|GO:0021540(corpus callosum morphogenesis)|GO:0021766(hippocampus development)|GO:0021819(layer formation in cerebral cortex)|GO:0021895(cerebral cortex neuron differentiation)|GO:0021987(cerebral cortex development)|GO:0030036(actin cytoskeleton organization)|GO:0030154(cell differentiation)|GO:0030426(growth cone)|GO:0031023(microtubule organizing center organization)|GO:0031252(cell leading edge)|GO:0031512(motile primary cilium)|GO:0031513(nonmotile primary cilium)|GO:0031965(nuclear membrane)|GO:0032319(regulation of Rho GTPase activity)|GO:0033267(axon part)|GO:0034452(dynactin binding)|GO:0042598(vesicular fraction)|GO:0042803(protein homodimerization activity)|GO:0043025(neuronal cell body)|GO:0043274(phospholipase binding)|GO:0045502(dynein binding)|GO:0045505(dynein intermediate chain binding)|GO:0045773(positive regulation of axon extension)|GO:0045931(positive regulation of mitotic cell cycle)|GO:0046469(platelet activating factor metabolic process)|GO:0047496(vesicle transport along microtubule)|GO:0048471(perinuclear region of cytoplasm)|GO:0048854(brain morphogenesis)|GO:0050885(neuromuscular process controlling balance)|GO:0051081(nuclear envelope disassembly)|GO:0051219(phosphoprotein binding)|GO:0051660(establishment of centrosome localization),"Homo sapiens platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (PAFAH1B1), mRNA [NM_000430]",chr17:2588767-2588826,hs|17p13.3,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",TRUE
1208_SCFD1_23256,Q8WVM8,sec1 family domain-containing protein 1 (sly1 homolog) (sly1p) (syntaxin-binding protein 1-like 2),SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23,642,function: plays a role in snare-pin assembly and golgi-to-er retrograde transport via its interaction with cog4. involved in vesicular transport between the endoplasmic reticulum and the golgi (by similarity). {eco:0000250}.,"subcellular location: cytoplasm {eco:0000250}. endoplasmic reticulum membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. golgi apparatus, golgi stack membrane {eco:0000250}; peripheral membrane protein {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SCFD1,23256,Hs.369168,ENST00000311943,THC2504264,"GO:0001666(response to hypoxia)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005798(Golgi-associated vesicle)|GO:0005801(cis-Golgi network)|GO:0005886(plasma membrane)|GO:0006890(retrograde vesicle-mediated transport, Golgi to ER)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006904(vesicle docking involved in exocytosis)|GO:0009636(response to toxin)|GO:0015031(protein transport)|GO:0016192(vesicle-mediated transport)|GO:0017119(Golgi transport complex)|GO:0032580(Golgi cisterna membrane)|GO:0047485(protein N-terminus binding)|GO:0051535(syntaxin-5 binding)|GO:0060628(regulation of ER to Golgi vesicle-mediated transport)","Homo sapiens sec1 family domain containing 1 (SCFD1), transcript variant 1, mRNA [NM_016106]",chr14:31204866-31204925,hs|14q12,sec1 family domain containing 1,TRUE
1209_DDX1_1653,Q92499,atp-dependent rna helicase ddx1 (ec 3.6.4.13) (dead box protein 1) (dead box protein retinoblastoma) (dbp-rb),DDX1,740,"function: acts as an atp-dependent rna helicase, able to unwind both rna-rna and rna-dna duplexes. possesses 5' single-stranded rna overhang nuclease activity. possesses atpase activity on various rna, but not dna polynucleotides. may play a role in rna clearance at dna double-strand breaks (dsbs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. together with rela, acts as a coactivator to enhance nf-kappa-b-mediated transcriptional activation. acts as a positive transcriptional regulator of cyclin ccnd2 expression. binds to the cyclin ccnd2 promoter region. associates with chromatin at the nf-kappa-b promoter region via association with rela. binds to poly(a) rna. may be involved in 3'-end cleavage and polyadenylation of pre-mrnas. component of the trna-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit rtcb: together with archease (zbtb8os), acts by facilitating the guanylylation of rtcb, a key intermediate step in trna ligation (pubmed:24870230). component of a multi-helicase-ticam1 complex that acts as a cytoplasmic sensor of viral double-stranded rna (dsrna) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule ticam1. specifically binds (via helicase atp-binding domain) on both short and long poly(i:c) dsrna (by similarity). {eco:0000250|uniprotkb:q91vr5, eco:0000269|pubmed:12183465, eco:0000269|pubmed:15567440, eco:0000269|pubmed:18335541, eco:0000269|pubmed:18710941, eco:0000269|pubmed:20573827, eco:0000269|pubmed:24870230}.; function: (microbial infection) required for hiv-1 rev function as well as for hiv-1 and coronavirus ibv replication. binds to the rre sequence of hiv-1 mrnas. {eco:0000269|pubmed:15567440}.; function: (microbial infection) required for coronavirus ibv replication. {eco:0000269|pubmed:20573827}.","subcellular location: nucleus. cytoplasm. cytoplasmic granule. cytoplasm, cytosol {eco:0000250|uniprotkb:q91vr5}. mitochondrion {eco:0000250|uniprotkb:q91vr5}. note=localized with mbnl1, tial1 and ybx1 in stress granules upon stress. localized with cstf2 in cleavage bodies. forms large aggregates called ddx1 bodies. relocalized into multiple foci (ir-induced foci or irif) after ir treatment, a process that depends on the presence of chromosomal dna and/or rna-dna duplexes. relocalized at sites of dna double-strand breaks (dsbs) in an atm-dependent manner after ir treatment. colocalized with rela in the nucleus upon tnf-alpha induction. enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low (pubmed:24608264). colocalizes in the cytosol with ddx21, dhx36 and ticam1. colocalizes in the mitochondria with ticam1 and poly(i:c) rna ligand. the multi-helicase-ticam1 complex may translocate to the mitochondria upon poly(i:c) stimulation (by similarity). {eco:0000250|uniprotkb:q91vr5, eco:0000269|pubmed:24608264}.; subcellular location: cytoplasm {eco:0000269|pubmed:20573827}. note=(microbial infection) relocalized to the cytoplasm with a perinuclear staining pattern in avian infectious bronchitis virus (ibv)-infected cells (pubmed:20573827). required for proper localization of hiv-1 rev (pubmed:15567440). {eco:0000269|pubmed:15567440, eco:0000269|pubmed:20573827}.","TISSUE SPECIFICITY: Highest levels of transcription in 2 retinoblastoma cell lines and in tissues of neuroectodermal origin including the retina, brain, and spinal cord. {ECO:0000269|PubMed:7689221}.",NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDX1,1653,Hs.440599,ENST00000381341,THC2508422,"GO:0000166(nucleotide binding)|GO:0000245(spliceosome assembly)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003712(transcription cofactor activity)|GO:0003723(RNA binding)|GO:0003724(RNA helicase activity)|GO:0004518(nuclease activity)|GO:0004527(exonuclease activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006302(double-strand break repair)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006397(mRNA processing)|GO:0006446(regulation of translational initiation)|GO:0007275(multicellular organismal development)|GO:0008026(ATP-dependent helicase activity)|GO:0008143(poly(A) RNA binding)|GO:0010494(stress granule)|GO:0016787(hydrolase activity)|GO:0030529(ribonucleoprotein complex)|GO:0032508(DNA duplex unwinding)|GO:0033677(DNA/RNA helicase activity)|GO:0071920(cleavage body)|GO:0072669(tRNA-splicing ligase complex)","Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 (DDX1), mRNA [NM_004939]",chr2:15770975-15771034,hs|2p24.3,DEAD (Asp-Glu-Ala-Asp) box polypeptide 1,TRUE
121_OGT_8473,O15294,udp-n-acetylglucosamine--peptide n-acetylglucosaminyltransferase 110 kda subunit (ec 2.4.1.255) (o-glcnac transferase subunit p110) (o-linked n-acetylglucosamine transferase 110 kda subunit) (ogt),OGT,1046,"function: catalyzes the transfer of a single n-acetylglucosamine from udp-glcnac to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked n-acetylglucosamine (o-glcnac) (pubmed:26678539, pubmed:23103939, pubmed:21240259, pubmed:21285374, pubmed:15361863). glycosylates a large and diverse number of proteins including histone h2b, akt1, ezh2, pfkl, kmt2e/mll5, mapt/tau and hcfc1. can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing (pubmed:21285374). probably by glycosylating kmt2e/mll5, stabilizes kmt2e/mll5 by preventing its ubiquitination (pubmed:26678539). involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'thr-308' phosphorylation of akt1, enhancing irs1 phosphorylation and attenuating insulin signaling (by similarity). involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase pfkl, inhibiting its activity (pubmed:22923583). component of a thap1/thap3-hcfc1-ogt complex that is required for the regulation of the transcriptional activity of rrm1. plays a key role in chromatin structure by mediating o-glcnacylation of 'ser-112' of histone h2b: recruited to cpg-rich transcription start sites of active genes via its interaction with tet proteins (tet1, tet2 or tet3) (pubmed:22121020, pubmed:23353889). as part of the nsl complex indirectly involved in acetylation of nucleosomal histone h4 on several lysine residues (pubmed:20018852). o-glcnacylation of 'ser-75' of ezh2 increases its stability, and facilitating the formation of h3k27me3 by the prc2/eed-ezh2 complex (pubmed:24474760). regulates circadian oscillation of the clock genes and glucose homeostasis in the liver. stabilizes clock proteins arntl/bmal1 and clock through o-glycosylation, which prevents their ubiquitination and subsequent degradation. promotes the clock-arntl/bmal1-mediated transcription of genes in the negative loop of the circadian clock such as per1/2 and cry1/2 (pubmed:12150998, pubmed:19451179, pubmed:20018868, pubmed:20200153, pubmed:21285374, pubmed:15361863). o-glycosylates hcfc1 and regulates its proteolytic processing and transcriptional activity (pubmed:21285374, pubmed:28584052, pubmed:28302723). regulates mitochondrial motility in neurons by mediating glycosylation of trak1 (by similarity). glycosylates hoxa1 (by similarity). {eco:0000250|uniprotkb:p56558, eco:0000250|uniprotkb:q8cgy8, eco:0000269|pubmed:12150998, eco:0000269|pubmed:15361863, eco:0000269|pubmed:19451179, eco:0000269|pubmed:20018852, eco:0000269|pubmed:20018868, eco:0000269|pubmed:20200153, eco:0000269|pubmed:21240259, eco:0000269|pubmed:21285374, eco:0000269|pubmed:22121020, eco:0000269|pubmed:22923583, eco:0000269|pubmed:23103939, eco:0000269|pubmed:23353889, eco:0000269|pubmed:24474760, eco:0000269|pubmed:26678539, eco:0000269|pubmed:28302723, eco:0000269|pubmed:28584052}.; function: isoform 2: the mitochondrial isoform (mogt) is cytotoxic and triggers apoptosis in several cell types including ins1, an insulinoma cell line. {eco:0000269|pubmed:20824293}.","subcellular location: nucleus {eco:0000269|pubmed:26678539}. cytoplasm {eco:0000269|pubmed:26678539}. note=predominantly localizes to the nucleus. {eco:0000269|pubmed:26678539}.; subcellular location: isoform 2: mitochondrion {eco:0000269|pubmed:20824293}. membrane {eco:0000269|pubmed:20824293}. note=associates with the mitochondrial inner membrane. {eco:0000269|pubmed:20824293}.; subcellular location: isoform 3: cytoplasm {eco:0000269|pubmed:21285374}. nucleus {eco:0000269|pubmed:20018852, eco:0000269|pubmed:21285374}. cell membrane {eco:0000250|uniprotkb:p56558}. mitochondrion membrane {eco:0000250|uniprotkb:p56558}. cell projection {eco:0000250|uniprotkb:p56558}. note=mostly in the nucleus. retained in the nucleus via interaction with hcfc1 (pubmed:21285374). after insulin induction, translocated from the nucleus to the cell membrane via phosphatidylinositide binding. colocalizes with akt1 at the plasma membrane. trak1 recruits this protein to mitochondria. in the absence of trak1, localizes in cytosol and nucleus (by similarity). {eco:0000250|uniprotkb:p56558, eco:0000269|pubmed:21285374}.; subcellular location: isoform 4: cytoplasm. nucleus.","TISSUE SPECIFICITY: Highly expressed in pancreas and to a lesser extent in skeletal muscle, heart, brain and placenta. Present in trace amounts in lung and liver. {ECO:0000269|PubMed:9083068}.","DISEASE: Note=Regulation of OGT activity and altered O-GlcNAcylations are implicated in diabetes and Alzheimer disease. O-GlcNAcylation of AKT1 affects insulin signaling and, possibly diabetes. Reduced O-GlcNAcylations and resulting increased phosphorylations of MAPT/TAU are observed in Alzheimer disease (AD) brain cerebrum.; DISEASE: Mental retardation, X-linked 106 (MRX106) [MIM:300997]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:26273451, ECO:0000269|PubMed:28302723, ECO:0000269|PubMed:28584052}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,OGT,8473,Hs.405410,ENST00000488174,THC2539465,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0006493(protein O-linked glycosylation)|GO:0007165(signal transduction)|GO:0007584(response to nutrient)|GO:0008047(enzyme activator activity)|GO:0008375(acetylglucosaminyltransferase activity)|GO:0016262(protein N-acetylglucosaminyltransferase activity)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0030854(positive regulation of granulocyte differentiation)|GO:0042277(peptide binding)|GO:0043085(positive regulation of catalytic activity)|GO:0045862(positive regulation of proteolysis)|GO:0048029(monosaccharide binding)|GO:0051571(positive regulation of histone H3-K4 methylation)|GO:0070207(protein homotrimerization)|GO:0070688(MLL5-L complex)|GO:0071300(cellular response to retinoic acid)","Homo sapiens O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) (OGT), transcript variant 1, mRNA [NM_181672]",chrX:70794142-70794201,hs|Xq13.1,O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase),TRUE
1210_SYBU_55638,Q9NX95,syntabulin (golgi-localized syntaphilin-related protein) (syntaxin-1-binding protein),SYBU GOLSYN KIAA1472,663,"function: part of a kinesin motor-adapter complex that is critical for the anterograde axonal transport of active zone components and contributes to activity-dependent presynaptic assembly during neuronal development. {eco:0000250, eco:0000269|pubmed:15459722}.","subcellular location: isoform 1: cytoplasm, cytoskeleton. cytoplasmic vesicle. note=colocalizes with syntaxin vesicles along microtubules in neuronal processes.; subcellular location: isoform 3: golgi apparatus membrane; single-pass membrane protein.; subcellular location: isoform 4: golgi apparatus membrane; single-pass membrane protein.; subcellular location: isoform 5: golgi apparatus membrane; single-pass membrane protein.","TISSUE SPECIFICITY: Isoform 3, isoform 4 and isoform 5 are expressed in HeLa cell line (at protein level). Isoform 3 is expressed in fetal and adult brain. Isoform 4 is expressed in numerous fetal tissues (brain, kidney, liver, lung, and thymus) and in adult brain, kidney, liver, lung, pancreas, colon, prostate, small intestine, testis and thymus. Isoform 5 is expressed in fetal brain, brain and small intestine. {ECO:0000269|PubMed:15656992}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,SYBU,55638,Hs.390738,ENST00000533065,THC2630498,GO:0000139(Golgi membrane)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005856(cytoskeleton)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016023(cytoplasmic membrane-bounded vesicle),"Homo sapiens syntabulin (syntaxin-interacting) (SYBU), transcript variant 9, mRNA [NM_017786]",chr8:110586683-110586624,hs|8q23.2,syntabulin (syntaxin-interacting),TRUE
1211_OCRL_4952,Q01968,"inositol polyphosphate 5-phosphatase ocrl (ec 3.1.3.36) (ec 3.1.3.56) (inositol polyphosphate 5-phosphatase ocrl-1) (ocrl-1) (lowe oculocerebrorenal syndrome protein) (phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (ec 3.1.3.86)",OCRL OCRL1,901,"function: catalyzes the hydrolysis of the 4-position phosphate of phosphatidylinositol 4,5-bisphosphate (ptdins(4,5)p2) and phosphatidylinositol-3,4,5-bisphosphate (ptdins(3,4,5)p3), with the greatest catalytic activity towards ptdins(4,5)p2 (pubmed:7761412, pubmed:15474001, pubmed:9430698, pubmed:10764818). able also to hydrolyzes the 4-phosphate of inositol 1,4,5-trisphosphate and of inositol 1,3,4,5-tetrakisphosphate (pubmed:7761412, pubmed:25869668). regulates traffic in the endosomal pathway by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with endosomes (pubmed:21971085). involved in primary cilia assembly (pubmed:22228094, pubmed:22543976). acts as a regulator of phagocytosis, hydrolyzing ptdins(4,5)p2 to promote phagosome closure, through attenuation of pi3k signaling (pubmed:22072788). {eco:0000269|pubmed:10764818, eco:0000269|pubmed:15474001, eco:0000269|pubmed:21971085, eco:0000269|pubmed:22072788, eco:0000269|pubmed:22228094, eco:0000269|pubmed:22543976, eco:0000269|pubmed:25869668, eco:0000269|pubmed:7761412, eco:0000269|pubmed:9430698}.","subcellular location: cytoplasmic vesicle, phagosome membrane {eco:0000250|uniprotkb:d3zgs3}. early endosome membrane {eco:0000269|pubmed:21971085, eco:0000269|pubmed:25869668}. membrane, clathrin-coated pit {eco:0000269|pubmed:25869668}. cell projection, cilium, photoreceptor outer segment {eco:0000269|pubmed:22543976}. cell projection, cilium {eco:0000269|pubmed:22543976}. cytoplasmic vesicle {eco:0000250|uniprotkb:d3zgs3}. endosome {eco:0000269|pubmed:21971085, eco:0000269|pubmed:25869668}. golgi apparatus, trans-golgi network {eco:0000250|uniprotkb:d3zgs3}. lysosome {eco:0000269|pubmed:9430698}. note=also found on macropinosomes (pubmed:25869668). colocalized with appl1 on phagosomes (pubmed:22072788). {eco:0000269|pubmed:22072788, eco:0000269|pubmed:25869668}.","TISSUE SPECIFICITY: Brain, skeletal muscle, heart, kidney, lung, placenta and fibroblasts. Expressed in the retina and the retinal pigment epithelium. {ECO:0000269|PubMed:22543976}.","DISEASE: Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]: X-linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination. {ECO:0000269|PubMed:10767176, ECO:0000269|PubMed:10923037, ECO:0000269|PubMed:19168822, ECO:0000269|PubMed:20133602, ECO:0000269|PubMed:21031565, ECO:0000269|PubMed:21233288, ECO:0000269|PubMed:9199559, ECO:0000269|PubMed:9632163, ECO:0000269|PubMed:9682219, ECO:0000269|PubMed:9788721}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dent disease 2 (DD2) [MIM:300555]: A renal disease belonging to the 'Dent disease complex', a group of disorders characterized by proximal renal tubular defect, hypercalciuria, nephrocalcinosis, and renal insufficiency. The spectrum of phenotypic features is remarkably similar in the various disorders, except for differences in the severity of bone deformities and renal impairment. Characteristic abnormalities include low-molecular-weight proteinuria and other features of Fanconi syndrome, such as glycosuria, aminoaciduria, and phosphaturia, but typically do not include proximal renal tubular acidosis. Progressive renal failure is common, as are nephrocalcinosis and kidney stones. {ECO:0000269|PubMed:15627218, ECO:0000269|PubMed:17384968, ECO:0000269|PubMed:21031565}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,OCRL,4952,Hs.126357,ENST00000371113,THC2485473,"GO:0004439(phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005769(early endosome)|GO:0005795(Golgi stack)|GO:0005798(Golgi-associated vesicle)|GO:0005829(cytosol)|GO:0006629(lipid metabolic process)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0016787(hydrolase activity)|GO:0030136(clathrin-coated vesicle)|GO:0046856(phosphatidylinositol dephosphorylation)|GO:0051056(regulation of small GTPase mediated signal transduction)","Homo sapiens oculocerebrorenal syndrome of Lowe (OCRL), transcript variant a, mRNA [NM_000276]",chrX:128726414-128726473,hs|Xq26.1,oculocerebrorenal syndrome of Lowe,TRUE
1212_PCF11_51585,O94913,pre-mrna cleavage complex 2 protein pcf11 (pre-mrna cleavage complex ii protein pcf11),PCF11 KIAA0824,1555,function: component of pre-mrna cleavage complex ii.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PCF11,51585,Hs.128959,ENST00000526160,THC2536537,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005849(mRNA cleavage factor complex)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006379(mRNA cleavage)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0031124(mRNA 3'-end processing)","PCF11, cleavage and polyadenylation factor subunit, homolog (S. cerevisiae) [Source:HGNC Symbol;Acc:30097] [ENST00000526160]",chr11:82869686-82869745,hs|11q14.1,"PCF11, cleavage and polyadenylation factor subunit, homolog (S. cerevisiae)",TRUE
1213_TIMM8B_26521,Q9Y5J9,mitochondrial import inner membrane translocase subunit tim8 b (ddp-like protein) (deafness dystonia protein 2),TIMM8B DDP2 DDPL TIM8B,83,function: probable mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. also required for the transfer of beta-barrel precursors from the tom complex to the sorting and assembly machinery (sam complex) of the outer membrane. acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space (by similarity). {eco:0000250}.,subcellular location: mitochondrion inner membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; intermembrane side {eco:0000250}.,"TISSUE SPECIFICITY: Ubiquitous, with highest expression in heart, kidney, liver and skeletal muscle. {ECO:0000269|PubMed:10611480}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TIMM8B,26521,Hs.279915,ENST00000507614,THC2471269,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006626(protein targeting to mitochondrion)|GO:0007605(sensory perception of sound)|GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0042719(mitochondrial intermembrane space protein transporter complex)|GO:0045039(protein import into mitochondrial inner membrane)|GO:0046872(metal ion binding)|GO:0072321(chaperone-mediated protein transport),"Homo sapiens translocase of inner mitochondrial membrane 8 homolog B (yeast) (TIMM8B), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_012459]",chr11:111955984-111955925,hs|11q23.1,translocase of inner mitochondrial membrane 8 homolog B (yeast),TRUE
1214_ZNF587_84914,Q96SQ5,zinc finger protein 587,ZNF587,575,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF587,84914,Hs.658251,ENST00000339656,THC2486350,"GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 587 (ZNF587), transcript variant 1, mRNA [NM_032828]",chr19:58376178-58376237,hs|19q13.43,zinc finger protein 587,TRUE
1215_ING5_84289,Q8WYH8,inhibitor of growth protein 5 (p28ing5),ING5,240,"function: component of the hbo1 complex which has a histone h4-specific acetyltransferase activity, a reduced activity toward histone h3 and is responsible for the bulk of histone h4 acetylation in vivo. component of the moz/morf complex which has a histone h3 acetyltransferase activity. through chromatin acetylation it may regulate dna replication and may function as a transcriptional coactivator (pubmed:12750254, pubmed:16387653). inhibits cell growth, induces a delay in s-phase progression and enhances fas-induced apoptosis in an inca1-dependent manner (pubmed:21750715). {eco:0000269|pubmed:12750254, eco:0000269|pubmed:16387653, eco:0000269|pubmed:21750715}.",subcellular location: nucleus {eco:0000269|pubmed:18794358}.,TISSUE SPECIFICITY: Down-regulated in bone marrow cells in acute myeloid leukemia patients as compared with normal bone marrow cells. {ECO:0000269|PubMed:21750715}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ING5,84289,Hs.529172,ENST00000313552,THC2472713,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006260(DNA replication)|GO:0006473(protein acetylation)|GO:0008270(zinc ion binding)|GO:0008285(negative regulation of cell proliferation)|GO:0016568(chromatin modification)|GO:0035064(methylated histone residue binding)|GO:0043966(histone H3 acetylation)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045926(negative regulation of growth)|GO:0046872(metal ion binding)|GO:0070776(MOZ/MORF histone acetyltransferase complex)","Homo sapiens inhibitor of growth family, member 5 (ING5), mRNA [NM_032329]",chr2:242668673-242668732,hs|2q37.3,"inhibitor of growth family, member 5",TRUE
1216_UBE2I_7329,P63279,sumo-conjugating enzyme ubc9 (ec 2.3.2.-) (ring-type e3 sumo transferase ubc9) (sumo-protein ligase) (ubiquitin carrier protein 9) (ubiquitin carrier protein i) (ubiquitin-conjugating enzyme e2 i) (ubiquitin-protein ligase i) (p18),UBE2I UBC9 UBCE9,158,"function: accepts the ubiquitin-like proteins sumo1, sumo2, sumo3, sumo4 and sumo1p1/sumo5 from the uble1a-uble1b e1 complex and catalyzes their covalent attachment to other proteins with the help of an e3 ligase such as ranbp2, cbx4 and znf451. can catalyze the formation of poly-sumo chains. necessary for sumoylation of foxl2 and kat5. essential for nuclear architecture and chromosome segregation. sumoylates p53/tp53 at 'lys-386'. mediates sumoylation of ercc6 which is essential for its transcription-coupled nucleotide excision repair activity (pubmed:26620705). {eco:0000269|pubmed:11451954, eco:0000269|pubmed:15809060, eco:0000269|pubmed:17466333, eco:0000269|pubmed:19638400, eco:0000269|pubmed:19744555, eco:0000269|pubmed:20077568, eco:0000269|pubmed:26524494, eco:0000269|pubmed:26620705, eco:0000269|pubmed:27211601, eco:0000269|pubmed:8668529}.","subcellular location: nucleus. cytoplasm. note=mainly nuclear. in spermatocytes, localizes in synaptonemal complexes. recruited by bcl11a into the nuclear body (by similarity). {eco:0000250}.","TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, pancreas, kidney, liver, lung, placenta and brain. Also expressed in testis and thymus. {ECO:0000269|PubMed:8610150}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBE2I,7329,Hs.302903,ENST00000403747,NP081817,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000166(nucleotide binding)|GO:0000795(synaptonemal complex)|GO:0001650(fibrillar center)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006464(protein modification process)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0007049(cell cycle)|GO:0007059(chromosome segregation)|GO:0007067(mitosis)|GO:0008022(protein C-terminus binding)|GO:0008134(transcription factor binding)|GO:0010469(regulation of receptor activity)|GO:0016567(protein ubiquitination)|GO:0016605(PML body)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0016925(protein sumoylation)|GO:0019789(SUMO ligase activity)|GO:0019899(enzyme binding)|GO:0030425(dendrite)|GO:0033145(positive regulation of steroid hormone receptor signaling pathway)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0043398(HLH domain binding)|GO:0043425(bHLH transcription factor binding)|GO:0044419(interspecies interaction between organisms)|GO:0045202(synapse)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0051301(cell division)|GO:0072500(negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor)","Homo sapiens ubiquitin-conjugating enzyme E2I (UBE2I), transcript variant 2, mRNA [NM_194259]",chr16:1374948-1375007,hs|16p13.3,ubiquitin-conjugating enzyme E2I,TRUE
1217_C15orf61_145853,A6NNL5,uncharacterized protein c15orf61,C15orf61,157,NA,subcellular location: secreted {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,C15orf61,145853,Hs.438385,ENST00000342683,THC2657260,GO:0005576(extracellular region),"Homo sapiens chromosome 15 open reading frame 61 (C15orf61), mRNA [NM_001143936]",chr15:67818881-67818940,hs|15q23,chromosome 15 open reading frame 61,TRUE
1218_CNOT2_4848,Q9NZN8,ccr4-not transcription complex subunit 2 (ccr4-associated factor 2),CNOT2 CDC36 NOT2 HSPC131 MSTP046,540,"function: component of the ccr4-not complex which is one of the major cellular mrna deadenylases and is linked to various cellular processes including bulk mrna degradation, mirna-mediated repression, translational repression during translational initiation and general transcription regulation. additional complex functions may be a consequence of its influence on mrna expression. required for the ccr4-not complex structural integrity. can repress transcription and may link the ccr4-not complex to transcriptional regulation; the repressive function may specifically involve the n-cor repressor complex containing hdac3, ncor1 and ncor2. involved in the maintenance of embryonic stem (es) cell identity. {eco:0000269|pubmed:14707134, eco:0000269|pubmed:16712523, eco:0000269|pubmed:21299754, eco:0000269|pubmed:22367759}.",subcellular location: cytoplasm {eco:0000269|pubmed:21299754}. nucleus {eco:0000305|pubmed:21299754}.,"TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain, heart, thymus, spleen, kidney, liver, small intestine, placenta, lung and peripheral blood leukocytes. {ECO:0000269|PubMed:10637334}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CNOT2,4848,Hs.730666,ENST00000551434,THC2538976,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening)|GO:0001104(RNA polymerase II transcription cofactor activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)","Homo sapiens CCR4-NOT transcription complex, subunit 2 (CNOT2), transcript variant 2, mRNA [NM_014515]",chr12:70740091-70747654,hs|12q15,"CCR4-NOT transcription complex, subunit 2",TRUE
1219_FOPNL_123811,Q96NB1,lish domain-containing protein fopnl (fgfr1op n-terminal-like protein) (fop-related protein of 20 kda),FOPNL C16orf63 FOR20 PHSECRG2,174,"function: involved in the biogenesis of cilia (pubmed:20551181). required for the recruitment of plk1 to centrosomes and s phase progression (pubmed:24018379). {eco:0000269|pubmed:20551181, eco:0000269|pubmed:24018379}.","subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {eco:0000269|pubmed:26643951}. cell projection, cilium {eco:0000250}. cytoplasm, cytoskeleton, cilium basal body {eco:0000250}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:20551181, eco:0000269|pubmed:24018379}. cytoplasmic granule {eco:0000269|pubmed:20551181}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite {eco:0000269|pubmed:20551181, eco:0000269|pubmed:26643951}. note=localizes to the centrosome throughout cell cycle progression (pubmed:24018379). localization to centrioles and pericentriolar satellites may be mediated by kiaa0753/ofip (pubmed:26643951). {eco:0000269|pubmed:24018379, eco:0000269|pubmed:26643951}.","TISSUE SPECIFICITY: Widely expressed. Detected in brain, heart, kidney, liver, lung, skeletal muscle, placenta and intestine. {ECO:0000269|PubMed:20551181}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FOPNL,123811,Hs.514179,ENST00000255759,THC2468681,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005856(cytoskeleton)|GO:0005932(microtubule basal body)|GO:0030030(cell projection organization)|GO:0031514(motile cilium)|GO:0034451(centriolar satellite)|GO:0034453(microtubule anchoring)|GO:0042384(cilium assembly),"Homo sapiens FGFR1OP N-terminal like (FOPNL), mRNA [NM_144600]",chr16:15959688-15959629,hs|16p13.11,FGFR1OP N-terminal like,TRUE
122_RPS21_6227,P63220,40s ribosomal protein s21 (small ribosomal subunit protein es21),RPS21,83,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:p63221}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:p63221, eco:0000269|pubmed:25957688}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS21,6227,Hs.190968,ENST00000492356,THC2478337,"GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0000461(endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0003674(molecular_function)|GO:0003735(structural constituent of ribosome)|GO:0005575(cellular_component)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030154(cell differentiation)|GO:0031018(endocrine pancreas development)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process)|GO:0047485(protein N-terminus binding)",ribosomal protein S21 [Source:HGNC Symbol;Acc:10409] [ENST00000492356],chr20:60963498-60963557,hs|20q13.33,ribosomal protein S21,TRUE
1220_PKP3_11187,Q9Y446,plakophilin-3,PKP3,797,function: may play a role in junctional plaques.,"subcellular location: nucleus. cell junction, desmosome. note=nuclear and associated with desmosomes.","TISSUE SPECIFICITY: Isoform PKP3a is found in desmosomes of most simple and stratified epithelia. Not found in foreskin fibroblasts and various sarcoma-derived cell lines. Beside dendritic reticular cells of lymphatic follicles not found in non-epithelial desmosome-bearing tissues. Isoform PKP3b is abundant in the desmosomes of stratified epithelial cell but absent in simple epithelial cells, it is also expressed in the colon and its tumors. {ECO:0000269|PubMed:24178805}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PKP3,11187,Hs.534395,ENST00000331563,THC2467403,GO:0005488(binding)|GO:0005634(nucleus)|GO:0005911(cell-cell junction)|GO:0007155(cell adhesion)|GO:0030057(desmosome),"Homo sapiens plakophilin 3 (PKP3), mRNA [NM_007183]",chr11:404785-404844,hs|11p15.5,plakophilin 3,TRUE
1221_COMMD3_23412,Q9UBI1,comm domain-containing protein 3 (protein bup) (protein pil),COMMD3 BUP C10orf8,195,"function: may modulate activity of cullin-ring e3 ubiquitin ligase (crl) complexes (pubmed:21778237). may down-regulate activation of nf-kappa-b (pubmed:15799966). modulates na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (enac) subunits (pubmed:23637203). {eco:0000269|pubmed:15799966, eco:0000269|pubmed:23637203, eco:0000305|pubmed:21778237}.",subcellular location: cytoplasm {eco:0000269|pubmed:21778237}. nucleus {eco:0000269|pubmed:21778237}.,TISSUE SPECIFICITY: Widely expressed with highest expression in thymus. {ECO:0000269|PubMed:15799966}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,COMMD3,23412,Hs.534398,ENST00000456711,THC2642472,GO:0005515(protein binding),"Homo sapiens COMM domain containing 3 (COMMD3), mRNA [NM_012071]",chr10:22608978-22609037,hs|10p12.2,COMM domain containing 3,TRUE
1222_SMARCC2_6601,Q8TAQ2,swi/snf complex subunit smarcc2 (brg1-associated factor 170) (baf170) (swi/snf complex 170 kda subunit) (swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily c member 2),SMARCC2 BAF170,1214,"function: involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of dna-nucleosome topology). component of swi/snf chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering dna-histone contacts within a nucleosome in an atp-dependent manner (pubmed:11018012). can stimulate the atpase activity of the catalytic subunit of these complexes (pubmed:10078207). may be required for corest dependent repression of neuronal specific gene promoters in non-neuronal cells (pubmed:12192000). belongs to the neural progenitors-specific chromatin remodeling complex (npbaf complex) and the neuron-specific chromatin remodeling complex (nbaf complex). during neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. the transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npbaf and nbaf complexes. as neural progenitors exit mitosis and differentiate into neurons, npbaf complexes which contain actl6a/baf53a and phf10/baf45a, are exchanged for homologous alternative actl6b/baf53b and dpf1/baf45b or dpf3/baf45c subunits in neuron-specific complexes (nbaf). the npbaf complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. the nbaf complex along with crest plays a role regulating the activity of genes essential for dendrite growth (by similarity). critical regulator of myeloid differentiation, controlling granulocytopoiesis and the expression of genes involved in neutrophil granule formation (by similarity). {eco:0000250|uniprotkb:q6pdg5, eco:0000269|pubmed:10078207, eco:0000269|pubmed:11018012, eco:0000269|pubmed:12192000, eco:0000303|pubmed:22952240, eco:0000303|pubmed:26601204}.",subcellular location: nucleus.,TISSUE SPECIFICITY: Ubiquitously expressed.,"DISEASE: Coffin-Siris syndrome 8 (CSS8) [MIM:618362]: A form of Coffin-Siris syndrome, a congenital multiple malformation syndrome with broad phenotypic and genetic variability. Cardinal features are intellectual disability, coarse facial features, hypertrichosis, and hypoplastic or absent fifth digit nails or phalanges. Additional features include malformations of the cardiac, gastrointestinal, genitourinary, and/or central nervous systems. Sucking/feeding difficulties, poor growth, ophthalmologic abnormalities, hearing impairment, and spinal anomalies are common findings. CSS8 patients manifest prominent speech impairment, hypotonia, feeding difficulties, behavioral abnormalities, and dysmorphic features such as hypertrichosis, thick eyebrows, thin upper lip vermilion, and upturned nose. CSS8 inheritance is autosomal dominant. {ECO:0000269|PubMed:30580808}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SMARCC2,6601,Hs.236030,ENST00000267064,THC2468964,"GO:0003677(DNA binding)|GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006337(nucleosome disassembly)|GO:0006338(chromatin remodeling)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0007399(nervous system development)|GO:0016514(SWI/SNF complex)|GO:0017053(transcriptional repressor complex)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0071564(npBAF complex)|GO:0071565(nBAF complex)","Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 (SMARCC2), transcript variant 2, mRNA [NM_139067]",chr12:56557192-56557133,hs|12q13.2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2",TRUE
1223_EIF3M_10480,Q7L2H7,eukaryotic translation initiation factor 3 subunit m (eif3m) (fetal lung protein b5) (hfl-b5) (pci domain-containing protein 1),EIF3M HFLB5 PCID1 GA17 PNAS-125,374,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17403899, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17403899). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000255|hamap-rule:mf_03012, eco:0000269|pubmed:17403899, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.; function: (microbial infection) may favor virus entry in case of infection with herpes simplex virus 1 (hsv1) or herpes simplex virus 2 (hsv2). {eco:0000269|pubmed:15919898}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03012}.,TISSUE SPECIFICITY: Broadly expressed. {ECO:0000269|PubMed:15919898}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3M,10480,Hs.502244,ENST00000531120,THC2470127,GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006413(translational initiation),"Homo sapiens eukaryotic translation initiation factor 3, subunit M (EIF3M), mRNA [NM_006360]",chr11:32623862-32623921,hs|11p13,"eukaryotic translation initiation factor 3, subunit M",TRUE
1224_RABGAP1_23637,Q9Y3P9,rab gtpase-activating protein 1 (gap and centrosome-associated protein) (rab6 gtpase-activating protein gapcena),RABGAP1 HSPC094,1069,"function: may act as a gtpase-activating protein of rab6a. may play a role in microtubule nucleation by centrosome. may participate in a rab6a-mediated pathway involved in the metaphase-anaphase transition. {eco:0000269|pubmed:10202141, eco:0000269|pubmed:16395330}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:10202141}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:10202141}. note=predominantly cytosolic but also associated with the centrosome. {eco:0000269|pubmed:10202141}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,RABGAP1,23637,Hs.271341,ENST00000373647,THC2463368,GO:0005096(GTPase activator activity)|GO:0005097(Rab GTPase activator activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005875(microtubule associated complex)|GO:0007049(cell cycle)|GO:0015631(tubulin binding)|GO:0043547(positive regulation of GTPase activity),"Homo sapiens RAB GTPase activating protein 1 (RABGAP1), mRNA [NM_012197]",chr9:125866353-125866412,hs|9q33.3,RAB GTPase activating protein 1,TRUE
1225_RNF114_55905,Q9Y508,e3 ubiquitin-protein ligase rnf114 (ec 2.3.2.27) (ring finger protein 114) (ring-type e3 ubiquitin transferase rnf114) (zinc finger protein 228) (zinc finger protein 313),RNF114 ZNF228 ZNF313,228,"function: e3 ubiquitin-protein ligase that promotes the ubiquitination of various substrates (pubmed:23645206, pubmed:25165885). in turn, participates in the regulation of many biological processes including cell cycle, apoptosis, osteoclastogenesis as well as innate or adaptive immunity (pubmed:25165885, pubmed:28708287). acts as negative regulator of nf-kappa-b-dependent transcription by promoting the ubiquitination and stabilization of the nf-kappa-b inhibitor tnfaip3 (pubmed:25165885). may promote the ubiquitination of traf6 as well (pubmed:28708287). acts also as a negative regulator of t-cell activation (pubmed:25165885). inhibits cellular dsrna responses and interferon production by targeting mavs component for proteasomal degradation (pubmed:25165885). ubiquitinates the cdk inhibitor cdkn1a leading to its degradationand probably also cdkn1b and cdkn1c (pubmed:23645206). this activity stimulates cell cycle g1-to-s phase transition and suppresses cellular senescence. may play a role in spermatogenesis. {eco:0000269|pubmed:23645206, eco:0000269|pubmed:25165885, eco:0000269|pubmed:28625874, eco:0000269|pubmed:28708287}.",subcellular location: cytoplasm {eco:0000269|pubmed:23645206}. nucleus {eco:0000269|pubmed:23645206}.,"TISSUE SPECIFICITY: Expressed in numerous tissues, including skin, CD4 lymphocytes and dendritic cells. Highest levels in testis. {ECO:0000269|PubMed:18364390}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF114,55905,Hs.144949,ENST00000244061,NP164941,GO:0005622(intracellular)|GO:0007275(multicellular organismal development)|GO:0007283(spermatogenesis)|GO:0008270(zinc ion binding)|GO:0030154(cell differentiation)|GO:0046872(metal ion binding),"Homo sapiens ring finger protein 114 (RNF114), mRNA [NM_018683]",chr20:48570320-48570379,hs|20q13.13,ring finger protein 114,TRUE
1226_PITPNA_5306,Q00169,phosphatidylinositol transfer protein alpha isoform (pi-tp-alpha) (ptdins transfer protein alpha) (ptdinstp alpha),PITPNA PITPN,270,function: catalyzes the transfer of ptdins and phosphatidylcholine between membranes.,subcellular location: cytoplasm.,TISSUE SPECIFICITY: Expressed in a wide range of tissues.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PITPNA,5306,Hs.429819,ENST00000313486,THC2507379,GO:0005543(phospholipid binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006629(lipid metabolic process)|GO:0006810(transport)|GO:0007411(axon guidance)|GO:0007601(visual perception)|GO:0008525(phosphatidylcholine transmembrane transporter activity)|GO:0008526(phosphatidylinositol transporter activity)|GO:0015914(phospholipid transport),"Homo sapiens phosphatidylinositol transfer protein, alpha (PITPNA), mRNA [NM_006224]",chr17:1421436-1421377,hs|17p13.3,"phosphatidylinositol transfer protein, alpha",TRUE
1227_HRASLS5_117245,Q96KN8,phospholipase a and acyltransferase 5 (ca(2+)-independent n-acyltransferase) (inat) (ec 2.3.1.-) (ec 3.1.1.32) (ec 3.1.1.4) (h-rev107-like protein 5) (hras-like suppressor 5) (hrsl5),PLAAT5 HRASLS5 HRLP5,279,"function: exhibits both phospholipase a1/2 and acyltransferase activities (pubmed:22825852, pubmed:26503625). shows phospholipase a1 (pla1) and a2 (pla2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids (pubmed:22825852). shows n-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (pc) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (pe), forming n-acylphosphatidylethanolamine (nape), which serves as precursor for n-acylethanolamines (naes) (pubmed:19000777, pubmed:22825852). {eco:0000269|pubmed:19000777, eco:0000269|pubmed:22825852, eco:0000303|pubmed:26503625}.",NA,TISSUE SPECIFICITY: Highest expression level in testis and pancreas.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,HRASLS5,117245,Hs.410316,ENST00000536887,THC2471736,NA,"Homo sapiens HRAS-like suppressor family, member 5 (HRASLS5), transcript variant 1, mRNA [NM_054108]",chr11:63229094-63229035,hs|11q12.3,"HRAS-like suppressor family, member 5",TRUE
1228_HPGD_3248,P15428,15-hydroxyprostaglandin dehydrogenase [nad(+)] (15-pgdh) (ec 1.1.1.141) (prostaglandin dehydrogenase 1) (short chain dehydrogenase/reductase family 36c member 1),HPGD PGDH1 SDR36C1,266,"function: prostaglandin inactivation. contributes to the regulation of events that are under the control of prostaglandin levels. catalyzes the nad-dependent dehydrogenation of lipoxin a4 to form 15-oxo-lipoxin a4. inhibits in vivo proliferation of colon cancer cells. {eco:0000269|pubmed:10837478, eco:0000269|pubmed:15574495, eco:0000269|pubmed:16828555}.",subcellular location: cytoplasm.,TISSUE SPECIFICITY: Detected in colon epithelium (at protein level). {ECO:0000269|PubMed:15574495}.,"DISEASE: Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 (PHOAR1) [MIM:259100]: A disease characterized by digital clubbing, periostosis, acroosteolysis, painful joint enlargement, and variable features of pachydermia that include thickened facial skin and a thickened scalp. Other developmental anomalies include delayed closure of the cranial sutures and congenital heart disease. {ECO:0000269|PubMed:18500342}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cranioosteoarthropathy (COA) [MIM:259100]: A form of osteoarthropathy characterized by swelling of the joints, digital clubbing, hyperhidrosis, delayed closure of the fontanels, periostosis, and variable patent ductus arteriosus. Pachydermia is not a prominent feature. {ECO:0000269|PubMed:18500342}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Isolated congenital nail clubbing (ICNC) [MIM:119900]: A rare genodermatosis characterized by enlargement of the nail plate and terminal segments of the fingers and toes, resulting from proliferation of the connective tissues between the nail matrix and the distal phalanx. It is usually symmetrical and bilateral (in some cases unilateral). In nail clubbing usually the distal end of the nail matrix is relatively high compared to the proximal end, while the nail plate is complete but its dimensions and diameter more or less vary in comparison to normal. There may be different fingers and toes involved to varying degrees. Some fingers or toes are spared, but the thumbs are almost always involved. {ECO:0000269|PubMed:18805827}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HPGD,3248,Hs.596913,ENST00000512410,THC2740694,GO:0000166(nucleotide binding)|GO:0003824(catalytic activity)|GO:0004957(prostaglandin E receptor activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006629(lipid metabolic process)|GO:0006631(fatty acid metabolic process)|GO:0006693(prostaglandin metabolic process)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0007565(female pregnancy)|GO:0007567(parturition)|GO:0016404(15-hydroxyprostaglandin dehydrogenase (NAD+) activity)|GO:0016491(oxidoreductase activity)|GO:0019372(lipoxygenase pathway)|GO:0030728(ovulation)|GO:0042803(protein homodimerization activity)|GO:0045786(negative regulation of cell cycle)|GO:0051287(NAD binding)|GO:0070403(NAD+ binding)|GO:0070493(thrombin receptor signaling pathway)|GO:0097070(ductus arteriosus closure),"Homo sapiens hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), transcript variant 1, mRNA [NM_000860]",chr4:175429875-175416745,hs|4q34.1,hydroxyprostaglandin dehydrogenase 15-(NAD),TRUE
1229_TCEB2_6923,Q15370,elongin-b (elob) (elongin 18 kda subunit) (rna polymerase ii transcription factor siii subunit b) (siii p18) (transcription elongation factor b polypeptide 2),ELOB TCEB2,118,"function: siii, also known as elongin, is a general transcription elongation factor that increases the rna polymerase ii transcription elongation past template-encoded arresting sites. subunit a is transcriptionally active and its transcription activity is strongly enhanced by binding to the dimeric complex of the siii regulatory subunits b and c (elongin bc complex) (pubmed:7638163). in embryonic stem cells, the elongin bc complex is recruited by epop to polycomb group (pcg) target genes in order generate genomic region that display both active and repressive chromatin properties, an important feature of pluripotent stem cells (by similarity). {eco:0000250|uniprotkb:p62869, eco:0000269|pubmed:7638163}.; function: the elongin bc complex seems to be involved as an adapter protein in the proteasomal degradation of target proteins via different e3 ubiquitin ligase complexes, including the von hippel-lindau ubiquitination complex cbc(vhl). by binding to bc-box motifs it seems to link target recruitment subunits, like vhl and members of the socs box family, to cullin/rbx1 modules that activate e2 ubiquitination enzymes. {eco:0000269|pubmed:10205047, eco:0000269|pubmed:12004076, eco:0000269|pubmed:12050673, eco:0000269|pubmed:15590694}.",subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEB2,6923,Hs.172772,ENST00000262306,THC2490486,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0006461(protein complex assembly)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0050434(positive regulation of viral transcription)","Homo sapiens transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) (TCEB2), transcript variant 2, mRNA [NM_207013]",chr16:2822062-2822003,hs|16p13.3,"transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)",TRUE
123_NEDD4L_23327,Q96PU5,e3 ubiquitin-protein ligase nedd4-like (ec 2.3.2.26) (hect-type e3 ubiquitin transferase ned4l) (nedd4.2) (nedd4-2),NEDD4L KIAA0439 NEDL3,975,"function: e3 ubiquitin-protein ligase which accepts ubiquitin from an e2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. inhibits tgf-beta signaling by triggering smad2 and tgfbr1 ubiquitination and proteasome-dependent degradation. promotes ubiquitination and internalization of various plasma membrane channels such as enac, scn2a/nav1.2, scn3a/nav1.3, scn5a/nav1.5, scn9a/nav1.7, scn10a/nav1.8, kcna3/kv1.3, kcnh2, eaat1, kcnq2/kv7.2, kcnq3/kv7.3 or clc5 (pubmed:26363003, pubmed:27445338). promotes ubiquitination and degradation of sgk1 and tnk2. ubiquitinates brat1 and this ubiquitination is enhanced in the presence of ndfip1 (pubmed:25631046). plays a role in dendrite formation by melanocytes (pubmed:23999003). involved in the regulation of tor signaling (pubmed:27694961). ubiquitinates and regulates protein levels of ntrk1 once this one is activated by ngf (pubmed:27445338). {eco:0000250|uniprotkb:q8cfi0, eco:0000269|pubmed:12911626, eco:0000269|pubmed:15040001, eco:0000269|pubmed:15217910, eco:0000269|pubmed:15489223, eco:0000269|pubmed:15496141, eco:0000269|pubmed:15576372, eco:0000269|pubmed:19144635, eco:0000269|pubmed:23999003, eco:0000269|pubmed:25631046, eco:0000269|pubmed:26363003, eco:0000269|pubmed:27445338, eco:0000269|pubmed:27694961}.","subcellular location: cytoplasm {eco:0000269|pubmed:15496141, eco:0000269|pubmed:18819914, eco:0000269|pubmed:27694961}. golgi apparatus {eco:0000269|pubmed:26363003}. endosome, multivesicular body {eco:0000269|pubmed:26363003}. note=may be recruited to exosomes by ndfip1.","TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in prostate, pancreas and kidney (PubMed:14615060, PubMed:15496141, PubMed:19664597). Expressed in melanocytes (PubMed:23999003). {ECO:0000269|PubMed:14615060, ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:19664597, ECO:0000269|PubMed:23999003}.","DISEASE: Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201]: A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH7 is an autosomal dominant disease characterized by delayed psychomotor development, intellectual disability, and seizures in some patients. Additional features include cleft palate and toe syndactyly. {ECO:0000269|PubMed:27694961}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEDD4L,23327,Hs.185677,ENST00000400345,THC2466281,GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0006464(protein modification process)|GO:0006814(sodium ion transport)|GO:0006883(cellular sodium ion homeostasis)|GO:0007588(excretion)|GO:0010038(response to metal ion)|GO:0010766(negative regulation of sodium ion transport)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0017080(sodium channel regulator activity)|GO:0019871(sodium channel inhibitor activity)|GO:0030104(water homeostasis)|GO:0042176(regulation of protein catabolic process)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0044419(interspecies interaction between organisms)|GO:0045807(positive regulation of endocytosis),"Homo sapiens neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L), transcript variant d, mRNA [NM_015277]",chr18:56065317-56065376,hs|18q21.31,"neural precursor cell expressed, developmentally down-regulated 4-like",TRUE
1230_MBOAT2_129642,Q6ZWT7,lysophospholipid acyltransferase 2 (lplat 2) (ec 2.3.1.-) (1-acylglycerophosphate o-acyltransferase) (ec 2.3.1.51) (1-acylglycerophosphoethanolamine o-acyltransferase) (ec 2.3.1.n7) (lysophosphatidic acid acyltransferase) (lpaat) (lyso-pa acyltransferase) (lysophosphatidylethanolamine acyltransferase) (lpeat) (lyso-pe acyltransferase) (membrane-bound o-acyltransferase domain-containing protein 2) (o-acyltransferase domain-containing protein 2),MBOAT2 OACT2,520,"function: acyltransferase which mediates the conversion of lysophosphatidylethanolamine (1-acyl-sn-glycero-3-phosphoethanolamine or lpe) into phosphatidylethanolamine (1,2-diacyl-sn-glycero-3-phosphoethanolamine or pe) (lpeat activity). catalyzes also the acylation of lysophosphatidic acid (lpa) into phosphatidic acid (pa) (lpaat activity). has also a very weak lysophosphatidylcholine acyltransferase (lpcat activity). prefers oleoyl-coa as the acyl donor. lysophospholipid acyltransferases (lplats) catalyze the reacylation step of the phospholipid remodeling pathway also known as the lands cycle. {eco:0000269|pubmed:18772128}.",subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Expressed in neutrophils. {ECO:0000269|PubMed:18772128}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MBOAT2,129642,Hs.467634,ENST00000305997,THC2464458,"GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity)|GO:0008654(phospholipid biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups)","Homo sapiens membrane bound O-acyltransferase domain containing 2 (MBOAT2), mRNA [NM_138799]",chr2:8998402-8998343,hs|2p25.1,membrane bound O-acyltransferase domain containing 2,TRUE
1231_FAM49B_51571,Q9NUQ9,protein fam49b (l1),FAM49B BM-009,324,NA,subcellular location: membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,FAM49B,51571,Hs.126941,ENST00000519540,THC2486440,NA,"Homo sapiens family with sequence similarity 49, member B (FAM49B), mRNA [NM_016623]",chr8:130853853-130853794,hs|8q24.21,"family with sequence similarity 49, member B",TRUE
1232_TOR3A_64222,Q9H497,torsin-3a (atp-dependent interferon-responsive protein) (torsin family 3 member a),TOR3A ADIR,397,NA,subcellular location: cytoplasm. endoplasmic reticulum lumen.,"TISSUE SPECIFICITY: Ubiquitously expressed. Highest expression in stomach, salivary glands and lymph nodes. Isoform 2 is expressed in placenta. {ECO:0000269|PubMed:11863361}.",NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,TOR3A,64222,Hs.584957,ENST00000367627,THC2466771,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0051085(chaperone mediated protein folding requiring cofactor),"Homo sapiens torsin family 3, member A (TOR3A), mRNA [NM_022371]",chr1:179064971-179065030,hs|1q25.2,"torsin family 3, member A",TRUE
1233_SUB1_10923,P53999,activated rna polymerase ii transcriptional coactivator p15 (positive cofactor 4) (pc4) (sub1 homolog) (p14),SUB1 PC4 RPO2TC1,127,"function: general coactivator that functions cooperatively with tafs and mediates functional interactions between upstream activators and the general transcriptional machinery. may be involved in stabilizing the multiprotein transcription complex. binds single-stranded dna. also binds, in vitro, non-specifically to double-stranded dna (ds dna). {eco:0000269|pubmed:16605275, eco:0000269|pubmed:16689930, eco:0000269|pubmed:7628453, eco:0000269|pubmed:8062391, eco:0000269|pubmed:8062392, eco:0000269|pubmed:9360603, eco:0000269|pubmed:9482861}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SUB1,10923,Hs.229641,ENST00000513013,THC2553325,GO:0003677(DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0005730(nucleolus)|GO:0006357(regulation of transcription from RNA polymerase II promoter),"Homo sapiens SUB1 homolog (S. cerevisiae) (SUB1), mRNA [NM_006713]",chr5:32599165-32601159,hs|5p13.3,SUB1 homolog (S. cerevisiae),TRUE
1235_VAMP8_8673,Q9BV40,vesicle-associated membrane protein 8 (vamp-8) (endobrevin) (edb),VAMP8,100,"function: snares, soluble n-ethylmaleimide-sensitive factor-attachment protein receptors, are essential proteins for fusion of cellular membranes. snares localized on opposing membranes assemble to form a trans-snare complex, an extended, parallel four alpha-helical bundle that drives membrane fusion. vamp8 is a snare involved in autophagy through the direct control of autophagosome membrane fusion with the lysososome membrane via its interaction with the stx17-snap29 binary t-snare complex (pubmed:23217709, pubmed:25686604). also required for dense-granule secretion in platelets (pubmed:12130530). plays also a role in regulated enzyme secretion in pancreatic acinar cells (by similarity). involved in the abscission of the midbody during cell division, which leads to completely separate daughter cells (by similarity). involved in the homotypic fusion of early and late endosomes (by similarity). {eco:0000250|uniprotkb:q9wuf4, eco:0000269|pubmed:12130530, eco:0000269|pubmed:23217709, eco:0000269|pubmed:25686604}.","subcellular location: lysosome membrane {eco:0000269|pubmed:25686604}; single-pass type iv membrane protein {eco:0000305}. early endosome membrane {eco:0000269|pubmed:25648148, eco:0000269|pubmed:9614193}; single-pass type iv membrane protein {eco:0000305}. late endosome membrane {eco:0000269|pubmed:25648148}; single-pass type iv membrane protein {eco:0000305}. cell membrane {eco:0000250|uniprotkb:o70404}; single-pass type iv membrane protein {eco:0000305}. note=perinuclear vesicular structures of the early and late endosomes, coated pits, and trans-golgi (by similarity). sub-tight junctional domain in retinal pigment epithelium cells. midbody region during cytokinesis. lumenal oriented, apical membranes of nephric tubular cell (by similarity). cycles through the apical but not through the basolateral plasma membrane (by similarity). apical region of acinar cells; in zymogen granule membranes (by similarity). {eco:0000250|uniprotkb:q9wuf4}.",TISSUE SPECIFICITY: Platelets. {ECO:0000269|PubMed:12130530}.,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VAMP8,8673,Hs.714302,ENST00000263864,THC2467134,GO:0005624(membrane fraction)|GO:0005739(mitochondrion)|GO:0005765(lysosomal membrane)|GO:0005769(early endosome)|GO:0005886(plasma membrane)|GO:0006461(protein complex assembly)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006906(vesicle fusion)|GO:0016021(integral to membrane)|GO:0016044(cellular membrane organization)|GO:0019905(syntaxin binding)|GO:0030667(secretory granule membrane)|GO:0031201(SNARE complex)|GO:0031902(late endosome membrane)|GO:0055037(recycling endosome),"Homo sapiens vesicle-associated membrane protein 8 (endobrevin) (VAMP8), mRNA [NM_003761]",chr2:85809032-85809091,hs|2p11.2,vesicle-associated membrane protein 8 (endobrevin),TRUE
1236_KLHDC10_23008,Q6PID8,kelch domain-containing protein 10,KLHDC10 KIAA0265,442,function: participates in the oxidative stress-induced cell death through map3k5 activation. inhibits ppp5c phosphatase activity on map3k5. {eco:0000269|pubmed:23102700}.,subcellular location: nucleus {eco:0000269|pubmed:23102700}. cytoplasm {eco:0000269|pubmed:23102700}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KLHDC10,23008,Hs.520710,NA,THC2480535,NA,"Homo sapiens kelch domain containing 10 (KLHDC10), mRNA [NM_014997]",chr7:129775441-129775500,hs|7q32.2,kelch domain containing 10,TRUE
1238_IFITM1_8519,P13164,interferon-induced transmembrane protein 1 (dispanin subfamily a member 2a) (dspa2a) (interferon-induced protein 17) (interferon-inducible protein 9-27) (leu-13 antigen) (cd antigen cd225),IFITM1 CD225 IFI17,125,"function: ifn-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. active against multiple viruses, including influenza a virus, sars coronavirus (sars-cov), marburg virus (marv), ebola virus (ebov), dengue virus (dnv), west nile virus (wnv), human immunodeficiency virus type 1 (hiv-1) and hepatitis c virus (hcv). can inhibit: influenza virus hemagglutinin protein-mediated viral entry, marv and ebov gp1,2-mediated viral entry and sars-cov s protein-mediated viral entry. also implicated in cell adhesion and control of cell growth and migration. plays a key role in the antiproliferative action of ifn-gamma either by inhibiting the erk activation or by arresting cell growth in g1 phase in a p53-dependent manner. acts as a positive regulator of osteoblast differentiation. {eco:0000269|pubmed:16847454, eco:0000269|pubmed:20064371, eco:0000269|pubmed:20838853, eco:0000269|pubmed:21177806, eco:0000269|pubmed:21253575, eco:0000269|pubmed:21976647, eco:0000269|pubmed:22479637, eco:0000269|pubmed:22634173}.","subcellular location: cell membrane {eco:0000269|pubmed:1383329, eco:0000269|pubmed:19499152, eco:0000269|pubmed:25105503}; single-pass membrane protein {eco:0000269|pubmed:19499152}.","TISSUE SPECIFICITY: Bone (at protein level). Levels greatly elevated in colon cancer, cervical cancer, esophageal cancer and ovarian cancer. Expressed in glioma cell lines. {ECO:0000269|PubMed:20838853, ECO:0000269|PubMed:22634173}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,IFITM1,8519,Hs.458414,ENST00000452428,THC2468840,GO:0005057(receptor signaling protein activity)|GO:0005886(plasma membrane)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0008285(negative regulation of cell proliferation)|GO:0009607(response to biotic stimulus)|GO:0009615(response to virus)|GO:0016021(integral to membrane)|GO:0019221(cytokine-mediated signaling pathway)|GO:0045087(innate immune response)|GO:0050776(regulation of immune response)|GO:0060337(type I interferon-mediated signaling pathway),"Homo sapiens interferon induced transmembrane protein 1 (9-27) (IFITM1), mRNA [NM_003641]",chr11:315209-315268,hs|11p15.5,interferon induced transmembrane protein 1 (9-27),TRUE
124_SHFM1_7979,P60896,26s proteasome complex subunit sem1 (26s proteasome complex subunit dss1) (deleted in split hand/split foot protein 1) (split hand/foot deleted protein 1) (split hand/foot malformation type 1 protein),SEM1 C7orf76 DSS1 SHFDG1 SHFM1,70,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair (pubmed:15117943). component of the trex-2 complex (transcription and export complex 2), composed of at least eny2, ganp, pcid2, sem1, and either centrin cetn2 or cetn3 (pubmed:22307388). the trex-2 complex functions in docking export-competent ribonucleoprotein particles (mrnps) to the nuclear entrance of the nuclear pore complex (nuclear basket). trex-2 participates in mrna export and accurate chromatin positioning in the nucleus by tethering genes to the nuclear periphery. binds and stabilizes brca2 and is thus involved in the control of r-loop-associated dna damage and thus transcription-associated genomic instability. r-loop accumulation increases in sem1-depleted cells. {eco:0000269|pubmed:1317798, eco:0000269|pubmed:15117943, eco:0000269|pubmed:22307388, eco:0000269|pubmed:24896180}.",NA,"TISSUE SPECIFICITY: Expressed in limb bud, craniofacial primordia and skin.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,SHFM1,7979,Hs.489201,ENST00000482389,THC2468775,GO:0000502(proteasome complex)|GO:0000724(double-strand break repair via homologous recombination)|GO:0005515(protein binding)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0032039(integrator complex),"Homo sapiens split hand/foot malformation (ectrodactyly) type 1 (SHFM1), mRNA [NM_006304]",chr7:96318218-96318159,hs|7q21.3,split hand/foot malformation (ectrodactyly) type 1,TRUE
1240_NOP10_55505,Q9NPE3,h/aca ribonucleoprotein complex subunit 3 (nucleolar protein 10) (nucleolar protein family a member 3) (snornp protein nop10),NOP10 NOLA3,64,"function: required for ribosome biogenesis and telomere maintenance. part of the h/aca small nucleolar ribonucleoprotein (h/aca snornp) complex, which catalyzes pseudouridylation of rrna. this involves the isomerization of uridine such that the ribose is subsequently attached to c5, instead of the normal n1. each rrna can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rrnas. may also be required for correct processing or intranuclear trafficking of terc, the rna component of the telomerase reverse transcriptase (tert) holoenzyme. {eco:0000269|pubmed:15044956}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:11074001}. nucleus, cajal body {eco:0000269|pubmed:11074001}. note=also localized to cajal bodies (coiled bodies).",NA,"DISEASE: Dyskeratosis congenita, autosomal recessive, 1 (DKCB1) [MIM:224230]: A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. {ECO:0000269|PubMed:17507419}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NOP10,55505,Hs.14317,ENST00000328848,THC2541321,GO:0001522(pseudouridine synthesis)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005732(small nucleolar ribonucleoprotein complex)|GO:0006364(rRNA processing)|GO:0015030(Cajal body),"Homo sapiens NOP10 ribonucleoprotein homolog (yeast) (NOP10), mRNA [NM_018648]",chr15:34634079-34634020,hs|15q14,NOP10 ribonucleoprotein homolog (yeast),TRUE
1241_C21orf33_8209,P0DPI2,"glutamine amidotransferase-like class 1 domain-containing protein 3a, mitochondrial",GATD3A C21orf33,268,NA,subcellular location: mitochondrion {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,C21orf33,8209,Hs.413482,ENST00000291577,THC2467935,GO:0005739(mitochondrion),"Homo sapiens chromosome 21 open reading frame 33 (C21orf33), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004649]",chr21:45565392-45565451,hs|21q22.3,chromosome 21 open reading frame 33,TRUE
1242_THOC2_57187,Q8NI27,tho complex subunit 2 (tho2) (htrex120),THOC2 CXorf3,1593,"function: required for efficient export of polyadenylated rna and spliced mrna. acts as component of the tho subcomplex of the trex complex which is thought to couple mrna transcription, processing and nuclear export, and which specifically associates with spliced mrna and not with unspliced pre-mrna. trex is recruited to spliced mrnas by a transcription-independent mechanism, binds to mrna upstream of the exon-junction complex (ejc) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mrna where it functions in mrna export to the cytoplasm via the tap/nfx1 pathway. the trex complex is essential for the export of kaposi's sarcoma-associated herpesvirus (kshv) intronless mrnas and infectious virus production. thoc2 (and probably the tho complex) is involved in releasing mrna from nuclear speckle domains. required for nxf1 localization to the nuclear rim. plays a role for proper neuronal development. {eco:0000269|pubmed:11979277, eco:0000269|pubmed:15833825, eco:0000269|pubmed:15998806, eco:0000269|pubmed:17190602, eco:0000269|pubmed:18974867, eco:0000269|pubmed:22893130, eco:0000269|pubmed:23222130, eco:0000269|pubmed:26166480}.",subcellular location: nucleus {eco:0000305}. nucleus speckle {eco:0000305}.,TISSUE SPECIFICITY: Expressed in the hippocampus and the cerebral cortex. {ECO:0000269|PubMed:26166480}.,"DISEASE: Mental retardation, X-linked 12 (MRX12) [MIM:300957]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX12 patients manifest variable degrees of intellectual disability. Commonly observed features included speech delay, elevated BMI, short stature, seizure disorders, gait disturbance, and tremors. {ECO:0000269|PubMed:26166480}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,THOC2,57187,Hs.149991,ENST00000245838,THC2497040,GO:0000346(transcription export complex)|GO:0000347(THO complex)|GO:0000445(THO complex part of transcription export complex)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0046784(intronless viral mRNA export from host nucleus),"Homo sapiens THO complex 2 (THOC2), mRNA [NM_001081550]",chrX:122734545-122734486,hs|Xq25,THO complex 2,TRUE
1243_DUSP16_80824,Q9BY84,dual specificity protein phosphatase 16 (ec 3.1.3.16) (ec 3.1.3.48) (mitogen-activated protein kinase phosphatase 7) (map kinase phosphatase 7) (mkp-7),DUSP16 KIAA1700 MKP7,665,"function: dual specificity protein phosphatase involved in the inactivation of map kinases. dephosphorylates mapk10 bound to arrb2. {eco:0000269|pubmed:11489891, eco:0000269|pubmed:15888437}.","subcellular location: cytoplasm. nucleus. cytoplasmic vesicle. note=after dissociation upon agtr stimulation, re-associates with arrb2 on endocytic vesicles.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DUSP16,80824,Hs.536535,NA,THC2723676,"GO:0000188(inactivation of MAPK activity)|GO:0004721(phosphoprotein phosphatase activity)|GO:0004725(protein tyrosine phosphatase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006470(protein dephosphorylation)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016311(dephosphorylation)|GO:0016787(hydrolase activity)|GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity)|GO:0045204(MAPK export from nucleus)|GO:0045209(MAPK phosphatase export from nucleus, leptomycin B sensitive)","Homo sapiens dual specificity phosphatase 16 (DUSP16), mRNA [NM_030640]",chr12:12627305-12627246,hs|12p13.2,dual specificity phosphatase 16,TRUE
1244_ETFB_2109,P38117,electron transfer flavoprotein subunit beta (beta-etf),ETFB FP585,255,"function: heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-coa dehydrogenases, glutaryl-coa and sarcosine dehydrogenase (pubmed:25416781, pubmed:15159392, pubmed:15975918). it transfers the electrons to the main mitochondrial respiratory chain via etf-ubiquinone oxidoreductase (probable). required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (pubmed:12815589, pubmed:7912128). etfb binds an amp molecule that probably has a purely structural role (pubmed:8962055, pubmed:15159392, pubmed:15975918). {eco:0000269|pubmed:12815589, eco:0000269|pubmed:15159392, eco:0000269|pubmed:15975918, eco:0000269|pubmed:25416781, eco:0000269|pubmed:7912128, eco:0000269|pubmed:8962055, eco:0000303|pubmed:17941859, eco:0000305}.","subcellular location: mitochondrion matrix {eco:0000305|pubmed:25023281, eco:0000305|pubmed:8504797}.","TISSUE SPECIFICITY: Abundant in liver, heart and skeletal muscle. A weak expression is seen in the brain, placenta, lung, kidney and pancreas. {ECO:0000269|PubMed:8504797}.","DISEASE: Glutaric aciduria 2B (GA2B) [MIM:231680]: An autosomal recessively inherited disorder of fatty acid, amino acid, and choline metabolism. It is characterized by multiple acyl-CoA dehydrogenase deficiencies resulting in large excretion not only of glutaric acid, but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids. {ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:7912128}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ETFB,2109,Hs.348531,ENST00000354232,NP1165274,GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006810(transport)|GO:0009055(electron carrier activity)|GO:0022904(respiratory electron transport chain)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens electron-transfer-flavoprotein, beta polypeptide (ETFB), transcript variant 2, mRNA [NM_001014763]",chr19:51848634-51848575,hs|19q13.41,"electron-transfer-flavoprotein, beta polypeptide",TRUE
1245_MCTS1_28985,Q9ULC4,malignant t-cell-amplified sequence 1 (mct-1) (multiple copies t-cell malignancies),MCTS1 MCT1,181,"function: anti-oncogene that plays a role in cell cycle regulation; decreases cell doubling time and anchorage-dependent growth; shortens the duration of g1 transit time and g1/s transition. when constitutively expressed, increases cdk4 and cdk6 kinases activity and ccnd1/cyclin d1 protein level, as well as g1 cyclin/cdk complex formation. involved in translation initiation; promotes recruitment of aminoacetyled initiator trna to p site of 40s ribosomes. can promote release of deacylated trna and mrna from recycled 40s subunits following abce1-mediated dissociation of post-termination ribosomal complexes into subunits. plays a role as translation enhancer; recruits the density-regulated protein/denr and binds to the cap complex of the 5'-terminus of mrnas, subsequently altering the mrna translation profile; up-regulates protein levels of bcl2l2, tfdp1, mre11, ccnd1 and e2f1, while mrna levels remains constant. hyperactivates dna damage signaling pathway; increased gamma-irradiation-induced phosphorylation of histone h2ax, and induces damage foci formation. increases the overall number of chromosomal abnormalities such as larger chromosomes formation and multiples chromosomal fusions when overexpressed in gamma-irradiated cells. may play a role in promoting lymphoid tumor development: lymphoid cell lines overexpressing mcts1 exhibit increased growth rates and display increased protection against apoptosis. may contribute to the pathogenesis and progression of breast cancer via promotion of angiogenesis through the decline of inhibitory thbs1/thrombospondin-1, and inhibition of apoptosis. involved in the process of proteasome degradation to down-regulate tumor suppressor p53/tp53 in breast cancer cell; positively regulates phosphorylation of mapk1 and mapk3. involved in translation initiation; promotes aminoacetyled initiator trna to p site of 40s ribosomes. can promote release of deacylated trna and mrna from recycled 40s subunits following abce1-mediated dissociation of post-termination ribosomal complexes into subunits. {eco:0000269|pubmed:10440924, eco:0000269|pubmed:11709712, eco:0000269|pubmed:12637315, eco:0000269|pubmed:15897892, eco:0000269|pubmed:16322206, eco:0000269|pubmed:16982740, eco:0000269|pubmed:17016429, eco:0000269|pubmed:17416211, eco:0000269|pubmed:20713520, eco:0000269|pubmed:9766643}.","subcellular location: cytoplasm {eco:0000269|pubmed:11709712, eco:0000269|pubmed:16982740}. note=nuclear relocalization after dna damage.",TISSUE SPECIFICITY: Ubiquitous. Over-expressed in T-cell lymphoid cell lines and in non-Hodgkin lymphoma cell lines as well as in a subset of primary large B-cell lymphomas. {ECO:0000269|PubMed:9766643}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MCTS1,28985,Hs.102696,ENST00000371315,THC2488599,"GO:0003723(RNA binding)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006974(response to DNA damage stimulus)|GO:0007049(cell cycle)|GO:0008284(positive regulation of cell proliferation)|GO:0040008(regulation of growth)","Homo sapiens malignant T cell amplified sequence 1 (MCTS1), transcript variant 1, mRNA [NM_014060]",chrX:119746090-119746149,hs|Xq24,malignant T cell amplified sequence 1,TRUE
1246_TAF1C_9013,Q15572,tata box-binding protein-associated factor rna polymerase i subunit c (rna polymerase i-specific tbp-associated factor 110 kda) (tafi110) (tata box-binding protein-associated factor 1c) (tbp-associated factor 1c) (transcription initiation factor sl1/tif-ib subunit c),TAF1C,869,"function: component of the transcription factor sl1/tif-ib complex, which is involved in the assembly of the pic (preinitiation complex) during rna polymerase i-dependent transcription. the rate of pic formation probably is primarily dependent on the rate of association of sl1/tif-ib with the rdna promoter. sl1/tif-ib is involved in stabilization of nucleolar transcription factor 1/ubtf on rdna. formation of sl1/tif-ib excludes the association of tbp with tfiid subunits. recruits rna polymerase i to the rrna gene promoter via interaction with rrn3. {eco:0000269|pubmed:11250903, eco:0000269|pubmed:15970593}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TAF1C,9013,Hs.153022,ENST00000378541,THC2494847,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006360(transcription from RNA polymerase I promoter)|GO:0006361(transcription initiation from RNA polymerase I promoter)|GO:0006362(transcription elongation from RNA polymerase I promoter)|GO:0006363(termination of RNA polymerase I transcription)|GO:0006366(transcription from RNA polymerase II promoter)","Homo sapiens TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa (TAF1C), transcript variant 1, mRNA [NM_005679]",chr16:84211547-84211488,hs|16q24.1,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa",TRUE
1247_CRYL1_51084,Q9Y2S2,lambda-crystallin homolog (ec 1.1.1.45) (l-gulonate 3-dehydrogenase) (gul3dh),CRYL1 CRY,319,NA,subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Widely expressed, with highest levels in liver and kidney. {ECO:0000269|PubMed:12527201}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,CRYL1,51084,Hs.370703,ENST00000298248,THC2466931,GO:0000166(nucleotide binding)|GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006631(fatty acid metabolic process)|GO:0016491(oxidoreductase activity)|GO:0042803(protein homodimerization activity)|GO:0050104(L-gulonate 3-dehydrogenase activity)|GO:0050662(coenzyme binding)|GO:0070403(NAD+ binding),"Homo sapiens crystallin, lambda 1 (CRYL1), mRNA [NM_015974]",chr13:20977891-20977832,hs|13q12.11,"crystallin, lambda 1",TRUE
1248_DHTKD1_55526,Q96HY7,"probable 2-oxoglutarate dehydrogenase e1 component dhktd1, mitochondrial (ec 1.2.4.2) (dehydrogenase e1 and transketolase domain-containing protein 1)",DHTKD1 KIAA1630,919,"function: the 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-coa and co(2). it contains multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (e1), dihydrolipoamide succinyltransferase (e2) and lipoamide dehydrogenase (e3) (by similarity). {eco:0000250}.",subcellular location: mitochondrion {eco:0000269|pubmed:23141294}.,NA,"DISEASE: Charcot-Marie-Tooth disease 2Q (CMT2Q) [MIM:615025]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:23141294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 2-aminoadipic 2-oxoadipic aciduria (AMOXAD) [MIM:204750]: A metabolic disorder characterized by increased levels of 2-oxoadipate and 2-hydroxyadipate in the urine, and elevated 2-aminoadipate in the plasma. Patients can have mild to severe intellectual disability, muscular hypotonia, developmental delay, ataxia, and epilepsy. Most cases are asymptomatic. {ECO:0000269|PubMed:23141293}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DHTKD1,55526,Hs.104980,ENST00000263035,NA,GO:0004591(oxoglutarate dehydrogenase (succinyl-transferring) activity)|GO:0005739(mitochondrion)|GO:0006096(glycolysis)|GO:0006099(tricarboxylic acid cycle)|GO:0016491(oxidoreductase activity)|GO:0030976(thiamine pyrophosphate binding),"Homo sapiens dehydrogenase E1 and transketolase domain containing 1 (DHTKD1), nuclear gene encoding mitochondrial protein, mRNA [NM_018706]",chr10:12165028-12165087,hs|10p14,dehydrogenase E1 and transketolase domain containing 1,TRUE
1249_ALDH1A3_220,P47895,aldehyde dehydrogenase family 1 member a3 (ec 1.2.1.36) (aldehyde dehydrogenase 6) (retinaldehyde dehydrogenase 3) (raldh-3) (raldh3),ALDH1A3 ALDH6,512,"function: nad-dependent aldehyde dehydrogenase that catalyzes the formation of retinoic acid (pubmed:27759097). has high activity with all-trans retinal, and has much lower in vitro activity with acetaldehyde (pubmed:27759097). required for the biosynthesis of normal levels of retinoic acid in the embryonic ocular and nasal regions; retinoic acid is required for normal embryonic development of the eye and the nasal region (by similarity). {eco:0000250|uniprotkb:q9jhw9, eco:0000269|pubmed:27759097}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:q9jhw9}.,"TISSUE SPECIFICITY: Expressed at low levels in many tissues and at higher levels in salivary gland, stomach, and kidney. {ECO:0000269|PubMed:7698756}.","DISEASE: Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]: A disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues. Ocular abnormalities like opacities of the cornea and lens, scaring of the retina and choroid, and other abnormalities may also be present. {ECO:0000269|PubMed:23312594, ECO:0000269|PubMed:23591992, ECO:0000269|PubMed:23646827, ECO:0000269|PubMed:23881059, ECO:0000269|PubMed:24024553, ECO:0000269|PubMed:24568872, ECO:0000269|PubMed:24777706}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ALDH1A3,220,Hs.459538,ENST00000346623,NP1072657,GO:0001822(kidney development)|GO:0002072(optic cup morphogenesis involved in camera-type eye development)|GO:0002138(retinoic acid biosynthetic process)|GO:0004029(aldehyde dehydrogenase (NAD) activity)|GO:0004030(aldehyde dehydrogenase [NAD(P)+] activity)|GO:0005737(cytoplasm)|GO:0016491(oxidoreductase activity)|GO:0021768(nucleus accumbens development)|GO:0021983(pituitary gland development)|GO:0031076(embryonic camera-type eye development)|GO:0042493(response to drug)|GO:0042573(retinoic acid metabolic process)|GO:0042574(retinal metabolic process)|GO:0042803(protein homodimerization activity)|GO:0043065(positive regulation of apoptosis)|GO:0048048(embryonic eye morphogenesis)|GO:0060166(olfactory pit development)|GO:0060324(face development)|GO:0070324(thyroid hormone binding)|GO:0070403(NAD+ binding),"Homo sapiens aldehyde dehydrogenase 1 family, member A3 (ALDH1A3), mRNA [NM_000693]",chr15:101456503-101456562,hs|15q26.3,"aldehyde dehydrogenase 1 family, member A3",TRUE
125_RPS27A_6233,P62979,ubiquitin-40s ribosomal protein s27a (ubiquitin carboxyl extension protein 80) [cleaved into: ubiquitin; 40s ribosomal protein s27a (small ribosomal subunit protein es31)],RPS27A UBA80 UBCEP1,156,"function: ubiquitin: exists either covalently attached to another protein, or free (unanchored). when covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator met of the ubiquitin (linear polyubiquitin chains). polyubiquitin chains, when attached to a target protein, have different functions depending on the lys residue of the ubiquitin that is linked: lys-6-linked may be involved in dna repair; lys-11-linked is involved in erad (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; lys-29-linked is involved in lysosomal degradation; lys-33-linked is involved in kinase modification; lys-48-linked is involved in protein degradation via the proteasome; lys-63-linked is involved in endocytosis, dna-damage responses as well as in signaling processes leading to activation of the transcription factor nf-kappa-b. linear polymer chains formed via attachment by the initiator met lead to cell signaling. ubiquitin is usually conjugated to lys residues of target proteins, however, in rare cases, conjugation to cys or ser residues has been observed. when polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling.; function: 40s ribosomal protein s27a: component of the 40s subunit of the ribosome.",subcellular location: ubiquitin: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,RPS27A,6233,Hs.546292,ENST00000402285,THC2563545,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000187(activation of MAPK activity)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0003735(structural constituent of ribosome)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006281(DNA repair)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007254(JNK cascade)|GO:0008063(Toll signaling pathway)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0010008(endosome membrane)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016044(cellular membrane organization)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016197(endosome transport)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030666(endocytic vesicle membrane)|GO:0031018(endocrine pancreas development)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0032480(negative regulation of type I interferon production)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042981(regulation of apoptosis)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0044267(cellular protein metabolic process)|GO:0045087(innate immune response)|GO:0046872(metal ion binding)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051403(stress-activated MAPK cascade)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)","Homo sapiens ribosomal protein S27a (RPS27A), transcript variant 1, mRNA [NM_002954]",chr2:55462079-55462603,hs|2p16.1,ribosomal protein S27a,TRUE
1250_MRPS35_60488,P82673,"28s ribosomal protein s35, mitochondrial (mrp-s35) (s35mt) (28s ribosomal protein s28, mitochondrial) (mrp-s28) (s28mt) (mitochondrial small ribosomal subunit protein ms35)",MRPS35 MRPS28 HDCMD11P MDS023 PSEC0213,323,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS35,60488,Hs.311072,ENST00000321446,THC2467968,"GO:0005739(mitochondrion)|GO:0005763(mitochondrial small ribosomal subunit)|GO:0005840(ribosome)|GO:0042769(DNA damage response, detection of DNA damage)|GO:0043043(peptide biosynthetic process)","Homo sapiens mitochondrial ribosomal protein S35 (MRPS35), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_021821]",chr12:27909106-27909165,hs|12p11.22,mitochondrial ribosomal protein S35,TRUE
1251_SNX12_29934,Q9UMY4,sorting nexin-12,SNX12,162,function: may be involved in several stages of intracellular trafficking. {eco:0000250}.,subcellular location: membrane {eco:0000305}; peripheral membrane protein {eco:0000305}; cytoplasmic side {eco:0000305}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SNX12,29934,Hs.260750,ENST00000374274,THC2511464,GO:0005515(protein binding)|GO:0007154(cell communication)|GO:0008289(lipid binding)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0035091(phosphatidylinositol binding),sorting nexin 12 [Source:HGNC Symbol;Acc:14976] [ENST00000374274],chrX:70279221-70279162,hs|Xq13.1,sorting nexin 12,TRUE
1252_SMG1_23049,Q96Q15,serine/threonine-protein kinase smg1 (smg-1) (hsmg-1) (ec 2.7.11.1) (61e3.4) (lambda/iota protein kinase c-interacting protein) (lambda-interacting protein),SMG1 ATX KIAA0421 LIP,3661,"function: serine/threonine protein kinase involved in both mrna surveillance and genotoxic stress response pathways. recognizes the substrate consensus sequence [st]-q. plays a central role in nonsense-mediated decay (nmd) of mrnas containing premature stop codons by phosphorylating upf1/rent1. recruited by release factors to stalled ribosomes together with smg8 and smg9 (forming the smg1c protein kinase complex), and upf1 to form the transient surf (smg1-upf1-erf1-erf3) complex. in ejc-dependent nmd, the surf complex associates with the exon junction complex (ejc) through upf2 and allows the formation of an upf1-upf2-upf3 surveillance complex which is believed to activate nmd. also acts as a genotoxic stress-activated protein kinase that displays some functional overlap with atm. can phosphorylate p53/tp53 and is required for optimal p53/tp53 activation after cellular exposure to genotoxic stress. its depletion leads to spontaneous dna damage and increased sensitivity to ionizing radiation (ir). may activate prkci but not prkcz. {eco:0000269|pubmed:11331269, eco:0000269|pubmed:11544179, eco:0000269|pubmed:15175154, eco:0000269|pubmed:16452507}.",subcellular location: nucleus {eco:0000269|pubmed:15175154}. cytoplasm {eco:0000269|pubmed:15175154}.,"TISSUE SPECIFICITY: Widely expressed, with highest level in heart and skeletal muscle. Expressed in placenta, brain, lung and spleen, but not in liver. {ECO:0000269|PubMed:15175154, ECO:0000269|PubMed:8524286}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SMG1,23049,Hs.460179,ENST00000378955,THC2498432,"GO:0000166(nucleotide binding)|GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006281(DNA repair)|GO:0006406(mRNA export from nucleus)|GO:0006950(response to stress)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0018105(peptidyl-serine phosphorylation)|GO:0046777(protein autophosphorylation)|GO:0046854(phosphatidylinositol phosphorylation)|GO:0046872(metal ion binding)","Homo sapiens smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) (SMG1), mRNA [NM_015092]",chr16:18872071-18872012,hs|16p12.3,"smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)",TRUE
1253_ANKRD11_29123,Q6UB99,ankyrin repeat domain-containing protein 11 (ankyrin repeat-containing cofactor 1),ANKRD11 ANCO1,2663,"function: chromatin regulator which modulates histone acetylation and gene expression in neural precursor cells (by similarity). may recruit histone deacetylases (hdacs) to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation (pubmed:15184363). has a role in proliferation and development of cortical neural precursors (pubmed:25556659). may also regulate bone homeostasis (by similarity). {eco:0000250|uniprotkb:e9q4f7, eco:0000269|pubmed:15184363, eco:0000269|pubmed:25556659}.","subcellular location: nucleus {eco:0000269|pubmed:15184363, eco:0000269|pubmed:25413698, eco:0000269|pubmed:25556659, eco:0000269|ref.1}. note=localizes to chromatin during prometaphase. {eco:0000269|pubmed:25413698}.",NA,"DISEASE: KBG syndrome (KBGS) [MIM:148050]: A syndrome characterized by macrodontia of the upper central incisors, distinctive craniofacial findings, short stature, skeletal anomalies, and neurologic involvement that includes global developmental delay, seizures, and intellectual disability. {ECO:0000269|PubMed:21782149, ECO:0000269|PubMed:25413698}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ANKRD11,29123,Hs.335003,ENST00000330736,THC2512843,GO:0001701(in utero embryonic development)|GO:0001894(tissue homeostasis)|GO:0005634(nucleus)|GO:0035264(multicellular organism growth)|GO:0048705(skeletal system morphogenesis)|GO:0060323(head morphogenesis)|GO:0060348(bone development),"Homo sapiens ankyrin repeat domain 11 (ANKRD11), mRNA [NM_013275]",chr16:89349843-89349784,hs|16q24.3,ankyrin repeat domain 11,TRUE
1254_C19orf50_79036,Q9BQD3,kxdl motif-containing protein 1,KXD1 C19orf50,176,"function: as part of the borc complex may play a role in lysosomes movement and localization at the cell periphery. associated with the cytosolic face of lysosomes, the borc complex may recruit arl8b and couple lysosomes to microtubule plus-end-directed kinesin motor (pubmed:25898167). may be involved in the biogenesis of lysosome-related organelles such as melanosomes (by similarity). {eco:0000250|uniprotkb:q80xh1, eco:0000269|pubmed:25898167}.",subcellular location: lysosome membrane {eco:0000305|pubmed:25898167}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C19orf50,79036,Hs.369785,ENST00000540691,THC2506326,GO:0005515(protein binding),"Homo sapiens chromosome 19 open reading frame 50 (C19orf50), transcript variant 2, mRNA [NM_024069]",chr19:18680075-18680134,hs|19p13.11,chromosome 19 open reading frame 50,TRUE
1255_SUPT4H1_6827,P63272,transcription elongation factor spt4 (hspt4) (drb sensitivity-inducing factor 14 kda subunit) (dsif p14) (drb sensitivity-inducing factor small subunit) (dsif small subunit),SUPT4H1 SPT4H SUPT4H,117,"function: component of the drb sensitivity-inducing factor complex (dsif complex), which regulates mrna processing and transcription elongation by rna polymerase ii. dsif positively regulates mrna capping by stimulating the mrna guanylyltransferase activity of rngtt/cap1a. dsif also acts cooperatively with the negative elongation factor complex (nelf complex) to enhance transcriptional pausing at sites proximal to the promoter. transcriptional pausing may facilitate the assembly of an elongation competent rna polymerase ii complex. dsif and nelf promote pausing by inhibition of the transcription elongation factor tfiis/s-ii. tfiis/s-ii binds to rna polymerase ii at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme. cleavage of blocked transcripts by rna polymerase ii promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites. dsif can also positively regulate transcriptional elongation and is required for the efficient activation of transcriptional elongation by the hiv-1 nuclear transcriptional activator, tat. dsif acts to suppress transcriptional pausing in transcripts derived from the hiv-1 ltr and blocks premature release of hiv-1 transcripts at terminator sequences. {eco:0000269|pubmed:10075709, eco:0000269|pubmed:10199401, eco:0000269|pubmed:10454543, eco:0000269|pubmed:10912001, eco:0000269|pubmed:11112772, eco:0000269|pubmed:11553615, eco:0000269|pubmed:12653964, eco:0000269|pubmed:12718890, eco:0000269|pubmed:15136722, eco:0000269|pubmed:15380072, eco:0000269|pubmed:16214896, eco:0000269|pubmed:9450929, eco:0000269|pubmed:9857195}.",subcellular location: nucleus {eco:0000269|pubmed:8649394}.,"TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8649394, ECO:0000269|PubMed:8786137}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SUPT4H1,6827,Hs.439481,ENST00000225504,THC2504662,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006338(chromatin remodeling)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0008270(zinc ion binding)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0032785(negative regulation of transcription elongation, DNA-dependent)|GO:0032786(positive regulation of transcription elongation, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding)|GO:0046982(protein heterodimerization activity)|GO:0050434(positive regulation of viral transcription)","Homo sapiens suppressor of Ty 4 homolog 1 (S. cerevisiae) (SUPT4H1), mRNA [NM_003168]",chr17:56423349-56423290,hs|17q22,suppressor of Ty 4 homolog 1 (S. cerevisiae),TRUE
1256_C19orf28_126321,Q6NUT3,major facilitator superfamily domain-containing protein 12,MFSD12 C19orf28,480,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C19orf28,126321,Hs.656901,ENST00000398558,THC2525022,GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0055085(transmembrane transport),"Homo sapiens chromosome 19 open reading frame 28 (C19orf28), transcript variant 1, mRNA [NM_021731]",chr19:3538383-3538324,hs|19p13.3,chromosome 19 open reading frame 28,TRUE
1257_PMVK_10654,Q15126,phosphomevalonate kinase (pmkase) (hpmk) (ec 2.7.4.2),PMVK PMKI,192,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:10191291, eco:0000269|pubmed:27052676}.","TISSUE SPECIFICITY: Heart, liver, skeletal muscle, kidney, and pancreas. Lower level in brain, placenta and lung. {ECO:0000269|PubMed:8663599}.","DISEASE: Porokeratosis 1, multiple types (POROK1) [MIM:175800]: A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported. {ECO:0000269|PubMed:26202976, ECO:0000269|PubMed:27052676}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PMVK,10654,Hs.30954,ENST00000368467,THC2512583,"GO:0000166(nucleotide binding)|GO:0004631(phosphomevalonate kinase activity)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005777(peroxisome)|GO:0005829(cytosol)|GO:0006468(protein phosphorylation)|GO:0006629(lipid metabolic process)|GO:0006695(cholesterol biosynthetic process)|GO:0008299(isoprenoid biosynthetic process)|GO:0016740(transferase activity)|GO:0019287(isopentenyl diphosphate biosynthetic process, mevalonate pathway)","Homo sapiens phosphomevalonate kinase (PMVK), mRNA [NM_006556]",chr1:154897457-154897398,hs|1q21.3,phosphomevalonate kinase,TRUE
1258_SRSF10_10772,O75494,"serine/arginine-rich splicing factor 10 (40 kda sr-repressor protein) (srrp40) (fus-interacting serine-arginine-rich protein 1) (splicing factor srp38) (splicing factor, arginine/serine-rich 13a) (tls-associated protein with ser-arg repeats) (tasr) (tls-associated protein with sr repeats) (tls-associated serine-arginine protein) (tls-associated sr protein)",SRSF10 FUSIP1 FUSIP2 SFRS13A TASR,262,"function: splicing factor that in its dephosphorylated form acts as a general repressor of pre-mrna splicing (pubmed:11684676, pubmed:12419250, pubmed:14765198). seems to interfere with the u1 snrnp 5'-splice recognition of snrnp70 (pubmed:14765198). required for splicing repression in m-phase cells and after heat shock (pubmed:14765198). also acts as a splicing factor that specifically promotes exon skipping during alternative splicing (pubmed:26876937). interaction with ythdc1, a rna-binding protein that recognizes and binds n6-methyladenosine (m6a)-containing rnas, prevents srsf10 from binding to its mrna-binding sites close to m6a-containing regions, leading to inhibit exon skipping during alternative splicing (pubmed:26876937). may be involved in regulation of alternative splicing in neurons, with isoform 1 acting as a positive and isoform 3 as a negative regulator (pubmed:12419250). {eco:0000269|pubmed:11684676, eco:0000269|pubmed:12419250, eco:0000269|pubmed:14765198, eco:0000269|pubmed:26876937}.","subcellular location: nucleus speckle {eco:0000269|pubmed:11684676, eco:0000269|pubmed:26876937}. cytoplasm {eco:0000269|pubmed:11684676}.","TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11684676, ECO:0000269|PubMed:11891055}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF10,10772,Hs.3530,ENST00000374457,THC2498321,"GO:0000166(nucleotide binding)|GO:0000244(assembly of spliceosomal tri-snRNP)|GO:0000375(RNA splicing, via transesterification reactions)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003676(nucleic acid binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006376(mRNA splice site selection)|GO:0006406(mRNA export from nucleus)|GO:0016482(cytoplasmic transport)|GO:0016607(nuclear speck)|GO:0048025(negative regulation of nuclear mRNA splicing, via spliceosome)|GO:0050733(RS domain binding)|GO:0051082(unfolded protein binding)","Homo sapiens serine/arginine-rich splicing factor 10 (SRSF10), transcript variant 1, mRNA [NM_006625]",chr1_gl000191_random:36433-36374,NA,serine/arginine-rich splicing factor 10,TRUE
1259_HPS4_89781,Q9NQG7,hermansky-pudlak syndrome 4 protein (light-ear protein homolog),HPS4 KIAA1667,708,"function: component of the bloc-3 complex, a complex that acts as a guanine exchange factor (gef) for rab32 and rab38, promotes the exchange of gdp to gtp, converting them from an inactive gdp-bound form into an active gtp-bound form. the bloc-3 complex plays an important role in the control of melanin production and melanosome biogenesis and promotes the membrane localization of rab32 and rab38 (pubmed:23084991). {eco:0000269|pubmed:23084991}.",NA,NA,"DISEASE: Hermansky-Pudlak syndrome 4 (HPS4) [MIM:614073]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. {ECO:0000269|PubMed:11836498}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,HPS4,89781,Hs.474436,ENST00000466781,THC2473325,GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0006605(protein targeting)|GO:0006996(organelle organization)|GO:0007040(lysosome organization)|GO:0007596(blood coagulation)|GO:0007599(hemostasis)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0030318(melanocyte differentiation)|GO:0042470(melanosome)|GO:0042803(protein homodimerization activity)|GO:0042827(platelet dense granule)|GO:0046983(protein dimerization activity)|GO:0048075(positive regulation of eye pigmentation)|GO:0050821(protein stabilization),"Homo sapiens Hermansky-Pudlak syndrome 4 (HPS4), transcript variant 1, mRNA [NM_022081]",chr22:26848159-26848100,hs|22q12.1,Hermansky-Pudlak syndrome 4,TRUE
126_ND4_4538,P03905,nadh-ubiquinone oxidoreductase chain 4 (ec 7.1.1.2) (nadh dehydrogenase subunit 4),MT-ND4 MTND4 NADH4 ND4,459,function: core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed to belong to the minimal assembly required for catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (by similarity). {eco:0000250}.,subcellular location: mitochondrion membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,"DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. {ECO:0000269|PubMed:1959619, ECO:0000269|PubMed:1959931, ECO:0000269|PubMed:3201231, ECO:0000269|PubMed:9452107}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001]: Part of a spectrum of Leber hereditary optic neuropathy. It is characterized by the association of optic atrophy and central vision loss with dystonia. {ECO:0000269|PubMed:8644732}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]: Genetically heterogeneous disorder, characterized by episodic vomiting, seizures, and recurrent cerebral insults resembling strokes and causing hemiparesis, hemianopsia, or cortical blindness. {ECO:0000269|PubMed:1323207}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ND4,4538,Hs.465808,ENST00000361381,THC2585555,"GO:0001666(response to hypoxia)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0007568(aging)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0009790(embryo development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0021549(cerebellum development)|GO:0022904(respiratory electron transport chain)|GO:0042773(ATP synthesis coupled electron transport)|GO:0070469(respiratory chain)",mitochondrially encoded NADH dehydrogenase 4 [Source:HGNC Symbol;Acc:7459] [ENST00000361381],chrM:11432-11491,NA,"NADH dehydrogenase, subunit 4 (complex I)",TRUE
1260_C1orf63_57035,Q9BUV0,arginine/serine-rich protein 1,RSRP1 C1orf63 HT033 NPD014,290,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C1orf63,57035,Hs.259412,NA,NA,NA,"Homo sapiens chromosome 1 open reading frame 63, mRNA (cDNA clone MGC:74698 IMAGE:6147639), complete cds. [BC065040]",chr1:25570084-25569181,hs|1p36.11,chromosome 1 open reading frame 63,TRUE
1261_PIGT_51604,Q969N2,gpi transamidase component pig-t (phosphatidylinositol-glycan biosynthesis class t protein),PIGT CGI-06 PSEC0163 UNQ716/PRO1379,578,"function: component of the gpi transamidase complex. essential for transfer of gpi to proteins, particularly for formation of carbonyl intermediates. {eco:0000269|pubmed:11483512}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:11483512}; single-pass type i membrane protein {eco:0000269|pubmed:11483512}.,NA,"DISEASE: Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398]: An autosomal recessive syndrome characterized by distinct facial features, intellectual disability, hypotonia and seizures, in combination with abnormal skeletal, endocrine, and ophthalmologic findings including impaired vision, as well as abnormal motility of the eyes. {ECO:0000269|PubMed:23636107}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paroxysmal nocturnal hemoglobinuria 2 (PNH2) [MIM:615399]: A disorder characterized by hemolytic anemia with hemoglobinuria, thromboses in large vessels, and a deficiency in hematopoiesis. Red blood cell breakdown with release of hemoglobin into the urine is manifested most prominently by dark-colored urine in the morning. {ECO:0000269|PubMed:23733340}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PIGT,51604,Hs.437388,ENST00000341555,THC2575050,GO:0003923(GPI-anchor transamidase activity)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006501(C-terminal protein lipidation)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016255(attachment of GPI anchor to protein)|GO:0030176(integral to endoplasmic reticulum membrane)|GO:0042765(GPI-anchor transamidase complex)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process),"Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class T (PIGT), transcript variant 1, mRNA [NM_015937]",chr20:44054816-44054875,hs|20q13.12,"phosphatidylinositol glycan anchor biosynthesis, class T",TRUE
1262_HSF1_3297,Q00613,heat shock factor protein 1 (hsf 1) (heat shock transcription factor 1) (hstf 1),HSF1 HSTF1,529,"function: function as a stress-inducible and dna-binding transcription factor that plays a central role in the transcriptional activation of the heat shock response (hsr), leading to the expression of a large class of molecular chaperones heat shock proteins (hsps) that protect cells from cellular insults' damage (pubmed:1871105, pubmed:11447121, pubmed:1986252, pubmed:7760831, pubmed:7623826, pubmed:8946918, pubmed:8940068, pubmed:9341107, pubmed:9121459, pubmed:9727490, pubmed:9499401, pubmed:9535852, pubmed:12659875, pubmed:12917326, pubmed:15016915, pubmed:25963659, pubmed:26754925). in unstressed cells, is present in a hsp90-containing multichaperone complex that maintains it in a non-dna-binding inactivated monomeric form (pubmed:9727490, pubmed:11583998, pubmed:16278218). upon exposure to heat and other stress stimuli, undergoes homotrimerization and activates hsp gene transcription through binding to site-specific heat shock elements (hses) present in the promoter regions of hsp genes (pubmed:1871105, pubmed:1986252, pubmed:8455624, pubmed:7935471, pubmed:7623826, pubmed:8940068, pubmed:9727490, pubmed:9499401, pubmed:10359787, pubmed:11583998, pubmed:12659875, pubmed:16278218, pubmed:25963659, pubmed:26754925). activation is reversible, and during the attenuation and recovery phase period of the hsr, returns to its unactivated form (pubmed:11583998, pubmed:16278218). binds to inverted 5'-ngaan-3' pentamer dna sequences (pubmed:1986252, pubmed:26727489). binds to chromatin at heat shock gene promoters (pubmed:25963659). plays also several other functions independently of its transcriptional activity. involved in the repression of ras-induced transcriptional activation of the c-fos gene in heat-stressed cells (pubmed:9341107). positively regulates pre-mrna 3'-end processing and polyadenylation of hsp70 mrna upon heat-stressed cells in a symplekin (sympk)-dependent manner (pubmed:14707147). plays a role in nuclear export of stress-induced hsp70 mrna (pubmed:17897941). plays a role in the regulation of mitotic progression (pubmed:18794143). plays also a role as a negative regulator of non-homologous end joining (nhej) repair activity in a dna damage-dependent manner (pubmed:26359349). involved in stress-induced cancer cell proliferation in a ier5-dependent manner (pubmed:26754925). {eco:0000269|pubmed:10359787, eco:0000269|pubmed:11447121, eco:0000269|pubmed:11583998, eco:0000269|pubmed:12659875, eco:0000269|pubmed:12917326, eco:0000269|pubmed:14707147, eco:0000269|pubmed:15016915, eco:0000269|pubmed:16278218, eco:0000269|pubmed:17897941, eco:0000269|pubmed:1871105, eco:0000269|pubmed:18794143, eco:0000269|pubmed:1986252, eco:0000269|pubmed:25963659, eco:0000269|pubmed:26359349, eco:0000269|pubmed:26727489, eco:0000269|pubmed:26754925, eco:0000269|pubmed:7623826, eco:0000269|pubmed:7760831, eco:0000269|pubmed:7935471, eco:0000269|pubmed:8455624, eco:0000269|pubmed:8940068, eco:0000269|pubmed:8946918, eco:0000269|pubmed:9121459, eco:0000269|pubmed:9341107, eco:0000269|pubmed:9499401, eco:0000269|pubmed:9535852, eco:0000269|pubmed:9727490}.; function: (microbial infection) plays a role in latent human immunodeficiency virus (hiv-1) transcriptional reactivation. binds to the hiv-1 long terminal repeat promoter (ltr) to reactivate viral transcription by recruiting cellular transcriptional elongation factors, such as cdk9, ccnt1 and ep300. {eco:0000269|pubmed:27189267}.","subcellular location: nucleus {eco:0000269|pubmed:10413683, eco:0000269|pubmed:10747973, eco:0000269|pubmed:11447121, eco:0000269|pubmed:11514557, eco:0000269|pubmed:12665592, eco:0000269|pubmed:12917326, eco:0000269|pubmed:14707147, eco:0000269|pubmed:15661742, eco:0000269|pubmed:19229036, eco:0000269|pubmed:21085490, eco:0000269|pubmed:25963659, eco:0000269|pubmed:26359349, eco:0000269|pubmed:27189267, eco:0000269|pubmed:27354066, eco:0000269|pubmed:7623826, eco:0000269|pubmed:8455624}. cytoplasm {eco:0000269|pubmed:10413683, eco:0000269|pubmed:10747973, eco:0000269|pubmed:12917326, eco:0000269|pubmed:15661742, eco:0000269|pubmed:21085490, eco:0000269|pubmed:26159920, eco:0000269|pubmed:26359349, eco:0000269|pubmed:27354066, eco:0000269|pubmed:7623826, eco:0000269|pubmed:8455624}. nucleus, nucleoplasm {eco:0000269|pubmed:10359787}. cytoplasm, perinuclear region {eco:0000269|pubmed:21085490}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:18794143}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:18794143}. chromosome, centromere, kinetochore {eco:0000269|pubmed:18794143}. note=the monomeric form is cytoplasmic in unstressed cells (pubmed:8455624, pubmed:26159920). predominantly nuclear protein in both unstressed and heat shocked cells (pubmed:10413683, pubmed:10359787). translocates in the nucleus upon heat shock (pubmed:8455624). nucleocytoplasmic shuttling protein (pubmed:26159920). colocalizes with ier5 in the nucleus (pubmed:27354066). colocalizes with bag3 to the nucleus upon heat stress (pubmed:8455624, pubmed:26159920). localizes in subnuclear granules called nuclear stress bodies (nsbs) upon heat shock (pubmed:11447121, pubmed:11514557, pubmed:10359787, pubmed:25963659, pubmed:10747973, pubmed:24581496, pubmed:19229036). colocalizes with sympk and sumo1 in nsbs upon heat shock (pubmed:11447121, pubmed:12665592, pubmed:11514557, pubmed:14707147, pubmed:10359787). colocalizes with prkaca/pka in the nucleus and nsbs upon heat shock (pubmed:21085490). relocalizes from the nucleus to the cytoplasm during the attenuation and recovery phase period of the heat shock response (pubmed:26159920). translocates in the cytoplasm in a ywhae- and xpo1/crm1-dependent manner (pubmed:12917326). together with histone h2ax, redistributed in discrete nuclear dna damage-induced foci after ionizing radiation (ir) (pubmed:26359349). colocalizes with calcium-responsive transactivator ss18l1 at kinetochore region on the mitotic chromosomes (pubmed:18794143). colocalizes with gamma tubulin at centrosome (pubmed:18794143). localizes at spindle pole in metaphase (pubmed:18794143). colocalizes with plk1 at spindle poles during prometaphase (pubmed:18794143). {eco:0000269|pubmed:10359787, eco:0000269|pubmed:10413683, eco:0000269|pubmed:10747973, eco:0000269|pubmed:11447121, eco:0000269|pubmed:11514557, eco:0000269|pubmed:12665592, eco:0000269|pubmed:12917326, eco:0000269|pubmed:14707147, eco:0000269|pubmed:18794143, eco:0000269|pubmed:21085490, eco:0000269|pubmed:24581496, eco:0000269|pubmed:25963659, eco:0000269|pubmed:26159920, eco:0000269|pubmed:26359349, eco:0000269|pubmed:27354066, eco:0000269|pubmed:8455624}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,HSF1,3297,Hs.530227,ENST00000527328,THC2469795,"GO:0001892(embryonic placenta development)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006468(protein phosphorylation)|GO:0007283(spermatogenesis)|GO:0008285(negative regulation of cell proliferation)|GO:0009408(response to heat)|GO:0032496(response to lipopolysaccharide)|GO:0032720(negative regulation of tumor necrosis factor production)|GO:0040018(positive regulation of multicellular organism growth)|GO:0043234(protein complex)|GO:0043565(sequence-specific DNA binding)|GO:0045120(pronucleus)|GO:0060136(embryonic process involved in female pregnancy)","Homo sapiens heat shock transcription factor 1 (HSF1), mRNA [NM_005526]",chr8:145538318-145538377,hs|8q24.3,heat shock transcription factor 1,TRUE
1263_FBXO25_26260,Q8TCJ0,f-box only protein 25,FBXO25 FBX25,367,function: substrate-recognition component of the scf (skp1-cul1-f-box protein)-type e3 ubiquitin ligase complex. may play a role in accumulation of expanded polyglutamine (polyq) protein huntingtin (htt) (by similarity). {eco:0000250}.,"subcellular location: nucleus {eco:0000269|pubmed:16278047, eco:0000269|pubmed:18287534}. note=in the nucleus, associates with a subnuclear dot-like structure. colocalized with skp1.",TISSUE SPECIFICITY: Expressed in all brain tissue observed. {ECO:0000269|PubMed:16278047}.,DISEASE: Note=A chromosomal aberration involving FBXO25 is a cause of X-linked mental retardation (XLMR). Translocation t(X;8)(p11.22;p23.3) with SHROOM4.,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FBXO25,26260,Hs.438454,ENST00000382824,THC2753724,GO:0000151(ubiquitin ligase complex)|GO:0003779(actin binding)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005634(nucleus)|GO:0016567(protein ubiquitination)|GO:0019005(SCF ubiquitin ligase complex),"Homo sapiens F-box protein 25 (FBXO25), transcript variant 1, mRNA [NM_183421]",chr8:418943-419002,hs|8p23.3,F-box protein 25,TRUE
1264_CAST_831,P20810,calpastatin (calpain inhibitor) (sperm bs-17 component),CAST,708,function: specific inhibition of calpain (calcium-dependent cysteine protease). plays a key role in postmortem tenderization of meat and have been proposed to be involved in muscle protein degradation in living tissue.,NA,NA,"DISEASE: Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads (PLACK) [MIM:616295]: An autosomal recessive disease characterized by generalized, continuous shedding of the outer layers of the epidermis, leukonychia, acral punctate keratosis, cheilitis, knuckle pads with multiple hyperkeratotic micropapules involving the interphalangeal joints, and palmoplantar keratoderma. {ECO:0000269|PubMed:25683118}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CAST,831,Hs.436186,ENST00000341926,THC2478131,GO:0004866(endopeptidase inhibitor activity)|GO:0005515(protein binding)|GO:0010859(calcium-dependent cysteine-type endopeptidase inhibitor activity)|GO:0010951(negative regulation of endopeptidase activity),"Homo sapiens calpastatin (CAST), transcript variant 6, mRNA [NM_001042440]",chr5:96108417-96108476,hs|5q15,calpastatin,TRUE
1265_THOC3_84321,Q96J01,tho complex subunit 3 (tho3) (tex1 homolog) (htrex45),THOC3,351,"function: required for efficient export of polyadenylated rna and spliced mrna. acts as component of the tho subcomplex of the trex complex which is thought to couple mrna transcription, processing and nuclear export, and which specifically associates with spliced mrna and not with unspliced pre-mrna. trex is recruited to spliced mrnas by a transcription-independent mechanism, binds to mrna upstream of the exon-junction complex (ejc) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mrna where it functions in mrna export to the cytoplasm via the tap/nfx1 pathway. the trex complex is essential for the export of kaposi's sarcoma-associated herpesvirus (kshv) intronless mrnas and infectious virus production. {eco:0000269|pubmed:11979277, eco:0000269|pubmed:15833825, eco:0000269|pubmed:15998806, eco:0000269|pubmed:17190602, eco:0000269|pubmed:18974867}.",subcellular location: nucleus {eco:0000305}. nucleus speckle {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,THOC3,84321,Hs.484227,ENST00000303154,THC2525152,GO:0000346(transcription export complex)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0046784(intronless viral mRNA export from host nucleus),"Homo sapiens THO complex 3 (THOC3), mRNA [NM_032361]",chr5:175386833-175386774,hs|5q35.2,THO complex 3,TRUE
1267_PPAPDC1B_84513,Q8NEB5,phospholipid phosphatase 5 (ec 3.1.3.4) (phosphatidic acid phosphatase type 2 domain-containing protein 1b),PLPP5 DPPL1 HTPAP PPAPDC1B,264,"function: displays magnesium-independent phosphatidate phosphatase activity in vitro. catalyzes the conversion of phosphatidic acid to diacylglycerol. may be a metastatic suppressor for hepatocellular carcinoma. {eco:0000269|pubmed:16261160, eco:0000269|pubmed:17590538}.",subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:17590538}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PPAPDC1B,84513,Hs.567619,ENST00000424479,THC2464061,GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0008195(phosphatidate phosphatase activity)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0046839(phospholipid dephosphorylation),"Homo sapiens phosphatidic acid phosphatase type 2 domain containing 1B (PPAPDC1B), transcript variant 1, mRNA [NM_001102559]",chr8:38120995-38120936,hs|8p11.23,phosphatidic acid phosphatase type 2 domain containing 1B,TRUE
1268_XYLT2_64132,Q9H1B5,xylosyltransferase 2 (ec 2.4.2.26) (peptide o-xylosyltransferase 1) (xylosyltransferase ii) (xt-ii) (xylt-ii),XYLT2 XT2 UNQ3058/PRO9878,865,"function: catalyzes the first step in the biosynthesis of chondroitin sulfate, heparan sulfate and dermatan sulfate proteoglycans, such as dcn. transfers d-xylose from udp-d-xylose to specific serine residues of the core protein. {eco:0000269|pubmed:17189265, eco:0000269|pubmed:26027496}.","subcellular location: golgi apparatus membrane {eco:0000305}; single-pass type ii membrane protein {eco:0000305}. secreted {eco:0000269|pubmed:17189265, eco:0000269|pubmed:25748573}.",TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in kidney and pancreas. {ECO:0000269|PubMed:11099377}.,"DISEASE: Spondyloocular syndrome (SOS) [MIM:605822]: A syndrome characterized by cataract, loss of vision due to retinal detachment, facial dysmorphism, facial hypotonia, normal height with disproportional short trunk, osteoporosis, immobile spine with thoracic kyphosis and reduced lumbal lordosis. {ECO:0000269|PubMed:26027496}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudoxanthoma elasticum (PXE) [MIM:264800]: A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:16571645}. Note=The gene represented in this entry acts as a disease modifier. PXE patients carrying causative ABCC6 mutations, manifest a more severe disease course characterized by earlier onset, frequent skin lesions and higher organ involvement, in the presence of XYLT2 variants. {ECO:0000269|PubMed:16571645}.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,XYLT2,64132,Hs.463416,ENST00000017003,NP862742,"GO:0000139(Golgi membrane)|GO:0005575(cellular_component)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0006024(glycosaminoglycan biosynthetic process)|GO:0008375(acetylglucosaminyltransferase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0030158(protein xylosyltransferase activity)","Homo sapiens xylosyltransferase II (XYLT2), mRNA [NM_022167]",chr17:48438440-48438499,hs|17q21.33,xylosyltransferase II,TRUE
1269_SLC37A3_84255,Q8NCC5,sugar phosphate exchanger 3 (solute carrier family 37 member 3),SLC37A3 SPX3,494,NA,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:21949678}; multi-pass membrane protein {eco:0000255}.,"TISSUE SPECIFICITY: Expressed in liver, kidney, intestine and pancreas. {ECO:0000269|PubMed:21949678}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,SLC37A3,84255,Hs.446021,ENST00000473060,NP600882,GO:0008643(carbohydrate transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0055085(transmembrane transport),"Homo sapiens solute carrier family 37 (glycerol-3-phosphate transporter), member 3 (SLC37A3), transcript variant 1, mRNA [NM_207113]",chr7:140033747-140033688,hs|7q34,"solute carrier family 37 (glycerol-3-phosphate transporter), member 3",TRUE
127_PIM3_415116,Q86V86,serine/threonine-protein kinase pim-3 (ec 2.7.11.1),PIM3,326,"function: proto-oncogene with serine/threonine kinase activity that can prevent apoptosis, promote cell survival and protein translation. may contribute to tumorigenesis through: the delivery of survival signaling through phosphorylation of bad which induces release of the anti-apoptotic protein bcl-x(l), the regulation of cell cycle progression, protein synthesis and by regulation of myc transcriptional activity. additionally to this role on tumorigenesis, can also negatively regulate insulin secretion by inhibiting the activation of mapk1/3 (erk1/2), through socs6. involved also in the control of energy metabolism and regulation of ampk activity in modulating myc and ppargc1a protein levels and cell growth. {eco:0000269|pubmed:15540201, eco:0000269|pubmed:16818649, eco:0000269|pubmed:17270021, eco:0000269|pubmed:17876606, eco:0000269|pubmed:18593906}.",subcellular location: cytoplasm {eco:0000269|pubmed:17876606}.,"TISSUE SPECIFICITY: Detected in various tissues, including the heart, brain, lung, kidney, spleen, placenta, skeletal muscle, and peripheral blood leukocytes. Not found or barely expressed in the normal adult endoderm-derived organs such as colon, thymus, liver, or small intestine. However, expression is augmented in premalignant and malignant lesions of these organs. {ECO:0000269|PubMed:15540201, ECO:0000269|PubMed:16818649, ECO:0000269|PubMed:17270021}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PIM3,415116,Hs.530381,ENST00000360612,THC2756317,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006468(protein phosphorylation)|GO:0007049(cell cycle)|GO:0007346(regulation of mitotic cell cycle)|GO:0043066(negative regulation of apoptosis)|GO:0061179(negative regulation of insulin secretion involved in cellular response to glucose stimulus),"Homo sapiens pim-3 oncogene (PIM3), mRNA [NM_001001852]",chr22:50357570-50357629,hs|22q13.33,pim-3 oncogene,TRUE
1270_EIF2AK1_27102,Q9BQI3,eukaryotic translation initiation factor 2-alpha kinase 1 (ec 2.7.11.1) (heme-controlled repressor) (hcr) (heme-regulated eukaryotic initiation factor eif-2-alpha kinase) (heme-regulated inhibitor) (hemin-sensitive initiation factor 2-alpha kinase),EIF2AK1 HRI KIAA1369 PRO1362,630,"function: inhibits protein synthesis at the translation initiation level, in response to various stress conditions, including oxidative stress, heme deficiency, osmotic shock and heat shock. exerts its function through the phosphorylation of eif2s1 at 'ser-48' and 'ser-51', thus preventing its recycling. binds hemin forming a 1:1 complex through a cysteine thiolate and histidine nitrogenous coordination. this binding occurs with moderate affinity, allowing it to sense the heme concentration within the cell. thanks to this unique heme-sensing capacity, plays a crucial role to shut off protein synthesis during acute heme-deficient conditions. in red blood cells (rbcs), controls hemoglobin synthesis ensuring a coordinated regulation of the synthesis of its heme and globin moieties. thus plays an essential protective role for rbc survival in anemias of iron deficiency. similarly, in hepatocytes, involved in heme-mediated translational control of cyp2b and cyp3a and possibly other hepatic p450 cytochromes. may also contain er stress during acute heme-deficient conditions (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Expressed predominantly in erythroid cells. At much lower levels, expressed in hepatocytes (at protein level). {ECO:0000269|PubMed:20071449}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF2AK1,27102,Hs.728827,ENST00000199389,THC2542670,GO:0000166(nucleotide binding)|GO:0004694(eukaryotic translation initiation factor 2alpha kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006950(response to stress)|GO:0008285(negative regulation of cell proliferation)|GO:0009605(response to external stimulus)|GO:0017148(negative regulation of translation)|GO:0020037(heme binding)|GO:0042803(protein homodimerization activity)|GO:0045993(negative regulation of translational initiation by iron)|GO:0046777(protein autophosphorylation)|GO:0046986(negative regulation of hemoglobin biosynthetic process),"Homo sapiens eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1), transcript variant 1, mRNA [NM_014413]",chr7:6063792-6063733,hs|7p22.1,eukaryotic translation initiation factor 2-alpha kinase 1,TRUE
1271_SS18L2_51188,Q9UHA2,ss18-like protein 2 (syt homolog 2),SS18L2,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,SS18L2,51188,Hs.534454,ENST00000011691,THC2461449,NA,"Homo sapiens synovial sarcoma translocation gene on chromosome 18-like 2 (SS18L2), mRNA [NM_016305]",chr3:42636316-42636375,hs|3p22.1,synovial sarcoma translocation gene on chromosome 18-like 2,TRUE
1272_GTPBP4_23560,Q9BZE4,nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb),GTPBP4 CRFG NOG1,634,function: involved in the biogenesis of the 60s ribosomal subunit. {eco:0000250}.,"subcellular location: nucleus, nucleolus {eco:0000269|pubmed:11316846, eco:0000269|pubmed:12429849, eco:0000269|ref.8}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GTPBP4,23560,Hs.215766,ENST00000538293,THC2513331,GO:0000079(regulation of cyclin-dependent protein kinase activity)|GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006184(GTP catabolic process)|GO:0008156(negative regulation of DNA replication)|GO:0008285(negative regulation of cell proliferation)|GO:0022408(negative regulation of cell-cell adhesion)|GO:0030336(negative regulation of cell migration)|GO:0031397(negative regulation of protein ubiquitination)|GO:0031965(nuclear membrane)|GO:0033342(negative regulation of collagen binding)|GO:0042254(ribosome biogenesis)|GO:0048471(perinuclear region of cytoplasm)|GO:0050821(protein stabilization),"Homo sapiens GTP binding protein 4 (GTPBP4), mRNA [NM_012341]",chr10:1063404-1063463,hs|10p15.3,GTP binding protein 4,TRUE
1273_NFIA_4774,Q12857,nuclear factor 1 a-type (nf1-a) (nuclear factor 1/a) (ccaat-box-binding transcription factor) (ctf) (nuclear factor i/a) (nf-i/a) (nfi-a) (tggca-binding protein),NFIA KIAA1439,509,function: recognizes and binds the palindromic sequence 5'-ttggcnnnnngccaa-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. these proteins are individually capable of activating transcription and replication.,subcellular location: nucleus.,NA,"DISEASE: Brain malformations with or without urinary tract defects (BRMUTD) [MIM:613735]: A syndrome characterized by corpus callosum hypoplasia or agenesis, hydrocephalus or ventricular enlargement, developmental delay, and urinary tract defects. {ECO:0000269|PubMed:24462883, ECO:0000269|PubMed:27081522}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NFIA,4774,Hs.191911,ENST00000371189,THC2507792,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006260(DNA replication)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008134(transcription factor binding)|GO:0019079(viral genome replication)|GO:0030054(cell junction)","Homo sapiens nuclear factor I/A (NFIA), transcript variant 1, mRNA [NM_001134673]",chr1:61928326-61928385,hs|1p31.3,nuclear factor I/A,TRUE
1274_C19orf63_284361,Q5UCC4,er membrane protein complex subunit 10 (hematopoietic signal peptide-containing membrane domain-containing protein 1),EMC10 C19orf63 HSM1 INM02 UNQ764/PRO1556,262,"function: promotes angiogenesis and tissue repair in the heart after myocardial infarction. stimulates cardiac endothelial cell migration and outgrowth via the activation of p38 mapk, pak and mapk2 signaling pathways. {eco:0000269|pubmed:28931551}.","subcellular location: isoform 1: membrane {eco:0000269|pubmed:22119785}; single-pass type i membrane protein {eco:0000255}.; subcellular location: isoform 2: secreted {eco:0000269|pubmed:19570817, eco:0000269|pubmed:20680400, eco:0000269|pubmed:28931551}.","TISSUE SPECIFICITY: Present in serum (at protein level). Increased expression seen in the left ventrice after myocardial infarction (at protein level). Expressed in the pituitary gland; very low levels in other brain regions. {ECO:0000269|PubMed:19570817, ECO:0000269|PubMed:20680400, ECO:0000269|PubMed:28931551}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C19orf63,284361,Hs.515550,ENST00000376918,NP862123,GO:0005576(extracellular region)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 19 open reading frame 63 (C19orf63), transcript variant HSS1, mRNA [NM_175063]",chr19:50986430-50986489,hs|19q13.33,chromosome 19 open reading frame 63,TRUE
1275_SNRPB2_6629,P08579,u2 small nuclear ribonucleoprotein b'' (u2 snrnp b''),SNRPB2,225,"function: involved in pre-mrna splicing as component of the spliceosome (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). associated with sn-rnp u2, where it contributes to the binding of stem loop iv of u2 snrna (pubmed:9716128). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166, eco:0000269|pubmed:9716128}.","subcellular location: nucleus {eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPB2,6629,Hs.280378,ENST00000246071,THC2538257,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005686(U2 snRNP)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein polypeptide B (SNRPB2), transcript variant 1, mRNA [NM_003092]",chr20:16721741-16721800,hs|20p12.1,small nuclear ribonucleoprotein polypeptide B,TRUE
1276_LSM5_23658,Q9Y4Y9,u6 snrna-associated sm-like protein lsm5,LSM5,91,"function: plays role in pre-mrna splicing as component of the u4/u6-u5 tri-snrnp complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome b complex) (pubmed:28781166). the heptameric lsm2-8 complex binds specifically to the 3'-terminal u-tract of u6 snrna (pubmed:10523320). {eco:0000269|pubmed:10523320, eco:0000269|pubmed:28781166}.","subcellular location: nucleus {eco:0000269|pubmed:10523320, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28781166}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LSM5,23658,Hs.424908,ENST00000480956,THC2494526,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030529(ribonucleoprotein complex)|GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay)","Homo sapiens LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM5), transcript variant 1, mRNA [NM_012322]",chr7:32526885-32526826,hs|7p14.3,"LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)",TRUE
1277_FABP5_2171,Q01469,"fatty acid-binding protein 5 (epidermal-type fatty acid-binding protein) (e-fabp) (fatty acid-binding protein, epidermal) (psoriasis-associated fatty acid-binding protein homolog) (pa-fabp)",FABP5,135,"function: intracellular carrier for long-chain fatty acids and related active lipids, such as the endocannabinoid, that regulates the metabolism and actions of the ligands they bind. in addition to the cytosolic transport, selectively delivers specific fatty acids from the cytosol to the nucleus, wherein they activate nuclear receptors (pubmed:22170058). delivers retinoic acid to the nuclear receptor peroxisome proliferator-activated receptor delta; which promotes proliferation and survival. may also serve as a synaptic carrier of endocannabinoid at central synapses and thus controls retrograde endocannabinoid signaling. modulates inflammation by regulating ptges induction via nf-kappa-b activation, and prostaglandin e2 (pge2) biosynthesis during inflammation (by similarity). may be involved in keratinocyte differentiation (pubmed:8092987). {eco:0000250|uniprotkb:q05816, eco:0000269|pubmed:22170058, eco:0000269|pubmed:8092987}.","subcellular location: cytoplasm {eco:0000269|pubmed:24692551, eco:0000269|pubmed:8092987}. nucleus {eco:0000269|pubmed:24692551}. cell junction, synapse {eco:0000250|uniprotkb:q05816}. cell junction, synapse, postsynaptic density {eco:0000250|uniprotkb:q05816}. secreted {eco:0000250|uniprotkb:q05816}. note=localizes primarily to the cytoplasm. upon certain ligand binding, a conformation change exposes a nuclear localization motif and the protein is transported into nucleus (pubmed:24692551). secreted by astrocytes, but not by neurons (by similarity). {eco:0000250|uniprotkb:q05816, eco:0000269|pubmed:24692551}.",TISSUE SPECIFICITY: Keratinocytes; highly expressed in psoriatic skin. {ECO:0000269|PubMed:8092987}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FABP5,2171,Hs.408061,ENST00000458175,THC2557360,GO:0005215(transporter activity)|GO:0005504(fatty acid binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0006006(glucose metabolic process)|GO:0006629(lipid metabolic process)|GO:0006656(phosphatidylcholine biosynthetic process)|GO:0008289(lipid binding)|GO:0008544(epidermis development)|GO:0015758(glucose transport),"Homo sapiens fatty acid binding protein 5 (psoriasis-associated) (FABP5), mRNA [NM_001444]",chr8:82196174-82196772,hs|8q21.13,fatty acid binding protein 5 (psoriasis-associated),TRUE
1278_GADD45B_4616,O75293,growth arrest and dna damage-inducible protein gadd45 beta (myeloid differentiation primary response protein myd118) (negative growth regulatory protein myd118),GADD45B MYD118,160,function: involved in the regulation of growth and apoptosis. mediates activation of stress-responsive mtk1/mekk4 mapkkk.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GADD45B,4616,Hs.110571,ENST00000215631,NP072739,GO:0000185(activation of MAPKKK activity)|GO:0000186(activation of MAPKK activity)|GO:0006469(negative regulation of protein kinase activity)|GO:0006915(apoptosis)|GO:0006950(response to stress)|GO:0007275(multicellular organismal development)|GO:0030154(cell differentiation)|GO:0051726(regulation of cell cycle),"Homo sapiens growth arrest and DNA-damage-inducible, beta (GADD45B), mRNA [NM_015675]",chr19:2478178-2478237,hs|19p13.3,"growth arrest and DNA-damage-inducible, beta",TRUE
1279_MFN2_9927,O95140,mitofusin-2 (ec 3.6.5.-) (transmembrane gtpase mfn2),MFN2 CPRP1 KIAA0214,757,"function: mitochondrial outer membrane gtpase that mediates mitochondrial clustering and fusion (pubmed:11181170, pubmed:11950885, pubmed:28114303). mitochondria are highly dynamic organelles, and their morphology is determined by the equilibrium between mitochondrial fusion and fission events (pubmed:28114303). overexpression induces the formation of mitochondrial networks (pubmed:28114303). membrane clustering requires gtpase activity and may involve a major rearrangement of the coiled coil domains (probable). plays a central role in mitochondrial metabolism and may be associated with obesity and/or apoptosis processes (by similarity). plays an important role in the regulation of vascular smooth muscle cell proliferation (by similarity). involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) (pubmed:23620051). is required for prkn recruitment to dysfunctional mitochondria (pubmed:23620051). involved in the control of unfolded protein response (upr) upon er stress including activation of apoptosis and autophagy during er stress (by similarity). acts as an upstream regulator of eif2ak3 and suppresses eif2ak3 activation under basal conditions (by similarity). {eco:0000250|uniprotkb:q80u63, eco:0000250|uniprotkb:q8r500, eco:0000269|pubmed:11181170, eco:0000269|pubmed:11950885, eco:0000269|pubmed:23620051, eco:0000269|pubmed:26085578, eco:0000269|pubmed:28114303, eco:0000305}.","subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:11181170, eco:0000269|pubmed:11950885, eco:0000269|pubmed:12499352, eco:0000269|pubmed:23620051}; multi-pass membrane protein {eco:0000269|pubmed:11181170, eco:0000269|pubmed:11950885, eco:0000269|pubmed:12499352, eco:0000269|pubmed:23620051}. note=colocalizes with bax during apoptosis. {eco:0000269|pubmed:12499352}.","TISSUE SPECIFICITY: Ubiquitous; expressed at low level. Highly expressed in heart and kidney. {ECO:0000269|PubMed:11950885, ECO:0000269|PubMed:12759376}.","DISEASE: Charcot-Marie-Tooth disease 2A2B (CMT2A2B) [MIM:617087]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2A2B is a severe form with autosomal recessive inheritance. {ECO:0000269|PubMed:18458227, ECO:0000269|PubMed:20350294, ECO:0000269|PubMed:21715711, ECO:0000269|PubMed:26085578, ECO:0000269|PubMed:26955893}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2A2A (CMT2A2A) [MIM:609260]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:15064763, ECO:0000269|PubMed:15549395, ECO:0000269|PubMed:16762064, ECO:0000269|PubMed:20350294, ECO:0000269|PubMed:22206013}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neuropathy, hereditary motor and sensory, 6A (HMSN6A) [MIM:601152]: An autosomal dominant neurologic disorder characterized by optic atrophy and peripheral sensorimotor neuropathy manifesting as axonal Charcot-Marie-Tooth disease. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. It is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies and primary peripheral axonal neuropathies. Peripheral axonal neuropathies are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, and normal or slightly reduced nerve conduction velocities. {ECO:0000269|PubMed:16437557, ECO:0000269|PubMed:20350294, ECO:0000269|PubMed:24604904, ECO:0000269|PubMed:26085578}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MFN2,9927,Hs.376681,ENST00000235329,THC2514422,GO:0000166(nucleotide binding)|GO:0001825(blastocyst formation)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005829(cytosol)|GO:0006626(protein targeting to mitochondrion)|GO:0007006(mitochondrial membrane organization)|GO:0007050(cell cycle arrest)|GO:0007596(blood coagulation)|GO:0008053(mitochondrial fusion)|GO:0015630(microtubule cytoskeleton)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0031306(intrinsic to mitochondrial outer membrane)|GO:0031625(ubiquitin protein ligase binding)|GO:0046580(negative regulation of Ras protein signal transduction)|GO:0048593(camera-type eye morphogenesis)|GO:0048662(negative regulation of smooth muscle cell proliferation)|GO:0051646(mitochondrion localization),"Homo sapiens mitofusin 2 (MFN2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_014874]",chr1:12073420-12073479,hs|1p36.22,mitofusin 2,TRUE
128_RPL35A_6165,P18077,60s ribosomal protein l35a (cell growth-inhibiting gene 33 protein) (large ribosomal subunit protein el33),RPL35A GIG33,110,function: required for the proliferation and viability of hematopoietic cells. plays a role in 60s ribosomal subunit formation. the protein was found to bind to both initiator and elongator trnas and consequently was assigned to the p site or p and a site. {eco:0000269|pubmed:18535205}.,NA,NA,"DISEASE: Diamond-Blackfan anemia 5 (DBA5) [MIM:612528]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:18535205}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL35A,6165,Hs.529631,ENST00000439255,THC2486364,GO:0000049(tRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042273(ribosomal large subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L35a (RPL35A), mRNA [NM_000996]",chr3:197680988-197682649,hs|3q29,ribosomal protein L35a,TRUE
1280_FZD4_8322,Q9ULV1,frizzled-4 (fz-4) (hfz4) (fze4) (cd antigen cd344),FZD4,537,"function: receptor for wnt proteins. most of frizzled receptors are coupled to the beta-catenin (ctnnb1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of gsk-3 kinase, nuclear accumulation of beta-catenin (ctnnb1) and activation of wnt target genes. plays a critical role in retinal vascularization by acting as a receptor for wnt proteins and norrin (ndp). in retina, it can be both activated by wnt protein-binding, but also by a wnt-independent signaling via binding of norrin (ndp), promoting in both cases beta-catenin (ctnnb1) accumulation and stimulation of lef/tcf-mediated transcriptional programs. a second signaling pathway involving pkc and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as pkc seems to be required for wnt-mediated inactivation of gsk-3 kinase. both pathways seem to involve interactions with g-proteins. may be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues.",subcellular location: membrane; multi-pass membrane protein. cell membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,"TISSUE SPECIFICITY: Almost ubiquitous. Largely expressed in adult heart, skeletal muscle, ovary, and fetal kidney. Moderate amounts in adult liver, kidney, pancreas, spleen, and fetal lung, and small amounts in placenta, adult lung, prostate, testis, colon, fetal brain and liver.","DISEASE: Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history. {ECO:0000269|PubMed:12172548, ECO:0000269|PubMed:14507768, ECO:0000269|PubMed:15035989, ECO:0000269|PubMed:15223780, ECO:0000269|PubMed:15370539, ECO:0000269|PubMed:15488808, ECO:0000269|PubMed:15733276, ECO:0000269|PubMed:15981244, ECO:0000269|PubMed:17093393, ECO:0000269|PubMed:17955262, ECO:0000269|PubMed:19172507, ECO:0000269|PubMed:19324841, ECO:0000269|PubMed:20340138}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FZD4,8322,Hs.591968,ENST00000531380,THC2786712,"GO:0001568(blood vessel development)|GO:0001570(vasculogenesis)|GO:0004871(signal transducer activity)|GO:0004872(receptor activity)|GO:0004930(G-protein coupled receptor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007223(Wnt receptor signaling pathway, calcium modulating pathway)|GO:0007420(brain development)|GO:0007605(sensory perception of sound)|GO:0009790(embryo development)|GO:0009986(cell surface)|GO:0010812(negative regulation of cell-substrate adhesion)|GO:0016055(Wnt receptor signaling pathway)|GO:0017147(Wnt-protein binding)|GO:0019955(cytokine binding)|GO:0030165(PDZ domain binding)|GO:0030182(neuron differentiation)|GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway)|GO:0031987(locomotion involved in locomotory behavior)|GO:0034446(substrate adhesion-dependent cell spreading)|GO:0035426(extracellular matrix-cell signaling)|GO:0042701(progesterone secretion)|GO:0042803(protein homodimerization activity)|GO:0042813(Wnt receptor activity)|GO:0042995(cell projection)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046982(protein heterodimerization activity)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0060070(canonical Wnt receptor signaling pathway)|GO:0061299(retina vasculature morphogenesis in camera-type eye)|GO:0061301(cerebellum vasculature morphogenesis)|GO:0061304(retinal blood vessel morphogenesis)|GO:0071300(cellular response to retinoic acid)","Homo sapiens frizzled family receptor 4 (FZD4), mRNA [NM_012193]",chr11:86656859-86656800,hs|11q14.2,frizzled family receptor 4,TRUE
1281_SNRPE_6635,P62304,small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme),SNRPE,92,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:23246290, pubmed:19325628, pubmed:23333303, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). as part of the u7 snrnp it is involved in histone 3'-end processing (pubmed:12975319). may indirectly play a role in hair development (pubmed:23246290). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:12975319, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:23246290, eco:0000269|pubmed:23333303, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11574479, eco:0000269|pubmed:11991638, eco:0000269|pubmed:23246290, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.","TISSUE SPECIFICITY: Widely expressed. In scalp skin, it is present in the hair follicle, the epidermis, and the dermis. {ECO:0000269|PubMed:23246290}.","DISEASE: Hypotrichosis 11 (HYPT11) [MIM:615059]: A form of hypotrichosis, a condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The extent of scalp and body hair involvement can be very variable, within as well as between families. HYPT11 is characterized by scanty or absent eyebrows and a highly variable degree of alopecia since birth, ranging from slight thinning of scalp and axillary hair to complete loss of scalp and body hair. Pubic hair remains mainly unaffected. {ECO:0000269|PubMed:23246290}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPE,6635,Hs.334612,ENST00000469451,NP108440,"GO:0000245(spliceosome assembly)|GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005683(U7 snRNP)|GO:0005689(U12-type spliceosomal complex)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0008334(histone mRNA metabolic process)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein polypeptide E (SNRPE), mRNA [NM_003094]",chr1:203832818-203834192,hs|1q32.1,small nuclear ribonucleoprotein polypeptide E,TRUE
1282_RARS_5917,P54136,"arginine--trna ligase, cytoplasmic (ec 6.1.1.19) (arginyl-trna synthetase) (argrs)",RARS,660,"function: forms part of a macromolecular complex that catalyzes the attachment of specific amino acids to cognate trnas during protein synthesis (pubmed:25288775). modulates the secretion of aimp1 and may be involved in generation of the inflammatory cytokine emap2 from aimp1 (pubmed:17443684). {eco:0000269|pubmed:17443684, eco:0000269|pubmed:25288775}.","subcellular location: cytoplasm {eco:0000269|pubmed:10791971, eco:0000269|pubmed:16055448, eco:0000269|pubmed:16430231}. cytoplasm, cytosol {eco:0000269|pubmed:19289464}.",NA,"DISEASE: Leukodystrophy, hypomyelinating, 9 (HLD9) [MIM:616140]: An autosomal recessive neurodegenerative disorder characterized by delayed psychomotor development, severe spasticity, nystagmus, and ataxia associated with diffuse hypomyelination apparent on brain MRI. {ECO:0000269|PubMed:24777941}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RARS,5917,Hs.654907,ENST00000520013,THC2470171,GO:0000049(tRNA binding)|GO:0000166(nucleotide binding)|GO:0004814(arginine-tRNA ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006420(arginyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0016874(ligase activity)|GO:0017101(aminoacyl-tRNA synthetase multienzyme complex)|GO:0034618(arginine binding),"Homo sapiens arginyl-tRNA synthetase (RARS), mRNA [NM_002887]",chr5:167946137-167946196,hs|5q34,arginyl-tRNA synthetase,TRUE
1283_TCEAL3_85012,Q969E4,transcription elongation factor a protein-like 3 (tcea-like protein 3) (transcription elongation factor s-ii protein-like 3),TCEAL3 MSTP072,200,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEAL3,85012,Hs.311776,ENST00000243286,NP833102,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens transcription elongation factor A (SII)-like 3 (TCEAL3), transcript variant 1, mRNA [NM_001006933]",chrX:102864665-102864724,hs|Xq22.2,transcription elongation factor A (SII)-like 3,TRUE
1284_MGP_4256,P08493,matrix gla protein (mgp) (cell growth-inhibiting gene 36 protein),MGP MGLAP GIG36,103,function: associates with the organic matrix of bone and cartilage. thought to act as an inhibitor of bone formation.,subcellular location: secreted.,NA,"DISEASE: Keutel syndrome (KTLS) [MIM:245150]: An autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis neural hearing loss and midfacial hypoplasia. {ECO:0000269|PubMed:9916809}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MGP,4256,Hs.365706,NA,THC2550449,GO:0001502(cartilage condensation)|GO:0001503(ossification)|GO:0005201(extracellular matrix structural constituent)|GO:0005509(calcium ion binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0005615(extracellular space)|GO:0005783(endoplasmic reticulum)|GO:0007275(multicellular organismal development)|GO:0007584(response to nutrient)|GO:0008147(structural constituent of bone)|GO:0009612(response to mechanical stimulus)|GO:0009725(response to hormone stimulus)|GO:0030154(cell differentiation)|GO:0030324(lung development)|GO:0030500(regulation of bone mineralization)|GO:0031012(extracellular matrix)|GO:0043234(protein complex)|GO:0048306(calcium-dependent protein binding)|GO:0048754(branching morphogenesis of a tube)|GO:0051592(response to calcium ion),"Homo sapiens matrix Gla protein (MGP), transcript variant 2, mRNA [NM_000900]",chr12:15034999-15034940,hs|12p12.3,matrix Gla protein,TRUE
1285_MICAL2_9645,O94851,[f-actin]-monooxygenase mical2 (ec 1.14.13.225) (molecule interacting with casl protein 2) (mical-2),MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2,1124,"function: nuclear monooxygenase that promotes depolymerization of f-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization (pubmed:24440334). in the absence of actin, it also functions as a nadph oxidase producing h(2)o(2) (by similarity). acts as a key regulator of the srf signaling pathway elicited by nerve growth factor and serum: mediates oxidation and subsequent depolymerization of nuclear actin, leading to increase mkl1/mrtf-a presence in the nucleus and promote srf:mkl1/mrtf-a-dependent gene transcription. does not activate srf:mkl1/mrtf-a through rhoa (pubmed:24440334). {eco:0000250|uniprotkb:q8tdz2, eco:0000269|pubmed:24440334}.",subcellular location: nucleus {eco:0000269|pubmed:24440334}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MICAL2,9645,Hs.501928,ENST00000525444,THC2767241,GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0008270(zinc ion binding)|GO:0016491(oxidoreductase activity)|GO:0046872(metal ion binding),"Homo sapiens microtubule associated monoxygenase, calponin and LIM domain containing 2 (MICAL2), mRNA [NM_014632]",chr11:12285229-12285288,hs|11p15.3,"microtubule associated monoxygenase, calponin and LIM domain containing 2",TRUE
1286_BCL6_604,P41182,b-cell lymphoma 6 protein (bcl-6) (b-cell lymphoma 5 protein) (bcl-5) (protein laz-3) (zinc finger and btb domain-containing protein 27) (zinc finger protein 51),BCL6 BCL5 LAZ3 ZBTB27 ZNF51,706,"function: transcriptional repressor mainly required for germinal center (gc) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. represses its target genes by binding directly to the dna sequence 5'-ttcctagaa-3' (bcl6-binding site) or indirectly by repressing the transcriptional activity of transcription factors. in gc b-cells, represses genes that function in differentiation, inflammation, apoptosis and cell cycle control, also autoregulates its transcriptional expression and up-regulates, indirectly, the expression of some genes important for gc reactions, such as aicda, through the repression of micrornas expression, like mir155. an important function is to allow gc b-cells to proliferate very rapidly in response to t-cell dependent antigens and tolerate the physiological dna breaks required for immunglobulin class switch recombination and somatic hypermutation without inducing a p53/tp53-dependent apoptotic response. in follicular helper cd4(+) t-cells (t(fh) cells), promotes the expression of t(fh)-related genes but inhibits the differentiation of t(h)1, t(h)2 and t(h)17 cells. also required for the establishment and maintenance of immunological memory for both t- and b-cells. suppresses macrophage proliferation through competition with stat5 for stat-binding motifs binding on certain target genes, such as ccl2 and ccnd2. in response to genotoxic stress, controls cell cycle arrest in gc b-cells in both p53/tp53-dependedent and -independent manners. besides, also controls neurogenesis through the alteration of the composition of notch-dependent transcriptional complexes at selective notch targets, such as hes5, including the recruitment of the deacetylase sirt1 and resulting in an epigenetic silencing leading to neuronal differentiation. {eco:0000269|pubmed:10981963, eco:0000269|pubmed:12402037, eco:0000269|pubmed:12414651, eco:0000269|pubmed:12504096, eco:0000269|pubmed:15454082, eco:0000269|pubmed:15577913, eco:0000269|pubmed:16142238, eco:0000269|pubmed:17828269, eco:0000269|pubmed:18212045, eco:0000269|pubmed:18280243, eco:0000269|pubmed:22113614, eco:0000269|pubmed:23166356, eco:0000269|pubmed:23911289, eco:0000269|pubmed:9649500}.","subcellular location: nucleus {eco:0000269|pubmed:12504096, eco:0000269|pubmed:17828269, eco:0000269|pubmed:22113614, eco:0000269|pubmed:23166356}.","TISSUE SPECIFICITY: Expressed in germinal center T- and B-cells and in primary immature dendritic cells. {ECO:0000269|PubMed:10981963, ECO:0000269|PubMed:12402037, ECO:0000269|PubMed:15454082, ECO:0000269|PubMed:16142238, ECO:0000269|PubMed:16455075, ECO:0000269|PubMed:17828269, ECO:0000269|PubMed:18212045, ECO:0000269|PubMed:9649500}.","DISEASE: Note=Chromosomal aberrations involving BCL6 are a cause of B-cell non-Hodgkin lymphomas (B-cell NHL), including diffuse large B-cell lymphoma and follicular lymphoma. Approximately 40% of diffuse large B-cell lymphomas and 5 to 10% of follicular lymphomas are associated with chromosomal translocations that deregulate expression of BCL6 by juxtaposing heterologous promoters to the BCL6 coding domain (PubMed:10469447, PubMed:10753856, PubMed:12414651, PubMed:11821949). Translocation t(3;14)(q27;q32). Translocation t(3;22)(q27;q11) with immunoglobulin gene regions (PubMed:11821949). Translocation t(3;7)(q27;p12) with IKZF1 gene 5'non-coding region (PubMed:10753856). Translocation t(3;6)(q27;p21) with Histone H4 (PubMed:12414651). Translocation t(3;16)(q27;p11) with IL21R. Translocation t(3;13)(q27;q14) with LCP1 (PubMed:10469447). {ECO:0000269|PubMed:10469447, ECO:0000269|PubMed:10753856, ECO:0000269|PubMed:11821949, ECO:0000269|PubMed:12414651}.; DISEASE: Note=A chromosomal aberration involving BCL6 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with POU2AF1/OBF1.; DISEASE: Note=A chromosomal aberration involving BCL6 may be a cause of lymphoma. Translocation t(3;4)(q27;p11) with ARHH/TTF.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,BCL6,604,Hs.478588,ENST00000419510,THC2466565,"GO:0000060(protein import into nucleus, translocation)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000902(cell morphogenesis)|GO:0001953(negative regulation of cell-matrix adhesion)|GO:0002634(regulation of germinal center formation)|GO:0002829(negative regulation of type 2 immune response)|GO:0002903(negative regulation of B cell apoptosis)|GO:0003682(chromatin binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005657(replication fork)|GO:0005730(nucleolus)|GO:0006974(response to DNA damage stimulus)|GO:0007283(spermatogenesis)|GO:0008104(protein localization)|GO:0008270(zinc ion binding)|GO:0008285(negative regulation of cell proliferation)|GO:0030036(actin cytoskeleton organization)|GO:0030183(B cell differentiation)|GO:0030308(negative regulation of cell growth)|GO:0030890(positive regulation of B cell proliferation)|GO:0031490(chromatin DNA binding)|GO:0032319(regulation of Rho GTPase activity)|GO:0032764(negative regulation of mast cell cytokine production)|GO:0035024(negative regulation of Rho protein signal transduction)|GO:0043065(positive regulation of apoptosis)|GO:0043066(negative regulation of apoptosis)|GO:0043380(regulation of memory T cell differentiation)|GO:0043565(sequence-specific DNA binding)|GO:0045596(negative regulation of cell differentiation)|GO:0045629(negative regulation of T-helper 2 cell differentiation)|GO:0045749(negative regulation of S phase of mitotic cell cycle)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0048294(negative regulation of isotype switching to IgE isotypes)|GO:0048821(erythrocyte development)|GO:0050727(regulation of inflammatory response)|GO:0050776(regulation of immune response)|GO:0051272(positive regulation of cellular component movement)","Homo sapiens B-cell CLL/lymphoma 6 (BCL6), transcript variant 2, mRNA [NM_001130845]",chr3:187439700-187439641,hs|3q27.3,B-cell CLL/lymphoma 6,TRUE
1287_MYO6_4646,Q9UM54,unconventional myosin-vi (unconventional myosin-6),MYO6 KIAA0389,1294,"function: myosins are actin-based motor molecules with atpase activity (by similarity). unconventional myosins serve in intracellular movements (by similarity). myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments (pubmed:10519557). has slow rate of actin-activated adp release due to weak atp binding (by similarity). functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration (by similarity). required for the structural integrity of the golgi apparatus via the p53-dependent pro-survival pathway (pubmed:16507995). appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells (pubmed:11447109). may act as a regulator of f-actin dynamics (by similarity). as part of the disp complex, may regulate the association of septins with actin and thereby regulate the actin cytoskeleton (pubmed:29467281). may play a role in transporting dab2 from the plasma membrane to specific cellular targets (by similarity). may play a role in the extension and network organization of neurites (by similarity). required for structural integrity of inner ear hair cells (by similarity). modulates rna polymerase ii-dependent transcription (pubmed:16949370). {eco:0000250|uniprotkb:q29122, eco:0000250|uniprotkb:q64331, eco:0000269|pubmed:10519557, eco:0000269|pubmed:11447109, eco:0000269|pubmed:16507995, eco:0000269|pubmed:16949370, eco:0000269|pubmed:29467281}.","subcellular location: golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:16507995}; peripheral membrane protein {eco:0000269|pubmed:16507995}. golgi apparatus {eco:0000269|pubmed:16507995}. nucleus {eco:0000269|pubmed:16507995, eco:0000269|pubmed:16949370}. cytoplasm, perinuclear region {eco:0000269|pubmed:16507995}. membrane, clathrin-coated pit {eco:0000269|pubmed:11447109}. cytoplasmic vesicle, clathrin-coated vesicle {eco:0000269|pubmed:11447109}. cell projection, filopodium {eco:0000269|pubmed:9852149}. cell projection, ruffle membrane {eco:0000269|pubmed:16507995}. cell projection, microvillus {eco:0000269|pubmed:9852149}. cytoplasm, cytosol {eco:0000269|pubmed:16949370}. note=also present in endocyctic vesicles (pubmed:16507995). translocates from membrane ruffles, endocytic vesicles and cytoplasm to golgi apparatus, perinuclear membrane and nucleus through induction by p53 and p53-induced dna damage (pubmed:16507995). recruited into membrane ruffles from cell surface by egf-stimulation (pubmed:9852149). colocalizes with dab2 in clathrin-coated pits/vesicles (pubmed:11967127). colocalizes with optn at the golgi complex and in vesicular structures close to the plasma membrane (by similarity). {eco:0000250|uniprotkb:q9i8d1, eco:0000269|pubmed:11967127, eco:0000269|pubmed:16507995, eco:0000269|pubmed:9852149}.; subcellular location: isoform 3: cytoplasmic vesicle, clathrin-coated vesicle membrane {eco:0000269|pubmed:11447109}.; subcellular location: isoform 4: cytoplasmic vesicle, clathrin-coated vesicle membrane. cell projection, ruffle membrane {eco:0000269|pubmed:11447109}.","TISSUE SPECIFICITY: Expressed in most tissues examined including heart, brain, placenta, pancreas, spleen, thymus, prostate, testis, ovary, small intestine and colon. Highest levels in brain, pancreas, testis and small intestine. Also expressed in fetal brain and cochlea. Isoform 1 and isoform 2, containing the small insert, and isoform 4, containing neither insert, are expressed in unpolarized epithelial cells. {ECO:0000269|PubMed:9259267}.","DISEASE: Deafness, autosomal dominant, 22 (DFNA22) [MIM:606346]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness. {ECO:0000269|PubMed:11468689}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 37 (DFNB37) [MIM:607821]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12687499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346]: An autosomal dominant sensorineural deafness associated with hypertrophic cardiomyopathy. {ECO:0000269|PubMed:15060111}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MYO6,4646,Hs.149387,ENST00000369985,THC2468530,"GO:0000166(nucleotide binding)|GO:0001726(ruffle)|GO:0003774(motor activity)|GO:0003779(actin binding)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005905(coated pit)|GO:0005938(cell cortex)|GO:0006886(intracellular protein transport)|GO:0006897(endocytosis)|GO:0007268(synaptic transmission)|GO:0007605(sensory perception of sound)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016461(unconventional myosin complex)|GO:0016591(DNA-directed RNA polymerase II, holoenzyme)|GO:0030048(actin filament-based movement)|GO:0030139(endocytic vesicle)|GO:0030330(DNA damage response, signal transduction by p53 class mediator)|GO:0030665(clathrin coated vesicle membrane)|GO:0031941(filamentous actin)|GO:0031965(nuclear membrane)|GO:0032587(ruffle membrane)|GO:0043531(ADP binding)|GO:0045334(clathrin-coated endocytic vesicle)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048471(perinuclear region of cytoplasm)|GO:0051015(actin filament binding)|GO:0051046(regulation of secretion)|GO:0060001(minus-end directed microfilament motor activity)","Homo sapiens myosin VI (MYO6), mRNA [NM_004999]",chr6:76625624-76625683,hs|6q14.1,myosin VI,TRUE
1288_COPS3_8533,Q9UNS2,cop9 signalosome complex subunit 3 (sgn3) (signalosome subunit 3) (jab1-containing signalosome subunit 3),COPS3 CSN3,423,"function: component of the cop9 signalosome complex (csn), a complex involved in various cellular and developmental processes. the csn complex is an essential regulator of the ubiquitin (ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of scf-type e3 ligase complexes, leading to decrease the ubl ligase activity of scf-type complexes such as scf, csa or ddb2. the complex is also involved in phosphorylation of p53/tp53, c-jun/jun, ikappabalpha/nfkbia, itpk1 and irf8/icsbp, possibly via its association with ck2 and pkd kinases. csn-dependent phosphorylation of tp53 and jun promotes and protects degradation by the ubl system, respectively. {eco:0000269|pubmed:11285227, eco:0000269|pubmed:11337588, eco:0000269|pubmed:12628923, eco:0000269|pubmed:12732143, eco:0000269|pubmed:9535219}.",subcellular location: cytoplasm {eco:0000269|pubmed:9535219}. nucleus {eco:0000269|pubmed:9535219}.,TISSUE SPECIFICITY: Widely expressed. Expressed at high level in heart and skeletal muscle. {ECO:0000269|PubMed:10191102}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,COPS3,8533,Hs.6076,ENST00000486032,THC2750922,GO:0001701(in utero embryonic development)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007165(signal transduction)|GO:0008180(signalosome)|GO:0009416(response to light stimulus)|GO:0010388(cullin deneddylation),"Homo sapiens COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis) (COPS3), transcript variant 1, mRNA [NM_003653]",chr17:17150284-17150225,hs|17p11.2,COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis),TRUE
1289_MSH6_2956,P52701,dna mismatch repair protein msh6 (hmsh6) (g/t mismatch-binding protein) (gtbp) (gtmbp) (muts protein homolog 6) (muts-alpha 160 kda subunit) (p160),MSH6 GTBP,1360,"function: component of the post-replicative dna mismatch repair system (mmr). heterodimerizes with msh2 to form muts alpha, which binds to dna mismatches thereby initiating dna repair. when bound, muts alpha bends the dna helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (idl) in the dna. after mismatch binding, forms a ternary complex with the mutl alpha heterodimer, which is thought to be responsible for directing the downstream mmr events, including strand discrimination, excision, and resynthesis. atp binding and hydrolysis play a pivotal role in mismatch repair functions. the atpase activity associated with muts alpha regulates binding similar to a molecular switch: mismatched dna provokes adp-->atp exchange, resulting in a discernible conformational transition that converts muts alpha into a sliding clamp capable of hydrolysis-independent diffusion along the dna backbone. this transition is crucial for mismatch repair. muts alpha may also play a role in dna homologous recombination repair. recruited on chromatin in g1 and early s phase via its pwwp domain that specifically binds trimethylated 'lys-36' of histone h3 (h3k36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the dna mismatch repair reaction. {eco:0000269|pubmed:10078208, eco:0000269|pubmed:10660545, eco:0000269|pubmed:15064730, eco:0000269|pubmed:21120944, eco:0000269|pubmed:23622243, eco:0000269|pubmed:9564049, eco:0000269|pubmed:9822679, eco:0000269|pubmed:9822680}.",subcellular location: nucleus {eco:0000269|pubmed:23622243}. chromosome {eco:0000269|pubmed:23622243}. note=associates with h3k36me3 via its pwwp domain.,NA,"DISEASE: Hereditary non-polyposis colorectal cancer 5 (HNPCC5) [MIM:614350]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. {ECO:0000269|PubMed:10480359, ECO:0000269|PubMed:10521294, ECO:0000269|PubMed:11586295, ECO:0000269|PubMed:12658575, ECO:0000269|PubMed:14974087, ECO:0000269|PubMed:15365995, ECO:0000269|PubMed:21120944, ECO:0000269|PubMed:22102614, ECO:0000269|PubMed:9354786}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Endometrial cancer (ENDMC) [MIM:608089]: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids. {ECO:0000269|PubMed:11153917, ECO:0000269|PubMed:14961575}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:17557300}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:10413423, ECO:0000269|PubMed:10537275, ECO:0000269|PubMed:10699937, ECO:0000269|PubMed:11153917, ECO:0000269|PubMed:11470537, ECO:0000269|PubMed:11709755, ECO:0000269|PubMed:11807791, ECO:0000269|PubMed:12522549, ECO:0000269|PubMed:14520694, ECO:0000269|PubMed:14961575, ECO:0000269|PubMed:15483016, ECO:0000269|PubMed:22102614}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MSH6,2956,Hs.445052,ENST00000543270,THC2712126,"GO:0000166(nucleotide binding)|GO:0000228(nuclear chromosome)|GO:0000287(magnesium ion binding)|GO:0000400(four-way junction DNA binding)|GO:0000710(meiotic mismatch repair)|GO:0000790(nuclear chromatin)|GO:0003682(chromatin binding)|GO:0003684(damaged DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0006200(ATP catabolic process)|GO:0006281(DNA repair)|GO:0006298(mismatch repair)|GO:0007131(reciprocal meiotic recombination)|GO:0008094(DNA-dependent ATPase activity)|GO:0008340(determination of adult lifespan)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis)|GO:0009411(response to UV)|GO:0016446(somatic hypermutation of immunoglobulin genes)|GO:0016447(somatic recombination of immunoglobulin gene segments)|GO:0016887(ATPase activity)|GO:0030983(mismatched DNA binding)|GO:0032137(guanine/thymine mispair binding)|GO:0032142(single guanine insertion binding)|GO:0032143(single thymine insertion binding)|GO:0032301(MutSalpha complex)|GO:0032357(oxidized purine DNA binding)|GO:0032405(MutLalpha complex binding)|GO:0042803(protein homodimerization activity)|GO:0043531(ADP binding)|GO:0043570(maintenance of DNA repeat elements)|GO:0045190(isotype switching)|GO:0045910(negative regulation of DNA recombination)|GO:0051096(positive regulation of helicase activity)","Homo sapiens mutS homolog 6 (E. coli) (MSH6), mRNA [NM_000179]",chr2:48033919-48033978,hs|2p16.3,mutS homolog 6 (E. coli),TRUE
129_NBPF3_84224,Q9H094,neuroblastoma breakpoint family member 3 (protein ae2) (protein shiiia4),NBPF3 L7,633,NA,subcellular location: cytoplasm {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in testis and fetal heart, as well as in non small cell lung carcinoma and neuroblastoma cell line. {ECO:0000269|PubMed:16079250}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NBPF3,84224,Hs.325422,ENST00000318249,THC2507180,GO:0005737(cytoplasm),"Homo sapiens neuroblastoma breakpoint family, member 3 (NBPF3), mRNA [NM_032264]",chr1:21811065-21811124,hs|1p36.12,"neuroblastoma breakpoint family, member 3",TRUE
1290_TARP_445347,Q0VGM3,tarp protein,TARP,111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,TARP,445347,Hs.534032,ENST00000443402,THC2545427,NA,"Homo sapiens TCR gamma alternate reading frame protein (TARP), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001003799]",chr7:38304953-38299824,hs|7p14.1,TCR gamma alternate reading frame protein,TRUE
1291_C19orf79_100131801,P0DJ07,"protein pet100 homolog, mitochondrial",PET100 C19orf79,73,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}. mitochondrion {eco:0000250}. note=localizes to a membrane-bound organelle. {eco:0000269|pubmed:22356826}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C19orf79,100131801,Hs.728837,ENST00000456958,THC2549174,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 19 open reading frame 79 (C19orf79), transcript variant 1, mRNA [NM_001171155]",chr19:7695482-7695541,hs|19p13.2,chromosome 19 open reading frame 79,TRUE
1292_RAN_5901,P62826,gtp-binding nuclear protein ran (androgen receptor-associated protein 24) (gtpase ran) (ras-like protein tc4) (ras-related nuclear protein),RAN ARA24 OK/SW-cl.81,216,"function: gtpase involved in nucleocytoplasmic transport, participating both to the import and the export from the nucleus of proteins and rnas (pubmed:10400640, pubmed:8276887, pubmed:8896452, pubmed:8636225, pubmed:8692944, pubmed:9351834, pubmed:9428644, pubmed:9822603, pubmed:26272610). switches between a cytoplasmic gdp- and a nuclear gtp-bound state by nucleotide exchange and gtp hydrolysis (pubmed:7819259, pubmed:8896452, pubmed:8636225, pubmed:8692944, pubmed:9351834, pubmed:9428644, pubmed:9822603, pubmed:29040603, pubmed:11336674, pubmed:26272610). nuclear import receptors such as importin beta bind their substrates only in the absence of gtp-bound ran and release them upon direct interaction with gtp-bound ran, while export receptors behave in the opposite way. thereby, ran controls cargo loading and release by transport receptors in the proper compartment and ensures the directionality of the transport (pubmed:8896452, pubmed:9351834, pubmed:9428644). interaction with ranbp1 induces a conformation change in the complex formed by xpo1 and ran that triggers the release of the nuclear export signal of cargo proteins (pubmed:20485264). ran (gtp-bound form) triggers microtubule assembly at mitotic chromosomes and is required for normal mitotic spindle assembly and chromosome segregation (pubmed:10408446, pubmed:29040603). required for normal progress through mitosis (pubmed:8421051, pubmed:12194828, pubmed:29040603). the complex with birc5/survivin plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the ran effector molecule tpx2 to microtubules (pubmed:18591255). acts as a negative regulator of the kinase activity of vrk1 and vrk2 (pubmed:18617507). enhances ar-mediated transactivation. transactivation decreases as the poly-gln length within ar increases (pubmed:10400640). {eco:0000269|pubmed:10400640, eco:0000269|pubmed:10408446, eco:0000269|pubmed:11336674, eco:0000269|pubmed:12194828, eco:0000269|pubmed:18591255, eco:0000269|pubmed:18617507, eco:0000269|pubmed:20485264, eco:0000269|pubmed:29040603, eco:0000269|pubmed:7819259, eco:0000269|pubmed:8276887, eco:0000269|pubmed:8421051, eco:0000269|pubmed:8636225, eco:0000269|pubmed:8692944, eco:0000269|pubmed:8896452, eco:0000269|pubmed:9351834, eco:0000269|pubmed:9428644, eco:0000269|pubmed:9822603, eco:0000305|pubmed:26272610}.","subcellular location: nucleus {eco:0000269|pubmed:10679025, eco:0000269|pubmed:12194828, eco:0000269|pubmed:8421051, eco:0000269|pubmed:8896452, eco:0000269|pubmed:9351834, eco:0000269|pubmed:9822603}. nucleus envelope {eco:0000269|pubmed:8896452, eco:0000269|pubmed:9822603}. cytoplasm, cytosol {eco:0000269|pubmed:8276887}. cytoplasm {eco:0000269|pubmed:10679025, eco:0000269|pubmed:12194828, eco:0000269|pubmed:9822603}. melanosome {eco:0000269|pubmed:17081065}. note=predominantly nuclear during interphase (pubmed:8421051, pubmed:12194828, pubmed:10679025). becomes dispersed throughout the cytoplasm during mitosis (pubmed:8421051, pubmed:12194828). identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:17081065). {eco:0000269|pubmed:10679025, eco:0000269|pubmed:12194828, eco:0000269|pubmed:17081065, eco:0000269|pubmed:8421051}.",TISSUE SPECIFICITY: Expressed in a variety of tissues. {ECO:0000269|PubMed:2108320}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RAN,5901,Hs.10842,ENST00000392369,THC2488402,"GO:0000166(nucleotide binding)|GO:0000785(chromatin)|GO:0003682(chromatin binding)|GO:0003713(transcription coactivator activity)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005634(nucleus)|GO:0005643(nuclear pore)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006184(GTP catabolic process)|GO:0006259(DNA metabolic process)|GO:0006405(RNA export from nucleus)|GO:0006611(protein export from nucleus)|GO:0006886(intracellular protein transport)|GO:0006913(nucleocytoplasmic transport)|GO:0007049(cell cycle)|GO:0007052(mitotic spindle organization)|GO:0007067(mitosis)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0016032(viral reproduction)|GO:0019058(viral infectious cycle)|GO:0030521(androgen receptor signaling pathway)|GO:0042470(melanosome)|GO:0044419(interspecies interaction between organisms)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046796(viral genome transport in host cell)|GO:0050681(androgen receptor binding)|GO:0051301(cell division)","Homo sapiens RAN, member RAS oncogene family (RAN), mRNA [NM_006325]",chr12:131360738-131360797,hs|12q24.33,"RAN, member RAS oncogene family",TRUE
1293_AMACR_23600,Q9UHK6,alpha-methylacyl-coa racemase (ec 5.1.99.4) (2-methylacyl-coa racemase),AMACR,382,"function: catalyzes the interconversion of (r)- and (s)-stereoisomers of alpha-methyl-branched-chain fatty acyl-coa esters (pubmed:7649182, pubmed:10655068, pubmed:11060359). acts only on coenzyme a thioesters, not on free fatty acids, and accepts as substrates a wide range of alpha-methylacyl-coas, including pristanoyl-coa, trihydroxycoprostanoyl-coa (an intermediate in bile acid synthesis), and arylpropionic acids like the anti-inflammatory drug ibuprofen (2-(4-isobutylphenyl)propionic acid) but neither 3-methyl-branched nor linear-chain acyl-coas (pubmed:7649182, pubmed:10655068, pubmed:11060359). {eco:0000269|pubmed:10655068, eco:0000269|pubmed:11060359, eco:0000269|pubmed:7649182}.","subcellular location: peroxisome {eco:0000269|pubmed:11060344, eco:0000269|pubmed:11060359, eco:0000269|pubmed:7649182}. mitochondrion {eco:0000269|pubmed:11060344, eco:0000269|pubmed:11060359, eco:0000269|pubmed:7649182}.",NA,"DISEASE: Alpha-methylacyl-CoA racemase deficiency (AMACRD) [MIM:614307]: A rare autosomal recessive peroxisomal disorder characterized by elevated plasma concentrations of pristanic acid C27-bile-acid intermediates, and adult onset of variable neurodegenerative symptoms affecting the central and peripheral nervous systems. Features may include seizures, visual failure, sensorimotor neuropathy, spasticity, migraine, and white matter hyperintensities on brain imaging. {ECO:0000269|PubMed:10655068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bile acid synthesis defect 4 (CBAS4) [MIM:214950]: A disorder characterized by the presence of trihydroxycoprostanic acid in the bile and absence of cholic acid. Patients manifest neonatal jaundice, intrahepatic cholestasis and bile duct deficiency. {ECO:0000269|PubMed:10655068, ECO:0000269|PubMed:12512044}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AMACR,23600,Hs.508343,ENST00000382079,THC2506019,GO:0005739(mitochondrion)|GO:0005777(peroxisome)|GO:0005782(peroxisomal matrix)|GO:0006699(bile acid biosynthetic process)|GO:0008111(alpha-methylacyl-CoA racemase activity)|GO:0008206(bile acid metabolic process)|GO:0016853(isomerase activity)|GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase)|GO:0044255(cellular lipid metabolic process),"Homo sapiens alpha-methylacyl-CoA racemase (AMACR), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_014324]",chr5:33998763-33989566,hs|5p13.2,alpha-methylacyl-CoA racemase,TRUE
1294_CAPRIN1_4076,Q14444,caprin-1 (cell cycle-associated protein 1) (cytoplasmic activation- and proliferation-associated protein 1) (gpi-anchored membrane protein 1) (gpi-anchored protein p137) (gpi-p137) (p137gpi) (membrane component chromosome 11 surface marker 1) (rna granule protein 105),CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105,709,"function: may regulate the transport and translation of mrnas of proteins involved in synaptic plasticity in neurons and cell proliferation and migration in multiple cell types. binds directly and selectively to myc and ccnd2 rnas. in neuronal cells, directly binds to several mrnas associated with rna granules, including bdnf, camk2a, creb1, map2, ntrk2 mrnas, as well as to grin1 and kpnb1 mrnas, but not to rrnas. {eco:0000269|pubmed:17210633}.","subcellular location: cytoplasm, cytosol. cell projection, dendrite. note=associated with rna granules. {eco:0000250}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CAPRIN1,4076,Hs.471818,ENST00000533657,THC2530998,GO:0000932(cytoplasmic mRNA processing body)|GO:0003723(RNA binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005887(integral to plasma membrane)|GO:0010494(stress granule)|GO:0017148(negative regulation of translation)|GO:0030154(cell differentiation)|GO:0030425(dendrite)|GO:0042995(cell projection)|GO:0050775(positive regulation of dendrite morphogenesis)|GO:0061003(positive regulation of dendritic spine morphogenesis),"Homo sapiens cell cycle associated protein 1 (CAPRIN1), transcript variant 1, mRNA [NM_005898]",chr11:34122551-34122610,hs|11p13,cell cycle associated protein 1,TRUE
1295_MIEN1_84299,Q9BRT3,migration and invasion enhancer 1 (hbv x-transactivated gene 4 protein) (hbv xag-transactivated protein 4) (protein c35),MIEN1 C17orf37 RDX12 XTP4,115,"function: increases cell migration by inducing filopodia formation at the leading edge of migrating cells. plays a role in regulation of apoptosis, possibly through control of casp3. may be involved in a redox-related process. {eco:0000269|pubmed:19503095, eco:0000269|pubmed:21628459}.","subcellular location: cytoplasm, cytosol. cell membrane; lipid-anchor; cytoplasmic side. note=concentrates at the leading edge of migrating cells. localizes outside membrane raft regions.","TISSUE SPECIFICITY: Among normal tissues, present only in Leydig cells. Strongly up-regulated in breast cancers and in brain cancer distant metastasis (at protein level). Up-regulated in prostate cancer cells and in the higher grades of prostate adenocarcinoma (at protein level). {ECO:0000269|PubMed:17121940, ECO:0000269|PubMed:19503095}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MIEN1,84299,Hs.333526,ENST00000498164,THC2467445,GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0008430(selenium binding)|GO:0016020(membrane)|GO:0030335(positive regulation of cell migration)|GO:0031235(intrinsic to internal side of plasma membrane)|GO:0043066(negative regulation of apoptosis)|GO:0045454(cell redox homeostasis)|GO:0051491(positive regulation of filopodium assembly),"Homo sapiens migration and invasion enhancer 1 (MIEN1), mRNA [NM_032339]",chr17:37885527-37885468,hs|17q12,migration and invasion enhancer 1,TRUE
1296_EXOC7_23265,Q9UPT5,exocyst complex component 7 (exocyst complex component exo70),EXOC7 EXO70 KIAA1067,735,"function: component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. in adipocytes, plays a crucial role in targeting slc2a4 vesicle to the plasma membrane in response to insulin, perhaps directing the vesicle to the precise site of fusion (by similarity). {eco:0000250}.","subcellular location: cytoplasm, cytosol {eco:0000250|uniprotkb:o35250}. cell membrane {eco:0000250|uniprotkb:o35250}; peripheral membrane protein {eco:0000305}. midbody, midbody ring {eco:0000269|pubmed:16213214}. note=translocates, as a preformed complex with exoc3/sec6 and exoc4/sec8, to the plasma membrane in response to insulin through the activation of arhq (by similarity). colocalizes with cntrl/centriolin at the midbody ring (pubmed:16213214). {eco:0000250|uniprotkb:o35250, eco:0000269|pubmed:16213214}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,EXOC7,23265,Hs.514496,ENST00000465252,THC2624152,GO:0000145(exocyst)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006887(exocytosis)|GO:0015031(protein transport)|GO:0034451(centriolar satellite),"Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 1, mRNA [NM_001013839]",chr17:74077164-74077105,hs|17q25.1,exocyst complex component 7,TRUE
1297_NRD1_4898,O43847,nardilysin (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c) (nardilysin convertase),NRDC NRD1,1151,function: cleaves peptide substrates on the n-terminus of arginine residues in dibasic pairs.,NA,"TISSUE SPECIFICITY: Primarily in adult heart, skeletal muscle, and testis and at much lower levels in other tissues.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,NRD1,4898,Hs.584782,ENST00000464385,NP1244077,GO:0004222(metalloendopeptidase activity)|GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0007528(neuromuscular junction development)|GO:0008233(peptidase activity)|GO:0008270(zinc ion binding)|GO:0008283(cell proliferation)|GO:0009986(cell surface)|GO:0016477(cell migration)|GO:0046872(metal ion binding)|GO:0048408(epidermal growth factor binding)|GO:0051044(positive regulation of membrane protein ectodomain proteolysis)|GO:0052548(regulation of endopeptidase activity),"Homo sapiens nardilysin (N-arginine dibasic convertase) (NRD1), transcript variant 1, mRNA [NM_002525]",chr1:52255062-52255003,hs|1p32.3,nardilysin (N-arginine dibasic convertase),TRUE
1298_MYO19_80179,Q96H55,unconventional myosin-xix (myosin head domain-containing protein 1),MYO19 MYOHD1,970,"function: actin-based motor molecule with atpase activity that localizes to the mitochondrion outer membrane (pubmed:19932026, pubmed:23568824, pubmed:25447992). motor protein that moves towards the plus-end of actin filaments (by similarity). required for mitochondrial inheritance during mitosis (pubmed:25447992). may be involved in mitochondrial transport or positioning (pubmed:23568824). {eco:0000250|uniprotkb:q5sv80, eco:0000269|pubmed:19932026, eco:0000269|pubmed:25447992, eco:0000305|pubmed:23568824}.","subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:19932026, eco:0000269|pubmed:23568824, eco:0000269|pubmed:25447992, eco:0000269|pubmed:26659663, eco:0000269|pubmed:27126804}; peripheral membrane protein {eco:0000269|pubmed:27126804}. cytoplasm, cytoskeleton {eco:0000269|pubmed:19932026}.",TISSUE SPECIFICITY: Widely expressed in multiple tissues and cell lines. {ECO:0000269|PubMed:19932026}.,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,MYO19,80179,Hs.302051,ENST00000415126,THC2467749,GO:0000166(nucleotide binding)|GO:0003774(motor activity)|GO:0003779(actin binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005856(cytoskeleton)|GO:0016020(membrane)|GO:0016459(myosin complex),"Homo sapiens myosin XIX (MYO19), transcript variant 1, mRNA [NM_025109]",chr17:34851731-34851672,hs|17q12,myosin XIX,TRUE
1299_SYPL1_6856,Q16563,synaptophysin-like protein 1 (pantophysin),SYPL1 SYPL,259,NA,subcellular location: cytoplasmic vesicle membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}. melanosome {eco:0000269|pubmed:17081065}. note=cytoplasmic transport vesicles (by similarity). identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,SYPL1,6856,Hs.80919,ENST00000011473,THC2492159,GO:0005215(transporter activity)|GO:0005887(integral to plasma membrane)|GO:0007268(synaptic transmission)|GO:0008021(synaptic vesicle)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030141(stored secretory granule)|GO:0030659(cytoplasmic vesicle membrane)|GO:0031410(cytoplasmic vesicle)|GO:0042470(melanosome),"Homo sapiens synaptophysin-like 1 (SYPL1), transcript variant 2, mRNA [NM_182715]",chr7:105731525-105731466,hs|7q22.3,synaptophysin-like 1,TRUE
13_H3F3A_3020,P84243,histone h3.3,H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B,136,"function: variant histone h3 which replaces conventional h3 in a wide range of nucleosomes in active genes. constitutes the predominant form of histone h3 in non-dividing cells and is incorporated into chromatin independently of dna synthesis. deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {eco:0000269|pubmed:14718166, eco:0000269|pubmed:15776021, eco:0000269|pubmed:16258499}.",subcellular location: nucleus. chromosome.,NA,"DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539269}. Note=The gene represented in this entry is involved in disease pathogenesis. H3F3A mutations affecting residues involved in post-translational modifications of histone H3.3 are recurrent in malignant, aggressive gliomas including glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG) (PubMed:22286061, PubMed:22286216). The mechanism through which mutations lead to tumorigenesis involves altered histones methylation, impaired regulation of Polycomb repressive complex 2 (PRC2) activity, and aberrant epigenetic regulation of gene expression (PubMed:23539269, PubMed:23539183, PubMed:23603901). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269, ECO:0000269|PubMed:23603901}.; DISEASE: Note=H3F3A and H3F3B mutations affecting residues involved in post-translational modifications of histone H3.3 are implicated in the pathogenesis of some bone and cartilage neoplasms. Mutations have been found with high prevalence in chondroblastoma and giant cell tumors of bone, and with low frequency in osteosarcoma, conventional chondrosarcoma and clear cell chondrosarcoma. Chondroblastoma samples frequently carry a H3F3B mutation affecting residue Lys-37 (H3K36), although H3F3A is mutated in some cases. Most giant cell tumors of bone harbor H3F3A mutations affecting residue Gly-35 (H3G34). {ECO:0000269|PubMed:24162739}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H3F3A,3020,Hs.533624,ENST00000366816,THC2571124,NA,"Homo sapiens H3 histone, family 3A (H3F3A), mRNA [NM_002107]",chr1:226259067-226259126,hs|1q42.12,"H3 histone, family 3A",TRUE
130_HLA-C_3107,P10321,"hla class i histocompatibility antigen, c alpha chain (hla-c) (hla-cw) (human leukocyte antigen c)",HLA-C HLAC,366,"function: antigen-presenting major histocompatibility complex class i (mhci) molecule with an important role in reproduction and antiviral immunity (pubmed:20972337, pubmed:24091323, pubmed:20439706, pubmed:11172028, pubmed:20104487, pubmed:28649982, pubmed:29312307). in complex with b2m/beta 2 microglobulin displays a restricted repertoire of self and viral peptides and acts as a dominant ligand for inhibitory and activating killer immunoglobulin receptors (kirs) expressed on nk cells (pubmed:16141329). in an allogeneic setting, such as during pregnancy, mediates interaction of extravillous trophoblasts with kir on uterine nk cells and regulate trophoblast invasion necessary for placentation and overall fetal growth (pubmed:20972337, pubmed:24091323). during viral infection, may present viral peptides with low affinity for kirs, impeding kir-mediated inhibition through peptide antagonism and favoring lysis of infected cells (pubmed:20439706). presents a restricted repertoire of viral peptides on antigen-presenting cells for recognition by alpha-beta t cell receptor (tcr) on hla-c-restricted cd8-positive t cells, guiding antigen-specific t cell immune response to eliminate infected cells, particularly in chronic viral infection settings such as hiv-1 or cmv infection (pubmed:11172028, pubmed:20104487, pubmed:28649982). both the peptide and the mhc molecule are recognized by tcr, the peptide is responsible for the fine specificity of antigen recognition and mhc residues account for the mhc restriction of t cells (by similarity). typically presents intracellular peptide antigens of 9 amino acids that arise from cytosolic proteolysis via proteasome. can bind different peptides containing allele-specific binding motifs, which are mainly defined by anchor residues at position 2 and 9. preferentially displays peptides having a restricted repertoire of hydrophobic or aromatic amino acids (phe, ile, leu, met, val and tyr) at the c-terminal anchor (pubmed:8265661, pubmed:25311805). {eco:0000250|uniprotkb:p04439, eco:0000269|pubmed:11172028, eco:0000269|pubmed:16141329, eco:0000269|pubmed:20104487, eco:0000269|pubmed:20439706, eco:0000269|pubmed:20972337, eco:0000269|pubmed:24091323, eco:0000269|pubmed:25311805, eco:0000269|pubmed:28649982, eco:0000269|pubmed:29312307, eco:0000269|pubmed:8265661}.; function: allele c*01:02: the peptide-bound form interacts with kir2dl2 and kir2dl3 inhibitory receptors on nk cells. the low affinity peptides compete with the high affinity peptides impeding kir-mediated inhibition and favoring lysis of infected cells (pubmed:20439706). presents to cd8-positive t cells a cmv epitope derived from ul83/pp65 (rcpemisvl), an immediate-early antigen necessary for initiating viral replication (pubmed:12947002). {eco:0000269|pubmed:12947002, eco:0000269|pubmed:20439706}.; function: allele c*04:01: presents a conserved hiv-1 epitope derived from env (sfncggeff) to memory cd8-positive t cells, eliciting very strong ifng responses (pubmed:20104487). presents cmv epitope derived from ul83/pp65 (qydpvaalf) to cd8-positive t cells, triggering t cell cytotoxic response (pubmed:12947002). {eco:0000269|pubmed:12947002, eco:0000269|pubmed:20104487}.; function: allele c*05:01: presents hiv-1 epitope derived from rev (saepvplql) to cd8-positive t cells, triggering t cell cytotoxic response. {eco:0000269|pubmed:11172028}.; function: allele c*06:02: in trophoblasts, interacts with kir2ds2 on uterine nk cells and triggers nk cell activation, including secretion of cytokines such as gmcsf that enhances trophoblast migration. {eco:0000269|pubmed:24091323}.; function: allele c*07:02: plays an important role in the control of chronic cmv infection. presents immunodominant cmv epitopes derived from ie1 (lsefcrvl and crvlccyvl) and ul28 (frcprrfcf), both antigens synthesized during immediate-early period of viral replication. elicits a strong anti-viral cd8-positive t cell immune response that increases markedly with age. {eco:0000269|pubmed:29312307}.; function: allele c*08:01: presents viral epitopes derived from cmv ul83 (vvcahelvc) and iav m1 (gilgfvftl), triggering cd8-positive t cell cytotoxic response. {eco:0000269|pubmed:12947002, eco:0000269|pubmed:24990997}.; function: allele c*12:02: presents cmv epitope derived from ul83 (vaftshehf) to cd8-positive t cells. {eco:0000269|pubmed:12947002}.; function: allele c*15:02: presents cmv epitope derived from ul83 cc (vvcahelvc) to cd8-positive t cells, triggering t cell cytotoxic response. {eco:0000269|pubmed:12947002}.","subcellular location: cell membrane {eco:0000269|pubmed:18420581, eco:0000269|pubmed:20972337, eco:0000269|pubmed:28649982}; single-pass type i membrane protein {eco:0000255}. endoplasmic reticulum membrane {eco:0000305|pubmed:18420581}; single-pass membrane protein {eco:0000255}.",TISSUE SPECIFICITY: Ubiquitous. Highly expressed in fetal extravillous trophoblasts in the decidua basalis (at protein level). {ECO:0000269|PubMed:20972337}.,"DISEASE: Psoriasis 1 (PSORS1) [MIM:177900]: A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis. {ECO:0000269|PubMed:16642438}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Allele C*06:02 presents a melanocyte autoantigen ADAMTSL5 (VRSRRCLRL) to Valpha3S1/Vbeta13S1 TCR on CD8-positive T cells, and may trigger an autoimmune response against melanocytes. {ECO:0000269|PubMed:26621454}.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HLA-C,3107,Hs.654404,ENST00000539307,NP1185402,GO:0000139(Golgi membrane)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005576(extracellular region)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006955(immune response)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019221(cytokine-mediated signaling pathway)|GO:0019882(antigen processing and presentation)|GO:0032393(MHC class I receptor activity)|GO:0042612(MHC class I protein complex)|GO:0044419(interspecies interaction between organisms)|GO:0050776(regulation of immune response)|GO:0060333(interferon-gamma-mediated signaling pathway)|GO:0060337(type I interferon-mediated signaling pathway)|GO:0071556(integral to lumenal side of endoplasmic reticulum membrane),"Homo sapiens major histocompatibility complex, class I, C (HLA-C), transcript variant 1, mRNA [NM_002117]",chr6:31236692-31236633,hs|6p21.33,"major histocompatibility complex, class I, C",TRUE
1300_C19orf56_51398,Q9Y284,protein asterix (wd repeat domain 83 opposite strand) (wdr83 opposite strand),WDR83OS C19orf56 CGI-140 My006 PTD008,106,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C19orf56,51398,Hs.108969,ENST00000222190,THC2500525,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 19 open reading frame 56 (C19orf56), mRNA [NM_016145]",chr19:12779185-12779126,hs|19p13.2,chromosome 19 open reading frame 56,TRUE
1301_PAICS_10606,P22234,multifunctional protein ade2 [includes: phosphoribosylaminoimidazole-succinocarboxamide synthase (ec 6.3.2.6) (saicar synthetase); phosphoribosylaminoimidazole carboxylase (ec 4.1.1.21) (air carboxylase) (airc)],PAICS ADE2 AIRC PAIS,425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,PAICS,10606,Hs.518774,ENST00000512576,THC2511006,"GO:0000166(nucleotide binding)|GO:0004638(phosphoribosylaminoimidazole carboxylase activity)|GO:0004639(phosphoribosylaminoimidazolesuccinocarboxamide synthase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005829(cytosol)|GO:0006144(purine base metabolic process)|GO:0006164(purine nucleotide biosynthetic process)|GO:0006189(de novo' IMP biosynthetic process)|GO:0009113(purine base biosynthetic process)|GO:0009168(purine ribonucleoside monophosphate biosynthetic process)|GO:0016829(lyase activity)|GO:0016874(ligase activity)|GO:0042802(identical protein binding)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), transcript variant 1, mRNA [NM_001079525]",chr4:57325538-57325597,hs|4q12,"phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase",TRUE
1302_NUCB2_4925,P80303,nucleobindin-2 (dna-binding protein nefa) (epididymis secretory protein li 109) (gastric cancer antigen zg4) (prepronesfatin) [cleaved into: nesfatin-1],NUCB2 NEFA,420,"function: calcium-binding protein. may have a role in calcium homeostasis.; function: nesfatin-1: anorexigenic peptide, seems to play an important role in hypothalamic pathways regulating food intake and energy homeostasis, acting in a leptin-independent manner. may also exert hypertensive roles and modulate blood pressure through directly acting on peripheral arterial resistance (by similarity). {eco:0000250}.",subcellular location: golgi apparatus {eco:0000269|pubmed:11749975}. membrane {eco:0000269|pubmed:11749975}; peripheral membrane protein {eco:0000269|pubmed:11749975}. cytoplasm {eco:0000269|pubmed:11749975}. secreted {eco:0000269|pubmed:11749975}. endoplasmic reticulum {eco:0000250}. nucleus envelope {eco:0000250}. note=golgi retention is mediated by its n-terminal region.; subcellular location: nesfatin-1: secreted.,"TISSUE SPECIFICITY: Predominantly expressed in spleen, testis and normal stomach. {ECO:0000269|PubMed:12087473}.",NA,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NUCB2,4925,Hs.654599,ENST00000458064,THC2462680,GO:0003677(DNA binding)|GO:0005509(calcium ion binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005886(plasma membrane),"Homo sapiens nucleobindin 2 (NUCB2), mRNA [NM_005013]",chr11:17351767-17351826,hs|11p15.1,nucleobindin 2,TRUE
1303_RUFY1_80230,Q96T51,run and fyve domain-containing protein 1 (fyve-finger protein eip1) (la-binding protein 1) (rab4-interacting protein) (zinc finger fyve domain-containing protein 12),RUFY1 RABIP4 ZFYVE12,708,function: binds phospholipid vesicles containing phosphatidylinositol 3-phosphate and participates in early endosomal trafficking. {eco:0000269|pubmed:14617813}.,subcellular location: cytoplasm. early endosome membrane; peripheral membrane protein.,"TISSUE SPECIFICITY: Broadly expressed, with highest levels in lung, testis, kidney and brain. {ECO:0000269|PubMed:11877430}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RUFY1,80230,Hs.306769,ENST00000508797,THC2788118,GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0006897(endocytosis)|GO:0008270(zinc ion binding)|GO:0008289(lipid binding)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0031901(early endosome membrane)|GO:0046872(metal ion binding),"Homo sapiens RUN and FYVE domain containing 1 (RUFY1), transcript variant 1, mRNA [NM_025158]",chr5:179036864-179036923,hs|5q35.3,RUN and FYVE domain containing 1,TRUE
1304_KLK3_354,P07288,prostate-specific antigen (psa) (ec 3.4.21.77) (gamma-seminoprotein) (seminin) (kallikrein-3) (p-30 antigen) (semenogelase),KLK3 APS,261,function: hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum.,subcellular location: secreted.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KLK3,354,Hs.171995,ENST00000326052,NP509056,GO:0004252(serine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008236(serine-type peptidase activity)|GO:0016525(negative regulation of angiogenesis),"Homo sapiens kallikrein-related peptidase 3 (KLK3), transcript variant 1, mRNA [NM_001648]",chr19:51361753-51361812,hs|19q13.33,kallikrein-related peptidase 3,TRUE
1305_PSMD1_5707,Q99460,26s proteasome non-atpase regulatory subunit 1 (26s proteasome regulatory subunit rpn2) (26s proteasome regulatory subunit s1) (26s proteasome subunit p112),PSMD1,953,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair. {eco:0000269|pubmed:1317798}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSMD1,5707,Hs.3887,ENST00000491229,THC2465502,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005488(binding)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0005838(proteasome regulatory particle)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030234(enzyme regulator activity)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042176(regulation of protein catabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 (PSMD1), transcript variant 1, mRNA [NM_002807]",chr2:232037369-232037428,hs|2q37.1,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 1",TRUE
1306_SLC38A1_81539,Q9H2H9,sodium-coupled neutral amino acid transporter 1 (amino acid transporter a1) (n-system amino acid transporter 2) (solute carrier family 38 member 1) (system a amino acid transporter 1) (system n amino acid transporter 1),SLC38A1 ATA1 NAT2 SAT1 SNAT1,487,"function: functions as a sodium-dependent amino acid transporter. mediates the saturable, ph-sensitive and electrogenic cotransport of glutamine and sodium ions with a stoichiometry of 1:1. may also transport small zwitterionic and aliphatic amino acids with a lower affinity. may supply glutamatergic and gabaergic neurons with glutamine which is required for the synthesis of the neurotransmitters glutamate and gaba. {eco:0000269|pubmed:10891391}.",subcellular location: cell membrane {eco:0000269|pubmed:15054072}; multi-pass membrane protein {eco:0000269|pubmed:15054072}. note=restricted to the somatodendritic compartment of neurons. found in the cellular processes of neurons in the developing brain (by similarity). {eco:0000250}.,"TISSUE SPECIFICITY: Expressed in the cerebral cortex by pyramidal and GABAergic neurons, astrocytes and other non-neuronal cells (at protein level). Expressed in placenta, heart, lung, skeletal muscle, spleen, stomach and testis. {ECO:0000269|PubMed:10891391, ECO:0000269|PubMed:12388062, ECO:0000269|PubMed:15054072, ECO:0000269|PubMed:16148032}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC38A1,81539,Hs.533770,NA,THC2535318,GO:0001504(neurotransmitter uptake)|GO:0005283(sodium:amino acid symporter activity)|GO:0005886(plasma membrane)|GO:0006811(ion transport)|GO:0006814(sodium ion transport)|GO:0006865(amino acid transport)|GO:0007268(synaptic transmission)|GO:0015175(neutral amino acid transmembrane transporter activity)|GO:0015293(symporter activity)|GO:0015804(neutral amino acid transport)|GO:0016021(integral to membrane)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0055085(transmembrane transport),"Homo sapiens solute carrier family 38, member 1 (SLC38A1), transcript variant 1, mRNA [NM_030674]",chr12:46577120-46577061,hs|12q13.11,"solute carrier family 38, member 1",TRUE
1307_TSG101_7251,Q99816,tumor susceptibility gene 101 protein (escrt-i complex subunit tsg101),TSG101,390,"function: component of the escrt-i complex, a regulator of vesicular trafficking process. binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (mvbs). mediates the association between the escrt-0 and escrt-i complex. required for completion of cytokinesis; the function requires cep55. may be involved in cell growth and differentiation. acts as a negative growth regulator. involved in the budding of many viruses through an interaction with viral proteins that contain a late-budding motif p-[st]-a-p. this interaction is essential for viral particle budding of numerous retroviruses. required for the exosomal release of sdcbp, cd63 and syndecan (pubmed:22660413). it may also play a role in the extracellular release of microvesicles that differ from the exosomes (pubmed:22315426). {eco:0000269|pubmed:11916981, eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893, eco:0000269|pubmed:21070952, eco:0000269|pubmed:21757351, eco:0000269|pubmed:22315426, eco:0000269|pubmed:22660413}.","subcellular location: cytoplasm {eco:0000269|pubmed:17853893}. early endosome membrane {eco:0000269|pubmed:23166352}; peripheral membrane protein {eco:0000305|pubmed:23166352}; cytoplasmic side {eco:0000305|pubmed:23166352}. late endosome membrane {eco:0000269|pubmed:11916981, eco:0000269|pubmed:17229889}; peripheral membrane protein. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:17853893}. midbody, midbody ring {eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893}. nucleus {eco:0000269|pubmed:17229889}. note=mainly cytoplasmic. membrane-associated when active and soluble when inactive. nuclear localization is cell cycle-dependent. interaction with cep55 is required for localization to the midbody during cytokinesis. {eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893}.","TISSUE SPECIFICITY: Heart, brain, placenta, lung, liver, skeletal, kidney and pancreas.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TSG101,7251,Hs.523512,ENST00000357193,THC2735363,"GO:0001558(regulation of cell growth)|GO:0003677(DNA binding)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0005770(late endosome)|GO:0005771(multivesicular body)|GO:0005886(plasma membrane)|GO:0006464(protein modification process)|GO:0006513(protein monoubiquitination)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0008285(negative regulation of cell proliferation)|GO:0008333(endosome to lysosome transport)|GO:0010008(endosome membrane)|GO:0015031(protein transport)|GO:0016044(cellular membrane organization)|GO:0016197(endosome transport)|GO:0030154(cell differentiation)|GO:0030216(keratinocyte differentiation)|GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity)|GO:0031625(ubiquitin protein ligase binding)|GO:0031902(late endosome membrane)|GO:0043130(ubiquitin binding)|GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway)|GO:0044419(interspecies interaction between organisms)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046755(non-lytic virus budding)|GO:0048306(calcium-dependent protein binding)|GO:0051301(cell division)","Homo sapiens tumor susceptibility gene 101 (TSG101), mRNA [NM_006292]",chr11:18502071-18502012,hs|11p15.1,tumor susceptibility gene 101,TRUE
1308_DPM1_8813,O60762,dolichol-phosphate mannosyltransferase subunit 1 (ec 2.4.1.83) (dolichol-phosphate mannose synthase subunit 1) (dpm synthase subunit 1) (dolichyl-phosphate beta-d-mannosyltransferase subunit 1) (mannose-p-dolichol synthase subunit 1) (mpd synthase subunit 1),DPM1,260,"function: transfers mannose from gdp-mannose to dolichol monophosphate to form dolichol phosphate mannose (dol-p-man) which is the mannosyl donor in pathways leading to n-glycosylation, glycosyl phosphatidylinositol membrane anchoring, and o-mannosylation of proteins; catalytic subunit of the dolichol-phosphate mannose (dpm) synthase complex.",subcellular location: endoplasmic reticulum.,NA,"DISEASE: Congenital disorder of glycosylation 1E (CDG1E) [MIM:608799]: A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Some CDG1E patients have features consistent with a dystroglycanopathy and congenital muscular dystrophy, including O-mannosylation defect, camptodactyly, elevated creatine kinase, motor delay and dystrophic changes on muscel biopsy. {ECO:0000269|PubMed:10642597, ECO:0000269|PubMed:10642602, ECO:0000269|PubMed:15669674, ECO:0000269|PubMed:23856421}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DPM1,8813,Hs.654951,ENST00000449701,THC2635827,"GO:0004169(dolichyl-phosphate-mannose-protein mannosyltransferase activity)|GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity)|GO:0005515(protein binding)|GO:0005537(mannose binding)|GO:0005624(membrane fraction)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006488(dolichol-linked oligosaccharide biosynthetic process)|GO:0006501(C-terminal protein lipidation)|GO:0006506(GPI anchor biosynthetic process)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0019348(dolichol metabolic process)|GO:0019673(GDP-mannose metabolic process)|GO:0033185(dolichol-phosphate-mannose synthase complex)|GO:0035268(protein mannosylation)|GO:0035269(protein O-linked mannosylation)|GO:0043178(alcohol binding)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)","Homo sapiens dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit (DPM1), mRNA [NM_003859]",chr20:49552695-49551725,hs|20q13.13,"dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit",TRUE
1309_RAB3IP_117177,Q96QF0,rab-3a-interacting protein (rab3a-interacting protein) (rabin-3) (ssx2-interacting protein),RAB3IP RABIN8,476,"function: guanine nucleotide exchange factor (gef) which may activate rab8a and rab8b (pubmed:12221131, pubmed:26824392). promotes the exchange of gdp to gtp, converting inactive gdp-bound rab proteins into their active gtp-bound form (pubmed:12221131, pubmed:26824392). mediates the release of gdp from rab8a and rab8b but not from rab3a or rab5 (pubmed:20937701, pubmed:26824392). modulates actin organization and promotes polarized transport of rab8a-specific vesicles to the cell surface (pubmed:12221131). together with rab11a, rab8a, the exocyst complex, pard3, prkci, anxa2, cdc42 and dnmbp promotes transcytosis of podxl to the apical membrane initiation sites (amis), apical surface formation and lumenogenesis (pubmed:20890297). {eco:0000269|pubmed:12221131, eco:0000269|pubmed:20890297, eco:0000269|pubmed:20937701, eco:0000269|pubmed:26824392}.","subcellular location: cytoplasm. nucleus. cytoplasm, cytoskeleton. cell projection, lamellipodium. note=predominantly cytoplasmic but a small proportion colocalizes with ssx2 in the nucleus. activation of protein kinase c results in redistribution to the periphery of lamellipodia. in the cytoskeleton, localizes to cortical actin.","TISSUE SPECIFICITY: Expressed in brain, kidney, heart, pancreas and placenta. Not detected in skeletal muscle or liver. {ECO:0000269|PubMed:12007189, ECO:0000269|PubMed:12221131}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,RAB3IP,117177,Hs.258209,ENST00000378809,THC2682887,GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005932(microtubule basal body)|GO:0006893(Golgi to plasma membrane transport)|GO:0015031(protein transport)|GO:0030027(lamellipodium)|GO:0030479(actin cortical patch)|GO:0033365(protein localization to organelle)|GO:0042384(cilium assembly),"Homo sapiens RAB3A interacting protein (rabin3) (RAB3IP), transcript variant alpha 2, mRNA [NM_175623]",chr12:70209304-70209363,hs|12q15,RAB3A interacting protein (rabin3),TRUE
131_POM121_9883,Q96HA1,nuclear envelope pore membrane protein pom 121 (nuclear envelope pore membrane protein pom 121a) (nucleoporin nup121) (pore membrane protein of 121 kda),POM121 KIAA0618 NUP121 POM121A,1249,function: essential component of the nuclear pore complex (npc). the repeat-containing domain may be involved in anchoring components of the pore complex to the pore membrane. when overexpressed in cells induces the formation of cytoplasmic annulate lamellae (al). {eco:0000269|pubmed:17900573}.,"subcellular location: nucleus, nuclear pore complex {eco:0000269|pubmed:17900573}. nucleus membrane {eco:0000269|pubmed:17900573}; single-pass membrane protein {eco:0000269|pubmed:17900573}. endoplasmic reticulum membrane {eco:0000250}; single-pass membrane protein {eco:0000250}. note=stably associated with the npc throughout interphase and the endoplasmic reticulum during metaphase. {eco:0000250}.",NA,NA,NA,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,POM121,9883,Hs.655217,ENST00000453279,THC2470302,GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005643(nuclear pore)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005975(carbohydrate metabolic process)|GO:0008645(hexose transport)|GO:0010827(regulation of glucose transport)|GO:0015031(protein transport)|GO:0015758(glucose transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016032(viral reproduction)|GO:0031965(nuclear membrane)|GO:0051028(mRNA transport)|GO:0055085(transmembrane transport),"Homo sapiens POM121 membrane glycoprotein (POM121), mRNA [NM_172020]",chr7:72418720-72418779,hs|7q11.23,POM121 membrane glycoprotein,TRUE
1310_TADA3_10474,O75528,transcriptional adapter 3 (ada3 homolog) (hada3) (staf54) (transcriptional adapter 3-like) (ada3-like protein),TADA3 ADA3 TADA3L,432,"function: functions as a component of the pcaf complex. the pcaf complex is capable of efficiently acetylating histones in a nucleosomal context. the pcaf complex could be considered as the human version of the yeast saga complex. also known as a coactivator for p53/tp53-dependent transcriptional activation. component of the atac complex, a complex with histone acetyltransferase activity on histones h3 and h4. {eco:0000269|pubmed:11707411, eco:0000269|pubmed:19103755}.","subcellular location: nucleus {eco:0000269|pubmed:11564863, eco:0000269|pubmed:9674425}.",TISSUE SPECIFICITY: Ubiquitously expressed.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TADA3,10474,Hs.386390,ENST00000492103,THC2469597,"GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0004402(histone acetyltransferase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex)|GO:0005730(nucleolus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0010628(positive regulation of gene expression)|GO:0016922(ligand-dependent nuclear receptor binding)|GO:0019904(protein domain specific binding)|GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity)|GO:0030520(estrogen receptor signaling pathway)|GO:0030914(STAGA complex)|GO:0033276(transcription factor TFTC complex)|GO:0043966(histone H3 acetylation)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens transcriptional adaptor 3 (TADA3), transcript variant 1, mRNA [NM_006354]",chr3:9821731-9821672,hs|3p25.3,transcriptional adaptor 3,TRUE
1311_TBC1D14_57533,Q9P2M4,tbc1 domain family member 14,TBC1D14 KIAA1322,693,"function: plays a role in the regulation of starvation-induced autophagosome formation (pubmed:22613832). together with the trappiii complex, regulates a constitutive trafficking step from peripheral recycling endosomes to the early golgi, maintaining the cycling pool of atg9 required for initiation of autophagy. {eco:0000269|pubmed:22613832, eco:0000269|pubmed:26711178}.","subcellular location: golgi apparatus, cis-golgi network {eco:0000269|pubmed:22613832, eco:0000269|pubmed:26711178}. golgi apparatus, trans-golgi network {eco:0000269|pubmed:22613832}. note=after amino acid starvation, golgi apparatus-associated protein levels increase compared with fed conditions. may be cycling between the golgi apparatus and an endosomal pool, redistributing to the golgi apparatus upon starvation.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TBC1D14,57533,Hs.518611,ENST00000409757,THC2601600,GO:0005096(GTPase activator activity)|GO:0005097(Rab GTPase activator activity)|GO:0005622(intracellular),"Homo sapiens TBC1 domain family, member 14 (TBC1D14), transcript variant 1, mRNA [NM_020773]",chr4:7034619-7034678,hs|4p16.1,"TBC1 domain family, member 14",TRUE
1312_TAB2_23118,Q9NYJ8,tgf-beta-activated kinase 1 and map3k7-binding protein 2 (mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (tak1-binding protein 2) (tab-2) (tgf-beta-activated kinase 1-binding protein 2),TAB2 KIAA0733 MAP3K7IP2,693,"function: adapter linking map3k7/tak1 and traf6. promotes map3k7 activation in the il1 signaling pathway. the binding of 'lys-63'-linked polyubiquitin chains to tab2 promotes autophosphorylation of map3k7 at 'thr-187'. involved in heart development. {eco:0000269|pubmed:10882101, eco:0000269|pubmed:11460167, eco:0000269|pubmed:20493459}.","subcellular location: membrane {eco:0000269|pubmed:10882101}; peripheral membrane protein {eco:0000269|pubmed:10882101}. cytoplasm, cytosol {eco:0000269|pubmed:10882101}. note=following il1 stimulation, translocation occurs from the membrane to cytosol.","TISSUE SPECIFICITY: Widely expressed. In the embryo, expressed in the ventricular trabeculae, endothelial cells of the conotruncal cushions of the outflow tract and in the endothelial cells lining the developing aortic valves. {ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:20493459}.","DISEASE: Congenital heart defects, multiple types, 2 (CHTD2) [MIM:614980]: A disease characterized by congenital developmental abnormalities involving structures of the heart. CHTD2 patients have left ventricular outflow tract obstruction, subaortic stenosis, residual aortic regurgitation, atrial fibrillation, bicuspid aortic valve and aortic dilation. {ECO:0000269|PubMed:20493459}. Note=The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving TAB2 has been found in a family with congenital heart disease. Translocation t(2;6)(q21;q25).",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TAB2,23118,Hs.269775,ENST00000470466,THC2485636,GO:0000187(activation of MAPK activity)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007254(JNK cascade)|GO:0007507(heart development)|GO:0008063(Toll signaling pathway)|GO:0008270(zinc ion binding)|GO:0010008(endosome membrane)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0045087(innate immune response)|GO:0045860(positive regulation of protein kinase activity)|GO:0046872(metal ion binding)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051403(stress-activated MAPK cascade)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)|GO:0070530(K63-linked polyubiquitin binding),"Homo sapiens TGF-beta activated kinase 1/MAP3K7 binding protein 2 (TAB2), mRNA [NM_015093]",chr6:149732565-149732624,hs|6q25.1,TGF-beta activated kinase 1/MAP3K7 binding protein 2,TRUE
1313_GLRX5_51218,Q86SX6,"glutaredoxin-related protein 5, mitochondrial (monothiol glutaredoxin-5)",GLRX5 C14orf87,157,"function: monothiol glutaredoxin involved in the biogenesis of iron-sulfur clusters (pubmed:20364084). involved in protein lipoylation, acting in the pathway that provides an iron-sulfur cluster to lipoate synthase (pubmed:24334290). required for normal iron homeostasis. required for normal regulation of hemoglobin synthesis by the iron-sulfur protein aco1 (pubmed:20364084). may protect cells against apoptosis due to reactive oxygen species and oxidative stress (by similarity). {eco:0000250|uniprotkb:q80y14, eco:0000269|pubmed:20364084, eco:0000269|pubmed:24334290}.",subcellular location: mitochondrion matrix {eco:0000269|pubmed:20364084}.,NA,"DISEASE: Anemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3) [MIM:616860]: A form of sideroblastic anemia, a bone marrow disorder defined by the presence of pathologic iron deposits in erythroblast mitochondria. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. SIDBA3 is refractory to treatment with vitamin B6, while iron chelation therapy may result in clinical improvement. SIDBA3 inheritance is autosomal recessive. {ECO:0000269|PubMed:17485548, ECO:0000269|PubMed:20364084, ECO:0000269|PubMed:25342667, ECO:0000269|PubMed:26100117}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spasticity, childhood-onset, with hyperglycinemia (SPAHGC) [MIM:616859]: An autosomal recessive disorder characterized by childhood-onset of spasticity, spinal lesions, leukodystrophy, optic atrophy in some patients, non-ketotic hyperglycinemia, and defective enzymatic glycine cleavage. Glycine levels in the cerebrospinal fluid are mildly increased in some but not all patients. The increase is less pronounced than in patients with classic non-ketotic hyperglycinemia. {ECO:0000269|PubMed:24334290}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GLRX5,51218,Hs.728210,ENST00000553672,THC2463309,"GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0009055(electron carrier activity)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0030097(hemopoiesis)|GO:0045454(cell redox homeostasis)|GO:0046872(metal ion binding)|GO:0051537(2 iron, 2 sulfur cluster binding)","Homo sapiens glutaredoxin 5 (GLRX5), nuclear gene encoding mitochondrial protein, mRNA [NM_016417]",chr14:96010787-96010846,hs|14q32.13,glutaredoxin 5,TRUE
1314_RCN1_5954,Q15293,reticulocalbin-1,RCN1 RCN,331,function: may regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-er compartment.,subcellular location: endoplasmic reticulum lumen.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RCN1,5954,Hs.97887,ENST00000531345,THC2469705,GO:0001701(in utero embryonic development)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0043010(camera-type eye development),"Homo sapiens reticulocalbin 1, EF-hand calcium binding domain (RCN1), mRNA [NM_002901]",chr11:32126817-32126876,hs|11p13,"reticulocalbin 1, EF-hand calcium binding domain",TRUE
1316_DNAJB1_3337,P25685,dnaj homolog subfamily b member 1 (dnaj protein homolog 1) (heat shock 40 kda protein 1) (hsp40) (heat shock protein 40) (human dnaj protein 1) (hdj-1),DNAJB1 DNAJ1 HDJ1 HSPF1,340,"function: interacts with hsp70 and can stimulate its atpase activity. stimulates the association between hsc70 and hip. negatively regulates heat shock-induced hsf1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (pubmed:9499401). stimulates atp hydrolysis and the folding of unfolded proteins mediated by hspa1a/b (in vitro) (pubmed:24318877). {eco:0000269|pubmed:24318877, eco:0000269|pubmed:9499401}.","subcellular location: cytoplasm {eco:0000269|pubmed:1586970}. nucleus {eco:0000269|pubmed:1586970}. nucleus, nucleolus {eco:0000269|pubmed:1586970}. note=translocates rapidly from the cytoplasm to the nucleus, and especially to the nucleoli, upon heat shock.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DNAJB1,3337,Hs.515210,ENST00000254322,THC2513543,GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006457(protein folding)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0031072(heat shock protein binding)|GO:0051082(unfolded protein binding)|GO:0051085(chaperone mediated protein folding requiring cofactor)|GO:0070389(chaperone cofactor-dependent protein refolding),"Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1), mRNA [NM_006145]",chr19:14625862-14625803,hs|19p13.12,"DnaJ (Hsp40) homolog, subfamily B, member 1",TRUE
1317_MYC_4609,P01106,myc proto-oncogene protein (class e basic helix-loop-helix protein 39) (bhlhe39) (proto-oncogene c-myc) (transcription factor p64),MYC BHLHE39,439,"function: transcription factor that binds dna in a non-specific manner, yet also specifically recognizes the core sequence 5'-cac[ga]tg-3'. activates the transcription of growth-related genes. binds to the vegfa promoter, promoting vegfa production and subsequent sprouting angiogenesis (pubmed:24940000). regulator of somatic reprogramming, controls self-renewal of embryonic stem cells. functions with taf6l to activate target gene expression through rna polymerase ii pause release (by similarity). {eco:0000250|uniprotkb:p01108, eco:0000269|pubmed:24940000, eco:0000269|pubmed:25956029}.","subcellular location: nucleus, nucleoplasm {eco:0000269|pubmed:17558397}. nucleus, nucleolus {eco:0000269|pubmed:17558397, eco:0000269|pubmed:25775507}.",NA,"DISEASE: Note=A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1. {ECO:0000269|PubMed:2069907}.; DISEASE: Burkitt lymphoma (BL) [MIM:113970]: A form of undifferentiated malignant lymphoma commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. {ECO:0000269|PubMed:2166998, ECO:0000269|PubMed:8220424}. Note=The gene represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving MYC are usually found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or t(2;8) which juxtapose MYC to one of the heavy or light chain immunoglobulin gene loci.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,MYC,4609,Hs.202453,ENST00000454617,THC2468611,"GO:0001658(branching involved in ureteric bud morphogenesis)|GO:0002053(positive regulation of mesenchymal cell proliferation)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005819(spindle)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006879(cellular iron ion homeostasis)|GO:0007050(cell cycle arrest)|GO:0008283(cell proliferation)|GO:0008284(positive regulation of cell proliferation)|GO:0032204(regulation of telomere maintenance)|GO:0042493(response to drug)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0070888(E-box binding)|GO:0090096(positive regulation of metanephric cap mesenchymal cell proliferation)","Homo sapiens v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]",chr8:128753268-128753327,hs|8q24.21,v-myc myelocytomatosis viral oncogene homolog (avian),TRUE
1318_GANAB_23193,Q14697,neutral alpha-glucosidase ab (ec 3.2.1.207) (alpha-glucosidase 2) (glucosidase ii subunit alpha),GANAB G2AN KIAA0088,944,"function: catalytic subunit of glucosidase ii that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the glc(2)man(9)glcnac(2) oligosaccharide precursor of immature glycoproteins (pubmed:10929008). required for pkd1/polycystin-1 and pkd2/polycystin-2 maturation and localization to the cell surface and cilia (pubmed:27259053). {eco:0000269|pubmed:10929008, eco:0000269|pubmed:27259053}.",subcellular location: endoplasmic reticulum {eco:0000305|pubmed:10929008}. golgi apparatus {eco:0000250|uniprotkb:p79403}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000269|pubmed:17081065}.,"TISSUE SPECIFICITY: Detected in placenta (PubMed:3881423). Isoform 1 and isoform 2 are expressed in the kidney and liver (PubMed:27259053). {ECO:0000269|PubMed:27259053, ECO:0000269|PubMed:3881423}.","DISEASE: Polycystic kidney disease 3 with or without polycystic liver disease (PKD3) [MIM:600666]: A form of polycystic kidney disease, a disorder characterized by progressive formation and enlargement of cysts in both kidneys, typically leading to end-stage renal disease in adult life. Cysts also occur in other organs, particularly the liver. PKD3 inheritance is autosomal dominant. {ECO:0000269|PubMed:27259053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=GANAB variations may act as a disease modifier in autosomal dominant polycystic liver disease in patients who have causative mutations in other genes, such as PKHD1 or ALG8. {ECO:0000269|PubMed:28375157}.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GANAB,23193,Hs.595071,ENST00000346178,THC2587237,"GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005794(Golgi apparatus)|GO:0005975(carbohydrate metabolic process)|GO:0006457(protein folding)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0030246(carbohydrate binding)|GO:0033919(glucan 1,3-alpha-glucosidase activity)|GO:0042470(melanosome)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)","Homo sapiens glucosidase, alpha; neutral AB (GANAB), transcript variant 3, mRNA [NM_198335]",chr11:62392561-62392502,hs|11q12.3,"glucosidase, alpha; neutral AB",TRUE
1319_ARL6IP5_10550,O75915,pra1 family protein 3 (adp-ribosylation factor-like protein 6-interacting protein 5) (arl-6-interacting protein 5) (aip-5) (cytoskeleton-related vitamin a-responsive protein) (dermal papilla-derived protein 11) (gtrap3-18) (glutamate transporter eaac1-interacting protein) (jm5) (prenylated rab acceptor protein 2) (protein jwa) (putative mapk-activating protein pm27),ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127,188,"function: regulates intracellular concentrations of taurine and glutamate. negatively modulates slc1a1/eaac1 glutamate transport activity by decreasing its affinity for glutamate in a pkc activity-dependent manner. may be involved in membrane traffic. {eco:0000250|uniprotkb:q8r5j9, eco:0000250|uniprotkb:q9es40}.","subcellular location: endoplasmic reticulum membrane {eco:0000250|uniprotkb:q9es40}; multi-pass membrane protein {eco:0000255}. cell membrane {eco:0000250|uniprotkb:q9es40}; multi-pass membrane protein {eco:0000255}. cytoplasm {eco:0000250|uniprotkb:q9es40}. cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q9es40}. note=also exists as a soluble form in the cytoplasm. associated with microtubules. {eco:0000250|uniprotkb:q9es40}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ARL6IP5,10550,Hs.730695,ENST00000273258,THC2465441,GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0008022(protein C-terminus binding)|GO:0015813(L-glutamate transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0051051(negative regulation of transport),"Homo sapiens ADP-ribosylation-like factor 6 interacting protein 5 (ARL6IP5), mRNA [NM_006407]",chr3:69154978-69155037,hs|3p14.1,ADP-ribosylation-like factor 6 interacting protein 5,TRUE
132_RPL21_6144,P46778,60s ribosomal protein l21 (large ribosomal subunit protein el21),RPL21,160,"function: component of the large ribosomal subunit. {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. endoplasmic reticulum {eco:0000250|uniprotkb:p49666}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:p49666, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Hypotrichosis 12 (HYPT12) [MIM:615885]: A form of hypotrichosis, a condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The extent of scalp and body hair involvement can be very variable, within as well as between families. HYPT12 patients have normal scalp hair density at birth. Hair loss begins during the first 6 months of life and gradually progresses to nearly complete loss of scalp hair. The remaining hairs grow slowly and are thin, sparse, dry, and fragile. Body hair, axillary and pubic hair, eyebrows and eyelashes are also sparse or absent. {ECO:0000269|PubMed:21412954}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL21,6144,Hs.381123,ENST00000483765,THC2532748,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L21 (RPL21), mRNA [NM_000982]",chr13:27830613-27830672,hs|13q12.2,ribosomal protein L21,TRUE
1320_FARSB_10056,Q9NSD9,phenylalanine--trna ligase beta subunit (ec 6.1.1.20) (phenylalanyl-trna synthetase beta subunit) (phers),FARSB FARSLB FRSB HSPC173,589,NA,subcellular location: cytoplasm {eco:0000305|pubmed:29573043}.,NA,"DISEASE: Rajab interstitial lung disease with brain calcifications (RILDBC) [MIM:613658]: An autosomal recessive, lethal neurodevelopmental disorder characterized by multiple clinical manifestations including intrauterine growth restriction, failure to thrive, developmental delay, hypotonia, interstitial lung disease, and liver dysfunction. Brain imaging shows abnormal periventricular white matter, basal ganglia echogenicity, cerebral volume loss, incomplete closure of the Sylvian fissures, and normal myelination. {ECO:0000269|PubMed:29573043, ECO:0000269|PubMed:29979980, ECO:0000269|PubMed:30014610}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FARSB,10056,Hs.471452,ENST00000536361,THC2630202,GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0003723(RNA binding)|GO:0004826(phenylalanine-tRNA ligase activity)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006432(phenylalanyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0016874(ligase activity),"Homo sapiens phenylalanyl-tRNA synthetase, beta subunit (FARSB), mRNA [NM_005687]",chr2:223436542-223436483,hs|2q36.1,"phenylalanyl-tRNA synthetase, beta subunit",TRUE
1321_MLLT4_4301,P55196,afadin (all1-fused gene from chromosome 6 protein) (protein af-6) (afadin adherens junction formation factor),AFDN AF6 MLLT4,1824,"function: belongs to an adhesion system, probably together with the e-cadherin-catenin system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (ajs) (by similarity). nectin- and actin-filament-binding protein that connects nectin to the actin cytoskeleton (pubmed:11024295). may play a key role in the organization of epithelial structures of the embryonic ectoderm (by similarity). essential for the organization of adherens junctions (pubmed:30463011). {eco:0000250|uniprotkb:o35889, eco:0000250|uniprotkb:q9qzq1, eco:0000269|pubmed:11024295, eco:0000269|pubmed:30463011}.","subcellular location: cell junction, adherens junction {eco:0000269|pubmed:30463011}. note=not found at cell-matrix ajs. {eco:0000250|uniprotkb:o35889}.",NA,DISEASE: Note=A chromosomal aberration involving AFDN is associated with acute leukemias. Translocation t(6;11)(q27;q23) with KMT2A/MLL1. The result is a rogue activator protein.,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MLLT4,4301,Hs.614974,ENST00000341575,THC2554046,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0005912(adherens junction)|GO:0007155(cell adhesion)|GO:0007165(signal transduction)|GO:0007267(cell-cell signaling)|GO:0008022(protein C-terminus binding)|GO:0030054(cell junction)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0045216(cell-cell junction organization),"Homo sapiens myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (MLLT4), transcript variant 1, mRNA [NM_001207008]",chr6:168372502-168372561,hs|6q27,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4",TRUE
1322_NIT2_56954,Q9NQR4,omega-amidase nit2 (ec 3.5.1.3) (nitrilase homolog 2),NIT2 CUA002,276,"function: has a omega-amidase activity. the role of omega-amidase is to remove potentially toxic intermediates by converting alpha-ketoglutaramate and alpha-ketosuccinamate to biologically useful alpha-ketoglutarate and oxaloacetate, respectively. overexpression decreases the colony-forming capacity of cultured cells by arresting cells in the g2 phase of the cell cycle. {eco:0000269|pubmed:17488281, eco:0000269|pubmed:19595734}.",subcellular location: cytoplasm {eco:0000269|pubmed:17488281}.,"TISSUE SPECIFICITY: Detected in fetal brain (at protein level). Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, prostate, spleen, thymus, prostate, testis, ovary, small intestine and colon. {ECO:0000269|PubMed:14528910, ECO:0000269|PubMed:17488281}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NIT2,56954,Hs.439152,ENST00000465368,THC2461940,"GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005813(centrosome)|GO:0006807(nitrogen compound metabolic process)|GO:0008150(biological_process)|GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds)|GO:0050152(omega-amidase activity)","Homo sapiens nitrilase family, member 2 (NIT2), mRNA [NM_020202]",chr3:100074086-100074145,hs|3q12.2,"nitrilase family, member 2",TRUE
1323_LBH_81606,Q53QV2,protein lbh (hlbh) (limb bud and heart development protein homolog),LBH,105,function: transcriptional activator which may act in mitogen-activated protein kinase signaling pathway. {eco:0000269|pubmed:17390236}.,subcellular location: nucleus {eco:0000269|pubmed:17390236}. cytoplasm {eco:0000269|pubmed:17390236}.,"TISSUE SPECIFICITY: Highly expressed in heart, and expressed at low levels in placenta, lung, skeletal muscle, kidney and liver. {ECO:0000269|PubMed:17390236}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LBH,81606,Hs.567598,ENST00000395323,THC2738167,"GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007275(multicellular organismal development)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens limb bud and heart development homolog (mouse) (LBH), mRNA [NM_030915]",chr2:30482471-30482530,hs|2p23.1,limb bud and heart development homolog (mouse),TRUE
1324_KIAA1430_57587,Q9P2B7,cilia- and flagella-associated protein 97,CFAP97 KIAA1430,532,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,KIAA1430,57587,Hs.535734,ENST00000458385,THC2502160,NA,"Homo sapiens KIAA1430 (KIAA1430), mRNA [NM_020827]",chr4:186081462-186081403,hs|4q35.1,KIAA1430,TRUE
1325_KIAA1324_57535,Q6UXG2,upf0577 protein kiaa1324 (estrogen-induced gene 121 protein),KIAA1324 EIG121 UNQ2426/PRO4985,1013,function: may protect cells from cell death by inducing cytosolic vacuolization and upregulating the autophagy pathway. {eco:0000269|pubmed:21072319}.,"subcellular location: cell membrane {eco:0000269|pubmed:21072319}; single-pass type i membrane protein {eco:0000269|pubmed:21072319}. late endosome membrane {eco:0000269|pubmed:21072319}; single-pass type i membrane protein {eco:0000269|pubmed:21072319}. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:21072319}; single-pass type i membrane protein {eco:0000269|pubmed:21072319}. lysosome membrane {eco:0000269|pubmed:21072319}; single-pass membrane protein {eco:0000269|pubmed:21072319}.",TISSUE SPECIFICITY: Expressed in normal endometrium but overexpressed in endometroid tumors. {ECO:0000269|PubMed:16322283}.,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KIAA1324,57535,Hs.708190,ENST00000369936,THC2505521,GO:0003674(molecular_function)|GO:0005764(lysosome)|GO:0005770(late endosome)|GO:0005802(trans-Golgi network)|GO:0005887(integral to plasma membrane)|GO:0016020(membrane)|GO:0016236(macroautophagy)|GO:0042981(regulation of apoptosis)|GO:0044090(positive regulation of vacuole organization)|GO:2000786(positive regulation of autophagic vacuole assembly),"Homo sapiens KIAA1324 (KIAA1324), mRNA [NM_020775]",chr1:109749302-109749361,hs|1p13.3,KIAA1324,TRUE
1326_PPP1CC_5501,P36873,serine/threonine-protein phosphatase pp1-gamma catalytic subunit (pp-1g) (ec 3.1.3.16) (protein phosphatase 1c catalytic subunit),PPP1CC,323,"function: protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. protein phosphatase 1 (pp1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. dephosphorylates rps6kb1. involved in regulation of ionic conductances and long-term synaptic plasticity. may play an important role in dephosphorylating substrates such as the postsynaptic density-associated ca(2+)/calmodulin dependent protein kinase ii. component of the ptw/pp1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. in balance with csnk1d and csnk1e, determines the circadian period length, through the regulation of the speed and rhythmicity of per1 and per2 phosphorylation. may dephosphorylate csnk1d and csnk1e. dephosphorylates the 'ser-418' residue of foxp3 in regulatory t-cells (treg) from patients with rheumatoid arthritis, thereby inactivating foxp3 and rendering treg cells functionally defective (pubmed:23396208). {eco:0000269|pubmed:17936702, eco:0000269|pubmed:20516061, eco:0000269|pubmed:21712997, eco:0000269|pubmed:23396208}.","subcellular location: cytoplasm {eco:0000269|pubmed:11739654}. nucleus. nucleus, nucleolus {eco:0000269|pubmed:11739654, eco:0000269|pubmed:20926688}. nucleus, nucleoplasm {eco:0000269|pubmed:11739654}. nucleus speckle {eco:0000269|pubmed:11739654}. chromosome, centromere, kinetochore {eco:0000269|pubmed:12529430}. cleavage furrow {eco:0000269|pubmed:12529430}. midbody {eco:0000269|pubmed:12529430}. mitochondrion {eco:0000269|pubmed:17936702}. note=colocalizes with spz1 in the nucleus (by similarity). colocalizes with uri1 at mitochondrion (pubmed:17936702). rapidly exchanges between the nucleolar, nucleoplasmic and cytoplasmic compartments (pubmed:11739654). highly mobile in cells and can be relocalized through interaction with targeting subunits (pubmed:17965019). in the presence of ppp1r8 relocalizes from the nucleolus to nuclear speckles (pubmed:11739654). shows a dynamic targeting to specific sites throughout the cell cycle (pubmed:12529430). highly concentrated in nucleoli of interphase cells and localizes at kinetochores early in mitosis (pubmed:12529430). relocalization to chromosome-containing regions occurs at the transition from early to late anaphase (pubmed:12529430). also accumulates at the cleavage furrow and midbody by telophase (pubmed:12529430). {eco:0000250|uniprotkb:p63087, eco:0000269|pubmed:11739654, eco:0000269|pubmed:12529430, eco:0000269|pubmed:17936702, eco:0000269|pubmed:17965019}.",NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PPP1CC,5501,Hs.79081,ENST00000340766,THC2470066,GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0000777(condensed chromosome kinetochore)|GO:0004722(protein serine/threonine phosphatase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005694(chromosome)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0005977(glycogen metabolic process)|GO:0006470(protein dephosphorylation)|GO:0006629(lipid metabolic process)|GO:0016607(nuclear speck)|GO:0016787(hydrolase activity)|GO:0019433(triglyceride catabolic process)|GO:0019901(protein kinase binding)|GO:0030496(midbody)|GO:0032154(cleavage furrow)|GO:0043234(protein complex)|GO:0046822(regulation of nucleocytoplasmic transport)|GO:0046872(metal ion binding)|GO:0051301(cell division)|GO:0070688(MLL5-L complex)|GO:0072357(PTW/PP1 phosphatase complex),"Homo sapiens protein phosphatase 1, catalytic subunit, gamma isozyme (PPP1CC), transcript variant 1, mRNA [NM_002710]",chr12:111157948-111157889,hs|12q24.11,"protein phosphatase 1, catalytic subunit, gamma isozyme",TRUE
1327_SELENBP1_8991,Q13228,methanethiol oxidase (mto) (ec 1.8.3.4) (56 kda selenium-binding protein) (sbp56) (sp56) (selenium-binding protein 1),SELENBP1 SBP,472,"function: catalyzes the oxidation of methanethiol, an organosulfur compound known to be produced in substantial amounts by gut bacteria (pubmed:29255262). selenium-binding protein which may be involved in the sensing of reactive xenobiotics in the cytoplasm. may be involved in intra-golgi protein transport (by similarity). {eco:0000250|uniprotkb:q8vif7, eco:0000269|pubmed:29255262}.","subcellular location: nucleus {eco:0000269|pubmed:14991897}. cytoplasm, cytosol {eco:0000269|pubmed:14991897, eco:0000269|pubmed:16223876}. membrane {eco:0000250|uniprotkb:q8vif7}; peripheral membrane protein {eco:0000250|uniprotkb:q8vif7}. note=may associate with golgi membrane (by similarity). may associate with the membrane of autophagosomes (by similarity). {eco:0000250|uniprotkb:q8vif7}.","TISSUE SPECIFICITY: Widely expressed. Highly expressed in liver, lung, colon, prostate, kidney and pancreas. In brain, present both in neurons and glia (at protein level). Down-regulated in lung adenocarcinoma, colorectal carcinoma and ovarian cancer. Two-fold up-regulated in brain and blood from schizophrenia patients. {ECO:0000269|PubMed:14991897, ECO:0000269|PubMed:16223876, ECO:0000269|PubMed:16380993, ECO:0000269|PubMed:16645984, ECO:0000269|PubMed:29255262, ECO:0000269|PubMed:9679983}.","DISEASE: Extraoral halitosis due to methanethiol oxidase deficiency (EHMTO) [MIM:618148]: An autosomal recessive malodor condition characterized by extraoral blood-borne halitosis resulting from the accumulation of sulfur-containing metabolites. In extraoral blood-borne halitosis, malodorant compounds are carried to the lungs, where they enter the breath. Affected individuals have a cabbage-like breath odor, high levels of methanethiol and dimethylsulfide in oral and nasal breath, and elevated urinary excretion of dimethylsulfoxide in the absence of intake of dimethylsulfide-containing food or use of sulfur-containing medication, lower-gastrointestinal problems, and known metabolic defects, such as methionine adenosyltransferase deficiency and tyrosinemia. {ECO:0000269|PubMed:29255262}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SELENBP1,8991,Hs.632460,ENST00000463664,NP1180129,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0008430(selenium binding)|GO:0015031(protein transport)|GO:0016020(membrane),"Homo sapiens selenium binding protein 1 (SELENBP1), mRNA [NM_003944]",chr1:151336906-151336847,hs|1q21.3,selenium binding protein 1,TRUE
1328_MT1L_4500,Q93083,metallothionein-1l (mt-1l) (metallothionein-il) (mt-il),MT1L,61,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. {eco:0000250}.,NA,TISSUE SPECIFICITY: Expressed in reticulocytes.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT1L,4500,Hs.647358,NA,THC2477025,NA,"Homo sapiens metallothionein 1L (gene/pseudogene) (MT1L), non-coding RNA [NR_001447]",chr16:56652580-56652639,hs|16q12.2,metallothionein 1L (gene/pseudogene),TRUE
1329_HMOX1_3162,P09601,heme oxygenase 1 (ho-1) (ec 1.14.14.18),HMOX1 HO HO1,288,"function: heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. biliverdin is subsequently converted to bilirubin by biliverdin reductase. under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. exhibits cytoprotective effects since excess of free heme sensitizes cells to undergo apoptosis.",subcellular location: microsome {eco:0000269|pubmed:22419571}. endoplasmic reticulum membrane {eco:0000269|pubmed:22419571}; peripheral membrane protein {eco:0000269|pubmed:22419571}; cytoplasmic side {eco:0000269|pubmed:22419571}.,TISSUE SPECIFICITY: Expressed at higher levels in renal cancer tissue than in normal tissue (at protein level). {ECO:0000269|PubMed:20855888}.,"DISEASE: Heme oxygenase 1 deficiency (HMOX1D) [MIM:614034]: A disease characterized by impaired stress hematopoiesis, resulting in marked erythrocyte fragmentation and intravascular hemolysis, coagulation abnormalities, endothelial damage, and iron deposition in renal and hepatic tissues. Clinical features include persistent hemolytic anemia, asplenia, nephritis, generalized erythematous rash, growth retardation and hepatomegaly. {ECO:0000269|PubMed:9884342}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HMOX1,3162,Hs.517581,ENST00000216117,THC2468207,"GO:0001525(angiogenesis)|GO:0001935(endothelial cell proliferation)|GO:0002246(wound healing involved in inflammatory response)|GO:0002686(negative regulation of leukocyte migration)|GO:0004392(heme oxygenase (decyclizing) activity)|GO:0004630(phospholipase D activity)|GO:0004871(signal transducer activity)|GO:0005615(extracellular space)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0005901(caveola)|GO:0006778(porphyrin metabolic process)|GO:0006788(heme oxidation)|GO:0006879(cellular iron ion homeostasis)|GO:0006916(anti-apoptosis)|GO:0006979(response to oxidative stress)|GO:0007165(signal transduction)|GO:0007243(intracellular protein kinase cascade)|GO:0007264(small GTPase mediated signal transduction)|GO:0007588(excretion)|GO:0008217(regulation of blood pressure)|GO:0008219(cell death)|GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis)|GO:0014806(smooth muscle hyperplasia)|GO:0016491(oxidoreductase activity)|GO:0019899(enzyme binding)|GO:0020037(heme binding)|GO:0031670(cellular response to nutrient)|GO:0032764(negative regulation of mast cell cytokine production)|GO:0034101(erythrocyte homeostasis)|GO:0034383(low-density lipoprotein particle clearance)|GO:0035094(response to nicotine)|GO:0042167(heme catabolic process)|GO:0042542(response to hydrogen peroxide)|GO:0042803(protein homodimerization activity)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0043305(negative regulation of mast cell degranulation)|GO:0043392(negative regulation of DNA binding)|GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity)|GO:0043524(negative regulation of neuron apoptosis)|GO:0043619(regulation of transcription from RNA polymerase II promoter in response to oxidative stress)|GO:0043627(response to estrogen stimulus)|GO:0045080(positive regulation of chemokine biosynthetic process)|GO:0045765(regulation of angiogenesis)|GO:0045766(positive regulation of angiogenesis)|GO:0045768(positive regulation of anti-apoptosis)|GO:0045909(positive regulation of vasodilation)|GO:0046872(metal ion binding)|GO:0048661(positive regulation of smooth muscle cell proliferation)|GO:0048662(negative regulation of smooth muscle cell proliferation)|GO:0050896(response to stimulus)|GO:0051090(regulation of sequence-specific DNA binding transcription factor activity)|GO:0051260(protein homooligomerization)|GO:0055072(iron ion homeostasis)|GO:0055085(transmembrane transport)|GO:0071456(cellular response to hypoxia)","Homo sapiens heme oxygenase (decycling) 1 (HMOX1), mRNA [NM_002133]",chr22:35790122-35790181,hs|22q12.3,heme oxygenase (decycling) 1,TRUE
133_UQCRQ_27089,O14949,cytochrome b-c1 complex subunit 8 (complex iii subunit 8) (complex iii subunit viii) (ubiquinol-cytochrome c reductase complex 9.5 kda protein) (ubiquinol-cytochrome c reductase complex ubiquinone-binding protein qp-c),UQCRQ,82,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. this subunit, together with cytochrome b, binds to ubiquinone.",subcellular location: mitochondrion inner membrane.,NA,"DISEASE: Mitochondrial complex III deficiency, nuclear 4 (MC3DN4) [MIM:615159]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:18439546}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCRQ,27089,Hs.146602,ENST00000378665,THC2562893,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006810(transport)|GO:0008121(ubiquinol-cytochrome-c reductase activity)|GO:0016020(membrane)|GO:0021539(subthalamus development)|GO:0021548(pons development)|GO:0021680(cerebellar Purkinje cell layer development)|GO:0021766(hippocampus development)|GO:0021794(thalamus development)|GO:0021854(hypothalamus development)|GO:0021860(pyramidal neuron development)|GO:0022904(respiratory electron transport chain)|GO:0030901(midbrain development)|GO:0070469(respiratory chain),"Homo sapiens ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa (UQCRQ), nuclear gene encoding mitochondrial protein, mRNA [NM_014402]",chr5:132203295-132203354,hs|5q31.1,"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa",TRUE
1330_PDIA4_9601,P13667,protein disulfide-isomerase a4 (ec 5.3.4.1) (endoplasmic reticulum resident protein 70) (er protein 70) (erp70) (endoplasmic reticulum resident protein 72) (er protein 72) (erp-72) (erp72),PDIA4 ERP70 ERP72,645,NA,subcellular location: endoplasmic reticulum lumen {eco:0000269|pubmed:12643545}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:17081065). {eco:0000269|pubmed:17081065}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PDIA4,9601,Hs.93659,ENST00000286091,THC2757699,GO:0003756(protein disulfide isomerase activity)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0006662(glycerol ether metabolic process)|GO:0009055(electron carrier activity)|GO:0009306(protein secretion)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0016853(isomerase activity)|GO:0042470(melanosome)|GO:0045454(cell redox homeostasis),"Homo sapiens protein disulfide isomerase family A, member 4 (PDIA4), mRNA [NM_004911]",chr7:148700963-148700904,hs|7q36.1,"protein disulfide isomerase family A, member 4",TRUE
1331_SDF4_51150,Q9BRK5,45 kda calcium-binding protein (cab45) (stromal cell-derived factor 4) (sdf-4),SDF4 CAB45 PSEC0034,362,function: may regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-er compartment. {eco:0000250}.; function: isoform 5 may be involved in the exocytosis of zymogens by pancreatic acini.,"subcellular location: isoform 1: golgi apparatus lumen {eco:0000250|uniprotkb:q61112}.; subcellular location: isoform 5: cytoplasm {eco:0000269|pubmed:17442889}. cell membrane {eco:0000269|pubmed:17442889}. cell projection, bleb. note=isoform 5 colocalizes with stx3 and stxbp1 isoform 2 at the plasma membrane and cell surface blebs. {eco:0000269|pubmed:17442889}.",TISSUE SPECIFICITY: Ubiquitous. Isoform 5 is expressed in pancreas. {ECO:0000269|PubMed:17442889}.,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SDF4,51150,Hs.42806,ENST00000478938,THC2555165,GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005770(late endosome)|GO:0005794(Golgi apparatus)|GO:0005796(Golgi lumen)|GO:0005886(plasma membrane)|GO:0009650(UV protection)|GO:0017156(calcium ion-dependent exocytosis)|GO:0021549(cerebellum development)|GO:0032059(bleb)|GO:0042802(identical protein binding)|GO:0045444(fat cell differentiation)|GO:0045471(response to ethanol)|GO:0070625(zymogen granule exocytosis),"Homo sapiens stromal cell derived factor 4 (SDF4), transcript variant 2, mRNA [NM_016176]",chr1:1152526-1152467,hs|1p36.33,stromal cell derived factor 4,TRUE
1332_IP6K2_51447,Q9UHH9,inositol hexakisphosphate kinase 2 (insp6 kinase 2) (insp6k2) (ec 2.7.4.-) (p(i)-uptake stimulator) (pius),IP6K2 IHPK2 TCCCIA00113,426,"function: converts inositol hexakisphosphate (insp6) to diphosphoinositol pentakisphosphate (insp7/pp-insp5). {eco:0000269|pubmed:10574768, eco:0000269|pubmed:30624931}.",subcellular location: nucleus {eco:0000269|pubmed:11502751}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IP6K2,51447,Hs.595983,ENST00000416707,THC2492801,GO:0000166(nucleotide binding)|GO:0000832(inositol hexakisphosphate 5-kinase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0008440(inositol trisphosphate 3-kinase activity)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0019221(cytokine-mediated signaling pathway)|GO:0030308(negative regulation of cell growth)|GO:0043065(positive regulation of apoptosis)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045111(intermediate filament cytoskeleton)|GO:0046854(phosphatidylinositol phosphorylation)|GO:0060337(type I interferon-mediated signaling pathway),"Homo sapiens inositol hexakisphosphate kinase 2 (IP6K2), transcript variant 3, mRNA [NM_001005910]",chr3:48731111-48731052,hs|3p21.31,inositol hexakisphosphate kinase 2,TRUE
1333_TMCO3_55002,Q6UWJ1,transmembrane and coiled-coil domain-containing protein 3 (putative lag1-interacting protein),TMCO3 C13orf11 UNQ2419/PRO4976,677,function: probable na(+)/h(+) antiporter. {eco:0000250}.,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in the cornea, lens capsule and choroid-retinal pigment epithelium (at protein level). {ECO:0000269|PubMed:27484837}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMCO3,55002,Hs.317593,ENST00000434316,NP387898,GO:0006812(cation transport)|GO:0015297(antiporter activity)|GO:0015299(solute:hydrogen antiporter activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0055085(transmembrane transport),"Homo sapiens transmembrane and coiled-coil domains 3 (TMCO3), mRNA [NM_017905]",chr13:114204292-114204351,hs|13q34,transmembrane and coiled-coil domains 3,TRUE
1334_HGSNAT_138050,Q68CP4,heparan-alpha-glucosaminide n-acetyltransferase (ec 2.3.1.78) (transmembrane protein 76),HGSNAT TMEM76,663,"function: lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-n-acetyl glucosaminidase. {eco:0000269|pubmed:16960811, eco:0000269|pubmed:17033958, eco:0000269|pubmed:19823584, eco:0000269|pubmed:20650889}.","subcellular location: lysosome membrane {eco:0000269|pubmed:16960811, eco:0000269|pubmed:17033958, eco:0000269|pubmed:17897319}; multi-pass membrane protein {eco:0000269|pubmed:16960811, eco:0000269|pubmed:17033958, eco:0000269|pubmed:17897319}. note=colocalizes with the lysosomal marker lamp2. the signal peptide is not cleaved upon translocation into the endoplasmic reticulum; the precursor is probably targeted to the lysosomes via the adapter protein complex-mediated pathway that involves tyrosine- and/or dileucine-based conserved amino acid motifs in the last c-terminus 16-amino acid domain.","TISSUE SPECIFICITY: Widely expressed, with highest level in leukocytes, heart, liver, skeletal muscle, lung, placenta and liver. {ECO:0000269|PubMed:16960811, ECO:0000269|PubMed:17033958}.","DISEASE: Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]: A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life. {ECO:0000269|PubMed:16960811, ECO:0000269|PubMed:17033958, ECO:0000269|PubMed:17397050, ECO:0000269|PubMed:18024218, ECO:0000269|PubMed:19479962, ECO:0000269|PubMed:19823584, ECO:0000269|PubMed:20583299, ECO:0000269|PubMed:20825431, ECO:0000269|PubMed:28101780}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 73 (RP73) [MIM:616544]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:25859010}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HGSNAT,138050,Hs.600384,ENST00000458501,THC2491749,"GO:0005765(lysosomal membrane)|GO:0007041(lysosomal transport)|GO:0015019(heparan-alpha-glucosaminide N-acetyltransferase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016746(transferase activity, transferring acyl groups)|GO:0051259(protein oligomerization)","Homo sapiens heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT), mRNA [NM_152419]",chr8:43056897-43056956,hs|8p11.21,heparan-alpha-glucosaminide N-acetyltransferase,TRUE
1335_KTN1_3895,Q86UP2,kinectin (cg-1 antigen) (kinesin receptor),KTN1 CG1 KIAA0004,1357,function: receptor for kinesin thus involved in kinesin-driven vesicle motility. accumulates in integrin-based adhesion complexes (iac) upon integrin aggregation by fibronectin.,subcellular location: endoplasmic reticulum membrane; single-pass type ii membrane protein. note=vesicle membrane protein anchored to the endoplasmic reticulum.,"TISSUE SPECIFICITY: High levels in peripheral blood lymphocytes, testis and ovary, lower levels in spleen, thymus, prostate, small intestine and colon.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KTN1,3895,Hs.509414,ENST00000553710,THC2679342,GO:0003674(molecular_function)|GO:0004872(receptor activity)|GO:0005624(membrane fraction)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005887(integral to plasma membrane)|GO:0007018(microtubule-based movement)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens kinectin 1 (kinesin receptor) (KTN1), transcript variant 4, mRNA [NM_004986]",chr14:56150895-56150954,hs|14q22.3,kinectin 1 (kinesin receptor),TRUE
1336_RAB18_22931,Q9NP72,ras-related protein rab-18,RAB18,206,function: plays a role in apical endocytosis/recycling. may be implicated in transport between the plasma membrane and early endosomes. plays a key role in eye and brain development and neurodegeneration. {eco:0000269|pubmed:21473985}.,subcellular location: cell membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Warburg micro syndrome 3 (WARBM3) [MIM:614222]: A rare syndrome characterized by microcephaly, microphthalmia, microcornia, congenital cataracts, optic atrophy, cortical dysplasia, in particular corpus callosum hypoplasia, severe mental retardation, spastic diplegia, and hypogonadism. {ECO:0000269|PubMed:21473985}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAB18,22931,Hs.406799,ENST00000540268,THC2778145,"GO:0000166(nucleotide binding)|GO:0001654(eye development)|GO:0003924(GTPase activity)|GO:0005524(ATP binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006897(endocytosis)|GO:0007264(small GTPase mediated signal transduction)|GO:0007420(brain development)|GO:0008134(transcription factor binding)|GO:0015031(protein transport)","Homo sapiens RAB18, member RAS oncogene family (RAB18), mRNA [NM_021252]",chr10:27828374-27828433,hs|10p12.1,"RAB18, member RAS oncogene family",TRUE
1337_SIDT2_51092,Q8NBJ9,sid1 transmembrane family member 2,SIDT2 CGI-40 PSEC0072 UNQ685/PRO1325,832,"function: mediates the translocation of rna and dna across the lysosomal membrane during rna and dna autophagy (rda), a process in which rna or dna is directly imported into lysosomes in an atp-dependent manner, and degraded (pubmed:27046251, pubmed:27846365). involved in the uptake of single-stranded oligonucleotides by living cells, a process called gymnosis (pubmed:28277980). involved in the uptake of single-stranded oligonucleotides by living cells, a process called gymnosis. in vitro, mediates the uptake of linear dna more efficiently than that of circular dna, but exhibits similar uptake efficacy toward rna and dna. binds long double-stranded rna (dsrna) (500 - 700 base pairs), but not dsrna shorter than 100 bp (by similarity). {eco:0000250|uniprotkb:q8cif6, eco:0000269|pubmed:27046251, eco:0000269|pubmed:27846365, eco:0000269|pubmed:28277980}.","subcellular location: lysosome membrane {eco:0000269|pubmed:17897319, eco:0000269|pubmed:28277980}; multi-pass membrane protein {eco:0000269|pubmed:17897319}. cell membrane {eco:0000269|pubmed:28277980}. note=mainly localizes to lysosomes and only partly to the plasma membrane (pubmed:28277980). lysosomal localization is required for sidt2-mediated intracellular degradation of endogenous rna (by similarity). {eco:0000250|uniprotkb:q8cif6, eco:0000269|pubmed:28277980}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SIDT2,51092,Hs.712144,ENST00000324225,THC2466042,GO:0005765(lysosomal membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens SID1 transmembrane family, member 2 (SIDT2), mRNA [NM_001040455]",chr11:117068077-117068136,hs|11q23.3,"SID1 transmembrane family, member 2",TRUE
1338_TOP1MT_116447,Q969P6,"dna topoisomerase i, mitochondrial (top1mt) (ec 5.6.2.1)",TOP1MT,601,"function: releases the supercoiling and torsional tension of dna introduced during duplication of mitochondrial dna by transiently cleaving and rejoining one strand of the dna duplex. introduces a single-strand break via transesterification at a target site in duplex dna. the scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a dna-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-oh dna strand. the free dna strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing dna supercoils. finally, in the religation step, the dna 5'-oh attacks the covalent intermediate to expel the active-site tyrosine and restore the dna phosphodiester backbone (by similarity). {eco:0000250, eco:0000269|pubmed:11526219}.",subcellular location: mitochondrion {eco:0000269|pubmed:11526219}.,"TISSUE SPECIFICITY: Ubiquitous; highest in skeletal muscle, heart, brain and fetal liver. {ECO:0000269|PubMed:11526219}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TOP1MT,116447,Hs.528574,ENST00000517857,THC2467548,GO:0000166(nucleotide binding)|GO:0003917(DNA topoisomerase type I activity)|GO:0003918(DNA topoisomerase (ATP-hydrolyzing) activity)|GO:0005524(ATP binding)|GO:0005694(chromosome)|GO:0005739(mitochondrion)|GO:0006265(DNA topological change)|GO:0031490(chromatin DNA binding)|GO:0042645(mitochondrial nucleoid),"Homo sapiens topoisomerase (DNA) I, mitochondrial (TOP1MT), nuclear gene encoding mitochondrial protein, mRNA [NM_052963]",chr8:144391634-144391575,hs|8q24.3,"topoisomerase (DNA) I, mitochondrial",TRUE
1339_RNASET2_8635,O00584,ribonuclease t2 (ec 4.6.1.19) (ribonuclease 6),RNASET2 RNASE6PL,256,"function: has ribonuclease activity, with higher activity at acidic ph. probably is involved in lysosomal degradation of ribosomal rna (by similarity). probably plays a role in cellular rna catabolism. {eco:0000250, eco:0000269|pubmed:16620762, eco:0000269|pubmed:19525954, eco:0000269|pubmed:22735700}.",subcellular location: secreted. lysosome lumen. endoplasmic reticulum lumen. note=subcellular fractionation of transfected ovarian cancer cells reveals full-length rnaset2 in the endoplasmic reticulum fraction and the 2 smaller rnaset2 proteolytic products in the lysosome fraction.,TISSUE SPECIFICITY: Ubiquitous. Higher expression levels observed in the temporal lobe and fetal brain. {ECO:0000269|PubMed:19525954}.,"DISEASE: Leukoencephalopathy, cystic, without megalencephaly (LCWM) [MIM:612951]: An infantile-onset syndrome of cerebral leukoencephalopathy. Affected newborns develop microcephaly and neurologic abnormalities including psychomotor impairment, seizures and sensorineural hearing impairment. The brain shows multifocal white matter lesions, anterior temporal lobe subcortical cysts, pericystic abnormal myelination, ventriculomegaly and intracranial calcifications. {ECO:0000269|PubMed:19525954, ECO:0000269|PubMed:21199949}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RNASET2,8635,Hs.529989,ENST00000467705,THC2486653,GO:0003723(RNA binding)|GO:0004519(endonuclease activity)|GO:0004540(ribonuclease activity)|GO:0005576(extracellular region)|GO:0006401(RNA catabolic process)|GO:0016787(hydrolase activity)|GO:0033897(ribonuclease T2 activity),"Homo sapiens ribonuclease T2 (RNASET2), mRNA [NM_003730]",chr6:167344538-167343227,hs|6q27,ribonuclease T2,TRUE
134_CD99_4267,P14209,cd99 antigen (12e7) (e2 antigen) (protein mic2) (t-cell surface glycoprotein e2) (cd antigen cd99),CD99 MIC2 MIC2X MIC2Y,185,"function: involved in t-cell adhesion processes and in spontaneous rosette formation with erythrocytes. plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. acts at the same site as, but independently of, pecam1. involved in t-cell adhesion processes (by similarity). {eco:0000250}.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CD99,4267,Hs.653349,ENST00000381192,THC2536742,GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion),"Homo sapiens CD99 molecule (CD99), transcript variant 1, mRNA [NM_002414]",chrY:2609197-2609256,hs|Yp11.31,CD99 molecule,TRUE
1340_VSIG10L_147645,Q86VR7,v-set and immunoglobulin domain-containing protein 10-like (vsig10-like protein),VSIG10L,867,NA,subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in the esophagus, particularly in the suprabasilar layers of the epithelium. Expression is largely reduced in esophageal metaplasia, dysplasia, and adenocarcinoma lesions. {ECO:0000269|PubMed:27467440}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,VSIG10L,147645,Hs.293236,ENST00000335624,THC2601567,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens V-set and immunoglobulin domain containing 10 like (VSIG10L), mRNA [NM_001163922]",chr19:51834918-51834859,hs|19q13.41,V-set and immunoglobulin domain containing 10 like,TRUE
1341_RABAC1_10567,Q9UI14,prenylated rab acceptor protein 1 (pra1 family protein 1),RABAC1 PRA1 PRAF1,185,function: general rab protein regulator required for vesicle formation from the golgi complex. may control vesicle docking and fusion by mediating the action of rab gtpases to the snare complexes. in addition it inhibits the removal of rab gtpases from the membrane by gdi. {eco:0000250|uniprotkb:o35394}.,"subcellular location: cell membrane {eco:0000250|uniprotkb:o35394}; multi-pass membrane protein {eco:0000255}. cytoplasm {eco:0000250|uniprotkb:o35394}. golgi apparatus {eco:0000250|uniprotkb:o35394}. cytoplasmic vesicle, secretory vesicle, synaptic vesicle {eco:0000250|uniprotkb:o35394}. note=according to some authors, it is an integral membrane protein, while others showed that it is cytoplasmic and membrane-associated to golgi and synaptic vesicles. {eco:0000250|uniprotkb:o35394}.","TISSUE SPECIFICITY: Ubiquitous. Strongest expression found in placenta, pituitary gland, kidney, lung and stomach. {ECO:0000269|PubMed:11520070}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RABAC1,10567,Hs.11417,ENST00000222008,THC2488845,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0008021(synaptic vesicle)|GO:0008022(protein C-terminus binding)|GO:0016021(integral to membrane)|GO:0030054(cell junction)|GO:0031410(cytoplasmic vesicle)|GO:0042802(identical protein binding)|GO:0045202(synapse)|GO:0070064(proline-rich region binding),"Homo sapiens Rab acceptor 1 (prenylated) (RABAC1), mRNA [NM_006423]",chr19:42460901-42460842,hs|19q13.2,Rab acceptor 1 (prenylated),TRUE
1342_ISCA2_122961,Q86U28,"iron-sulfur cluster assembly 2 homolog, mitochondrial (hesb-like domain-containing protein 1)",ISCA2 HBLD1,154,function: involved in the maturation of mitochondrial 4fe-4s proteins functioning late in the iron-sulfur cluster assembly pathway. may be involved in the binding of an intermediate of fe/s cluster assembly. {eco:0000269|pubmed:22323289}.,subcellular location: mitochondrion {eco:0000269|pubmed:22323289}.,NA,"DISEASE: Multiple mitochondrial dysfunctions syndrome 4 (MMDS4) [MIM:616370]: A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. {ECO:0000269|PubMed:25539947}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ISCA2,122961,Hs.291079,ENST00000556816,THC2463076,GO:0005198(structural molecule activity)|GO:0005739(mitochondrion)|GO:0016226(iron-sulfur cluster assembly)|GO:0046872(metal ion binding)|GO:0051536(iron-sulfur cluster binding),"Homo sapiens iron-sulfur cluster assembly 2 homolog (S. cerevisiae) (ISCA2), mRNA [NM_194279]",chr14:74961983-74962042,hs|14q24.3,iron-sulfur cluster assembly 2 homolog (S. cerevisiae),TRUE
1343_DAAM1_23002,Q9Y4D1,disheveled-associated activator of morphogenesis 1,DAAM1 KIAA0666,1078,"function: binds to disheveled (dvl) and rho, and mediates wnt-induced dvl-rho complex formation. may play a role as a scaffolding protein to recruit rho-gdp and rho-gef, thereby enhancing rho-gtp formation. can direct nucleation and elongation of new actin filaments. involved in building functional cilia (pubmed:16630611, pubmed:17482208). involved in the organization of the subapical actin network in multiciliated epithelial cells (by similarity). together with daam2, required for myocardial maturation and sarcomere assembly (by similarity). {eco:0000250|uniprotkb:b0dob5, eco:0000250|uniprotkb:q8bpm0, eco:0000269|pubmed:16630611, eco:0000269|pubmed:17482208}.","subcellular location: cytoplasm {eco:0000269|pubmed:16630611}. cytoplasm, cytoskeleton, cilium basal body {eco:0000269|pubmed:26644512}. note=perinuclear.",TISSUE SPECIFICITY: Expressed in all tissues examined.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,DAAM1,23002,Hs.654934,ENST00000351081,THC2484993,GO:0003779(actin binding)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0016043(cellular component organization)|GO:0017048(Rho GTPase binding)|GO:0030036(actin cytoskeleton organization),"Homo sapiens dishevelled associated activator of morphogenesis 1 (DAAM1), mRNA [NM_014992]",chr14:59836230-59836289,hs|14q23.1,dishevelled associated activator of morphogenesis 1,TRUE
1344_SEC31A_22872,O94979,protein transport protein sec31a (abp125) (abp130) (sec31-like protein 1) (sec31-related protein a) (web1-like protein),SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334,1220,"function: component of the coat protein complex ii (copii) which promotes the formation of transport vesicles from the endoplasmic reticulum (er) (pubmed:10788476). the coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules (by similarity). {eco:0000250|uniprotkb:q9z2q1, eco:0000269|pubmed:10788476}.","subcellular location: cytoplasm {eco:0000250}. cytoplasmic vesicle, copii-coated vesicle membrane {eco:0000269|pubmed:10788476, eco:0000269|pubmed:16957052, eco:0000269|pubmed:22358839, eco:0000269|pubmed:27716508}; peripheral membrane protein; cytoplasmic side. endoplasmic reticulum membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. cytoplasm, cytosol {eco:0000269|pubmed:17428803}. note=associates with membranes in a gtp-dependent manner (by similarity). localizes to endoplasmic reticulum exit sites (eres), also known as transitional endoplasmic reticulum (ter) (pubmed:25201882, pubmed:28442536, pubmed:17428803). {eco:0000250|uniprotkb:q9z2q1, eco:0000269|pubmed:17428803, eco:0000269|pubmed:25201882, eco:0000269|pubmed:28442536}.","TISSUE SPECIFICITY: Abundantly and ubiquitously expressed. {ECO:0000269|PubMed:10574704, ECO:0000269|PubMed:10788476}.",DISEASE: Note=A chromosomal aberration involving SEC31A is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;4)(p23;q21) with ALK.,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC31A,22872,Hs.370024,ENST00000505479,NP707801,GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005829(cytosol)|GO:0006888(ER to Golgi vesicle-mediated transport)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0030127(COPII vesicle coat)|GO:0031410(cytoplasmic vesicle)|GO:0043231(intracellular membrane-bounded organelle)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0048208(COPII vesicle coating)|GO:0048306(calcium-dependent protein binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0051592(response to calcium ion),"Homo sapiens SEC31 homolog A (S. cerevisiae) (SEC31A), transcript variant 5, mRNA [NM_001077207]",chr4:83740388-83740329,hs|4q21.22,SEC31 homolog A (S. cerevisiae),TRUE
1345_ENOSF1_55556,Q7L5Y1,mitochondrial enolase superfamily member 1 (ec 4.2.1.68) (antisense rna to thymidylate synthase) (rts) (l-fuconate dehydratase),ENOSF1 RTS TYMSAS,443,"function: plays a role in the catabolism of l-fucose, a sugar that is part of the carbohydrates that are attached to cellular glycoproteins. catalyzes the dehydration of l-fuconate to 2-keto-3-deoxy-l-fuconate by the abstraction of the 2-proton to generate an enediolate intermediate that is stabilized by the magnesium ion (pubmed:24697329). {eco:0000269|pubmed:24697329}.",subcellular location: mitochondrion {eco:0000269|pubmed:16162288}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ENOSF1,55556,Hs.369762,ENST00000340116,THC2495879,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005739(mitochondrion)|GO:0008150(biological_process)|GO:0009063(cellular amino acid catabolic process)|GO:0016853(isomerase activity)|GO:0046872(metal ion binding),"Homo sapiens enolase superfamily member 1 (ENOSF1), transcript variant 1, mRNA [NM_017512]",chr18:674217-674158,hs|18p11.32,enolase superfamily member 1,TRUE
1346_HBXIP_10542,O43504,ragulator complex protein lamtor5 (hepatitis b virus x-interacting protein) (hbv x-interacting protein) (hbx-interacting protein) (late endosomal/lysosomal adaptor and mapk and mtor activator 5),LAMTOR5 HBXIP XIP,91,"function: as part of the ragulator complex it is involved in amino acid sensing and activation of mtorc1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. activated by amino acids through a mechanism involving the lysosomal v-atpase, the ragulator functions as a guanine nucleotide exchange factor activating the small gtpases rag. activated ragulator and rag gtpases function as a scaffold recruiting mtorc1 to lysosomes where it is in turn activated. when complexed to birc5, interferes with apoptosome assembly, preventing recruitment of pro-caspase-9 to oligomerized apaf1, thereby selectively suppressing apoptosis initiated via the mitochondrial/cytochrome c pathway. down-regulates hepatitis b virus (hbv) replication. {eco:0000269|pubmed:12773388, eco:0000269|pubmed:22980980}.",subcellular location: cytoplasm. lysosome.,"TISSUE SPECIFICITY: Highly expressed in skeletal and cardiac muscle, followed by pancreas, kidney, liver, brain, placenta and lung. Elevated levels in both cancerous and non-cancerous liver tissue of patients with chronic HBV infection compared with hepatic tissue without HBV infection.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HBXIP,10542,Hs.439815,ENST00000256644,THC2534490,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006916(anti-apoptosis)|GO:0009615(response to virus)|GO:0019079(viral genome replication)|GO:0043154(negative regulation of caspase activity),"Homo sapiens hepatitis B virus x interacting protein (HBXIP), mRNA [NM_006402]",chr1:110944166-110944107,hs|1p13.3,hepatitis B virus x interacting protein,TRUE
1347_ARL2BP_23568,Q9Y2Y0,adp-ribosylation factor-like protein 2-binding protein (arf-like 2-binding protein) (arl2-binding protein) (binder of arf2 protein 1),ARL2BP BART BART1,163,"function: together with arl2, plays a role in the nuclear translocation, retention and transcriptional activity of stat3. may play a role as an effector of arl2. {eco:0000269|pubmed:18234692}.","subcellular location: cytoplasm. mitochondrion intermembrane space. cytoplasm, cytoskeleton, microtubule organizing center, centrosome. nucleus. cytoplasm, cytoskeleton, spindle. cytoplasm, cytoskeleton, cilium basal body. note=the complex formed with arl2bp, arl2 and slc25a4 is expressed in mitochondria (by similarity). detected in the midbody matrix. not detected in the golgi, nucleus and on the mitotic spindle. centrosome-associated throughout the cell cycle. not detected to interphase microtubules. in retina photoreceptor cells, localized in the distal connecting cilia, basal body, ciliary-associated centriole, and ciliary rootlet. interaction with arl2 may be required for cilia basal body localization. {eco:0000250}.","TISSUE SPECIFICITY: Expressed in retina pigment epithelial cells (at protein level). Widely expressed. {ECO:0000269|PubMed:10488091, ECO:0000269|PubMed:23849777}.","DISEASE: Retinitis pigmentosa 82 with or without situs inversus (RP82) [MIM:615434]: An autosomal recessive disorder characterized by variable association of retinitis pigmentosa with situs inversus. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. Situs inversus is a congenital abnormality in which organs in the thorax and the abdomen are opposite to their normal positions due to lateral transposition. {ECO:0000269|PubMed:23849777, ECO:0000269|PubMed:27790702}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,ARL2BP,23568,Hs.632873,ENST00000219204,THC2469942,GO:0003713(transcription coactivator activity)|GO:0005083(small GTPase regulator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005758(mitochondrial intermembrane space)|GO:0005813(centrosome)|GO:0005819(spindle)|GO:0005856(cytoskeleton)|GO:0007165(signal transduction)|GO:0030496(midbody)|GO:0042517(positive regulation of tyrosine phosphorylation of Stat3 protein)|GO:0051457(maintenance of protein location in nucleus),"Homo sapiens ADP-ribosylation factor-like 2 binding protein (ARL2BP), mRNA [NM_012106]",chr16:57287470-57287529,hs|16q13,ADP-ribosylation factor-like 2 binding protein,TRUE
1348_ARFIP1_27236,P53367,arfaptin-1 (adp-ribosylation factor-interacting protein 1),ARFIP1,373,"function: plays a role in controlling biogenesis of secretory granules at the trans-golgi network. mechanisitically, binds arf-gtp at the neck of a growing secretory granule precursor and forms a protective scaffold. once the granule precursor has been completely loaded, active prkd1 phosphorylates arfip1 and releases it from arfs. in turn, arfs induce fission. through this mechanism, ensures proper secretory granule formation at the golgi of pancreatic beta cells. {eco:0000269|pubmed:22981988}.","subcellular location: golgi apparatus {eco:0000269|pubmed:22981988}. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:21239483}.","TISSUE SPECIFICITY: Ubiquitously expressed. Higher levels in liver, pancreas, placenta, skeletal muscle and heart.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ARFIP1,27236,Hs.416089,ENST00000353617,THC2462556,GO:0000139(Golgi membrane)|GO:0003674(molecular_function)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0050708(regulation of protein secretion),"Homo sapiens ADP-ribosylation factor interacting protein 1 (ARFIP1), transcript variant 1, mRNA [NM_001025595]",chr4:153832920-153832979,hs|4q31.3,ADP-ribosylation factor interacting protein 1,TRUE
1349_NMT1_4836,P30419,glycylpeptide n-tetradecanoyltransferase 1 (ec 2.3.1.97) (myristoyl-coa:protein n-myristoyltransferase 1) (nmt 1) (type i n-myristoyltransferase) (peptide n-myristoyltransferase 1),NMT1 NMT,496,"function: adds a myristoyl group to the n-terminal glycine residue of certain cellular and viral proteins. {eco:0000269|pubmed:22865860, eco:0000269|pubmed:25255805, eco:0000269|pubmed:9353336, eco:0000269|pubmed:9506952}.","subcellular location: cytoplasm {eco:0000269|pubmed:9353336, eco:0000269|pubmed:9506952}. cytoplasm, cytosol {eco:0000269|pubmed:9353336}. membrane {eco:0000269|pubmed:9506952}; peripheral membrane protein {eco:0000269|pubmed:9506952}. note=copurifies with ribosomes. {eco:0000269|pubmed:9353336}.","TISSUE SPECIFICITY: Heart, gut, kidney, liver and placenta.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NMT1,4836,Hs.532790,ENST00000258960,THC2573409,"GO:0001701(in utero embryonic development)|GO:0003824(catalytic activity)|GO:0004379(glycylpeptide N-tetradecanoyltransferase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006498(N-terminal protein lipidation)|GO:0006499(N-terminal protein myristoylation)|GO:0006915(apoptosis)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008633(activation of pro-apoptotic gene products)|GO:0009249(protein lipoylation)|GO:0015629(actin cytoskeleton)|GO:0016746(transferase activity, transferring acyl groups)|GO:0030054(cell junction)","Homo sapiens N-myristoyltransferase 1 (NMT1), mRNA [NM_021079]",chr17:43186308-43186367,hs|17q21.31,N-myristoyltransferase 1,TRUE
135_TRMT112_51504,Q9UI30,multifunctional methyltransferase subunit trm112-like protein (trna methyltransferase 112 homolog),TRMT112 AD-001 HSPC152 HSPC170,125,"function: acts as an activator of both rrna/trna and protein methyltransferases (pubmed:25851604). together with methyltransferase bud23, methylates the n(7) position of a guanine in 18s rrna (pubmed:25851604). the heterodimer with hemk2/n6amt1 catalyzes n5-methylation of etf1 on 'gln-185', using s-adenosyl l-methionine as methyl donor (pubmed:18539146). the heterodimer with alkbh8 catalyzes the methylation of 5-carboxymethyl uridine to 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in target trna species (pubmed:20308323). involved in the pre-rrna processing steps leading to small-subunit rrna production (pubmed:25851604). {eco:0000269|pubmed:18539146, eco:0000269|pubmed:20308323, eco:0000269|pubmed:25851604}.","subcellular location: nucleus, nucleoplasm {eco:0000269|pubmed:25851604}. cytoplasm, perinuclear region {eco:0000269|pubmed:25851604}. note=localizes to a polarized perinuclear structure, overlapping partially with the golgi and lysosomes (pubmed:25851604). {eco:0000269|pubmed:25851604}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRMT112,51504,Hs.333579,ENST00000537918,THC2468911,GO:0005515(protein binding)|GO:0008276(protein methyltransferase activity)|GO:0018364(peptidyl-glutamine methylation)|GO:0043234(protein complex),"Homo sapiens tRNA methyltransferase 11-2 homolog (S. cerevisiae) (TRMT112), mRNA [NM_016404]",chr11:64084293-64084234,hs|11q13.1,tRNA methyltransferase 11-2 homolog (S. cerevisiae),TRUE
1350_MDH1_4190,P40925,"malate dehydrogenase, cytoplasmic (ec 1.1.1.37) (cytosolic malate dehydrogenase) (diiodophenylpyruvate reductase) (ec 1.1.1.96)",MDH1 MDHA,334,NA,subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MDH1,4190,Hs.526521,ENST00000539945,THC2585080,GO:0004470(malic enzyme activity)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006094(gluconeogenesis)|GO:0006099(tricarboxylic acid cycle)|GO:0006107(oxaloacetate metabolic process)|GO:0006108(malate metabolic process)|GO:0006734(NADH metabolic process)|GO:0016491(oxidoreductase activity)|GO:0030060(L-malate dehydrogenase activity)|GO:0044262(cellular carbohydrate metabolic process)|GO:0051287(NAD binding),"Homo sapiens malate dehydrogenase 1, NAD (soluble) (MDH1), transcript variant 2, mRNA [NM_005917]",chr2:63834237-63834296,hs|2p15,"malate dehydrogenase 1, NAD (soluble)",TRUE
1351_NAA38_51691,Q9BRA0,"n-alpha-acetyltransferase 38, natc auxiliary subunit (lsm domain-containing protein 1) (phosphonoformate immuno-associated protein 2)",NAA38 LSMD1 MAK31 PFAAP2,125,function: auxillary component of the n-terminal acetyltransferase c (natc) complex which catalyzes acetylation of n-terminal methionine residues. {eco:0000269|pubmed:19398576}.,subcellular location: cytoplasm {eco:0000269|pubmed:19398576}. nucleus {eco:0000269|pubmed:19398576}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NAA38,51691,Hs.655046,ENST00000249299,THC2492301,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0008380(RNA splicing)|GO:0017070(U6 snRNA binding)|GO:0030529(ribonucleoprotein complex)","Homo sapiens N(alpha)-acetyltransferase 38, NatC auxiliary subunit (NAA38), mRNA [NM_016200]",chr7:117832041-117832100,hs|7q31.31,"N(alpha)-acetyltransferase 38, NatC auxiliary subunit",TRUE
1352_THOC4_10189,Q86V81,tho complex subunit 4 (tho4) (ally of aml-1 and lef-1) (aly/ref export factor) (transcriptional coactivator aly/ref) (bzip-enhancing factor bef),ALYREF ALY BEF THOC4,257,"function: export adapter involved in nuclear export of spliced and unspliced mrna. binds mrna which is thought to be transferred to the nxf1-nxt1 heterodimer for export (tap/nfx1 pathway) (pubmed:15833825, pubmed:15998806, pubmed:17190602, pubmed:11707413, pubmed:11675789, pubmed:11979277, pubmed:18364396, pubmed:22144908, pubmed:22893130, pubmed:23222130, pubmed:25662211). component of the trex complex which is thought to couple mrna transcription, processing and nuclear export, and specifically associates with spliced mrna and not with unspliced pre-mrna (pubmed:15833825, pubmed:15998806, pubmed:17190602). trex is recruited to spliced mrnas by a transcription-independent mechanism, binds to mrna upstream of the exon-junction complex (ejc) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mrna where it functions in mrna export to the cytoplasm (pubmed:15833825, pubmed:15998806, pubmed:17190602). trex recruitment occurs via an interaction between alyref/thoc4 and the cap-binding protein ncbp1 (pubmed:15833825, pubmed:15998806, pubmed:17190602). the trex complex is essential for the export of kaposi's sarcoma-associated herpesvirus (kshv) intronless mrnas and infectious virus production; alyref/thoc4 mediates the recruitment of the trex complex to the intronless viral mrna (pubmed:18974867). required for trex complex assembly and for linking ddx39b to the cap-binding complex (cbc) (pubmed:15998806, pubmed:17984224). in conjunction with thoc5 functions in nxf1-nxt1 mediated nuclear export of hsp70 mrna; both proteins enhance the rna binding activity of nxf1 and are required for nxf1 localization to the nuclear rim (pubmed:19165146). involved in the nuclear export of intronless mrna; proposed to be recruited to intronless mrna by atp-bound ddx39b. involved in transcription elongation and genome stability (pubmed:12438613, pubmed:17984224). involved in mrna export of c5-methylcytosine (m5c)-containing mrnas: specifically recognizes and binds m5c mrnas and mediates their nucleo-cytoplasmic shuttling (pubmed:28418038). {eco:0000269|pubmed:11675789, eco:0000269|pubmed:11707413, eco:0000269|pubmed:11979277, eco:0000269|pubmed:12438613, eco:0000269|pubmed:15833825, eco:0000269|pubmed:15998806, eco:0000269|pubmed:17190602, eco:0000269|pubmed:17984224, eco:0000269|pubmed:18364396, eco:0000269|pubmed:18974867, eco:0000269|pubmed:19165146, eco:0000269|pubmed:22144908, eco:0000269|pubmed:22893130, eco:0000269|pubmed:23222130, eco:0000269|pubmed:25662211, eco:0000269|pubmed:28418038}.; function: acts as chaperone and promotes the dimerization of transcription factors containing basic leucine zipper (bzip) domains and thereby promotes transcriptional activation. {eco:0000269|pubmed:10488337}.","subcellular location: nucleus {eco:0000269|pubmed:10488337, eco:0000269|pubmed:19324961, eco:0000269|pubmed:23826332, eco:0000269|pubmed:28418038, eco:0000305|pubmed:18974867}. nucleus speckle {eco:0000269|pubmed:19324961, eco:0000269|pubmed:23826332}. cytoplasm {eco:0000269|pubmed:19324961, eco:0000269|pubmed:28418038}. note=colocalizes with the core ejc, alyref/thoc4, nxf1 and ddx39b in the nucleus and nuclear speckles. travels to the cytoplasm as part of the exon junction complex (ejc) bound to mrna (pubmed:19324961). localizes to regions surrounding nuclear speckles known as perispeckles in which trex complex assembly seems to occur (pubmed:23826332). {eco:0000269|pubmed:19324961, eco:0000269|pubmed:23826332}.",TISSUE SPECIFICITY: Expressed in a wide variety of cancer types. {ECO:0000269|PubMed:25662211}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,THOC4,10189,Hs.534385,ENST00000505490,THC2462842,"GO:0000166(nucleotide binding)|GO:0000346(transcription export complex)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006406(mRNA export from nucleus)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0044419(interspecies interaction between organisms)|GO:0046784(intronless viral mRNA export from host nucleus)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens THO complex 4 (THOC4), mRNA [NM_005782]",chr17:79845823-79845764,hs|17q25.3,THO complex 4,TRUE
1353_LAS1L_81887,Q9Y4W2,ribosomal biogenesis protein las1l (protein las1 homolog),LAS1L MSTP060,734,"function: involved in the biogenesis of the 60s ribosomal subunit. required for maturation of the 28s rrna. functions as a component of the five friends of methylated chtop (5fmc) complex; the 5fmc complex is recruited to znf148 by methylated chtop, leading to desumoylation of znf148 and subsequent transactivation of znf148 target genes. {eco:0000269|pubmed:20647540, eco:0000269|pubmed:22872859}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:12429849, eco:0000269|pubmed:20647540}. nucleus, nucleoplasm {eco:0000250}. cytoplasm {eco:0000250}. note=mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (by similarity). localizes mainly to the granular component, the region implicated in the later steps of rrna processing and subunit assembly and export. {eco:0000250}.",NA,"DISEASE: Wilson-Turner X-linked mental retardation syndrome (WTS) [MIM:309585]: A neurologic disorder characterized by severe intellectual disability, dysmorphic facial features, hypogonadism, short stature, and truncal obesity. Affected females have a milder phenotype than affected males. {ECO:0000269|PubMed:25644381}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LAS1L,81887,Hs.522675,ENST00000484069,THC2477740,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0071339(MLL1 complex),"Homo sapiens LAS1-like (S. cerevisiae) (LAS1L), transcript variant 1, mRNA [NM_031206]",chrX:64732577-64732518,hs|Xq12,LAS1-like (S. cerevisiae),TRUE
1354_SET_6418,Q9NQR1,n-lysine methyltransferase kmt5a (ec 2.1.1.-) (h4-k20-hmtase kmt5a) (histone-lysine n-methyltransferase kmt5a) (ec 2.1.1.43) (lysine n-methyltransferase 5a) (lysine-specific methylase 5a) (pr/set domain-containing protein 07) (pr-set7) (pr/set07) (set domain-containing protein 8),KMT5A PRSET7 SET07 SET8 SETD8,393,"function: protein-lysine n-methyltransferase that monomethylates both histones and non-histone proteins. specifically monomethylates 'lys-20' of histone h4 (h4k20me1). h4k20me1 is enriched during mitosis and represents a specific tag for epigenetic transcriptional repression. mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. required for cell proliferation, probably by contributing to the maintenance of proper higher-order structure of dna during mitosis. involved in chromosome condensation and proper cytokinesis. nucleosomes are preferred as substrate compared to free histones. mediates monomethylation of p53/tp53 at 'lys-382', leading to repress p53/tp53-target genes. plays a negative role in tgf-beta response regulation and a positive role in cell migration. {eco:0000269|pubmed:12086618, eco:0000269|pubmed:12121615, eco:0000269|pubmed:15200950, eco:0000269|pubmed:15933069, eco:0000269|pubmed:15933070, eco:0000269|pubmed:16517599, eco:0000269|pubmed:17707234, eco:0000269|pubmed:23478445}.",subcellular location: nucleus. chromosome. note=specifically localizes to mitotic chromosomes. colocalized with sirt2 at mitotic foci. associates with chromosomes during mitosis; association is increased in a h(2)o(2)-induced oxidative stress-dependent manner. associates with silent chromatin on euchromatic arms. not associated with constitutive heterochromatin.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SET,6418,Hs.436687,ENST00000322030,THC2465434,"GO:0004864(protein phosphatase inhibitor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005829(cytosol)|GO:0006260(DNA replication)|GO:0006334(nucleosome assembly)|GO:0006337(nucleosome disassembly)|GO:0006913(nucleocytoplasmic transport)|GO:0008601(protein phosphatase type 2A regulator activity)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0035067(negative regulation of histone acetylation)|GO:0042393(histone binding)|GO:0043234(protein complex)|GO:0043524(negative regulation of neuron apoptosis)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048471(perinuclear region of cytoplasm)","Homo sapiens SET nuclear oncogene (SET), transcript variant 2, mRNA [NM_003011]",chr9:131457742-131457801,hs|9q34.11,SET nuclear oncogene,TRUE
1355_SIVA1_10572,O15304,apoptosis regulatory protein siva (cd27-binding protein) (cd27bp),SIVA1 SIVA,175,"function: induces cd27-mediated apoptosis. inhibits bcl2l1 isoform bcl-x(l) anti-apoptotic activity. inhibits activation of nf-kappa-b and promotes t-cell receptor-mediated apoptosis. {eco:0000269|pubmed:12011449, eco:0000269|pubmed:14739602, eco:0000269|pubmed:15034012, eco:0000269|pubmed:15958577, eco:0000269|pubmed:16491128}.","subcellular location: cytoplasm {eco:0000269|pubmed:15034012}. nucleus {eco:0000269|pubmed:15034012}. note=in the nucleus, accumulates in dot-like structures.","TISSUE SPECIFICITY: Ubiquitous. Mostly expressed in thymus, testis, ovary, prostate, small intestine and spleen and less in colon.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SIVA1,10572,Hs.112058,ENST00000329967,THC2466645,GO:0001618(viral receptor activity)|GO:0005175(CD27 receptor binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0006924(activation-induced cell death of T cells)|GO:0008270(zinc ion binding)|GO:0008635(activation of caspase activity by cytochrome c)|GO:0008656(caspase activator activity)|GO:0009615(response to virus)|GO:0019987(negative regulation of anti-apoptosis)|GO:0032088(negative regulation of NF-kappaB transcription factor activity)|GO:0044419(interspecies interaction between organisms)|GO:0046872(metal ion binding),"Homo sapiens SIVA1, apoptosis-inducing factor (SIVA1), transcript variant 1, mRNA [NM_006427]",chr14:105223086-105225812,hs|14q32.33,"SIVA1, apoptosis-inducing factor",TRUE
1356_MT1H_4496,P80294,metallothionein-1h (mt-1h) (metallothionein-0) (mt-0) (metallothionein-ih) (mt-ih),MT1H,61,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT1H,4496,Hs.438462,ENST00000332374,THC2474500,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0045926(negative regulation of growth)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0071276(cellular response to cadmium ion)|GO:0071294(cellular response to zinc ion),"Homo sapiens metallothionein 1H (MT1H), mRNA [NM_005951]",chr16:056670790-056670849,hs|16q12.2,metallothionein 1H,TRUE
1357_BZW1_9689,Q7L1Q6,basic leucine zipper and w2 domain-containing protein 1 (protein orf),BZW1 BZAP45 KIAA0005,419,function: enhances histone h4 gene transcription but does not seem to bind dna directly. {eco:0000269|pubmed:11524015}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,BZW1,9689,Hs.355983,ENST00000409600,THC2537600,"GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016070(RNA metabolic process)","Homo sapiens basic leucine zipper and W2 domains 1 (BZW1), transcript variant 4, mRNA [NM_014670]",chr2:201688131-201688189,hs|2q33.1,basic leucine zipper and W2 domains 1,TRUE
1358_TOM1L2_146691,Q6ZVM7,tom1-like protein 2 (target of myb-like protein 2),TOM1L2,507,"function: probable role in protein transport. may regulate growth factor-induced mitogenic signaling. {eco:0000269|pubmed:16412388, eco:0000269|pubmed:16479011}.",NA,TISSUE SPECIFICITY: Ubiquitously expressed with higher expression in heart and skeletal muscle. {ECO:0000269|PubMed:11997338}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TOM1L2,146691,Hs.462379,NA,THC2663814,GO:0006886(intracellular protein transport),"Homo sapiens target of myb1-like 2 (chicken) (TOM1L2), transcript variant 3, mRNA [NM_001082968]",chr17:17747058-17746999,hs|17p11.2,target of myb1-like 2 (chicken),TRUE
1359_SP3_6670,Q02447,transcription factor sp3 (spr-2),SP3,781,"function: transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. binds to gt and gc boxes promoter elements. competes with sp1 for the gc-box promoters. weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping. {eco:0000269|pubmed:10391891, eco:0000269|pubmed:11812829, eco:0000269|pubmed:12419227, eco:0000269|pubmed:12837748, eco:0000269|pubmed:15247228, eco:0000269|pubmed:15494207, eco:0000269|pubmed:15554904, eco:0000269|pubmed:16781829, eco:0000269|pubmed:17548428, eco:0000269|pubmed:18187045, eco:0000269|pubmed:18617891, eco:0000269|pubmed:9278495}.","subcellular location: nucleus. nucleus, pml body. note=localizes to the nuclear periphery and in nuclear dots when sumoylated. some localization in pml nuclear bodies.",TISSUE SPECIFICITY: Ubiquitously expressed.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SP3,6670,Hs.531587,ENST00000465379,THC2466406,"GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription)|GO:0001503(ossification)|GO:0001779(natural killer cell differentiation)|GO:0001829(trophectodermal cell differentiation)|GO:0001889(liver development)|GO:0001892(embryonic placenta development)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003690(double-stranded DNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0016605(PML body)|GO:0017053(transcriptional repressor complex)|GO:0030183(B cell differentiation)|GO:0030217(T cell differentiation)|GO:0030219(megakaryocyte differentiation)|GO:0030224(monocyte differentiation)|GO:0030324(lung development)|GO:0030851(granulocyte differentiation)|GO:0043353(enucleate erythrocyte differentiation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0048596(embryonic camera-type eye morphogenesis)|GO:0048706(embryonic skeletal system development)|GO:0060136(embryonic process involved in female pregnancy)|GO:0060216(definitive hemopoiesis)","Homo sapiens Sp3 transcription factor (SP3), transcript variant 1, mRNA [NM_003111]",chr2:174773350-174773291,hs|2q31.1,Sp3 transcription factor,TRUE
136_RPL17_6139,P18621,60s ribosomal protein l17 (60s ribosomal protein l23) (large ribosomal subunit protein ul22) (pd-1),RPL17,184,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,"TISSUE SPECIFICITY: Expressed in pancreas, lung, colon, cystic duct, gall bladder, kidney and liver. Expressed at high levels in the well differentiated pancreatic tumor cell lines HPAF, COLO 357 and Capan-1, the moderately differentiated pancreatic tumor cell lines T3M-4, AsPc-1 and BxPc-3, the poorly differentiated pancreatic tumor cell line MIA PaCa-2, and the pancreatic tumor cell lines of undefined differentiation status such as SW979. Expressed at lower levels in the poorly differentiated pancreatic tumor cell lines HCG-25 and PANC-1. {ECO:0000269|PubMed:1793733}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL17,6139,Hs.374588,ENST00000418495,THC2596675,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L17 (RPL17), transcript variant 1, mRNA [NM_000985]",chr18:47015801-47015742,hs|18q21.1,ribosomal protein L17,TRUE
1360_DCAF13_25879,Q9NV06,ddb1- and cul4-associated factor 13 (wd repeat and sof domain-containing protein 1),DCAF13 WDSOF1 HSPC064,445,"function: possible role in ribosomal rna processing (by similarity). may function as a substrate receptor for cul4-ddb1 e3 ubiquitin-protein ligase complex. {eco:0000250, eco:0000269|pubmed:16949367}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:24754225}. note=in the nucleolus, localizes predominantly in the granular component, but also detected in the fibrillar center and dense fibrillar component. {eco:0000269|pubmed:24754225}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DCAF13,25879,Hs.532265,ENST00000518554,THC2515308,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006364(rRNA processing)|GO:0016567(protein ubiquitination)|GO:0030529(ribonucleoprotein complex)|GO:0080008(CUL4 RING ubiquitin ligase complex),"Homo sapiens DDB1 and CUL4 associated factor 13 (DCAF13), mRNA [NM_015420]",chr8:104453758-104453817,hs|8q22.3,DDB1 and CUL4 associated factor 13,TRUE
1361_IARS_3376,P41252,"isoleucine--trna ligase, cytoplasmic (ec 6.1.1.5) (isoleucyl-trna synthetase) (irs) (ilers)",IARS,1262,function: catalyzes the specific attachment of an amino acid to its cognate trna in a 2 step reaction: the amino acid (aa) is first activated by atp to form aa-amp and then transferred to the acceptor end of the trna. {eco:0000269|pubmed:8052601}.,"subcellular location: cytoplasm {eco:0000269|pubmed:27426735, eco:0000269|pubmed:7721108}. cytoplasm, cytosol {eco:0000269|pubmed:19289464}.",TISSUE SPECIFICITY: Expressed in liver and muscle (at protein level). {ECO:0000269|PubMed:27426735}.,"DISEASE: Growth retardation, impaired intellectual development, hypotonia, and hepatopathy (GRIDHH) [MIM:617093]: An autosomal recessive disorder characterized by severe growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and hepatic dysfunction. {ECO:0000269|PubMed:27426735}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IARS,3376,Hs.445403,ENST00000375660,THC2543510,GO:0000166(nucleotide binding)|GO:0004812(aminoacyl-tRNA ligase activity)|GO:0004822(isoleucine-tRNA ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006428(isoleucyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0016874(ligase activity),"Homo sapiens isoleucyl-tRNA synthetase (IARS), transcript variant long, mRNA [NM_013417]",chr9:94972930-94972871,hs|9q22.31,isoleucyl-tRNA synthetase,TRUE
1362_ADD1_118,P35611,alpha-adducin (erythrocyte adducin subunit alpha),ADD1 ADDA,737,function: membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. binds to calmodulin.,"subcellular location: cytoplasm, cytoskeleton. cell membrane; peripheral membrane protein; cytoplasmic side.",TISSUE SPECIFICITY: Expressed in all tissues. Found in much higher levels in reticulocytes than the beta subunit.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ADD1,118,Hs.183706,ENST00000264758,NP839374,GO:0003779(actin binding)|GO:0005516(calmodulin binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0008134(transcription factor binding)|GO:0008290(F-actin capping protein complex)|GO:0030036(actin cytoskeleton organization)|GO:0030507(spectrin binding)|GO:0032092(positive regulation of protein binding)|GO:0042803(protein homodimerization activity)|GO:0046872(metal ion binding)|GO:0046982(protein heterodimerization activity)|GO:0051015(actin filament binding)|GO:0051016(barbed-end actin filament capping)|GO:0051017(actin filament bundle assembly),"Homo sapiens adducin 1 (alpha) (ADD1), transcript variant 4, mRNA [NM_176801]",chr4:2931548-2931607,hs|4p16.3,adducin 1 (alpha),TRUE
1363_LEF1_51176,Q9UJU2,lymphoid enhancer-binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha),LEF1,399,"function: participates in the wnt signaling pathway. activates transcription of target genes in the presence of ctnnb1 and ep300. may play a role in hair cell differentiation and follicle morphogenesis. tle1, tle2, tle3 and tle4 repress transactivation mediated by lef1 and ctnnb1. regulates t-cell receptor alpha enhancer function. binds dna in a sequence-specific manner. piag antagonizes both wnt-dependent and wnt-independent activation by lef1 (by similarity). isoform 3 lacks the ctnnb1 interaction domain and may be an antagonist for wnt signaling. isoform 5 transcriptionally activates the fibronectin promoter, binds to and represses transcription from the e-cadherin promoter in a ctnnb1-independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells. isoform 1 transcriptionally activates myc and ccnd1 expression and enhances proliferation of pancreatic tumor cells. {eco:0000250, eco:0000269|pubmed:11266540, eco:0000269|pubmed:19653274, eco:0000269|pubmed:2010090}.",subcellular location: nucleus {eco:0000255|prosite-prorule:pru00267}. note=found in nuclear bodies upon piasg binding. {eco:0000250}.,"TISSUE SPECIFICITY: Detected in thymus. Not detected in normal colon, but highly expressed in colon cancer biopsies and colon cancer cell lines. Expressed in several pancreatic tumors and weakly expressed in normal pancreatic tissue. Isoforms 1 and 5 are detected in several pancreatic cell lines. {ECO:0000269|PubMed:19653274}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LEF1,51176,Hs.555947,ENST00000503879,THC2603330,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001569(patterning of blood vessels)|GO:0001649(osteoblast differentiation)|GO:0001755(neural crest cell migration)|GO:0001756(somitogenesis)|GO:0001822(kidney development)|GO:0001837(epithelial to mesenchymal transition)|GO:0001944(vasculature development)|GO:0002040(sprouting angiogenesis)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0005737(cytoplasm)|GO:0006917(induction of apoptosis)|GO:0007155(cell adhesion)|GO:0007420(brain development)|GO:0008013(beta-catenin binding)|GO:0008134(transcription factor binding)|GO:0008284(positive regulation of cell proliferation)|GO:0008301(DNA bending activity)|GO:0010226(response to lithium ion)|GO:0010628(positive regulation of gene expression)|GO:0010718(positive regulation of epithelial to mesenchymal transition)|GO:0014070(response to organic cyclic compound)|GO:0016055(Wnt receptor signaling pathway)|GO:0016202(regulation of striated muscle tissue development)|GO:0021542(dentate gyrus development)|GO:0021854(hypothalamus development)|GO:0021861(forebrain radial glial cell differentiation)|GO:0021873(forebrain neuroblast division)|GO:0021879(forebrain neuron differentiation)|GO:0021943(formation of radial glial scaffolds)|GO:0022008(neurogenesis)|GO:0022407(regulation of cell-cell adhesion)|GO:0022408(negative regulation of cell-cell adhesion)|GO:0022409(positive regulation of cell-cell adhesion)|GO:0030111(regulation of Wnt receptor signaling pathway)|GO:0030223(neutrophil differentiation)|GO:0030284(estrogen receptor activity)|GO:0030307(positive regulation of cell growth)|GO:0030326(embryonic limb morphogenesis)|GO:0030331(estrogen receptor binding)|GO:0030335(positive regulation of cell migration)|GO:0030509(BMP signaling pathway)|GO:0030520(estrogen receptor signaling pathway)|GO:0030854(positive regulation of granulocyte differentiation)|GO:0030879(mammary gland development)|GO:0031100(organ regeneration)|GO:0032696(negative regulation of interleukin-13 production)|GO:0032713(negative regulation of interleukin-4 production)|GO:0032714(negative regulation of interleukin-5 production)|GO:0032993(protein-DNA complex)|GO:0033153(T cell receptor V(D)J recombination)|GO:0035326(enhancer binding)|GO:0042100(B cell proliferation)|GO:0042393(histone binding)|GO:0042475(odontogenesis of dentine-containing tooth)|GO:0043027(caspase inhibitor activity)|GO:0043066(negative regulation of apoptosis)|GO:0043154(negative regulation of caspase activity)|GO:0043392(negative regulation of DNA binding)|GO:0043565(sequence-specific DNA binding)|GO:0043586(tongue development)|GO:0043588(skin development)|GO:0043923(positive regulation by host of viral transcription)|GO:0043966(histone H3 acetylation)|GO:0043967(histone H4 acetylation)|GO:0044212(transcription regulatory region DNA binding)|GO:0045063(T-helper 1 cell differentiation),"Homo sapiens lymphoid enhancer-binding factor 1 (LEF1), transcript variant 1, mRNA [NM_016269]",chr4:108968805-108968746,hs|4q25,lymphoid enhancer-binding factor 1,TRUE
1364_DHCR7_1717,Q9UBM7,7-dehydrocholesterol reductase (7-dhc reductase) (ec 1.3.1.21) (delta7-sterol reductase) (sterol delta(7)-reductase) (sterol reductase sr-2),DHCR7 D7SR,475,"function: production of cholesterol by reduction of c7-c8 double bond of 7-dehydrocholesterol (7-dhc). {eco:0000269|pubmed:25637936, eco:0000269|pubmed:9465114, eco:0000269|pubmed:9634533}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:9878250}; multi-pass membrane protein {eco:0000255}.,"TISSUE SPECIFICITY: Widely expressed. Most abundant in adrenal gland, liver, testis, and brain. {ECO:0000269|PubMed:9465114, ECO:0000269|PubMed:9878250}.","DISEASE: Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]: An autosomal recessive frequent inborn disorder of sterol metabolism with characteristic congenital malformations and mental retardation. Children with SLOS have elevated serum 7-dehydrocholesterol (7-DHC) levels and low serum cholesterol levels. SLOS occurs in relatively high frequency: approximately 1 in 20,000 to 30,000 births in populations of northern and central European background. Historically, a clinical distinction often was made between classic ('type I') SLOS and the more severely affected ('type II') patients. There is, in reality, a clinical and biochemical continuum from mild to severe SLOS. {ECO:0000269|PubMed:10677299, ECO:0000269|PubMed:10995508, ECO:0000269|PubMed:11175299, ECO:0000269|PubMed:11427181, ECO:0000269|PubMed:12949967, ECO:0000269|PubMed:15954111, ECO:0000269|PubMed:25637936, ECO:0000269|PubMed:9653161, ECO:0000269|PubMed:9683613}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DHCR7,1717,Hs.503134,ENST00000355527,THC2469933,GO:0001568(blood vessel development)|GO:0005640(nuclear outer membrane)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006695(cholesterol biosynthetic process)|GO:0009791(post-embryonic development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0030154(cell differentiation)|GO:0030324(lung development)|GO:0035264(multicellular organism growth)|GO:0042127(regulation of cell proliferation)|GO:0045540(regulation of cholesterol biosynthetic process)|GO:0047598(7-dehydrocholesterol reductase activity),"Homo sapiens 7-dehydrocholesterol reductase (DHCR7), transcript variant 1, mRNA [NM_001360]",chr11:71145573-71145514,hs|11q13.4,7-dehydrocholesterol reductase,TRUE
1365_RAB5A_5868,P20339,ras-related protein rab-5a (ec 3.6.5.2),RAB5A RAB5,215,"function: small gtpase which cycles between active gtp-bound and inactive gdp-bound states. in its active state, binds to a variety of effector proteins to regulate cellular responses such as of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. active gtp-bound form is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. rab5a is required for the fusion of plasma membranes and early endosomes (pubmed:10818110, pubmed:14617813, pubmed:16410077, pubmed:15378032). contributes to the regulation of filopodia extension (pubmed:14978216). required for the exosomal release of sdcbp, cd63, pdcd6ip and syndecan (pubmed:22660413). regulates maturation of apoptotic cell-containing phagosomes, probably downstream of dyn2 and pik3c3 (by similarity). {eco:0000250|uniprotkb:q9cqd1, eco:0000269|pubmed:10818110, eco:0000269|pubmed:14617813, eco:0000269|pubmed:14978216, eco:0000269|pubmed:15378032, eco:0000269|pubmed:16410077, eco:0000269|pubmed:22660413}.","subcellular location: cell membrane {eco:0000269|pubmed:23815289}; lipid-anchor {eco:0000305|pubmed:7991565}; cytoplasmic side {eco:0000250|uniprotkb:p18066}. early endosome membrane {eco:0000269|pubmed:23815289, eco:0000269|pubmed:25869668}; lipid-anchor {eco:0000305|pubmed:7991565}. melanosome {eco:0000269|pubmed:17081065}. cytoplasmic vesicle {eco:0000269|pubmed:10818110}. cell projection, ruffle {eco:0000250|uniprotkb:p18066}. membrane {eco:0000269|pubmed:23815289}. cytoplasm, cytosol. cytoplasmic vesicle, phagosome membrane {eco:0000250|uniprotkb:q9cqd1}. endosome membrane {eco:0000269|pubmed:22431521}. note=enriched in stage i melanosomes (pubmed:17081065). alternates between membrane-bound and cytosolic forms (probable). {eco:0000269|pubmed:17081065, eco:0000305}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAB5A,5868,Hs.475663,ENST00000455772,THC2469129,GO:0000166(nucleotide binding)|GO:0001726(ruffle)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005769(early endosome)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0006897(endocytosis)|GO:0007264(small GTPase mediated signal transduction)|GO:0007399(nervous system development)|GO:0007596(blood coagulation)|GO:0010008(endosome membrane)|GO:0015031(protein transport)|GO:0019001(guanyl nucleotide binding)|GO:0019003(GDP binding)|GO:0030139(endocytic vesicle)|GO:0030154(cell differentiation)|GO:0031901(early endosome membrane)|GO:0042470(melanosome)|GO:0045121(membrane raft)|GO:0045921(positive regulation of exocytosis)|GO:0051489(regulation of filopodium assembly)|GO:2000286(receptor internalization involved in canonical Wnt receptor signaling pathway),"Homo sapiens RAB5A, member RAS oncogene family (RAB5A), mRNA [NM_004162]",chr3:20026192-20026251,hs|3p24.3,"RAB5A, member RAS oncogene family",TRUE
1366_YIPF1_54432,Q9Y548,protein yipf1 (yip1 family member 1),YIPF1,306,NA,"subcellular location: golgi apparatus, cis-golgi network membrane {eco:0000269|pubmed:27999994}; multi-pass membrane protein {eco:0000305}. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:27999994, eco:0000269|pubmed:28286305}. late endosome membrane {eco:0000269|pubmed:27999994}. note=mainly localizes within medial-/trans-golgi and trans-golgi network (tgn), while less so within cis-golgi. {eco:0000269|pubmed:27999994, eco:0000269|pubmed:28286305}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,YIPF1,54432,Hs.11923,ENST00000072644,THC2461929,GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030133(transport vesicle),"Homo sapiens Yip1 domain family, member 1 (YIPF1), transcript variant 1, mRNA [NM_018982]",chr1:54317610-54317551,hs|1p32.3,"Yip1 domain family, member 1",TRUE
1367_KIF13B_23303,Q9NQT8,kinesin-like protein kif13b (kinesin-like protein gakin),KIF13B GAKIN KIAA0639,1826,function: involved in reorganization of the cortical cytoskeleton. regulates axon formation by promoting the formation of extra axons. may be functionally important for the intracellular trafficking of maguks and associated protein complexes. {eco:0000269|pubmed:20194617}.,"subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:20194617}. cell projection, axon {eco:0000269|pubmed:20194617}. note=accumulates at the distal part of the microtubules in the tips of axons, but not of dendrites.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,KIF13B,23303,Hs.444767,ENST00000524189,THC2529708,GO:0000166(nucleotide binding)|GO:0003777(microtubule motor activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0006605(protein targeting)|GO:0007018(microtubule-based movement)|GO:0007165(signal transduction)|GO:0019901(protein kinase binding)|GO:0030424(axon)|GO:0042110(T cell activation)|GO:0042995(cell projection)|GO:0050770(regulation of axonogenesis)|GO:0071889(14-3-3 protein binding),"Homo sapiens kinesin family member 13B (KIF13B), mRNA [NM_015254]",chr8:28924878-28924819,hs|8p12,kinesin family member 13B,TRUE
1368_VEZF1_7716,Q14119,vascular endothelial zinc finger 1 (putative transcription factor db1) (zinc finger protein 161),VEZF1 DB1 ZNF161,521,function: possible transcription factor. specifically binds to the ct/gc-rich region of the interleukin-3 promoter and mediates tax transactivation of il-3. {eco:0000269|pubmed:8035792}.,subcellular location: nucleus {eco:0000269|pubmed:8035792}.,TISSUE SPECIFICITY: Ubiquitously expressed. Highest levels in skeletal muscle and kidney. {ECO:0000269|PubMed:8035792}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,VEZF1,7716,Hs.463569,ENST00000258963,THC2565435,GO:0001525(angiogenesis)|GO:0001885(endothelial cell development)|GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006968(cellular defense response)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens vascular endothelial zinc finger 1 (VEZF1), mRNA [NM_007146]",chr17:56049012-56048953,hs|17q22,vascular endothelial zinc finger 1,TRUE
1369_JUNB_3726,P17275,transcription factor jun-b,JUNB,347,function: transcription factor involved in regulating gene activity following the primary growth factor response. binds to the dna sequence 5'-tga[cg]tca-3'.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,JUNB,3726,Hs.25292,ENST00000302754,THC2536702,GO:0000785(chromatin)|GO:0001570(vasculogenesis)|GO:0001649(osteoblast differentiation)|GO:0001701(in utero embryonic development)|GO:0001829(trophectodermal cell differentiation)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0009416(response to light stimulus)|GO:0009612(response to mechanical stimulus)|GO:0009987(cellular process)|GO:0014070(response to organic cyclic compound)|GO:0030316(osteoclast differentiation)|GO:0032570(response to progesterone stimulus)|GO:0032870(cellular response to hormone stimulus)|GO:0033687(osteoblast proliferation)|GO:0034097(response to cytokine stimulus)|GO:0042493(response to drug)|GO:0043434(response to peptide hormone stimulus)|GO:0043565(sequence-specific DNA binding)|GO:0045597(positive regulation of cell differentiation)|GO:0046022(positive regulation of transcription from RNA polymerase II promoter during mitosis)|GO:0046697(decidualization)|GO:0046983(protein dimerization activity)|GO:0051412(response to corticosterone stimulus)|GO:0051591(response to cAMP)|GO:0051726(regulation of cell cycle)|GO:0060136(embryonic process involved in female pregnancy)|GO:0060716(labyrinthine layer blood vessel development)|GO:0071277(cellular response to calcium ion),"Homo sapiens jun B proto-oncogene (JUNB), mRNA [NM_002229]",chr19:12904047-12904106,hs|19p13.2,jun B proto-oncogene,TRUE
137_RPL14_9045,P50914,60s ribosomal protein l14 (cag-isl 7) (large ribosomal subunit protein el14),RPL14,215,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL14,9045,Hs.730621,ENST00000396203,THC2522146,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042273(ribosomal large subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L14 (RPL14), transcript variant 1, mRNA [NM_001034996]",chr3:40503688-40503748,hs|3p22.1,ribosomal protein L14,TRUE
1370_GOLPH3_64083,Q9H4A6,golgi phosphoprotein 3 (coat protein gpp34) (mitochondrial dna absence factor) (midas),GOLPH3 GPP34,298,"function: phosphatidylinositol-4-phosphate-binding protein that links golgi membranes to the cytoskeleton and may participate in the tensile force required for vesicle budding from the golgi. thereby, may play a role in golgi membrane trafficking and could indirectly give its flattened shape to the golgi apparatus. may also bind to the coatomer to regulate golgi membrane trafficking. may play a role in anterograde transport from the golgi to the plasma membrane and regulate secretion. has also been involved in the control of the localization of golgi enzymes through interaction with their cytoplasmic part. may play an indirect role in cell migration. has also been involved in the modulation of mtor signaling. may also be involved in the regulation of mitochondrial lipids biosynthesis. {eco:0000269|pubmed:16263763, eco:0000269|pubmed:19553991, eco:0000269|pubmed:19837035, eco:0000269|pubmed:22745132, eco:0000269|pubmed:23027862, eco:0000269|pubmed:23345592, eco:0000269|pubmed:23500462}.","subcellular location: golgi apparatus, golgi stack membrane; peripheral membrane protein; cytoplasmic side. golgi apparatus, trans-golgi network membrane; peripheral membrane protein; cytoplasmic side. mitochondrion intermembrane space. cell membrane {eco:0000250}. endosome {eco:0000250}. note=phosphatidylinositol 4-phosphate-binding and oligomerization participate in the recruitment onto golgi membranes. {eco:0000305}.",TISSUE SPECIFICITY: Detected in muscle fibers of patients with mitochondrial diseases; not detected in normal muscle fibers.,NA,NA,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GOLPH3,64083,Hs.408909,ENST00000499354,THC2518260,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005758(mitochondrial intermembrane space)|GO:0005768(endosome)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0008283(cell proliferation)|GO:0010821(regulation of mitochondrion organization)|GO:0031965(nuclear membrane)|GO:0032008(positive regulation of TOR signaling cascade)|GO:0032580(Golgi cisterna membrane),"Homo sapiens golgi phosphoprotein 3 (coat-protein) (GOLPH3), mRNA [NM_022130]",chr5:32125336-32125277,hs|5p13.3,golgi phosphoprotein 3 (coat-protein),TRUE
1371_FBXL5_26234,Q9UKA1,f-box/lrr-repeat protein 5 (f-box and leucine-rich repeat protein 5) (f-box protein fbl4/fbl5) (p45skp2-like protein),FBXL5 FBL4 FBL5 FLR1,691,"function: component of some scf (skp1-cullin-f-box) protein ligase complex that plays a central role in iron homeostasis by promoting the ubiquitination and subsequent degradation of ireb2/irp2. upon high iron and oxygen level, it specifically recognizes and binds ireb2/irp2, promoting its ubiquitination and degradation by the proteasome. promotes ubiquitination and subsequent degradation of dctn1/p150-glued. {eco:0000269|pubmed:17532294, eco:0000269|pubmed:19762596, eco:0000269|pubmed:19762597}.","subcellular location: cytoplasm, perinuclear region {eco:0000269|pubmed:17532294}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FBXL5,26234,Hs.643433,ENST00000382358,THC2606008,GO:0000151(ubiquitin ligase complex)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005506(iron ion binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0016567(protein ubiquitination)|GO:0019005(SCF ubiquitin ligase complex)|GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0055072(iron ion homeostasis),"Homo sapiens F-box and leucine-rich repeat protein 5 (FBXL5), transcript variant 1, mRNA [NM_012161]",chr4:15607016-15606957,hs|4p15.32,F-box and leucine-rich repeat protein 5,TRUE
1372_TPD52L1_7164,Q16890,tumor protein d53 (hd53) (tumor protein d52-like 1),TPD52L1,204,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,TPD52L1,7164,Hs.591347,ENST00000392482,THC2614556,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006917(induction of apoptosis)|GO:0006919(activation of caspase activity)|GO:0008656(caspase activator activity)|GO:0042802(identical protein binding)|GO:0042803(protein homodimerization activity)|GO:0043406(positive regulation of MAP kinase activity)|GO:0046330(positive regulation of JNK cascade)|GO:0046982(protein heterodimerization activity)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens tumor protein D52-like 1 (TPD52L1), transcript variant 2, mRNA [NM_001003395]",chr6:125584445-125584504,hs|6q22.31,tumor protein D52-like 1,TRUE
1373_TPM3_7170,P06753,tropomyosin alpha-3 chain (gamma-tropomyosin) (tropomyosin-3) (tropomyosin-5) (htm5),TPM3,285,"function: binds to actin filaments in muscle and non-muscle cells. plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. smooth muscle contraction is regulated by interaction with caldesmon. in non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. {eco:0000250|uniprotkb:p09493}.","subcellular location: cytoplasm, cytoskeleton {eco:0000305}.",NA,"DISEASE: Nemaline myopathy 1 (NEM1) [MIM:609284]: A form of nemaline myopathy with autosomal dominant or recessive inheritance. Nemaline myopathies are disorders characterized by muscle weakness of varying onset and severity, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. Autosomal dominant NEM1 is characterized by a moderate phenotype with onset between birth and early second decade of life. Weakness is diffuse and symmetric with slow progression often with need for a wheelchair in adulthood. The autosomal recessive form has onset at birth with moderate to severe hypotonia and diffuse weakness. In the most severe cases, death can occur before 2 years. Less severe cases have delayed major motor milestones, and these patients may walk, but often need a wheelchair before 10 years. {ECO:0000269|PubMed:10587521, ECO:0000269|PubMed:17376686, ECO:0000269|PubMed:24692096, ECO:0000269|PubMed:7704029}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving TPM3 is found in papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1 generates the TRK fusion transcript by fusing the amino end of isoform 2 of TPM3 to the 3'-end of NTRK1. {ECO:0000269|PubMed:2869410}.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19953533, ECO:0000269|PubMed:20951040, ECO:0000269|PubMed:24692096}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cap myopathy 1 (CAPM1) [MIM:609284]: A rare congenital skeletal muscle disorder characterized by the presence of cap-like structures which are well demarcated and peripherally located under the sarcolemma and show abnormal accumulation of sarcomeric proteins. Clinical features are early onset of hypotonia and slowly progressive muscle weakness. Respiratory problems are common. {ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19487656, ECO:0000269|PubMed:19553118, ECO:0000269|PubMed:24239060, ECO:0000269|PubMed:24692096}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TPM3,7170,Hs.644306,ENST00000330188,THC2503132,GO:0001725(stress fiber)|GO:0003674(molecular_function)|GO:0003779(actin binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005862(muscle thin filament tropomyosin)|GO:0006928(cellular component movement)|GO:0006936(muscle contraction)|GO:0006937(regulation of muscle contraction)|GO:0015629(actin cytoskeleton)|GO:0030049(muscle filament sliding),"Homo sapiens tropomyosin 3 (TPM3), transcript variant 3, mRNA [NM_001043352]",chr1:154127824-154127780,hs|1q21.3,tropomyosin 3,TRUE
1374_PSMA6_5687,P60900,proteasome subunit alpha type-6 (ec 3.4.25.1) (27 kda prosomal protein) (pros-27) (p27k) (macropain iota chain) (multicatalytic endopeptidase complex iota chain) (proteasome iota chain),PSMA6 PROS27,246,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). {eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.",subcellular location: cytoplasm {eco:0000269|pubmed:12181345}. nucleus {eco:0000269|pubmed:12181345}. note=colocalizes with trim5 in cytoplasmic bodies. {eco:0000250|uniprotkb:q9qum9}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMA6,5687,Hs.446260,ENST00000554541,THC2557024,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0003723(RNA binding)|GO:0004175(endopeptidase activity)|GO:0004298(threonine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0005844(polysome)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016363(nuclear matrix)|GO:0019773(proteasome core complex, alpha-subunit complex)|GO:0030016(myofibril)|GO:0030017(sarcomere)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0035639(purine ribonucleoside triphosphate binding)|GO:0042981(regulation of apoptosis)|GO:0050727(regulation of inflammatory response)|GO:0051059(NF-kappaB binding)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, alpha type, 6 (PSMA6), mRNA [NM_002791]",chr14:35786496-35786555,hs|14q13.2,"proteasome (prosome, macropain) subunit, alpha type, 6",TRUE
1375_ARID4B_51742,Q4LE39,at-rich interactive domain-containing protein 4b (arid domain-containing protein 4b) (180 kda sin3-associated polypeptide) (sin3-associated polypeptide p180) (breast cancer-associated antigen brcaa1) (histone deacetylase complex subunit sap180) (retinoblastoma-binding protein 1-like 1),ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180,1312,"function: acts as a transcriptional repressor (pubmed:12724404). may function in the assembly and/or enzymatic activity of the sin3a corepressor complex or in mediating interactions between the complex and other regulatory complexes (pubmed:12724404). plays a role in the regulation of epigenetic modifications at the pws/as imprinting center near the snrpn promoter, where it might function as part of a complex with rb1 and arid4a. involved in spermatogenesis, together with arid4a, where it functions as a transcriptional coactivator for ar (androgen receptor) and enhances expression of genes required for sperm maturation. regulates expression of the tight junction protein cldn3 in the testis, which is important for integrity of the blood-testis barrier. plays a role in myeloid homeostasis where it regulates the histone methylation state of bone marrow cells and expression of various genes involved in hematopoiesis. may function as a leukemia suppressor (by similarity). {eco:0000250|uniprotkb:a2cg63, eco:0000269|pubmed:12724404}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00355}. cytoplasm {eco:0000269|pubmed:11481388, eco:0000269|pubmed:15247124}. note=cytoplasmic in breast cancer cells. {eco:0000269|pubmed:15247124}.","TISSUE SPECIFICITY: Highly expressed in the testis and in breast, lung, colon, pancreatic and ovarian cancers. Expressed at low levels in the thymus, prostate and ovary. {ECO:0000269|PubMed:11481388, ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:15247124}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARID4B,51742,Hs.575782,ENST00000264183,THC2779546,"GO:0003674(molecular_function)|GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005575(cellular_component)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008150(biological_process)","Homo sapiens AT rich interactive domain 4B (RBP1-like) (ARID4B), transcript variant 1, mRNA [NM_016374]",chr1:235330409-235330350,hs|1q42.3,AT rich interactive domain 4B (RBP1-like),TRUE
1376_MORF4L2_9643,Q15014,mortality factor 4-like protein 2 (morf-related gene x protein) (protein msl3-2) (transcription factor-like protein mrgx),MORF4L2 KIAA0026 MRGX,288,"function: component of the nua4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone h4 and h2a. this modification may both alter nucleosome - dna interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. this complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and dna repair. the nua4 complex atpase and helicase activities seem to be, at least in part, contributed by the association of ruvbl1 and ruvbl2 with ep400. nua4 may also play a direct role in dna repair when directly recruited to sites of dna damage. also component of the msin3a complex which acts to repress transcription by deacetylation of nucleosomal histones.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MORF4L2,9643,Hs.326387,ENST00000423833,THC2510218,"GO:0001558(regulation of cell growth)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006281(DNA repair)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016568(chromatin modification)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0051155(positive regulation of striated muscle cell differentiation)","Homo sapiens mortality factor 4 like 2 (MORF4L2), transcript variant 2, mRNA [NM_012286]",chrX:102930926-102930867,hs|Xq22.2,mortality factor 4 like 2,TRUE
1377_TRIM2_23321,Q9C040,tripartite motif-containing protein 2 (ec 2.3.2.27) (e3 ubiquitin-protein ligase trim2) (ring finger protein 86) (ring-type e3 ubiquitin transferase trim2),TRIM2 KIAA0517 RNF86,744,function: ube2d1-dependent e3 ubiquitin-protein ligase that mediates the ubiquitination of nefl and of phosphorylated bcl2l11. plays a neuroprotective function. may play a role in neuronal rapid ischemic tolerance. {eco:0000250|uniprotkb:q9esn6}.,subcellular location: cytoplasm {eco:0000250|uniprotkb:q9esn6}.,NA,"DISEASE: Charcot-Marie-Tooth disease 2R (CMT2R) [MIM:615490]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:23562820}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRIM2,23321,Hs.435711,ENST00000437508,THC2464172,GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0043526(neuroprotection)|GO:0046872(metal ion binding),"Homo sapiens tripartite motif containing 2 (TRIM2), transcript variant 1, mRNA [NM_015271]",chr4:154257365-154257424,hs|4q31.3,tripartite motif containing 2,TRUE
1378_CHD7_55636,Q9P2D1,chromodomain-helicase-dna-binding protein 7 (chd-7) (ec 3.6.4.12) (atp-dependent helicase chd7),CHD7 KIAA1416,2997,function: probable transcription regulator. maybe involved in the in 45s precursor rrna production. {eco:0000269|pubmed:22646239}.,"subcellular location: isoform 1: nucleus {eco:0000269|pubmed:20453063}.; subcellular location: isoform 3: nucleus, nucleolus {eco:0000269|pubmed:22646239}.","TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues. {ECO:0000269|PubMed:15300250, ECO:0000269|PubMed:22646239}.","DISEASE: CHARGE syndrome (CHARGES) [MIM:214800]: Common cause of congenital anomalies. Is characterized by a non-random pattern of congenital anomalies including choanal atresia and malformations of the heart, inner ear, and retina. {ECO:0000269|PubMed:15300250, ECO:0000269|PubMed:16400610, ECO:0000269|PubMed:16763960, ECO:0000269|PubMed:18074359, ECO:0000269|PubMed:18445044, ECO:0000269|PubMed:19021638, ECO:0000269|PubMed:20453063, ECO:0000269|PubMed:21158681, ECO:0000269|PubMed:21554267, ECO:0000269|PubMed:21931733, ECO:0000269|PubMed:22461308, ECO:0000269|PubMed:22462537, ECO:0000269|PubMed:25818041}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Idiopathic scoliosis 3 (IS3) [MIM:608765]: An abnormality of the vertebral column in which patients develop lateral curvature of the spine of at least 10 degrees. {ECO:0000269|PubMed:17436250}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:18834967, ECO:0000269|PubMed:21158681, ECO:0000269|PubMed:25077900}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CHD7,55636,Hs.20395,ENST00000527825,NP1132891,"GO:0000166(nucleotide binding)|GO:0001501(skeletal system development)|GO:0001568(blood vessel development)|GO:0001701(in utero embryonic development)|GO:0003007(heart morphogenesis)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007417(central nervous system development)|GO:0007512(adult heart development)|GO:0007605(sensory perception of sound)|GO:0007626(locomotory behavior)|GO:0007628(adult walking behavior)|GO:0008015(blood circulation)|GO:0016568(chromatin modification)|GO:0016817(hydrolase activity, acting on acid anhydrides)|GO:0021545(cranial nerve development)|GO:0030217(T cell differentiation)|GO:0030540(female genitalia development)|GO:0035116(embryonic hindlimb morphogenesis)|GO:0040018(positive regulation of multicellular organism growth)|GO:0042472(inner ear morphogenesis)|GO:0043584(nose development)|GO:0048806(genitalia development)|GO:0050890(cognition)|GO:0060021(palate development)|GO:0060041(retina development in camera-type eye)|GO:0060123(regulation of growth hormone secretion)|GO:0060173(limb development)|GO:0060324(face development)","Homo sapiens chromodomain helicase DNA binding protein 7 (CHD7), mRNA [NM_017780]",chr8:61693569-61693628,hs|8q12.2,chromodomain helicase DNA binding protein 7,TRUE
1379_KPNA4_3840,O00629,importin subunit alpha-3 (importin alpha q1) (qip1) (karyopherin subunit alpha-4),KPNA4 QIP1,521,"function: functions in nuclear protein import as an adapter protein for nuclear receptor kpnb1. binds specifically and directly to substrates containing either a simple or bipartite nls motif. docking of the importin/substrate complex to the nuclear pore complex (npc) is mediated by kpnb1 through binding to nucleoporin fxfg repeats and the complex is subsequently translocated through the pore by an energy requiring, ran-dependent mechanism. at the nucleoplasmic side of the npc, ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where gtp hydrolysis releases ran from importin. the directionality of nuclear import is thought to be conferred by an asymmetric distribution of the gtp- and gdp-bound forms of ran between the cytoplasm and nucleus. in vitro, mediates the nuclear import of human cytomegalovirus ul84 by recognizing a non-classical nls. in vitro, mediates the nuclear import of human cytomegalovirus ul84 by recognizing a non-classical nls.",subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in testis, ovary, small intestine, heart, skeletal muscle, lung and pancreas, but barely detectable in kidney, thymus, colon and peripheral blood leukocytes.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KPNA4,3840,Hs.730660,ENST00000334256,THC2468287,GO:0005488(binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006607(NLS-bearing substrate import into nucleus)|GO:0006886(intracellular protein transport)|GO:0008565(protein transporter activity),"Homo sapiens karyopherin alpha 4 (importin alpha 3) (KPNA4), mRNA [NM_002268]",chr3:160218102-160218043,hs|3q25.33,karyopherin alpha 4 (importin alpha 3),TRUE
138_RPL37_6167,P61927,60s ribosomal protein l37 (g1.16) (large ribosomal subunit protein el37),RPL37,97,function: binds to the 23s rrna. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL37,6167,Hs.80545,ENST00000504562,THC2589105,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0046872(metal ion binding),"Homo sapiens ribosomal protein L37 (RPL37), mRNA [NM_000997]",chr5:40834588-40834324,hs|5p13.1,ribosomal protein L37,TRUE
1380_PSMD3_5709,O43242,26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit rpn3) (26s proteasome regulatory subunit s3) (proteasome subunit p58),PSMD3,534,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair. {eco:0000269|pubmed:1317798}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSMD3,5709,Hs.12970,ENST00000415039,THC2550930,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005488(binding)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030234(enzyme regulator activity)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042176(regulation of protein catabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 (PSMD3), mRNA [NM_002809]",chr17:38154147-38154206,hs|17q21.1,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 3",TRUE
1381_ARPC5L_81873,Q9BPX5,actin-related protein 2/3 complex subunit 5-like protein (arp2/3 complex 16 kda subunit 2) (arc16-2),ARPC5L,153,function: may function as component of the arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (npf) mediates the formation of branched actin networks.,"subcellular location: cytoplasm, cytoskeleton {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ARPC5L,81873,Hs.132499,ENST00000465124,THC2561727,GO:0003779(actin binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0030833(regulation of actin filament polymerization),"Homo sapiens actin related protein 2/3 complex, subunit 5-like (ARPC5L), mRNA [NM_030978]",chr9:127637422-127639207,hs|9q33.3,"actin related protein 2/3 complex, subunit 5-like",TRUE
1382_PGC_5225,Q86YN6,peroxisome proliferator-activated receptor gamma coactivator 1-beta (pgc-1-beta) (ppar-gamma coactivator 1-beta) (ppargc-1-beta) (pgc-1-related estrogen receptor alpha coactivator),PPARGC1B PERC PGC1 PGC1B PPARGC1,1023,"function: plays a role of stimulator of transcription factors and nuclear receptors activities. activates transcriptional activity of estrogen receptor alpha, nuclear respiratory factor 1 (nrf1) and glucocorticoid receptor in the presence of glucocorticoids. may play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. may be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. induces the expression of perm1 in the skeletal muscle in an esrra-dependent manner. {eco:0000269|pubmed:11854298, eco:0000269|pubmed:12678921, eco:0000269|pubmed:15546003, eco:0000269|pubmed:23836911}.",subcellular location: nucleus {eco:0000269|pubmed:11854298}.,"TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,PGC,5225,Hs.1867,ENST00000424183,NP1454388,GO:0004190(aspartic-type endopeptidase activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006508(proteolysis)|GO:0007586(digestion)|GO:0008233(peptidase activity),"Homo sapiens progastricsin (pepsinogen C) (PGC), transcript variant 1, mRNA [NM_002630]",chr6:41704536-41704477,hs|6p21.1,progastricsin (pepsinogen C),TRUE
1383_SYNCRIP_10492,O60506,"heterogeneous nuclear ribonucleoprotein q (hnrnp q) (glycine- and tyrosine-rich rna-binding protein) (gry-rbp) (ns1-associated protein 1) (synaptotagmin-binding, cytoplasmic rna-interacting protein)",SYNCRIP HNRPQ NSAP1,623,"function: heterogenous nuclear ribonucleoprotein (hnrnp) implicated in mrna processing mechanisms. component of the crd-mediated complex that promotes myc mrna stability. isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mrna, splicing intermediates and mature mrna protein complexes. isoform 1 binds to apob mrna au-rich sequences. isoform 1 is part of the apob mrna editosome complex and may modulate the postranscriptional c to u rna-editing of the apob mrna through either by binding to a1cf (apobec1 complementation factor), to apobec1 or to rna itself. may be involved in translationally coupled mrna turnover. implicated with other rna-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the fos mrna mediated by the major coding-region determinant of instability (mcrd) domain. interacts in vitro preferentially with poly(a) and poly(u) rna sequences. isoform 3 may be involved in cytoplasmic vesicle-based mrna transport through interaction with synaptotagmins. component of the gait (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. upon interferon-gamma activation assembles into the gait complex which binds to stem loop-containing gait elements in the 3'-utr of diverse inflammatory mrnas (such as ceruplasmin) and suppresses their translation; seems not to be essential for gait complex function. {eco:0000269|pubmed:11051545, eco:0000269|pubmed:11134005, eco:0000269|pubmed:11352648, eco:0000269|pubmed:11574476, eco:0000269|pubmed:19029303, eco:0000269|pubmed:23071094}.","subcellular location: cytoplasm {eco:0000269|pubmed:11574476, eco:0000269|pubmed:17289661, eco:0000269|pubmed:19029303}. microsome {eco:0000250|uniprotkb:q7tmk9}. endoplasmic reticulum {eco:0000250}. nucleus {eco:0000250|uniprotkb:q7tmk9}. note=the tyrosine phosphorylated form bound to rna is found in microsomes (by similarity). localized in cytoplasmic mrnp granules containing untranslated mrnas (by similarity). {eco:0000250|uniprotkb:o43390, eco:0000250|uniprotkb:q7tmk9}.; subcellular location: isoform 1: nucleus, nucleoplasm {eco:0000250|uniprotkb:q7tmk9}. note=expressed predominantly in the nucleoplasm. {eco:0000250|uniprotkb:q7tmk9}.; subcellular location: isoform 2: nucleus, nucleoplasm {eco:0000250|uniprotkb:q7tmk9}. note=expressed predominantly in the nucleoplasm. {eco:0000250|uniprotkb:q7tmk9}.; subcellular location: isoform 3: nucleus, nucleoplasm {eco:0000250|uniprotkb:q7tmk9}. note=expressed predominantly in the nucleoplasm. {eco:0000250|uniprotkb:q7tmk9}.","TISSUE SPECIFICITY: Ubiquitously expressed. Detected in heart, brain, pancreas, placenta, spleen, lung, liver, skeletal muscle, kidney, thymus, prostate, uterus, small intestine, colon, peripheral blood and testis. {ECO:0000269|PubMed:11352648}.",NA,NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SYNCRIP,10492,Hs.571177,ENST00000369622,NP074855,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005792(microsome)|GO:0006396(RNA processing)|GO:0008143(poly(A) RNA binding)|GO:0008380(RNA splicing)|GO:0030529(ribonucleoprotein complex)|GO:0044419(interspecies interaction between organisms)|GO:0070934(CRD-mediated mRNA stabilization)|GO:0070937(CRD-mediated mRNA stability complex)|GO:0071013(catalytic step 2 spliceosome)|GO:0071204(histone pre-mRNA 3'end processing complex)","Homo sapiens synaptotagmin binding, cytoplasmic RNA interacting protein (SYNCRIP), transcript variant 1, mRNA [NM_006372]",chr6:86329122-86329063,hs|6q14.3,"synaptotagmin binding, cytoplasmic RNA interacting protein",TRUE
1384_GRB2_2885,P62993,growth factor receptor-bound protein 2 (adapter protein grb2) (protein ash) (sh2/sh3 adapter grb2),GRB2 ASH,217,"function: adapter protein that provides a critical link between cell surface growth factor receptors and the ras signaling pathway.; function: isoform 2 does not bind to phosphorylated epidermal growth factor receptor (egfr) but inhibits egf-induced transactivation of a ras-responsive element. isoform 2 acts as a dominant negative protein over grb2 and by suppressing proliferative signals, may trigger active programmed cell death.",subcellular location: nucleus {eco:0000269|pubmed:21179510}. cytoplasm {eco:0000269|pubmed:21179510}. endosome {eco:0000269|pubmed:21179510}. golgi apparatus {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GRB2,2885,Hs.444356,ENST00000392562,THC2469995,GO:0001784(phosphotyrosine binding)|GO:0005070(SH3/SH2 adaptor activity)|GO:0005154(epidermal growth factor receptor binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007265(Ras protein signal transduction)|GO:0007267(cell-cell signaling)|GO:0007411(axon guidance)|GO:0007568(aging)|GO:0007596(blood coagulation)|GO:0008286(insulin receptor signaling pathway)|GO:0008543(fibroblast growth factor receptor signaling pathway)|GO:0012506(vesicle membrane)|GO:0016020(membrane)|GO:0019904(protein domain specific binding)|GO:0030154(cell differentiation)|GO:0031295(T cell costimulation)|GO:0031623(receptor internalization)|GO:0034329(cell junction assembly)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042770(signal transduction in response to DNA damage)|GO:0043234(protein complex)|GO:0043408(regulation of MAPKKK cascade)|GO:0043560(insulin receptor substrate binding)|GO:0044419(interspecies interaction between organisms)|GO:0046875(ephrin receptor binding)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0048646(anatomical structure formation involved in morphogenesis)|GO:0050900(leukocyte migration)|GO:0051219(phosphoprotein binding)|GO:0051291(protein heterooligomerization)|GO:0060670(branching involved in embryonic placenta morphogenesis)|GO:0071479(cellular response to ionizing radiation)|GO:2000379(positive regulation of reactive oxygen species metabolic process),"Homo sapiens growth factor receptor-bound protein 2 (GRB2), transcript variant 1, mRNA [NM_002086]",chr17:73314394-73314335,hs|17q25.1,growth factor receptor-bound protein 2,TRUE
1385_ITGB1_3688,P05556,integrin beta-1 (fibronectin receptor subunit beta) (glycoprotein iia) (gpiia) (vla-4 subunit beta) (cd antigen cd29),ITGB1 FNRB MDF2 MSK12,798,"function: integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence g-f-p-g-e-r in collagen. integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-v/beta-1 are receptors for fibronectin. alpha-4/beta-1 recognizes one or more domains within the alternatively spliced cs-1 and cs-5 regions of fibronectin. integrin alpha-5/beta-1 is a receptor for fibrinogen. integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. integrin alpha-6/beta-1 (itga6:itgb1) is present in oocytes and is involved in sperm-egg fusion (by similarity). integrin alpha-4/beta-1 is a receptor for vcam1. it recognizes the sequence q-i-d-s in vcam1. integrin alpha-9/beta-1 is a receptor for vcam1, cytotactin and osteopontin. it recognizes the sequence a-e-i-d-g-i-e-l in cytotactin. integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and cspg4. alpha-3/beta-1 may mediate with lgals3 the stimulation by cspg4 of endothelial cells migration. integrin alpha-v/beta-1 is a receptor for vitronectin. beta-1 integrins recognize the sequence r-g-d in a wide array of ligands. isoform 2 interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). when associated with alpha-7/beta-1 integrin, regulates cell adhesion and laminin matrix deposition. involved in promoting endothelial cell motility and angiogenesis. involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. may be involved in up-regulation of the activity of kinases such as pkc via binding to krt1. together with krt1 and rack1, serves as a platform for src activation or inactivation. plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis. integrin alpha-3/beta-1 provides a docking site for fap (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. itga4:itgb1 binds to fractalkine (cx3cl1) and may act as its coreceptor in cx3cr1-dependent fractalkine signaling (pubmed:23125415, pubmed:24789099). itga4:itgb1 and itga5:itgb1 bind to pla2g2a via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (pubmed:18635536, pubmed:25398877). itga5:itgb1 acts as a receptor for fibrillin-1 (fbn1) and mediates r-g-d-dependent cell adhesion to fbn1 (pubmed:12807887, pubmed:17158881). itga5:itgb1 is a receptor for il1b and binding is essential for il1b signaling (pubmed:29030430). {eco:0000250|uniprotkb:p09055, eco:0000269|pubmed:10455171, eco:0000269|pubmed:12473654, eco:0000269|pubmed:12807887, eco:0000269|pubmed:16256741, eco:0000269|pubmed:17158881, eco:0000269|pubmed:18635536, eco:0000269|pubmed:18804435, eco:0000269|pubmed:19064666, eco:0000269|pubmed:21768292, eco:0000269|pubmed:23125415, eco:0000269|pubmed:24789099, eco:0000269|pubmed:25398877, eco:0000269|pubmed:29030430, eco:0000269|pubmed:7523423}.; function: isoform 5: isoform 5 displaces isoform 1 in striated muscles. {eco:0000250}.; function: (microbial infection) integrin itga2:itgb1 acts as a receptor for human echoviruses 1 and 8. {eco:0000269|pubmed:8411387}.; function: (microbial infection) acts as a receptor for cytomegalovirus/hhv-5. {eco:0000269|pubmed:20660204}.; function: (microbial infection) acts as a receptor for epstein-barr virus/hhv-4. {eco:0000269|pubmed:17945327}.; function: (microbial infection) integrin itga5:itgb1 acts as a receptor for human parvovirus b19. {eco:0000269|pubmed:12907437}.; function: (microbial infection) integrin itga2:itgb1 acts as a receptor for human rotavirus. {eco:0000269|pubmed:12941907}.; function: (microbial infection) acts as a receptor for mammalian reovirus. {eco:0000269|pubmed:16501085}.; function: (microbial infection) in case of hiv-1 infection, integrin itga5:itgb1 binding to extracellular viral tat protein seems to enhance angiogenesis in kaposi's sarcoma lesions. {eco:0000269|pubmed:10397733}.","subcellular location: cell membrane {eco:0000303|pubmed:10455171}; single-pass type i membrane protein {eco:0000255}. cell projection, invadopodium membrane {eco:0000269|pubmed:10455171}; single-pass type i membrane protein {eco:0000255}. cell projection, ruffle membrane {eco:0000303|pubmed:10455171}; single-pass type i membrane protein {eco:0000255}. recycling endosome {eco:0000269|pubmed:16256741}. melanosome {eco:0000269|pubmed:17081065}. cleavage furrow {eco:0000269|pubmed:17956333}. cell projection, lamellipodium {eco:0000269|pubmed:11919189}. cell projection, ruffle {eco:0000269|pubmed:11919189}. cell junction, focal adhesion {eco:0000269|pubmed:17158881}. cell surface {eco:0000269|pubmed:17158881}. note=isoform 2 does not localize to focal adhesions. highly enriched in stage i melanosomes. located on plasma membrane of neuroblastoma nmb7 cells. in a lung cancer cell line, in prometaphase and metaphase, localizes diffusely at the membrane and in a few intracellular vesicles. in early telophase, detected mainly on the matrix-facing side of the cells. by mid-telophase, concentrated to the ingressing cleavage furrow, mainly to the basal side of the furrow. in late telophase, concentrated to the extending protrusions formed at the opposite ends of the spreading daughter cells, in vesicles at the base of the lamellipodia formed by the separating daughter cells. colocalizes with itgb1bp1 and metastatic suppressor protein nme2 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen. translocates from peripheral focal adhesions sites to fibrillar adhesions in a itgb1bp1-dependent manner. enriched preferentially at invadopodia, cell membrane protrusions that correspond to sites of cell invasion, in a collagen-dependent manner. localized at plasma and ruffle membranes in a collagen-independent manner. {eco:0000269|pubmed:10455171, eco:0000303|pubmed:10455171}.; subcellular location: isoform 5: cell membrane, sarcolemma {eco:0000250}. cell junction {eco:0000250}. note=in cardiac muscle, isoform 5 is found in costameres and intercalated disks. {eco:0000250}.","TISSUE SPECIFICITY: Isoform 1 is widely expressed, other isoforms are generally coexpressed with a more restricted distribution. Isoform 2 is expressed in skin, liver, skeletal muscle, cardiac muscle, placenta, umbilical vein endothelial cells, neuroblastoma cells, lymphoma cells, hepatoma cells and astrocytoma cells. Isoform 3 and isoform 4 are expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Isoform 4, rather than isoform 3, is selectively expressed in peripheral T-cells. Isoform 3 is expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets, on the surface of erythroleukemia cells and in various hematopoietic cell lines. Isoform 5 is expressed specifically in striated muscle (skeletal and cardiac muscle). {ECO:0000269|PubMed:1551917, ECO:0000269|PubMed:2249781, ECO:0000269|PubMed:7544298, ECO:0000269|PubMed:7545396, ECO:0000269|PubMed:7681433, ECO:0000269|PubMed:9494094}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ITGB1,3688,Hs.643813,ENST00000374956,THC2788664,GO:0000082(G1/S transition of mitotic cell cycle)|GO:0001669(acrosomal vesicle)|GO:0001701(in utero embryonic development)|GO:0001708(cell fate specification)|GO:0001726(ruffle)|GO:0001894(tissue homeostasis)|GO:0001948(glycoprotein binding)|GO:0001968(fibronectin binding)|GO:0002020(protease binding)|GO:0002042(cell migration involved in sprouting angiogenesis)|GO:0003779(actin binding)|GO:0004872(receptor activity)|GO:0005178(integrin binding)|GO:0005515(protein binding)|GO:0005518(collagen binding)|GO:0005604(basement membrane)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0005912(adherens junction)|GO:0005925(focal adhesion)|GO:0006874(cellular calcium ion homeostasis)|GO:0006968(cellular defense response)|GO:0007155(cell adhesion)|GO:0007156(homophilic cell adhesion)|GO:0007159(leukocyte cell-cell adhesion)|GO:0007160(cell-matrix adhesion)|GO:0007229(integrin-mediated signaling pathway)|GO:0007275(multicellular organismal development)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0008277(regulation of G-protein coupled receptor protein signaling pathway)|GO:0008284(positive regulation of cell proliferation)|GO:0008285(negative regulation of cell proliferation)|GO:0008305(integrin complex)|GO:0008354(germ cell migration)|GO:0009986(cell surface)|GO:0010811(positive regulation of cell-substrate adhesion)|GO:0010976(positive regulation of neuron projection development)|GO:0014704(intercalated disc)|GO:0014823(response to activity)|GO:0016021(integral to membrane)|GO:0016477(cell migration)|GO:0019717(synaptosome)|GO:0019901(protein kinase binding)|GO:0019904(protein domain specific binding)|GO:0030056(hemidesmosome)|GO:0030183(B cell differentiation)|GO:0030335(positive regulation of cell migration)|GO:0031345(negative regulation of cell projection organization)|GO:0031594(neuromuscular junction)|GO:0031667(response to nutrient levels)|GO:0032154(cleavage furrow)|GO:0032587(ruffle membrane)|GO:0032594(protein transport within lipid bilayer)|GO:0033631(cell-cell adhesion mediated by integrin)|GO:0034329(cell junction assembly)|GO:0034667(alpha3-beta1 integrin complex)|GO:0034679(alpha9-beta1 integrin complex)|GO:0034698(response to gonadotropin stimulus)|GO:0042277(peptide binding)|GO:0042383(sarcolemma)|GO:0042470(melanosome)|GO:0042493(response to drug)|GO:0043065(positive regulation of apoptosis)|GO:0043209(myelin sheath)|GO:0043236(laminin binding)|GO:0043410(positive regulation of MAPKKK cascade)|GO:0044419(interspecies interaction between organisms)|GO:0045121(membrane raft)|GO:0045214(sarcomere organization)|GO:0045665(negative regulation of neuron differentiation)|GO:0045666(positive regulation of neuron differentiation)|GO:0045807(positive regulation of endocytosis)|GO:0046982(protein heterodimerization activity)|GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)|GO:0050776(regulation of immune response)|GO:0050900(leukocyte migration)|GO:0051393(alpha-actinin binding)|GO:0051726(regulation of cell cycle),"Homo sapiens integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) (ITGB1), transcript variant 1A, mRNA [NM_002211]",chr10:33189502-33189443,hs|10p11.22,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",TRUE
1386_RALGAPA2_57186,Q2PPJ7,ral gtpase-activating protein subunit alpha-2 (250 kda substrate of akt) (as250) (p220),RALGAPA2 C20orf74 KIAA1272,1873,function: catalytic subunit of the heterodimeric ralgap2 complex which acts as a gtpase activator for the ras-like small gtpases rala and ralb. {eco:0000250}.,subcellular location: cytoplasm {eco:0000269|pubmed:16490346}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RALGAPA2,57186,Hs.472285,ENST00000430436,THC2644089,GO:0005096(GTPase activator activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0017123(Ral GTPase activator activity)|GO:0032859(activation of Ral GTPase activity)|GO:0046982(protein heterodimerization activity)|GO:0051056(regulation of small GTPase mediated signal transduction),"Homo sapiens Ral GTPase activating protein, alpha subunit 2 (catalytic) (RALGAPA2), mRNA [NM_020343]",chr20:20370498-20370439,hs|20p11.23,"Ral GTPase activating protein, alpha subunit 2 (catalytic)",TRUE
1387_RPA1_6117,P27694,"replication protein a 70 kda dna-binding subunit (rp-a p70) (replication factor a protein 1) (rf-a protein 1) (single-stranded dna-binding protein) [cleaved into: replication protein a 70 kda dna-binding subunit, n-terminally processed]",RPA1 REPA1 RPA70,616,"function: as part of the heterotrimeric replication protein a complex (rpa/rp-a), binds and stabilizes single-stranded dna intermediates, that form during dna replication or upon dna stress. it prevents their reannealing and in parallel, recruits and activates different proteins and complexes involved in dna metabolism (pubmed:27723720, pubmed:27723717). thereby, it plays an essential role both in dna replication and the cellular response to dna damage (pubmed:9430682). in the cellular response to dna damage, the rpa complex controls dna repair and dna damage checkpoint activation. through recruitment of atrip activates the atr kinase a master regulator of the dna damage response (pubmed:24332808). it is required for the recruitment of the dna double-strand break repair factors rad51 and rad52 to chromatin in response to dna damage (pubmed:17765923). also recruits to sites of dna damage proteins like xpa and xpg that are involved in nucleotide excision repair and is required for this mechanism of dna repair (pubmed:7697716). plays also a role in base excision repair (ber) probably through interaction with ung (pubmed:9765279). also recruits smarcal1/harp, which is involved in replication fork restart, to sites of dna damage. may also play a role in telomere maintenance (pubmed:17959650). as part of the alternative replication protein a complex, arpa, binds single-stranded dna and probably plays a role in dna repair. compared to the rpa2-containing, canonical rpa complex, may not support chromosomal dna replication and cell cycle progression through s-phase. the arpa may not promote efficient priming by dna polymerase alpha but could support dna synthesis by polymerase delta in presence of pcna and replication factor c (rfc), the dual incision/excision reaction of nucleotide excision repair and rad51-dependent strand exchange (pubmed:19996105). {eco:0000269|pubmed:12791985, eco:0000269|pubmed:17765923, eco:0000269|pubmed:17959650, eco:0000269|pubmed:19116208, eco:0000269|pubmed:19996105, eco:0000269|pubmed:24332808, eco:0000269|pubmed:27723717, eco:0000269|pubmed:27723720, eco:0000269|pubmed:7697716, eco:0000269|pubmed:7700386, eco:0000269|pubmed:9430682, eco:0000269|pubmed:9765279}.","subcellular location: nucleus {eco:0000269|pubmed:17959650}. nucleus, pml body {eco:0000269|pubmed:17959650}. note=enriched in pml bodies in cells displaying alternative lengthening of their telomeres. {eco:0000269|pubmed:17959650}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RPA1,6117,Hs.461925,ENST00000254719,THC2467849,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000718(nucleotide-excision repair, DNA damage removal)|GO:0000722(telomere maintenance via recombination)|GO:0000723(telomere maintenance)|GO:0000724(double-strand break repair via homologous recombination)|GO:0000730(DNA recombinase assembly)|GO:0003677(DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005662(DNA replication factor A complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006260(DNA replication)|GO:0006261(DNA-dependent DNA replication)|GO:0006271(DNA strand elongation involved in DNA replication)|GO:0006281(DNA repair)|GO:0006283(transcription-coupled nucleotide-excision repair)|GO:0006289(nucleotide-excision repair)|GO:0006297(nucleotide-excision repair, DNA gap filling)|GO:0006302(double-strand break repair)|GO:0006310(DNA recombination)|GO:0015629(actin cytoskeleton)|GO:0016605(PML body)|GO:0032201(telomere maintenance via semi-conservative replication)|GO:0046872(metal ion binding)","Homo sapiens replication protein A1, 70kDa (RPA1), mRNA [NM_002945]",chr17:1801166-1801225,hs|17p13.3,"replication protein A1, 70kDa",TRUE
1388_RBBP4_5928,Q09028,histone-binding protein rbbp4 (chromatin assembly factor 1 subunit c) (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-i p48) (nucleosome-remodeling factor subunit rbap48) (retinoblastoma-binding protein 4) (rbbp-4) (retinoblastoma-binding protein p48),RBBP4 RBAP48,425,"function: core histone-binding subunit that may target chromatin assembly factors, chromatin remodeling factors and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal dna. component of several complexes which regulate chromatin metabolism. these include the chromatin assembly factor 1 (caf-1) complex, which is required for chromatin assembly following dna replication and dna repair; the core histone deacetylase (hdac) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the nurd complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; the prc2/eed-ezh2 complex, which promotes repression of homeotic genes during development; and the nurf (nucleosome remodeling factor) complex. {eco:0000269|pubmed:10866654}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBBP4,5928,Hs.16003,ENST00000373493,THC2482436,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006260(DNA replication)|GO:0006334(nucleosome assembly)|GO:0006338(chromatin remodeling)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007049(cell cycle)|GO:0008094(DNA-dependent ATPase activity)|GO:0008285(negative regulation of cell proliferation)|GO:0016580(Sin3 complex)|GO:0016581(NuRD complex)|GO:0016589(NURF complex)|GO:0031497(chromatin assembly)|GO:0033186(CAF-1 complex)|GO:0034080(CenH3-containing nucleosome assembly at centromere)|GO:0035098(ESC/E(Z) complex)|GO:0042393(histone binding)|GO:0042826(histone deacetylase binding)","Homo sapiens retinoblastoma binding protein 4 (RBBP4), transcript variant 1, mRNA [NM_005610]",chr1:33145808-33145867,hs|1p35.1,retinoblastoma binding protein 4,TRUE
1389_NDUFS6_4726,O75380,"nadh dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (complex i-13kd-a) (ci-13kd-a) (nadh-ubiquinone oxidoreductase 13 kda-a subunit)",NDUFS6,124,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN9 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:15372108, ECO:0000269|PubMed:19259137}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFS6,4726,Hs.408257,ENST00000274137,THC2582420,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0009055(electron carrier activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (NDUFS6), nuclear gene encoding mitochondrial protein, mRNA [NM_004553]",chr5:1802479-1814502,hs|5p15.33,"NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)",TRUE
139_BBS5_129880,Q8N3I7,bardet-biedl syndrome 5 protein,BBS5,341,"function: the bbsome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. the bbsome complex is required for ciliogenesis but is dispensable for centriolar satellite function. this ciliogenic function is mediated in part by the rab8 gdp/gtp exchange factor, which localizes to the basal body and contacts the bbsome. rab8(gtp) enters the primary cilium and promotes extension of the ciliary membrane. firstly the bbsome associates with the ciliary membrane and binds to rab3ip/rabin8, the guanosyl exchange factor (gef) for rab8 and then the rab8-gtp localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. the bbsome complex, together with the ltzl1, controls smo ciliary trafficking and contributes to the sonic hedgehog (shh) pathway regulation. required for bbsome complex ciliary localization but not for the proper complex assembly. {eco:0000269|pubmed:17574030, eco:0000269|pubmed:22072986}.","subcellular location: cell projection, cilium membrane. cytoplasm. cytoplasm, cytoskeleton, cilium basal body {eco:0000250}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite. note=localizes to basal bodies. {eco:0000250}.",NA,"DISEASE: Bardet-Biedl syndrome 5 (BBS5) [MIM:615983]: A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:15137946, ECO:0000269|PubMed:18203199, ECO:0000269|PubMed:21344540}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,BBS5,129880,Hs.233398,ENST00000472667,THC2512213,GO:0001947(heart looping)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0005929(cilium)|GO:0005932(microtubule basal body)|GO:0007601(visual perception)|GO:0009296(flagellum assembly)|GO:0032266(phosphatidylinositol-3-phosphate binding)|GO:0032402(melanosome transport)|GO:0034464(BBSome)|GO:0042384(cilium assembly)|GO:0050896(response to stimulus)|GO:0060170(cilium membrane),"Homo sapiens Bardet-Biedl syndrome 5 (BBS5), mRNA [NM_152384]",chr2:170362885-170362944,hs|2q31.1,Bardet-Biedl syndrome 5,TRUE
1390_BEX2_84707,Q9BXY8,protein bex2 (brain-expressed x-linked protein 2) (hbex2),BEX2,128,"function: regulator of mitochondrial apoptosis and g1 cell cycle in breast cancer. protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of bcl2 protein family, which involves the positive regulation of anti-apoptotic member bcl2 and the negative regulation of pro-apoptotic members bad, bak1 and puma. required for the normal cell cycle progression during g1 in breast cancer cells through the regulation of ccnd1 and cdkn1a. regulates the level of pp2a regulatory subunit b and pp2a phosphatase activity. {eco:0000269|pubmed:19711341}.",subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000269|pubmed:16314316}.,"TISSUE SPECIFICITY: Expressed in central nervous system, with high level in pituitary, cerebellum and temporal lobe. Widely expressed in breast cancer cell lines. {ECO:0000269|PubMed:15958283, ECO:0000269|PubMed:19711341}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BEX2,84707,Hs.398989,ENST00000536889,THC2496822,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0042981(regulation of apoptosis)|GO:0051726(regulation of cell cycle),"Homo sapiens brain expressed X-linked 2 (BEX2), transcript variant 3, mRNA [NM_032621]",chrX:102564421-102564362,hs|Xq22.1,brain expressed X-linked 2,TRUE
1391_PDIA5_10954,Q14554,protein disulfide-isomerase a5 (ec 5.3.4.1) (protein disulfide isomerase-related protein),PDIA5 PDIR,519,NA,subcellular location: endoplasmic reticulum lumen {eco:0000255|prosite-prorule:pru10138}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PDIA5,10954,Hs.477352,ENST00000316218,THC2461859,GO:0003756(protein disulfide isomerase activity)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005789(endoplasmic reticulum membrane)|GO:0006457(protein folding)|GO:0006662(glycerol ether metabolic process)|GO:0006950(response to stress)|GO:0009055(electron carrier activity)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0016491(oxidoreductase activity)|GO:0016853(isomerase activity)|GO:0045454(cell redox homeostasis)|GO:0055114(oxidation-reduction process),"Homo sapiens protein disulfide isomerase family A, member 5 (PDIA5), transcript variant 1, mRNA [NM_006810]",chr3:122880268-122880751,hs|3q21.1,"protein disulfide isomerase family A, member 5",TRUE
1392_C20orf108_116151,Q96KR6,"protein fam210b, mitochondrial",FAM210B C20orf108 PSEC0265,192,"function: plays a role in erythroid differentiation (pubmed:26968549). involved in cell proliferation and tumor cell growth suppression (pubmed:28594398). involved in the metabolic reprogramming of cancer cells in a pdk4-dependent manner (pubmed:28594398). {eco:0000269|pubmed:26968549, eco:0000269|pubmed:28594398}.",subcellular location: mitochondrion {eco:0000269|pubmed:26968549}. mitochondrion outer membrane {eco:0000269|pubmed:28594398}; multi-pass membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in late erythroblast differentiation stages (PubMed:26968549). Underexpressed in ovarian cancer epithelia cells compared with normal human ovarian surface epithelia (PubMed:28594398). {ECO:0000269|PubMed:26968549, ECO:0000269|PubMed:28594398}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C20orf108,116151,Hs.143736,ENST00000371384,THC2468290,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 20 open reading frame 108 (C20orf108), mRNA [NM_080821]",chr20:54943040-54943099,hs|20q13.2,chromosome 20 open reading frame 108,TRUE
1393_PSMB7_5695,Q99436,proteasome subunit beta type-7 (ec 3.4.25.1) (macropain chain z) (multicatalytic endopeptidase complex chain z) (proteasome subunit z),PSMB7 Z,277,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). within the 20s core complex, psmb7 displays a trypsin-like activity. {eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.","subcellular location: cytoplasm {eco:0000269|pubmed:12181345, eco:0000269|pubmed:18549262}. nucleus {eco:0000269|pubmed:12181345, eco:0000269|pubmed:18549262}.",TISSUE SPECIFICITY: Expressed at a low level in colonic mucosa. Up-regulated in colorectal cancer tissues. {ECO:0000269|PubMed:18549262}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMB7,5695,Hs.213470,ENST00000259457,THC2688393,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0004298(threonine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, beta type, 7 (PSMB7), mRNA [NM_002799]",chr9:127115950-127115891,hs|9q33.3,"proteasome (prosome, macropain) subunit, beta type, 7",TRUE
1394_PCGF3_10336,Q3KNV8,polycomb group ring finger protein 3 (ring finger protein 3a),PCGF3 RNF3 RNF3A,242,"function: component of a polycomb group (pcg) multiprotein prc1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including hox genes, throughout development. pcg prc1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone h2a 'lys-119', rendering chromatin heritably changed in its expressibility. within the prc1-like complex, regulates rnf2 ubiquitin ligase activity (pubmed:26151332). plays a redundant role with pcgf5 as part of a prc1-like complex that mediates monoubiquitination of histone h2a 'lys-119' on the x chromosome and is required for normal silencing of one copy of the x chromosome in xx females (by similarity). {eco:0000250|uniprotkb:q8btq0, eco:0000269|pubmed:26151332}.","subcellular location: nucleus {eco:0000269|pubmed:21282530}. nucleus, nucleoplasm {eco:0000250|uniprotkb:q8btq0}. note=recruited by the non-coding rna xist to specific nuclear foci that probably correspond to the inactivated x chromosome. {eco:0000250|uniprotkb:q8btq0}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PCGF3,10336,Hs.144309,ENST00000362003,THC2463034,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0031519(PcG protein complex)|GO:0046872(metal ion binding)","Homo sapiens polycomb group ring finger 3 (PCGF3), mRNA [NM_006315]",chr4:763746-763805,hs|4p16.3,polycomb group ring finger 3,TRUE
1395_CCT6A_908,P40227,t-complex protein 1 subunit zeta (tcp-1-zeta) (acute morphine dependence-related protein 2) (cct-zeta-1) (htr3) (tcp20),CCT6A CCT6 CCTZ,531,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:25467444, eco:0000305}.",subcellular location: cytoplasm {eco:0000269|pubmed:8034610}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CCT6A,908,Hs.82916,ENST00000419314,THC2591591,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005832(chaperonin-containing T-complex)|GO:0006457(protein folding)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens chaperonin containing TCP1, subunit 6A (zeta 1) (CCT6A), transcript variant 1, mRNA [NM_001762]",chr7:56130749-56130808,hs|7p11.2,"chaperonin containing TCP1, subunit 6A (zeta 1)",TRUE
1396_HIST2H2AB_317772,Q8IUE6,histone h2a type 2-b,HIST2H2AB,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST2H2AB,317772,Hs.664173,ENST00000331128,THC2675691,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 2, H2ab (HIST2H2AB), mRNA [NM_175065]",chr1:149859244-149859185,hs|1q21.2,"histone cluster 2, H2ab",TRUE
1397_SAR1B_51128,Q9Y6B6,gtp-binding protein sar1b (gtp-binding protein b) (gtbpb),SAR1B SARA2 SARB,198,function: involved in transport from the endoplasmic reticulum to the golgi apparatus. activated by the guanine nucleotide exchange factor preb. involved in the selection of the protein cargo and the assembly of the copii coat complex.,"subcellular location: endoplasmic reticulum membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. golgi apparatus, golgi stack membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. note=associated with the endoplasmic reticulum and golgi stacks, in particular in the juxta-nuclear golgi region. {eco:0000250}.","TISSUE SPECIFICITY: Expressed in many tissues including small intestine, liver, muscle and brain.","DISEASE: Chylomicron retention disease (CMRD) [MIM:246700]: An autosomal recessive disorder of severe fat malabsorption associated with failure to thrive in infancy. The condition is characterized by deficiency of fat-soluble vitamins, low blood cholesterol levels, and a selective absence of chylomicrons from blood. Affected individuals accumulate chylomicron-like particles in membrane-bound compartments of enterocytes, which contain large cytosolic lipid droplets. {ECO:0000269|PubMed:12692552, ECO:0000269|PubMed:17309654, ECO:0000269|PubMed:19274794}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SAR1B,51128,Hs.432984,ENST00000508363,THC2482112,GO:0000166(nucleotide binding)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006184(GTP catabolic process)|GO:0006886(intracellular protein transport)|GO:0006888(ER to Golgi vesicle-mediated transport)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0032580(Golgi cisterna membrane)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0046872(metal ion binding)|GO:0048208(COPII vesicle coating),"Homo sapiens SAR1 homolog B (S. cerevisiae) (SAR1B), transcript variant 1, mRNA [NM_001033503]",chr5:133942405-133942346,hs|5q31.1,SAR1 homolog B (S. cerevisiae),TRUE
1398_BANP_54971,Q8N9N5,protein banp (ben domain-containing protein 1) (btg3-associated nuclear protein) (scaffold/matrix-associated region-1-binding protein),BANP BEND1 SMAR1,519,"function: controls v(d)j recombination during t-cell development by repressing t-cell receptor (tcr) beta enhancer function. binds to scaffold/matrix attachment region beta (s/marbeta), an atc-rich dna sequence located upstream of the tcr beta enhancer. represses cyclin d1 transcription by recruiting hdac1 to its promoter, thereby diminishing h3k9ac, h3s10ph and h4k8ac levels. promotes tp53 'ser-15' phosphorylation and nuclear accumulation, which causes cell cycle arrest (by similarity). {eco:0000250, eco:0000269|pubmed:16166625}.",subcellular location: nucleus {eco:0000269|pubmed:16166625}.,TISSUE SPECIFICITY: Down-regulated in breast cancer cell lines. {ECO:0000269|PubMed:16166625}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BANP,54971,Hs.461705,ENST00000540932,THC2500542,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007049(cell cycle)|GO:0007275(multicellular organismal development)|GO:0016568(chromatin modification)","Homo sapiens BTG3 associated nuclear protein (BANP), transcript variant 2, mRNA [NM_079837]",chr16:88110663-88110722,hs|16q24.2,BTG3 associated nuclear protein,TRUE
1399_PSCA_8000,O43653,prostate stem cell antigen,PSCA UNQ206/PRO232,114,function: may be involved in the regulation of cell proliferation. has a cell-proliferation inhibition activity in vitro. {eco:0000269|pubmed:18488030}.; function: may act as a modulator of nicotinic acetylcholine receptors (nachrs) activity. in vitro inhibits nicotine-induced signaling probably implicating alpha-3:beta-2- or alpha-7-containing nachrs. {eco:0000305|pubmed:25680266}.,"subcellular location: cell membrane {eco:0000269|pubmed:9465086}; lipid-anchor, gpi-anchor {eco:0000269|pubmed:9465086}.","TISSUE SPECIFICITY: Highly expressed in prostate (basal, secretory and neuroendocrine epithelium cells). Also found in bladder (transitional epithelium), placenta (trophoblasts), stomach (neuroendocrine cells), colon (neuroendocrine cells) and kidney (collecting ducts). Overexpressed in prostate cancers and expression is correlated with tumor stage, grade and androgen-independence. Highly expressed in prostate cancer bone metastases. Expressed in gastric epithelial cells, mainly in the isthmus (at protein level). Not detected in normal intestinal epithelium (at protein level). Expressed in brain cortex; expression is significantly increased in the front cortex of Alzheimer disease patients. {ECO:0000269|PubMed:10713670, ECO:0000269|PubMed:18488030, ECO:0000269|PubMed:25680266}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PSCA,8000,Hs.652235,ENST00000301258,THC2464313,GO:0005886(plasma membrane)|GO:0031225(anchored to membrane),"Homo sapiens prostate stem cell antigen (PSCA), transcript variant 1, mRNA [NM_005672]",chr8:143763976-143764035,hs|8q24.3,prostate stem cell antigen,TRUE
14_UBOX5_22888,O94941,ring finger protein 37 (ec 2.3.2.27) (ring-type e3 ubiquitin transferase rnf37) (u-box domain-containing protein 5) (ubcm4-interacting protein 5) (huip5) (ubiquitin-conjugating enzyme 7-interacting protein 5),UBOX5 KIAA0860 RNF37 UBCE7IP5 UIP5,541,function: may have a ubiquitin-protein ligase activity acting as an e3 ubiquitin-protein ligase or as a ubiquitin-ubiquitin ligase promoting elongation of ubiquitin chains on substrates. {eco:0000250|uniprotkb:q925f4}.,"subcellular location: nucleus {eco:0000269|pubmed:11274149, eco:0000269|pubmed:11435423}. note=enriched in nuclear bodies. {eco:0000269|pubmed:11274149}.","TISSUE SPECIFICITY: Expressed in liver, heart, brain, kidney and testis. {ECO:0000269|PubMed:11435423}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBOX5,22888,Hs.654646,ENST00000217173,THC2609472,GO:0000151(ubiquitin ligase complex)|GO:0000209(protein polyubiquitination)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005634(nucleus)|GO:0008270(zinc ion binding)|GO:0034450(ubiquitin-ubiquitin ligase activity)|GO:0046872(metal ion binding),"Homo sapiens U-box domain containing 5 (UBOX5), transcript variant 1, mRNA [NM_014948]",chr20:3088958-3088899,hs|20p13,U-box domain containing 5,TRUE
140_HSPE1_3336,P61604,"10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (chaperonin 10) (cpn10) (early-pregnancy factor) (epf)",HSPE1,102,"function: co-chaperonin implicated in mitochondrial protein import and macromolecular assembly. together with hsp60, facilitates the correct folding of imported proteins. may also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (pubmed:7912672, pubmed:1346131, pubmed:11422376). the functional units of these chaperonins consist of heptameric rings of the large subunit hsp60, which function as a back-to-back double ring. in a cyclic reaction, hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of atp and association with 2 heptameric rings of the co-chaperonin hsp10. this leads to sequestration of the substrate protein in the inner cavity of hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. synchronous hydrolysis of atp in all hsp60 subunits results in the dissociation of the chaperonin rings and the release of adp and the folded substrate protein (probable). {eco:0000269|pubmed:11422376, eco:0000269|pubmed:1346131, eco:0000269|pubmed:7912672, eco:0000305|pubmed:25918392}.",subcellular location: mitochondrion matrix.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSPE1,3336,Hs.1197,ENST00000465573,THC2558376,GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006457(protein folding)|GO:0006919(activation of caspase activity)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0051082(unfolded protein binding)|GO:0051087(chaperone binding),"Homo sapiens heat shock 10kDa protein 1 (chaperonin 10) (HSPE1), nuclear gene encoding mitochondrial protein, mRNA [NM_002157]",chr2:198367803-198367942,hs|2q33.1,heat shock 10kDa protein 1 (chaperonin 10),TRUE
1400_FOXJ3_22887,Q9UPW0,forkhead box protein j3,FOXJ3 KIAA1041,622,function: transcriptional activator of mef2c involved in the regulation pf adult muscle fiber type identity and skeletal muscle regeneration. {eco:0000250|uniprotkb:q8bur3}.,subcellular location: nucleus {eco:0000255|prosite-prorule:pru00089}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FOXJ3,22887,Hs.26023,ENST00000545068,THC2493844,"GO:0003690(double-stranded DNA binding)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0007389(pattern specification process)|GO:0008134(transcription factor binding)|GO:0008301(DNA bending activity)|GO:0009790(embryo development)|GO:0009888(tissue development)|GO:0019904(protein domain specific binding)|GO:0043565(sequence-specific DNA binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0048513(organ development)|GO:0051090(regulation of sequence-specific DNA binding transcription factor activity)","Homo sapiens forkhead box J3 (FOXJ3), transcript variant 1, mRNA [NM_014947]",chr1:42642599-42642540,hs|1p34.2,forkhead box J3,TRUE
1401_NDUFA13_51079,Q9P0J0,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (cell death regulatory protein grim-19) (complex i-b16.6) (ci-b16.6) (gene associated with retinoic and interferon-induced mortality 19 protein) (grim-19) (gene associated with retinoic and ifn-induced mortality 19 protein) (nadh-ubiquinone oxidoreductase b16.6 subunit),NDUFA13 GRIM19 CDA016 CGI-39,144,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis (pubmed:27626371). complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (pubmed:27626371). involved in the interferon/all-trans-retinoic acid (ifn/ra) induced cell death. this apoptotic activity is inhibited by interaction with viral irf1. prevents the transactivation of stat3 target genes. may play a role in card15-mediated innate mucosal responses and serve to regulate intestinal epithelial cell responses to microbes (pubmed:15753091). {eco:0000269|pubmed:12628925, eco:0000269|pubmed:12867595, eco:0000269|pubmed:15753091, eco:0000269|pubmed:27626371}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:12628925, eco:0000269|pubmed:15059901, eco:0000269|pubmed:15367666}; single-pass membrane protein {eco:0000255}; matrix side. nucleus {eco:0000269|pubmed:12628925}. note=localizes mainly in the mitochondrion (pubmed:12628925). may be translocated into the nucleus upon ifn/ra treatment. {eco:0000269|pubmed:12628925, eco:0000269|pubmed:15059901}.","TISSUE SPECIFICITY: Widely expressed, with highest expression in heart, skeletal muscle, liver, kidney and placenta. In intestinal mucosa, down-regulated in areas involved in Crohn disease and ulcerative colitis. {ECO:0000269|PubMed:10924506}.","DISEASE: Hurthle cell thyroid carcinoma (HCTC) [MIM:607464]: A rare type of thyroid cancer accounting for only about 3-10% of all differentiated thyroid cancers. These neoplasms are considered a variant of follicular carcinoma of the thyroid and are referred to as follicular carcinoma, oxyphilic type. {ECO:0000269|PubMed:15841082}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mitochondrial complex I deficiency, nuclear type 28 (MC1DN28) [MIM:618249]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN28 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:25901006}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA13,51079,Hs.534453,ENST00000502506,THC2532997,"GO:0003954(NADH dehydrogenase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005746(mitochondrial respiratory chain)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006606(protein import into nucleus)|GO:0006810(transport)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0017148(negative regulation of translation)|GO:0022904(respiratory electron transport chain)|GO:0030262(apoptotic nuclear change)|GO:0030308(negative regulation of cell growth)|GO:0031966(mitochondrial membrane)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0072593(reactive oxygen species metabolic process)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 (NDUFA13), nuclear gene encoding mitochondrial protein, mRNA [NM_015965]",chr19:19638092-19638151,hs|19p13.11,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13",TRUE
1402_A2M_2,P01023,alpha-2-macroglobulin (alpha-2-m) (c3 and pzp-like alpha-2-macroglobulin domain-containing protein 5),A2M CPAMD5 FWP007,1474,"function: is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. this protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. when a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. the entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). following cleavage in the bait region, a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase.",subcellular location: secreted {eco:0000269|pubmed:6203908}.,TISSUE SPECIFICITY: Secreted in plasma. {ECO:0000269|PubMed:6203908}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,A2M,2,Hs.212838,ENST00000540099,NP1159902,"GO:0001869(negative regulation of complement activation, lectin pathway)|GO:0002576(platelet degranulation)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005829(cytosol)|GO:0007264(small GTPase mediated signal transduction)|GO:0007596(blood coagulation)|GO:0007597(blood coagulation, intrinsic pathway)|GO:0019838(growth factor binding)|GO:0019899(enzyme binding)|GO:0019959(interleukin-8 binding)|GO:0019966(interleukin-1 binding)|GO:0030168(platelet activation)|GO:0031093(platelet alpha granule lumen)|GO:0043120(tumor necrosis factor binding)|GO:0051056(regulation of small GTPase mediated signal transduction)","Homo sapiens alpha-2-macroglobulin (A2M), mRNA [NM_000014]",chr12:9221418-9221359,hs|12p13.31,alpha-2-macroglobulin,TRUE
1403_HGS_9146,O14964,hepatocyte growth factor-regulated tyrosine kinase substrate (hrs) (protein pp110),HGS HRS,777,"function: involved in intracellular signal transduction mediated by cytokines and growth factors. when associated with stam, it suppresses dna signaling upon stimulation by il-2 and gm-csf. could be a direct effector of pi3-kinase in vesicular pathway via early endosomes and may regulate trafficking to early and late endosomes by recruiting clathrin. may concentrate ubiquitinated receptors within clathrin-coated regions. involved in down-regulation of receptor tyrosine kinase via multivesicular body (mvbs) when complexed with stam (escrt-0 complex). the escrt-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes. may contribute to the efficient recruitment of smads to the activin receptor complex. involved in receptor recycling via its association with the cart complex, a multiprotein complex required for efficient transferrin receptor recycling but not for egfr degradation.","subcellular location: cytoplasm {eco:0000250|uniprotkb:q9jj50}. early endosome membrane {eco:0000269|pubmed:23166352, eco:0000269|pubmed:24790097}; peripheral membrane protein {eco:0000305|pubmed:23166352, eco:0000305|pubmed:24790097}; cytoplasmic side {eco:0000305|pubmed:23166352, eco:0000305|pubmed:24790097}. endosome, multivesicular body membrane {eco:0000250|uniprotkb:q9jj50}; peripheral membrane protein {eco:0000250|uniprotkb:q9jj50}. note=colocalizes with ubqln1 in ubiquitin-rich cytoplasmic aggregates that are not endocytic compartments. {eco:0000269|pubmed:16159959}.","TISSUE SPECIFICITY: Ubiquitous expression in adult and fetal tissues with higher expression in testis and peripheral blood leukocytes. {ECO:0000269|PubMed:9407053, ECO:0000269|PubMed:9630564}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HGS,9146,Hs.730823,ENST00000442335,THC2509659,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005769(early endosome)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0007165(signal transduction)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0008285(negative regulation of cell proliferation)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016197(endosome transport)|GO:0019904(protein domain specific binding)|GO:0031901(early endosome membrane)|GO:0032585(multivesicular body membrane)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042176(regulation of protein catabolic process)|GO:0043231(intracellular membrane-bounded organelle)|GO:0046426(negative regulation of JAK-STAT cascade)|GO:0046872(metal ion binding),"Homo sapiens hepatocyte growth factor-regulated tyrosine kinase substrate (HGS), mRNA [NM_004712]",chr17:79669087-79669146,hs|17q25.3,hepatocyte growth factor-regulated tyrosine kinase substrate,TRUE
1404_DPYSL3_1809,Q14195,dihydropyrimidinase-related protein 3 (drp-3) (collapsin response mediator protein 4) (crmp-4) (unc-33-like phosphoprotein 1) (ulip-1),DPYSL3 CRMP4 DRP3 ULIP ULIP1,570,"function: necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. plays a role in axon guidance, neuronal growth cone collapse and cell migration (by similarity). {eco:0000250}.","subcellular location: cytoplasm {eco:0000250}. cell projection, growth cone {eco:0000250}. note=colocalizes with synaptic vesicle protein 2 in the central region of the growth cone. {eco:0000250}.",TISSUE SPECIFICITY: Mainly expressed in heart and skeletal muscle. Also strongly expressed in fetal brain and spinal cord.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DPYSL3,1809,Hs.519659,ENST00000398514,THC2578103,"GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006208(pyrimidine base catabolic process)|GO:0007399(nervous system development)|GO:0007411(axon guidance)|GO:0010976(positive regulation of neuron projection development)|GO:0010977(negative regulation of neuron projection development)|GO:0016812(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides)|GO:0017124(SH3 domain binding)|GO:0030027(lamellipodium)|GO:0030336(negative regulation of cell migration)|GO:0030426(growth cone)|GO:0031941(filamentous actin)|GO:0035374(chondroitin sulfate binding)|GO:0044297(cell body)|GO:0048678(response to axon injury)|GO:0051017(actin filament bundle assembly)|GO:0051219(phosphoprotein binding)|GO:0051260(protein homooligomerization)|GO:0051491(positive regulation of filopodium assembly)|GO:0051764(actin crosslink formation)|GO:0070382(exocytic vesicle)|GO:0071345(cellular response to cytokine stimulus)","Homo sapiens dihydropyrimidinase-like 3 (DPYSL3), transcript variant 2, mRNA [NM_001387]",chr5:146770596-146770537,hs|5q32,dihydropyrimidinase-like 3,TRUE
1405_ATXN2_6311,Q99700,ataxin-2 (spinocerebellar ataxia type 2 protein) (trinucleotide repeat-containing gene 13 protein),ATXN2 ATX2 SCA2 TNRC13,1313,"function: involved in egfr trafficking, acting as negative regulator of endocytic egfr internalization at the plasma membrane. {eco:0000269|pubmed:18602463}.",subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Expressed in the brain, heart, liver, skeletal muscle, pancreas and placenta. Isoform 1 is predominant in the brain and spinal cord. Isoform 4 is more abundant in the cerebellum. In the brain, broadly expressed in the amygdala, caudate nucleus, corpus callosum, hippocampus, hypothalamus, substantia nigra, subthalamic nucleus and thalamus. {ECO:0000269|PubMed:8896555, ECO:0000269|PubMed:8896556, ECO:0000269|PubMed:8896557, ECO:0000269|PubMed:9480749}.","DISEASE: Spinocerebellar ataxia 2 (SCA2) [MIM:183090]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. In some patients, SCA2 presents as pure familial parkinsonism without cerebellar signs. {ECO:0000269|PubMed:8896555, ECO:0000269|PubMed:8896556, ECO:0000269|PubMed:8896557}. Note=The disease is caused by mutations affecting the gene represented in this entry. SCA2 is caused by expansion of a CAG repeat resulting in about 36 to 52 repeats in some patients. Longer expansions result in earlier the expansion, onset of the disease.; DISEASE: Amyotrophic lateral sclerosis 13 (ALS13) [MIM:183090]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:20740007}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. An increased risk for developing amyotrophic lateral sclerosis seems to be conferred by CAG repeat intermediate expansions greater than 23 but below the threshold for developing spinocerebellar ataxia.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ATXN2,6311,Hs.76253,ENST00000484991,THC2560996,GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0005844(polysome)|GO:0006417(regulation of translation)|GO:0008022(protein C-terminus binding)|GO:0008219(cell death)|GO:0010494(stress granule)|GO:0016070(RNA metabolic process)|GO:0021702(cerebellar Purkinje cell differentiation)|GO:0030529(ribonucleoprotein complex)|GO:0033962(cytoplasmic mRNA processing body assembly)|GO:0034063(stress granule assembly)|GO:0040015(negative regulation of multicellular organism growth)|GO:0048471(perinuclear region of cytoplasm)|GO:0048812(neuron projection morphogenesis)|GO:0048872(homeostasis of number of cells)|GO:0050658(RNA transport)|GO:0050905(neuromuscular process),"Homo sapiens ataxin 2 (ATXN2), mRNA [NM_002973]",chr12:111890389-111890330,hs|12q24.12,ataxin 2,TRUE
1406_CCDC85C_317762,A6NKD9,coiled-coil domain-containing protein 85c,CCDC85C,419,"function: may play a role in cell-cell adhesion and epithelium development through its interaction with proteins of the beta-catenin family (probable). may play an important role in cortical development, especially in the maintenance of radial glia (by similarity). {eco:0000250|uniprotkb:e9q6b2, eco:0000305|pubmed:25009281}.","subcellular location: cell junction, tight junction {eco:0000250|uniprotkb:e9q6b2}. cell junction, adherens junction {eco:0000269|pubmed:25009281}. note=localizes to the apical junction of radial glia in the wall of lateral ventricles of the developing brain. colocalizes with tjp1 on the meshwork-like structure of adherens junctions on the lateral ventricles wall. {eco:0000250|uniprotkb:e9q6b2}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CCDC85C,317762,Hs.709288,ENST00000380243,THC2463458,NA,"Homo sapiens coiled-coil domain containing 85C (CCDC85C), mRNA [NM_001144995]",chr14:99978443-99978384,hs|14q32.2,coiled-coil domain containing 85C,TRUE
1407_FXR1_8087,P51114,fragile x mental retardation syndrome-related protein 1 (hfxr1p),FXR1,621,function: rna-binding protein required for embryonic and postnatal development of muscle tissue. may regulate intracellular transport and local translation of certain mrnas (by similarity). {eco:0000250}.,subcellular location: cytoplasm {eco:0000269|pubmed:7781595}.,"TISSUE SPECIFICITY: Expressed in all tissues examined including heart, brain, kidney and testis. {ECO:0000269|PubMed:7781595}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FXR1,8087,Hs.478407,ENST00000472339,THC2617151,GO:0002151(G-quadruplex RNA binding)|GO:0003723(RNA binding)|GO:0003730(mRNA 3'-UTR binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005844(polysome)|GO:0006915(apoptosis)|GO:0007275(multicellular organismal development)|GO:0007517(muscle organ development)|GO:0017148(negative regulation of translation)|GO:0030154(cell differentiation)|GO:0043034(costamere),"Homo sapiens fragile X mental retardation, autosomal homolog 1 (FXR1), transcript variant 3, mRNA [NM_001013439]",chr3:180694169-180694228,hs|3q26.33,"fragile X mental retardation, autosomal homolog 1",TRUE
1408_ESRP2_80004,Q9H6T0,epithelial splicing regulatory protein 2 (rna-binding motif protein 35b) (rna-binding protein 35b),ESRP2 RBM35B PP7059,727,"function: mrna splicing factor that regulates the formation of epithelial cell-specific isoforms. specifically regulates the expression of fgfr2-iiib, an epithelial cell-specific isoform of fgfr2. also regulates the splicing of cd44, ctnnd1, enah, 3 transcripts that undergo changes in splicing during the epithelial-to-mesenchymal transition (emt). acts by directly binding specific sequences in mrnas. binds the gu-rich sequence motifs in the ise/iss-3, a cis-element regulatory region present in the mrna of fgfr2. {eco:0000269|pubmed:19285943}.",subcellular location: nucleus {eco:0000269|pubmed:19285943}.,TISSUE SPECIFICITY: Epithelial cell-specific. {ECO:0000269|PubMed:19285943}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ESRP2,80004,Hs.592053,ENST00000251366,THC2464692,GO:0000166(nucleotide binding)|GO:0003729(mRNA binding)|GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0043484(regulation of RNA splicing),"Homo sapiens epithelial splicing regulatory protein 2 (ESRP2), mRNA [NM_024939]",chr16:68263113-68263054,hs|16q22.1,epithelial splicing regulatory protein 2,TRUE
1409_MAP2K3_5606,P46734,dual specificity mitogen-activated protein kinase kinase 3 (map kinase kinase 3) (mapkk 3) (ec 2.7.12.2) (mapk/erk kinase 3) (mek 3) (stress-activated protein kinase kinase 2) (sapk kinase 2) (sapkk-2) (sapkk2),MAP2K3 MEK3 MKK3 PRKMK3 SKK2,347,"function: dual specificity kinase. is activated by cytokines and environmental stress in vivo. catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the map kinase p38. part of a signaling cascade that begins with the activation of the adrenergic receptor adra1b and leads to the activation of mapk14. {eco:0000269|pubmed:21224381, eco:0000269|pubmed:8622669}.",NA,TISSUE SPECIFICITY: Abundant expression is seen in the skeletal muscle. It is also widely expressed in other tissues.,DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MAP2K3,5606,Hs.514012,ENST00000316920,THC2626553,"GO:0000166(nucleotide binding)|GO:0000187(activation of MAPK activity)|GO:0002224(toll-like receptor signaling pathway)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0004674(protein serine/threonine kinase activity)|GO:0004708(MAP kinase kinase activity)|GO:0004713(protein tyrosine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006954(inflammatory response)|GO:0007165(signal transduction)|GO:0008063(Toll signaling pathway)|GO:0019901(protein kinase binding)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042035(regulation of cytokine biosynthetic process)|GO:0045087(innate immune response)|GO:0045860(positive regulation of protein kinase activity)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0051403(stress-activated MAPK cascade)|GO:0060048(cardiac muscle contraction)","Homo sapiens mitogen-activated protein kinase kinase 3 (MAP2K3), transcript variant B, mRNA [NM_145109]",chr17:21218464-21218523,hs|17p11.2,mitogen-activated protein kinase kinase 3,TRUE
141_CAMKK2_10645,Q96RR4,calcium/calmodulin-dependent protein kinase kinase 2 (cam-kk 2) (cam-kinase kinase 2) (camkk 2) (ec 2.7.11.17) (calcium/calmodulin-dependent protein kinase kinase beta) (cam-kk beta) (cam-kinase kinase beta) (camkk beta),CAMKK2 CAMKKB KIAA0787,588,"function: calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. isoform 1, isoform 2 and isoform 3 phosphorylate camk1 and camk4. isoform 3 phosphorylates camk1d. isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. efficiently phosphorylates 5'-amp-activated protein kinase (ampk) trimer, including that consisting of prkaa1, prkab1 and prkag1. this phosphorylation is stimulated in response to ca(2+) signals (by similarity). seems to be involved in hippocampal activation of creb1 (by similarity). may play a role in neurite growth. isoform 3 may promote neurite elongation, while isoform 1 may promoter neurite branching. {eco:0000250, eco:0000269|pubmed:11395482, eco:0000269|pubmed:12935886, eco:0000269|pubmed:21957496, eco:0000269|pubmed:9662074}.","subcellular location: nucleus {eco:0000269|pubmed:21957496}. cytoplasm {eco:0000269|pubmed:21957496}. cell projection, neuron projection {eco:0000269|pubmed:21957496}. note=predominantly nuclear in unstimulated cells, relocalizes into cytoplasm and neurites after forskolin induction. {eco:0000269|pubmed:21957496}.","TISSUE SPECIFICITY: Ubiquitously expressed with higher levels in the brain. Intermediate levels are detected in spleen, prostate, thyroid and leukocytes. The lowest level is in lung. {ECO:0000269|PubMed:9662074}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CAMKK2,10645,Hs.297343,ENST00000324774,THC2554224,"GO:0000165(MAPKKK cascade)|GO:0000166(nucleotide binding)|GO:0004683(calmodulin-dependent protein kinase activity)|GO:0004713(protein tyrosine kinase activity)|GO:0005509(calcium ion binding)|GO:0005516(calmodulin binding)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0006468(protein phosphorylation)|GO:0019722(calcium-mediated signaling)|GO:0045859(regulation of protein kinase activity)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046777(protein autophosphorylation)","Homo sapiens calcium/calmodulin-dependent protein kinase kinase 2, beta (CAMKK2), transcript variant 1, mRNA [NM_006549]",chr12:121675671-121675612,hs|12q24.31,"calcium/calmodulin-dependent protein kinase kinase 2, beta",TRUE
1410_MAGOHB_55110,Q96A72,protein mago nashi homolog 2,MAGOHB MAGOH2,148,"function: required for pre-mrna splicing as component of the spliceosome (pubmed:28502770, pubmed:29301961, pubmed:30705154). plays a redundant role with magoh in the exon junction complex and in the nonsense-mediated decay (nmd) pathway (pubmed:23917022). {eco:0000269|pubmed:23917022, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961, eco:0000269|pubmed:30705154}.","subcellular location: nucleus {eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961, eco:0000269|pubmed:30705154}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MAGOHB,55110,Hs.104650,ENST00000537852,THC2518533,GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0051028(mRNA transport),"Homo sapiens mago-nashi homolog B (Drosophila) (MAGOHB), mRNA [NM_018048]",chr12:10758734-10758675,hs|12p13.2,mago-nashi homolog B (Drosophila),TRUE
1411_MAFG_4097,O15525,transcription factor mafg (v-maf musculoaponeurotic fibrosarcoma oncogene homolog g) (hmaf),MAFG,162,"function: since they lack a putative transactivation domain, the small mafs behave as transcriptional repressors when they dimerize among themselves (pubmed:11154691). however, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as nfe2, nfe2l1 and nfe2l2, and recruiting them to specific dna-binding sites (pubmed:8932385, pubmed:9421508, pubmed:11154691). small maf proteins heterodimerize with fos and may act as competitive repressors of the nfe2l2 transcription factor (pubmed:11154691). transcription factor, component of erythroid-specific transcription factor nfe2l2 (pubmed:11154691). activates globin gene expression when associated with nfe2l2 (pubmed:11154691). may be involved in signal transduction of extracellular h(+) (by similarity). {eco:0000250|uniprotkb:q76mx4, eco:0000269|pubmed:11154691, eco:0000269|pubmed:8932385, eco:0000269|pubmed:9421508}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00978, eco:0000269|pubmed:11154691}.",TISSUE SPECIFICITY: Highly expressed in skeletal muscle. Also expressed in heart and brain.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,MAFG,4097,Hs.252229,ENST00000357736,THC2482373,"GO:0001701(in utero embryonic development)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007596(blood coagulation)|GO:0030534(adult behavior)|GO:0030641(regulation of cellular pH)|GO:0042127(regulation of cell proliferation)|GO:0043565(sequence-specific DNA binding)|GO:0045604(regulation of epidermal cell differentiation)","Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) (MAFG), transcript variant 1, mRNA [NM_002359]",chr17:79879842-79879783,hs|17q25.3,v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian),TRUE
1412_KLHDC9_126823,Q8NEP7,kelch domain-containing protein 9 (kelch/ankyrin repeat-containing cyclin a1-interacting protein),KLHDC9 KARCA1,349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,KLHDC9,126823,Hs.507290,ENST00000469647,THC2499957,NA,"Homo sapiens kelch domain containing 9 (KLHDC9), transcript variant 2, mRNA [NM_001007255]",chr1:161070036-161070095,hs|1q23.3,kelch domain containing 9,TRUE
1413_PSMD7_5713,P51665,26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit rpn8) (26s proteasome regulatory subunit s12) (mov34 protein homolog) (proteasome subunit p40),PSMD7 MOV34L,324,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair. {eco:0000269|pubmed:1317798}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSMD7,5713,Hs.440604,ENST00000219313,THC2469533,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0005838(proteasome regulatory particle)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 (PSMD7), mRNA [NM_002811]",chr16:74340102-74340161,hs|16q23.1,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 7",TRUE
1414_PPP6C_5537,O00743,"serine/threonine-protein phosphatase 6 catalytic subunit (pp6c) (ec 3.1.3.16) [cleaved into: serine/threonine-protein phosphatase 6 catalytic subunit, n-terminally processed]",PPP6C PPP6,305,"function: catalytic subunit of protein phosphatase 6 (pp6) (pubmed:17079228, pubmed:29053956). pp6 is a component of a signaling pathway regulating cell cycle progression in response to il2 receptor stimulation (pubmed:10227379). n-terminal domain restricts g1 to s phase progression in cancer cells, in part through control of cyclin d1 (pubmed:17568194). during mitosis, regulates spindle positioning (pubmed:27335426). downregulates map3k7 kinase activation of the il1 signaling pathway by dephosphorylation of map3k7 (pubmed:17079228). participates also in the innate immune defense against viruses by desphosphorylating rig-i/ddx58, an essential step that triggers rig-i/ddx58-mediated signaling activation (pubmed:29053956). {eco:0000269|pubmed:10227379, eco:0000269|pubmed:17079228, eco:0000269|pubmed:17568194, eco:0000269|pubmed:27335426, eco:0000269|pubmed:29053956}.","subcellular location: mitochondrion {eco:0000269|pubmed:29053956}. cytoplasm {eco:0000269|pubmed:16769727, eco:0000269|pubmed:17568194}.","TISSUE SPECIFICITY: Ubiquitously expressed in all tissues tested with highest expression levels in testis, heart, kidney, brain, stomach, liver and skeletal muscle and lowest in placenta, lung colon and spleen. {ECO:0000269|PubMed:16769727, ECO:0000269|PubMed:9013334}.",NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PPP6C,5537,Hs.594307,ENST00000451402,THC2466331,GO:0000082(G1/S transition of mitotic cell cycle)|GO:0004722(protein serine/threonine phosphatase activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006470(protein dephosphorylation)|GO:0007049(cell cycle)|GO:0016787(hydrolase activity)|GO:0046872(metal ion binding),"Homo sapiens protein phosphatase 6, catalytic subunit (PPP6C), transcript variant 2, mRNA [NM_002721]",chr9:127911554-127911495,hs|9q33.3,"protein phosphatase 6, catalytic subunit",TRUE
1415_PFDN2_5202,Q9UHV9,prefoldin subunit 2,PFDN2 PFD2 HSPC231,154,function: binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it. binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. {eco:0000269|pubmed:9630229}.,subcellular location: nucleus {eco:0000269|pubmed:17936702}. cytoplasm {eco:0000269|pubmed:17936702}. mitochondrion {eco:0000269|pubmed:17936702}.,NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PFDN2,5202,Hs.492516,ENST00000368010,THC2467137,GO:0006457(protein folding)|GO:0016272(prefoldin complex)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens prefoldin subunit 2 (PFDN2), mRNA [NM_012394]",chr1:161070598-161070539,hs|1q23.3,prefoldin subunit 2,TRUE
1416_NAAA_27163,Q02083,n-acylethanolamine-hydrolyzing acid amidase (ec 3.5.1.60) (acid ceramidase-like protein) (n-acylsphingosine amidohydrolase-like) (asah-like protein) [cleaved into: n-acylethanolamine-hydrolyzing acid amidase subunit alpha; n-acylethanolamine-hydrolyzing acid amidase subunit beta],NAAA ASAHL PLT,359,"function: degrades bioactive fatty acid amides to their corresponding acids, with the following preference: n-palmitoylethanolamine > n-myristoylethanolamine > n-lauroylethanolamine = n-stearoylethanolamine > n-arachidonoylethanolamine > n-oleoylethanolamine (pubmed:15655246, pubmed:17980170, pubmed:18793752, pubmed:30301806). also exhibits weak hydrolytic activity against the ceramides n-lauroylsphingosine and n-palmitoylsphingosine (pubmed:15655246). {eco:0000269|pubmed:15655246, eco:0000269|pubmed:17980170, eco:0000269|pubmed:18793752, eco:0000269|pubmed:30301806}.","subcellular location: lysosome {eco:0000305|pubmed:10610717, eco:0000305|pubmed:15655246, eco:0000305|pubmed:18793752}. membrane {eco:0000269|pubmed:30301806}; peripheral membrane protein {eco:0000269|pubmed:30301806}.","TISSUE SPECIFICITY: Expressed in numerous tissues, with highest levels in liver and kidney, followed by pancreas. {ECO:0000269|PubMed:10610717}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NAAA,27163,Hs.437365,ENST00000286733,THC2525743,GO:0003674(molecular_function)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0006629(lipid metabolic process)|GO:0008134(transcription factor binding)|GO:0008150(biological_process)|GO:0016787(hydrolase activity),"Homo sapiens N-acylethanolamine acid amidase (NAAA), transcript variant 1, mRNA [NM_014435]",chr4:76835052-76834993,hs|4q21.1,N-acylethanolamine acid amidase,TRUE
1417_XRN1_54464,Q8IZH2,5'-3' exoribonuclease 1 (ec 3.1.13.-) (strand-exchange protein 1 homolog),XRN1 SEP1,1706,"function: major 5'-3' exoribonuclease involved in mrna decay. required for the 5'-3'-processing of the g4 tetraplex-containing dna and rna substrates. the kinetic of hydrolysis is faster for g4 rna tetraplex than for g4 dna tetraplex and monomeric rna tetraplex. binds to rna and dna (by similarity). plays a role in replication-dependent histone mrna degradation. may act as a tumor suppressor protein in osteogenic sarcoma (ogs). {eco:0000250|uniprotkb:p97789, eco:0000269|pubmed:18172165}.","subcellular location: cytoplasm {eco:0000269|pubmed:12515382, eco:0000269|pubmed:14580940, eco:0000269|pubmed:9802570}. note=discrete foci at the inner surface of the cell membrane.","TISSUE SPECIFICITY: Expressed in heart, brain, pancreas, spleen, testis, osteogenic sarcoma (OGS) biopsy and primary cell lines. {ECO:0000269|PubMed:12426100}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,XRN1,54464,Hs.435103,ENST00000264951,THC2491436,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0000956(nuclear-transcribed mRNA catabolic process)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0008409(5'-3' exonuclease activity)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016075(rRNA catabolic process)|GO:0016787(hydrolase activity)|GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay)|GO:0045111(intermediate filament cytoskeleton)|GO:0071028(nuclear mRNA surveillance)|GO:0071044(histone mRNA catabolic process)","Homo sapiens 5'-3' exoribonuclease 1 (XRN1), transcript variant 1, mRNA [NM_019001]",chr3:142025671-142025612,hs|3q23,5'-3' exoribonuclease 1,TRUE
1418_YBX1_4904,P67809,y-box-binding protein 1 (yb-1) (ccaat-binding transcription factor i subunit a) (cbf-a) (dna-binding protein b) (dbpb) (enhancer factor i subunit a) (efi-a) (nuclease-sensitive element-binding protein 1) (y-box transcription factor),YBX1 NSEP1 YB1,324,"function: dna- and rna-binding protein involved in various processes, such as translational repression, rna stabilization, mrna splicing, dna repair and transcription regulation (pubmed:8188694, pubmed:10817758, pubmed:11698476, pubmed:14718551, pubmed:18809583, pubmed:31358969). predominantly acts as a rna-binding protein: binds preferentially to the 5'-[cu]cugcg-3' rna motif and specifically recognizes mrna transcripts modified by c5-methylcytosine (m5c) (pubmed:19561594, pubmed:31358969). promotes mrna stabilization: acts by binding to m5c-containing mrnas and recruiting the mrna stability maintainer elavl1, thereby preventing mrna decay (pubmed:10817758, pubmed:11698476, pubmed:31358969). component of the crd-mediated complex that promotes myc mrna stability (pubmed:19029303). contributes to the regulation of translation by modulating the interaction between the mrna and eukaryotic initiation factors (by similarity). plays a key role in rna composition of extracellular exosomes by defining the sorting of small non-coding rnas, such as trnas, y rnas, vault rnas and mirnas (pubmed:27559612, pubmed:29073095). probably sorts rnas in exosomes by recognizing and binding c5-methylcytosine (m5c)-containing rnas (pubmed:28341602, pubmed:29073095). acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mrnas, possibly by binding to m5c-containing mrnas (pubmed:29712925). also involved in pre-mrna alternative splicing regulation: binds to splice sites in pre-mrna and regulates splice site selection (pubmed:12604611). also able to bind dna: regulates transcription of the multidrug resistance gene mdr1 is enhanced in presence of the apex1 acetylated form at 'lys-6' and 'lys-7' (pubmed:18809583). binds to promoters that contain a y-box (5'-ctgattggccaa-3'), such as mdr1 and hla class ii genes (pubmed:8188694, pubmed:18809583). promotes separation of dna strands that contain mismatches or are modified by cisplatin (pubmed:14718551). has endonucleolytic activity and can introduce nicks or breaks into double-stranded dna, suggesting a role in dna repair (pubmed:14718551). the secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (pubmed:19483673). {eco:0000250|uniprotkb:q28618, eco:0000269|pubmed:10817758, eco:0000269|pubmed:11698476, eco:0000269|pubmed:12604611, eco:0000269|pubmed:14718551, eco:0000269|pubmed:18809583, eco:0000269|pubmed:19029303, eco:0000269|pubmed:19483673, eco:0000269|pubmed:19561594, eco:0000269|pubmed:27559612, eco:0000269|pubmed:28341602, eco:0000269|pubmed:29073095, eco:0000269|pubmed:29712925, eco:0000269|pubmed:31358969, eco:0000269|pubmed:8188694}.","subcellular location: cytoplasm {eco:0000269|pubmed:12604611, eco:0000269|pubmed:14718551, eco:0000269|pubmed:15806160}. nucleus {eco:0000269|pubmed:12604611, eco:0000269|pubmed:14718551, eco:0000269|pubmed:15806160}. cytoplasmic granule {eco:0000269|pubmed:17289661, eco:0000269|pubmed:18335541, eco:0000269|pubmed:19029303, eco:0000269|pubmed:25229427}. secreted {eco:0000269|pubmed:19483673}. secreted, extracellular exosome {eco:0000269|pubmed:27559612, eco:0000269|pubmed:28341602}. note=predominantly cytoplasmic in proliferating cells (pubmed:12604611). cytotoxic stress and dna damage enhance translocation to the nucleus (pubmed:14718551). localized in cytoplasmic mrnp granules containing untranslated mrnas (pubmed:25229427). shuttles between nucleus and cytoplasm (pubmed:25229427). localized with ddx1, mbnl1 and tial1 in stress granules upon stress (pubmed:18335541). secreted by mesangial and monocytic cells after inflammatory challenges (pubmed:19483673). {eco:0000269|pubmed:12604611, eco:0000269|pubmed:14718551, eco:0000269|pubmed:18335541, eco:0000269|pubmed:19483673, eco:0000269|pubmed:25229427}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YBX1,4904,Hs.473583,ENST00000436427,THC2496346,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0001701(in utero embryonic development)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005689(U12-type spliceosomal complex)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0010494(stress granule)|GO:0030529(ribonucleoprotein complex)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0051154(negative regulation of striated muscle cell differentiation)|GO:0051781(positive regulation of cell division)|GO:0070934(CRD-mediated mRNA stabilization)|GO:0070937(CRD-mediated mRNA stability complex)|GO:0071204(histone pre-mRNA 3'end processing complex)","Homo sapiens Y box binding protein 1 (YBX1), mRNA [NM_004559]",chr1:43167695-43167754,hs|1p34.2,Y box binding protein 1,TRUE
1419_TBL1XR1_79718,Q9BZK7,f-box-like/wd repeat-containing protein tbl1xr1 (nuclear receptor corepressor/hdac3 complex subunit tblr1) (tbl1-related protein 1) (transducin beta-like 1x-related protein 1),TBL1XR1 IRA1 TBLR1,514,"function: f-box-like protein involved in the recruitment of the ubiquitin/19s proteasome complex to nuclear receptor-regulated transcription units. plays an essential role in transcription activation mediated by nuclear receptors. probably acts as integral component of the n-cor corepressor complex that mediates the recruitment of the 19s proteasome complex, leading to the subsequent proteasomal degradation of n-cor complex, thereby allowing cofactor exchange, and transcription activation. {eco:0000269|pubmed:14980219}.",subcellular location: nucleus {eco:0000305}.,"TISSUE SPECIFICITY: Widely expressed including the pituitary, hypothalamus, white and brown adipose tissue, muscle and liver. {ECO:0000269|PubMed:26769062}.","DISEASE: Pierpont syndrome (PRPTS) [MIM:602342]: An autosomal dominant syndrome characterized by multiple congenital anomalies, global developmental delay, learning disability, palmar and plantar fat pads, and distinctive facial characteristics, especially when smiling. {ECO:0000269|PubMed:26769062}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, autosomal dominant 41 (MRD41) [MIM:616944]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD41 patients manifest delayed psychomotor development, variable severity of intellectual disability, and delayed language. Non-specific dysmorphic features and autistic behavior is observed in some patients. {ECO:0000269|PubMed:22495309, ECO:0000269|PubMed:23160955, ECO:0000269|PubMed:25102098, ECO:0000269|PubMed:27133561}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TBL1XR1,79718,Hs.715026,ENST00000457928,THC2467714,"GO:0000118(histone deacetylase complex)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003677(DNA binding)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005876(spindle microtubule)|GO:0008013(beta-catenin binding)|GO:0016568(chromatin modification)|GO:0017053(transcriptional repressor complex)|GO:0042393(histone binding)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0044212(transcription regulatory region DNA binding)|GO:0044255(cellular lipid metabolic process)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0047485(protein N-terminus binding)|GO:0060070(canonical Wnt receptor signaling pathway)","Homo sapiens transducin (beta)-like 1 X-linked receptor 1 (TBL1XR1), mRNA [NM_024665]",chr3:176741259-176741200,hs|3q26.32,transducin (beta)-like 1 X-linked receptor 1,TRUE
142_RPL13_6137,P26373,60s ribosomal protein l13 (breast basic conserved protein 1) (large ribosomal subunit protein el13),RPL13 BBC1 OK/SW-cl.46,211,NA,NA,TISSUE SPECIFICITY: Higher levels of expression in benign breast lesions than in carcinomas.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL13,6137,Hs.410817,ENST00000399461,THC2565690,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0022626(cytosolic ribosome)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L13 (RPL13), transcript variant 2, mRNA [NM_033251]",chr16:89629349-89629408,hs|16q24.3,ribosomal protein L13,TRUE
1420_TCF3_6929,P15923,transcription factor e2-alpha (class b basic helix-loop-helix protein 21) (bhlhb21) (immunoglobulin enhancer-binding factor e12/e47) (immunoglobulin transcription factor 1) (kappa-e2-binding factor) (transcription factor 3) (tcf-3) (transcription factor itf-1),TCF3 BHLHB21 E2A ITF1,654,"function: transcriptional regulator. involved in the initiation of neuronal differentiation. heterodimers between tcf3 and tissue-specific basic helix-loop-helix (bhlh) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early b-cell differentiation. dimers bind dna on e-box motifs: 5'-canntg-3'. binds to the kappa-e2 site in the kappa immunoglobulin gene enhancer. binds to ieb1 and ieb2, which are short dna sequences in the insulin gene transcription control region. {eco:0000250|uniprotkb:p15806}.",subcellular location: nucleus.,NA,"DISEASE: Note=Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family (PubMed:1967983, PubMed:1671560). Translocation t(17;19)(q22;p13.3) with HLF (PubMed:1386162). Inversion inv(19)(p13;q13) with TFPT (PubMed:10086727). {ECO:0000269|PubMed:10086727, ECO:0000269|PubMed:1386162, ECO:0000269|PubMed:1671560, ECO:0000269|PubMed:1967983}.; DISEASE: Agammaglobulinemia 8, autosomal dominant (AGM8) [MIM:616941]: A form of agammaglobulinemia, a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:24216514}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCF3,6929,Hs.371282,ENST00000262965,THC2469262,"GO:0000080(G1 phase of mitotic cell cycle)|GO:0000788(nuclear nucleosome)|GO:0001779(natural killer cell differentiation)|GO:0002326(B cell lineage commitment)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005737(cytoplasm)|GO:0006351(transcription, DNA-dependent)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007399(nervous system development)|GO:0008134(transcription factor binding)|GO:0030183(B cell differentiation)|GO:0030890(positive regulation of B cell proliferation)|GO:0031435(mitogen-activated protein kinase kinase kinase binding)|GO:0032496(response to lipopolysaccharide)|GO:0033077(T cell differentiation in thymus)|GO:0033152(immunoglobulin V(D)J recombination)|GO:0042493(response to drug)|GO:0042692(muscle cell differentiation)|GO:0042803(protein homodimerization activity)|GO:0043234(protein complex)|GO:0043425(bHLH transcription factor binding)|GO:0043565(sequence-specific DNA binding)|GO:0043966(histone H3 acetylation)|GO:0043967(histone H4 acetylation)|GO:0044212(transcription regulatory region DNA binding)|GO:0045666(positive regulation of neuron differentiation)|GO:0045787(positive regulation of cell cycle)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046982(protein heterodimerization activity)|GO:0048468(cell development)|GO:0048541(Peyer's patch development)|GO:0050821(protein stabilization)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0051149(positive regulation of muscle cell differentiation)|GO:0070491(repressing transcription factor binding)|GO:0070644(vitamin D response element binding)|GO:0070888(E-box binding)","Homo sapiens transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) (TCF3), transcript variant 1, mRNA [NM_003200]",chr19:1609391-1609332,hs|19p13.3,transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47),TRUE
1421_DUSP12_11266,Q9UNI6,dual specificity protein phosphatase 12 (ec 3.1.3.16) (ec 3.1.3.48) (dual specificity tyrosine phosphatase yvh1),DUSP12,340,"function: dual specificity phosphatase; can dephosphorylate both phosphotyrosine and phosphoserine or phosphothreonine residues. can dephosphorylate glucokinase (in vitro) (by similarity). has phosphatase activity with the synthetic substrate 6,8-difluoro-4-methylumbelliferyl phosphate and other in vitro substrates (pubmed:10446167, pubmed:24531476). {eco:0000250|uniprotkb:q9jim4, eco:0000269|pubmed:10446167, eco:0000269|pubmed:24531476}.","subcellular location: nucleus {eco:0000269|pubmed:10446167}. cytoplasm, cytosol {eco:0000269|pubmed:10446167}. note=primarily nuclear. detected in a mesh-like pattern in the cytosol. {eco:0000269|pubmed:10446167}.","TISSUE SPECIFICITY: Ubiquitous, highest expression in spleen, testis, ovary, and peripheral blood leukocytes and lower expression in liver and lung.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DUSP12,11266,Hs.416216,ENST00000367943,THC2702411,GO:0004725(protein tyrosine phosphatase activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006464(protein modification process)|GO:0006470(protein dephosphorylation)|GO:0007254(JNK cascade)|GO:0008138(protein tyrosine/serine/threonine phosphatase activity)|GO:0008270(zinc ion binding)|GO:0016787(hydrolase activity)|GO:0019900(kinase binding)|GO:0033133(positive regulation of glucokinase activity)|GO:0035335(peptidyl-tyrosine dephosphorylation)|GO:0046872(metal ion binding),"Homo sapiens dual specificity phosphatase 12 (DUSP12), mRNA [NM_007240]",chr1:161726752-161726811,hs|1q23.3,dual specificity phosphatase 12,TRUE
1422_CADM1_23705,Q9BY67,cell adhesion molecule 1 (immunoglobulin superfamily member 4) (igsf4) (nectin-like protein 2) (necl-2) (spermatogenic immunoglobulin superfamily) (sgigsf) (synaptic cell adhesion molecule) (syncam) (tumor suppressor in lung cancer 1) (tslc-1),CADM1 IGSF4 IGSF4A NECL2 SYNCAM TSLC1,442,"function: mediates homophilic cell-cell adhesion in a ca(2+)-independent manner. also mediates heterophilic cell-cell adhesion with cadm3 and nectin3 in a ca(2+)-independent manner. acts as a tumor suppressor in non-small-cell lung cancer (nsclc) cells. interaction with crtam promotes natural killer (nk) cell cytotoxicity and interferon-gamma (ifn-gamma) secretion by cd8+ cells in vitro as well as nk cell-mediated rejection of tumors expressing cadm3 in vivo. may contribute to the less invasive phenotypes of lepidic growth tumor cells. in mast cells, may mediate attachment to and promote communication with nerves. cadm1, together with mitf, is essential for development and survival of mast cells in vivo. acts as a synaptic cell adhesion molecule and plays a role in the formation of dendritic spines and in synapse assembly (by similarity). may be involved in neuronal migration, axon growth, pathfinding, and fasciculation on the axons of differentiating neurons. may play diverse roles in the spermatogenesis including in the adhesion of spermatocytes and spermatids to sertoli cells and for their normal differentiation into mature spermatozoa. {eco:0000250, eco:0000269|pubmed:11279526, eco:0000269|pubmed:12050160, eco:0000269|pubmed:12234973, eco:0000269|pubmed:12920246, eco:0000269|pubmed:15811952, eco:0000269|pubmed:15905536, eco:0000269|pubmed:22438059}.","subcellular location: cell membrane {eco:0000269|pubmed:11279526, eco:0000269|pubmed:22438059}; single-pass type i membrane protein {eco:0000269|pubmed:11279526}. cell junction, synapse {eco:0000250|uniprotkb:q8r5m8}. note=localized to the basolateral plasma membrane of epithelial cells in gall bladder. {eco:0000250|uniprotkb:q8r5m8}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CADM1,23705,Hs.370510,ENST00000540852,THC2655069,GO:0001913(T cell mediated cytotoxicity)|GO:0005102(receptor binding)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0006915(apoptosis)|GO:0007155(cell adhesion)|GO:0007156(homophilic cell adhesion)|GO:0007157(heterophilic cell-cell adhesion)|GO:0007275(multicellular organismal development)|GO:0007283(spermatogenesis)|GO:0008022(protein C-terminus binding)|GO:0008037(cell recognition)|GO:0016021(integral to membrane)|GO:0016323(basolateral plasma membrane)|GO:0030154(cell differentiation)|GO:0030165(PDZ domain binding)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0042271(susceptibility to natural killer cell mediated cytotoxicity)|GO:0042803(protein homodimerization activity)|GO:0045216(cell-cell junction organization)|GO:0045954(positive regulation of natural killer cell mediated cytotoxicity)|GO:0050715(positive regulation of cytokine secretion)|GO:0050798(activated T cell proliferation)|GO:0051606(detection of stimulus),"Homo sapiens cell adhesion molecule 1 (CADM1), transcript variant 1, mRNA [NM_014333]",chr11:115047212-115047153,hs|11q23.3,cell adhesion molecule 1,TRUE
1423_CHCHD7_79145,Q9BUK0,coiled-coil-helix-coiled-coil-helix domain-containing protein 7,CHCHD7,85,NA,subcellular location: mitochondrion intermembrane space {eco:0000305}.,NA,"DISEASE: Note=A chromosomal aberration involving CHCHD7 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(6;8)(p21.3-22;q13) with PLAG1. {ECO:0000269|PubMed:16736500}.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,CHCHD7,79145,Hs.436913,ENST00000355315,THC2477257,GO:0005739(mitochondrion),"Homo sapiens coiled-coil-helix-coiled-coil-helix domain containing 7 (CHCHD7), transcript variant 1, mRNA [NM_001011667]",chr8:57131066-57131125,hs|8q12.1,coiled-coil-helix-coiled-coil-helix domain containing 7,TRUE
1424_ITPRIPL2_162073,Q3MIP1,"inositol 1,4,5-trisphosphate receptor-interacting protein-like 2",ITPRIPL2,535,NA,subcellular location: membrane; single-pass type i membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,ITPRIPL2,162073,Hs.530899,ENST00000381440,THC2508446,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens inositol 1,4,5-trisphosphate receptor interacting protein-like 2 (ITPRIPL2), transcript variant 1, mRNA [NM_001034841]",chr16:19132844-19132903,hs|16p12.3,"inositol 1,4,5-trisphosphate receptor interacting protein-like 2",TRUE
1425_SSRP1_6749,Q08945,fact complex subunit ssrp1 (chromatin-specific transcription elongation factor 80 kda subunit) (facilitates chromatin transcription complex 80 kda subunit) (fact 80 kda subunit) (factp80) (facilitates chromatin transcription complex subunit ssrp1) (recombination signal sequence recognition protein 1) (structure-specific recognition protein 1) (hssrp1) (t160),SSRP1 FACT80,709,"function: component of the fact complex, a general chromatin factor that acts to reorganize nucleosomes. the fact complex is involved in multiple processes that require dna as a template such as mrna elongation, dna replication and dna repair. during transcription elongation the fact complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. it facilitates the passage of rna polymerase ii and transcription by promoting the dissociation of one histone h2a-h2b dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of rna polymerase ii. the fact complex is probably also involved in phosphorylation of 'ser-392' of p53/tp53 via its association with ck2 (casein kinase ii). binds specifically to double-stranded dna and at low levels to dna modified by the antitumor agent cisplatin. may potentiate cisplatin-induced cell death by blocking replication and repair of modified dna. also acts as a transcriptional coactivator for p63/tp63. {eco:0000269|pubmed:10912001, eco:0000269|pubmed:11239457, eco:0000269|pubmed:12374749, eco:0000269|pubmed:12934006, eco:0000269|pubmed:16713563, eco:0000269|pubmed:9489704, eco:0000269|pubmed:9566881, eco:0000269|pubmed:9836642}.","subcellular location: nucleus {eco:0000269|pubmed:10421373, eco:0000269|pubmed:22002106}. nucleus, nucleolus {eco:0000269|pubmed:22002106}. chromosome {eco:0000269|pubmed:10421373}. note=colocalizes with rna polymerase ii on chromatin. recruited to actively transcribed loci. {eco:0000250|uniprotkb:q05344}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SSRP1,6749,Hs.523680,ENST00000293880,THC2534023,"GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005694(chromosome)|GO:0005737(cytoplasm)|GO:0006260(DNA replication)|GO:0006281(DNA repair)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0050434(positive regulation of viral transcription)","Homo sapiens structure specific recognition protein 1 (SSRP1), mRNA [NM_003146]",chr11:57093651-57093592,hs|11q12.1,structure specific recognition protein 1,TRUE
1426_FAM164A_51101,Q96GY0,zinc finger c2hc domain-containing protein 1a,ZC2HC1A C8orf70 FAM164A CGI-62,325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM164A,51101,Hs.271876,ENST00000263849,THC2464566,NA,"Homo sapiens family with sequence similarity 164, member A (FAM164A), mRNA [NM_016010]",chr8:79629610-79629669,hs|8q21.12,"family with sequence similarity 164, member A",TRUE
1427_PFKM_5213,P08237,"atp-dependent 6-phosphofructokinase, muscle type (atp-pfk) (pfk-m) (ec 2.7.1.11) (6-phosphofructokinase type a) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphohexokinase)",PFKM PFKX,780,"function: catalyzes the phosphorylation of d-fructose 6-phosphate to fructose 1,6-bisphosphate by atp, the first committing step of glycolysis.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03184}.,NA,"DISEASE: Glycogen storage disease 7 (GSD7) [MIM:232800]: A metabolic disorder characterized by exercise intolerance with associated nausea and vomiting, muscle cramping, exertional myopathy and compensated hemolysis. Short bursts of intense activity are particularly difficult. Severe muscle cramps and myoglobinuria develop after vigorous exercise. {ECO:0000269|PubMed:22133655, ECO:0000269|PubMed:24427140, ECO:0000269|PubMed:7513946, ECO:0000269|PubMed:7825568, ECO:0000269|PubMed:8889589}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PFKM,5213,Hs.75160,ENST00000547581,THC2484178,"GO:0000166(nucleotide binding)|GO:0003872(6-phosphofructokinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005529(sugar binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005945(6-phosphofructokinase complex)|GO:0005975(carbohydrate metabolic process)|GO:0006002(fructose 6-phosphate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006096(glycolysis)|GO:0008022(protein C-terminus binding)|GO:0016208(AMP binding)|GO:0016301(kinase activity)|GO:0016324(apical plasma membrane)|GO:0016740(transferase activity)|GO:0019900(kinase binding)|GO:0030388(fructose 1,6-bisphosphate metabolic process)|GO:0032024(positive regulation of insulin secretion)|GO:0042593(glucose homeostasis)|GO:0042802(identical protein binding)|GO:0046716(muscle cell homeostasis)|GO:0046872(metal ion binding)|GO:0051259(protein oligomerization)|GO:0051289(protein homotetramerization)|GO:0070061(fructose binding)|GO:0070095(fructose-6-phosphate binding)","Homo sapiens phosphofructokinase, muscle (PFKM), transcript variant 4, mRNA [NM_000289]",chr12:48539724-48539783,hs|12q13.11,"phosphofructokinase, muscle",TRUE
1428_MRPS14_63931,O60783,"28s ribosomal protein s14, mitochondrial (mrp-s14) (s14mt) (mitochondrial small ribosomal subunit protein us14m)",MRPS14,128,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,"DISEASE: Combined oxidative phosphorylation deficiency 38 (COXPD38) [MIM:618378]: An autosomal recessive disorder due to mitochondrial dysfunction and characterized by perinatal hypertrophic cardiomyopathy, growth retardation, muscle hypotonia, elevated lactate, dysmorphy and mental retardation. {ECO:0000269|PubMed:30358850}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS14,63931,Hs.654858,ENST00000367677,THC2505317,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein S14 (MRPS14), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_022100]",chr1:174983720-174983661,hs|1q25.1,mitochondrial ribosomal protein S14,TRUE
1429_FRMD8_83786,Q9BZ67,ferm domain-containing protein 8 (band4.1 inhibitor lrp interactor) (bili) (irhom tail-associated protein) (itap),FRMD8 FKSG44,464,"function: promotes the cell surface stability of irhom1/rhbdf1 and irhom2/rhbdf2 and prevents their degradation via the endolysosomal pathway. by acting on irhoms, involved in adam17-mediated shedding of tnf, amphiregulin/areg, hbegf and tgfa from the cell surface (pubmed:29897333, pubmed:29897336). negatively regulates wnt signaling, possibly by antagonizing the recruitment of axin1 to lrp6 (pubmed:19572019). {eco:0000269|pubmed:19572019, eco:0000269|pubmed:29897333, eco:0000269|pubmed:29897336}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:19572019, eco:0000269|pubmed:29897333}. cell membrane {eco:0000269|pubmed:19572019, eco:0000269|pubmed:29897333}.","TISSUE SPECIFICITY: Widely expressed, with high expression in heart and spleen. {ECO:0000269|PubMed:19572019}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FRMD8,83786,Hs.578433,ENST00000317568,THC2488705,GO:0005488(binding)|GO:0005856(cytoskeleton),"Homo sapiens FERM domain containing 8 (FRMD8), mRNA [NM_031904]",chr11:65180932-65180991,hs|11q13.1,FERM domain containing 8,TRUE
143_STX16_8675,O14662,syntaxin-16 (syn16),STX16,325,function: snare involved in vesicular transport from the late endosomes to the trans-golgi network. {eco:0000269|pubmed:18195106}.,subcellular location: golgi apparatus membrane; single-pass type iv membrane protein.; subcellular location: isoform c: cytoplasm.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack developmental defects characteristic of Albright hereditary osteodystrophy, and typically show no other endocrine abnormalities besides resistance to PTH. {ECO:0000269|PubMed:14561710, ECO:0000269|PubMed:15800843}. Note=The gene represented in this entry is involved in disease pathogenesis. Microdeletions involving STX16 can cause loss of methylation at exon A/B of GNAS, resulting in PHP1B.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,STX16,8675,Hs.307913,ENST00000371141,THC2492080,"GO:0000139(Golgi membrane)|GO:0005484(SNAP receptor activity)|GO:0005515(protein binding)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005792(microsome)|GO:0005794(Golgi apparatus)|GO:0006886(intracellular protein transport)|GO:0006891(intra-Golgi vesicle-mediated transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport)|GO:0031201(SNARE complex)|GO:0042147(retrograde transport, endosome to Golgi)","Homo sapiens syntaxin 16 (STX16), transcript variant 1, mRNA [NM_001001433]",chr20:57254353-57254412,hs|20q13.32,syntaxin 16,TRUE
1430_DLD_1738,P09622,"dihydrolipoyl dehydrogenase, mitochondrial (ec 1.8.1.4) (dihydrolipoamide dehydrogenase) (glycine cleavage system l protein)",DLD GCSL LAD PHE3,509,"function: lipoamide dehydrogenase is a component of the glycine cleavage system as well as an e3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex) (pubmed:15712224, pubmed:16442803, pubmed:16770810, pubmed:17404228, pubmed:20160912, pubmed:20385101). the 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion (pubmed:29211711). a fraction of the 2-oxoglutarate dehydrogenase complex also localizes in the nucleus and is required for lysine succinylation of histones: associates with kat2a on chromatin and provides succinyl-coa to histone succinyltransferase kat2a (pubmed:29211711). in monomeric form may have additional moonlighting function as serine protease (pubmed:17404228). involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction (by similarity). {eco:0000250|uniprotkb:q811c4, eco:0000269|pubmed:15712224, eco:0000269|pubmed:16442803, eco:0000269|pubmed:16770810, eco:0000269|pubmed:17404228, eco:0000269|pubmed:20160912, eco:0000269|pubmed:20385101, eco:0000269|pubmed:29211711}.","subcellular location: mitochondrion matrix {eco:0000305|pubmed:29211711, eco:0000305|pubmed:3693355}. nucleus {eco:0000269|pubmed:29211711}. cell projection, cilium, flagellum {eco:0000250|uniprotkb:q811c4}. cytoplasmic vesicle, secretory vesicle, acrosome {eco:0000269|pubmed:15888450}. note=mainly localizes in the mitochondrion. a small fraction localizes to the nucleus, where the 2-oxoglutarate dehydrogenase complex is required for histone succinylation. {eco:0000269|pubmed:29211711}.",NA,"DISEASE: Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]: An autosomal recessive metabolic disorder characterized biochemically by a combined deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), pyruvate dehydrogenase complex (PDC), and alpha-ketoglutarate dehydrogenase complex (KGDC). Clinically, affected individuals have lactic acidosis and neurologic deterioration due to sensitivity of the central nervous system to defects in oxidative metabolism. {ECO:0000269|PubMed:10448086, ECO:0000269|PubMed:11687750, ECO:0000269|PubMed:12925875, ECO:0000269|PubMed:15712224, ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:8506365, ECO:0000269|PubMed:8968745, ECO:0000269|PubMed:9540846, ECO:0000269|PubMed:9934985}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,DLD,1738,Hs.131711,ENST00000539590,THC2469812,"GO:0004148(dihydrolipoyl dehydrogenase activity)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006090(pyruvate metabolic process)|GO:0006099(tricarboxylic acid cycle)|GO:0006103(2-oxoglutarate metabolic process)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006508(proteolysis)|GO:0006554(lysine catabolic process)|GO:0007369(gastrulation)|GO:0007568(aging)|GO:0009083(branched chain family amino acid catabolic process)|GO:0009106(lipoate metabolic process)|GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate)|GO:0016491(oxidoreductase activity)|GO:0019861(flagellum)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042391(regulation of membrane potential)|GO:0043159(acrosomal matrix)|GO:0043544(lipoamide binding)|GO:0045252(oxoglutarate dehydrogenase complex)|GO:0045254(pyruvate dehydrogenase complex)|GO:0045454(cell redox homeostasis)|GO:0048240(sperm capacitation)|GO:0050660(flavin adenine dinucleotide binding)|GO:0051068(dihydrolipoamide metabolic process)|GO:0051287(NAD binding)","Homo sapiens dihydrolipoamide dehydrogenase (DLD), mRNA [NM_000108]",chr7:107560039-107560098,hs|7q31.1,dihydrolipoamide dehydrogenase,TRUE
1431_ZNF462_58499,Q96JM2,zinc finger protein 462 (zinc finger pbx1-interacting protein) (zfpip),ZNF462 KIAA1803,2506,"function: zinc finger nuclear factor involved in transcription by regulating chromatin structure and organization (pubmed:20219459, pubmed:21570965). involved in the pluripotency and differentiation of embryonic stem cells by regulating sox2, pou5f1/oct4, and nanog (pubmed:21570965). by binding pbx1, prevents the heterodimerization of pbx1 and hoxa9 and their binding to dna (by similarity). regulates neuronal development and neural cell differentiation (pubmed:21570965). {eco:0000250|uniprotkb:b1awl2, eco:0000269|pubmed:20219459, eco:0000269|pubmed:21570965}.","subcellular location: nucleus {eco:0000269|pubmed:20219459, eco:0000269|pubmed:21570965}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF462,58499,Hs.370379,ENST00000457913,THC2470688,"GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0043392(negative regulation of DNA binding)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 462 (ZNF462), mRNA [NM_021224]",chr9:109773650-109773709,hs|9q31.2,zinc finger protein 462,TRUE
1433_SASH1_23328,O94885,sam and sh3 domain-containing protein 1 (proline-glutamate repeat-containing protein),SASH1 KIAA0790 PEPE1,1247,"function: is a positive regulator of nf-kappa-b signaling downstream of tlr4 activation. it acts as a scaffold molecule to assemble a molecular complex that includes traf6, map3k7, chuk and ikbkb, thereby facilitating nf-kappa-b signaling activation (pubmed:23776175). regulates traf6 and map3k7 ubiquitination (pubmed:23776175). involved in the regulation of cell mobility (pubmed:23333244, pubmed:23776175, pubmed:25315659). regulates lipolysaccharide (lps)-induced endothelial cell migration (pubmed:23776175). is involved in the regulation of skin pigmentation through the control of melanocyte migration in the epidermis (pubmed:23333244). {eco:0000269|pubmed:23333244, eco:0000269|pubmed:23776175, eco:0000269|pubmed:25315659}.",subcellular location: cytoplasm {eco:0000269|pubmed:23333244}.,"TISSUE SPECIFICITY: Expressed ubiquitously, with highest levels in lung, placenta, spleen and thymus. Down-regulated in the majority (74%) of breast tumors in comparison with corresponding normal breast epithelial tissues. Expressed in the epidermis, epidermal keratinocytes, dermal fibroblasts and melanocytes (PubMed:23333244, PubMed:26203640). {ECO:0000269|PubMed:12771949, ECO:0000269|PubMed:23333244, ECO:0000269|PubMed:26203640}.","DISEASE: Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]: A form of dyschromatosis universalis, an autosomal dominant pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macules distributed randomly over the body, that appear in infancy or early childhood. The trunk and extremities are the dominant sites of abnormal pigmentation. Facial lesions can be seen in 50% of affected individuals, but involvement of palms and soles is unusual. Abnormalities of hair and nails have also been reported. Dyschromatosis universalis hereditaria may be associated with abnormalities of dermal connective tissue, nerve tissue, or other systemic complications. {ECO:0000269|PubMed:23333244, ECO:0000269|PubMed:26203640, ECO:0000269|PubMed:27659786, ECO:0000269|PubMed:27840890, ECO:0000269|PubMed:27885802, ECO:0000269|PubMed:29956681}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma (CAPOK) [MIM:618373]: An autosomal recessive genodermatosis characterized by hypo- and hyperpigmented macular skin lesions, progressive alopecia, palmoplantar keratoderma, dystrophic nails, teeth abnormalities and a predisposition to squamous cell carcinoma. {ECO:0000269|PubMed:25315659}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SASH1,23328,Hs.193133,ENST00000537769,THC2477159,NA,"Homo sapiens SAM and SH3 domain containing 1 (SASH1), mRNA [NM_015278]",chr6:148870116-148870175,hs|6q24.3,SAM and SH3 domain containing 1,TRUE
1434_PKN2_5586,Q16513,serine/threonine-protein kinase n2 (ec 2.7.11.13) (pkn gamma) (protein kinase c-like 2) (protein-kinase c-related kinase 2),PKN2 PRK2 PRKCL2,984,"function: pkc-related serine/threonine-protein kinase and rho/rac effector protein that participates in specific signal transduction responses in the cell. plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. phosphorylates cttn in hyaluronan-induced astrocytes and hence decreases cttn ability to associate with filamentous actin. phosphorylates hdac5, therefore lead to impair hdac5 import. direct rhoa target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. required for g2/m phases of the cell cycle progression and abscission during cytokinesis in a ect2-dependent manner. stimulates fyn kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. inhibits akt pro-survival-induced kinase activity. mediates rho protein-induced transcriptional activation via the c-fos serum response factor (srf). involved in the negative regulation of ciliogenesis (pubmed:27104747). {eco:0000269|pubmed:10226025, eco:0000269|pubmed:10926925, eco:0000269|pubmed:11777936, eco:0000269|pubmed:11781095, eco:0000269|pubmed:15123640, eco:0000269|pubmed:15364941, eco:0000269|pubmed:17332740, eco:0000269|pubmed:20188095, eco:0000269|pubmed:20974804, eco:0000269|pubmed:21754995, eco:0000269|pubmed:27104747, eco:0000269|pubmed:9121475}.; function: (microbial infection) phosphorylates hcv ns5b leading to stimulation of hcv rna replication. {eco:0000269|pubmed:15364941}.","subcellular location: cytoplasm {eco:0000269|pubmed:11356191, eco:0000269|pubmed:17332740}. nucleus {eco:0000269|pubmed:11356191}. membrane {eco:0000250|uniprotkb:q8bww9}. cell projection, lamellipodium {eco:0000269|pubmed:11356191}. cytoplasm, cytoskeleton {eco:0000269|pubmed:11356191}. cleavage furrow {eco:0000269|pubmed:17332740}. midbody {eco:0000269|pubmed:17332740}. cell junction {eco:0000269|pubmed:20974804}. note=colocalizes with ptpn13 in lamellipodia-like structures, regions of large actin turnover. accumulates during telophase at the cleavage furrow and concentrates finally around the midbody in cytokinesis. recruited to nascent cell-cell contacts at the apical surface of cells. in the course of viral infection, colocalizes with hcv ns5b at perinuclear region in the cytoplasm. {eco:0000269|pubmed:11356191, eco:0000269|pubmed:17332740}.","TISSUE SPECIFICITY: Ubiquitous. Expressed in numerous tumor cell lines, especially in bladder tumor cells. {ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:21754995}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,PKN2,5586,Hs.440833,ENST00000370505,THC2464372,GO:0000166(nucleotide binding)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0004697(protein kinase C activity)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006468(protein phosphorylation)|GO:0007165(signal transduction)|GO:0042826(histone deacetylase binding),"Homo sapiens protein kinase N2 (PKN2), mRNA [NM_006256]",chr1:89299168-89299227,hs|1p22.2,protein kinase N2,TRUE
144_SPON2_10417,Q9BUD6,spondin-2 (differentially expressed in cancerous and non-cancerous lung cells 1) (dil-1) (mindin),SPON2 DIL1 UNQ435/PRO866,331,function: cell adhesion protein that promotes adhesion and outgrowth of hippocampal embryonic neurons. binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the ecm for microbial pathogens (by similarity). binds bacterial lipopolysaccharide (lps). {eco:0000250}.,"subcellular location: secreted, extracellular space, extracellular matrix {eco:0000250}.",TISSUE SPECIFICITY: Expressed in normal lung tissue but not in lung carcinoma cell lines. {ECO:0000269|PubMed:10512675}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SPON2,10417,Hs.635350,ENST00000431380,THC2601265,GO:0005102(receptor binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0007155(cell adhesion)|GO:0007411(axon guidance)|GO:0045087(innate immune response)|GO:0046872(metal ion binding),"Homo sapiens spondin 2, extracellular matrix protein (SPON2), transcript variant 1, mRNA [NM_012445]",chr4:1160797-1160738,hs|4p16.3,"spondin 2, extracellular matrix protein",TRUE
145_IGFBP7_3490,Q16270,insulin-like growth factor-binding protein 7 (ibp-7) (igf-binding protein 7) (igfbp-7) (igfbp-rp1) (mac25 protein) (pgi2-stimulating factor) (prostacyclin-stimulating factor) (tumor-derived adhesion factor) (taf),IGFBP7 MAC25 PSF,282,"function: binds igf-i and igf-ii with a relatively low affinity. stimulates prostacyclin (pgi2) production. stimulates cell adhesion. {eco:0000269|pubmed:8117260, eco:0000269|pubmed:8939990}.",subcellular location: secreted.,NA,"DISEASE: Retinal arterial macroaneurysm with supravalvular pulmonic stenosis (RAMSVPS) [MIM:614224]: An autosomal recessive condition characterized by the bilateral appearance of 'beading' along the major retinal arterial trunks, with the subsequent formation of macroaneurysms. Affected individuals also have supravalvular pulmonic stenosis, often requiring surgical correction. {ECO:0000269|PubMed:21835307}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IGFBP7,3490,Hs.479808,ENST00000295666,THC2596412,GO:0001558(regulation of cell growth)|GO:0005515(protein binding)|GO:0005520(insulin-like growth factor binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0007155(cell adhesion)|GO:0008285(negative regulation of cell proliferation)|GO:0031012(extracellular matrix),"Homo sapiens insulin-like growth factor binding protein 7 (IGFBP7), mRNA [NM_001553]",chr4:57897482-57897423,hs|4q12,insulin-like growth factor binding protein 7,TRUE
146_SMPD4_55627,Q9NXE4,sphingomyelin phosphodiesterase 4 (ec 3.1.4.12) (neutral sphingomyelinase 3) (nsmase-3) (nsmase3) (neutral sphingomyelinase iii),SMPD4 KIAA1418 SKNY,866,"function: catalyzes the hydrolysis of membrane sphingomyelin to form phosphorylcholine and ceramide (pubmed:16517606). may sensitize cells to dna damage-induced apoptosis (pubmed:18505924). {eco:0000269|pubmed:16517606, eco:0000269|pubmed:18505924}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:16517606, eco:0000269|pubmed:18505924}; single-pass membrane protein {eco:0000255}. golgi apparatus membrane {eco:0000269|pubmed:16517606}; single-pass membrane protein {eco:0000255}. nucleus envelope {eco:0000250|uniprotkb:q6zpr5}.","TISSUE SPECIFICITY: Widely expressed, with highest levels in heart and skeletal muscle. {ECO:0000269|PubMed:16517606, ECO:0000269|PubMed:18505924}.",NA,NA,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SMPD4,55627,Hs.516450,ENST00000409031,THC2579667,GO:0000139(Golgi membrane)|GO:0004767(sphingomyelin phosphodiesterase activity)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0006685(sphingomyelin catabolic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0046475(glycerophospholipid catabolic process)|GO:0046513(ceramide biosynthetic process)|GO:0046872(metal ion binding)|GO:0050290(sphingomyelin phosphodiesterase D activity)|GO:0071356(cellular response to tumor necrosis factor),"Homo sapiens sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) (SMPD4), transcript variant 2, mRNA [NM_017951]",chr2:130909079-130909020,hs|2q21.1,"sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3)",TRUE
147_RPL36_25873,Q9Y3U8,60s ribosomal protein l36 (large ribosomal subunit protein el36),RPL36,105,"function: component of the large ribosomal subunit. {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. note=detected on cytosolic polysomes (pubmed:25957688). {eco:0000250|uniprotkb:q2ygt9, eco:0000269|pubmed:25957688}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL36,25873,Hs.408018,ENST00000394580,THC2579250,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L36 (RPL36), transcript variant 2, mRNA [NM_015414]",chr19:5691418-5691555,hs|19p13.3,ribosomal protein L36,TRUE
148_PERP_64065,Q96FX8,p53 apoptosis effector related to pmp-22 (keratinocyte-associated protein 1) (kcp-1) (p53-induced protein pigpc1) (transmembrane protein thw),PERP KCP1 KRTCAP1 PIGPC1 THW,193,function: component of intercellular desmosome junctions. plays a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly. plays a role as an effector in the tp53-dependent apoptotic pathway (by similarity). {eco:0000250}.,"subcellular location: cell junction, desmosome {eco:0000250|uniprotkb:q9jk95}. cell membrane {eco:0000250|uniprotkb:q9jk95}; multi-pass membrane protein {eco:0000255}. note=associated with desmosomes. {eco:0000250|uniprotkb:q9jk95}.","TISSUE SPECIFICITY: Expressed in skin, heart, placental, liver, pancreas, keratinocytes and dermal fibroblasts. {ECO:0000269|PubMed:12752121}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PERP,64065,Hs.201446,ENST00000265603,THC2545695,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006915(apoptosis)|GO:0007155(cell adhesion)|GO:0016021(integral to membrane)|GO:0030054(cell junction)|GO:0030057(desmosome),"Homo sapiens PERP, TP53 apoptosis effector (PERP), mRNA [NM_022121]",chr6:138412115-138412056,hs|6q23.3,"PERP, TP53 apoptosis effector",TRUE
149_RPS11_6205,P62280,40s ribosomal protein s11 (small ribosomal subunit protein us17),RPS11,158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS11,6205,Hs.433529,ENST00000270625,THC2548321,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S11 (RPS11), mRNA [NM_001015]",chr19:50001265-50002789,hs|19q13.33,ribosomal protein S11,TRUE
1490_LGALS3_3958,P17931,galectin-3 (gal-3) (35 kda lectin) (carbohydrate-binding protein 35) (cbp 35) (galactose-specific lectin 3) (galactoside-binding protein) (galbp) (ige-binding protein) (l-31) (laminin-binding protein) (lectin l-29) (mac-2 antigen),LGALS3 MAC2,250,"function: galactose-specific lectin which binds ige. may mediate with the alpha-3, beta-1 integrin the stimulation by cspg4 of endothelial cells migration. together with dmbt1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (by similarity). in the nucleus: acts as a pre-mrna splicing factor. involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells. together with trim16, coordinates the recognition of membrane damage with mobilization of the core autophagy regulators atg16l1 and becn1 in response to damaged endomembranes. {eco:0000250, eco:0000269|pubmed:15181153, eco:0000269|pubmed:19594635, eco:0000269|pubmed:19616076, eco:0000269|pubmed:27693506}.",subcellular location: cytoplasm. nucleus. secreted. note=secreted by a non-classical secretory pathway and associates with the cell surface.,TISSUE SPECIFICITY: A major expression is found in the colonic epithelium. It is also abundant in the activated macrophages. Expressed in fetal membranes. {ECO:0000269|PubMed:19497882}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LGALS3,3958,Hs.531081,ENST00000254301,THC2745323,GO:0001501(skeletal system development)|GO:0005515(protein binding)|GO:0005529(sugar binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0005737(cytoplasm)|GO:0005743(mitochondrial inner membrane)|GO:0005886(plasma membrane)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0019863(IgE binding)|GO:0030154(cell differentiation)|GO:0030198(extracellular matrix organization)|GO:0031012(extracellular matrix)|GO:0045087(innate immune response),"Homo sapiens lectin, galactoside-binding, soluble, 3 (LGALS3), transcript variant 1, mRNA [NM_002306]",chr14:55609454-55611879,hs|14q22.3,"lectin, galactoside-binding, soluble, 3",TRUE
15_NDRG1_10397,Q92597,protein ndrg1 (differentiation-related gene 1 protein) (drg-1) (n-myc downstream-regulated gene 1 protein) (nickel-specific induction protein cap43) (reducing agents and tunicamycin-responsive protein) (rtp) (rit42),NDRG1 CAP43 DRG1 RTP,394,"function: stress-responsive protein involved in hormone responses, cell growth, and differentiation. acts as a tumor suppressor in many cell types. necessary but not sufficient for p53/tp53-mediated caspase activation and apoptosis. has a role in cell trafficking, notably of the schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. required for vesicular recycling of cdh1 and tf. may also function in lipid trafficking. protects cells from spindle disruption damage. functions in p53/tp53-dependent mitotic spindle checkpoint. regulates microtubule dynamics and maintains euploidy. {eco:0000269|pubmed:15247272, eco:0000269|pubmed:15377670, eco:0000269|pubmed:17786215, eco:0000269|pubmed:9766676}.","subcellular location: cytoplasm, cytosol. cytoplasm, cytoskeleton, microtubule organizing center, centrosome. nucleus. cell membrane. note=mainly cytoplasmic but differentially localized to other regions. associates with the plasma membrane in intestinal epithelia and lactating mammary gland. translocated to the nucleus in a p53/tp53-dependent manner. in prostate epithelium and placental chorion, located in both the cytoplasm and in the nucleus. no nuclear localization in colon epithelium cells. in intestinal mucosa, prostate and renal cortex, located predominantly adjacent to adherens junctions. cytoplasmic with granular staining in proximal tubular cells of the kidney and salivary gland ducts. recruits to the membrane of recycling/sorting and late endosomes via binding to phosphatidylinositol 4-phosphate. associates with microtubules. colocalizes with tubg1 in the centrosome. cytoplasmic location increased with hypoxia. phosphorylated form found associated with centromeres during s-phase of mitosis and with the plasma membrane.","TISSUE SPECIFICITY: Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Also expressed in heart, brain, skeletal muscle, lung, liver and pancreas. Low levels in peripheral blood leukocytes and in tissues of the immune system. Expressed mainly in epithelial cells. Also found in Schwann cells of peripheral neurons. Reduced expression in adenocarcinomas compared to normal tissues. In colon, prostate and placental membranes, the cells that border the lumen show the highest expression. {ECO:0000269|PubMed:12432451, ECO:0000269|PubMed:8939898, ECO:0000269|PubMed:9251681, ECO:0000269|PubMed:9605764}.","DISEASE: Charcot-Marie-Tooth disease 4D (CMT4D) [MIM:601455]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269|PubMed:10831399}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NDRG1,10397,Hs.372914,ENST00000519278,THC2508926,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005874(microtubule)|GO:0005886(plasma membrane)|GO:0005913(cell-cell adherens junction)|GO:0008017(microtubule binding)|GO:0010038(response to metal ion)|GO:0015630(microtubule cytoskeleton)|GO:0017137(Rab GTPase binding)|GO:0030330(DNA damage response, signal transduction by p53 class mediator)|GO:0043015(gamma-tubulin binding)|GO:0045296(cadherin binding)|GO:0045576(mast cell activation)|GO:0048471(perinuclear region of cytoplasm)|GO:0055038(recycling endosome membrane)|GO:0071456(cellular response to hypoxia)|GO:0090232(positive regulation of spindle checkpoint)","Homo sapiens N-myc downstream regulated 1 (NDRG1), transcript variant 2, mRNA [NM_006096]",chr8:134249778-134249719,hs|8q24.22,N-myc downstream regulated 1,TRUE
150_YWHAG_7532,P61981,"14-3-3 protein gamma (protein kinase c inhibitor protein 1) (kcip-1) [cleaved into: 14-3-3 protein gamma, n-terminally processed]",YWHAG,247,"function: adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. binding generally results in the modulation of the activity of the binding partner. {eco:0000269|pubmed:16511572}.",subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in brain, skeletal muscle, and heart. {ECO:0000269|PubMed:10486217}.","DISEASE: Epileptic encephalopathy, early infantile, 56 (EIEE56) [MIM:617665]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE56 is an autosomal dominant condition. {ECO:0000269|PubMed:28777935}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YWHAG,7532,Hs.520974,ENST00000307630,THC2538280,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0005080(protein kinase C binding)|GO:0005159(insulin-like growth factor receptor binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006469(negative regulation of protein kinase activity)|GO:0006605(protein targeting)|GO:0008426(protein kinase C inhibitor activity)|GO:0009966(regulation of signal transduction)|GO:0019904(protein domain specific binding)|GO:0030971(receptor tyrosine kinase binding)|GO:0045664(regulation of neuron differentiation)|GO:0048167(regulation of synaptic plasticity),"Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (YWHAG), mRNA [NM_012479]",chr7:75956192-75956133,hs|7q11.23,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide",TRUE
151_ILDR1_286676,Q86SU0,immunoglobulin-like domain-containing receptor 1,ILDR1,546,function: putative membrane receptor.,"subcellular location: cell membrane {eco:0000269|pubmed:15381095}; single-pass type i membrane protein {eco:0000269|pubmed:15381095}.; subcellular location: isoform 5: cytoplasm, cytosol {eco:0000269|pubmed:15381095}.","TISSUE SPECIFICITY: Mainly expressed in prostate and to a lower extent in testis, pancreas, kidney, heart and liver. {ECO:0000269|PubMed:15381095}.","DISEASE: Deafness, autosomal recessive, 42 (DFNB42) [MIM:609646]: A prelingual, non-progressive form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:21255762}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ILDR1,286676,Hs.98484,ENST00000344209,NP852727,GO:0004872(receptor activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0016021(integral to membrane),"Homo sapiens immunoglobulin-like domain containing receptor 1 (ILDR1), transcript variant 2, mRNA [NM_175924]",chr3:121707033-121706974,hs|3q13.33,immunoglobulin-like domain containing receptor 1,TRUE
152_FAM162A_26355,Q96A26,protein fam162a (e2-induced gene 5 protein) (growth and transformation-dependent protein) (hgtd-p),FAM162A C3orf28 E2IG5 DC16 FWP001,154,"function: proposed to be involved in regulation of apoptosis; the exact mechanism may differ between cell types/tissues. may be involved in hypoxia-induced cell death of transformed cells implicating cytochrome c release and caspase activation (such as casp9) and inducing mitochondrial permeability transition. may be involved in hypoxia-induced cell death of neuronal cells probably by promoting release of aifm1 from mitochondria to cytoplasm and its translocation to the nucleus; however, the involvement of caspases has been reported conflictingly. {eco:0000269|pubmed:15082785}.","subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}. mitochondrion {eco:0000269|pubmed:15082785, eco:0000269|pubmed:16698020}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM162A,26355,Hs.584881,ENST00000477892,THC2590769,GO:0005739(mitochondrion)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens family with sequence similarity 162, member A (FAM162A), mRNA [NM_014367]",chr3:122128730-122128789,hs|3q21.1,"family with sequence similarity 162, member A",TRUE
153_C1orf198_84886,Q9H425,uncharacterized protein c1orf198,C1orf198,327,NA,subcellular location: cytoplasm {eco:0000269|pubmed:22361696}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,C1orf198,84886,Hs.520494,ENST00000366663,THC2468585,NA,"Homo sapiens chromosome 1 open reading frame 198 (C1orf198), transcript variant 1, mRNA [NM_032800]",chr1:230973004-230972945,hs|1q42.2,chromosome 1 open reading frame 198,TRUE
154_SYNGR2_9144,O43760,synaptogyrin-2 (cellugyrin),SYNGR2 UNQ352/PRO615,224,"function: may play a role in regulated exocytosis. in neuronal cells, modulates the localization of synaptophysin/syp into synaptic-like microvesicles and may therefore play a role in the formation and/or the maturation of this vesicles. may also play a role in glut4 storage and transport to the plasma membrane. {eco:0000250|uniprotkb:o54980}.; function: (microbial infection) may play a role in the assembly of cytoplasmic inclusion bodies required for sfts phlebovirus replication. {eco:0000269|pubmed:27226560}.","subcellular location: cytoplasmic vesicle membrane {eco:0000250|uniprotkb:o54980}; multi-pass membrane protein {eco:0000255}. cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {eco:0000250|uniprotkb:o54980}; multi-pass membrane protein {eco:0000255}. note=localizes to cytoplasmic vesicles associated with the recycling endosomes. {eco:0000250|uniprotkb:o54980}.; subcellular location: lipid droplet. note=(microbial infection) upon sfts phlebovirus infection, the protein localizes in lipid droplets and inclusion bodies. {eco:0000269|pubmed:27226560}.",TISSUE SPECIFICITY: Ubiquitous; low expression in brain. {ECO:0000269|PubMed:9760194}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SYNGR2,9144,Hs.464210,NA,NA,GO:0005887(integral to plasma membrane)|GO:0008021(synaptic vesicle)|GO:0016020(membrane)|GO:0016023(cytoplasmic membrane-bounded vesicle),"Homo sapiens synaptogyrin 2, mRNA (cDNA clone MGC:102914 IMAGE:4746277), complete cds. [BC105992]",chr17:76168747-76168805,hs|17q25.3,synaptogyrin 2,TRUE
155_C11orf75_56935,Q9NRQ5,single-pass membrane and coiled-coil domain-containing protein 4 (protein fn5),SMCO4 C11orf75 FN5,59,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C11orf75,56935,Hs.438064,ENST00000298966,THC2498117,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 11 open reading frame 75 (C11orf75), mRNA [NM_020179]",chr11:93211791-93211732,hs|11q21,chromosome 11 open reading frame 75,TRUE
156_ARF1_375,P84077,adp-ribosylation factor 1,ARF1,181,"function: gtp-binding protein involved in protein trafficking among different compartments. modulates vesicle budding and uncoating within the golgi complex. deactivation induces the redistribution of the entire golgi complex to the endoplasmic reticulum, suggesting a crucial role in protein trafficking. in its gtp-bound form, its triggers the association with coat proteins with the golgi membrane. the hydrolysis of arf1-bound gtp, which is mediated by arfgaps proteins, is required for dissociation of coat proteins from golgi membranes and vesicles. the gtp-bound form interacts with pick1 to limit pick1-mediated inhibition of arp2/3 complex activity; the function is linked to ampa receptor (ampar) trafficking, regulation of synaptic plasicity of excitatory synapses and spine shrinkage during long-term depression (ltd).; function: (microbial infection) functions as an allosteric activator of the cholera toxin catalytic subunit, an adp-ribosyltransferase. {eco:0000305}.","subcellular location: golgi apparatus {eco:0000269|pubmed:17555535}. cytoplasm, perinuclear region {eco:0000269|pubmed:17555535}. cell junction, synapse, synaptosome {eco:0000250}. cell junction, synapse, postsynaptic density {eco:0000250}. membrane {eco:0000305}; lipid-anchor {eco:0000305}. golgi apparatus, trans-golgi network membrane {eco:0000250|uniprotkb:p84078}; lipid-anchor {eco:0000250|uniprotkb:p84078}.",NA,"DISEASE: Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185]: A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH8 is an autosomal dominant disease characterized by developmental disabilities, speech delay, seizures and attention deficit hyperactivity disorder. {ECO:0000269|PubMed:28868155}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ARF1,375,Hs.286221,ENST00000272102,THC2561556,"GO:0000139(Golgi membrane)|GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005057(receptor signaling protein activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0006878(cellular copper ion homeostasis)|GO:0006890(retrograde vesicle-mediated transport, Golgi to ER)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0007264(small GTPase mediated signal transduction)|GO:0015031(protein transport)|GO:0016032(viral reproduction)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0030017(sarcomere)|GO:0048205(COPI coating of Golgi vesicle)|GO:0048471(perinuclear region of cytoplasm)|GO:0050690(regulation of defense response to virus by virus)","Homo sapiens ADP-ribosylation factor 1 (ARF1), transcript variant 1, mRNA [NM_001024227]",chr1:228286845-228286904,hs|1q42.13,ADP-ribosylation factor 1,TRUE
157_RPS13_6207,P62277,40s ribosomal protein s13 (small ribosomal subunit protein us15),RPS13,151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS13,6207,Hs.446588,ENST00000525828,THC2581408,GO:0003729(mRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0033119(negative regulation of RNA splicing)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S13 (RPS13), mRNA [NM_001017]",chr11:17096663-17095974,hs|11p15.1,ribosomal protein S13,TRUE
158_NUPR1_26471,O60356,nuclear protein 1 (candidate of metastasis 1) (protein p8),NUPR1 COM1,82,"function: transcription regulator that converts stress signals into a program of gene expression that empowers cells with resistance to the stress induced by a change in their microenvironment. thereby participates in regulation of many process namely cell-cycle, apoptosis, autophagy and dna repair responses (pubmed:16478804, pubmed:19650074, pubmed:16300740, pubmed:19723804, pubmed:11056169, pubmed:22858377, pubmed:11940591, pubmed:18690848, pubmed:22565310, pubmed:20181828, pubmed:30451898). controls cell cycle progression and protects cells from genotoxic stress induced by doxorubicin through the complex formation with tp53 and ep300 that binds cdkn1a promoter leading to transcriptional induction of cdkn1a (pubmed:18690848). protects pancreatic cancer cells from stress-induced cell death by binding the relb promoter and activating its transcription, leading to ier3 transactivation (pubmed:22565310). negatively regulates apoptosis through interaction with ptma (pubmed:16478804). inhibits autophagy-induced apoptosis in cardiac cells through foxo3 interaction, inducing cytoplasmic translocation of foxo3 thereby preventing the foxo3 association with the pro-autophagic bnip3 promoter (pubmed:20181828). inhibits cell growth and facilitates programmed cell death by apoptosis after adriamycin-induced dna damage through transactivation of tp53 (by similarity). regulates methamphetamine-induced apoptosis and autophagy through ddit3-mediated endoplasmic reticulum stress pathway (by similarity). participates to dna repair following gamma-irradiation by facilitating dna access of the transcription machinery through interaction with msl1 leading to inhibition of histone h4' lys-16' acetylation (h4k16ac) (pubmed:19650074). coactivator of pax2 transcription factor activity, both by recruiting ep300 to increase pax2 transcription factor activity and by binding paxip1 to suppress paxip1-induced inhibition on pax2 (pubmed:11940591). positively regulates cell cycle progression through interaction with cops5 inducing cytoplasmic translocation of cdkn1b leading to the cdkn1b degradation (pubmed:16300740). coordinates, through its interaction with ep300, the assiociation of myod1, ep300 and ddx5 to the myog promoter, leading to inhibition of cell-cycle progression and myogenic differentiation promotion (pubmed:19723804). negatively regulates beta cell proliferation via inhibition of cell-cycle regulatory genes expression through the suppression of their promoter activities (by similarity). also required for lhb expression and ovarian maturation (by similarity). exacerbates cns inflammation and demyelination upon cuprizone treatment (by similarity). {eco:0000250|uniprotkb:o54842, eco:0000250|uniprotkb:q9wtk0, eco:0000269|pubmed:11056169, eco:0000269|pubmed:11940591, eco:0000269|pubmed:16300740, eco:0000269|pubmed:16478804, eco:0000269|pubmed:18690848, eco:0000269|pubmed:19650074, eco:0000269|pubmed:19723804, eco:0000269|pubmed:20181828, eco:0000269|pubmed:22565310, eco:0000269|pubmed:22858377, eco:0000269|pubmed:30451898}.","subcellular location: nucleus {eco:0000269|pubmed:10092851, eco:0000269|pubmed:16300740}. cytoplasm {eco:0000269|pubmed:16300740}. cytoplasm, perinuclear region {eco:0000269|pubmed:16300740}.","TISSUE SPECIFICITY: Widely expressed, with high levels in liver, pancreas, prostate, ovary, colon, thyroid, spinal cord, trachea and adrenal gland, moderate levels in heart, placenta, lung, skeletal muscle, kidney, testis, small intestine, stomach and lymph node, and low levels in brain, spleen, thymus and bone marrow. Not detected in peripheral blood leukocytes. {ECO:0000269|PubMed:10092851}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NUPR1,26471,Hs.513463,ENST00000395641,THC2554444,GO:0003674(molecular_function)|GO:0005634(nucleus)|GO:0006917(induction of apoptosis)|GO:0016049(cell growth),"Homo sapiens nuclear protein, transcriptional regulator, 1 (NUPR1), transcript variant 1, mRNA [NM_001042483]",chr16:28548880-28548821,hs|16p11.2,"nuclear protein, transcriptional regulator, 1",TRUE
159_MGST2_4258,Q99735,microsomal glutathione s-transferase 2 (microsomal gst-2) (ec 2.5.1.18) (microsomal gst-ii),MGST2 GST2,147,"function: can catalyze the production of ltc4 from lta4 and reduced glutathione. can catalyze the conjugation of 1-chloro-2,4-dinitrobenzene with reduced glutathione.",subcellular location: endoplasmic reticulum membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. microsome membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MGST2,4258,Hs.81874,ENST00000265498,THC2615764,GO:0002540(leukotriene production involved in inflammatory response)|GO:0004364(glutathione transferase activity)|GO:0004464(leukotriene-C4 synthase activity)|GO:0004602(glutathione peroxidase activity)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0005886(plasma membrane)|GO:0006750(glutathione biosynthetic process)|GO:0006805(xenobiotic metabolic process)|GO:0008047(enzyme activator activity)|GO:0010243(response to organic nitrogen)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0019370(leukotriene biosynthetic process)|GO:0031965(nuclear membrane)|GO:0032496(response to lipopolysaccharide),"Homo sapiens microsomal glutathione S-transferase 2 (MGST2), transcript variant 1, mRNA [NM_002413]",chr4:140625256-140625315,hs|4q31.1,microsomal glutathione S-transferase 2,TRUE
16_ORAI1_84876,Q96D31,calcium release-activated calcium channel protein 1 (protein orai-1) (transmembrane protein 142a),ORAI1 CRACM1 TMEM142A,301,"function: ca(2+) release-activated ca(2+) (crac) channel subunit which mediates ca(2+) influx following depletion of intracellular ca(2+) stores and channel activation by the ca(2+) sensor, stim1 (pubmed:16582901, pubmed:16645049, pubmed:16733527, pubmed:16766533, pubmed:16807233, pubmed:19249086, pubmed:23307288, pubmed:24351972, pubmed:24591628, pubmed:28219928). crac channels are the main pathway for ca(2+) influx in t-cells and promote the immune response to pathogens by activating the transcription factor nfat (pubmed:16582901). {eco:0000269|pubmed:16582901, eco:0000269|pubmed:16645049, eco:0000269|pubmed:16733527, eco:0000269|pubmed:16766533, eco:0000269|pubmed:16807233, eco:0000269|pubmed:19249086, eco:0000269|pubmed:23307288, eco:0000269|pubmed:24351972, eco:0000269|pubmed:24591628, eco:0000269|pubmed:28219928}.","subcellular location: cell membrane {eco:0000269|pubmed:16582901, eco:0000269|pubmed:16645049, eco:0000269|pubmed:19249086, eco:0000269|pubmed:22641696, eco:0000269|pubmed:23307288, eco:0000269|pubmed:24351972, eco:0000269|pubmed:27185316, eco:0000269|pubmed:28058752, eco:0000269|pubmed:28219928}; multi-pass membrane protein {eco:0000269|pubmed:16582901, eco:0000269|pubmed:16645049, eco:0000269|pubmed:19249086, eco:0000269|pubmed:22641696, eco:0000269|pubmed:24351972}. note=isoform beta is more mobile in the plasma membrane (pubmed:23307288). colocalizes with stim1 at the cell membrane (pubmed:27185316). {eco:0000269|pubmed:23307288, eco:0000269|pubmed:27185316}.",NA,"DISEASE: Immunodeficiency 9 (IMD9) [MIM:612782]: An immune disorder characterized by recurrent infections, impaired activation and proliferative response of T-cells, decreased T-cell production of cytokines, and normal lymphocytes counts and serum immunoglobulin levels. In surviving patients ectodermal dysplasia with anhidrosis and non-progressive myopathy may be observed. {ECO:0000269|PubMed:16147976, ECO:0000269|PubMed:16582901}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]: A rare congenital myopathy characterized by regular arrays of membrane tubules on muscle biopsies without additional histopathological hallmarks. Tubular aggregates in muscle are structures of variable appearance consisting of an outer tubule containing either one or more microtubule-like structures or amorphous material. TAM2 patients have myopathy and pupillary abnormalities. {ECO:0000269|PubMed:24591628, ECO:0000269|PubMed:28058752}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,ORAI1,84876,Hs.55148,ENST00000330079,THC2487014,GO:0005216(ion channel activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006811(ion transport)|GO:0007596(blood coagulation)|GO:0015279(store-operated calcium channel activity)|GO:0030168(platelet activation)|GO:0051924(regulation of calcium ion transport)|GO:0051928(positive regulation of calcium ion transport),ORAI calcium release-activated calcium modulator 1 [Source:HGNC Symbol;Acc:25896] [ENST00000330079],chr12:122080078-122080137,hs|12q24.31,ORAI calcium release-activated calcium modulator 1,TRUE
160_DUSP1_1843,P28562,dual specificity protein phosphatase 1 (ec 3.1.3.16) (ec 3.1.3.48) (dual specificity protein phosphatase hvh1) (mitogen-activated protein kinase phosphatase 1) (map kinase phosphatase 1) (mkp-1) (protein-tyrosine phosphatase cl100),DUSP1 CL100 MKP1 PTPN10 VH1,367,"function: dual specificity phosphatase that dephosphorylates map kinase mapk1/erk2 on both 'thr-183' and 'tyr-185', regulating its activity during the meiotic cell cycle. {eco:0000250|uniprotkb:p28563}.",subcellular location: nucleus {eco:0000250|uniprotkb:q91790}.,"TISSUE SPECIFICITY: Expressed at high levels in the lung, liver placenta and pancreas. Moderate levels seen in the heart and skeletal muscle. Lower levels found in the brain and kidney. {ECO:0000269|PubMed:8106404}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DUSP1,1843,Hs.171695,ENST00000457103,THC2528308,GO:0000188(inactivation of MAPK activity)|GO:0001706(endoderm formation)|GO:0004726(non-membrane spanning protein tyrosine phosphatase activity)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006470(protein dephosphorylation)|GO:0006979(response to oxidative stress)|GO:0007049(cell cycle)|GO:0008330(protein tyrosine/threonine phosphatase activity)|GO:0009416(response to light stimulus)|GO:0016787(hydrolase activity)|GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity)|GO:0032355(response to estradiol stimulus)|GO:0032526(response to retinoic acid)|GO:0032870(cellular response to hormone stimulus)|GO:0033574(response to testosterone stimulus)|GO:0035556(intracellular signal transduction)|GO:0042542(response to hydrogen peroxide)|GO:0042981(regulation of apoptosis)|GO:0043065(positive regulation of apoptosis)|GO:0045768(positive regulation of anti-apoptosis)|GO:0051384(response to glucocorticoid stimulus)|GO:0051591(response to cAMP)|GO:0051592(response to calcium ion),"Homo sapiens dual specificity phosphatase 1 (DUSP1), mRNA [NM_004417]",chr5:172195355-172195296,hs|5q35.1,dual specificity phosphatase 1,TRUE
161_CDK2AP1_8099,O14519,cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (deleted in oral cancer 1) (doc-1) (putative oral cancer suppressor),CDK2AP1 CDKAP1 DOC1,115,function: specific inhibitor of the cell-cycle kinase cdk2. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CDK2AP1,8099,Hs.725139,ENST00000261692,THC2565323,GO:0000084(S phase of mitotic cell cycle)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006261(DNA-dependent DNA replication)|GO:0006468(protein phosphorylation)|GO:0007049(cell cycle),"Homo sapiens cyclin-dependent kinase 2 associated protein 1 (CDK2AP1), mRNA [NM_004642]",chr12:123745880-123745821,hs|12q24.31,cyclin-dependent kinase 2 associated protein 1,TRUE
162_CEBPD_1052,P49716,ccaat/enhancer-binding protein delta (c/ebp delta) (nuclear factor nf-il6-beta) (nf-il6-beta),CEBPD,269,"function: transcription activator that recognizes two different dna motifs: the ccaat homology common to many promoters and the enhanced core homology common to many enhancers (pubmed:16397300). important transcription factor regulating the expression of genes involved in immune and inflammatory responses (pubmed:1741402, pubmed:16397300). transcriptional activator that enhances il6 transcription alone and as heterodimer with cebpb (pubmed:1741402). {eco:0000269|pubmed:1741402}.",subcellular location: nucleus {eco:0000305|pubmed:16397300}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,CEBPD,1052,Hs.440829,ENST00000542385,THC2592018,GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0043565(sequence-specific DNA binding)|GO:0046983(protein dimerization activity),"Homo sapiens CCAAT/enhancer binding protein (C/EBP), delta (CEBPD), mRNA [NM_005195]",chr8:48649665-48649606,hs|8q11.21,"CCAAT/enhancer binding protein (C/EBP), delta",TRUE
163_ATP13A3_79572,Q9H7F0,probable cation-transporting atpase 13a3 (ec 7.2.2.-) (atpase family homolog up-regulated in senescence cells 1),ATP13A3 AFURS1,1226,NA,subcellular location: membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,ATP13A3,79572,Hs.529609,ENST00000256031,THC2603435,"GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0006812(cation transport)|GO:0015662(ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0016887(ATPase activity)|GO:0046872(metal ion binding)","Homo sapiens ATPase type 13A3 (ATP13A3), mRNA [NM_024524]",chr3:194123543-194123484,hs|3q29,ATPase type 13A3,TRUE
164_UBC_7316,P62837,ubiquitin-conjugating enzyme e2 d2 (ec 2.3.2.23) ((e3-independent) e2 ubiquitin-conjugating enzyme d2) (ec 2.3.2.24) (e2 ubiquitin-conjugating enzyme d2) (ubiquitin carrier protein d2) (ubiquitin-conjugating enzyme e2(17)kb 2) (ubiquitin-conjugating enzyme e2-17 kda 2) (ubiquitin-protein ligase d2) (p53-regulated ubiquitin-conjugating enzyme 1),UBE2D2 PUBC1 UBC4 UBC5B UBCH4 UBCH5B,147,"function: accepts ubiquitin from the e1 complex and catalyzes its covalent attachment to other proteins. in vitro catalyzes 'lys-48'-linked polyubiquitination. mediates the selective degradation of short-lived and abnormal proteins. functions in the e6/e6-ap-induced ubiquitination of p53/tp53. mediates ubiquitination of pex5 and autoubiquitination of stub1 and traf6. involved in the signal-induced conjugation and subsequent degradation of nfkbia, fbxw2-mediated gcm1 ubiquitination and degradation, mdm2-dependent degradation of p53/tp53 and the activation of mavs in the mitochondria by ddx58/rig-i in response to viral infection. essential for viral activation of irf3. {eco:0000269|pubmed:10329681, eco:0000269|pubmed:15280377, eco:0000269|pubmed:18042044, eco:0000269|pubmed:18359941, eco:0000269|pubmed:18703417, eco:0000269|pubmed:19854139, eco:0000269|pubmed:20061386, eco:0000269|pubmed:20403326, eco:0000269|pubmed:20525694}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,UBC,7316,Hs.520348,ENST00000339647,THC2526818,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000187(activation of MAPK activity)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006281(DNA repair)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007254(JNK cascade)|GO:0008063(Toll signaling pathway)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0010008(endosome membrane)|GO:0016032(viral reproduction)|GO:0016044(cellular membrane organization)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016197(endosome transport)|GO:0030666(endocytic vesicle membrane)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0032480(negative regulation of type I interferon production)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042981(regulation of apoptosis)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0045087(innate immune response)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051403(stress-activated MAPK cascade)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)","Homo sapiens ubiquitin C (UBC), mRNA [NM_021009]",chr12:125396272-125396213,hs|12q24.31,ubiquitin C,TRUE
165_LSM14A_26065,Q8ND56,protein lsm14 homolog a (protein fam61a) (protein scd6 homolog) (putative alpha-synuclein-binding protein) (alphasnbp) (rna-associated protein 55a) (hrap55) (hrap55a),LSM14A C19orf13 FAM61A RAP55 RAP55A,463,"function: essential for formation of p-bodies, cytoplasmic structures that provide storage sites for non-translating mrnas. {eco:0000269|pubmed:16484376, eco:0000269|pubmed:17074753}.","subcellular location: cytoplasm, p-body {eco:0000269|pubmed:16484376, eco:0000269|pubmed:17074753}. cytoplasm, stress granule {eco:0000269|pubmed:16484376}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LSM14A,26065,Hs.407368,ENST00000433627,NP409626,GO:0000932(cytoplasmic mRNA processing body)|GO:0005737(cytoplasm)|GO:0006417(regulation of translation)|GO:0007275(multicellular organismal development)|GO:0010494(stress granule)|GO:0030529(ribonucleoprotein complex)|GO:0033962(cytoplasmic mRNA processing body assembly)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens LSM14A, SCD6 homolog A (S. cerevisiae) (LSM14A), transcript variant 2, mRNA [NM_015578]",chr19:34718765-34718824,hs|19q13.11,"LSM14A, SCD6 homolog A (S. cerevisiae)",TRUE
166_RPS17_6218,P08708,40s ribosomal protein s17 (small ribosomal subunit protein es17),RPS17 RPS17L,135,NA,NA,NA,"DISEASE: Diamond-Blackfan anemia 4 (DBA4) [MIM:612527]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:17647292, ECO:0000269|PubMed:19061985}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS17,6218,Hs.433427,ENST00000330244,THC2513112,GO:0000028(ribosomal small subunit assembly)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0034101(erythrocyte homeostasis)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S17 (RPS17), mRNA [NM_001021]",chr15:82821242-82821183,hs|15q25.2,ribosomal protein S17,TRUE
167_ATP5E_514,P56381,"atp synthase subunit epsilon, mitochondrial (atpase subunit epsilon) (atp synthase f1 subunit epsilon)",ATP5F1E ATP5E,51,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core, and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(1) domain and of the central stalk which is part of the complex rotary element. rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of atp in three separate catalytic sites on the beta subunits (by similarity). {eco:0000250}.",subcellular location: mitochondrion. mitochondrion inner membrane.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Mitochondrial complex V deficiency, nuclear type 3 (MC5DN3) [MIM:614053]: A mitochondrial disorder with heterogeneous clinical manifestations including dysmorphic features, psychomotor retardation, hypotonia, growth retardation, cardiomyopathy, enlarged liver, hypoplastic kidneys and elevated lactate levels in urine, plasma and cerebrospinal fluid. {ECO:0000269|PubMed:20566710}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5E,514,Hs.177530,ENST00000395659,THC2558976,"GO:0000275(mitochondrial proton-transporting ATP synthase complex, catalytic core F(1))|GO:0005739(mitochondrion)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0005759(mitochondrial matrix)|GO:0006200(ATP catabolic process)|GO:0006811(ion transport)|GO:0015992(proton transport)|GO:0016020(membrane)|GO:0016787(hydrolase activity)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)|GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism)|GO:0046961(proton-transporting ATPase activity, rotational mechanism)","Homo sapiens ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (ATP5E), nuclear gene encoding mitochondrial protein, mRNA [NM_006886]",chr20:57603871-57603812,hs|20q13.32,"ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit",TRUE
168_C16orf53_79447,Q9BTK6,paxip1-associated glutamate-rich protein 1 (glutamate-rich coactivator interacting with src1) (gas) (paxip1-associated protein 1) (ptip-associated protein 1),PAGR1 C16orf53 PA1,254,"function: its association with the histone methyltransferase mll2/mll3 complex is suggesting a role in epigenetic transcriptional activation. however, in association with paxip1/ptip is proposed to function at least in part independently of the mll2/mll3 complex. proposed to be recruited by paxip1 to sites of dna damage where the pagr1:paxip1 complex is required for cell survival in response to dna damage independently of the mll2/mll3 complex (pubmed:19124460). however, its function in dna damage has been questioned (by similarity). during immunoglobulin class switching in activated b-cells is involved in transcription regulation of downstream switch regions at the immunoglobulin heavy-chain (igh) locus independently of the mll2/mll3 complex (by similarity). involved in both estrogen receptor-regulated gene transcription and estrogen-stimulated g1/s cell-cycle transition (pubmed:19039327). acts as transcriptional cofactor for nuclear hormone receptors. inhibits the induction properties of several steroid receptors such as nr3c1, ar and pparg; the mechanism of inhibition appears to be gene-dependent (pubmed:23161582). {eco:0000250|uniprotkb:q99l02, eco:0000269|pubmed:19039327, eco:0000269|pubmed:19124460, eco:0000269|pubmed:23161582, eco:0000305}.",subcellular location: nucleus {eco:0000269|pubmed:19039327}.,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:19039327}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C16orf53,79447,Hs.702841,ENST00000320330,THC2524401,GO:0005515(protein binding),"Homo sapiens chromosome 16 open reading frame 53 (C16orf53), mRNA [NM_024516]",chr16:29831332-29831391,hs|16p11.2,chromosome 16 open reading frame 53,TRUE
169_OAZ1_4946,P54368,ornithine decarboxylase antizyme 1 (az1) (odc-az),OAZ1 OAZ,228,"function: ornithine decarboxylase (odc) antizyme protein that negatively regulates odc activity and intracellular polyamine biosynthesis and uptake in response to increased intracellular polyamine levels. binds to odc monomers, inhibiting the assembly of the functional odc homodimer, and targets the monomers for ubiquitin-independent proteolytic destruction by the 26s proteasome (pubmed:17900240, pubmed:26305948, pubmed:26443277). triggers odc degradation by inducing the exposure of a cryptic proteasome-interacting surface of odc (pubmed:26305948). stabilizes azin2 by interfering with its ubiquitination (pubmed:17900240). also inhibits cellular uptake of polyamines by inactivating the polyamine uptake transporter. smad1/oaz1/psmb4 complex mediates the degradation of the crebbp/ep300 repressor snip1. involved in the translocation of azin2 from er-golgi intermediate compartment (ergic) to the cytosol (pubmed:12097147). {eco:0000269|pubmed:12097147, eco:0000269|pubmed:17900240, eco:0000269|pubmed:26305948, eco:0000269|pubmed:26443277}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,OAZ1,4946,Hs.446427,ENST00000322297,THC2592115,GO:0005829(cytosol)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006596(polyamine biosynthetic process)|GO:0008073(ornithine decarboxylase inhibitor activity)|GO:0034641(cellular nitrogen compound metabolic process),"Homo sapiens ornithine decarboxylase antizyme 1 (OAZ1), mRNA [NM_004152]",chr19:2273174-2273233,hs|19p13.3,ornithine decarboxylase antizyme 1,TRUE
17_CYTB_4519,P00156,cytochrome b (complex iii subunit 3) (complex iii subunit iii) (cytochrome b-c1 complex subunit 3) (ubiquinol-cytochrome-c reductase complex cytochrome b subunit),MT-CYB COB CYTB MTCYB,380,function: component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex) that is part of the mitochondrial respiratory chain. the b-c1 complex mediates electron transfer from ubiquinol to cytochrome c. contributes to the generation of a proton gradient across the mitochondrial membrane that is then used for atp synthesis. {eco:0000250|uniprotkb:p00157}.,subcellular location: mitochondrion inner membrane {eco:0000250|uniprotkb:p00157}; multi-pass membrane protein {eco:0000250|uniprotkb:p00157}.,NA,"DISEASE: Note=Defects in MT-CYB are a rare cause of mitochondrial dysfunction underlying different myopathies. They include mitochondrial encephalomyopathy, hypertrophic cardiomyopathy (HCM), and sporadic mitochondrial myopathy (MM). In mitochondrial myopathy, exercise intolerance is the predominant symptom. Additional features include lactic acidosis, muscle weakness and/or myoglobinuria. Defects in MTCYB are also found in cases of exercise intolerance accompanied by deafness, mental retardation, retinitis pigmentosa, cataract, growth retardation, epilepsy (multisystem disorder). {ECO:0000269|PubMed:11047755, ECO:0000269|PubMed:11601507}.; DISEASE: Cardiomyopathy, infantile histiocytoid (CMIH) [MIM:500000]: A heart disease characterized by the presence of pale granular foamy histiocyte-like cells within the myocardium. It usually affects children younger than 2 years of age, with a clear predominance of females over males. Infants present with dysrhythmia or cardiac arrest. The clinical course is usually fulminant, sometimes simulating sudden infant death syndrome. {ECO:0000269|PubMed:10960495}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. {ECO:0000269|PubMed:1732158}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYTB,4519,NA,ENST00000361789,THC2477476,NA,mitochondrially encoded cytochrome b [Source:HGNC Symbol;Acc:7427] [ENST00000361789],chrM:15663-15722,NA,cytochrome b,TRUE
170_C15orf63_25764,Q9NX55,huntingtin-interacting protein k (huntingtin yeast partner k),HYPK C15orf63 HSPC136,129,"function: has a chaperone-like activity preventing polyglutamine (polyq) aggregation of htt (pubmed:17947297). protects against htt polyq-mediated apoptosis in neuro2a neuronal cells (pubmed:17947297). regulator of the n-terminal acetyltransferase naa10-naa15 complex (pubmed:20154145, pubmed:29754825). has been in one study shown to be required for optimal naa10-naa15 complex-mediated n-terminal acetylation (pubmed:20154145). however, has been shown in another study to act in vitro as an inhibitor of naa10-naa15 complex-mediated n-terminal acetylation (pubmed:29754825). {eco:0000269|pubmed:17947297, eco:0000269|pubmed:20154145, eco:0000269|pubmed:29754825}.",subcellular location: nucleus. cytoplasm.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C15orf63,25764,Hs.730672,ENST00000409617,THC2463348,NA,"Homo sapiens chromosome 15 open reading frame 63 (C15orf63), transcript variant 1, mRNA [NM_016400]",chr15:44093979-44094038,hs|15q15.3,chromosome 15 open reading frame 63,TRUE
171_NDUFA1_4694,O15239,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (complex i-mwfe) (ci-mwfe) (nadh-ubiquinone oxidoreductase mwfe subunit),NDUFA1,70,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}; matrix side {eco:0000305}.,TISSUE SPECIFICITY: Primarily expressed in heart and skeletal muscle.,"DISEASE: Mitochondrial complex I deficiency, nuclear type 12 (MC1DN12) [MIM:301020]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:17262856}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA1,4694,Hs.534168,ENST00000371437,THC2467889,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0031966(mitochondrial membrane)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (NDUFA1), nuclear gene encoding mitochondrial protein, mRNA [NM_004541]",chrX:119007295-119007354,hs|Xq24,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa",TRUE
172_GOLGA6L9_440295,A6NEM1,golgin subfamily a member 6-like protein 9,GOLGA6L9 GOLGA6L20,432,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,GOLGA6L9,440295,Hs.630181,ENST00000306827,THC2574212,NA,"Homo sapiens golgin A6 family-like 9 (GOLGA6L9), mRNA [NM_198181]",chr15:82728575-82728634,hs|15q25.2,golgin A6 family-like 9,TRUE
173_NME2_4831,P22392,nucleoside diphosphate kinase b (ndk b) (ndp kinase b) (ec 2.7.4.6) (c-myc purine-binding transcription factor puf) (histidine protein kinase ndkb) (ec 2.7.13.3) (nm23-h2),NME2 NM23B,152,"function: major role in the synthesis of nucleoside triphosphates other than atp. the atp gamma phosphate is transferred to the ndp beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (by similarity). negatively regulates rho activity by interacting with akap13/lbc (pubmed:15249197). acts as a transcriptional activator of the myc gene; binds dna non-specifically (pubmed:8392752, pubmed:19435876). binds to both single-stranded guanine- and cytosine-rich strands within the nuclease hypersensitive element (nhe) iii(1) region of the myc gene promoter. does not bind to duplex nhe iii(1) (pubmed:19435876). has g-quadruplex (g4) dna-binding activity, which is independent of its nucleotide-binding and kinase activity. binds both folded and unfolded g4 with similar low nanomolar affinities. stabilizes folded g4s regardless of whether they are prefolded or not (pubmed:25679041). exhibits histidine protein kinase activity (pubmed:20946858). {eco:0000250|uniprotkb:p36010, eco:0000269|pubmed:15249197, eco:0000269|pubmed:19435876, eco:0000269|pubmed:20946858, eco:0000269|pubmed:25679041, eco:0000269|pubmed:8392752}.","subcellular location: cytoplasm {eco:0000269|pubmed:16442775}. nucleus {eco:0000269|pubmed:16442775}. cell projection, lamellipodium {eco:0000269|pubmed:11919189}. cell projection, ruffle {eco:0000269|pubmed:11919189}. note=isoform 3 is mainly cytoplasmic and isoform 1 and isoform 3 are excluded from the nucleolus. colocalizes with itgb1 and itgb1bp1 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen but not on vitronectin or laminin substrates. {eco:0000269|pubmed:11919189, eco:0000269|pubmed:16442775}.",TISSUE SPECIFICITY: Isoform 1 and isoform 3 are ubiquitously expressed. {ECO:0000269|PubMed:16442775}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NME2,4831,Hs.463456,ENST00000514264,THC2526143,"GO:0000166(nucleotide binding)|GO:0001726(ruffle)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0004550(nucleoside diphosphate kinase activity)|GO:0004673(protein histidine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006165(nucleoside diphosphate phosphorylation)|GO:0006183(GTP biosynthetic process)|GO:0006228(UTP biosynthetic process)|GO:0006241(CTP biosynthetic process)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007155(cell adhesion)|GO:0009117(nucleotide metabolic process)|GO:0009142(nucleoside triphosphate biosynthetic process)|GO:0015949(nucleobase, nucleoside and nucleotide interconversion)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0030027(lamellipodium)|GO:0043066(negative regulation of apoptosis)|GO:0045618(positive regulation of keratinocyte differentiation)|GO:0045682(regulation of epidermis development)|GO:0046872(metal ion binding)|GO:0050679(positive regulation of epithelial cell proliferation)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens non-metastatic cells 2, protein (NM23B) expressed in (NME2), transcript variant 1, mRNA [NM_002512]",chr17:49248919-49248978,hs|17q21.33,"non-metastatic cells 2, protein (NM23B) expressed in",TRUE
174_YWHAZ_7534,P63104,14-3-3 protein zeta/delta (protein kinase c inhibitor protein 1) (kcip-1),YWHAZ,245,"function: adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. binding generally results in the modulation of the activity of the binding partner. induces arhgef7 activity on rac1 as well as lamellipodia and membrane ruffle formation (pubmed:16959763). in neurons, regulates spine maturation through the modulation of arhgef7 activity (by similarity). {eco:0000250|uniprotkb:o55043, eco:0000269|pubmed:14578935, eco:0000269|pubmed:15071501, eco:0000269|pubmed:15644438, eco:0000269|pubmed:16376338, eco:0000269|pubmed:16959763, eco:0000269|pubmed:9360956}.",subcellular location: cytoplasm {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. note=located to stage i to stage iv melanosomes.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YWHAZ,7534,Hs.492407,ENST00000353245,THC2597130,GO:0002553(histamine secretion by mast cell)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006626(protein targeting to mitochondrion)|GO:0006916(anti-apoptosis)|GO:0007165(signal transduction)|GO:0007596(blood coagulation)|GO:0008134(transcription factor binding)|GO:0014069(postsynaptic density)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019904(protein domain specific binding)|GO:0030168(platelet activation)|GO:0031252(cell leading edge)|GO:0042470(melanosome)|GO:0042493(response to drug)|GO:0043234(protein complex)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), transcript variant 2, mRNA [NM_145690]",chr8:101931167-101931108,hs|8q22.3,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide",TRUE
175_IRF2BP2_359948,Q7Z5L9,interferon regulatory factor 2-binding protein 2 (irf-2-binding protein 2) (irf-2bp2),IRF2BP2,587,"function: acts as a transcriptional corepressor in a irf2-dependent manner; this repression is not mediated by histone deacetylase activities (pubmed:12799427). represses the nfat1-dependent transactivation of nfat-responsive promoters (pubmed:21576369). acts as a coactivator of vegfa expression in cardiac and skeletal muscles (pubmed:20702774). plays a role in immature b-cell differentiation (pubmed:27016798). {eco:0000269|pubmed:12799427, eco:0000269|pubmed:20702774, eco:0000269|pubmed:21576369, eco:0000269|pubmed:27016798}.",subcellular location: cytoplasm. nucleus.,NA,"DISEASE: Immunodeficiency, common variable, 14 (CVID14) [MIM:617765]: A primary immunodeficiency resulting in recurrent sinopulmonary infections since early childhood, and characterized by hypogammaglobulinemia with undetectable IgG and IgA, poor response to vaccination, and decreased levels of switched memory B cells. CVID14 inheritance is autosomal dominant. {ECO:0000269|PubMed:27016798}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IRF2BP2,359948,Hs.350268,ENST00000366609,THC2462151,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens interferon regulatory factor 2 binding protein 2 (IRF2BP2), transcript variant 1, mRNA [NM_182972]",chr1:234742632-234742573,hs|1q42.3,interferon regulatory factor 2 binding protein 2,TRUE
176_ORC6_23594,Q9Y5N6,origin recognition complex subunit 6,ORC6 ORC6L,252,"function: component of the origin recognition complex (orc) that binds origins of replication. dna-binding is atp-dependent. the specific dna sequences that define origins of replication have not been identified yet. orc is required to assemble the pre-replication complex necessary to initiate dna replication. does not bind histone h3 and h4 trimethylation marks h3k9me3, h3k27me3 and h4k20me3. {eco:0000269|pubmed:22427655}.",subcellular location: nucleus.,NA,"DISEASE: Meier-Gorlin syndrome 3 (MGORS3) [MIM:613803]: A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:21358632}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ORC6,23594,Hs.49760,ENST00000219097,THC2570603,GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000808(origin recognition complex)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005664(nuclear origin of replication recognition complex)|GO:0006260(DNA replication),"Homo sapiens origin recognition complex, subunit 6 (ORC6), transcript variant 1, mRNA [NM_014321]",chr16:46732004-46732063,hs|16q11.2,"origin recognition complex, subunit 6",TRUE
177_RPL10A_4736,P62906,60s ribosomal protein l10a (csa-19) (large ribosomal subunit protein ul1) (neural precursor cell expressed developmentally down-regulated protein 6) (nedd-6),RPL10A NEDD6,217,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL10A,4736,Hs.546269,ENST00000467020,THC2504865,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0009653(anatomical structure morphogenesis)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L10a (RPL10A), mRNA [NM_007104]",chr6:35438429-35438488,hs|6p21.31,ribosomal protein L10a,TRUE
178_ZC3H11A_9877,O75152,zinc finger ccch domain-containing protein 11a,ZC3H11A KIAA0663 ZC3HDC11A,810,function: involved in nuclear mrna export; probably mediated by association with the trex complex. {eco:0000269|pubmed:22928037}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ZC3H11A,9877,Hs.532399,ENST00000545588,THC2469745,GO:0003676(nucleic acid binding)|GO:0005515(protein binding)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens zinc finger CCCH-type containing 11A (ZC3H11A), mRNA [NM_014827]",chr1:203823138-203823197,hs|1q32.1,zinc finger CCCH-type containing 11A,TRUE
179_ATF4_468,P18848,cyclic amp-dependent transcription factor atf-4 (camp-dependent transcription factor atf-4) (activating transcription factor 4) (cyclic amp-responsive element-binding protein 2) (creb-2) (camp-responsive element-binding protein 2) (dna-binding protein taxreb67) (tax-responsive enhancer element-binding protein 67) (taxreb67),ATF4 CREB2 TXREB,351,"function: transcriptional activator. binds the camp response element (cre) (consensus: 5'-gtgacgt[ac][ag]-3'), a sequence present in many viral and cellular promoters. cooperates with foxo1 in osteoblasts to regulate glucose homeostasis through suppression of beta-cell production and decrease in insulin production (by similarity). it binds to a tax-responsive enhancer element in the long terminal repeat of htlv-i. regulates the induction of ddit3/chop and asparagine synthetase (asns) in response to endoplasmic reticulum (er) stress. in concert with ddit3/chop, activates the transcription of trib3 and promotes er stress-induced neuronal apoptosis by regulating the transcriptional induction of bbc3/puma. activates transcription of sirt4. regulates the circadian expression of the core clock component per2 and the serotonin transporter slc6a4. binds in a circadian time-dependent manner to the camp response elements (cre) in the slc6a4 and per2 promoters and periodically activates the transcription of these genes. during er stress response, activates the transcription of nlrp1, possibly in concert with other factors (pubmed:26086088). {eco:0000250, eco:0000269|pubmed:15775988, eco:0000269|pubmed:16682973, eco:0000269|pubmed:18940792, eco:0000269|pubmed:26086088}.","subcellular location: cytoplasm {eco:0000250|uniprotkb:q9es19}. cell membrane {eco:0000250|uniprotkb:q9es19}. nucleus {eco:0000269|pubmed:16682973, eco:0000269|pubmed:22974638}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:20873783}. note=colocalizes with gabbr1 in hippocampal neuron dendritic membranes (by similarity). colocalizes with nek6 at the centrosome (pubmed:20873783). {eco:0000250|uniprotkb:q9es19, eco:0000269|pubmed:20873783}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ATF4,468,Hs.496487,ENST00000337304,THC2591853,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006094(gluconeogenesis)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006520(cellular amino acid metabolic process)|GO:0034976(response to endoplasmic reticulum stress)|GO:0043565(sequence-specific DNA binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046983(protein dimerization activity)","Homo sapiens activating transcription factor 4 (tax-responsive enhancer element B67) (ATF4), transcript variant 1, mRNA [NM_001675]",chr22:39918577-39918636,hs|22q13.1,activating transcription factor 4 (tax-responsive enhancer element B67),TRUE
18_RPL18_6141,Q07020,60s ribosomal protein l18 (large ribosomal subunit protein el18),RPL18,188,"function: component of the large ribosomal subunit. {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:q95342}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q95342, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Diamond-Blackfan anemia 18 (DBA18) [MIM:618310]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA18 inheritance is autosomal dominant. {ECO:0000269|PubMed:28280134}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL18,6141,Hs.515517,ENST00000549370,THC2588277,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L18 (RPL18), mRNA [NM_000979]",chr19:49120023-49119441,hs|19q13.33,ribosomal protein L18,TRUE
180_GLTSCR2_29997,Q9NZM5,ribosome biogenesis protein nop53 (glioma tumor suppressor candidate region gene 2 protein) (protein interacting with carboxyl terminus 1) (pict-1) (p60),NOP53 GLT GLTSCR2 PICT1,478,"function: nucleolar protein which is involved in the integration of the 5s rnp into the ribosomal large subunit during ribosome biogenesis (pubmed:24120868). in ribosome biogenesis, may also play a role in rrna transcription (pubmed:27729611). also functions as a nucleolar sensor that regulates the activation of p53/tp53 in response to ribosome biogenesis perturbation, dna damage and other stress conditions (pubmed:21741933, pubmed:24120868, pubmed:27829214). dna damage or perturbation of ribosome biogenesis disrupt the interaction between nop53 and rpl11 allowing rpl11 transport to the nucleoplasm where it can inhibit mdm2 and allow p53/tp53 activation (pubmed:24120868, pubmed:27829214). it may also positively regulate the function of p53/tp53 in cell cycle arrest and apoptosis through direct interaction, preventing its mdm2-dependent ubiquitin-mediated proteasomal degradation (pubmed:22522597). originally identified as a tumor suppressor, it may also play a role in cell proliferation and apoptosis by positively regulating the stability of pten, thereby antagonizing the pi3k-akt/pkb signaling pathway (pubmed:15355975, pubmed:16971513, pubmed:27729611). may also inhibit cell proliferation and increase apoptosis through its interaction with nf2 (pubmed:21167305). may negatively regulate npm1 by regulating its nucleoplasmic localization, oligomerization and ubiquitin-mediated proteasomal degradation (pubmed:25818168). thereby, may prevent npm1 interaction with myc and negatively regulate transcription mediated by the myc-npm1 complex (pubmed:25956029). may also regulate cellular aerobic respiration (pubmed:24556985). in the cellular response to viral infection, may play a role in the attenuation of interferon-beta through the inhibition of ddx58/rig-1 (pubmed:27824081). {eco:0000269|pubmed:15355975, eco:0000269|pubmed:16971513, eco:0000269|pubmed:21167305, eco:0000269|pubmed:21741933, eco:0000269|pubmed:22522597, eco:0000269|pubmed:24120868, eco:0000269|pubmed:24556985, eco:0000269|pubmed:25818168, eco:0000269|pubmed:25956029, eco:0000269|pubmed:27729611, eco:0000269|pubmed:27824081, eco:0000269|pubmed:27829214}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:10196275, eco:0000269|pubmed:12429849, eco:0000269|pubmed:20042497, eco:0000269|pubmed:22292050, eco:0000269|pubmed:22522597, eco:0000269|pubmed:24923447, eco:0000269|pubmed:25956029, eco:0000269|pubmed:27729611, eco:0000269|pubmed:27829214}. nucleus, nucleoplasm {eco:0000269|pubmed:22522597, eco:0000269|pubmed:24923447, eco:0000269|pubmed:26903295, eco:0000269|pubmed:27323397}. note=in the nucleolus may be more specifically localized to the fibrillar center (pubmed:27729611). mainly nucleolar it relocalizes to the nucleoplasm under specific conditions including ribosomal stress enabling it to interact and regulate nucleoplasmic proteins like p53/tp53 (pubmed:22522597, pubmed:24923447, pubmed:27323397, pubmed:26903295). also detected in the cytosol (pubmed:24923447, pubmed:27824081). {eco:0000269|pubmed:22522597, eco:0000269|pubmed:24923447, eco:0000269|pubmed:26903295, eco:0000269|pubmed:27323397, eco:0000269|pubmed:27729611, eco:0000269|pubmed:27824081}.","TISSUE SPECIFICITY: Expressed at high levels in heart and pancreas, moderate levels in placenta, liver, skeletal muscle, and kidney, and low levels in brain and lung. {ECO:0000269|PubMed:10708517}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GLTSCR2,29997,Hs.421907,ENST00000325566,THC2497427,GO:0003674(molecular_function)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0008150(biological_process)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens glioma tumor suppressor candidate region gene 2 (GLTSCR2), mRNA [NM_015710]",chr19:48259961-48260274,hs|19q13.33,glioma tumor suppressor candidate region gene 2,TRUE
181_ATP5L_10632,O75964,"atp synthase subunit g, mitochondrial (atpase subunit g) (atp synthase membrane subunit g)",ATP5MG ATP5L,103,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core, and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain. minor subunit located with subunit a in the membrane.",subcellular location: mitochondrion. mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5L,10632,Hs.486360,ENST00000529770,THC2784865,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006811(ion transport)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G (ATP5L), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_006476]",chr11:118279768-118279827,hs|11q23.3,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G",TRUE
182_PRNP_5621,P04156,major prion protein (prp) (ascr) (prp27-30) (prp33-35c) (cd antigen cd230),PRNP ALTPRP PRIP PRP,253,"function: its primary physiological function is unclear. may play a role in neuronal development and synaptic plasticity. may be required for neuronal myelin sheath maintenance. may promote myelin homeostasis through acting as an agonist for adgrg6 receptor. may play a role in iron uptake and iron homeostasis. soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (by similarity). association with gpc1 (via its heparan sulfate chains) targets prnp to lipid rafts. also provides cu(2+) or zn(2+) for the ascorbate-mediated gpc1 deaminase degradation of its heparan sulfate side chains (by similarity). {eco:0000250|uniprotkb:p04925, eco:0000269|pubmed:12732622, eco:0000269|pubmed:19936054, eco:0000269|pubmed:20564047, eco:0000305}.","subcellular location: cell membrane; lipid-anchor, gpi-anchor {eco:0000269|pubmed:19936054}. golgi apparatus {eco:0000250|uniprotkb:p04925}. note=targeted to lipid rafts via association with the heparan sulfate chains of gpc1. colocates, in the presence of cu(2+), to vesicles in para- and perinuclear regions, where both proteins undergo internalization. heparin displaces prnp from lipid rafts and promotes endocytosis. {eco:0000269|pubmed:19936054}.",NA,"DISEASE: Note=PrP is found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases, like: Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), Gerstmann-Straussler disease (GSD), Huntington disease-like type 1 (HDL1) and kuru in humans; scrapie in sheep and goat; bovine spongiform encephalopathy (BSE) in cattle; transmissible mink encephalopathy (TME); chronic wasting disease (CWD) of mule deer and elk; feline spongiform encephalopathy (FSE) in cats and exotic ungulate encephalopathy (EUE) in nyala and greater kudu. The prion diseases illustrate three manifestations of CNS degeneration: (1) infectious (2) sporadic and (3) dominantly inherited forms. TME, CWD, BSE, FSE, EUE are all thought to occur after consumption of prion-infected foodstuffs. {ECO:0000269|PubMed:8105771}.; DISEASE: Creutzfeldt-Jakob disease (CJD) [MIM:123400]: Occurs primarily as a sporadic disorder (1 per million), while 10-15% are familial. Accidental transmission of CJD to humans appears to be iatrogenic (contaminated human growth hormone (HGH), corneal transplantation, electroencephalographic electrode implantation, etc.). Epidemiologic studies have failed to implicate the ingestion of infected animal meat in the pathogenesis of CJD in human. The triad of microscopic features that characterize the prion diseases consists of (1) spongiform degeneration of neurons, (2) severe astrocytic gliosis that often appears to be out of proportion to the degree of nerve cell loss, and (3) amyloid plaque formation. CJD is characterized by progressive dementia and myoclonic seizures, affecting adults in mid-life. Some patients present sleep disorders, abnormalities of high cortical function, cerebellar and corticospinal disturbances. The disease ends in death after a 3-12 months illness. {ECO:0000269|PubMed:10790216, ECO:0000269|PubMed:1439789, ECO:0000269|PubMed:1671440, ECO:0000269|PubMed:1975028, ECO:0000269|PubMed:19927125, ECO:0000269|PubMed:7902693, ECO:0000269|PubMed:7906019, ECO:0000269|PubMed:7913755, ECO:0000269|PubMed:8461023, ECO:0000269|PubMed:8909447}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fatal familial insomnia (FFI) [MIM:600072]: Autosomal dominant disorder and is characterized by neuronal degeneration limited to selected thalamic nuclei and progressive insomnia. {ECO:0000269|PubMed:1347910, ECO:0000269|PubMed:1439789, ECO:0000269|PubMed:19927125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gerstmann-Straussler disease (GSD) [MIM:137440]: A rare inherited prion disease characterized by adult onset of memory loss, dementia, ataxia, and pathologic deposition of amyloid-like plaques in the brain. GSD presents with progressive limb and truncal ataxia, dysarthria, and cognitive decline in the thirties and forties, and the average disease duration is 7 years. {ECO:0000269|PubMed:10581485, ECO:0000269|PubMed:11709001, ECO:0000269|PubMed:1363810, ECO:0000269|PubMed:1439789, ECO:0000269|PubMed:19927125, ECO:0000269|PubMed:2564168, ECO:0000269|PubMed:7699395, ECO:0000269|PubMed:7783876, ECO:0000269|PubMed:7902972, ECO:0000269|PubMed:8797472, ECO:0000269|PubMed:9786248}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Huntington disease-like 1 (HDL1) [MIM:603218]: Autosomal dominant, early-onset neurodegenerative disorder with prominent psychiatric features. {ECO:0000269|PubMed:9792871}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Kuru (KURU) [MIM:245300]: Kuru is transmitted during ritualistic cannibalism, among natives of the New Guinea highlands. Patients exhibit various movement disorders like cerebellar abnormalities, rigidity of the limbs, and clonus. Emotional lability is present, and dementia is conspicuously absent. Death usually occurs from 3 to 12 month after onset. {ECO:0000269|PubMed:19923577, ECO:0000269|PubMed:26061765}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Spongiform encephalopathy with neuropsychiatric features (SENF) [MIM:606688]: Autosomal dominant presenile dementia with a rapidly progressive and protracted clinical course. The dementia was characterized clinically by frontotemporal features, including early personality changes. Some patients had memory loss, several showed aggressiveness, hyperorality and verbal stereotypy, others had parkinsonian symptoms. {ECO:0000269|PubMed:12214108, ECO:0000269|PubMed:9266722}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PRNP,5621,Hs.472010,ENST00000379440,THC2517843,GO:0001933(negative regulation of protein phosphorylation)|GO:0005507(copper ion binding)|GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006878(cellular copper ion homeostasis)|GO:0006916(anti-apoptosis)|GO:0006979(response to oxidative stress)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0007411(axon guidance)|GO:0008017(microtubule binding)|GO:0008152(metabolic process)|GO:0015631(tubulin binding)|GO:0019898(extrinsic to membrane)|GO:0031225(anchored to membrane)|GO:0032689(negative regulation of interferon-gamma production)|GO:0032700(negative regulation of interleukin-17 production)|GO:0032703(negative regulation of interleukin-2 production)|GO:0042802(identical protein binding)|GO:0043008(ATP-dependent protein binding)|GO:0043231(intracellular membrane-bounded organelle)|GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity)|GO:0045121(membrane raft)|GO:0046007(negative regulation of activated T cell proliferation)|GO:0046686(response to cadmium ion)|GO:0046688(response to copper ion)|GO:0046872(metal ion binding)|GO:0050860(negative regulation of T cell receptor signaling pathway)|GO:0051087(chaperone binding)|GO:0051260(protein homooligomerization)|GO:0070885(negative regulation of calcineurin-NFAT signaling pathway),"Homo sapiens prion protein (PRNP), transcript variant 4, mRNA [NM_001080122]",chr20:4667049-4667108,hs|20p13,prion protein,TRUE
183_CD24_100133941,P25063,signal transducer cd24 (small cell lung carcinoma cluster 4 antigen) (cd antigen cd24),CD24 CD24A,80,"function: may have a pivotal role in cell differentiation of different cell types. signaling could be triggered by the binding of a lectin-like ligand to the cd24 carbohydrates, and transduced by the release of second messengers derived from the gpi-anchor. modulates b-cell activation responses. promotes ag-dependent proliferation of b-cells, and prevents their terminal differentiation into antibody-forming cells (pubmed:11313396). in association with siglec10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (damps) such as hmgb1, hsp70 and hsp90. plays a role in the control of autoimmunity (by similarity). {eco:0000250|uniprotkb:p24807, eco:0000269|pubmed:11313396}.","subcellular location: cell membrane; lipid-anchor, gpi-anchor.","TISSUE SPECIFICITY: B-cells. Expressed in a number of B-cell lines including P32/ISH and Namalwa. Expressed in erythroleukemia cell and small cell lung carcinoma cell lines. Also expressed on the surface of T-cells. {ECO:0000269|PubMed:14657362, ECO:0000269|PubMed:8753773}.","DISEASE: Multiple sclerosis (MS) [MIM:126200]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:14657362}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CD24,100133941,Hs.644105,NA,NA,GO:0001666(response to hypoxia)|GO:0001775(cell activation)|GO:0001959(regulation of cytokine-mediated signaling pathway)|GO:0002237(response to molecule of bacterial origin)|GO:0002768(immune response-regulating cell surface receptor signaling pathway)|GO:0004871(signal transducer activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0007204(elevation of cytosolic calcium ion concentration)|GO:0007411(axon guidance)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0009986(cell surface)|GO:0016020(membrane)|GO:0016055(Wnt receptor signaling pathway)|GO:0016337(cell-cell adhesion)|GO:0016477(cell migration)|GO:0019901(protein kinase binding)|GO:0030296(protein tyrosine kinase activator activity)|GO:0030856(regulation of epithelial cell differentiation)|GO:0031225(anchored to membrane)|GO:0031295(T cell costimulation)|GO:0032597(B cell receptor transport into membrane raft)|GO:0032600(chemokine receptor transport out of membrane raft)|GO:0032913(negative regulation of transforming growth factor-beta3 production)|GO:0042104(positive regulation of activated T cell proliferation)|GO:0042325(regulation of phosphorylation)|GO:0042632(cholesterol homeostasis)|GO:0043406(positive regulation of MAP kinase activity)|GO:0043408(regulation of MAPKKK cascade)|GO:0043627(response to estrogen stimulus)|GO:0045121(membrane raft)|GO:0045730(respiratory burst)|GO:0061098(positive regulation of protein tyrosine kinase activity),"Homo sapiens CD24 signal transducer mRNA, complete cds and 3' region. [L33930]",chrY:21152877-21152818,hs|Yq11.222,CD24 molecule,TRUE
184_CHCHD2_51142,Q9Y6H1,coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (aging-associated gene 10 protein) (hcv ns2 trans-regulated protein) (ns2tp),CHCHD2 C7orf17 AAG10,151,"function: transcription factor. binds to the oxygen responsive element of cox4i2 and activates its transcription under hypoxia conditions (4% oxygen), as well as normoxia conditions (20% oxygen) (pubmed:23303788). {eco:0000269|pubmed:23303788}.",subcellular location: nucleus {eco:0000269|pubmed:23303788}. mitochondrion {eco:0000269|pubmed:25662902}. mitochondrion intermembrane space {eco:0000269|pubmed:25662902}. note=mainly localised in the intermembrane space. {eco:0000269|pubmed:25662902}.,NA,"DISEASE: Parkinson disease 22 (PARK22) [MIM:616710]: An autosomal dominant form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:25662902}. Note=The gene represented in this entry may be involved in disease pathogenesis.",NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,CHCHD2,51142,Hs.389996,ENST00000395422,THC2465350,GO:0005739(mitochondrion),"Homo sapiens coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2), nuclear gene encoding mitochondrial protein, mRNA [NM_016139]",chr7:56169358-56169299,hs|7p11.2,coiled-coil-helix-coiled-coil-helix domain containing 2,TRUE
185_NGFRAP1_27018,Q00994,protein bex3 (brain-expressed x-linked protein 3) (nerve growth factor receptor-associated protein 1) (ovarian granulosa cell 13.0 kda protein hgr74) (p75ntr-associated cell death executor),BEX3 DXS6984E NADE NGFRAP1,111,function: may be a signaling adapter molecule involved in p75ntr-mediated apoptosis induced by ngf. plays a role in zinc-triggered neuronal death (by similarity). may play an important role in the pathogenesis of neurogenetic diseases. {eco:0000250}.,subcellular location: nucleus. cytoplasm. note=shuttles between the cytoplasm and the nucleus. associates with replicating mitochondria (by similarity). {eco:0000250}.,"TISSUE SPECIFICITY: Found in ovarian granulosa cells, testis, prostate and seminal vesicle tissue. High levels also detected in liver. {ECO:0000269|PubMed:15958283}.",NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NGFRAP1,27018,Hs.448588,ENST00000372635,THC2467842,GO:0005123(death receptor binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006915(apoptosis)|GO:0007275(multicellular organismal development)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0008625(induction of apoptosis via death domain receptors)|GO:0043028(caspase regulator activity)|GO:0043281(regulation of caspase activity)|GO:0046872(metal ion binding)|GO:0048011(nerve growth factor receptor signaling pathway),"Homo sapiens nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), transcript variant 3, mRNA [NM_014380]",chrX:102632908-102632967,hs|Xq22.2,nerve growth factor receptor (TNFRSF16) associated protein 1,TRUE
186_PSMB1_5689,P20618,proteasome subunit beta type-1 (ec 3.4.25.1) (macropain subunit c5) (multicatalytic endopeptidase complex subunit c5) (proteasome component c5) (proteasome gamma chain),PSMB1 PSC5,241,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). {eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.",subcellular location: cytoplasm {eco:0000269|pubmed:12181345}. nucleus {eco:0000269|pubmed:12181345}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMB1,5689,Hs.352768,ENST00000262193,THC2551239,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0004298(threonine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, beta type, 1 (PSMB1), mRNA [NM_002793]",chr6:170844312-170844253,hs|6q27,"proteasome (prosome, macropain) subunit, beta type, 1",TRUE
187_INE1_8552,O15225,putative inactivation escape 1 protein,INE1 DXS6974E,51,NA,NA,"TISSUE SPECIFICITY: Highly expressed in pancreas, heart and liver followed by brain, placenta, lung, skeletal muscle and kidney. Mostly expressed in females. {ECO:0000269|PubMed:9244435}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,INE1,8552,Hs.657350,ENST00000456273,THC2480909,NA,"Homo sapiens inactivation escape 1 (non-protein coding) (INE1), non-coding RNA [NR_024616]",chrX:47065063-47065122,hs|Xp11.23,inactivation escape 1 (non-protein coding),TRUE
189_SPINT2_10653,O43291,kunitz-type protease inhibitor 2 (hepatocyte growth factor activator inhibitor type 2) (hai-2) (placental bikunin),SPINT2 HAI2 KOP,252,"function: inhibitor of hgf activator. also inhibits plasmin, plasma and tissue kallikrein, and factor xia.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in placenta, kidney, pancreas, prostate, testis, thymus, and trachea.","DISEASE: Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies (DIAR3) [MIM:270420]: A disease characterized by life-threatening secretory diarrhea, severe metabolic acidosis and hyponatremia. Hyponatremia is secondary to extraordinarily high fecal sodium loss, with low or normal excretion of urinary sodium, in the absence of infectious, autoimmune and endocrine causes. {ECO:0000269|PubMed:19185281}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SPINT2,10653,Hs.31439,ENST00000301244,NP086200,GO:0004866(endopeptidase inhibitor activity)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0005576(extracellular region)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0006928(cellular component movement)|GO:0010951(negative regulation of endopeptidase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens serine peptidase inhibitor, Kunitz type, 2 (SPINT2), transcript variant a, mRNA [NM_021102]",chr19:38782859-38782918,hs|19q13.2,"serine peptidase inhibitor, Kunitz type, 2",TRUE
19_NPIP_9284,Q9UND3,nuclear pore complex-interacting protein family member a1 (nuclear pore complex-interacting protein) (npip),NPIPA1 NPIP,350,NA,"subcellular location: nucleus, nuclear pore complex {eco:0000269|pubmed:11586358}. nucleus membrane {eco:0000269|pubmed:11586358}. note=colocalizes with nuclear pore complex protein nup62.",TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11586358}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NPIP,9284,Hs.676266,ENST00000165086,THC2566175,GO:0005634(nucleus)|GO:0005643(nuclear pore)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0031965(nuclear membrane)|GO:0051028(mRNA transport),"Homo sapiens nuclear pore complex interacting protein (NPIP), mRNA [NM_006985]",chr16:15045747-15045818,hs|16p13.11,nuclear pore complex interacting protein,TRUE
190_ND5_4540,P03915,nadh-ubiquinone oxidoreductase chain 5 (ec 7.1.1.2) (nadh dehydrogenase subunit 5),MT-ND5 MTND5 NADH5 ND5,603,function: core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed to belong to the minimal assembly required for catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (by similarity). {eco:0000250}.,subcellular location: mitochondrion inner membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,"DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. {ECO:0000269|PubMed:16240359, ECO:0000269|PubMed:1732158, ECO:0000269|PubMed:1900003, ECO:0000269|PubMed:8213825}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:11938446, ECO:0000269|PubMed:12796552, ECO:0000269|PubMed:17400793}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]: Genetically heterogeneous disorder, characterized by episodic vomiting, seizures, and recurrent cerebral insults resembling strokes and causing hemiparesis, hemianopsia, or cortical blindness. {ECO:0000269|PubMed:12509858, ECO:0000269|PubMed:15767514, ECO:0000269|PubMed:17400793, ECO:0000269|PubMed:9299505}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ND5,4540,Hs.723616,ENST00000361567,THC2492414,"GO:0001666(response to hypoxia)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0010243(response to organic nitrogen)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0019717(synaptosome)|GO:0022904(respiratory electron transport chain)|GO:0042542(response to hydrogen peroxide)|GO:0042773(ATP synthesis coupled electron transport)|GO:0070469(respiratory chain)",mitochondrially encoded NADH dehydrogenase 5 [Source:HGNC Symbol;Acc:7461] [ENST00000361567],chrM:13887-13946,NA,"NADH dehydrogenase, subunit 5 (complex I)",TRUE
191_CMTM6_54918,Q9NX76,cklf-like marvel transmembrane domain-containing protein 6 (chemokine-like factor superfamily member 6),CMTM6 CKLFSF6,183,"function: master regulator of recycling and plasma membrane expression of pd-l1/cd274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. associates with both constitutive and ifng-induced pd-l1/cd274 at recycling endosomes, where it protects pd-l1/cd274 from being targeted for lysosomal degradation, likely by preventing its stub1-mediated ubiquitination. may stabilize pd-l1/cd274 expression on antigen presenting cells and potentiates inhibitory signaling by pdcd1/cd279, its receptor on t-cells, ultimately triggering t-cell anergy. {eco:0000269|pubmed:28813410, eco:0000269|pubmed:28813417}.","subcellular location: cell membrane {eco:0000269|pubmed:28813410, eco:0000269|pubmed:28813417}; multi-pass membrane protein {eco:0000255}. early endosome membrane {eco:0000269|pubmed:28813417}; multi-pass membrane protein {eco:0000255}. recycling endosome membrane {eco:0000269|pubmed:28813417}; multi-pass membrane protein {eco:0000255}. note=co-localizes with pd-l1/cd274 in the plasma membrane and in recycling endosomes. {eco:0000269|pubmed:28813417}.","TISSUE SPECIFICITY: Expressed in the leukocytes, placenta and testis. {ECO:0000269|PubMed:12782130}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CMTM6,54918,Hs.380627,ENST00000205636,THC2468223,GO:0005125(cytokine activity)|GO:0005615(extracellular space)|GO:0006935(chemotaxis)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens CKLF-like MARVEL transmembrane domain containing 6 (CMTM6), mRNA [NM_017801]",chr3:32524319-32524260,hs|3p22.3,CKLF-like MARVEL transmembrane domain containing 6,TRUE
192_NPY_4852,Q15761,neuropeptide y receptor type 5 (npy5-r) (npy-y5 receptor) (npyy5-r) (y5 receptor),NPY5R NPYR5,445,function: receptor for neuropeptide y and peptide yy. the activity of this receptor is mediated by g proteins that inhibit adenylate cyclase activity. seems to be associated with food intake. could be involved in feeding disorders.,subcellular location: cell membrane; multi-pass membrane protein.,TISSUE SPECIFICITY: Brain; hypothalamus.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NPY,4852,Hs.1832,ENST00000407573,THC2763338,"GO:0001664(G-protein-coupled receptor binding)|GO:0004930(G-protein coupled receptor activity)|GO:0005102(receptor binding)|GO:0005184(neuropeptide hormone activity)|GO:0005246(calcium channel regulator activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005623(cell)|GO:0006816(calcium ion transport)|GO:0006928(cellular component movement)|GO:0007187(G-protein signaling, coupled to cyclic nucleotide second messenger)|GO:0007218(neuropeptide signaling pathway)|GO:0007268(synaptic transmission)|GO:0007586(digestion)|GO:0007610(behavior)|GO:0007631(feeding behavior)|GO:0008015(blood circulation)|GO:0008283(cell proliferation)|GO:0008343(adult feeding behavior)|GO:0021954(central nervous system neuron development)|GO:0021987(cerebral cortex development)|GO:0031175(neuron projection development)|GO:0031841(neuropeptide Y receptor binding)|GO:0032100(positive regulation of appetite)|GO:0045776(negative regulation of blood pressure)|GO:0050909(sensory perception of taste)","Homo sapiens neuropeptide Y (NPY), mRNA [NM_000905]",chr7:24331284-24331343,hs|7p15.3,neuropeptide Y,TRUE
193_ATP6_4508,O75348,v-type proton atpase subunit g 1 (v-atpase subunit g 1) (v-atpase 13 kda subunit 1) (vacuolar proton pump subunit g 1) (vacuolar proton pump subunit m16),ATP6V1G1 ATP6G ATP6G1 ATP6J,118,"function: catalytic subunit of the peripheral v1 complex of vacuolar atpase (v-atpase). v-atpase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. in aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of fe(2+) prolyl hydroxylase (phd) enzymes, and leading to hif1a hydroxylation and subsequent proteasomal degradation (pubmed:28296633). {eco:0000269|pubmed:28296633}.",NA,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12384298}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ATP6,4508,Hs.528050,ENST00000361899,THC2574381,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006811(ion transport)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0015986(ATP synthesis coupled proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)|GO:0055093(response to hyperoxia)",mitochondrially encoded ATP synthase 6 [Source:HGNC Symbol;Acc:7414] [ENST00000361899],chrM:8836-8895,NA,ATP synthase F0 subunit 6,TRUE
194_ATP6V0C_527,P27449,v-type proton atpase 16 kda proteolipid subunit (v-atpase 16 kda proteolipid subunit) (vacuolar proton pump 16 kda proteolipid subunit),ATP6V0C ATP6C ATP6L ATPL,155,function: proton-conducting pore forming subunit of the membrane integral v0 complex of vacuolar atpase. v-atpase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.,subcellular location: vacuole membrane; multi-pass membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP6V0C,527,Hs.389107,ENST00000330398,THC2570800,"GO:0005515(protein binding)|GO:0005773(vacuole)|GO:0005774(vacuolar membrane)|GO:0006811(ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0008286(insulin receptor signaling pathway)|GO:0010008(endosome membrane)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0015992(proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031625(ubiquitin protein ligase binding)|GO:0033179(proton-transporting V-type ATPase, V0 domain)|GO:0033572(transferrin transport)|GO:0044419(interspecies interaction between organisms)|GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism)|GO:0046961(proton-transporting ATPase activity, rotational mechanism)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (ATP6V0C), transcript variant 1, mRNA [NM_001694]",chr16:2570094-2570153,hs|16p13.3,"ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c",TRUE
195_NDUFB9_4715,Q9Y6M9,nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (complex i-b22) (ci-b22) (lyr motif-containing protein 3) (nadh-ubiquinone oxidoreductase b22 subunit),NDUFB9 LYRM3 UQOR22,179,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed to be not involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 24 (MC1DN24) [MIM:618245]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN24 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:22200994}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB9,4715,Hs.15977,ENST00000518657,THC2573104,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0007605(sensory perception of sound)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa (NDUFB9), nuclear gene encoding mitochondrial protein, mRNA [NM_005005]",chr8:125562118-125562177,hs|8q24.13,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa",TRUE
196_HNRNPM_4670,P52272,heterogeneous nuclear ribonucleoprotein m (hnrnp m),HNRNPM HNRPM NAGR1,730,"function: pre-mrna binding protein in vivo, binds avidly to poly(g) and poly(u) rna homopolymers in vitro. involved in splicing. acts as a receptor for carcinoembryonic antigen in kupffer cells, may initiate a series of signaling events leading to tyrosine phosphorylation of proteins and induction of il-1 alpha, il-6, il-10 and tumor necrosis factor alpha cytokines.","subcellular location: nucleus, nucleolus {eco:0000269|ref.5}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPM,4670,Hs.465808,NA,NP1135521,"GO:0000166(nucleotide binding)|GO:0000380(alternative nuclear mRNA splicing, via spliceosome)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005730(nucleolus)|GO:0005887(integral to plasma membrane)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016363(nuclear matrix)|GO:0019904(protein domain specific binding)|GO:0042382(paraspeckles)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein M (HNRNPM), transcript variant 1, mRNA [NM_005968]",chr19:8553853-8553912,hs|19p13.2,heterogeneous nuclear ribonucleoprotein M,TRUE
197_GGCT_79017,O75223,gamma-glutamylcyclotransferase (ec 4.3.2.9) (cytochrome c-releasing factor 21),GGCT C7orf24 CRF21,188,"function: catalyzes the formation of 5-oxoproline from gamma-glutamyl dipeptides and may play a significant role in glutathione homeostasis. induces release of cytochrome c from mitochondria with resultant induction of apoptosis. {eco:0000269|pubmed:16765912, eco:0000269|pubmed:18515354}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GGCT,79017,Hs.530024,ENST00000497601,THC2605513,"GO:0001836(release of cytochrome c from mitochondria)|GO:0003839(gamma-glutamylcyclotransferase activity)|GO:0005829(cytosol)|GO:0006750(glutathione biosynthetic process)|GO:0006805(xenobiotic metabolic process)|GO:0016746(transferase activity, transferring acyl groups)|GO:0042803(protein homodimerization activity)","Homo sapiens gamma-glutamylcyclotransferase (GGCT), transcript variant 1, mRNA [NM_024051]",chr7:30536417-30536358,hs|7p14.3,gamma-glutamylcyclotransferase,TRUE
198_ATP9A_10079,O75110,probable phospholipid-transporting atpase iia (ec 7.6.2.1) (atpase class ii type 9a),ATP9A ATPIIA KIAA0611,1047,NA,"subcellular location: early endosome membrane {eco:0000269|pubmed:21914794}; multi-pass membrane protein {eco:0000269|pubmed:21914794}. recycling endosome {eco:0000269|pubmed:21914794}. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:21914794}. note=efficient exit from the endoplasmic reticulum does not require tmem30a, nor tmem30b.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,ATP9A,10079,Hs.649234,ENST00000338821,THC2510679,"GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0004012(phospholipid-translocating ATPase activity)|GO:0005524(ATP binding)|GO:0005769(early endosome)|GO:0005802(trans-Golgi network)|GO:0006812(cation transport)|GO:0015662(ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0045332(phospholipid translocation)|GO:0048471(perinuclear region of cytoplasm)|GO:0055037(recycling endosome)","Homo sapiens ATPase, class II, type 9A (ATP9A), mRNA [NM_006045]",chr20:50213418-50213359,hs|20q13.2,"ATPase, class II, type 9A",TRUE
199_MAEA_10296,Q7L5Y9,e3 ubiquitin-protein transferase maea (ec 2.3.2.27) (cell proliferation-inducing gene 5 protein) (erythroblast macrophage protein) (human lung cancer oncogene 10 protein) (hlc-10) (macrophage erythroblast attacher) (p44emlp),MAEA EMP HLC10 PIG5,396,"function: core component of the ctlh e3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from ube2h and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor hbp1. maea and rmnd5a are both required for catalytic activity of the ctlh e3 ubiquitin-protein ligase complex (pubmed:29911972). maea is required for normal cell proliferation (pubmed:29911972). the ctlh e3 ubiquitin-protein ligase complex is not required for the degradation of enzymes involved in gluconeogenesis, such as fbp1 (pubmed:29911972). plays a role in erythroblast enucleation during erythrocyte maturation and in the development of mature macrophages (by similarity). mediates the attachment of erythroid cell to mature macrophages; this maea-mediated contact inhibits erythroid cell apoptosis (pubmed:9763581). participates in erythroblastic island formation, which is the functional unit of definitive erythropoiesis. associates with f-actin to regulate actin distribution in erythroblasts and macrophages (by similarity). may contribute to nuclear architecture and cells division events (probable). {eco:0000250|uniprotkb:q4vc33, eco:0000269|pubmed:29911972, eco:0000269|pubmed:9763581, eco:0000305|pubmed:16510120}.","subcellular location: cytoplasm {eco:0000250|uniprotkb:q4vc33}. nucleus, nucleoplasm {eco:0000269|pubmed:17467196, eco:0000269|pubmed:24143168, eco:0000269|pubmed:29911972}. nucleus matrix {eco:0000269|pubmed:16510120}. cell membrane {eco:0000269|pubmed:9763581}. cytoplasm, cytoskeleton {eco:0000269|pubmed:16510120}. note=detected in a nuclear, speckled-like pattern (pubmed:16510120). localized with condensed chromatin at prophase; detected in nuclear spindle poles at metaphase and in the contractile ring during telophase and cytokinesis (pubmed:16510120). present in cytoplasm, nuclear matrix and at the cell surface in macrophages; predominantly nuclear in immature macrophages and predominantly detected at the cell surface in mature macrophages. colocalizes with f-actin in macrophages (by similarity). {eco:0000250|uniprotkb:q4vc33, eco:0000269|pubmed:16510120}.",TISSUE SPECIFICITY: Detected at macrophage membranes (at protein level). Ubiquitous. {ECO:0000269|PubMed:9763581}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,MAEA,10296,Hs.139896,ENST00000382947,NP1473781,GO:0003779(actin binding)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005819(spindle)|GO:0005826(actomyosin contractile ring)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007010(cytoskeleton organization)|GO:0007049(cell cycle)|GO:0007155(cell adhesion)|GO:0007346(regulation of mitotic cell cycle)|GO:0016363(nuclear matrix)|GO:0033033(negative regulation of myeloid cell apoptosis)|GO:0043249(erythrocyte maturation)|GO:0048822(enucleate erythrocyte development)|GO:0051301(cell division),"Homo sapiens macrophage erythroblast attacher (MAEA), transcript variant 1, mRNA [NM_001017405]",chr4:1333799-1333858,hs|4p16.3,macrophage erythroblast attacher,TRUE
2_AR_367,P10275,androgen receptor (dihydrotestosterone receptor) (nuclear receptor subfamily 3 group c member 4),AR DHTR NR3C4,920,"function: steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. transcription factor activity is modulated by bound coactivator and corepressor proteins like zbtb7a that recruits ncor1 and ncor2 to the androgen response elements/are on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (pubmed:20812024). transcription activation is also down-regulated by nr0b2. activated, but not phosphorylated, by hipk3 and zipk/dapk3. {eco:0000269|pubmed:14664718, eco:0000269|pubmed:15563469, eco:0000269|pubmed:17591767, eco:0000269|pubmed:17911242, eco:0000269|pubmed:18084323, eco:0000269|pubmed:19345326, eco:0000269|pubmed:20812024, eco:0000269|pubmed:20980437, eco:0000269|pubmed:25091737}.; function: isoform 3 and isoform 4 lack the c-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones. {eco:0000269|pubmed:19244107}.","subcellular location: nucleus {eco:0000269|pubmed:12958311, eco:0000269|pubmed:15634333, eco:0000269|pubmed:17587566, eco:0000269|pubmed:19244107, eco:0000269|pubmed:19345326, eco:0000269|pubmed:25091737}. cytoplasm {eco:0000269|pubmed:12958311, eco:0000269|pubmed:17587566, eco:0000269|pubmed:19244107}. note=detected at the promoter of target genes (pubmed:25091737). predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. can also translocate to the nucleus in unligated form in the presence of rack1. {eco:0000269|pubmed:12958311, eco:0000269|pubmed:17587566, eco:0000269|pubmed:25091737}.","TISSUE SPECIFICITY: Isoform 2 is mainly expressed in heart and skeletal muscle (PubMed:15634333). Isoform 3 is expressed by basal and stromal cells of prostate (at protein level) (PubMed:19244107). {ECO:0000269|PubMed:15634333, ECO:0000269|PubMed:19244107}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,AR,367,Hs.496240,ENST00000544984,NP1401665,"GO:0000790(nuclear chromatin)|GO:0001701(in utero embryonic development)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003706(ligand-regulated transcription factor activity)|GO:0004872(receptor activity)|GO:0004882(androgen receptor activity)|GO:0005102(receptor binding)|GO:0005496(steroid binding)|GO:0005497(androgen binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006351(transcription, DNA-dependent)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006810(transport)|GO:0007165(signal transduction)|GO:0007267(cell-cell signaling)|GO:0007548(sex differentiation)|GO:0008013(beta-catenin binding)|GO:0008134(transcription factor binding)|GO:0008219(cell death)|GO:0008270(zinc ion binding)|GO:0008283(cell proliferation)|GO:0008284(positive regulation of cell proliferation)|GO:0008584(male gonad development)|GO:0010467(gene expression)|GO:0016049(cell growth)|GO:0019102(male somatic sex determination)|GO:0019899(enzyme binding)|GO:0030424(axon)|GO:0030425(dendrite)|GO:0030521(androgen receptor signaling pathway)|GO:0030850(prostate gland development)|GO:0032868(response to insulin stimulus)|GO:0033148(positive regulation of estrogen receptor signaling pathway)|GO:0034339(regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor)|GO:0042327(positive regulation of phosphorylation)|GO:0043066(negative regulation of apoptosis)|GO:0043410(positive regulation of MAPKKK cascade)|GO:0043565(sequence-specific DNA binding)|GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway)|GO:0044212(transcription regulatory region DNA binding)|GO:0045720(negative regulation of integrin biosynthetic process)|GO:0045726(positive regulation of integrin biosynthetic process)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0045945(positive regulation of transcription from RNA polymerase III promoter)|GO:0046661(male sex differentiation)|GO:0046872(metal ion binding)|GO:0046983(protein dimerization activity)|GO:0048638(regulation of developmental growth)|GO:0048645(organ formation)|GO:0048808(male genitalia morphogenesis)|GO:0050680(negative regulation of epithelial cell proliferation)|GO:0050681(androgen receptor binding)|GO:0050790(regulation of catalytic activity)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0060520(activation of prostate induction by androgen receptor signaling pathway)|GO:0060571(morphogenesis of an epithelial fold)|GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis)|GO:0060685(regulation of prostatic bud formation)|GO:0060736(prostate gland growth)|GO:0060740(prostate gland epithelium morphogenesis)|GO:0060742(epithelial cell differentiation involved in prostate gland development)|GO:0060748(tertiary branching involved in mammary gland duct morphogenesis)|GO:0060749(mammary gland alveolus development)|GO:0090003(regulation of establishment of protein localization in plasma membrane)","Homo sapiens androgen receptor (AR), transcript variant 1, mRNA [NM_000044]",chrX:66944033-66944092,hs|Xq12,androgen receptor,TRUE
20_DBI_1622,P07108,acyl-coa-binding protein (acbp) (diazepam-binding inhibitor) (dbi) (endozepine) (ep),DBI,87,function: binds medium- and long-chain acyl-coa esters with very high affinity and may function as an intracellular carrier of acyl-coa esters. it is also able to displace diazepam from the benzodiazepine (bzd) recognition site located on the gaba type a receptor. it is therefore possible that this protein also acts as a neuropeptide to modulate the action of the gaba receptor.,"subcellular location: endoplasmic reticulum {eco:0000269|pubmed:17953517, eco:0000269|pubmed:21698759}. golgi apparatus {eco:0000269|pubmed:17953517, eco:0000269|pubmed:21698759}. note=golgi localization is dependent on ligand binding (pubmed:17953517). {eco:0000269|pubmed:17953517}.","TISSUE SPECIFICITY: Isoform 1 is ubiquitous, with a moderate expression level. Isoform 2 is ubiquitous with high level in liver and adipose tissue. Isoform 3 is ubiquitous with strong expression in adipose tissue and heart. {ECO:0000269|PubMed:16055366, ECO:0000269|PubMed:21698759}.",NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DBI,1622,Hs.78888,ENST00000475783,THC2542243,GO:0000062(fatty-acyl-CoA binding)|GO:0006810(transport)|GO:0008289(lipid binding)|GO:0030156(benzodiazepine receptor binding),"Homo sapiens diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) (DBI), transcript variant 1, mRNA [NM_020548]",chr2:120130017-120130076,hs|2q14.2,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",TRUE
200_BRI3_25798,Q9NQX7,integral membrane protein 2c (cerebral protein 14) (transmembrane protein bri3) [cleaved into: ct-bri3],ITM2C BRI3 hucep-14 NPD018 PSEC0047,267,"function: negative regulator of amyloid-beta peptide production. may inhibit the processing of app by blocking its access to alpha- and beta-secretase. binding to the beta-secretase-cleaved app c-terminal fragment is negligible, suggesting that itm2c is a poor gamma-secretase cleavage inhibitor. may play a role in tnf-induced cell death and neuronal differentiation (by similarity). {eco:0000250, eco:0000269|pubmed:18452648, eco:0000269|pubmed:19366692}.",subcellular location: lysosome membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}. cell membrane {eco:0000269|pubmed:19114711}; single-pass type ii membrane protein {eco:0000269|pubmed:19114711}.,"TISSUE SPECIFICITY: High levels in the brain, specifically in the cerebral cortex, medulla, amygdala, hippocampus, thalamus, caudate nucleus, cerebellum, olfactory lobe and spinal cord. Very low levels in other organs. {ECO:0000269|PubMed:11290423, ECO:0000269|PubMed:15606899}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BRI3,25798,Hs.567438,ENST00000297290,THC2560298,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens brain protein I3 (BRI3), transcript variant 1, mRNA [NM_015379]",chr7:97920709-97920768,hs|7q21.3,brain protein I3,TRUE
201_TPD52_7163,P55327,tumor protein d52 (protein n8),TPD52,224,NA,NA,"TISSUE SPECIFICITY: Isoform 2 is expressed in colon, breast, prostate, pancreas and kidney tumor cell lines. Isoform 2 is expressed at high levels in kidney, prostate, brain, small intestine and pancreas, at moderate levels in placenta and colon, at low levels in lung, liver and heart, and at very low levels in spleen, thymus, peripheral mononuclear blood cells, testis and ovary. {ECO:0000269|PubMed:8632896}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,TPD52,7163,Hs.368433,ENST00000523319,THC2467322,GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0009653(anatomical structure morphogenesis)|GO:0030183(B cell differentiation)|GO:0042803(protein homodimerization activity)|GO:0046903(secretion)|GO:0046982(protein heterodimerization activity)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens tumor protein D52 (TPD52), transcript variant 1, mRNA [NM_001025252]",chr8:80949165-80949106,hs|8q21.13,tumor protein D52,TRUE
202_NACA_4666,Q13765,nascent polypeptide-associated complex subunit alpha (nac-alpha) (alpha-nac) (allergen hom s 2),NACA HSD48,215,"function: prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (er). binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (srp), which normally targets nascent secretory peptides to the er. also reduces the inherent affinity of ribosomes for protein translocation sites in the er membrane (m sites). may act as a specific coactivator for jun, binding to dna and stabilizing the interaction of jun homodimers with target gene promoters. {eco:0000269|pubmed:10982809, eco:0000269|pubmed:15784678, eco:0000269|pubmed:9877153}.","subcellular location: cytoplasm. nucleus. note=the heterodimer is located mainly in the cytosol, and the homodimer in the nucleus.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:16201836}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NACA,4666,Hs.505735,ENST00000549259,THC2563118,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005854(nascent polypeptide-associated complex)|GO:0006351(transcription, DNA-dependent)|GO:0006412(translation)|GO:0015031(protein transport)|GO:0044419(interspecies interaction between organisms)","Homo sapiens nascent polypeptide-associated complex alpha subunit (NACA), transcript variant 1, mRNA [NM_001113203]",chr12:57106686-57106627,hs|12q13.3,nascent polypeptide-associated complex alpha subunit,TRUE
203_TMEM87A_25963,Q8NBN3,transmembrane protein 87a,TMEM87A PSEC0094,555,function: may be involved in retrograde transport from endosomes to the trans-golgi network (tgn). {eco:0000269|pubmed:26157166}.,subcellular location: golgi apparatus membrane {eco:0000269|pubmed:26157166}; multi-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM87A,25963,Hs.730697,ENST00000448392,THC2551560,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 87A (TMEM87A), transcript variant 1, mRNA [NM_015497]",chr15:42503478-42503419,hs|15q15.1,transmembrane protein 87A,TRUE
204_SEC11C_90701,Q9BY50,signal peptidase complex catalytic subunit sec11c (ec 3.4.21.89) (microsomal signal peptidase 21 kda subunit) (spase 21 kda subunit) (sec11 homolog c) (sec11-like protein 3) (spc21),SEC11C SEC11L3 SPC21 SPCS4C,192,function: component of the microsomal signal peptidase complex which removes signal peptides from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum. {eco:0000250}.,subcellular location: microsome membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}. endoplasmic reticulum membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC11C,90701,Hs.45107,ENST00000299714,THC2461226,GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006112(energy reserve metabolic process)|GO:0006465(signal peptide processing)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008236(serine-type peptidase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0050796(regulation of insulin secretion),"Homo sapiens SEC11 homolog C (S. cerevisiae) (SEC11C), mRNA [NM_033280]",chr18:56824892-56825917,hs|18q21.32,SEC11 homolog C (S. cerevisiae),TRUE
205_HSPB1_3315,P04792,heat shock protein beta-1 (hspb1) (28 kda heat shock protein) (estrogen-regulated 24 kda protein) (heat shock 27 kda protein) (hsp 27) (stress-responsive protein 27) (srp27),HSPB1 HSP27 HSP28,205,"function: small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (pubmed:10383393, pubmed:20178975). plays a role in stress resistance and actin organization (pubmed:19166925). through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (pubmed:23728742). {eco:0000269|pubmed:10383393, eco:0000269|pubmed:19166925, eco:0000269|pubmed:20178975, eco:0000269|pubmed:23728742}.","subcellular location: cytoplasm {eco:0000269|pubmed:10777697, eco:0000269|pubmed:28144995}. nucleus {eco:0000269|pubmed:19464326}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:10777697}. note=cytoplasmic in interphase cells. colocalizes with mitotic spindles in mitotic cells. translocates to the nucleus during heat shock and resides in sub-nuclear structures known as sc35 speckles or nuclear splicing speckles. {eco:0000269|pubmed:19464326}.","TISSUE SPECIFICITY: Detected in all tissues tested: skeletal muscle, heart, aorta, large intestine, small intestine, stomach, esophagus, bladder, adrenal gland, thyroid, pancreas, testis, adipose tissue, kidney, liver, spleen, cerebral cortex, blood serum and cerebrospinal fluid. Highest levels are found in the heart and in tissues composed of striated and smooth muscle. {ECO:0000269|PubMed:1560006}.","DISEASE: Charcot-Marie-Tooth disease 2F (CMT2F) [MIM:606595]: A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Onset of Charcot-Marie-Tooth disease type 2F is between 15 and 25 years with muscle weakness and atrophy usually beginning in feet and legs (peroneal distribution). Upper limb involvement occurs later. {ECO:0000269|PubMed:15122254, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:22176143, ECO:0000269|PubMed:22206013, ECO:0000269|PubMed:23728742}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]: A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:15122254, ECO:0000269|PubMed:18832141, ECO:0000269|PubMed:18952241, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:20870250, ECO:0000269|PubMed:22176143, ECO:0000269|PubMed:23643870, ECO:0000269|PubMed:23728742, ECO:0000269|PubMed:23948568, ECO:0000269|PubMed:25965061, ECO:0000269|PubMed:28144995}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,HSPB1,3315,Hs.520973,ENST00000447574,NP1168573,GO:0000502(proteasome complex)|GO:0001525(angiogenesis)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005625(soluble fraction)|GO:0005626(insoluble fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005819(spindle)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006446(regulation of translational initiation)|GO:0006469(negative regulation of protein kinase activity)|GO:0006916(anti-apoptosis)|GO:0006928(cellular component movement)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0008219(cell death)|GO:0008426(protein kinase C inhibitor activity)|GO:0009615(response to virus)|GO:0009986(cell surface)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030018(Z disc)|GO:0032731(positive regulation of interleukin-1 beta production)|GO:0035767(endothelial cell chemotaxis)|GO:0035924(cellular response to vascular endothelial growth factor stimulus)|GO:0042535(positive regulation of tumor necrosis factor biosynthetic process)|GO:0043066(negative regulation of apoptosis)|GO:0043122(regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0043130(ubiquitin binding)|GO:0043292(contractile fiber)|GO:0043534(blood vessel endothelial cell migration)|GO:0072568(protein kinase C delta binding),"Homo sapiens heat shock 27kDa protein 1 (HSPB1), mRNA [NM_001540]",chr7:75933396-75933455,hs|7q11.23,heat shock 27kDa protein 1,TRUE
206_DAZAP2_9802,Q15038,daz-associated protein 2 (deleted in azoospermia-associated protein 2),DAZAP2 KIAA0058,168,NA,"subcellular location: cytoplasm. nucleus. note=predominantly nuclear in macrophages, stimulation of il17rb with its ligand il17e induces accumulation in the cytoplasm.","TISSUE SPECIFICITY: Widely expressed. Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocytes. Down-regulated in multiple myeloma. {ECO:0000269|PubMed:10857750}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,DAZAP2,9802,Hs.369761,ENST00000449723,THC2529044,GO:0005515(protein binding)|GO:0050699(WW domain binding),"Homo sapiens DAZ associated protein 2 (DAZAP2), transcript variant 1, mRNA [NM_014764]",chr12:51637402-51637461,hs|12q13.13,DAZ associated protein 2,TRUE
207_FAU_2197,P62861,40s ribosomal protein s30 (small ribosomal subunit protein es30),FAU,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,FAU,2197,Hs.387208,ENST00000526555,THC2564571,GO:0003674(molecular_function)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005575(cellular_component)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008150(biological_process)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (FAU), mRNA [NM_001997]",chr11:64888495-64888262,hs|11q13.1,Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,TRUE
208_TBCA_6902,O75347,tubulin-specific chaperone a (tcp1-chaperonin cofactor a) (tubulin-folding cofactor a) (cfa),TBCA,108,function: tubulin-folding protein; involved in the early step of the tubulin folding pathway.,"subcellular location: cytoplasm, cytoskeleton.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TBCA,6902,Hs.291212,ENST00000518338,THC2630648,GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005874(microtubule)|GO:0006457(protein folding)|GO:0007021(tubulin complex assembly)|GO:0007023(post-chaperonin tubulin folding pathway)|GO:0015630(microtubule cytoskeleton)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding)|GO:0051087(chaperone binding),"Homo sapiens tubulin folding cofactor A (TBCA), mRNA [NM_004607]",chr5:76987258-76987199,hs|5q14.1,tubulin folding cofactor A,TRUE
209_RPL41_6171,P62945,60s ribosomal protein l41 (hg12) (large ribosomal subunit protein el41),RPL41,25,function: interacts with the beta subunit of protein kinase ckii and stimulates phosphorylation of dna topoisomerase ii alpha by ckii.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL41,6171,Hs.157160,ENST00000552314,THC2574959,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L41 (RPL41), transcript variant 2, mRNA [NM_001035267]",chr12:56511329-56511388,hs|12q13.2,ribosomal protein L41,TRUE
21_GTF2I_2969,P78347,general transcription factor ii-i (gtfii-i) (tfii-i) (bruton tyrosine kinase-associated protein 135) (bap-135) (btk-associated protein 135) (srf-phox1-interacting protein) (spin) (williams-beuren syndrome chromosomal region 6 protein),GTF2I BAP135 WBSCR6,998,"function: interacts with the basal transcription machinery by coordinating the formation of a multiprotein complex at the c-fos promoter, and linking specific signal responsive activator complexes. promotes the formation of stable high-order complexes of srf and phox1 and interacts cooperatively with phox1 to promote serum-inducible transcription of a reporter gene deriven by the c-fos serum response element (sre). acts as a coregulator for usf1 by binding independently two promoter elements, a pyrimidine-rich initiator (inr) and an upstream e-box. required for the formation of functional arid3a dna-binding complexes and for activation of immunoglobulin heavy-chain transcription upon b-lymphocyte activation. {eco:0000269|pubmed:10373551, eco:0000269|pubmed:11373296, eco:0000269|pubmed:16738337}.","subcellular location: cytoplasm {eco:0000269|pubmed:10373551}. nucleus {eco:0000255|prosite-prorule:pru00484, eco:0000269|pubmed:10373551}. note=colocalizes with btk in the cytoplasm.","TISSUE SPECIFICITY: Ubiquitous. Isoform 1 is strongly expressed in fetal brain, weakly in adult brain, muscle, and lymphoblasts and is almost undetectable in other adult tissues, while the other isoforms are equally expressed in all adult tissues.","DISEASE: Note=GTF2I is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of GTF2I may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GTF2I,2969,Hs.647041,ENST00000460938,THC2495829,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0007165(signal transduction)|GO:0009790(embryo development)|GO:0016525(negative regulation of angiogenesis)|GO:0042995(cell projection)|GO:0043025(neuronal cell body)|GO:0051019(mitogen-activated protein kinase binding)","Homo sapiens general transcription factor IIi (GTF2I), transcript variant 1, mRNA [NM_032999]",chr7:74174900-74174959,hs|7q11.23,general transcription factor IIi,TRUE
210_POTEG_404785,Q6S5H5,"pote ankyrin domain family member g (ankrd26-like family c member 2) (prostate, ovary, testis-expressed protein on chromosome 14) (pote-14)",POTEG A26C2 POTE14,508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,POTEG,404785,Hs.640191,ENST00000409832,THC2582745,NA,"POTE ankyrin domain family, member G [Source:HGNC Symbol;Acc:33896] [ENST00000409832]",chr14:19589961-19590020,hs|14q11.2,"POTE ankyrin domain family, member G",TRUE
211_RPS15_6209,P62841,40s ribosomal protein s15 (rig protein) (small ribosomal subunit protein us19),RPS15 RIG,145,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS15,6209,Hs.406683,ENST00000233609,THC2566036,GO:0000056(ribosomal small subunit export from nucleus)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S15 (RPS15), mRNA [NM_001018]",chr19:1440162-1440221,hs|19p13.3,ribosomal protein S15,TRUE
212_ZRANB2_9406,O95218,"zinc finger ran-binding domain-containing protein 2 (zinc finger protein 265) (zinc finger, splicing)",ZRANB2 ZIS ZNF265,330,function: splice factor required for alternative splicing of tra2b/sfrs10 transcripts. may interfere with constitutive 5'-splice site selection. {eco:0000269|pubmed:11448987}.,subcellular location: nucleus {eco:0000269|pubmed:11448987}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZRANB2,9406,Hs.194718,ENST00000254821,THC2497005,"GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006397(mRNA processing)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0046872(metal ion binding)","Homo sapiens zinc finger, RAN-binding domain containing 2 (ZRANB2), transcript variant 2, mRNA [NM_005455]",chr1:71529272-71529213,hs|1p31.1,"zinc finger, RAN-binding domain containing 2",TRUE
213_HMGN2P46_283651,Q86SG4,putative dresden prostate carcinoma protein 2 (d-pca-2) (high mobility group nucleosome-binding domain-containing protein 2 pseudogene 46),HMGN2P46 C15orf21,172,NA,NA,TISSUE SPECIFICITY: Very high expression in prostate and prostate cancer. Faint expression in other tissues. {ECO:0000269|PubMed:15027122}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,HMGN2P46,283651,Hs.574240,ENST00000409454,THC2480728,NA,"Homo sapiens high mobility group nucleosomal binding domain 2 pseudogene 46 (HMGN2P46), non-coding RNA [NR_022014]",chr15:45848835-45848894,hs|15q21.1,high mobility group nucleosomal binding domain 2 pseudogene 46,TRUE
214_UQCRB_7381,P14927,cytochrome b-c1 complex subunit 7 (complex iii subunit 7) (complex iii subunit vii) (qp-c) (ubiquinol-cytochrome c reductase complex 14 kda protein),UQCRB UQBP,111,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. this component is involved in redox-linked proton pumping.",subcellular location: mitochondrion inner membrane.,NA,"DISEASE: Mitochondrial complex III deficiency, nuclear 3 (MC3DN3) [MIM:615158]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:12709789}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCRB,7381,Hs.131255,ENST00000521948,THC2546410,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005746(mitochondrial respiratory chain)|GO:0006119(oxidative phosphorylation)|GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c)|GO:0006810(transport)|GO:0008121(ubiquinol-cytochrome-c reductase activity)|GO:0009060(aerobic respiration)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0055114(oxidation-reduction process)","Homo sapiens ubiquinol-cytochrome c reductase binding protein (UQCRB), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_006294]",chr8:97244123-97244064,hs|8q22.1,ubiquinol-cytochrome c reductase binding protein,TRUE
215_ATP6V1G1_9550,O75348,v-type proton atpase subunit g 1 (v-atpase subunit g 1) (v-atpase 13 kda subunit 1) (vacuolar proton pump subunit g 1) (vacuolar proton pump subunit m16),ATP6V1G1 ATP6G ATP6G1 ATP6J,118,"function: catalytic subunit of the peripheral v1 complex of vacuolar atpase (v-atpase). v-atpase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. in aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of fe(2+) prolyl hydroxylase (phd) enzymes, and leading to hif1a hydroxylation and subsequent proteasomal degradation (pubmed:28296633). {eco:0000269|pubmed:28296633}.",NA,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12384298}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ATP6V1G1,9550,Hs.388654,ENST00000374050,NP082649,"GO:0005622(intracellular)|GO:0005765(lysosomal membrane)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006811(ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0008286(insulin receptor signaling pathway)|GO:0008553(hydrogen-exporting ATPase activity, phosphorylative mechanism)|GO:0015992(proton transport)|GO:0016471(vacuolar proton-transporting V-type ATPase complex)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0016887(ATPase activity)|GO:0033572(transferrin transport)|GO:0051117(ATPase binding)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 (ATP6V1G1), mRNA [NM_004888]",chr9:117360145-117360204,hs|9q32,"ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1",TRUE
216_WDR6_11180,Q9NNW5,wd repeat-containing protein 6,WDR6,1121,"function: enhances the stk11/lkb1-induced cell growth suppression activity. negative regulator of amino acid starvation-induced autophagy. {eco:0000269|pubmed:17216128, eco:0000269|pubmed:22354037}.",subcellular location: cytoplasm {eco:0000269|pubmed:17216128}. note=colocalizes in the cytoplasm with stk11/lkb1.,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10903905}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,WDR6,11180,Hs.654815,ENST00000354294,THC2487323,GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0008180(signalosome)|GO:0008285(negative regulation of cell proliferation)|GO:0043560(insulin receptor substrate binding),"Homo sapiens WD repeat domain 6 (WDR6), mRNA [NM_018031]",chr3:49053234-49053293,hs|3p21.31,WD repeat domain 6,TRUE
217_CD63_967,P08962,cd63 antigen (granulophysin) (lysosomal-associated membrane protein 3) (lamp-3) (melanoma-associated antigen me491) (oma81h) (ocular melanoma-associated antigen) (tetraspanin-30) (tspan-30) (cd antigen cd63),CD63 MLA1 TSPAN30,238,"function: functions as cell surface receptor for timp1 and plays a role in the activation of cellular signaling cascades. plays a role in the activation of itgb1 and integrin signaling, leading to the activation of akt, fak/ptk2 and map kinases. promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of akt and fak/ptk2. plays a role in vegfa signaling via its role in regulating the internalization of kdr/vegfr2. plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the pmel luminal domain that is essential for the development and maturation of melanocytes. plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of selp trafficking. may play a role in mast cell degranulation in response to ms4a2/fceri stimulation, but not in mast cell degranulation in response to other stimuli. {eco:0000269|pubmed:16917503, eco:0000269|pubmed:21803846, eco:0000269|pubmed:21962903, eco:0000269|pubmed:23632027, eco:0000269|pubmed:24635319}.","subcellular location: cell membrane {eco:0000269|pubmed:15351990, eco:0000269|pubmed:19640571, eco:0000269|pubmed:23632027}; multi-pass membrane protein {eco:0000255}. lysosome membrane {eco:0000269|pubmed:17897319, eco:0000269|pubmed:19640571, eco:0000269|pubmed:1993697, eco:0000269|pubmed:22431521, eco:0000269|pubmed:23632027}; multi-pass membrane protein {eco:0000255}. late endosome membrane {eco:0000269|pubmed:10793155, eco:0000269|pubmed:23632027}; multi-pass membrane protein {eco:0000255}. endosome, multivesicular body {eco:0000269|pubmed:21962903}. melanosome {eco:0000269|pubmed:21962903}. secreted, extracellular exosome {eco:0000269|pubmed:22660413}. cell surface {eco:0000269|pubmed:16917503, eco:0000269|pubmed:23632027, eco:0000269|pubmed:24635319}. note=also found in weibel-palade bodies of endothelial cells (pubmed:10793155). located in platelet dense granules (pubmed:7682577). detected in a subset of pre-melanosomes. detected on intralumenal vesicles (ilvs) within multivesicular bodies (pubmed:21962903). {eco:0000269|pubmed:10793155, eco:0000269|pubmed:21962903, eco:0000269|pubmed:7682577}.","TISSUE SPECIFICITY: Detected in platelets (at protein level). Dysplastic nevi, radial growth phase primary melanomas, hematopoietic cells, tissue macrophages. {ECO:0000269|PubMed:19640571}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CD63,967,Hs.445570,ENST00000257857,THC2494498,GO:0002576(platelet degranulation)|GO:0005765(lysosomal membrane)|GO:0005768(endosome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007596(blood coagulation)|GO:0010008(endosome membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030168(platelet activation)|GO:0031088(platelet dense granule membrane)|GO:0031902(late endosome membrane),"Homo sapiens CD63 molecule (CD63), transcript variant 1, mRNA [NM_001780]",chr12:56119331-56119272,hs|12q13.2,CD63 molecule,TRUE
218_CHKA_1119,P35790,choline kinase alpha (ck) (ec 2.7.1.32) (chetk-alpha) (ethanolamine kinase) (ek) (ec 2.7.1.82),CHKA CHK CKI,457,function: has a key role in phospholipid biosynthesis and may contribute to tumor cell growth. catalyzes the first step in phosphatidylcholine biosynthesis. contributes to phosphatidylethanolamine biosynthesis. phosphorylates choline and ethanolamine. has higher activity with choline. {eco:0000269|pubmed:19915674}.,subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CHKA,1119,Hs.77221,ENST00000265689,THC2462038,GO:0000166(nucleotide binding)|GO:0004103(choline kinase activity)|GO:0004305(ethanolamine kinase activity)|GO:0004871(signal transducer activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006629(lipid metabolic process)|GO:0006646(phosphatidylethanolamine biosynthetic process)|GO:0006656(phosphatidylcholine biosynthetic process)|GO:0006657(CDP-choline pathway)|GO:0006869(lipid transport)|GO:0007165(signal transduction)|GO:0008144(drug binding)|GO:0008654(phospholipid biosynthetic process)|GO:0019695(choline metabolic process)|GO:0033265(choline binding),"Homo sapiens choline kinase alpha (CHKA), transcript variant 1, mRNA [NM_001277]",chr11:67820509-67820450,hs|11q13.2,choline kinase alpha,TRUE
219_RPL36AL_6166,Q969Q0,60s ribosomal protein l36a-like (large ribosomal subunit protein el42-like),RPL36AL,106,NA,subcellular location: cytoplasm {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:12490704}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPL36AL,6166,Hs.444749,ENST00000298289,THC2467831,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens ribosomal protein L36a-like (RPL36AL), mRNA [NM_001001]",chr14:50085582-50085523,hs|14q21.3,ribosomal protein L36a-like,TRUE
22_EXOC3L2_90332,Q2M3D2,exocyst complex component 3-like protein 2 (hbv x-transactivated gene 7 protein) (hbv xag-transactivated protein 7),EXOC3L2 XTP7,409,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,EXOC3L2,90332,Hs.337557,ENST00000252482,THC2480663,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens exocyst complex component 3-like 2 (EXOC3L2), mRNA [NM_138568]",chr19:45716082-45716023,hs|19q13.32,exocyst complex component 3-like 2,TRUE
220_KHSRP_8570,Q92945,far upstream element-binding protein 2 (fuse-binding protein 2) (kh type-splicing regulatory protein) (ksrp) (p75),KHSRP FUBP2,711,"function: binds to the dendritic targeting element and may play a role in mrna trafficking (by similarity). part of a ternary complex that binds to the downstream control sequence (dcs) of the pre-mrna. mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. may interact with single-stranded dna from the far-upstream element (fuse). may activate gene expression. also involved in degradation of inherently unstable mrnas that contain au-rich elements (ares) in their 3'-utr, possibly by recruiting degradation machinery to are-containing mrnas. {eco:0000250, eco:0000269|pubmed:11003644, eco:0000269|pubmed:8940189, eco:0000269|pubmed:9136930}.",subcellular location: nucleus {eco:0000269|pubmed:19198587}. cytoplasm {eco:0000269|pubmed:19198587}. note=a small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites. {eco:0000250}.,TISSUE SPECIFICITY: Detected in neural and non-neural cell lines.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KHSRP,8570,Hs.91142,ENST00000398148,THC2535701,"GO:0000375(RNA splicing, via transesterification reactions)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006397(mRNA processing)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0051028(mRNA transport)","Homo sapiens KH-type splicing regulatory protein (KHSRP), mRNA [NM_003685]",chr19:6413914-6413855,hs|19p13.3,KH-type splicing regulatory protein,TRUE
221_BACE2_25825,Q9Y5Z0,beta-secretase 2 (ec 3.4.23.45) (aspartic-like protease 56 kda) (aspartyl protease 1) (asp1) (asp 1) (beta-site amyloid precursor protein cleaving enzyme 2) (beta-site app cleaving enzyme 2) (down region aspartic protease) (drap) (memapsin-1) (membrane-associated aspartic protease 1) (theta-secretase),BACE2 AEPLC ALP56 ASP21 CDA13 UNQ418/PRO852,518,"function: responsible for the proteolytic processing of the amyloid precursor protein (app). cleaves app, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble app, and a corresponding cell-associated c-terminal fragment which is later released by gamma-secretase. it has also been shown that it can cleave app between residues 671 and 672. responsible also for the proteolytic processing of cltrn in pancreatic beta cells (pubmed:21907142). {eco:0000269|pubmed:10591213, eco:0000269|pubmed:11083922, eco:0000269|pubmed:11423558, eco:0000269|pubmed:15857888, eco:0000269|pubmed:16816112, eco:0000269|pubmed:21907142}.",subcellular location: cell membrane {eco:0000269|pubmed:21907142}; single-pass type i membrane protein {eco:0000255}. golgi apparatus {eco:0000269|pubmed:11423558}. endoplasmic reticulum. endosome.,"TISSUE SPECIFICITY: Brain. Present in neurons within the hippocampus, frontal cortex and temporal cortex (at protein level). Expressed at low levels in most peripheral tissues and at higher levels in colon, kidney, pancreas, placenta, prostate, stomach and trachea. Expressed at low levels in the brain. Found in spinal cord, medulla oblongata, substantia nigra and locus coruleus. Expressed in the ductal epithelium of both normal and malignant prostate. {ECO:0000269|PubMed:10591213, ECO:0000269|PubMed:10677483, ECO:0000269|PubMed:10683441, ECO:0000269|PubMed:10749877, ECO:0000269|PubMed:10838186, ECO:0000269|PubMed:10965118, ECO:0000269|PubMed:11083922}.",NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BACE2,25825,Hs.529408,ENST00000330333,THC2468305,GO:0004190(aspartic-type endopeptidase activity)|GO:0005768(endosome)|GO:0005783(endoplasmic reticulum)|GO:0005794(Golgi apparatus)|GO:0006508(proteolysis)|GO:0006509(membrane protein ectodomain proteolysis)|GO:0008233(peptidase activity)|GO:0009986(cell surface)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016486(peptide hormone processing)|GO:0042985(negative regulation of amyloid precursor protein biosynthetic process),"Homo sapiens beta-site APP-cleaving enzyme 2 (BACE2), transcript variant a, mRNA [NM_012105]",chr21:42647696-42647755,hs|21q22.3,beta-site APP-cleaving enzyme 2,TRUE
222_ACSS1_84532,Q9NUB1,"acetyl-coenzyme a synthetase 2-like, mitochondrial (ec 6.2.1.1) (acetate--coa ligase 2) (acetyl-coa synthetase 2) (acecs2) (acyl-coa synthetase short-chain family member 1) (propionate--coa ligase) (ec 6.2.1.17)",ACSS1 ACAS2L KIAA1846,689,"function: catalyzes the synthesis of acetyl-coa from short-chain fatty acids (pubmed:16788062). acetate is the preferred substrate (pubmed:16788062). can also utilize propionate with a much lower affinity (by similarity). provides acetyl-coa that is utilized mainly for oxidation under ketogenic conditions (by similarity). involved in thermogenesis under ketogenic conditions, using acetate as a vital fuel when carbohydrate availability is insufficient (by similarity). {eco:0000250|uniprotkb:q99nb1, eco:0000269|pubmed:16788062}.",subcellular location: mitochondrion matrix {eco:0000269|pubmed:16788062}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ACSS1,84532,Hs.529353,ENST00000537502,NP1140206,GO:0000166(nucleotide binding)|GO:0003824(catalytic activity)|GO:0003987(acetate-CoA ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006069(ethanol oxidation)|GO:0006085(acetyl-CoA biosynthetic process)|GO:0006805(xenobiotic metabolic process)|GO:0016208(AMP binding)|GO:0016874(ligase activity)|GO:0019413(acetate biosynthetic process)|GO:0019542(propionate biosynthetic process),"Homo sapiens acyl-CoA synthetase short-chain family member 1 (ACSS1), nuclear gene encoding mitochondrial protein, mRNA [NM_032501]",chr20:24987088-24987029,hs|20p11.21,acyl-CoA synthetase short-chain family member 1,TRUE
224_RPL23A_6147,P62750,60s ribosomal protein l23a (large ribosomal subunit protein ul23),RPL23A,156,"function: component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. binds a specific region on the 26s rrna. may promote p53/tp53 degradation possibly through the stimulation of mdm2-mediated tp53 polyubiquitination (pubmed:26203195). {eco:0000250, eco:0000269|pubmed:26203195}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL23A,6147,Hs.419463,ENST00000473896,THC2544962,GO:0000166(nucleotide binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008283(cell proliferation)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0031932(TORC2 complex)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L23a (RPL23A), mRNA [NM_000984]",chr17:27050590-27050649,hs|17q11.2,ribosomal protein L23a,TRUE
225_COX5B_1329,P10606,"cytochrome c oxidase subunit 5b, mitochondrial (cytochrome c oxidase polypeptide vb)",COX5B,129,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX5B,1329,Hs.1342,ENST00000491989,THC2465799,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005740(mitochondrial envelope)|GO:0005743(mitochondrial inner membrane)|GO:0007585(respiratory gaseous exchange)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0046872(metal ion binding),"Homo sapiens cytochrome c oxidase subunit Vb (COX5B), nuclear gene encoding mitochondrial protein, mRNA [NM_001862]",chr2:98263902-98264513,hs|2q11.2,cytochrome c oxidase subunit Vb,TRUE
226_RPS19_6223,P39019,40s ribosomal protein s19 (small ribosomal subunit protein es19),RPS19,145,function: required for pre-rrna processing and maturation of 40s ribosomal subunits. {eco:0000269|pubmed:16990592}.,"subcellular location: nucleus {eco:0000269|pubmed:12586610, eco:0000269|pubmed:17517689}. note=located more specifically in the nucleoli.",TISSUE SPECIFICITY: Higher level expression is seen in the colon carcinoma tissue than normal colon tissue.,"DISEASE: Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:10590074, ECO:0000269|PubMed:11112378, ECO:0000269|PubMed:12586610, ECO:0000269|PubMed:12750732, ECO:0000269|PubMed:15384984, ECO:0000269|PubMed:17517689, ECO:0000269|PubMed:18412286, ECO:0000269|PubMed:9988267, ECO:0000269|Ref.24}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPS19,6223,Hs.438429,ENST00000221975,THC2548810,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0009991(response to extracellular stimulus)|GO:0010467(gene expression)|GO:0015669(gas transport)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030218(erythrocyte differentiation)|GO:0031018(endocrine pancreas development)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process)|GO:0048856(anatomical structure development)|GO:0051272(positive regulation of cellular component movement),"Homo sapiens ribosomal protein S19 (RPS19), mRNA [NM_001022]",chr19:42365231-42373109,hs|19q13.2,ribosomal protein S19,TRUE
2261_KLK2_3817,P20151,kallikrein-2 (ec 3.4.21.35) (glandular kallikrein-1) (hgk-1) (tissue kallikrein-2),KLK2,261,function: glandular kallikreins cleave met-lys and arg-ser bonds in kininogen to release lys-bradykinin.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,KLK2,3817,Hs.515560,ENST00000358049,THC2468010,GO:0004252(serine-type endopeptidase activity)|GO:0006508(proteolysis)|GO:0008233(peptidase activity),"Homo sapiens kallikrein-related peptidase 2 (KLK2), transcript variant 2, mRNA [NM_001002231]",chr19:51383223-51383282,hs|19q13.33,kallikrein-related peptidase 2,TRUE
227_C20orf3_57136,Q9HDC9,adipocyte plasma membrane-associated protein (protein bscv),APMAP C20orf3 UNQ1869/PRO4305,416,function: exhibits strong arylesterase activity with beta-naphthyl acetate and phenyl acetate. may play a role in adipocyte differentiation. {eco:0000269|pubmed:18513186}.,subcellular location: membrane {eco:0000269|pubmed:18513186}; single-pass type ii membrane protein {eco:0000269|pubmed:18513186}.,"TISSUE SPECIFICITY: Liver, glomerular and tubular structures of the kidney, endothelial cells, arterial wall and pancreatic islets of Langerhans (at protein level). Found ubiquitously in adult as well as in embryonic tissues. In adult tissue, the highest expression is found in the liver, placenta and heart. Found on the cell surface of monocytes. In embryonic tissue, the highest expression levels is found in the liver and the kidney. {ECO:0000269|PubMed:18513186}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C20orf3,57136,Hs.472330,ENST00000447138,THC2773624,GO:0004064(arylesterase activity)|GO:0008150(biological_process)|GO:0009058(biosynthetic process)|GO:0009986(cell surface)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016844(strictosidine synthase activity),"Homo sapiens chromosome 20 open reading frame 3 (C20orf3), mRNA [NM_020531]",chr20:24943659-24943600,hs|20p11.21,chromosome 20 open reading frame 3,TRUE
228_PSME2_5721,Q9UL46,proteasome activator complex subunit 2 (11s regulator complex subunit beta) (reg-beta) (activator of multicatalytic protease subunit 2) (proteasome activator 28 subunit beta) (pa28b) (pa28beta),PSME2,239,function: implicated in immunoproteasome assembly and required for efficient antigen processing. the pa28 activator complex enhances the generation of class i binding peptides by altering the cleavage pattern of the proteasome.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSME2,5721,Hs.434081,ENST00000216802,THC2582263,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008537(proteasome activator complex)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) activator subunit 2 (PA28 beta) (PSME2), mRNA [NM_002818]",chr14:24612636-24612577,hs|14q12,"proteasome (prosome, macropain) activator subunit 2 (PA28 beta)",TRUE
229_SOD1_6647,P00441,superoxide dismutase [cu-zn] (ec 1.15.1.1) (superoxide dismutase 1) (hsod1),SOD1,154,function: destroys radicals which are normally produced within the cells and which are toxic to biological systems.,subcellular location: cytoplasm {eco:0000269|pubmed:19741096}. mitochondrion {eco:0000269|pubmed:19741096}. nucleus {eco:0000269|pubmed:22496122}. note=predominantly cytoplasmic; the pathogenic variants als1 arg-86 and ala-94 gradually aggregates and accumulates in mitochondria. {eco:0000269|pubmed:19741096}.,NA,"DISEASE: Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:10400992, ECO:0000269|PubMed:10430435, ECO:0000269|PubMed:10732812, ECO:0000269|PubMed:11369193, ECO:0000269|PubMed:11535232, ECO:0000269|PubMed:12145308, ECO:0000269|PubMed:12402272, ECO:0000269|PubMed:12754496, ECO:0000269|PubMed:12963370, ECO:0000269|PubMed:14506936, ECO:0000269|PubMed:15056757, ECO:0000269|PubMed:18301754, ECO:0000269|PubMed:18378676, ECO:0000269|PubMed:18552350, ECO:0000269|PubMed:19741096, ECO:0000269|PubMed:21220647, ECO:0000269|PubMed:21247266, ECO:0000269|PubMed:27604643, ECO:0000269|PubMed:7496169, ECO:0000269|PubMed:7501156, ECO:0000269|PubMed:7647793, ECO:0000269|PubMed:7655468, ECO:0000269|PubMed:7655469, ECO:0000269|PubMed:7655471, ECO:0000269|PubMed:7700376, ECO:0000269|PubMed:7795609, ECO:0000269|PubMed:7836951, ECO:0000269|PubMed:7870076, ECO:0000269|PubMed:7881433, ECO:0000269|PubMed:7887412, ECO:0000269|PubMed:7951252, ECO:0000269|PubMed:7980516, ECO:0000269|PubMed:7997024, ECO:0000269|PubMed:8069312, ECO:0000269|PubMed:8179602, ECO:0000269|PubMed:8351519, ECO:0000269|PubMed:8446170, ECO:0000269|PubMed:8528216, ECO:0000269|PubMed:8682505, ECO:0000269|PubMed:8907321, ECO:0000269|PubMed:8938700, ECO:0000269|PubMed:8990014, ECO:0000269|PubMed:9101297, ECO:0000269|PubMed:9131652, ECO:0000269|PubMed:9455977, ECO:0000269|PubMed:9541385}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SOD1,6647,Hs.443914,ENST00000535823,THC2533074,GO:0000187(activation of MAPK activity)|GO:0000303(response to superoxide)|GO:0001541(ovarian follicle development)|GO:0001819(positive regulation of cytokine production)|GO:0001890(placenta development)|GO:0001895(retina homeostasis)|GO:0001975(response to amphetamine)|GO:0002262(myeloid cell homeostasis)|GO:0002576(platelet degranulation)|GO:0004784(superoxide dismutase activity)|GO:0005507(copper ion binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0005777(peroxisome)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006302(double-strand break repair)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006749(glutathione metabolic process)|GO:0006801(superoxide metabolic process)|GO:0006879(cellular iron ion homeostasis)|GO:0006916(anti-apoptosis)|GO:0007283(spermatogenesis)|GO:0007566(embryo implantation)|GO:0007569(cell aging)|GO:0007596(blood coagulation)|GO:0007605(sensory perception of sound)|GO:0007626(locomotory behavior)|GO:0008217(regulation of blood pressure)|GO:0008219(cell death)|GO:0008270(zinc ion binding)|GO:0009408(response to heat)|GO:0010033(response to organic substance)|GO:0016491(oxidoreductase activity)|GO:0019226(transmission of nerve impulse)|GO:0019430(removal of superoxide radicals)|GO:0030168(platelet activation)|GO:0030346(protein phosphatase 2B binding)|GO:0031012(extracellular matrix)|GO:0031410(cytoplasmic vesicle)|GO:0031667(response to nutrient levels)|GO:0032287(peripheral nervous system myelin maintenance)|GO:0032839(dendrite cytoplasm)|GO:0033081(regulation of T cell differentiation in thymus)|GO:0040014(regulation of multicellular organism growth)|GO:0042493(response to drug)|GO:0042542(response to hydrogen peroxide)|GO:0042554(superoxide anion generation)|GO:0042803(protein homodimerization activity)|GO:0043025(neuronal cell body)|GO:0043065(positive regulation of apoptosis)|GO:0043085(positive regulation of catalytic activity)|GO:0043234(protein complex)|GO:0043524(negative regulation of neuron apoptosis)|GO:0045471(response to ethanol)|GO:0045541(negative regulation of cholesterol biosynthetic process)|GO:0045859(regulation of protein kinase activity)|GO:0046620(regulation of organ growth)|GO:0046688(response to copper ion)|GO:0046716(muscle cell homeostasis)|GO:0046872(metal ion binding)|GO:0048538(thymus development)|GO:0048678(response to axon injury)|GO:0050665(hydrogen peroxide biosynthetic process)|GO:0051087(chaperone binding)|GO:0051881(regulation of mitochondrial membrane potential)|GO:0060047(heart contraction)|GO:0060052(neurofilament cytoskeleton organization)|GO:0060087(relaxation of vascular smooth muscle)|GO:0060088(auditory receptor cell stereocilium organization),"Homo sapiens superoxide dismutase 1, soluble (SOD1), mRNA [NM_000454]",chr21:33040890-33040949,hs|21q22.11,"superoxide dismutase 1, soluble",TRUE
23_ND2_4536,P03891,nadh-ubiquinone oxidoreductase chain 2 (ec 7.1.1.2) (nadh dehydrogenase subunit 2),MT-ND2 MTND2 NADH2 ND2,347,function: core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed to belong to the minimal assembly required for catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (by similarity). {eco:0000250}.,subcellular location: mitochondrion inner membrane; multi-pass membrane protein.,NA,"DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. {ECO:0000269|PubMed:1732158, ECO:0000269|PubMed:1900003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alzheimer disease mitochondrial (AD-MT) [MIM:502500]: Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:1370613}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ND2,4536,Hs.631494,ENST00000361453,THC2588692,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0014069(postsynaptic density)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0022904(respiratory electron transport chain)|GO:0042773(ATP synthesis coupled electron transport)|GO:0070469(respiratory chain)|GO:0072593(reactive oxygen species metabolic process)",mitochondrially encoded NADH dehydrogenase 2 [Source:HGNC Symbol;Acc:7456] [ENST00000361453],chrM:4914-4973,NA,MTND2,TRUE
230_RPS26_6231,P62854,40s ribosomal protein s26 (small ribosomal subunit protein es26),RPS26,115,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:p49171}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:p49171, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Diamond-Blackfan anemia 10 (DBA10) [MIM:613309]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:20116044, ECO:0000269|PubMed:24942156}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS26,6231,Hs.567235,ENST00000539199,THC2470192,GO:0003729(mRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0033119(negative regulation of RNA splicing)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S26 (RPS26), mRNA [NM_001029]",chr12:56437923-56437982,hs|12q13.2,ribosomal protein S26,TRUE
231_B4GALT1_2683,P15291,"beta-1,4-galactosyltransferase 1 (beta-1,4-galtase 1) (beta4gal-t1) (b4gal-t1) (ec 2.4.1.-) (beta-n-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (beta-n-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (ec 2.4.1.38) (lactose synthase a protein) (ec 2.4.1.22) (n-acetyllactosamine synthase) (ec 2.4.1.90) (nal synthase) (udp-gal:beta-glcnac beta-1,4-galactosyltransferase 1) (udp-galactose:beta-n-acetylglucosamine beta-1,4-galactosyltransferase 1) [cleaved into: processed beta-1,4-galactosyltransferase 1]",B4GALT1 GGTB2,398,"function: the golgi complex form catalyzes the production of lactose in the lactating mammary gland and could also be responsible for the synthesis of complex-type n-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.; function: the cell surface form functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, as those occurring during development and egg fertilization, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix.","subcellular location: isoform long: golgi apparatus, golgi stack membrane {eco:0000269|pubmed:1714903, eco:0000269|pubmed:20378551}; single-pass type ii membrane protein. cell membrane {eco:0000269|pubmed:1714903}; single-pass type ii membrane protein. cell surface {eco:0000269|pubmed:1714903}. cell projection, filopodium {eco:0000250|uniprotkb:p15535}. note=found in trans cisternae of golgi but is mainly localized at the plasma membrane (pubmed:1714903). b4galt1 cell surface expression is regulated by ube2q1 (by similarity). {eco:0000250|uniprotkb:p15535, eco:0000269|pubmed:1714903}.; subcellular location: isoform short: golgi apparatus, golgi stack membrane {eco:0000269|pubmed:1714903}; single-pass type ii membrane protein. note=found in trans cisternae of golgi. {eco:0000269|pubmed:1714903}.; subcellular location: processed beta-1,4-galactosyltransferase 1: secreted {eco:0000303|pubmed:2120039}. note=soluble form found in body fluids. {eco:0000303|pubmed:2120039}.","TISSUE SPECIFICITY: Ubiquitously expressed, but at very low levels in fetal and adult brain.","DISEASE: Congenital disorder of glycosylation 2D (CDG2D) [MIM:607091]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:11901181}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,B4GALT1,2683,Hs.272011,ENST00000379731,THC2531485,"GO:0000138(Golgi trans cisterna)|GO:0000139(Golgi membrane)|GO:0002064(epithelial cell development)|GO:0002526(acute inflammatory response)|GO:0003831(beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity)|GO:0003945(N-acetyllactosamine synthase activity)|GO:0004461(lactose synthase activity)|GO:0005576(extracellular region)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0005975(carbohydrate metabolic process)|GO:0005989(lactose biosynthetic process)|GO:0006012(galactose metabolic process)|GO:0006486(protein glycosylation)|GO:0007155(cell adhesion)|GO:0007339(binding of sperm to zona pellucida)|GO:0007341(penetration of zona pellucida)|GO:0008092(cytoskeletal protein binding)|GO:0008285(negative regulation of cell proliferation)|GO:0008378(galactosyltransferase activity)|GO:0009312(oligosaccharide biosynthetic process)|GO:0009897(external side of plasma membrane)|GO:0016021(integral to membrane)|GO:0016323(basolateral plasma membrane)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0030057(desmosome)|GO:0030112(glycocalyx)|GO:0030198(extracellular matrix organization)|GO:0030879(mammary gland development)|GO:0031526(brush border membrane)|GO:0032580(Golgi cisterna membrane)|GO:0035250(UDP-galactosyltransferase activity)|GO:0042803(protein homodimerization activity)|GO:0043014(alpha-tubulin binding)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0045136(development of secondary sexual characteristics)|GO:0046872(metal ion binding)|GO:0048487(beta-tubulin binding)|GO:0048754(branching morphogenesis of a tube)|GO:0050900(leukocyte migration)|GO:0051270(regulation of cellular component movement)|GO:0060046(regulation of acrosome reaction)|GO:0060054(positive regulation of epithelial cell proliferation involved in wound healing)|GO:0060055(angiogenesis involved in wound healing)|GO:0060058(positive regulation of apoptosis involved in mammary gland involution)","Homo sapiens UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (B4GALT1), mRNA [NM_001497]",chr9:33110782-33110723,hs|9p21.1,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1",TRUE
232_ACPP_55,P15309,prostatic acid phosphatase (pap) (ec 3.1.3.2) (5'-nucleotidase) (5'-nt) (ec 3.1.3.5) (ecto-5'-nucleotidase) (thiamine monophosphatase) (tmpase) [cleaved into: papf39],ACPP,386,"function: a non-specific tyrosine phosphatase that dephosphorylates a diverse number of substrates under acidic conditions (ph 4-6) including alkyl, aryl, and acyl orthophosphate monoesters and phosphorylated proteins. has lipid phosphatase activity and inactivates lysophosphatidic acid in seminal plasma.; function: isoform 2: the cellular form also has ecto-5'-nucleotidase activity in dorsal root ganglion (drg) neurons. generates adenosine from amp which acts as a pain suppressor. acts as a tumor suppressor of prostate cancer through dephosphorylation of erbb2 and deactivation of mapk-mediated signaling.","subcellular location: isoform 1: secreted {eco:0000305|pubmed:17638863}.; subcellular location: isoform 2: cell membrane {eco:0000269|pubmed:17638863, eco:0000269|pubmed:17897319}; single-pass type i membrane protein {eco:0000255}. lysosome membrane {eco:0000269|pubmed:17638863, eco:0000269|pubmed:17897319}; single-pass type i membrane protein {eco:0000255}. note=appears to shuttle between the cell membrane and intracellular vesicles. colocalizes with flot1 at cell membrane and in intracellular vesicles (pubmed:17638863). colocalizes with lamp2 on the lysosome membrane (pubmed:17897319). {eco:0000269|pubmed:17638863, eco:0000269|pubmed:17897319}.","TISSUE SPECIFICITY: Highly expressed in the prostate, restricted to glandular and ductal epithelial cells. Also expressed in bladder, kidney, pancreas, lung, cervix, testis and ovary. Weak expression in a subset of pancreatic islet cells, squamous epithelia, the pilosebaceous unit, colonic neuroendocrine cells and skin adnexal structures. Isoform 2 also expressed in the sarcolemma of skeletal muscle. Levels of this cellular isoform decreased in prostate cancer. {ECO:0000269|PubMed:17638863, ECO:0000269|PubMed:21487525}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ACPP,55,Hs.433060,ENST00000336375,THC2478204,GO:0003993(acid phosphatase activity)|GO:0005576(extracellular region)|GO:0005622(intracellular)|GO:0005765(lysosomal membrane)|GO:0005886(plasma membrane)|GO:0008253(5'-nucleotidase activity)|GO:0016787(hydrolase activity),"Homo sapiens acid phosphatase, prostate (ACPP), transcript variant 1, mRNA [NM_001099]",chr3:132077343-132077402,hs|3q22.1,"acid phosphatase, prostate",TRUE
233_COX7A2_1347,P14406,"cytochrome c oxidase subunit 7a2, mitochondrial (cytochrome c oxidase subunit viia-liver/heart) (cytochrome c oxidase subunit viia-l) (cytochrome c oxidase subunit viial)",COX7A2 COX7AL,83,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX7A2,1347,Hs.70312,ENST00000459637,THC2544595,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005746(mitochondrial respiratory chain)|GO:0009055(electron carrier activity)|GO:0016020(membrane),"Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 2 (liver) (COX7A2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001865]",chr6:75947606-75947547,hs|6q14.1,cytochrome c oxidase subunit VIIa polypeptide 2 (liver),TRUE
234_ARPC3_10094,O15145,actin-related protein 2/3 complex subunit 3 (arp2/3 complex 21 kda subunit) (p21-arc),ARPC3 ARC21,178,"function: component of the arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (npf) (pubmed:9230079). the arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (pubmed:9230079). in addition to its role in the cytoplasmic cytoskeleton, the arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged dna (pubmed:29925947). the arp2/3 complex promotes homologous recombination (hr) repair in response to dna damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (dsbs) (pubmed:29925947). {eco:0000269|pubmed:29925947, eco:0000269|pubmed:9230079}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:9230079, eco:0000269|pubmed:9359840}. cell projection {eco:0000269|pubmed:9230079, eco:0000269|pubmed:9359840}. nucleus {eco:0000269|pubmed:29925947}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ARPC3,10094,Hs.524741,ENST00000467622,THC2470128,GO:0003779(actin binding)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005885(Arp2/3 protein complex)|GO:0006928(cellular component movement)|GO:0015629(actin cytoskeleton)|GO:0030027(lamellipodium)|GO:0030833(regulation of actin filament polymerization),"Homo sapiens actin related protein 2/3 complex, subunit 3, 21kDa (ARPC3), mRNA [NM_005719]",chr12:110872809-110872750,hs|12q24.11,"actin related protein 2/3 complex, subunit 3, 21kDa",TRUE
235_ATP2C1_27032,P98194,calcium-transporting atpase type 2c member 1 (atpase 2c1) (ec 7.2.2.10) (atp-dependent ca(2+) pump pmr1),ATP2C1 KIAA1347 PMR1L HUSSY-28,919,function: this magnesium-dependent enzyme catalyzes the hydrolysis of atp coupled with the transport of the calcium.,subcellular location: golgi apparatus membrane {eco:0000269|pubmed:12707275}; multi-pass membrane protein {eco:0000269|pubmed:12707275}.,"TISSUE SPECIFICITY: Found in most tissues except colon, thymus, spleen and leukocytes. Most abundant in keratinocytes and kidney.","DISEASE: Hailey-Hailey disease (HHD) [MIM:169600]: Autosomal dominant disorder characterized by persistent blisters and suprabasal cell separation (acantholysis) of the epidermis, due to impaired keratinocyte adhesion. Patients lacking all isoforms except isoform 2 have HHD. {ECO:0000269|PubMed:10615129, ECO:0000269|PubMed:10767338, ECO:0000269|PubMed:11841554, ECO:0000269|PubMed:11874499, ECO:0000269|PubMed:28035777}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP2C1,27032,Hs.584884,ENST00000510168,THC2628458,"GO:0000139(Golgi membrane)|GO:0000166(nucleotide binding)|GO:0004871(signal transducer activity)|GO:0005388(calcium-transporting ATPase activity)|GO:0005509(calcium ion binding)|GO:0005524(ATP binding)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0006754(ATP biosynthetic process)|GO:0006812(cation transport)|GO:0006816(calcium ion transport)|GO:0006828(manganese ion transport)|GO:0006874(cellular calcium ion homeostasis)|GO:0007165(signal transduction)|GO:0008544(epidermis development)|GO:0015410(manganese-transporting ATPase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016339(calcium-dependent cell-cell adhesion)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0030026(cellular manganese ion homeostasis)|GO:0030145(manganese ion binding)|GO:0031532(actin cytoskeleton reorganization)|GO:0032468(Golgi calcium ion homeostasis)|GO:0032472(Golgi calcium ion transport)|GO:0034220(ion transmembrane transport)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0046872(metal ion binding)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, Ca++ transporting, type 2C, member 1 (ATP2C1), transcript variant 1, mRNA [NM_014382]",chr3:130720645-130720704,hs|3q22.1,"ATPase, Ca++ transporting, type 2C, member 1",TRUE
238_CASC3_22794,O15234,protein casc3 (cancer susceptibility candidate gene 3 protein) (metastatic lymph node gene 51 protein) (mln 51) (protein barentsz) (btz),CASC3 MLN51,703,"function: required for pre-mrna splicing as component of the spliceosome (pubmed:28502770, pubmed:29301961). core component of the splicing-dependent multiprotein exon junction complex (ejc) deposited at splice junctions on mrnas. the ejc is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during ejc assembly or during subsequent mrna metabolism. the ejc marks the position of the exon-exon junction in the mature mrna for the gene expression machinery and the core components remain bound to spliced mrnas throughout all stages of mrna metabolism thereby influencing downstream processes including nuclear mrna export, subcellular mrna localization, translation efficiency and nonsense-mediated mrna decay (nmd). stimulates the atpase and rna-helicase activities of eif4a3. plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. component of the dendritic ribonucleoprotein particles (rnps) in hippocampal neurons. may play a role in mrna transport. binds spliced mrna in sequence-independent manner, 20-24 nucleotides upstream of mrna exon-exon junctions. binds poly(g) and poly(u) rna homopolymer. {eco:0000269|pubmed:17375189, eco:0000269|pubmed:17652158, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}.","subcellular location: cytoplasm {eco:0000269|pubmed:12080473}. cytoplasm, perinuclear region {eco:0000250|uniprotkb:q8k3w3}. nucleus {eco:0000269|pubmed:12080473, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}. nucleus speckle {eco:0000269|pubmed:16170325}. cytoplasm, stress granule {eco:0000269|pubmed:17652158}. cytoplasm, cytoplasmic ribonucleoprotein granule {eco:0000250|uniprotkb:q8k3x0}. cell projection, dendrite {eco:0000250|uniprotkb:q8k3x0}. note=shuttles between the nucleus and the cytoplasm in a xpo1/crm1-dependent manner. transported to the cytoplasm as part of the exon junction complex (ejc) bound to mrna (pubmed:15166247). in nuclear speckles, colocalizes with magoh. under stress conditions, colocalizes with fmr1 and tia1, but not magoh and rbm8a ejc core factors, in cytoplasmic stress granules (pubmed:17652158). in the dendrites of hippocampal neurons, localizes to dendritic ribonucleoprotein granules (by similarity). {eco:0000250|uniprotkb:q8k3x0, eco:0000269|pubmed:15166247, eco:0000269|pubmed:17652158}.","TISSUE SPECIFICITY: Widely expressed. Overexpressed in breast cancers and metastasis, as well as in gastric cancers. {ECO:0000269|PubMed:12080473}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CASC3,22794,Hs.730662,ENST00000418132,THC2665474,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006397(mRNA processing)|GO:0006417(regulation of translation)|GO:0006810(transport)|GO:0006950(response to stress)|GO:0008150(biological_process)|GO:0008298(intracellular mRNA localization)|GO:0008380(RNA splicing)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016607(nuclear speck)|GO:0019899(enzyme binding)|GO:0030529(ribonucleoprotein complex)|GO:0031625(ubiquitin protein ligase binding)|GO:0035145(exon-exon junction complex)|GO:0042802(identical protein binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0051028(mRNA transport)","Homo sapiens cancer susceptibility candidate 3 (CASC3), mRNA [NM_007359]",chr17:38328337-38328396,hs|17q21.1,cancer susceptibility candidate 3,TRUE
239_DDR1_780,Q08345,epithelial discoidin domain-containing receptor 1 (epithelial discoidin domain receptor 1) (ec 2.7.10.1) (cd167 antigen-like family member a) (cell adhesion kinase) (discoidin receptor tyrosine kinase) (hgk2) (mammary carcinoma kinase 10) (mck-10) (protein-tyrosine kinase 3a) (protein-tyrosine kinase rtk-6) (trk e) (tyrosine kinase ddr) (tyrosine-protein kinase cak) (cd antigen cd167a),DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE,913,"function: tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. collagen binding triggers a signaling pathway that involves src and leads to the activation of map kinases. regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases mmp2, mmp7 and mmp9, and thereby facilitates cell migration and wound healing. required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. required for normal ear morphology and normal hearing (by similarity). promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. also plays a role in tumor cell invasion. phosphorylates ptpn11. {eco:0000250, eco:0000269|pubmed:12065315, eco:0000269|pubmed:16234985, eco:0000269|pubmed:16337946, eco:0000269|pubmed:19401332, eco:0000269|pubmed:20093046, eco:0000269|pubmed:20432435, eco:0000269|pubmed:20884741, eco:0000269|pubmed:21044884, eco:0000269|pubmed:9659899}.",subcellular location: isoform 1: cell membrane; single-pass type i membrane protein.; subcellular location: isoform 2: cell membrane; single-pass type i membrane protein.; subcellular location: isoform 3: secreted {eco:0000305}.; subcellular location: isoform 4: cell membrane; single-pass type i membrane protein.,"TISSUE SPECIFICITY: Detected in T-47D, MDA-MB-175 and HBL-100 breast carcinoma cells, A-431 epidermoid carcinoma cells, SW48 and SNU-C2B colon carcinoma cells and Hs 294T melanoma cells (at protein level). Expressed at low levels in most adult tissues and is highest in the brain, lung, placenta and kidney. Lower levels of expression are detected in melanocytes, heart, liver, skeletal muscle and pancreas. Abundant in breast carcinoma cell lines. In the colonic mucosa, expressed in epithelia but not in the connective tissue of the lamina propria. In the thyroid gland, expressed in the epithelium of the thyroid follicles. In pancreas, expressed in the islets of Langerhans cells, but not in the surrounding epithelial cells of the exocrine pancreas. In kidney, expressed in the epithelia of the distal tubules. Not expressed in connective tissue, endothelial cells, adipose tissue, muscle cells or cells of hematopoietic origin. {ECO:0000269|PubMed:7845687, ECO:0000269|PubMed:7848919, ECO:0000269|PubMed:8247543}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DDR1,780,Hs.631988,ENST00000376575,THC2473922,"GO:0000166(nucleotide binding)|GO:0001558(regulation of cell growth)|GO:0001952(regulation of cell-matrix adhesion)|GO:0004672(protein kinase activity)|GO:0004714(transmembrane receptor protein tyrosine kinase activity)|GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005576(extracellular region)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion)|GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway)|GO:0007566(embryo implantation)|GO:0008285(negative regulation of cell proliferation)|GO:0016323(basolateral plasma membrane)|GO:0016772(transferase activity, transferring phosphorus-containing groups)|GO:0018108(peptidyl-tyrosine phosphorylation)|GO:0031100(organ regeneration)|GO:0043583(ear development)|GO:0043588(skin development)|GO:0060444(branching involved in mammary gland duct morphogenesis)|GO:0060749(mammary gland alveolus development)","Homo sapiens discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 2, mRNA [NM_013993]",chr6:30867869-30867928,hs|6p21.33,discoidin domain receptor tyrosine kinase 1,TRUE
24_ATP5G2_517,Q06055,"atp synthase f(0) complex subunit c2, mitochondrial (atp synthase lipid-binding protein) (atp synthase membrane subunit c locus 2) (atp synthase proteolipid p2) (atp synthase proton-transporting mitochondrial f(0) complex subunit c2) (atpase protein 9) (atpase subunit c)",ATP5MC2 ATP5G2 PSEC0033,141,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain. a homomeric c-ring of probably 10 subunits is part of the complex rotary element.",subcellular location: mitochondrion membrane; multi-pass membrane protein.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5G2,517,NA,ENST00000550241,NA,"GO:0005215(transporter activity)|GO:0005739(mitochondrion)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0008289(lipid binding)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0015986(ATP synthesis coupled proton transport)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031966(mitochondrial membrane)|GO:0045263(proton-transporting ATP synthase complex, coupling factor F(o))","ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) [Source:HGNC Symbol;Acc:842] [ENST00000550241]",chr12:54026642-54026583,hs|12q13.13,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)",TRUE
240_USP11_8237,P51784,ubiquitin carboxyl-terminal hydrolase 11 (ec 3.4.19.12) (deubiquitinating enzyme 11) (ubiquitin thioesterase 11) (ubiquitin-specific-processing protease 11),USP11 UHX1,963,"function: protease that can remove conjugated ubiquitin from target proteins and polyubiquitin chains (pubmed:12084015, pubmed:15314155, pubmed:17897950, pubmed:19874889, pubmed:20233726, pubmed:24724799). inhibits the degradation of target proteins by the proteasome (pubmed:12084015). cleaves preferentially 'lys-6' and 'lys-63'-linked ubiquitin chains. has lower activity with 'lys-11' and 'lys-33'-linked ubiquitin chains, and extremely low activity with 'lys-27', 'lys-29' and 'lys-48'-linked ubiquitin chains (in vitro) (pubmed:24724799). plays a role in the regulation of pathways leading to nf-kappa-b activation (pubmed:17897950, pubmed:19874889). plays a role in the regulation of dna repair after double-stranded dna breaks (pubmed:15314155, pubmed:20233726). acts as a chromatin regulator via its association with the polycomb group (pcg) multiprotein prc1-like complex; may act by deubiquitinating components of the prc1-like complex (pubmed:20601937). {eco:0000269|pubmed:15314155, eco:0000269|pubmed:17897950, eco:0000269|pubmed:18408009, eco:0000269|pubmed:19874889, eco:0000269|pubmed:20233726, eco:0000269|pubmed:24724799}.","subcellular location: nucleus {eco:0000269|pubmed:12084015, eco:0000269|pubmed:15314155, eco:0000269|pubmed:20233726}. cytoplasm {eco:0000269|pubmed:15314155}. chromosome {eco:0000269|pubmed:20233726, eco:0000269|pubmed:20601937}. note=predominantly nuclear (pubmed:12084015, pubmed:15314155). associates with chromatin (pubmed:20601937, pubmed:20233726). {eco:0000269|pubmed:12084015, eco:0000269|pubmed:15314155, eco:0000269|pubmed:20233726, eco:0000269|pubmed:20601937}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,USP11,8237,Hs.171501,ENST00000467378,THC2531986,GO:0004197(cysteine-type endopeptidase activity)|GO:0004221(ubiquitin thiolesterase activity)|GO:0004843(ubiquitin-specific protease activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006508(proteolysis)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0008233(peptidase activity)|GO:0016579(protein deubiquitination),"Homo sapiens ubiquitin specific peptidase 11 (USP11), mRNA [NM_004651]",chrX:47107052-47107204,hs|Xp11.23,ubiquitin specific peptidase 11,TRUE
241_RAB3D_9545,O95716,ras-related protein rab-3d,RAB3D GOV RAB16,219,function: protein transport. probably involved in regulated exocytosis (by similarity). {eco:0000250}.,subcellular location: cell membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}.,TISSUE SPECIFICITY: Highly expressed in granulocytes of peripheral blood. Constitutively expressed at low levels in all hematopoietic cell lines investigated.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAB3D,9545,Hs.655274,ENST00000222120,THC2659541,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005739(mitochondrion)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0007264(small GTPase mediated signal transduction)|GO:0015031(protein transport)|GO:0017157(regulation of exocytosis)|GO:0018125(peptidyl-cysteine methylation)|GO:0030133(transport vesicle)|GO:0042588(zymogen granule)|GO:0051020(GTPase binding),"Homo sapiens RAB3D, member RAS oncogene family (RAB3D), mRNA [NM_004283]",chr19:11432794-11432735,hs|19p13.2,"RAB3D, member RAS oncogene family",TRUE
242_HMGB2_3148,P26583,high mobility group protein b2 (high mobility group protein 2) (hmg-2),HMGB2 HMG2,209,"function: multifunctional protein with various roles in different cellular compartments. may act in a redox sensitive manner. in the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and v(d)j recombination and probably other processes. binds dna with a preference to non-canonical dna structures such as single-stranded dna. can bent dna and enhance dna flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (pubmed:7797075, pubmed:11909973, pubmed:19522541, pubmed:18413230, pubmed:19965638, pubmed:20123072). involved in v(d)j recombination by acting as a cofactor of the rag complex: acts by stimulating cleavage and rag protein binding at the 23 bp spacer of conserved recombination signal sequences (rss) (by similarity). proposed to be involved in the innate immune response to nucleic acids by acting as a promiscuous immunogenic dna/rna sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (by similarity). in the extracellular compartment acts as a chemokine. promotes proliferation and migration of endothelial cells implicating ager/rage (pubmed:19811285). has antimicrobial activity in gastrointestinal epithelial tissues (pubmed:23877675). involved in inflammatory response to antigenic stimulus coupled with proinflammatory activity (by similarity). involved in modulation of neurogenesis probably by regulation of neural stem proliferation (by similarity). involved in articular cartilage surface maintenance implicating lef1 and the wnt/beta-catenin pathway (by similarity). {eco:0000250|uniprotkb:p09429, eco:0000250|uniprotkb:p30681, eco:0000269|pubmed:11909973, eco:0000269|pubmed:18413230, eco:0000269|pubmed:19522541, eco:0000269|pubmed:19811285, eco:0000269|pubmed:19965638, eco:0000269|pubmed:23877675, eco:0000269|pubmed:7797075, eco:0000305|pubmed:20123072}.","subcellular location: nucleus {eco:0000269|pubmed:11909973, eco:0000269|pubmed:12925773, eco:0000269|pubmed:23877675}. chromosome {eco:0000269|pubmed:12925773}. cytoplasm {eco:0000269|pubmed:11909973, eco:0000269|pubmed:23877675}. secreted {eco:0000269|pubmed:19811285, eco:0000269|pubmed:23877675}. note=in basal state predominantly nuclear. {eco:0000305}.",TISSUE SPECIFICITY: Expressed in gastric and intestinal tissues (at protein level). {ECO:0000269|PubMed:23877675}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,HMGB2,3148,Hs.434953,ENST00000511316,THC2502562,"GO:0000793(condensed chromosome)|GO:0001938(positive regulation of endothelial cell proliferation)|GO:0003677(DNA binding)|GO:0003684(damaged DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006265(DNA topological change)|GO:0006288(base-excision repair, DNA ligation)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006325(chromatin organization)|GO:0006334(nucleosome assembly)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0007283(spermatogenesis)|GO:0007289(spermatid nucleus differentiation)|GO:0008301(DNA bending activity)|GO:0008584(male gonad development)|GO:0019904(protein domain specific binding)|GO:0032075(positive regulation of nuclease activity)|GO:0033151(V(D)J recombination)|GO:0042056(chemoattractant activity)|GO:0043234(protein complex)|GO:0043388(positive regulation of DNA binding)|GO:0044212(transcription regulatory region DNA binding)|GO:0045648(positive regulation of erythrocyte differentiation)|GO:0045654(positive regulation of megakaryocyte differentiation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0048471(perinuclear region of cytoplasm)|GO:0048545(response to steroid hormone stimulus)|GO:0050786(RAGE receptor binding)|GO:0050918(positive chemotaxis)|GO:0051103(DNA ligation involved in DNA repair)|GO:0060326(cell chemotaxis)|GO:0071222(cellular response to lipopolysaccharide)","Homo sapiens high mobility group box 2 (HMGB2), transcript variant 1, mRNA [NM_002129]",chr4:174253072-174253013,hs|4q34.1,high mobility group box 2,TRUE
243_NFKBIA_4792,P25963,nf-kappa-b inhibitor alpha (i-kappa-b-alpha) (ikb-alpha) (ikappabalpha) (major histocompatibility complex enhancer-binding protein mad3),NFKBIA IKBA MAD3 NFKBI,317,"function: inhibits the activity of dimeric nf-kappa-b/rel complexes by trapping rel dimers in the cytoplasm through masking of their nuclear localization signals. on cellular stimulation by immune and proinflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric rela to translocate to the nucleus and activate transcription. {eco:0000269|pubmed:7479976}.",subcellular location: cytoplasm. nucleus. note=shuttles between the nucleus and the cytoplasm by a nuclear localization signal (nls) and a crm1-dependent nuclear export. {eco:0000250}.,NA,"DISEASE: Ectodermal dysplasia and immunodeficiency 2 (EDAID2) [MIM:612132]: A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. This form of ectodermal dysplasia is associated with decreased production of pro-inflammatory cytokines and certain interferons, rendering patients susceptible to infection. EDAID2 inheritance is autosomal dominant. {ECO:0000269|PubMed:14523047, ECO:0000269|PubMed:18412279}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NFKBIA,4792,Hs.81328,ENST00000554001,THC2668804,"GO:0000060(protein import into nucleus, translocation)|GO:0002224(toll-like receptor signaling pathway)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0007253(cytoplasmic sequestering of NF-kappaB)|GO:0008063(Toll signaling pathway)|GO:0008134(transcription factor binding)|GO:0008139(nuclear localization sequence binding)|GO:0010745(negative regulation of macrophage derived foam cell differentiation)|GO:0010875(positive regulation of cholesterol efflux)|GO:0010888(negative regulation of lipid storage)|GO:0019899(enzyme binding)|GO:0031072(heat shock protein binding)|GO:0031625(ubiquitin protein ligase binding)|GO:0031663(lipopolysaccharide-mediated signaling pathway)|GO:0032088(negative regulation of NF-kappaB transcription factor activity)|GO:0032270(positive regulation of cellular protein metabolic process)|GO:0032495(response to muramyl dipeptide)|GO:0032496(response to lipopolysaccharide)|GO:0033256(I-kappaB/NF-kappaB complex)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042127(regulation of cell proliferation)|GO:0042345(regulation of NF-kappaB import into nucleus)|GO:0042802(identical protein binding)|GO:0042994(cytoplasmic sequestering of transcription factor)|GO:0043330(response to exogenous dsRNA)|GO:0043392(negative regulation of DNA binding)|GO:0044419(interspecies interaction between organisms)|GO:0045087(innate immune response)|GO:0045638(negative regulation of myeloid cell differentiation)|GO:0045746(negative regulation of Notch signaling pathway)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050852(T cell receptor signaling pathway)|GO:0051059(NF-kappaB binding)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0070417(cellular response to cold)|GO:0070427(nucleotide-binding oligomerization domain containing 1 signaling pathway)|GO:0070431(nucleotide-binding oligomerization domain containing 2 signaling pathway)","Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA), mRNA [NM_020529]",chr14:35870847-35870788,hs|14q13.2,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",TRUE
244_RPL7_6129,P18124,60s ribosomal protein l7 (large ribosomal subunit protein ul30),RPL7,248,function: component of the large ribosomal subunit (pubmed:12962325). binds to g-rich structures in 28s rrna and in mrnas. plays a regulatory role in the translation apparatus; inhibits cell-free translation of mrnas. {eco:0000305|pubmed:12962325}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL7,6129,Hs.571841,ENST00000352983,THC2465604,GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0042273(ribosomal large subunit biogenesis)|GO:0042803(protein homodimerization activity)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L7 (RPL7), mRNA [NM_000971]",chr8:74203307-74202911,hs|8q21.11,ribosomal protein L7,TRUE
245_HNRNPC_3183,P07910,heterogeneous nuclear ribonucleoproteins c1/c2 (hnrnp c1/c2),HNRNPC HNRPC,306,"function: binds pre-mrna and nucleates the assembly of 40s hnrnp particles (pubmed:8264621). interacts with poly-u tracts in the 3'-utr or 5'-utr of mrna and modulates the stability and the level of translation of bound mrna molecules (pubmed:12509468, pubmed:16010978, pubmed:7567451, pubmed:8264621). single hnrnpc tetramers bind 230-240 nucleotides. trimers of hnrnpc tetramers bind 700 nucleotides (pubmed:8264621). may play a role in the early steps of spliceosome assembly and pre-mrna splicing. n6-methyladenosine (m6a) has been shown to alter the local structure in mrnas and long non-coding rnas (lncrnas) via a mechanism named 'm(6)a-switch', facilitating binding of hnrnpc, leading to regulation of mrna splicing (pubmed:25719671). {eco:0000269|pubmed:12509468, eco:0000269|pubmed:16010978, eco:0000269|pubmed:25719671, eco:0000269|pubmed:7567451, eco:0000269|pubmed:8264621}.",subcellular location: nucleus. note=component of ribonucleosomes.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPC,3183,Hs.508848,ENST00000556897,THC2487809,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0042802(identical protein binding)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRNPC), transcript variant 1, mRNA [NM_031314]",chr14:21679231-21679172,hs|14q11.2,heterogeneous nuclear ribonucleoprotein C (C1/C2),TRUE
246_NDUFB4_4710,O95168,nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (complex i-b15) (ci-b15) (nadh-ubiquinone oxidoreductase b15 subunit),NDUFB4,129,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}; matrix side {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB4,4710,Hs.304613,ENST00000496588,THC2718177,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0006979(response to oxidative stress)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa (NDUFB4), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004547]",chr3:120321089-120321148,hs|3q13.33,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa",TRUE
247_UBA52_7311,P62987,ubiquitin-60s ribosomal protein l40 (cep52) (ubiquitin a-52 residue ribosomal protein fusion product 1) [cleaved into: ubiquitin; 60s ribosomal protein l40 (large ribosomal subunit protein el40)],UBA52 UBCEP2,128,"function: ubiquitin: exists either covalently attached to another protein, or free (unanchored). when covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator met of the ubiquitin (linear polyubiquitin chains). polyubiquitin chains, when attached to a target protein, have different functions depending on the lys residue of the ubiquitin that is linked: lys-6-linked may be involved in dna repair; lys-11-linked is involved in erad (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; lys-29-linked is involved in lysosomal degradation; lys-33-linked is involved in kinase modification; lys-48-linked is involved in protein degradation via the proteasome; lys-63-linked is involved in endocytosis, dna-damage responses as well as in signaling processes leading to activation of the transcription factor nf-kappa-b. linear polymer chains formed via attachment by the initiator met lead to cell signaling. ubiquitin is usually conjugated to lys residues of target proteins, however, in rare cases, conjugation to cys or ser residues has been observed. when polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling.; function: 60s ribosomal protein l40: component of the 60s subunit of the ribosome. ribosomal protein l40 is essential for translation of a subset of cellular transcripts, and especially for cap-dependent translation of vesicular stomatitis virus mrnas.",subcellular location: ubiquitin: cytoplasm {eco:0000250}. nucleus {eco:0000250}.; subcellular location: 60s ribosomal protein l40: cytoplasm {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,UBA52,7311,Hs.5308,ENST00000442744,THC2563771,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000187(activation of MAPK activity)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0003735(structural constituent of ribosome)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0005886(plasma membrane)|GO:0006281(DNA repair)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006464(protein modification process)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007254(JNK cascade)|GO:0008063(Toll signaling pathway)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0010008(endosome membrane)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016044(cellular membrane organization)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016197(endosome transport)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030666(endocytic vesicle membrane)|GO:0031018(endocrine pancreas development)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0032480(negative regulation of type I interferon production)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042981(regulation of apoptosis)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0044267(cellular protein metabolic process)|GO:0045087(innate immune response)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051403(stress-activated MAPK cascade)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)","Homo sapiens ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52), transcript variant 1, mRNA [NM_001033930]",chr19:18685887-18685946,hs|19p13.11,ubiquitin A-52 residue ribosomal protein fusion product 1,TRUE
248_OR51E2_81285,Q9H255,olfactory receptor 51e2 (hpraj) (olfactory receptor or11-16) (prostate-specific g-protein coupled receptor),OR51E2 PSGR,320,"function: olfactory receptor (pubmed:29249973, pubmed:27226631). activated by the odorant, beta-ionone, a synthetic terpenoid (pubmed:29249973, pubmed:27226631, pubmed:19389702). the activity of this receptor is propably mediated by g-proteins leading to the elevation of intracellular ca(2+), camp and activation of the protein kinases pka and mapk3/mapk1 (pubmed:27226631, pubmed:29249973). stimulation of or51e2 by beta-ionone affects melanocyte proliferation, differentiation, and melanogenesis (pubmed:27226631). activation of or51e2 by beta-ionone increases proliferation and migration of primary retinal pigment epithelial (rpe) cells (pubmed:29249973). activated also by the short-chain fatty acids (scfa) acetate and propionate. in response to scfa, may positively regulate renin secretion and increase blood pressure (pubmed:23401498). may also be activated by steroid hormones and regulate cell proliferation (pubmed:19389702). activated by l-lactate in glomus cells (by similarity). {eco:0000250|uniprotkb:q8vbv9, eco:0000269|pubmed:19389702, eco:0000269|pubmed:23401498, eco:0000269|pubmed:27226631, eco:0000269|pubmed:29249973}.","subcellular location: cell membrane {eco:0000269|pubmed:23401498, eco:0000269|pubmed:27226631, eco:0000269|pubmed:29249973}; multi-pass membrane protein {eco:0000255}. early endosome membrane {eco:0000269|pubmed:27226631}; multi-pass membrane protein {eco:0000255}.","TISSUE SPECIFICITY: Highly expressed in the prostate (PubMed:11707321). Also expressed in spleen, liver, olfactory epithelium, retinal pigment epithelium and medulla oblongata (PubMed:29249973, PubMed:11707321, PubMed:16491480). In the retinal pigment epithelium expression is restricted to the pigment cells and choroid (at protein level) (PubMed:29249973). Expressed in epidermal melanocytes (at protein level) (PubMed:27226631). {ECO:0000269|PubMed:11707321, ECO:0000269|PubMed:16491480, ECO:0000269|PubMed:27226631, ECO:0000269|PubMed:29249973}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,OR51E2,81285,Hs.501758,ENST00000396950,THC2483468,GO:0004871(signal transducer activity)|GO:0004872(receptor activity)|GO:0004930(G-protein coupled receptor activity)|GO:0004984(olfactory receptor activity)|GO:0005886(plasma membrane)|GO:0007608(sensory perception of smell)|GO:0016021(integral to membrane)|GO:0050896(response to stimulus)|GO:0050911(detection of chemical stimulus involved in sensory perception of smell),"Homo sapiens olfactory receptor, family 51, subfamily E, member 2 (OR51E2), mRNA [NM_030774]",chr11:4701498-4701439,hs|11p15.4,"olfactory receptor, family 51, subfamily E, member 2",TRUE
249_CCDC72_51372,Q9Y2S6,translation machinery-associated protein 7 (coiled-coil domain-containing protein 72),TMA7 CCDC72 HSPC016 HSPC330,64,NA,NA,TISSUE SPECIFICITY: Expressed in dermal papilla cells with aggregative behavior. {ECO:0000269|PubMed:16096800}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,CCDC72,51372,Hs.356440,ENST00000477624,THC2506853,NA,coiled-coil domain containing 72 [Source:HGNC Symbol;Acc:26932] [ENST00000477624],chr3:48485552-48485611,hs|3p21.31,coiled-coil domain containing 72,TRUE
25_PEBP1_5037,P30086,phosphatidylethanolamine-binding protein 1 (pebp-1) (hcnppp) (neuropolypeptide h3) (prostatic-binding protein) (raf kinase inhibitor protein) (rkip) [cleaved into: hippocampal cholinergic neurostimulating peptide (hcnp)],PEBP1 PBP PEBP,187,"function: binds atp, opioids and phosphatidylethanolamine. has lower affinity for phosphatidylinositol and phosphatidylcholine. serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase (by similarity). inhibits the kinase activity of raf1 by inhibiting its activation and by dissociating the raf1/mek complex and acting as a competitive inhibitor of mek phosphorylation. {eco:0000250, eco:0000269|pubmed:18294816}.; function: hcnp may be involved in the function of the presynaptic cholinergic neurons of the central nervous system. hcnp increases the production of choline acetyltransferase but not acetylcholinesterase. seems to be mediated by a specific receptor (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PEBP1,5037,Hs.433863,ENST00000418769,THC2535532,GO:0000166(nucleotide binding)|GO:0001505(regulation of neurotransmitter levels)|GO:0001933(negative regulation of protein phosphorylation)|GO:0002026(regulation of the force of heart contraction)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0005102(receptor binding)|GO:0005524(ATP binding)|GO:0005615(extracellular space)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005791(rough endoplasmic reticulum)|GO:0005794(Golgi apparatus)|GO:0006979(response to oxidative stress)|GO:0007286(spermatid development)|GO:0007420(brain development)|GO:0007568(aging)|GO:0008021(synaptic vesicle)|GO:0008289(lipid binding)|GO:0008429(phosphatidylethanolamine binding)|GO:0009408(response to heat)|GO:0009611(response to wounding)|GO:0009636(response to toxin)|GO:0009986(cell surface)|GO:0010243(response to organic nitrogen)|GO:0014070(response to organic cyclic compound)|GO:0014823(response to activity)|GO:0019717(synaptosome)|GO:0030414(peptidase inhibitor activity)|GO:0042493(response to drug)|GO:0042755(eating behavior)|GO:0043025(neuronal cell body)|GO:0043409(negative regulation of MAPKKK cascade)|GO:0043679(axon terminus)|GO:0043950(positive regulation of cAMP-mediated signaling)|GO:0045177(apical part of cell)|GO:0045471(response to ethanol)|GO:0045840(positive regulation of mitosis)|GO:0051019(mitogen-activated protein kinase binding)|GO:0051412(response to corticosterone stimulus)|GO:0051591(response to cAMP)|GO:0051592(response to calcium ion)|GO:0051602(response to electrical stimulus)|GO:0060409(positive regulation of acetylcholine metabolic process),"Homo sapiens phosphatidylethanolamine binding protein 1 (PEBP1), mRNA [NM_002567]",chr12:118583256-118583315,hs|12q24.23,phosphatidylethanolamine binding protein 1,TRUE
250_KPNB1_3837,Q14974,importin subunit beta-1 (importin-90) (karyopherin subunit beta-1) (nuclear factor p97) (pore targeting complex 97 kda subunit) (ptac97),KPNB1 NTF97,876,"function: functions in nuclear protein import, either in association with an adapter protein, like an importin-alpha subunit, which binds to nuclear localization signals (nls) in cargo substrates, or by acting as autonomous nuclear transport receptor. acting autonomously, serves itself as nls receptor. docking of the importin/substrate complex to the nuclear pore complex (npc) is mediated by kpnb1 through binding to nucleoporin fxfg repeats and the complex is subsequently translocated through the pore by an energy requiring, ran-dependent mechanism. at the nucleoplasmic side of the npc, ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where gtp hydrolysis releases ran from importin. the directionality of nuclear import is thought to be conferred by an asymmetric distribution of the gtp- and gdp-bound forms of ran between the cytoplasm and nucleus. mediates autonomously the nuclear import of ribosomal proteins rpl23a, rps7 and rpl5. binds to a beta-like import receptor binding (bib) domain of rpl23a. in association with ipo7 mediates the nuclear import of h1 histone. in vitro, mediates nuclear import of h2a, h2b, h3 and h4 histones. in case of hiv-1 infection, binds and mediates the nuclear import of hiv-1 rev. imports snai1 and prkci into the nucleus. {eco:0000269|pubmed:10228156, eco:0000269|pubmed:11891849, eco:0000269|pubmed:19386897, eco:0000269|pubmed:24699649, eco:0000269|pubmed:9687515}.",subcellular location: cytoplasm {eco:0000269|pubmed:11891849}. nucleus envelope {eco:0000269|pubmed:11891849}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KPNB1,3837,Hs.532793,NA,THC2565834,"GO:0000060(protein import into nucleus, translocation)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005643(nuclear pore)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006606(protein import into nucleus)|GO:0006607(NLS-bearing substrate import into nucleus)|GO:0006610(ribosomal protein import into nucleus)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0008139(nuclear localization sequence binding)|GO:0008270(zinc ion binding)|GO:0008565(protein transporter activity)|GO:0016032(viral reproduction)|GO:0019058(viral infectious cycle)|GO:0019904(protein domain specific binding)|GO:0031965(nuclear membrane)|GO:0044419(interspecies interaction between organisms)|GO:0046796(viral genome transport in host cell)","Homo sapiens karyopherin (importin) beta 1 (KPNB1), mRNA [NM_002265]",chr17:45760373-45760432,hs|17q21.32,karyopherin (importin) beta 1,TRUE
251_COX2_4513,P35354,prostaglandin g/h synthase 2 (ec 1.14.99.1) (cyclooxygenase-2) (cox-2) (phs ii) (prostaglandin h2 synthase 2) (pgh synthase 2) (pghs-2) (prostaglandin-endoperoxide synthase 2),PTGS2 COX2,604,"function: converts arachidonate to prostaglandin h2 (pgh2), a committed step in prostanoid synthesis (pubmed:26859324, pubmed:27226593). constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and brain, and in pathological conditions, such as in cancer. ptgs2 is responsible for production of inflammatory prostaglandins. up-regulation of ptgs2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumor angiogenesis. in cancer cells, ptgs2 is a key step in the production of prostaglandin e2 (pge2), which plays important roles in modulating motility, proliferation and resistance to apoptosis. during neuroinflammation, plays a role in neuronal secretion of specialized preresolving mediators (spms), especially 15-r-lipoxin a4, that regulates phagocytic microglia (by similarity). {eco:0000250|uniprotkb:q05769, eco:0000269|pubmed:16373578, eco:0000269|pubmed:26859324, eco:0000269|pubmed:27226593}.",subcellular location: microsome membrane; peripheral membrane protein. endoplasmic reticulum membrane; peripheral membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX2,4513,Hs.197320,ENST00000361739,THC2584826,"GO:0004129(cytochrome-c oxidase activity)|GO:0005507(copper ion binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006123(mitochondrial electron transport, cytochrome c to oxygen)|GO:0006810(transport)|GO:0007595(lactation)|GO:0009055(electron carrier activity)|GO:0009409(response to cold)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0020037(heme binding)|GO:0022904(respiratory electron transport chain)|GO:0046872(metal ion binding)|GO:0070469(respiratory chain)",mitochondrially encoded cytochrome c oxidase II [Source:HGNC Symbol;Acc:7421] [ENST00000361739],chrM:7987-8046,NA,cytochrome c oxidase subunit II,TRUE
252_NDUFC1_4717,O43677,"nadh dehydrogenase [ubiquinone] 1 subunit c1, mitochondrial (complex i-kfyi) (ci-kfyi) (nadh-ubiquinone oxidoreductase kfyi subunit)",NDUFC1,76,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000250|uniprotkb:q02376}; single-pass membrane protein {eco:0000250|uniprotkb:q02376}; matrix side {eco:0000250|uniprotkb:q02376}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFC1,4717,Hs.84549,ENST00000394223,THC2507890,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa (NDUFC1), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_002494]",chr4:140213694-140211198,hs|4q31.1,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa",TRUE
254_HILPDA_29923,Q9Y5L2,hypoxia-inducible lipid droplet-associated protein (hypoxia-inducible gene 2 protein),HILPDA C7orf68 HIG2,63,"function: increases intracellular lipid accumulation. stimulates expression of cytokines including il6, mif and vegfa. enhances cell growth and proliferation. {eco:0000269|pubmed:15930302, eco:0000269|pubmed:20624928}.",subcellular location: lipid droplet. secreted. membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Highly expressed in renal cell carcinoma cells but barely detectable in adjacent normal kidney tissue. Detected in some cervical and endometrial cancers. Expression also detected in fetal kidney with little or no expression observed in normal adult heart, liver, lung, pancreas, prostate or spinal cord (at protein level). {ECO:0000269|PubMed:15930302, ECO:0000269|PubMed:20624928, ECO:0000269|PubMed:21614900}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HILPDA,29923,Hs.706124,ENST00000466473,THC2461902,GO:0001819(positive regulation of cytokine production)|GO:0005102(receptor binding)|GO:0005615(extracellular space)|GO:0005811(lipid particle)|GO:0006950(response to stress)|GO:0008284(positive regulation of cell proliferation)|GO:0009986(cell surface)|GO:0010884(positive regulation of lipid storage)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030141(stored secretory granule)|GO:0035425(autocrine signaling),"Homo sapiens chromosome 7 open reading frame 68 (C7orf68), transcript variant 1, mRNA [NM_013332]",chr7:128098381-128098440,hs|7q32.1,hypoxia inducible lipid droplet-associated,TRUE
255_RANBP2_5903,P49792,e3 sumo-protein ligase ranbp2 (ec 2.3.2.-) (358 kda nucleoporin) (nuclear pore complex protein nup358) (nucleoporin nup358) (ran-binding protein 2) (ranbp2) (p270),RANBP2 NUP358,3224,"function: e3 sumo-protein ligase which facilitates sumo1 and sumo2 conjugation by ube2i (pubmed:11792325, pubmed:12032081, pubmed:15378033, pubmed:22194619, pubmed:15931224). involved in transport factor (ran-gtp, karyopherin)-mediated protein import via the f-g repeat-containing domain which acts as a docking site for substrates (pubmed:7775481). binds single-stranded rna (in vitro) (pubmed:7775481). may bind dna (pubmed:7775481). component of the nuclear export pathway (pubmed:10078529). specific docking site for the nuclear export factor exportin-1 (pubmed:10078529). sumoylates pml at 'lys-490' which is essential for the proper assembly of pml-nb (pubmed:22155184). recruits bicd2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during g2 phase of cell cycle (pubmed:20386726). probable inactive ppiase with no peptidyl-prolyl cis-trans isomerase activity (pubmed:20676357, pubmed:23353830). {eco:0000269|pubmed:11792325, eco:0000269|pubmed:12032081, eco:0000269|pubmed:15378033, eco:0000269|pubmed:15931224, eco:0000269|pubmed:20386726, eco:0000269|pubmed:20676357, eco:0000269|pubmed:22155184, eco:0000269|pubmed:22194619, eco:0000269|pubmed:23353830, eco:0000269|pubmed:7775481, eco:0000303|pubmed:10078529}.","subcellular location: nucleus {eco:0000269|pubmed:7775481}. nucleus membrane {eco:0000269|pubmed:11839768}. nucleus, nuclear pore complex {eco:0000269|pubmed:11839768, eco:0000269|pubmed:20386726, eco:0000269|pubmed:23353830, eco:0000269|pubmed:7603572}. nucleus envelope {eco:0000269|pubmed:20386726}. note=detected in diffuse and discrete intranuclear foci (pubmed:11839768). cytoplasmic filaments (pubmed:7775481). {eco:0000269|pubmed:11839768, eco:0000269|pubmed:7775481}.",NA,"DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RANBP2,5903,Hs.199561,ENST00000283195,THC2536155,GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005643(nuclear pore)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006457(protein folding)|GO:0006606(protein import into nucleus)|GO:0008270(zinc ion binding)|GO:0008536(Ran GTPase binding)|GO:0008645(hexose transport)|GO:0010827(regulation of glucose transport)|GO:0015031(protein transport)|GO:0015758(glucose transport)|GO:0016032(viral reproduction)|GO:0016853(isomerase activity)|GO:0016925(protein sumoylation)|GO:0046872(metal ion binding)|GO:0046907(intracellular transport)|GO:0051028(mRNA transport)|GO:0055085(transmembrane transport),"Homo sapiens RAN binding protein 2 (RANBP2), mRNA [NM_006267]",chr2:109400435-109400494,hs|2q12.3,RAN binding protein 2,TRUE
256_PARK7_11315,Q99497,protein/nucleic acid deglycase dj-1 (ec 3.1.2.-) (ec 3.5.1.-) (ec 3.5.1.124) (maillard deglycase) (oncogene dj1) (parkinson disease protein 7) (parkinsonism-associated deglycase) (protein dj-1) (dj-1),PARK7,189,"function: protein and nucleotide deglycase that catalyzes the deglycation of the maillard adducts formed between amino groups of proteins or nucleotides and reactive carbonyl groups of glyoxals (pubmed:25416785, pubmed:28596309). thus, functions as a protein deglycase that repairs methylglyoxal- and glyoxal-glycated proteins, and releases repaired proteins and lactate or glycolate, respectively. deglycates cysteine, arginine and lysine residues in proteins, and thus reactivates these proteins by reversing glycation by glyoxals. acts on early glycation intermediates (hemithioacetals and aminocarbinols), preventing the formation of advanced glycation endproducts (age) that cause irreversible damage (pubmed:25416785, pubmed:28013050, pubmed:26995087). also functions as a nucleotide deglycase able to repair glycated guanine in the free nucleotide pool (gtp, gdp, gmp, dgtp) and in dna and rna. is thus involved in a major nucleotide repair system named guanine glycation repair (gg repair), dedicated to reversing methylglyoxal and glyoxal damage via nucleotide sanitization and direct nucleic acid repair (pubmed:28596309). also displays an apparent glyoxalase activity that in fact reflects its deglycase activity (pubmed:22523093). plays an important role in cell protection against oxidative stress and cell death acting as oxidative stress sensor and redox-sensitive chaperone and protease; functions probably related to its primary function (pubmed:17015834, pubmed:20304780, pubmed:18711745, pubmed:12796482, pubmed:19229105, pubmed:25416785, pubmed:26995087). it is involved in neuroprotective mechanisms like the stabilization of nfe2l2 and pink1 proteins, male fertility as a positive regulator of androgen signaling pathway as well as cell growth and transformation through, for instance, the modulation of nf-kappa-b signaling pathway (pubmed:12612053, pubmed:15502874, pubmed:14749723, pubmed:17015834, pubmed:21097510, pubmed:18711745). eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death (pubmed:16390825). required for correct mitochondrial morphology and function as well as for autophagy of dysfunctional mitochondria (pubmed:19229105, pubmed:16632486). plays a role in regulating expression or stability of the mitochondrial uncoupling proteins slc25a14 and slc25a27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via l-type channels during pacemaking (pubmed:18711745). regulates astrocyte inflammatory responses, may modulate lipid rafts-dependent endocytosis in astrocytes and neuronal cells (pubmed:23847046). in pancreatic islets, involved in the maintenance of mitochondrial reactive oxygen species (ros) levels and glucose homeostasis in an age- and diet dependent manner. protects pancreatic beta cells from cell death induced by inflammatory and cytotoxic setting (by similarity). binds to a number of mrnas containing multiple copies of gg or cc motifs and partially inhibits their translation but dissociates following oxidative stress (pubmed:18626009). metal-binding protein able to bind copper as well as toxic mercury ions, enhances the cell protection mechanism against induced metal toxicity (pubmed:23792957). in macrophages, interacts with the nadph oxidase subunit ncf1 to direct nadph oxidase-dependent ros production, and protects against sepsis (by similarity). {eco:0000250|uniprotkb:q99lx0, eco:0000269|pubmed:11477070, eco:0000269|pubmed:12612053, eco:0000269|pubmed:12855764, eco:0000269|pubmed:12939276, eco:0000269|pubmed:14749723, eco:0000269|pubmed:15181200, eco:0000269|pubmed:15502874, eco:0000269|pubmed:15976810, eco:0000269|pubmed:16390825, eco:0000269|pubmed:17015834, eco:0000269|pubmed:18626009, eco:0000269|pubmed:18711745, eco:0000269|pubmed:19229105, eco:0000269|pubmed:20186336, eco:0000269|pubmed:20304780, eco:0000269|pubmed:21097510, eco:0000269|pubmed:22523093, eco:0000269|pubmed:23792957, eco:0000269|pubmed:23847046, eco:0000269|pubmed:25416785, eco:0000269|pubmed:26995087, eco:0000269|pubmed:28013050, eco:0000269|pubmed:28596309, eco:0000269|pubmed:9070310}.","subcellular location: cell membrane {eco:0000250|uniprotkb:q99lx0}; lipid-anchor {eco:0000250|uniprotkb:q99lx0}. cytoplasm {eco:0000269|pubmed:12851414, eco:0000269|pubmed:14579415, eco:0000269|pubmed:15976810, eco:0000269|pubmed:19229105, eco:0000269|pubmed:28596309}. nucleus {eco:0000269|pubmed:12851414, eco:0000269|pubmed:14579415, eco:0000269|pubmed:15976810, eco:0000269|pubmed:16390825, eco:0000269|pubmed:28596309}. membrane raft {eco:0000250|uniprotkb:o88767}. mitochondrion {eco:0000269|pubmed:15181200, eco:0000269|pubmed:18711745, eco:0000269|pubmed:19229105}. note=under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage (pubmed:18711745). detected in tau inclusions in brains from neurodegenerative disease patients (pubmed:14705119). membrane raft localization in astrocytes and neuronal cells requires palmitoylation. {eco:0000269|pubmed:14705119, eco:0000269|pubmed:18711745}.","TISSUE SPECIFICITY: Highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart. Detected at slightly lower levels in placenta and brain (at protein level). Detected in astrocytes, Sertoli cells, spermatogonia, spermatids and spermatozoa. Expressed by pancreatic islets at higher levels than surrounding exocrine tissues (PubMed:22611253). {ECO:0000269|PubMed:14579415, ECO:0000269|PubMed:14662519, ECO:0000269|PubMed:14705119, ECO:0000269|PubMed:22611253, ECO:0000269|PubMed:9070310}.","DISEASE: Parkinson disease 7 (PARK7) [MIM:606324]: A neurodegenerative disorder characterized by resting tremor, postural tremor, bradykinesia, muscular rigidity, anxiety and psychotic episodes. PARK7 has onset before 40 years, slow progression and initial good response to levodopa. Some patients may show traits reminiscent of amyotrophic lateral sclerosis-parkinsonism/dementia complex (Guam disease). {ECO:0000269|PubMed:12446870, ECO:0000269|PubMed:12851414, ECO:0000269|PubMed:12953260, ECO:0000269|PubMed:14607841, ECO:0000269|PubMed:14713311, ECO:0000269|PubMed:15254937, ECO:0000269|PubMed:15365989, ECO:0000269|PubMed:17846173, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:22523093, ECO:0000269|PubMed:23792957, ECO:0000269|PubMed:23847046}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PARK7,11315,Hs.419640,ENST00000377491,THC2470063,GO:0003729(mRNA binding)|GO:0004601(peroxidase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0006914(autophagy)|GO:0007005(mitochondrion organization)|GO:0007338(single fertilization)|GO:0008233(peptidase activity)|GO:0008344(adult locomotory behavior)|GO:0030424(axon)|GO:0032091(negative regulation of protein binding)|GO:0034599(cellular response to oxidative stress)|GO:0042493(response to drug)|GO:0042743(hydrogen peroxide metabolic process)|GO:0042803(protein homodimerization activity)|GO:0043526(neuroprotection)|GO:0050727(regulation of inflammatory response)|GO:0050821(protein stabilization)|GO:0051583(dopamine uptake)|GO:0051899(membrane depolarization)|GO:0051920(peroxiredoxin activity)|GO:0060081(membrane hyperpolarization)|GO:0060548(negative regulation of cell death)|GO:0060765(regulation of androgen receptor signaling pathway)|GO:0070301(cellular response to hydrogen peroxide)|GO:2000277(positive regulation of oxidative phosphorylation uncoupler activity),"Homo sapiens parkinson protein 7 (PARK7), transcript variant 1, mRNA [NM_007262]",chr1:8045168-8045227,hs|1p36.23,parkinson protein 7,TRUE
257_HIST3H3_8290,Q16695,histone h3.1t (h3/t) (h3t) (h3/g),HIST3H3 H3FT,136,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,TISSUE SPECIFICITY: Expressed in testicular cells.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST3H3,8290,Hs.248171,ENST00000366696,THC2482551,GO:0000723(telomere maintenance)|GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 3, H3 (HIST3H3), mRNA [NM_003493]",chr1:228612705-228612646,hs|1q42.13,"histone cluster 3, H3",TRUE
258_C6orf62_81688,Q9GZU0,uncharacterized protein c6orf62 (hbv x-transactivated gene 12 protein) (hbv xag-transactivated protein 12),C6orf62 XTP12 Nbla00237,229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C6orf62,81688,Hs.9676,ENST00000378119,THC2469595,GO:0003674(molecular_function)|GO:0005622(intracellular)|GO:0008150(biological_process),"Homo sapiens chromosome 6 open reading frame 62 (C6orf62), mRNA [NM_030939]",chr6:24705229-24705170,hs|6p22.3,chromosome 6 open reading frame 62,TRUE
259_ANAPC11_51529,Q9NYG5,anaphase-promoting complex subunit 11 (apc11) (cyclosome subunit 11) (hepatocellular carcinoma-associated ring finger protein),ANAPC11 HSPC214,84,"function: together with the cullin protein anapc2, constitutes the catalytic component of the anaphase promoting complex/cyclosome (apc/c), a cell cycle-regulated e3 ubiquitin ligase that controls progression through mitosis and the g1 phase of the cell cycle. the apc/c complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'lys-48'- and 'lys-63'-linked polyubiquitin chains. may recruit the e2 ubiquitin-conjugating enzymes to the complex. {eco:0000269|pubmed:11739784, eco:0000269|pubmed:18485873}.",subcellular location: cytoplasm {eco:0000269|pubmed:11573242}. nucleus {eco:0000269|pubmed:11573242}.,"TISSUE SPECIFICITY: Expressed at high levels in skeletal muscle and heart; in moderate levels in brain, kidney, and liver; and at low levels in colon, thymus, spleen, small intestine, placenta, lung and peripheral blood leukocyte. {ECO:0000269|PubMed:11573242}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ANAPC11,51529,Hs.534456,ENST00000357385,THC2476505,GO:0000075(cell cycle checkpoint)|GO:0000278(mitotic cell cycle)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005680(anaphase-promoting complex)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0007067(mitosis)|GO:0007094(mitotic cell cycle spindle assembly checkpoint)|GO:0008270(zinc ion binding)|GO:0016567(protein ubiquitination)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0046872(metal ion binding)|GO:0051301(cell division)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070979(protein K11-linked ubiquitination),"Homo sapiens anaphase promoting complex subunit 11 (ANAPC11), transcript variant 1, mRNA [NM_001002244]",chr17:79858019-79858078,hs|17q25.3,anaphase promoting complex subunit 11,TRUE
26_RPL31_6160,P62899,60s ribosomal protein l31 (large ribosomal subunit protein el31),RPL31,125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL31,6160,Hs.469473,ENST00000409733,THC2465680,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L31 (RPL31), transcript variant 1, mRNA [NM_000993]",chr2:101622498-101622835,hs|2q11.2,ribosomal protein L31,TRUE
260_EMP2_2013,P54851,epithelial membrane protein 2 (emp-2) (protein xmp),EMP2 XMP,167,"function: functions as a key regulator of cell membrane composition by regulating proteins surface expression. also, plays a role in regulation of processes including cell migration, cell proliferation, cell contraction and cell adhesion. negatively regulates caveolae formation by reducing cav1 expression and cav1 amount by increasing lysosomal degradation (pubmed:24814193). facilitates surface trafficking and formation of lipid rafts bearing gpi-anchor proteins (by similarity). regulates surface expression of mhc1 and icam1 proteins increasing susceptibility to t-cell mediated cytotoxicity (by similarity). regulates the plasma membrane expression of the integrin heterodimers itga6-itgb1, itga5-itgb3 and itga5-itgb1 resulting in modulation of cell-matrix adhesion (pubmed:16216233). also regulates many processes through ptk2. regulates blood vessel endothelial cell migration and angiogenesis by regulating vegf protein expression through ptk2 activation (pubmed:23439602). regulates cell migration and cell contraction through ptk2 and src activation (pubmed:21637765, pubmed:22728127). regulates focal adhesion density, f-actin conformation and cell adhesion capacity through interaction with ptk2 (pubmed:19494199). positively regulates cell proliferation (pubmed:24814193). plays a role during cell death and cell blebbing (pubmed:12107182). promotes angiogenesis and vasculogenesis through induction of vegfa via a hif1a-dependent pathway (pubmed:23334331). also plays a role in embryo implantation by regulating surface trafficking of integrin heterodimer itga5-itgb3 (pubmed:16487956). may play a role in glomerular filtration (by similarity). {eco:0000250|uniprotkb:f1qik8, eco:0000250|uniprotkb:o88662, eco:0000269|pubmed:12107182, eco:0000269|pubmed:16216233, eco:0000269|pubmed:16487956, eco:0000269|pubmed:19494199, eco:0000269|pubmed:21637765, eco:0000269|pubmed:22728127, eco:0000269|pubmed:23334331, eco:0000269|pubmed:23439602, eco:0000269|pubmed:24814193}.","subcellular location: golgi apparatus membrane {eco:0000250|uniprotkb:o88662}; multi-pass membrane protein {eco:0000255}. cell membrane {eco:0000269|pubmed:12107182, eco:0000269|pubmed:21637765}. apical cell membrane {eco:0000250|uniprotkb:o88662}. membrane raft {eco:0000269|pubmed:21637765}. cytoplasm {eco:0000269|pubmed:21637765}. nucleus {eco:0000250|uniprotkb:q66hh2}. note=localizes in cytoplasm, foot processes and cell bodies of podocytes and nucleus of endothelial cells of kidney. localizes to the apical cell surface in the luminal epithelium and glandular epithelium. colocalized with itgb1 and gpi-anchor proteins on plasma membrane. {eco:0000250|uniprotkb:o88662, eco:0000250|uniprotkb:q66hh2}.","TISSUE SPECIFICITY: Expressed in ciliary body epithelia, sclera, cornea, and retinal pigment epithelium (at protein level) (PubMed:12710941). {ECO:0000269|PubMed:12710941}.","DISEASE: Nephrotic syndrome 10 (NPHS10) [MIM:615861]: A form of nephrotic syndrome, a renal disease clinically characterized by focal segmental glomerulosclerosis, progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. NPHS10 is a steroid-sensitive form characterized by onset in childhood and remission without end-stage kidney disease. {ECO:0000269|PubMed:24814193}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,EMP2,2013,Hs.531561,ENST00000359543,THC2464796,GO:0008283(cell proliferation)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens epithelial membrane protein 2 (EMP2), mRNA [NM_001424]",chr16:10626759-10626700,hs|16p13.13,epithelial membrane protein 2,TRUE
261_APLP2_334,Q06481,amyloid-like protein 2 (aplp-2) (apph) (amyloid protein homolog) (cdei box-binding protein) (cdebp),APLP2 APPL2,763,"function: may play a role in the regulation of hemostasis. the soluble form may have inhibitory properties towards coagulation factors. may interact with cellular g-protein signaling pathways. may bind to the dna 5'-gtcacatg-3'(cdei box). inhibits trypsin, chymotrypsin, plasmin, factor xia and plasma and glandular kallikrein. modulates the cu/zn nitric oxide-catalyzed autodegradation of gpc1 heparan sulfate side chains in fibroblasts (by similarity). {eco:0000250, eco:0000269|pubmed:8307156}.",subcellular location: cell membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}. nucleus {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in placenta, brain, heart, lung, liver, kidney and endothelial tissues.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,APLP2,334,Hs.370247,ENST00000263574,NP1159710,GO:0001967(suckling behavior)|GO:0003677(DNA binding)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005886(plasma membrane)|GO:0006878(cellular copper ion homeostasis)|GO:0007176(regulation of epidermal growth factor receptor activity)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007617(mating behavior)|GO:0007626(locomotory behavior)|GO:0009790(embryo development)|GO:0016021(integral to membrane)|GO:0030414(peptidase inhibitor activity)|GO:0030900(forebrain development)|GO:0030901(midbrain development)|GO:0042802(identical protein binding)|GO:0050885(neuromuscular process controlling balance),"Homo sapiens amyloid beta (A4) precursor-like protein 2 (APLP2), transcript variant 1, mRNA [NM_001642]",chr11:130014421-130014480,hs|11q24.3,amyloid beta (A4) precursor-like protein 2,TRUE
262_HSPD1_3329,P10809,"60 kda heat shock protein, mitochondrial (ec 5.6.1.7) (60 kda chaperonin) (chaperonin 60) (cpn60) (heat shock protein 60) (hsp-60) (hsp60) (hucha60) (mitochondrial matrix protein p1) (p60 lymphocyte protein)",HSPD1 HSP60,573,"function: chaperonin implicated in mitochondrial protein import and macromolecular assembly. together with hsp10, facilitates the correct folding of imported proteins. may also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (pubmed:1346131, pubmed:11422376). the functional units of these chaperonins consist of heptameric rings of the large subunit hsp60, which function as a back-to-back double ring. in a cyclic reaction, hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of atp and association with 2 heptameric rings of the co-chaperonin hsp10. this leads to sequestration of the substrate protein in the inner cavity of hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. synchronous hydrolysis of atp in all hsp60 subunits results in the dissociation of the chaperonin rings and the release of adp and the folded substrate protein (probable). {eco:0000269|pubmed:11422376, eco:0000269|pubmed:1346131, eco:0000305|pubmed:25918392}.",subcellular location: mitochondrion matrix.,NA,"DISEASE: Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:11898127}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]: A severe autosomal recessive hypomyelinating leukodystrophy. Clinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurs within the first two decades of life. {ECO:0000269|PubMed:18571143}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSPD1,3329,Hs.727543,ENST00000345042,THC2533637,GO:0000166(nucleotide binding)|GO:0001530(lipopolysaccharide binding)|GO:0002039(p53 binding)|GO:0002368(B cell cytokine production)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002842(positive regulation of T cell mediated immune response to tumor cell)|GO:0003688(DNA replication origin binding)|GO:0003697(single-stranded DNA binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0005769(early endosome)|GO:0005829(cytosol)|GO:0005905(coated pit)|GO:0006200(ATP catabolic process)|GO:0006458(de novo' protein folding)|GO:0006919(activation of caspase activity)|GO:0006986(response to unfolded protein)|GO:0008219(cell death)|GO:0009986(cell surface)|GO:0016887(ATPase activity)|GO:0019907(cyclin-dependent protein kinase activating kinase holoenzyme complex)|GO:0030135(coated vesicle)|GO:0030141(stored secretory granule)|GO:0032727(positive regulation of interferon-alpha production)|GO:0032729(positive regulation of interferon-gamma production)|GO:0032733(positive regulation of interleukin-10 production)|GO:0032735(positive regulation of interleukin-12 production)|GO:0032755(positive regulation of interleukin-6 production)|GO:0042026(protein refolding)|GO:0042100(B cell proliferation)|GO:0042110(T cell activation)|GO:0042113(B cell activation)|GO:0043032(positive regulation of macrophage activation)|GO:0043065(positive regulation of apoptosis)|GO:0043066(negative regulation of apoptosis)|GO:0043498(cell surface binding)|GO:0044419(interspecies interaction between organisms)|GO:0044459(plasma membrane part)|GO:0046696(lipopolysaccharide receptor complex)|GO:0048291(isotype switching to IgG isotypes)|GO:0050821(protein stabilization)|GO:0050870(positive regulation of T cell activation)|GO:0051082(unfolded protein binding)|GO:0051087(chaperone binding)|GO:0051131(chaperone-mediated protein complex assembly)|GO:0051604(protein maturation),"Homo sapiens heat shock 60kDa protein 1 (chaperonin) (HSPD1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_002156]",chr2:198351440-198351381,hs|2q33.1,heat shock 60kDa protein 1 (chaperonin),TRUE
263_RPL27_6155,P61353,60s ribosomal protein l27 (large ribosomal subunit protein el27),RPL27,136,"function: component of the large ribosomal subunit (pubmed:12962325, pubmed:23636399, pubmed:25957688, pubmed:25901680). required for proper rrna processing and maturation of 28s and 5.8s rrnas (pubmed:25424902). {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25424902, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:a1xqu5}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:a1xqu5, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Diamond-Blackfan anemia 16 (DBA16) [MIM:617408]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:25424902}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL27,6155,Hs.514196,ENST00000253788,THC2522564,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L27 (RPL27), mRNA [NM_000988]",chr17:41154694-41154753,hs|17q21.31,ribosomal protein L27,TRUE
264_SEC11A_23478,P67812,signal peptidase complex catalytic subunit sec11a (ec 3.4.21.89) (endopeptidase sp18) (microsomal signal peptidase 18 kda subunit) (spase 18 kda subunit) (sec11 homolog a) (sec11-like protein 1) (spc18),SEC11A SEC11L1 SPC18 SPCS4A,179,function: component of the microsomal signal peptidase complex which removes signal peptides from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum. {eco:0000250}.,subcellular location: microsome membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}. endoplasmic reticulum membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC11A,23478,Hs.9534,ENST00000455959,THC2502117,GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006112(energy reserve metabolic process)|GO:0006465(signal peptide processing)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008236(serine-type peptidase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0050796(regulation of insulin secretion),"Homo sapiens SEC11 homolog A (S. cerevisiae) (SEC11A), mRNA [NM_014300]",chr15:85213059-85213000,hs|15q25.3,SEC11 homolog A (S. cerevisiae),TRUE
266_UTRN_7402,P46939,utrophin (dystrophin-related protein 1) (drp-1),UTRN DMDL DRP1,3433,function: may play a role in anchoring the cytoskeleton to the plasma membrane. {eco:0000250}.,"subcellular location: cell junction, synapse, postsynaptic cell membrane; peripheral membrane protein; cytoplasmic side. cytoplasm, cytoskeleton. note=neuromuscular junction.",TISSUE SPECIFICITY: Isoform 1 has high expression in muscle. Isoforms Up70 and Up140 were found in all the adult and fetal tissues tested and relatively abundant in lung and kidney. {ECO:0000269|PubMed:10369873}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,UTRN,7402,Hs.133135,ENST00000367545,THC2586966,GO:0001954(positive regulation of cell-matrix adhesion)|GO:0003779(actin binding)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006936(muscle contraction)|GO:0007517(muscle organ development)|GO:0008270(zinc ion binding)|GO:0016010(dystrophin-associated glycoprotein complex)|GO:0030054(cell junction)|GO:0031594(neuromuscular junction)|GO:0045211(postsynaptic membrane),"Homo sapiens utrophin (UTRN), mRNA [NM_007124]",chr6:145173938-145173997,hs|6q24.2,utrophin,TRUE
267_ACTB_60,P60709,"actin, cytoplasmic 1 (beta-actin) [cleaved into: actin, cytoplasmic 1, n-terminally processed]",ACTB,375,"function: actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (pubmed:29581253). actin exists in both monomeric (g-actin) and polymeric (f-actin) forms, both forms playing key functions, such as cell motility and contraction (pubmed:29581253). in addition to their role in the cytoplasmic cytoskeleton, g- and f-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged dna (pubmed:29925947). {eco:0000269|pubmed:29581253, eco:0000269|pubmed:29925947}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:11687588, eco:0000269|pubmed:17289661}. nucleus {eco:0000269|pubmed:11687588, eco:0000269|pubmed:29925947}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas. {eco:0000269|pubmed:17289661}.",NA,"DISEASE: Dystonia, juvenile-onset (DJO) [MIM:607371]: A form of dystonia with juvenile onset. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. Patients with juvenile-onset dystonia manifest progressive, generalized, dopa-unresponsive dystonia, developmental malformations and sensory hearing loss. {ECO:0000269|PubMed:16685646}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior-predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ACTB,60,Hs.520640,ENST00000462494,THC2557333,GO:0000166(nucleotide binding)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006457(protein folding)|GO:0006928(cellular component movement)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0019894(kinesin binding)|GO:0019901(protein kinase binding)|GO:0030424(axon)|GO:0030529(ribonucleoprotein complex)|GO:0030863(cortical cytoskeleton)|GO:0030957(Tat protein binding)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0035267(NuA4 histone acetyltransferase complex)|GO:0043234(protein complex)|GO:0044267(cellular protein metabolic process)|GO:0045216(cell-cell junction organization)|GO:0050998(nitric-oxide synthase binding)|GO:0051084(de novo' posttranslational protein folding)|GO:0051592(response to calcium ion)|GO:0070688(MLL5-L complex),"Homo sapiens actin, beta (ACTB), mRNA [NM_001101]",chr7:5566846-5566787,hs|7p22.1,"actin, beta",TRUE
268_ADM_133,Q7Z4H4,protein adm2 (intermedin) [cleaved into: adrenomedullin-2 (am2) (intermedin-long) (imdl); intermedin-short (imds)],ADM2 AM2,148,"function: adrenomedullin-2: may play a role as physiological regulators of gastrointestinal, cardiovascular bioactivities mediated by the calcrl/ramps receptor complexes. activates the camp-dependent pathway. {eco:0000269|pubmed:14615490}.; function: intermedin-short: may play a role as physiological regulators of gastrointestinal, cardiovascular bioactivities mediated by the calcrl/ramps receptor complexes. activates the camp-dependent pathway. {eco:0000269|pubmed:14615490}.",subcellular location: secreted.,"TISSUE SPECIFICITY: Expressed in the esophagus, stomach, jejunum, ileum, ileocecum, ascending colon, transverse colon, descending colon and rectum. Expressed in myocardial cells of the heart, renal tubular cells, hypothalamus, and pituitary. {ECO:0000269|PubMed:14615490, ECO:0000269|PubMed:16359754}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ADM,133,Hs.441047,ENST00000528655,THC2591417,GO:0001666(response to hypoxia)|GO:0001843(neural tube closure)|GO:0002026(regulation of the force of heart contraction)|GO:0005102(receptor binding)|GO:0005179(hormone activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0006171(cAMP biosynthetic process)|GO:0006701(progesterone biosynthetic process)|GO:0007165(signal transduction)|GO:0007204(elevation of cytosolic calcium ion concentration)|GO:0007267(cell-cell signaling)|GO:0007507(heart development)|GO:0007565(female pregnancy)|GO:0007568(aging)|GO:0008015(blood circulation)|GO:0008209(androgen metabolic process)|GO:0008284(positive regulation of cell proliferation)|GO:0008285(negative regulation of cell proliferation)|GO:0009409(response to cold)|GO:0009611(response to wounding)|GO:0010033(response to organic substance)|GO:0010460(positive regulation of heart rate)|GO:0019933(cAMP-mediated signaling)|GO:0031100(organ regeneration)|GO:0031102(neuron projection regeneration)|GO:0031700(adrenomedullin receptor binding)|GO:0032496(response to lipopolysaccharide)|GO:0032868(response to insulin stimulus)|GO:0042475(odontogenesis of dentine-containing tooth)|GO:0042594(response to starvation)|GO:0045768(positive regulation of anti-apoptosis)|GO:0045906(negative regulation of vasoconstriction)|GO:0045909(positive regulation of vasodilation)|GO:0046879(hormone secretion)|GO:0048589(developmental growth)|GO:0051384(response to glucocorticoid stimulus)|GO:0055074(calcium ion homeostasis)|GO:0060670(branching involved in embryonic placenta morphogenesis)|GO:0060712(spongiotrophoblast layer development),"Homo sapiens adrenomedullin (ADM), mRNA [NM_001124]",chr11:10328780-10328839,hs|11p15.4,adrenomedullin,TRUE
269_ATP5H_10476,O75947,"atp synthase subunit d, mitochondrial (atpase subunit d) (atp synthase peripheral stalk subunit d)",ATP5PD ATP5H My032,161,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core, and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/atp6 static relative to the rotary elements.",subcellular location: mitochondrion. mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5H,10476,Hs.514465,ENST00000301587,THC2466325,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006811(ion transport)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d (ATP5H), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_006356]",chr17:73035037-73034978,hs|17q25.1,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d",TRUE
27_NBPF15_284565,Q8N660,neuroblastoma breakpoint family member 15 (neuroblastoma breakpoint family member 16),NBPF15 NBPF16,670,NA,subcellular location: cytoplasm {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitously expressed with a higher expression observed in breast and liver. Also expressed in neuroblastoma cell line. {ECO:0000269|PubMed:16079250}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NBPF15,284565,Hs.656782,ENST00000281815,THC2499712,GO:0005737(cytoplasm),"Homo sapiens neuroblastoma breakpoint family, member 15 (NBPF15), transcript variant 2, mRNA [NM_173638]",chr1:148596075-148596134,hs|1q21.2,"neuroblastoma breakpoint family, member 15",TRUE
270_COX3_4514,Q7GIM7,cytochrome c oxidase subunit 3,COX3 CO3 COIII DKFZp686F15101 MTCO3 HS5781_0023 HS5782_0023,261,"function: subunits i, ii and iii form the functional core of the enzyme complex. {eco:0000256|rulebase:ru003375}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,COX3,4514,Hs.631493,ENST00000362079,THC2470323,"GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006123(mitochondrial electron transport, cytochrome c to oxygen)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)",mitochondrially encoded cytochrome c oxidase III [Source:HGNC Symbol;Acc:7422] [ENST00000362079],chrM:9410-9469,NA,cytochrome c oxidase III,TRUE
271_RPS4X_6191,P62701,"40s ribosomal protein s4, x isoform (scr10) (single copy abundant mrna protein) (small ribosomal subunit protein es4)",RPS4X CCG2 RPS4 SCAR,263,NA,subcellular location: cytoplasm {eco:0000269|pubmed:17289661}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS4X,6191,Hs.118076,ENST00000486733,THC2563635,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0005844(polysome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0007275(multicellular organismal development)|GO:0008284(positive regulation of cell proliferation)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0045727(positive regulation of translation),"Homo sapiens ribosomal protein S4, X-linked (RPS4X), mRNA [NM_001007]",chrX:71493113-71492595,hs|Xq13.1,"ribosomal protein S4, X-linked",TRUE
272_HBB_3043,P68871,hemoglobin subunit beta (beta-globin) (hemoglobin beta chain) [cleaved into: lvv-hemorphin-7; spinorphin],HBB,147,"function: involved in oxygen transport from the lung to the various peripheral tissues. {eco:0000269|pubmed:28066926}.; function: lvv-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.; function: spinorphin: functions as an endogenous inhibitor of enkephalin-degrading enzymes such as dpp3, and as a selective antagonist of the p2rx3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation.",NA,TISSUE SPECIFICITY: Red blood cells. {ECO:0000269|PubMed:6539334}.,"DISEASE: Heinz body anemias (HEIBAN) [MIM:140700]: Form of non-spherocytic hemolytic anemia of Dacie type 1. After splenectomy, which has little benefit, basophilic inclusions called Heinz bodies are demonstrable in the erythrocytes. Before splenectomy, diffuse or punctate basophilia may be evident. Most of these cases are probably instances of hemoglobinopathy. The hemoglobin demonstrates heat lability. Heinz bodies are observed also with the Ivemark syndrome (asplenia with cardiovascular anomalies) and with glutathione peroxidase deficiency. {ECO:0000269|PubMed:186485, ECO:0000269|PubMed:2599881, ECO:0000269|PubMed:6259091, ECO:0000269|PubMed:8704193}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Beta-thalassemia (B-THAL) [MIM:613985]: A form of thalassemia. Thalassemias are common monogenic diseases occurring mostly in Mediterranean and Southeast Asian populations. The hallmark of beta-thalassemia is an imbalance in globin-chain production in the adult HbA molecule. Absence of beta chain causes beta(0)-thalassemia, while reduced amounts of detectable beta globin causes beta(+)-thalassemia. In the severe forms of beta-thalassemia, the excess alpha globin chains accumulate in the developing erythroid precursors in the marrow. Their deposition leads to a vast increase in erythroid apoptosis that in turn causes ineffective erythropoiesis and severe microcytic hypochromic anemia. Clinically, beta-thalassemia is divided into thalassemia major which is transfusion dependent, thalassemia intermedia (of intermediate severity), and thalassemia minor that is asymptomatic. {ECO:0000269|PubMed:12144064, ECO:0000269|PubMed:12149194, ECO:0000269|PubMed:15481886, ECO:0000269|PubMed:2399911, ECO:0000269|PubMed:6166632, ECO:0000269|PubMed:7693620}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sickle cell anemia (SKCA) [MIM:603903]: Characterized by abnormally shaped red cells resulting in chronic anemia and periodic episodes of pain, serious infections and damage to vital organs. Normal red blood cells are round and flexible and flow easily through blood vessels, but in sickle cell anemia, the abnormal hemoglobin (called Hb S) causes red blood cells to become stiff. They are C-shaped and resembles a sickle. These stiffer red blood cells can led to microvascular occlusion thus cutting off the blood supply to nearby tissues. {ECO:0000269|PubMed:1195378, ECO:0000269|PubMed:13464827, ECO:0000269|PubMed:16001361, ECO:0000269|PubMed:24100324, ECO:0000269|Ref.10}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Beta-thalassemia, dominant, inclusion body type (B-THALIB) [MIM:603902]: An autosomal dominant form of beta thalassemia characterized by moderate anemia, lifelong jaundice, cholelithiasis and splenomegaly, marked morphologic changes in the red cells, erythroid hyperplasia of the bone marrow with increased numbers of multinucleate red cell precursors, and the presence of large inclusion bodies in the normoblasts, both in the marrow and in the peripheral blood after splenectomy. {ECO:0000269|PubMed:1971109}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,HBB,3043,Hs.523443,ENST00000335295,THC2465732,GO:0004601(peroxidase activity)|GO:0005344(oxygen transporter activity)|GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0005833(hemoglobin complex)|GO:0006810(transport)|GO:0007596(blood coagulation)|GO:0008217(regulation of blood pressure)|GO:0010942(positive regulation of cell death)|GO:0015671(oxygen transport)|GO:0019825(oxygen binding)|GO:0020037(heme binding)|GO:0030185(nitric oxide transport)|GO:0030492(hemoglobin binding)|GO:0031720(haptoglobin binding)|GO:0031838(haptoglobin-hemoglobin complex)|GO:0042542(response to hydrogen peroxide)|GO:0042744(hydrogen peroxide catabolic process)|GO:0045429(positive regulation of nitric oxide biosynthetic process)|GO:0046872(metal ion binding)|GO:0050880(regulation of blood vessel size)|GO:0051291(protein heterooligomerization),"Homo sapiens hemoglobin, beta (HBB), mRNA [NM_000518]",chr11:5246777-5246718,hs|11p15.4,"hemoglobin, beta",TRUE
273_MAGED1_9500,Q9Y5V3,melanoma-associated antigen d1 (mage tumor antigen ccf) (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog),MAGED1 NRAGE PP2250 PRO2292,778,"function: involved in the apoptotic response after nerve growth factor (ngf) binding in neuronal cells. inhibits cell cycle progression, and facilitates ngfr-mediated apoptosis. may act as a regulator of the function of dlx family members. may enhance ubiquitin ligase activity of ring-type zinc finger-containing e3 ubiquitin-protein ligases. proposed to act through recruitment and/or stabilization of the ubl-conjugating enzyme (e2) at the e3:substrate complex. plays a role in the circadian rhythm regulation. may act as rora co-regulator, modulating the expression of core clock genes such as arntl/bmal1 and nfil3, induced, or nr1d1, repressed. {eco:0000269|pubmed:20864041}.",subcellular location: cytoplasm {eco:0000250}. cell membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. nucleus {eco:0000250}. note=expression shifts from the cytoplasm to the plasma membrane upon stimulation with ngf. {eco:0000250}.,TISSUE SPECIFICITY: Expressed in bone marrow stromal cells from both multiple myeloma patients and healthy donors. Seems to be ubiquitously expressed.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MAGED1,9500,Hs.5258,NA,NA,"GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006915(apoptosis)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0042981(regulation of apoptosis)|GO:0043234(protein complex)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050680(negative regulation of epithelial cell proliferation)","Homo sapiens NRAGE mRNA, complete cds. [AF217963]",chrX:51645019-51645286,hs|Xp11.22,"melanoma antigen family D, 1",TRUE
274_SNRPD3_6634,P62318,small nuclear ribonucleoprotein sm d3 (sm-d3) (snrnp core protein d3),SNRPD3,126,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:19325628, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). as part of the u7 snrnp it is involved in histone pre-mrna 3'-end processing (by similarity). {eco:0000250|uniprotkb:p62320, eco:0000269|pubmed:11991638, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11574479, eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPD3,6634,Hs.356549,ENST00000215829,THC2466818,"GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005683(U7 snRNP)|GO:0005689(U12-type spliceosomal complex)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0008334(histone mRNA metabolic process)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0019899(enzyme binding)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)|GO:0071208(histone pre-mRNA DCP binding)","Homo sapiens small nuclear ribonucleoprotein D3 polypeptide 18kDa (SNRPD3), mRNA [NM_004175]",chr22:24968033-24968092,hs|22q11.23,small nuclear ribonucleoprotein D3 polypeptide 18kDa,TRUE
275_RPL37A_6168,P61513,60s ribosomal protein l37a (large ribosomal subunit protein el43),RPL37A,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL37A,6168,Hs.433701,ENST00000359681,THC2532660,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0046872(metal ion binding),"Homo sapiens ribosomal protein L37a (RPL37A), mRNA [NM_000998]",chr2:217364080-217364688,hs|2q35,ribosomal protein L37a,TRUE
276_TMBIM6_7009,P55061,bax inhibitor 1 (bi-1) (testis-enhanced gene transcript protein) (transmembrane bax inhibitor motif-containing protein 6),TMBIM6 BI1 TEGT,237,"function: suppressor of apoptosis (pubmed:21075086). modulates unfolded protein response signaling (pubmed:21075086). modulates er calcium homeostasis by acting as a calcium-leak channel (pubmed:22128171). negatively regulates autophagy and autophagosome formation, especially during periods of nutrient deprivation, and reduces cell survival during starvation (by similarity). {eco:0000250|uniprotkb:q9d2c7, eco:0000269|pubmed:21075086, eco:0000269|pubmed:22128171}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:21075086, eco:0000269|pubmed:22128171}; multi-pass membrane protein {eco:0000269|pubmed:21075086, eco:0000269|pubmed:22128171}.",TISSUE SPECIFICITY: Highly abundant in testis. {ECO:0000269|PubMed:8530040}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMBIM6,7009,Hs.730613,ENST00000542631,THC2465579,GO:0005626(insoluble fraction)|GO:0005634(nucleus)|GO:0005783(endoplasmic reticulum)|GO:0005887(integral to plasma membrane)|GO:0016020(membrane)|GO:0043066(negative regulation of apoptosis),"Homo sapiens transmembrane BAX inhibitor motif containing 6 (TMBIM6), transcript variant 1, mRNA [NM_003217]",chr12:50158418-50158477,hs|12q13.12,transmembrane BAX inhibitor motif containing 6,TRUE
277_SNHG8_100093630,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,SNHG8,100093630,Hs.535762,NA,THC2722842,NA,"Homo sapiens small nucleolar RNA host gene 8 (non-protein coding) (SNHG8), transcript variant 1, non-coding RNA [NR_003584]",chr4:119200825-119200884,hs|4q26,small nucleolar RNA host gene 8 (non-protein coding),TRUE
278_SSR2_6746,P43308,translocon-associated protein subunit beta (trap-beta) (signal sequence receptor subunit beta) (ssr-beta),SSR2 TRAPB HSD25,183,function: trap proteins are part of a complex whose function is to bind calcium to the er membrane and thereby regulate the retention of er resident proteins.,subcellular location: endoplasmic reticulum membrane; single-pass type i membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SSR2,6746,Hs.74564,ENST00000488179,NP1200879,GO:0005048(signal sequence binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006613(cotranslational protein targeting to membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens signal sequence receptor, beta (translocon-associated protein beta) (SSR2), mRNA [NM_003145]",chr1:155978936-155978877,hs|1q22,"signal sequence receptor, beta (translocon-associated protein beta)",TRUE
279_CTDSP2_10106,O14595,carboxy-terminal domain rna polymerase ii polypeptide a small phosphatase 2 (ec 3.1.3.16) (nuclear lim interactor-interacting factor 2) (nli-interacting factor 2) (protein os-4) (small c-terminal domain phosphatase 2) (small ctd phosphatase 2) (scp2),CTDSP2 NIF2 OS4 SCP2,271,"function: preferentially catalyzes the dephosphorylation of 'ser-5' within the tandem 7 residue repeats in the c-terminal domain (ctd) of the largest rna polymerase ii subunit polr2a. negatively regulates rna polymerase ii transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation. recruited by rest to neuronal genes that contain re-1 elements, leading to neuronal gene silencing in non-neuronal cells. may contribute to the development of sarcomas. {eco:0000269|pubmed:12721286, eco:0000269|pubmed:15681389}.",subcellular location: nucleus {eco:0000250}.,TISSUE SPECIFICITY: Expression is restricted to non-neuronal tissues. Highest expression in pancreas and lowest in liver. {ECO:0000269|PubMed:15681389}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTDSP2,10106,Hs.524530,ENST00000398073,THC2468109,GO:0004721(phosphoprotein phosphatase activity)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006470(protein dephosphorylation)|GO:0008420(CTD phosphatase activity)|GO:0016787(hydrolase activity)|GO:0046872(metal ion binding),"Homo sapiens CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 (CTDSP2), mRNA [NM_005730]",chr12:58213870-58213811,hs|12q14.1,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2",TRUE
28_EEF1D_1936,P29692,elongation factor 1-delta (ef-1-delta) (antigen ny-co-4),EEF1D EF1D,281,"function: isoform 1: ef-1-beta and ef-1-delta stimulate the exchange of gdp bound to ef-1-alpha to gtp, regenerating ef-1-alpha for another round of transfer of aminoacyl-trnas to the ribosome.; function: isoform 2: regulates induction of heat-shock-responsive genes through association with heat shock transcription factors and direct dna-binding at heat shock promoter elements (hse).",subcellular location: isoform 2: nucleus {eco:0000269|pubmed:21597468}.,"TISSUE SPECIFICITY: Isoform 2 is specifically expressed in brain, cerebellum and testis.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,EEF1D,1936,Hs.333388,ENST00000524624,THC2503086,"GO:0003746(translation elongation factor activity)|GO:0004871(signal transducer activity)|GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0005853(eukaryotic translation elongation factor 1 complex)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0007165(signal transduction)|GO:0008135(translation factor activity, nucleic acid binding)|GO:0010467(gene expression)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0044267(cellular protein metabolic process)","Homo sapiens eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) (EEF1D), transcript variant 1, mRNA [NM_032378]",chr8:144661995-144661936,hs|8q24.3,eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein),TRUE
280_C11orf31_280636,Q8IZQ5,selenoprotein h (selh),SELENOH C11orf31 SELH,122,function: may be involved in a redox-related process. {eco:0000305}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,C11orf31,280636,Hs.655373,ENST00000534386,THC2475635,GO:0008430(selenium binding)|GO:0045454(cell redox homeostasis),"Homo sapiens chromosome 11 open reading frame 31 (C11orf31), mRNA [NM_170746]",chr11:57510441-57510500,hs|11q12.1,chromosome 11 open reading frame 31,TRUE
281_RPL29_6159,P47914,60s ribosomal protein l29 (cell surface heparin-binding protein hip) (large ribosomal subunit protein el29),RPL29,159,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL29,6159,Hs.425125,ENST00000458386,THC2510893,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0007566(embryo implantation)|GO:0008201(heparin binding)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L29 (RPL29), mRNA [NM_000992]",chr3:52027825-52027766,hs|3p21.2,ribosomal protein L29,TRUE
282_SERP1_27230,Q9Y6X1,stress-associated endoplasmic reticulum protein 1 (ribosome-attached membrane protein 4),SERP1 RAMP4,66,function: interacts with target proteins during their translocation into the lumen of the endoplasmic reticulum. protects unfolded target proteins against degradation during er stress. may facilitate glycosylation of target proteins after termination of er stress. may modulate the use of n-glycosylation sites on target proteins (by similarity). {eco:0000250}.,subcellular location: membrane; single-pass type iv membrane protein. endoplasmic reticulum membrane {eco:0000250}; single-pass membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SERP1,27230,Hs.518326,ENST00000479209,THC2497913,GO:0001501(skeletal system development)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005840(ribosome)|GO:0006006(glucose metabolic process)|GO:0006464(protein modification process)|GO:0006486(protein glycosylation)|GO:0006950(response to stress)|GO:0007009(plasma membrane organization)|GO:0009791(post-embryonic development)|GO:0010259(multicellular organismal aging)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030968(endoplasmic reticulum unfolded protein response)|GO:0032024(positive regulation of insulin secretion)|GO:0045727(positive regulation of translation)|GO:0046622(positive regulation of organ growth)|GO:0048644(muscle organ morphogenesis)|GO:0060124(positive regulation of growth hormone secretion),"Homo sapiens stress-associated endoplasmic reticulum protein 1 (SERP1), mRNA [NM_014445]",chr3:150260406-150260347,hs|3q25.1,stress-associated endoplasmic reticulum protein 1,TRUE
283_MZT2B_80097,Q6NZ67,mitotic-spindle organizing protein 2b (mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2b),MZT2B FAM128B MOZART2B,158,NA,"subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:20360068}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:20360068}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,MZT2B,80097,Hs.469925,ENST00000309451,THC2522736,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005819(spindle)|GO:0005856(cytoskeleton)|GO:0008274(gamma-tubulin ring complex),"Homo sapiens mitotic spindle organizing protein 2B (MZT2B), mRNA [NM_025029]",chr2:130948210-130948269,hs|2q21.1,mitotic spindle organizing protein 2B,TRUE
284_DSP_1832,P15924,desmoplakin (dp) (250/210 kda paraneoplastic pemphigus antigen),DSP,2871,function: major high molecular weight protein of desmosomes. involved in the organization of the desmosomal cadherin-plakoglobin complexes into discrete plasma membrane domains and in the anchoring of intermediate filaments to the desmosomes.,"subcellular location: cell junction, desmosome {eco:0000269|pubmed:12802069}. cytoplasm, cytoskeleton {eco:0000269|pubmed:12802069}. cell membrane {eco:0000250|uniprotkb:e9q557}. note=innermost portion of the desmosomal plaque. colocalizes with epidermal krt5-krt14 and simple krt8-krt18 keratins and vim intermediate filaments network (pubmed:12802069). localizes at the intercalated disk in cardiomyocytes (by similarity). {eco:0000250|uniprotkb:e9q557, eco:0000269|pubmed:12802069}.",TISSUE SPECIFICITY: Isoform DPI is apparently an obligate constituent of all desmosomes. Isoform DPII resides predominantly in tissues and cells of stratified origin.,"DISEASE: Keratoderma, palmoplantar, striate 2 (SPPK2) [MIM:612908]: A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present. {ECO:0000269|PubMed:9887343}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, with woolly hair and keratoderma (DCWHK) [MIM:605676]: An autosomal recessive cardiocutaneous syndrome characterized by a generalized striate keratoderma particularly affecting the palmoplantar epidermis, woolly hair, and dilated left ventricular cardiomyopathy. {ECO:0000269|PubMed:11063735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 8 (ARVD8) [MIM:607450]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:12373648, ECO:0000269|PubMed:15941723, ECO:0000269|PubMed:20031617}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655]: An autosomal recessive genodermatosis characterized by skin fragility with blistering, focal and diffuse palmoplantar keratoderma, hyperkeratotic plaques on the trunk and limbs, and woolly hair with varying degrees of alopecia. {ECO:0000269|PubMed:11841538}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa, lethal acantholytic (EBLA) [MIM:609638]: A form of epidermolysis bullosa characterized by severe fragility of skin and mucous membranes. The phenotype is lethal in the neonatal period because of immense transcutaneous fluid loss. Typical features include universal alopecia, neonatal teeth, and nail loss. Histopathology of the skin shows suprabasal clefting and acantholysis throughout the spinous layer, mimicking pemphigus. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis (DCWHKTA) [MIM:615821]: A cardiocutaneous syndrome characterized by biventricular dilated cardiomyopathy, hyperkeratosis, woolly hair, palmoplantar keratoderma, and hypo/oligodontia. {ECO:0000269|PubMed:16628197, ECO:0000269|PubMed:20940358, ECO:0000269|PubMed:22795705}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,DSP,1832,Hs.519873,ENST00000418664,THC2490571,"GO:0001533(cornified envelope)|GO:0005198(structural molecule activity)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005886(plasma membrane)|GO:0005916(fascia adherens)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0008544(epidermis development)|GO:0016323(basolateral plasma membrane)|GO:0016337(cell-cell adhesion)|GO:0018149(peptide cross-linking)|GO:0030054(cell junction)|GO:0030057(desmosome)|GO:0030216(keratinocyte differentiation)|GO:0030674(protein binding, bridging)|GO:0034332(adherens junction organization)|GO:0042060(wound healing)|GO:0043588(skin development)","Homo sapiens desmoplakin (DSP), transcript variant 1, mRNA [NM_004415]",chr6:7586582-7586641,hs|6p24.3,desmoplakin,TRUE
285_NPRL3_8131,Q12980,gator complex protein nprl3 (-14 gene protein) (alpha-globin regulatory element-containing gene protein) (nitrogen permease regulator 3-like protein) (protein cgthba),NPRL3 C16orf35 CGTHBA MARE,569,"function: as a component of the gator1 complex functions as an inhibitor of the amino acid-sensing branch of the torc1 pathway. the gator1 complex strongly increases gtp hydrolysis by rraga and rragb within rragc-containing heterodimers, thereby deactivating rrags, releasing mtorc1 from lysosomal surface and inhibiting mtorc1 signaling. the gator1 complex is negatively regulated by gator2 the other gator subcomplex in this amino acid-sensing branch of the torc1 pathway. {eco:0000269|pubmed:23723238}.",subcellular location: lysosome membrane {eco:0000269|pubmed:28199306}. note=localization to lysosomes is amino acid-independent. {eco:0000269|pubmed:28199306}.,"TISSUE SPECIFICITY: Widely expressed. Expressed in the frontal lobe cortex as well as in the temporal, parietal, and occipital lobes (PubMed:27173016, PubMed:26505888). {ECO:0000269|PubMed:26505888, ECO:0000269|PubMed:27173016}.","DISEASE: Note=Inactivating mutations and truncating deletions in the genes encoding GATOR1 proteins are detected in glioblastoma and ovarian tumors and are associated with loss of heterozygosity events. Inactivation of GATOR1 proteins promotes constitutive localization of mTORC1 to the lysosomal membrane and blocks mTORC1 inactivation following amino acid withdrawal (PubMed:23723238). {ECO:0000269|PubMed:23723238}.; DISEASE: Epilepsy, familial focal, with variable foci 3 (FFEVF3) [MIM:617118]: An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions, including the temporal, frontal, parietal, and occipital lobes. Seizure types commonly include temporal lobe epilepsy, frontal lobe epilepsy, and nocturnal frontal lobe epilepsy. Some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. A subset of patients have structural brain abnormalities. Penetrance of the disorder is incomplete. {ECO:0000269|PubMed:26285051, ECO:0000269|PubMed:26505888, ECO:0000269|PubMed:27173016}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NPRL3,8131,Hs.19699,ENST00000463178,THC2523541,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens nitrogen permease regulator-like 3 (S. cerevisiae) (NPRL3), transcript variant 2, mRNA [NM_001039476]",chr16:136841-136782,hs|16p13.3,nitrogen permease regulator-like 3 (S. cerevisiae),TRUE
286_NFIC_4782,P08651,nuclear factor 1 c-type (nf1-c) (nuclear factor 1/c) (ccaat-box-binding transcription factor) (ctf) (nuclear factor i/c) (nf-i/c) (nfi-c) (tggca-binding protein),NFIC NFI,508,function: recognizes and binds the palindromic sequence 5'-ttggcnnnnngccaa-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. these proteins are individually capable of activating transcription and replication.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NFIC,4782,Hs.170131,NA,THC2551757,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006260(DNA replication)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","Homo sapiens nuclear factor I/C (CCAAT-binding transcription factor) (NFIC), transcript variant 2, mRNA [NM_205843]",chr19:3465248-3465307,hs|19p13.3,nuclear factor I/C (CCAAT-binding transcription factor),TRUE
287_USMG5_84833,Q96IX5,"atp synthase membrane subunit dapit, mitochondrial (diabetes-associated protein in insulin-sensitive tissues) (hcv f-transactivated protein 2) (up-regulated during skeletal muscle growth protein 5)",ATP5MD DAPIT HCVFTP2 USMG5 PD04912,58,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (probable). minor subunit required to maintain the atp synthase population in the mitochondria (pubmed:21345788). {eco:0000269|pubmed:21345788, eco:0000305}.",subcellular location: mitochondrion membrane {eco:0000269|pubmed:21345788}; single-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,USMG5,84833,Hs.500921,ENST00000369811,THC2479338,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens up-regulated during skeletal muscle growth 5 homolog (mouse) (USMG5), transcript variant 2, mRNA [NM_032747]",chr10:105148909-105148850,hs|10q24.33,up-regulated during skeletal muscle growth 5 homolog (mouse),TRUE
288_PUM1_9698,Q14671,pumilio homolog 1 (hspum) (pumilio-1),PUM1 KIAA0099 PUMH1,1186,"function: sequence-specific rna-binding protein that acts as a post-transcriptional repressor by binding the 3'-utr of mrna targets. binds to an rna consensus sequence, the pumilio response element (pre), 5'-uguanaua-3', that is related to the nanos response element (nre) (pubmed:21572425, pubmed:18328718, pubmed:21653694, pubmed:21397187). mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the ccr4-pop2-not deadenylase leading to translational inhibition and mrna degradation (pubmed:22955276). also mediates deadenylation-independent repression by promoting accessibility of mirnas (pubmed:18776931, pubmed:20818387, pubmed:20860814, pubmed:22345517). following growth factor stimulation, phosphorylated and binds to the 3'-utr of cdkn1b/p27 mrna, inducing a local conformational change that exposes mirna-binding sites, promoting association of mir-221 and mir-222, efficient suppression of cdkn1b/p27 expression, and rapid entry to the cell cycle (pubmed:20818387). acts as a post-transcriptional repressor of e2f3 mrnas by binding to its 3'-utr and facilitating mirna regulation (pubmed:22345517, pubmed:29474920). represses a program of genes necessary to maintain genomic stability such as key mitotic, dna repair and dna replication factors. its ability to repress those target mrnas is regulated by the lncrna norad (non-coding rna activated by dna damage) which, due to its high abundance and multitude of pumilio binding sites, is able to sequester a significant fraction of pum1 and pum2 in the cytoplasm (pubmed:26724866). involved in neuronal functions by regulating atxn1 mrna levels: acts by binding to the 3'-utr of atxn1 transcripts, leading to their down-regulation independently of the mirna machinery (pubmed:25768905, pubmed:29474920). plays a role in cytoplasmic sensing of viral infection (pubmed:25340845). in testis, acts as a post-transcriptional regulator of spermatogenesis by binding to the 3'-utr of mrnas coding for regulators of p53/tp53. involved in embryonic stem cell renewal by facilitating the exit from the ground state: acts by targeting mrnas coding for naive pluripotency transcription factors and accelerates their down-regulation at the onset of differentiation (by similarity). binds specifically to mirna mir199a precursor, with pum2, regulates mirna mir199a expression at a postranscriptional level (pubmed:28431233). {eco:0000250|uniprotkb:q80u78, eco:0000269|pubmed:18328718, eco:0000269|pubmed:18776931, eco:0000269|pubmed:20818387, eco:0000269|pubmed:20860814, eco:0000269|pubmed:21397187, eco:0000269|pubmed:21572425, eco:0000269|pubmed:21653694, eco:0000269|pubmed:22345517, eco:0000269|pubmed:22955276, eco:0000269|pubmed:25340845, eco:0000269|pubmed:25768905, eco:0000269|pubmed:26724866, eco:0000269|pubmed:28431233, eco:0000269|pubmed:29474920}.","subcellular location: cytoplasm {eco:0000305|pubmed:26724866}. cytoplasm, p-body {eco:0000305|pubmed:20818387}. cytoplasmic granule {eco:0000269|pubmed:25340845}. note=recruited to cytoplasmic stress granules upon viral infection. {eco:0000269|pubmed:25340845}.","TISSUE SPECIFICITY: Expressed in brain, heart, kidney, muscle, intestine and stomach. Not expressed in cerebellum, corpus callosum, caudate nucleus, hippocampus, medulla oblongata and putamen. Expressed in all fetal tissues tested. {ECO:0000269|PubMed:12459267}.","DISEASE: Spinocerebellar ataxia 47 (SCA47) [MIM:617931]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA47 is an autosomal dominant disease with a highly variable phenotype and incomplete penetrance. Clinical features include developmental disability, ataxia, and seizures. {ECO:0000269|PubMed:29474920}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,PUM1,9698,Hs.281707,ENST00000440538,THC2469817,GO:0003723(RNA binding)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006417(regulation of translation)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0016044(cellular membrane organization),"Homo sapiens pumilio homolog 1 (Drosophila) (PUM1), transcript variant 1, mRNA [NM_001020658]",chr1:31405766-31405707,hs|1p35.2,pumilio homolog 1 (Drosophila),TRUE
289_NDUFA8_4702,P51970,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (complex i-19kd) (ci-19kd) (complex i-pgiv) (ci-pgiv) (nadh-ubiquinone oxidoreductase 19 kda subunit),NDUFA8,172,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:21310150}; peripheral membrane protein {eco:0000269|pubmed:21310150}. mitochondrion intermembrane space {eco:0000269|pubmed:21310150}. mitochondrion {eco:0000269|pubmed:23676665}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA8,4702,Hs.495039,ENST00000373768,THC2687568,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0005758(mitochondrial intermembrane space)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa (NDUFA8), nuclear gene encoding mitochondrial protein, mRNA [NM_014222]",chr9:124906467-124906408,hs|9q33.2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa",TRUE
29_HSP90B1_7184,P14625,endoplasmin (94 kda glucose-regulated protein) (grp-94) (heat shock protein 90 kda beta member 1) (tumor rejection antigen 1) (gp96 homolog),HSP90B1 GRP94 TRA1,803,"function: molecular chaperone that functions in the processing and transport of secreted proteins (by similarity). when associated with cnpy3, required for proper folding of toll-like receptors (by similarity). functions in endoplasmic reticulum associated degradation (erad) (pubmed:18264092). has atpase activity (by similarity). {eco:0000250|uniprotkb:p08113, eco:0000269|pubmed:18264092}.","subcellular location: endoplasmic reticulum lumen {eco:0000305|pubmed:12475965}. sarcoplasmic reticulum lumen {eco:0000250|uniprotkb:p41148}. melanosome {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSP90B1,7184,Hs.192374,ENST00000421266,THC2465650,GO:0000166(nucleotide binding)|GO:0001666(response to hypoxia)|GO:0003723(RNA binding)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0006457(protein folding)|GO:0006916(anti-apoptosis)|GO:0006950(response to stress)|GO:0015031(protein transport)|GO:0019903(protein phosphatase binding)|GO:0030433(ER-associated protein catabolic process)|GO:0030496(midbody)|GO:0031247(actin rod assembly)|GO:0042470(melanosome)|GO:0043666(regulation of phosphoprotein phosphatase activity)|GO:0044459(plasma membrane part)|GO:0046790(virion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0050750(low-density lipoprotein particle receptor binding)|GO:0051082(unfolded protein binding)|GO:0051208(sequestering of calcium ion)|GO:0071318(cellular response to ATP),"Homo sapiens heat shock protein 90kDa beta (Grp94), member 1 (HSP90B1), mRNA [NM_003299]",chr12:104341536-104341595,hs|12q23.3,"heat shock protein 90kDa beta (Grp94), member 1",TRUE
290_BRD2_6046,P25440,bromodomain-containing protein 2 (o27.1.1) (really interesting new gene 3 protein),BRD2 KIAA9001 RING3,801,"function: may play a role in spermatogenesis or folliculogenesis (by similarity). binds hyperacetylated chromatin and plays a role in the regulation of transcription, probably by chromatin remodeling. regulates transcription of the ccnd1 gene. plays a role in nucleosome assembly. {eco:0000250, eco:0000269|pubmed:18406326}.",subcellular location: nucleus {eco:0000305}. note=detected on chromatin and nucleosomes.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BRD2,6046,Hs.75243,ENST00000443797,THC2465305,GO:0004674(protein serine/threonine kinase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007283(spermatogenesis),"Homo sapiens bromodomain containing 2 (BRD2), transcript variant 1, mRNA [NM_005104]",chr6:32949018-32949077,hs|6p21.32,bromodomain containing 2,TRUE
291_CTBP2_1488,P56545,c-terminal-binding protein 2 (ctbp2),CTBP2,445,function: corepressor targeting diverse transcription regulators. functions in brown adipose tissue (bat) differentiation (by similarity). {eco:0000250}.; function: isoform 2 probably acts as a scaffold for specialized synapses.,"subcellular location: nucleus {eco:0000305}. cell junction, synapse {eco:0000250}.","TISSUE SPECIFICITY: Ubiquitous. Highest levels in heart, skeletal muscle, and pancreas.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTBP2,1488,Hs.501345,ENST00000337195,THC2486385,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0008285(negative regulation of cell proliferation)|GO:0016491(oxidoreductase activity)|GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)|GO:0017053(transcriptional repressor complex)|GO:0019079(viral genome replication)|GO:0030054(cell junction)|GO:0030154(cell differentiation)|GO:0045202(synapse)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048037(cofactor binding)|GO:0050872(white fat cell differentiation)|GO:0051287(NAD binding)|GO:0055114(oxidation-reduction process)","Homo sapiens C-terminal binding protein 2 (CTBP2), transcript variant 2, mRNA [NM_022802]",chr10:126677529-126677470,hs|10q26.13,C-terminal binding protein 2,TRUE
292_CSNK1D_1453,P48730,casein kinase i isoform delta (cki-delta) (ckid) (ec 2.7.11.1) (tau-protein kinase csnk1d) (ec 2.7.11.26),CSNK1D HCKID,415,"function: essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including wnt signaling, dna repair and circadian rhythms. it can phosphorylate a large number of proteins. casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. phosphorylates connexin-43/gja1, map1a, snapin, mapt/tau, top2a, dck, hif1a, eif6, p53/tp53, dvl2, dvl3, esr1, aib1/ncoa3, dnmt1, pkd2, yap1, per1 and per2. central component of the circadian clock. in balance with pp1, determines the circadian period length through the regulation of the speed and rhythmicity of per1 and per2 phosphorylation. controls per1 and per2 nuclear transport and degradation. yap1 phosphorylation promotes its scf(beta-trcp) e3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. dnmt1 phosphorylation reduces its dna-binding activity. phosphorylation of esr1 and aib1/ncoa3 stimulates their activity and coactivation. phosphorylation of dvl2 and dvl3 regulates wnt3a signaling pathway that controls neurite outgrowth. eif6 phosphorylation promotes its nuclear export. triggers down-regulation of dopamine receptors in the forebrain. activates dck in vitro by phosphorylation. top2a phosphorylation favors dna cleavable complex formation. may regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. modulates connexin-43/gja1 gap junction assembly by phosphorylation. probably involved in lymphocyte physiology. regulates fast synaptic transmission mediated by glutamate. {eco:0000269|pubmed:10606744, eco:0000269|pubmed:12270943, eco:0000269|pubmed:14761950, eco:0000269|pubmed:16027726, eco:0000269|pubmed:17562708, eco:0000269|pubmed:17962809, eco:0000269|pubmed:19043076, eco:0000269|pubmed:19339517, eco:0000269|pubmed:20041275, eco:0000269|pubmed:20048001, eco:0000269|pubmed:20407760, eco:0000269|pubmed:20637175, eco:0000269|pubmed:20696890, eco:0000269|pubmed:20699359, eco:0000269|pubmed:21084295, eco:0000269|pubmed:21422228, eco:0000269|pubmed:23636092}.","subcellular location: cytoplasm. nucleus. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. cytoplasm, perinuclear region. cell membrane. cytoplasm, cytoskeleton, spindle. golgi apparatus. note=localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. recruited to the spindle apparatus and the centrosomes in response to dna-damage. correct subcellular localization requires kinase activity.","TISSUE SPECIFICITY: Expressed in all tissues examined, including brain, heart, lung, liver, pancreas, kidney, placenta and skeletal muscle. However, kinase activity is not uniform, with highest kinase activity in splenocytes. In blood, highly expressed in hemopoietic cells and mature granulocytes. Also found in monocytes and lymphocytes. {ECO:0000269|PubMed:15070676, ECO:0000269|PubMed:16027726}.","DISEASE: Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224]: A disorder characterized by very early sleep onset and offset. Individuals are 'morning larks' with a 4 hours advance of the sleep, temperature and melatonin rhythms. {ECO:0000269|PubMed:15800623, ECO:0000269|PubMed:23636092}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CSNK1D,1453,Hs.631725,NA,THC2563327,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000278(mitotic cell cycle)|GO:0001934(positive regulation of protein phosphorylation)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005813(centrosome)|GO:0005819(spindle)|GO:0005829(cytosol)|GO:0005876(spindle microtubule)|GO:0005886(plasma membrane)|GO:0006281(DNA repair)|GO:0006468(protein phosphorylation)|GO:0007165(signal transduction)|GO:0016055(Wnt receptor signaling pathway)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0032922(circadian regulation of gene expression)|GO:0042752(regulation of circadian rhythm)|GO:0048471(perinuclear region of cytoplasm)|GO:0050321(tau-protein kinase activity)|GO:0051225(spindle assembly)|GO:0090263(positive regulation of canonical Wnt receptor signaling pathway),"Homo sapiens casein kinase 1, delta (CSNK1D), transcript variant 2, mRNA [NM_139062]",chr17:80200612-80200553,hs|17q25.3,"casein kinase 1, delta",TRUE
293_RPL7A_6130,P62424,60s ribosomal protein l7a (large ribosomal subunit protein el8) (pla-x polypeptide) (surfeit locus protein 3),RPL7A SURF-3 SURF3,266,NA,NA,NA,DISEASE: Note=Chromosomal recombination involving RPL7A activates the receptor kinase domain of the TRK oncogene.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL7A,6130,Hs.499839,ENST00000468019,THC2560213,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042254(ribosome biogenesis)|GO:0042788(polysomal ribosome)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L7a (RPL7A), mRNA [NM_000972]",chr9:136217529-136217862,hs|9q34.2,ribosomal protein L7a,TRUE
295_ULK1_8408,O75385,serine/threonine-protein kinase ulk1 (ec 2.7.11.1) (autophagy-related protein 1 homolog) (atg1) (hatg1) (unc-51-like kinase 1),ULK1 KIAA0722,1050,"function: serine/threonine-protein kinase involved in autophagy in response to starvation. acts upstream of phosphatidylinositol 3-kinase pik3c3 to regulate the formation of autophagophores, the precursors of autophagosomes. part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mtorc1) via interaction with rptor. activated via phosphorylation by ampk and also acts as a regulator of ampk by mediating phosphorylation of ampk subunits prkaa1, prkab2 and prkag1, leading to negatively regulate ampk activity. may phosphorylate atg13/kiaa0652 and rptor; however such data need additional evidences. plays a role early in neuronal differentiation and is required for granule cell axon formation. may also phosphorylate sesn2 and sqstm1 to regulate autophagy (pubmed:25040165). {eco:0000269|pubmed:18936157, eco:0000269|pubmed:21460634, eco:0000269|pubmed:21795849, eco:0000269|pubmed:25040165}.","subcellular location: cytoplasm, cytosol {eco:0000250}. preautophagosomal structure {eco:0000250}. note=under starvation conditions, is localized to puncate structures primarily representing the isolation membrane that sequesters a portion of the cytoplasm resulting in the formation of an autophagosome. {eco:0000250}.","TISSUE SPECIFICITY: Ubiquitously expressed. Detected in the following adult tissues: skeletal muscle, heart, pancreas, brain, placenta, liver, kidney, and lung.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ULK1,8408,Hs.47061,ENST00000321867,THC2482052,GO:0000045(autophagic vacuole assembly)|GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005776(autophagic vacuole)|GO:0005829(cytosol)|GO:0006468(protein phosphorylation)|GO:0007165(signal transduction)|GO:0007265(Ras protein signal transduction)|GO:0008104(protein localization)|GO:0010506(regulation of autophagy)|GO:0010508(positive regulation of autophagy)|GO:0021707(cerebellar granule cell differentiation)|GO:0021933(radial glia guided migration of cerebellar granule cell)|GO:0030659(cytoplasmic vesicle membrane)|GO:0031102(neuron projection regeneration)|GO:0031175(neuron projection development)|GO:0031623(receptor internalization)|GO:0031669(cellular response to nutrient levels)|GO:0032403(protein complex binding)|GO:0034045(pre-autophagosomal structure membrane)|GO:0042594(response to starvation)|GO:0043005(neuron projection)|GO:0043025(neuronal cell body)|GO:0046777(protein autophosphorylation)|GO:0048671(negative regulation of collateral sprouting)|GO:0048675(axon extension)|GO:0051386(regulation of nerve growth factor receptor signaling pathway)|GO:0070969(ULK1-ATG13-FIP200 complex),"Homo sapiens unc-51-like kinase 1 (C. elegans) (ULK1), mRNA [NM_003565]",chr12:132407576-132407635,hs|12q24.33,unc-51-like kinase 1 (C. elegans),TRUE
296_NDUFS5_4725,O43920,nadh dehydrogenase [ubiquinone] iron-sulfur protein 5 (complex i-15 kda) (ci-15 kda) (nadh-ubiquinone oxidoreductase 15 kda subunit),NDUFS5,106,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}. mitochondrion intermembrane space {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFS5,4725,Hs.632385,ENST00000372969,THC2469488,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0005758(mitochondrial intermembrane space)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0032981(mitochondrial respiratory chain complex I assembly)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) (NDUFS5), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004552]",chr1:39500182-39500241,hs|1p34.3,"NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)",TRUE
297_UQCRH_7388,P07919,"cytochrome b-c1 complex subunit 6, mitochondrial (complex iii subunit 6) (complex iii subunit viii) (cytochrome c1 non-heme 11 kda protein) (mitochondrial hinge protein) (ubiquinol-cytochrome c reductase complex 11 kda protein)",UQCRH,91,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. this protein may mediate formation of the complex between cytochromes c and c1.",subcellular location: mitochondrion inner membrane {eco:0000250|uniprotkb:p00127}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCRH,7388,Hs.481571,ENST00000496387,THC2637581,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005746(mitochondrial respiratory chain)|GO:0005750(mitochondrial respiratory chain complex III)|GO:0006119(oxidative phosphorylation)|GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c)|GO:0006810(transport)|GO:0008121(ubiquinol-cytochrome-c reductase activity)|GO:0009060(aerobic respiration)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0032403(protein complex binding)|GO:0051291(protein heterooligomerization)|GO:0055114(oxidation-reduction process)","Homo sapiens ubiquinol-cytochrome c reductase hinge protein (UQCRH), nuclear gene encoding mitochondrial protein, mRNA [NM_006004]",chr1:46775954-46782248,hs|1p34.1,ubiquinol-cytochrome c reductase hinge protein,TRUE
298_RPL24_6152,P83731,60s ribosomal protein l24 (60s ribosomal protein l30) (large ribosomal subunit protein el24),RPL24,157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL24,6152,Hs.477028,ENST00000394077,THC2483185,GO:0000027(ribosomal large subunit assembly)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010458(exit from mitosis)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0021554(optic nerve development)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0031290(retinal ganglion cell axon guidance)|GO:0031575(mitotic cell cycle G1/S transition checkpoint)|GO:0044267(cellular protein metabolic process)|GO:0060041(retina development in camera-type eye),"Homo sapiens ribosomal protein L24 (RPL24), mRNA [NM_000986]",chr3:101401280-101400008,hs|3q12.3,ribosomal protein L24,TRUE
299_NDUFC2_4718,O95298,nadh dehydrogenase [ubiquinone] 1 subunit c2 (complex i-b14.5b) (ci-b14.5b) (human lung cancer oncogene 1 protein) (hlc-1) (nadh-ubiquinone oxidoreductase subunit b14.5b),NDUFC2 HLC1,119,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}; matrix side {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFC2,4718,Hs.407860,ENST00000324742,THC2550212,"GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa (NDUFC2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004549]",chr11:77780999-77780940,hs|11q14.1,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa",TRUE
3_ND3_4537,P03897,nadh-ubiquinone oxidoreductase chain 3 (ec 7.1.1.2) (nadh dehydrogenase subunit 3),MT-ND3 MTND3 NADH3 ND3,115,function: core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed to belong to the minimal assembly required for catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (by similarity). {eco:0000250}.,subcellular location: mitochondrion membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,"DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:17152068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:11456298, ECO:0000269|PubMed:14705112, ECO:0000269|PubMed:20818383}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ND3,4537,NA,ENST00000361227,THC2572830,"GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0006979(response to oxidative stress)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0009642(response to light intensity)|GO:0009725(response to hormone stimulus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)",mitochondrially encoded NADH dehydrogenase 3 [Source:HGNC Symbol;Acc:7458] [ENST00000361227],chrM:10345-10404,NA,"NADH dehydrogenase, subunit 3 (complex I)",TRUE
30_LOC100132247_100132247,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC100132247,100132247,Hs.720286,ENST00000451409,THC2480903,NA,"Homo sapiens nuclear pore complex interacting protein related gene (LOC100132247), mRNA [NM_001135865]",chr16:22547503-22547562,hs|16p12.2,nuclear pore complex interacting protein related gene,TRUE
300_GNL3_26354,Q9BVP2,guanine nucleotide-binding protein-like 3 (e2-induced gene 3 protein) (novel nucleolar protein 47) (nnp47) (nucleolar gtp-binding protein 3) (nucleostemin),GNL3 E2IG3 NS,549,"function: may be required to maintain the proliferative capacity of stem cells. stabilizes mdm2 by preventing its ubiquitination, and hence proteasomal degradation (by similarity). {eco:0000250, eco:0000269|pubmed:12464630, eco:0000269|pubmed:16012751}.","subcellular location: nucleus {eco:0000250|uniprotkb:q811s9}. nucleus, nucleolus {eco:0000269|pubmed:11790298, eco:0000269|pubmed:12429849, eco:0000269|pubmed:12464630}. note=shuttles between the nucleus and nucleolus. {eco:0000250|uniprotkb:q811s9}.",TISSUE SPECIFICITY: Increased levels in lung tissue in cancer patients. {ECO:0000269|PubMed:16012751}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GNL3,26354,Hs.313544,ENST00000496254,THC2549499,GO:0000166(nucleotide binding)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0042127(regulation of cell proliferation),"Homo sapiens guanine nucleotide binding protein-like 3 (nucleolar) (GNL3), transcript variant 1, mRNA [NM_014366]",chr3:52728336-52728395,hs|3p21.1,guanine nucleotide binding protein-like 3 (nucleolar),TRUE
301_ANKRD37_353322,Q7Z713,ankyrin repeat domain-containing protein 37 (low-density lipoprotein receptor-related protein 2-binding protein) (hlrp2bp),ANKRD37 LPR2BP,158,NA,subcellular location: nucleus {eco:0000269|pubmed:15809689}. cytoplasm {eco:0000269|pubmed:15809689}.,"TISSUE SPECIFICITY: Mainly expressed in testis, small intestine, colon, blood leukocytes and in pancreatic adenocarcinoma cells. {ECO:0000269|PubMed:15809689}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,ANKRD37,353322,Hs.508154,ENST00000335174,THC2471653,GO:0005634(nucleus)|GO:0005737(cytoplasm),"Homo sapiens ankyrin repeat domain 37 (ANKRD37), mRNA [NM_181726]",chr4:186321293-186321352,hs|4q35.1,ankyrin repeat domain 37,TRUE
302_SRSF3_6428,P84103,"serine/arginine-rich splicing factor 3 (pre-mrna-splicing factor srp20) (splicing factor, arginine/serine-rich 3)",SRSF3 SFRS3 SRP20,164,"function: splicing factor that specifically promotes exon-inclusion during alternative splicing (pubmed:26876937). interaction with ythdc1, a rna-binding protein that recognizes and binds n6-methyladenosine (m6a)-containing rnas, promotes recruitment of srsf3 to its mrna-binding elements adjacent to m6a sites, leading to exon-inclusion during alternative splicing (pubmed:26876937). also functions as export adapter involved in mrna nuclear export (pubmed:11336712, pubmed:18364396, pubmed:28984244). binds mrna which is thought to be transferred to the nxf1-nxt1 heterodimer for export (tap/nxf1 pathway); enhances nxf1-nxt1 rna-binding activity (pubmed:11336712, pubmed:18364396). involved in nuclear export of m6a-containing mrnas via interaction with ythdc1: interaction with ythdc1 facilitates m6a-containing mrna-binding to both srsf3 and nxf1, promoting mrna nuclear export (pubmed:28984244). rna-binding is semi-sequence specific (pubmed:17036044). {eco:0000269|pubmed:11336712, eco:0000269|pubmed:17036044, eco:0000269|pubmed:18364396, eco:0000269|pubmed:26876937, eco:0000269|pubmed:28984244}.",subcellular location: nucleus {eco:0000269|pubmed:11336712}. nucleus speckle {eco:0000269|pubmed:26876937}. cytoplasm {eco:0000269|pubmed:11336712}. note=recruited to nuclear speckles following interaction with ythdc1. {eco:0000269|pubmed:26876937}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF3,6428,Hs.405144,ENST00000373715,THC2578148,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006406(mRNA export from nucleus)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0031124(mRNA 3'-end processing)","Homo sapiens serine/arginine-rich splicing factor 3 (SRSF3), transcript variant 1, mRNA [NM_003017]",chr6:36570424-36570483,hs|6p21.31,serine/arginine-rich splicing factor 3,TRUE
303_RPL13AP3_645683,Q6NVV1,putative 60s ribosomal protein l13a protein rpl13ap3 (60s ribosomal protein l13a pseudogene 3),RPL13AP3,102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL13AP3,645683,Hs.663461,ENST00000494676,THC2489113,GO:0003735(structural constituent of ribosome)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens ribosomal protein L13a pseudogene 3 (RPL13AP3), non-coding RNA [NR_004844]",chr14:56233429-56233489,hs|14q22.3,ribosomal protein L13a pseudogene 3,TRUE
304_ZNF706_51123,Q9Y5V0,zinc finger protein 706,ZNF706 HSPC038 PNAS-113,76,function: transcription repressor involved in the exit of embryonic stem cells (escs) from self-renewal. acts by repressing expression of klf4. {eco:0000250|uniprotkb:q9d115}.,subcellular location: cytoplasm {eco:0000250|uniprotkb:q9d115}. nucleus {eco:0000250|uniprotkb:q9d115}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF706,51123,Hs.374485,ENST00000519882,THC2519651,GO:0005622(intracellular)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens zinc finger protein 706 (ZNF706), transcript variant 1, mRNA [NM_001042510]",chr8:102211377-102211318,hs|8q22.3,zinc finger protein 706,TRUE
305_NFE2L1_4779,Q14494,"endoplasmic reticulum membrane sensor nfe2l1 (locus control region-factor 1) (lcr-f1) (nuclear factor erythroid 2-related factor 1) (nf-e2-related factor 1) (nfe2-related factor 1) (nuclear factor, erythroid derived 2, like 1) (protein nrf1, p120 form) (transcription factor 11) (tcf-11) [cleaved into: transcription factor nrf1 (protein nrf1, p110 form)]",NFE2L1 HBZ17 NRF1 TCF11,772,"function: endoplasmic reticulum membrane sensor nfe2l1: endoplasmic reticulum membrane sensor that translocates into the nucleus in response to various stresses to act as a transcription factor (pubmed:20932482, pubmed:24448410). constitutes a precursor of the transcription factor nrf1 (by similarity). able to detect various cellular stresses, such as cholesterol excess, oxidative stress or proteasome inhibition (pubmed:20932482). in response to stress, it is released from the endoplasmic reticulum membrane following cleavage by the protease ddi2 and translocates into the nucleus to form the transcription factor nrf1 (by similarity). acts as a key sensor of cholesterol excess: in excess cholesterol conditions, the endoplasmic reticulum membrane form of the protein directly binds cholesterol via its crac motif, preventing cleavage and release of the transcription factor nrf1, thereby allowing expression of genes promoting cholesterol removal, such as cd36 (by similarity). involved in proteasome homeostasis: in response to proteasome inhibition, it is released from the endoplasmic reticulum membrane, translocates to the nucleus and activates expression of genes encoding proteasome subunits (pubmed:20932482). {eco:0000250|uniprotkb:q61985, eco:0000269|pubmed:20932482, eco:0000269|pubmed:24448410}.; function: transcription factor nrf1: cnc-type bzip family transcription factor that translocates to the nucleus and regulates expression of target genes in response to various stresses (pubmed:8932385, pubmed:9421508). heterodimerizes with small-maf proteins (maff, mafg or mafk) and binds dna motifs including the antioxidant response elements (ares), which regulate expression of genes involved in oxidative stress response (pubmed:8932385, pubmed:9421508). activates or represses expression of target genes, depending on the context (pubmed:8932385, pubmed:9421508). plays a key role in cholesterol homeostasis by acting as a sensor of cholesterol excess: in low cholesterol conditions, translocates into the nucleus and represses expression of genes involved in defense against cholesterol excess, such as cd36 (by similarity). in excess cholesterol conditions, the endoplasmic reticulum membrane form of the protein directly binds cholesterol via its crac motif, preventing cleavage and release of the transcription factor nrf1, thereby allowing expression of genes promoting cholesterol removal (by similarity). critical for redox balance in response to oxidative stress: acts by binding the ares motifs on promoters and mediating activation of oxidative stress response genes, such as gclc, gclm, gss, mt1 and mt2 (by similarity). plays an essential role during fetal liver hematopoiesis: probably has a protective function against oxidative stress and is involved in lipid homeostasis in the liver (by similarity). involved in proteasome homeostasis: in response to proteasome inhibition, mediates the 'bounce-back' of proteasome subunits by translocating into the nucleus and activating expression of genes encoding proteasome subunits (pubmed:20932482). also involved in regulating glucose flux (by similarity). together with cebpb; represses expression of dspp during odontoblast differentiation (pubmed:15308669). in response to ascorbic acid induction, activates expression of sp7/osterix in osteoblasts. {eco:0000250|uniprotkb:q61985, eco:0000269|pubmed:15308669, eco:0000269|pubmed:20932482, eco:0000269|pubmed:8932385, eco:0000269|pubmed:9421508}.","subcellular location: endoplasmic reticulum membrane sensor nfe2l1: endoplasmic reticulum membrane {eco:0000269|pubmed:16687406, eco:0000269|pubmed:24448410, eco:0000269|pubmed:24998528}; single-pass type ii membrane protein {eco:0000269|pubmed:20932482, eco:0000269|pubmed:24448410}. endoplasmic reticulum membrane {eco:0000269|pubmed:16687406, eco:0000269|pubmed:24448410, eco:0000269|pubmed:24998528}; single-pass type iii membrane protein {eco:0000269|pubmed:20932482, eco:0000269|pubmed:24448410}. note=in normal conditions, probably has a single-pass type ii membrane protein topology, with the dna-binding domain facing the endoplasmic reticulum lumen (pubmed:24448410). following cellular stress, it is rapidly and efficiently retrotranslocated to the cytosolic side of the membrane, a process dependent on p97/vcp, to have a single-pass type iii membrane protein topology with the major part of the protein facing the cytosol (pubmed:24448410). retrotranslocated proteins are normally rapidly degraded by the proteasome and active species do not accumulate (pubmed:24448410). however, retrotranslocated protein nfe2l1 escapes degradation and is cleaved at leu-104 by ddi2, releasing the protein from the endoplasmic reticulum membrane and forming the transcription factor nrf1 that translocates into the nucleus (pubmed:24448410). {eco:0000269|pubmed:24448410}.; subcellular location: transcription factor nrf1: nucleus {eco:0000255|prosite-prorule:pru00978, eco:0000269|pubmed:16687406, eco:0000269|pubmed:20932482, eco:0000269|pubmed:24998528, eco:0000269|pubmed:27528193}. note=translocates into the nucleus following cleavage of endoplasmic reticulum membrane sensor nfe2l1 by aspartyl protease ddi2. {eco:0000269|pubmed:24448410, eco:0000269|pubmed:27528193}.",NA,NA,NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,NFE2L1,4779,Hs.514284,ENST00000361665,NP1162487,"GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003712(transcription cofactor activity)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006783(heme biosynthetic process)|GO:0006954(inflammatory response)|GO:0009653(anatomical structure morphogenesis)|GO:0043565(sequence-specific DNA binding)|GO:0046983(protein dimerization activity)","Homo sapiens nuclear factor (erythroid-derived 2)-like 1 (NFE2L1), mRNA [NM_003204]",chr17:46138789-46138848,hs|17q21.32,nuclear factor (erythroid-derived 2)-like 1,TRUE
306_LBR_3930,Q14739,delta(14)-sterol reductase lbr (delta-14-sr) (ec 1.3.1.70) (3-beta-hydroxysterol delta (14)-reductase) (c-14 sterol reductase) (c14sr) (integral nuclear envelope inner membrane protein) (lmn2r) (lamin-b receptor) (sterol c14-reductase),LBR,615,"function: catalyzes the reduction of the c14-unsaturated bond of lanosterol, as part of the metabolic pathway leading to cholesterol biosynthesis (pubmed:9630650, pubmed:12618959, pubmed:16784888, pubmed:21327084, pubmed:27336722). plays a critical role in myeloid cell cholesterol biosynthesis which is essential to both myeloid cell growth and functional maturation (by similarity). mediates the activation of nadph oxidases, perhaps by maintaining critical levels of cholesterol required for membrane lipid raft formation during neutrophil differentiation (by similarity). anchors the lamina and the heterochromatin to the inner nuclear membrane (pubmed:10828963). {eco:0000250|uniprotkb:q3u9g9, eco:0000269|pubmed:10828963, eco:0000269|pubmed:12618959, eco:0000269|pubmed:16784888, eco:0000269|pubmed:21327084, eco:0000269|pubmed:27336722, eco:0000269|pubmed:9630650}.",subcellular location: nucleus inner membrane {eco:0000269|pubmed:8157662}; multi-pass membrane protein {eco:0000255}. endoplasmic reticulum membrane {eco:0000269|pubmed:21327084}. cytoplasm {eco:0000269|pubmed:21327084}. nucleus {eco:0000269|pubmed:21327084}. note=nucleus; nuclear rim. {eco:0000269|pubmed:21327084}.,"TISSUE SPECIFICITY: Expressed in the bone marrow, liver, heart, adrenal gland, lung, placenta and uterus (PubMed:16784888). Expressed in osteoclasts and osteoblast-like cells (PubMed:21327084). {ECO:0000269|PubMed:16784888, ECO:0000269|PubMed:21327084}.","DISEASE: Pelger-Huet anomaly (PHA) [MIM:169400]: An autosomal dominant inherited abnormality of granulocytes, characterized by abnormal ovoid shape, reduced nuclear segmentation and an apparently looser chromatin structure. {ECO:0000269|PubMed:14617022}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Greenberg dysplasia (GRBGD) [MIM:215140]: A rare autosomal recessive chondrodystrophy characterized by early in utero lethality. Affected fetuses typically present with fetal hydrops, short-limbed dwarfism, and a marked disorganization of chondro-osseous calcification, and ectopic ossification centers. {ECO:0000269|PubMed:12618959, ECO:0000269|PubMed:21327084, ECO:0000269|PubMed:27336722}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Reynolds syndrome (REYNS) [MIM:613471]: A syndrome specifically associating limited cutaneous systemic sclerosis and primary biliary cirrhosis. It is characterized by liver disease, telangiectasia, abrupt onset of digital paleness or cyanosis in response to cold exposure or stress (Raynaud phenomenon), and variable features of scleroderma. The liver disease is characterized by pruritis, jaundice, hepatomegaly, increased serum alkaline phosphatase and positive serum mitochondrial autoantibodies, all consistent with primary biliary cirrhosis. {ECO:0000269|PubMed:20522425}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Pelger-Huet anomaly with mild skeletal anomalies (PHASK) [MIM:618019]: A disease characterized by abnormal nuclear shape and chromatin organization in blood granulocytes, short stature, and mild skeletal anomalies. Initial skeletal features may improve with age. {ECO:0000269|PubMed:23824842, ECO:0000269|PubMed:25348816}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LBR,3930,Hs.435166,ENST00000338179,THC2468913,"GO:0003677(DNA binding)|GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005521(lamin binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005637(nuclear inner membrane)|GO:0005639(integral to nuclear inner membrane)|GO:0005643(nuclear pore)|GO:0006695(cholesterol biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor)|GO:0055114(oxidation-reduction process)|GO:0070087(chromo shadow domain binding)","Homo sapiens lamin B receptor (LBR), transcript variant 1, mRNA [NM_002296]",chr1:225589341-225589282,hs|1q42.12,lamin B receptor,TRUE
308_MIF_4282,Q15011,homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (methyl methanesulfonate (mmf)-inducible fragment protein 1),HERPUD1 HERP KIAA0025 MIF1,391,"function: component of the endoplasmic reticulum quality control (erqc) system also called er-associated degradation (erad) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins. could enhance presenilin-mediated amyloid-beta protein 40 generation. binds to ubiquilins and this interaction is required for efficient degradation of cd3d via the erad pathway (pubmed:18307982). {eco:0000269|pubmed:16289116, eco:0000269|pubmed:18307982}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:10922362}; multi-pass membrane protein {eco:0000269|pubmed:10922362}.,"TISSUE SPECIFICITY: Widely expressed; in the brain, expression seems to be restricted to neurons and vascular smooth muscle cells. Present in activated microglia in senile plaques in the brain of patients with Alzheimer disease.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MIF,4282,Hs.407995,ENST00000215754,THC2465329,"GO:0001516(prostaglandin biosynthetic process)|GO:0004167(dopachrome isomerase activity)|GO:0005102(receptor binding)|GO:0005125(cytokine activity)|GO:0005126(cytokine receptor binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0006954(inflammatory response)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0008283(cell proliferation)|GO:0009986(cell surface)|GO:0010629(negative regulation of gene expression)|GO:0010739(positive regulation of protein kinase A signaling cascade)|GO:0016853(isomerase activity)|GO:0019752(carboxylic acid metabolic process)|GO:0030890(positive regulation of B cell proliferation)|GO:0033138(positive regulation of peptidyl-serine phosphorylation)|GO:0042056(chemoattractant activity)|GO:0042327(positive regulation of phosphorylation)|GO:0043030(regulation of macrophage activation)|GO:0043066(negative regulation of apoptosis)|GO:0043498(cell surface binding)|GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator)|GO:0045087(innate immune response)|GO:0048146(positive regulation of fibroblast proliferation)|GO:0050178(phenylpyruvate tautomerase activity)|GO:0050715(positive regulation of cytokine secretion)|GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)|GO:0050918(positive chemotaxis)|GO:0070207(protein homotrimerization)|GO:0070374(positive regulation of ERK1 and ERK2 cascade)|GO:0071157(negative regulation of cell cycle arrest)|GO:0090344(negative regulation of cell aging)","Homo sapiens macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF), mRNA [NM_002415]",chr22:24237346-24237405,hs|22q11.23,macrophage migration inhibitory factor (glycosylation-inhibiting factor),TRUE
309_TMC8_147138,Q8IU68,transmembrane channel-like protein 8 (epidermodysplasia verruciformis protein 2),TMC8 EVER2 EVIN2,726,function: probable ion channel. {eco:0000250}.,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12426567}; multi-pass membrane protein {eco:0000269|pubmed:12426567}.,"TISSUE SPECIFICITY: Expressed in placenta, prostate and testis. {ECO:0000269|PubMed:12906855}.","DISEASE: Epidermodysplasia verruciformis 2 (EV2) [MIM:618231]: A form of epidermodysplasia verruciformis, a rare genodermatosis associated with a high risk of skin carcinoma that results from an abnormal susceptibility to infection by specific human papillomaviruses, including the oncogenic HPV5. Infection leads to the early development of disseminated flat wart-like and pityriasis versicolor-like skin lesions. Cutaneous Bowen's carcinomas in situ and invasive squamous cell carcinomas develop in about half of the patients, mainly on sun-exposed skin areas. EV2 inheritance is autosomal recessive. {ECO:0000269|PubMed:12426567, ECO:0000269|PubMed:28646613}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMC8,147138,Hs.592102,ENST00000318430,THC2480490,GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane channel-like 8 (TMC8), mRNA [NM_152468]",chr17:76135247-76135306,hs|17q25.3,transmembrane channel-like 8,TRUE
31_MAT2A_4144,P31153,s-adenosylmethionine synthase isoform type-2 (adomet synthase 2) (ec 2.5.1.6) (methionine adenosyltransferase 2) (mat 2) (methionine adenosyltransferase ii) (mat-ii),MAT2A AMS2 MATA2,395,"function: catalyzes the formation of s-adenosylmethionine from methionine and atp. the reaction comprises two steps that are both catalyzed by the same enzyme: formation of s-adenosylmethionine (adomet) and triphosphate, and subsequent hydrolysis of the triphosphate. {eco:0000269|pubmed:10644686, eco:0000269|pubmed:23189196, eco:0000269|pubmed:25075345}.",NA,TISSUE SPECIFICITY: Detected in kidney. {ECO:0000269|PubMed:1426236}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MAT2A,4144,Hs.516157,ENST00000424323,THC2465708,GO:0000166(nucleotide binding)|GO:0004478(methionine adenosyltransferase activity)|GO:0005524(ATP binding)|GO:0005829(cytosol)|GO:0006556(S-adenosylmethionine biosynthetic process)|GO:0006805(xenobiotic metabolic process)|GO:0007623(circadian rhythm)|GO:0009416(response to light stimulus)|GO:0009725(response to hormone stimulus)|GO:0016740(transferase activity)|GO:0032259(methylation)|GO:0042493(response to drug)|GO:0046872(metal ion binding)|GO:0051591(response to cAMP),"Homo sapiens methionine adenosyltransferase II, alpha (MAT2A), mRNA [NM_005911]",chr2:85772302-85772361,hs|2p11.2,"methionine adenosyltransferase II, alpha",TRUE
310_AKAP1_8165,Q92667,"a-kinase anchor protein 1, mitochondrial (a-kinase anchor protein 149 kda) (akap 149) (dual specificity a-kinase-anchoring protein 1) (d-akap-1) (protein kinase a-anchoring protein 1) (prka1) (spermatid a-kinase anchor protein 84) (s-akap84)",AKAP1 AKAP149 PRKA1,903,function: binds to type i and ii regulatory subunits of protein kinase a and anchors them to the cytoplasmic face of the mitochondrial outer membrane.,subcellular location: mitochondrion outer membrane {eco:0000250|uniprotkb:o08715}.,"TISSUE SPECIFICITY: Isoform 1 is detected in thymus, prostate, testis, ovary, colon and small intestine (PubMed:8769136). Isoform 2 is highly expressed in testis and detected at much lower levels in kidney, pancreas, liver, lung and brain (PubMed:7499250). {ECO:0000269|PubMed:7499250, ECO:0000269|PubMed:8769136}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,AKAP1,8165,Hs.463506,ENST00000481416,THC2467844,GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005759(mitochondrial matrix)|GO:0005811(lipid particle)|GO:0005829(cytosol)|GO:0007596(blood coagulation)|GO:0008017(microtubule binding)|GO:0010614(negative regulation of cardiac muscle hypertrophy)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019901(protein kinase binding)|GO:0019904(protein domain specific binding)|GO:0030061(mitochondrial crista)|GO:0030346(protein phosphatase 2B binding)|GO:0031594(neuromuscular junction)|GO:0032869(cellular response to insulin stimulus)|GO:0032947(protein complex scaffold)|GO:0034237(protein kinase A regulatory subunit binding)|GO:0035308(negative regulation of protein dephosphorylation)|GO:0045211(postsynaptic membrane)|GO:0048487(beta-tubulin binding)|GO:0051534(negative regulation of NFAT protein import into nucleus)|GO:0070887(cellular response to chemical stimulus),"Homo sapiens A kinase (PRKA) anchor protein 1 (AKAP1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_003488]",chr17:55198512-55198571,hs|17q22,A kinase (PRKA) anchor protein 1,TRUE
311_EFNA1_1942,P20827,"ephrin-a1 (eph-related receptor tyrosine kinase ligand 1) (lerk-1) (immediate early response protein b61) (tumor necrosis factor alpha-induced protein 4) (tnf alpha-induced protein 4) [cleaved into: ephrin-a1, secreted form]",EFNA1 EPLG1 LERK1 TNFAIP4,205,"function: cell surface gpi-bound ligand for eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. binds promiscuously eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. plays an important role in angiogenesis and tumor neovascularization. the recruitment of vav2, vav3 and pi3-kinase p85 subunit by phosphorylated epha2 is critical for efna1-induced rac1 gtpase activation and vascular endothelial cell migration and assembly. exerts anti-oncogenic effects in tumor cells through activation and down-regulation of epha2. activates epha2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. acts as a negative regulator in the tumorigenesis of gliomas by down-regulating epha2 and fak. can evoke collapse of embryonic neuronal growth cone and regulates dendritic spine morphogenesis. {eco:0000269|pubmed:17332925, eco:0000269|pubmed:18794797}.","subcellular location: cell membrane {eco:0000269|pubmed:18794797}; lipid-anchor, gpi-anchor {eco:0000269|pubmed:18794797}.; subcellular location: ephrin-a1, secreted form: secreted {eco:0000269|pubmed:18794797}.",TISSUE SPECIFICITY: Brain. Down-regulated in primary glioma tissues compared to the normal tissues. The soluble monomeric form is expressed in the glioblastoma multiforme (GBM) and breast cancer cells (at protein level). {ECO:0000269|PubMed:17332925}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,EFNA1,1942,Hs.516664,ENST00000368407,THC2467875,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000187(activation of MAPK activity)|GO:0003180(aortic valve morphogenesis)|GO:0003183(mitral valve morphogenesis)|GO:0003199(endocardial cushion to mesenchymal transition involved in heart valve formation)|GO:0005102(receptor binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007267(cell-cell signaling)|GO:0010719(negative regulation of epithelial to mesenchymal transition)|GO:0014028(notochord formation)|GO:0016477(cell migration)|GO:0030182(neuron differentiation)|GO:0033628(regulation of cell adhesion mediated by integrin)|GO:0034446(substrate adhesion-dependent cell spreading)|GO:0043535(regulation of blood vessel endothelial cell migration)|GO:0045765(regulation of angiogenesis)|GO:0046658(anchored to plasma membrane)|GO:0046875(ephrin receptor binding)|GO:0048013(ephrin receptor signaling pathway)|GO:0050730(regulation of peptidyl-tyrosine phosphorylation)|GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)|GO:0050770(regulation of axonogenesis)|GO:0061002(negative regulation of dendritic spine morphogenesis),"Homo sapiens ephrin-A1 (EFNA1), transcript variant 1, mRNA [NM_004428]",chr1:155107208-155107267,hs|1q22,ephrin-A1,TRUE
312_GABARAPL2_11345,P60520,gamma-aminobutyric acid receptor-associated protein-like 2 (gaba(a) receptor-associated protein-like 2) (ganglioside expression factor 2) (gef-2) (general protein transport factor p16) (golgi-associated atpase enhancer of 16 kda) (gate-16) (map1 light chain 3-related protein),GABARAPL2 FLC3A GEF2,117,"function: ubiquitin-like modifier involved in intra-golgi traffic. modulates intra-golgi transport through coupling between nsf activity and snares activation. it first stimulates the atpase activity of nsf which in turn stimulates the association with gosr1 (by similarity). involved in autophagy. plays a role in mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ros production. whereas lc3s are involved in elongation of the phagophore membrane, the gabarap/gate-16 subfamily is essential for a later stage in autophagosome maturation. {eco:0000250, eco:0000269|pubmed:20418806, eco:0000269|pubmed:23209295}.","subcellular location: golgi apparatus {eco:0000250}. cytoplasmic vesicle, autophagosome {eco:0000269|pubmed:12507496, eco:0000269|pubmed:15169837, eco:0000269|pubmed:17580304, eco:0000269|pubmed:19056683, eco:0000269|pubmed:22311637}.","TISSUE SPECIFICITY: Ubiquitous. Expressed at high levels in the brain, heart, prostate, ovary, spleen and skeletal muscle. Expressed at very low levels in lung, thymus and small intestine. {ECO:0000269|PubMed:11146101, ECO:0000269|PubMed:11414770}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GABARAPL2,11345,Hs.461379,ENST00000037243,THC2507945,GO:0000139(Golgi membrane)|GO:0000149(SNARE binding)|GO:0000421(autophagic vacuole membrane)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005624(membrane fraction)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006891(intra-Golgi vesicle-mediated transport)|GO:0006914(autophagy)|GO:0008017(microtubule binding)|GO:0015031(protein transport)|GO:0032781(positive regulation of ATPase activity)|GO:0048487(beta-tubulin binding)|GO:0050811(GABA receptor binding)|GO:0051117(ATPase binding),"Homo sapiens GABA(A) receptor-associated protein-like 2 (GABARAPL2), mRNA [NM_007285]",chr16:75611548-75611607,hs|16q23.1,GABA(A) receptor-associated protein-like 2,TRUE
313_ATP6AP1_537,Q15904,v-type proton atpase subunit s1 (v-atpase subunit s1) (protein xap-3) (v-atpase ac45 subunit) (v-atpase s1 accessory protein) (vacuolar proton pump subunit s1),ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,470,"function: accessory subunit of the proton-transporting vacuolar (v)-atpase protein pump, which is required for luminal acidification of secretory vesicles. guides the v-type atpase into specialized subcellular compartments, such as neuroendocrine regulated secretory vesicles or the ruffled border of the osteoclast, thereby regulating its activity. involved in membrane trafficking and ca(2+)-dependent membrane fusion. may play a role in the assembly of the v-type atpase complex. in aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of fe(2+) prolyl hydroxylase (phd) enzymes, and leading to hif1a hydroxylation and subsequent proteasomal degradation (pubmed:28296633). {eco:0000269|pubmed:28296633, eco:0000305|pubmed:27231034}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:27231034}; single-pass membrane protein {eco:0000305}. endoplasmic reticulum-golgi intermediate compartment membrane {eco:0000269|pubmed:27231034}. note=not detected in trans-golgi network. {eco:0000269|pubmed:27231034}.,"TISSUE SPECIFICITY: widely expressed, with highest levels in brain and lowest in liver and duodenum. {ECO:0000269|PubMed:27231034}.","DISEASE: Immunodeficiency 47 (IMD47) [MIM:300972]: A complex immunodeficiency syndrome characterized by hypogammaglobulinemia, recurrent bacterial infections, defective glycosylation of serum proteins, and liver disease with neonatal jaundice and hepatosplenomegaly. Some patients may also have neurologic features, including seizures, mild intellectual disability, and behavioral abnormalities. Inheritance is X-linked recessive. {ECO:0000269|PubMed:27231034}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP6AP1,537,Hs.6551,ENST00000455205,THC2512632,"GO:0000166(nucleotide binding)|GO:0005215(transporter activity)|GO:0005524(ATP binding)|GO:0005773(vacuole)|GO:0005774(vacuolar membrane)|GO:0006811(ion transport)|GO:0007568(aging)|GO:0008219(cell death)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0015992(proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016469(proton-transporting two-sector ATPase complex)|GO:0033180(proton-transporting V-type ATPase, V1 domain)|GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism)|GO:0046961(proton-transporting ATPase activity, rotational mechanism)","Homo sapiens ATPase, H+ transporting, lysosomal accessory protein 1 (ATP6AP1), mRNA [NM_001183]",chrX:153664652-153664711,hs|Xq28,"ATPase, H+ transporting, lysosomal accessory protein 1",TRUE
314_TUG1_55000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,TUG1,55000,Hs.554829,NA,THC2467500,NA,"Homo sapiens taurine upregulated 1 (non-protein coding) (TUG1), non-coding RNA [NR_002323]",chr22:31371927-31371986,hs|22q12.2,taurine upregulated 1 (non-protein coding),TRUE
315_SOX4_6659,Q06945,transcription factor sox-4,SOX4,474,function: transcriptional activator that binds with high affinity to the t-cell enhancer motif 5'-aacaaag-3' motif.,"subcellular location: nucleus {eco:0000255|prosite-prorule:pru00267, eco:0000269|pubmed:16631117}.","TISSUE SPECIFICITY: Testis, brain, and heart.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SOX4,6659,Hs.643910,ENST00000244745,THC2467796,"GO:0000976(transcription regulatory region sequence-specific DNA binding)|GO:0001046(core promoter sequence-specific DNA binding)|GO:0001071(nucleic acid binding transcription factor activity)|GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription)|GO:0001105(RNA polymerase II transcription coactivator activity)|GO:0001501(skeletal system development)|GO:0001841(neural tube formation)|GO:0002328(pro-B cell differentiation)|GO:0003183(mitral valve morphogenesis)|GO:0003211(cardiac ventricle formation)|GO:0003215(cardiac right ventricle morphogenesis)|GO:0003289(atrial septum primum morphogenesis)|GO:0003357(noradrenergic neuron differentiation)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0007507(heart development)|GO:0008284(positive regulation of cell proliferation)|GO:0008285(negative regulation of cell proliferation)|GO:0014009(glial cell proliferation)|GO:0021510(spinal cord development)|GO:0021522(spinal cord motor neuron differentiation)|GO:0021782(glial cell development)|GO:0030177(positive regulation of Wnt receptor signaling pathway)|GO:0030217(T cell differentiation)|GO:0031018(endocrine pancreas development)|GO:0031397(negative regulation of protein ubiquitination)|GO:0031647(regulation of protein stability)|GO:0032024(positive regulation of insulin secretion)|GO:0035019(somatic stem cell maintenance)|GO:0035910(ascending aorta morphogenesis)|GO:0042593(glucose homeostasis)|GO:0042769(DNA damage response, detection of DNA damage)|GO:0043065(positive regulation of apoptosis)|GO:0043066(negative regulation of apoptosis)|GO:0045727(positive regulation of translation)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046826(negative regulation of protein export from nucleus)|GO:0048485(sympathetic nervous system development)|GO:0050821(protein stabilization)|GO:0060070(canonical Wnt receptor signaling pathway)|GO:0060174(limb bud formation)|GO:0060412(ventricular septum morphogenesis)|GO:0060548(negative regulation of cell death)|GO:0060563(neuroepithelial cell differentiation)|GO:0060993(kidney morphogenesis)|GO:0071333(cellular response to glucose stimulus)|GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)|GO:2000761(positive regulation of N-terminal peptidyl-lysine acetylation)","Homo sapiens SRY (sex determining region Y)-box 4 (SOX4), mRNA [NM_003107]",chr6:21596985-21597044,hs|6p22.3,SRY (sex determining region Y)-box 4,TRUE
316_HIST1H1C_3006,P16403,histone h1.2 (histone h1c) (histone h1d) (histone h1s-1),H1-2 H1F2 HIST1H1C,213,"function: histone h1 protein binds to linker dna between nucleosomes forming the macromolecular structure known as the chromatin fiber. histones h1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and dna methylation (by similarity). {eco:0000250}.",subcellular location: nucleus. chromosome. note=mainly localizes in euchromatin. distribution goes in parallel with dna concentration.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H1C,3006,Hs.7644,ENST00000343677,THC2467269,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly)|GO:0016584(nucleosome positioning),"Homo sapiens histone cluster 1, H1c (HIST1H1C), mRNA [NM_005319]",chr6:26056109-26056050,hs|6p22.2,"histone cluster 1, H1c",TRUE
317_RPL13A_23521,P40429,60s ribosomal protein l13a (23 kda highly basic protein) (large ribosomal subunit protein ul13),RPL13A,203,"function: associated with ribosomes but is not required for canonical ribosome function and has extra-ribosomal functions. component of the gait (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. upon interferon-gamma activation and subsequent phosphorylation dissociates from the ribosome and assembles into the gait complex which binds to stem loop-containing gait elements in the 3'-utr of diverse inflammatory mrnas (such as ceruplasmin) and suppresses their translation. in the gait complex interacts with m7g cap-bound eif4g at or near the eif3-binding site and blocks the recruitment of the 43s ribosomal complex. involved in methylation of rrna. {eco:0000269|pubmed:14567916, eco:0000269|pubmed:17218275, eco:0000269|pubmed:17921318, eco:0000269|pubmed:23071094}.",subcellular location: cytoplasm {eco:0000305|pubmed:14567916}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL13A,23521,Hs.523185,ENST00000474171,NP1210591,GO:0003735(structural constituent of ribosome)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015934(large ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L13a (RPL13A), mRNA [NM_012423]",chr19:49994724-49994783,hs|19q13.33,ribosomal protein L13a,TRUE
318_MINOS1_440574,Q5TGZ0,micos complex subunit mic10 (mitochondrial inner membrane organizing system protein 1),MICOS10 C1orf151 MIC10 MINOS1,78,"function: component of the micos complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. {eco:0000269|pubmed:22114354}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:22114354}; single-pass membrane protein {eco:0000269|pubmed:22114354}. note=the c-terminus is located in the intermembrane space (by similarity), while the location of the n-terminus has not been determined yet. as some programs predict the presence of 2 closely apposed membrane domains, it has been proposed that the protein may cross the membrane twice and that both termini may face the intermembrane space (pubmed:22114354). {eco:0000250, eco:0000269|pubmed:22114354}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MINOS1,440574,Hs.466662,ENST00000485362,THC2523860,GO:0003674(molecular_function)|GO:0005739(mitochondrion)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens mitochondrial inner membrane organizing system 1 (MINOS1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001032363]",chr1:19953035-19953094,hs|1p36.13,mitochondrial inner membrane organizing system 1,TRUE
319_TUBB4B_10383,P68371,tubulin beta-4b chain (tubulin beta-2 chain) (tubulin beta-2c chain),TUBB4B TUBB2C,445,"function: tubulin is the major constituent of microtubules. it binds two moles of gtp, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.","subcellular location: cytoplasm, cytoskeleton.",TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:20191564}.,DISEASE: Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879]: An autosomal dominant disease characterized by severe retinal degeneration and sensorineural hearing loss. Symptoms occur within the first decade of life. Onset at birth is observed in some patients. {ECO:0000269|PubMed:29198720}. Note=The disease is caused by mutations affecting the gene represented in this entry.,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TUBB4B,10383,Hs.433615,ENST00000340384,NP1153870,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000278(mitotic cell cycle)|GO:0003924(GTPase activity)|GO:0005198(structural molecule activity)|GO:0005525(GTP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0006457(protein folding)|GO:0006928(cellular component movement)|GO:0007018(microtubule-based movement)|GO:0042267(natural killer cell mediated cytotoxicity)|GO:0042288(MHC class I protein binding)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding)|GO:0051258(protein polymerization),"Homo sapiens tubulin, beta 4B class IVb (TUBB4B), mRNA [NM_006088]",chr9:140138101-140138159,hs|9q34.3,"tubulin, beta 4B class IVb",TRUE
32_CDH1_999,P12830,cadherin-1 (cam 120/80) (epithelial cadherin) (e-cadherin) (uvomorulin) (cd antigen cd324) [cleaved into: e-cad/ctf1; e-cad/ctf2; e-cad/ctf3],CDH1 CDHE UVO,882,"function: cadherins are calcium-dependent cell adhesion proteins (pubmed:11976333). they preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. cdh1 is involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells (pubmed:11976333). has a potent invasive suppressor role. it is a ligand for integrin alpha-e/beta-7. {eco:0000269|pubmed:11976333, eco:0000269|pubmed:16417575}.; function: e-cad/ctf2 promotes non-amyloidogenic degradation of abeta precursors. has a strong inhibitory effect on app c99 and c83 production. {eco:0000269|pubmed:16417575}.; function: (microbial infection) serves as a receptor for listeria monocytogenes; internalin a (inla) binds to this protein and promotes uptake of the bacteria. {eco:0000269|pubmed:10406800, eco:0000269|pubmed:17540170, eco:0000269|pubmed:8601315}.","subcellular location: cell junction, adherens junction {eco:0000269|pubmed:28169360}. cell membrane {eco:0000269|pubmed:19403558, eco:0000269|pubmed:28301459}; single-pass type i membrane protein. endosome. golgi apparatus, trans-golgi network. note=colocalizes with dlgap5 at sites of cell-cell contact in intestinal epithelial cells. anchored to actin microfilaments through association with alpha-, beta- and gamma-catenin. sequential proteolysis induced by apoptosis or calcium influx, results in translocation from sites of cell-cell contact to the cytoplasm. colocalizes with rab11a endosomes during its transport from the golgi apparatus to the plasma membrane.",TISSUE SPECIFICITY: Non-neural epithelial tissues.,"DISEASE: Hereditary diffuse gastric cancer (HDGC) [MIM:137215]: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. {ECO:0000269|PubMed:10319582, ECO:0000269|PubMed:12216071}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Heterozygous CDH1 germline mutations are responsible for familial cases of diffuse gastric cancer. Somatic mutations has also been found in patients with sporadic diffuse gastric cancer and lobular breast cancer.; DISEASE: Endometrial cancer (ENDMC) [MIM:608089]: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:8075649}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Breast cancer, lobular (LBC) [MIM:137215]: A type of breast cancer that begins in the milk-producing glands (lobules) of the breast. {ECO:0000269|PubMed:17660459}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580]: A form of blepharocheilodontic syndrome, a rare autosomal dominant disorder. It is characterized by lower eyelid ectropion, upper eyelid distichiasis, euryblepharon, bilateral cleft lip and palate, and features of ectodermal dysplasia, including hair anomalies, conical teeth and tooth agenesis. An additional rare manifestation is imperforate anus. There is considerable phenotypic variability among affected individuals. {ECO:0000269|PubMed:28301459}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CDH1,999,Hs.461086,ENST00000261769,THC2469338,"GO:0001701(in utero embryonic development)|GO:0001829(trophectodermal cell differentiation)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0005913(cell-cell adherens junction)|GO:0005925(focal adhesion)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0007155(cell adhesion)|GO:0007156(homophilic cell adhesion)|GO:0007416(synapse assembly)|GO:0008013(beta-catenin binding)|GO:0009636(response to toxin)|GO:0009898(internal side of plasma membrane)|GO:0009986(cell surface)|GO:0010033(response to organic substance)|GO:0015629(actin cytoskeleton)|GO:0016021(integral to membrane)|GO:0016235(aggresome)|GO:0016323(basolateral plasma membrane)|GO:0016328(lateral plasma membrane)|GO:0016337(cell-cell adhesion)|GO:0016342(catenin complex)|GO:0019538(protein metabolic process)|GO:0019903(protein phosphatase binding)|GO:0019904(protein domain specific binding)|GO:0021983(pituitary gland development)|GO:0022408(negative regulation of cell-cell adhesion)|GO:0030054(cell junction)|GO:0031175(neuron projection development)|GO:0032794(GTPase activating protein binding)|GO:0033268(node of Ranvier)|GO:0033561(regulation of water loss via skin)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0042153(RPTP-like protein binding)|GO:0042493(response to drug)|GO:0042993(positive regulation of transcription factor import into nucleus)|GO:0043219(lateral loop)|GO:0043220(Schmidt-Lanterman incisure)|GO:0043281(regulation of caspase activity)|GO:0043296(apical junction complex)|GO:0045177(apical part of cell)|GO:0045216(cell-cell junction organization)|GO:0045295(gamma-catenin binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0048471(perinuclear region of cytoplasm)|GO:0050776(regulation of immune response)|GO:0050839(cell adhesion molecule binding)|GO:0051260(protein homooligomerization)|GO:0060662(salivary gland cavitation)|GO:0060693(regulation of branching involved in salivary gland morphogenesis)|GO:0070830(tight junction assembly)|GO:0071230(cellular response to amino acid stimulus)|GO:0071285(cellular response to lithium ion)|GO:0071681(cellular response to indole-3-methanol)|GO:2000008(regulation of protein localization at cell surface)","Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), mRNA [NM_004360]",chr16:68869214-68869273,hs|16q22.1,"cadherin 1, type 1, E-cadherin (epithelial)",TRUE
320_MLEC_9761,Q14165,malectin,MLEC KIAA0152,292,function: carbohydrate-binding protein with a strong ligand preference for glc2-n-glycan. may play a role in the early steps of protein n-glycosylation (by similarity). {eco:0000250}.,subcellular location: endoplasmic reticulum membrane {eco:0000250}; single-pass type i membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MLEC,9761,Hs.507074,ENST00000228506,THC2556345,GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005975(carbohydrate metabolic process)|GO:0006457(protein folding)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0030246(carbohydrate binding)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process),"Homo sapiens malectin (MLEC), mRNA [NM_014730]",chr12:121132789-121132942,hs|12q24.31,malectin,TRUE
321_SSB_6741,P05455,lupus la protein (la autoantigen) (la ribonucleoprotein) (sjoegren syndrome type b antigen) (ss-b),SSB,408,"function: binds to the 3' poly(u) terminus of nascent rna polymerase iii transcripts, protecting them from exonuclease digestion and facilitating their folding and maturation (pubmed:3192525, pubmed:2470590). in case of coxsackievirus b3 infection, binds to the viral internal ribosome entry site (ires) and stimulates the ires-mediated translation (pubmed:12384597). {eco:0000269|pubmed:12384597, eco:0000269|pubmed:2470590, eco:0000269|pubmed:3192525}.",subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SSB,6741,Hs.632535,ENST00000409333,THC2492984,GO:0000049(tRNA binding)|GO:0000166(nucleotide binding)|GO:0003729(mRNA binding)|GO:0005634(nucleus)|GO:0006396(RNA processing)|GO:0006400(tRNA modification)|GO:0008334(histone mRNA metabolic process)|GO:0030529(ribonucleoprotein complex),"Homo sapiens Sjogren syndrome antigen B (autoantigen La) (SSB), mRNA [NM_003142]",chr2:170668314-170668373,hs|2q31.1,Sjogren syndrome antigen B (autoantigen La),TRUE
322_ARF4_378,P18085,adp-ribosylation factor 4,ARF4 ARF2,180,"function: gtp-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an adp-ribosyltransferase. involved in protein trafficking; may modulate vesicle budding and uncoating within the golgi apparatus.",subcellular location: golgi apparatus. membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ARF4,378,Hs.652183,ENST00000486310,NP1201645,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007264(small GTPase mediated signal transduction)|GO:0007420(brain development)|GO:0015031(protein transport)|GO:0016192(vesicle-mediated transport)|GO:0048678(response to axon injury),"Homo sapiens ADP-ribosylation factor 4 (ARF4), mRNA [NM_001660]",chr3:57557101-57557072,hs|3p14.3,ADP-ribosylation factor 4,TRUE
323_TMEM50A_23585,O95807,transmembrane protein 50a (small membrane protein 1),TMEM50A SMP1 UNQ386/PRO718,157,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TMEM50A,23585,Hs.705699,ENST00000498135,THC2494440,GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 50A (TMEM50A), mRNA [NM_014313]",chr1:25687190-25687249,hs|1p36.11,transmembrane protein 50A,TRUE
324_CELF1_10658,Q92879,cugbp elav-like family member 1 (celf-1) (50 kda nuclear polyadenylated rna-binding protein) (bruno-like protein 2) (cug triplet repeat rna-binding protein 1) (cug-bp1) (cug-bp- and etr-3-like factor 1) (deadenylation factor cug-bp) (embryo deadenylation element-binding protein homolog) (eden-bp homolog) (rna-binding protein brunol-2),CELF1 BRUNOL2 CUGBP CUGBP1 NAB50,486,"function: rna-binding protein implicated in the regulation of several post-transcriptional events. involved in pre-mrna alternative splicing, mrna translation and stability. mediates exon inclusion and/or exclusion in pre-mrna that are subject to tissue-specific and developmentally regulated alternative splicing. specifically activates exon 5 inclusion of cardiac isoforms of tnnt2 during heart remodeling at the juvenile to adult transition. acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (sm) exon but exclusion of the non-muscle (nm) exon in actinin pre-mrnas. activates sm exon 5 inclusion by antagonizing the repressive effect of ptb. promotes exclusion of exon 11 of the insr pre-mrna. inhibits, together with hnrnph1, insulin receptor (ir) pre-mrna exon 11 inclusion in myoblast. increases translation and controls the choice of translation initiation codon of cebpb mrna. increases mrna translation of cebpb in aging liver (by similarity). increases translation of cdkn1a mrna by antagonizing the repressive effect of calr3. mediates rapid cytoplasmic mrna deadenylation. recruits the deadenylase parn to the poly(a) tail of eden-containing mrnas to promote their deadenylation. required for completion of spermatogenesis (by similarity). binds to (cug)n triplet repeats in the 3'-utr of transcripts such as dmpk and to bruno response elements (bres). binds to muscle-specific splicing enhancer (mse) intronic sites flanking the alternative exon 5 of tnnt2 pre-mrna. binds to au-rich sequences (ares or eden-like) localized in the 3'-utr of jun and fos mrnas. binds to the ir rna. binds to the 5'-region of cdkn1a and cebpb mrnas. binds with the 5'-region of cebpb mrna in aging liver. may be a specific regulator of mirna biogenesis. binds to primary microrna pri-mir140 and, with celf2, negatively regulates the processing to mature mirna (pubmed:28431233). {eco:0000250, eco:0000269|pubmed:10536163, eco:0000269|pubmed:11124939, eco:0000269|pubmed:11158314, eco:0000269|pubmed:12649496, eco:0000269|pubmed:12799066, eco:0000269|pubmed:14726956, eco:0000269|pubmed:16601207, eco:0000269|pubmed:16946708, eco:0000269|pubmed:28431233}.",subcellular location: nucleus {eco:0000269|pubmed:8948631}. cytoplasm {eco:0000269|pubmed:8948631}. note=rna-binding activity is detected in both nuclear and cytoplasmic compartments.,"TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10893231, ECO:0000269|PubMed:11158314, ECO:0000269|PubMed:16862542}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CELF1,10658,Hs.595333,ENST00000532048,THC2467030,"GO:0000166(nucleotide binding)|GO:0000900(translation repressor activity, nucleic acid binding)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006376(mRNA splice site selection)|GO:0006397(mRNA processing)|GO:0007281(germ cell development)|GO:0009790(embryo development)|GO:0016246(RNA interference)|GO:0030529(ribonucleoprotein complex)|GO:0042835(BRE binding)|GO:0043484(regulation of RNA splicing)","Homo sapiens CUGBP, Elav-like family member 1 (CELF1), transcript variant 5, mRNA [NM_001172640]",chr11:47492063-47492004,hs|11p11.2,"CUGBP, Elav-like family member 1",TRUE
325_RPS14_6208,P62263,40s ribosomal protein s14 (small ribosomal subunit protein us11),RPS14 PRO2640,151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS14,6208,Hs.381126,ENST00000519690,THC2569129,GO:0000028(ribosomal small subunit assembly)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006417(regulation of translation)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030218(erythrocyte differentiation)|GO:0030490(maturation of SSU-rRNA)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0045182(translation regulator activity)|GO:0048027(mRNA 5'-UTR binding),"Homo sapiens ribosomal protein S14 (RPS14), transcript variant 1, mRNA [NM_001025071]",chr5:149826518-149826459,hs|5q33.1,ribosomal protein S14,TRUE
326_FPGS_2356,Q05932,"folylpolyglutamate synthase, mitochondrial (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs) (tetrahydrofolylpolyglutamate synthase) (tetrahydrofolate synthase)",FPGS,587,"function: catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. unsubstituted reduced folates are the preferred substrates. metabolizes methotrexate (mtx) to polyglutamates. {eco:0000269|pubmed:8408018, eco:0000269|pubmed:8408019, eco:0000269|pubmed:8408021, eco:0000269|pubmed:8662720}.","subcellular location: isoform 1: mitochondrion inner membrane {eco:0000269|pubmed:16169100}. mitochondrion matrix {eco:0000269|pubmed:16169100, eco:0000269|pubmed:8408020, eco:0000269|pubmed:8662720}.; subcellular location: isoform 2: cytoplasm {eco:0000269|pubmed:8662720}.",NA,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FPGS,2356,Hs.335084,ENST00000393706,THC2468364,"GO:0000166(nucleotide binding)|GO:0004326(tetrahydrofolylpolyglutamate synthase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0005829(cytosol)|GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0006730(one-carbon metabolic process)|GO:0006766(vitamin metabolic process)|GO:0006767(water-soluble vitamin metabolic process)|GO:0009058(biosynthetic process)|GO:0016020(membrane)|GO:0016874(ligase activity)|GO:0046655(folic acid metabolic process)|GO:0046901(tetrahydrofolylpolyglutamate biosynthetic process)","Homo sapiens folylpolyglutamate synthase (FPGS), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004957]",chr9:130575924-130575983,hs|9q34.11,folylpolyglutamate synthase,TRUE
327_AP3D1_8943,O14617,ap-3 complex subunit delta-1 (ap-3 complex subunit delta) (adaptor-related protein complex 3 subunit delta-1) (delta-adaptin),AP3D1 PRO0039,1153,"function: part of the ap-3 complex, an adaptor-related complex which is not clathrin-associated. the complex is associated with the golgi region as well as more peripheral structures. it facilitates the budding of vesicles from the golgi membrane and may be directly involved in trafficking to lysosomes. involved in process of cd8+ t-cell and nk cell degranulation (pubmed:26744459). in concert with the bloc-1 complex, ap-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals (by similarity). {eco:0000250|uniprotkb:o54774, eco:0000269|pubmed:26744459}.",subcellular location: cytoplasm {eco:0000250}. golgi apparatus membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}.,"TISSUE SPECIFICITY: Present in all adult tissues examined with the highest levels in skeletal muscle, heart, pancreas and testis. {ECO:0000269|PubMed:9151686}.","DISEASE: Hermansky-Pudlak syndrome 10 (HPS10) [MIM:617050]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS10 patients manifest albinism, neutropenia, immunodeficiency, neurodevelopmental delay, generalized seizures, and impaired hearing. {ECO:0000269|PubMed:26744459}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,AP3D1,8943,Hs.512815,ENST00000350812,THC2584291,"GO:0000139(Golgi membrane)|GO:0005215(transporter activity)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006726(eye pigment biosynthetic process)|GO:0006886(intracellular protein transport)|GO:0008565(protein transporter activity)|GO:0010008(endosome membrane)|GO:0016020(membrane)|GO:0016192(vesicle-mediated transport)|GO:0019882(antigen processing and presentation)|GO:0030117(membrane coat)|GO:0033365(protein localization to organelle)|GO:0048007(antigen processing and presentation, exogenous lipid antigen via MHC class Ib)|GO:0048499(synaptic vesicle membrane organization)|GO:0051138(positive regulation of NK T cell differentiation)|GO:0061088(regulation of sequestering of zinc ion)","Homo sapiens adaptor-related protein complex 3, delta 1 subunit (AP3D1), transcript variant 2, mRNA [NM_003938]",chr19:2114272-2114213,hs|19p13.3,"adaptor-related protein complex 3, delta 1 subunit",TRUE
328_C14orf2_9556,P56378,"atp synthase subunit atp5mpl, mitochondrial (6.8 kda mitochondrial proteolipid protein) (mlq) (atp synthase membrane subunit 6.8pl)",ATP5MPL C14orf2 MP68 PRO1574,58,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (probable). minor subunit required to maintain the atp synthase population in the mitochondria (pubmed:24330338). {eco:0000269|pubmed:24330338, eco:0000305}.",subcellular location: mitochondrion membrane {eco:0000269|pubmed:24330338}; single-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C14orf2,9556,Hs.109052,ENST00000557040,THC2580801,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005739(mitochondrion)|GO:0008150(biological_process),"Homo sapiens chromosome 14 open reading frame 2 (C14orf2), transcript variant 1, mRNA [NM_004894]",chr14:104381404-104378998,hs|14q32.33,chromosome 14 open reading frame 2,TRUE
329_FOLH1_2346,Q04609,glutamate carboxypeptidase 2 (ec 3.4.17.21) (cell growth-inhibiting gene 27 protein) (folate hydrolase 1) (folylpoly-gamma-glutamate carboxypeptidase) (fgcp) (glutamate carboxypeptidase ii) (gcpii) (membrane glutamate carboxypeptidase) (mgcp) (n-acetylated-alpha-linked acidic dipeptidase i) (naaladase i) (prostate-specific membrane antigen) (psm) (psma) (pteroylpoly-gamma-glutamate carboxypeptidase),FOLH1 FOLH NAALAD1 PSM PSMA GIG27,750,"function: has both folate hydrolase and n-acetylated-alpha-linked-acidic dipeptidase (naaladase) activity. has a preference for tri-alpha-glutamate peptides. in the intestine, required for the uptake of folate. in the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, n-aceylaspartylglutamate (naag), thereby releasing glutamate. involved in prostate tumor progression.; function: also exhibits a dipeptidyl-peptidase iv type activity. in vitro, cleaves gly-pro-amc.",subcellular location: cell membrane {eco:0000269|pubmed:9809977}; single-pass type ii membrane protein {eco:0000269|pubmed:9809977}.; subcellular location: isoform psma': cytoplasm {eco:0000269|pubmed:9809977}.,"TISSUE SPECIFICITY: Highly expressed in prostate epithelium. Detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon and brain (at protein level). Detected in the small intestine, brain, kidney, liver, spleen, colon, trachea, spinal cord and the capillary endothelium of a variety of tumors. Expressed specifically in jejunum brush border membranes. In the brain, highly expressed in the ventral striatum and brain stem. Also expressed in fetal liver and kidney. Isoform PSMA' is the most abundant form in normal prostate. Isoform PSMA-1 is the most abundant form in primary prostate tumors. Isoform PSMA-3 is also found in normal prostate as well as in brain and liver. Isoform PSMA-9 is specifically expressed in prostate cancer. {ECO:0000269|PubMed:11092759, ECO:0000269|PubMed:14716746, ECO:0000269|PubMed:16555021, ECO:0000269|PubMed:17150306, ECO:0000269|PubMed:9375657}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FOLH1,2346,Hs.654487,ENST00000356696,THC2463955,GO:0004180(carboxypeptidase activity)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006508(proteolysis)|GO:0006760(folic acid-containing compound metabolic process)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0016020(membrane)|GO:0016805(dipeptidase activity)|GO:0046872(metal ion binding),"Homo sapiens folate hydrolase (prostate-specific membrane antigen) 1 (FOLH1), transcript variant 1, mRNA [NM_004476]",chr11:49168419-49168360,hs|11p11.12,folate hydrolase (prostate-specific membrane antigen) 1,TRUE
33_ANKK1_255239,Q8NFD2,ankyrin repeat and protein kinase domain-containing protein 1 (ec 2.7.11.1) (protein kinase pkk2) (sugen kinase 288) (sgk288) (x-kinase),ANKK1 PKK2 SGK288,765,NA,NA,"TISSUE SPECIFICITY: Highly expressed in brain and weakly expressed in placenta and spinal cord. {ECO:0000269|PubMed:14741327, ECO:0000269|PubMed:15146457}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,ANKK1,255239,Hs.448473,ENST00000303941,THC2488697,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005524(ATP binding),"Homo sapiens ankyrin repeat and kinase domain containing 1 (ANKK1), mRNA [NM_178510]",chr11:113271043-113271102,hs|11q23.2,ankyrin repeat and kinase domain containing 1,TRUE
330_FKBP2_2286,P26885,peptidyl-prolyl cis-trans isomerase fkbp2 (ppiase fkbp2) (ec 5.2.1.8) (13 kda fk506-binding protein) (13 kda fkbp) (fkbp-13) (fk506-binding protein 2) (fkbp-2) (immunophilin fkbp13) (rotamase),FKBP2 FKBP13,142,function: ppiases accelerate the folding of proteins. it catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.,subcellular location: endoplasmic reticulum membrane {eco:0000305}; peripheral membrane protein {eco:0000305}.,TISSUE SPECIFICITY: T-cells and thymus.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FKBP2,2286,Hs.227729,ENST00000541388,THC2574952,GO:0000413(protein peptidyl-prolyl isomerization)|GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0005515(protein binding)|GO:0005528(FK506 binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006457(protein folding)|GO:0016020(membrane)|GO:0016853(isomerase activity)|GO:0018208(peptidyl-proline modification),"Homo sapiens FK506 binding protein 2, 13kDa (FKBP2), transcript variant 1, mRNA [NM_004470]",chr11:64011463-64011522,hs|11q13.1,"FK506 binding protein 2, 13kDa",TRUE
331_HIST1H2AD_3013,P20671,histone h2a type 1-d (histone h2a.3) (histone h2a/g),H2AC7 H2AFG HIST1H2AD,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2AD,3013,Hs.679229,ENST00000341023,THC2486071,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 1, H2ad (HIST1H2AD), mRNA [NM_021065]",chr6:26199142-26199083,hs|6p22.2,"histone cluster 1, H2ad",TRUE
332_RPL8_6132,P62917,60s ribosomal protein l8 (large ribosomal subunit protein ul2),RPL8,257,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,subcellular location: cytoplasm {eco:0000303|pubmed:12962325}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL8,6132,Hs.178551,ENST00000529920,THC2505209,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L8 (RPL8), transcript variant 1, mRNA [NM_000973]",chr8:146015752-146015301,hs|8q24.3,ribosomal protein L8,TRUE
333_HNRNPA3_220988,P51991,heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3),HNRNPA3 HNRPA3,378,"function: plays a role in cytoplasmic trafficking of rna. binds to the cis-acting response element, a2re. may be involved in pre-mrna splicing. {eco:0000269|pubmed:11886857}.",subcellular location: nucleus {eco:0000250}. note=component of ribonucleosomes.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPA3,220988,Hs.516539,NA,THC2493321,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0030529(ribonucleoprotein complex)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0051028(mRNA transport)|GO:0051033(RNA transmembrane transporter activity)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3), mRNA [NM_194247]",chr2:178087920-178087979,hs|2q31.2,heterogeneous nuclear ribonucleoprotein A3,TRUE
334_RALBP1_10928,Q15311,rala-binding protein 1 (ralbp1) (76 kda ral-interacting protein) (dinitrophenyl s-glutathione atpase) (dnp-sg atpase) (ral-interacting protein 1),RALBP1 RLIP1 RLIP76,655,"function: can activate specifically hydrolysis of gtp bound to rac1 and cdc42, but not rala. mediates atp-dependent transport of s-(2,4-dinitrophenyl)-glutathione (dnp-sg) and doxorubicin (dox) and is the major atp-dependent transporter of glutathione conjugates of electrophiles (gs-e) and dox in erythrocytes. can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with cdk1 to switch off endocytosis, one of its substrates would be epn1/epsin. {eco:0000269|pubmed:11437348, eco:0000269|pubmed:12775724, eco:0000269|pubmed:7673236}.",subcellular location: membrane {eco:0000269|pubmed:11437348}; peripheral membrane protein {eco:0000269|pubmed:11437348}.,TISSUE SPECIFICITY: Expressed ubiquitously but at low levels. Shows a strong expression in the erythrocytes. {ECO:0000269|PubMed:11437348}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RALBP1,10928,Hs.528993,ENST00000383432,THC2491007,"GO:0005096(GTPase activator activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006200(ATP catabolic process)|GO:0006810(transport)|GO:0006935(chemotaxis)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0017160(Ral GTPase binding)|GO:0030675(Rac GTPase activator activity)|GO:0032855(positive regulation of Rac GTPase activity)|GO:0043087(regulation of GTPase activity)|GO:0043089(positive regulation of Cdc42 GTPase activity)|GO:0043492(ATPase activity, coupled to movement of substances)|GO:0043547(positive regulation of GTPase activity)|GO:0048365(Rac GTPase binding)|GO:0051056(regulation of small GTPase mediated signal transduction)","Homo sapiens ralA binding protein 1 (RALBP1), mRNA [NM_006788]",chr18:9537396-9537455,hs|18p11.22,ralA binding protein 1,TRUE
335_BNIP3_664,O60238,bcl2/adenovirus e1b 19 kda protein-interacting protein 3-like (adenovirus e1b19k-binding protein b5) (bcl2/adenovirus e1b 19 kda protein-interacting protein 3a) (nip3-like protein x) (nip3l),BNIP3L BNIP3A BNIP3H NIX,219,"function: induces apoptosis. interacts with viral and cellular anti-apoptosis proteins. can overcome the suppressors bcl-2 and bcl-xl, although high levels of bcl-xl expression will inhibit apoptosis. inhibits apoptosis induced by bnip3. involved in mitochondrial quality control via its interaction with spata18/mieap: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named malm) leading to the degradation of damaged proteins inside mitochondria. the physical interaction of spata18/mieap, bnip3 and bnip3l/nix at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. may function as a tumor suppressor. {eco:0000269|pubmed:10381623, eco:0000269|pubmed:21264228}.",subcellular location: nucleus envelope. endoplasmic reticulum. mitochondrion outer membrane. membrane {eco:0000305}; single-pass membrane protein {eco:0000305}. note=colocalizes with spata18 at the mitochondrion outer membrane.,NA,NA,NA,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BNIP3,664,Hs.144873,NA,THC2513792,GO:0001666(response to hypoxia)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006338(chromatin remodeling)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006917(induction of apoptosis)|GO:0008219(cell death)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008634(negative regulation of survival gene product expression)|GO:0010637(negative regulation of mitochondrial fusion)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030425(dendrite)|GO:0031307(integral to mitochondrial outer membrane)|GO:0031966(mitochondrial membrane)|GO:0042802(identical protein binding)|GO:0042803(protein homodimerization activity)|GO:0043243(positive regulation of protein complex disassembly)|GO:0043653(mitochondrial fragmentation involved in apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0045837(negative regulation of membrane potential)|GO:0046902(regulation of mitochondrial membrane permeability)|GO:0046982(protein heterodimerization activity)|GO:0048102(autophagic cell death)|GO:0050873(brown fat cell differentiation)|GO:0051020(GTPase binding)|GO:0051402(neuron apoptosis)|GO:0051607(defense response to virus)|GO:0055093(response to hyperoxia)|GO:0070301(cellular response to hydrogen peroxide)|GO:0071260(cellular response to mechanical stimulus)|GO:0071279(cellular response to cobalt ion)|GO:0071456(cellular response to hypoxia)|GO:0072593(reactive oxygen species metabolic process)|GO:0090141(positive regulation of mitochondrial fission)|GO:0090200(positive regulation of release of cytochrome c from mitochondria),"Homo sapiens BCL2/adenovirus E1B 19kDa interacting protein 3 (BNIP3), nuclear gene encoding mitochondrial protein, mRNA [NM_004052]",chr10:133781370-133781311,hs|10q26.3,BCL2/adenovirus E1B 19kDa interacting protein 3,TRUE
336_STEAP1_26872,Q9UHE8,metalloreductase steap1 (ec 1.16.1.-) (six-transmembrane epithelial antigen of prostate 1),STEAP1 PRSS24 STEAP,339,function: metalloreductase that has the ability to reduce both fe(3+) to fe(2+) and cu(2+) to cu(1+). uses nad(+) as acceptor. {eco:0000250|uniprotkb:q9cwr7}.,subcellular location: endosome membrane {eco:0000250|uniprotkb:q9cwr7}; multi-pass membrane protein {eco:0000250|uniprotkb:q9cwr7}.,TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in prostate tumors. {ECO:0000269|PubMed:16609065}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,STEAP1,26872,Hs.61635,ENST00000297205,THC2476297,GO:0005215(transporter activity)|GO:0005506(iron ion binding)|GO:0005768(endosome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0005911(cell-cell junction)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0009055(electron carrier activity)|GO:0010008(endosome membrane)|GO:0015267(channel activity)|GO:0016491(oxidoreductase activity)|GO:0022900(electron transport chain)|GO:0046872(metal ion binding)|GO:0050660(flavin adenine dinucleotide binding)|GO:0055072(iron ion homeostasis),"Homo sapiens six transmembrane epithelial antigen of the prostate 1 (STEAP1), mRNA [NM_012449]",chr7:89794004-89794063,hs|7q21.13,six transmembrane epithelial antigen of the prostate 1,TRUE
337_ATP1B3_483,P54709,sodium/potassium-transporting atpase subunit beta-3 (sodium/potassium-dependent atpase subunit beta-3) (atpb-3) (cd antigen cd298),ATP1B3,279,"function: this is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of atp coupled with the exchange of na(+) and k(+) ions across the plasma membrane. the exact function of the beta-3 subunit is not known.",subcellular location: cell membrane {eco:0000269|pubmed:17081065}; single-pass type ii membrane protein {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP1B3,483,Hs.477789,ENST00000466678,THC2568210,GO:0005391(sodium:potassium-exchanging ATPase activity)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0005890(sodium:potassium-exchanging ATPase complex)|GO:0005901(caveola)|GO:0006754(ATP biosynthetic process)|GO:0006810(transport)|GO:0006813(potassium ion transport)|GO:0006814(sodium ion transport)|GO:0007596(blood coagulation)|GO:0016021(integral to membrane)|GO:0034220(ion transmembrane transport)|GO:0042470(melanosome)|GO:0050900(leukocyte migration)|GO:0055085(transmembrane transport),"Homo sapiens ATPase, Na+/K+ transporting, beta 3 polypeptide (ATP1B3), mRNA [NM_001679]",chr3:141644942-141645001,hs|3q23,"ATPase, Na+/K+ transporting, beta 3 polypeptide",TRUE
338_DUT_1854,P33316,"deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dutpase) (ec 3.6.1.23) (dutp pyrophosphatase)",DUT,252,"function: this enzyme is involved in nucleotide metabolism: it produces dump, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dutp so that uracil cannot be incorporated into dna. {eco:0000269|pubmed:8805593}.","subcellular location: isoform 2: nucleus {eco:0000269|pubmed:8631816, eco:0000269|pubmed:9070952}.; subcellular location: isoform 3: mitochondrion {eco:0000269|pubmed:8631816, eco:0000269|pubmed:9070952}.","TISSUE SPECIFICITY: Found in a variety of tissues. Isoform 3 expression is constitutive, while isoform 2 expression correlates with the onset of DNA replication (at protein level). Isoform 2 degradation coincides with the cessation of nuclear DNA replication (at protein level). {ECO:0000269|PubMed:9228092}.",NA,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DUT,1854,Hs.527980,ENST00000249783,NP1199025,"GO:0004170(dUTP diphosphatase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005739(mitochondrion)|GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0006206(pyrimidine base metabolic process)|GO:0006260(DNA replication)|GO:0009117(nucleotide metabolic process)|GO:0016787(hydrolase activity)|GO:0046080(dUTP metabolic process)|GO:0046134(pyrimidine nucleoside biosynthetic process)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens deoxyuridine triphosphatase (DUT), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001025248]",chr15:48633763-48634258,hs|15q21.1,deoxyuridine triphosphatase,TRUE
339_SEPW1_6415,P63302,selenoprotein w (selw),SELENOW SELW SEPW1,87,function: plays a role as a glutathione (gsh)-dependent antioxidant. may be involved in a redox-related process. may play a role in the myopathies of selenium deficiency (by similarity). {eco:0000250}.,subcellular location: cytoplasm.,"TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in skeletal muscle and heart, moderate levels in brain, spinal cord, thyroid, spleen, prostate, ovary, small intestine and colon, and lowest levels in liver and lymph node. {ECO:0000269|PubMed:10718624, ECO:0000269|PubMed:12818432}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SEPW1,6415,Hs.631549,ENST00000509570,THC2536656,GO:0005737(cytoplasm)|GO:0008430(selenium binding)|GO:0016209(antioxidant activity)|GO:0045454(cell redox homeostasis),"Homo sapiens selenoprotein W, 1 (SEPW1), mRNA [NM_003009]",chr19:48287827-48287886,hs|19q13.33,"selenoprotein W, 1",TRUE
34_PTPRF_5792,P10586,receptor-type tyrosine-protein phosphatase f (ec 3.1.3.48) (leukocyte common antigen related) (lar),PTPRF LAR,1907,"function: possible cell adhesion receptor. it possesses an intrinsic protein tyrosine phosphatase activity (ptpase) and dephosphorylates epha2 regulating its activity.; function: the first ptpase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one.",subcellular location: membrane; single-pass type i membrane protein.,NA,"DISEASE: Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2) [MIM:616001]: A group of congenital deformities encompassing total absence of breasts and nipple (amastia), absence of the nipple (athelia), and absence of the mammary gland (amazia). {ECO:0000269|PubMed:24781087}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PTPRF,5792,Hs.272062,ENST00000359947,THC2617582,GO:0001960(negative regulation of cytokine-mediated signaling pathway)|GO:0004725(protein tyrosine phosphatase activity)|GO:0004872(receptor activity)|GO:0005001(transmembrane receptor protein tyrosine phosphatase activity)|GO:0005158(insulin receptor binding)|GO:0005624(membrane fraction)|GO:0005768(endosome)|GO:0005792(microsome)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion)|GO:0007156(homophilic cell adhesion)|GO:0007185(transmembrane receptor protein tyrosine phosphatase signaling pathway)|GO:0007399(nervous system development)|GO:0008285(negative regulation of cell proliferation)|GO:0016787(hydrolase activity)|GO:0030426(growth cone)|GO:0030971(receptor tyrosine kinase binding)|GO:0031345(negative regulation of cell projection organization)|GO:0035335(peptidyl-tyrosine dephosphorylation)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042301(phosphate binding)|GO:0043025(neuronal cell body)|GO:0043525(positive regulation of neuron apoptosis)|GO:0046627(negative regulation of insulin receptor signaling pathway)|GO:0050775(positive regulation of dendrite morphogenesis)|GO:0050803(regulation of synapse structure and activity)|GO:0051387(negative regulation of nerve growth factor receptor signaling pathway)|GO:0060076(excitatory synapse),"Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript variant 1, mRNA [NM_002840]",chr1:44089183-44089242,hs|1p34.2,"protein tyrosine phosphatase, receptor type, F",TRUE
340_H2AFJ_55766,Q9BTM1,histone h2a.j (h2a/j),H2AFJ,129,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus {eco:0000250}. chromosome {eco:0000250}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H2AFJ,55766,Hs.524280,ENST00000228929,THC2467257,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens H2A histone family, member J (H2AFJ), transcript variant 1, mRNA [NM_177925]",chr12:14927627-14927686,hs|12p12.3,"H2A histone family, member J",TRUE
341_KRTCAP2_200185,Q8N6L1,keratinocyte-associated protein 2 (kcp-2) (dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit kcp2) (oligosaccharyl transferase subunit kcp2),KRTCAP2 KCP2,136,"function: subunit of the oligosaccharyl transferase (ost) complex that catalyzes the initial transfer of a defined glycan (glc(3)man(9)glcnac(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an asn-x-ser/thr consensus motif in nascent polypeptide chains, the first step in protein n-glycosylation. n-glycosylation occurs cotranslationally and the complex associates with the sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (er). all subunits are required for a maximal enzyme activity (pubmed:22467853). may be involved in n-glycosylation of app (amyloid-beta precursor protein). can modulate gamma-secretase cleavage of app by enhancing endoprotelysis of psen1 (pubmed:21768116). {eco:0000269|pubmed:21768116, eco:0000269|pubmed:22467853}.",subcellular location: endoplasmic reticulum {eco:0000269|pubmed:21768116}. endoplasmic reticulum membrane {eco:0000269|pubmed:22266900}; multi-pass membrane protein {eco:0000269|pubmed:22266900}.,"TISSUE SPECIFICITY: Expressed in skin, heart, placental, liver, skeletal muscle, kidney, pancreas, keratinocytes and dermal fibroblasts. {ECO:0000269|PubMed:12752121}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KRTCAP2,200185,Hs.516671,ENST00000492892,THC2507520,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0008250(oligosaccharyltransferase complex)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens keratinocyte associated protein 2 (KRTCAP2), mRNA [NM_173852]",chr1:155142299-155142010,hs|1q22,keratinocyte associated protein 2,TRUE
342_HNRNPH1_3187,P31943,"heterogeneous nuclear ribonucleoprotein h (hnrnp h) [cleaved into: heterogeneous nuclear ribonucleoprotein h, n-terminally processed]",HNRNPH1 HNRPH HNRPH1,449,"function: this protein is a component of the heterogeneous nuclear ribonucleoprotein (hnrnp) complexes which provide the substrate for the processing events that pre-mrnas undergo before becoming functional, translatable mrnas in the cytoplasm. mediates pre-mrna alternative splicing regulation. inhibits, together with cugbp1, insulin receptor (ir) pre-mrna exon 11 inclusion in myoblast. binds to the ir rna. binds poly(rg). {eco:0000269|pubmed:11003644, eco:0000269|pubmed:16946708}.","subcellular location: nucleus, nucleoplasm.",TISSUE SPECIFICITY: Expressed ubiquitously.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPH1,3187,Hs.604001,ENST00000511300,THC2593108,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006396(RNA processing)|GO:0008266(poly(U) RNA binding)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0015629(actin cytoskeleton)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0043484(regulation of RNA splicing)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (H) (HNRNPH1), mRNA [NM_005520]",chr5:179041542-179041483,hs|5q35.3,heterogeneous nuclear ribonucleoprotein H1 (H),TRUE
343_TARDBP_23435,Q13148,tar dna-binding protein 43 (tdp-43),TARDBP TDP43,414,"function: rna-binding protein that is involved in various steps of rna biogenesis and processing (pubmed:23519609). preferentially binds, via its two rna recognition motifs rrm1 and rrm2, to gu-repeats on rna molecules predominantly localized within long introns and in the 3'utr of mrnas (pubmed:23519609, pubmed:24240615, pubmed:24464995). in turn, regulates the splicing of many non-coding and protein-coding rnas including proteins involved in neuronal survival, as well as mrnas that encode proteins relevant for neurodegenerative diseases (pubmed:21358640, pubmed:29438978). plays a role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts (pubmed:28794432). regulates also mrna stability by recruiting cnot7/caf1 deadenylase on mrna 3'utr leading to poly(a) tail deadenylation and thus shortening (pubmed:30520513). in response to oxidative insult, associates with stalled ribosomes localized to stress granules (sgs) and contributes to cell survival (pubmed:23398327, pubmed:19765185). participates also in the normal skeletal muscle formation and regeneration, forming cytoplasmic myo-granules and binding mrnas that encode sarcomeric proteins (pubmed:30464263). plays a role in the maintenance of the circadian clock periodicity via stabilization of the cry1 and cry2 proteins in a fbxl3-dependent manner (pubmed:27123980). {eco:0000269|pubmed:11285240, eco:0000269|pubmed:17481916, eco:0000269|pubmed:19765185, eco:0000269|pubmed:21358640, eco:0000269|pubmed:23398327, eco:0000269|pubmed:23519609, eco:0000269|pubmed:24240615, eco:0000269|pubmed:24464995, eco:0000269|pubmed:27123980, eco:0000269|pubmed:28794432, eco:0000269|pubmed:29438978, eco:0000269|pubmed:30464263, eco:0000269|pubmed:30520513}.","subcellular location: nucleus {eco:0000269|pubmed:17023659, eco:0000269|pubmed:17481916, eco:0000269|pubmed:18957508, eco:0000269|pubmed:19765185, eco:0000269|pubmed:28663553, eco:0000269|pubmed:29438978}. cytoplasm {eco:0000269|pubmed:18957508, eco:0000269|pubmed:23398327, eco:0000269|pubmed:30464263}. cytoplasm, stress granule {eco:0000269|pubmed:19765185, eco:0000269|pubmed:23398327}. note=continuously travels in and out of the nucleus (pubmed:18957508). localizes to stress granules in response to oxidative stress (pubmed:19765185). {eco:0000269|pubmed:18957508, eco:0000269|pubmed:19765185}.","TISSUE SPECIFICITY: Ubiquitously expressed. In particular, expression is high in pancreas, placenta, lung, genital tract and spleen.","DISEASE: Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:18288693, ECO:0000269|PubMed:18309045, ECO:0000269|PubMed:18372902, ECO:0000269|PubMed:18396105, ECO:0000269|PubMed:18438952, ECO:0000269|PubMed:19224587, ECO:0000269|PubMed:19350673, ECO:0000269|PubMed:19655382, ECO:0000269|PubMed:19695877, ECO:0000269|PubMed:20740007, ECO:0000269|PubMed:21220647, ECO:0000269|PubMed:21418058, ECO:0000269|PubMed:22456481}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TARDBP,23435,Hs.300624,ENST00000240185,THC2533331,"GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003723(RNA binding)|GO:0003730(mRNA 3'-UTR binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006397(mRNA processing)|GO:0008219(cell death)|GO:0008380(RNA splicing)|GO:0043922(negative regulation by host of viral transcription)|GO:0070935(3'-UTR-mediated mRNA stabilization)","Homo sapiens TAR DNA binding protein (TARDBP), mRNA [NM_007375]",chr1:11084030-11084089,hs|1p36.22,TAR DNA binding protein,TRUE
345_CCDC56_28958,Q9Y2R0,"cytochrome c oxidase assembly factor 3 homolog, mitochondrial (coiled-coil domain-containing protein 56) (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kda)",COA3 CCDC56 MITRAC12 HSPC009,106,"function: core component of the mitrac (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. mitrac complexes regulate both translation of mitochondrial encoded components and assembly of nuclear-encoded components imported in mitochondrion. required for efficient translation of mt-co1 and mitochondrial respiratory chain complex iv assembly. {eco:0000269|pubmed:23260140}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:23260140}; single-pass membrane protein {eco:0000269|pubmed:23260140}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CCDC56,28958,Hs.16059,ENST00000328434,THC2465925,GO:0005739(mitochondrion)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens coiled-coil domain containing 56 (CCDC56), mRNA [NM_001040431]",chr17:40949733-40949674,hs|17q21.31,coiled-coil domain containing 56,TRUE
346_WASH2P_375260,Q6VEQ5,was protein family homolog 2 (cxyorf1-like protein on chromosome 2) (protein fam39b),WASH2P FAM39B,465,"function: acts as a nucleation-promoting factor at the surface of endosomes, where it recruits and activates the arp2/3 complex to induce actin polymerization, playing a key role in the fission of tubules that serve as transport intermediates during endosome sorting. involved in endocytic trafficking of egf. its assembly in the wash core complex seems to inhibit its npf activity and via washc2 is required for its membrane targeting. involved in transferrin receptor recycling. regulates the trafficking of endosomal alpha5beta1 integrin to the plasma membrane and involved in invasive cell migration. in t-cells involved in endosome-to-membrane recycling of receptors including t-cell receptor (tcr), cd28 and itgal; proposed to be implicated in t-cell proliferation and effector function. in dendritic cells involved in endosome-to-membrane recycling of major histocompatibility complex (mhc) class ii probably involving retromer and subsequently allowing antigen sampling, loading and presentation during t-cell activation. involved in arp2/3 complex-dependent actin assembly driving salmonella typhimurium invasion independent of ruffling. involved in the exocytosis of mmp14 leading to matrix remodeling during invasive migration and implicating late endosome-to-plasma membrane tubular connections and cooperation with the exocyst complex. involved in negative regulation of autophagy independently from its role in endosomal sorting by inhibiting becn1 ubiquitination to inactivate pik3c3/vps34 activity (by similarity). {eco:0000250|uniprotkb:a8k0z3, eco:0000250|uniprotkb:c4amc7, eco:0000250|uniprotkb:q8vdd8}.","subcellular location: early endosome membrane {eco:0000250|uniprotkb:a8k0z3}. recycling endosome membrane {eco:0000250|uniprotkb:q8vdd8}. late endosome {eco:0000250|uniprotkb:a8k0z3}. cytoplasmic vesicle, autophagosome {eco:0000250|uniprotkb:q8vdd8}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {eco:0000250|uniprotkb:q8vdd8}. note=localization to the endosome membrane is mediated via its interaction with washc2. {eco:0000250|uniprotkb:a8k0z3}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,WASH2P,375260,Hs.459573,ENST00000487568,NP1191380,NA,"Homo sapiens WAS protein family homolog 2 pseudogene (WASH2P), non-coding RNA [NR_024077]",chr2:114356517-114356576,hs|2q13,WAS protein family homolog 2 pseudogene,TRUE
347_TDG_6996,Q13569,g/t mismatch-specific thymine dna glycosylase (ec 3.2.2.29) (thymine-dna glycosylase) (htdg),TDG,410,"function: dna glycosylase that plays a key role in active dna demethylation: specifically recognizes and binds 5-formylcytosine (5fc) and 5-carboxylcytosine (5cac) in the context of cpg sites and mediates their excision through base-excision repair (ber) to install an unmethylated cytosine. cannot remove 5-hydroxymethylcytosine (5hmc). according to an alternative model, involved in dna demethylation by mediating dna glycolase activity toward 5-hydroxymethyluracil (5hmu) produced by deamination of 5hmc. also involved in dna repair by acting as a thymine-dna glycosylase that mediates correction of g/t mispairs to g/c pairs: in the dna of higher eukaryotes, hydrolytic deamination of 5-methylcytosine to thymine leads to the formation of g/t mismatches. its role in the repair of canonical base damage is however minor compared to its role in dna demethylation. it is capable of hydrolyzing the carbon-nitrogen bond between the sugar-phosphate backbone of the dna and a mispaired thymine. in addition to the g/t, it can remove thymine also from c/t and t/t mispairs in the order g/t >> c/t > t/t. it has no detectable activity on apyrimidinic sites and does not catalyze the removal of thymine from a/t pairs or from single-stranded dna. it can also remove uracil and 5-bromouracil from mispairs with guanine. {eco:0000269|pubmed:21862836, eco:0000269|pubmed:22327402, eco:0000269|pubmed:22573813, eco:0000269|pubmed:22962365, eco:0000269|pubmed:8127859, eco:0000269|pubmed:8407958, eco:0000269|pubmed:8662714}.",subcellular location: nucleus {eco:0000269|pubmed:8662714}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TDG,6996,Hs.584809,ENST00000392872,THC2468774,"GO:0003684(damaged DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006281(DNA repair)|GO:0006284(base-excision repair)|GO:0006285(base-excision repair, AP site formation)|GO:0006298(mismatch repair)|GO:0008152(metabolic process)|GO:0008263(pyrimidine-specific mismatch base pair DNA N-glycosylase activity)|GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds)|GO:0030983(mismatched DNA binding)|GO:0045008(depyrimidination)","Homo sapiens thymine-DNA glycosylase (TDG), mRNA [NM_003211]",chr12:104382442-104382501,hs|12q23.3,thymine-DNA glycosylase,TRUE
348_RPS16_6217,P62249,40s ribosomal protein s16 (small ribosomal subunit protein us9),RPS16,146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS16,6217,Hs.397609,ENST00000251453,THC2529528,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S16 (RPS16), mRNA [NM_001020]",chr19:39924395-39924336,hs|19q13.2,ribosomal protein S16,TRUE
349_PARP1_142,P09874,poly [adp-ribose] polymerase 1 (parp-1) (ec 2.4.2.30) (adp-ribosyltransferase diphtheria toxin-like 1) (artd1) (dna adp-ribosyltransferase parp1) (ec 2.4.2.-) (nad(+) adp-ribosyltransferase 1) (adprt 1) (poly[adp-ribose] synthase 1) (protein poly-adp-ribosyltransferase parp1) (ec 2.4.2.-),PARP1 ADPRT PPOL,1014,"function: poly-adp-ribosyltransferase that mediates poly-adp-ribosylation of proteins and plays a key role in dna repair (pubmed:17177976, pubmed:18172500, pubmed:19344625, pubmed:19661379, pubmed:23230272, pubmed:25043379, pubmed:26344098). mainly mediates glutamate and aspartate adp-ribosylation of target proteins: the adp-d-ribosyl group of nad(+) is transferred to the acceptor carboxyl group of glutamate and aspartate residues and further adp-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units (pubmed:7852410, pubmed:9315851, pubmed:19764761, pubmed:25043379). mediates the poly(adp-ribosyl)ation of a number of proteins, including itself, aplf and chfr (pubmed:17396150, pubmed:19764761). also mediates serine adp-ribosylation of target proteins following interaction with hpf1; hpf1 conferring serine specificity (pubmed:28190768). probably also catalyzes tyrosine adp-ribosylation of target proteins following interaction with hpf1 (pubmed:30257210). catalyzes the poly-adp-ribosylation of histones in a hpf1-dependent manner (pubmed:27067600). involved in the base excision repair (ber) pathway by catalyzing the poly-adp-ribosylation of a limited number of acceptor proteins involved in chromatin architecture and in dna metabolism (pubmed:17177976, pubmed:18172500, pubmed:19344625, pubmed:19661379, pubmed:23230272). adp-ribosylation follows dna damage and appears as an obligatory step in a detection/signaling pathway leading to the reparation of dna strand breaks (pubmed:17177976, pubmed:18172500, pubmed:19344625, pubmed:19661379, pubmed:23230272). in addition to base excision repair (ber) pathway, also involved in double-strand breaks (dsbs) repair: together with timeless, accumulates at dna damage sites and promotes homologous recombination repair by mediating poly-adp-ribosylation (pubmed:26344098, pubmed:30356214). in addition to proteins, also able to adp-ribosylate dna: catalyzes adp-ribosylation of dna strand break termini containing terminal phosphates and a 2'-oh group in single- and double-stranded dna, respectively (pubmed:27471034). required for parp9 and dtx3l recruitment to dna damage sites (pubmed:23230272). parp1-dependent parp9-dtx3l-mediated ubiquitination promotes the rapid and specific recruitment of 53bp1/tp53bp1, uimc1/rap80, and brca1 to dna damage sites (pubmed:23230272). acts as a regulator of transcription: positively regulates the transcription of mtus1 and negatively regulates the transcription of mtus2/tip150 (pubmed:19344625). with eef1a1 and txk, forms a complex that acts as a t-helper 1 (th1) cell-specific transcription factor and binds the promoter of ifn-gamma to directly regulate its transcription, and is thus involved importantly in th1 cytokine production (pubmed:17177976). involved in the synthesis of atp in the nucleus, together with nmnat1, parg and nudt5 (pubmed:27257257). nuclear atp generation is required for extensive chromatin remodeling events that are energy-consuming (pubmed:27257257). {eco:0000269|pubmed:17177976, eco:0000269|pubmed:17396150, eco:0000269|pubmed:18172500, eco:0000269|pubmed:19344625, eco:0000269|pubmed:19661379, eco:0000269|pubmed:19764761, eco:0000269|pubmed:23230272, eco:0000269|pubmed:25043379, eco:0000269|pubmed:26344098, eco:0000269|pubmed:27067600, eco:0000269|pubmed:27257257, eco:0000269|pubmed:27471034, eco:0000269|pubmed:28190768, eco:0000269|pubmed:30257210, eco:0000269|pubmed:30356214, eco:0000269|pubmed:7852410, eco:0000269|pubmed:9315851}.","subcellular location: nucleus {eco:0000269|pubmed:17177976, eco:0000269|pubmed:21799911, eco:0000269|pubmed:23230272}. nucleus, nucleolus {eco:0000269|pubmed:9518481}. chromosome {eco:0000269|pubmed:23230272, eco:0000269|pubmed:26344098}. note=localizes to sites of dna damage. {eco:0000269|pubmed:23230272, eco:0000269|pubmed:26344098}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,PARP1,142,Hs.177766,ENST00000366794,THC2766228,"GO:0000723(telomere maintenance)|GO:0003677(DNA binding)|GO:0003950(NAD+ ADP-ribosyltransferase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005730(nucleolus)|GO:0006281(DNA repair)|GO:0006284(base-excision repair)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006471(protein ADP-ribosylation)|GO:0008134(transcription factor binding)|GO:0008270(zinc ion binding)|GO:0016540(protein autoprocessing)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0032869(cellular response to insulin stimulus)|GO:0040009(regulation of growth rate)|GO:0042769(DNA damage response, detection of DNA damage)|GO:0046872(metal ion binding)|GO:0047485(protein N-terminus binding)|GO:0051287(NAD binding)","Homo sapiens poly (ADP-ribose) polymerase 1 (PARP1), mRNA [NM_001618]",chr1:226548410-226548376,hs|1q42.12,poly (ADP-ribose) polymerase 1,TRUE
35_MYO1C_4641,Q12965,unconventional myosin-ie (myosin-ic) (unconventional myosin 1e),MYO1E MYO1C,1108,"function: myosins are actin-based motor molecules with atpase activity. unconventional myosins serve in intracellular movements. their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. binds to membranes containing anionic phospholipids via its tail domain. required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. in dendritic cells, may control the movement of class ii-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via arl14ep and arl14. {eco:0000269|pubmed:11940582, eco:0000269|pubmed:17257598, eco:0000269|pubmed:20860408}.","subcellular location: cytoplasm. cytoplasm, cytoskeleton. cytoplasmic vesicle. cytoplasmic vesicle, clathrin-coated vesicle. cell junction {eco:0000250}. note=colocalizes with f-actin (by similarity). in cultured podocytes, it localizes close to and is associated with the cytoplasmic membrane, with enrichment at the lamellipodia tips. colocalizes with cytoplasmic vesicles, including endocytic clathrin-coated vesicles. colocalizes with dynamin at cytoplasmic vesicles. {eco:0000250}.","TISSUE SPECIFICITY: Expressed in the immune system. In the kidney, predominantly expressed in the glomerulus, including podocytes. {ECO:0000269|PubMed:21458045, ECO:0000269|PubMed:21756023}.","DISEASE: Focal segmental glomerulosclerosis 6 (FSGS6) [MIM:614131]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. FSGS6 is a childhood-onset disorder resulting in nephrotic syndrome, which includes massive proteinuria, hypoalbuminemia, hyperlipidemia, and edema. {ECO:0000269|PubMed:21697813, ECO:0000269|PubMed:21756023}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,MYO1C,4641,Hs.286226,ENST00000361007,THC2469590,GO:0000166(nucleotide binding)|GO:0001725(stress fiber)|GO:0003774(motor activity)|GO:0003779(actin binding)|GO:0005516(calmodulin binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005643(nuclear pore)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0005902(microvillus)|GO:0005903(brush border)|GO:0008022(protein C-terminus binding)|GO:0009925(basal plasma membrane)|GO:0015031(protein transport)|GO:0016328(lateral plasma membrane)|GO:0016461(unconventional myosin complex)|GO:0031941(filamentous actin)|GO:0045160(myosin I complex)|GO:0051028(mRNA transport)|GO:0060171(stereocilium membrane),"Homo sapiens myosin IC (MYO1C), transcript variant 3, mRNA [NM_033375]",chr17:1368434-1368375,hs|17p13.3,myosin IC,TRUE
350_RPL28_6158,P46779,60s ribosomal protein l28 (large ribosomal subunit protein el28),RPL28,137,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL28,6158,Hs.652114,ENST00000458349,THC2465747,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L28 (RPL28), transcript variant 2, mRNA [NM_000991]",chr19:55899332-55899391,hs|19q13.42,ribosomal protein L28,TRUE
351_CCT4_10575,P50991,t-complex protein 1 subunit delta (tcp-1-delta) (cct-delta) (stimulator of tar rna-binding),CCT4 CCTD SRB,539,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). as part of the tric complex may play a role in the assembly of bbsome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (pubmed:20080638). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:20080638, eco:0000269|pubmed:25467444, eco:0000305}.","subcellular location: cytoplasm {eco:0000269|pubmed:17081065, eco:0000269|pubmed:20080638}. melanosome {eco:0000269|pubmed:17081065}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:20080638}. cytoplasm, cytoskeleton, cilium basal body {eco:0000250|uniprotkb:p80315}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000269|pubmed:17081065}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,CCT4,10575,Hs.421509,ENST00000544079,THC2668666,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005832(chaperonin-containing T-complex)|GO:0005856(cytoskeleton)|GO:0006457(protein folding)|GO:0042470(melanosome)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens chaperonin containing TCP1, subunit 4 (delta) (CCT4), mRNA [NM_006430]",chr2:62095734-62095675,hs|2p15,"chaperonin containing TCP1, subunit 4 (delta)",TRUE
352_HP1BP3_50809,Q5SSJ5,heterochromatin protein 1-binding protein 3 (protein hp1-bp74),HP1BP3,553,"function: component of heterochromatin that maintains heterochromatin integrity during g1/s progression and regulates the duration of g1 phase to critically influence cell proliferative capacity (pubmed:24830416). mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance and self-renewal(pubmed:25100860). {eco:0000269|pubmed:24830416, eco:0000269|pubmed:25100860}.","subcellular location: nucleus {eco:0000269|pubmed:24830416}. chromosome {eco:0000269|pubmed:20042602, eco:0000269|pubmed:24830416}. note=localized in nuclei but not in nucleoli in interphase. colocalized with chromosomes in mitosis, with a gradually increased during g1 progression and a maximum level during late g1 phase (g1/s). {eco:0000269|pubmed:24830416}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HP1BP3,50809,Hs.142442,ENST00000375003,NP1151900,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens heterochromatin protein 1, binding protein 3 (HP1BP3), mRNA [NM_016287]",chr1:21069352-21069293,hs|1p36.12,"heterochromatin protein 1, binding protein 3",TRUE
353_GPI_2821,Q9BRB3,phosphatidylinositol n-acetylglucosaminyltransferase subunit q (ec 2.4.1.198) (n-acetylglucosamyl transferase component gpi1) (phosphatidylinositol-glycan biosynthesis class q protein) (pig-q),PIGQ GPI1,760,"function: part of the complex catalyzing the transfer of n-acetylglucosamine from udp-n-acetylglucosamine to phosphatidylinositol, the first step of gpi biosynthesis.",subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GPI,2821,Hs.466471,ENST00000415930,THC2510745,GO:0001525(angiogenesis)|GO:0004347(glucose-6-phosphate isomerase activity)|GO:0005125(cytokine activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006094(gluconeogenesis)|GO:0006096(glycolysis)|GO:0006959(humoral immune response)|GO:0007599(hemostasis)|GO:0008083(growth factor activity)|GO:0016853(isomerase activity),"Homo sapiens glucose-6-phosphate isomerase (GPI), transcript variant 2, mRNA [NM_000175]",chr19:34891174-34891233,hs|19q13.11,glucose-6-phosphate isomerase,TRUE
354_SLC12A7_10723,Q9Y666,solute carrier family 12 member 7 (electroneutral potassium-chloride cotransporter 4) (k-cl cotransporter 4),SLC12A7 KCC4,1083,"function: mediates electroneutral potassium-chloride cotransport when activated by cell swelling. may mediate k(+) uptake into deiters' cells in the cochlea and contribute to k(+) recycling in the inner ear. important for the survival of cochlear outer and inner hair cells and the maintenance of the organ of corti. may be required for basolateral cl(-) extrusion in the kidney and contribute to renal acidification (by similarity). {eco:0000250, eco:0000269|pubmed:10913127}.",subcellular location: cell membrane; multi-pass membrane protein.,"TISSUE SPECIFICITY: Detected in muscle, brain, lung, heart and kidney.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC12A7,10723,Hs.172613,ENST00000264930,NP923564,GO:0005215(transporter activity)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0006813(potassium ion transport)|GO:0006814(sodium ion transport)|GO:0006821(chloride transport)|GO:0006884(cell volume homeostasis)|GO:0015293(symporter activity)|GO:0015379(potassium:chloride symporter activity)|GO:0055085(transmembrane transport),"Homo sapiens solute carrier family 12 (potassium/chloride transporters), member 7 (SLC12A7), mRNA [NM_006598]",chr5:1050582-1050523,hs|5p15.33,"solute carrier family 12 (potassium/chloride transporters), member 7",TRUE
355_CYB5R3_1727,P00387,nadh-cytochrome b5 reductase 3 (b5r) (cytochrome b5 reductase) (ec 1.6.2.2) (diaphorase-1) [cleaved into: nadh-cytochrome b5 reductase 3 membrane-bound form; nadh-cytochrome b5 reductase 3 soluble form],CYB5R3 DIA1,301,"function: desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction.",subcellular location: isoform 1: endoplasmic reticulum membrane; lipid-anchor; cytoplasmic side. mitochondrion outer membrane; lipid-anchor; cytoplasmic side.; subcellular location: isoform 2: cytoplasm. note=produces the soluble form found in erythrocytes.,TISSUE SPECIFICITY: Isoform 2 is expressed at late stages of erythroid maturation.,"DISEASE: Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]: A form of methemoglobinemia, a hematologic disease characterized by the presence of excessive amounts of methemoglobin in blood cells, resulting in decreased oxygen carrying capacity of the blood, cyanosis and hypoxia. There are two types of methemoglobinemia CYB5R3-related. In type 1, the defect affects the soluble form of the enzyme, is restricted to red blood cells, and causes well-tolerated methemoglobinemia. In type 2, the defect affects both the soluble and microsomal forms of the enzyme and is thus generalized, affecting red cells, leukocytes and all body tissues. Type 2 methemoglobinemia is associated with mental deficiency and other neurologic symptoms. {ECO:0000269|PubMed:10807796, ECO:0000269|PubMed:12393396, ECO:0000269|PubMed:1400360, ECO:0000269|PubMed:15622768, ECO:0000269|PubMed:15953014, ECO:0000269|PubMed:1707593, ECO:0000269|PubMed:1898726, ECO:0000269|PubMed:7718898, ECO:0000269|PubMed:8119939, ECO:0000269|PubMed:9695975, ECO:0000269|PubMed:9886302}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYB5R3,1727,Hs.561064,ENST00000407332,THC2545901,GO:0004128(cytochrome-b5 reductase activity)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005833(hemoglobin complex)|GO:0006695(cholesterol biosynthetic process)|GO:0006766(vitamin metabolic process)|GO:0006767(water-soluble vitamin metabolic process)|GO:0008015(blood circulation)|GO:0016020(membrane)|GO:0016491(oxidoreductase activity)|GO:0071949(FAD binding),"Homo sapiens cytochrome b5 reductase 3 (CYB5R3), transcript variant 2, mRNA [NM_007326]",chr22:43014929-43014870,hs|22q13.2,cytochrome b5 reductase 3,TRUE
356_DNAJA4_55466,Q8WW22,dnaj homolog subfamily a member 4,DNAJA4,397,NA,subcellular location: membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,DNAJA4,55466,Hs.513053,ENST00000394852,THC2466730,GO:0005524(ATP binding)|GO:0006457(protein folding)|GO:0009408(response to heat)|GO:0016020(membrane)|GO:0031072(heat shock protein binding)|GO:0046872(metal ion binding)|GO:0051082(unfolded protein binding),"Homo sapiens DnaJ (Hsp40) homolog, subfamily A, member 4 (DNAJA4), transcript variant 1, mRNA [NM_018602]",chr15:78574350-78574409,hs|15q25.1,"DnaJ (Hsp40) homolog, subfamily A, member 4",TRUE
357_SKP1_6500,P63208,s-phase kinase-associated protein 1 (cyclin-a/cdk2-associated protein p19) (p19a) (organ of corti protein 2) (ocp-2) (organ of corti protein ii) (ocp-ii) (rna polymerase ii elongation factor-like protein) (siii) (transcription elongation factor b polypeptide 1-like) (p19skp1),SKP1 EMC19 OCP2 SKP1A TCEB1L,163,"function: essential component of the scf (skp1-cul1-f-box protein) ubiquitin ligase complex, which mediates the ubiquitination of proteins involved in cell cycle progression, signal transduction and transcription. in the scf complex, serves as an adapter that links the f-box protein to cul1. the functional specificity of the scf complex depends on the f-box protein as substrate recognition component. scf(btrc) and scf(fbxw11) direct ubiquitination of ctnnb1 and participate in wnt signaling. scf(fbxw11) directs ubiquitination of phosphorylated nfkbia. scf(btrc) directs ubiquitination of nfkbib, nfkbie, atf4, smad3, smad4, cdc25a, fbxo5, cep68 and probably nfkb2 (pubmed:25704143). scf(skp2) directs ubiquitination of phosphorylated cdkn1b/p27kip and is involved in regulation of g1/s transition. scf(skp2) directs ubiquitination of orc1, cdt1, rbl2, elf4, cdkn1a, rag2, foxo1a, and probably myc and tal1. scf(fbxw7) directs ubiquitination of cyclin e, notch1 released notch intracellular domain (nicd), and probably psen1. scf(fbxw2) directs ubiquitination of gcm1. scf(fbxo32) directs ubiquitination of myod1. scf(fbxo7) directs ubiquitination of birc2 and dlgap5. scf(fbxo33) directs ubiquitination of ybx1. scf(fbxo11) directs ubiquitination of bcl6 and dtl but does not seem to direct ubiquitination of tp53. scf(btrc) mediates the ubiquitination of nfkbia at 'lys-21' and 'lys-22'; the degradation frees the associated nfkb1-rela dimer to translocate into the nucleus and to activate transcription. scf(ccnf) directs ubiquitination of ccp110. scf(fbxl3) and scf(fbxl21) direct ubiquitination of cry1 and cry2. scf(fbxo9) directs ubiquitination of tti1 and telo2. scf(fbxo10) directs ubiquitination of bcl2. {eco:0000269|pubmed:16209941, eco:0000269|pubmed:20181953, eco:0000269|pubmed:22113614, eco:0000269|pubmed:23431138, eco:0000269|pubmed:25704143, eco:0000269|pubmed:28727686}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,SKP1,6500,Hs.171626,ENST00000522552,THC2596001,GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0016032(viral reproduction)|GO:0016567(protein ubiquitination)|GO:0019005(SCF ubiquitin ligase complex)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0031519(PcG protein complex)|GO:0035518(histone H2A monoubiquitination)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle),"Homo sapiens S-phase kinase-associated protein 1 (SKP1), transcript variant 1, mRNA [NM_006930]",chr5:133493214-133493155,hs|5q31.1,S-phase kinase-associated protein 1,TRUE
358_PPP3CA_5530,Q08209,serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform (ec 3.1.3.16) (cam-prp catalytic subunit) (calmodulin-dependent calcineurin a subunit alpha isoform),PPP3CA CALNA CNA,521,"function: calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular ca(2+)-mediated signals (pubmed:15671020, pubmed:18838687, pubmed:19154138, pubmed:23468591). many of the substrates contain a pxixit motif and/or a lxvp motif (pubmed:17498738, pubmed:17502104, pubmed:23468591, pubmed:27974827, pubmed:22343722). in response to increased ca(2+) levels, dephosphorylates and activates phosphatase ssh1 which results in cofilin dephosphorylation (pubmed:15671020). in response to increased ca(2+) levels following mitochondrial depolarization, dephosphorylates dnm1l inducing dnm1l translocation to the mitochondrion (pubmed:18838687). dephosphorylates heat shock protein hspb1 (by similarity). dephosphorylates and activates transcription factor nfatc1 (pubmed:19154138). in response to increased ca(2+) levels, regulates nfat-mediated transcription probably by dephosphorylating nfat and promoting its nuclear translocation (pubmed:26248042). dephosphorylates and inactivates transcription factor elk1 (pubmed:19154138). dephosphorylates darpp32 (pubmed:19154138). may dephosphorylate crtc2 at 'ser-171' resulting in crtc2 dissociation from 14-3-3 proteins (pubmed:30611118). {eco:0000250|uniprotkb:p48452, eco:0000269|pubmed:15671020, eco:0000269|pubmed:17498738, eco:0000269|pubmed:17502104, eco:0000269|pubmed:18838687, eco:0000269|pubmed:19154138, eco:0000269|pubmed:22343722, eco:0000269|pubmed:23468591, eco:0000269|pubmed:26248042, eco:0000269|pubmed:27974827, eco:0000269|pubmed:30611118}.","subcellular location: cytoplasm {eco:0000269|pubmed:19154138, eco:0000269|pubmed:22343722}. cell membrane {eco:0000269|pubmed:22343722}; peripheral membrane protein {eco:0000269|pubmed:22343722}. cell membrane, sarcolemma {eco:0000250|uniprotkb:p63329}. cytoplasm, myofibril, sarcomere, z line {eco:0000250|uniprotkb:p63329}. cell projection, dendritic spine {eco:0000269|pubmed:22343722}. note=colocalizes with actn1 and myoz2 at the z line in heart and skeletal muscle (by similarity). recruited to the cell membrane by scaffold protein akap5 following l-type ca(2+)-channel activation (pubmed:22343722). {eco:0000250|uniprotkb:p63329, eco:0000269|pubmed:22343722}.",TISSUE SPECIFICITY: Expressed in keratinocytes (at protein level). {ECO:0000269|PubMed:29043977}.,"DISEASE: Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE1 is an autosomal dominant condition with onset of seizures between the first weeks and first years of life. {ECO:0000269|PubMed:28942967, ECO:0000269|PubMed:29432562}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development (ACCIID) [MIM:618265]: An autosomal dominant disease characterized by moderate to severe intellectual disability, craniosynostosis, cleft palate, micrognathia, arthrogryposis, and short stature. Some patients may present bone abnormalities and generalized seizures. {ECO:0000269|PubMed:29432562}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,PPP3CA,5530,Hs.435512,ENST00000394853,THC2784375,GO:0000082(G1/S transition of mitotic cell cycle)|GO:0001975(response to amphetamine)|GO:0004722(protein serine/threonine phosphatase activity)|GO:0004723(calcium-dependent protein serine/threonine phosphatase activity)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005625(soluble fraction)|GO:0005626(insoluble fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0005955(calcineurin complex)|GO:0006470(protein dephosphorylation)|GO:0006606(protein import into nucleus)|GO:0006816(calcium ion transport)|GO:0006950(response to stress)|GO:0016020(membrane)|GO:0016787(hydrolase activity)|GO:0030018(Z disc)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046676(negative regulation of insulin secretion)|GO:0046982(protein heterodimerization activity)|GO:0048741(skeletal muscle fiber development)|GO:0050804(regulation of synaptic transmission)|GO:0060079(regulation of excitatory postsynaptic membrane potential)|GO:0071333(cellular response to glucose stimulus),"Homo sapiens protein phosphatase 3, catalytic subunit, alpha isozyme (PPP3CA), transcript variant 1, mRNA [NM_000944]",chr4:101946738-101946679,hs|4q24,"protein phosphatase 3, catalytic subunit, alpha isozyme",TRUE
359_UHMK1_127933,Q8TAS1,serine/threonine-protein kinase kist (ec 2.7.11.1) (kinase interacting with stathmin) (pam cooh-terminal interactor protein 2) (p-cip2) (u2af homology motif kinase 1),UHMK1 KIS KIST,419,"function: upon serum stimulation, phosphorylates cdkn1b/p27kip1, thus controlling cdkn1b subcellular location and cell cycle progression in g1 phase. may be involved in trafficking and/or processing of rna (by similarity). {eco:0000250}.",subcellular location: nucleus {eco:0000269|pubmed:23419774}.,"TISSUE SPECIFICITY: Widely expressed, with highest levels in skeletal muscle, kidney, placenta and peripheral blood leukocytes. {ECO:0000269|PubMed:12093740}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UHMK1,127933,Hs.127310,ENST00000489294,NP1160641,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007050(cell cycle arrest)|GO:0016740(transferase activity)|GO:0018105(peptidyl-serine phosphorylation)|GO:0030424(axon)|GO:0031175(neuron projection development)|GO:0032839(dendrite cytoplasm)|GO:0043021(ribonucleoprotein binding)|GO:0045948(positive regulation of translational initiation)|GO:0046777(protein autophosphorylation)|GO:0046825(regulation of protein export from nucleus)|GO:0071598(neuronal RNA granule),"Homo sapiens U2AF homology motif (UHM) kinase 1 (UHMK1), transcript variant 1, mRNA [NM_175866]",chr1:162499308-162499367,hs|1q23.3,U2AF homology motif (UHM) kinase 1,TRUE
36_SEC61B_10952,P60468,protein transport protein sec61 subunit beta,SEC61B,96,"function: component of sec61 channel-forming translocon complex that mediates transport of signal peptide-containing precursor polypeptides across endoplasmic reticulum (er) (by similarity). required for pkd1/polycystin-1 biogenesis (by similarity). {eco:0000250|uniprotkb:p60467, eco:0000250|uniprotkb:q9cqs8}.",subcellular location: endoplasmic reticulum membrane; single-pass membrane protein.,NA,"DISEASE: Note=Loss-of-function SEC61B variations may cause autosomal dominant polycystic liver disease (PCLD) in patients that lack variations in known causative genes, such as PRKCSH and SEC63. {ECO:0000305|PubMed:28375157}.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC61B,10952,Hs.191887,ENST00000498603,THC2613940,"GO:0000060(protein import into nucleus, translocation)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030433(ER-associated protein catabolic process)|GO:0030970(retrograde protein transport, ER to cytosol)|GO:0031205(endoplasmic reticulum Sec complex)|GO:0048408(epidermal growth factor binding)","Homo sapiens Sec61 beta subunit (SEC61B), mRNA [NM_006808]",chr9:101992679-101992738,hs|9q22.33,Sec61 beta subunit,TRUE
360_SREBF1_6720,P36956,sterol regulatory element-binding protein 1 (srebp-1) (class d basic helix-loop-helix protein 1) (bhlhd1) (sterol regulatory element-binding transcription factor 1) [cleaved into: processed sterol regulatory element-binding protein 1],SREBF1 BHLHD1 SREBP1,1147,function: transcriptional activator required for lipid homeostasis. regulates transcription of the ldl receptor gene as well as the fatty acid and to a lesser degree the cholesterol synthesis pathway (by similarity). binds to the sterol regulatory element 1 (sre-1) (5'-atcaccccac-3'). has dual sequence specificity binding to both an e-box motif (5'-atcacgtga-3') and to sre-1 (5'-atcaccccac-3'). {eco:0000250|uniprotkb:q9wtn3}.,"subcellular location: endoplasmic reticulum membrane {eco:0000250|uniprotkb:q9wtn3}; multi-pass membrane protein {eco:0000255}. golgi apparatus membrane {eco:0000250|uniprotkb:q9wtn3}; multi-pass membrane protein {eco:0000255}. cytoplasmic vesicle, copii-coated vesicle membrane {eco:0000250|uniprotkb:q9wtn3}; multi-pass membrane protein {eco:0000255}. note=moves from the endoplasmic reticulum to the golgi in the absence of sterols. {eco:0000250|uniprotkb:q9wtn3}.; subcellular location: processed sterol regulatory element-binding protein 1: nucleus {eco:0000250|uniprotkb:q9wtn3}.; subcellular location: isoform srebp-1adelta: nucleus {eco:0000269|pubmed:18267114}.; subcellular location: isoform srebp-1cdelta: nucleus {eco:0000269|pubmed:18267114}.","TISSUE SPECIFICITY: Expressed in a wide variety of tissues, most abundant in liver and adrenal gland. In fetal tissues lung and liver shows highest expression. Isoform SREBP-1C predominates in liver, adrenal gland and ovary, whereas isoform SREBP-1A predominates in hepatoma cell lines. Isoform SREBP-1A and isoform SREBP-1C are found in kidney, brain, white fat, and muscle.",NA,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SREBF1,6720,Hs.592123,ENST00000355815,THC2470281,"GO:0000139(Golgi membrane)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006629(lipid metabolic process)|GO:0008202(steroid metabolic process)|GO:0008203(cholesterol metabolic process)|GO:0008610(lipid biosynthetic process)|GO:0009267(cellular response to starvation)|GO:0010867(positive regulation of triglyceride biosynthetic process)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031410(cytoplasmic vesicle)|GO:0032810(sterol response element binding)|GO:0044444(cytoplasmic part)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","Homo sapiens sterol regulatory element binding transcription factor 1 (SREBF1), transcript variant 1, mRNA [NM_001005291]",chr17:17715478-17715419,hs|17p11.2,sterol regulatory element binding transcription factor 1,TRUE
361_EIF1_10209,P41567,eukaryotic translation initiation factor 1 (eif1) (a121) (protein translation factor sui1 homolog) (sui1iso1),EIF1 SUI1,113,function: necessary for scanning and involved in initiation site selection. promotes the assembly of 48s ribosomal complexes at the authentic initiation codon of a conventional capped mrna.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF1,10209,Hs.150580,ENST00000469308,THC2500008,"GO:0003743(translation initiation factor activity)|GO:0005737(cytoplasm)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0006950(response to stress)|GO:0008135(translation factor activity, nucleic acid binding)","Homo sapiens eukaryotic translation initiation factor 1 (EIF1), mRNA [NM_005801]",chr17:39847171-39847230,hs|17q21.2,eukaryotic translation initiation factor 1,TRUE
362_CYP1B1_1545,Q16678,cytochrome p450 1b1 (ec 1.14.14.1) (cypib1) (hydroperoxy icosatetraenoate dehydratase) (ec 4.2.1.152),CYP1B1,543,"function: a cytochrome p450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (pubmed:20972997, pubmed:11555828, pubmed:12865317, pubmed:10681376, pubmed:15258110). mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by nadph via cytochrome p450 reductase (nadph--hemoprotein reductase) (pubmed:20972997, pubmed:11555828, pubmed:12865317, pubmed:10681376, pubmed:15258110). exhibits catalytic activity for the formation of hydroxyestrogens from estrone (e1) and 17beta-estradiol (e2), namely 2- and 4-hydroxy e1 and e2. displays a predominant hydroxylase activity toward e2 at the c-4 position (pubmed:11555828, pubmed:12865317). metabolizes testosterone and progesterone to b or d ring hydroxylated metabolites (pubmed:10426814). may act as a major enzyme for all-trans retinoic acid biosynthesis in extrahepatic tissues. catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid (pubmed:10681376, pubmed:15258110). catalyzes the epoxidation of double bonds of certain pufa. converts arachidonic acid toward epoxyeicosatrienoic acid (epetre) regioisomers, 8,9-, 11,12-, and 14,15- epetre, that function as lipid mediators in the vascular system (pubmed:20972997). additionally, displays dehydratase activity toward oxygenated eicosanoids hydroperoxyeicosatetraenoates (hpetes). this activity is independent of cytochrome p450 reductase, nadph, and o2 (pubmed:21068195). also involved in the oxidative metabolism of xenobiotics, particularly converting polycyclic aromatic hydrocarbons and heterocyclic aryl amines procarcinogens to dna-damaging products (pubmed:10426814). plays an important role in retinal vascular development. under hyperoxic o2 conditions, promotes retinal angiogenesis and capillary morphogenesis, likely by metabolizing the oxygenated products generated during the oxidative stress. also, contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of postn expression (by similarity). {eco:0000250|uniprotkb:q64429, eco:0000269|pubmed:10426814, eco:0000269|pubmed:10681376, eco:0000269|pubmed:11555828, eco:0000269|pubmed:12865317, eco:0000269|pubmed:15258110, eco:0000269|pubmed:20972997, eco:0000269|pubmed:21068195}.","subcellular location: endoplasmic reticulum membrane {eco:0000250|uniprotkb:q64429}; peripheral membrane protein {eco:0000250|uniprotkb:q64429}. microsome membrane {eco:0000250|uniprotkb:q64429}; peripheral membrane protein {eco:0000250|uniprotkb:q64429}. mitochondrion {eco:0000250|uniprotkb:q64429}. note=located primarily in endoplasmic reticulum. upon treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (tcdd), cyp1b1 is also targeted to mitochondria. {eco:0000250|uniprotkb:q64429}.","TISSUE SPECIFICITY: Expressed in heart, brain, lung, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes (PubMed:8175734). Expressed in retinal endothelial cells and umbilical vein endothelial cells (at protein level) (PubMed:19005183). {ECO:0000269|PubMed:19005183, ECO:0000269|PubMed:8175734}.","DISEASE: Anterior segment dysgenesis 6 (ASGD6) [MIM:617315]: A form of anterior segment dysgenesis, a group of defects affecting anterior structures of the eye including cornea, iris, lens, trabecular meshwork, and Schlemm canal. Anterior segment dysgeneses result from abnormal migration or differentiation of the neural crest derived mesenchymal cells that give rise to components of the anterior chamber during eye development. Different anterior segment anomalies may exist alone or in combination, including iris hypoplasia, enlarged or reduced corneal diameter, corneal vascularization and opacity, posterior embryotoxon, corectopia, polycoria, abnormal iridocorneal angle, ectopia lentis, and anterior synechiae between the iris and posterior corneal surface. Clinical conditions falling within the phenotypic spectrum of anterior segment dysgeneses include aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters anomaly, and iridogoniodysgenesis. ASGD6 patients predominantly manifest Peters anomaly. Peters anomaly consists of corneal leukoma, defects in the posterior structures of the cornea such as absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iridocorneal and/or keratolenticular adhesions. Over 50% of patients develop glaucoma in childhood. {ECO:0000269|PubMed:11403040}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]: An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. {ECO:0000269|PubMed:10227395, ECO:0000269|PubMed:10655546, ECO:0000269|PubMed:11184479, ECO:0000269|PubMed:11527932, ECO:0000269|PubMed:11774072, ECO:0000269|PubMed:11980847, ECO:0000269|PubMed:12036985, ECO:0000269|PubMed:12525557, ECO:0000269|PubMed:14635112, ECO:0000269|PubMed:14640114, ECO:0000269|PubMed:15255109, ECO:0000269|PubMed:15342693, ECO:0000269|PubMed:15475877, ECO:0000269|PubMed:16490498, ECO:0000269|PubMed:16688110, ECO:0000269|PubMed:16735994, ECO:0000269|PubMed:16862072, ECO:0000269|PubMed:18470941, ECO:0000269|PubMed:9463332, ECO:0000269|PubMed:9497261}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry.; DISEASE: Glaucoma 1, open angle, A (GLC1A) [MIM:137750]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:11774072}. Note=The gene represented in this entry acts as a disease modifier. Digenic mutations in CYP1B1 and MYOC have been found in a family segregating both primary adult-onset and juvenile forms of open angle glaucoma (PubMed:11774072). All affected family members with mutations in both MYOC and CYP1B1 had juvenile glaucoma, whereas those with only the MYOC mutation had the adult-onset form (PubMed:11774072). {ECO:0000269|PubMed:11774072}.",NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYP1B1,1545,Hs.154654,ENST00000260630,THC2729686,"GO:0001525(angiogenesis)|GO:0004497(monooxygenase activity)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006725(cellular aromatic compound metabolic process)|GO:0006805(xenobiotic metabolic process)|GO:0007601(visual perception)|GO:0008210(estrogen metabolic process)|GO:0009055(electron carrier activity)|GO:0009404(toxin metabolic process)|GO:0009636(response to toxin)|GO:0010033(response to organic substance)|GO:0016020(membrane)|GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen)|GO:0019825(oxygen binding)|GO:0020037(heme binding)|GO:0043542(endothelial cell migration)|GO:0046872(metal ion binding)|GO:0055114(oxidation-reduction process)|GO:0061298(retina vasculature development in camera-type eye)|GO:0070330(aromatase activity)|GO:0071603(endothelial cell-cell adhesion)","Homo sapiens cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1), mRNA [NM_000104]",chr2:38295503-38295444,hs|2p22.2,"cytochrome P450, family 1, subfamily B, polypeptide 1",TRUE
363_EEF1B2_1933,P24534,elongation factor 1-beta (ef-1-beta),EEF1B2 EEF1B EF1B,225,function: ef-1-beta and ef-1-delta stimulate the exchange of gdp bound to ef-1-alpha to gtp.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EEF1B2,1933,Hs.421608,ENST00000392221,THC2570764,GO:0003746(translation elongation factor activity)|GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0005853(eukaryotic translation elongation factor 1 complex)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation elongation factor 1 beta 2 (EEF1B2), transcript variant 1, mRNA [NM_001959]",chr2:207027551-207027610,hs|2q33.3,eukaryotic translation elongation factor 1 beta 2,TRUE
364_TCF25_22980,Q9BQ70,transcription factor 25 (tcf-25) (nuclear localized protein 1),TCF25 KIAA1049 NULP1 FKSG26,676,function: may play a role in cell death control. acts as a transcriptional repressor. has been shown to repress transcription of srf in vitro and so may play a role in heart development. {eco:0000269|pubmed:16574069}.,"subcellular location: nucleus {eco:0000269|pubmed:16574069, eco:0000269|pubmed:18068114}. note=some staining in the cytosol.","TISSUE SPECIFICITY: In the embryo, widely expressed with highest levels in brain. In the adult, highest expression is found in the heart. {ECO:0000269|PubMed:16574069}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCF25,22980,Hs.415342,ENST00000310554,THC2632198,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005488(binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0007507(heart development),"Homo sapiens transcription factor 25 (basic helix-loop-helix) (TCF25), mRNA [NM_014972]",chr16:89940253-89949803,hs|16q24.3,transcription factor 25 (basic helix-loop-helix),TRUE
365_SNRNP70_6625,P08621,u1 small nuclear ribonucleoprotein 70 kda (u1 snrnp 70 kda) (u1-70k) (snrnp70),SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1,437,"function: component of the spliceosomal u1 snrnp, which is essential for recognition of the pre-mrna 5' splice-site and the subsequent assembly of the spliceosome (pubmed:19325628, pubmed:25555158). snrnp70 binds to the loop i region of u1-snrna (pubmed:2467746, pubmed:19325628, pubmed:25555158). {eco:0000269|pubmed:19325628, eco:0000269|pubmed:2467746, eco:0000269|pubmed:25555158}.; function: isoform 3: truncated isoforms that lack the rrm domain cannot bind u1-snrna. {eco:0000269|pubmed:2467746}.; function: isoform 4: truncated isoforms that lack the rrm domain cannot bind u1-snrna. {eco:0000269|pubmed:2467746}.","subcellular location: nucleus speckle {eco:0000269|pubmed:17656373}. nucleus, nucleoplasm {eco:0000269|pubmed:17656373, eco:0000269|pubmed:21113136}. note=colocalizes with scnm1 and luc7l2 in nuclear speckles. {eco:0000250|uniprotkb:q62376}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRNP70,6625,Hs.467097,ENST00000401730,NP092684,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0043484(regulation of RNA splicing)","Homo sapiens small nuclear ribonucleoprotein 70kDa (U1) (SNRNP70), mRNA [NM_003089]",chr19:49611756-49611815,hs|19q13.33,small nuclear ribonucleoprotein 70kDa (U1),TRUE
366_TMEFF2_23671,Q9UIK5,tomoregulin-2 (tr-2) (hyperplastic polyposis protein 1) (transmembrane protein with egf-like and two follistatin-like domains),TMEFF2 HPP1 TENB2 TPEF UNQ178/PRO204,374,"function: may be a survival factor for hippocampal and mesencephalic neurons. the shedded form up-regulates cancer cell proliferation, probably by promoting erk1/2 phosphorylation. {eco:0000269|pubmed:10903839, eco:0000269|pubmed:17942404}.",subcellular location: isoform 1: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.; subcellular location: isoform 2: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.; subcellular location: isoform 3: secreted.,"TISSUE SPECIFICITY: Highly expressed in adult and fetal brain, spinal cord and prostate. Expressed in all brain regions except the pituitary gland, with highest levels in amygdala and corpus callosum. Expressed in the pericryptal myofibroblasts and other stromal cells of normal colonic mucosa. Expressed in prostate carcinoma. Down-regulated in colorectal cancer. Present in Alzheimer disease plaques (at protein level). Isoform 3 is expressed weakly in testis and at high levels in normal and cancerous prostate. {ECO:0000269|PubMed:10903839, ECO:0000269|PubMed:10987305, ECO:0000269|PubMed:11120884, ECO:0000269|PubMed:11668495, ECO:0000269|PubMed:16439095, ECO:0000269|PubMed:16805794}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEFF2,23671,Hs.144513,ENST00000272771,THC2464259,GO:0003674(molecular_function)|GO:0005576(extracellular region)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 2 (TMEFF2), mRNA [NM_016192]",chr2:192815005-192814946,hs|2q32.3,transmembrane protein with EGF-like and two follistatin-like domains 2,TRUE
367_TUBA1B_10376,P68363,tubulin alpha-1b chain (alpha-tubulin ubiquitous) (tubulin k-alpha-1) (tubulin alpha-ubiquitous chain) [cleaved into: detyrosinated tubulin alpha-1b chain],TUBA1B,451,"function: tubulin is the major constituent of microtubules. it binds two moles of gtp, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.","subcellular location: cytoplasm, cytoskeleton.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TUBA1B,10376,Hs.524390,ENST00000547765,THC2529286,GO:0000166(nucleotide binding)|GO:0000226(microtubule cytoskeleton organization)|GO:0003924(GTPase activity)|GO:0005198(structural molecule activity)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0005881(cytoplasmic microtubule)|GO:0006457(protein folding)|GO:0007017(microtubule-based process)|GO:0007018(microtubule-based movement)|GO:0030705(cytoskeleton-dependent intracellular transport)|GO:0044267(cellular protein metabolic process)|GO:0051084(de novo' posttranslational protein folding)|GO:0051258(protein polymerization)|GO:0051301(cell division),"Homo sapiens tubulin, alpha 1b (TUBA1B), mRNA [NM_006082]",chr12:49521692-49521633,hs|12q13.12,"tubulin, alpha 1b",TRUE
368_PSMB4_5692,P28070,proteasome subunit beta type-4 (ec 3.4.25.1) (26 kda prosomal protein) (hsbpros26) (pros-26) (macropain beta chain) (multicatalytic endopeptidase complex beta chain) (proteasome beta chain) (proteasome chain 3) (hsn3),PSMB4 PROS26,264,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). smad1/oaz1/psmb4 complex mediates the degradation of the crebbp/ep300 repressor snip1. {eco:0000269|pubmed:12097147, eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.",subcellular location: cytoplasm {eco:0000269|pubmed:12181345}. nucleus {eco:0000269|pubmed:12181345}.,NA,"DISEASE: Proteasome-associated autoinflammatory syndrome 3 (PRAAS3) [MIM:617591]: An autoinflammatory disorder characterized by onset in early infancy and recurrent fever, nodular dermatitis, myositis, panniculitis-induced lipodystrophy, lymphadenopathy, and immune dysregulation. Variable accompanying features may include joint contractures, hepatosplenomegaly, anemia, thrombocytopenia, recurrent infections, autoantibodies, and hypergammaglobulinemia. Some patients may have intracranial calcifications. PRAAS3 inheritance is autosomal recessive or digenic. {ECO:0000269|PubMed:26524591}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMB4,5692,Hs.89545,ENST00000493673,THC2693070,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0001530(lipopolysaccharide binding)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0002862(negative regulation of inflammatory response to antigenic stimulus)|GO:0004298(threonine-type endopeptidase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4), mRNA [NM_002796]",chr1:151374330-151374389,hs|1q21.3,"proteasome (prosome, macropain) subunit, beta type, 4",TRUE
369_KIAA1244_57221,Q5TH69,brefeldin a-inhibited guanine nucleotide-exchange protein 3 (arfgef family member 3),ARFGEF3 BIG3 C6orf92 KIAA1244,2177,"function: participates in the regulation of systemic glucose homeostasis, where it negatively regulates insulin granule biogenesis in pancreatic islet beta cells (by similarity). also regulates glucagon granule production in pancreatic alpha cells (by similarity). inhibits nuclear translocation of the transcriptional coregulator phb2 and may enhance estrogen receptor alpha (esr1) transcriptional activity in breast cancer cells (pubmed:19496786). {eco:0000250|uniprotkb:q3ugy8, eco:0000269|pubmed:19496786}.","subcellular location: cytoplasm {eco:0000269|pubmed:19496786}. cytoplasmic vesicle, secretory vesicle {eco:0000250|uniprotkb:q3ugy8}. cytoplasmic vesicle, secretory vesicle membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.","TISSUE SPECIFICITY: Expressed in breast cancer cell lines. Not expressed in normal tissues such as duct, mammary gland, lung, heart, liver, kidnay, bone marrow. {ECO:0000269|PubMed:19496786}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KIAA1244,57221,Hs.194408,ENST00000251691,THC2609340,GO:0005086(ARF guanyl-nucleotide exchange factor activity)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0010923(negative regulation of phosphatase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0032012(regulation of ARF protein signal transduction),"Homo sapiens KIAA1244 (KIAA1244), mRNA [NM_020340]",chr6:138665613-138665672,hs|6q23.3,KIAA1244,TRUE
37_RPL34_6164,P49207,60s ribosomal protein l34 (large ribosomal subunit protein el34),RPL34,117,"function: component of the large ribosomal subunit. {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. endoplasmic reticulum {eco:0000250|uniprotkb:q29223}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q29223, eco:0000269|pubmed:25957688}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL34,6164,Hs.438227,ENST00000506397,THC2566373,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L34 (RPL34), transcript variant 2, mRNA [NM_033625]",chr4:109546305-109546364,hs|4q25,ribosomal protein L34,TRUE
370_NACA2_342538,Q9H009,nascent polypeptide-associated complex subunit alpha-2 (alpha-nac-like) (hom s 2.01) (nascent polypeptide-associated complex subunit alpha-like) (nac-alpha-like),NACA2 NACAL,215,"function: prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (er). binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (srp), which normally targets nascent secretory peptides to the er. also reduces the inherent affinity of ribosomes for protein translocation sites in the er membrane (m sites) (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,TISSUE SPECIFICITY: Expressed specifically in testis and skeletal muscle. {ECO:0000269|PubMed:16201836}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NACA2,342538,Hs.591178,ENST00000521764,NA,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0015031(protein transport),"Homo sapiens nascent polypeptide-associated complex alpha subunit 2 (NACA2), mRNA [NM_199290]",chr17:59668045-59667986,hs|17q23.2,nascent polypeptide-associated complex alpha subunit 2,TRUE
371_CAPZA1_829,P52907,f-actin-capping protein subunit alpha-1 (capz alpha-1),CAPZA1,286,"function: f-actin-capping proteins bind in a ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. may play a role in the formation of epithelial cell junctions. {eco:0000269|pubmed:22891260}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,CAPZA1,829,Hs.514934,ENST00000263168,THC2517938,GO:0003779(actin binding)|GO:0005576(extracellular region)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006461(protein complex assembly)|GO:0006928(cellular component movement)|GO:0007596(blood coagulation)|GO:0008290(F-actin capping protein complex)|GO:0015629(actin cytoskeleton)|GO:0030036(actin cytoskeleton organization)|GO:0045087(innate immune response)|GO:0051693(actin filament capping)|GO:0071203(WASH complex),"Homo sapiens capping protein (actin filament) muscle Z-line, alpha 1 (CAPZA1), mRNA [NM_006135]",chr1:113214149-113214208,hs|1p13.2,"capping protein (actin filament) muscle Z-line, alpha 1",TRUE
372_LSM3_27258,P62310,u6 snrna-associated sm-like protein lsm3,LSM3 MDS017,102,"function: plays role in pre-mrna splicing as component of the u4/u6-u5 tri-snrnp complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome b complex) (pubmed:28781166). the heptameric lsm2-8 complex binds specifically to the 3'-terminal u-tract of u6 snrna (pubmed:10523320). {eco:0000269|pubmed:10523320, eco:0000269|pubmed:28781166}.","subcellular location: nucleus {eco:0000269|pubmed:10523320, eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28781166}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LSM3,27258,Hs.111632,ENST00000306024,THC2466049,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM3), mRNA [NM_014463]",chr3:14239786-14239845,hs|3p25.1,"LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)",TRUE
373_MTCH1_23787,Q9NZJ7,mitochondrial carrier homolog 1 (presenilin-associated protein),MTCH1 PSAP CGI-64 UNQ1871/PRO4314,389,function: potential mitochondrial transporter. may play a role in apoptosis. {eco:0000269|pubmed:12377771}.,subcellular location: mitochondrion inner membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Widely expressed with a predominant expression in brain. {ECO:0000269|PubMed:10551805}.,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MTCH1,23787,Hs.485262,ENST00000373565,NP1157134,GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006810(transport)|GO:0006919(activation of caspase activity)|GO:0009966(regulation of signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0043065(positive regulation of apoptosis)|GO:0045161(neuronal ion channel clustering),"Homo sapiens mitochondrial carrier 1 (MTCH1), nuclear gene encoding mitochondrial protein, mRNA [NM_014341]",chr6:36936110-36936051,hs|6p21.2,mitochondrial carrier 1,TRUE
374_BRP44_25874,Q9Y5U8,mitochondrial pyruvate carrier 1 (brain protein 44-like protein),MPC1 BRP44L CGI-129 HSPC040 PNAS-115,109,function: mediates the uptake of pyruvate into mitochondria. {eco:0000269|pubmed:22628558}.,subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:22628558}; multi-pass membrane protein {eco:0000269|pubmed:22628558}.,NA,"DISEASE: Mitochondrial pyruvate carrier deficiency (MPYCD) [MIM:614741]: An autosomal recessive metabolic disorder characterized by severely delayed psychomotor development, mild dysmorphic features, hepatomegaly, marked metabolic acidosis, hyperlactacidemia with normal lactate/pyruvate, and encephalopathy. Some patients have epilepsy and peripheral neuropathy. {ECO:0000269|PubMed:22628558}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BRP44,25874,Hs.517768,ENST00000271373,THC2468773,GO:0005739(mitochondrion),"Homo sapiens brain protein 44 (BRP44), transcript variant 2, mRNA [NM_015415]",chr1:167889288-167889229,hs|1q24.2,brain protein 44,TRUE
375_GPX1_2876,P07203,glutathione peroxidase 1 (gpx-1) (gshpx-1) (ec 1.11.1.9) (cellular glutathione peroxidase),GPX1,203,function: protects the hemoglobin in erythrocytes from oxidative breakdown.,subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GPX1,2876,Hs.76686,ENST00000419349,THC2587440,"GO:0001836(release of cytochrome c from mitochondria)|GO:0001885(endothelial cell development)|GO:0004602(glutathione peroxidase activity)|GO:0004866(endopeptidase inhibitor activity)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006144(purine base metabolic process)|GO:0006195(purine nucleotide catabolic process)|GO:0006629(lipid metabolic process)|GO:0006641(triglyceride metabolic process)|GO:0006749(glutathione metabolic process)|GO:0006916(anti-apoptosis)|GO:0006917(induction of apoptosis)|GO:0007605(sensory perception of sound)|GO:0008631(induction of apoptosis by oxidative stress)|GO:0009410(response to xenobiotic stimulus)|GO:0009611(response to wounding)|GO:0009636(response to toxin)|GO:0009650(UV protection)|GO:0010269(response to selenium ion)|GO:0010951(negative regulation of endopeptidase activity)|GO:0014902(myotube differentiation)|GO:0016491(oxidoreductase activity)|GO:0017124(SH3 domain binding)|GO:0018158(protein oxidation)|GO:0033194(response to hydroperoxide)|GO:0033599(regulation of mammary gland epithelial cell proliferation)|GO:0040029(regulation of gene expression, epigenetic)|GO:0042311(vasodilation)|GO:0042542(response to hydrogen peroxide)|GO:0042744(hydrogen peroxide catabolic process)|GO:0043154(negative regulation of caspase activity)|GO:0043403(skeletal muscle tissue regeneration)|GO:0043523(regulation of neuron apoptosis)|GO:0043534(blood vessel endothelial cell migration)|GO:0045444(fat cell differentiation)|GO:0045454(cell redox homeostasis)|GO:0048741(skeletal muscle fiber development)|GO:0051450(myoblast proliferation)|GO:0051897(positive regulation of protein kinase B signaling cascade)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)|GO:0060047(heart contraction)|GO:0060055(angiogenesis involved in wound healing)|GO:0061136(regulation of proteasomal protein catabolic process)","Homo sapiens glutathione peroxidase 1 (GPX1), transcript variant 2, mRNA [NM_201397]",chr3:49394680-49394621,hs|3p21.31,glutathione peroxidase 1,TRUE
376_MSMB_4477,P08118,beta-microseminoprotein (immunoglobulin-binding factor) (igbf) (pn44) (prostate secreted seminal plasma protein) (prostate secretory protein of 94 amino acids) (psp-94) (psp94) (seminal plasma beta-inhibin),MSMB PRSP,114,NA,subcellular location: secreted. note=sperm surface.,"TISSUE SPECIFICITY: Strongly expressed in prostate, liver, kidney, breast and penis. Also expressed in pancreas, esophagus, stomach, deodenum, colon, trachea, lung, salivary glands and fallopian tube. PSP94 is expressed in lung and breast, whereas PSP57 is found in kidney and bladder. {ECO:0000269|PubMed:7566962, ECO:0000269|PubMed:7671139}.","DISEASE: Prostate cancer, hereditary, 13 (HPC13) [MIM:611928]: A condition associated with familial predisposition to cancer of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,MSMB,4477,Hs.255462,ENST00000478719,THC2546123,GO:0003674(molecular_function)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005634(nucleus)|GO:0008150(biological_process),"Homo sapiens microseminoprotein, beta- (MSMB), transcript variant PSP94, mRNA [NM_002443]",chr10:51562359-51562418,hs|10q11.23,"microseminoprotein, beta-",TRUE
377_PDE4C_5143,Q08493,"camp-specific 3',5'-cyclic phosphodiesterase 4c (ec 3.1.4.53) (dpde1) (pde21)",PDE4C DPDE1,712,"function: hydrolyzes the second messenger camp, which is a key regulator of many important physiological processes. {eco:0000269|pubmed:17727341}.","subcellular location: cell projection, cilium {eco:0000250}.",TISSUE SPECIFICITY: Expressed in various tissues but not in cells of the immune system.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,PDE4C,5143,Hs.132584,ENST00000355502,THC2475141,"GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity)|GO:0005829(cytosol)|GO:0006198(cAMP catabolic process)|GO:0007165(signal transduction)|GO:0008081(phosphoric diester hydrolase activity)|GO:0008144(drug binding)|GO:0016787(hydrolase activity)|GO:0046676(negative regulation of insulin secretion)|GO:0046872(metal ion binding)|GO:0072372(primary cilium)","Homo sapiens phosphodiesterase 4C, cAMP-specific (PDE4C), transcript variant 1, mRNA [NM_000923]",chr19:18320982-18320923,hs|19p13.11,"phosphodiesterase 4C, cAMP-specific",TRUE
378_SNRPF_6636,P62306,small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf),SNRPF PBSCF,86,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:19325628, pubmed:23333303, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). as part of the u7 snrnp it is involved in histone 3'-end processing (pubmed:12975319). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:12975319, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:23333303, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11574479, eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPF,6636,Hs.105465,ENST00000549580,THC2716859,"GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005683(U7 snRNP)|GO:0005689(U12-type spliceosomal complex)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0008334(histone mRNA metabolic process)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein polypeptide F (SNRPF), mRNA [NM_003095]",chr12:96255070-96259159,hs|12q23.1,small nuclear ribonucleoprotein polypeptide F,TRUE
379_ELP2_55250,Q6IA86,elongator complex protein 2 (elp2) (shinc-2) (stat3-interacting protein 1) (stip1),ELP2 STATIP1,826,"function: component of the rna polymerase ii elongator complex, a multiprotein complex associated with the rna polymerase ii (pol ii) holoenzyme, and which is involved in transcriptional elongation (pubmed:11714725, pubmed:11818576). the elongator complex catalyzes formation of carboxymethyluridine in the wobble base at position 34 in trnas (pubmed:29332244). {eco:0000269|pubmed:11714725, eco:0000269|pubmed:11818576, eco:0000303|pubmed:29332244}.","subcellular location: cytoplasm {eco:0000269|pubmed:11714725, eco:0000269|pubmed:11818576}. nucleus {eco:0000269|pubmed:11714725, eco:0000269|pubmed:11818576}.",NA,"DISEASE: Mental retardation, autosomal recessive 58 (MRT58) [MIM:617270]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT58 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:25847581}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ELP2,55250,Hs.8739,ENST00000544274,THC2468797,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0008023(transcription elongation factor complex)|GO:0016591(DNA-directed RNA polymerase II, holoenzyme)|GO:0019901(protein kinase binding)|GO:0046425(regulation of JAK-STAT cascade)","Homo sapiens elongation protein 2 homolog (S. cerevisiae) (ELP2), transcript variant 2, mRNA [NM_018255]",chr18:33754520-33754579,hs|18q12.2,elongation protein 2 homolog (S. cerevisiae),TRUE
38_PDLIM5_10611,Q96HC4,pdz and lim domain protein 5 (enigma homolog) (enigma-like pdz and lim domains protein),PDLIM5 ENH L9,596,function: may play an important role in the heart development by scaffolding pkc to the z-disk region. may play a role in the regulation of cardiomyocyte expansion. overexpression promotes the development of heart hypertrophy. contributes to the regulation of dendritic spine morphogenesis in neurons. may restrain postsynaptic growth of excitatory synapses (by similarity). {eco:0000250}.,"subcellular location: cell junction, synapse, postsynaptic density {eco:0000250|uniprotkb:q62920}. cell junction, synapse, presynapse {eco:0000250|uniprotkb:q62920}. cell junction, synapse, postsynapse {eco:0000250|uniprotkb:q62920}. cytoplasm, cytosol {eco:0000250|uniprotkb:q62920}. note=detected both at presynaptic and postsynaptic sites, exclusively at excitatory synapses, but not inhibitory synapses, in hippocampal neurons. {eco:0000250|uniprotkb:q62920}.","TISSUE SPECIFICITY: Heart and skeletal muscle specific. Expression is commonly increased in the brain of patients with bipolar disorder, schizophrenia, and major depression. {ECO:0000269|PubMed:10429367, ECO:0000269|PubMed:16044170, ECO:0000269|PubMed:16213469}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PDLIM5,10611,Hs.480311,ENST00000317968,THC2566908,GO:0003779(actin binding)|GO:0005080(protein kinase C binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0008270(zinc ion binding)|GO:0014069(postsynaptic density)|GO:0015629(actin cytoskeleton)|GO:0019717(synaptosome)|GO:0030018(Z disc)|GO:0030054(cell junction)|GO:0042805(actinin binding)|GO:0045202(synapse)|GO:0045211(postsynaptic membrane)|GO:0046872(metal ion binding)|GO:0047485(protein N-terminus binding)|GO:0051963(regulation of synapse assembly)|GO:0061001(regulation of dendritic spine morphogenesis),"Homo sapiens PDZ and LIM domain 5 (PDLIM5), transcript variant 1, mRNA [NM_006457]",chr4:95589078-95589137,hs|4q22.3,PDZ and LIM domain 5,TRUE
380_HLA-G_3135,P17693,"hla class i histocompatibility antigen, alpha chain g (hla g antigen) (mhc class i antigen g) [cleaved into: soluble hla class i histocompatibility antigen, alpha chain g (shla-g)]",HLA-G HLA-6.0 HLAG,338,"function: isoform 1: non-classical major histocompatibility class ib molecule involved in immune regulatory processes at the maternal-fetal interface (pubmed:23184984, pubmed:29262349, pubmed:19304799). in complex with b2m/beta-2 microglobulin binds a limited repertoire of nonamer self-peptides derived from intracellular proteins including histones and ribosomal proteins (pubmed:7584149, pubmed:8805247). peptide-bound hla-g-b2m complex acts as a ligand for inhibitory/activating kir2dl4, lilrb1 and lilrb2 receptors on uterine immune cells to promote fetal development while maintaining maternal-fetal tolerance (pubmed:23184984, pubmed:29262349, pubmed:16366734, pubmed:19304799, pubmed:20448110, pubmed:27859042). upon interaction with kir2dl4 and lilrb1 receptors on decidual nk cells, it triggers nk cell senescence-associated secretory phenotype as a molecular switch to promote vascular remodeling and fetal growth in early pregnancy (pubmed:23184984, pubmed:29262349, pubmed:16366734, pubmed:19304799). through interaction with kir2dl4 receptor on decidual macrophages induces proinflammatory cytokine production mainly associated with tissue remodeling (pubmed:19304799). through interaction with lilrb2 receptor triggers differentiation of type 1 regulatory t cells and myeloid-derived suppressor cells, both of which actively maintain maternal-fetal tolerance (pubmed:20448110, pubmed:27859042). may play a role in balancing tolerance and antiviral-immunity at maternal-fetal interface by keeping in check the effector functions of nk, cd8+ t cells and b cells (pubmed:10190900, pubmed:11290782, pubmed:24453251). reprograms b cells toward an immune suppressive phenotype via lilrb1 (pubmed:24453251). may induce immune activation/suppression via intercellular membrane transfer (trogocytosis), likely enabling interaction with kir2dl4, which resides mostly in endosomes (pubmed:20179272, pubmed:26460007). through interaction with the inhibitory receptor cd160 on endothelial cells may control angiogenesis in immune privileged sites (pubmed:16809620). {eco:0000269|pubmed:10190900, eco:0000269|pubmed:11290782, eco:0000269|pubmed:16366734, eco:0000269|pubmed:16809620, eco:0000269|pubmed:19304799, eco:0000269|pubmed:20179272, eco:0000269|pubmed:20448110, eco:0000269|pubmed:23184984, eco:0000269|pubmed:24453251, eco:0000269|pubmed:26460007, eco:0000269|pubmed:27859042, eco:0000269|pubmed:29262349, eco:0000269|pubmed:7584149, eco:0000269|pubmed:8805247}.; function: isoform 2: likely does not bind b2m and presents peptides. negatively regulates nk cell- and cd8+ t cell-mediated cytotoxicity (pubmed:11290782). {eco:0000269|pubmed:11290782, eco:0000305}.; function: isoform 3: likely does not bind b2m and presents peptides. negatively regulates nk cell- and cd8+ t cell-mediated cytotoxicity (pubmed:11290782). {eco:0000269|pubmed:11290782, eco:0000305}.; function: isoform 4: likely does not bind b2m and presents peptides. negatively regulates nk cell- and cd8+ t cell-mediated cytotoxicity (pubmed:11290782). {eco:0000269|pubmed:11290782, eco:0000305}.; function: isoform 5: non-classical major histocompatibility class ib molecule involved in immune regulatory processes at the maternal-fetal interface (pubmed:23184984, pubmed:29262349, pubmed:19304799). in complex with b2m/beta-2 microglobulin binds a limited repertoire of nonamer self-peptides derived from intracellular proteins including histones and ribosomal proteins (pubmed:7584149, pubmed:8805247). peptide-bound hla-g-b2m complex acts as a ligand for inhibitory/activating kir2dl4, lilrb1 and lilrb2 receptors on uterine immune cells to promote fetal development while maintaining maternal-fetal tolerance (pubmed:23184984, pubmed:29262349, pubmed:16366734, pubmed:19304799, pubmed:20448110). upon interaction with kir2dl4 and lilrb1 receptors on decidual nk cells, it triggers nk cell senescence-associated secretory phenotype as a molecular switch to promote vascular remodeling and fetal growth in early pregnancy (pubmed:23184984, pubmed:29262349, pubmed:16366734, pubmed:19304799). through interaction with kir2dl4 receptor on decidual macrophages induces proinflammatory cytokine production mainly associated with tissue remodeling (pubmed:19304799). through interaction with lilrb2 receptor triggers differentiation of type 1 regulatory t cells and myeloid-derived suppressor cells, both of which actively maintain maternal-fetal tolerance (pubmed:20448110). reprograms b cells toward an immune suppressive phenotype via lilrb1 (pubmed:24453251). {eco:0000269|pubmed:16366734, eco:0000269|pubmed:19304799, eco:0000269|pubmed:20448110, eco:0000269|pubmed:23184984, eco:0000269|pubmed:24453251, eco:0000269|pubmed:29262349, eco:0000269|pubmed:7584149, eco:0000269|pubmed:8805247}.; function: isoform 6: likely does not bind b2m and presents peptides. {eco:0000305}.; function: isoform 7: likely does not bind b2m and presents peptides. {eco:0000305}.","subcellular location: isoform 1: cell membrane {eco:0000269|pubmed:20448110, eco:0000269|pubmed:7584149}; single-pass type i membrane protein {eco:0000255}. endoplasmic reticulum membrane {eco:0000269|pubmed:11520457}. early endosome membrane {eco:0000269|pubmed:16366734}.; subcellular location: soluble hla class i histocompatibility antigen, alpha chain g: secreted {eco:0000269|pubmed:23737137}.; subcellular location: isoform 2: cell membrane {eco:0000269|pubmed:11290782}; single-pass type i membrane protein {eco:0000255}.; subcellular location: isoform 3: cell membrane {eco:0000269|pubmed:11290782}; single-pass type i membrane protein {eco:0000255}.; subcellular location: isoform 4: cell membrane {eco:0000269|pubmed:11290782}; single-pass type i membrane protein {eco:0000255}.; subcellular location: isoform 5: secreted {eco:0000269|pubmed:11137219, eco:0000269|pubmed:7558941, eco:0000269|pubmed:7584149, eco:0000269|pubmed:7989753}. early endosome {eco:0000269|pubmed:16366734}.; subcellular location: isoform 6: secreted {eco:0000269|pubmed:7989753}.; subcellular location: isoform 7: secreted {eco:0000269|pubmed:11137219}.; subcellular location: cell projection, filopodium membrane {eco:0000269|pubmed:26460007}. note=hla-g trogocytosis from extravillous trophoblast's filopodia occurs in the majority of decidual nk cells. {eco:0000269|pubmed:26460007}.","TISSUE SPECIFICITY: Expressed in adult eye (PubMed:1570318). Expressed in immune cell subsets including monocytes, myeloid and plasmacytoid dendritic cells and regulatory T cells (Tr1)(at protein level) (PubMed:20448110). Secreted by follicular dendritic cell and follicular helper T cells (PubMed:24453251). Isoform 5: Detected in physiological fluids including amniotic fluid and serum (PubMed:11137219). Isoform 7: Expressed in placenta, amniotic membrane, skin cord blood and peripheral blood mononuclear cells (PubMed:11137219). {ECO:0000269|PubMed:11137219, ECO:0000269|PubMed:1570318, ECO:0000269|PubMed:16210391, ECO:0000269|PubMed:20448110, ECO:0000269|PubMed:24453251, ECO:0000269|PubMed:26460007, ECO:0000269|PubMed:7589701}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HLA-G,3135,Hs.512152,ENST00000428701,NP598444,GO:0000139(Golgi membrane)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005886(plasma membrane)|GO:0006955(immune response)|GO:0006968(cellular defense response)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019221(cytokine-mediated signaling pathway)|GO:0019882(antigen processing and presentation)|GO:0032393(MHC class I receptor activity)|GO:0042612(MHC class I protein complex)|GO:0050776(regulation of immune response)|GO:0060333(interferon-gamma-mediated signaling pathway)|GO:0060337(type I interferon-mediated signaling pathway)|GO:0071556(integral to lumenal side of endoplasmic reticulum membrane),"Homo sapiens major histocompatibility complex, class I, G (HLA-G), mRNA [NM_002127]",chr6:29798694-29798753,hs|6p22.1,"major histocompatibility complex, class I, G",TRUE
381_PRRC2B_84726,Q5JSZ5,protein prrc2b (hla-b-associated transcript 2-like 1) (proline-rich coiled-coil protein 2b),PRRC2B BAT2L BAT2L1 KIAA0515,2229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,PRRC2B,84726,Hs.495349,ENST00000320547,THC2466530,GO:0005515(protein binding),"Homo sapiens proline-rich coiled-coil 2B (PRRC2B), mRNA [NM_013318]",chr9:134375328-134375387,hs|9q34.13,proline-rich coiled-coil 2B,TRUE
382_UQCR10_29796,Q9UDW1,cytochrome b-c1 complex subunit 9 (complex iii subunit 9) (complex iii subunit x) (cytochrome c1 non-heme 7 kda protein) (ubiquinol-cytochrome c reductase complex 7.2 kda protein),UQCR10 UCRC HSPC119,63,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. this subunit interacts with cytochrome c1 (by similarity). {eco:0000250}.",subcellular location: mitochondrion inner membrane {eco:0000250}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCR10,29796,Hs.284292,ENST00000332801,THC2466513,"GO:0005739(mitochondrion)|GO:0005740(mitochondrial envelope)|GO:0005743(mitochondrial inner membrane)|GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c)|GO:0006810(transport)|GO:0008121(ubiquinol-cytochrome-c reductase activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens ubiquinol-cytochrome c reductase, complex III subunit X (UQCR10), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_001003684]",chr22:30165827-30165886,hs|22q12.2,"ubiquinol-cytochrome c reductase, complex III subunit X",TRUE
383_TBC1D8_11138,Q0IIM8,tbc1 domain family member 8b,TBC1D8B,1120,"function: involved in vesicular recycling, probably as a rab11b gtpase-activating protein. {eco:0000269|pubmed:30661770}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:30661770}.",TISSUE SPECIFICITY: Kidney (at protein level). {ECO:0000269|PubMed:30661770}.,"DISEASE: Nephrotic syndrome 20 (NPHS20) [MIM:301028]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS20 is a X-linked, steroid-resistant form with onset at birth or in the first years of life in affected males. Death in childhood may occur in absence of renal transplantation. Carrier females may be unaffected or have a mild disease with proteinuria. {ECO:0000269|PubMed:30661770}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TBC1D8,11138,Hs.442657,NA,THC2463776,GO:0005096(GTPase activator activity)|GO:0005097(Rab GTPase activator activity)|GO:0005509(calcium ion binding)|GO:0005622(intracellular)|GO:0008015(blood circulation)|GO:0008284(positive regulation of cell proliferation)|GO:0016020(membrane),"Homo sapiens TBC1 domain family, member 8 (with GRAM domain) (TBC1D8), mRNA [NM_001102426]",chr2:101623784-101623725,hs|2q11.2,"TBC1 domain family, member 8 (with GRAM domain)",TRUE
385_EIF3D_8664,O15371,eukaryotic translation initiation factor 3 subunit d (eif3d) (eukaryotic translation initiation factor 3 subunit 7) (eif-3-zeta) (eif3 p66),EIF3D EIF3S7,548,"function: mrna cap-binding component of the eukaryotic translation initiation factor 3 (eif-3) complex, a complex required for several steps in the initiation of protein synthesis of a specialized repertoire of mrnas (pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:18599441, pubmed:25849773). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). in the eif-3 complex, eif3d specifically recognizes and binds the 7-methylguanosine cap of a subset of mrnas (pubmed:27462815). {eco:0000269|pubmed:18599441, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.; function: (microbial infection) in case of fcv infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of vp2 (pubmed:18056426). {eco:0000269|pubmed:18056426}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03003}.,NA,"DISEASE: Note=Defects in EIF3D are associated with some cancers, such as prostate, breast and colon cancers. Disease susceptibility may be associated with variations affecting the gene represented in this entry. Down-regulation inhibits proliferation of cancers (PubMed:25370813, PubMed:25322666, PubMed:25682860, PubMed:26617750, PubMed:26008152, PubMed:26036682, PubMed:27035563). {ECO:0000269|PubMed:25322666, ECO:0000269|PubMed:25370813, ECO:0000269|PubMed:25682860, ECO:0000269|PubMed:26008152, ECO:0000269|PubMed:26036682, ECO:0000269|PubMed:26617750, ECO:0000269|PubMed:27035563}.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3D,8664,Hs.55682,ENST00000462641,THC2481222,GO:0001732(formation of translation initiation complex)|GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit D (EIF3D), mRNA [NM_003753]",chr22:36906978-36906919,hs|22q12.3,"eukaryotic translation initiation factor 3, subunit D",TRUE
386_LRRC8A_56262,Q8IWT6,volume-regulated anion channel subunit lrrc8a (leucine-rich repeat-containing protein 8a) (swelling protein 1),LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247,810,"function: essential component of the volume-regulated anion channel (vrac, also named vsoac channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes (pubmed:24725410, pubmed:24790029, pubmed:26530471, pubmed:26824658, pubmed:28193731, pubmed:29769723). the vrac channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine (pubmed:24725410, pubmed:24790029, pubmed:26530471, pubmed:26824658, pubmed:28193731). mediates efflux of amino acids, such as aspartate and glutamate, in response to osmotic stress (pubmed:28193731). lrrc8a and lrrc8d are required for the uptake of the drug cisplatin (pubmed:26530471). required for in vivo channel activity, together with at least one other family member (lrrc8b, lrrc8c, lrrc8d or lrrc8e); channel characteristics depend on the precise subunit composition (pubmed:24790029, pubmed:26824658, pubmed:28193731). can form functional channels by itself (in vitro) (pubmed:26824658). involved in b-cell development: required for the pro-b cell to pre-b cell transition (pubmed:14660746). also required for t-cell development (by similarity). may play a role in lysosome homeostasis (pubmed:31270356). {eco:0000250|uniprotkb:q80wg5, eco:0000269|pubmed:14660746, eco:0000269|pubmed:24725410, eco:0000269|pubmed:24790029, eco:0000269|pubmed:26530471, eco:0000269|pubmed:26824658, eco:0000269|pubmed:28193731, eco:0000269|pubmed:29769723, eco:0000269|pubmed:31270356}.","subcellular location: cell membrane {eco:0000269|pubmed:24725410, eco:0000269|pubmed:24782309, eco:0000269|pubmed:24790029, eco:0000269|pubmed:26824658, eco:0000305|pubmed:29769723}; multi-pass membrane protein {eco:0000269|pubmed:24725410, eco:0000269|pubmed:24782309, eco:0000269|pubmed:24790029}. note=the leucine-rich repeat (lrr) domain is on the cytoplasmic side of the cell membrane. {eco:0000269|pubmed:24782309}.","TISSUE SPECIFICITY: Expressed in brain, kidney, ovary, lung, liver, heart, and fetal brain and liver. Found at high levels in bone marrow; lower levels are detected in peripheral blood cells. Expressed on T-cells as well as on B-lineage cells. {ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:14660746}.","DISEASE: Agammaglobulinemia 5, autosomal dominant (AGM5) [MIM:613506]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:14660746}. Note=The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving LRRC8 has been found in a patient with congenital agammaglobulinemia. Translocation t(9;20)(q33.2;q12). The translocation truncates the LRRC8 gene, resulting in deletion of the eighth, ninth, and half of the seventh LRR domains.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LRRC8A,56262,Hs.643600,ENST00000259324,THC2782681,GO:0002329(pre-B cell differentiation)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030154(cell differentiation),"Homo sapiens leucine rich repeat containing 8 family, member A (LRRC8A), transcript variant 2, mRNA [NM_019594]",chr9:131680227-131680286,hs|9q34.11,"leucine rich repeat containing 8 family, member A",TRUE
387_RPS3A_6189,P61247,40s ribosomal protein s3a (small ribosomal subunit protein es1) (v-fos transformation effector protein) (fte-1),RPS3A FTE1 MFTL,264,function: may play a role during erythropoiesis through regulation of transcription factor ddit3. {eco:0000255|hamap-rule:mf_03122}.,"subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03122, eco:0000269|pubmed:17289661}. nucleus {eco:0000255|hamap-rule:mf_03122}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,RPS3A,6189,Hs.356572,ENST00000512797,THC2568491,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006917(induction of apoptosis)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030154(cell differentiation)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S3A (RPS3A), mRNA [NM_001006]",chr4:152025345-152025404,hs|4q31.3,ribosomal protein S3A,TRUE
388_SND1_27044,Q7KZF4,staphylococcal nuclease domain-containing protein 1 (ec 3.1.31.1) (100 kda coactivator) (ebna2 coactivator p100) (tudor domain-containing protein 11) (p100 co-activator),SND1 TDRD11,910,"function: endonuclease that mediates mirna decay of both protein-free and ago2-loaded mirnas (pubmed:28546213, pubmed:18453631). as part of its function in mirna decay, regulates mrnas involved in g1-to-s phase transition (pubmed:28546213). functions as a bridging factor between stat6 and the basal transcription factor (pubmed:12234934). plays a role in pim1 regulation of myb activity (pubmed:9809063). functions as a transcriptional coactivator for stat5 (by similarity). {eco:0000250|uniprotkb:q78py7, eco:0000269|pubmed:12234934, eco:0000269|pubmed:18453631, eco:0000269|pubmed:28546213, eco:0000269|pubmed:9809063}.; function: (microbial infection) functions as a transcriptional coactivator for the epstein-barr virus nuclear antigen 2 (ebna2). {eco:0000269|pubmed:7651391}.","subcellular location: cytoplasm {eco:0000269|pubmed:14508492, eco:0000269|pubmed:17081065}. nucleus {eco:0000269|pubmed:12234934, eco:0000269|pubmed:14508492, eco:0000269|pubmed:17081065, eco:0000269|pubmed:7651391}. melanosome {eco:0000269|pubmed:17081065}. note=in il-4 stimulated cells colocalizes with stat6 in the nucleus (pubmed:12234934). identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:17081065). {eco:0000269|pubmed:12234934, eco:0000269|pubmed:17081065}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:7651391}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,SND1,27044,Hs.122523,ENST00000438400,THC2564057,"GO:0003676(nucleic acid binding)|GO:0003712(transcription cofactor activity)|GO:0004518(nuclease activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016442(RNA-induced silencing complex)|GO:0031047(gene silencing by RNA)|GO:0042470(melanosome)|GO:0044419(interspecies interaction between organisms)","Homo sapiens staphylococcal nuclease and tudor domain containing 1 (SND1), mRNA [NM_014390]",chr7:127732513-127732572,hs|7q32.1,staphylococcal nuclease and tudor domain containing 1,TRUE
389_RPL6_6128,Q02878,60s ribosomal protein l6 (large ribosomal subunit protein el6) (neoplasm-related protein c140) (tax-responsive enhancer element-binding protein 107) (taxreb107),RPL6 TXREB1,288,"function: component of the large ribosomal subunit. {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000305|pubmed:12962325}.; function: (microbial infection) specifically binds to domain c of the tax-responsive enhancer element in the long terminal repeat of htlv-i (pubmed:8457378). {eco:0000269|pubmed:8457378}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:q2ygt9}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q2ygt9, eco:0000269|pubmed:25957688}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL6,6128,Hs.546283,ENST00000424576,THC2526368,"GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)","Homo sapiens ribosomal protein L6 (RPL6), transcript variant 1, mRNA [NM_001024662]",chr12:112843662-112843127,hs|12q24.13,ribosomal protein L6,TRUE
39_SLC35E4_339665,Q6ICL7,solute carrier family 35 member e4,SLC35E4,350,function: putative transporter. {eco:0000250}.,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC35E4,339665,Hs.660384,ENST00000343605,THC2515763,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens solute carrier family 35, member E4 (SLC35E4), mRNA [NM_001001479]",chr22:31043087-31043146,hs|22q12.2,"solute carrier family 35, member E4",TRUE
390_IGFBP2_3485,P18065,insulin-like growth factor-binding protein 2 (ibp-2) (igf-binding protein 2) (igfbp-2),IGFBP2 BP2 IBP2,325,function: inhibits igf-mediated growth and developmental rates. igf-binding proteins prolong the half-life of the igfs and have been shown to either inhibit or stimulate the growth promoting effects of the igfs on cell culture. they alter the interaction of igfs with their cell surface receptors. {eco:0000269|pubmed:19081843}.,subcellular location: secreted.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IGFBP2,3485,Hs.438102,ENST00000490362,THC2466327,GO:0001558(regulation of cell growth)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0006950(response to stress)|GO:0007165(signal transduction)|GO:0007565(female pregnancy)|GO:0007568(aging)|GO:0007584(response to nutrient)|GO:0009612(response to mechanical stimulus)|GO:0010226(response to lithium ion)|GO:0016324(apical plasma membrane)|GO:0031410(cytoplasmic vesicle)|GO:0031994(insulin-like growth factor I binding)|GO:0031995(insulin-like growth factor II binding)|GO:0032355(response to estradiol stimulus)|GO:0032526(response to retinoic acid)|GO:0032870(cellular response to hormone stimulus)|GO:0042104(positive regulation of activated T cell proliferation)|GO:0042493(response to drug)|GO:0043567(regulation of insulin-like growth factor receptor signaling pathway)|GO:0051384(response to glucocorticoid stimulus),"Homo sapiens insulin-like growth factor binding protein 2, 36kDa (IGFBP2), mRNA [NM_000597]",chr2:217529086-217529145,hs|2q35,"insulin-like growth factor binding protein 2, 36kDa",TRUE
391_NDUFB2_4708,O95178,"nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (complex i-aggg) (ci-aggg) (nadh-ubiquinone oxidoreductase aggg subunit)",NDUFB2,105,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB2,4708,Hs.655788,ENST00000464564,THC2536884,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (NDUFB2), nuclear gene encoding mitochondrial protein, mRNA [NM_004546]",chr7:140404686-140404745,hs|7q34,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa",TRUE
392_SPARC_6678,P09486,sparc (basement-membrane protein 40) (bm-40) (osteonectin) (on) (secreted protein acidic and rich in cysteine),SPARC ON,303,"function: appears to regulate cell growth through interactions with the extracellular matrix and cytokines. binds calcium and copper, several types of collagen, albumin, thrombospondin, pdgf and cell membranes. there are two calcium binding sites; an acidic domain that binds 5 to 8 ca(2+) with a low affinity and an ef-hand loop that binds a ca(2+) ion with a high affinity.","subcellular location: secreted, extracellular space, extracellular matrix, basement membrane {eco:0000269|pubmed:2306517, eco:0000269|pubmed:3400777, eco:0000269|pubmed:7495300, eco:0000269|pubmed:9457905}. note=in or around the basement membrane.",NA,"DISEASE: Osteogenesis imperfecta 17 (OI17) [MIM:616507]: An autosomal recessive form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. {ECO:0000269|PubMed:26027498}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SPARC,6678,Hs.111779,ENST00000520687,THC2568052,GO:0001503(ossification)|GO:0002576(platelet degranulation)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005518(collagen binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0005604(basement membrane)|GO:0005615(extracellular space)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007165(signal transduction)|GO:0007507(heart development)|GO:0007596(blood coagulation)|GO:0009629(response to gravity)|GO:0010288(response to lead ion)|GO:0030168(platelet activation)|GO:0030324(lung development)|GO:0031093(platelet alpha granule lumen)|GO:0031988(membrane-bounded vesicle)|GO:0032496(response to lipopolysaccharide)|GO:0033591(response to L-ascorbic acid)|GO:0034097(response to cytokine stimulus)|GO:0042127(regulation of cell proliferation)|GO:0043434(response to peptide hormone stimulus)|GO:0045471(response to ethanol)|GO:0046686(response to cadmium ion)|GO:0048839(inner ear development)|GO:0050840(extracellular matrix binding)|GO:0051384(response to glucocorticoid stimulus)|GO:0051591(response to cAMP)|GO:0051592(response to calcium ion)|GO:0071363(cellular response to growth factor stimulus),"Homo sapiens secreted protein, acidic, cysteine-rich (osteonectin) (SPARC), mRNA [NM_003118]",chr5:151042244-151042185,hs|5q33.1,"secreted protein, acidic, cysteine-rich (osteonectin)",TRUE
393_COX7C_1350,P15954,"cytochrome c oxidase subunit 7c, mitochondrial (cytochrome c oxidase polypeptide viic)",COX7C,63,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane {eco:0000250}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX7C,1350,Hs.430075,ENST00000509578,THC2470074,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIIc (COX7C), nuclear gene encoding mitochondrial protein, mRNA [NM_001867]",chr5:85916510-85916569,hs|5q14.3,cytochrome c oxidase subunit VIIc,TRUE
394_NDUFA4_4697,O00483,cytochrome c oxidase subunit ndufa4 (complex i-mlrq) (ci-mlrq) (nadh-ubiquinone oxidoreductase mlrq subunit),NDUFA4,81,"function: cytochrome c oxidase (cox, complex iv) is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. required for complex iv maintenance. {eco:0000269|pubmed:22902835}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:23746447}; peripheral membrane protein {eco:0000269|pubmed:23746447}; matrix side {eco:0000269|pubmed:23746447}.,NA,"DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:23746447}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA4,4697,Hs.50098,ENST00000482299,THC2608037,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (NDUFA4), nuclear gene encoding mitochondrial protein, mRNA [NM_002489]",chr7:10973244-10973185,hs|7p21.3,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa",TRUE
395_CRNDE_643911,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,CRNDE,643911,Hs.237396,NA,THC2707285,NA,"Homo sapiens colorectal neoplasia differentially expressed (non-protein coding) (CRNDE), transcript variant 1, non-coding RNA [NR_034105]",chr16:54952978-54952919,hs|16q12.2,colorectal neoplasia differentially expressed (non-protein coding),TRUE
396_PFDN5_5204,Q99471,prefoldin subunit 5 (myc modulator 1) (c-myc-binding protein mm-1),PFDN5 MM1 PFD5,154,function: binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it. binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. represses the transcriptional activity of myc. {eco:0000269|pubmed:9630229}.,subcellular location: isoform 1: nucleus.; subcellular location: isoform 2: cytoplasm.; subcellular location: isoform 3: nucleus.,TISSUE SPECIFICITY: Highly expressed in pancreas and skeletal muscle and moderately in other tissues.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PFDN5,5204,Hs.655327,ENST00000552548,THC2621973,"GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006457(protein folding)|GO:0016272(prefoldin complex)|GO:0044267(cellular protein metabolic process)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding)|GO:0090090(negative regulation of canonical Wnt receptor signaling pathway)","Homo sapiens prefoldin subunit 5 (PFDN5), transcript variant 1, mRNA [NM_002624]",chr12:53691919-53693096,hs|12q13.13,prefoldin subunit 5,TRUE
397_STMN1_3925,P16949,stathmin (leukemia-associated phosphoprotein p18) (metablastin) (oncoprotein 18) (op18) (phosphoprotein p19) (pp19) (prosolin) (protein pr22) (pp17),STMN1 C1orf215 LAP18 OP18,149,function: involved in the regulation of the microtubule (mt) filament system by destabilizing microtubules. prevents assembly and promotes disassembly of microtubules. phosphorylation at ser-16 may be required for axon formation during neurogenesis. involved in the control of the learned and innate fear (by similarity). {eco:0000250}.,"subcellular location: cytoplasm, cytoskeleton.","TISSUE SPECIFICITY: Ubiquitous. Expression is strongest in fetal and adult brain, spinal cord, and cerebellum, followed by thymus, bone marrow, testis, and fetal liver. Expression is intermediate in colon, ovary, placenta, uterus, and trachea, and is readily detected at substantially lower levels in all other tissues examined. Lowest expression is found in adult liver. Present in much greater abundance in cells from patients with acute leukemia of different subtypes than in normal peripheral blood lymphocytes, non-leukemic proliferating lymphoid cells, bone marrow cells, or cells from patients with chronic lymphoid or myeloid leukemia. {ECO:0000269|PubMed:12676564, ECO:0000269|PubMed:1917919}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,STMN1,3925,Hs.209983,ENST00000357865,THC2565861,GO:0004871(signal transducer activity)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0007019(microtubule depolymerization)|GO:0007052(mitotic spindle organization)|GO:0007165(signal transduction)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0009615(response to virus)|GO:0015631(tubulin binding)|GO:0030154(cell differentiation)|GO:0035556(intracellular signal transduction),"Homo sapiens stathmin 1 (STMN1), transcript variant 1, mRNA [NM_203401]",chr1:26227152-26227093,hs|1p36.11,stathmin 1,TRUE
398_PDXDC1_23042,Q6P996,pyridoxal-dependent decarboxylase domain-containing protein 1 (ec 4.1.1.-),PDXDC1 KIAA0251,788,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,PDXDC1,23042,Hs.370781,ENST00000396410,THC2470351,GO:0016829(lyase activity)|GO:0016831(carboxy-lyase activity)|GO:0019752(carboxylic acid metabolic process)|GO:0030170(pyridoxal phosphate binding),"Homo sapiens pyridoxal-dependent decarboxylase domain containing 1 (PDXDC1), mRNA [NM_015027]",chr16:15131214-15131273,hs|16p13.11,pyridoxal-dependent decarboxylase domain containing 1,TRUE
399_UQCR11_10975,O14957,cytochrome b-c1 complex subunit 10 (complex iii subunit 10) (complex iii subunit xi) (ubiquinol-cytochrome c reductase complex 6.4 kda protein),UQCR11 UQCR,56,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain.; function: this protein may be closely linked to the iron-sulfur protein in the complex and function as an iron-sulfur protein binding factor.",subcellular location: mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCR11,10975,Hs.8372,ENST00000262946,THC2647145,GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0006810(transport)|GO:0008121(ubiquinol-cytochrome-c reductase activity)|GO:0009055(electron carrier activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain),"Homo sapiens ubiquinol-cytochrome c reductase, complex III subunit XI (UQCR11), nuclear gene encoding mitochondrial protein, mRNA [NM_006830]",chr19:1598153-1598094,hs|19p13.3,"ubiquinol-cytochrome c reductase, complex III subunit XI",TRUE
4_MALAT1_378938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,MALAT1,378938,Hs.621695,NA,THC2550262,NA,"Homo sapiens metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) (MALAT1), non-coding RNA [NR_002819]",chr11:65270142-65270201,hs|11q13.1,metastasis associated lung adenocarcinoma transcript 1 (non-protein coding),TRUE
40_TMPRSS2_7113,O15393,transmembrane protease serine 2 (ec 3.4.21.-) (serine protease 10) [cleaved into: transmembrane protease serine 2 non-catalytic chain; transmembrane protease serine 2 catalytic chain],TMPRSS2 PRSS10,492,"function: serine protease that proteolytically cleaves and activates the viral spike glycoproteins which facilitate virus-cell membrane fusions; spike proteins are synthesized and maintained in precursor intermediate folding states and proteolysis permits the refolding and energy release required to create stable virus-cell linkages and membrane coalescence. facilitates human sars coronavirus (sars-cov) infection via two independent mechanisms, proteolytic cleavage of ace2, which might promote viral uptake, and cleavage of coronavirus spike glycoprotein which activates the glycoprotein for cathepsin l-independent host cell entry. proteolytically cleaves and activates the spike glycoproteins of human coronavirus 229e (hcov-229e) and human coronavirus emc (hcov-emc) and the fusion glycoproteins f0 of sendai virus (sev), human metapneumovirus (hmpv), human parainfluenza 1, 2, 3, 4a and 4b viruses (hpiv). essential for spread and pathogenesis of influenza a virus (strains h1n1, h3n2 and h7n9); involved in proteolytic cleavage and activation of hemagglutinin (ha) protein which is essential for viral infectivity. {eco:0000269|pubmed:21068237, eco:0000269|pubmed:21325420, eco:0000269|pubmed:23536651, eco:0000269|pubmed:23966399, eco:0000269|pubmed:24027332, eco:0000269|pubmed:24227843}.","subcellular location: cell membrane {eco:0000269|pubmed:20382709, eco:0000269|pubmed:21068237}; single-pass type ii membrane protein {eco:0000269|pubmed:20382709, eco:0000269|pubmed:21068237}.; subcellular location: transmembrane protease serine 2 catalytic chain: secreted {eco:0000269|pubmed:20382709}. note=activated by cleavage and secreted. {eco:0000269|pubmed:20382709}.","TISSUE SPECIFICITY: Highly expressed in prostate epithelial cells and in prostate cancers. Expressed in type II pneumocytes in the lung (at protein level). Expressed strongly in small intestine. Also expressed in colon, stomach and salivary gland. {ECO:0000269|PubMed:11169526, ECO:0000269|PubMed:20382709, ECO:0000269|PubMed:21325420}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMPRSS2,7113,Hs.439309,NA,NA,NA,Homo sapiens transmembrane protease serine 2 (TMPRSS2) mRNA,chr21:41758436-41758495,NA,"transmembrane protease, serine 2",TRUE
400_CKB_1152,P12277,creatine kinase b-type (ec 2.7.3.2) (brain creatine kinase) (b-ck) (creatine kinase b chain) (creatine phosphokinase b-type) (cpk-b),CKB CKBB,381,"function: reversibly catalyzes the transfer of phosphate between atp and various phosphogens (e.g. creatine phosphate). creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.",subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CKB,1152,Hs.173724,ENST00000553652,THC2571578,GO:0000166(nucleotide binding)|GO:0004111(creatine kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006600(creatine metabolic process)|GO:0007420(brain development)|GO:0030644(cellular chloride ion homeostasis)|GO:0034641(cellular nitrogen compound metabolic process),"Homo sapiens creatine kinase, brain (CKB), mRNA [NM_001823]",chr14:103986208-103986149,hs|14q32.32,"creatine kinase, brain",TRUE
401_RPN1_6184,P04843,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kda subunit) (ribophorin i) (rpn-i) (ribophorin-1),RPN1,607,"function: subunit of the oligosaccharyl transferase (ost) complex that catalyzes the initial transfer of a defined glycan (glc(3)man(9)glcnac(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an asn-x-ser/thr consensus motif in nascent polypeptide chains, the first step in protein n-glycosylation. n-glycosylation occurs cotranslationally and the complex associates with the sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (er). all subunits are required for a maximal enzyme activity. {eco:0000250|uniprotkb:e2rq08}.","subcellular location: endoplasmic reticulum {eco:0000250|uniprotkb:e2rq08, eco:0000250|uniprotkb:q9gmb0}. endoplasmic reticulum membrane; single-pass type i membrane protein {eco:0000305}. melanosome. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.",TISSUE SPECIFICITY: Expressed in all tissues tested. {ECO:0000269|PubMed:12887896}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RPN1,6184,Hs.518244,ENST00000296255,THC2576376,GO:0004579(dolichyl-diphosphooligosaccharide-protein glycotransferase activity)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006464(protein modification process)|GO:0006486(protein glycosylation)|GO:0008250(oligosaccharyltransferase complex)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0019718(rough microsome)|GO:0042470(melanosome)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribophorin I (RPN1), mRNA [NM_002950]",chr3:128339200-128339141,hs|3q21.3,ribophorin I,TRUE
402_C12orf62_84987,Q96I36,cytochrome c oxidase assembly protein cox14,COX14 C12orf62,57,"function: core component of the mitrac (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. requires for coordination of the early steps of cytochrome c oxidase assembly with the synthesis of mt-co1. {eco:0000269|pubmed:22243966, eco:0000269|pubmed:22356826}.","subcellular location: mitochondrion membrane {eco:0000269|pubmed:22243966, eco:0000269|pubmed:22356826}; single-pass membrane protein {eco:0000269|pubmed:22243966, eco:0000269|pubmed:22356826}.",NA,"DISEASE: Note=Defects in COX14 may be a cause of a mitochondrial disorder presenting with severe congenital lactic acidosis and dysmorphic features associated with a COX assembly defect. Other features include brain hypertrophy, diffuse alteration of the white-matter myelination, and numerous cavities in the parieto-occipital region, brainstem, and cerebellum, as well as hepatomegaly, hypertrophic cardiomyopathy, renal hypoplasia, and adrenal-gland hyperplasia. {ECO:0000269|PubMed:22243966}.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C12orf62,84987,Hs.388645,ENST00000550487,THC2548637,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 12 open reading frame 62 (C12orf62), mRNA [NM_032901]",chr12:50514125-50514184,hs|12q13.12,chromosome 12 open reading frame 62,TRUE
403_CUTA_51596,O60888,protein cuta (acetylcholinesterase-associated protein) (brain acetylcholinesterase putative membrane anchor),CUTA ACHAP C6orf82,179,function: may form part of a complex of membrane proteins attached to acetylcholinesterase (ache).,NA,TISSUE SPECIFICITY: Ubiquitous. Widely expressed in brain. {ECO:0000269|PubMed:10800960}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CUTA,51596,Hs.520070,ENST00000486590,THC2494124,GO:0005515(protein binding)|GO:0008104(protein localization)|GO:0010038(response to metal ion)|GO:0016020(membrane)|GO:0019899(enzyme binding),"Homo sapiens cutA divalent cation tolerance homolog (E. coli) (CUTA), transcript variant 2, mRNA [NM_015921]",chr6:33384421-33384362,hs|6p21.32,cutA divalent cation tolerance homolog (E. coli),TRUE
404_ELL2_22936,O00472,rna polymerase ii elongation factor ell2,ELL2,640,"function: elongation factor component of the super elongation complex (sec), a complex required to increase the catalytic rate of rna polymerase ii transcription by suppressing transient pausing by the polymerase at multiple sites along the dna. component of the little elongation complex (lec), a complex required to regulate small nuclear rna (snrna) gene transcription by rna polymerase ii and iii (pubmed:22195968). plays a role in immunoglobulin secretion in plasma cells: directs efficient alternative mrna processing, influencing both proximal poly(a) site choice and exon skipping, as well as immunoglobulin heavy chain (igh) alternative processing. probably acts by regulating histone modifications accompanying transition from membrane-specific to secretory igh mrna expression. {eco:0000269|pubmed:20159561, eco:0000269|pubmed:20471948, eco:0000269|pubmed:22195968, eco:0000269|pubmed:23251033}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ELL2,22936,Hs.192221,ENST00000237853,THC2462670,"GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0008023(transcription elongation factor complex)","Homo sapiens elongation factor, RNA polymerase II, 2 (ELL2), mRNA [NM_012081]",chr5:95223218-95223159,hs|5q15,"elongation factor, RNA polymerase II, 2",TRUE
405_BCAM_4059,P50895,basal cell adhesion molecule (auberger b antigen) (b-cam cell surface glycoprotein) (f8/g253 antigen) (lutheran antigen) (lutheran blood group glycoprotein) (cd antigen cd239),BCAM LU MSK19,628,function: laminin alpha-5 receptor. may mediate intracellular signaling. {eco:0000269|pubmed:9616226}.,subcellular location: membrane; single-pass type i membrane protein.,TISSUE SPECIFICITY: Wide tissue distribution (highest in the pancreas and very low in brain). Closely associated with the basal layer of cells in epithelia and the endothelium of blood vessel walls.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BCAM,4059,Hs.625725,ENST00000270233,NP1138028,GO:0004888(transmembrane receptor activity)|GO:0005055(laminin receptor activity)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion)|GO:0007160(cell-matrix adhesion)|GO:0007165(signal transduction)|GO:0009897(external side of plasma membrane)|GO:0009986(cell surface)|GO:0043236(laminin binding),"Homo sapiens basal cell adhesion molecule (Lutheran blood group) (BCAM), transcript variant 1, mRNA [NM_005581]",chr19:45324572-45324631,hs|19q13.32,basal cell adhesion molecule (Lutheran blood group),TRUE
407_EDEM3_80267,Q9BZQ6,"er degradation-enhancing alpha-mannosidase-like protein 3 (ec 3.2.1.113) (alpha-1,2-mannosidase edem3)",EDEM3 C1orf22,932,"function: involved in endoplasmic reticulum-associated degradation (erad). accelerates the glycoprotein erad by proteasomes, by catalyzing mannose trimming from man8glcnac2 to man7glcnac2 in the n-glycans. seems to have alpha 1,2-mannosidase activity (by similarity). {eco:0000250, eco:0000269|pubmed:25092655}.",subcellular location: endoplasmic reticulum lumen {eco:0000255|prosite-prorule:pru10138}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EDEM3,80267,Hs.523811,ENST00000318130,THC2493079,"GO:0004569(glycoprotein endo-alpha-1,2-mannosidase activity)|GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity)|GO:0005509(calcium ion binding)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005789(endoplasmic reticulum membrane)|GO:0006457(protein folding)|GO:0006516(glycoprotein catabolic process)|GO:0006986(response to unfolded protein)|GO:0016020(membrane)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)","Homo sapiens ER degradation enhancer, mannosidase alpha-like 3 (EDEM3), mRNA [NM_025191]",chr1:184660017-184659958,hs|1q25.3,"ER degradation enhancer, mannosidase alpha-like 3",TRUE
408_HNRNPK_3190,P61978,heterogeneous nuclear ribonucleoprotein k (hnrnp k) (transformation up-regulated nuclear protein) (tunp),HNRNPK HNRPK,463,"function: one of the major pre-mrna-binding proteins. binds tenaciously to poly(c) sequences. likely to play a role in the nuclear metabolism of hnrnas, particularly for pre-mrnas that contain cytidine-rich sequences. can also bind poly(c) single-stranded dna. plays an important role in p53/tp53 response to dna damage, acting at the level of both transcription activation and repression. when sumoylated, acts as a transcriptional coactivator of p53/tp53, playing a role in p21/cdkn1a and 14-3-3 sigma/sfn induction (by similarity). as far as transcription repression is concerned, acts by interacting with long intergenic rna p21 (lincrna-p21), a non-coding rna induced by p53/tp53. this interaction is necessary for the induction of apoptosis, but not cell cycle arrest. {eco:0000250, eco:0000269|pubmed:16360036, eco:0000269|pubmed:20673990, eco:0000269|pubmed:22825850}.","subcellular location: cytoplasm {eco:0000269|pubmed:1729596}. nucleus, nucleoplasm {eco:0000269|pubmed:16360036, eco:0000269|pubmed:1729596, eco:0000269|pubmed:18775702, eco:0000269|pubmed:22721921}. cell projection, podosome {eco:0000269|pubmed:22721921}. note=recruited to p53/tp53-responsive promoters, in the presence of functional p53/tp53 (pubmed:16360036). in case of asfv infection, there is a shift in the localization which becomes predominantly nuclear (pubmed:18775702).",NA,"DISEASE: Au-Kline syndrome (AUKS) [MIM:616580]: A disorder characterized by intellectual disability, facial dysmorphism, cardiac defects, and connective tissue and skeletal abnormalities. Dysmorphic features include long palpebral fissures, ptosis, a broad prominent nasal bridge, hypoplastic alae nasi, an open downturned mouth, ears with underdeveloped and thick helices, high palate, and a unique tongue with a prominent median crease. Hypotonia, hyporeflexia, and high pain tolerance are additional features. {ECO:0000269|PubMed:26173930}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPK,3190,Hs.522257,ENST00000435158,THC2570187,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0000790(nuclear chromatin)|GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding)|GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription)|GO:0003677(DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006396(RNA processing)|GO:0007165(signal transduction)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0010988(regulation of low-density lipoprotein particle clearance)|GO:0030529(ribonucleoprotein complex)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0044419(interspecies interaction between organisms)|GO:0045716(positive regulation of low-density lipoprotein particle receptor biosynthetic process)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048260(positive regulation of receptor-mediated endocytosis)|GO:0071013(catalytic step 2 spliceosome)|GO:0072369(regulation of lipid transport by positive regulation of transcription from an RNA polymerase II promoter)","Homo sapiens heterogeneous nuclear ribonucleoprotein K (HNRNPK), transcript variant 1, mRNA [NM_002140]",chr9:86583500-86583441,hs|9q21.32,heterogeneous nuclear ribonucleoprotein K,TRUE
409_TPM1_7168,P09493,tropomyosin alpha-1 chain (alpha-tropomyosin) (tropomyosin-1),TPM1 C15orf13 TMSA,284,"function: binds to actin filaments in muscle and non-muscle cells (pubmed:23170982). plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (pubmed:23170982). smooth muscle contraction is regulated by interaction with caldesmon. in non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.","subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:p04692}. note=associates with f-actin stress fibers. {eco:0000250|uniprotkb:p04692}.","TISSUE SPECIFICITY: Detected in primary breast cancer tissues but undetectable in normal breast tissues in Sudanese patients. Isoform 1 is expressed in adult and fetal skeletal muscle and cardiac tissues, with higher expression levels in the cardiac tissues. Isoform 10 is expressed in adult and fetal cardiac tissues, but not in skeletal muscle. {ECO:0000269|PubMed:15249230, ECO:0000269|Ref.15}.","DISEASE: Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:7898523, ECO:0000269|PubMed:8205619, ECO:0000269|PubMed:8523464, ECO:0000269|PubMed:9822100}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11273725}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Left ventricular non-compaction 9 (LVNC9) [MIM:611878]: A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC9 is an autosomal dominant condition. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TPM1,7168,Hs.133892,ENST00000404484,NP1211088,GO:0001725(stress fiber)|GO:0003065(positive regulation of heart rate by epinephrine)|GO:0003779(actin binding)|GO:0005200(structural constituent of cytoskeleton)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005862(muscle thin filament tropomyosin)|GO:0006928(cellular component movement)|GO:0006936(muscle contraction)|GO:0006937(regulation of muscle contraction)|GO:0007010(cytoskeleton organization)|GO:0008016(regulation of heart contraction)|GO:0008307(structural constituent of muscle)|GO:0015629(actin cytoskeleton)|GO:0030017(sarcomere)|GO:0030049(muscle filament sliding)|GO:0030336(negative regulation of cell migration)|GO:0031529(ruffle organization)|GO:0032059(bleb)|GO:0032587(ruffle membrane)|GO:0032781(positive regulation of ATPase activity)|GO:0034614(cellular response to reactive oxygen species)|GO:0042060(wound healing)|GO:0045214(sarcomere organization)|GO:0045785(positive regulation of cell adhesion)|GO:0051496(positive regulation of stress fiber assembly)|GO:0055010(ventricular cardiac muscle tissue morphogenesis)|GO:0060048(cardiac muscle contraction),"Homo sapiens tropomyosin 1 (alpha) (TPM1), transcript variant 3, mRNA [NM_001018004]",chr15:63363982-63364041,hs|15q22.2,tropomyosin 1 (alpha),TRUE
41_NKX3-1_4824,Q99801,homeobox protein nkx-3.1 (homeobox protein nk-3 homolog a),NKX3-1 NKX3.1 NKX3A,234,"function: transcription factor, which binds preferentially the consensus sequence 5'-taagt[ag]-3' and can behave as a transcriptional repressor. plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of pc-3 prostate cancer cells. {eco:0000269|pubmed:19462257}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00108, eco:0000269|pubmed:11137288}.","TISSUE SPECIFICITY: Highly expressed in the prostate and, at a lower level, in the testis. {ECO:0000269|PubMed:9226374, ECO:0000269|PubMed:9537602}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NKX3-1,4824,Hs.55999,ENST00000380871,THC2470662,"GO:0000976(transcription regulatory region sequence-specific DNA binding)|GO:0000988(protein binding transcription factor activity)|GO:0001047(core promoter binding)|GO:0001756(somitogenesis)|GO:0001934(positive regulation of protein phosphorylation)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0004882(androgen receptor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006919(activation of caspase activity)|GO:0007275(multicellular organismal development)|GO:0007431(salivary gland development)|GO:0007507(heart development)|GO:0008134(transcription factor binding)|GO:0008284(positive regulation of cell proliferation)|GO:0008285(negative regulation of cell proliferation)|GO:0008633(activation of pro-apoptotic gene products)|GO:0008656(caspase activator activity)|GO:0010628(positive regulation of gene expression)|GO:0010629(negative regulation of gene expression)|GO:0010942(positive regulation of cell death)|GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade)|GO:0030284(estrogen receptor activity)|GO:0030295(protein kinase activator activity)|GO:0030331(estrogen receptor binding)|GO:0030520(estrogen receptor signaling pathway)|GO:0030521(androgen receptor signaling pathway)|GO:0033574(response to testosterone stimulus)|GO:0035690(cellular response to drug)|GO:0042826(histone deacetylase binding)|GO:0043280(positive regulation of caspase activity)|GO:0043491(protein kinase B signaling cascade)|GO:0043565(sequence-specific DNA binding)|GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway)|GO:0043621(protein self-association)|GO:0044212(transcription regulatory region DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045930(negative regulation of mitotic cell cycle)|GO:0045931(positive regulation of mitotic cell cycle)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048754(branching morphogenesis of a tube)|GO:0050680(negative regulation of epithelial cell proliferation)|GO:0051781(positive regulation of cell division)|GO:0060037(pharyngeal system development)|GO:0060442(branching involved in prostate gland morphogenesis)|GO:0060664(epithelial cell proliferation involved in salivary gland morphogenesis)|GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development)|GO:0071347(cellular response to interleukin-1)|GO:0071356(cellular response to tumor necrosis factor)|GO:0071383(cellular response to steroid hormone stimulus)|GO:0071456(cellular response to hypoxia)|GO:0071850(mitotic cell cycle arrest)|GO:0071899(negative regulation of estrogen receptor binding)|GO:2000500(positive regulation of induction of apoptosis in response to chemical stimulus)","Homo sapiens NK3 homeobox 1 (NKX3-1), mRNA [NM_006167]",chr8:23536318-23536259,hs|8p21.2,NK3 homeobox 1,TRUE
410_C6orf115_58527,Q9P1F3,costars family protein abracl (abra c-terminal-like protein),ABRACL C6orf115 HSPC280 PRO2013,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C6orf115,58527,Hs.600861,ENST00000367660,THC2463611,NA,"Homo sapiens chromosome 6 open reading frame 115 (C6orf115), mRNA [NM_021243]",chr6:139364343-139364402,hs|6q24.1,chromosome 6 open reading frame 115,TRUE
411_PPDPF_79144,Q9H3Y8,pancreatic progenitor cell differentiation and proliferation factor (exocrine differentiation and proliferation factor),PPDPF C20orf149 EXPDF,114,function: probable regulator of exocrine pancreas development. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PPDPF,79144,Hs.79625,ENST00000370178,THC2580274,GO:0007275(multicellular organismal development)|GO:0030154(cell differentiation),"Homo sapiens pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) (PPDPF), mRNA [NM_024299]",chr20:62153440-62153499,hs|20q13.33,pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish),TRUE
412_RPS4Y1_6192,P22090,"40s ribosomal protein s4, y isoform 1 (small ribosomal subunit protein es4)",RPS4Y1 RPS4Y PRO2646,263,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS4Y1,6192,Hs.282376,ENST00000430575,THC2509923,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0005844(polysome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0007275(multicellular organismal development)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S4, Y-linked 1 (RPS4Y1), mRNA [NM_001008]",chrY:2722790-2733165,hs|Yp11.31,"ribosomal protein S4, Y-linked 1",TRUE
414_DSTN_11034,P60981,destrin (actin-depolymerizing factor) (adf),DSTN ACTDP DSN,165,function: actin-depolymerizing protein. severs actin filaments (f-actin) and binds to actin monomers (g-actin). acts in a ph-independent manner. {eco:0000269|pubmed:11812157}.,NA,TISSUE SPECIFICITY: Widely distributed in various tissues.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,DSTN,11034,Hs.304192,ENST00000543261,THC2479900,GO:0000910(cytokinesis)|GO:0003779(actin binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0006928(cellular component movement)|GO:0008154(actin polymerization or depolymerization)|GO:0015629(actin cytoskeleton)|GO:0030836(positive regulation of actin filament depolymerization)|GO:0030864(cortical actin cytoskeleton)|GO:0051014(actin filament severing),"Homo sapiens destrin (actin depolymerizing factor) (DSTN), transcript variant 2, mRNA [NM_001011546]",chr20:17588567-17588626,hs|20p12.1,destrin (actin depolymerizing factor),TRUE
415_EPAS1_2034,Q99814,endothelial pas domain-containing protein 1 (epas-1) (basic-helix-loop-helix-pas protein mop2) (class e basic helix-loop-helix protein 73) (bhlhe73) (hif-1-alpha-like factor) (hlf) (hypoxia-inducible factor 2-alpha) (hif-2-alpha) (hif2-alpha) (member of pas protein 2) (pas domain-containing protein 2),EPAS1 BHLHE73 HIF2A MOP2 PASD2,870,"function: transcription factor involved in the induction of oxygen regulated genes. heterodimerizes with arnt; heterodimer binds to core dna sequence 5'-tacgtg-3' within the hypoxia response element (hre) of target gene promoters (by similarity). regulates the vascular endothelial growth factor (vegf) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. may also play a role in the formation of the endothelium that gives rise to the blood brain barrier. potent activator of the tie-2 tyrosine kinase expression. activation requires recruitment of transcriptional coactivators such as crebbp and probably ep300. interaction with redox regulatory protein apex seems to activate ctad (by similarity). {eco:0000250, eco:0000250|uniprotkb:p97481}.","subcellular location: nucleus {eco:0000250|uniprotkb:p97481, eco:0000255|prosite-prorule:pru00981}. nucleus speckle {eco:0000250|uniprotkb:p97481}. note=colocalizes with hif3a in the nucleus and speckles. {eco:0000250|uniprotkb:p97481}.","TISSUE SPECIFICITY: Expressed in most tissues, with highest levels in placenta, lung and heart. Selectively expressed in endothelial cells.","DISEASE: Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]: An autosomal dominant disorder characterized by elevated serum hemoglobin and hematocrit, and normal platelet and leukocyte counts. {ECO:0000269|PubMed:18184961, ECO:0000269|PubMed:18378852, ECO:0000269|PubMed:19208626, ECO:0000269|PubMed:22367913}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,EPAS1,2034,Hs.468410,ENST00000466465,THC2470173,GO:0001525(angiogenesis)|GO:0001666(response to hypoxia)|GO:0001892(embryonic placenta development)|GO:0001974(blood vessel remodeling)|GO:0002027(regulation of heart rate)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0004871(signal transducer activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0005737(cytoplasm)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006979(response to oxidative stress)|GO:0007005(mitochondrion organization)|GO:0007165(signal transduction)|GO:0007275(multicellular organismal development)|GO:0007601(visual perception)|GO:0008134(transcription factor binding)|GO:0030097(hemopoiesis)|GO:0030154(cell differentiation)|GO:0030218(erythrocyte differentiation)|GO:0030324(lung development)|GO:0035035(histone acetyltransferase binding)|GO:0042415(norepinephrine metabolic process)|GO:0043129(surfactant homeostasis)|GO:0043565(sequence-specific DNA binding)|GO:0043619(regulation of transcription from RNA polymerase II promoter in response to oxidative stress)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046982(protein heterodimerization activity)|GO:0048469(cell maturation)|GO:0048625(myoblast cell fate commitment),"Homo sapiens endothelial PAS domain protein 1 (EPAS1), mRNA [NM_001430]",chr2:46613666-46613725,hs|2p21,endothelial PAS domain protein 1,TRUE
416_CCDC47_57003,Q96A33,coiled-coil domain-containing protein 47 (calumin),CCDC47 GK001 MSTP041 PSEC0077,483,"function: involved in the regulation of calcium ion homeostasis in the endoplasmic reticulum (pubmed:30401460). required for proper protein degradation via the erad pathway (pubmed:25009997). has an essential role in the maintenance of endoplasmic reticulum organization during embryogenesis (by similarity). {eco:0000250|uniprotkb:q9d024, eco:0000269|pubmed:25009997, eco:0000269|pubmed:30401460}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:30401460}. rough endoplasmic reticulum membrane {eco:0000250|uniprotkb:q9d024}.,NA,"DISEASE: Trichohepatoneurodevelopmental syndrome (THNS) [MIM:618268]: An autosomal recessive complex multisystem disorder characterized by woolly or coarse hair, liver dysfunction, pruritus, dysmorphic features, hypotonia, and global developmental delay. {ECO:0000269|PubMed:30401460}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CCDC47,57003,Hs.202011,ENST00000225726,THC2469550,GO:0005509(calcium ion binding)|GO:0005575(cellular_component)|GO:0005783(endoplasmic reticulum)|GO:0005792(microsome)|GO:0006983(ER overload response)|GO:0008150(biological_process)|GO:0009790(embryo development)|GO:0009791(post-embryonic development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0055074(calcium ion homeostasis),"Homo sapiens coiled-coil domain containing 47 (CCDC47), mRNA [NM_020198]",chr17:61822985-61822926,hs|17q23.3,coiled-coil domain containing 47,TRUE
417_PNISR_25957,Q8TF01,"arginine/serine-rich protein pnisr (pnn-interacting serine/arginine-rich protein) (sr-related protein) (sr-rich protein) (serine/arginine-rich-splicing regulatory protein 130) (srrp130) (splicing factor, arginine/serine-rich 130) (splicing factor, arginine/serine-rich 18)",PNISR C6orf111 SFRS18 SRRP130 HSPC261 HSPC306,805,NA,subcellular location: nucleus speckle {eco:0000269|pubmed:14578391}.,"TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, thymus, spleen, kidney, liver, placenta and leukocytes. {ECO:0000269|PubMed:14578391}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PNISR,25957,Hs.520287,ENST00000476159,THC2543757,GO:0005634(nucleus)|GO:0016607(nuclear speck),"Homo sapiens PNN-interacting serine/arginine-rich protein (PNISR), transcript variant 1, mRNA [NM_032870]",chr6:99850503-99850444,hs|6q16.2,PNN-interacting serine/arginine-rich protein,TRUE
418_ALDH2_217,P05091,"aldehyde dehydrogenase, mitochondrial (ec 1.2.1.3) (aldh class 2) (aldh-e2) (aldhi)",ALDH2 ALDM,517,NA,subcellular location: mitochondrion matrix.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,ALDH2,217,Hs.604551,ENST00000261733,NP1204885,GO:0004029(aldehyde dehydrogenase (NAD) activity)|GO:0004030(aldehyde dehydrogenase [NAD(P)+] activity)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0005975(carbohydrate metabolic process)|GO:0006066(alcohol metabolic process)|GO:0006069(ethanol oxidation)|GO:0006805(xenobiotic metabolic process)|GO:0007268(synaptic transmission)|GO:0009055(electron carrier activity)|GO:0016491(oxidoreductase activity)|GO:0042136(neurotransmitter biosynthetic process),"Homo sapiens aldehyde dehydrogenase 2 family (mitochondrial) (ALDH2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_000690]",chr12:112247691-112247750,hs|12q24.12,aldehyde dehydrogenase 2 family (mitochondrial),TRUE
419_HK2_3099,P52789,hexokinase-2 (ec 2.7.1.1) (hexokinase type ii) (hk ii) (hexokinase-b) (muscle form hexokinase),HK2,917,"function: catalyzes the phosphorylation of hexose, such as d-glucose and d-fructose, to hexose 6-phosphate (d-glucose 6-phosphate and d-fructose 6-phosphate, respectively) (pubmed:23185017, pubmed:26985301, pubmed:29298880). mediates the initial step of glycolysis by catalyzing phosphorylation of d-glucose to d-glucose 6-phosphate (pubmed:29298880). plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis (pubmed:18350175). {eco:0000269|pubmed:18350175, eco:0000269|pubmed:23185017, eco:0000269|pubmed:26985301, eco:0000269|pubmed:29298880}.","subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:18350175}; peripheral membrane protein {eco:0000305}. cytoplasm, cytosol {eco:0000269|pubmed:18350175}. note=the mitochondrial-binding peptide (mbp) region promotes association with the mitochondrial outer membrane (pubmed:29298880). the interaction with the mitochondrial outer membrane via the mitochondrial-binding peptide (mbp) region promotes higher stability of the protein (pubmed:29298880). release from the mitochondrial outer membrane into the cytosol induces permeability transition pore (ptp) opening and apoptosis (pubmed:18350175). {eco:0000269|pubmed:18350175, eco:0000269|pubmed:29298880}.",TISSUE SPECIFICITY: Predominant hexokinase isozyme expressed in insulin-responsive tissues such as skeletal muscle. {ECO:0000269|PubMed:8250948}.,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HK2,3099,Hs.591588,ENST00000290573,THC2461818,GO:0000166(nucleotide binding)|GO:0004396(hexokinase activity)|GO:0005524(ATP binding)|GO:0005536(glucose binding)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006096(glycolysis)|GO:0007595(lactation)|GO:0008637(apoptotic mitochondrial changes)|GO:0008645(hexose transport)|GO:0015758(glucose transport)|GO:0016020(membrane)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0046324(regulation of glucose import)|GO:0046835(carbohydrate phosphorylation)|GO:0055085(transmembrane transport),"Homo sapiens hexokinase 2 (HK2), mRNA [NM_000189]",chr2:75120331-75120390,hs|2p12,hexokinase 2,TRUE
42_RPL35_11224,P42766,60s ribosomal protein l35 (large ribosomal subunit protein ul29),RPL35,123,function: component of the large ribosomal subunit. {eco:0000305|pubmed:12962325}.,NA,NA,"DISEASE: Diamond-Blackfan anemia 19 (DBA19) [MIM:618312]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA19 inheritance is autosomal dominant. {ECO:0000269|PubMed:28280134}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL35,11224,Hs.182825,ENST00000348462,THC2567561,GO:0003729(mRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L35 (RPL35), mRNA [NM_007209]",chr9:127623708-127622495,hs|9q33.3,ribosomal protein L35,TRUE
420_NDUFB1_4707,O75438,nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (complex i-mnll) (ci-mnll) (nadh-ubiquinone oxidoreductase mnll subunit),NDUFB1,58,function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.,subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}; matrix side {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB1,4707,Hs.183435,ENST00000553666,THC2470501,"GO:0003954(NADH dehydrogenase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa (NDUFB1), nuclear gene encoding mitochondrial protein, mRNA [NM_004545]",chr14:92583912-92583853,hs|14q32.12,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa",TRUE
421_DNAJB2_3300,P25686,dnaj homolog subfamily b member 2 (heat shock 40 kda protein 3) (heat shock protein j1) (hsj-1),DNAJB2 HSJ1 HSPF3,324,"function: functions as a co-chaperone, regulating the substrate binding and activating the atpase activity of chaperones of the hsp70/heat shock protein 70 family (pubmed:7957263, pubmed:22219199). in parallel, also contributes to the ubiquitin-dependent proteasomal degradation of misfolded proteins (pubmed:15936278, pubmed:21625540). thereby, may regulate the aggregation and promote the functional recovery of misfolded proteins like htt, mc4r, prkn, rho and sod1 and be crucial for many biological processes (pubmed:12754272, pubmed:20889486, pubmed:21719532, pubmed:22396390, pubmed:24023695). isoform 1 which is localized to the endoplasmic reticulum membranes may specifically function in er-associated protein degradation of misfolded proteins (pubmed:15936278). {eco:0000269|pubmed:12754272, eco:0000269|pubmed:15936278, eco:0000269|pubmed:20889486, eco:0000269|pubmed:21625540, eco:0000269|pubmed:21719532, eco:0000269|pubmed:22219199, eco:0000269|pubmed:22396390, eco:0000269|pubmed:24023695, eco:0000269|pubmed:7957263}.","subcellular location: isoform 2: cytoplasm {eco:0000269|pubmed:12754272, eco:0000269|pubmed:21625540}. nucleus {eco:0000269|pubmed:12754272}.; subcellular location: isoform 1: endoplasmic reticulum membrane {eco:0000269|pubmed:12754272}; lipid-anchor {eco:0000269|pubmed:12754272}; cytoplasmic side {eco:0000269|pubmed:12754272}.","TISSUE SPECIFICITY: More abundantly expressed in neocortex, cerebellum, spinal cord and retina where it is expressed by neuronal cells (at protein level) (PubMed:1599432, PubMed:12754272). Detected at much lower level in non-neuronal tissues including kidney, lung, heart, skeletal muscle, spleen and testis (at protein level) (PubMed:12754272, PubMed:1599432). Isoform 1 is more abundant in neocortex and cerebellum compared to isoform 2 (at protein level) (PubMed:12754272). {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:1599432}.","DISEASE: Distal spinal muscular atrophy, autosomal recessive, 5 (DSMA5) [MIM:614881]: An autosomal recessive neurologic disorder characterized by young adult onset of slowly progressive distal muscle weakness and atrophy resulting in gait impairment and loss of reflexes due to impaired function of motor nerves. Sensation and cognition are not impaired. {ECO:0000269|PubMed:22522442, ECO:0000269|PubMed:24627108, ECO:0000269|PubMed:25274842}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DNAJB2,3300,Hs.77768,ENST00000477917,THC2680116,GO:0000502(proteasome complex)|GO:0005515(protein binding)|GO:0006457(protein folding)|GO:0006986(response to unfolded protein)|GO:0008285(negative regulation of cell proliferation)|GO:0016234(inclusion body)|GO:0030308(negative regulation of cell growth)|GO:0030433(ER-associated protein catabolic process)|GO:0030544(Hsp70 protein binding)|GO:0031072(heat shock protein binding)|GO:0031398(positive regulation of protein ubiquitination)|GO:0031593(polyubiquitin binding)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0051082(unfolded protein binding)|GO:0070628(proteasome binding)|GO:0090084(negative regulation of inclusion body assembly)|GO:0090086(negative regulation of protein deubiquitination),"Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 2 (DNAJB2), transcript variant 2, mRNA [NM_006736]",chr2:220151526-220151585,hs|2q35,"DnaJ (Hsp40) homolog, subfamily B, member 2",TRUE
422_EIF3C_8663,Q99613,eukaryotic translation initiation factor 3 subunit c (eif3c) (eukaryotic translation initiation factor 3 subunit 8) (eif3 p110),EIF3C EIF3S8,913,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17581632, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17581632). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000255|hamap-rule:mf_03002, eco:0000269|pubmed:17581632, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03002}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3C,8663,Hs.567374,ENST00000543862,THC2511417,GO:0003743(translation initiation factor activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit C (EIF3C), transcript variant 2, mRNA [NM_001037808]",chr16:28746857-28746916,hs|16p11.2,"eukaryotic translation initiation factor 3, subunit C",TRUE
423_KRT18_3875,P05783,"keratin, type i cytoskeletal 18 (cell proliferation-inducing gene 46 protein) (cytokeratin-18) (ck-18) (keratin-18) (k18)",KRT18 CYK18 PIG46,430,"function: involved in the uptake of thrombin-antithrombin complexes by hepatic cells (by similarity). when phosphorylated, plays a role in filament reorganization. involved in the delivery of mutated cftr to the plasma membrane. together with krt8, is involved in interleukin-6 (il-6)-mediated barrier protection. {eco:0000250, eco:0000269|pubmed:15529338, eco:0000269|pubmed:16424149, eco:0000269|pubmed:17213200, eco:0000269|pubmed:7523419, eco:0000269|pubmed:8522591, eco:0000269|pubmed:9298992, eco:0000269|pubmed:9524113}.","subcellular location: cytoplasm, perinuclear region. nucleus, nucleolus.","TISSUE SPECIFICITY: Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma. {ECO:0000269|PubMed:17213200, ECO:0000269|PubMed:2422083, ECO:0000269|PubMed:2434380, ECO:0000269|PubMed:2434381}.","DISEASE: Cirrhosis (CIRRH) [MIM:215600]: A liver disease characterized by severe panlobular liver-cell swelling with Mallory body formation, prominent pericellular fibrosis, and marked deposits of copper. Clinical features include abdomen swelling, jaundice and pulmonary hypertension. {ECO:0000269|PubMed:12724528, ECO:0000269|PubMed:9011570}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KRT18,3875,Hs.406013,ENST00000548496,THC2526743,GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005882(intermediate filament)|GO:0007049(cell cycle)|GO:0009653(anatomical structure morphogenesis)|GO:0033209(tumor necrosis factor-mediated signaling pathway)|GO:0034451(centriolar satellite)|GO:0043000(Golgi to plasma membrane CFTR protein transport)|GO:0043066(negative regulation of apoptosis)|GO:0044419(interspecies interaction between organisms)|GO:0045095(keratin filament)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens keratin 18 (KRT18), transcript variant 1, mRNA [NM_000224]",chr12:53346116-53346554,hs|12q13.13,keratin 18,TRUE
424_SHISA5_51246,Q8N114,protein shisa-5 (putative nf-kappa-b-activating protein 120) (scotin),SHISA5 SCOTIN PSEC0133,240,function: can induce apoptosis in a caspase-dependent manner and plays a role in p53/tp53-dependent apoptosis. {eco:0000269|pubmed:12135983}.,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12135983}; single-pass type i membrane protein {eco:0000269|pubmed:12135983}. nucleus membrane {eco:0000269|pubmed:12135983}.,NA,NA,NA,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SHISA5,51246,Hs.414579,ENST00000417962,THC2524614,GO:0004871(signal transducer activity)|GO:0005634(nucleus)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0007165(signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031965(nuclear membrane)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0050699(WW domain binding),"Homo sapiens shisa homolog 5 (Xenopus laevis) (SHISA5), mRNA [NM_016479]",chr3:48509336-48509277,hs|3p21.31,shisa homolog 5 (Xenopus laevis),TRUE
427_SURF4_6836,O15260,surfeit locus protein 4,SURF4 SURF-4,269,function: may play a role in the maintenance of the architecture of the endoplasmic reticulum-golgi intermediate compartment and of the golgi. {eco:0000269|pubmed:18287528}.,"subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:15308636, eco:0000269|pubmed:18287528}; multi-pass membrane protein {eco:0000255}. endoplasmic reticulum-golgi intermediate compartment membrane {eco:0000269|pubmed:18287528}; multi-pass membrane protein {eco:0000255}. golgi apparatus membrane {eco:0000269|pubmed:18287528}; multi-pass membrane protein {eco:0000255}. note=cycles between the endoplasmic reticulum and the golgi. {eco:0000269|pubmed:18287528}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SURF4,6836,Hs.512465,ENST00000371989,THC2465161,GO:0000139(Golgi membrane)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0007030(Golgi organization)|GO:0010638(positive regulation of organelle organization)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0032527(protein exit from endoplasmic reticulum)|GO:0033116(ER-Golgi intermediate compartment membrane)|GO:0034498(early endosome to Golgi transport),"Homo sapiens surfeit 4 (SURF4), mRNA [NM_033161]",chr9:136228402-136228343,hs|9q34.2,surfeit 4,TRUE
428_SPCS2_9789,Q15005,signal peptidase complex subunit 2 (ec 3.4.-.-) (microsomal signal peptidase 25 kda subunit) (spase 25 kda subunit),SPCS2 KIAA0102 SPC25,226,function: component of the microsomal signal peptidase complex which removes signal peptides from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum. {eco:0000250}.,subcellular location: microsome membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}. endoplasmic reticulum membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SPCS2,9789,Hs.282700,ENST00000543748,THC2568951,GO:0005783(endoplasmic reticulum)|GO:0005787(signal peptidase complex)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006112(energy reserve metabolic process)|GO:0006465(signal peptide processing)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0050796(regulation of insulin secretion),"Homo sapiens signal peptidase complex subunit 2 homolog (S. cerevisiae) (SPCS2), mRNA [NM_014752]",chr11:74688489-74688548,hs|11q13.4,signal peptidase complex subunit 2 homolog (S. cerevisiae),TRUE
429_CYB561_1534,P49447,cytochrome b561 (cytochrome b-561),CYB561,251,function: secretory vesicle-specific electron transport protein.,"subcellular location: cytoplasmic vesicle, secretory vesicle membrane {eco:0000250|uniprotkb:p10897}; multi-pass membrane protein. note=secretory vesicle containing catecholamines and amidated peptides. {eco:0000250|uniprotkb:p10897}.","TISSUE SPECIFICITY: Expressed in many tissues, in particular the brain especially in the cortex and hippocampus. {ECO:0000269|PubMed:29343526}.","DISEASE: Orthostatic hypotension 2 (ORTHYP2) [MIM:618182]: An autosomal recessive disorder characterized by severe orthostatic hypotension apparent from infancy or early childhood, low plasma and urinary levels of norepinephrine and epinephrine, and episodic hypoglycemia. Some patients may also have renal dysfunction and reduced life expectancy. Orthostatic hypotension, also known as postural hypotension, is a finding defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure occurring 3 minutes after a person has risen from supine to standing. Symptoms include dizziness, blurred vision, and sometimes syncope. {ECO:0000269|PubMed:29343526}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYB561,1534,Hs.355264,ENST00000392976,NP1155110,GO:0000293(ferric-chelate reductase activity)|GO:0004128(cytochrome-b5 reductase activity)|GO:0005887(integral to plasma membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0006810(transport)|GO:0016020(membrane)|GO:0022900(electron transport chain)|GO:0046872(metal ion binding),"Homo sapiens cytochrome b-561 (CYB561), transcript variant 2, mRNA [NM_001017916]",chr17:61509928-61509869,hs|17q23.3,cytochrome b-561,TRUE
43_PXN_5829,P49023,paxillin,PXN,591,function: cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).,"subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:20489202}. cell junction, focal adhesion {eco:0000269|pubmed:20489202, eco:0000269|pubmed:23128389}. cytoplasm, cell cortex {eco:0000250|uniprotkb:q8vi36}. note=colocalizes with integrins at the cell periphery. colocalize with pxn to membrane ruffles and the leading edge of migrating cells (pubmed:23128389). {eco:0000250, eco:0000269|pubmed:23128389}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,PXN,5829,Hs.446336,NA,THC2476357,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005875(microtubule associated complex)|GO:0005886(plasma membrane)|GO:0005925(focal adhesion)|GO:0006936(muscle contraction)|GO:0007155(cell adhesion)|GO:0007160(cell-matrix adhesion)|GO:0007165(signal transduction)|GO:0007172(signal complex assembly)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0008013(beta-catenin binding)|GO:0008270(zinc ion binding)|GO:0017166(vinculin binding)|GO:0030027(lamellipodium)|GO:0030054(cell junction)|GO:0034329(cell junction assembly)|GO:0034614(cellular response to reactive oxygen species)|GO:0046872(metal ion binding)|GO:0060396(growth hormone receptor signaling pathway),"Homo sapiens paxillin, mRNA (cDNA clone IMAGE:6252827), complete cds. [BC052611]",chr12:120656057-120655998,hs|12q24.23,paxillin,TRUE
430_NPC2_10577,P61916,npc intracellular cholesterol transporter 2 (epididymal secretory protein e1) (human epididymis-specific protein 1) (he1) (niemann-pick disease type c2 protein),NPC2 HE1,151,"function: intracellular cholesterol transporter which acts in concert with npc1 and plays an important role in the egress of cholesterol from the lysosomal compartment (pubmed:17018531, pubmed:11125141, pubmed:18772377, pubmed:29580834, pubmed:15937921). unesterified cholesterol that has been released from ldls in the lumen of the late endosomes/lysosomes is transferred by npc2 to the cholesterol-binding pocket in the n-terminal domain of npc1 (pubmed:17018531, pubmed:18772377, pubmed:27238017). may bind and mobilize cholesterol that is associated with membranes (pubmed:18823126). npc2 binds cholesterol with a 1:1 stoichiometry (pubmed:17018531). can bind a variety of sterols, including lathosterol, desmosterol and the plant sterols stigmasterol and beta-sitosterol (pubmed:17018531). the secreted form of ncp2 regulates biliary cholesterol secretion via stimulation of abcg5/abcg8-mediated cholesterol transport (by similarity). {eco:0000250|uniprotkb:q9z0j0, eco:0000269|pubmed:11125141, eco:0000269|pubmed:15937921, eco:0000269|pubmed:17018531, eco:0000269|pubmed:18772377, eco:0000269|pubmed:18823126, eco:0000269|pubmed:27238017, eco:0000269|pubmed:29580834}.","subcellular location: secreted {eco:0000269|pubmed:11125141, eco:0000269|pubmed:15937921, eco:0000269|pubmed:19723497, eco:0000269|pubmed:21315718}. endoplasmic reticulum {eco:0000269|pubmed:19723497}. lysosome {eco:0000269|pubmed:15937921, eco:0000269|pubmed:19723497, eco:0000305|pubmed:11125141}. note=interaction with cell-surface m6pr mediates endocytosis and targeting to lysosomes. {eco:0000305|pubmed:11125141}.","TISSUE SPECIFICITY: Detected in gallbladder bile (PubMed:21315718). Detected in fibroblasts, kidney, liver, spleen, small intestine, placenta and testis (at protein level) (PubMed:11125141). Epididymis. {ECO:0000269|PubMed:11125141, ECO:0000269|PubMed:19664597, ECO:0000269|PubMed:21315718}.","DISEASE: Niemann-Pick disease C2 (NPC2) [MIM:607625]: A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C2 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. {ECO:0000269|PubMed:11125141, ECO:0000269|PubMed:11567215, ECO:0000269|PubMed:12447927, ECO:0000269|PubMed:12955717, ECO:0000269|PubMed:15937921, ECO:0000269|PubMed:16126423, ECO:0000269|PubMed:18772377}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NPC2,10577,Hs.433222,ENST00000554482,THC2533612,GO:0005576(extracellular region)|GO:0005764(lysosome)|GO:0009615(response to virus)|GO:0015485(cholesterol binding)|GO:0015914(phospholipid transport)|GO:0019747(regulation of isoprenoid metabolic process)|GO:0019899(enzyme binding)|GO:0030301(cholesterol transport)|GO:0032366(intracellular sterol transport)|GO:0032367(intracellular cholesterol transport)|GO:0033344(cholesterol efflux)|GO:0042632(cholesterol homeostasis)|GO:0046836(glycolipid transport),"Homo sapiens Niemann-Pick disease, type C2 (NPC2), mRNA [NM_006432]",chr14:74946813-74946754,hs|14q24.3,"Niemann-Pick disease, type C2",TRUE
431_ACTG1_71,P63261,"actin, cytoplasmic 2 (gamma-actin) [cleaved into: actin, cytoplasmic 2, n-terminally processed]",ACTG1 ACTG,375,function: actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {eco:0000305|pubmed:29581253}.,"subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:28493397}.",NA,"DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959, ECO:0000269|PubMed:22938506, ECO:0000269|PubMed:25388789}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior-predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in ACTG1 has been found in a patient with isolated coloboma, a defect of the eye characterized by the absence of ocular structures due to abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Isolated colobomas may be associated with an abnormally small eye (microphthalmia) or small cornea. {ECO:0000269|PubMed:28493397}.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ACTG1,71,Hs.514581,ENST00000331925,THC2470232,GO:0000166(nucleotide binding)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006928(cellular component movement)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0015629(actin cytoskeleton)|GO:0019901(protein kinase binding)|GO:0030016(myofibril)|GO:0030424(axon)|GO:0031941(filamentous actin)|GO:0034329(cell junction assembly)|GO:0034332(adherens junction organization)|GO:0042802(identical protein binding)|GO:0045214(sarcomere organization)|GO:0045216(cell-cell junction organization)|GO:0051592(response to calcium ion),"Homo sapiens actin, gamma 1 (ACTG1), transcript variant 2, mRNA [NM_001614]",chr17:79477064-79477014,hs|17q25.3,"actin, gamma 1",TRUE
432_ATP5G3_518,P48201,"atp synthase f(0) complex subunit c3, mitochondrial (atp synthase lipid-binding protein) (atp synthase membrane subunit c locus 3) (atp synthase proteolipid p3) (atp synthase proton-transporting mitochondrial f(0) complex subunit c3) (atpase protein 9) (atpase subunit c)",ATP5MC3 ATP5G3,142,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain. a homomeric c-ring of probably 10 subunits is part of the complex rotary element.",subcellular location: mitochondrion membrane; multi-pass membrane protein.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5G3,518,Hs.429,ENST00000497075,THC2494518,"GO:0005215(transporter activity)|GO:0005739(mitochondrion)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0007568(aging)|GO:0008289(lipid binding)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0015986(ATP synthesis coupled proton transport)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031966(mitochondrial membrane)|GO:0045263(proton-transporting ATP synthase complex, coupling factor F(o))|GO:0045471(response to ethanol)","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) (ATP5G3), nuclear gene encoding mitochondrial protein, transcript variant 3, mRNA [NM_001002258]",chr2:176043073-176043014,hs|2q31.1,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)",TRUE
433_CANX_821,P27824,calnexin (ip90) (major histocompatibility complex class i antigen-binding protein p88) (p90),CANX,592,"function: calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. it may act in assisting protein assembly and/or in the retention within the er of unassembled protein subunits. it seems to play a major role in the quality control apparatus of the er by the retention of incorrectly folded proteins. associated with partial t-cell antigen receptor complexes that escape the er of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. additionally it may play a role in receptor-mediated endocytosis at the synapse.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:22314232}; single-pass type i membrane protein {eco:0000255}. endoplasmic reticulum {eco:0000269|pubmed:22314232}. melanosome {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:12643545, pubmed:17081065). the palmitoylated form preferentially localizes to the perinuclear rough er (pubmed:22314232). {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065, eco:0000269|pubmed:22314232}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CANX,821,Hs.567968,ENST00000247461,NP852722,GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005529(sugar binding)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005789(endoplasmic reticulum membrane)|GO:0006457(protein folding)|GO:0009306(protein secretion)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0042470(melanosome)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0071556(integral to lumenal side of endoplasmic reticulum membrane),"Homo sapiens calnexin (CANX), transcript variant 1, mRNA [NM_001746]",chr5:179156908-179156967,hs|5q35.3,calnexin,TRUE
434_HNRNPA1_3178,P09651,"heterogeneous nuclear ribonucleoprotein a1 (hnrnp a1) (helix-destabilizing protein) (single-strand rna-binding protein) (hnrnp core protein a1) [cleaved into: heterogeneous nuclear ribonucleoprotein a1, n-terminally processed]",HNRNPA1 HNRPA1,372,"function: involved in the packaging of pre-mrna into hnrnp particles, transport of poly(a) mrna from the nucleus to the cytoplasm and may modulate splice site selection (pubmed:17371836). may bind to specific mirna hairpins (pubmed:28431233). binds to the ires and thereby inhibits the translation of the apoptosis protease activating factor apaf1 (pubmed:31498791). {eco:0000269|pubmed:17371836, eco:0000269|pubmed:28431233, eco:0000269|pubmed:31498791}.; function: (microbial infection) may play a role in hcv rna replication. {eco:0000269|pubmed:17229681}.; function: (microbial infection) cleavage by enterovirus 71 protease 3c results in increased translation of apoptosis protease activating factor apaf1, leading to apoptosis. {eco:0000269|pubmed:17229681}.","subcellular location: nucleus {eco:0000269|pubmed:17289661, eco:0000269|pubmed:27694260}. cytoplasm {eco:0000269|pubmed:17289661}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas. shuttles continuously between the nucleus and the cytoplasm along with mrna. component of ribonucleosomes (pubmed:17289661). {eco:0000269|pubmed:17289661, eco:0000269|pubmed:27694260}.; subcellular location: cytoplasm {eco:0000269|pubmed:17229681}. note=(microbial infection) in the course of viral infection, colocalizes with hcv ns5b at speckles in the cytoplasm in a hcv-replication dependent manner. {eco:0000269|pubmed:17229681}.",NA,"DISEASE: Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 (IBMPFD3) [MIM:615424]: An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance. {ECO:0000269|PubMed:23455423}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:23455423, ECO:0000269|PubMed:27694260}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPA1,3178,Hs.546261,ENST00000340913,NP1190980,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003697(single-stranded DNA binding)|GO:0003723(RNA binding)|GO:0003727(single-stranded RNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006397(mRNA processing)|GO:0006405(RNA export from nucleus)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0030529(ribonucleoprotein complex)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0044419(interspecies interaction between organisms)|GO:0051028(mRNA transport)|GO:0051168(nuclear export)|GO:0051170(nuclear import)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), transcript variant 2, mRNA [NM_031157]",chr12:54678844-54678903,hs|12q13.13,heterogeneous nuclear ribonucleoprotein A1,TRUE
435_ZNF24_7572,P17028,zinc finger protein 24 (retinoic acid suppression protein a) (rsg-a) (zinc finger and scan domain-containing protein 3) (zinc finger protein 191) (zinc finger protein kox17),ZNF24 KOX17 ZNF191 ZSCAN3,368,"function: transcription factor required for myelination of differentiated oligodendrocytes. required for the conversion of oligodendrocytes from the premyelinating to the myelinating state. in the developing central nervous system (cns), involved in the maintenance in the progenitor stage by promoting the cell cycle. specifically binds to the 5'-tcat-3' dna sequence (by similarity). has transcription repressor activity in vitro. {eco:0000250, eco:0000269|pubmed:10585455}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00187, eco:0000269|pubmed:24224020}.",TISSUE SPECIFICITY: Expressed in many tissues except in heart.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,ZNF24,7572,Hs.514802,ENST00000399061,THC2461836,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0008270(zinc ion binding)|GO:0016032(viral reproduction)|GO:0042552(myelination)|GO:0043565(sequence-specific DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 24 (ZNF24), mRNA [NM_006965]",chr18:32917307-32917248,hs|18q12.2,zinc finger protein 24,TRUE
436_PRAC_84366,Q96KF2,"small nuclear protein prac1 (prostate cancer susceptibility candidate protein 1) (prostate, rectum and colon expressed gene protein)",PRAC1 C17orf92 PRAC,57,NA,subcellular location: nucleus {eco:0000269|pubmed:11340635}.,"TISSUE SPECIFICITY: Highly expressed in prostate, rectum, and distal colon, and weakly expressed in bladder. Expressed in prostate cancer cell lines. {ECO:0000269|PubMed:11340635}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PRAC,84366,Hs.116467,ENST00000290294,THC2476573,GO:0005634(nucleus),"Homo sapiens prostate cancer susceptibility candidate (PRAC), mRNA [NM_032391]",chr17:46799206-46799147,hs|17q21.32,prostate cancer susceptibility candidate,TRUE
437_PRR13_54458,Q9NZ81,proline-rich protein 13 (taxane-resistance protein),PRR13 TXR1 BM-041,148,function: negatively regulates tsp1 expression at the level of transcription. this down-regulation was shown to reduce taxane-induced apoptosis. {eco:0000269|pubmed:16847352}.,subcellular location: nucleus {eco:0000269|pubmed:16847352}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRR13,54458,Hs.426359,ENST00000429243,THC2469385,"GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens proline rich 13 (PRR13), transcript variant 3, mRNA [NM_001005354]",chr12:53840341-53840400,hs|12q13.13,proline rich 13,TRUE
438_AHCY_191,P23526,adenosylhomocysteinase (adohcyase) (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase),AHCY SAHH,432,function: adenosylhomocysteine is a competitive inhibitor of s-adenosyl-l-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine. {eco:0000269|pubmed:12590576}.,subcellular location: cytoplasm {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.,NA,"DISEASE: Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752]: A metabolic disorder characterized by hypermethioninemia associated with failure to thrive, mental and motor retardation, facial dysmorphism with abnormal hair and teeth, and myocardiopathy. {ECO:0000269|PubMed:15024124, ECO:0000269|PubMed:16736098, ECO:0000269|PubMed:19177456, ECO:0000269|PubMed:20852937}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AHCY,191,Hs.388004,ENST00000538132,THC2465429,GO:0004013(adenosylhomocysteinase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006730(one-carbon metabolic process)|GO:0006805(xenobiotic metabolic process)|GO:0016787(hydrolase activity)|GO:0032259(methylation)|GO:0042470(melanosome),"Homo sapiens adenosylhomocysteinase (AHCY), transcript variant 1, mRNA [NM_000687]",chr20:32868180-32868121,hs|20q11.22,adenosylhomocysteinase,TRUE
439_TAX1BP1_8887,Q86VP1,tax1-binding protein 1 (traf6-binding protein),TAX1BP1 T6BP PRO0105,789,"function: inhibits tnf-induced apoptosis by mediating the tnfaip3 anti-apoptotic activity. degraded by caspase-3-like family proteins upon tnf-induced apoptosis. may also play a role in the pro-inflammatory cytokine il-1 signaling cascade. {eco:0000269|pubmed:10435631, eco:0000269|pubmed:10920205}.",NA,TISSUE SPECIFICITY: Expressed in all tissues tested.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TAX1BP1,8887,Hs.34576,ENST00000416801,THC2549435,GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0008270(zinc ion binding)|GO:0019900(kinase binding)|GO:0032088(negative regulation of NF-kappaB transcription factor activity)|GO:0032480(negative regulation of type I interferon production)|GO:0045087(innate immune response),"Homo sapiens Tax1 (human T-cell leukemia virus type I) binding protein 1 (TAX1BP1), transcript variant 1, mRNA [NM_006024]",chr7:27867426-27868292,hs|7p15.2,Tax1 (human T-cell leukemia virus type I) binding protein 1,TRUE
44_RPLP1_6176,P05386,60s acidic ribosomal protein p1 (large ribosomal subunit protein p1),RPLP1 RRP1,114,function: plays an important role in the elongation step of protein synthesis.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPLP1,6176,Hs.356502,ENST00000488122,THC2465651,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein, large, P1 (RPLP1), transcript variant 1, mRNA [NM_001003]",chr15:69747814-69747873,hs|15q23,"ribosomal protein, large, P1",TRUE
440_NOP58_51602,Q9Y2X3,nucleolar protein 58 (nucleolar protein 5),NOP58 NOL5 NOP5 HSPC120,529,"function: required for 60s ribosomal subunit biogenesis (by similarity). core component of box c/d small nucleolar ribonucleoprotein (snornp) particles. required for the biogenesis of box c/d snornas such as u3, u8 and u14 snornas. {eco:0000250, eco:0000269|pubmed:15574333, eco:0000269|pubmed:17636026, eco:0000269|pubmed:19620283}.","subcellular location: nucleus, nucleolus. nucleus, nucleoplasm {eco:0000305}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NOP58,51602,Hs.471104,ENST00000478508,THC2537671,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005732(small nucleolar ribonucleoprotein complex)|GO:0005737(cytoplasm)|GO:0006364(rRNA processing)|GO:0006608(snRNP protein import into nucleus)|GO:0015030(Cajal body)|GO:0016049(cell growth)|GO:0030515(snoRNA binding)|GO:0031428(box C/D snoRNP complex)|GO:0070761(pre-snoRNP complex),"Homo sapiens NOP58 ribonucleoprotein homolog (yeast) (NOP58), mRNA [NM_015934]",chr2:203167727-203168114,hs|2q33.1,NOP58 ribonucleoprotein homolog (yeast),TRUE
441_NSUN5P2_260294,Q63ZY6,putative methyltransferase nsun5c (ec 2.1.1.-) (nol1/nop2/sun domain family member 5c) (williams-beuren syndrome chromosomal region 20c protein),NSUN5P2 NSUN5C WBSCR20B WBSCR20C,315,function: may have s-adenosyl-l-methionine-dependent methyl-transferase activity. {eco:0000305}.,NA,"TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11978965, ECO:0000269|PubMed:12073013}.","DISEASE: Note=NSUN5C is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,NSUN5P2,260294,Hs.510927,ENST00000444583,THC2478748,GO:0008168(methyltransferase activity)|GO:0016740(transferase activity),"Homo sapiens NOP2/Sun domain family, member 5 pseudogene 2 (NSUN5P2), non-coding RNA [NR_033323]",chr7:72418889-72418830,hs|7q11.23,"NOP2/Sun domain family, member 5 pseudogene 2",TRUE
442_PNRC1_10957,Q12796,proline-rich nuclear receptor coactivator 1 (proline-rich protein 2) (protein b4-2),PNRC1 PROL2,327,function: nuclear receptor coactivator. may play a role in signal transduction. {eco:0000269|pubmed:10894149}.,subcellular location: nucleus {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in liver, lung, fat and NK/T cells. {ECO:0000269|PubMed:11574675}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PNRC1,10957,Hs.75969,ENST00000336032,THC2506301,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens proline-rich nuclear receptor coactivator 1 (PNRC1), mRNA [NM_006813]",chr6:89794426-89794485,hs|6q15,proline-rich nuclear receptor coactivator 1,TRUE
443_BMPR1B_658,O00238,bone morphogenetic protein receptor type-1b (bmp type-1b receptor) (bmpr-1b) (ec 2.7.11.30) (cd antigen cdw293),BMPR1B,502,"function: on ligand binding, forms a receptor complex consisting of two type ii and two type i transmembrane serine/threonine kinases. type ii receptors phosphorylate and activate type i receptors which autophosphorylate, then bind and activate smad transcriptional regulators. receptor for bmp7/op-1 and gdf5. positively regulates chondrocyte differentiation through gdf5 interaction. {eco:0000250|uniprotkb:p36898}.",subcellular location: cell membrane {eco:0000250|uniprotkb:p36898}. membrane; single-pass type i membrane protein.,NA,"DISEASE: Acromesomelic dysplasia, Demirhan type (AMDD) [MIM:609441]: A form of chondrodysplasia. Acromesomelic chondrodysplasias are rare hereditary skeletal disorders characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMDD inheritance is autosomal recessive. {ECO:0000269|PubMed:15805157, ECO:0000269|PubMed:24129431, ECO:0000269|PubMed:26105076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly A2 (BDA2) [MIM:112600]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. In brachydactyly type A2 shortening of the middle phalanges is confined to the index finger and the second toe, all other digits being more or less normal. Because of a rhomboid or triangular shape of the affected middle phalanx, the end of the second finger usually deviates radially. {ECO:0000269|PubMed:14523231, ECO:0000269|PubMed:16957682}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly A1, D (BDA1D) [MIM:616849]: A form of brachydactyly type A1. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type A1 is characterized by middle phalanges of all the digits rudimentary or fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are short. BDA1D inheritance is autosomal dominant. {ECO:0000269|PubMed:25758993}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BMPR1B,658,Hs.598475,ENST00000515059,THC2708803,"GO:0000166(nucleotide binding)|GO:0001501(skeletal system development)|GO:0001502(cartilage condensation)|GO:0001550(ovarian cumulus expansion)|GO:0001654(eye development)|GO:0004674(protein serine/threonine kinase activity)|GO:0004675(transmembrane receptor protein serine/threonine kinase activity)|GO:0004702(receptor signaling protein serine/threonine kinase activity)|GO:0004872(receptor activity)|GO:0005024(transforming growth factor beta receptor activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006468(protein phosphorylation)|GO:0016362(activin receptor activity, type II)|GO:0030501(positive regulation of bone mineralization)|GO:0030509(BMP signaling pathway)|GO:0035108(limb morphogenesis)|GO:0042698(ovulation cycle)|GO:0043235(receptor complex)|GO:0045597(positive regulation of cell differentiation)|GO:0045669(positive regulation of osteoblast differentiation)|GO:0046332(SMAD binding)|GO:0046872(metal ion binding)","Homo sapiens bone morphogenetic protein receptor, type IB (BMPR1B), mRNA [NM_001203]",chr4:96077721-96077780,hs|4q22.3,"bone morphogenetic protein receptor, type IB",TRUE
444_CBS_875,P35520,cystathionine beta-synthase (ec 4.2.1.22) (beta-thionase) (serine sulfhydrase),CBS,551,"function: hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of l-serine is displaced by l-homocysteine in a beta-replacement reaction to form l-cystathionine, the precursor of l-cysteine. this catabolic route allows the elimination of l-methionine and the toxic metabolite l-homocysteine (pubmed:23981774, pubmed:20506325, pubmed:23974653). also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (by similarity). {eco:0000250|uniprotkb:p32232, eco:0000269|pubmed:20506325, eco:0000269|pubmed:23974653, eco:0000269|pubmed:23981774}.","subcellular location: cytoplasm {eco:0000269|pubmed:17087506, eco:0000269|pubmed:23981774}. nucleus {eco:0000269|pubmed:17087506}.","TISSUE SPECIFICITY: In the adult strongly expressed in liver and pancreas, some expression in heart and brain, weak expression in lung and kidney. In the fetus, expressed in brain, liver and kidney.","DISEASE: Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]: An enzymatic deficiency resulting in altered sulfur metabolism and homocystinuria. The clinical features of untreated homocystinuria due to CBS deficiency include myopia, ectopia lentis, mental retardation, skeletal anomalies resembling Marfan syndrome, and thromboembolic events. Light skin and hair can also be present. Biochemical features include increased urinary homocystine and methionine. {ECO:0000269|PubMed:10215408, ECO:0000269|PubMed:10408774, ECO:0000269|PubMed:10462600, ECO:0000269|PubMed:11013450, ECO:0000269|PubMed:11359213, ECO:0000269|PubMed:11553052, ECO:0000269|PubMed:12007221, ECO:0000269|PubMed:12124992, ECO:0000269|PubMed:12815602, ECO:0000269|PubMed:1301198, ECO:0000269|PubMed:14635102, ECO:0000269|PubMed:15146473, ECO:0000269|PubMed:15365998, ECO:0000269|PubMed:15993874, ECO:0000269|PubMed:16205833, ECO:0000269|PubMed:16429402, ECO:0000269|PubMed:20506325, ECO:0000269|PubMed:21240075, ECO:0000269|PubMed:21520339, ECO:0000269|PubMed:22738154, ECO:0000269|PubMed:23974653, ECO:0000269|PubMed:23981774, ECO:0000269|PubMed:25044645, ECO:0000269|PubMed:7506602, ECO:0000269|PubMed:7564249, ECO:0000269|PubMed:7611293, ECO:0000269|PubMed:7635485, ECO:0000269|PubMed:7762555, ECO:0000269|PubMed:7849717, ECO:0000269|PubMed:7967489, ECO:0000269|PubMed:7981678, ECO:0000269|PubMed:8353501, ECO:0000269|PubMed:8528202, ECO:0000269|PubMed:8755636, ECO:0000269|PubMed:8803779, ECO:0000269|PubMed:8990018, ECO:0000269|PubMed:9156316, ECO:0000269|PubMed:9266356, ECO:0000269|PubMed:9361025, ECO:0000269|PubMed:9889017}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CBS,875,Hs.533013,ENST00000398168,THC2468454,GO:0001958(endochondral ossification)|GO:0001974(blood vessel remodeling)|GO:0004122(cystathionine beta-synthase activity)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006535(cysteine biosynthetic process from serine)|GO:0006563(L-serine metabolic process)|GO:0006565(L-serine catabolic process)|GO:0006801(superoxide metabolic process)|GO:0008652(cellular amino acid biosynthetic process)|GO:0016829(lyase activity)|GO:0019343(cysteine biosynthetic process via cystathionine)|GO:0019346(transsulfuration)|GO:0019448(L-cysteine catabolic process)|GO:0019899(enzyme binding)|GO:0020037(heme binding)|GO:0021587(cerebellum morphogenesis)|GO:0030170(pyridoxal phosphate binding)|GO:0030823(regulation of cGMP metabolic process)|GO:0031625(ubiquitin protein ligase binding)|GO:0031667(response to nutrient levels)|GO:0042803(protein homodimerization activity)|GO:0043231(intracellular membrane-bounded organelle)|GO:0043418(homocysteine catabolic process)|GO:0043506(regulation of JUN kinase activity)|GO:0046872(metal ion binding)|GO:0050667(homocysteine metabolic process)|GO:0050880(regulation of blood vessel size)|GO:0051593(response to folic acid)|GO:0060135(maternal process involved in female pregnancy)|GO:0060351(cartilage development involved in endochondral bone morphogenesis)|GO:0070814(hydrogen sulfide biosynthetic process),"Homo sapiens cystathionine-beta-synthase (CBS), transcript variant 1, mRNA [NM_000071]",chr21:44473378-44473319,hs|21q22.3,cystathionine-beta-synthase,TRUE
445_MARCKS_4082,P29966,"myristoylated alanine-rich c-kinase substrate (marcks) (protein kinase c substrate, 80 kda protein, light chain) (80k-l protein) (pkcsl)",MARCKS MACS PRKCSL,332,"function: marcks is the most prominent cellular substrate for protein kinase c. this protein binds calmodulin, actin, and synapsin. marcks is a filamentous (f) actin cross-linking protein.","subcellular location: cytoplasm, cytoskeleton {eco:0000305}. membrane {eco:0000305}; lipid-anchor {eco:0000305}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,MARCKS,4082,Hs.519909,ENST00000368635,THC2470248,GO:0005080(protein kinase C binding)|GO:0005516(calmodulin binding)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005886(plasma membrane)|GO:0005938(cell cortex)|GO:0006112(energy reserve metabolic process)|GO:0015629(actin cytoskeleton)|GO:0042585(germinal vesicle)|GO:0050796(regulation of insulin secretion)|GO:0051015(actin filament binding),"Homo sapiens myristoylated alanine-rich protein kinase C substrate (MARCKS), mRNA [NM_002356]",chr6:114182911-114182970,hs|6q21,myristoylated alanine-rich protein kinase C substrate,TRUE
446_RPL26_6154,P61254,60s ribosomal protein l26 (large ribosomal subunit protein ul24),RPL26,145,function: component of the large ribosomal subunit. {eco:0000305|pubmed:26100019}.,NA,NA,"DISEASE: Diamond-Blackfan anemia 11 (DBA11) [MIM:614900]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:22431104}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL26,6154,Hs.644794,ENST00000293842,THC2561695,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042273(ribosomal large subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L26 (RPL26), mRNA [NM_000987]",chr17:8283239-8283180,hs|17p13.1,ribosomal protein L26,TRUE
447_SEC61G_23480,P60059,protein transport protein sec61 subunit gamma,SEC61G,68,function: component of sec61 channel-forming translocon complex that mediates transport of signal peptide-containing precursor polypeptides across endoplasmic reticulum (er). {eco:0000250|uniprotkb:p60058}.,subcellular location: endoplasmic reticulum membrane {eco:0000250}; single-pass membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC61G,23480,Hs.488282,ENST00000450622,THC2662491,GO:0005575(cellular_component)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0008565(protein transporter activity)|GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0045047(protein targeting to ER),"Homo sapiens Sec61 gamma subunit (SEC61G), transcript variant 1, mRNA [NM_014302]",chr7:54823522-54820105,hs|7p11.2,Sec61 gamma subunit,TRUE
448_GOLGA4_2803,Q13439,golgin subfamily a member 4 (256 kda golgin) (golgin-245) (protein 72.1) (trans-golgi p230),GOLGA4,2230,"function: involved in vesicular trafficking at the golgi apparatus level. may play a role in delivery of transport vesicles containing gpi-linked proteins from the trans-golgi network through its interaction with macf1. involved in endosome-to-golgi trafficking (pubmed:29084197). {eco:0000269|pubmed:15265687, eco:0000269|pubmed:29084197}.","subcellular location: cytoplasm. golgi apparatus membrane {eco:0000269|pubmed:10209123, eco:0000269|pubmed:10209125, eco:0000269|pubmed:11303027, eco:0000269|pubmed:14718928, eco:0000269|pubmed:15265687}; peripheral membrane protein. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:29084197}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GOLGA4,2803,Hs.344151,ENST00000361924,THC2576262,GO:0000042(protein targeting to Golgi)|GO:0000139(Golgi membrane)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005802(trans-Golgi network)|GO:0016020(membrane)|GO:0016192(vesicle-mediated transport)|GO:0043001(Golgi to plasma membrane protein transport),"Homo sapiens golgin A4 (GOLGA4), transcript variant 2, mRNA [NM_002078]",chr3:37366001-37366060,hs|3p22.2,golgin A4,TRUE
449_GALNT11_63917,Q8NCW6,polypeptide n-acetylgalactosaminyltransferase 11 (ec 2.4.1.41) (polypeptide galnac transferase 11) (galnac-t11) (pp-gantase 11) (protein-udp acetylgalactosaminyltransferase 11) (udp-galnac:polypeptide n-acetylgalactosaminyltransferase 11),GALNT11,608,"function: polypeptide n-acetylgalactosaminyltransferase that catalyzes the initiation of protein o-linked glycosylation and is involved in left/right asymmetry by mediating o-glycosylation of notch1. o-glycosylation of notch1 promotes activation of notch1, modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (lro). polypeptide n-acetylgalactosaminyltransferases catalyze the transfer of an n-acetyl-d-galactosamine residue to a serine or threonine residue on the protein receptor. displays the same enzyme activity toward muc1, muc4, and ea2 than galnt1. not involved in glycosylation of erythropoietin (epo). {eco:0000269|pubmed:11925450, eco:0000269|pubmed:24226769}.",subcellular location: golgi apparatus membrane {eco:0000269|pubmed:11925450}; single-pass type ii membrane protein {eco:0000269|pubmed:11925450}.,"TISSUE SPECIFICITY: Highly expressed in kidney. Expressed at intermediate level in brain, heart and skeletal muscle. Weakly expressed other tissues. In kidney, it is strongly expressed in tubules but not expressed in glomeruli. {ECO:0000269|PubMed:11925450}.","DISEASE: Note=Defects in GALNT11 may be a cause of heterotaxy, a congenital heart disease resulting from abnormalities in left-right (LR) body patterning. {ECO:0000269|PubMed:21282601}.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GALNT11,63917,Hs.647109,ENST00000434507,THC2463494,"GO:0000139(Golgi membrane)|GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity)|GO:0005529(sugar binding)|GO:0005794(Golgi apparatus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016757(transferase activity, transferring glycosyl groups)","Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) (GALNT11), mRNA [NM_022087]",chr7:151819145-151819204,hs|7q36.1,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),TRUE
45_MKNK2_2872,Q9HBH9,map kinase-interacting serine/threonine-protein kinase 2 (ec 2.7.11.1) (map kinase signal-integrating kinase 2) (mapk signal-integrating kinase 2) (mnk2),MKNK2 GPRK7 MNK2,465,"function: serine/threonine-protein kinase that phosphorylates sfpq/psf, hnrnpa1 and eif4e. may play a role in the response to environmental stress and cytokines. appears to regulate translation by phosphorylating eif4e, thus increasing the affinity of this protein for the 7-methylguanosine-containing mrna cap. required for mediating pp2a-inhibition-induced eif4e phosphorylation. triggers eif4e shuttling from cytoplasm to nucleus. isoform 1 displays a high basal kinase activity, but isoform 2 exhibits a very low kinase activity. acts as a mediator of the suppressive effects of ifngamma on hematopoiesis. negative regulator for signals that control generation of arsenic trioxide as(2)o(3)-dependent apoptosis and anti-leukemic responses. involved in anti-apoptotic signaling in response to serum withdrawal. {eco:0000269|pubmed:11154262, eco:0000269|pubmed:11463832, eco:0000269|pubmed:12897141, eco:0000269|pubmed:16111636, eco:0000269|pubmed:17965020, eco:0000269|pubmed:18299328, eco:0000269|pubmed:20823271, eco:0000269|pubmed:20927323, eco:0000269|pubmed:21149447}.","subcellular location: isoform 2: nucleus, pml body.; subcellular location: isoform 1: cytoplasm.",TISSUE SPECIFICITY: Ubiquitously expressed in all tissues examined. Isoform 2 is expressed at higher levels in the ovary than is isoform 1. {ECO:0000269|PubMed:11013076}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MKNK2,2872,Hs.515032,ENST00000250896,THC2492223,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005524(ATP binding)|GO:0006417(regulation of translation)|GO:0006468(protein phosphorylation)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0007243(intracellular protein kinase cascade)|GO:0030097(hemopoiesis)|GO:0046872(metal ion binding)|GO:0071243(cellular response to arsenic-containing substance),"Homo sapiens MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 1, mRNA [NM_017572]",chr19:2037572-2037513,hs|19p13.3,MAP kinase interacting serine/threonine kinase 2,TRUE
450_MRPS18B_28973,Q9Y676,"28s ribosomal protein s18b, mitochondrial (mrp-s18-b) (mrps18-b) (s18mt-b) (28s ribosomal protein s18-2, mitochondrial) (mrp-s18-2) (mitochondrial small ribosomal subunit protein bs18b) (mitochondrial small ribosomal subunit protein ms40)",MRPS18B C6orf14 HSPC183 PTD017,258,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS18B,28973,Hs.655329,ENST00000460640,NP1168570,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005763(mitochondrial small ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein S18B (MRPS18B), nuclear gene encoding mitochondrial protein, mRNA [NM_014046]",chr6:30594091-30594150,hs|6p21.33,mitochondrial ribosomal protein S18B,TRUE
451_SLIRP_81892,Q9GZT3,"sra stem-loop-interacting rna-binding protein, mitochondrial",SLIRP C14orf156 DC23 DC50 PD04872,109,"function: rna-binding protein that acts as a nuclear receptor corepressor. probably acts by binding the sra rna, and repressing the sra-mediated nuclear receptor coactivation. binds the str7 loop of sra rna. also able to repress glucocorticoid (gr), androgen (ar), thyroid (tr) and vdr-mediated transactivation. {eco:0000269|pubmed:16762838}.","subcellular location: mitochondrion {eco:0000269|pubmed:16762838}. nucleus {eco:0000269|pubmed:16762838}. note=predominantly mitochondrial. some fraction is nuclear. in the nucleus, it is recruited to nuclear receptor target promoters.","TISSUE SPECIFICITY: Ubiquitously expressed, with highest level in heart, liver, skeletal muscle and testis. {ECO:0000269|PubMed:16762838}.",NA,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SLIRP,81892,Hs.655105,ENST00000556956,THC2466496,"GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens SRA stem-loop interacting RNA binding protein (SLIRP), mRNA [NM_031210]",chr14:78182164-78183839,hs|14q24.3,SRA stem-loop interacting RNA binding protein,TRUE
452_CHSY1_22856,Q86X52,chondroitin sulfate synthase 1 (ec 2.4.1.175) (ec 2.4.1.226) (chondroitin glucuronyltransferase 1) (chondroitin synthase 1) (chsy-1) (glucuronosyl-n-acetylgalactosaminyl-proteoglycan 4-beta-n-acetylgalactosaminyltransferase 1) (n-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (n-acetylgalactosaminyltransferase 1),CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487,802,"function: has both beta-1,3-glucuronic acid and beta-1,4-n-acetylgalactosamine transferase activity. transfers glucuronic acid (glcua) from udp-glcua and n-acetylgalactosamine (galnac) from udp-galnac to the non-reducing end of the elongating chondroitin polymer. involved in the negative control of osteogenesis likely through the modulation of notch signaling. {eco:0000269|pubmed:11514575, eco:0000269|pubmed:21129727}.","subcellular location: golgi apparatus, golgi stack membrane {eco:0000305|pubmed:11514575}; single-pass type ii membrane protein {eco:0000305|pubmed:11514575}. secreted {eco:0000269|pubmed:21129727}.","TISSUE SPECIFICITY: Ubiquitous, with the highest levels in placenta. Detected at low levels in brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, adrenal gland, mammary gland, stomach, small intestine, lung and peripheral blood leukocytes. {ECO:0000269|PubMed:11514575, ECO:0000269|PubMed:12907687}.","DISEASE: Temtamy preaxial brachydactyly syndrome (TPBS) [MIM:605282]: A syndrome characterized by multiple congenital anomalies, mental retardation, sensorineural deafness, talon cusps of upper central incisors, growth retardation, and bilateral symmetric digital anomalies mainly in the form of preaxial brachydactyly and hyperphalangism. {ECO:0000269|PubMed:21129727, ECO:0000269|PubMed:21129728}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CHSY1,22856,Hs.110488,ENST00000254190,THC2467520,"GO:0005576(extracellular region)|GO:0005794(Golgi apparatus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0016758(transferase activity, transferring hexosyl groups)|GO:0030206(chondroitin sulfate biosynthetic process)|GO:0030279(negative regulation of ossification)|GO:0031667(response to nutrient levels)|GO:0032580(Golgi cisterna membrane)|GO:0046872(metal ion binding)|GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity)|GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","Homo sapiens chondroitin sulfate synthase 1 (CHSY1), mRNA [NM_014918]",chr15:101716122-101716063,hs|15q26.3,chondroitin sulfate synthase 1,TRUE
453_NCL_4691,P19338,nucleolin (protein c23),NCL,710,function: nucleolin is the major nucleolar protein of growing eukaryotic cells. it is found associated with intranucleolar chromatin and pre-ribosomal particles. it induces chromatin decondensation by binding to histone h1. it is thought to play a role in pre-rrna transcription and ribosome assembly. may play a role in the process of transcriptional elongation. binds rna oligonucleotides with 5'-uuaggg-3' repeats more tightly than the telomeric single-stranded dna 5'-ttaggg-3' repeats. {eco:0000269|pubmed:10393184}.,"subcellular location: nucleus, nucleolus. cytoplasm. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NCL,4691,Hs.79110,ENST00000322732,THC2496344,GO:0000166(nucleotide binding)|GO:0001525(angiogenesis)|GO:0003676(nucleic acid binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005938(cell cortex)|GO:0008022(protein C-terminus binding)|GO:0030529(ribonucleoprotein complex)|GO:0042162(telomeric DNA binding),"Homo sapiens nucleolin (NCL), mRNA [NM_005381]",chr2:232319780-232319721,hs|2q37.1,nucleolin,TRUE
454_CALM2_805,P0DP24,calmodulin-2,CALM2 CAM2 CAMB,149,"function: calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. together with ccp110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (pubmed:16760425). mediates calcium-dependent inactivation of cacna1c (pubmed:26969752). positively regulates calcium-activated potassium channel activity of kcnn2 (pubmed:27165696). {eco:0000269|pubmed:16760425, eco:0000269|pubmed:26969752, eco:0000269|pubmed:27165696}.","subcellular location: cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:16760425}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:16760425}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. note=distributed throughout the cell during interphase, but during mitosis becomes dramatically localized to the spindle poles and the spindle microtubules.",NA,"DISEASE: Long QT syndrome 15 (LQT15) [MIM:616249]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24917665, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM2 are the cause of LQT15.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,CALM2,805,Hs.468442,ENST00000432899,THC2584179,NA,"Homo sapiens calmodulin 2 (phosphorylase kinase, delta) (CALM2), mRNA [NM_001743]",chr2:47387407-47387348,hs|2p21,"calmodulin 2 (phosphorylase kinase, delta)",TRUE
455_DYNLL1_8655,P63167,"dynein light chain 1, cytoplasmic (8 kda dynein light chain) (dlc8) (dynein light chain lc8-type 1) (protein inhibitor of neuronal nitric oxide synthase) (pin)",DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1,89,function: acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. may play a role in changing or maintaining the spatial distribution of cytoskeletal structures.; function: binds and inhibits the catalytic activity of neuronal nitric oxide synthase.; function: promotes transactivation functions of esr1 and plays a role in the nuclear localization of esr1.; function: regulates apoptotic activities of bcl2l11 by sequestering it to microtubules. upon apoptotic stimuli the bcl2l11-dynll1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters bcl2 thus neutralizing its antiapoptotic activity.,"subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. cytoplasm, cytoskeleton. nucleus. mitochondrion. note=upon induction of apoptosis translocates together with bcl2l11 to mitochondria.",TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:8628263}.,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,DYNLL1,8655,Hs.5120,ENST00000549989,THC2514623,"GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0003774(motor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005868(cytoplasmic dynein complex)|GO:0005874(microtubule)|GO:0005886(plasma membrane)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006810(transport)|GO:0006915(apoptosis)|GO:0007017(microtubule-based process)|GO:0007292(female gamete generation)|GO:0008180(signalosome)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008633(activation of pro-apoptotic gene products)|GO:0009653(anatomical structure morphogenesis)|GO:0019899(enzyme binding)|GO:0030036(actin cytoskeleton organization)|GO:0030235(nitric-oxide synthase regulator activity)|GO:0042326(negative regulation of phosphorylation)|GO:0042803(protein homodimerization activity)|GO:0044419(interspecies interaction between organisms)","Homo sapiens dynein, light chain, LC8-type 1 (DYNLL1), transcript variant 1, mRNA [NM_001037494]",chr12:120936092-120936151,hs|12q24.31,"dynein, light chain, LC8-type 1",TRUE
456_PDCD6_10016,O75340,programmed cell death protein 6 (apoptosis-linked gene 2 protein homolog) (alg-2),PDCD6 ALG2,191,"function: calcium sensor that plays a key role in processes such as endoplasmic reticulum (er)-golgi vesicular transport, endosomal biogenesis or membrane repair. acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium: calcium-binding triggers exposure of apolar surface, promoting interaction with different sets of proteins thanks to 3 different hydrophobic pockets, leading to translocation to membranes (pubmed:20691033, pubmed:25667979). involved in er-golgi transport by promoting the association between pdcd6ip and tsg101, thereby bridging together the escrt-iii and escrt-i complexes (pubmed:19520058). together with pef1, acts as calcium-dependent adapter for the bcr(klhl12) complex, a complex involved in er-golgi transport by regulating the size of copii coats (pubmed:27716508). in response to cytosolic calcium increase, the heterodimer formed with pef1 interacts with, and bridges together the bcr(klhl12) complex and sec31 (sec31a or sec31b), promoting monoubiquitination of sec31 and subsequent collagen export, which is required for neural crest specification (pubmed:27716508). involved in the regulation of the distribution and function of mcoln1 in the endosomal pathway (pubmed:19864416). promotes localization and polymerization of tfg at endoplasmic reticulum exit site (pubmed:27813252). required for t-cell receptor-, fas-, and glucocorticoid-induced apoptosis (by similarity). may mediate ca(2+)-regulated signals along the death pathway: interaction with dapk1 can accelerate apoptotic cell death by increasing caspase-3 activity (pubmed:16132846). its role in apoptosis may however be indirect, as suggested by knockout experiments (by similarity). may inhibit kdr/vegfr2-dependent angiogenesis; the function involves inhibition of vegf-induced phosphorylation of the akt signaling pathway (pubmed:21893193). in case of infection by hiv-1 virus, indirectly inhibits hiv-1 production by affecting viral gag expression and distribution (pubmed:27784779). {eco:0000250|uniprotkb:p12815, eco:0000269|pubmed:16132846, eco:0000269|pubmed:19520058, eco:0000269|pubmed:19864416, eco:0000269|pubmed:20691033, eco:0000269|pubmed:21893193, eco:0000269|pubmed:25667979, eco:0000269|pubmed:27716508, eco:0000269|pubmed:27784779, eco:0000269|pubmed:27813252}.; function: isoform 2: has a lower ca(2+) affinity than isoform 1 (by similarity). {eco:0000250|uniprotkb:p12815}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:16957052, eco:0000269|pubmed:27813252}; peripheral membrane protein {eco:0000269|pubmed:16957052}. cytoplasmic vesicle, copii-coated vesicle membrane {eco:0000269|pubmed:27716508}. cytoplasm {eco:0000269|pubmed:27716508, eco:0000269|pubmed:27784779}. nucleus {eco:0000269|pubmed:17045351, eco:0000269|pubmed:21122810, eco:0000269|pubmed:27784779}. endosome {eco:0000269|pubmed:19864416}. note=interaction with rbm22 induces relocalization from the cytoplasm to the nucleus (pubmed:17045351). translocated from the cytoplasm to the nucleus after heat shock cell treatment. accumulates in cytoplasmic vesicle-like organelles after heat shock treatment, which may represent stress granules (pubmed:21122810). in response to calcium increase, relocates from cytoplasm to copii vesicle coat (pubmed:27716508). localizes to endoplasmic reticulum exit site (eres) (pubmed:27813252). {eco:0000269|pubmed:17045351, eco:0000269|pubmed:21122810, eco:0000269|pubmed:27716508, eco:0000269|pubmed:27813252}.",NA,NA,NA,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PDCD6,10016,Hs.50823,ENST00000511482,THC2558280,"GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006919(activation of caspase activity)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0016020(membrane)|GO:0031965(nuclear membrane)|GO:0042803(protein homodimerization activity)|GO:0046983(protein dimerization activity)|GO:0048306(calcium-dependent protein binding)|GO:0051592(response to calcium ion)|GO:0060090(binding, bridging)","Homo sapiens programmed cell death 6 (PDCD6), mRNA [NM_013232]",chr5:314812-314871,hs|5p15.33,programmed cell death 6,TRUE
457_NEK9_91754,Q8TD19,serine/threonine-protein kinase nek9 (ec 2.7.11.1) (nercc1 kinase) (never in mitosis a-related kinase 9) (nima-related protein kinase 9) (nima-related kinase 8) (nek8),NEK9 KIAA1995 NEK8 NERCC,979,"function: pleiotropic regulator of mitotic progression, participating in the control of spindle dynamics and chromosome separation. phosphorylates different histones, myelin basic protein, beta-casein, and bicd2. phosphorylates histone h3 on serine and threonine residues and beta-casein on serine residues. important for g1/s transition and s phase progression. phosphorylates nek6 and nek7 and stimulates their activity by releasing the autoinhibitory functions of tyr-108 and tyr-97 respectively. {eco:0000269|pubmed:12840024, eco:0000269|pubmed:14660563, eco:0000269|pubmed:19941817}.",subcellular location: cytoplasm {eco:0000269|pubmed:14660563}. nucleus {eco:0000269|pubmed:14660563}.,"TISSUE SPECIFICITY: Most abundant in heart, liver, kidney and testis. Also expressed in smooth muscle cells and fibroblasts.","DISEASE: Lethal congenital contracture syndrome 10 (LCCS10) [MIM:617022]: A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. {ECO:0000269|PubMed:26908619}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Nevus comedonicus (NC) [MIM:617025]: A rare type of epidermal nevus characterized by closely arranged, dilated, plugged follicular ostia in a honeycomb pattern. The plugged ostia contain lamellated keratinaceous material, and their appearance resembles black dots. NC may be non-pyogenic with an acne-like appearance or associated with the formation of cysts, papules, pustules, and abscesses. Most commonly it affects the face and neck area and, by exception, other anatomical regions, including genital area, palms, and soles. NC lesions might present with various patterns of distribution: unilateral, bilateral, linear, interrupted, segmental, or blaschkoid. {ECO:0000269|PubMed:27153399}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, Perthes disease, and upward gaze palsy (APUG) [MIM:614262]: An autosomal recessive, syndromic form of arthrogryposis, a disease characterized by persistent joints flexure or contracture. APUG patients manifest an unusual combination of arthrogryposis, upward gaze palsy, and avascular necrosis of the hip (Perthes disease). {ECO:0000269|PubMed:26633546}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEK9,91754,Hs.730635,ENST00000238616,THC2495594,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0007049(cell cycle)|GO:0007067(mitosis)|GO:0019901(protein kinase binding)|GO:0046872(metal ion binding)|GO:0051301(cell division),"Homo sapiens NIMA (never in mitosis gene a)- related kinase 9 (NEK9), mRNA [NM_033116]",chr14:75548984-75548925,hs|14q24.3,NIMA (never in mitosis gene a)- related kinase 9,TRUE
458_RBM8A_9939,Q9Y5S9,rna-binding protein 8a (binder of ovca1-1) (bov-1) (rna-binding motif protein 8a) (rna-binding protein y14) (ribonucleoprotein rbm8a),RBM8A RBM8 HSPC114 MDS014,174,"function: required for pre-mrna splicing as component of the spliceosome (pubmed:28502770, pubmed:29301961). core component of the splicing-dependent multiprotein exon junction complex (ejc) deposited at splice junctions on mrnas. the ejc is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during ejc assembly or during subsequent mrna metabolism. the ejc marks the position of the exon-exon junction in the mature mrna for the gene expression machinery and the core components remain bound to spliced mrnas throughout all stages of mrna metabolism thereby influencing downstream processes including nuclear mrna export, subcellular mrna localization, translation efficiency and nonsense-mediated mrna decay (nmd). the magoh-rbm8a heterodimer inhibits the atpase activity of eif4a3, thereby trapping the atp-bound ejc core onto spliced mrna in a stable conformation. the magoh-rbm8a heterodimer interacts with the ejc key regulator pym1 leading to ejc disassembly in the cytoplasm and translation enhancement of ejc-bearing spliced mrnas by recruiting them to the ribosomal 48s preinitiation complex. its removal from cytoplasmic mrnas requires translation initiation from ejc-bearing spliced mrnas. associates preferentially with mrnas produced by splicing. does not interact with pre-mrnas, introns, or mrnas produced from intronless cdnas. associates with both nuclear mrnas and newly exported cytoplasmic mrnas. the magoh-rbm8a heterodimer is a component of the nonsense mediated decay (nmd) pathway. involved in the splicing modulation of bcl2l1/bcl-x (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as bcl-x(s); the function is different from the established ejc assembly. {eco:0000269|pubmed:12121612, eco:0000269|pubmed:12718880, eco:0000269|pubmed:12730685, eco:0000269|pubmed:16209946, eco:0000269|pubmed:19409878, eco:0000269|pubmed:22203037, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}.","subcellular location: nucleus {eco:0000269|pubmed:11030346, eco:0000269|pubmed:19324961, eco:0000269|pubmed:28502770, eco:0000269|pubmed:29301961}. nucleus speckle {eco:0000269|pubmed:11030346, eco:0000269|pubmed:19324961}. cytoplasm {eco:0000269|pubmed:11030346, eco:0000269|pubmed:19324961}. note=nucleocytoplasmic shuttling protein (pubmed:11030346). travels to the cytoplasm as part of the exon junction complex (ejc) bound to mrna. colocalizes with the core ejc, alyref/thoc4, nxf1 and uap56 in the nucleus and nuclear speckles (pubmed:19324961). {eco:0000269|pubmed:11030346, eco:0000269|pubmed:19324961}.",TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Thrombocytopenia-absent radius syndrome (TAR) [MIM:274000]: An autosomal recessive disorder characterized by bilateral absence of the radii with the presence of both thumbs, thrombocytopenia, low numbers of megakaryocytes, and bleeding episodes in the first year of life. Thrombocytopenic episodes decrease with age. Skeletal anomalies range from absence of radii to virtual absence of upper limbs, with or without lower limb defects such as malformations of the hip and knee. {ECO:0000269|PubMed:22366785}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBM8A,9939,Hs.591455,ENST00000369307,THC2544685,"GO:0000166(nucleotide binding)|GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006406(mRNA export from nucleus)|GO:0006417(regulation of translation)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0035145(exon-exon junction complex)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens RNA binding motif protein 8A (RBM8A), mRNA [NM_005105]",chr1:145509245-145509304,hs|1q21.1,RNA binding motif protein 8A,TRUE
459_CLTC_1213,Q00610,clathrin heavy chain 1 (clathrin heavy chain on chromosome 17) (clh-17),CLTC CLH17 CLTCL2 KIAA0034,1675,"function: clathrin is the major protein of the polyhedral coat of coated pits and vesicles. two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-golgi network. acts as component of the tacc3/ch-tog/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge (pubmed:15858577, pubmed:16968737, pubmed:21297582). the tacc3/ch-tog/clathrin complex is required for the maintenance of kinetochore fiber tension (pubmed:23532825). plays a role in early autophagosome formation (pubmed:20639872). {eco:0000269|pubmed:15858577, eco:0000269|pubmed:16968737, eco:0000269|pubmed:20639872, eco:0000269|pubmed:21297582, eco:0000269|pubmed:23532825}.","subcellular location: cytoplasmic vesicle membrane {eco:0000269|pubmed:17081065}; peripheral membrane protein {eco:0000269|pubmed:17081065}; cytoplasmic side {eco:0000269|pubmed:17081065}. membrane, coated pit {eco:0000269|pubmed:17081065}; peripheral membrane protein {eco:0000269|pubmed:17081065}; cytoplasmic side {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:15858577, eco:0000269|pubmed:16968737, eco:0000269|pubmed:23918938}. note=cytoplasmic face of coated pits and vesicles. identified by mass spectrometry in melanosome fractions from stage i to stage iv. in complex with tacc3 and ckap5 (forming the tacc3/ch-tog/clathrin complex) localized to inter-microtubule bridges in mitotic spindles. {eco:0000269|pubmed:25596274}.",NA,"DISEASE: Mental retardation, autosomal dominant 56 (MRD56) [MIM:617854]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:26822784, ECO:0000269|PubMed:29100083}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CLTC,1213,Hs.491351,ENST00000498711,THC2509197,GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005819(spindle)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006886(intracellular protein transport)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006898(receptor-mediated endocytosis)|GO:0007067(mitosis)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007411(axon guidance)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0030118(clathrin coat)|GO:0030130(clathrin coat of trans-Golgi network vesicle)|GO:0030132(clathrin coat of coated pit)|GO:0030136(clathrin-coated vesicle)|GO:0030659(cytoplasmic vesicle membrane)|GO:0031410(cytoplasmic vesicle)|GO:0031623(receptor internalization)|GO:0033572(transferrin transport)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042470(melanosome)|GO:0048011(nerve growth factor receptor signaling pathway),"Homo sapiens clathrin, heavy chain (Hc) (CLTC), mRNA [NM_004859]",chr17:57771899-57771958,hs|17q23.1,"clathrin, heavy chain (Hc)",TRUE
46_ERGIC1_57222,Q969X5,endoplasmic reticulum-golgi intermediate compartment protein 1 (er-golgi intermediate compartment 32 kda protein) (ergic-32),ERGIC1 ERGIC32 KIAA1181 HT034,290,function: possible role in transport between endoplasmic reticulum and golgi. {eco:0000303|pubmed:15308636}.,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:15308636}; multi-pass membrane protein {eco:0000269|pubmed:15308636}. endoplasmic reticulum-golgi intermediate compartment membrane {eco:0000269|pubmed:15308636}; multi-pass membrane protein {eco:0000269|pubmed:15308636}. golgi apparatus membrane {eco:0000269|pubmed:15308636}; multi-pass membrane protein {eco:0000269|pubmed:15308636}. note=cycles between the endoplasmic reticulum and the golgi.,NA,"DISEASE: Arthrogryposis multiplex congenita, neurogenic type (AMCN) [MIM:208100]: A form of arthrogryposis multiplex congenita, a heterogeneous group of disorders characterized by multiple joint contractures resulting, in some cases, from reduced or absent fetal movements. AMCN is due to a neurogenic defect and is characterized by congenital immobility of the limbs with fixation of multiple joints, and muscle wasting. AMCN transmission pattern is consistent with autosomal recessive inheritance in several families. Penetrance may be incomplete in females. {ECO:0000269|PubMed:28317099}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ERGIC1,57222,Hs.509163,ENST00000523215,THC2495093,GO:0000139(Golgi membrane)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0006888(ER to Golgi vesicle-mediated transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport)|GO:0033116(ER-Golgi intermediate compartment membrane),"Homo sapiens endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 (ERGIC1), mRNA [NM_001031711]",chr5:172379624-172379683,hs|5q35.1,endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1,TRUE
460_NOTCH2_4853,Q04721,neurogenic locus notch homolog protein 2 (notch 2) (hn2) [cleaved into: notch 2 extracellular truncation (n2ecd); notch 2 intracellular domain (n2icd)],NOTCH2,2471,"function: functions as a receptor for membrane-bound ligands jagged-1 (jag1), jagged-2 (jag2) and delta-1 (dll1) to regulate cell-fate determination. upon ligand activation through the released notch intracellular domain (nicd) it forms a transcriptional activator complex with rbpj/rbpsuh and activates genes of the enhancer of split locus (pubmed:21378985, pubmed:21378989). affects the implementation of differentiation, proliferation and apoptotic programs (by similarity). involved in bone remodeling and homeostasis. in collaboration with rela/p65 enhances nfatc1 promoter activity and positively regulates rankl-induced osteoclast differentiation (pubmed:29149593). positively regulates self-renewal of liver cancer cells (pubmed:25985737). {eco:0000250|uniprotkb:o35516, eco:0000269|pubmed:21378985, eco:0000269|pubmed:21378989, eco:0000269|pubmed:25985737, eco:0000269|pubmed:29149593}.","subcellular location: notch 2 extracellular truncation: cell membrane {eco:0000269|pubmed:29329397, eco:0000269|pubmed:9244302}; single-pass type i membrane protein {eco:0000269|pubmed:9244302}.; subcellular location: notch 2 intracellular domain: nucleus {eco:0000269|pubmed:25985737}. cytoplasm {eco:0000269|pubmed:25985737}. note=following proteolytical processing nicd is translocated to the nucleus. retained at the cytoplasm by tcim (pubmed:25985737). {eco:0000269|pubmed:25985737}.","TISSUE SPECIFICITY: Expressed in the brain, heart, kidney, lung, skeletal muscle and liver. Ubiquitously expressed in the embryo. {ECO:0000269|PubMed:21378985}.","DISEASE: Alagille syndrome 2 (ALGS2) [MIM:610205]: A form of Alagille syndrome, an autosomal dominant multisystem disorder. It is clinically defined by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems. {ECO:0000269|PubMed:16773578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hajdu-Cheney syndrome (HJCYS) [MIM:102500]: A rare, autosomal dominant skeletal disorder characterized by the association of facial anomalies, acro-osteolysis, general osteoporosis, insufficient ossification of the skull, and periodontal disease (premature loss of permanent teeth). Other features include cleft palate, congenital heart defects, polycystic kidneys, orthopedic problems and anomalies of the genitalia, intestines and eyes. {ECO:0000269|PubMed:21378985, ECO:0000269|PubMed:21378989, ECO:0000269|PubMed:21681853, ECO:0000269|PubMed:21712856, ECO:0000269|PubMed:21793104, ECO:0000269|PubMed:23389697, ECO:0000269|PubMed:29149593}. Note=The disease is caused by mutations affecting the gene represented in this entry. NOTCH2 nonsense and frameshift mutations associated with Hajdu-Cheney syndrome cluster to the last coding exon of the gene. Mutant mRNA products escape nonsense-mediated decay and the resulting truncated NOTCH2 proteins act in a gain-of-function manner (PubMed:21378989). The pathological mechanism at cellular level involves disruption of a high affinity degron recognized by FBXW7 at the C-terminus, loss of interaction with FBXW7, reduced ubiquitination and degradation, and increased NOTCH2 levels. Bone marrow cells derived from HJCYS patients have an enhanced capacity of osteoclastogenesis due to sustained NOTCH2 activity (PubMed:29149593). {ECO:0000269|PubMed:21378989, ECO:0000269|PubMed:29149593}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NOTCH2,4853,Hs.487360,ENST00000256646,THC2496862,"GO:0001709(cell fate determination)|GO:0003706(ligand-regulated transcription factor activity)|GO:0004872(receptor activity)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005788(endoplasmic reticulum lumen)|GO:0005796(Golgi lumen)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006916(anti-apoptosis)|GO:0006917(induction of apoptosis)|GO:0007050(cell cycle arrest)|GO:0007219(Notch signaling pathway)|GO:0007220(Notch receptor processing)|GO:0007275(multicellular organismal development)|GO:0007399(nervous system development)|GO:0008285(negative regulation of cell proliferation)|GO:0009887(organ morphogenesis)|GO:0009986(cell surface)|GO:0010467(gene expression)|GO:0016049(cell growth)|GO:0019827(stem cell maintenance)|GO:0030097(hemopoiesis)|GO:0030154(cell differentiation)|GO:0042246(tissue regeneration)|GO:0046579(positive regulation of Ras protein signal transduction)|GO:0046849(bone remodeling)|GO:0050793(regulation of developmental process)","Homo sapiens notch 2 (NOTCH2), transcript variant 1, mRNA [NM_024408]",chr1:120454917-120454858,hs|1p12,notch 2,TRUE
461_C7orf28B_221960,P86790,vacuolar fusion protein ccz1 homolog b (vacuolar fusion protein ccz1 homolog-like),CCZ1B C7orf28B,482,NA,subcellular location: lysosome membrane {eco:0000269|pubmed:17897319}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C7orf28B,221960,Hs.567779,ENST00000467004,NA,GO:0005765(lysosomal membrane)|GO:0016020(membrane),"Homo sapiens chromosome 7 open reading frame 28B (C7orf28B), mRNA [NM_198097]",chr7:6838783-6838724,hs|7p22.1,chromosome 7 open reading frame 28B,TRUE
462_EIF3E_3646,P60228,eukaryotic translation initiation factor 3 subunit e (eif3e) (eukaryotic translation initiation factor 3 subunit 6) (viral integration site protein int-6 homolog) (eif-3 p48),EIF3E EIF3S6 INT6,445,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17581632, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17581632). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). required for nonsense-mediated mrna decay (nmd); may act in conjunction with upf2 to divert mrnas from translation to the nmd pathway (pubmed:17468741). may interact with mcm7 and epas1 and regulate the proteasome-mediated degradation of these proteins (pubmed:17310990, pubmed:17324924). {eco:0000255|hamap-rule:mf_03004, eco:0000269|pubmed:17310990, eco:0000269|pubmed:17324924, eco:0000269|pubmed:17468741, eco:0000269|pubmed:17581632, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.","subcellular location: cytoplasm. nucleus, pml body.","TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at highest levels in appendix, lymph, pancreas, skeletal muscle, spleen and thymus. {ECO:0000269|PubMed:8688078, ECO:0000269|PubMed:9295280}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3E,3646,Hs.405590,ENST00000521614,THC2494284,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0000785(chromatin)|GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0010467(gene expression)|GO:0016605(PML body)|GO:0044267(cellular protein metabolic process)|GO:0045947(negative regulation of translational initiation)|GO:0047485(protein N-terminus binding)","Homo sapiens eukaryotic translation initiation factor 3, subunit E (EIF3E), mRNA [NM_001568]",chr8:109215654-109215312,hs|8q23.1,"eukaryotic translation initiation factor 3, subunit E",TRUE
463_ATPIF1_93974,Q9UII2,"atpase inhibitor, mitochondrial (atp synthase f1 subunit epsilon) (inhibitor of f(1)f(o)-atpase) (if(1)) (if1)",ATP5IF1 ATPI ATPIF1,106,"function: endogenous f(1)f(o)-atpase inhibitor limiting atp depletion when the mitochondrial membrane potential falls below a threshold and the f(1)f(o)-atp synthase starts hydrolyzing atp to pump protons out of the mitochondrial matrix. required to avoid the consumption of cellular atp when the f(1)f(o)-atp synthase enzyme acts as an atp hydrolase. indirectly acts as a regulator of heme synthesis in erythroid tissues: regulates heme synthesis by modulating the mitochondrial ph and redox potential, allowing fech to efficiently catalyze the incorporation of iron into protoporphyrin ix to produce heme. {eco:0000269|pubmed:12110673, eco:0000269|pubmed:15528193, eco:0000269|pubmed:19559621, eco:0000269|pubmed:23135403}.",subcellular location: mitochondrion {eco:0000269|pubmed:12110673}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ATPIF1,93974,Hs.590908,ENST00000465645,THC2468048,GO:0001525(angiogenesis)|GO:0001937(negative regulation of endothelial cell proliferation)|GO:0004857(enzyme inhibitor activity)|GO:0005516(calmodulin binding)|GO:0005739(mitochondrion)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006091(generation of precursor metabolites and energy)|GO:0009986(cell surface)|GO:0042030(ATPase inhibitor activity)|GO:0042803(protein homodimerization activity)|GO:0043086(negative regulation of catalytic activity)|GO:0043532(angiostatin binding)|GO:0045980(negative regulation of nucleotide metabolic process)|GO:0051117(ATPase binding)|GO:0051260(protein homooligomerization)|GO:0051289(protein homotetramerization)|GO:0051346(negative regulation of hydrolase activity),"Homo sapiens ATPase inhibitory factor 1 (ATPIF1), nuclear gene encoding mitochondrial protein, transcript variant 3, mRNA [NM_178191]",chr1:28564499-28564558,hs|1p35.3,ATPase inhibitory factor 1,TRUE
464_MAVS_57506,Q7Z434,mitochondrial antiviral-signaling protein (mavs) (card adapter inducing interferon beta) (cardif) (interferon beta promoter stimulator protein 1) (ips-1) (putative nf-kappa-b-activating protein 031n) (virus-induced-signaling adapter) (visa),MAVS IPS1 KIAA1271 VISA,540,"function: required for innate immune defense against viruses (pubmed:16125763, pubmed:16127453, pubmed:16153868, pubmed:16177806, pubmed:19631370, pubmed:20451243, pubmed:23087404). acts downstream of dhx33, ddx58/rig-i and ifih1/mda5, which detect intracellular dsrna produced during viral replication, to coordinate pathways leading to the activation of nf-kappa-b, irf3 and irf7, and to the subsequent induction of antiviral cytokines such as ifn-beta and rantes (ccl5) (pubmed:16125763, pubmed:16127453, pubmed:16153868, pubmed:16177806, pubmed:19631370, pubmed:20451243, pubmed:23087404, pubmed:25636800). peroxisomal and mitochondrial mavs act sequentially to create an antiviral cellular state (pubmed:20451243). upon viral infection, peroxisomal mavs induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial mavs activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response (pubmed:20451243). may activate the same pathways following detection of extracellular dsrna by tlr3 (pubmed:16153868). may protect cells from apoptosis (pubmed:16125763). {eco:0000269|pubmed:16125763, eco:0000269|pubmed:16127453, eco:0000269|pubmed:16153868, eco:0000269|pubmed:16177806, eco:0000269|pubmed:19631370, eco:0000269|pubmed:20451243, eco:0000269|pubmed:23087404, eco:0000269|pubmed:25636800}.","subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:16125763}. mitochondrion {eco:0000269|pubmed:11780052, eco:0000269|pubmed:17709747}. peroxisome {eco:0000269|pubmed:20451243}.","TISSUE SPECIFICITY: Present in T-cells, monocytes, epithelial cells and hepatocytes (at protein level). Ubiquitously expressed, with highest levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes. {ECO:0000269|PubMed:16125763, ECO:0000269|PubMed:16127453, ECO:0000269|PubMed:16153868}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MAVS,57506,Hs.570362,ENST00000428216,THC2461420,"GO:0001934(positive regulation of protein phosphorylation)|GO:0002218(activation of innate immune response)|GO:0002230(positive regulation of defense response to virus by host)|GO:0004871(signal transducer activity)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0007165(signal transduction)|GO:0009615(response to virus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019901(protein kinase binding)|GO:0032480(negative regulation of type I interferon production)|GO:0032727(positive regulation of interferon-alpha production)|GO:0032728(positive regulation of interferon-beta production)|GO:0032757(positive regulation of interleukin-8 production)|GO:0032760(positive regulation of tumor necrosis factor production)|GO:0033160(positive regulation of protein import into nucleus, translocation)|GO:0042742(defense response to bacterium)|GO:0042993(positive regulation of transcription factor import into nucleus)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0044419(interspecies interaction between organisms)|GO:0045087(innate immune response)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0050700(CARD domain binding)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0060340(positive regulation of type I interferon-mediated signaling pathway)|GO:0071360(cellular response to exogenous dsRNA)|GO:0071651(positive regulation of chemokine (C-C motif) ligand 5 production)|GO:0071660(positive regulation of IP-10 production)","Homo sapiens mitochondrial antiviral signaling protein (MAVS), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_020746]",chr20:3848217-3848276,hs|20p13,mitochondrial antiviral signaling protein,TRUE
465_DHCR24_1718,Q15392,delta(24)-sterol reductase (ec 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol delta-24-reductase) (diminuto/dwarf1 homolog) (seladin-1),DHCR24 KIAA0018,516,"function: catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis (pubmed:11519011, pubmed:21671375, pubmed:25637936, pubmed:22178193). in addition to its cholesterol-synthesizing activity, can protects cells from oxidative stress by reducing caspase 3 activity during apoptosis induced by oxidative stress (pubmed:11007892, pubmed:22010141). also protects against amyloid-beta peptide-induced apoptosis (pubmed:11007892). {eco:0000269|pubmed:11007892, eco:0000269|pubmed:11519011, eco:0000269|pubmed:21671375, eco:0000269|pubmed:22010141, eco:0000269|pubmed:22178193, eco:0000269|pubmed:25637936}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:11007892, eco:0000269|pubmed:22010141}; single-pass membrane protein {eco:0000255}. golgi apparatus membrane {eco:0000269|pubmed:11007892}; single-pass membrane protein {eco:0000255}.","TISSUE SPECIFICITY: Highly expressed in brain and adrenal gland with moderate expression in liver, lung, spleen, prostate and spinal cord. Low expression in heart, uterus and prostate. Undetectable in blood cells. In the brain, strongly expressed in cortical regions, substantia nigra, caudate nucleus, hippocampus, medulla oblongata and pons. In brains affected by Alzheimer disease, expression in the inferior temporal lobe is substantially lower than in the frontal cortex. {ECO:0000269|PubMed:11007892, ECO:0000269|PubMed:11519011}.","DISEASE: Desmosterolosis (DESMOS) [MIM:602398]: Rare autosomal recessive disorder characterized by multiple congenital anomalies and elevated levels of the cholesterol precursor desmosterol in plasma, tissue, and cultured cells. {ECO:0000269|PubMed:11519011, ECO:0000269|PubMed:21671375}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DHCR24,1718,Hs.498727,ENST00000371269,THC2497269,"GO:0000139(Golgi membrane)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006695(cholesterol biosynthetic process)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006979(response to oxidative stress)|GO:0007050(cell cycle arrest)|GO:0007265(Ras protein signal transduction)|GO:0008104(protein localization)|GO:0008285(negative regulation of cell proliferation)|GO:0008762(UDP-N-acetylmuramate dehydrogenase activity)|GO:0009888(tissue development)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016044(cellular membrane organization)|GO:0016614(oxidoreductase activity, acting on CH-OH group of donors)|GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor)|GO:0019899(enzyme binding)|GO:0030539(male genitalia development)|GO:0031639(plasminogen activation)|GO:0042605(peptide antigen binding)|GO:0042987(amyloid precursor protein catabolic process)|GO:0043154(negative regulation of caspase activity)|GO:0043526(neuroprotection)|GO:0043588(skin development)|GO:0050614(delta24-sterol reductase activity)|GO:0050660(flavin adenine dinucleotide binding)","Homo sapiens 24-dehydrocholesterol reductase (DHCR24), mRNA [NM_014762]",chr1:55315569-55315510,hs|1p32.3,24-dehydrocholesterol reductase,TRUE
466_ARPC2_10109,O15144,actin-related protein 2/3 complex subunit 2 (arp2/3 complex 34 kda subunit) (p34-arc),ARPC2 ARC34 PRO2446,300,"function: actin-binding component of the arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (npf) (pubmed:9230079). the arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (pubmed:9230079). seems to contact the mother actin filament (pubmed:9230079). in addition to its role in the cytoplasmic cytoskeleton, the arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged dna (pubmed:29925947). the arp2/3 complex promotes homologous recombination (hr) repair in response to dna damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (dsbs) (pubmed:29925947). {eco:0000269|pubmed:29925947, eco:0000269|pubmed:9230079}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:9230079}. cell projection {eco:0000269|pubmed:9230079}. cell junction, synapse, synaptosome {eco:0000250|uniprotkb:q9cvb6}. nucleus {eco:0000269|pubmed:29925947}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ARPC2,10109,Hs.529303,ENST00000470146,THC2513590,GO:0003779(actin binding)|GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005885(Arp2/3 protein complex)|GO:0005925(focal adhesion)|GO:0006928(cellular component movement)|GO:0015629(actin cytoskeleton)|GO:0030838(positive regulation of actin filament polymerization)|GO:0031252(cell leading edge)|GO:0042995(cell projection),"Homo sapiens actin related protein 2/3 complex, subunit 2, 34kDa (ARPC2), transcript variant 1, mRNA [NM_152862]",chr2:219118658-219118717,hs|2q35,"actin related protein 2/3 complex, subunit 2, 34kDa",TRUE
467_PCBP1_5093,Q15365,poly(rc)-binding protein 1 (alpha-cp1) (heterogeneous nuclear ribonucleoprotein e1) (hnrnp e1) (nucleic acid-binding protein sub2.3),PCBP1,356,"function: single-stranded nucleic acid binding protein that binds preferentially to oligo dc. in case of infection by poliovirus, plays a role in initiation of viral rna replication in concert with the viral protein 3cd (pubmed:12414943). {eco:0000269|pubmed:12414943}.",subcellular location: nucleus. cytoplasm. note=loosely bound in the nucleus. may shuttle between the nucleus and the cytoplasm.,"TISSUE SPECIFICITY: Abundantly expressed in skeletal muscle, thymus and peripheral blood leukocytes while a lower expression is observed in prostate, spleen, testis, ovary, small intestine, heart, liver, adrenal and thyroid glands.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PCBP1,5093,Hs.2853,ENST00000303577,THC2587580,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016071(mRNA metabolic process)|GO:0030529(ribonucleoprotein complex)","Homo sapiens poly(rC) binding protein 1 (PCBP1), mRNA [NM_006196]",chr2:70315971-70316030,hs|2p13.3,poly(rC) binding protein 1,TRUE
468_DGCR2_9993,P98153,integral membrane protein dgcr2/idd,DGCR2 IDD KIAA0163,550,"function: putative adhesion receptor, that could be involved in cell-cell or cell-matrix interactions required for normal cell differentiation and migration.",subcellular location: membrane; single-pass type i membrane protein.,"TISSUE SPECIFICITY: Predominantly expressed in brain, heart, lung and fetal kidney. Low levels in liver and adult kidney.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DGCR2,9993,Hs.517357,ENST00000545799,THC2562503,GO:0004872(receptor activity)|GO:0005488(binding)|GO:0005529(sugar binding)|GO:0007155(cell adhesion)|GO:0009887(organ morphogenesis)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens DiGeorge syndrome critical region gene 2 (DGCR2), transcript variant 1, mRNA [NM_005137]",chr22:19023859-19023801,hs|22q11.21,DiGeorge syndrome critical region gene 2,TRUE
469_ASRGL1_80150,Q7L266,isoaspartyl peptidase/l-asparaginase (ec 3.4.19.5) (ec 3.5.1.1) (asparaginase-like protein 1) (beta-aspartyl-peptidase) (isoaspartyl dipeptidase) (l-asparagine amidohydrolase) [cleaved into: isoaspartyl peptidase/l-asparaginase alpha chain; isoaspartyl peptidase/l-asparaginase beta chain],ASRGL1 ALP CRASH,308,"function: has both l-asparaginase and beta-aspartyl peptidase activity. may be involved in the production of l-aspartate, which can act as an excitatory neurotransmitter in some brain regions. is highly active with l-asp beta-methyl ester. besides, has catalytic activity toward beta-aspartyl dipeptides and their methyl esters, including beta-l-asp-l-phe, beta-l-asp-l-phe methyl ester (aspartame), beta-l-asp-l-ala, beta-l-asp-l-leu and beta-l-asp-l-lys. does not have aspartylglucosaminidase activity and is inactive toward glcnac-l-asn. likewise, has no activity toward glutamine. {eco:0000269|pubmed:19839645, eco:0000269|pubmed:27106100}.","subcellular location: cytoplasm {eco:0000269|pubmed:11984834, eco:0000269|pubmed:27106100}. note=midpiece of sperm tail.","TISSUE SPECIFICITY: Expressed in brain, kidney, testis and tissues of the gastrointestinal tract. Present in sperm (at protein level). Over-expressed in uterine, mammary, prostatic and ovarian carcinoma. {ECO:0000269|PubMed:11984834, ECO:0000269|PubMed:14654938}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ASRGL1,80150,Hs.535326,ENST00000525708,THC2496961,GO:0003948(N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity)|GO:0004067(asparaginase activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0015630(microtubule cytoskeleton)|GO:0016787(hydrolase activity)|GO:0033345(asparagine catabolic process via L-aspartate)|GO:0051604(protein maturation),"Homo sapiens asparaginase like 1 (ASRGL1), transcript variant 1, mRNA [NM_001083926]",chr11:62159917-62159976,hs|11q12.3,asparaginase like 1,TRUE
47_ARL6IP1_23204,Q15041,adp-ribosylation factor-like protein 6-interacting protein 1 (arl-6-interacting protein 1) (aip-1) (apoptotic regulator in the membrane of the endoplasmic reticulum),ARL6IP1 ARL6IP ARMER KIAA0069,203,"function: positively regulates slc1a1/eaac1-mediated glutamate transport by increasing its affinity for glutamate in a pkc activity-dependent manner. promotes the catalytic efficiency of slc1a1/eaac1 probably by reducing its interaction with arl6ip5, a negative regulator of slc1a1/eaac1-mediated glutamate transport (by similarity). plays a role in the formation and stabilization of endoplasmic reticulum tubules (pubmed:24262037). negatively regulates apoptosis, possibly by modulating the activity of caspase-9 (casp9). inhibits cleavage of casp9-dependent substrates and downstream markers of apoptosis but not casp9 itself (pubmed:12754298). may be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation (pubmed:10995579). {eco:0000250|uniprotkb:q9jkw0, eco:0000269|pubmed:12754298, eco:0000269|pubmed:24262037, eco:0000303|pubmed:10995579}.","subcellular location: endomembrane system {eco:0000269|pubmed:10995579}; multi-pass membrane protein {eco:0000269|pubmed:10995579}. endoplasmic reticulum membrane {eco:0000269|pubmed:12754298, eco:0000269|pubmed:24076029, eco:0000269|pubmed:24262037}; multi-pass membrane protein {eco:0000269|pubmed:24076029}. endoplasmic reticulum {eco:0000250|uniprotkb:q9jkw0}. note=predominantly localized to intracytoplasmic membranes. preferentially localizes at the er tubules and the edge of the er sheets, both of which are characterized by a high membrane curvature. {eco:0000269|pubmed:24262037}.","TISSUE SPECIFICITY: Expressed in all hematopoietic cell lineages, but the highest level of expression is found in early myeloid progenitor cells. Expressed in brain, bone marrow, thymus and lung. Expressed at low level in liver, kidney and spleen. Not detected in heart. {ECO:0000269|PubMed:10995579}.","DISEASE: Spastic paraplegia 61, autosomal recessive (SPG61) [MIM:615685]: A complicated form of spastic paraplegia with polysensory and motor neuropathy. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:24482476, ECO:0000269|PubMed:30237576}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ARL6IP1,23204,Hs.634882,ENST00000546206,THC2515752,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005784(Sec61 translocon complex)|GO:0005829(cytosol)|GO:0006613(cotranslational protein targeting to membrane)|GO:0012505(endomembrane system)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1), mRNA [NM_015161]",chr16:18805921-18804634,hs|16p12.3,ADP-ribosylation factor-like 6 interacting protein 1,TRUE
470_SCCPDH_51097,Q8NBX0,saccharopine dehydrogenase-like oxidoreductase (ec 1.-.-.-),SCCPDH CGI-49,429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,SCCPDH,51097,Hs.498397,ENST00000366509,THC2468929,GO:0000166(nucleotide binding)|GO:0005739(mitochondrion)|GO:0016491(oxidoreductase activity)|GO:0030496(midbody),"Homo sapiens saccharopine dehydrogenase (putative) (SCCPDH), mRNA [NM_016002]",chr1:246930666-246930725,hs|1q44,saccharopine dehydrogenase (putative),TRUE
471_NDUFB8_4714,O95169,"nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (complex i-ashi) (ci-ashi) (nadh-ubiquinone oxidoreductase ashi subunit)",NDUFB8,186,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000255}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN32 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:29429571}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB8,4714,Hs.523215,ENST00000370322,THC2558398,"GO:0003954(NADH dehydrogenase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0005783(endoplasmic reticulum)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa (NDUFB8), nuclear gene encoding mitochondrial protein, mRNA [NM_005004]",chr10:102283579-102283520,hs|10q24.31,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa",TRUE
473_RPL5_6125,P46777,60s ribosomal protein l5 (large ribosomal subunit protein ul18),RPL5 MSTP030,297,"function: component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. the small ribosomal subunit (ssu) binds messenger rnas (mrnas) and translates the encoded message by selecting cognate aminoacyl-transfer rna (trna) molecules. the large subunit (lsu) contains the ribosomal catalytic site termed the peptidyl transferase center (ptc), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by trnas into a polypeptide chain. the nascent polypeptides leave the ribosome through a tunnel in the lsu and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. as part of the 5s rnp/5s ribonucleoprotein particle it is an essential component of the lsu, required for its formation and the maturation of rrnas (pubmed:12962325, pubmed:19061985, pubmed:24120868, pubmed:23636399). it also couples ribosome biogenesis to p53/tp53 activation. as part of the 5s rnp it accumulates in the nucleoplasm and inhibits mdm2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of tp53 (pubmed:24120868). {eco:0000269|pubmed:12962325, eco:0000269|pubmed:19061985, eco:0000269|pubmed:23636399, eco:0000269|pubmed:24120868}.","subcellular location: cytoplasm {eco:0000269|pubmed:15469983, eco:0000269|ref.7}. nucleus, nucleolus {eco:0000269|pubmed:15469983, eco:0000269|ref.7}.",NA,"DISEASE: Diamond-Blackfan anemia 6 (DBA6) [MIM:612561]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:19061985, ECO:0000269|PubMed:19191325}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL5,6125,Hs.532359,ENST00000497519,THC2503410,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008097(5S rRNA binding)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0042273(ribosomal large subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L5 (RPL5), mRNA [NM_000969]",chr1:93303074-93303132,hs|1p22.1,ribosomal protein L5,TRUE
474_RPL18A_6142,Q02543,60s ribosomal protein l18a (large ribosomal subunit protein el20),RPL18A,176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL18A,6142,Hs.337766,ENST00000222247,THC2593644,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L18a (RPL18A), mRNA [NM_000980]",chr19:17972985-17973738,hs|19p13.11,ribosomal protein L18a,TRUE
475_PDHA1_5160,P08559,"pyruvate dehydrogenase e1 component subunit alpha, somatic form, mitochondrial (ec 1.2.4.1) (pdhe1-a type i)",PDHA1 PHE1A,390,"function: the pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-coa and co(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {eco:0000269|pubmed:19081061, eco:0000269|pubmed:7782287}.",subcellular location: mitochondrion matrix.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]: An enzymatic defect causing primary lactic acidosis in children. It is associated with a broad clinical spectrum ranging from fatal lactic acidosis in the newborn to chronic neurologic dysfunction with structural abnormalities in the central nervous system without systemic acidosis. {ECO:0000269|PubMed:1293379, ECO:0000269|PubMed:1338114, ECO:0000269|PubMed:1551669, ECO:0000269|PubMed:1909401, ECO:0000269|PubMed:27864847, ECO:0000269|PubMed:7545958, ECO:0000269|PubMed:7573035, ECO:0000269|PubMed:7757088, ECO:0000269|PubMed:7887409, ECO:0000269|PubMed:7967473, ECO:0000269|PubMed:8032855, ECO:0000269|PubMed:8199595, ECO:0000269|PubMed:8498846, ECO:0000269|PubMed:8504306, ECO:0000269|PubMed:8664900, ECO:0000269|PubMed:8844217, ECO:0000269|PubMed:9266390, ECO:0000269|PubMed:9671272}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PDHA1,5160,Hs.530331,ENST00000478795,THC2469925,"GO:0004738(pyruvate dehydrogenase activity)|GO:0004739(pyruvate dehydrogenase (acetyl-transferring) activity)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006090(pyruvate metabolic process)|GO:0006096(glycolysis)|GO:0008152(metabolic process)|GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate)|GO:0016491(oxidoreductase activity)|GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor)","Homo sapiens pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_000284]",chrX:19377888-19377947,hs|Xp22.12,pyruvate dehydrogenase (lipoamide) alpha 1,TRUE
476_EIF3H_8667,O15372,eukaryotic translation initiation factor 3 subunit h (eif3h) (eukaryotic translation initiation factor 3 subunit 3) (eif-3-gamma) (eif3 p40 subunit),EIF3H EIF3S3,352,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17581632, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17581632). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000255|hamap-rule:mf_03007, eco:0000269|pubmed:17581632, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03007}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3H,8667,Hs.492599,ENST00000521861,THC2518066,GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit H (EIF3H), mRNA [NM_003756]",chr8:117657150-117657091,hs|8q23.3,"eukaryotic translation initiation factor 3, subunit H",TRUE
477_SRSF5_6430,Q13243,"serine/arginine-rich splicing factor 5 (delayed-early protein hrs) (pre-mrna-splicing factor srp40) (splicing factor, arginine/serine-rich 5)",SRSF5 HRS SFRS5 SRP40,272,function: plays a role in constitutive splicing and can modulate the selection of alternative splice sites.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF5,6430,Hs.632326,ENST00000556647,THC2539172,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006376(mRNA splice site selection)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)","Homo sapiens serine/arginine-rich splicing factor 5 (SRSF5), transcript variant 1, mRNA [NM_001039465]",chr14:70238133-70238192,hs|14q24.2,serine/arginine-rich splicing factor 5,TRUE
478_VDAC1_7416,P21796,voltage-dependent anion-selective channel protein 1 (vdac-1) (hvdac1) (outer mitochondrial membrane protein porin 1) (plasmalemmal porin) (porin 31hl) (porin 31hm),VDAC1 VDAC,283,"function: forms a channel through the mitochondrial outer membrane and also the plasma membrane. the channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis. it adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mv. the open state has a weak anion selectivity whereas the closed state is cation-selective (pubmed:11845315, pubmed:18755977, pubmed:20230784, pubmed:8420959). may participate in the formation of the permeability transition pore complex (ptpc) responsible for the release of mitochondrial products that triggers apoptosis (pubmed:15033708, pubmed:25296756). {eco:0000269|pubmed:11845315, eco:0000269|pubmed:15033708, eco:0000269|pubmed:18755977, eco:0000269|pubmed:20230784, eco:0000269|pubmed:25296756, eco:0000269|pubmed:8420959}.","subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:7539795}; multi-pass membrane protein {eco:0000269|pubmed:18755977, eco:0000269|pubmed:18832158}. cell membrane {eco:0000269|pubmed:25168729, eco:0000269|pubmed:25296756}; multi-pass membrane protein {eco:0000269|pubmed:18755977, eco:0000269|pubmed:18832158}. membrane raft {eco:0000269|pubmed:25168729}; multi-pass membrane protein {eco:0000269|pubmed:18755977, eco:0000269|pubmed:18832158}.","TISSUE SPECIFICITY: Heart, liver and skeletal muscle.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VDAC1,7416,Hs.519320,ENST00000395047,THC2545245,GO:0001662(behavioral fear response)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005743(mitochondrial inner membrane)|GO:0005886(plasma membrane)|GO:0006820(anion transport)|GO:0006915(apoptosis)|GO:0007270(neuron-neuron synaptic transmission)|GO:0007612(learning)|GO:0008308(voltage-gated anion channel activity)|GO:0015288(porin activity)|GO:0016020(membrane)|GO:0042645(mitochondrial nucleoid)|GO:0044070(regulation of anion transport)|GO:0044419(interspecies interaction between organisms)|GO:0046930(pore complex)|GO:0055085(transmembrane transport),"Homo sapiens voltage-dependent anion channel 1 (VDAC1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_003374]",chr5:133307961-133307902,hs|5q31.1,voltage-dependent anion channel 1,TRUE
48_RPS6_6194,P62753,40s ribosomal protein s6 (phosphoprotein np33) (small ribosomal subunit protein es6),RPS6 OK/SW-cl.2,249,function: may play an important role in controlling cell growth and proliferation through the selective translation of particular classes of mrna.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPS6,6194,Hs.408073,ENST00000315377,THC2508881,GO:0000028(ribosomal small subunit assembly)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008286(insulin receptor signaling pathway)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019901(protein kinase binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0031929(TOR signaling cascade)|GO:0042274(ribosomal small subunit biogenesis)|GO:0042593(glucose homeostasis)|GO:0043065(positive regulation of apoptosis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S6 (RPS6), mRNA [NM_001010]",chr9:19376365-19376306,hs|9p22.1,ribosomal protein S6,TRUE
481_ATP5O_539,P48047,"atp synthase subunit o, mitochondrial (atp synthase peripheral stalk subunit oscp) (oligomycin sensitivity conferral protein) (oscp)",ATP5PO ATP5O ATPO,213,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/atp6 static relative to the rotary elements.",subcellular location: mitochondrion {eco:0000250}. mitochondrion inner membrane {eco:0000250}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5O,539,Hs.409140,ENST00000429064,NP1072202,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005215(transporter activity)|GO:0005496(steroid binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0005886(plasma membrane)|GO:0006200(ATP catabolic process)|GO:0006754(ATP biosynthetic process)|GO:0006811(ion transport)|GO:0008144(drug binding)|GO:0015992(proton transport)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0032403(protein complex binding)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)|GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism)|GO:0055085(transmembrane transport)","Homo sapiens ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (ATP5O), nuclear gene encoding mitochondrial protein, mRNA [NM_001697]",chr21:35275858-35275799,hs|21q22.11,"ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit",TRUE
482_SSR4_6748,P51571,translocon-associated protein subunit delta (trap-delta) (signal sequence receptor subunit delta) (ssr-delta),SSR4 TRAPD,173,function: trap proteins are part of a complex whose function is to bind calcium to the er membrane and thereby regulate the retention of er resident proteins.,subcellular location: endoplasmic reticulum membrane; single-pass type i membrane protein.,NA,"DISEASE: Congenital disorder of glycosylation 1Y (CDG1Y) [MIM:300934]: A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:24218363}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SSR4,6748,Hs.409223,ENST00000482902,THC2564074,GO:0005509(calcium ion binding)|GO:0005783(endoplasmic reticulum)|GO:0005784(Sec61 translocon complex)|GO:0005789(endoplasmic reticulum membrane)|GO:0006886(intracellular protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens signal sequence receptor, delta (SSR4), transcript variant 2, mRNA [NM_006280]",chrX:153063256-153063571,hs|Xq28,"signal sequence receptor, delta",TRUE
483_EML4_27436,Q9HC35,echinoderm microtubule-associated protein-like 4 (emap-4) (restrictedly overexpressed proliferation-associated protein) (ropp 120),EML4 C2orf2 EMAPL4,981,"function: may modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic. {eco:0000250}.","subcellular location: cytoplasm, cytoskeleton {eco:0000305}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,EML4,27436,Hs.730709,ENST00000318522,THC2504795,GO:0003674(molecular_function)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0007017(microtubule-based process)|GO:0007067(mitosis),"Homo sapiens echinoderm microtubule associated protein like 4 (EML4), transcript variant 1, mRNA [NM_019063]",chr2:42559572-42559631,hs|2p21,echinoderm microtubule associated protein like 4,TRUE
484_CYB5A_1528,P00167,cytochrome b5 (microsomal cytochrome b5 type a) (mcb5),CYB5A CYB5,134,function: cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases.,subcellular location: isoform 1: endoplasmic reticulum membrane; single-pass membrane protein; cytoplasmic side. microsome membrane; single-pass membrane protein; cytoplasmic side.; subcellular location: isoform 2: cytoplasm.,NA,"DISEASE: Methemoglobinemia and ambiguous genitalia (METAG) [MIM:250790]: An autosomal recessive disorder characterized by sex steroid deficiency but normal glucocorticoid and mineralocorticoid reserve, male undermasculinization, absent or disturbed pubertal development, decreased levels of erythrocyte cytochrome B5, and excessive amounts of methemoglobin in blood cells resulting in cyanosis and hypoxia. {ECO:0000269|PubMed:20080843, ECO:0000269|PubMed:22170710, ECO:0000269|PubMed:8168836}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYB5A,1528,Hs.465413,ENST00000494131,THC2780885,GO:0004033(aldo-keto reductase (NADP) activity)|GO:0004129(cytochrome-c oxidase activity)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006766(vitamin metabolic process)|GO:0006767(water-soluble vitamin metabolic process)|GO:0006810(transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019899(enzyme binding)|GO:0020037(heme binding)|GO:0022900(electron transport chain)|GO:0046872(metal ion binding),"Homo sapiens cytochrome b5 type A (microsomal) (CYB5A), transcript variant 2, mRNA [NM_001914]",chr18:71920777-71920718,hs|18q22.3,cytochrome b5 type A (microsomal),TRUE
485_TSPAN1_10103,O60635,tetraspanin-1 (tspan-1) (tetraspan net-1) (tetraspanin tm4-c),TSPAN1,241,NA,subcellular location: lysosome membrane {eco:0000269|pubmed:19508227}; multi-pass membrane protein {eco:0000269|pubmed:19508227}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TSPAN1,10103,Hs.38972,ENST00000475163,THC2535731,GO:0005765(lysosomal membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens tetraspanin 1 (TSPAN1), mRNA [NM_005727]",chr1:46651173-46651232,hs|1p34.1,tetraspanin 1,TRUE
486_SRPR_6734,P08240,signal recognition particle receptor subunit alpha (sr-alpha) (docking protein alpha) (dp-alpha),SRPRA SRPR,638,"function: component of the srp (signal recognition particle) receptor. ensures, in conjunction with the signal recognition particle, the correct targeting of the nascent secretory proteins to the endoplasmic reticulum membrane system.","subcellular location: endoplasmic reticulum membrane; peripheral membrane protein. note=thought to be anchored in the membrane through an interaction with sr-beta, which contains a bona fide transmembrane domain.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SRPR,6734,Hs.368376,ENST00000332118,THC2470221,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0004872(receptor activity)|GO:0005047(signal recognition particle binding)|GO:0005525(GTP binding)|GO:0005783(endoplasmic reticulum)|GO:0005785(signal recognition particle receptor complex)|GO:0005789(endoplasmic reticulum membrane)|GO:0006613(cotranslational protein targeting to membrane)|GO:0006614(SRP-dependent cotranslational protein targeting to membrane)|GO:0006810(transport)|GO:0006886(intracellular protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens signal recognition particle receptor (docking protein) (SRPR), transcript variant 1, mRNA [NM_003139]",chr11:126132951-126132892,hs|11q24.2,signal recognition particle receptor (docking protein),TRUE
487_CTSF_8722,Q9UBX1,cathepsin f (catsf) (ec 3.4.22.41),CTSF,484,function: thiol protease which is believed to participate in intracellular degradation and turnover of proteins. has also been implicated in tumor invasion and metastasis.,subcellular location: lysosome.,"TISSUE SPECIFICITY: High expression levels in heart, skeletal muscle, brain, testis and ovary; moderate levels in prostate, placenta, liver and colon; and no detectable expression in peripheral leukocytes and thymus.","DISEASE: Ceroid lipofuscinosis, neuronal, 13 (CLN13) [MIM:615362]: A form of neuronal ceroid lipofuscinosis characterized by adult onset of progressive cognitive decline and motor dysfunction leading to dementia and often early death. Some patients develop seizures. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material. {ECO:0000269|PubMed:23297359}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTSF,8722,Hs.11590,ENST00000527141,THC2467407,GO:0004197(cysteine-type endopeptidase activity)|GO:0005764(lysosome)|GO:0006508(proteolysis)|GO:0008233(peptidase activity),"Homo sapiens cathepsin F (CTSF), mRNA [NM_003793]",chr11:66331002-66330943,hs|11q13.2,cathepsin F,TRUE
488_MYL12B_103910,O14950,"myosin regulatory light chain 12b (mlc-2a) (mlc-2) (myosin regulatory light chain 2-b, smooth muscle isoform) (myosin regulatory light chain 20 kda) (mlc20) (myosin regulatory light chain mrlc2) (shujun-1)",MYL12B MRLC2 MYLC2B,172,"function: myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. phosphorylation triggers actin polymerization in vascular smooth muscle. implicated in cytokinesis, receptor capping, and cell locomotion. {eco:0000269|pubmed:10965042}.",NA,"TISSUE SPECIFICITY: Ubiquitously expressed in various hematopoietic cells. {ECO:0000269|PubMed:11436981, ECO:0000269|PubMed:18480596}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MYL12B,103910,Hs.464472,ENST00000400177,THC2555071,GO:0001725(stress fiber)|GO:0005509(calcium ion binding)|GO:0005829(cytosol)|GO:0006936(muscle contraction)|GO:0007411(axon guidance)|GO:0008360(regulation of cell shape)|GO:0016460(myosin II complex)|GO:0030018(Z disc)|GO:0045177(apical part of cell),"Homo sapiens myosin, light chain 12B, regulatory (MYL12B), transcript variant 2, mRNA [NM_033546]",chr18:3278058-3278117,hs|18p11.31,"myosin, light chain 12B, regulatory",TRUE
489_MTMR4_9110,Q9NYA4,myotubularin-related protein 4 (ec 3.1.3.48) (fyve domain-containing dual specificity protein phosphatase 2) (fyve-dsp2) (zinc finger fyve domain-containing protein 11),MTMR4 KIAA0647 ZFYVE11,1195,"function: dephosphorylates proteins phosphorylated on ser, thr, and tyr residues and low molecular weight phosphatase substrate para-nitrophenylphosphate. phosphorylates phosphatidylinositol 3,4,5-trisphosphate (pip3). {eco:0000269|pubmed:11302699}.",subcellular location: cytoplasm {eco:0000269|pubmed:11302699}. membrane {eco:0000269|pubmed:11302699}; peripheral membrane protein {eco:0000269|pubmed:11302699}. note=localized to perinuclear region.,"TISSUE SPECIFICITY: Expressed in brain, heart, kidney, spleen, liver, colon, testis, muscle, placenta, thyroid gland, pancreas, ovary, prostate, skin, peripheral blood, and bone marrow. {ECO:0000269|PubMed:11302699}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MTMR4,9110,Hs.514373,ENST00000323456,THC2468680,GO:0004725(protein tyrosine phosphatase activity)|GO:0005737(cytoplasm)|GO:0006470(protein dephosphorylation)|GO:0016020(membrane)|GO:0016787(hydrolase activity)|GO:0035335(peptidyl-tyrosine dephosphorylation)|GO:0046872(metal ion binding),"Homo sapiens myotubularin related protein 4 (MTMR4), mRNA [NM_004687]",chr17:56566975-56566916,hs|17q22,myotubularin related protein 4,TRUE
49_U2AF1_7307,Q8WU68,splicing factor u2af 26 kda subunit (u2 auxiliary factor 26) (u2 small nuclear rna auxiliary factor 1-like protein 4) (u2af1-like 4) (u2(rnu2) small nuclear rna auxiliary factor 1-like protein 3) (u2 small nuclear rna auxiliary factor 1-like protein 3) (u2af1-like protein 3),U2AF1L4 U2AF1-RS3 U2AF1L3,220,function: rna-binding protein that function as a pre-mrna splicing factor. plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-rna interactions required for accurate 3'-splice site selection. acts by enhancing the binding of u2af2 to weak pyrimidine tracts. also participates in the regulation of alternative pre-mrna splicing. activates exon 5 skipping of ptprc during t-cell activation; an event reversed by gfi1. binds to rna at the ag dinucleotide at the 3'-splice site (by similarity). shows a preference for agc or aga (by similarity). {eco:0000250|uniprotkb:q8bgj9}.,subcellular location: nucleus {eco:0000250|uniprotkb:q8bgj9}. nucleus speckle {eco:0000250|uniprotkb:q8bgj9}. cytoplasm {eco:0000250|uniprotkb:q8bgj9}. note=interaction with c1qbp is required for the nuclear translocation. displays active nucleo-cytoplasmic shuttling. {eco:0000250|uniprotkb:q8bgj9}.,"TISSUE SPECIFICITY: Isoform 2 is widely expressed. Isoform 3 is highly expressed in heart, brain and lung, lower expressed in thymus and much lower expressed in peripheral blood leukocytes. {ECO:0000269|PubMed:17312947}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,U2AF1,7307,Hs.365116,ENST00000398137,THC2475389,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005730(nucleolus)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0015030(Cajal body)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0046872(metal ion binding)|GO:0050733(RS domain binding)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens U2 small nuclear RNA auxiliary factor 1 (U2AF1), transcript variant c, mRNA [NM_001025204]",chr21:44513222-44513163,hs|21q22.3,U2 small nuclear RNA auxiliary factor 1,TRUE
490_ABCC5_10057,O15440,multidrug resistance-associated protein 5 (atp-binding cassette sub-family c member 5) (multi-specific organic anion transporter c) (moat-c) (smrp) (pabc11),ABCC5 MRP5,1437,function: acts as a multispecific organic anion pump which can transport nucleotide analogs. {eco:0000269|pubmed:10840050}.,subcellular location: membrane; multi-pass membrane protein.,TISSUE SPECIFICITY: All isoforms are equally expressed in retina. {ECO:0000269|PubMed:17521428}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ABCC5,10057,Hs.728765,ENST00000437205,NP086323,"GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005624(membrane fraction)|GO:0005887(integral to plasma membrane)|GO:0006810(transport)|GO:0008514(organic anion transmembrane transporter activity)|GO:0015711(organic anion transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016887(ATPase activity)|GO:0032496(response to lipopolysaccharide)|GO:0032868(response to insulin stimulus)|GO:0042626(ATPase activity, coupled to transmembrane movement of substances)|GO:0048471(perinuclear region of cytoplasm)|GO:0055085(transmembrane transport)","Homo sapiens ATP-binding cassette, sub-family C (CFTR/MRP), member 5 (ABCC5), transcript variant 1, mRNA [NM_005688]",chr3:183637801-183637742,hs|3q27.1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 5",TRUE
491_KDELR2_11014,P33947,er lumen protein-retaining receptor 2 (erd2-like protein 1) (elp-1) (kdel endoplasmic reticulum protein retention receptor 2) (kdel receptor 2),KDELR2 ERD2.2,212,"function: receptor for the c-terminal sequence motif k-d-e-l that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the golgi back to the endoplasmic reticulum (pubmed:1325562, pubmed:18086916). binding is ph dependent, and is optimal at ph 5-5.4 (by similarity). {eco:0000250|uniprotkb:q5zkx9, eco:0000269|pubmed:1325562, eco:0000269|pubmed:18086916}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:1325562, eco:0000269|pubmed:18086916}; multi-pass membrane protein {eco:0000250|uniprotkb:q5zkx9}. golgi apparatus membrane {eco:0000269|pubmed:1325562, eco:0000269|pubmed:18086916}; multi-pass membrane protein {eco:0000250|uniprotkb:q5zkx9}. cytoplasmic vesicle, copi-coated vesicle membrane {eco:0000269|pubmed:18086916}; multi-pass membrane protein {eco:0000250|uniprotkb:q5zkx9}. note=localized in the golgi in the absence of bound proteins with the sequence motif k-d-e-l. trafficks back to the endoplasmic reticulum together with cargo proteins containing the sequence motif k-d-e-l. {eco:0000269|pubmed:1325562, eco:0000305|pubmed:18086916}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KDELR2,11014,Hs.654552,ENST00000258739,THC2544356,GO:0004872(receptor activity)|GO:0005046(KDEL sequence binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005801(cis-Golgi network)|GO:0006621(protein retention in ER lumen)|GO:0006886(intracellular protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport),"Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), transcript variant 1, mRNA [NM_006854]",chr7:6500941-6500882,hs|7p22.1,KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,TRUE
492_DAP3_7818,P51398,"28s ribosomal protein s29, mitochondrial (mrp-s29) (s29mt) (death-associated protein 3) (dap-3) (ionizing radiation resistance conferring protein) (mitochondrial small ribosomal subunit protein ms29)",DAP3 MRPS29,398,function: involved in mediating interferon-gamma-induced cell death.,"subcellular location: mitochondrion {eco:0000269|pubmed:11162496, eco:0000269|pubmed:20563667}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,DAP3,7818,Hs.516746,ENST00000477394,THC2469943,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0008637(apoptotic mitochondrial changes)|GO:0015935(small ribosomal subunit),"Homo sapiens death associated protein 3 (DAP3), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_033657]",chr1:155708157-155708216,hs|1q22,death associated protein 3,TRUE
493_HOXB13_10481,Q92826,homeobox protein hox-b13,HOXB13,284,function: sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. binds preferentially to methylated dna (pubmed:28473536). {eco:0000269|pubmed:28473536}.,subcellular location: nucleus.,NA,"DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:22236224, ECO:0000269|PubMed:22714738, ECO:0000269|PubMed:23064873, ECO:0000269|PubMed:23292082, ECO:0000269|PubMed:25629170, ECO:0000269|PubMed:27424772}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,HOXB13,10481,Hs.66731,ENST00000290295,THC2672852,GO:0001525(angiogenesis)|GO:0002009(morphogenesis of an epithelium)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0007275(multicellular organismal development)|GO:0008544(epidermis development)|GO:0009611(response to wounding)|GO:0033574(response to testosterone stimulus)|GO:0040008(regulation of growth)|GO:0043565(sequence-specific DNA binding)|GO:0060527(prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis)|GO:0060743(epithelial cell maturation involved in prostate gland development),"Homo sapiens homeobox B13 (HOXB13), mRNA [NM_006361]",chr17:46802203-46802144,hs|17q21.32,homeobox B13,TRUE
494_MT2A_4502,P02795,metallothionein-2 (mt-2) (metallothionein-2a) (metallothionein-ii) (mt-ii),MT2A CES1 MT2,61,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT2A,4502,Hs.647371,ENST00000245185,THC2508419,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006878(cellular copper ion homeostasis)|GO:0008270(zinc ion binding)|GO:0019221(cytokine-mediated signaling pathway)|GO:0045926(negative regulation of growth)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0060333(interferon-gamma-mediated signaling pathway)|GO:0071294(cellular response to zinc ion),"Homo sapiens metallothionein 2A (MT2A), mRNA [NM_005953]",chr16:56643281-56643340,hs|16q12.2,metallothionein 2A,TRUE
495_EIF4H_7458,Q15056,eukaryotic translation initiation factor 4h (eif-4h) (williams-beuren syndrome chromosomal region 1 protein),EIF4H KIAA0038 WBSCR1 WSCR1,248,"function: stimulates the rna helicase activity of eif4a in the translation initiation complex. binds weakly mrna. {eco:0000269|pubmed:10585411, eco:0000269|pubmed:11418588}.","subcellular location: cytoplasm, perinuclear region {eco:0000250}.","TISSUE SPECIFICITY: The short isoform is the predominant isoform and is expressed alone in liver and skeletal muscle. Both isoforms are expressed in fibroblast, spleen, testis and bone marrow. Levels are high in lung and pancreas and low in heart, frontal cortex and kidney. {ECO:0000269|PubMed:11003705, ECO:0000269|PubMed:8812460}.","DISEASE: Note=EIF4H is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of EIF4H may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. {ECO:0000269|PubMed:8812460}.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF4H,7458,Hs.520943,ENST00000353999,NP1199963,"GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0008135(translation factor activity, nucleic acid binding)|GO:0010467(gene expression)|GO:0016281(eukaryotic translation initiation factor 4F complex)|GO:0044267(cellular protein metabolic process)|GO:0044419(interspecies interaction between organisms)|GO:0048471(perinuclear region of cytoplasm)","Homo sapiens eukaryotic translation initiation factor 4H (EIF4H), transcript variant 1, mRNA [NM_022170]",chr7:73611194-73611253,hs|7q11.23,eukaryotic translation initiation factor 4H,TRUE
496_CNPY2_10330,Q9Y2B0,protein canopy homolog 2 (mir-interacting saposin-like protein) (putative secreted protein zsig9) (transmembrane protein 4),CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426,182,function: positive regulator of neurite outgrowth by stabilizing myosin regulatory light chain (mrlc). it prevents mir-mediated mrlc ubiquitination and its subsequent proteasomal degradation.,subcellular location: endoplasmic reticulum {eco:0000255|prosite-prorule:pru10138}.,"TISSUE SPECIFICITY: Expressed in different tissues. Highest levels are detected in adult placenta, liver and pancreas. {ECO:0000269|PubMed:12826659}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CNPY2,10330,Hs.8752,ENST00000273308,THC2466950,GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005887(integral to plasma membrane),"Homo sapiens canopy 2 homolog (zebrafish) (CNPY2), transcript variant 1, mRNA [NM_014255]",chr12:56704317-56704258,hs|12q13.3,canopy 2 homolog (zebrafish),TRUE
497_STARD3NL_83930,O95772,stard3 n-terminal-like protein (mln64 n-terminal domain homolog),STARD3NL MENTHO UNQ855/PRO1864,234,function: tethering protein that creates contact site between the endoplasmic reticulum and late endosomes: localizes to late endosome membranes and contacts the endoplasmic reticulum via interaction with vapa and vapb (pubmed:24105263). {eco:0000269|pubmed:24105263}.,subcellular location: late endosome membrane {eco:0000269|pubmed:24105263}; multi-pass membrane protein {eco:0000255}. note=localizes to contact sites between the endoplasmic reticulum and late endosomes: associates with the endoplasmic reticulum membrane via interaction with vapa and vapb. {eco:0000269|pubmed:24105263}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,STARD3NL,83930,Hs.728820,ENST00000544203,THC2468674,GO:0005768(endosome)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031902(late endosome membrane),"Homo sapiens STARD3 N-terminal like (STARD3NL), mRNA [NM_032016]",chr7:38270039-38270098,hs|7p14.1,STARD3 N-terminal like,TRUE
498_PIGY_84992,Q3MUY2,phosphatidylinositol n-acetylglucosaminyltransferase subunit y (phosphatidylinositol-glycan biosynthesis class y protein) (pig-y),PIGY,71,"function: component of the gpi-glcnac transferase (gpi-gnt) complex in the endoplasmic reticulum, a complex that catalyzes transfer of glcnac from udp-glcnac to an acceptor phosphatidylinositol, the first step in the production of gpi-anchors for cell surface proteins. may act by regulating the catalytic subunit piga. {eco:0000269|pubmed:16162815}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:16162815}; multi-pass membrane protein {eco:0000269|pubmed:16162815}.,NA,"DISEASE: Hyperphosphatasia with mental retardation syndrome 6 (HPMRS6) [MIM:616809]: An autosomal recessive, multisystem disorder characterized by severe developmental delay, dysmorphism, seizures, cataracts, and early death in some patients. {ECO:0000269|PubMed:26293662}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PIGY,84992,Hs.26136,ENST00000273968,THC2469182,GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005886(plasma membrane)|GO:0006506(GPI anchor biosynthetic process)|GO:0009893(positive regulation of metabolic process)|GO:0016021(integral to membrane),"Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class Y (PIGY), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_001042616]",chr4:89442331-89442272,hs|4q22.1,"phosphatidylinositol glycan anchor biosynthesis, class Y",TRUE
499_TCEAL4_79921,Q96EI5,transcription elongation factor a protein-like 4 (tcea-like protein 4) (transcription elongation factor s-ii protein-like 4),TCEAL4 NPD017,215,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEAL4,79921,Hs.194329,ENST00000415568,NP417800,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens transcription elongation factor A (SII)-like 4 (TCEAL4), transcript variant 1, mRNA [NM_024863]",chrX:102842228-102842287,hs|Xq22.2,transcription elongation factor A (SII)-like 4,TRUE
5_GGT6_124975,Q6P531,glutathione hydrolase 6 (ec 3.4.19.13) (gamma-glutamyltransferase 6) (ggt 6) (ec 2.3.2.2) (gamma-glutamyltranspeptidase 6) [cleaved into: glutathione hydrolase 6 heavy chain; glutathione hydrolase 6 light chain],GGT6,493,function: cleaves glutathione conjugates. {eco:0000250}.,subcellular location: membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GGT6,124975,Hs.130749,ENST00000381550,THC2491198,"GO:0003840(gamma-glutamyltransferase activity)|GO:0006749(glutathione metabolic process)|GO:0006750(glutathione biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016746(transferase activity, transferring acyl groups)|GO:0019370(leukotriene biosynthetic process)|GO:0031362(anchored to external side of plasma membrane)","Homo sapiens gamma-glutamyltransferase 6 (GGT6), transcript variant 2, mRNA [NM_153338]",chr17:4461097-4461038,hs|17p13.2,gamma-glutamyltransferase 6,TRUE
50_HERPUD1_9709,Q15011,homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (methyl methanesulfonate (mmf)-inducible fragment protein 1),HERPUD1 HERP KIAA0025 MIF1,391,"function: component of the endoplasmic reticulum quality control (erqc) system also called er-associated degradation (erad) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins. could enhance presenilin-mediated amyloid-beta protein 40 generation. binds to ubiquilins and this interaction is required for efficient degradation of cd3d via the erad pathway (pubmed:18307982). {eco:0000269|pubmed:16289116, eco:0000269|pubmed:18307982}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:10922362}; multi-pass membrane protein {eco:0000269|pubmed:10922362}.,"TISSUE SPECIFICITY: Widely expressed; in the brain, expression seems to be restricted to neurons and vascular smooth muscle cells. Present in activated microglia in senile plaques in the brain of patients with Alzheimer disease.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HERPUD1,9709,Hs.146393,ENST00000439977,THC2485199,GO:0003674(molecular_function)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006874(cellular calcium ion homeostasis)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030968(endoplasmic reticulum unfolded protein response)|GO:0043154(negative regulation of caspase activity),"Homo sapiens homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1), transcript variant 1, mRNA [NM_014685]",chr16:56977700-56977759,hs|16q13,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",TRUE
500_F11R_50848,Q9Y624,junctional adhesion molecule a (jam-a) (junctional adhesion molecule 1) (jam-1) (platelet f11 receptor) (platelet adhesion molecule 1) (pam-1) (cd antigen cd321),F11R JAM1 JCAM UNQ264/PRO301,299,"function: seems to play a role in epithelial tight junction formation. appears early in primordial forms of cell junctions and recruits pard3 (pubmed:11489913). the association of the pard6-pard3 complex may prevent the interaction of pard3 with jam1, thereby preventing tight junction assembly (by similarity). plays a role in regulating monocyte transmigration involved in integrity of epithelial barrier (by similarity). ligand for integrin alpha-l/beta-2 involved in memory t-cell and neutrophil transmigration (pubmed:11812992). involved in platelet activation (pubmed:10753840). {eco:0000250|uniprotkb:o88792, eco:0000269|pubmed:10753840, eco:0000269|pubmed:11489913, eco:0000269|pubmed:11812992}.; function: (microbial infection) acts as a receptor for mammalian reovirus sigma-1. {eco:0000269|pubmed:11239401}.; function: (microbial infection) acts as a receptor for human rotavirus strain wa. {eco:0000269|pubmed:25481868}.","subcellular location: cell junction, tight junction {eco:0000269|pubmed:11171323}. cell membrane {eco:0000269|pubmed:11171323}; single-pass type i membrane protein {eco:0000269|pubmed:11171323}. note=localized at tight junctions of both epithelial and endothelial cells. {eco:0000269|pubmed:11171323}.","TISSUE SPECIFICITY: Expressed in endothelium, epithelium and leukocytes (at protein level). {ECO:0000269|PubMed:11812992}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,F11R,50848,Hs.517293,ENST00000368026,THC2469628,GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0005923(tight junction)|GO:0006954(inflammatory response)|GO:0007155(cell adhesion)|GO:0007596(blood coagulation)|GO:0016021(integral to membrane)|GO:0030855(epithelial cell differentiation)|GO:0034329(cell junction assembly)|GO:0044419(interspecies interaction between organisms)|GO:0045216(cell-cell junction organization)|GO:0050900(leukocyte migration)|GO:0070830(tight junction assembly),"Homo sapiens F11 receptor (F11R), mRNA [NM_016946]",chr1:160966092-160966033,hs|1q23.3,F11 receptor,TRUE
501_POLR2H_5437,P52434,"dna-directed rna polymerases i, ii, and iii subunit rpabc3 (rna polymerases i, ii, and iii subunit abc3) (dna-directed rna polymerase ii subunit h) (dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide) (rpb17) (rpb8 homolog) (hrpb8)",POLR2H,150,"function: dna-dependent rna polymerase catalyzes the transcription of dna into rna using the four ribonucleoside triphosphates as substrates. common component of rna polymerases i, ii and iii which synthesize ribosomal rna precursors, mrna precursors and many functional non-coding rnas, and small rnas, such as 5s rrna and trnas, respectively. {eco:0000269|pubmed:9852112}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:9852112, eco:0000269|ref.6}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,POLR2H,5437,Hs.432574,ENST00000476003,THC2686089,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003899(DNA-directed RNA polymerase activity)|GO:0004672(protein kinase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005665(DNA-directed RNA polymerase II, core complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006281(DNA repair)|GO:0006283(transcription-coupled nucleotide-excision repair)|GO:0006289(nucleotide-excision repair)|GO:0006351(transcription, DNA-dependent)|GO:0006360(transcription from RNA polymerase I promoter)|GO:0006361(transcription initiation from RNA polymerase I promoter)|GO:0006362(transcription elongation from RNA polymerase I promoter)|GO:0006363(termination of RNA polymerase I transcription)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0006370(mRNA capping)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0006385(transcription elongation from RNA polymerase III promoter)|GO:0006386(termination of RNA polymerase III transcription)|GO:0006468(protein phosphorylation)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0050434(positive regulation of viral transcription)","Homo sapiens polymerase (RNA) II (DNA directed) polypeptide H (POLR2H), mRNA [NM_006232]",chr3:184086244-184086303,hs|3q27.1,polymerase (RNA) II (DNA directed) polypeptide H,TRUE
502_NBPF10_100132406,Q6P3W6,neuroblastoma breakpoint family member 10,NBPF10,841,NA,subcellular location: cytoplasm {eco:0000305}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NBPF10,100132406,Hs.714127,ENST00000369190,THC2551861,GO:0005737(cytoplasm),"Homo sapiens neuroblastoma breakpoint family, member 10 (NBPF10), mRNA [NM_001039703]",chr1:145313371-145313430,hs|1q21.1,"neuroblastoma breakpoint family, member 10",TRUE
503_KIF5C_3800,O60282,kinesin heavy chain isoform 5c (kinesin heavy chain neuron-specific 2),KIF5C KIAA0531 NKHC2,957,"function: involved in synaptic transmission (pubmed:24812067). mediates dendritic trafficking of mrnas (by similarity). kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. required for anterograde axonal transportation of mapk8ip3/jip3 which is essential for mapk8ip3/jip3 function in axon elongation (by similarity). {eco:0000250|uniprotkb:p28738, eco:0000250|uniprotkb:p56536, eco:0000269|pubmed:24812067}.","subcellular location: cytoplasm, cytoskeleton {eco:0000305}. cell projection, dendrite {eco:0000269|pubmed:24812067}. note=abundant in distal regions of dendrites. {eco:0000269|pubmed:24812067}.","TISSUE SPECIFICITY: Highest expression in brain, prostate and testis, and moderate expression in kidney, small intestine and ovary.","DISEASE: Cortical dysplasia, complex, with other brain malformations 2 (CDCBM2) [MIM:615282]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Clinical features include intrauterine growth retardation, fetal akinesia, seizures, microcephaly, lack of psychomotor development, and arthrogryposis. Brain imaging shows malformations of cortical development, including polymicrogyria, gyral simplification, and thin corpus callosum. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:23603762, ECO:0000269|PubMed:24812067, ECO:0000269|PubMed:29048727}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,KIF5C,3800,Hs.660699,ENST00000435030,THC2561166,GO:0000166(nucleotide binding)|GO:0003777(microtubule motor activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005871(kinesin complex)|GO:0005874(microtubule)|GO:0006996(organelle organization)|GO:0007018(microtubule-based movement)|GO:0008045(motor axon guidance)|GO:0034190(apolipoprotein receptor binding)|GO:0035253(ciliary rootlet)|GO:0043005(neuron projection),"Homo sapiens kinesin family member 5C (KIF5C), mRNA [NM_004522]",chr2:149883078-149883137,hs|2q23.1,kinesin family member 5C,TRUE
504_IER2_9592,Q9BTL4,immediate early response gene 2 protein (protein etr101),IER2 ETR101 PIP92,223,"function: dna-binding protein that seems to act as a transcription factor (pubmed:19584537). involved in the regulation of neuronal differentiation, acts upon jnk-signaling pathway activation and plays a role in neurite outgrowth in hippocampal cells (by similarity). may mediate with fibp fgf-signaling in the establishment of laterality in the embryo (by similarity). promotes cell motility, seems to stimulate tumor metastasis (pubmed:22120713). {eco:0000250|uniprotkb:b7sxm5, eco:0000250|uniprotkb:q6p7d3, eco:0000269|pubmed:19584537, eco:0000269|pubmed:22120713}.","subcellular location: cytoplasm {eco:0000269|pubmed:22120713}. nucleus {eco:0000269|pubmed:22120713}. note=cytoplasmic during quiescence, translocates to the nucleus upon stimulation. {eco:0000269|pubmed:22120713}.",TISSUE SPECIFICITY: Expressed in activated T-cells (at protein level) (PubMed:22120713). Expression increases in metastatic tumor cells (at protein level) (PubMed:22120713). {ECO:0000269|PubMed:22120713}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,IER2,9592,Hs.501629,ENST00000292433,THC2469604,GO:0005737(cytoplasm),"Homo sapiens immediate early response 2 (IER2), mRNA [NM_004907]",chr19:13265649-13265708,hs|19p13.2,immediate early response 2,TRUE
506_SPOCK1_6695,Q08629,testican-1 (protein spock),SPOCK1 SPOCK TIC1 TICN1,439,function: may play a role in cell-cell and cell-matrix interactions. may contribute to various neuronal mechanisms in the central nervous system.,"subcellular location: secreted, extracellular space, extracellular matrix.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SPOCK1,6695,Hs.596136,ENST00000394945,THC2650060,GO:0001558(regulation of cell growth)|GO:0001764(neuron migration)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0004869(cysteine-type endopeptidase inhibitor activity)|GO:0005509(calcium ion binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0007155(cell adhesion)|GO:0007165(signal transduction)|GO:0007399(nervous system development)|GO:0008191(metalloendopeptidase inhibitor activity)|GO:0010812(negative regulation of cell-substrate adhesion)|GO:0010951(negative regulation of endopeptidase activity)|GO:0010977(negative regulation of neuron projection development)|GO:0014069(postsynaptic density)|GO:0016528(sarcoplasm)|GO:0021953(central nervous system neuron differentiation)|GO:0022008(neurogenesis)|GO:0031594(neuromuscular junction)|GO:0033268(node of Ranvier),"Homo sapiens sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 (SPOCK1), mRNA [NM_004598]",chr5:136311246-136311187,hs|5q31.2,"sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1",TRUE
507_H1F0_3005,P07305,"histone h1.0 (histone h1') (histone h1(0)) [cleaved into: histone h1.0, n-terminally processed]",H1-0 H1F0 H1FV,194,function: histones h1 are necessary for the condensation of nucleosome chains into higher-order structures. the histones h1.0 are found in cells that are in terminal stages of differentiation or that have low rates of cell division.,"subcellular location: nucleus {eco:0000255|prosite-prorule:pru00837, eco:0000269|pubmed:18993075}. chromosome {eco:0000255|prosite-prorule:pru00837, eco:0000269|pubmed:18993075}. note=the rna edited version has been localized to nuclear speckles. during mitosis, it appears in the vicinity of condensed chromosomes.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H1F0,3005,Hs.226117,ENST00000340857,THC2513918,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005694(chromosome)|GO:0005794(Golgi apparatus)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006334(nucleosome assembly)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis),"Homo sapiens H1 histone family, member 0 (H1F0), mRNA [NM_005318]",chr22:38203147-38203206,hs|22q13.1,"H1 histone family, member 0",TRUE
509_PILRB_29990,Q9UKJ0,paired immunoglobulin-like type 2 receptor beta (activating receptor pilr-beta) (cell surface receptor fdfact),PILRB FDFACT PP1551,227,function: paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. pilrb is thought to act as a cellular signaling activating receptor that associates with itam-bearing adapter molecules on the cell surface.,subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PILRB,29990,Hs.632314,ENST00000413850,THC2480313,GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005887(integral to plasma membrane)|GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway)|GO:0007171(activation of transmembrane receptor protein tyrosine kinase activity)|GO:0016020(membrane),"Homo sapiens paired immunoglobin-like type 2 receptor beta (PILRB), transcript variant 3, mRNA [NM_178238]",chr7:99965239-99965298,hs|7q22.1,paired immunoglobin-like type 2 receptor beta,TRUE
51_SLC45A3_85414,Q96JT2,solute carrier family 45 member 3 (prostate cancer-associated protein 6) (prostein),SLC45A3 PCANAP6 PRST,553,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Prostate specific. Expressed in all prostatic glandular cells. Expressed both in normal and cancerous prostates. {ECO:0000269|PubMed:11245466, ECO:0000269|PubMed:14997204}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,SLC45A3,85414,Hs.278695,ENST00000367145,NP1165434,GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0055085(transmembrane transport),"Homo sapiens solute carrier family 45, member 3 (SLC45A3), mRNA [NM_033102]",chr1:205627096-205627037,hs|1q32.1,"solute carrier family 45, member 3",TRUE
510_CDC42_998,P60953,cell division control protein 42 homolog (ec 3.6.5.2) (g25k gtp-binding protein),CDC42,191,"function: plasma membrane-associated small gtpase which cycles between an active gtp-bound and an inactive gdp-bound state. in active state binds to a variety of effector proteins to regulate cellular responses. involved in epithelial cell polarization processes. regulates the bipolar attachment of spindle microtubules to kinetochores before chromosome congression in metaphase (pubmed:15642749). regulates cell migration (pubmed:17038317). in neurons, plays a role in the extension and maintenance of the formation of filopodia, thin and actin-rich surface projections (pubmed:14978216). required for dock10-mediated spine formation in purkinje cells and hippocampal neurons. facilitates filopodia formation upon dock11-activation (by similarity). upon activation by camkii, modulates dendritic spine structural plasticity by relaying camkii transient activation to synapse-specific, long-term signaling (by similarity). also plays a role in phagocytosis through organization of the f-actin cytoskeleton associated with forming phagocytic cups (pubmed:26465210). {eco:0000250|uniprotkb:p60766, eco:0000250|uniprotkb:q8cfn2, eco:0000269|pubmed:14978216, eco:0000269|pubmed:15642749, eco:0000269|pubmed:17038317, eco:0000269|pubmed:26465210}.","subcellular location: cell membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:15642749}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:15642749}. midbody {eco:0000269|pubmed:15642749}. cell projection, dendrite {eco:0000250|uniprotkb:p60766}. note=localizes to spindle during prometaphase cells. moves to the central spindle as cells progressed through anaphase to telophase (pubmed:15642749). localizes at the end of cytokinesis in the intercellular bridge formed between two daughter cells (pubmed:15642749). its localization is regulated by the activities of guanine nucleotide exchange factor ect2 and gtpase activating protein racgap1 (pubmed:15642749). colocalizes with nek6 in the centrosome (pubmed:20873783). in its active gtp-bound form localizes to the leading edge membrane of migrating dendritic cells (by similarity). {eco:0000250|uniprotkb:p60766, eco:0000269|pubmed:15642749, eco:0000269|pubmed:20873783}.",NA,"DISEASE: Takenouchi-Kosaki syndrome (TKS) [MIM:616737]: A syndrome characterized by macrothrombocytopenia, lymphedema, mental retardation, developmental delay, and distinctive facial features. {ECO:0000269|PubMed:26386261, ECO:0000269|PubMed:26708094}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CDC42,998,Hs.467637,ENST00000400259,THC2465366,GO:0000139(Golgi membrane)|GO:0000166(nucleotide binding)|GO:0003334(keratinocyte development)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0007088(regulation of mitosis)|GO:0007097(nuclear migration)|GO:0007163(establishment or maintenance of cell polarity)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007264(small GTPase mediated signal transduction)|GO:0007399(nervous system development)|GO:0007411(axon guidance)|GO:0007596(blood coagulation)|GO:0010628(positive regulation of gene expression)|GO:0010629(negative regulation of gene expression)|GO:0030036(actin cytoskeleton organization)|GO:0030141(stored secretory granule)|GO:0030175(filopodium)|GO:0030225(macrophage differentiation)|GO:0030496(midbody)|GO:0030742(GTP-dependent protein binding)|GO:0031069(hair follicle morphogenesis)|GO:0031274(positive regulation of pseudopodium assembly)|GO:0031295(T cell costimulation)|GO:0031333(negative regulation of protein complex assembly)|GO:0031424(keratinization)|GO:0031435(mitogen-activated protein kinase kinase kinase binding)|GO:0031647(regulation of protein stability)|GO:0031996(thioesterase binding)|GO:0033138(positive regulation of peptidyl-serine phosphorylation)|GO:0034332(adherens junction organization)|GO:0034613(cellular protein localization)|GO:0035088(establishment or maintenance of apical/basal cell polarity)|GO:0035264(multicellular organism growth)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042176(regulation of protein catabolic process)|GO:0042692(muscle cell differentiation)|GO:0042995(cell projection)|GO:0043497(regulation of protein heterodimerization activity)|GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)|GO:0045177(apical part of cell)|GO:0045740(positive regulation of DNA replication)|GO:0045859(regulation of protein kinase activity)|GO:0046330(positive regulation of JNK cascade)|GO:0046847(filopodium assembly)|GO:0048664(neuron fate determination)|GO:0051017(actin filament bundle assembly)|GO:0051056(regulation of small GTPase mediated signal transduction)|GO:0051149(positive regulation of muscle cell differentiation)|GO:0051233(spindle midzone)|GO:0051301(cell division)|GO:0051489(regulation of filopodium assembly)|GO:0051647(nucleus localization)|GO:0051988(regulation of attachment of spindle microtubules to kinetochore)|GO:0060070(canonical Wnt receptor signaling pathway)|GO:0060684(epithelial-mesenchymal cell signaling)|GO:0060789(hair follicle placode formation)|GO:0071338(positive regulation of hair follicle cell proliferation)|GO:0071777(positive regulation of cell cycle cytokinesis)|GO:0072686(mitotic spindle)|GO:0090136(epithelial cell-cell adhesion),"Homo sapiens cell division cycle 42 (GTP binding protein, 25kDa) (CDC42), transcript variant 3, mRNA [NM_001039802]",chr1:22419269-22419328,hs|1p36.12,"cell division cycle 42 (GTP binding protein, 25kDa)",TRUE
511_SLC25A5_292,P05141,"adp/atp translocase 2 (adp,atp carrier protein 2) (adp,atp carrier protein, fibroblast isoform) (adenine nucleotide translocator 2) (ant 2) (solute carrier family 25 member 5) [cleaved into: adp/atp translocase 2, n-terminally processed]",SLC25A5 ANT2,298,function: catalyzes the exchange of cytoplasmic adp with mitochondrial atp across the mitochondrial inner membrane. as part of the mitotic spindle-associated mmxd complex it may play a role in chromosome segregation. {eco:0000269|pubmed:20797633}.,subcellular location: mitochondrion inner membrane; multi-pass membrane protein.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC25A5,292,Hs.632282,ENST00000317881,THC2465313,GO:0005215(transporter activity)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005887(integral to plasma membrane)|GO:0006112(energy reserve metabolic process)|GO:0006810(transport)|GO:0007059(chromosome segregation)|GO:0015207(adenine transmembrane transporter activity)|GO:0015853(adenine transport)|GO:0016020(membrane)|GO:0016032(viral reproduction)|GO:0042645(mitochondrial nucleoid)|GO:0044419(interspecies interaction between organisms)|GO:0050796(regulation of insulin secretion)|GO:0055085(transmembrane transport)|GO:0071817(MMXD complex),"Homo sapiens solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 (SLC25A5), nuclear gene encoding mitochondrial protein, mRNA [NM_001152]",chrX:118605131-118605190,hs|Xq24,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5",TRUE
512_HIST1H2BK_85236,O60814,histone h2b type 1-k (h2b k) (hira-interacting protein 1),H2BC12 H2BFT HIRIP1 HIST1H2BK,126,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; function: has broad antibacterial activity. may contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2BK,85236,Hs.437275,ENST00000396891,THC2763449,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly)|GO:0042742(defense response to bacterium),"Homo sapiens histone cluster 1, H2bk (HIST1H2BK), mRNA [NM_080593]",chr6:27106250-27106191,hs|6p22.1,"histone cluster 1, H2bk",TRUE
513_ZMIZ1_57178,Q9ULJ6,zinc finger miz domain-containing protein 1 (pias-like protein zimp10) (retinoic acid-induced protein 17),ZMIZ1 KIAA1224 RAI17 ZIMP10,1067,"function: acts as transcriptional coactivator. increases ligand-dependent transcriptional activity of ar and promotes ar sumoylation. the stimulation of ar activity is dependent upon sumoylation (pubmed:14609956, pubmed:26522984). involved in transcriptional activation of a subset of notch1 target genes including myc. involved in thymocyte and t cell development (by similarity). {eco:0000250|uniprotkb:q6p1e1, eco:0000269|pubmed:14609956, eco:0000269|pubmed:26522984}.",subcellular location: nucleus speckle {eco:0000269|pubmed:14609956}. cytoplasm {eco:0000269|pubmed:14609956}.,"TISSUE SPECIFICITY: Expressed most abundantly in ovary and, at lower levels, in prostate, spleen and testis. Weak expression, if any, in thymus, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:14609956}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZMIZ1,57178,Hs.193118,ENST00000334512,THC2491898,"GO:0001570(vasculogenesis)|GO:0001701(in utero embryonic development)|GO:0003007(heart morphogenesis)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007296(vitellogenesis)|GO:0007569(cell aging)|GO:0008270(zinc ion binding)|GO:0016607(nuclear speck)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding)|GO:0048146(positive regulation of fibroblast proliferation)|GO:0048589(developmental growth)|GO:0048844(artery morphogenesis)","Homo sapiens zinc finger, MIZ-type containing 1 (ZMIZ1), mRNA [NM_020338]",chr10:81076036-81076095,hs|10q22.3,"zinc finger, MIZ-type containing 1",TRUE
514_NR2F2_7026,P24468,coup transcription factor 2 (coup-tf2) (apolipoprotein a-i regulatory protein 1) (arp-1) (coup transcription factor ii) (coup-tf ii) (nuclear receptor subfamily 2 group f member 2),NR2F2 ARP1 TFCOUP2,414,"function: ligand-activated transcription factor. activated by high concentrations of 9-cis-retinoic acid and all-trans-retinoic acid, but not by dexamethasone, cortisol or progesterone (in vitro). regulation of the apolipoprotein a-i gene transcription. binds to dna site a. {eco:0000269|pubmed:18798693, eco:0000269|pubmed:1899293, eco:0000269|pubmed:9343308}.",subcellular location: nucleus.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]: A disorder characterized by congenital developmental abnormalities involving structures of the heart. Common defects include transposition of the great arteries, aortic stenosis, atrial septal defect, ventricular septal defect, pulmonic stenosis, and patent ductus arteriosus. Some patients also have cardiac arrhythmias, which may be due to the anatomic defect itself or to surgical interventions. {ECO:0000269|PubMed:24702954}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NR2F2,7026,Hs.347991,ENST00000394166,THC2466703,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001764(neuron migration)|GO:0001937(negative regulation of endothelial cell proliferation)|GO:0001945(lymph vessel development)|GO:0001972(retinoic acid binding)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003706(ligand-regulated transcription factor activity)|GO:0003707(steroid hormone receptor activity)|GO:0003714(transcription corepressor activity)|GO:0004872(receptor activity)|GO:0004879(ligand-dependent nuclear receptor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006629(lipid metabolic process)|GO:0007165(signal transduction)|GO:0007519(skeletal muscle tissue development)|GO:0008270(zinc ion binding)|GO:0009952(anterior/posterior pattern formation)|GO:0009956(radial pattern formation)|GO:0010596(negative regulation of endothelial cell migration)|GO:0030522(intracellular receptor mediated signaling pathway)|GO:0030900(forebrain development)|GO:0032355(response to estradiol stimulus)|GO:0042803(protein homodimerization activity)|GO:0043565(sequence-specific DNA binding)|GO:0045736(negative regulation of cyclin-dependent protein kinase activity)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0048514(blood vessel morphogenesis)|GO:0060173(limb development)|GO:0060849(regulation of transcription involved in lymphatic endothelial cell fate commitment)","Homo sapiens nuclear receptor subfamily 2, group F, member 2 (NR2F2), transcript variant 1, mRNA [NM_021005]",chr15:96881957-96882016,hs|15q26.2,"nuclear receptor subfamily 2, group F, member 2",TRUE
515_ACO2_50,Q99798,"aconitate hydratase, mitochondrial (aconitase) (ec 4.2.1.3) (citrate hydro-lyase)",ACO2,780,function: catalyzes the isomerization of citrate to isocitrate via cis-aconitate. {eco:0000250|uniprotkb:p16276}.,subcellular location: mitochondrion {eco:0000250|uniprotkb:p16276}.,NA,"DISEASE: Infantile cerebellar-retinal degeneration (ICRD) [MIM:614559]: A severe autosomal recessive neurodegenerative disorder characterized by onset between ages 2 and 6 months of truncal hypotonia, athetosis, seizures, and ophthalmologic abnormalities, particularly optic atrophy and retinal degeneration. Affected individuals show profound psychomotor retardation, with only some achieving rolling, sitting, or recognition of family. Brain MRI shows progressive cerebral and cerebellar degeneration. {ECO:0000269|PubMed:22405087, ECO:0000269|PubMed:25351951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Optic atrophy 9 (OPA9) [MIM:616289]: A condition that features progressive visual loss in association with optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. {ECO:0000269|PubMed:25351951}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ACO2,50,Hs.643610,ENST00000544234,THC2543646,"GO:0003994(aconitate hydratase activity)|GO:0005506(iron ion binding)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006091(generation of precursor metabolites and energy)|GO:0006099(tricarboxylic acid cycle)|GO:0006101(citrate metabolic process)|GO:0006102(isocitrate metabolic process)|GO:0008152(metabolic process)|GO:0016829(lyase activity)|GO:0046872(metal ion binding)|GO:0051538(3 iron, 4 sulfur cluster binding)|GO:0051539(4 iron, 4 sulfur cluster binding)|GO:0052632(citrate hydro-lyase (cis-aconitate-forming) activity)|GO:0052633(isocitrate hydro-lyase (cis-aconitate-forming) activity)","Homo sapiens aconitase 2, mitochondrial (ACO2), nuclear gene encoding mitochondrial protein, mRNA [NM_001098]",chr22:41924818-41924877,hs|22q13.2,"aconitase 2, mitochondrial",TRUE
516_TACSTD2_4070,P09758,tumor-associated calcium signal transducer 2 (cell surface glycoprotein trop-2) (membrane component chromosome 1 surface marker 1) (pancreatic carcinoma marker protein ga733-1),TACSTD2 GA733-1 M1S1 TROP2,323,function: may function as a growth factor receptor.,subcellular location: membrane; single-pass type i membrane protein.,"TISSUE SPECIFICITY: Placenta, pancreatic carcinoma cell lines.","DISEASE: Corneal dystrophy, gelatinous drop-like (GDLD) [MIM:204870]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. GDLD is an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness. Clinical manifestations, which appear in the first decade of life, include blurred vision, photophobia, and foreign-body sensation. By the third decade, raised, yellowish-gray, gelatinous masses severely impair visual acuity. {ECO:0000269|PubMed:10192395}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TACSTD2,4070,Hs.23582,ENST00000371225,THC2468807,GO:0004872(receptor activity)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0007601(visual perception)|GO:0008283(cell proliferation)|GO:0016020(membrane)|GO:0050896(response to stimulus),"Homo sapiens tumor-associated calcium signal transducer 2 (TACSTD2), mRNA [NM_002353]",chr1:59041468-59041409,hs|1p32.1,tumor-associated calcium signal transducer 2,TRUE
517_NME3_4832,Q13232,nucleoside diphosphate kinase 3 (ndk 3) (ndp kinase 3) (ec 2.7.4.6) (dr-nm23) (nucleoside diphosphate kinase c) (ndpkc) (nm23-h3),NME3,169,"function: major role in the synthesis of nucleoside triphosphates other than atp. the atp gamma phosphate is transferred to the ndp beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. probably has a role in normal hematopoiesis by inhibition of granulocyte differentiation and induction of apoptosis.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,NME3,4832,Hs.514065,ENST00000219302,THC2620196,GO:0000166(nucleotide binding)|GO:0004550(nucleoside diphosphate kinase activity)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0006183(GTP biosynthetic process)|GO:0006228(UTP biosynthetic process)|GO:0006241(CTP biosynthetic process)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0009117(nucleotide metabolic process)|GO:0016301(kinase activity)|GO:0016740(transferase activity)|GO:0046872(metal ion binding),"Homo sapiens non-metastatic cells 3, protein expressed in (NME3), mRNA [NM_002513]",chr16:1820410-1820351,hs|16p13.3,"non-metastatic cells 3, protein expressed in",TRUE
519_NBPF11_200030,Q86T75,neuroblastoma breakpoint family member 11 (neuroblastoma breakpoint family member 24),NBPF11 NBPF24,865,NA,subcellular location: cytoplasm {eco:0000305}.,TISSUE SPECIFICITY: Expressed in spinal cord. {ECO:0000269|PubMed:16079250}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NBPF11,200030,Hs.515947,ENST00000309471,THC2526527,NA,"Homo sapiens neuroblastoma breakpoint family, member 11 (NBPF11), mRNA [NM_183372]",chr1:146036007-146035948,hs|1q21.1,"neuroblastoma breakpoint family, member 11",TRUE
52_RPS20_6224,P60866,40s ribosomal protein s20 (small ribosomal subunit protein us10),RPS20,119,NA,subcellular location: cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS20,6224,Hs.8102,ENST00000521262,THC2540737,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S20 (RPS20), transcript variant 2, mRNA [NM_001023]",chr8:56985718-56985659,hs|8q12.1,ribosomal protein S20,TRUE
520_PTGES3_10728,Q15185,prostaglandin e synthase 3 (ec 5.3.99.3) (cytosolic prostaglandin e2 synthase) (cpges) (hsp90 co-chaperone) (progesterone receptor complex p23) (telomerase-binding protein p23),PTGES3 P23 TEBP,160,"function: cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide h2 (pgh2) to prostaglandin e2 (pge2) (pubmed:10922363). molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes (pubmed:11274138, pubmed:12077419). facilitates hif alpha proteins hydroxylation via interaction with egln1/phd2, leading to recruit egln1/phd2 to the hsp90 pathway (pubmed:24711448). {eco:0000269|pubmed:10922363, eco:0000269|pubmed:11274138, eco:0000269|pubmed:12077419, eco:0000269|pubmed:24711448}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:q3zbf7}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PTGES3,10728,Hs.50425,ENST00000552354,NP1196612,"GO:0000723(telomere maintenance)|GO:0000781(chromosome, telomeric region)|GO:0001516(prostaglandin biosynthetic process)|GO:0003720(telomerase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005697(telomerase holoenzyme complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006633(fatty acid biosynthetic process)|GO:0006692(prostanoid metabolic process)|GO:0007165(signal transduction)|GO:0016853(isomerase activity)|GO:0050220(prostaglandin-E synthase activity)|GO:0051082(unfolded protein binding)|GO:0070389(chaperone cofactor-dependent protein refolding)","Homo sapiens prostaglandin E synthase 3 (cytosolic) (PTGES3), mRNA [NM_006601]",chr12:57057465-57057407,hs|12q13.3,prostaglandin E synthase 3 (cytosolic),TRUE
521_YTHDF2_51441,Q9Y5A9,yth domain-containing family protein 2 (cll-associated antigen kw-14) (high-glucose-regulated protein 8) (renal carcinoma antigen ny-ren-2),YTHDF2 HGRG8,579,"function: specifically recognizes and binds n6-methyladenosine (m6a)-containing rnas, and regulates mrna stability (pubmed:24284625, pubmed:26046440, pubmed:26318451). m6a is a modification present at internal sites of mrnas and some non-coding rnas and plays a role in mrna stability and processing (pubmed:24284625, pubmed:22575960, pubmed:25412658, pubmed:25412661). acts as a regulator of mrna stability by promoting degradation of m6a-containing mrnas via interaction with the ccr4-not and ribonuclease p/mrp complexes, depending on the context (pubmed:24284625, pubmed:26046440, pubmed:27558897, pubmed:30930054). m6a-containing mrnas containing a binding site for rida/hrsp12 (5'-gguuc-3') are preferentially degraded by endoribonucleolytic cleavage: cooperative binding of rida/hrsp12 and ythdf2 to transcripts leads to recruitment of the ribonuclease p/mrp complex (pubmed:30930054). other m6a-containing mrnas undergo deadenylation via direct interaction between ythdf2 and cnot1, leading to recruitment of the ccr4-not and subsequent deadenylation of m6a-containing mrnas (pubmed:27558897). required maternally to regulate oocyte maturation: probably acts by binding to m6a-containing mrnas, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain early zygotic development (by similarity). also involved in hematopoietic stem cells specification by binding to m6a-containing mrnas, leading to promote their degradation (pubmed:30065315). also acts as a regulator of neural development by promoting m6a-dependent degradation of neural development-related mrna targets (by similarity). regulates circadian regulation of hepatic lipid metabolism: acts by promoting m6a-dependent degradation of ppara transcripts (pubmed:30428350). regulates the innate immune response to infection by inhibiting the type i interferon response: acts by binding to m6a-containing ifnb transcripts and promoting their degradation (pubmed:30559377). also acts as a promoter of cap-independent mrna translation following heat shock stress: upon stress, relocalizes to the nucleus and specifically binds mrnas with some m6a methylation mark at their 5'-utr, protecting demethylation of mrnas by fto, thereby promoting cap-independent mrna translation (pubmed:26458103). {eco:0000250|uniprotkb:q91yt7, eco:0000269|pubmed:22575960, eco:0000269|pubmed:24284625, eco:0000269|pubmed:25412658, eco:0000269|pubmed:25412661, eco:0000269|pubmed:26046440, eco:0000269|pubmed:26318451, eco:0000269|pubmed:26458103, eco:0000269|pubmed:27558897, eco:0000269|pubmed:30065315, eco:0000269|pubmed:30428350, eco:0000269|pubmed:30559377, eco:0000269|pubmed:30930054}.; function: (microbial infection) promotes viral gene expression and replication of polyomavirus sv40: acts by binding to n6-methyladenosine (m6a)-containing viral rnas (pubmed:29447282). {eco:0000269|pubmed:29447282}.; function: (microbial infection) promotes viral gene expression and virion production of kaposis sarcoma-associated herpesvirus (kshv) at some stage of the kshv life cycle (in islk.219 and islk.bac16 cells) (pubmed:29659627). acts by binding to n6-methyladenosine (m6a)-containing viral rnas (pubmed:29659627). {eco:0000269|pubmed:29659627}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:26458103}. nucleus {eco:0000269|pubmed:26458103}. cytoplasm, p-body {eco:0000269|pubmed:24284625}. note=localizes to the cytosol and relocates to the nucleus following heat shock stress (pubmed:26458103). {eco:0000269|pubmed:26458103}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YTHDF2,51441,Hs.532286,ENST00000478283,NP1181810,GO:0006959(humoral immune response),"Homo sapiens YTH domain family, member 2 (YTHDF2), transcript variant 1, mRNA [NM_016258]",chr1:29095448-29095507,hs|1p35.3,"YTH domain family, member 2",TRUE
522_COX6A1_1337,P12074,"cytochrome c oxidase subunit 6a1, mitochondrial (cytochrome c oxidase polypeptide via-liver) (cytochrome c oxidase subunit via-liver) (cox via-l)",COX6A1 COX6AL,109,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane.,NA,"DISEASE: Charcot-Marie-Tooth disease, recessive, intermediate type, D (CMTRID) [MIM:616039]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Recessive intermediate forms of Charcot-Marie-Tooth disease are characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. {ECO:0000269|PubMed:25152455}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX6A1,1337,Hs.369624,ENST00000549525,THC2521098,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005751(mitochondrial respiratory chain complex IV)|GO:0006091(generation of precursor metabolites and energy)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1), nuclear gene encoding mitochondrial protein, mRNA [NM_004373]",chr12:120878417-120878476,hs|12q24.31,cytochrome c oxidase subunit VIa polypeptide 1,TRUE
523_TRMT5_57570,Q32P41,trna (guanine(37)-n1)-methyltransferase (ec 2.1.1.228) (m1g-methyltransferase) (trna [gm37] methyltransferase) (trna methyltransferase 5 homolog),TRMT5 KIAA1393 TRM5,509,"function: involved in mitochondrial trna methylation (pubmed:26189817). specifically methylates the n1 position of guanosine-37 in various trnas. methylation is not dependent on the nature of the nucleoside 5' of the target nucleoside. this is the first step in the biosynthesis of wybutosine (yw), a modified base adjacent to the anticodon of trnas and required for accurate decoding. {eco:0000269|pubmed:26189817}.","subcellular location: mitochondrion matrix {eco:0000255|hamap-rule:mf_03152, eco:0000269|pubmed:26189817}. nucleus {eco:0000255|hamap-rule:mf_03152}. cytoplasm {eco:0000255|hamap-rule:mf_03152}. note=predominantly in the mitochondria and in the nucleus. {eco:0000255|hamap-rule:mf_03152}.",NA,"DISEASE: Combined oxidative phosphorylation deficiency 26 (COXPD26) [MIM:616539]: A mitochondrial disorder characterized by lactic acidosis, multiple mitochondrial respiratory-chain-complex deficiencies in skeletal muscle, and additional variable features including hypertrophic cardiomyopathy, exercise intolerance, and failure to thrive. {ECO:0000269|PubMed:26189817}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRMT5,57570,Hs.380159,ENST00000261249,THC2478826,GO:0005737(cytoplasm)|GO:0008033(tRNA processing)|GO:0008168(methyltransferase activity)|GO:0016740(transferase activity),"Homo sapiens TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae) (TRMT5), mRNA [NM_020810]",chr14:61438337-61438278,hs|14q23.1,TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),TRUE
524_ACAA1_30,P09110,"3-ketoacyl-coa thiolase, peroxisomal (ec 2.3.1.16) (acetyl-coa acyltransferase) (beta-ketothiolase) (peroxisomal 3-oxoacyl-coa thiolase)",ACAA1 ACAA PTHIO,424,NA,subcellular location: peroxisome.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,ACAA1,30,Hs.643487,ENST00000358122,NP1204779,"GO:0003988(acetyl-CoA C-acyltransferase activity)|GO:0005515(protein binding)|GO:0005777(peroxisome)|GO:0005782(peroxisomal matrix)|GO:0006091(generation of precursor metabolites and energy)|GO:0006631(fatty acid metabolic process)|GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups)|GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase)|GO:0043231(intracellular membrane-bounded organelle)|GO:0044255(cellular lipid metabolic process)","Homo sapiens acetyl-CoA acyltransferase 1 (ACAA1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001607]",chr3:38164415-38164356,hs|3p22.2,acetyl-CoA acyltransferase 1,TRUE
525_TAF7_6879,Q15545,transcription initiation factor tfiid subunit 7 (rna polymerase ii tbp-associated factor subunit f) (transcription initiation factor tfiid 55 kda subunit) (taf(ii)55) (tafii-55) (tafii55),TAF7 TAF2F TAFII55,349,"function: functions as a component of the dna-binding general transcription factor complex tfiid, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. present in both of the previously described tfiid species which either lack or contain tafii30 (tfiid alpha and tfiid beta respectively). {eco:0000269|pubmed:10438527}.",subcellular location: nucleus {eco:0000250|uniprotkb:q9r1c0}.,TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TAF7,6879,Hs.438838,ENST00000313368,THC2596956,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000296(spermine transport)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005669(transcription factor TFIID complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0006352(transcription initiation, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0006469(negative regulation of protein kinase activity)|GO:0008024(positive transcription elongation factor complex b)|GO:0008134(transcription factor binding)|GO:0030520(estrogen receptor signaling pathway)|GO:0033276(transcription factor TFTC complex)|GO:0035035(histone acetyltransferase binding)|GO:0035067(negative regulation of histone acetylation)|GO:0042809(vitamin D receptor binding)|GO:0044212(transcription regulatory region DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046966(thyroid hormone receptor binding)|GO:0071339(MLL1 complex)","Homo sapiens TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa (TAF7), mRNA [NM_005642]",chr5:140698187-140698128,hs|5q31.3,"TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa",TRUE
526_PDIA3_2923,P30101,protein disulfide-isomerase a3 (ec 5.3.4.1) (58 kda glucose-regulated protein) (58 kda microsomal protein) (p58) (disulfide isomerase er-60) (endoplasmic reticulum resident protein 57) (er protein 57) (erp57) (endoplasmic reticulum resident protein 60) (er protein 60) (erp60),PDIA3 ERP57 ERP60 GRP58,505,NA,"subcellular location: endoplasmic reticulum {eco:0000269|pubmed:23826168}. endoplasmic reticulum lumen {eco:0000250}. melanosome {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:12643545). {eco:0000269|pubmed:12643545}.",TISSUE SPECIFICITY: Detected in the flagellum and head region of spermatozoa (at protein level). {ECO:0000269|PubMed:20400973}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PDIA3,2923,Hs.591095,ENST00000537673,THC2575805,GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0003756(protein disulfide isomerase activity)|GO:0004197(cysteine-type endopeptidase activity)|GO:0004629(phospholipase C activity)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0006457(protein folding)|GO:0006606(protein import into nucleus)|GO:0006621(protein retention in ER lumen)|GO:0006662(glycerol ether metabolic process)|GO:0007165(signal transduction)|GO:0009055(electron carrier activity)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0016853(isomerase activity)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0042470(melanosome)|GO:0043065(positive regulation of apoptosis)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0045454(cell redox homeostasis),"Homo sapiens protein disulfide isomerase family A, member 3 (PDIA3), mRNA [NM_005313]",chr15:44063401-44063758,hs|15q15.3,"protein disulfide isomerase family A, member 3",TRUE
527_PALM2-AKAP2_445815,B1ALY0,palm2 and akap2 fusion (fragment),PALM2AKAP2,433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,PALM2-AKAP2,445815,Hs.591908,ENST00000302798,NP924285,NA,"Homo sapiens PALM2-AKAP2 readthrough (PALM2-AKAP2), transcript variant 2, mRNA [NM_147150]",chr9:112932095-112932154,hs|9q31.3,PALM2-AKAP2 readthrough,TRUE
528_CD81_975,P60033,cd81 antigen (26 kda cell surface protein tapa-1) (target of the antiproliferative antibody 1) (tetraspanin-28) (tspan-28) (cd antigen cd81),CD81 TAPA1 TSPAN28,236,"function: structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (terms), which act as platforms for receptor clustering and signaling. essential for trafficking and compartmentalization of cd19 receptor on the surface of activated b cells (pubmed:20237408, pubmed:27881302, pubmed:16449649). upon initial encounter with microbial pathogens, enables the assembly of cd19-cr2/cd21 and b cell receptor (bcr) complexes at signaling terms, lowering the threshold dose of antigen required to trigger b cell clonal expansion and antibody production (pubmed:15161911, pubmed:20237408). in t cells, facilitates the localization of cd247/cd3 zeta at antigen-induced synapses with b cells, providing for costimulation and polarization toward t helper type 2 phenotype (pubmed:22307619, pubmed:23858057, pubmed:8766544). present in mhc class ii compartments, may also play a role in antigen presentation (pubmed:8409388, pubmed:8766544). can act both as positive and negative regulator of homotypic or heterotypic cell-cell fusion processes. positively regulates sperm-egg fusion and may be involved in acrosome reaction (by similarity). in myoblasts, associates with cd9 and ptgfrn and inhibits myotube fusion during muscle regeneration (by similarity). in macrophages, associates with cd9 and beta-1 and beta-2 integrins, and prevents macrophage fusion into multinucleated giant cells specialized in ingesting complement-opsonized large particles (pubmed:12796480). also prevents the fusion of mononuclear cell progenitors into osteoclasts in charge of bone resorption (by similarity). may regulate the compartmentalization of enzymatic activities. in t cells, defines the subcellular localization of dntpase samhd1 and permits its degradation by the proteasome, thereby controlling intracellular dntp levels (pubmed:28871089). also involved in cell adhesion and motility. positively regulates integrin-mediated adhesion of macrophages, particularly relevant for the inflammatory response in the lung (by similarity). {eco:0000250|uniprotkb:p35762, eco:0000269|pubmed:12796480, eco:0000269|pubmed:15161911, eco:0000269|pubmed:16449649, eco:0000269|pubmed:20237408, eco:0000269|pubmed:22307619, eco:0000269|pubmed:23858057, eco:0000269|pubmed:27881302, eco:0000269|pubmed:28871089, eco:0000269|pubmed:8409388, eco:0000269|pubmed:8766544}.; function: (microbial infection) acts as a receptor for hepatitis c virus (hcv) in hepatocytes. association with cldn1 and the cldn1-cd81 receptor complex is essential for hcv entry into host cell. {eco:0000269|pubmed:20375010, eco:0000269|pubmed:21516087, eco:0000269|pubmed:26116703}.; function: (microbial infection) involved in samhd1-dependent restriction of hiv-1 replication. may support early replication of both r5- and x4-tropic hiv-1 viruses in t cells, likely via proteasome-dependent degradation of samhd1. {eco:0000269|pubmed:28871089}.; function: (microbial infection) specifically required for plasmodium falciparum infectivity of hepatocytes, controlling sporozoite entry into hepatocytes via the parasitophorous vacuole and subsequent parasite differentiation to exoerythrocytic forms. {eco:0000269|pubmed:12483205}.","subcellular location: cell membrane {eco:0000269|pubmed:1383329, eco:0000269|pubmed:1695320, eco:0000269|pubmed:20237408, eco:0000269|pubmed:22307619, eco:0000269|pubmed:2398277}; multi-pass membrane protein {eco:0000255}. basolateral cell membrane {eco:0000269|pubmed:20375010}; multi-pass membrane protein {eco:0000255}. note=associates with cldn1 and the cldn1-cd81 complex localizes to the basolateral cell membrane. {eco:0000269|pubmed:20375010}.","TISSUE SPECIFICITY: Expressed on B cells (at protein level) (PubMed:20237408). Expressed in hepatocytes (at protein level) (PubMed:12483205). Expressed in monocytes/macrophages (at protein level) (PubMed:12796480). Expressed on both naive and memory CD4-positive T cells (at protein level) (PubMed:22307619). {ECO:0000269|PubMed:12483205, ECO:0000269|PubMed:12796480, ECO:0000269|PubMed:20237408, ECO:0000269|PubMed:22307619}.","DISEASE: Immunodeficiency, common variable, 6 (CVID6) [MIM:613496]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:20237408}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CD81,975,Hs.54457,ENST00000468153,THC2532647,"GO:0000187(activation of MAPK activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006661(phosphatidylinositol biosynthetic process)|GO:0008104(protein localization)|GO:0008283(cell proliferation)|GO:0008284(positive regulation of cell proliferation)|GO:0009611(response to wounding)|GO:0016324(apical plasma membrane)|GO:0040008(regulation of growth)|GO:0043128(positive regulation of 1-phosphatidylinositol 4-kinase activity)|GO:0044419(interspecies interaction between organisms)|GO:0046488(phosphatidylinositol metabolic process)|GO:0046718(entry of virus into host cell)|GO:0046813(virion attachment, binding of host cell surface receptor)|GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)|GO:0050776(regulation of immune response)","Homo sapiens CD81 molecule (CD81), mRNA [NM_004356]",chr11:2418184-2418243,hs|11p15.5,CD81 molecule,TRUE
529_BTBD6_90135,Q96KE9,btb/poz domain-containing protein 6 (lens btb domain protein),BTBD6 BDPL,485,"function: adapter protein for the cul3 e3 ubiquitin-protein ligase complex (by similarity). involved in late neuronal development and muscle formation (by similarity). {eco:0000250|uniprotkb:a9jrd8, eco:0000250|uniprotkb:q2le78}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:q2le78}. note=found in punctated bodies in the cytoplasm. {eco:0000250|uniprotkb:q2le78}.,TISSUE SPECIFICITY: Expressed in lens. {ECO:0000269|PubMed:12107413}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BTBD6,90135,Hs.7367,ENST00000536364,THC2462718,GO:0000932(cytoplasmic mRNA processing body)|GO:0005737(cytoplasm),"Homo sapiens BTB (POZ) domain containing 6 (BTBD6), mRNA [NM_033271]",chr14:105717302-105717361,hs|14q32.33,BTB (POZ) domain containing 6,TRUE
53_PABPC1_26986,P11940,polyadenylate-binding protein 1 (pabp-1) (poly(a)-binding protein 1),PABPC1 PAB1 PABP1 PABPC2,636,"function: binds the poly(a) tail of mrna, including that of its own transcript, and regulates processes of mrna metabolism such as pre-mrna splicing and mrna stability (pubmed:11051545, pubmed:17212783, pubmed:25480299). its function in translational initiation regulation can either be enhanced by paip1 or repressed by paip2 (pubmed:11051545, pubmed:20573744). can probably bind to cytoplasmic rna sequences other than poly(a) in vivo. involved in translationally coupled mrna turnover (pubmed:11051545). implicated with other rna-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the fos mrna mediated by the major coding-region determinant of instability (mcrd) domain (pubmed:11051545). involved in regulation of nonsense-mediated decay (nmd) of mrnas containing premature stop codons; for the recognition of premature termination codons (ptc) and initiation of nmd a competitive interaction between upf1 and pabpc1 with the ribosome-bound release factors is proposed (pubmed:18447585). by binding to long poly(a) tails, may protect them from uridylation by zcchc6/zcchc11 and hence contribute to mrna stability (pubmed:25480299). {eco:0000269|pubmed:11051545, eco:0000269|pubmed:17212783, eco:0000269|pubmed:18447585, eco:0000269|pubmed:20573744, eco:0000269|pubmed:25480299}.; function: (microbial infection) positively regulates the replication of dengue virus (denv). {eco:0000269|pubmed:26735137}.","subcellular location: cytoplasm {eco:0000269|pubmed:20573744, eco:0000269|pubmed:7908267, eco:0000269|pubmed:9582337}. nucleus {eco:0000269|pubmed:18799579, eco:0000269|pubmed:9582337}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas (pubmed:17289661). shuttles between the cytoplasm and the nucleus (pubmed:9582337). {eco:0000269|pubmed:17289661, eco:0000269|pubmed:9582337}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PABPC1,26986,Hs.387804,ENST00000523636,THC2468984,"GO:0000166(nucleotide binding)|GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006378(mRNA polyadenylation)|GO:0006412(translation)|GO:0008022(protein C-terminus binding)|GO:0008143(poly(A) RNA binding)|GO:0008380(RNA splicing)|GO:0008494(translation activator activity)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030529(ribonucleoprotein complex)|GO:0044267(cellular protein metabolic process)|GO:0045727(positive regulation of translation)|GO:0048255(mRNA stabilization)|GO:0071013(catalytic step 2 spliceosome)|GO:2000623(negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)","Homo sapiens poly(A) binding protein, cytoplasmic 1 (PABPC1), mRNA [NM_002568]",chr8:101716541-101715545,hs|8q22.3,"poly(A) binding protein, cytoplasmic 1",TRUE
530_NUDT4_11163,Q9NZJ9,"diphosphoinositol polyphosphate phosphohydrolase 2 (dipp-2) (ec 3.6.1.52) (diadenosine 5',5'''-p1,p6-hexaphosphate hydrolase 2) (nucleoside diphosphate-linked moiety x motif 4) (nudix motif 4)",NUDT4 DIPP2 KIAA0487 HDCMB47P,180,"function: cleaves a beta-phosphate from the diphosphate groups in pp-insp5 (diphosphoinositol pentakisphosphate), pp-insp4 and [pp]2-insp4 (bisdiphosphoinositol tetrakisphosphate), suggesting that it may play a role in signal transduction. also able to catalyze the hydrolysis of dinucleoside oligophosphate ap6a, but not ap5a. the major reaction products are adp and p4a from ap6a. also able to hydrolyze 5-phosphoribose 1-diphosphate. does not play a role in u8 snorna decapping activity. binds u8 snorna. {eco:0000269|pubmed:10777568}.",subcellular location: cytoplasm {eco:0000269|pubmed:12121577}.,"TISSUE SPECIFICITY: Expressed in heart and, at lower level in skeletal muscle, pancreas and kidney. {ECO:0000269|PubMed:10777568}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NUDT4,11163,Hs.506325,ENST00000337179,THC2491867,GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0008486(diphosphoinositol-polyphosphate diphosphatase activity)|GO:0009187(cyclic nucleotide metabolic process)|GO:0016787(hydrolase activity)|GO:0019722(calcium-mediated signaling)|GO:0019935(cyclic-nucleotide-mediated signaling)|GO:0035556(intracellular signal transduction)|GO:0046831(regulation of RNA export from nucleus)|GO:0046872(metal ion binding)|GO:0046907(intracellular transport),"Homo sapiens nudix (nucleoside diphosphate linked moiety X)-type motif 4 (NUDT4), transcript variant 2, mRNA [NM_199040]",chr12:93795822-93795881,hs|12q22,nudix (nucleoside diphosphate linked moiety X)-type motif 4,TRUE
531_SMARCA4_6597,P51532,transcription activator brg1 (ec 3.6.4.-) (atp-dependent helicase smarca4) (brg1-associated factor 190a) (baf190a) (mitotic growth and transcription activator) (protein brg-1) (protein brahma homolog 1) (snf2-beta) (swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a member 4),SMARCA4 BAF190A BRG1 SNF2B SNF2L4,1647,"function: involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of dna-nucleosome topology). component of swi/snf chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering dna-histone contacts within a nucleosome in an atp-dependent manner. component of the crest-brg1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. in resting neurons, transcription of the c-fos promoter is inhibited by smarca4-dependent recruitment of a phospho-rb1-hdac repressor complex. upon calcium influx, rb1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. at the same time, there is increased recruitment of crebbp to the promoter by a crest-dependent mechanism, which leads to transcriptional activation. the crest-brg1 complex also binds to the nr2b promoter, and activity-dependent induction of nr2b expression involves the release of hdac1 and recruitment of crebbp. belongs to the neural progenitors-specific chromatin remodeling complex (npbaf complex) and the neuron-specific chromatin remodeling complex (nbaf complex). during neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. the transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npbaf and nbaf complexes. as neural progenitors exit mitosis and differentiate into neurons, npbaf complexes which contain actl6a/baf53a and phf10/baf45a, are exchanged for homologous alternative actl6b/baf53b and dpf1/baf45b or dpf3/baf45c subunits in neuron-specific complexes (nbaf). the npbaf complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. the nbaf complex along with crest plays a role regulating the activity of genes essential for dendrite growth. smarca4/baf190a may promote neural stem cell self-renewal/proliferation by enhancing notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to shh-dependent differentiating cues (by similarity). acts as a corepressor of zeb1 to regulate e-cadherin transcription and is required for induction of epithelial-mesenchymal transition (emt) by zeb1. binds via dlx1 to enhancers located in the intergenic region between dlx5 and dlx6 and this binding is stabilized by the long non-coding rna (lncrna) evf2 (by similarity). binds to rna in a promiscuous manner (by similarity). binding to rnas including lncrna evf2 leads to inhibition of smarca4 atpase and chromatin remodeling activities (by similarity). {eco:0000250|uniprotkb:q3tkt4, eco:0000269|pubmed:19571879, eco:0000269|pubmed:20418909, eco:0000269|pubmed:29374058, eco:0000303|pubmed:22952240, eco:0000303|pubmed:26601204}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00549, eco:0000269|pubmed:20418909}. note=colocalizes with long non-coding rna evf2 in nuclear rna clouds. {eco:0000250|uniprotkb:q3tkt4}.","TISSUE SPECIFICITY: Colocalizes with ZEB1 in E-cadherin-negative cells from established lines, and stroma of normal colon as well as in de-differentiated epithelial cells at the invasion front of colorectal carcinomas (at protein level). {ECO:0000269|PubMed:20418909}.","DISEASE: Rhabdoid tumor predisposition syndrome 2 (RTPS2) [MIM:613325]: A familial cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumors. Rhabdoid tumors are the most aggressive and lethal malignancies occurring in early childhood. {ECO:0000269|PubMed:20137775}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Coffin-Siris syndrome 4 (CSS4) [MIM:614609]: A form of Coffin-Siris syndrome, a congenital multiple malformation syndrome with broad phenotypic and genetic variability. Cardinal features are intellectual disability, coarse facial features, hypertrichosis, and hypoplastic or absent fifth digit nails or phalanges. Additional features include malformations of the cardiac, gastrointestinal, genitourinary, and/or central nervous systems. Sucking/feeding difficulties, poor growth, ophthalmologic abnormalities, hearing impairment, and spinal anomalies are common findings. Both autosomal dominant and autosomal recessive inheritance patterns have been reported. {ECO:0000269|PubMed:22426308}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SMARCA4,6597,Hs.327527,ENST00000344626,NP1155130,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000166(nucleotide binding)|GO:0000790(nuclear chromatin)|GO:0000792(heterochromatin)|GO:0000902(cell morphogenesis)|GO:0001570(vasculogenesis)|GO:0001701(in utero embryonic development)|GO:0001832(blastocyst growth)|GO:0001835(blastocyst hatching)|GO:0001889(liver development)|GO:0002039(p53 binding)|GO:0003407(neural retina development)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003713(transcription coactivator activity)|GO:0003714(transcription corepressor activity)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005719(nuclear euchromatin)|GO:0005726(perichromatin fibrils)|GO:0006337(nucleosome disassembly)|GO:0006338(chromatin remodeling)|GO:0006346(methylation-dependent chromatin silencing)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0007399(nervous system development)|GO:0007403(glial cell fate determination)|GO:0007507(heart development)|GO:0008094(DNA-dependent ATPase activity)|GO:0008134(transcription factor binding)|GO:0010424(DNA methylation on cytosine within a CG sequence)|GO:0016514(SWI/SNF complex)|GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides)|GO:0030198(extracellular matrix organization)|GO:0030216(keratinocyte differentiation)|GO:0030308(negative regulation of cell growth)|GO:0030900(forebrain development)|GO:0030902(hindbrain development)|GO:0030957(Tat protein binding)|GO:0035116(embryonic hindlimb morphogenesis)|GO:0043923(positive regulation by host of viral transcription)|GO:0043966(histone H3 acetylation)|GO:0045749(negative regulation of S phase of mitotic cell cycle)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0047485(protein N-terminus binding)|GO:0048562(embryonic organ morphogenesis)|GO:0048730(epidermis morphogenesis)|GO:0050681(androgen receptor binding)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0060318(definitive erythrocyte differentiation)|GO:0060347(heart trabecula formation)|GO:0060766(negative regulation of androgen receptor signaling pathway)|GO:0070577(histone acetyl-lysine binding)|GO:0071564(npBAF complex)|GO:0071565(nBAF complex)|GO:0071778(WINAC complex)","Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4), transcript variant 3, mRNA [NM_003072]",chr19:11172673-11172732,hs|19p13.2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",TRUE
532_ACTN1_87,P12814,alpha-actinin-1 (alpha-actinin cytoskeletal isoform) (f-actin cross-linking protein) (non-muscle alpha-actinin-1),ACTN1,892,function: f-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. this is a bundling protein.,"subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:24069336, eco:0000269|pubmed:7750553}. cytoplasm, myofibril, sarcomere, z line {eco:0000269|pubmed:7750553}. cell membrane {eco:0000250|uniprotkb:q9z1p2}. cell junction {eco:0000250|uniprotkb:q9z1p2}. cell projection, ruffle {eco:0000250|uniprotkb:q7tpr4}. note=colocalizes with myoz2 and ppp3ca at the z-line of heart and skeletal muscle. colocalizes with psd in membrane ruffles and central reticular structures. {eco:0000250|uniprotkb:q7tpr4}.",NA,"DISEASE: Bleeding disorder, platelet-type 15 (BDPLT15) [MIM:615193]: An autosomal dominant form of macrothrombocytopenia. Affected individuals usually have no or only mild bleeding tendency, such as epistaxis. Laboratory studies show decreased numbers of large platelets and anisocytosis, but the platelets show no in vitro functional abnormalities. {ECO:0000269|PubMed:23434115, ECO:0000269|PubMed:24069336}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ACTN1,87,Hs.356285,ENST00000556083,THC2574401,GO:0001725(stress fiber)|GO:0001726(ruffle)|GO:0002576(platelet degranulation)|GO:0003779(actin binding)|GO:0005178(integrin binding)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0005916(fascia adherens)|GO:0005925(focal adhesion)|GO:0007596(blood coagulation)|GO:0017166(vinculin binding)|GO:0019904(protein domain specific binding)|GO:0030018(Z disc)|GO:0030168(platelet activation)|GO:0030864(cortical actin cytoskeleton)|GO:0031093(platelet alpha granule lumen)|GO:0031143(pseudopodium)|GO:0034329(cell junction assembly)|GO:0042981(regulation of apoptosis)|GO:0048041(focal adhesion assembly)|GO:0051015(actin filament binding)|GO:0051017(actin filament bundle assembly)|GO:0051271(negative regulation of cellular component movement),"actinin, alpha 1 [Source:HGNC Symbol;Acc:163] [ENST00000556083]",chr14:69354033-69353974,hs|14q24.1,"actinin, alpha 1",TRUE
533_TMEM59_9528,Q9BXS4,transmembrane protein 59 (liver membrane-bound protein),TMEM59 C1orf8 HSPC001 UNQ169/PRO195,323,"function: acts as a regulator of autophagy in response to s.aureus infection by promoting activation of lc3 (map1lc3a, map1lc3b or map1lc3c). acts by interacting with atg16l1, leading to promote a functional complex between lc3 and atg16l1 and promoting lc3 lipidation and subsequent activation of autophagy (pubmed:27273576, pubmed:23376921). modulates the o-glycosylation and complex n-glycosylation steps occurring during the golgi maturation of several proteins such as app, bace1, seap or prnp (pubmed:20427278). inhibits app transport to the cell surface and further shedding (pubmed:20427278). {eco:0000269|pubmed:20427278, eco:0000269|pubmed:23376921, eco:0000269|pubmed:27273576}.","subcellular location: late endosome membrane {eco:0000269|pubmed:23376921, eco:0000269|pubmed:27273576}; single-pass type i membrane protein {eco:0000255}. lysosome membrane {eco:0000269|pubmed:23376921, eco:0000269|pubmed:27273576}; single-pass type i membrane protein {eco:0000255}. cell membrane {eco:0000269|pubmed:23376921}; single-pass type i membrane protein {eco:0000255}. golgi apparatus membrane {eco:0000269|pubmed:20427278}; single-pass type i membrane protein {eco:0000255}. note=mainly localizes to late endosomes/lysosomes. probably first exported to the cell surface and then actively endocytosed to transiently localize in early endosomes on its way to the late endosomal/lysosomal compartment where it becomes quickly degraded. {eco:0000269|pubmed:23376921}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM59,9528,Hs.523262,ENST00000470395,THC2585978,GO:0000139(Golgi membrane)|GO:0005794(Golgi apparatus)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 59 (TMEM59), mRNA [NM_004872]",chr1:54497886-54497827,hs|1p32.3,transmembrane protein 59,TRUE
534_MRPS24_64951,Q96EL2,"28s ribosomal protein s24, mitochondrial (mrp-s24) (s24mt) (mitochondrial small ribosomal subunit protein us3m) (bmrp-47) (bmrp47)",MRPS24 HSPC335,167,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS24,64951,Hs.284286,ENST00000418740,THC2467689,GO:0003674(molecular_function)|GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0005762(mitochondrial large ribosomal subunit)|GO:0005763(mitochondrial small ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0008150(biological_process),"Homo sapiens mitochondrial ribosomal protein S24 (MRPS24), nuclear gene encoding mitochondrial protein, mRNA [NM_032014]",chr7:43906220-43906161,hs|7p13,mitochondrial ribosomal protein S24,TRUE
535_MKRN1_23608,Q9UHC7,e3 ubiquitin-protein ligase makorin-1 (ec 2.3.2.27) (ring finger protein 61) (ring-type e3 ubiquitin transferase makorin-1),MKRN1 RNF61,482,"function: e3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. these substrates include filip1, p53/tp53, cdkn1a and tert. keeps cells alive by suppressing p53/tp53 under normal conditions, but stimulates apoptosis by repressing cdkn1a under stress conditions. acts as a negative regulator of telomerase. has negative and positive effects on rna polymerase ii-dependent transcription. {eco:0000269|pubmed:16785614, eco:0000269|pubmed:19536131}.",NA,"TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10843807, ECO:0000269|PubMed:16785614}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MKRN1,23608,Hs.728819,ENST00000539898,THC2508588,GO:0003674(molecular_function)|GO:0003676(nucleic acid binding)|GO:0003682(chromatin binding)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0016874(ligase activity)|GO:0046872(metal ion binding),"Homo sapiens makorin ring finger protein 1 (MKRN1), transcript variant 1, mRNA [NM_013446]",chr7:140153026-140152967,hs|7q34,makorin ring finger protein 1,TRUE
536_MANF_7873,P55145,mesencephalic astrocyte-derived neurotrophic factor (arginine-rich protein) (protein armet),MANF ARMET ARP,182,"function: selectively promotes the survival of dopaminergic neurons of the ventral mid-brain (pubmed:12794311). modulates gabaergic transmission to the dopaminergic neurons of the substantia nigra (by similarity). enhances spontaneous, as well as evoked, gabaergic inhibitory postsynaptic currents in dopaminergic neurons (by similarity). inhibits cell proliferation and endoplasmic reticulum (er) stress-induced cell death (pubmed:18561914, pubmed:22637475, pubmed:29497057). retained in the er/sarcoplasmic reticulum (sr) through association with the endoplasmic reticulum chaperone protein hspa5 under normal conditions (pubmed:22637475). up-regulated and secreted by the er/sr in response to er stress and hypoxia (pubmed:22637475). following secretion by the er/sr, directly binds to 3-o-sulfogalactosylceramide, a lipid sulfatide in the outer cell membrane of target cells (pubmed:29497057). sulfatide binding promotes its cellular uptake by endocytosis, and is required for its role in alleviating er stress and cell toxicity under hypoxic and er stress conditions (pubmed:29497057). {eco:0000250|uniprotkb:p0c5h9, eco:0000269|pubmed:12794311, eco:0000269|pubmed:18561914, eco:0000269|pubmed:22637475, eco:0000269|pubmed:29497057}.","subcellular location: secreted {eco:0000269|pubmed:12794311, eco:0000269|pubmed:18561914, eco:0000269|pubmed:22637475, eco:0000269|pubmed:29497057}. endoplasmic reticulum lumen {eco:0000305|pubmed:29497057}. sarcoplasmic reticulum lumen {eco:0000269|pubmed:22637475}. note=retained in the endoplasmic reticulum (er), and sarcoplasmic reticulum (sr) under normal conditions (pubmed:22637475). up-regulated and secreted by the er/sr in response to er stress and hypoxia (pubmed:22637475, pubmed:29497057). {eco:0000269|pubmed:22637475, eco:0000269|pubmed:29497057}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MANF,7873,Hs.436446,ENST00000470900,THC2468566,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005576(extracellular region)|GO:0006986(response to unfolded protein)|GO:0008083(growth factor activity)|GO:0008150(biological_process),"Homo sapiens mesencephalic astrocyte-derived neurotrophic factor (MANF), mRNA [NM_006010]",chr3:51426687-51426746,hs|3p21.2,mesencephalic astrocyte-derived neurotrophic factor,TRUE
537_DGKD_8527,Q16760,diacylglycerol kinase delta (dag kinase delta) (ec 2.7.1.107) (130 kda diacylglycerol kinase) (diglyceride kinase delta) (dgk-delta),DGKD KIAA0145,1214,function: may function as signaling molecule. {eco:0000269|pubmed:17880279}.; function: isoform 2 may be involved in cell growth and tumorigenesis. involved in clathrin-dependent endocytosis. {eco:0000269|pubmed:17880279}.,subcellular location: isoform 2: cytoplasm {eco:0000269|pubmed:12200442}.; subcellular location: isoform 1: membrane {eco:0000269|pubmed:12200442}; peripheral membrane protein {eco:0000269|pubmed:12200442}.,"TISSUE SPECIFICITY: Isoform 2 is ubiquitously expressed also in tumor tissues. Isoform 1 is expressed in ovary, spleen and some tumor-derived cells. {ECO:0000269|PubMed:12200442}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DGKD,8527,Hs.471675,ENST00000409813,THC2583364,GO:0000166(nucleotide binding)|GO:0004143(diacylglycerol kinase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006897(endocytosis)|GO:0007165(signal transduction)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007205(activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway)|GO:0007275(multicellular organismal development)|GO:0007596(blood coagulation)|GO:0010033(response to organic substance)|GO:0015031(protein transport)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016049(cell growth)|GO:0016740(transferase activity)|GO:0019932(second-messenger-mediated signaling)|GO:0019992(diacylglycerol binding)|GO:0030168(platelet activation)|GO:0042803(protein homodimerization activity)|GO:0046339(diacylglycerol metabolic process)|GO:0046872(metal ion binding)|GO:0046982(protein heterodimerization activity)|GO:0051260(protein homooligomerization),"Homo sapiens diacylglycerol kinase, delta 130kDa (DGKD), transcript variant 2, mRNA [NM_152879]",chr2:234380636-234380695,hs|2q37.1,"diacylglycerol kinase, delta 130kDa",TRUE
538_THRAP3_9967,Q9Y2W1,thyroid hormone receptor-associated protein 3 (bclaf1 and thrap3 family member 2) (thyroid hormone receptor-associated protein complex 150 kda component) (trap150),THRAP3 BCLAF2 TRAP150,955,"function: involved in pre-mrna splicing. remains associated with spliced mrna after splicing which probably involves interactions with the exon junction complex (ejc). can trigger mrna decay which seems to be independent of nonsense-mediated decay involving premature stop codons (ptc) recognition. may be involved in nuclear mrna decay. involved in regulation of signal-induced alternative splicing. during splicing of ptprc/cd45 is proposed to sequester phosphorylated sfpq from ptprc/cd45 pre-mrna in resting t-cells. involved in cyclin-d1/ccnd1 mrna stability probably by acting as component of the snarp complex which associates with both the 3'end of the ccnd1 gene and its mrna. involved in response to dna damage. is excluced from dna damage sites in a manner that parallels transcription inhibition; the function may involve the snarp complex. initially thought to play a role in transcriptional coactivation through its association with the trap complex; however, it is not regarded as a stable mediator complex subunit. cooperatively with helz2, enhances the transcriptional activation mediated by pparg, maybe through the stabilization of the pparg binding to dna in presence of ligand. may play a role in the terminal stage of adipocyte differentiation. plays a role in the positive regulation of the circadian clock. acts as a coactivator of the clock-arntl/bmal1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes (pubmed:24043798). {eco:0000269|pubmed:20123736, eco:0000269|pubmed:20932480, eco:0000269|pubmed:22424773, eco:0000269|pubmed:23525231, eco:0000269|pubmed:24043798}.","subcellular location: nucleus {eco:0000269|pubmed:20123736, eco:0000269|pubmed:23525231}. nucleus, nucleoplasm {eco:0000269|pubmed:24100041}. nucleus speckle {eco:0000269|pubmed:24100041}.",TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10198638}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,THRAP3,9967,Hs.160211,ENST00000354618,THC2613958,"GO:0000166(nucleotide binding)|GO:0001104(RNA polymerase II transcription cofactor activity)|GO:0003712(transcription cofactor activity)|GO:0003713(transcription coactivator activity)|GO:0004872(receptor activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0016592(mediator complex)|GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity)|GO:0030518(steroid hormone receptor signaling pathway)|GO:0030521(androgen receptor signaling pathway)|GO:0042809(vitamin D receptor binding)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046966(thyroid hormone receptor binding)","Homo sapiens thyroid hormone receptor associated protein 3 (THRAP3), mRNA [NM_005119]",chr1:36770822-36770881,hs|1p34.3,thyroid hormone receptor associated protein 3,TRUE
539_MAML1_9794,Q92585,mastermind-like protein 1 (mam-1),MAML1 KIAA0200,1016,"function: acts as a transcriptional coactivator for notch proteins. has been shown to amplify notch-induced transcription of hes1. enhances phosphorylation and proteolytic turnover of the notch intracellular domain in the nucleus through interaction with cdk8. binds to crebbp/cbp which promotes nucleosome acetylation at notch enhancers and activates transcription. induces phosphorylation and localization of crebbp to nuclear foci. plays a role in hematopoietic development by regulating notch-mediated lymphoid cell fate decisions. {eco:0000269|pubmed:11101851, eco:0000269|pubmed:11390662, eco:0000269|pubmed:12050117, eco:0000269|pubmed:15546612, eco:0000269|pubmed:17317671}.","subcellular location: nucleus speckle {eco:0000269|pubmed:11101851}. note=nuclear, in a punctate manner.","TISSUE SPECIFICITY: Widely expressed with highest levels in heart, pancreas, peripheral blood leukocytes and spleen. {ECO:0000269|PubMed:11101851}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MAML1,9794,Hs.631951,ENST00000292599,THC2466490,"GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006468(protein phosphorylation)|GO:0007219(Notch signaling pathway)|GO:0010467(gene expression)|GO:0010831(positive regulation of myotube differentiation)|GO:0016607(nuclear speck)|GO:0019901(protein kinase binding)|GO:0042605(peptide antigen binding)|GO:0043231(intracellular membrane-bounded organelle)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","Homo sapiens mastermind-like 1 (Drosophila) (MAML1), mRNA [NM_014757]",chr5:179204179-179204238,hs|5q35.3,mastermind-like 1 (Drosophila),TRUE
54_P4HB_5034,P07237,protein disulfide-isomerase (pdi) (ec 5.3.4.1) (cellular thyroid hormone-binding protein) (prolyl 4-hydroxylase subunit beta) (p55),P4HB ERBA2L PDI PDIA1 PO4DB,508,"function: this multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. at the cell surface, seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. may therefore cause structural modifications of exofacial proteins. inside the cell, seems to form/rearrange disulfide bonds of nascent proteins. at high concentrations, functions as a chaperone that inhibits aggregation of misfolded proteins. at low concentrations, facilitates aggregation (anti-chaperone activity). may be involved with other chaperones in the structural modification of the tg precursor in hormone biogenesis. also acts a structural subunit of various enzymes such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein mttp. receptor for lgals9; the interaction retains p4hb at the cell surface of th2 t helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration (pubmed:21670307). {eco:0000269|pubmed:10636893, eco:0000269|pubmed:12485997, eco:0000269|pubmed:21670307}.","subcellular location: endoplasmic reticulum {eco:0000269|pubmed:23475612}. endoplasmic reticulum lumen {eco:0000269|pubmed:10636893, eco:0000269|pubmed:23475612}. melanosome {eco:0000269|pubmed:12643545, eco:0000269|pubmed:17081065}. cell membrane {eco:0000269|pubmed:21670307}; peripheral membrane protein {eco:0000305}. note=highly abundant. in some cell types, seems to be also secreted or associated with the plasma membrane, where it undergoes constant shedding and replacement from intracellular sources (probable). localizes near cd4-enriched regions on lymphoid cell surfaces (pubmed:11181151). identified by mass spectrometry in melanosome fractions from stage i to stage iv (pubmed:10636893). colocalizes with mttp in the endoplasmic reticulum (pubmed:23475612). {eco:0000269|pubmed:10636893, eco:0000269|pubmed:11181151, eco:0000269|pubmed:23475612, eco:0000305}.",NA,"DISEASE: Cole-Carpenter syndrome 1 (CLCRP1) [MIM:112240]: A form of Cole-Carpenter syndrome, a disorder characterized by features of osteogenesis imperfecta such as bone deformities and severe bone fragility with frequent fractures, in association with craniosynostosis, ocular proptosis, hydrocephalus, growth failure and distinctive facial features. Craniofacial findings include marked frontal bossing, midface hypoplasia, and micrognathia. Despite the craniosynostosis and hydrocephalus, intellectual development is normal. CLCRP1 inheritance is autosomal dominant. {ECO:0000269|PubMed:25683117}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,P4HB,5034,Hs.464336,NA,THC2581483,GO:0003756(protein disulfide isomerase activity)|GO:0004656(procollagen-proline 4-dioxygenase activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005792(microsome)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005886(plasma membrane)|GO:0006629(lipid metabolic process)|GO:0006662(glycerol ether metabolic process)|GO:0009055(electron carrier activity)|GO:0009986(cell surface)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0016853(isomerase activity)|GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline)|GO:0042157(lipoprotein metabolic process)|GO:0042470(melanosome)|GO:0045454(cell redox homeostasis)|GO:0046982(protein heterodimerization activity),"Homo sapiens mRNA for OK/SW-CL.24, complete cds. [AB062434]",chr17:79801098-79801039,hs|17q25.3,"prolyl 4-hydroxylase, beta polypeptide",TRUE
540_CSTB_1476,P04080,cystatin-b (cpi-b) (liver thiol proteinase inhibitor) (stefin-b),CSTB CST6 STFB,98,"function: this is an intracellular thiol proteinase inhibitor. tightly binding reversible inhibitor of cathepsins l, h and b.",subcellular location: cytoplasm {eco:0000269|pubmed:11139332}. nucleus {eco:0000269|pubmed:11139332}.,NA,"DISEASE: Epilepsy, progressive myoclonic 1 (EPM1) [MIM:254800]: An autosomal recessive disorder characterized by severe, stimulus-sensitive myoclonus and tonic-clonic seizures. The onset, occurring between 6 and 13 years of age, is characterized by convulsions. Myoclonus begins 1 to 5 years later. The twitchings occur predominantly in the proximal muscles of the extremities and are bilaterally symmetrical, although asynchronous. At first small, they become late in the clinical course so violent that the victim is thrown to the floor. Mental deterioration and eventually dementia develop. {ECO:0000269|PubMed:9012407}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CSTB,1476,Hs.695,ENST00000291568,THC2503761,GO:0002020(protease binding)|GO:0004866(endopeptidase inhibitor activity)|GO:0004869(cysteine-type endopeptidase inhibitor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0008344(adult locomotory behavior)|GO:0010466(negative regulation of peptidase activity)|GO:0010951(negative regulation of endopeptidase activity)|GO:0042981(regulation of apoptosis),"Homo sapiens cystatin B (stefin B) (CSTB), mRNA [NM_000100]",chr21:45194115-45194056,hs|21q22.3,cystatin B (stefin B),TRUE
541_LAGE3_8270,Q14657,ekc/keops complex subunit lage3 (l antigen family member 3) (protein eso-3) (protein itba2),LAGE3 DXS9879E ESO3 ITBA2,143,"function: component of the ekc/keops complex that is required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)a37) in trnas that read codons beginning with adenine. the complex is probably involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-amp (tc-amp) to the n6 group of a37. lage3 functions as a dimerization module for the complex. {eco:0000305|pubmed:22912744, eco:0000305|pubmed:27903914}.","subcellular location: cytoplasm {eco:0000269|pubmed:28805828}. nucleus {eco:0000269|pubmed:22912744, eco:0000269|pubmed:27903914, eco:0000269|pubmed:28805828}.","TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12384295, ECO:0000269|PubMed:8786131}.","DISEASE: Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006]: A form of Galloway-Mowat syndrome, a severe renal-neurological disease characterized by early-onset nephrotic syndrome associated with microcephaly, central nervous system abnormalities, developmental delays, and a propensity for seizures. Brain anomalies include gyration defects ranging from lissencephaly to pachygyria and polymicrogyria, and cerebellar hypoplasia. Most patients show facial dysmorphism characterized by a small, narrow forehead, large/floppy ears, deep-set eyes, hypertelorism and micrognathia. Additional variable features are visual impairment and arachnodactyly. Most patients die in early childhood. {ECO:0000269|PubMed:28805828}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LAGE3,8270,Hs.444619,ENST00000357360,THC2464063,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens L antigen family, member 3 (LAGE3), mRNA [NM_006014]",chrX:153706252-153706193,hs|Xq28,"L antigen family, member 3",TRUE
542_TM2D3_80213,Q9BRN9,tm2 domain-containing protein 3 (beta-amyloid-binding protein-like protein 2) (bbp-like protein 2),TM2D3 BLP2,247,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11278849}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TM2D3,80213,Hs.288912,ENST00000333202,NP337149,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens TM2 domain containing 3 (TM2D3), transcript variant 1, mRNA [NM_078474]",chr15:102182271-102182212,hs|15q26.3,TM2 domain containing 3,TRUE
543_RHOU_58480,Q7L0Q8,rho-related gtp-binding protein rhou (cdc42-like gtpase 1) (gtp-binding protein-like 1) (rho gtpase-like protein arhu) (ryu gtpase) (wnt-1 responsive cdc42 homolog 1) (wrch-1),RHOU ARHU CDC42L1 G28K WRCH1 SB128,258,"function: acts upstream of pak1 to regulate the actin cytoskeleton, adhesion turnover and increase cell migration. stimulates quiescent cells to reenter the cell cycle. has no detectable gtpase activity but its high intrinsic guanine nucleotide exchange activity suggests it is constitutively gtp-bound. plays a role in the regulation of cell morphology and cytoskeletal organization. required in the control of cell shape. {eco:0000269|pubmed:11459829, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058, eco:0000269|pubmed:18086875, eco:0000269|pubmed:21834987}.","subcellular location: cell membrane {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}; lipid-anchor {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}; cytoplasmic side {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}. golgi apparatus membrane {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}; lipid-anchor {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}. cell junction, focal adhesion {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}. cell projection, podosome {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}. note=localizes to podosomes in src-transformed cells. {eco:0000269|pubmed:16046391, eco:0000269|pubmed:16472646, eco:0000269|pubmed:17620058}.","TISSUE SPECIFICITY: Ubiquitously expressed in all tissues examined. Expressed at high levels in the stomach, small intestine, brain, skeletal muscle and placenta. {ECO:0000269|PubMed:11459829, ECO:0000269|PubMed:14731133}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RHOU,58480,Hs.647774,ENST00000366691,THC2602064,GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000139(Golgi membrane)|GO:0000166(nucleotide binding)|GO:0002102(podosome)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005925(focal adhesion)|GO:0007010(cytoskeleton organization)|GO:0007264(small GTPase mediated signal transduction)|GO:0008360(regulation of cell shape)|GO:0016601(Rac protein signal transduction)|GO:0030036(actin cytoskeleton organization)|GO:0030054(cell junction)|GO:0042995(cell projection)|GO:0046872(metal ion binding)|GO:0051056(regulation of small GTPase mediated signal transduction),"Homo sapiens ras homolog gene family, member U (RHOU), transcript variant 1, mRNA [NM_021205]",chr1:228882099-228882158,hs|1q42.13,"ras homolog gene family, member U",TRUE
544_MGST3_4259,O14880,microsomal glutathione s-transferase 3 (microsomal gst-3) (glutathione peroxidase mgst3) (ec 1.11.1.-) (ltc4 synthase mgst3) (ec 4.4.1.20) (microsomal glutathione s-transferase iii) (microsomal gst-iii),MGST3,152,"function: catalyzes oxydation of hydroxy-fatty acids (pubmed:9278457). also catalyzes the conjugation of a reduced glutathione to leukotriene a4 in vitro (pubmed:9278457). may participate to the lipid metabolism (pubmed:9278457). {eco:0000269|pubmed:9278457, eco:0000303|pubmed:9278457}.",subcellular location: endoplasmic reticulum membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. microsome membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. microsome membrane {eco:0000305}; lipid-anchor {eco:0000305}. membrane {eco:0000269|pubmed:9278457}.,"TISSUE SPECIFICITY: Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. {ECO:0000269|PubMed:9278457}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MGST3,4259,Hs.191734,ENST00000367886,THC2545693,GO:0002540(leukotriene production involved in inflammatory response)|GO:0004364(glutathione transferase activity)|GO:0004601(peroxidase activity)|GO:0004602(glutathione peroxidase activity)|GO:0005624(membrane fraction)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006629(lipid metabolic process)|GO:0006805(xenobiotic metabolic process)|GO:0007165(signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0019370(leukotriene biosynthetic process),"Homo sapiens microsomal glutathione S-transferase 3 (MGST3), mRNA [NM_004528]",chr1:165624688-165624747,hs|1q24.1,microsomal glutathione S-transferase 3,TRUE
545_MGEA5_10724,O60502,protein o-glcnacase (oga) (ec 3.2.1.169) (beta-n-acetylglucosaminidase) (beta-n-acetylhexosaminidase) (beta-hexosaminidase) (meningioma-expressed antigen 5) (n-acetyl-beta-d-glucosaminidase) (n-acetyl-beta-glucosaminidase) (nuclear cytoplasmic o-glcnacase and acetyltransferase) (ncoat),OGA HEXC KIAA0679 MEA5 MGEA5,916,"function: isoform 1: cleaves glcnac but not galnac from o-glycosylated proteins. can use p-nitrophenyl-beta-glcnac and 4-methylumbelliferone-glcnac as substrates but not p-nitrophenyl-beta-galnac or p-nitrophenyl-alpha-glcnac (in vitro) (pubmed:11148210). does not bind acetyl-coa and does not have histone acetyltransferase activity (pubmed:24088714). {eco:0000269|pubmed:11148210, eco:0000269|pubmed:11788610, eco:0000269|pubmed:20673219, eco:0000269|pubmed:22365600, eco:0000269|pubmed:24088714}.; function: isoform 3: cleaves glcnac but not galnac from o-glycosylated proteins. can use p-nitrophenyl-beta-glcnac as substrate but not p-nitrophenyl-beta-galnac or p-nitrophenyl-alpha-glcnac (in vitro), but has about six times lower specific activity than isoform 1. {eco:0000269|pubmed:20673219}.","subcellular location: isoform 3: nucleus {eco:0000269|pubmed:11341771}.; subcellular location: isoform 1: cytoplasm {eco:0000269|pubmed:11148210, eco:0000269|pubmed:11341771, eco:0000269|pubmed:11788610}.","TISSUE SPECIFICITY: Ubiquitous. Shows highest expression in the brain, placenta and pancreas. {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11341771}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MGEA5,10724,Hs.500842,ENST00000361464,THC2470155,"GO:0004402(histone acetyltransferase activity)|GO:0004415(hyalurononglucosaminidase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006044(N-acetylglucosamine metabolic process)|GO:0006516(glycoprotein catabolic process)|GO:0006612(protein targeting to membrane)|GO:0007568(aging)|GO:0010524(positive regulation of calcium ion transport into cytosol)|GO:0010616(negative regulation of cardiac muscle adaptation)|GO:0016746(transferase activity, transferring acyl groups)|GO:0016798(hydrolase activity, acting on glycosyl bonds)|GO:0031343(positive regulation of cell killing)|GO:0032024(positive regulation of insulin secretion)|GO:0043243(positive regulation of protein complex disassembly)|GO:0045862(positive regulation of proteolysis)|GO:0046060(dATP metabolic process)|GO:0046326(positive regulation of glucose import)|GO:0048545(response to steroid hormone stimulus)|GO:0051054(positive regulation of DNA metabolic process)|GO:0051901(positive regulation of mitochondrial depolarization)|GO:0060051(negative regulation of protein glycosylation)|GO:0060124(positive regulation of growth hormone secretion)|GO:0070265(necrotic cell death)","Homo sapiens meningioma expressed antigen 5 (hyaluronidase) (MGEA5), transcript variant 1, mRNA [NM_012215]",chr10:103544394-103544335,hs|10q24.32,meningioma expressed antigen 5 (hyaluronidase),TRUE
546_REXO2_25996,Q9Y3B8,"oligoribonuclease, mitochondrial (ec 3.1.-.-) (rna exonuclease 2 homolog) (small fragment nuclease)",REXO2 SFN SMFN CGI-114,237,function: 3'-to-5' exoribonuclease specific for small oligoribonucleotides. active on small (primarily </=5 nucleotides in length) single-stranded rna and dna oligomers. may have a role in cellular nucleotide recycling. {eco:0000269|pubmed:23741365}.,subcellular location: isoform 1: mitochondrion intermembrane space. mitochondrion matrix.; subcellular location: isoform 2: nucleus.; subcellular location: isoform 3: cytoplasm.,NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,REXO2,25996,Hs.714231,ENST00000546316,THC2546197,"GO:0003676(nucleic acid binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005739(mitochondrion)|GO:0005886(plasma membrane)|GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0008408(3'-5' exonuclease activity)|GO:0009117(nucleotide metabolic process)","Homo sapiens REX2, RNA exonuclease 2 homolog (S. cerevisiae) (REXO2), nuclear gene encoding mitochondrial protein, mRNA [NM_015523]",chr11:114320860-114320919,hs|11q23.2,"REX2, RNA exonuclease 2 homolog (S. cerevisiae)",TRUE
547_MTA1_9112,Q13330,metastasis-associated protein mta1,MTA1,715,"function: transcriptional coregulator which can act as both a transcriptional corepressor and coactivator. as a part of the histone-deacetylase multiprotein complex (nurd), regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target dna. in conjunction with other components of nurd, acts as a transcriptional corepressor of brca1, esr1, tff1 and cdkn1a. acts as a transcriptional coactivator of bcas3, pax5 and sumo2, independent of the nurd complex. stimulates the expression of wnt1 by inhibiting the expression of its transcriptional corepressor six3. regulates p53-dependent and -independent dna repair processes following genotoxic stress. regulates the stability and function of p53/tp53 by inhibiting its ubiquitination by cop1 and mdm2 thereby regulating the p53-dependent dna repair. plays an important role in tumorigenesis, tumor invasion, and metastasis. involved in the epigenetic regulation of esr1 expression in breast cancer in a tfap2c, ifi16 and hdac4/5/6-dependent manner. plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (ld) cycles. positively regulates the clock-arntl/bmal1 heterodimer mediated transcriptional activation of its own transcription and the transcription of cry1. regulates deacetylation of arntl/bmal1 by regulating sirt1 expression, resulting in derepressing cry1-mediated transcription repression. isoform short binds to esr1 and sequesters it in the cytoplasm and enhances its non-genomic responses. with tfcp2l1, promotes establishment and maintenance of pluripotency in embryonic stem cells (escs) and inhibits endoderm differentiation (by similarity). {eco:0000250|uniprotkb:q8k4b0, eco:0000269|pubmed:16617102, eco:0000269|pubmed:17671180, eco:0000269|pubmed:17922032, eco:0000269|pubmed:19837670, eco:0000269|pubmed:21965678, eco:0000269|pubmed:24413532}.","subcellular location: isoform short: cytoplasm.; subcellular location: isoform long: nucleus. nucleus envelope. cytoplasm. cytoplasm, cytoskeleton. note=associated with microtubules. localization at the nuclear envelope is tpr-dependent.","TISSUE SPECIFICITY: Widely expressed. High expression in brain, liver, kidney, and cardiac muscle, ovaries, adrenal glands and virgin mammary glands. Higher in tumors than in adjacent normal tissue from the same individual. Up-regulated in a wide variety of cancers including breast, liver, ovarian, and colorectal cancer and its expression levels are closely correlated with tumor aggressiveness and metastasis. {ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:24970816}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,MTA1,9112,Hs.525629,ENST00000331320,NA,GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007165(signal transduction)|GO:0008270(zinc ion binding)|GO:0016581(NuRD complex)|GO:0043231(intracellular membrane-bounded organelle)|GO:0043565(sequence-specific DNA binding)|GO:0046872(metal ion binding),"Homo sapiens metastasis associated 1 (MTA1), transcript variant 1, mRNA [NM_004689]",chr14:105936979-105937038,hs|14q32.33,metastasis associated 1,TRUE
548_SCYL1_57410,Q96KG9,n-terminal kinase-like protein (coated vesicle-associated kinase of 90 kda) (scy1-like protein 1) (telomerase regulation-associated protein) (telomerase transcriptional element-interacting factor) (teratoma-associated tyrosine kinase),SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019,808,"function: regulates copi-mediated retrograde protein traffic at the interface between the golgi apparatus and the endoplasmic reticulum (pubmed:18556652). involved in the maintenance of the golgi apparatus morphology (pubmed:26581903). has no detectable kinase activity in vitro (pubmed:18556652). {eco:0000269|pubmed:18556652, eco:0000269|pubmed:26581903}.; function: isoform 6 acts as transcriptional activator. it binds to three different types of gc-rich dna binding sites (box-a, -b and -c) in the beta-polymerase promoter region. it also binds to the tert promoter region. {eco:0000269|pubmed:18556652}.","subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:18556652}. endoplasmic reticulum-golgi intermediate compartment {eco:0000269|pubmed:18556652}. golgi apparatus, cis-golgi network {eco:0000269|pubmed:18556652}. note=localized to the endoplasmic reticulum-golgi intermediate and cis-golgi in an arf1-independent manner.; subcellular location: isoform 1: cytoplasm. note=cytoplasmic throughout the cell cycle.; subcellular location: isoform 2: cytoplasm. note=cytoplasmic throughout the cell cycle.; subcellular location: isoform 3: cytoplasm. cytoplasm, cytoskeleton, microtubule organizing center, centrosome. note=cytoplasmic during interphase and centrosomal during mitosis, it localizes to the centrosomes in a microtubule-independent manner.; subcellular location: isoform 6: nucleus {eco:0000269|pubmed:15504359}.",TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12036289}.,"DISEASE: Spinocerebellar ataxia, autosomal recessive, 21 (SCAR21) [MIM:616719]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy. {ECO:0000269|PubMed:26581903}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,SCYL1,57410,Hs.238839,ENST00000270176,NP349879,"GO:0003677(DNA binding)|GO:0004713(protein tyrosine kinase activity)|GO:0005488(binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0005801(cis-Golgi network)|GO:0005815(microtubule organizing center)|GO:0005856(cytoskeleton)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006890(retrograde vesicle-mediated transport, Golgi to ER)|GO:0016192(vesicle-mediated transport)|GO:0016772(transferase activity, transferring phosphorus-containing groups)|GO:0030126(COPI vesicle coat)","Homo sapiens SCY1-like 1 (S. cerevisiae) (SCYL1), transcript variant A, mRNA [NM_020680]",chr11:65306114-65306173,hs|11q13.1,SCY1-like 1 (S. cerevisiae),TRUE
549_REPIN1_29803,Q9BWE0,replication initiator 1 (60 kda origin-specific dna-binding protein) (60 kda replication initiation region protein) (att-binding protein) (dhfr oribeta-binding protein rip60) (zinc finger protein 464),REPIN1 RIP60 ZNF464,567,"function: sequence-specific double-stranded dna-binding protein required for initiation of chromosomal dna replication. binds on 5'-att-3' reiterated sequences downstream of the origin of bidirectional replication (obr) and a second, homologous att sequence of opposite orientation situated within the obr zone. facilitates dna bending.",subcellular location: nucleus {eco:0000269|pubmed:10606657}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,REPIN1,29803,Hs.647086,ENST00000425389,THC2469543,GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005664(nuclear origin of replication recognition complex)|GO:0006260(DNA replication)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens replication initiator 1 (REPIN1), transcript variant 2, mRNA [NM_014374]",chr7:150071004-150071063,hs|7q36.1,replication initiator 1,TRUE
55_LAMP1_3916,P11279,lysosome-associated membrane glycoprotein 1 (lamp-1) (lysosome-associated membrane protein 1) (cd107 antigen-like family member a) (cd antigen cd107a),LAMP1,417,function: presents carbohydrate ligands to selectins. also implicated in tumor cell metastasis.; function: acts as a receptor for lassa virus protein. {eco:0000269|pubmed:24970085}.,"subcellular location: cell membrane {eco:0000250|uniprotkb:p05300}; single-pass type i membrane protein {eco:0000255}. endosome membrane; single-pass type i membrane protein {eco:0000255}. lysosome membrane {eco:0000269|pubmed:16176980, eco:0000269|pubmed:17897319}; single-pass type i membrane protein {eco:0000255}. late endosome {eco:0000269|pubmed:16176980}. note=this protein shuttles between lysosomes, endosomes, and the plasma membrane (by similarity). colocalizes with osbpl1a at the late endosome (pubmed:16176980). {eco:0000250|uniprotkb:p05300, eco:0000269|pubmed:16176980, eco:0000269|pubmed:17897319}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LAMP1,3916,Hs.494419,ENST00000472564,THC2599880,GO:0005624(membrane fraction)|GO:0005764(lysosome)|GO:0005765(lysosomal membrane)|GO:0005770(late endosome)|GO:0005771(multivesicular body)|GO:0005887(integral to plasma membrane)|GO:0006914(autophagy)|GO:0009897(external side of plasma membrane)|GO:0010008(endosome membrane)|GO:0030425(dendrite)|GO:0031410(cytoplasmic vesicle)|GO:0042383(sarcolemma)|GO:0042470(melanosome)|GO:0042599(lamellar body)|GO:0043025(neuronal cell body)|GO:0048102(autophagic cell death),"Homo sapiens lysosomal-associated membrane protein 1 (LAMP1), mRNA [NM_005561]",chr13:113977667-113977726,hs|13q34,lysosomal-associated membrane protein 1,TRUE
550_TCEB1_6921,Q15369,elongin-c (eloc) (elongin 15 kda subunit) (rna polymerase ii transcription factor siii subunit c) (siii p15) (transcription elongation factor b polypeptide 1),ELOC TCEB1,112,"function: siii, also known as elongin, is a general transcription elongation factor that increases the rna polymerase ii transcription elongation past template-encoded arresting sites. subunit a is transcriptionally active and its transcription activity is strongly enhanced by binding to the dimeric complex of the siii regulatory subunits b and c (elongin bc complex) (pubmed:7821821). in embryonic stem cells, the elongin bc complex is recruited by epop to polycomb group (pcg) target genes in order generate genomic region that display both active and repressive chromatin properties, an important feature of pluripotent stem cells (by similarity). {eco:0000250|uniprotkb:p83940, eco:0000269|pubmed:7821821}.; function: the elongin bc complex seems to be involved as an adapter protein in the proteasomal degradation of target proteins via different e3 ubiquitin ligase complexes, including the von hippel-lindau ubiquitination complex cbc(vhl). by binding to bc-box motifs it seems to link target recruitment subunits, like vhl and members of the socs box family, to cullin/rbx1 modules that activate e2 ubiquitination enzymes. {eco:0000269|pubmed:10205047, eco:0000269|pubmed:12004076, eco:0000269|pubmed:12050673, eco:0000269|pubmed:15590694}.",subcellular location: nucleus {eco:0000305}.,TISSUE SPECIFICITY: Overexpressed in prostate cancer cell line PC-3 and breast cancer cell line SK-BR-3. {ECO:0000269|PubMed:12004003}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEB1,6921,Hs.554594,ENST00000520242,THC2599947,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005829(cytosol)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0044419(interspecies interaction between organisms)|GO:0050434(positive regulation of viral transcription),"Homo sapiens transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) (TCEB1), transcript variant 1, mRNA [NM_005648]",chr8:74858931-74858872,hs|8q21.11,"transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)",TRUE
551_GNG10_2790,P50151,guanine nucleotide-binding protein g(i)/g(s)/g(o) subunit gamma-10,GNG10 GNGT10,68,"function: guanine nucleotide-binding proteins (g proteins) are involved as a modulator or transducer in various transmembrane signaling systems. the beta and gamma chains are required for the gtpase activity, for replacement of gdp by gtp, and for g protein-effector interaction. interacts with beta-1 and beta-2, but not with beta-3.",subcellular location: cell membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}.,TISSUE SPECIFICITY: Abundantly and ubiquitously expressed.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GNG10,2790,Hs.534196,ENST00000374293,THC2467906,GO:0003924(GTPase activity)|GO:0004871(signal transducer activity)|GO:0005834(heterotrimeric G-protein complex)|GO:0005886(plasma membrane)|GO:0006112(energy reserve metabolic process)|GO:0006184(GTP catabolic process)|GO:0007165(signal transduction)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007268(synaptic transmission)|GO:0071377(cellular response to glucagon stimulus),"Homo sapiens guanine nucleotide binding protein (G protein), gamma 10 (GNG10), transcript variant 1, mRNA [NM_001017998]",chr9:114432370-114432429,hs|9q31.3,"guanine nucleotide binding protein (G protein), gamma 10",TRUE
552_ADAR_103,P55265,double-stranded rna-specific adenosine deaminase (drada) (ec 3.5.4.37) (136 kda double-stranded rna-binding protein) (p136) (interferon-inducible protein 4) (ifi-4) (k88dsrbp),ADAR ADAR1 DSRAD G1P1 IFI4,1226,"function: catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded rna (dsrna) referred to as a-to-i rna editing (pubmed:7972084, pubmed:7565688, pubmed:12618436). this may affect gene expression and function in a number of ways that include mrna translation by changing codons and hence the amino acid sequence of proteins; pre-mrna splicing by altering splice site recognition sequences; rna stability by changing sequences involved in nuclease recognition; genetic stability in the case of rna virus genomes by changing sequences during viral rna replication; and rna structure-dependent activities such as microrna production or targeting or protein-rna interactions. can edit both viral and cellular rnas and can edit rnas at multiple sites (hyper-editing) or at specific sites (site-specific editing). its cellular rna substrates include: bladder cancer-associated protein (blcap), neurotransmitter receptors for glutamate (gria2) and serotonin (htr2c) and gaba receptor (gabra3). site-specific rna editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. exhibits low-level editing at the gria2 q/r site, but edits efficiently at the r/g site and hotspot1. its viral rna substrates include: hepatitis c virus (hcv), vesicular stomatitis virus (vsv), measles virus (mv), hepatitis delta virus (hdv), and human immunodeficiency virus type 1 (hiv-1). exhibits either a proviral (hdv, mv, vsv and hiv-1) or an antiviral effect (hcv) and this can be editing-dependent (hdv and hcv), editing-independent (vsv and mv) or both (hiv-1). impairs hcv replication via rna editing at multiple sites. enhances the replication of mv, vsv and hiv-1 through an editing-independent mechanism via suppression of eif2ak2/pkr activation and function. stimulates both the release and infectivity of hiv-1 viral particles by an editing-dependent mechanism where it associates with viral rnas and edits adenosines in the 5'utr and the rev and tat coding sequence. can enhance viral replication of hdv via a-to-i editing at a site designated as amber/w, thereby changing an uag amber stop codon to an uig tryptophan (w) codon that permits synthesis of the large delta antigen (l-hdag) which has a key role in the assembly of viral particles. however, high levels of adar1 inhibit hdv replication. {eco:0000269|pubmed:12618436, eco:0000269|pubmed:15556947, eco:0000269|pubmed:15858013, eco:0000269|pubmed:16120648, eco:0000269|pubmed:16475990, eco:0000269|pubmed:17079286, eco:0000269|pubmed:19605474, eco:0000269|pubmed:19651874, eco:0000269|pubmed:19710021, eco:0000269|pubmed:19908260, eco:0000269|pubmed:21289159, eco:0000269|pubmed:22278222, eco:0000269|pubmed:7565688, eco:0000269|pubmed:7972084}.","subcellular location: isoform 1: cytoplasm {eco:0000269|pubmed:7565688}. nucleus {eco:0000269|pubmed:24753571, eco:0000269|pubmed:7565688}. note=shuttles between the cytoplasm and nucleus (pubmed:7565688, pubmed:24753571). nuclear import is mediated by tnpo1 (pubmed:24753571). {eco:0000269|pubmed:24753571, eco:0000269|pubmed:7565688}.; subcellular location: isoform 5: cytoplasm {eco:0000269|pubmed:19124606}. nucleus {eco:0000269|pubmed:19124606, eco:0000269|pubmed:7565688}. nucleus, nucleolus {eco:0000269|pubmed:12665561}. note=predominantly nuclear but can shuttle between nucleus and cytoplasm. tnpo1 can mediate its nuclear import whereas xpo5 can mediate its nuclear export. {eco:0000269|pubmed:19124606}.","TISSUE SPECIFICITY: Ubiquitously expressed, highest levels were found in brain and lung (PubMed:7972084). Isoform 5 is expressed at higher levels in astrocytomas as compared to normal brain tissue and expression increases strikingly with the severity of the tumor, being higher in the most aggressive tumors. {ECO:0000269|PubMed:18178553, ECO:0000269|PubMed:7972084}.","DISEASE: Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]: An autosomal dominant pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the face and the dorsal parts of the hands and feet, that appear in infancy or early childhood. {ECO:0000269|PubMed:12916015, ECO:0000269|PubMed:15146470, ECO:0000269|PubMed:15659327}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]: A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood. {ECO:0000269|PubMed:23001123}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ADAR,103,Hs.12341,ENST00000368474,THC2496962,GO:0003677(DNA binding)|GO:0003725(double-stranded RNA binding)|GO:0003726(double-stranded RNA adenosine deaminase activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006382(adenosine to inosine editing)|GO:0006397(mRNA processing)|GO:0016553(base conversion or substitution editing)|GO:0016556(mRNA modification)|GO:0016787(hydrolase activity)|GO:0019221(cytokine-mediated signaling pathway)|GO:0031047(gene silencing by RNA)|GO:0043066(negative regulation of apoptosis)|GO:0046872(metal ion binding)|GO:0060337(type I interferon-mediated signaling pathway),"Homo sapiens adenosine deaminase, RNA-specific (ADAR), transcript variant 1, mRNA [NM_001111]",chr1:154554789-154554730,hs|1q21.3,"adenosine deaminase, RNA-specific",TRUE
553_METTL7A_25840,Q9H8H3,methyltransferase-like protein 7a (ec 2.1.1.-) (protein aam-b),METTL7A PRO0066 UNQ1902/PRO4348,244,function: probable methyltransferase. {eco:0000250}.,"subcellular location: lipid droplet {eco:0000269|pubmed:18477614, eco:0000269|pubmed:19773358}. endoplasmic reticulum {eco:0000269|pubmed:19773358}. membrane {eco:0000269|pubmed:18477614}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,METTL7A,25840,Hs.728181,ENST00000550097,NP075556,GO:0005783(endoplasmic reticulum)|GO:0005811(lipid particle)|GO:0008152(metabolic process)|GO:0008168(methyltransferase activity)|GO:0016020(membrane)|GO:0016740(transferase activity),"Homo sapiens methyltransferase like 7A (METTL7A), mRNA [NM_014033]",chr12:51326101-51326160,hs|12q13.12,methyltransferase like 7A,TRUE
554_C17orf89_284184,A1L188,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8,NDUFAF8 C17orf89,74,"function: involved in the assembly of mitochondrial nadh:ubiquinone oxidoreductase complex (complex i, mt-nd1) (pubmed:27499296). required to stabilize ndufaf5 (pubmed:27499296). {eco:0000269|pubmed:27499296}.",subcellular location: mitochondrion {eco:0000269|pubmed:27499296}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C17orf89,284184,Hs.356545,ENST00000431388,THC2524836,GO:0005739(mitochondrion),"Homo sapiens chromosome 17 open reading frame 89 (C17orf89), mRNA [NM_001086521]",chr17:79215020-79215079,hs|17q25.3,chromosome 17 open reading frame 89,TRUE
555_RAD21_5885,O60216,double-strand-break repair protein rad21 homolog (hhr21) (nuclear matrix protein 1) (nxp-1) (scc1 homolog) [cleaved into: 64-kda c-terminal product (64-kda carboxy-terminal product) (65-kda carboxy-terminal product)],RAD21 HR21 KIAA0078 NXP1 SCC1,631,"function: double-strand-break repair protein rad21 homolog: as a member of the cohesin complex, involved in sister chromatid cohesion from the time of dna replication in s phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative dna repair, and the prevention of inappropriate recombination between repetitive regions (pubmed:11509732). the cohesin complex may also play a role in spindle pole assembly during mitosis (pubmed:11590136). in interphase, cohesins may function in the control of gene expression by binding to numerous sites within the genome (by similarity). may control runx1 gene expression (probable). binds to and represses apob gene promoter (pubmed:25575569). may play a role in embryonic gut development, possibly through the regulation of enteric neuron development (by similarity). {eco:0000250|uniprotkb:q61550, eco:0000250|uniprotkb:q6tel1, eco:0000269|pubmed:11509732, eco:0000269|pubmed:11590136, eco:0000269|pubmed:25575569, eco:0000305|pubmed:25575569}.; function: 64-kda c-terminal product: may promote apoptosis. {eco:0000269|pubmed:11875078, eco:0000269|pubmed:12417729}.","subcellular location: double-strand-break repair protein rad21 homolog: nucleus {eco:0000269|pubmed:11073952, eco:0000269|pubmed:11509732, eco:0000269|pubmed:12417729}. nucleus matrix {eco:0000269|pubmed:10623634, eco:0000269|pubmed:11590136}. chromosome {eco:0000269|pubmed:11073952, eco:0000269|pubmed:11590136}. chromosome, centromere {eco:0000269|pubmed:11073952}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:11073952, eco:0000269|pubmed:11590136}. note=associates with chromatin (pubmed:11590136, pubmed:11073952). before prophase, scattered along chromosome arms (pubmed:11073952). during prophase and prometaphase, most cohesins dissociate from the arms of condensing chromosome, possibly through plk1-mediated phosphorylation (pubmed:11931760). a small amount of cohesin remains in centromeric regions and is removed from chromosomes only at the onset of anaphase. at anaphase, cleavage by separase/espl1 leads to the dissociation of cohesin from chromosomes and chromosome separation (pubmed:11073952, pubmed:11509732). {eco:0000269|pubmed:11073952, eco:0000269|pubmed:11509732, eco:0000269|pubmed:11590136, eco:0000269|pubmed:11931760}.; subcellular location: 64-kda c-terminal product: cytoplasm, cytosol {eco:0000269|pubmed:11875078, eco:0000269|pubmed:12417729}. nucleus {eco:0000269|pubmed:11875078, eco:0000269|pubmed:12417729}.",TISSUE SPECIFICITY: Expressed in the gut (at protein level). {ECO:0000269|PubMed:25575569}.,"DISEASE: Cornelia de Lange syndrome 4 (CDLS4) [MIM:614701]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. It is characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:22633399}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mungan syndrome (MGS) [MIM:611376]: An autosomal recessive disease characterized by visceral neuromyopathy, intestinal dysmotility and chronic intestinal pseudoobstruction, megaduodenum, long-segment Barrett esophagus, and a variety of cardiac valve or septal defects such as membranous ventricular septal defect, pulmonary and tricuspid valve regurgitation. {ECO:0000269|PubMed:25575569}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,RAD21,5885,Hs.81848,ENST00000297338,THC2465285,"GO:0000087(M phase of mitotic cell cycle)|GO:0000228(nuclear chromosome)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0000775(chromosome, centromeric region)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0006302(double-strand break repair)|GO:0006310(DNA recombination)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006915(apoptosis)|GO:0007059(chromosome segregation)|GO:0007091(mitotic metaphase/anaphase transition)|GO:0007131(reciprocal meiotic recombination)|GO:0008278(cohesin complex)|GO:0051301(cell division)|GO:0071168(protein localization to chromatin)","Homo sapiens RAD21 homolog (S. pombe) (RAD21), mRNA [NM_006265]",chr8:117858409-117858350,hs|8q24.11,RAD21 homolog (S. pombe),TRUE
556_POGZ_23126,Q7Z3K3,pogo transposable element with znf domain (suppressor of hairy wing homolog 5) (zinc finger protein 280e) (zinc finger protein 635),POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003,1410,function: plays a role in mitotic cell cycle progression and is involved in kinetochore assembly and mitotic sister chromatid cohesion. probably through its association with cbx5 plays a role in mitotic chromosome segregation by regulating aurora kinase b/aurkb activation and aurkb and cbx5 dissociation from chromosome arms. {eco:0000269|pubmed:20562864}.,"subcellular location: nucleus. chromosome. cytoplasm. note=according to some authors, it is not localized to mitotic chromatin (pubmed:19244240). recruited to trimethylated 'lys-9' of histone h3 (h3k9me3). {eco:0000269|pubmed:19244240}.",NA,"DISEASE: Note=Defects in POGZ may be associated with neuropsychiatric disorders such as autism spectrum disorders (ASD), bipolar affective disorders and early dementia onset. ASD are characterized by impairments in reciprocal social interaction and communication as well as restricted and stereotyped patterns of interest and activities. ASD include forms with moderate to severe cognitive impairment and milder forms with higher cognitive ability (Asperger syndrome). {ECO:0000269|PubMed:25694107}.; DISEASE: White-Sutton syndrome (WHSUS) [MIM:616364]: A mental retardation syndrome characterized by developmental delay, intellectual disability, hypotonia, behavioral abnormalities, and dysmorphic facial features. Variable features include short stature, microcephaly, strabismus and hearing loss. {ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:26739615}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,POGZ,23126,Hs.489873,ENST00000368863,THC2579437,"GO:0000790(nuclear chromatin)|GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007049(cell cycle)|GO:0007064(mitotic sister chromatid cohesion)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)|GO:0051301(cell division)|GO:0051382(kinetochore assembly)","Homo sapiens pogo transposable element with ZNF domain (POGZ), transcript variant 1, mRNA [NM_015100]",chr1:151377075-151377016,hs|1q21.3,pogo transposable element with ZNF domain,TRUE
557_CTDSP1_58190,Q9GZU7,carboxy-terminal domain rna polymerase ii polypeptide a small phosphatase 1 (ec 3.1.3.16) (nuclear lim interactor-interacting factor 3) (nli-if) (nli-interacting factor 3) (small c-terminal domain phosphatase 1) (scp1) (small ctd phosphatase 1),CTDSP1 NIF3 NLIIF SCP1,261,"function: preferentially catalyzes the dephosphorylation of 'ser-5' within the tandem 7 residue repeats in the c-terminal domain (ctd) of the largest rna polymerase ii subunit polr2a. negatively regulates rna polymerase ii transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation. recruited by rest to neuronal genes that contain re-1 elements, leading to neuronal gene silencing in non-neuronal cells. {eco:0000269|pubmed:12721286, eco:0000269|pubmed:15681389}.",subcellular location: nucleus {eco:0000269|pubmed:12721286}. note=colocalizes with rna polymerase ii.,"TISSUE SPECIFICITY: Expression is restricted to non-neuronal tissues. Highest expression in skeletal muscle, spleen, lung and placenta. {ECO:0000269|PubMed:15681389}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CTDSP1,58190,Hs.444468,ENST00000273062,THC2468382,GO:0004721(phosphoprotein phosphatase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006470(protein dephosphorylation)|GO:0008420(CTD phosphatase activity)|GO:0016787(hydrolase activity)|GO:0045665(negative regulation of neuron differentiation)|GO:0046872(metal ion binding)|GO:0050768(negative regulation of neurogenesis),"Homo sapiens CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 (CTDSP1), transcript variant 1, mRNA [NM_021198]",chr2:219270601-219270660,hs|2q35,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1",TRUE
558_SLC25A36_55186,Q96CQ1,solute carrier family 25 member 36,SLC25A36,311,"function: mitochondrial transporter that imports/exports pyrimidine nucleotides into and from mitochondria. transports preferentially cytosine and uracil (deoxy)nucleoside mono-, di-, and triphosphates by uniport and antiport mechanism. also transports guanine but not adenine (deoxy)nucleotides. is inhibited strongly by pyridoxal 5'-phosphate, 4,7-diphenyl-1,10-phenanthroline, tannic acid, and mercurials (mercury dichloride, mersalyl acid, p-hydroxymercuribenzoate). participates in mitochondrial genome maintenance, regulation of mitochondrial membrane potential and mitochondrial respiration. {eco:0000269|pubmed:25320081}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:25320081}; multi-pass membrane protein {eco:0000255}.,TISSUE SPECIFICITY: Expressed at moderate level. {ECO:0000269|PubMed:17210862}.,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC25A36,55186,Hs.144130,ENST00000511757,THC2775604,GO:0005488(binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0032355(response to estradiol stimulus)|GO:0055085(transmembrane transport),"Homo sapiens solute carrier family 25, member 36 (SLC25A36), transcript variant 2, mRNA [NM_018155]",chr3:140695415-140695474,hs|3q23,"solute carrier family 25, member 36",TRUE
559_BSDC1_55108,Q9NW68,bsd domain-containing protein 1,BSDC1 UNQ2494/PRO5781,430,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,BSDC1,55108,Hs.353454,ENST00000341071,THC2788373,NA,"Homo sapiens BSD domain containing 1 (BSDC1), transcript variant 2, mRNA [NM_018045]",chr1:32830970-32830911,hs|1p35.1,BSD domain containing 1,TRUE
56_ALPK1_80216,Q96QP1,alpha-protein kinase 1 (ec 2.7.11.1) (chromosome 4 kinase) (lymphocyte alpha-protein kinase),ALPK1 KIAA1527 LAK,1244,"function: serine/threonine-protein kinase that detects bacterial pathogen-associated molecular pattern metabolites (pamps) and initiates an innate immune response, a critical step for pathogen elimination and engagement of adaptive immunity (pubmed:28877472, pubmed:28222186, pubmed:30111836). specifically recognizes and binds adp-d-glycero-beta-d-manno-heptose (adp-heptose), a potent pamp present in all gram-negative and some gram-positive bacteria (pubmed:30111836). adp-heptose-binding stimulates its kinase activity to phosphorylate and activate tifa, triggering proinflammatory nf-kappa-b signaling (pubmed:30111836). may be involved in monosodium urate monohydrate (msu)-induced inflammation by mediating phosphorylation of unconventional myosin myo9a (pubmed:27169898). may also play a role in apical protein transport by mediating phosphorylation of unconventional myosin myo1a (pubmed:15883161). {eco:0000269|pubmed:15883161, eco:0000269|pubmed:27169898, eco:0000269|pubmed:28222186, eco:0000269|pubmed:28877472, eco:0000269|pubmed:30111836}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:30111836}.",TISSUE SPECIFICITY: Highly expressed in liver. {ECO:0000269|PubMed:10819331}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ALPK1,80216,Hs.652825,ENST00000309610,THC2486927,GO:0004674(protein serine/threonine kinase activity)|GO:0005524(ATP binding)|GO:0006468(protein phosphorylation)|GO:0016301(kinase activity),alpha-kinase 1 [Source:HGNC Symbol;Acc:20917] [ENST00000309610],chr4:113336615-113336674,hs|4q25,alpha-kinase 1,TRUE
561_DYNC1LI2_1783,O43237,"cytoplasmic dynein 1 light intermediate chain 2 (dynein light intermediate chain 2, cytosolic) (lic-2) (lic53/55)",DYNC1LI2 DNCLI2 LIC2,492,function: acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. may play a role in binding dynein to membranous organelles or chromosomes.,"subcellular location: cytoplasm, cytoskeleton {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,DYNC1LI2,1783,Hs.369068,ENST00000443351,THC2469609,GO:0000166(nucleotide binding)|GO:0003774(motor activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005856(cytoskeleton)|GO:0005868(cytoplasmic dynein complex)|GO:0005874(microtubule)|GO:0006810(transport),"Homo sapiens dynein, cytoplasmic 1, light intermediate chain 2 (DYNC1LI2), mRNA [NM_006141]",chr16:66757710-66757651,hs|16q22.1,"dynein, cytoplasmic 1, light intermediate chain 2",TRUE
562_COX17_10063,Q14061,cytochrome c oxidase copper chaperone,COX17,63,"function: copper metallochaperone essential for the assembly of the mitochondrial respiratory chain complex iv (civ), also known as cytochrome c oxidase. binds two copper ions and delivers them to the metallochaperone sco1 which transports the copper ions to the cu(a) site on the cytochrome c oxidase subunit ii (mt-co2/cox2). {eco:0000269|pubmed:19393246}.",subcellular location: mitochondrion intermembrane space {eco:0000269|pubmed:19393246}. cytoplasm {eco:0000269|pubmed:19393246}.,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10982038}.,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX17,10063,Hs.534383,ENST00000468918,THC2461314,GO:0005507(copper ion binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005758(mitochondrial intermembrane space)|GO:0006091(generation of precursor metabolites and energy)|GO:0006825(copper ion transport)|GO:0007420(brain development)|GO:0007507(heart development)|GO:0008047(enzyme activator activity)|GO:0016531(copper chaperone activity)|GO:0046872(metal ion binding),"Homo sapiens COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) (COX17), nuclear gene encoding mitochondrial protein, mRNA [NM_005694]",chr3:119396074-119394045,hs|3q13.33,COX17 cytochrome c oxidase assembly homolog (S. cerevisiae),TRUE
563_YWHAQ_10971,P27348,14-3-3 protein theta (14-3-3 protein t-cell) (14-3-3 protein tau) (protein hs1),YWHAQ,245,"function: adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. binding generally results in the modulation of the activity of the binding partner. negatively regulates the kinase activity of pdpk1. {eco:0000269|pubmed:12177059}.","subcellular location: cytoplasm. note=in neurons, axonally transported to the nerve terminals.","TISSUE SPECIFICITY: Abundantly expressed in brain, heart and pancreas, and at lower levels in kidney and placenta. Up-regulated in the lumbar spinal cord from patients with sporadic amyotrophic lateral sclerosis (ALS) compared with controls, with highest levels of expression in individuals with predominant lower motor neuron involvement. {ECO:0000269|PubMed:11080204}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YWHAQ,10971,Hs.74405,ENST00000381844,THC2730314,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0006605(protein targeting)|GO:0007264(small GTPase mediated signal transduction)|GO:0019904(protein domain specific binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0047485(protein N-terminus binding)","Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (YWHAQ), mRNA [NM_006826]",chr2:9724224-9724165,hs|2p25.1,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide",TRUE
564_HIST2H2AC_8338,Q16777,histone h2a type 2-c (histone h2a-gl101) (histone h2a/q),HIST2H2AC H2AFQ,129,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST2H2AC,8338,Hs.408067,ENST00000331380,THC2482784,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 2, H2ac (HIST2H2AC), mRNA [NM_003517]",chr1:149858838-149858897,hs|1q21.2,"histone cluster 2, H2ac",TRUE
565_LRIG1_26018,Q96JA1,leucine-rich repeats and immunoglobulin-like domains protein 1 (lig-1),LRIG1 LIG1,1093,"function: acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. {eco:0000269|pubmed:15282549}.",subcellular location: cell membrane {eco:0000269|pubmed:15282549}; single-pass type i membrane protein {eco:0000305|pubmed:15282549}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11414704}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LRIG1,26018,Hs.518055,ENST00000383702,THC2489006,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1), mRNA [NM_015541]",chr3:66429656-66429597,hs|3p14.1,leucine-rich repeats and immunoglobulin-like domains 1,TRUE
566_MEAF6_64769,Q9HAF1,chromatin modification-related protein meaf6 (myst/esa1-associated factor 6) (esa1-associated factor 6 homolog) (protein eaf6 homolog) (heaf6) (sarcoma antigen ny-sar-91),MEAF6 C1orf149 CENP-28 EAF6,191,"function: component of the nua4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone h4 and h2a. this modification may both alter nucleosome - dna interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. component of the hbo1 complex which has a histone h4-specific acetyltransferase activity, a reduced activity toward histone h3 and is responsible for the bulk of histone h4 acetylation in vivo. component of the moz/morf complex which has a histone h3 acetyltransferase activity. {eco:0000269|pubmed:14966270, eco:0000269|pubmed:16387653, eco:0000269|pubmed:18794358}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:18794358}. chromosome, centromere, kinetochore {eco:0000269|pubmed:20813266}.",NA,DISEASE: Note=A chromosomal aberration involving MEAF6 may be a cause of endometrial stromal tumors. Translocation t(1;6)(p34;p21) with PHF1. {ECO:0000269|PubMed:22761769}.,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MEAF6,64769,Hs.17118,ENST00000487788,THC2607314,"GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016568(chromatin modification)|GO:0035267(NuA4 histone acetyltransferase complex)|GO:0043968(histone H2A acetylation)|GO:0043981(histone H4-K5 acetylation)|GO:0043982(histone H4-K8 acetylation)|GO:0043983(histone H4-K12 acetylation)|GO:0043984(histone H4-K16 acetylation)|GO:0044154(histone H3-K14 acetylation)|GO:0070776(MOZ/MORF histone acetyltransferase complex)","Homo sapiens MYST/Esa1-associated factor 6 (MEAF6), mRNA [NM_022756]",chr1:37959110-37959051,hs|1p34.3,MYST/Esa1-associated factor 6,TRUE
567_YWHAB_7529,P31946,"14-3-3 protein beta/alpha (protein 1054) (protein kinase c inhibitor protein 1) (kcip-1) [cleaved into: 14-3-3 protein beta/alpha, n-terminally processed]",YWHAB,246,"function: adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. binding generally results in the modulation of the activity of the binding partner. negative regulator of osteogenesis. blocks the nuclear translocation of the phosphorylated form (by akt1) of srpk2 and antagonizes its stimulatory effect on cyclin d1 expression resulting in blockage of neuronal apoptosis elicited by srpk2. negative regulator of signaling cascades that mediate activation of map kinases via akap13. {eco:0000269|pubmed:17717073, eco:0000269|pubmed:19592491, eco:0000269|pubmed:21224381}.","subcellular location: cytoplasm {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.; subcellular location: vacuole membrane {eco:0000269|pubmed:11260479}. note=(microbial infection) upon infection with chlamydia trachomatis, this protein is associated with the pathogen-containing vacuole membrane where it colocalizes with incg. {eco:0000269|pubmed:11260479}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,YWHAB,7529,Hs.643544,ENST00000372839,THC2465164,"GO:0000165(MAPKKK cascade)|GO:0000186(activation of MAPKK activity)|GO:0003714(transcription corepressor activity)|GO:0004497(monooxygenase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0006605(protein targeting)|GO:0006915(apoptosis)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007264(small GTPase mediated signal transduction)|GO:0007265(Ras protein signal transduction)|GO:0007411(axon guidance)|GO:0008022(protein C-terminus binding)|GO:0008286(insulin receptor signaling pathway)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008633(activation of pro-apoptotic gene products)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0017053(transcriptional repressor complex)|GO:0019899(enzyme binding)|GO:0019904(protein domain specific binding)|GO:0035308(negative regulation of protein dephosphorylation)|GO:0042470(melanosome)|GO:0042826(histone deacetylase binding)|GO:0043085(positive regulation of catalytic activity)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0048471(perinuclear region of cytoplasm)|GO:0050815(phosphoserine binding)|GO:0051219(phosphoprotein binding)|GO:0051220(cytoplasmic sequestering of protein)","Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB), transcript variant 1, mRNA [NM_003404]",chr20:43536954-43537013,hs|20q13.12,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide",TRUE
568_CCNI_10983,Q14094,cyclin-i,CCNI,377,NA,NA,"TISSUE SPECIFICITY: Highest levels in adult heart, brain and skeletal muscle. Lower levels in adult placenta, lung, kidney and pancreas. Also high levels in fetal brain and lower levels in fetal lung, liver and kidney. Also abundant in testis and thyroid. {ECO:0000269|PubMed:7493655}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,CCNI,10983,Hs.518827,ENST00000537948,THC2548526,GO:0007283(spermatogenesis),"Homo sapiens cyclin I (CCNI), mRNA [NM_006835]",chr4:77969564-77969505,hs|4q21.1,cyclin I,TRUE
569_NAP1L1_4673,P55209,nucleosome assembly protein 1-like 1 (nap-1-related protein) (hnrp),NAP1L1 NRP,391,function: plays a key role in the regulation of embryonic neurogenesis (by similarity). promotes the proliferation of neural progenitors and inhibits neuronal differentiation during cortical development (by similarity). regulates neurogenesis via the modulation of rassf10; regulates rassf10 expression by promoting setd1a-mediated h3k4 methylation at the rassf10 promoter (by similarity). {eco:0000250|uniprotkb:p28656}.,subcellular location: nucleus {eco:0000269|pubmed:17081065}. melanosome {eco:0000269|pubmed:17081065}. cytoplasm {eco:0000250|uniprotkb:p28656}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv.,TISSUE SPECIFICITY: Ubiquitously expressed.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NAP1L1,4673,Hs.524599,ENST00000261182,THC2465166,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005678(chromatin assembly complex)|GO:0006260(DNA replication)|GO:0006334(nucleosome assembly)|GO:0008284(positive regulation of cell proliferation)|GO:0042470(melanosome),"Homo sapiens nucleosome assembly protein 1-like 1 (NAP1L1), transcript variant 1, mRNA [NM_139207]",chr12:76440082-76440023,hs|12q21.2,nucleosome assembly protein 1-like 1,TRUE
57_FUT6_2528,P51993,"alpha-(1,3)-fucosyltransferase 6 (ec 2.4.1.65) (fucosyltransferase 6) (fucosyltransferase vi) (fuc-tvi) (fuct-vi) (galactoside 3-l-fucosyltransferase)",FUT6 FCT3A,359,"function: enzyme involved in the biosynthesis of the e-selectin ligand, sialyl-lewis x. catalyzes the transfer of fucose from gdp-beta-fucose to alpha-2,3 sialylated substrates.","subcellular location: golgi apparatus, golgi stack membrane; single-pass type ii membrane protein. note=membrane-bound form in trans cisternae of golgi.","TISSUE SPECIFICITY: Kidney, liver, colon, small intestine, bladder, uterus and salivary gland.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FUT6,2528,Hs.631846,NA,THC2482527,"GO:0005794(Golgi apparatus)|GO:0006486(protein glycosylation)|GO:0008417(fucosyltransferase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0017060(3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity)|GO:0032580(Golgi cisterna membrane)|GO:0042355(L-fucose catabolic process)|GO:0046920(alpha(1,3)-fucosyltransferase activity)","Human alpha (1,3) fucosyltransferase (FUT6) mRNA, major transcript I, complete cds. [U27333]",chr19:5830832-5774135,hs|19p13.3,"fucosyltransferase 6 (alpha (1,3) fucosyltransferase)",TRUE
570_RPLP0_6175,P05388,60s acidic ribosomal protein p0 (60s ribosomal protein l10e) (large ribosomal subunit protein ul10),RPLP0,317,function: ribosomal protein p0 is the functional equivalent of e.coli protein l10.,"subcellular location: nucleus {eco:0000269|pubmed:19188445}. cytoplasm {eco:0000269|pubmed:19188445}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas (pubmed:19188445, pubmed:17289661). {eco:0000269|pubmed:17289661, eco:0000269|pubmed:19188445}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPLP0,6175,Hs.546285,ENST00000551258,NP1207855,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0042254(ribosome biogenesis)|GO:0044267(cellular protein metabolic process)|GO:0044419(interspecies interaction between organisms),"Homo sapiens ribosomal protein, large, P0 (RPLP0), transcript variant 2, mRNA [NM_053275]",chr12:120635147-120634701,hs|12q24.23,"ribosomal protein, large, P0",TRUE
571_CMTM4_146223,Q8IZR5,cklf-like marvel transmembrane domain-containing protein 4 (chemokine-like factor superfamily member 4),CMTM4 CKLFSF4,234,"function: acts as a backup for cmtm6 to regulate plasma membrane expression of pd-l1/cd274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. may protect pd-l1/cd274 from being polyubiquitinated and targeted for degradation. {eco:0000269|pubmed:28813410}.",subcellular location: membrane {eco:0000255}; multi-pass membrane protein {eco:0000255}.,TISSUE SPECIFICITY: Highly expressed in testis and prostate. {ECO:0000269|PubMed:12782130}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CMTM4,146223,Hs.643961,ENST00000394106,THC2461395,GO:0005125(cytokine activity)|GO:0005615(extracellular space)|GO:0006935(chemotaxis)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens CKLF-like MARVEL transmembrane domain containing 4 (CMTM4), transcript variant 2, mRNA [NM_181521]",chr16:66648837-66648778,hs|16q21,CKLF-like MARVEL transmembrane domain containing 4,TRUE
572_DDIT4_54541,Q9NX09,dna damage-inducible transcript 4 protein (hif-1 responsive protein rtp801) (protein regulated in development and dna damage response 1) (redd-1),DDIT4 REDD1 RTP801,232,"function: regulates cell growth, proliferation and survival via inhibition of the activity of the mammalian target of rapamycin complex 1 (mtorc1). inhibition of mtorc1 is mediated by a pathway that involves ddit4/redd1, akt1, the tsc1-tsc2 complex and the gtpase rheb. plays an important role in responses to cellular energy levels and cellular stress, including responses to hypoxia and dna damage. regulates p53/tp53-mediated apoptosis in response to dna damage via its effect on mtorc1 activity. its role in the response to hypoxia depends on the cell type; it mediates mtorc1 inhibition in fibroblasts and thymocytes, but not in hepatocytes (by similarity). required for mtorc1-mediated defense against viral protein synthesis and virus replication (by similarity). inhibits neuronal differentiation and neurite outgrowth mediated by ngf via its effect on mtorc1 activity. required for normal neuron migration during embryonic brain development. plays a role in neuronal cell death. {eco:0000250, eco:0000269|pubmed:15545625, eco:0000269|pubmed:15632201, eco:0000269|pubmed:15988001, eco:0000269|pubmed:17005863, eco:0000269|pubmed:17379067, eco:0000269|pubmed:19557001, eco:0000269|pubmed:20166753, eco:0000269|pubmed:21460850}.","subcellular location: mitochondrion {eco:0000250}. cytoplasm, cytosol {eco:0000269|pubmed:12453409}.","TISSUE SPECIFICITY: Broadly expressed, with lowest levels in brain, skeletal muscle and intestine. Up-regulated in substantia nigra neurons from Parkinson disease patients (at protein level). {ECO:0000269|PubMed:11884613, ECO:0000269|PubMed:12453409, ECO:0000269|PubMed:17005863, ECO:0000269|PubMed:17379067}.",NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDIT4,54541,Hs.523012,ENST00000307365,THC2591713,GO:0001666(response to hypoxia)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006915(apoptosis)|GO:0032007(negative regulation of TOR signaling cascade)|GO:0043241(protein complex disassembly)|GO:0045820(negative regulation of glycolysis)|GO:0071889(14-3-3 protein binding)|GO:0072593(reactive oxygen species metabolic process),"Homo sapiens DNA-damage-inducible transcript 4 (DDIT4), mRNA [NM_019058]",chr10:74035363-74035422,hs|10q22.1,DNA-damage-inducible transcript 4,TRUE
573_RBBP7_5931,Q16576,histone-binding protein rbbp7 (histone acetyltransferase type b subunit 2) (nucleosome-remodeling factor subunit rbap46) (retinoblastoma-binding protein 7) (rbbp-7) (retinoblastoma-binding protein p46),RBBP7 RBAP46,425,"function: core histone-binding subunit that may target chromatin remodeling factors, histone acetyltransferases and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal dna. component of several complexes which regulate chromatin metabolism. these include the type b histone acetyltransferase (hat) complex, which is required for chromatin assembly following dna replication; the core histone deacetylase (hdac) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the nurd complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; and the prc2/eed-ezh2 complex, which promotes repression of homeotic genes during development; and the nurf (nucleosome remodeling factor) complex. {eco:0000269|pubmed:10866654}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBBP7,5931,Hs.495755,ENST00000465244,THC2493474,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006260(DNA replication)|GO:0006334(nucleosome assembly)|GO:0007275(multicellular organismal development)|GO:0008283(cell proliferation)|GO:0016568(chromatin modification)|GO:0016581(NuRD complex)|GO:0030308(negative regulation of cell growth)|GO:0034080(CenH3-containing nucleosome assembly at centromere)|GO:0035098(ESC/E(Z) complex)|GO:0070370(cellular heat acclimation),"Homo sapiens retinoblastoma binding protein 7 (RBBP7), transcript variant 2, mRNA [NM_002893]",chrX:16863069-16863010,hs|Xp22.2,retinoblastoma binding protein 7,TRUE
574_SLC19A2_10560,O60779,thiamine transporter 1 (thtr-1) (thtr1) (solute carrier family 19 member 2) (thiamine carrier 1) (tc1),SLC19A2 THT1 TRMA,497,"function: high-affinity transporter for the intake of thiamine. {eco:0000269|pubmed:10391222, eco:0000269|pubmed:10542220}.","subcellular location: cell membrane {eco:0000305|pubmed:10391222, eco:0000305|pubmed:10542220}; multi-pass membrane protein {eco:0000255}.","TISSUE SPECIFICITY: Ubiquitous; most abundant in skeletal and cardiac muscle. Medium expression in placenta, heart, liver and kidney, low in lung. {ECO:0000269|PubMed:10391222, ECO:0000269|PubMed:10542220}.","DISEASE: Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270]: An autosomal recessive disease characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness. Onset is typically between infancy and adolescence, but all of the cardinal findings are often not present initially. The anemia, and sometimes the diabetes, improves with high doses of thiamine. Other more variable features include optic atrophy, congenital heart defects, short stature, and stroke. {ECO:0000269|PubMed:10391221, ECO:0000269|PubMed:10874303}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC19A2,10560,Hs.30246,ENST00000236137,THC2485904,GO:0005542(folic acid binding)|GO:0005886(plasma membrane)|GO:0006766(vitamin metabolic process)|GO:0006767(water-soluble vitamin metabolic process)|GO:0006810(transport)|GO:0008517(folic acid transporter activity)|GO:0008518(reduced folate carrier activity)|GO:0015234(thiamine transmembrane transporter activity)|GO:0015403(thiamine uptake transmembrane transporter activity)|GO:0015884(folic acid transport)|GO:0015888(thiamine transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0042723(thiamine-containing compound metabolic process)|GO:0071934(thiamine transmembrane transport),"Homo sapiens solute carrier family 19 (thiamine transporter), member 2 (SLC19A2), mRNA [NM_006996]",chr1:169433321-169433262,hs|1q24.2,"solute carrier family 19 (thiamine transporter), member 2",TRUE
575_NDUFA5_4698,Q16718,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (complex i subunit b13) (complex i-13kd-b) (ci-13kd-b) (nadh-ubiquinone oxidoreductase 13 kda-b subunit),NDUFA5,116,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in all tissues examined with highest levels in heart, skeletal muscle and brain. {ECO:0000269|PubMed:9048877}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA5,4698,Hs.651219,ENST00000355749,THC2605956,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016651(oxidoreductase activity, acting on NADH or NADPH)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (NDUFA5), nuclear gene encoding mitochondrial protein, mRNA [NM_005000]",chr7:123181228-123181169,hs|7q31.32,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa",TRUE
576_H3F3B_3021,P84243,histone h3.3,H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B,136,"function: variant histone h3 which replaces conventional h3 in a wide range of nucleosomes in active genes. constitutes the predominant form of histone h3 in non-dividing cells and is incorporated into chromatin independently of dna synthesis. deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {eco:0000269|pubmed:14718166, eco:0000269|pubmed:15776021, eco:0000269|pubmed:16258499}.",subcellular location: nucleus. chromosome.,NA,"DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539269}. Note=The gene represented in this entry is involved in disease pathogenesis. H3F3A mutations affecting residues involved in post-translational modifications of histone H3.3 are recurrent in malignant, aggressive gliomas including glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG) (PubMed:22286061, PubMed:22286216). The mechanism through which mutations lead to tumorigenesis involves altered histones methylation, impaired regulation of Polycomb repressive complex 2 (PRC2) activity, and aberrant epigenetic regulation of gene expression (PubMed:23539269, PubMed:23539183, PubMed:23603901). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269, ECO:0000269|PubMed:23603901}.; DISEASE: Note=H3F3A and H3F3B mutations affecting residues involved in post-translational modifications of histone H3.3 are implicated in the pathogenesis of some bone and cartilage neoplasms. Mutations have been found with high prevalence in chondroblastoma and giant cell tumors of bone, and with low frequency in osteosarcoma, conventional chondrosarcoma and clear cell chondrosarcoma. Chondroblastoma samples frequently carry a H3F3B mutation affecting residue Lys-37 (H3K36), although H3F3A is mutated in some cases. Most giant cell tumors of bone harbor H3F3A mutations affecting residue Gly-35 (H3G34). {ECO:0000269|PubMed:24162739}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H3F3B,3021,Hs.180877,ENST00000254810,THC2564107,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly)|GO:0007420(brain development)|GO:0007596(blood coagulation)|GO:0009725(response to hormone stimulus),"Homo sapiens H3 histone, family 3B (H3.3B) (H3F3B), mRNA [NM_005324]",chr17:73773882-73773823,hs|17q25.1,"H3 histone, family 3B (H3.3B)",TRUE
577_TMEM141_85014,Q96I45,transmembrane protein 141,TMEM141,108,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TMEM141,85014,Hs.356744,ENST00000465017,THC2625803,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 141 (TMEM141), mRNA [NM_032928]",chr9:139687580-139687639,hs|9q34.3,transmembrane protein 141,TRUE
578_WSB1_26118,Q9Y6I7,wd repeat and socs box-containing protein 1 (wsb-1) (socs box-containing wd protein swip-1),WSB1 SWIP1,421,"function: probable substrate-recognition component of a scf-like ecs (elongin-cullin-socs-box protein) e3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. recognizes type ii iodothyronine deiodinase/dio2. confers constitutive instability to hipk2 through proteasomal degradation. {eco:0000269|pubmed:15601820, eco:0000269|pubmed:15965468, eco:0000269|pubmed:18093972}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,WSB1,26118,Hs.446017,ENST00000348811,THC2472462,GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0008150(biological_process)|GO:0035556(intracellular signal transduction),"Homo sapiens WD repeat and SOCS box containing 1 (WSB1), transcript variant 1, mRNA [NM_015626]",chr17:25639668-25639727,hs|17q11.1,WD repeat and SOCS box containing 1,TRUE
579_FTH1_2495,P02794,"ferritin heavy chain (ferritin h subunit) (ec 1.16.3.1) (cell proliferation-inducing gene 15 protein) [cleaved into: ferritin heavy chain, n-terminally processed]",FTH1 FTH FTHL6 OK/SW-cl.84 PIG15,183,"function: stores iron in a soluble, non-toxic, readily available form. important for iron homeostasis. has ferroxidase activity. iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. also plays a role in delivery of iron to cells. mediates iron uptake in capsule cells of the developing kidney (by similarity). {eco:0000250}.",NA,TISSUE SPECIFICITY: Expressed in the liver. {ECO:0000269|PubMed:11389486}.,"DISEASE: Hemochromatosis 5 (HFE5) [MIM:615517]: A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading. {ECO:0000269|PubMed:11389486}. Note=The disease is caused by mutations affecting the gene represented in this entry. In a Japanese family affected by HFE5, a single point mutation has been detected in the iron-responsive element (IRE) in the 5'-UTR of FTH1 mRNA. This mutation leads to an increased binding affinity for iron regulatory protein and thereby to the efficient suppression of mRNA translation.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FTH1,2495,Hs.524910,ENST00000534180,THC2565886,GO:0004322(ferroxidase activity)|GO:0005506(iron ion binding)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006826(iron ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0006880(intracellular sequestering of iron ion)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006955(immune response)|GO:0008043(intracellular ferritin complex)|GO:0008199(ferric iron binding)|GO:0008283(cell proliferation)|GO:0008285(negative regulation of cell proliferation)|GO:0016044(cellular membrane organization)|GO:0016491(oxidoreductase activity)|GO:0060547(negative regulation of necrotic cell death),"Homo sapiens ferritin, heavy polypeptide 1 (FTH1), mRNA [NM_002032]",chr11:61732096-61732038,hs|11q12.3,"ferritin, heavy polypeptide 1",TRUE
58_RPL12_6136,P30050,60s ribosomal protein l12 (large ribosomal subunit protein ul11),RPL12,165,function: binds directly to 26s ribosomal rna. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL12,6136,Hs.408054,ENST00000497322,THC2527067,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),ribosomal protein L12 [Source:HGNC Symbol;Acc:10302] [ENST00000497322],chr9:130210197-130210138,hs|9q33.3,ribosomal protein L12,TRUE
580_HMGB1_3146,P09429,high mobility group protein b1 (high mobility group protein 1) (hmg-1),HMGB1 HMG1,215,"function: multifunctional redox sensitive protein with various roles in different cellular compartments. in the nucleus is one of the major chromatin-associated non-histone proteins and acts as a dna chaperone involved in replication, transcription, chromatin remodeling, v(d)j recombination, dna repair and genome stability. proposed to be an universal biosensor for nucleic acids. promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. in the cytoplasm functions as sensor and/or chaperone for immunogenic nucleic acids implicating the activation of tlr9-mediated immune responses, and mediates autophagy. acts as danger associated molecular pattern (damp) molecule that amplifies immune responses during tissue injury (pubmed:27362237). released to the extracellular environment can bind dna, nucleosomes, il-1 beta, cxcl12, ager isoform 2/srage, lipopolysaccharide (lps) and lipoteichoic acid (lta), and activates cells through engagement of multiple surface receptors. in the extracellular compartment fully reduced hmgb1 (released by necrosis) acts as a chemokine, disulfide hmgb1 (actively secreted) as a cytokine, and sulfonyl hmgb1 (released from apoptotic cells) promotes immunological tolerance (pubmed:23519706, pubmed:23446148, pubmed:23994764, pubmed:25048472). has proangiogdenic activity (by similarity). may be involved in platelet activation (by similarity). binds to phosphatidylserine and phosphatidylethanolamide (by similarity). bound to rage mediates signaling for neuronal outgrowth (by similarity). may play a role in accumulation of expanded polyglutamine (polyq) proteins such as huntingtin (htt) or tbp (pubmed:23303669, pubmed:25549101). {eco:0000250|uniprotkb:p10103, eco:0000250|uniprotkb:p12682, eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:23303669, eco:0000269|pubmed:25549101, eco:0000269|pubmed:27362237, eco:0000305|pubmed:23446148, eco:0000305|pubmed:23519706, eco:0000305|pubmed:23994764, eco:0000305|pubmed:25048472}.; function: nuclear functions are attributed to fully reduced hgmb1. associates with chromatin and binds dna with a preference to non-canonical dna structures such as single-stranded dna, dna-containing cruciforms or bent structures, supercoiled dna and zdna. can bent dna and enhance dna flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (pubmed:20123072). may have an enhancing role in nucleotide excision repair (ner) (by similarity). however, effects in ner using in vitro systems have been reported conflictingly (pubmed:19446504, pubmed:19360789). may be involved in mismatch repair (mmr) and base excision repair (ber) pathways (pubmed:15014079, pubmed:16143102, pubmed:17803946). may be involved in double strand break repair such as non-homologous end joining (nhej) (by similarity). involved in v(d)j recombination by acting as a cofactor of the rag complex: acts by stimulating cleavage and rag protein binding at the 23 bp spacer of conserved recombination signal sequences (rss) (by similarity). in vitro can displace histone h1 from highly bent dna (by similarity). can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (by similarity). enhances binding of sterol regulatory element-binding proteins (srebps) such as srebf1 to their cognate dna sequences and increases their transcriptional activities (by similarity). facilitates binding of tp53 to dna (pubmed:23063560). proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating hspb1; however, this function has been questioned (by similarity). can modulate the activity of the telomerase complex and may be involved in telomere maintenance (by similarity). {eco:0000250|uniprotkb:p10103, eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:15014079, eco:0000269|pubmed:16143102, eco:0000269|pubmed:17803946, eco:0000269|pubmed:19446504, eco:0000269|pubmed:23063560, eco:0000305|pubmed:19360789, eco:0000305|pubmed:20123072}.; function: in the cytoplasm proposed to dissociate the becn1:bcl2 complex via competitive interaction with becn1 leading to autophagy activation (pubmed:20819940). involved in oxidative stress-mediated autophagy (pubmed:21395369). can protect becn1 and atg5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (by similarity). in myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (by similarity). involved in endosomal translocation and activation of tlr9 in response to cpg-dna in macrophages (by similarity). {eco:0000250|uniprotkb:p63158, eco:0000269|pubmed:20819940, eco:0000269|pubmed:21395369}.; function: in the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. fully reduced hgmb1 (which subsequently gets oxidized after release) in association with cxcl12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the cxcl12:hmgb1 complex triggers cxcr4 homodimerization (pubmed:22370717). induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating ager/rage and itgam (by similarity). can bind to various types of dna and rna including microbial unmethylated cpg-dna to enhance the innate immune response to nucleic acids. proposed to act in promiscuous dna/rna sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (by similarity). promotes extracellular dna-induced aim2 inflammasome activation implicating ager/rage (pubmed:24971542). disulfide hmgb1 binds to transmembrane receptors, such as ager/rage, tlr2, tlr4 and probably trem1, thus activating their signal transduction pathways. mediates the release of cytokines/chemokines such as tnf, il-1, il-6, il-8, ccl2, ccl3, ccl4 and cxcl10 (pubmed:12765338, pubmed:18354232, pubmed:19264983, pubmed:20547845, pubmed:24474694). promotes secretion of interferon-gamma by macrophage-stimulated natural killer (nk) cells in concert with other cytokines like il-2 or il-12 (pubmed:15607795). tlr4 is proposed to be the primary receptor promoting macrophage activation and signaling through tlr4 seems to implicate ly96/md-2 (pubmed:20547845). in bacterial lps- or lta-mediated inflammatory responses binds to the endotoxins and transfers them to cd14 for signaling to the respective tlr4:ly96 and tlr2 complexes (pubmed:18354232, pubmed:21660935, pubmed:25660311). contributes to tumor proliferation by association with acer/rage (by similarity). can bind to il1-beta and signals through the il1r1:il1rap receptor complex (pubmed:18250463). binding to class a cpg activates cytokine production in plasmacytoid dendritic cells implicating tlr9, myd88 and ager/rage and can activate autoreactive b cells. via hmgb1-containing chromatin immune complexes may also promote b cell responses to endogenous tlr9 ligands through a b-cell receptor (bcr)-dependent and acer/rage-independent mechanism (by similarity). inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-adp-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (by similarity). in adaptive immunity may be involved in enhancing immunity through activation of effector t cells and suppression of regulatory t (treg) cells (pubmed:15944249, pubmed:22473704). in contrast, without implicating effector or regulatory t-cells, required for tumor infiltration and activation of t-cells expressing the lymphotoxin lta:ltb heterotrimer thus promoting tumor malignant progression (by similarity). also reported to limit proliferation of t-cells (by similarity). released hmgb1:nucleosome complexes formed during apoptosis can signal through tlr2 to induce cytokine production (pubmed:19064698). involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ros)-dependent oxidation specifically on cys-106 (pubmed:18631454). during macrophage activation by activated lymphocyte-derived self apoptotic dna (ald-dna) promotes recruitment of ald-dna to endosomes (by similarity). {eco:0000250|uniprotkb:p10103, eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:12765338, eco:0000269|pubmed:15607795, eco:0000269|pubmed:15944249, eco:0000269|pubmed:18250463, eco:0000269|pubmed:18354232, eco:0000269|pubmed:18631454, eco:0000269|pubmed:19064698, eco:0000269|pubmed:19264983, eco:0000269|pubmed:20547845, eco:0000269|pubmed:21660935, eco:0000269|pubmed:22370717, eco:0000269|pubmed:22473704, eco:0000269|pubmed:24474694, eco:0000269|pubmed:24971542, eco:0000269|pubmed:25660311, eco:0000269|ref.8}.","subcellular location: nucleus {eco:0000269|pubmed:12231511, eco:0000269|pubmed:17114460, eco:0000269|pubmed:20819940, eco:0000269|pubmed:22869893, eco:0000269|pubmed:27362237}. chromosome {eco:0000250|uniprotkb:p10103, eco:0000250|uniprotkb:p63159, eco:0000305}. cytoplasm {eco:0000269|pubmed:11154118, eco:0000269|pubmed:12231511, eco:0000269|pubmed:17114460, eco:0000269|pubmed:20819940, eco:0000269|pubmed:22869893}. secreted {eco:0000250|uniprotkb:p63158, eco:0000269|pubmed:12231511, eco:0000269|pubmed:14532127, eco:0000269|pubmed:15944249, eco:0000269|pubmed:19811284, eco:0000269|pubmed:22869893}. cell membrane {eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:11154118}; peripheral membrane protein {eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:11154118}; extracellular side {eco:0000250|uniprotkb:p63158, eco:0000250|uniprotkb:p63159, eco:0000269|pubmed:11154118}. endosome {eco:0000250|uniprotkb:p63158}. endoplasmic reticulum-golgi intermediate compartment {eco:0000250|uniprotkb:p63158}. note=in basal state predominantly nuclear. shuttles between the cytoplasm and the nucleus (pubmed:12231511, pubmed:17114460). translocates from the nucleus to the cytoplasm upon autophagy stimulation (pubmed:20819940). release from macrophages in the extracellular milieu requires the activation of nlrc4 or nlrp3 inflammasomes (by similarity). passively released to the extracellular milieu from necrotic cells by diffusion, involving the fully reduced hgmb1 which subsequently gets oxidized (pubmed:19811284). also released from apoptotic cells (pubmed:16855214, pubmed:18631454). active secretion from a variety of immune and non-immune cells such as macrophages, monocytes, neutrophils, dendritic cells and natural killer cells in response to various stimuli such as lps and cytokines involves a nonconventional secretory process via secretory lysosomes (pubmed:12231511, pubmed:14532127, pubmed:15944249). secreted by plasma cells in response to lps (by similarity). found on the surface of activated platelets (pubmed:11154118). an increased chromatin association is observed when associated with the adenovirus protein pvii (pubmed:27362237). {eco:0000250|uniprotkb:p63158, eco:0000269|pubmed:11154118, eco:0000269|pubmed:12231511, eco:0000269|pubmed:14532127, eco:0000269|pubmed:15944249, eco:0000269|pubmed:16855214, eco:0000269|pubmed:17114460, eco:0000269|pubmed:18631454, eco:0000269|pubmed:19811284, eco:0000269|pubmed:20819940, eco:0000269|pubmed:27362237, eco:0000305|pubmed:20123072}.",TISSUE SPECIFICITY: Ubiquituous. Expressed in platelets (PubMed:11154118). {ECO:0000269|PubMed:11154118}.,NA,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,HMGB1,3146,Hs.434102,ENST00000341423,THC2465672,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000793(condensed chromosome)|GO:0001654(eye development)|GO:0001773(myeloid dendritic cell activation)|GO:0002407(dendritic cell chemotaxis)|GO:0002437(inflammatory response to antigenic stimulus)|GO:0003677(DNA binding)|GO:0003684(damaged DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005125(cytokine activity)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006265(DNA topological change)|GO:0006288(base-excision repair, DNA ligation)|GO:0006309(DNA fragmentation involved in apoptotic nuclear change)|GO:0006310(DNA recombination)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0008134(transcription factor binding)|GO:0008301(DNA bending activity)|GO:0009986(cell surface)|GO:0010858(calcium-dependent protein kinase regulator activity)|GO:0017053(transcriptional repressor complex)|GO:0017055(negative regulation of RNA polymerase II transcriptional preinitiation complex assembly)|GO:0030295(protein kinase activator activity)|GO:0030324(lung development)|GO:0031175(neuron projection development)|GO:0033151(V(D)J recombination)|GO:0042056(chemoattractant activity)|GO:0043005(neuron projection)|GO:0043065(positive regulation of apoptosis)|GO:0043280(positive regulation of caspase activity)|GO:0043388(positive regulation of DNA binding)|GO:0045087(innate immune response)|GO:0045639(positive regulation of myeloid cell differentiation)|GO:0045819(positive regulation of glycogen catabolic process)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0050786(RAGE receptor binding)|GO:0050918(positive chemotaxis)|GO:0051103(DNA ligation involved in DNA repair)|GO:0051384(response to glucocorticoid stimulus)|GO:0070491(repressing transcription factor binding)","Homo sapiens high mobility group box 1 (HMGB1), mRNA [NM_002128]",chr13:31034087-31034028,hs|13q12.3,high mobility group box 1,TRUE
581_PDCD6IP_10015,Q8WUM4,programmed cell death 6-interacting protein (pdcd6-interacting protein) (alg-2-interacting protein 1) (alg-2-interacting protein x) (hp95),PDCD6IP AIP1 ALIX KIAA1375,868,"function: multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. class e vps protein involved in concentration and sorting of cargo proteins of the multivesicular body (mvb) for incorporation into intralumenal vesicles (ilvs) that are generated by invagination and scission from the limiting membrane of the endosome. binds to the phospholipid lysobisphosphatidic acid (lbpa) which is abundant in mvbs internal membranes. the mvb pathway requires the sequential function of escrt-o, -i,-ii and -iii complexes (pubmed:14739459). the escrt machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (pubmed:17853893, pubmed:17556548). adapter for a subset of escrt-iii proteins, such as chmp4, to function at distinct membranes. required for completion of cytokinesis (pubmed:17853893, pubmed:17556548, pubmed:18641129). may play a role in the regulation of both apoptosis and cell proliferation. regulates exosome biogenesis in concert with sdc1/4 and sdcbp (pubmed:22660413). by interacting with f-actin, pard3 and tjp1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier (by similarity). {eco:0000250|uniprotkb:q9wu78, eco:0000269|pubmed:14739459, eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893, eco:0000269|pubmed:18641129, eco:0000269|pubmed:22660413}.; function: (microbial infection) involved in hiv-1 virus budding. can replace tsg101 it its role of supporting hiv-1 release; this function requires the interaction with chmp4b. the escrt machinery also functions in topologically equivalent membrane fission events, such as enveloped virus budding (hiv-1 and other lentiviruses). {eco:0000269|pubmed:14505569, eco:0000269|pubmed:14505570, eco:0000269|pubmed:14519844, eco:0000269|pubmed:17556548, eco:0000269|pubmed:18641129}.","subcellular location: cytoplasm, cytosol {eco:0000250|uniprotkb:q9qza2}. melanosome {eco:0000269|pubmed:17081065}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893}. secreted, extracellular exosome {eco:0000269|pubmed:22660413}. cell junction, tight junction {eco:0000250|uniprotkb:q9wu78}. midbody, midbody ring {eco:0000269|pubmed:17853893, eco:0000269|pubmed:18641129}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. colocalized with cep55 at centrosomes of non-dividing cells. component of the actomyosin-tight junction complex (by similarity). pdcd6ip targeting to the midbody requires the interaction with cep55 (pubmed:18641129). {eco:0000250|uniprotkb:q9qza2, eco:0000250|uniprotkb:q9wu78, eco:0000269|pubmed:17081065, eco:0000269|pubmed:17556548, eco:0000269|pubmed:17853893, eco:0000269|pubmed:18641129}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,PDCD6IP,10015,Hs.475896,ENST00000307296,THC2490302,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006915(apoptosis)|GO:0007049(cell cycle)|GO:0015031(protein transport)|GO:0042470(melanosome)|GO:0044419(interspecies interaction between organisms)|GO:0048306(calcium-dependent protein binding)|GO:0051301(cell division),"Homo sapiens programmed cell death 6 interacting protein (PDCD6IP), transcript variant 1, mRNA [NM_013374]",chr3:33908324-33908383,hs|3p22.3,programmed cell death 6 interacting protein,TRUE
582_BRK1_55845,Q8WUW1,protein brick1 (brk1),BRK1 C3orf10 HSPC300 MDS027,75,"function: involved in regulation of actin and microtubule organization. part of a wave complex that activates the arp2/3 complex. as component of the wave1 complex, required for bdnf-ntrk2 endocytic trafficking and signaling from early endosomes (by similarity). {eco:0000250|uniprotkb:q91vr8, eco:0000269|pubmed:18560548}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,BRK1,55845,Hs.649307,ENST00000256463,THC2561654,GO:0005737(cytoplasm)|GO:0005856(cytoskeleton),"Homo sapiens BRICK1, SCAR/WAVE actin-nucleating complex subunit (BRK1), mRNA [NM_018462]",chr3:10168506-10168565,hs|3p25.3,"BRICK1, SCAR/WAVE actin-nucleating complex subunit",TRUE
583_RPL9_6133,P32969,60s ribosomal protein l9 (large ribosomal subunit protein ul6),RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9,192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL9,6133,Hs.412370,ENST00000504470,THC2521222,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L9 (RPL9), transcript variant 2, mRNA [NM_001024921]",chr4:39458026-39456506,hs|4p14,ribosomal protein L9,TRUE
584_TUBA1C_84790,Q9BQE3,tubulin alpha-1c chain (alpha-tubulin 6) (tubulin alpha-6 chain) [cleaved into: detyrosinated tubulin alpha-1c chain],TUBA1C TUBA6,449,"function: tubulin is the major constituent of microtubules. it binds two moles of gtp, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.","subcellular location: cytoplasm, cytoskeleton.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TUBA1C,84790,Hs.652390,ENST00000301072,THC2469898,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005198(structural molecule activity)|GO:0005525(GTP binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0005881(cytoplasmic microtubule)|GO:0006457(protein folding)|GO:0007017(microtubule-based process)|GO:0007018(microtubule-based movement)|GO:0030705(cytoskeleton-dependent intracellular transport)|GO:0044267(cellular protein metabolic process)|GO:0051084(de novo' posttranslational protein folding)|GO:0051258(protein polymerization)|GO:0051301(cell division),"Homo sapiens tubulin, alpha 1c (TUBA1C), mRNA [NM_032704]",chr12:49667030-49667089,hs|12q13.12,"tubulin, alpha 1c",TRUE
585_RPS24_6229,P62847,40s ribosomal protein s24 (small ribosomal subunit protein es24),RPS24,133,function: required for processing of pre-rrna and maturation of 40s ribosomal subunits. {eco:0000269|pubmed:18230666}.,NA,"TISSUE SPECIFICITY: Mature tissues, such as adult brain, skeletal muscle, heart, and kidney, express low levels, whereas tissues and organs with significant populations of proliferating cells, such as fetal brain, placenta, bone marrow, and various glandular organs, contain significantly higher levels. {ECO:0000269|PubMed:17186470}.","DISEASE: Diamond-Blackfan anemia 3 (DBA3) [MIM:610629]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:17186470}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPS24,6229,Hs.280130,ENST00000467106,THC2572247,"GO:0000166(nucleotide binding)|GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0031369(translation initiation factor binding)|GO:0034101(erythrocyte homeostasis)|GO:0042274(ribosomal small subunit biogenesis)|GO:0044267(cellular protein metabolic process)","Homo sapiens ribosomal protein S24 (RPS24), transcript variant c, mRNA [NM_001026]",chr10:79795371-79795430,hs|10q22.3,ribosomal protein S24,TRUE
586_PPP2CB_5516,P62714,serine/threonine-protein phosphatase 2a catalytic subunit beta isoform (pp2a-beta) (ec 3.1.3.16),PPP2CB,309,"function: pp2a can modulate the activity of phosphorylase b kinase casein kinase 2, mitogen-stimulated s6 kinase, and map-2 kinase. {eco:0000269|pubmed:2555176}.","subcellular location: cytoplasm {eco:0000269|pubmed:16541025}. nucleus {eco:0000269|pubmed:16541025}. chromosome, centromere {eco:0000269|pubmed:16541025}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:16541025}. note=in prometaphase cells, but not in anaphase cells, localizes at centromeres. during mitosis, also found at spindle poles.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,PPP2CB,5516,Hs.491440,ENST00000406655,THC2468959,"GO:0000159(protein phosphatase type 2A complex)|GO:0000775(chromosome, centromeric region)|GO:0000922(spindle pole)|GO:0004722(protein serine/threonine phosphatase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0006470(protein dephosphorylation)|GO:0008022(protein C-terminus binding)|GO:0010468(regulation of gene expression)|GO:0016787(hydrolase activity)|GO:0042542(response to hydrogen peroxide)|GO:0043066(negative regulation of apoptosis)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0046580(negative regulation of Ras protein signal transduction)|GO:0046677(response to antibiotic)|GO:0046872(metal ion binding)","Homo sapiens protein phosphatase 2, catalytic subunit, beta isozyme (PPP2CB), mRNA [NM_001009552]",chr8:30643206-30643147,hs|8p12,"protein phosphatase 2, catalytic subunit, beta isozyme",TRUE
587_BTF3_689,P78410,butyrophilin subfamily 3 member a2,BTN3A2 BT3.2 BTF3 BTF4,334,"function: plays a role in t-cell responses in the adaptive immune response. inhibits the release of ifng from activated t-cells. {eco:0000269|pubmed:21918970, eco:0000269|pubmed:22767497}.","subcellular location: cell membrane {eco:0000269|pubmed:21918970, eco:0000269|pubmed:22767497}; single-pass type i membrane protein {eco:0000269|pubmed:21918970, eco:0000269|pubmed:22767497}.",TISSUE SPECIFICITY: Detected in T-cells and natural killer cells. {ECO:0000269|PubMed:21918970}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BTF3,689,Hs.591768,ENST00000514505,THC2523324,"GO:0001701(in utero embryonic development)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)","Homo sapiens basic transcription factor 3 (BTF3), transcript variant 1, mRNA [NM_001037637]",chr5:72801186-72801245,hs|5q13.2,basic transcription factor 3,TRUE
588_TPT1_7178,P13693,translationally-controlled tumor protein (tctp) (fortilin) (histamine-releasing factor) (hrf) (p23),TPT1,172,function: involved in calcium binding and microtubule stabilization.,subcellular location: cytoplasm {eco:0000269|pubmed:9059837}.,"TISSUE SPECIFICITY: Found in several healthy and tumoral cells including erythrocytes, hepatocytes, macrophages, platelets, keratinocytes, erythroleukemia cells, gliomas, melanomas, hepatoblastomas, and lymphomas. It cannot be detected in kidney and renal cell carcinoma (RCC). Expressed in placenta and prostate. {ECO:0000269|PubMed:9059837}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TPT1,7178,Hs.374596,ENST00000442760,THC2574335,GO:0005509(calcium ion binding)|GO:0005615(extracellular space)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005771(multivesicular body)|GO:0006816(calcium ion transport)|GO:0006874(cellular calcium ion homeostasis)|GO:0006916(anti-apoptosis)|GO:0008134(transcription factor binding)|GO:0009615(response to virus)|GO:0019827(stem cell maintenance)|GO:0042981(regulation of apoptosis)|GO:0045298(tubulin complex),"Homo sapiens tumor protein, translationally-controlled 1 (TPT1), mRNA [NM_003295]",chr13:45914235-45914176,hs|13q14.13,"tumor protein, translationally-controlled 1",TRUE
589_FDPS_2224,P14324,"farnesyl pyrophosphate synthase (fpp synthase) (fps) (ec 2.5.1.10) ((2e,6e)-farnesyl diphosphate synthase) (dimethylallyltranstransferase) (ec 2.5.1.1) (farnesyl diphosphate synthase) (geranyltranstransferase)",FDPS FPS KIAA1293,419,"function: key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (fpp), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. fpp also serves as substrate for protein farnesylation and geranylgeranylation. catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate.",subcellular location: cytoplasm.,NA,"DISEASE: Porokeratosis 9, multiple types (POROK9) [MIM:616631]: A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported. {ECO:0000269|PubMed:26202976}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FDPS,2224,Hs.335918,ENST00000489324,THC2559464,GO:0004161(dimethylallyltranstransferase activity)|GO:0004337(geranyltranstransferase activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006695(cholesterol biosynthetic process)|GO:0008299(isoprenoid biosynthetic process)|GO:0016740(transferase activity)|GO:0044419(interspecies interaction between organisms)|GO:0046872(metal ion binding),"Homo sapiens farnesyl diphosphate synthase (FDPS), transcript variant 1, mRNA [NM_002004]",chr1:155290269-155290328,hs|1q22,farnesyl diphosphate synthase,TRUE
59_MLPH_79083,Q9BV36,melanophilin (exophilin-3) (slp homolog lacking c2 domains a) (slac2-a) (synaptotagmin-like protein 2a),MLPH SLAC2A,600,function: rab effector protein involved in melanosome transport. serves as link between melanosome-bound rab27a and the motor protein myo5a. {eco:0000269|pubmed:12062444}.,subcellular location: cytoplasm.,NA,"DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MLPH,79083,Hs.102406,ENST00000464123,THC2493595,GO:0003779(actin binding)|GO:0005737(cytoplasm)|GO:0006605(protein targeting)|GO:0015629(actin cytoskeleton)|GO:0017137(Rab GTPase binding)|GO:0030318(melanocyte differentiation)|GO:0031489(myosin V binding)|GO:0032400(melanosome localization)|GO:0043473(pigmentation)|GO:0046872(metal ion binding)|GO:0051010(microtubule plus-end binding),"Homo sapiens melanophilin (MLPH), transcript variant 1, mRNA [NM_024101]",chr2:238462524-238462583,hs|2q37.3,melanophilin,TRUE
590_PSMA1_5682,P25786,proteasome subunit alpha type-1 (ec 3.4.25.1) (30 kda prosomal protein) (pros-30) (macropain subunit c2) (multicatalytic endopeptidase complex subunit c2) (proteasome component c2) (proteasome nu chain),PSMA1 HC2 NU PROS30 PSC2,263,"function: component of the 20s core proteasome complex involved in the proteolytic degradation of most intracellular proteins. this complex plays numerous essential roles within the cell by associating with different regulatory particles. associated with two 19s regulatory particles, forms the 26s proteasome and thus participates in the atp-dependent degradation of ubiquitinated proteins. the 26s proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. associated with the pa200 or pa28, the 20s proteasome mediates ubiquitin-independent protein degradation. this type of proteolysis is required in several pathways including spermatogenesis (20s-pa200 complex) or generation of a subset of mhc class i-presented antigenic peptides (20s-pa28 complex). {eco:0000269|pubmed:15244466, eco:0000269|pubmed:27176742, eco:0000269|pubmed:8610016}.",subcellular location: cytoplasm {eco:0000269|pubmed:12181345}. nucleus {eco:0000269|pubmed:12181345}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMA1,5682,Hs.102798,ENST00000528307,THC2495670,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0003723(RNA binding)|GO:0004298(threonine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005844(polysome)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019773(proteasome core complex, alpha-subunit complex)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process)","Homo sapiens proteasome (prosome, macropain) subunit, alpha type, 1 (PSMA1), transcript variant 1, mRNA [NM_148976]",chr11:14526628-14526569,hs|11p15.2,"proteasome (prosome, macropain) subunit, alpha type, 1",TRUE
591_ECHDC2_55268,Q86YB7,"enoyl-coa hydratase domain-containing protein 2, mitochondrial",ECHDC2,292,NA,subcellular location: mitochondrion {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,ECHDC2,55268,Hs.476319,ENST00000358358,THC2540101,GO:0005739(mitochondrion)|GO:0006629(lipid metabolic process)|GO:0006631(fatty acid metabolic process)|GO:0016829(lyase activity),"Homo sapiens enoyl CoA hydratase domain containing 2 (ECHDC2), transcript variant 2, mRNA [NM_018281]",chr1:53361964-53361905,hs|1p32.3,enoyl CoA hydratase domain containing 2,TRUE
592_NET1_10276,Q7Z628,neuroepithelial cell-transforming gene 1 protein (proto-oncogene p65 net1) (rho guanine nucleotide exchange factor 8),NET1 ARHGEF8,596,function: acts as guanine nucleotide exchange factor (gef) for rhoa gtpase. may be involved in activation of the sapk/jnk pathway stimulates genotoxic stress-induced rhob activity in breast cancer cells leading to their cell death. {eco:0000269|pubmed:21373644}.,subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8649828}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NET1,10276,Hs.25155,ENST00000380337,THC2573549,GO:0001558(regulation of cell growth)|GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005089(Rho guanyl-nucleotide exchange factor activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006915(apoptosis)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0032321(positive regulation of Rho GTPase activity)|GO:0035023(regulation of Rho protein signal transduction)|GO:0043065(positive regulation of apoptosis)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0051056(regulation of small GTPase mediated signal transduction)|GO:0070301(cellular response to hydrogen peroxide)|GO:0071479(cellular response to ionizing radiation),"Homo sapiens neuroepithelial cell transforming 1 (NET1), transcript variant 1, mRNA [NM_001047160]",chr10:5500236-5500295,hs|10p15.1,neuroepithelial cell transforming 1,TRUE
593_NUDT9_53343,Q9BW91,"adp-ribose pyrophosphatase, mitochondrial (ec 3.6.1.13) (adp-ribose diphosphatase) (adp-ribose phosphohydrolase) (adenosine diphosphoribose pyrophosphatase) (adpr-ppase) (nucleoside diphosphate-linked moiety x motif 9) (nudix motif 9)",NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771,350,function: hydrolyzes adp-ribose (adpr) to amp and ribose 5'-phosphate.,subcellular location: isoform 1: mitochondrion.,TISSUE SPECIFICITY: Ubiquitously expressed but isoform 1 is the most predominant isoform. {ECO:0000269|PubMed:12427752}.,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NUDT9,53343,Hs.149500,ENST00000302174,THC2481221,GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0016787(hydrolase activity)|GO:0019144(ADP-sugar diphosphatase activity)|GO:0043262(adenosine-diphosphatase activity)|GO:0046032(ADP catabolic process)|GO:0046709(IDP catabolic process)|GO:0047631(ADP-ribose diphosphatase activity),"Homo sapiens nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_024047]",chr4:88379293-88379352,hs|4q22.1,nudix (nucleoside diphosphate linked moiety X)-type motif 9,TRUE
594_HSBP1_3281,O75506,heat shock factor-binding protein 1 (nasopharyngeal carcinoma-associated antigen 13) (npc-a-13),HSBP1 HSF1BP,76,function: negative regulator of the heat shock response. negatively affects hsf1 dna-binding activity. may have a role in the suppression of the activation of the stress response during the aging process.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSBP1,3281,Hs.250899,ENST00000433866,THC2525509,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003714(transcription corepressor activity)|GO:0005634(nucleus)|GO:0005856(cytoskeleton)|GO:0006936(muscle contraction),"Homo sapiens heat shock factor binding protein 1 (HSBP1), mRNA [NM_001537]",chr16:83845186-83845245,hs|16q23.3,heat shock factor binding protein 1,TRUE
595_TMEM106C_79022,Q9BVX2,transmembrane protein 106c (endoplasmic reticulum membrane protein overexpressed in cancer),TMEM106C EMOC,250,NA,subcellular location: endoplasmic reticulum membrane {eco:0000269|ref.1}; multi-pass membrane protein {eco:0000269|ref.1}. membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TMEM106C,79022,Hs.596726,ENST00000449758,THC2469245,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 106C (TMEM106C), transcript variant 2, mRNA [NM_024056]",chr12:48362562-48362621,hs|12q13.11,transmembrane protein 106C,TRUE
596_RPS23_6228,P62266,40s ribosomal protein s23 (small ribosomal subunit protein us12),RPS23,143,"function: component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (pubmed:28257692, pubmed:23636399, pubmed:25957688, pubmed:25901680). the small ribosomal subunit (ssu) binds messenger rnas (mrnas) and translates the encoded message by selecting cognate aminoacyl-transfer rna (trna) molecules. the large subunit (lsu) contains the ribosomal catalytic site termed the peptidyl transferase center (ptc), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by trnas into a polypeptide chain. the nascent polypeptides leave the ribosome through a tunnel in the lsu and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel (pubmed:23636399, pubmed:25957688, pubmed:25901680). plays an important role in translational accuracy (pubmed:28257692). {eco:0000269|pubmed:23636399, eco:0000269|pubmed:25901680, eco:0000269|pubmed:25957688, eco:0000269|pubmed:28257692}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:q6sa96}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q6sa96, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Brachycephaly, trichomegaly, and developmental delay (BTDD) [MIM:617412]: An autosomal dominant developmental disorder characterized by brachycephaly, ciliary trichomegaly, dysmorphic features of the face and hands, hearing loss, and developmental delay with short stature. Intellectual disability and autism spectrum disorder may be present in some patients. {ECO:0000269|PubMed:28257692}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPS23,6228,Hs.527193,ENST00000503605,THC2552196,GO:0003674(molecular_function)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S23 (RPS23), mRNA [NM_001025]",chr5:81573551-81572318,hs|5q14.2,ribosomal protein S23,TRUE
597_COMMD6_170622,Q7Z4G1,comm domain-containing protein 6,COMMD6 MSTP076,85,"function: may modulate activity of cullin-ring e3 ubiquitin ligase (crl) complexes (pubmed:21778237). down-regulates activation of nf-kappa-b. inhibits tnf-induced nfkb1 activation. {eco:0000269|pubmed:15799966, eco:0000269|pubmed:16573520, eco:0000305|pubmed:21778237}.","subcellular location: nucleus {eco:0000269|pubmed:16573520, eco:0000269|pubmed:21778237}. cytoplasm {eco:0000269|pubmed:16573520}.","TISSUE SPECIFICITY: Ubiquitous. Expressed in brain, heart, skeletal muscle, lung, pancreas, liver, kidney, small intestine and placenta. {ECO:0000269|PubMed:15799966, ECO:0000269|PubMed:16573520}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,COMMD6,170622,Hs.508266,ENST00000483290,NP1189257,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm),"Homo sapiens COMM domain containing 6 (COMMD6), transcript variant 1, mRNA [NM_203497]",chr13:76100703-76100644,hs|13q22.2,COMM domain containing 6,TRUE
598_GALNT7_51809,Q86SF2,n-acetylgalactosaminyltransferase 7 (ec 2.4.1.41) (polypeptide galnac transferase 7) (galnac-t7) (pp-gantase 7) (protein-udp acetylgalactosaminyltransferase 7) (udp-galnac:polypeptide n-acetylgalactosaminyltransferase 7),GALNT7,657,"function: glycopeptide transferase involved in o-linked oligosaccharide biosynthesis, which catalyzes the transfer of an n-acetyl-d-galactosamine residue to an already glycosylated peptide. in contrast to other proteins of the family, it does not act as a peptide transferase that transfers galnac onto serine or threonine residue on the protein receptor, but instead requires the prior addition of a galnac on a peptide before adding additional galnac moieties. some peptide transferase activity is however not excluded, considering that its appropriate peptide substrate may remain unidentified. {eco:0000269|pubmed:10544240, eco:0000269|pubmed:11925450}.",subcellular location: golgi apparatus membrane {eco:0000250}; single-pass type ii membrane protein {eco:0000250}.,"TISSUE SPECIFICITY: Widely expressed. Expressed in uterus, retina, kidney, small intestine, omentum, stomach and CNS. {ECO:0000269|PubMed:10544240}.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GALNT7,51809,Hs.548088,ENST00000265000,THC2466922,"GO:0000139(Golgi membrane)|GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity)|GO:0005529(sugar binding)|GO:0005794(Golgi apparatus)|GO:0005975(carbohydrate metabolic process)|GO:0006493(protein O-linked glycosylation)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016757(transferase activity, transferring glycosyl groups)","Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (GALNT7), mRNA [NM_017423]",chr4:174244878-174244937,hs|4q34.1,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7),TRUE
599_COX7A2L_9167,O14548,"cytochrome c oxidase subunit 7a-related protein, mitochondrial (cox7a-related protein) (cytochrome c oxidase subunit viia-related protein) (eb1)",COX7A2L COX7AR COX7RP,114,function: involved in the regulation of oxidative phosphorylation and energy metabolism (by similarity). necessary for the assembly of mitochondrial respiratory supercomplex (by similarity). {eco:0000250|uniprotkb:q61387}.,subcellular location: mitochondrion inner membrane {eco:0000250}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX7A2L,9167,Hs.339639,ENST00000482463,THC2507005,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005746(mitochondrial respiratory chain)|GO:0009055(electron carrier activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), nuclear gene encoding mitochondrial protein, mRNA [NM_004718]",chr2:42577932-42577873,hs|2p21,cytochrome c oxidase subunit VIIa polypeptide 2 like,TRUE
6_EPCAM_4072,P16422,epithelial cell adhesion molecule (ep-cam) (adenocarcinoma-associated antigen) (cell surface glycoprotein trop-1) (epithelial cell surface antigen) (epithelial glycoprotein) (egp) (epithelial glycoprotein 314) (egp314) (hegp314) (ks 1/4 antigen) (ksa) (major gastrointestinal tumor-associated protein ga733-2) (tumor-associated calcium signal transducer 1) (cd antigen cd326),EPCAM GA733-2 M1S2 M4S1 MIC18 TACSTD1 TROP1,314,"function: may act as a physical homophilic interaction molecule between intestinal epithelial cells (iecs) and intraepithelial lymphocytes (iels) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection. plays a role in embryonic stem cells proliferation and differentiation. up-regulates the expression of fabp5, myc and cyclins a and e. {eco:0000269|pubmed:15195135, eco:0000269|pubmed:15922867, eco:0000269|pubmed:19785009, eco:0000269|pubmed:20064925}.","subcellular location: lateral cell membrane {eco:0000269|pubmed:15195135, eco:0000269|pubmed:16054130, eco:0000269|pubmed:19785009}; single-pass type i membrane protein {eco:0000269|pubmed:16054130}. cell junction, tight junction {eco:0000269|pubmed:16054130}. note=colocalizes with cldn7 at the lateral cell membrane and tight junction. {eco:0000269|pubmed:16054130}.",TISSUE SPECIFICITY: Highly and selectively expressed by undifferentiated rather than differentiated embryonic stem cells (ESC). Levels rapidly diminish as soon as ESC's differentiate (at protein levels). Expressed in almost all epithelial cell membranes but not on mesodermal or neural cell membranes. Found on the surface of adenocarcinoma. {ECO:0000269|PubMed:20064925}.,"DISEASE: Diarrhea 5, with tufting enteropathy, congenital (DIAR5) [MIM:613217]: An intractable diarrhea of infancy characterized by villous atrophy and absence of inflammation, with intestinal epithelial cell dysplasia manifesting as focal epithelial tufts in the duodenum and jejunum. {ECO:0000269|PubMed:18572020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary non-polyposis colorectal cancer 8 (HNPCC8) [MIM:613244]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. {ECO:0000269|PubMed:19098912}. Note=The disease is caused by mutations affecting the gene represented in this entry. HNPCC8 results from heterozygous deletion of 3-prime exons of EPCAM and intergenic regions directly upstream of MSH2, resulting in transcriptional read-through and epigenetic silencing of MSH2 in tissues expressing EPCAM.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,EPCAM,4072,Hs.542050,ENST00000456133,NP1212094,GO:0001657(ureteric bud development)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005923(tight junction)|GO:0008284(positive regulation of cell proliferation)|GO:0009986(cell surface)|GO:0016021(integral to membrane)|GO:0016323(basolateral plasma membrane)|GO:0016324(apical plasma membrane)|GO:0016328(lateral plasma membrane)|GO:0030054(cell junction),"Homo sapiens epithelial cell adhesion molecule (EPCAM), mRNA [NM_002354]",chr2:47613894-47613953,hs|2p21,epithelial cell adhesion molecule,TRUE
60_RPL36A_6173,P83881,60s ribosomal protein l36a (60s ribosomal protein l44) (cell growth-inhibiting gene 15 protein) (cell migration-inducing gene 6 protein) (large ribosomal subunit protein el42),RPL36A RPL44 GIG15 MIG6,106,NA,subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPL36A,6173,Hs.432485,ENST00000553110,THC2525241,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L36a (RPL36A), transcript variant 1, mRNA [NM_021029]",chrX:100650720-100650779,hs|Xq22.1,ribosomal protein L36a,TRUE
600_PYCR2_29920,Q96C36,pyrroline-5-carboxylate reductase 2 (p5c reductase 2) (p5cr 2) (ec 1.5.1.2),PYCR2,320,"function: housekeeping enzyme that catalyzes the last step in proline biosynthesis. in some cell types, such as erythrocytes, its primary function may be the generation of nadp(+). can utilize both nad and nadp. has higher affinity for nadp, but higher catalytic efficiency with nadh (pubmed:2722838, pubmed:6894153). involved in cellular response to oxidative stress (pubmed:25865492). {eco:0000269|pubmed:25865492, eco:0000269|pubmed:2722838, eco:0000269|pubmed:6894153}.","subcellular location: cytoplasm {eco:0000269|pubmed:2722838}. mitochondrion {eco:0000269|pubmed:23024808, eco:0000269|pubmed:25865492}.","TISSUE SPECIFICITY: Detected in erythrocytes (at protein level) (PubMed:2722838, PubMed:6894153). Expressed in fetal brain (PubMed:25865492). {ECO:0000269|PubMed:25865492, ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.","DISEASE: Leukodystrophy, hypomyelinating, 10 (HLD10) [MIM:616420]: An autosomal recessive neurologic disorder characterized by postnatal microcephaly, severely delayed psychomotor development, hypomyelination, and reduced cerebral white-matter volume. {ECO:0000269|PubMed:25865492}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PYCR2,29920,Hs.654718,ENST00000478402,THC2497895,"GO:0000166(nucleotide binding)|GO:0004735(pyrroline-5-carboxylate reductase activity)|GO:0005737(cytoplasm)|GO:0006561(proline biosynthetic process)|GO:0008652(cellular amino acid biosynthetic process)|GO:0016491(oxidoreductase activity)|GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)","Homo sapiens pyrroline-5-carboxylate reductase family, member 2 (PYCR2), mRNA [NM_013328]",chr1:226107730-226107671,hs|1q42.12,"pyrroline-5-carboxylate reductase family, member 2",TRUE
601_DAD1_1603,P61803,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit dad1 (oligosaccharyl transferase subunit dad1) (defender against cell death 1) (dad-1),DAD1,113,"function: subunit of the oligosaccharyl transferase (ost) complex that catalyzes the initial transfer of a defined glycan (glc(3)man(9)glcnac(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an asn-x-ser/thr consensus motif in nascent polypeptide chains, the first step in protein n-glycosylation (pubmed:22467853). n-glycosylation occurs cotranslationally and the complex associates with the sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (er). all subunits are required for a maximal enzyme activity (by similarity). required for the assembly of both sst3a- and ss3b-containing ost complexes. loss of the dad1 protein triggers apoptosis (pubmed:22467853). {eco:0000250|uniprotkb:e2r4x3, eco:0000269|pubmed:22467853}.",subcellular location: endoplasmic reticulum membrane; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DAD1,1603,Hs.82890,ENST00000535847,THC2500324,GO:0001824(blastocyst development)|GO:0004576(oligosaccharyl transferase activity)|GO:0004579(dolichyl-diphosphooligosaccharide-protein glycotransferase activity)|GO:0005789(endoplasmic reticulum membrane)|GO:0006486(protein glycosylation)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0007584(response to nutrient)|GO:0008250(oligosaccharyltransferase complex)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0042493(response to drug)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process),"Homo sapiens defender against cell death 1 (DAD1), mRNA [NM_001344]",chr14:23034008-23033949,hs|14q11.2,defender against cell death 1,TRUE
602_REEP3_221035,Q6NUK4,receptor expression-enhancing protein 3,REEP3 C10orf74,255,function: microtubule-binding protein required to ensure proper cell division and nuclear envelope reassembly by sequestering the endoplasmic reticulum away from chromosomes during mitosis. probably acts by clearing the endoplasmic reticulum membrane from metaphase chromosomes. {eco:0000269|pubmed:23911198}.,subcellular location: endoplasmic reticulum membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,TISSUE SPECIFICITY: Expressed in circumvallate papillae. {ECO:0000269|PubMed:16720576}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,REEP3,221035,Hs.499833,ENST00000298249,THC2784631,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens receptor accessory protein 3 (REEP3), mRNA [NM_001001330]",chr10:65380604-65380663,hs|10q21.3,receptor accessory protein 3,TRUE
603_PDCD7_10081,Q8N8D1,programmed cell death protein 7 (es18) (hes18),PDCD7,485,function: promotes apoptosis when overexpressed. {eco:0000250}.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PDCD7,10081,Hs.458596,ENST00000380204,THC2463451,GO:0005634(nucleus)|GO:0005689(U12-type spliceosomal complex)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0008380(RNA splicing)|GO:0051384(response to glucocorticoid stimulus),"Homo sapiens programmed cell death 7 (PDCD7), mRNA [NM_005707]",chr15:65421454-65421395,hs|15q22.31,programmed cell death 7,TRUE
604_RPL10L_140801,Q96L21,60s ribosomal protein l10-like (large ribosomal subunit protein ul16-like),RPL10L,214,function: may play a role in compensating for the inactivated x-linked gene during spermatogenesis. {eco:0000269|pubmed:12490704}.,NA,TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:12490704}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL10L,140801,Hs.308332,ENST00000298283,THC2475356,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0007283(spermatogenesis)|GO:0022625(cytosolic large ribosomal subunit),"Homo sapiens ribosomal protein L10-like (RPL10L), mRNA [NM_080746]",chr14:47120573-47120514,hs|14q21.2,ribosomal protein L10-like,TRUE
605_YTHDF1_54915,Q9BYJ9,yth domain-containing family protein 1 (dermatomyositis associated with cancer putative autoantigen 1) (daca-1),YTHDF1 C20orf21,559,"function: specifically recognizes and binds n6-methyladenosine (m6a)-containing mrnas, and promotes mrna translation efficiency (pubmed:24284625, pubmed:26046440, pubmed:26318451). m6a is a modification present at internal sites of mrnas and some non-coding rnas and plays a role in the efficiency of mrna splicing, processing and stability (pubmed:24284625). acts as a regulator of mrna translation efficiency: promotes ribosome loading to m6a-containing mrnas and interacts with translation initiation factors eif3 (eif3a or eif3b) to facilitate translation initiation (pubmed:26046440). required to facilitate learning and memory formation in the hippocampus by enhancing protein synthesis upon neuronal stimulation: in response to neuronal stimulation, binds to m6a-containing neuronal mrnas, promoting their translation, thereby contributing to learning and memory (by similarity). acts as a regulator of axon guidance by binding to m6a-containing robo3 transcripts, thereby promoting their translation (by similarity). acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells (by similarity). acts by binding and promoting translation of m6a-containing transcripts encoding proteins involved in lysosomal degradation and phagosome maturation, leading to increased antigen degradation in myeloid dendritic cells (by similarity). in the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation (by similarity). {eco:0000250|uniprotkb:p59326, eco:0000269|pubmed:24284625, eco:0000269|pubmed:26046440, eco:0000269|pubmed:26318451}.",subcellular location: cytoplasm {eco:0000303|pubmed:26046440}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,YTHDF1,54915,Hs.11747,ENST00000370339,THC2465870,NA,"Homo sapiens YTH domain family, member 1 (YTHDF1), mRNA [NM_017798]",chr20:61826871-61826812,hs|20q13.33,"YTH domain family, member 1",TRUE
606_UBL5_59286,Q9BZL1,ubiquitin-like protein 5,UBL5,73,NA,subcellular location: cytoplasm {eco:0000269|pubmed:11161819}.,"TISSUE SPECIFICITY: Ubiquitous. Highest level of expression in heart, skeletal muscle, kidney, liver, iris and lymphoblasts. {ECO:0000269|PubMed:11161819}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,UBL5,59286,Hs.534477,ENST00000358666,THC2476296,GO:0003674(molecular_function)|GO:0005737(cytoplasm)|GO:0008150(biological_process),"Homo sapiens ubiquitin-like 5 (UBL5), transcript variant 1, mRNA [NM_024292]",chr19:9939311-9939531,hs|19p13.2,ubiquitin-like 5,TRUE
607_C20orf30_29058,Q96A57,transmembrane protein 230,TMEM230 C20orf30 HSPC274 UNQ2432/PRO4992,120,function: involved in trafficking and recycling of synaptic vesicles. {eco:0000269|pubmed:27270108}.,"subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. golgi apparatus, trans-golgi network {eco:0000269|pubmed:27270108}. cytoplasmic vesicle, secretory vesicle, synaptic vesicle {eco:0000269|pubmed:27270108}. early endosome {eco:0000269|pubmed:27270108}. recycling endosome {eco:0000269|pubmed:27270108}. late endosome {eco:0000269|pubmed:27270108}. cytoplasmic vesicle, autophagosome {eco:0000269|pubmed:27270108}.",NA,"DISEASE: Parkinson disease (PARK) [MIM:168600]: A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features. {ECO:0000269|PubMed:27270108}. Note=The gene represented in this entry may be involved in disease pathogenesis. Genetic variants in TMEM230 and DNAJC13 have been found in the same large multigenerational family with adult-onset Parkinson disease. The pathological role of each gene and therefore the exact molecular basis of the disease is unclear. {ECO:0000305|PubMed:27270108}.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C20orf30,29058,Hs.472024,ENST00000379286,THC2496309,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 20 open reading frame 30 (C20orf30), transcript variant 2, mRNA [NM_001009924]",chr20:5080740-5080681,hs|20p13,chromosome 20 open reading frame 30,TRUE
608_CCDC6_8030,Q16204,coiled-coil domain-containing protein 6 (papillary thyroid carcinoma-encoded protein) (protein h4),CCDC6 D10S170 TST1,474,NA,"subcellular location: cytoplasm. cytoplasm, cytoskeleton {eco:0000305}. note=may be a cytoskeletal protein.",TISSUE SPECIFICITY: Ubiquitously expressed.,DISEASE: Note=A chromosomal aberration involving CCDC6 is found in papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,CCDC6,8030,Hs.591360,ENST00000263102,THC2524420,GO:0005200(structural constituent of cytoskeleton)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0008150(biological_process)|GO:0017124(SH3 domain binding),"Homo sapiens coiled-coil domain containing 6 (CCDC6), mRNA [NM_005436]",chr10:61548670-61548611,hs|10q21.2,coiled-coil domain containing 6,TRUE
609_HNRNPD_3184,Q14103,heterogeneous nuclear ribonucleoprotein d0 (hnrnp d0) (au-rich element rna-binding protein 1),HNRNPD AUF1 HNRPD,355,"function: binds with high affinity to rna molecules that contain au-rich elements (ares) found within the 3'-utr of many proto-oncogenes and cytokine mrnas. also binds to double- and single-stranded dna sequences in a specific manner and functions a transcription factor. each of the rna-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-uuag-3' sequence and also weaker to the single-stranded 5'-ttaggg-3' telomeric dna repeat. binds rna oligonucleotides with 5'-uuaggg-3' repeats more tightly than the telomeric single-stranded dna 5'-ttaggg-3' repeats. binding of rrm1 to dna inhibits the formation of dna quadruplex structure which may play a role in telomere elongation. may be involved in translationally coupled mrna turnover. implicated with other rna-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the fos mrna mediated by the major coding-region determinant of instability (mcrd) domain. may play a role in the regulation of the rhythmic expression of circadian clock core genes. directly binds to the 3'utr of cry1 mrna and induces cry1 rhythmic translation. may also be involved in the regulation of per2 translation. {eco:0000269|pubmed:10080887, eco:0000269|pubmed:11051545, eco:0000269|pubmed:24423872}.",subcellular location: nucleus. cytoplasm. note=localized in cytoplasmic mrnp granules containing untranslated mrnas. component of ribonucleosomes. cytoplasmic localization oscillates diurnally.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,HNRNPD,3184,Hs.480073,ENST00000352301,THC2566009,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006396(RNA processing)|GO:0006401(RNA catabolic process)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030529(ribonucleoprotein complex)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0042162(telomeric DNA binding)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0048255(mRNA stabilization)","Homo sapiens heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) (HNRNPD), transcript variant 1, mRNA [NM_031370]",chr4:83275239-83275180,hs|4q21.22,"heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)",TRUE
61_KLC3_147700,Q6P597,kinesin light chain 3 (klc2-like) (kinesin light chain 2),KLC3 KLC2 KLC2L,504,function: kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport.,"subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q68g30, eco:0000250|uniprotkb:q91w40}. note=in elongating spermatid tail midpiece, localized in outer dense fibers (odfs) and associates with mitochondria. also localizes to the manchette in elongating spermatids. {eco:0000250|uniprotkb:q68g30, eco:0000250|uniprotkb:q91w40}.",NA,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,KLC3,147700,Hs.636501,ENST00000494686,THC2767053,GO:0003777(microtubule motor activity)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005871(kinesin complex)|GO:0005874(microtubule)|GO:0008017(microtubule binding)|GO:0008808(cardiolipin synthase activity)|GO:0009434(microtubule-based flagellum)|GO:0019894(kinesin binding)|GO:0035253(ciliary rootlet)|GO:0043005(neuron projection),kinesin light chain 3 [Source:HGNC Symbol;Acc:20717] [ENST00000494686],chr19:45850341-45850400,hs|19q13.32,kinesin light chain 3,TRUE
610_USP9X_8239,Q93008,"probable ubiquitin carboxyl-terminal hydrolase faf-x (ec 3.4.19.12) (deubiquitinating enzyme faf-x) (fat facets in mammals) (hfam) (fat facets protein-related, x-linked) (ubiquitin thioesterase faf-x) (ubiquitin-specific protease 9, x chromosome) (ubiquitin-specific-processing protease faf-x)",USP9X DFFRX FAM USP9,2570,"function: deubiquitinase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. may therefore play an important regulatory role at the level of protein turnover by preventing degradation of proteins through the removal of conjugated ubiquitin. specifically hydrolyzes 'lys-48'-, 'lys-29'- and 'lys-33'-linked polyubiquitins chains. essential component of tgf-beta/bmp signaling cascade. specifically deubiquitinates monoubiquitinated smad4, opposing the activity of e3 ubiquitin-protein ligase trim33. deubiquitinates alkylation repair enzyme alkbh3. otud4 recruits usp7 and usp9x to stabilize alkbh3, thereby promoting the repair of alkylated dna lesions (pubmed:25944111). regulates chromosome alignment and segregation in mitosis by regulating the localization of birc5/survivin to mitotic centromeres. involved in axonal growth and neuronal cell migration (pubmed:16322459, pubmed:18254724, pubmed:19135894, pubmed:24607389). regulates cellular clock function by enhancing the protein stability and transcriptional activity of the core circadian protein arntl/bmal1 via its deubiquitinating activity (pubmed:29626158). {eco:0000269|pubmed:16322459, eco:0000269|pubmed:18254724, eco:0000269|pubmed:19135894, eco:0000269|pubmed:24607389, eco:0000269|pubmed:25944111, eco:0000269|pubmed:29626158}.","subcellular location: cytoplasm {eco:0000269|pubmed:19135894}. cell projection, growth cone {eco:0000269|pubmed:24607389}.",TISSUE SPECIFICITY: Widely expressed in embryonic and adult tissues.,"DISEASE: Mental retardation, X-linked 99 (MRX99) [MIM:300919]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:24607389}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,USP9X,8239,Hs.77578,ENST00000324545,THC2469492,GO:0004197(cysteine-type endopeptidase activity)|GO:0004221(ubiquitin thiolesterase activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0006508(proteolysis)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0007049(cell cycle)|GO:0007059(chromosome segregation)|GO:0007067(mitosis)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0007292(female gamete generation)|GO:0008233(peptidase activity)|GO:0008234(cysteine-type peptidase activity)|GO:0016579(protein deubiquitination)|GO:0030509(BMP signaling pathway)|GO:0051301(cell division)|GO:0070410(co-SMAD binding),"Homo sapiens ubiquitin specific peptidase 9, X-linked (USP9X), transcript variant 3, mRNA [NM_001039590]",chrX:41091942-41092001,hs|Xp11.4,"ubiquitin specific peptidase 9, X-linked",TRUE
611_KIAA1429_25962,Q69YN4,protein virilizer homolog,VIRMA KIAA1429 MSTP054,1812,"function: associated component of the wmm complex, a complex that mediates n6-methyladenosine (m6a) methylation of rnas, a modification that plays a role in the efficiency of mrna splicing and rna processing (pubmed:24981863, pubmed:29507755). acts as a key regulator of m6a methylation by promoting m6a methylation of mrnas in the 3'-utr near the stop codon: recruits the catalytic core components mettl3 and mettl14, thereby guiding m6a methylation at specific sites (pubmed:29507755). required for mrna polyadenylation via its role in selective m6a methylation: m6a methylation of mrnas in the 3'-utr near the stop codon correlating with alternative polyadenylation (apa) (pubmed:29507755). {eco:0000269|pubmed:24981863, eco:0000269|pubmed:29507755}.","subcellular location: nucleus speckle {eco:0000269|pubmed:24100041}. nucleus, nucleoplasm {eco:0000269|pubmed:24100041}. cytoplasm {eco:0000250|uniprotkb:a2aiv2}. note=mainly nuclear with some fraction located in the cytoplasm. zc3h13 is required to anchor component of the macom subcomplex, such as virma, in the nucleus. {eco:0000250|uniprotkb:a2aiv2}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KIAA1429,25962,Hs.202238,ENST00000517624,THC2600949,GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing),"Homo sapiens KIAA1429 (KIAA1429), transcript variant 1, mRNA [NM_015496]",chr8:95500972-95500913,hs|8q22.1,KIAA1429,TRUE
612_ARHGAP1_392,Q07960,rho gtpase-activating protein 1 (cdc42 gtpase-activating protein) (gtpase-activating protein rhogap) (rho-related small gtpase protein activator) (rho-type gtpase-activating protein 1) (p50-rhogap),ARHGAP1 CDC42GAP RHOGAP1,439,"function: gtpase activator for the rho, rac and cdc42 proteins, converting them to the putatively inactive gdp-bound state. cdc42 seems to be the preferred substrate.",subcellular location: cytoplasm.,TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARHGAP1,392,Hs.138860,ENST00000311956,THC2465777,GO:0001726(ruffle)|GO:0005070(SH3/SH2 adaptor activity)|GO:0005096(GTPase activator activity)|GO:0005100(Rho GTPase activator activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0007165(signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0007266(Rho protein signal transduction)|GO:0017124(SH3 domain binding)|GO:0030675(Rac GTPase activator activity)|GO:0032321(positive regulation of Rho GTPase activity)|GO:0043087(regulation of GTPase activity)|GO:0043231(intracellular membrane-bounded organelle)|GO:0051056(regulation of small GTPase mediated signal transduction),"Homo sapiens Rho GTPase activating protein 1 (ARHGAP1), mRNA [NM_004308]",chr11:46698725-46698666,hs|11p11.2,Rho GTPase activating protein 1,TRUE
613_FNBP4_23360,Q8N3X1,formin-binding protein 4 (formin-binding protein 30),FNBP4 FBP30 KIAA1014,1017,NA,NA,TISSUE SPECIFICITY: Highly expressed in the eye. {ECO:0000269|PubMed:23703728}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FNBP4,23360,Hs.6834,ENST00000263773,THC2465997,NA,"Homo sapiens formin binding protein 4 (FNBP4), mRNA [NM_015308]",chr11:47738209-47738150,hs|11p11.2,formin binding protein 4,TRUE
614_SNX3_8724,O60493,sorting nexin-3 (protein sdp3),SNX3,162,"function: phosphoinositide-binding protein required for multivesicular body formation. specifically binds phosphatidylinositol 3-phosphate (ptdins(p3)). also can bind phosphatidylinositol 4-phosphate (ptdins(p4)), phosphatidylinositol 5-phosphate (ptdins(p5)) and phosphatidylinositol 3,5-biphosphate (ptdins(3,5)p2) (by similarity). plays a role in protein transport between cellular compartments. together with rab7a facilitates endosome membrane association of the retromer cargo-selective subcomplex (csc/vps). may in part act as component of the snx3-retromer complex which mediates the retrograde endosome-to-tgn transport of wls distinct from the snx-bar retromer pathway (pubmed:21725319, pubmed:24344282). promotes stability and cell surface expression of epithelial sodium channel (enac) subunits scnn1a and scnn1g (by similarity). not involved in egfr degradation. involved in the regulation of phagocytosis in dendritic cells possibly by regulating eea1 recruitment to the nascent phagosomes (pubmed:23237080). involved in iron homeostasis through regulation of endocytic recycling of the transferrin receptor tfrc presumably by delivering the transferrin:transferrin receptor complex to recycling endosomes; the function may involve the csc retromer subcomplex (by similarity). in the case of salmonella enterica infection plays arole in maturation of the salmonella-containing vacuole (scv) and promotes recruitment of lamp1 to scvs (pubmed:20482551). {eco:0000250|uniprotkb:o70492, eco:0000269|pubmed:11433298, eco:0000269|pubmed:18767904, eco:0000269|pubmed:21725319, eco:0000269|pubmed:23237080, eco:0000269|pubmed:24344282, eco:0000305|pubmed:21725319}.","subcellular location: early endosome {eco:0000269|pubmed:11433298, eco:0000269|pubmed:21725319}. cytoplasmic vesicle, phagosome {eco:0000269|pubmed:23237080}. note=colocalizes to clathrin-coated endosomal vesicles morphologically distinct from retromer-decorated non-branched endosomal tubule structures (pubmed:21725319) colocalizes with eea1 on nascent phagosomes in dendritic cells but competes with eea1 for binding to phagosomal membrane (pubmed:23237080). in the case of salmonella enterica infection localizes to salmonella-containing vacuoles (scvs) from which snx3-containing tubules form 30-60 min after infection (pubmed:20482551). {eco:0000269|pubmed:20482551, eco:0000269|pubmed:21725319, eco:0000269|pubmed:23237080}.",NA,DISEASE: Note=A chromosomal aberration involving SNX3 has been found in patients with syndromic microphthalmia. Translocation t(6;13)(q21;q12). {ECO:0000269|PubMed:12471201}.,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SNX3,8724,Hs.12102,ENST00000368979,THC2522325,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0006897(endocytosis)|GO:0007154(cell communication)|GO:0008289(lipid binding)|GO:0010008(endosome membrane)|GO:0015031(protein transport)|GO:0019903(protein phosphatase binding)|GO:0032266(phosphatidylinositol-3-phosphate binding),"Homo sapiens sorting nexin 3 (SNX3), transcript variant 1, mRNA [NM_003795]",chr6:108532968-108532909,hs|6q21,sorting nexin 3,TRUE
615_C14orf166_51637,Q9Y224,"rna transcription, translation and transport factor protein (cle7 homolog) (cle) (hcle)",RTRAF C14orf166 CGI-99,244,"function: rna-binding protein involved in modulation of mrna transcription by polymerase ii (pubmed:16950395). component of the trna-splicing ligase complex and is required for trna ligation (pubmed:24870230). may be required for rna transport (pubmed:24608264). {eco:0000269|pubmed:16950395, eco:0000269|pubmed:24608264, eco:0000269|pubmed:24870230}.; function: (microbial infection) in case of infection by influenza virus a (iva), is involved in viral replication (pubmed:21900157). {eco:0000269|pubmed:21900157}.","subcellular location: nucleus {eco:0000269|pubmed:15147888, eco:0000269|pubmed:24608264}. cytoplasm, cytosol {eco:0000269|pubmed:15147888, eco:0000269|pubmed:24608264}. cytoplasm, perinuclear region {eco:0000269|pubmed:15147888}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:15147888}. note=may localize at the centrosome during mitosis (pubmed:15147888). shuttles between the cytosol and the nucleus: enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low (pubmed:24608264). {eco:0000269|pubmed:15147888, eco:0000269|pubmed:24608264}.; subcellular location: nucleus {eco:0000269|pubmed:26864902}. cytoplasm {eco:0000269|pubmed:26864902}. note=(microbial infection) following influenza a virus (iav) infection, included in influenza a virions via its association with packaged viral ribonucleoproteins (vrnp) in the nucleus and cytoplasm (pubmed:21900157, pubmed:26864902). {eco:0000269|pubmed:21900157, eco:0000269|pubmed:26864902}.","TISSUE SPECIFICITY: Widely expressed. Expressed at high level in heart and skeletal muscle. Expressed at intermediate level in liver, pancreas, fetal brain and fetal lung. Weakly expressed in adult brain, adult lung, placenta, fetal liver and fetal kidney. Overexpressed in many brain tumors. {ECO:0000269|PubMed:15147888}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,C14orf166,51637,Hs.534457,ENST00000553479,THC2614567,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005815(microtubule organizing center)|GO:0005856(cytoskeleton)|GO:0042802(identical protein binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0072669(tRNA-splicing ligase complex),"Homo sapiens chromosome 14 open reading frame 166 (C14orf166), mRNA [NM_016039]",chr14:52471314-52471373,hs|14q22.1,chromosome 14 open reading frame 166,TRUE
616_GRP_2922,O43739,"cytohesin-3 (arf nucleotide-binding site opener 3) (protein arno3) (general receptor of phosphoinositides 1) (grp1) (ph, sec7 and coiled-coil domain-containing protein 3)",CYTH3 ARNO3 GRP1 PSCD3,400,"function: promotes guanine-nucleotide exchange on arf1 and arf6. promotes the activation of arf factors through replacement of gdp with gtp. play a role in the epithelial polarization (by similarity). {eco:0000250|uniprotkb:o08967, eco:0000269|pubmed:23940353, eco:0000269|pubmed:9707577}.","subcellular location: cytoplasm, cytosol. cell membrane {eco:0000250|uniprotkb:o08967}; peripheral membrane protein {eco:0000250|uniprotkb:o08967}. cell junction, adherens junction {eco:0000250|uniprotkb:o08967}. cell junction, tight junction {eco:0000250|uniprotkb:o08967}. note=translocates from the cytosol to membranes enriched in phosphatidylinositol 3,4,5-trisphosphate. {eco:0000250|uniprotkb:o08967}.","TISSUE SPECIFICITY: Almost absent from liver, thymus and peripheral blood lymphocytes.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GRP,2922,Hs.153444,ENST00000256857,THC2664755,GO:0005102(receptor binding)|GO:0005184(neuropeptide hormone activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0007165(signal transduction)|GO:0007218(neuropeptide signaling pathway),"Homo sapiens gastrin-releasing peptide (GRP), transcript variant 1, mRNA [NM_002091]",chr18:56897918-56897977,hs|18q21.32,gastrin-releasing peptide,TRUE
617_RDH11_51109,Q8TC12,retinol dehydrogenase 11 (ec 1.1.1.300) (androgen-regulated short-chain dehydrogenase/reductase 1) (hcv core-binding protein hcbp12) (prostate short-chain dehydrogenase/reductase 1) (retinal reductase 1) (ralr1) (short chain dehydrogenase/reductase family 7c member 1),RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82,318,"function: retinol dehydrogenase with a clear preference for nadp. displays high activity towards 9-cis, 11-cis and all-trans-retinol, and to a lesser extent on 13-cis-retinol (pubmed:12226107, pubmed:12036956, pubmed:29410696). exhibits a low reductive activity towards unsaturated medium-chain aldehydes such as cis -6-nonenal and no activity toward nonanal or 4-hydroxy-nonenal (pubmed:15865448). has no dehydrogenase activity towards steroid (pubmed:12226107, pubmed:12036956). {eco:0000269|pubmed:12036956, eco:0000269|pubmed:12226107, eco:0000269|pubmed:15865448, eco:0000269|pubmed:29410696}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12036956}; single-pass type ii membrane protein {eco:0000269|pubmed:12036956}.,"TISSUE SPECIFICITY: Predominantly expressed in the epithelial cells of prostate, in both basal and luminal secretory cell populations. Expressed at low levels in spleen, thymus, testis, ovary, small intestine, colon, peripherical blood leukocytes, kidney, adrenal gland and fetal liver. Not detected in prostatic fibromuscular stromal cells, endothelial cells, or infiltrating lymphocytes. {ECO:0000269|PubMed:11245473}.","DISEASE: Retinal dystrophy, juvenile cataracts, and short stature syndrome (RDJCSS) [MIM:616108]: A disorder characterized by retinal dystrophy resulting in progressive decrease in visual acuity and difficulties with night vision in the first decade of life, development of juvenile cataracts, facial dysmorphism, psychomotor developmental delays, learning disabilities and short stature. Ophthalmological findings include salt-and-pepper retinopathy, attenuation of the arterioles, generalized rod-cone dysfunction, mottled macula at an early age, and peripapillary sparing of the retinal pigment epithelium. {ECO:0000269|PubMed:24916380}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RDH11,51109,Hs.719925,ENST00000553578,THC2510623,GO:0000166(nucleotide binding)|GO:0001523(retinoid metabolic process)|GO:0004745(retinol dehydrogenase activity)|GO:0005622(intracellular)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0008202(steroid metabolic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0042572(retinol metabolic process)|GO:0052650(NADP-retinol dehydrogenase activity),"Homo sapiens retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11), mRNA [NM_016026]",chr14:68144288-68144229,hs|14q24.1,retinol dehydrogenase 11 (all-trans/9-cis/11-cis),TRUE
618_FKBP5_2289,Q13451,peptidyl-prolyl cis-trans isomerase fkbp5 (ppiase fkbp5) (ec 5.2.1.8) (51 kda fk506-binding protein) (51 kda fkbp) (fkbp-51) (54 kda progesterone receptor-associated immunophilin) (androgen-regulated protein 6) (ff1 antigen) (fk506-binding protein 5) (fkbp-5) (fkbp54) (p54) (hsp90-binding immunophilin) (rotamase),FKBP5 AIG6 FKBP51,457,function: immunophilin protein with ppiase and co-chaperone activities. component of unligated steroid receptors heterocomplexes through interaction with heat-shock protein 90 (hsp90). plays a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors maintaining the complex into the cytoplasm when unliganded.,subcellular location: cytoplasm. nucleus.,"TISSUE SPECIFICITY: Widely expressed, enriched in testis compared to other tissues.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FKBP5,2289,Hs.407190,ENST00000543400,THC2712288,GO:0000413(protein peptidyl-prolyl isomerization)|GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0005488(binding)|GO:0005528(FK506 binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006457(protein folding)|GO:0016020(membrane)|GO:0016853(isomerase activity)|GO:0018208(peptidyl-proline modification)|GO:0031072(heat shock protein binding),"Homo sapiens FK506 binding protein 5 (FKBP5), transcript variant 1, mRNA [NM_004117]",chr6:35543314-35543255,hs|6p21.31,FK506 binding protein 5,TRUE
619_NSUN2_54888,Q08J23,rna cytosine c(5)-methyltransferase nsun2 (ec 2.1.1.-) (myc-induced sun domain-containing protein) (misu) (nol1/nop2/sun domain family member 2) (substrate of aim1/aurora kinase b) (mrna cytosine c(5)-methyltransferase) (ec 2.1.1.-) (trna cytosine c(5)-methyltransferase) (ec 2.1.1.-) (ec 2.1.1.203) (trna methyltransferase 4 homolog) (htrm4),NSUN2 SAKI TRM4,767,"function: rna cytosine c(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5c) in various rnas, such as trnas, mrnas and some long non-coding rnas (lncrnas) (pubmed:17071714, pubmed:22995836, pubmed:31358969, pubmed:31199786). involved in various processes, such as epidermal stem cell differentiation, testis differentiation and maternal to zygotic transition during early development: acts by increasing protein synthesis; cytosine c(5)-methylation promoting trna stability and preventing mrna decay (pubmed:31199786). methylates cytosine to 5-methylcytosine (m5c) at positions 34 and 48 of intron-containing trna(leu)(caa) precursors, and at positions 48, 49 and 50 of trna(gly)(gcc) precursors (pubmed:17071714, pubmed:22995836, pubmed:31199786). trna methylation is required generation of rna fragments derived from trnas (trfs) (pubmed:31199786). also mediates c(5)-methylation of mitochondrial trnas (pubmed:31276587). catalyzes cytosine c(5)-methylation of mrnas, leading to stabilize them and prevent mrna decay: mrna stabilization involves ybx1 that specifically recognizes and binds m5c-modified transcripts (pubmed:22395603, pubmed:31358969). cytosine c(5)-methylation of mrnas also regulates mrna export: methylated transcripts are specifically recognized by thoc4/alyref, which mediates mrna nucleo-cytoplasmic shuttling (pubmed:28418038). also mediates cytosine c(5)-methylation of non-coding rnas, such as vault rnas (vtrnas), promoting their processing into regulatory small rnas (pubmed:23871666). cytosine c(5)-methylation of vtrna vtrna1.1 promotes its processing into small-vault rna4 (svrna4) and regulates epidermal differentiation (pubmed:31186410). may act downstream of myc to regulate epidermal cell growth and proliferation (by similarity). required for proper spindle assembly and chromosome segregation, independently of its methyltransferase activity (pubmed:19596847). {eco:0000250|uniprotkb:q1hfz0, eco:0000269|pubmed:17071714, eco:0000269|pubmed:19596847, eco:0000269|pubmed:22395603, eco:0000269|pubmed:22995836, eco:0000269|pubmed:23871666, eco:0000269|pubmed:28418038, eco:0000269|pubmed:31186410, eco:0000269|pubmed:31199786, eco:0000269|pubmed:31276587, eco:0000269|pubmed:31358969}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:17071714, eco:0000269|pubmed:17215513, eco:0000269|pubmed:31276587}. cytoplasm {eco:0000269|pubmed:17071714, eco:0000269|pubmed:31276587}. mitochondrion {eco:0000269|pubmed:31276587, eco:0000269|pubmed:31287866}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:19596847}. secreted, extracellular exosome {eco:0000250|uniprotkb:q1hfz0}. note=concentrated in the nucleolus during interphase and translocates to the spindle during mitosis as an rna-protein complex that includes 18s ribosomal rna (pubmed:19596847). in testis, localizes to the chromatoid body (by similarity). {eco:0000250|uniprotkb:q1hfz0, eco:0000269|pubmed:19596847}.",TISSUE SPECIFICITY: Expressed in adult and fetal brain and in lymphoblastoid cells. {ECO:0000269|PubMed:22541559}.,"DISEASE: Mental retardation, autosomal recessive 5 (MRT5) [MIM:611091]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:22541559, ECO:0000269|PubMed:22541562}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NSUN2,54888,Hs.481526,ENST00000513888,THC2603179,GO:0000049(tRNA binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0008033(tRNA processing)|GO:0008168(methyltransferase activity)|GO:0016428(tRNA (cytosine-5-)-methyltransferase activity)|GO:0016740(transferase activity)|GO:0030488(tRNA methylation),"Homo sapiens NOP2/Sun domain family, member 2 (NSUN2), transcript variant 1, mRNA [NM_017755]",chr5:6599588-6599529,hs|5p15.31,"NOP2/Sun domain family, member 2",TRUE
62_RPL39_6170,P62891,60s ribosomal protein l39 (large ribosomal subunit protein el39),RPL39,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL39,6170,Hs.558387,ENST00000468844,THC2590912,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L39 (RPL39), mRNA [NM_001000]",chrX:118920630-118920571,hs|Xq24,ribosomal protein L39,TRUE
620_AGSK1_80154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,AGSK1,80154,Hs.546614,ENST00000357253,THC2476453,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens golgin subfamily A member 2-like (AGSK1), non-coding RNA [NR_026811]",chr15:82764270-82764211,hs|15q25.2,golgin subfamily A member 2-like,TRUE
621_CHP_11261,Q99653,calcineurin b homologous protein 1 (calcineurin b-like protein) (calcium-binding protein chp) (calcium-binding protein p22) (ef-hand calcium-binding domain-containing protein p22),CHP1 CHP,195,"function: calcium-binding protein involved in different processes such as regulation of vesicular trafficking, plasma membrane na(+)/h(+) exchanger and gene transcription. involved in the constitutive exocytic membrane traffic. mediates the association between microtubules and membrane-bound organelles of the endoplasmic reticulum and golgi apparatus and is also required for the targeting and fusion of transcytotic vesicles (tcv) with the plasma membrane. functions as an integral cofactor in cell ph regulation by controlling plasma membrane-type na(+)/h(+) exchange activity. affects the ph sensitivity of slc9a1/nhe1 by increasing its sensitivity at acidic ph. required for the stabilization and localization of slc9a1/nhe1 at the plasma membrane. inhibits serum- and gtpase-stimulated na(+)/h(+) exchange. plays a role as an inhibitor of ribosomal rna transcription by repressing the nucleolar ubf1 transcriptional activity. may sequester ubf1 in the nucleoplasm and limit its translocation to the nucleolus. associates to the ribosomal gene promoter. acts as a negative regulator of the calcineurin/nfat signaling pathway. inhibits nfat nuclear translocation and transcriptional activity by suppressing the calcium-dependent calcineurin phosphatase activity. also negatively regulates the kinase activity of the apoptosis-induced kinase stk17b. inhibits both stk17b auto- and substrate-phosphorylations in a calcium-dependent manner. {eco:0000269|pubmed:10593895, eco:0000269|pubmed:11350981, eco:0000269|pubmed:15035633, eco:0000269|pubmed:8901634}.","subcellular location: nucleus {eco:0000250|uniprotkb:p61023}. cytoplasm {eco:0000250|uniprotkb:p61023}. cytoplasm, cytoskeleton {eco:0000250|uniprotkb:p61023}. endomembrane system {eco:0000250|uniprotkb:p61023}. endoplasmic reticulum-golgi intermediate compartment {eco:0000250|uniprotkb:p61023}. endoplasmic reticulum {eco:0000250|uniprotkb:p61023}. cell membrane {eco:0000269|pubmed:15035633}. membrane {eco:0000269|pubmed:11350981}; lipid-anchor {eco:0000269|pubmed:25255805}. note=localizes in cytoplasmic compartments in dividing cells. localizes in the nucleus in quiescent cells. exported from the nucleus to the cytoplasm through a nuclear export signal (nes) and crm1-dependent pathway. may shuttle between nucleus and cytoplasm. localizes with the microtubule-organizing center (mtoc) and extends toward the periphery along microtubules. associates with membranes of the early secretory pathway in a gapdh-independent, n-myristoylation- and calcium-dependent manner. colocalizes with the mitotic spindle microtubules. colocalizes with gapdh along microtubules. colocalizes with slc9a1 at the reticulum endoplasmic and plasma membrane. colocalizes with stk17b at the plasma membrane. {eco:0000250|uniprotkb:p61023}.","TISSUE SPECIFICITY: Ubiquitously expressed. Has been found in fetal eye, lung, liver, muscle, heart, kidney, thymus and spleen. {ECO:0000269|PubMed:8901634}.",NA,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CHP,11261,Hs.406234,ENST00000334660,NP1075687,GO:0005509(calcium ion binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006813(potassium ion transport)|GO:0007264(small GTPase mediated signal transduction)|GO:0015459(potassium channel regulator activity)|GO:0017156(calcium ion-dependent exocytosis)|GO:0045056(transcytosis),"Homo sapiens calcium binding protein P22 (CHP), mRNA [NM_007236]",chr15:41573979-41574038,hs|15q15.1,calcium binding protein P22,TRUE
622_SNRPD1_6632,P62316,small nuclear ribonucleoprotein sm d2 (sm-d2) (snrnp core protein d2),SNRPD2 SNRPD1,118,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:19325628, pubmed:23333303, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:23333303, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPD1,6632,Hs.464734,ENST00000300413,THC2662556,"GO:0000245(spliceosome assembly)|GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005689(U12-type spliceosomal complex)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein D1 polypeptide 16kDa (SNRPD1), mRNA [NM_006938]",chr18:19209071-19209130,hs|18q11.2,small nuclear ribonucleoprotein D1 polypeptide 16kDa,TRUE
623_CKS2_1164,P33552,cyclin-dependent kinases regulatory subunit 2 (cks-2),CKS2,79,function: binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CKS2,1164,Hs.83758,ENST00000314355,THC2461683,GO:0000079(regulation of cyclin-dependent protein kinase activity)|GO:0007049(cell cycle)|GO:0007051(spindle organization)|GO:0007127(meiosis I)|GO:0008283(cell proliferation)|GO:0016538(cyclin-dependent protein kinase regulator activity)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0051301(cell division),"Homo sapiens CDC28 protein kinase regulatory subunit 2 (CKS2), mRNA [NM_001827]",chr9:91931523-91931582,hs|9q22.2,CDC28 protein kinase regulatory subunit 2,TRUE
624_PHB2_11331,Q99623,prohibitin-2 (b-cell receptor-associated protein bap37) (d-prohibitin) (repressor of estrogen receptor activity),PHB2 BAP REA,299,"function: acts as a mediator of transcriptional repression by nuclear hormone receptors via recruitment of histone deacetylases (by similarity). functions as an estrogen receptor (er)-selective coregulator that potentiates the inhibitory activities of antiestrogens and represses the activity of estrogens. competes with ncoa1 for modulation of er transcriptional activity. in mitochondria, regulates cytochrome-c oxidase assembly (cox) and mitochondrial respiration. binding to sphingoid 1-phosphate (spp) modulates its regulator activity (pubmed:20959514). {eco:0000250|uniprotkb:o35129, eco:0000269|pubmed:10359819, eco:0000269|pubmed:20959514, eco:0000303|pubmed:11302691}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:20959514}. cytoplasm {eco:0000269|pubmed:19496786}. nucleus {eco:0000269|pubmed:19496786, eco:0000269|pubmed:20959514}.",NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PHB2,11331,Hs.504620,ENST00000543465,NP1179606,"GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0016020(membrane)|GO:0030331(estrogen receptor binding)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens prohibitin 2 (PHB2), transcript variant 2, mRNA [NM_007273]",chr12:7074658-7074599,hs|12p13.31,prohibitin 2,TRUE
625_CNIH4_29097,Q9P003,protein cornichon homolog 4 (cnih-4) (cornichon family ampa receptor auxiliary protein 4),CNIH4 HSPC163,139,"function: involved in g protein-coupled receptors (gpcrs) trafficking from the endoplasmic reticulum to the cell surface; it promotes the exit of gpcrs from the early secretory pathway, likely through interaction with the copii machinery (pubmed:24405750). {eco:0000269|pubmed:24405750}.",subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. endoplasmic reticulum {eco:0000269|pubmed:24405750}. endoplasmic reticulum-golgi intermediate compartment {eco:0000269|pubmed:24405750}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CNIH4,29097,Hs.445890,ENST00000366860,NP1156560,GO:0005783(endoplasmic reticulum)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0035556(intracellular signal transduction),"Homo sapiens cornichon homolog 4 (Drosophila) (CNIH4), mRNA [NM_014184]",chr1:224563539-224563598,hs|1q42.11,cornichon homolog 4 (Drosophila),TRUE
626_GOLGA3_2802,Q08378,golgin subfamily a member 3 (golgi complex-associated protein of 170 kda) (gcp170) (golgin-160),GOLGA3,1498,function: golgi auto-antigen; probably involved in maintaining golgi structure.,"subcellular location: cytoplasm. golgi apparatus, golgi stack membrane; peripheral membrane protein.","TISSUE SPECIFICITY: Expressed in all tissues tested. Expressed in liver, testis, lung, heart, salivary gland and kidney. {ECO:0000269|PubMed:15951434}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GOLGA3,2802,Hs.507333,ENST00000450791,THC2539407,GO:0000139(Golgi membrane)|GO:0005215(transporter activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0006891(intra-Golgi vesicle-mediated transport)|GO:0016020(membrane)|GO:0017119(Golgi transport complex)|GO:0032580(Golgi cisterna membrane),"Homo sapiens golgin A3 (GOLGA3), transcript variant 1, mRNA [NM_005895]",chr12:133345737-133345678,hs|12q24.33,golgin A3,TRUE
627_TPI1_7167,P60174,triosephosphate isomerase (tim) (ec 5.3.1.1) (methylglyoxal synthase) (ec 4.2.3.3) (triose-phosphate isomerase),TPI1 TPI,286,"function: triosephosphate isomerase is an extremely efficient metabolic enzyme that catalyzes the interconversion between dihydroxyacetone phosphate (dhap) and d-glyceraldehyde-3-phosphate (g3p) in glycolysis and gluconeogenesis. {eco:0000269|pubmed:18562316}.; function: it is also responsible for the non-negligible production of methylglyoxal a reactive cytotoxic side-product that modifies and can alter proteins, dna and lipids. {eco:0000250|uniprotkb:p00939}.",subcellular location: cytoplasm {eco:0000255|prosite-prorule:pru10127}.,NA,"DISEASE: Triosephosphate isomerase deficiency (TPID) [MIM:615512]: An autosomal recessive multisystem disorder characterized by congenital hemolytic anemia, progressive neuromuscular dysfunction, susceptibility to bacterial infection, and cardiomyopathy. {ECO:0000269|PubMed:2876430, ECO:0000269|PubMed:8503454, ECO:0000269|PubMed:8571957, ECO:0000269|PubMed:9338582, ECO:0000269|Ref.37}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TPI1,7167,Hs.524219,ENST00000535434,THC2552672,GO:0004807(triose-phosphate isomerase activity)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0006006(glucose metabolic process)|GO:0006094(gluconeogenesis)|GO:0006096(glycolysis)|GO:0006098(pentose-phosphate shunt)|GO:0009790(embryo development)|GO:0016853(isomerase activity)|GO:0019682(glyceraldehyde-3-phosphate metabolic process),"Homo sapiens triosephosphate isomerase 1 (TPI1), transcript variant 1, mRNA [NM_000365]",chr12:6979746-6979805,hs|12p13.31,triosephosphate isomerase 1,TRUE
628_NFIB_4781,O00712,nuclear factor 1 b-type (nf1-b) (nuclear factor 1/b) (ccaat-box-binding transcription factor) (ctf) (nuclear factor i/b) (nf-i/b) (nfi-b) (tggca-binding protein),NFIB,420,"function: transcriptional activator of gfap, essential for proper brain development (pubmed:30388402). recognizes and binds the palindromic sequence 5'-ttggcnnnnngccaa-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. these proteins are individually capable of activating transcription and replication. {eco:0000269|pubmed:30388402}.",subcellular location: nucleus.,NA,"DISEASE: Macrocephaly, acquired, with impaired intellectual development (MACID) [MIM:618286]: An autosomal dominant disorder characterized by postnatal macrocephaly and borderline to mild mental retardation. Additional variable neurodevelopmental features include muscular hypotonia, motor and speech delay, attention deficit disorder, autism spectrum disorder, and behavioral abnormalities. Some patients present corpus callosum dysgenesis. {ECO:0000269|PubMed:30388402}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NFIB,4781,Hs.644095,ENST00000380959,THC2500574,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity)|GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription)|GO:0001106(RNA polymerase II transcription corepressor activity)|GO:0002062(chondrocyte differentiation)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006260(DNA replication)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0008285(negative regulation of cell proliferation)|GO:0010001(glial cell differentiation)|GO:0021740(principal sensory nucleus of trigeminal nerve development)|GO:0021960(anterior commissure morphogenesis)|GO:0030900(forebrain development)|GO:0030902(hindbrain development)|GO:0043392(negative regulation of DNA binding)|GO:0044300(cerebellar mossy fiber)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0060486(Clara cell differentiation)|GO:0060502(epithelial cell proliferation involved in lung morphogenesis)|GO:0060509(Type I pneumocyte differentiation)|GO:0060510(Type II pneumocyte differentiation)|GO:0060916(mesenchymal cell proliferation involved in lung development)|GO:0061141(lung ciliated cell differentiation)|GO:0071679(commissural neuron axon guidance)|GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development)|GO:2000795(negative regulation of epithelial cell proliferation involved in lung morphogenesis),"Homo sapiens nuclear factor I/B (NFIB), transcript variant 3, mRNA [NM_005596]",chr9:14081998-14081939,hs|9p23,nuclear factor I/B,TRUE
629_RBM5_10181,P52756,rna-binding protein 5 (protein g15) (putative tumor suppressor luca15) (rna-binding motif protein 5) (renal carcinoma antigen ny-ren-9),RBM5 H37 LUCA15,815,"function: component of the spliceosome a complex. regulates alternative splicing of a number of mrnas. may modulate splice site pairing after recruitment of the u1 and u2 snrnps to the 5' and 3' splice sites of the intron. may both positively and negatively regulate apoptosis by regulating the alternative splicing of several genes involved in this process, including fas and casp2/caspase-2. in the case of fas, promotes exclusion of exon 6 thereby producing a soluble form of fas that inhibits apoptosis. in the case of casp2/caspase-2, promotes exclusion of exon 9 thereby producing a catalytically active form of casp2/caspase-2 that induces apoptosis. {eco:0000269|pubmed:10949932, eco:0000269|pubmed:12207175, eco:0000269|pubmed:12581154, eco:0000269|pubmed:15192330, eco:0000269|pubmed:16585163, eco:0000269|pubmed:18840686, eco:0000269|pubmed:18851835}.",subcellular location: nucleus {eco:0000269|pubmed:18851835}.,TISSUE SPECIFICITY: Isoform 5 is widely expressed in normal tissues and is expressed at increased levels in T-leukemic cell lines.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBM5,10181,Hs.439480,ENST00000536082,THC2577900,"GO:0000166(nucleotide binding)|GO:0000245(spliceosome assembly)|GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005730(nucleolus)|GO:0006396(RNA processing)|GO:0008270(zinc ion binding)|GO:0008285(negative regulation of cell proliferation)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0043065(positive regulation of apoptosis)|GO:0046872(metal ion binding)","Homo sapiens RNA binding motif protein 5 (RBM5), transcript variant 1, mRNA [NM_005778]",chr3:50156137-50156196,hs|3p21.31,RNA binding motif protein 5,TRUE
630_AHCYL1_10768,O43865,s-adenosylhomocysteine hydrolase-like protein 1 (dc-expressed ahcy-like molecule) (ip(3)rs binding protein released with ip(3)) (irbit) (putative adenosylhomocysteinase 2) (s-adenosyl-l-homocysteine hydrolase 2) (adohcyase 2),AHCYL1 DCAL IRBIT XPVKONA,530,"function: multifaceted cellular regulator which coordinates several essential cellular functions including regulation of epithelial hco3(-) and fluid secretion, mrna processing and dna replication. regulates itpr1 sensitivity to inositol 1,4,5-trisphosphate competing for the common binding site and acting as endogenous 'pseudoligand' whose inhibitory activity can be modulated by its phosphorylation status. in the pancreatic and salivary ducts, at resting state, attenuates inositol 1,4,5-trisphosphate-induced calcium release by interacting with itpr1 (pubmed:16793548). when extracellular stimuli induce itpr1 phosphorylation or inositol 1,4,5-trisphosphate production, dissociates of itpr1 to interact with cftr and slc26a6 mediating their synergistic activation by calcium and camp that stimulates the epithelial secretion of electrolytes and fluid (by similarity). also activates basolateral slc4a4 isoform 1 to coordinate fluid and hco3(-) secretion (pubmed:16769890). inhibits the effect of stk39 on slc4a4 and cftr by recruiting pp1 phosphatase which activates slc4a4, slc26a6 and cftr through dephosphorylation (by similarity). mediates the induction of slc9a3 surface expression produced by angiotensin-2 (pubmed:20584908). depending on the cell type, activates slc9a3 in response to calcium or reverses slc9a3r2-dependent calcium inhibition (pubmed:18829453). may modulate the polyadenylation state of specific mrnas, both by controlling the subcellular location of fip1l1 and by inhibiting papola activity, in response to a stimulus that alters its phosphorylation state (pubmed:19224921). acts as a (datp)-dependent inhibitor of ribonucleotide reductase large subunit rrm1, controlling the endogenous dntp pool and ensuring normal cell cycle progression (pubmed:25237103). in vitro does not exhibit any s-adenosyl-l-homocysteine hydrolase activity (by similarity). {eco:0000250|uniprotkb:b5dfn2, eco:0000250|uniprotkb:q80sw1, eco:0000269|pubmed:16769890, eco:0000269|pubmed:16793548, eco:0000269|pubmed:18829453, eco:0000269|pubmed:19224921, eco:0000269|pubmed:20584908, eco:0000269|pubmed:25237103}.","subcellular location: endoplasmic reticulum {eco:0000250|uniprotkb:q80sw1}. cytoplasm, cytosol {eco:0000250|uniprotkb:q80sw1}. microsome {eco:0000250|uniprotkb:q80sw1}. apical cell membrane {eco:0000250|uniprotkb:b5dfn2}. note=associates with membranes when phosphorylated, probably through interaction with itpr1. {eco:0000250|uniprotkb:q80sw1}.",TISSUE SPECIFICITY: Expressed in dendritic cells. {ECO:0000269|PubMed:11904675}.,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,AHCYL1,10768,Hs.485365,ENST00000359172,THC2484902,GO:0004013(adenosylhomocysteinase activity)|GO:0005783(endoplasmic reticulum)|GO:0006378(mRNA polyadenylation)|GO:0006611(protein export from nucleus)|GO:0006730(one-carbon metabolic process)|GO:0010765(positive regulation of sodium ion transport)|GO:0016787(hydrolase activity)|GO:0031440(regulation of mRNA 3'-end processing)|GO:0032412(regulation of ion transmembrane transporter activity),"Homo sapiens adenosylhomocysteinase-like 1 (AHCYL1), transcript variant 1, mRNA [NM_006621]",chr1:110564765-110564824,hs|1p13.3,adenosylhomocysteinase-like 1,TRUE
631_HEXIM1_10614,O94992,protein hexim1 (cardiac lineage protein 1) (estrogen down-regulated gene 1 protein) (hexamethylene bis-acetamide-inducible protein 1) (menage a quatre protein 1),HEXIM1 CLP1 EDG1 HIS1 MAQ1,359,"function: transcriptional regulator which functions as a general rna polymerase ii transcription inhibitor (pubmed:14580347, pubmed:15713661, pubmed:15201869). in cooperation with 7sk snrna sequesters p-tefb in a large inactive 7sk snrnp complex preventing rna polymerase ii phosphorylation and subsequent transcriptional elongation (pubmed:12832472, pubmed:14580347, pubmed:15713661, pubmed:15201869). may also regulate nf-kappa-b, esr1, nr3c1 and ciita-dependent transcriptional activity (pubmed:15940264, pubmed:15941832, pubmed:17088550). plays a role in the regulation of dna virus-mediated innate immune response by assembling into the hdp-rnp complex, a complex that serves as a platform for irf3 phosphorylation and subsequent innate immune response activation through the cgas-sting pathway (pubmed:28712728). {eco:0000269|pubmed:12581153, eco:0000269|pubmed:12832472, eco:0000269|pubmed:14580347, eco:0000269|pubmed:15201869, eco:0000269|pubmed:15713661, eco:0000269|pubmed:15940264, eco:0000269|pubmed:15941832, eco:0000269|pubmed:17088550, eco:0000269|pubmed:28712728}.","subcellular location: nucleus {eco:0000269|pubmed:12581153, eco:0000269|pubmed:12832472, eco:0000269|pubmed:12941847, eco:0000269|pubmed:16362050, eco:0000269|pubmed:17395637}. cytoplasm {eco:0000269|pubmed:12581153, eco:0000269|pubmed:17395637}. note=binds alpha-importin and is mostly nuclear (pubmed:16362050).","TISSUE SPECIFICITY: Ubiquitously expressed with higher expression in placenta. HEXIM1 and HEXIM2 are differentially expressed. Expressed in endocrine tissues. {ECO:0000269|PubMed:12941847, ECO:0000269|PubMed:15713661}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HEXIM1,10614,Hs.730687,ENST00000332499,THC2466542,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0004861(cyclin-dependent protein kinase inhibitor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007507(heart development)|GO:0017069(snRNA binding)|GO:0045736(negative regulation of cyclin-dependent protein kinase activity)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens hexamethylene bis-acetamide inducible 1 (HEXIM1), mRNA [NM_006460]",chr17:43227915-43227974,hs|17q21.31,hexamethylene bis-acetamide inducible 1,TRUE
632_NOS1_4842,P29475,"nitric oxide synthase, brain (ec 1.14.13.39) (constitutive nos) (nc-nos) (nos type i) (neuronal nos) (n-nos) (nnos) (peptidyl-cysteine s-nitrosylase nos1) (bnos)",NOS1,1434,"function: produces nitric oxide (no) which is a messenger molecule with diverse functions throughout the body. in the brain and peripheral nervous system, no displays many properties of a neurotransmitter. probably has nitrosylase activity and mediates cysteine s-nitrosylation of cytoplasmic target proteins such srr.","subcellular location: cell membrane, sarcolemma; peripheral membrane protein. cell projection, dendritic spine {eco:0000250}. note=in skeletal muscle, it is localized beneath the sarcolemma of fast-twitch muscle fiber by associating with the dystrophin glycoprotein complex. in neurons, enriched in dendritic spines (by similarity). {eco:0000250}.","TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed: detected in skeletal muscle and brain, also in testis, lung and kidney, and at low levels in heart, adrenal gland and retina. Not detected in the platelets. Isoform 3 is expressed only in testis. Isoform 4 is detected in testis, skeletal muscle, lung, and kidney, at low levels in the brain, but not in the heart and adrenal gland.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NOS1,4842,Hs.654410,ENST00000544320,NP080236,"GO:0001666(response to hypoxia)|GO:0001917(photoreceptor inner segment)|GO:0002028(regulation of sodium ion transport)|GO:0004517(nitric-oxide synthase activity)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006527(arginine catabolic process)|GO:0006809(nitric oxide biosynthetic process)|GO:0006941(striated muscle contraction)|GO:0007520(myoblast fusion)|GO:0007596(blood coagulation)|GO:0009408(response to heat)|GO:0010181(FMN binding)|GO:0010523(negative regulation of calcium ion transport into cytosol)|GO:0016491(oxidoreductase activity)|GO:0016529(sarcoplasmic reticulum)|GO:0018119(peptidyl-cysteine S-nitrosylation)|GO:0020037(heme binding)|GO:0030168(platelet activation)|GO:0033555(multicellular organismal response to stress)|GO:0034617(tetrahydrobiopterin binding)|GO:0034618(arginine binding)|GO:0035066(positive regulation of histone acetylation)|GO:0042136(neurotransmitter biosynthetic process)|GO:0042383(sarcolemma)|GO:0042738(exogenous drug catabolic process)|GO:0042995(cell projection)|GO:0043197(dendritic spine)|GO:0043267(negative regulation of potassium ion transport)|GO:0045202(synapse)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045909(positive regulation of vasodilation)|GO:0046870(cadmium ion binding)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0050660(flavin adenine dinucleotide binding)|GO:0050661(NADP binding)|GO:0051346(negative regulation of hydrolase activity)|GO:0051612(negative regulation of serotonin uptake)|GO:0055117(regulation of cardiac muscle contraction)|GO:0071363(cellular response to growth factor stimulus)","Homo sapiens nitric oxide synthase 1 (neuronal) (NOS1), transcript variant 1, mRNA [NM_000620]",chr12:117691552-117691493,hs|12q24.22,nitric oxide synthase 1 (neuronal),TRUE
633_USP54_159195,Q70EL1,inactive ubiquitin carboxyl-terminal hydrolase 54 (inactive ubiquitin-specific peptidase 54),USP54 C10orf29,1684,function: has no peptidase activity.,NA,TISSUE SPECIFICITY: Weakly expressed in a few tissues. {ECO:0000269|PubMed:14715245}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,USP54,159195,Hs.657355,ENST00000408019,NP1138716,GO:0004221(ubiquitin thiolesterase activity)|GO:0005515(protein binding)|GO:0006511(ubiquitin-dependent protein catabolic process),"Homo sapiens ubiquitin specific peptidase 54 (USP54), mRNA [NM_152586]",chr10:75257445-75257386,hs|10q22.2,ubiquitin specific peptidase 54,TRUE
634_MRPL41_64975,Q8IXM3,"39s ribosomal protein l41, mitochondrial (l41mt) (mrp-l41) (39s ribosomal protein l27 homolog) (bcl-2-interacting mitochondrial ribosomal protein l41) (cell proliferation-inducing gene 3 protein) (mrp-l27 homolog) (mitochondrial large ribosomal subunit protein ml41)",MRPL41 BMRP MRPL27 RPML27 PIG3,137,"function: component of the mitochondrial ribosome large subunit (pubmed:28892042, pubmed:25838379, pubmed:25278503). also involved in apoptosis and cell cycle (pubmed:16024796, pubmed:16256947). enhances p53/tp53 stability, thereby contributing to p53/tp53-induced apoptosis in response to growth-inhibitory condition. enhances p53/tp53 translocation to the mitochondria. has the ability to arrest the cell cycle at the g1 phase, possibly by stabilizing the cdkn1a and cdkn1b (p27kip1) proteins (pubmed:16024796). {eco:0000269|pubmed:16024796, eco:0000269|pubmed:16256947, eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.","subcellular location: mitochondrion {eco:0000269|pubmed:16024796, eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.","TISSUE SPECIFICITY: Present in kidney, liver, thymus and testis, and at lower level in brain and spleen (at protein level). {ECO:0000269|PubMed:15547950}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,MRPL41,64975,Hs.44017,ENST00000371443,THC2469867,GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0005762(mitochondrial large ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006915(apoptosis)|GO:0007049(cell cycle)|GO:0030529(ribonucleoprotein complex),"Homo sapiens mitochondrial ribosomal protein L41 (MRPL41), nuclear gene encoding mitochondrial protein, mRNA [NM_032477]",chr9:140446838-140446897,hs|9q34.3,mitochondrial ribosomal protein L41,TRUE
635_GUCY1A3_2982,Q02108,guanylate cyclase soluble subunit alpha-1 (gcs-alpha-1) (ec 4.6.1.2) (guanylate cyclase soluble subunit alpha-3) (gcs-alpha-3) (soluble guanylate cyclase large subunit),GUCY1A1 GUC1A3 GUCSA3 GUCY1A3,690,NA,subcellular location: cytoplasm {eco:0000305}.,TISSUE SPECIFICITY: Detected in brain cortex and lung (at protein level). {ECO:0000269|PubMed:1352257}.,"DISEASE: Moyamoya disease 6 with or without achalasia (MYMY6) [MIM:615750]: A form of Moyamoya disease, a progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. MYMY6 is characterized by severe cerebral angiopathy and onset of severe achalasia in infancy or early childhood. {ECO:0000269|PubMed:24581742}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,GUCY1A3,2982,Hs.24258,ENST00000455639,THC2483073,"GO:0000166(nucleotide binding)|GO:0004383(guanylate cyclase activity)|GO:0004872(receptor activity)|GO:0005525(GTP binding)|GO:0005737(cytoplasm)|GO:0006182(cGMP biosynthetic process)|GO:0007263(nitric oxide mediated signal transduction)|GO:0007596(blood coagulation)|GO:0008015(blood circulation)|GO:0008074(guanylate cyclase complex, soluble)|GO:0020037(heme binding)|GO:0030168(platelet activation)|GO:0035556(intracellular signal transduction)","Homo sapiens guanylate cyclase 1, soluble, alpha 3 (GUCY1A3), transcript variant 1, mRNA [NM_000856]",chr4:156643328-156651224,hs|4q32.1,"guanylate cyclase 1, soluble, alpha 3",TRUE
636_PRDX4_10549,Q13162,peroxiredoxin-4 (ec 1.11.1.15) (antioxidant enzyme aoe372) (aoe37-2) (peroxiredoxin iv) (prx-iv) (thioredoxin peroxidase ao372) (thioredoxin-dependent peroxide reductase a0372),PRDX4,271,"function: thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. regulates the activation of nf-kappa-b in the cytosol by a modulation of i-kappa-b-alpha phosphorylation. {eco:0000269|pubmed:9388242}.","subcellular location: cytoplasm {eco:0000269|pubmed:18052930, eco:0000269|pubmed:9388242}. endoplasmic reticulum {eco:0000269|pubmed:18052930}. note=cotranslationally translocated to and retained within the endoplasmic reticulum. a small fraction of the protein is cytoplasmic. {eco:0000269|pubmed:18052930}.",NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRDX4,10549,Hs.83383,ENST00000379341,THC2468870,GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0007252(I-kappaB phosphorylation)|GO:0008379(thioredoxin peroxidase activity)|GO:0016491(oxidoreductase activity),"Homo sapiens peroxiredoxin 4 (PRDX4), mRNA [NM_006406]",chrX:23700566-23700625,hs|Xp22.11,peroxiredoxin 4,TRUE
637_MAGT1_84061,Q9H0U3,magnesium transporter protein 1 (magt1) (dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit magt1) (oligosaccharyl transferase subunit magt1) (implantation-associated protein) (iap),MAGT1 IAG2 PSEC0084 UNQ628/PRO1244,335,"function: acts as accessory component of the n-oligosaccharyl transferase (ost) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an asn-x-ser/thr consensus motif in nascent polypeptide chains. involved in n-glycosylation of stt3b-dependent substrates. specifically required for the glycosylation of a subset of acceptor sites that are near cysteine residues; in this function seems to act redundantly with tusc3. in its oxidized form proposed to form transient mixed disulfides with a glycoprotein substrate to facilitate access of stt3b to the unmodified acceptor site. has also oxidoreductase-independent functions in the stt3b-containing ost complex possibly involving substrate recognition. {eco:0000269|pubmed:25135935, eco:0000269|pubmed:26864433, eco:0000305}.; function: may be involved in mg(2+) transport in epithelial cells. {eco:0000305|pubmed:15804357, eco:0000305|pubmed:19717468}.",subcellular location: cell membrane {eco:0000269|pubmed:19717468}; multi-pass membrane protein {eco:0000269|pubmed:19717468}. endoplasmic reticulum {eco:0000269|pubmed:25135935}. endoplasmic reticulum membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,"TISSUE SPECIFICITY: Ubiquitous. Expressed at very low levels in brain, lung and kidney. {ECO:0000269|PubMed:12887896, ECO:0000269|PubMed:15804357, ECO:0000269|PubMed:19717468}.","DISEASE: Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia (XMEN) [MIM:300853]: A disease characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. {ECO:0000269|PubMed:21796205}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MAGT1,84061,Hs.323562,ENST00000453109,THC2531932,GO:0005783(endoplasmic reticulum)|GO:0005887(integral to plasma membrane)|GO:0006487(protein N-linked glycosylation)|GO:0008250(oligosaccharyltransferase complex)|GO:0015095(magnesium ion transmembrane transporter activity)|GO:0015693(magnesium ion transport)|GO:0016020(membrane)|GO:0050890(cognition),"Homo sapiens magnesium transporter 1 (MAGT1), mRNA [NM_032121]",chrX:77081964-77081905,hs|Xq21.1,magnesium transporter 1,TRUE
638_RYBP_23429,Q8N488,ring1 and yy1-binding protein (apoptin-associating protein 1) (apap-1) (death effector domain-associated factor) (ded-associated factor) (yy1 and e4tf1-associated factor 1),RYBP DEDAF YEAF1,228,"function: component of a polycomb group (pcg) multiprotein prc1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including hox genes, throughout development. pcg prc1-like complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone h2a 'lys-119', rendering chromatin heritably changed in its expressibility (pubmed:25519132). component of a prc1-like complex that mediates monoubiquitination of histone h2a 'lys-119' on the x chromosome and is required for normal silencing of one copy of the x chromosome in xx females. may stimulate ubiquitination of histone h2a 'lys-119' by recruiting the complex to target sites (by similarity). inhibits ubiquitination and subsequent degradation of tp53, and thereby plays a role in regulating transcription of tp53 target genes (pubmed:19098711). may also regulate the ubiquitin-mediated proteasomal degradation of other proteins like fank1 to regulate apoptosis (pubmed:14765135, pubmed:27060496). may be implicated in the regulation of the transcription as a repressor of the transcriptional activity of e4tf1 (pubmed:11953439). may bind to dna (by similarity). may play a role in the repression of tumor growth and metastasis in breast cancer by down-regulating srrm3 (pubmed:27748911). {eco:0000250|uniprotkb:q8cci5, eco:0000269|pubmed:11953439, eco:0000269|pubmed:14765135, eco:0000269|pubmed:19098711, eco:0000269|pubmed:27060496, eco:0000269|pubmed:27748911}.","subcellular location: nucleus {eco:0000269|pubmed:11395500, eco:0000269|pubmed:11953439, eco:0000269|pubmed:14765135, eco:0000269|pubmed:27060496}. cytoplasm {eco:0000269|pubmed:11395500, eco:0000269|pubmed:14765135}. nucleus, nucleoplasm {eco:0000250|uniprotkb:q8cci5}. note=primarily found in the nucleus. detected in a punctate pattern likely to represent polycomb group (pcg) bodies (by similarity). {eco:0000250|uniprotkb:q8cci5}.","TISSUE SPECIFICITY: Down-regulated in breast cancer tissues and in several breast cancer cell lines (at protein level) (PubMed:27748911). Widely expressed with highest levels in lymphoid tissues and placenta. {ECO:0000269|PubMed:11395500, ECO:0000269|PubMed:11953439, ECO:0000269|PubMed:14765135, ECO:0000269|PubMed:27748911}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RYBP,23429,Hs.7910,ENST00000477973,THC2468996,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003677(DNA binding)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006915(apoptosis)|GO:0007275(multicellular organismal development)|GO:0008270(zinc ion binding)|GO:0031519(PcG protein complex)|GO:0035518(histone H2A monoubiquitination)|GO:0046872(metal ion binding)","Homo sapiens RING1 and YY1 binding protein (RYBP), mRNA [NM_012234]",chr3:72426321-72426262,hs|3p13,RING1 and YY1 binding protein,TRUE
639_HECTD1_25831,Q9ULT8,e3 ubiquitin-protein ligase hectd1 (ec 2.3.2.26) (e3 ligase for inhibin receptor) (eulir) (hect domain-containing protein 1) (hect-type e3 ubiquitin transferase hectd1),HECTD1 KIAA1131,2610,function: e3 ubiquitin-protein ligase which accepts ubiquitin from an e2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. mediates 'lys-63'-linked polyubiquitination of hsp90aa1 which leads to its intracellular localization and reduced secretion. negatively regulating hsp90aa1 secretion in cranial mesenchyme cells may impair their emigration and may be essential for the correct development of the cranial neural folds and neural tube closure. {eco:0000250|uniprotkb:q69zr2}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,HECTD1,25831,Hs.708017,ENST00000261312,THC2522183,GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0006464(protein modification process)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0046872(metal ion binding),"Homo sapiens HECT domain containing 1 (HECTD1), mRNA [NM_015382]",chr14:31569500-31569441,hs|14q12,HECT domain containing 1,TRUE
64_COX6C_1345,P09669,cytochrome c oxidase subunit 6c (cytochrome c oxidase polypeptide vic),COX6C,75,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.",subcellular location: mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX6C,1345,Hs.351875,ENST00000522940,THC2509868,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIc (COX6C), nuclear gene encoding mitochondrial protein, mRNA [NM_004374]",chr8:100899787-100899728,hs|8q22.2,cytochrome c oxidase subunit VIc,TRUE
640_VPS35_55737,Q96QK1,vacuolar protein sorting-associated protein 35 (hvps35) (maternal-embryonic 3) (vesicle protein sorting 35),VPS35 MEM3 TCCCTA00141,796,"function: acts as component of the retromer cargo-selective complex (csc). the csc is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. the recruitment of the csc to the endosomal membrane involves rab7a and snx3. the csc seems to associate with the cytoplasmic domain of cargo proteins predominantly via vps35; however, these interactions seem to be of low affinity and retromer snx proteins may also contribute to cargo selectivity thus questioning the classical function of the csc. the snx-bar retromer mediates retrograde transport of cargo proteins from endosomes to the trans-golgi network (tgn) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. the snx3-retromer mediates the retrograde endosome-to-tgn transport of wls distinct from the snx-bar retromer pathway. the snx27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. the csc seems to act as recruitment hub for other proteins, such as the wash complex and tbc1d5 (probable). required for retrograde transport of lysosomal enzyme receptor igf2r and slc11a2. required to regulate transcytosis of the polymeric immunoglobulin receptor (pigr-piga) (pubmed:15078903, pubmed:15247922, pubmed:20164305). required for endosomal localization of washc2c (pubmed:22070227, pubmed:28892079). mediates the association of the csc with the wash complex via washc2 (pubmed:22070227, pubmed:24980502, pubmed:24819384). required for the endosomal localization of tbc1d5 (pubmed:20923837). {eco:0000269|pubmed:15078903, eco:0000269|pubmed:15247922, eco:0000269|pubmed:20164305, eco:0000269|pubmed:20923837, eco:0000269|pubmed:22070227, eco:0000269|pubmed:23395371, eco:0000269|pubmed:24819384, eco:0000269|pubmed:24980502, eco:0000269|pubmed:28892079, eco:0000303|pubmed:21725319, eco:0000303|pubmed:22070227, eco:0000303|pubmed:22513087, eco:0000303|pubmed:23563491}.; function: (microbial infection) the heterotrimeric retromer cargo-selective complex (csc) mediates the exit of human papillomavirus from the early endosome and the delivery to the golgi apparatus. {eco:0000269|pubmed:25693203, eco:0000269|pubmed:30122350}.","subcellular location: cytoplasm. membrane; peripheral membrane protein. endosome {eco:0000269|pubmed:15078903, eco:0000269|pubmed:28892079}. early endosome {eco:0000305}. late endosome {eco:0000305}. note=localizes to tubular profiles adjacent to endosomes. {eco:0000269|pubmed:15078903}.","TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart, brain, placenta, skeletal muscle, spleen, thymus, testis, ovary, small intestine, kidney and colon.","DISEASE: Parkinson disease 17 (PARK17) [MIM:614203]: An autosomal dominant, adult-onset form of Parkinson disease. Parkinson disease is a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:21763482, ECO:0000269|PubMed:21763483, ECO:0000269|PubMed:22517097, ECO:0000269|PubMed:23395371, ECO:0000269|PubMed:24819384, ECO:0000269|PubMed:24980502}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VPS35,55737,Hs.454528,ENST00000541330,THC2465404,"GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005829(cytosol)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0042147(retrograde transport, endosome to Golgi)","Homo sapiens vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35), mRNA [NM_018206]",chr16:46694239-46694180,hs|16q11.2,vacuolar protein sorting 35 homolog (S. cerevisiae),TRUE
641_TMSB4X_7114,P62328,thymosin beta-4 (t beta-4) (fx) [cleaved into: hematopoietic system regulatory peptide (seraspenide)],TMSB4X TB4X THYB4 TMSB4,44,function: plays an important role in the organization of the cytoskeleton (by similarity). binds to and sequesters actin monomers (g actin) and therefore inhibits actin polymerization. {eco:0000250}.; function: seraspenide inhibits the entry of hematopoietic pluripotent stem cells into the s-phase. {eco:0000250}.,"subcellular location: cytoplasm, cytoskeleton.",TISSUE SPECIFICITY: Expressed in several hemopoietic cell lines and lymphoid malignant cells. Decreased levels in myeloma cells. {ECO:0000269|PubMed:3500230}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TMSB4X,7114,Hs.437277,ENST00000380633,THC2551359,GO:0001649(osteoblast differentiation)|GO:0002576(platelet degranulation)|GO:0003779(actin binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0007596(blood coagulation)|GO:0030036(actin cytoskeleton organization)|GO:0030168(platelet activation)|GO:0030334(regulation of cell migration)|GO:0031093(platelet alpha granule lumen)|GO:0042989(sequestering of actin monomers),"Homo sapiens thymosin beta 4, X-linked (TMSB4X), mRNA [NM_021109]",chrX:12995002-12995061,hs|Xp22.2,"thymosin beta 4, X-linked",TRUE
642_ERH_2079,P84090,enhancer of rudimentary homolog,ERH,104,function: may have a role in the cell cycle.,NA,TISSUE SPECIFICITY: Expressed in all tissues examined. {ECO:0000269|PubMed:8786099}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ERH,2079,Hs.509791,ENST00000557016,THC2468924,"GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0006213(pyrimidine nucleoside metabolic process)|GO:0007049(cell cycle)|GO:0030496(midbody)","Homo sapiens enhancer of rudimentary homolog (Drosophila) (ERH), mRNA [NM_004450]",chr14:69846976-69846917,hs|14q24.1,enhancer of rudimentary homolog (Drosophila),TRUE
644_WASF2_10163,Q9Y6W5,wiskott-aldrich syndrome protein family member 2 (wasp family protein member 2) (protein wave-2) (verprolin homology domain-containing protein 2),WASF2 WAVE2,498,"function: downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small gtpases to the actin cytoskeleton. promotes formation of actin filaments. part of the wave complex that regulates lamellipodia formation. the wave complex regulates actin filament reorganization via its interaction with the arp2/3 complex. {eco:0000269|pubmed:10381382, eco:0000269|pubmed:16275905}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250}. cell projection, lamellipodium {eco:0000250}. note=at the interface between the lamellipodial actin meshwork and the membrane. {eco:0000250}.","TISSUE SPECIFICITY: Expressed in all tissues with strongest expression in placenta, lung, and peripheral blood leukocytes, but not in skeletal muscle. {ECO:0000269|PubMed:10381382}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,WASF2,10163,Hs.469244,ENST00000430629,THC2576486,"GO:0001525(angiogenesis)|GO:0001667(ameboidal cell migration)|GO:0001726(ruffle)|GO:0003779(actin binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0006897(endocytosis)|GO:0007188(G-protein signaling, coupled to cAMP nucleotide second messenger)|GO:0015629(actin cytoskeleton)|GO:0016601(Rac protein signal transduction)|GO:0030027(lamellipodium)|GO:0030032(lamellipodium assembly)|GO:0030036(actin cytoskeleton organization)|GO:0030048(actin filament-based movement)","Homo sapiens WAS protein family, member 2 (WASF2), transcript variant 1, mRNA [NM_006990]",chr1:27730833-27730774,hs|1p36.11,"WAS protein family, member 2",TRUE
645_PGRMC2_10424,O15173,membrane-associated progesterone receptor component 2 (progesterone membrane-binding protein) (steroid receptor protein dg6),PGRMC2 DG6 PMBP,223,function: receptor for steroids. {eco:0000305}.,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PGRMC2,10424,Hs.507910,ENST00000394276,THC2469122,GO:0003707(steroid hormone receptor activity)|GO:0004872(receptor activity)|GO:0005496(steroid binding)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0020037(heme binding)|GO:0043401(steroid hormone mediated signaling pathway),"Homo sapiens progesterone receptor membrane component 2 (PGRMC2), mRNA [NM_006320]",chr4:129191396-129191337,hs|4q28.2,progesterone receptor membrane component 2,TRUE
646_FASTK_10922,Q14296,fas-activated serine/threonine kinase (fast kinase) (ec 2.7.11.8),FASTK,549,"function: phosphorylates the splicing regulator tia1, thereby promoting the inclusion of fas exon 6, which leads to an mrna encoding a pro-apoptotic form of the receptor. {eco:0000269|pubmed:17135269, eco:0000269|pubmed:7544399}.; function: isoform 4: required for the biogenesis of some mitochondrial-encoded mrnas, specifically stabilizes nd6 (nadh dehydrogenase complex subunit 6) mrna, and regulates its levels. {eco:0000269|pubmed:25704814}.",subcellular location: isoform 4: mitochondrion matrix {eco:0000269|pubmed:25704814}. note=colocalizes with mitochondrial rna granules. {eco:0000269|pubmed:25704814}.,"TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FASTK,10922,Hs.647094,ENST00000460980,THC2470864,GO:0000166(nucleotide binding)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0006468(protein phosphorylation)|GO:0006915(apoptosis)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0016740(transferase activity)|GO:0033867(Fas-activated serine/threonine kinase activity)|GO:0043484(regulation of RNA splicing),"Homo sapiens Fas-activated serine/threonine kinase (FASTK), transcript variant 1, mRNA [NM_006712]",chr7:150773779-150773720,hs|7q36.1,Fas-activated serine/threonine kinase,TRUE
647_GOLGB1_2804,Q14789,golgin subfamily b member 1 (372 kda golgi complex-associated protein) (gcp372) (giantin) (macrogolgin),GOLGB1,3259,function: may participate in forming intercisternal cross-bridges of the golgi complex.,subcellular location: golgi apparatus membrane; single-pass type i membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GOLGB1,2804,Hs.213389,NA,THC2469007,GO:0000139(Golgi membrane)|GO:0005515(protein binding)|GO:0005793(ER-Golgi intermediate compartment)|GO:0005794(Golgi apparatus)|GO:0005795(Golgi stack)|GO:0007030(Golgi organization)|GO:0016020(membrane)|GO:0016021(integral to membrane),H.sapiens giantin mRNA. [X75304],chr3:121383003-121382944,hs|3q13.33,golgin B1,TRUE
649_TCP1_6950,P17987,t-complex protein 1 subunit alpha (tcp-1-alpha) (cct-alpha),TCP1 CCT1 CCTA,556,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). as part of the tric complex may play a role in the assembly of bbsome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (pubmed:20080638). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:20080638, eco:0000269|pubmed:25467444, eco:0000305}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:1630492}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:20080638}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TCP1,6950,Hs.363137,ENST00000392168,THC2597556,GO:0000166(nucleotide binding)|GO:0000242(pericentriolar material)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005720(nuclear heterochromatin)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005815(microtubule organizing center)|GO:0005829(cytosol)|GO:0005832(chaperonin-containing T-complex)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006457(protein folding)|GO:0007021(tubulin complex assembly)|GO:0030054(cell junction)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens t-complex 1 (TCP1), transcript variant 1, mRNA [NM_030752]",chr6:160200132-160200073,hs|6q25.3,t-complex 1,TRUE
65_ZKSCAN1_7586,P17029,zinc finger protein with krab and scan domains 1 (zinc finger protein 139) (zinc finger protein 36) (zinc finger protein kox18),ZKSCAN1 KOX18 ZNF139 ZNF36,563,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000255|prosite-prorule:pru00187}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZKSCAN1,7586,Hs.615360,ENST00000482979,NA,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0016032(viral reproduction)|GO:0046872(metal ion binding)",zinc finger with KRAB and SCAN domains 1 [Source:HGNC Symbol;Acc:13101] [ENST00000482979],chr7:99622179-99622238,hs|7q22.1,zinc finger with KRAB and SCAN domains 1,TRUE
650_SQLE_6713,Q14534,squalene monooxygenase (ec 1.14.14.17) (squalene epoxidase) (se),SQLE ERG1,574,"function: catalyzes the stereospecific oxidation of squalene to (s)-2,3-epoxysqualene, and is considered to be a rate-limiting enzyme in steroid biosynthesis. {eco:0000269|pubmed:10666321, eco:0000269|pubmed:30626872}.","subcellular location: microsome membrane {eco:0000269|pubmed:26434806, eco:0000269|pubmed:28972164, eco:0000269|pubmed:30626872}; peripheral membrane protein {eco:0000269|pubmed:26434806, eco:0000269|pubmed:28972164}. endoplasmic reticulum membrane {eco:0000305|pubmed:26434806}; peripheral membrane protein {eco:0000269|pubmed:26434806, eco:0000269|pubmed:28972164}.",TISSUE SPECIFICITY: Detected in liver (at protein level). {ECO:0000269|PubMed:30626872}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SQLE,6713,Hs.71465,ENST00000265896,THC2469162,GO:0004506(squalene monooxygenase activity)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006695(cholesterol biosynthetic process)|GO:0006725(cellular aromatic compound metabolic process)|GO:0010033(response to organic substance)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016126(sterol biosynthetic process)|GO:0016491(oxidoreductase activity)|GO:0050660(flavin adenine dinucleotide binding),"Homo sapiens squalene epoxidase (SQLE), mRNA [NM_003129]",chr8:126034443-126034502,hs|8q24.13,squalene epoxidase,TRUE
651_TSEN34_79042,Q9BSV6,trna-splicing endonuclease subunit sen34 (ec 4.6.1.16) (leukocyte receptor cluster member 5) (trna-intron endonuclease sen34) (hssen34),TSEN34 LENG5 SEN34,310,"function: constitutes one of the two catalytic subunit of the trna-splicing endonuclease complex, a complex responsible for identification and cleavage of the splice sites in pre-trna. it cleaves pre-trna at the 5'- and 3'-splice sites to release the intron. the products are an intron and two trna half-molecules bearing 2',3'-cyclic phosphate and 5'-oh termini. there are no conserved sequences at the splice sites, but the intron is invariably located at the same site in the gene, placing the splice sites an invariant distance from the constant structural features of the trna body. it probably carries the active site for 3'-splice site cleavage. the trna splicing endonuclease is also involved in mrna processing via its association with pre-mrna 3'-end processing factors, establishing a link between pre-trna splicing and pre-mrna 3'-end formation, suggesting that the endonuclease subunits function in multiple rna-processing events. {eco:0000269|pubmed:15109492}.","subcellular location: nucleus {eco:0000269|pubmed:15109492}. nucleus, nucleolus {eco:0000269|pubmed:15109492}. note=may be transiently localized in the nucleolus.",NA,"DISEASE: Pontocerebellar hypoplasia 2C (PCH2C) [MIM:612390]: A disorder characterized by an abnormally small cerebellum and brainstem, and progressive microcephaly from birth combined with extrapyramidal dyskinesia. Severe chorea occurs and epilepsy is frequent. There are no signs of spinal cord anterior horn cells degeneration. {ECO:0000269|PubMed:18711368}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TSEN34,79042,Hs.15580,ENST00000496583,THC2466284,GO:0000213(tRNA-intron endonuclease activity)|GO:0000214(tRNA-intron endonuclease complex)|GO:0000379(tRNA-type intron splice site recognition and cleavage)|GO:0003676(nucleic acid binding)|GO:0004519(endonuclease activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006397(mRNA processing)|GO:0016787(hydrolase activity),"Homo sapiens tRNA splicing endonuclease 34 homolog (S. cerevisiae) (TSEN34), transcript variant 2, mRNA [NM_001077446]",chr19:54697390-54697449,hs|19q13.42,tRNA splicing endonuclease 34 homolog (S. cerevisiae),TRUE
652_HN1_51155,Q9UK76,"jupiter microtubule associated homolog 1 (androgen-regulated protein 2) (hematological and neurological expressed 1 protein) [cleaved into: jupiter microtubule associated homolog 1, n-terminally processed]",JPT1 ARM2 HN1,154,"function: modulates negatively akt-mediated gsk3b signaling (pubmed:21323578, pubmed:22155408). induces ctnnb1 'ser-33' phosphorylation and degradation through the suppression of the inhibitory 'ser-9' phosphorylation of gsk3b, which represses the function of the apc:ctnnb1:gsk3b complex and the interaction with cdh1/e-cadherin in adherent junctions (pubmed:25169422). plays a role in the regulation of cell cycle and cell adhesion (pubmed:25169422, pubmed:25450365). has an inhibitory role on ar-signaling pathway through the induction of receptor proteosomal degradation (pubmed:22155408). {eco:0000269|pubmed:21323578, eco:0000269|pubmed:22155408, eco:0000269|pubmed:25169422, eco:0000269|pubmed:25450365}.",subcellular location: nucleus {eco:0000269|pubmed:21323578}. cytoplasm {eco:0000269|pubmed:25169422}.,"TISSUE SPECIFICITY: Expressed in testis, skeletal muscle, thymus, prostate, colon, peripheral blood cells, brain and placenta. {ECO:0000269|PubMed:15094197}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HN1,51155,Hs.532803,ENST00000481647,THC2547480,GO:0005634(nucleus),"Homo sapiens hematological and neurological expressed 1 (HN1), transcript variant 3, mRNA [NM_001002033]",chr17:73132162-73132103,hs|17q25.1,hematological and neurological expressed 1,TRUE
653_NUFIP2_57532,Q7Z417,nuclear fragile x mental retardation-interacting protein 2 (82 kda fmrp-interacting protein) (82-fip) (cell proliferation-inducing gene 1 protein) (fmrp-interacting protein 2),NUFIP2 KIAA1321 PIG1,695,function: binds rna. {eco:0000269|pubmed:12837692}.,"subcellular location: nucleus {eco:0000269|pubmed:12837692, eco:0000269|pubmed:26184334}. cytoplasm {eco:0000269|pubmed:12837692, eco:0000269|pubmed:26184334}. cytoplasm, stress granule {eco:0000269|pubmed:26184334}. note=distribution is cell cycle-modulated, being cytoplasmic in the g2/m phase and accumulating in nucleus during the g1 phase (pubmed:12837692). {eco:0000269|pubmed:12837692, eco:0000269|pubmed:26184334}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NUFIP2,57532,Hs.462598,ENST00000225388,THC2524933,GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0042788(polysomal ribosome),"Homo sapiens nuclear fragile X mental retardation protein interacting protein 2 (NUFIP2), mRNA [NM_020772]",chr17:27584718-27584659,hs|17q11.2,nuclear fragile X mental retardation protein interacting protein 2,TRUE
654_RPS3_6188,P23396,40s ribosomal protein s3 (ec 4.2.99.18) (small ribosomal subunit protein us3),RPS3 OK/SW-cl.26,243,"function: involved in translation as a component of the 40s small ribosomal subunit (pubmed:8706699). has endonuclease activity and plays a role in repair of damaged dna (pubmed:7775413). cleaves phosphodiester bonds of dnas containing altered bases with broad specificity and cleaves supercoiled dna more efficiently than relaxed dna (pubmed:15707971). displays high binding affinity for 7,8-dihydro-8-oxoguanine (8-oxog), a common dna lesion caused by reactive oxygen species (ros) (pubmed:14706345). has also been shown to bind with similar affinity to intact and damaged dna (pubmed:18610840). stimulates the n-glycosylase activity of the base excision protein ogg1 (pubmed:15518571). enhances the uracil excision activity of ung1 (pubmed:18973764). also stimulates the cleavage of the phosphodiester backbone by apex1 (pubmed:18973764). when located in the mitochondrion, reduces cellular ros levels and mitochondrial dna damage (pubmed:23911537). has also been shown to negatively regulate dna repair in cells exposed to hydrogen peroxide (pubmed:17049931). plays a role in regulating transcription as part of the nf-kappa-b p65-p50 complex where it binds to the rela/p65 subunit, enhances binding of the complex to dna and promotes transcription of target genes (pubmed:18045535). represses its own translation by binding to its cognate mrna (pubmed:20217897). binds to and protects tp53/p53 from mdm2-mediated ubiquitination (pubmed:19656744). involved in spindle formation and chromosome movement during mitosis by regulating microtubule polymerization (pubmed:23131551). involved in induction of apoptosis through its role in activation of casp8 (pubmed:14988002). induces neuronal apoptosis by interacting with the e2f1 transcription factor and acting synergistically with it to up-regulate pro-apoptotic proteins bcl2l11/bim and hrk/dp5 (pubmed:20605787). interacts with tradd following exposure to uv radiation and induces apoptosis by caspase-dependent jnk activation (pubmed:22510408). {eco:0000269|pubmed:14706345, eco:0000269|pubmed:14988002, eco:0000269|pubmed:15518571, eco:0000269|pubmed:15707971, eco:0000269|pubmed:17049931, eco:0000269|pubmed:18045535, eco:0000269|pubmed:18610840, eco:0000269|pubmed:18973764, eco:0000269|pubmed:19656744, eco:0000269|pubmed:20217897, eco:0000269|pubmed:20605787, eco:0000269|pubmed:22510408, eco:0000269|pubmed:23131551, eco:0000269|pubmed:23911537, eco:0000269|pubmed:7775413, eco:0000269|pubmed:8706699}.","subcellular location: cytoplasm {eco:0000269|pubmed:16314389, eco:0000269|pubmed:17289661, eco:0000269|pubmed:17560175, eco:0000269|pubmed:18045535, eco:0000269|pubmed:20217897, eco:0000269|pubmed:21871177}. nucleus {eco:0000269|pubmed:17560175, eco:0000269|pubmed:18045535, eco:0000269|pubmed:19460357, eco:0000269|pubmed:20217897, eco:0000269|pubmed:21871177}. nucleus, nucleolus {eco:0000269|pubmed:16314389, eco:0000269|pubmed:19460357}. mitochondrion inner membrane {eco:0000269|pubmed:23911537}; peripheral membrane protein {eco:0000269|pubmed:23911537}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:23131551}. note=in normal cells, located mainly in the cytoplasm with small amounts in the nucleus but translocates to the nucleus in cells undergoing apoptosis (by similarity). nuclear translocation is induced by dna damaging agents such as hydrogen peroxide (pubmed:17560175). accumulates in the mitochondrion in response to increased ros levels (pubmed:23911537). localizes to the spindle during mitosis (pubmed:23131551). localized in cytoplasmic mrnp granules containing untranslated mrnas (pubmed:17289661). {eco:0000250|uniprotkb:p62908, eco:0000269|pubmed:17289661, eco:0000269|pubmed:17560175, eco:0000269|pubmed:23131551, eco:0000269|pubmed:23911537}.",NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,RPS3,6188,Hs.546286,ENST00000529173,THC2565949,GO:0003684(damaged DNA binding)|GO:0003729(mRNA binding)|GO:0003735(structural constituent of ribosome)|GO:0003906(DNA-(apurinic or apyrimidinic site) lyase activity)|GO:0004519(endonuclease activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006917(induction of apoptosis)|GO:0006919(activation of caspase activity)|GO:0006974(response to DNA damage stimulus)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019901(protein kinase binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0032088(negative regulation of NF-kappaB transcription factor activity)|GO:0032587(ruffle membrane)|GO:0044267(cellular protein metabolic process)|GO:0045738(negative regulation of DNA repair)|GO:0051059(NF-kappaB binding)|GO:0051536(iron-sulfur cluster binding),"Homo sapiens ribosomal protein S3 (RPS3), mRNA [NM_001005]",chr11:75115105-75115164,hs|11q13.4,ribosomal protein S3,TRUE
655_CCT2_10576,P78371,t-complex protein 1 subunit beta (tcp-1-beta) (cct-beta),CCT2 99D8.1 CCTB,535,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). as part of the tric complex may play a role in the assembly of bbsome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (pubmed:20080638). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:20080638, eco:0000269|pubmed:25467444, eco:0000305}.",subcellular location: cytoplasm {eco:0000269|pubmed:20080638}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CCT2,10576,Hs.189772,ENST00000550010,NP1204387,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005832(chaperonin-containing T-complex)|GO:0006457(protein folding)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens chaperonin containing TCP1, subunit 2 (beta) (CCT2), transcript variant 1, mRNA [NM_006431]",chr12:69995181-69995240,hs|12q15,"chaperonin containing TCP1, subunit 2 (beta)",TRUE
656_ANK3_288,Q12955,ankyrin-3 (ank-3) (ankyrin-g),ANK3,4377,"function: in skeletal muscle, required for costamere localization of dmd and betadag1 (by similarity). membrane-cytoskeleton linker. may participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of ranvier and axonal initial segments. regulates kcna1 channel activity in function of dietary mg(2+) levels, and thereby contributes to the regulation of renal mg(2+) reabsorption (pubmed:23903368). {eco:0000250, eco:0000269|pubmed:17974005}.; function: isoform 5: may be part of a golgi-specific membrane cytoskeleton in association with beta-spectrin. {eco:0000305|pubmed:17974005}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:21223964}. cell projection, axon {eco:0000250|uniprotkb:o70511}. cell membrane, sarcolemma {eco:0000269|pubmed:21223964}. cell junction, synapse, postsynaptic cell membrane {eco:0000250|uniprotkb:o70511}. lysosome {eco:0000250|uniprotkb:g5e8k5}. cell membrane, sarcolemma, t-tubule {eco:0000250|uniprotkb:o70511}. note=in skeletal muscle, localized at costameres and neuromuscular junctions. in macrophages, associated with lysosomes. {eco:0000250|uniprotkb:g5e8k5, eco:0000250|uniprotkb:o70511}.; subcellular location: isoform 5: cytoplasm, cytoskeleton {eco:0000269|pubmed:8666667}. golgi apparatus {eco:0000269|pubmed:8666667}.","TISSUE SPECIFICITY: Expressed in brain, neurons, muscles and other tissues. {ECO:0000269|PubMed:21223964, ECO:0000269|PubMed:7836469}.","DISEASE: Note=Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility. {ECO:0000269|PubMed:22865819}.; DISEASE: Mental retardation, autosomal recessive 37 (MRT37) [MIM:615493]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT37 patients manifest delayed global development with speech delay, hypotonia, spasticity, and a sleep disorder. Severe behavioral abnormalities include aggression, hyperactivity, and grinding of the teeth. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation, has been shown to be the cause of moderate intellectual disability, an ADHD-like phenotype and behavioral problems in a consanguineous family (PubMed:23390136). {ECO:0000269|PubMed:23390136}.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ANK3,288,Hs.499725,ENST00000423532,THC2483895,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0007165(signal transduction)|GO:0016323(basolateral plasma membrane)|GO:0045184(establishment of protein localization),"Homo sapiens ankyrin 3, node of Ranvier (ankyrin G) (ANK3), transcript variant 1, mRNA [NM_020987]",chr10:61786072-61786041,hs|10q21.2,"ankyrin 3, node of Ranvier (ankyrin G)",TRUE
657_LRPAP1_4043,P30533,alpha-2-macroglobulin receptor-associated protein (alpha-2-mrap) (low density lipoprotein receptor-related protein-associated protein 1) (rap),LRPAP1 A2MRAP,357,function: molecular chaperone for ldl receptor-related proteins that may regulate their ligand binding activity along the secretory pathway. {eco:0000269|pubmed:7774585}.,"subcellular location: rough endoplasmic reticulum lumen {eco:0000269|pubmed:7774585}. endoplasmic reticulum-golgi intermediate compartment lumen {eco:0000269|pubmed:7774585}. golgi apparatus, cis-golgi network {eco:0000269|pubmed:7774585}. golgi apparatus lumen {eco:0000269|pubmed:7774585}. endosome lumen {eco:0000269|pubmed:7774585}. cell surface {eco:0000269|pubmed:11384978}. note=may be associated with receptors at the cell surface. {eco:0000269|pubmed:11384978}.",NA,"DISEASE: Myopia 23, autosomal recessive (MYP23) [MIM:615431]: A refractive error of the eye, in which parallel rays from a distant object come to focus in front of the retina, vision being better for near objects than for far. {ECO:0000269|PubMed:23830514}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LRPAP1,4043,Hs.533136,ENST00000500728,THC2470316,GO:0004873(asialoglycoprotein receptor activity)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005886(plasma membrane)|GO:0006457(protein folding)|GO:0008201(heparin binding)|GO:0009968(negative regulation of signal transduction)|GO:0009986(cell surface)|GO:0010916(negative regulation of very-low-density lipoprotein particle clearance)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport)|GO:0031982(vesicle)|GO:0032091(negative regulation of protein binding)|GO:0035473(lipase binding)|GO:0048019(receptor antagonist activity)|GO:0048237(rough endoplasmic reticulum lumen)|GO:0050750(low-density lipoprotein particle receptor binding)|GO:0051082(unfolded protein binding)|GO:0070326(very-low-density lipoprotein particle receptor binding),"Homo sapiens low density lipoprotein receptor-related protein associated protein 1 (LRPAP1), mRNA [NM_002337]",chr4:3514407-3514348,hs|4p16.3,low density lipoprotein receptor-related protein associated protein 1,TRUE
658_CASC4_113201,Q6P4E1,protein casc4 (cancer susceptibility candidate gene 4 protein),CASC4 UNQ2573/PRO6308,436,NA,subcellular location: membrane {eco:0000305}; single-pass type ii membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,CASC4,113201,Hs.512867,ENST00000345795,THC2469136,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens cancer susceptibility candidate 4 (CASC4), transcript variant 1, mRNA [NM_138423]",chr15:44707627-44707686,hs|15q15.3,cancer susceptibility candidate 4,TRUE
659_DYNLT1_6993,P63172,dynein light chain tctex-type 1 (protein cw-1) (t-complex testis-specific protein 1 homolog),DYNLT1 TCTEL1 TCTEX-1 TCTEX1,113,"function: acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. binds to transport cargos and is involved in apical cargo transport such as rhodopsin-bearing vesicles in polarized epithelia. may also be a accessory component of axonemal dynein.; function: plays a role in neuronal morphogenesis; the function is independent of cytoplasmic dynein and seems to be coupled to regulation of the actin cytoskeleton by enhancing rac1 activity. the function in neurogenesis may be regulated by association with a g-protein beta-gamma dimer. may function as a receptor-independent activator of heterotrimeric g-protein signaling; the activation appears to be independent of a nucleotide exchange. plays a role in regulating neurogenesis; inhibits the genesis of neurons from precursor cells during cortical development presumably by antagonizing arhgef2. involved in the regulation of mitotic spindle orientation (by similarity). unrelated to the role in retrograde microtubule-associated movement may play a role in the dimerization of cytoplasmic proteins/domains such as for acvr2b. binds to the cytoplasmic domain of acvr2b and, in vitro, inhibits acvr2b signaling (pubmed:27502274). {eco:0000250, eco:0000269|pubmed:27502274}.; function: (microbial infection) is involved in intracellular targeting of d-type retrovirus gag polyproteins to the cytoplasmic assembly site. {eco:0000269|pubmed:18647839}.","subcellular location: golgi apparatus {eco:0000250}. cytoplasm {eco:0000250}. cytoplasm, cytoskeleton, spindle {eco:0000250}. note=localizes to mitotic spindles. {eco:0000250}.","TISSUE SPECIFICITY: Expressed in heart, placenta, skeletal muscle kidney, pancreas, spleen, prostate, testis, ovary, ileum and colon. Expressed in lung endothelial and smooth muscle cells (at protein level). {ECO:0000269|PubMed:14583445}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,DYNLT1,6993,Hs.445999,ENST00000367088,THC2505771,GO:0000132(establishment of mitotic spindle orientation)|GO:0003774(motor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005819(spindle)|GO:0005856(cytoskeleton)|GO:0005868(cytoplasmic dynein complex)|GO:0005874(microtubule)|GO:0006810(transport)|GO:0007049(cell cycle)|GO:0007067(mitosis)|GO:0007399(nervous system development)|GO:0008277(regulation of G-protein coupled receptor protein signaling pathway)|GO:0019060(intracellular transport of viral proteins in host cell)|GO:0032314(regulation of Rac GTPase activity)|GO:0042802(identical protein binding)|GO:0044419(interspecies interaction between organisms)|GO:0048812(neuron projection morphogenesis)|GO:0050768(negative regulation of neurogenesis)|GO:0051301(cell division)|GO:0051493(regulation of cytoskeleton organization),"Homo sapiens dynein, light chain, Tctex-type 1 (DYNLT1), mRNA [NM_006519]",chr6:159057743-159057684,hs|6q25.3,"dynein, light chain, Tctex-type 1",TRUE
66_FOXA1_3169,P55317,hepatocyte nuclear factor 3-alpha (hnf-3-alpha) (hnf-3a) (forkhead box protein a1) (transcription factor 3a) (tcf-3a),FOXA1 HNF3A TCF3A,472,"function: transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. binds dna with the consensus sequence 5'-[ac]a[at]t[ag]tt[gt][ag][ct]t[ct]-3' (by similarity). proposed to play a role in translating the epigenetic signatures into cell type-specific enhancer-driven transcriptional programs. its differential recruitment to chromatin is dependent on distribution of histone h3 methylated at 'lys-5' (h3k4me2) in estrogen-regulated genes. involved in the development of multiple endoderm-derived organ systems such as liver, pancreas, lung and prostate; foxa1 and foxa2 seem to have at least in part redundant roles (by similarity). modulates the transcriptional activity of nuclear hormone receptors. is involved in esr1-mediated transcription; required for esr1 binding to the nkx2-1 promoter in breast cancer cells; binds to the rprm promoter and is required for the estrogen-induced repression of rprm. involved in regulation of apoptosis by inhibiting the expression of bcl2. involved in cell cycle regulation by activating expression of cdkn1b, alone or in conjunction with brca1. originally described as a transcription activator for a number of liver genes such as afp, albumin, tyrosine aminotransferase, pepck, etc. interacts with the cis-acting regulatory regions of these genes. involved in glucose homeostasis. {eco:0000250, eco:0000269|pubmed:16087863, eco:0000269|pubmed:16331276, eco:0000269|pubmed:18358809, eco:0000269|pubmed:19127412, eco:0000269|pubmed:19917725}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00089, eco:0000269|pubmed:15987773, eco:0000269|pubmed:16331276}.","TISSUE SPECIFICITY: Highly expressed in prostate and ESR1-positive breast tumors. Overexpressed in esophageal and lung adenocarcinomas. {ECO:0000269|PubMed:12234996, ECO:0000269|PubMed:15987773, ECO:0000269|PubMed:16331276}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FOXA1,3169,Hs.163484,ENST00000250448,THC2463841,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0006338(chromatin remodeling)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007389(pattern specification process)|GO:0008134(transcription factor binding)|GO:0008301(DNA bending activity)|GO:0008634(negative regulation of survival gene product expression)|GO:0009790(embryo development)|GO:0010719(negative regulation of epithelial to mesenchymal transition)|GO:0010817(regulation of hormone levels)|GO:0019904(protein domain specific binding)|GO:0030324(lung development)|GO:0032355(response to estradiol stimulus)|GO:0033148(positive regulation of estrogen receptor signaling pathway)|GO:0035239(tube morphogenesis)|GO:0042445(hormone metabolic process)|GO:0042593(glucose homeostasis)|GO:0043565(sequence-specific DNA binding)|GO:0044212(transcription regulatory region DNA binding)|GO:0045666(positive regulation of neuron differentiation)|GO:0045931(positive regulation of mitotic cell cycle)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048665(neuron fate specification)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0060441(epithelial tube branching involved in lung morphogenesis)|GO:0060487(lung epithelial cell differentiation)|GO:0060528(secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development)|GO:0060738(epithelial-mesenchymal signaling involved in prostate gland development)|GO:0060740(prostate gland epithelium morphogenesis)|GO:0060741(prostate gland stromal morphogenesis)|GO:0060743(epithelial cell maturation involved in prostate gland development)|GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin)","Homo sapiens forkhead box A1 (FOXA1), mRNA [NM_004496]",chr14:38059513-38059454,hs|14q21.1,forkhead box A1,TRUE
660_GRB10_2887,Q13322,growth factor receptor-bound protein 10 (grb10 adapter protein) (insulin receptor-binding protein grb-ir),GRB10 GRBIR KIAA0207,594,"function: adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways. binds to, and suppress signals from, activated receptors tyrosine kinases, including the insulin (insr) and insulin-like growth factor (igf1r) receptors. the inhibitory effect can be achieved by 2 mechanisms: interference with the signaling pathway and increased receptor degradation. delays and reduces akt1 phosphorylation in response to insulin stimulation. blocks association between insr and irs1 and irs2 and prevents insulin-stimulated irs1 and irs2 tyrosine phosphorylation. recruits nedd4 to igf1r, leading to igf1r ubiquitination, increased internalization and degradation by both the proteasomal and lysosomal pathways. may play a role in mediating insulin-stimulated ubiquitination of insr, leading to proteasomal degradation. negatively regulates wnt signaling by interacting with lrp6 intracellular portion and interfering with the binding of axin1 to lrp6. positive regulator of the kdr/vegfr-2 signaling pathway. may inhibit nedd4-mediated degradation of kdr/vegfr-2. {eco:0000269|pubmed:12493740, eco:0000269|pubmed:15060076, eco:0000269|pubmed:16434550, eco:0000269|pubmed:17376403}.","subcellular location: cytoplasm {eco:0000250}. note=when complexed with nedd4 and igf1r, follows igf1r internalization, remaining associated with early endosomes. uncouples from igf1r-containing endosomes before the sorting of the receptor to the lysosomal compartment (by similarity). {eco:0000250}.","TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues, including fetal and postnatal liver, lung, kidney, skeletal muscle, heart, spleen, skin and brain. {ECO:0000269|PubMed:11527390}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GRB10,2887,Hs.164060,ENST00000403097,THC2659469,GO:0005070(SH3/SH2 adaptor activity)|GO:0005158(insulin receptor binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0007165(signal transduction)|GO:0008286(insulin receptor signaling pathway)|GO:0030178(negative regulation of Wnt receptor signaling pathway)|GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway)|GO:0032868(response to insulin stimulus)|GO:0042326(negative regulation of phosphorylation)|GO:0042327(positive regulation of phosphorylation)|GO:0045719(negative regulation of glycogen biosynthetic process)|GO:0046325(negative regulation of glucose import)|GO:0046627(negative regulation of insulin receptor signaling pathway)|GO:0048009(insulin-like growth factor receptor signaling pathway),"Homo sapiens growth factor receptor-bound protein 10 (GRB10), transcript variant 4, mRNA [NM_001001555]",chr7:50657872-50657813,hs|7p12.1,growth factor receptor-bound protein 10,TRUE
661_EDF1_8721,O60869,endothelial differentiation-related factor 1 (edf-1) (multiprotein-bridging factor 1) (mbf1),EDF1,148,"function: transcriptional coactivator stimulating nr5a1 and ligand-dependent nr1h3/lxra and pparg transcriptional activities. enhances the dna-binding activity of atf1, atf2, creb1 and nr5a1. regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. may function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism. {eco:0000269|pubmed:10567391, eco:0000269|pubmed:12040021, eco:0000269|pubmed:15112053, eco:0000269|pubmed:9813014}.",subcellular location: cytoplasm. nucleus. note=also nuclear upon binding to nr5a1 and treatment of cells with tpa or forskolin.,"TISSUE SPECIFICITY: Expressed in brain, liver, lung, kidney and heart (at protein level). Ubiquitously expressed. More abundant in heart, pancreas, liver, intestine and adipose tissues. {ECO:0000269|PubMed:10567391, ECO:0000269|PubMed:12040021, ECO:0000269|PubMed:9813014}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EDF1,8721,Hs.174050,ENST00000224073,THC2482586,"GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0004402(histone acetyltransferase activity)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005669(transcription factor TFIID complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007275(multicellular organismal development)|GO:0008168(methyltransferase activity)|GO:0019216(regulation of lipid metabolic process)|GO:0030154(cell differentiation)|GO:0043388(positive regulation of DNA binding)|GO:0043565(sequence-specific DNA binding)|GO:0045446(endothelial cell differentiation)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens endothelial differentiation-related factor 1 (EDF1), transcript variant beta, mRNA [NM_153200]",chr9:139757418-139757359,hs|9q34.3,endothelial differentiation-related factor 1,TRUE
662_AUTS2_26053,Q8WXX7,autism susceptibility gene 2 protein,AUTS2 KIAA0442,1259,"function: component of a polycomb group (pcg) multiprotein prc1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including hox genes, throughout development. pcg prc1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone h2a 'lys-119', rendering chromatin heritably changed in its expressibility (pubmed:25519132). the prc1-like complex that contains pcgf5, rnf2, csnk2b, rybp and auts2 has decreased histone h2a ubiquitination activity, due to the phosphorylation of rnf2 by csnk2b (pubmed:25519132). as a consequence, the complex mediates transcriptional activation (pubmed:25519132). in the cytoplasm, plays a role in axon and dendrite elongation and in neuronal migration during embryonic brain development. promotes reorganization of the actin cytoskeleton, lamellipodia formation and neurite elongation via its interaction with rac guanine nucleotide exchange factors, which then leads to the activation of rac1 (by similarity). {eco:0000250|uniprotkb:a0a087wpf7, eco:0000269|pubmed:25519132}.","subcellular location: nucleus {eco:0000269|pubmed:25519132}. cytoplasm, cytoskeleton {eco:0000250|uniprotkb:a0a087wpf7}. cell projection, growth cone {eco:0000250|uniprotkb:a0a087wpf7}. note=detected both in cytoplasm and nucleus. colocalizes with rac1 at actin-rich growth cones. detected on the promoter region of actively transcribed genes. {eco:0000250|uniprotkb:a0a087wpf7}.","TISSUE SPECIFICITY: Strongly expressed in brain, skeletal muscle and kidney. Also expressed in placenta, lung and leukocytes. {ECO:0000269|PubMed:12160723, ECO:0000269|PubMed:23332918}.","DISEASE: Mental retardation, autosomal dominant 26 (MRD26) [MIM:615834]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD26 features include autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms. {ECO:0000269|PubMed:23332918}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,AUTS2,26053,Hs.21631,ENST00000406775,NP651821,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens autism susceptibility candidate 2 (AUTS2), transcript variant 1, mRNA [NM_015570]",chr7:70257414-70257473,hs|7q11.22,autism susceptibility candidate 2,TRUE
663_ZFAND6_54469,Q6FIF0,an1-type zinc finger protein 6 (associated with prk1 protein) (zinc finger a20 domain-containing protein 3),ZFAND6 AWP1 ZA20D3 HT032,208,"function: involved in regulation of tnf-alpha induced nf-kappa-b activation and apoptosis. involved in modulation of 'lys-48'-linked polyubiquitination status of traf2 and decreases association of traf2 with ripk1. required for pts1 target sequence-dependent protein import into peroxisomes and pex5 stability; may cooperate with pex6. in vitro involved in pex5 export from the cytosol to peroxisomes (by similarity). {eco:0000250, eco:0000269|pubmed:19285159, eco:0000269|pubmed:21810480}.",subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Widely expressed with high level in heart, skeletal muscle, liver, kidney and placenta. {ECO:0000269|PubMed:11054541}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZFAND6,54469,Hs.730626,ENST00000261749,THC2569061,GO:0003674(molecular_function)|GO:0003677(DNA binding)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens zinc finger, AN1-type domain 6 (ZFAND6), transcript variant 1, mRNA [NM_019006]",chr15:80430454-80430513,hs|15q25.1,"zinc finger, AN1-type domain 6",TRUE
664_AKT2_208,P31751,rac-beta serine/threonine-protein kinase (ec 2.7.11.1) (protein kinase akt-2) (protein kinase b beta) (pkb beta) (rac-pk-beta),AKT2,481,"function: akt2 is one of 3 closely related serine/threonine-protein kinases (akt1, akt2 and akt3) called the akt kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. this is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. akt is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the slc2a4/glut4 glucose transporter to the cell surface. phosphorylation of ptpn1 at 'ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. phosphorylation of tbc1d4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. akt regulates also the storage of glucose in the form of glycogen by phosphorylating gsk3a at 'ser-21' and gsk3b at 'ser-9', resulting in inhibition of its kinase activity. phosphorylation of gsk3 isoforms by akt is also thought to be one mechanism by which cell proliferation is driven. akt regulates also cell survival via the phosphorylation of map3k5 (apoptosis signal-related kinase). phosphorylation of 'ser-83' decreases map3k5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. akt mediates insulin-stimulated protein synthesis by phosphorylating tsc2 at 'ser-939' and 'thr-1462', thereby activating mtorc1 signaling and leading to both phosphorylation of 4e-bp1 and in activation of rps6kb1. akt is involved in the phosphorylation of members of the foxo factors (forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. in particular, foxo1 is phosphorylated at 'thr-24', 'ser-256' and 'ser-319'. foxo3 and foxo4 are phosphorylated on equivalent sites. akt has an important role in the regulation of nf-kappa-b-dependent gene transcription and positively regulates the activity of creb1 (cyclic amp (camp)-response element binding protein). the phosphorylation of creb1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as bcl2 and mcl1. akt phosphorylates 'ser-454' on atp citrate lyase (acly), thereby potentially regulating acly activity and fatty acid synthesis. activates the 3b isoform of cyclic nucleotide phosphodiesterase (pde3b) via phosphorylation of 'ser-273', resulting in reduced cyclic amp levels and inhibition of lipolysis. phosphorylates pikfyve on 'ser-318', which results in increased pi(3)p-5 activity. the rho gtpase-activating protein dlc1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. akt plays a role as key modulator of the akt-mtor signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. signals downstream of phosphatidylinositol 3-kinase (pi(3)k) to mediate the effects of various growth factors such as platelet-derived growth factor (pdgf), epidermal growth factor (egf), insulin and insulin-like growth factor i (igf-i). akt mediates the antiapoptotic effects of igf-i. essential for the spata13-mediated regulation of cell migration and adhesion assembly and disassembly. may be involved in the regulation of the placental development.; function: one of the few specific substrates of akt2 identified recently is pitx2. phosphorylation of pitx2 impairs its association with the ccnd1 mrna-stabilizing complex thus shortening the half-life of ccnd1. akt2 seems also to be the principal isoform responsible of the regulation of glucose uptake. phosphorylates c2cd5 on 'ser-197' during insulin-stimulated adipocytes. akt2 is also specifically involved in skeletal muscle differentiation, one of its substrates in this process being ankrd2. down-regulation by rna interference reduces the expression of the phosphorylated form of bad, resulting in the induction of caspase-dependent apoptosis. phosphorylates clk2 on 'thr-343'.","subcellular location: cytoplasm. nucleus. cell membrane; peripheral membrane protein. early endosome {eco:0000250|uniprotkb:q60823}. note=localizes within both nucleus and cytoplasm of proliferative primary myoblasts and mostly within the nucleus of differentiated primary myoblasts. by virtue of the n-terminal ph domain, is recruited to sites of the plasma membrane containing increased pi(3,4,5)p3 or pi(3,4)p2, cell membrane targeting is also facilitared by interaction with clip3. colocalizes with wdfy2 in early endosomes (by similarity). {eco:0000250|uniprotkb:q60823}.",TISSUE SPECIFICITY: Expressed in all cell types so far analyzed.,"DISEASE: Note=Defects in AKT2 are a cause of susceptibility to breast cancer (BC). AKT2 promotes metastasis of tumor cells without affecting the latency of tumor development. With AKT3, plays also a pivotal role in the biology of glioblastoma.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:15166380, ECO:0000269|PubMed:19164855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) [MIM:240900]: A disorder characterized by hypoglycemia, low insulin levels, low serum levels of ketone bodies and branched-chain amino acids, left-sided hemihypertrophy, neonatal macrosomia, reduced consciousness and hypoglycemic seizures. {ECO:0000269|PubMed:21979934}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,AKT2,208,Hs.631535,ENST00000358335,THC2497599,GO:0000166(nucleotide binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005080(protein kinase C binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005975(carbohydrate metabolic process)|GO:0006417(regulation of translation)|GO:0006464(protein modification process)|GO:0006810(transport)|GO:0006970(response to osmotic stress)|GO:0007165(signal transduction)|GO:0007275(multicellular organismal development)|GO:0008286(insulin receptor signaling pathway)|GO:0008643(carbohydrate transport)|GO:0009967(positive regulation of signal transduction)|GO:0010628(positive regulation of gene expression)|GO:0010748(negative regulation of plasma membrane long-chain fatty acid transport)|GO:0010765(positive regulation of sodium ion transport)|GO:0010907(positive regulation of glucose metabolic process)|GO:0014850(response to muscle activity)|GO:0016301(kinase activity)|GO:0016310(phosphorylation)|GO:0030027(lamellipodium)|GO:0030334(regulation of cell migration)|GO:0030335(positive regulation of cell migration)|GO:0031982(vesicle)|GO:0032000(positive regulation of fatty acid beta-oxidation)|GO:0032593(insulin-responsive compartment)|GO:0032869(cellular response to insulin stimulus)|GO:0032870(cellular response to hormone stimulus)|GO:0033119(negative regulation of RNA splicing)|GO:0033138(positive regulation of peptidyl-serine phosphorylation)|GO:0043066(negative regulation of apoptosis)|GO:0043154(negative regulation of caspase activity)|GO:0043491(protein kinase B signaling cascade)|GO:0045429(positive regulation of nitric oxide biosynthetic process)|GO:0045444(fat cell differentiation)|GO:0045725(positive regulation of glycogen biosynthetic process)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046326(positive regulation of glucose import)|GO:0046328(regulation of JNK cascade)|GO:0050927(positive regulation of positive chemotaxis)|GO:0060644(mammary gland epithelial cell differentiation)|GO:0070887(cellular response to chemical stimulus)|GO:0071156(regulation of cell cycle arrest)|GO:2000147(positive regulation of cell motility),"Homo sapiens v-akt murine thymoma viral oncogene homolog 2 (AKT2), transcript variant 1, mRNA [NM_001626]",chr19:40738356-40738297,hs|19q13.2,v-akt murine thymoma viral oncogene homolog 2,TRUE
665_SLC2A4RG_56731,Q9NR83,slc2a4 regulator (glut4 enhancer factor) (gef) (huntington disease gene regulatory region-binding protein 1) (hdbp-1),SLC2A4RG HDBP1,387,"function: transcription factor involved in slc2a4 and hd gene transactivation. binds to the consensus sequence 5'-gccggcg-3'. {eco:0000269|pubmed:14625278, eco:0000269|pubmed:14630949}.",subcellular location: cytoplasm. nucleus. note=shuttles between the cytoplasm and the nucleus.,"TISSUE SPECIFICITY: According to PubMed:14630949, expressed in heart, skeletal muscle, liver, kidney and pancreas; undetectable in lung, placenta or brain. According to PubMed:14625278, ubiquitously expressed, with lowest expression in brain and ileum. {ECO:0000269|PubMed:14625278, ECO:0000269|PubMed:14630949}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,SLC2A4RG,56731,Hs.435126,ENST00000266077,THC2494668,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens SLC2A4 regulator (SLC2A4RG), mRNA [NM_020062]",chr20:62374774-62374833,hs|20q13.33,SLC2A4 regulator,TRUE
666_RRAGA_10670,Q7L523,ras-related gtp-binding protein a (rag a) (raga) (adenovirus e3 14.7 kda-interacting protein 1) (fip-1),RRAGA,313,"function: guanine nucleotide-binding protein that plays a crucial role in the cellular response to amino acid availability through regulation of the mtorc1 signaling cascade. forms heterodimeric rag complexes with rragc or rragd and cycles between an inactive gdp-bound and an active gtp-bound form. in its active form participates in the relocalization of mtorc1 to the lysosomes and its subsequent activation by the gtpase rheb. involved in the rcc1/ran-gtpase pathway. may play a direct role in a tnf-alpha signaling pathway leading to induction of cell death. may alternatively act as a cellular target for adenovirus e3-14.7k, an inhibitor of tnf-alpha functions, thereby affecting cell death. {eco:0000269|pubmed:20381137, eco:0000269|pubmed:25936802, eco:0000269|pubmed:8995684, eco:0000269|pubmed:9394008}.","subcellular location: cytoplasm {eco:0000269|pubmed:8995684, eco:0000269|pubmed:9394008}. nucleus {eco:0000269|pubmed:8995684, eco:0000269|pubmed:9394008}. lysosome {eco:0000269|pubmed:20381137}. note=predominantly cytoplasmic. may shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state (pubmed:8995684, pubmed:9394008). colocalizes in vivo with adenovirus e3-14.7k mainly to the cytoplasm especially near the nuclear membrane and in discrete foci on or near the plasma membrane (pubmed:8995684). {eco:0000269|pubmed:20381137, eco:0000269|pubmed:8995684, eco:0000269|pubmed:9394008}.","TISSUE SPECIFICITY: Ubiquitously expressed with highest levels of expression in skeletal muscle, heart, and brain. {ECO:0000269|PubMed:8995684}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RRAGA,10670,Hs.702275,ENST00000380527,THC2469593,GO:0000166(nucleotide binding)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0005794(Golgi apparatus)|GO:0006915(apoptosis)|GO:0008219(cell death)|GO:0019048(virus-host interaction)|GO:0032008(positive regulation of TOR signaling cascade)|GO:0034613(cellular protein localization)|GO:0042803(protein homodimerization activity)|GO:0043231(intracellular membrane-bounded organelle)|GO:0044419(interspecies interaction between organisms)|GO:0045919(positive regulation of cytolysis)|GO:0046982(protein heterodimerization activity)|GO:0051219(phosphoprotein binding)|GO:0071230(cellular response to amino acid stimulus),"Homo sapiens Ras-related GTP binding A (RRAGA), mRNA [NM_006570]",chr9:19050839-19050898,hs|9p22.1,Ras-related GTP binding A,TRUE
667_RNF130_55819,Q86XS8,e3 ubiquitin-protein ligase rnf130 (ec 2.3.2.27) (goliath homolog) (h-goliath) (ring finger protein 130) (ring-type e3 ubiquitin transferase rnf130),RNF130,419,"function: may have a role during the programmed cell death of hematopoietic cells (by similarity). acts as an e3 ubiquitin-protein ligase. {eco:0000250, eco:0000269|pubmed:16549277}.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}. cytoplasm {eco:0000269|pubmed:16549277}.,TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in leukocytes. Not expressed in erythroblasts. {ECO:0000269|PubMed:16549277}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF130,55819,Hs.484363,ENST00000522885,THC2788420,GO:0004842(ubiquitin-protein ligase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006915(apoptosis)|GO:0008270(zinc ion binding)|GO:0012501(programmed cell death)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0046872(metal ion binding),"Homo sapiens ring finger protein 130 (RNF130), mRNA [NM_018434]",chr5:179382621-179382562,hs|5q35.3,ring finger protein 130,TRUE
668_EIF4A1_1973,P60842,eukaryotic initiation factor 4a-i (eif-4a-i) (eif4a-i) (ec 3.6.4.13) (atp-dependent rna helicase eif4a-1),EIF4A1 DDX2A EIF4A,406,"function: atp-dependent rna helicase which is a subunit of the eif4f complex involved in cap recognition and is required for mrna binding to ribosome. in the current model of translation initiation, eif4a unwinds rna secondary structures in the 5'-utr of mrnas which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. {eco:0000269|pubmed:19153607, eco:0000269|pubmed:19204291}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF4A1,1973,Hs.129673,ENST00000293831,THC2529399,"GO:0000166(nucleotide binding)|GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening)|GO:0000339(RNA cap binding)|GO:0003729(mRNA binding)|GO:0003743(translation initiation factor activity)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0008026(ATP-dependent helicase activity)|GO:0008135(translation factor activity, nucleic acid binding)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016281(eukaryotic translation initiation factor 4F complex)|GO:0016787(hydrolase activity)|GO:0031100(organ regeneration)|GO:0044267(cellular protein metabolic process)","Homo sapiens eukaryotic translation initiation factor 4A1 (EIF4A1), transcript variant 1, mRNA [NM_001416]",chr17:7481719-7481778,hs|17p13.1,eukaryotic translation initiation factor 4A1,TRUE
669_IFT57_55081,Q9NWB7,intraflagellar transport protein 57 homolog (dermal papilla-derived protein 8) (estrogen-related receptor beta-like protein 1) (hip1-interacting protein) (mhs4r2),IFT57 DERP8 ESRRBL1 HIPPI,429,"function: required for the formation of cilia. plays an indirect role in sonic hedgehog signaling, cilia being required for all activity of the hedgehog pathway (by similarity). has pro-apoptotic function via its interaction with hip1, leading to recruit caspase-8 (casp8) and trigger apoptosis. has the ability to bind dna sequence motif 5'-aaagacatg-3' present in the promoter of caspase genes such as casp1, casp8 and casp10, suggesting that it may act as a transcription regulator; however the relevance of such function remains unclear. {eco:0000250, eco:0000269|pubmed:11788820, eco:0000269|pubmed:17107665, eco:0000269|pubmed:17623017}.","subcellular location: cytoplasm, cytoskeleton, cilium basal body {eco:0000250}. note=concentrates within the inner segment of cilia. {eco:0000250}.","TISSUE SPECIFICITY: Present in many tissues such as brain, thymus, lymph node, lung, liver, skin and kidney (at protein level). {ECO:0000269|PubMed:11788820}.","DISEASE: Orofaciodigital syndrome 18 (OFD18) [MIM:617927]: A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD18 is an autosomal recessive form characterized by short stature, brachymesophalangy, pre- and postaxial polysyndactyly, and stocky femoral necks, as well as oral anomalies and dysmorphic facial features. {ECO:0000269|PubMed:27060890}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,IFT57,55081,Hs.412196,ENST00000264538,THC2750863,"GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005856(cytoskeleton)|GO:0005929(cilium)|GO:0005932(microtubule basal body)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006915(apoptosis)|GO:0006919(activation of caspase activity)|GO:0042981(regulation of apoptosis)","Homo sapiens intraflagellar transport 57 homolog (Chlamydomonas) (IFT57), mRNA [NM_018010]",chr3:107881424-107881365,hs|3q13.12,intraflagellar transport 57 homolog (Chlamydomonas),TRUE
67_VHL_7428,P40337,von hippel-lindau disease tumor suppressor (protein g7) (pvhl),VHL,213,"function: involved in the ubiquitination and subsequent proteasomal degradation via the von hippel-lindau ubiquitination complex. seems to act as a target recruitment subunit in the e3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (hif) under normoxic conditions. involved in transcriptional repression through interaction with hif1a, hif1an and histone deacetylases. ubiquitinates, in an oxygen-responsive manner, adrb2. {eco:0000269|pubmed:10944113, eco:0000269|pubmed:17981124, eco:0000269|pubmed:19584355}.",subcellular location: isoform 1: cytoplasm. membrane; peripheral membrane protein. nucleus. note=found predominantly in the cytoplasm and with less amounts nuclear or membrane-associated. colocalizes with adrb2 at the cell membrane.; subcellular location: isoform 3: cytoplasm. nucleus. note=equally distributed between the nucleus and the cytoplasm but not membrane-associated.,TISSUE SPECIFICITY: Expressed in the adult and fetal brain and kidney.,"DISEASE: Pheochromocytoma (PCC) [MIM:171300]: A catecholamine-producing tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. {ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:14500403, ECO:0000269|PubMed:9663592}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: von Hippel-Lindau disease (VHLD) [MIM:193300]: VHLD is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign neoplasms, most frequently retinal, cerebellar and spinal hemangioblastoma, renal cell carcinoma (RCC), pheochromocytoma, and pancreatic tumors. VHL type 1 is without pheochromocytoma, type 2 is with pheochromocytoma. VHL type 2 is further subdivided into types 2A (pheochromocytoma, retinal angioma, and hemangioblastomas without renal cell carcinoma and pancreatic cyst) and 2B (pheochromocytoma, retinal angioma, and hemangioblastomas with renal cell carcinoma and pancreatic cyst). {ECO:0000269|PubMed:10408776, ECO:0000269|PubMed:10533030, ECO:0000269|PubMed:10627136, ECO:0000269|PubMed:10635329, ECO:0000269|PubMed:16502427, ECO:0000269|PubMed:7728151, ECO:0000269|PubMed:7987306, ECO:0000269|PubMed:8493574, ECO:0000269|PubMed:8592333, ECO:0000269|PubMed:8634692, ECO:0000269|PubMed:8730290, ECO:0000269|PubMed:8825918, ECO:0000269|PubMed:8956040, ECO:0000269|PubMed:9452032, ECO:0000269|PubMed:9452106, ECO:0000269|PubMed:9829911, ECO:0000269|PubMed:9829912, ECO:0000269|Ref.41}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]: An autosomal recessive disorder characterized by an increase in serum red blood cell mass, hypersensitivity of erythroid progenitors to erythropoietin, increased erythropoietin serum levels, and normal oxygen affinity. Patients with ECYT2 carry a high risk for peripheral thrombosis and cerebrovascular events. {ECO:0000269|PubMed:12393546, ECO:0000269|PubMed:12844285}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal cell carcinoma (RCC) [MIM:144700]: Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into clear cell renal carcinoma (non-papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma. Clear cell renal cell carcinoma is the most common subtype. {ECO:0000269|PubMed:11986208}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VHL,7428,Hs.517792,NA,THC2528499,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000902(cell morphogenesis)|GO:0001525(angiogenesis)|GO:0001666(response to hypoxia)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005783(endoplasmic reticulum)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006508(proteolysis)|GO:0006916(anti-apoptosis)|GO:0006950(response to stress)|GO:0008134(transcription factor binding)|GO:0008285(negative regulation of cell proliferation)|GO:0016020(membrane)|GO:0016567(protein ubiquitination)|GO:0030163(protein catabolic process)|GO:0030182(neuron differentiation)|GO:0030198(extracellular matrix organization)|GO:0030891(VCB complex)|GO:0042069(regulation of catecholamine metabolic process)|GO:0043534(blood vessel endothelial cell migration)|GO:0045471(response to ethanol)|GO:0045597(positive regulation of cell differentiation)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0050821(protein stabilization)","Homo sapiens von Hippel-Lindau tumor suppressor (VHL), transcript variant 1, mRNA [NM_000551]",chr3:10194625-10194679,hs|3p25.3,von Hippel-Lindau tumor suppressor,TRUE
670_EID1_23741,Q9Y6B2,ep300-interacting inhibitor of differentiation 1 (21 kda prb-associated protein) (crebbp/ep300 inhibitory protein 1) (e1a-like inhibitor of differentiation 1) (eid-1),EID1 C15orf3 CRI1 RBP21 PNAS-22 PTD014,187,"function: interacts with rb1 and ep300 and acts as a repressor of myod1 transactivation. inhibits ep300 and cbp histone acetyltransferase activity. may be involved in coupling cell cycle exit to the transcriptional activation of genes required for cellular differentiation. may act as a candidate coinhibitory factor for nr0b2 that can be directly linked to transcription inhibitory mechanisms. {eco:0000269|pubmed:11073989, eco:0000269|pubmed:11073990}.","subcellular location: nucleus {eco:0000269|pubmed:11223246}. cytoplasm {eco:0000269|pubmed:11223246}. note=may shuttle between nucleus and cytoplasm. {eco:0000250|uniprotkb:q9dcr4, eco:0000269|pubmed:11223246}.","TISSUE SPECIFICITY: Widely expressed. Most abundantly expressed in heart, skeletal muscle, pancreas, brain and testis. Expressed at much lower levels in placenta and peripheral blood leukocyte. Barely detectable in lung. Also weakly expressed in lung carcinoma A-549 and various leukemia cell lines. {ECO:0000269|PubMed:11073990, ECO:0000269|PubMed:11223246}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EID1,23741,Hs.255973,ENST00000530028,THC2574603,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007049(cell cycle)|GO:0030154(cell differentiation)|GO:0035034(histone acetyltransferase regulator activity)|GO:0035035(histone acetyltransferase binding)|GO:0035065(regulation of histone acetylation)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens EP300 interacting inhibitor of differentiation 1 (EID1), mRNA [NM_014335]",chr15:49170981-49171040,hs|15q21.1,EP300 interacting inhibitor of differentiation 1,TRUE
671_C7orf55_154791,Q96HJ9,"protein fmc1 homolog (atp synthase assembly factor fmc1, mitochondrial) (formation of mitochondrial complex v assembly factor 1 homolog)",FMC1 C7orf55 HSPC268,113,function: plays a role in the assembly/stability of the mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) (pubmed:28719601). {eco:0000269|pubmed:28719601}.,subcellular location: mitochondrion {eco:0000269|pubmed:28719601}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C7orf55,154791,Hs.718441,ENST00000481123,THC2521982,GO:0005739(mitochondrion),"Homo sapiens chromosome 7 open reading frame 55 (C7orf55), nuclear gene encoding mitochondrial protein, mRNA [NM_197964]",chr7:139030466-139030525,hs|7q34,chromosome 7 open reading frame 55,TRUE
672_PTP4A1_7803,Q93096,protein tyrosine phosphatase type iva 1 (ec 3.1.3.48) (ptp(caaxi)) (protein-tyrosine phosphatase 4a1) (protein-tyrosine phosphatase of regenerating liver 1) (prl-1),PTP4A1 PRL1 PTPCAAX1,173,"function: protein tyrosine phosphatase which stimulates progression from g1 into s phase during mitosis. may play a role in the development and maintenance of differentiating epithelial tissues. enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis. {eco:0000269|pubmed:12235145, eco:0000269|pubmed:12782572, eco:0000269|pubmed:14643450}.","subcellular location: cell membrane. early endosome. endoplasmic reticulum. cytoplasm. cytoplasm, cytoskeleton, spindle. note=and mitotic spindle.","TISSUE SPECIFICITY: Expressed in bone marrow, lymph nodes, T lymphocytes, spleen, thymus and tonsil. Overexpressed in tumor cell lines. {ECO:0000269|PubMed:10940933, ECO:0000269|PubMed:12235145}.",NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,PTP4A1,7803,Hs.227777,ENST00000370650,THC2470170,GO:0004725(protein tyrosine phosphatase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005769(early endosome)|GO:0005783(endoplasmic reticulum)|GO:0005819(spindle)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0007049(cell cycle)|GO:0007275(multicellular organismal development)|GO:0009898(internal side of plasma membrane)|GO:0016787(hydrolase activity)|GO:0030335(positive regulation of cell migration)|GO:0035335(peptidyl-tyrosine dephosphorylation),"Homo sapiens protein tyrosine phosphatase type IVA, member 1 (PTP4A1), mRNA [NM_003463]",chr6:64291197-64291256,hs|6q12,"protein tyrosine phosphatase type IVA, member 1",TRUE
673_TMEM9B_56674,Q9NQ34,transmembrane protein 9b,TMEM9B C11orf15 UNQ712/PRO1375,198,"function: enhances production of proinflammatory cytokines induced by tnf, il1b, and tlr ligands. has a role in tnf activation of both the nf-kappab and mapk pathways. {eco:0000269|pubmed:18541524}.",subcellular location: lysosome membrane {eco:0000269|pubmed:18541524}; single-pass membrane protein {eco:0000255}. early endosome membrane {eco:0000269|pubmed:18541524}; single-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM9B,56674,Hs.501853,ENST00000534025,THC2468779,GO:0004871(signal transducer activity)|GO:0007165(signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade),"Homo sapiens TMEM9 domain family, member B (TMEM9B), mRNA [NM_020644]",chr11:8968962-8968903,hs|11p15.4,"TMEM9 domain family, member B",TRUE
674_HIST1H2BL_8340,Q99880,histone h2b type 1-l (histone h2b.c) (h2b/c),H2BC13 H2BFC HIST1H2BL,126,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2BL,8340,Hs.137594,ENST00000377401,THC2484590,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 1, H2bl (HIST1H2BL), mRNA [NM_003519]",chr6:27775345-27775286,hs|6p22.1,"histone cluster 1, H2bl",TRUE
675_SOCS2_8835,O14508,suppressor of cytokine signaling 2 (socs-2) (cytokine-inducible sh2 protein 2) (cis-2) (stat-induced stat inhibitor 2) (ssi-2),SOCS2 CIS2 SSI2 STATI2,198,function: socs family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. socs2 appears to be a negative regulator in the growth hormone/igf1 signaling pathway. probable substrate recognition component of a scf-like ecs (elongin bc-cul2/5-socs-box protein) e3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.,NA,"TISSUE SPECIFICITY: High expression in heart, placenta, lung, kidney and prostate.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,SOCS2,8835,Hs.485572,ENST00000549206,THC2495423,GO:0001558(regulation of cell growth)|GO:0005070(SH3/SH2 adaptor activity)|GO:0005131(growth hormone receptor binding)|GO:0005148(prolactin receptor binding)|GO:0005159(insulin-like growth factor receptor binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0006916(anti-apoptosis)|GO:0007259(JAK-STAT cascade)|GO:0007568(aging)|GO:0008269(JAK pathway signal transduction adaptor activity)|GO:0009966(regulation of signal transduction)|GO:0009968(negative regulation of signal transduction)|GO:0032355(response to estradiol stimulus)|GO:0032870(cellular response to hormone stimulus)|GO:0035556(intracellular signal transduction)|GO:0043434(response to peptide hormone stimulus)|GO:0046425(regulation of JAK-STAT cascade)|GO:0060396(growth hormone receptor signaling pathway),"Homo sapiens suppressor of cytokine signaling 2 (SOCS2), mRNA [NM_003877]",chr12:93969799-93969858,hs|12q22,suppressor of cytokine signaling 2,TRUE
676_EIF3A_8661,P56537,eukaryotic translation initiation factor 6 (eif-6) (b(2)gcn homolog) (b4 integrin interactor) (cab) (p27(bbp)),EIF6 EIF3A ITGB4BP OK/SW-cl.27,245,"function: binds to the 60s ribosomal subunit and prevents its association with the 40s ribosomal subunit to form the 80s initiation complex in the cytoplasm. behaves as a stimulatory translation initiation factor downstream insulin/growth factors. is also involved in ribosome biogenesis. associates with pre-60s subunits in the nucleus and is involved in its nuclear export. cytoplasmic release of tif6 from 60s subunits and nuclear relocalization is promoted by a rack1 (rack1)-dependent protein kinase c activity (pubmed:10085284, pubmed:14654845, pubmed:21536732). in tissues responsive to insulin, controls fatty acid synthesis and glycolysis by exerting translational control of adipogenic transcription factors such as cebpb, cebpd and atf4 that have g/c rich or uorf in their 5'utr. required for ros-dependent megakaryocyte maturation and platelets formation, controls the expression of mitochondrial respiratory chain genes involved in reactive oxygen species (ros) synthesis (by similarity). involved in mirna-mediated gene silencing by the rna-induced silencing complex (risc). required for both mirna-mediated translational repression and mirna-mediated cleavage of complementary mrnas by risc (pubmed:17507929). modulates cell cycle progression and global translation of pre-b cells, its activation seems to be rate-limiting in tumorigenesis and tumor growth (by similarity). {eco:0000255|hamap-rule:mf_03132, eco:0000269|pubmed:10085284, eco:0000269|pubmed:14654845, eco:0000269|pubmed:17507929, eco:0000269|pubmed:21536732}.","subcellular location: cytoplasm. nucleus, nucleolus. note=shuttles between cytoplasm and nucleus/nucleolus.",TISSUE SPECIFICITY: Expressed at very high levels in colon carcinoma with lower levels in normal colon and ileum and lowest levels in kidney and muscle (at protein level). {ECO:0000269|PubMed:11290417}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,EIF3A,8661,Hs.523299,ENST00000541549,THC2590961,GO:0001732(formation of translation initiation complex)|GO:0003743(translation initiation factor activity)|GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0010467(gene expression)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit A (EIF3A), mRNA [NM_003750]",chr10:120795387-120795328,hs|10q26.11,"eukaryotic translation initiation factor 3, subunit A",TRUE
677_ZNF598_90850,Q86UK7,e3 ubiquitin-protein ligase znf598 (ec 2.3.2.27) (zinc finger protein 598),ZNF598,904,"function: e3 ubiquitin-protein ligase that plays a key role in the ribosome quality control (rqc), a pathway that takes place when a ribosome has stalled during translation (pubmed:28065601, pubmed:28132843). required for ribosomes to terminally stall during translation of poly(a) sequences by mediating monoubiquitination of 40s ribosomal protein rps10/es10, rps20/us10 and rps3/us3 (pubmed:28065601, pubmed:28132843). stalling precludes synthesis of a long poly-lysine tail and initiates the rqc pathway to degrade the potentially detrimental aberrant nascent polypeptide (pubmed:28065601, pubmed:28132843). also acts as a component of the 4ehp-gyf2 complex, a multiprotein complex that acts as a repressor of translation initiation (pubmed:22751931). {eco:0000269|pubmed:22751931, eco:0000269|pubmed:28065601, eco:0000269|pubmed:28132843}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ZNF598,90850,Hs.343828,NA,THC2611438,GO:0005622(intracellular)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens mRNA for FLJ00086 protein, partial cds. [AK024487]",chr16:2047756-2047697,hs|16p13.3,zinc finger protein 598,TRUE
678_TFF3_7033,Q07654,trefoil factor 3 (intestinal trefoil factor) (hitf) (polypeptide p1.b) (hp1.b),TFF3 ITF TFI,94,function: involved in the maintenance and repair of the intestinal mucosa. promotes the mobility of epithelial cells in healing processes (motogen). {eco:0000269|pubmed:11694446}.,"subcellular location: secreted, extracellular space, extracellular matrix {eco:0000269|pubmed:8454642}. cytoplasm {eco:0000269|pubmed:10824705, eco:0000269|pubmed:8454642}.","TISSUE SPECIFICITY: Expressed in goblet cells of the intestines and colon (at protein level). Expressed by goblet cells of small and large intestinal epithelia and also by the uterus. Also expressed in the hypothalamus where it is detected in paraventricular, periventricular and supraoptic nuclei (at protein level). {ECO:0000269|PubMed:8346203, ECO:0000269|PubMed:8454642}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TFF3,7033,Hs.82961,ENST00000518498,NP098809,GO:0003674(molecular_function)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0006952(defense response)|GO:0007586(digestion)|GO:0032579(apical lamina of hyaline layer),"Homo sapiens trefoil factor 3 (intestinal) (TFF3), mRNA [NM_003226]",chr21:43731813-43731777,hs|21q22.3,trefoil factor 3 (intestinal),TRUE
679_SELS_55829,Q9BQE4,selenoprotein s (sels) (vcp-interacting membrane protein),SELENOS SELS VIMP AD-015 SBBI8,189,"function: involved in the degradation process of misfolded endoplasmic reticulum (er) luminal proteins. participates in the transfer of misfolded proteins from the er to the cytosol, where they are destroyed by the proteasome in a ubiquitin-dependent manner. probably acts by serving as a linker between derl1, which mediates the retrotranslocation of misfolded proteins into the cytosol, and the atpase complex vcp, which mediates the translocation and ubiquitination. {eco:0000269|pubmed:15215856}.",subcellular location: endoplasmic reticulum membrane; single-pass membrane protein. cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SELS,55829,Hs.32148,ENST00000526043,THC2542809,"GO:0002865(negative regulation of acute inflammatory response to antigenic stimulus)|GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0005886(plasma membrane)|GO:0006111(regulation of gluconeogenesis)|GO:0006886(intracellular protein transport)|GO:0006916(anti-apoptosis)|GO:0006983(ER overload response)|GO:0008430(selenium binding)|GO:0009749(response to glucose stimulus)|GO:0016021(integral to membrane)|GO:0016209(antioxidant activity)|GO:0019899(enzyme binding)|GO:0030176(integral to endoplasmic reticulum membrane)|GO:0030433(ER-associated protein catabolic process)|GO:0030968(endoplasmic reticulum unfolded protein response)|GO:0030970(retrograde protein transport, ER to cytosol)|GO:0032715(negative regulation of interleukin-6 production)|GO:0032720(negative regulation of tumor necrosis factor production)|GO:0032869(cellular response to insulin stimulus)|GO:0034361(very-low-density lipoprotein particle)|GO:0034362(low-density lipoprotein particle)|GO:0034599(cellular response to oxidative stress)|GO:0045184(establishment of protein localization)|GO:0045454(cell redox homeostasis)|GO:0045719(negative regulation of glycogen biosynthetic process)|GO:0046325(negative regulation of glucose import)|GO:0050728(negative regulation of inflammatory response)|GO:0051771(negative regulation of nitric-oxide synthase biosynthetic process)|GO:0051775(response to redox state)|GO:0071222(cellular response to lipopolysaccharide)|GO:0080164(regulation of nitric oxide metabolic process)","Homo sapiens selenoprotein S (SELS), transcript variant 2, mRNA [NM_018445]",chr15:101812652-101812593,hs|15q26.3,selenoprotein S,TRUE
68_GNAS_2778,Q5JWF2,guanine nucleotide-binding protein g(s) subunit alpha isoforms xlas (adenylate cyclase-stimulating g alpha protein) (extra large alphas protein) (xlalphas),GNAS GNAS1,1037,"function: guanine nucleotide-binding proteins (g proteins) function as transducers in numerous signaling pathways controlled by g protein-coupled receptors (gpcrs). signaling involves the activation of adenylyl cyclases, resulting in increased levels of the signaling molecule camp. gnas functions downstream of several gpcrs, including beta-adrenergic receptors. xlas isoforms interact with the same set of receptors as gnas isoforms (by similarity). {eco:0000250|uniprotkb:q6r0h7}.",subcellular location: cell membrane {eco:0000269|pubmed:27120771}; peripheral membrane protein {eco:0000250|uniprotkb:q63803}. apical cell membrane {eco:0000269|pubmed:27120771}.,NA,"DISEASE: GNAS hyperfunction (GNASHYP) [MIM:139320]: This condition is characterized by increased trauma-related bleeding tendency, prolonged bleeding time, brachydactyly and mental retardation. Both the XLas isoforms and the ALEX protein are mutated which strongly reduces the interaction between them and this may allow unimpeded activation of the XLas isoforms. {ECO:0000269|PubMed:11583302, ECO:0000269|PubMed:12719376}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080]: A rare adrenal defect characterized by multiple, bilateral, non-pigmented, benign, adrenocortical nodules. It results in excessive production of cortisol leading to ACTH-independent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:12727968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack developmental defects characteristic of Albright hereditary osteodystrophy, and typically show no other endocrine abnormalities besides resistance to PTH. {ECO:0000269|PubMed:11029463, ECO:0000269|PubMed:11067869, ECO:0000269|PubMed:11294659, ECO:0000269|PubMed:12858292, ECO:0000269|PubMed:14561710, ECO:0000269|PubMed:15592469, ECO:0000269|PubMed:15800843}. Note=The disease is caused by mutations affecting the gene represented in this entry. Most affected individuals have defects in methylation of the gene. In some cases microdeletions involving the STX16 appear to cause loss of methylation at exon A/B of GNAS, resulting in PHP1B. Paternal uniparental isodisomy have also been observed.; DISEASE: Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. It is commonly associated with Albright hereditary osteodystrophy whose features are short stature, obesity, round facies, short metacarpals and ectopic calcification. {ECO:0000269|PubMed:11788646}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GNAS,2778,Hs.125898,ENST00000474497,THC2534972,GO:0000166(nucleotide binding)|GO:0001726(ruffle)|GO:0001894(tissue homeostasis)|GO:0001958(endochondral ossification)|GO:0003674(molecular_function)|GO:0003924(GTPase activity)|GO:0004016(adenylate cyclase activity)|GO:0004871(signal transducer activity)|GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005525(GTP binding)|GO:0005576(extracellular region)|GO:0005622(intracellular)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005834(heterotrimeric G-protein complex)|GO:0005886(plasma membrane)|GO:0006112(energy reserve metabolic process)|GO:0006171(cAMP biosynthetic process)|GO:0006184(GTP catabolic process)|GO:0006306(DNA methylation)|GO:0006833(water transport)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007190(activation of adenylate cyclase activity)|GO:0007191(activation of adenylate cyclase activity by dopamine receptor signaling pathway)|GO:0007565(female pregnancy)|GO:0007596(blood coagulation)|GO:0007606(sensory perception of chemical stimulus)|GO:0007608(sensory perception of smell)|GO:0007610(behavior)|GO:0009306(protein secretion)|GO:0009791(post-embryonic development)|GO:0019001(guanyl nucleotide binding)|GO:0030133(transport vesicle)|GO:0030168(platelet activation)|GO:0031224(intrinsic to membrane)|GO:0031234(extrinsic to internal side of plasma membrane)|GO:0031410(cytoplasmic vesicle)|GO:0031683(G-protein beta/gamma-subunit complex binding)|GO:0031852(mu-type opioid receptor binding)|GO:0032588(trans-Golgi network membrane)|GO:0035116(embryonic hindlimb morphogenesis)|GO:0035255(ionotropic glutamate receptor binding)|GO:0035264(multicellular organism growth)|GO:0040032(post-embryonic body morphogenesis)|GO:0042493(response to drug)|GO:0043588(skin development)|GO:0045669(positive regulation of osteoblast differentiation)|GO:0045672(positive regulation of osteoclast differentiation)|GO:0046872(metal ion binding)|GO:0046907(intracellular transport)|GO:0048701(embryonic cranial skeleton morphogenesis)|GO:0050796(regulation of insulin secretion)|GO:0051216(cartilage development)|GO:0055085(transmembrane transport)|GO:0071377(cellular response to glucagon stimulus)|GO:0071514(genetic imprinting),"Homo sapiens GNAS complex locus (GNAS), transcript variant 7, mRNA [NM_001077489]",chr20:57486004-57486063,hs|20q13.32,GNAS complex locus,TRUE
680_ZFP36L1_677,Q07352,"mrna decay activator protein zfp36l1 (butyrate response factor 1) (egf-response factor 1) (erf-1) (tpa-induced sequence 11b) (zinc finger protein 36, c3h1 type-like 1) (zfp36-like 1)",ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B,338,"function: zinc-finger rna-binding protein that destabilizes several cytoplasmic au-rich element (are)-containing mrna transcripts by promoting their poly(a) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (pubmed:12198173, pubmed:15538381, pubmed:15467755, pubmed:17030608, pubmed:19179481, pubmed:20702587, pubmed:24700863, pubmed:25106868, pubmed:25014217, pubmed:26542173). acts as a 3'-untranslated region (utr) are mrna-binding adapter protein to communicate signaling events to the mrna decay machinery (pubmed:15687258). functions by recruiting the ccr4-not deadenylase complex and components of the cytoplasmic rna decay machinery to the bound are-containing mrnas, and hence promotes are-mediated mrna deadenylation and decay processes (pubmed:15687258, pubmed:18326031, pubmed:25106868). induces also the degradation of are-containing mrnas even in absence of poly(a) tail (by similarity). binds to 3'-utr are of numerous mrnas (pubmed:12198173, pubmed:15538381, pubmed:15467755, pubmed:17030608, pubmed:19179481, pubmed:20702587, pubmed:24700863, pubmed:25106868, pubmed:25014217, pubmed:26542173). positively regulates early adipogenesis by promoting are-mediated mrna decay of immediate early genes (iegs) (by similarity). promotes are-mediated mrna decay of mineralocorticoid receptor nr3c2 mrna in response to hypertonic stress (pubmed:24700863). negatively regulates hematopoietic/erythroid cell differentiation by promoting are-mediated mrna decay of the transcription factor stat5b mrna (pubmed:20702587). positively regulates monocyte/macrophage cell differentiation by promoting are-mediated mrna decay of the cyclin-dependent kinase cdk6 mrna (pubmed:26542173). promotes degradation of are-containing pluripotency-associated mrnas in embryonic stem cells (escs), such as nanog, through a fibroblast growth factor (fgf)-induced mapk-dependent signaling pathway, and hence attenuates esc self-renewal and positively regulates mesendoderm differentiation (by similarity). may play a role in mediating pro-apoptotic effects in malignant b-cells by promoting are-mediated mrna decay of bcl2 mrna (pubmed:25014217). in association with zfp36l2 maintains quiescence on developing b lymphocytes by promoting are-mediated decay of several mrnas encoding cell cycle regulators that help b cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (vdj) recombination and functional immune cell formation (by similarity). together with zfp36l2 is also necessary for thymocyte development and prevention of t-cell acute lymphoblastic leukemia (t-all) transformation by promoting are-mediated mrna decay of the oncogenic transcription factor notch1 mrna (by similarity). participates in the delivery of target are-mrnas to processing bodies (pbs) (pubmed:17369404). in addition to its cytosolic mrna-decay function, plays a role in the regulation of nuclear mrna 3'-end processing; modulates mrna 3'-end maturation efficiency of the dll4 mrna through binding with an are embedded in a weak noncanonical polyadenylation (poly(a)) signal in endothelial cells (pubmed:21832157). also involved in the regulation of stress granule (sg) and p-body (pb) formation and fusion (pubmed:15967811). plays a role in vasculogenesis and endocardial development (by similarity). plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (pubmed:27182009). plays a role in myoblast cell differentiation (by similarity). {eco:0000250|uniprotkb:p17431, eco:0000250|uniprotkb:p23950, eco:0000269|pubmed:12198173, eco:0000269|pubmed:15467755, eco:0000269|pubmed:15538381, eco:0000269|pubmed:15687258, eco:0000269|pubmed:15967811, eco:0000269|pubmed:17030608, eco:0000269|pubmed:17369404, eco:0000269|pubmed:18326031, eco:0000269|pubmed:19179481, eco:0000269|pubmed:20702587, eco:0000269|pubmed:21832157, eco:0000269|pubmed:24700863, eco:0000269|pubmed:25014217, eco:0000269|pubmed:25106868, eco:0000269|pubmed:26542173, eco:0000269|pubmed:27182009}.","subcellular location: nucleus {eco:0000269|pubmed:12198173}. cytoplasm {eco:0000269|pubmed:12198173}. cytoplasmic granule {eco:0000269|pubmed:15967811}. cytoplasm, p-body {eco:0000269|pubmed:15967811, eco:0000269|pubmed:17369404}. note=shuttles between the nucleus and the cytoplasm in a xpo1/crm1-dependent manner (by similarity). component of cytoplasmic stress granules (pubmed:15967811). localizes in processing bodies (pbs) (pubmed:17369404). {eco:0000250|uniprotkb:p23950, eco:0000269|pubmed:15967811, eco:0000269|pubmed:17369404}.","TISSUE SPECIFICITY: Expressed mainly in the basal epidermal layer, weakly in the suprabasal epidermal layers (PubMed:27182009). Expressed in epidermal keratinocytes (at protein level) (PubMed:27182009). Expressed in osteoblasts (PubMed:15465005). {ECO:0000269|PubMed:15465005, ECO:0000269|PubMed:27182009}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,ZFP36L1,677,Hs.85155,ENST00000439696,THC2579588,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)|GO:0001570(vasculogenesis)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006402(mRNA catabolic process)|GO:0006417(regulation of translation)|GO:0008270(zinc ion binding)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0017091(AU-rich element binding)|GO:0043488(regulation of mRNA stability)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 36, C3H type-like 1 (ZFP36L1), transcript variant 1, mRNA [NM_004926]",chr14:69254535-69254476,hs|14q24.1,"zinc finger protein 36, C3H type-like 1",TRUE
681_RPSA_3921,P08865,40s ribosomal protein sa (37 kda laminin receptor precursor) (37lrp) (37/67 kda laminin receptor) (lrp/lr) (67 kda laminin receptor) (67lr) (colon carcinoma laminin-binding protein) (laminin receptor 1) (lamr) (laminin-binding protein precursor p40) (lbp/p40) (multidrug resistance-associated protein mgr1-ag) (nem/1chd4) (small ribosomal subunit protein us2),RPSA LAMBR LAMR1,295,"function: required for the assembly and/or stability of the 40s ribosomal subunit. required for the processing of the 20s rrna-precursor to mature 18s rrna in a late step of the maturation of 40s ribosomal subunits. also functions as a cell surface receptor for laminin. plays a role in cell adhesion to the basement membrane and in the consequent activation of signaling transduction pathways. may play a role in cell fate determination and tissue morphogenesis. acts as a ppp1r16b-dependent substrate of ppp1ca. {eco:0000255|hamap-rule:mf_03016, eco:0000269|pubmed:16263087, eco:0000269|pubmed:6300843}.; function: (microbial infection) acts as a receptor for the adeno-associated viruses 2,3,8 and 9. {eco:0000269|pubmed:16973587}.; function: (microbial infection) acts as a receptor for the dengue virus. {eco:0000269|pubmed:15507651}.; function: (microbial infection) acts as a receptor for the sindbis virus. {eco:0000269|pubmed:1385835}.; function: (microbial infection) acts as a receptor for the venezuelan equine encephalitis virus. {eco:0000269|pubmed:1385835}.; function: (microbial infection) acts as a receptor for the pathogenic prion protein. {eco:0000269|pubmed:11689427, eco:0000269|pubmed:9396609}.; function: (microbial infection) acts as a receptor for bacteria. {eco:0000269|pubmed:15516338}.","subcellular location: cell membrane. cytoplasm. nucleus {eco:0000255|hamap-rule:mf_03016}. note=67lr is found at the surface of the plasma membrane, with its c-terminal laminin-binding domain accessible to extracellular ligands. 37lrp is found at the cell surface, in the cytoplasm and in the nucleus (by similarity). colocalizes with ppp1r16b in the cell membrane. {eco:0000255|hamap-rule:mf_03016}.",NA,"DISEASE: Asplenia, isolated congenital (ICAS) [MIM:271400]: A rare primary immunodeficiency and life-threatening condition, often presenting with pneumococcal sepsis. Most affected individuals die of severe bacterial infections in early childhood. Isolated asplenia is distinct from asplenia associated with other complex visceral defects, notably heterotaxy syndromes such as Ivemark syndrome. {ECO:0000269|PubMed:23579497}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,RPSA,3921,Hs.449909,ENST00000427417,NP1159534,"GO:0000028(ribosomal small subunit assembly)|GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0000461(endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0003735(structural constituent of ribosome)|GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006407(rRNA export from nucleus)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0007155(cell adhesion)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030686(90S preribosome)|GO:0031018(endocrine pancreas development)|GO:0043022(ribosome binding)|GO:0044267(cellular protein metabolic process)","Homo sapiens ribosomal protein SA (RPSA), transcript variant 1, mRNA [NM_002295]",chr3:39453420-39453479,hs|3p22.1,ribosomal protein SA,TRUE
682_ARFGAP3_26286,Q9NP61,adp-ribosylation factor gtpase-activating protein 3 (arf gap 3),ARFGAP3 ARFGAP1,516,function: gtpase-activating protein (gap) for adp ribosylation factor 1 (arf1). hydrolysis of arf1-bound gtp may lead to dissociation of coatomer from golgi-derived membranes to allow fusion with target membranes. {eco:0000269|pubmed:11172815}.,subcellular location: cytoplasm {eco:0000269|pubmed:17760859}. golgi apparatus membrane {eco:0000269|pubmed:17760859}; peripheral membrane protein {eco:0000269|pubmed:17760859}; cytoplasmic side {eco:0000269|pubmed:17760859}. note=also found on peripheral punctate structures likely to be endoplasmic reticulum-golgi intermediate compartment.,"TISSUE SPECIFICITY: Widely expressed. Highest expression in endocrine glands (pancreas, pituitary gland, salivary gland, and prostate) and testis with a much higher expression in the testis than in the ovary. {ECO:0000269|PubMed:10704287}.",NA,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ARFGAP3,26286,Hs.685225,ENST00000263245,THC2469231,GO:0000139(Golgi membrane)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0008060(ARF GTPase activator activity)|GO:0008270(zinc ion binding)|GO:0008565(protein transporter activity)|GO:0009306(protein secretion)|GO:0016020(membrane)|GO:0016192(vesicle-mediated transport)|GO:0032312(regulation of ARF GTPase activity)|GO:0046872(metal ion binding),"Homo sapiens ADP-ribosylation factor GTPase activating protein 3 (ARFGAP3), transcript variant 1, mRNA [NM_014570]",chr22:43192987-43192928,hs|22q13.2,ADP-ribosylation factor GTPase activating protein 3,TRUE
683_MRPL3_11222,P09001,"39s ribosomal protein l3, mitochondrial (l3mt) (mrp-l3) (mitochondrial large ribosomal subunit protein ul3m)",MRPL3 MRL3 RPML3,348,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,"DISEASE: Combined oxidative phosphorylation deficiency 9 (COXPD9) [MIM:614582]: A mitochondrial disease characterized by failure to thrive, poor feeding, hypertrophic cardiomyopathy, hepatomegaly, and psychomotor retardation. Death in infancy has been observed in some cases. {ECO:0000269|PubMed:21786366}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPL3,11222,Hs.205163,ENST00000264995,THC2469728,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005762(mitochondrial large ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein L3 (MRPL3), nuclear gene encoding mitochondrial protein, mRNA [NM_007208]",chr3:131181203-131181144,hs|3q22.1,mitochondrial ribosomal protein L3,TRUE
684_CRLS1_54675,Q9UJA2,cardiolipin synthase (cmp-forming) (cls) (ec 2.7.8.41) (protein gcd10 homolog),CRLS1 C20orf155 CLS1,301,"function: catalyzes the synthesis of cardiolipin (cl) (diphosphatidylglycerol) by specifically transferring a phosphatidyl group from cdp-diacylglycerol to phosphatidylglycerol (pg). cl is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions. {eco:0000269|pubmed:16547353, eco:0000269|pubmed:16678169}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:16547353}; multi-pass membrane protein {eco:0000269|pubmed:16547353}.,"TISSUE SPECIFICITY: Highly expressed in tissues such as heart, skeletal muscle and liver. {ECO:0000269|PubMed:16547353}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CRLS1,54675,Hs.224764,ENST00000452938,THC2480568,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0008654(phospholipid biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016740(transferase activity)|GO:0016780(phosphotransferase activity, for other substituted phosphate groups)","Homo sapiens cardiolipin synthase 1 (CRLS1), transcript variant 1, mRNA [NM_019095]",chr20:6017851-6017910,hs|20p12.3,cardiolipin synthase 1,TRUE
685_ARIH2_10425,O95376,e3 ubiquitin-protein ligase arih2 (ari-2) (protein ariadne-2 homolog) (ec 2.3.2.31) (ring-type e3 ubiquitin transferase arih2) (triad1 protein),ARIH2 ARI2 TRIAD1 HT005,493,"function: e3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme e2 ube2l3 (pubmed:16118314, pubmed:17646546, pubmed:19340006, pubmed:24076655). acts as an atypical e3 ubiquitin-protein ligase by working together with cullin-5-ring ubiquitin ligase complex (ecs complex, also named crl5 complex) and initiating ubiquitination of ecs substrates: associates with ecs complex and specifically mediates addition of the first ubiquitin on ecs targets (by similarity). the initial ubiquitin is then elongated (by similarity). e3 ubiquitin-protein ligase activity is activated upon binding to neddylated form of the ecs complex (pubmed:24076655). mediates 'lys-6', 'lys-48'-and 'lys-63'-linked polyubiquitination (pubmed:16118314, pubmed:17646546, pubmed:19340006). may play a role in myelopoiesis (pubmed:19340006). {eco:0000250|uniprotkb:q9y4x5, eco:0000269|pubmed:16118314, eco:0000269|pubmed:17646546, eco:0000269|pubmed:19340006, eco:0000269|pubmed:24076655}.",subcellular location: nucleus {eco:0000269|pubmed:16118314}. cytoplasm {eco:0000269|pubmed:19340006}.,TISSUE SPECIFICITY: Widely expressed with higher expression in granulocytes. {ECO:0000269|PubMed:16118314}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ARIH2,10425,Hs.633601,ENST00000356401,THC2469486,GO:0000209(protein polyubiquitination)|GO:0003676(nucleic acid binding)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007275(multicellular organismal development)|GO:0008270(zinc ion binding)|GO:0016874(ligase activity)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0046872(metal ion binding)|GO:0048588(developmental cell growth)|GO:0070534(protein K63-linked ubiquitination)|GO:0070936(protein K48-linked ubiquitination)|GO:0071425(hemopoietic stem cell proliferation),"Homo sapiens ariadne homolog 2 (Drosophila) (ARIH2), mRNA [NM_006321]",chr3:49022899-49022958,hs|3p21.31,ariadne homolog 2 (Drosophila),TRUE
686_CLNS1A_1207,P54105,"methylosome subunit picln (chloride channel, nucleotide sensitive 1a) (chloride conductance regulatory protein icln) (i(cln)) (chloride ion current inducer protein) (clci) (reticulocyte picln)",CLNS1A CLCI ICLN,237,"function: involved in both the assembly of spliceosomal snrnps and the methylation of sm proteins (pubmed:21081503, pubmed:18984161). chaperone that regulates the assembly of spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome. thereby, plays an important role in the splicing of cellular pre-mrnas. most spliceosomal snrnps contain a common set of sm proteins snrpb, snrpd1, snrpd2, snrpd3, snrpe, snrpf and snrpg that assemble in a heptameric protein ring on the sm site of the small nuclear rna to form the core snrnp. in the cytosol, the sm proteins snrpd1, snrpd2, snrpe, snrpf and snrpg are trapped in an inactive 6s picln-sm complex by the chaperone clns1a that controls the assembly of the core snrnp. dissociation by the smn complex of clns1a from the trapped sm proteins and their transfer to an smn-sm complex triggers the assembly of core snrnps and their transport to the nucleus. may also indirectly participate in cellular volume control by activation of a swelling-induced chloride conductance pathway. {eco:0000269|pubmed:10330151, eco:0000269|pubmed:11713266, eco:0000269|pubmed:18984161, eco:0000269|pubmed:21081503}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161, eco:0000269|pubmed:21081503}. nucleus {eco:0000269|pubmed:18984161, eco:0000269|pubmed:21081503}. cytoplasm, cytoskeleton {eco:0000269|pubmed:18984161}. note=a small fraction is also associated with the cytoskeleton (pubmed:18984161).",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,CLNS1A,1207,Hs.430733,ENST00000526009,THC2580128,GO:0000387(spliceosomal snRNP assembly)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006810(transport)|GO:0006821(chloride transport)|GO:0006884(cell volume homeostasis)|GO:0008015(blood circulation)|GO:0016070(RNA metabolic process)|GO:0034660(ncRNA metabolic process),"Homo sapiens chloride channel, nucleotide-sensitive, 1A (CLNS1A), mRNA [NM_001293]",chr11:77327395-77327336,hs|11q14.1,"chloride channel, nucleotide-sensitive, 1A",TRUE
687_GTF2H5_404672,Q6ZYL4,general transcription factor iih subunit 5 (general transcription factor iih polypeptide 5) (tfb5 ortholog) (tfiih basal transcription factor complex ttd-a subunit),GTF2H5 C6orf175 TTDA,71,"function: component of the general transcription and dna repair factor iih (tfiih) core complex, which is involved in general and transcription-coupled nucleotide excision repair (ner) of damaged dna and, when complexed to cak, in rna transcription by rna polymerase ii. in ner, tfiih acts by opening dna around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new dna fragment. in transcription, tfiih has an essential role in transcription initiation. when the pre-initiation complex (pic) has been established, tfiih is required for promoter opening and promoter escape. phosphorylation of the c-terminal tail (ctd) of the largest subunit of rna polymerase ii by the kinase module cak controls the initiation of transcription. necessary for the stability of the tfiih complex and for the presence of normal levels of tfiih in the cell. {eco:0000269|pubmed:15220921}.",subcellular location: nucleus {eco:0000269|pubmed:15220921}.,NA,"DISEASE: Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395]: A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. {ECO:0000269|PubMed:15220921}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GTF2H5,404672,Hs.356224,ENST00000438073,THC2463911,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0006289(nucleotide-excision repair)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens general transcription factor IIH, polypeptide 5 (GTF2H5), mRNA [NM_207118]",chr6:158613211-158613270,hs|6q25.3,"general transcription factor IIH, polypeptide 5",TRUE
688_DEXI_28955,O95424,dexamethasone-induced protein (protein myle),DEXI MYLE,95,NA,NA,"TISSUE SPECIFICITY: Highest levels in heart. Also expressed in brain, liver, pancreas, placenta and lung. Up-regulated in emphysematous lung compared to normal lung. {ECO:0000269|PubMed:11472984}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,DEXI,28955,Hs.592051,ENST00000331808,THC2655311,NA,"Homo sapiens Dexi homolog (mouse) (DEXI), mRNA [NM_014015]",chr16:11022840-11022781,hs|16p13.13,Dexi homolog (mouse),TRUE
689_ROMO1_140823,P60602,reactive oxygen species modulator 1 (ros modulator 1) (epididymis tissue protein li 175) (glyrichin) (mitochondrial targeting gxxxg motif protein) (mtgm) (protein mgr2 homolog),ROMO1 C20orf52,79,"function: induces production of reactive oxygen species (ros) which are necessary for cell proliferation. may play a role in inducing oxidative dna damage and replicative senescence. may play a role in the coordination of mitochondrial morphology and cell proliferation.; function: has antibacterial activity against a variety of bacteria including s.aureus, p.aeruginosa and m.tuberculosis. acts by inducing bacterial membrane breakage.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:16842742, eco:0000269|pubmed:19535734}; single-pass membrane protein {eco:0000269|pubmed:16842742, eco:0000269|pubmed:19535734}.","TISSUE SPECIFICITY: Up-regulated in a number of cancer cell lines when compared to a normal lung fibroblast cell line. Highly expressed in brain tumors. {ECO:0000269|PubMed:16842742, ECO:0000269|PubMed:19535734}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ROMO1,140823,Hs.472564,ENST00000336695,THC2478459,GO:0001302(replicative cell aging)|GO:0003674(molecular_function)|GO:0005739(mitochondrion)|GO:0008284(positive regulation of cell proliferation)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031966(mitochondrial membrane)|GO:0034614(cellular response to reactive oxygen species)|GO:2000379(positive regulation of reactive oxygen species metabolic process),"Homo sapiens reactive oxygen species modulator 1 (ROMO1), nuclear gene encoding mitochondrial protein, mRNA [NM_080748]",chr20:34288841-34288900,hs|20q11.22,reactive oxygen species modulator 1,TRUE
69_HN1L_90861,Q9H910,jupiter microtubule associated homolog 2 (hematological and neurological expressed 1-like protein) (hn1-like protein),JPT2 C16orf34 HN1L L11,190,NA,subcellular location: cytoplasm {eco:0000269|pubmed:15094197}. nucleus {eco:0000269|pubmed:15094197}.,"TISSUE SPECIFICITY: Expressed in liver, kidney, prostate, testis and uterus. {ECO:0000269|PubMed:15094197}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,HN1L,90861,Hs.513261,ENST00000248098,THC2469324,GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane),"Homo sapiens hematological and neurological expressed 1-like (HN1L), mRNA [NM_144570]",chr16:1751289-1751348,hs|16p13.3,hematological and neurological expressed 1-like,TRUE
690_ISCU_23479,Q9H1K1,"iron-sulfur cluster assembly enzyme iscu, mitochondrial (nifu-like n-terminal domain-containing protein) (nifu-like protein)",ISCU NIFUN,167,"function: scaffold protein for the de novo synthesis of iron-sulfur (fe-s) clusters within mitochondria, which is required for maturation of both mitochondrial and cytoplasmic [2fe-2s] and [4fe-4s] proteins (pubmed:11060020). first, a [2fe-2s] cluster is transiently assembled on the scaffold protein iscu. in a second step, the cluster is released from iscu, transferred to a glutaredoxin glrx5, followed by the formation of mitochondrial [2fe-2s] proteins, the synthesis of [4fe-4s] clusters and their target-specific insertion into the recipient apoproteins. cluster assembly on iscu depends on the function of the cysteine desulfurase complex nfs1-lyrm4/isd11, which serves as the sulfur donor for cluster synthesis, the iron-binding protein frataxin as the putative iron donor, and the electron transfer chain comprised of ferredoxin reductase and ferredoxin, which receive their electrons from nadh (by similarity). {eco:0000250|uniprotkb:q03020, eco:0000269|pubmed:11060020}.; function: isoform 2: functions as a cytoplasmic scaffold protein for the de novo synthesis of iron-sulfur clusters in the cytoplasm. {eco:0000269|pubmed:29309586}.","subcellular location: isoform 1: mitochondrion {eco:0000269|pubmed:11060020, eco:0000269|pubmed:26702583}.; subcellular location: isoform 2: cytoplasm. nucleus {eco:0000269|pubmed:11060020}.","TISSUE SPECIFICITY: Detected in heart, liver, skeletal muscle, brain, pancreas, kidney, lung and placenta. {ECO:0000269|PubMed:11060020, ECO:0000269|PubMed:8875867}.","DISEASE: Myopathy with exercise intolerance Swedish type (MEIS) [MIM:255125]: Autosomal recessive metabolic disease characterized by lifelong severe exercise intolerance, in which minor exertion causes fatigue of active muscles, shortness of breath, and cardiac palpitations in association with lactic acidosis. The biochemical phenotype is characterized by a deficiency in mitochondrial iron-sulfur proteins and impaired muscle oxidative metabolism. {ECO:0000269|PubMed:18304497}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ISCU,23479,Hs.615131,ENST00000545932,THC2511033,GO:0005506(iron ion binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0009399(nitrogen fixation)|GO:0016226(iron-sulfur cluster assembly)|GO:0032947(protein complex scaffold)|GO:0046872(metal ion binding)|GO:0051536(iron-sulfur cluster binding),"Homo sapiens iron-sulfur cluster scaffold homolog (E. coli) (ISCU), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_014301]",chr12:108963027-108963086,hs|12q23.3,iron-sulfur cluster scaffold homolog (E. coli),TRUE
691_SDF2L1_23753,Q9HCN8,stromal cell-derived factor 2-like protein 1 (sdf2-like protein 1) (pwp1-interacting protein 8),SDF2L1 UNQ1941/PRO4424,221,NA,subcellular location: endoplasmic reticulum lumen {eco:0000255|prosite-prorule:pru10138}.,"TISSUE SPECIFICITY: Ubiquitously expressed with high expression in testis, moderate expression in the pancreas, spleen, prostate, small intestine and colon. Very low expression is seen in brain and skeletal muscle. {ECO:0000269|PubMed:11162531}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,SDF2L1,23753,Hs.303116,ENST00000248958,THC2462325,GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0016020(membrane),"Homo sapiens stromal cell-derived factor 2-like 1 (SDF2L1), mRNA [NM_022044]",chr22:21998511-21998570,hs|22q11.21,stromal cell-derived factor 2-like 1,TRUE
692_ANAPC5_51433,Q9UJX4,anaphase-promoting complex subunit 5 (apc5) (cyclosome subunit 5),ANAPC5 APC5,755,"function: component of the anaphase promoting complex/cyclosome (apc/c), a cell cycle-regulated e3 ubiquitin ligase that controls progression through mitosis and the g1 phase of the cell cycle. the apc/c complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'lys-48'- and 'lys-63'-linked polyubiquitin chains. {eco:0000269|pubmed:18485873}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ANAPC5,51433,Hs.7101,ENST00000543649,NP710791,GO:0000075(cell cycle checkpoint)|GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000090(mitotic anaphase)|GO:0000278(mitotic cell cycle)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005488(binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005680(anaphase-promoting complex)|GO:0005829(cytosol)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0007094(mitotic cell cycle spindle assembly checkpoint)|GO:0016567(protein ubiquitination)|GO:0019903(protein phosphatase binding)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0051301(cell division)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070979(protein K11-linked ubiquitination),"Homo sapiens anaphase promoting complex subunit 5 (ANAPC5), transcript variant 1, mRNA [NM_016237]",chr12:121746267-121746208,hs|12q24.31,anaphase promoting complex subunit 5,TRUE
693_ZMAT2_153527,Q96NC0,zinc finger matrin-type protein 2,ZMAT2,199,function: involved in pre-mrna splicing as a component of the spliceosome. {eco:0000269|pubmed:28781166}.,subcellular location: nucleus {eco:0000269|pubmed:28781166}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZMAT2,153527,Hs.350194,ENST00000274712,THC2468624,GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens zinc finger, matrin-type 2 (ZMAT2), mRNA [NM_144723]",chr5:140086051-140086110,hs|5q31.3,"zinc finger, matrin-type 2",TRUE
694_GCN1L1_10985,Q92616,eif-2-alpha kinase activator gcn1 (gcn1 eif-2-alpha kinase activator homolog) (gcn1-like protein 1) (general control of amino-acid synthesis 1-like protein 1) (translational activator gcn1) (hsgcn1),GCN1 GCN1L1 KIAA0219,2671,"function: acts as a positive activator of the eif2ak4/gcn2 protein kinase activity in response to amino acid starvation. forms a complex with eif2ak4/gcn2 on translating ribosomes; during this process, gcn1 seems to act as a chaperone to facilitate delivery of uncharged trnas that enter the a site of ribosomes to the trna-binding domain of eif2ak4/gcn2, and hence stimulating eif2ak4/gcn2 kinase activity. participates in the repression of global protein synthesis and in gene-specific mrna translation activation, such as the transcriptional activator atf4, by promoting the eif2ak4/gcn2-mediated phosphorylation of eukaryotic translation initiation factor 2 (eif-2-alpha/eif2s1) on 'ser-52', and hence allowing atf4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion. {eco:0000250|uniprotkb:e9pva8, eco:0000250|uniprotkb:p33892}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:e9pva8}. note=associates with ribosomes in undifferentiated neuroblastoma cells and increases after neuronal differentiation. {eco:0000250|uniprotkb:e9pva8}.,"TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:9039502). Expressed in skeletal muscules, ovary and testis (PubMed:9234705). {ECO:0000269|PubMed:9039502, ECO:0000269|PubMed:9234705}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GCN1L1,10985,Hs.298716,ENST00000300648,THC2491253,"GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006417(regulation of translation)|GO:0008135(translation factor activity, nucleic acid binding)","Homo sapiens GCN1 general control of amino-acid synthesis 1-like 1 (yeast) (GCN1L1), mRNA [NM_006836]",chr12:120565144-120565085,hs|12q24.23,GCN1 general control of amino-acid synthesis 1-like 1 (yeast),TRUE
696_ECI2_10455,O75521,"enoyl-coa delta isomerase 2, mitochondrial (ec 5.3.3.8) (drs-1) (delta(3),delta(2)-enoyl-coa isomerase) (d3,d2-enoyl-coa isomerase) (diazepam-binding inhibitor-related protein 1) (dbi-related protein 1) (dodecenoyl-coa isomerase) (hepatocellular carcinoma-associated antigen 88) (peroxisomal 3,2-trans-enoyl-coa isomerase) (peci) (renal carcinoma antigen ny-ren-1)",ECI2 DRS1 HCA88 PECI,394,function: able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-coa species. has a preference for 3-trans substrates (by similarity). {eco:0000250}.,subcellular location: isoform 1: mitochondrion {eco:0000250}.; subcellular location: isoform 2: peroxisome matrix.,"TISSUE SPECIFICITY: Abundant in heart, skeletal muscle and liver. Expressed in CD34(+) T-cells and CD34(+) bone marrow cells. {ECO:0000269|PubMed:15217832}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ECI2,10455,Hs.15250,ENST00000464583,THC2742330,GO:0000062(fatty-acyl-CoA binding)|GO:0004165(dodecenoyl-CoA delta-isomerase activity)|GO:0005488(binding)|GO:0005739(mitochondrion)|GO:0005777(peroxisome)|GO:0005782(peroxisomal matrix)|GO:0009062(fatty acid catabolic process)|GO:0016853(isomerase activity)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens enoyl-CoA delta isomerase 2 (ECI2), transcript variant 2, mRNA [NM_206836]",chr6:4116182-4116123,hs|6p25.2,enoyl-CoA delta isomerase 2,TRUE
697_N4BP2L2_10443,Q92802,nedd4-binding protein 2-like 2 (phosphonoformate immuno-associated protein 5),N4BP2L2 CG005 PFAAP5,583,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,N4BP2L2,10443,Hs.507680,ENST00000511143,THC2749144,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens NEDD4 binding protein 2-like 2 (N4BP2L2), transcript variant 2, mRNA [NM_014887]",chr13:33091850-33091791,hs|13q13.1,NEDD4 binding protein 2-like 2,TRUE
698_SF1_7536,Q13285,steroidogenic factor 1 (sf-1) (stf-1) (hsf-1) (adrenal 4-binding protein) (fushi tarazu factor homolog 1) (nuclear receptor subfamily 5 group a member 1) (steroid hormone receptor ad4bp),NR5A1 AD4BP FTZF1 SF1,461,"function: transcriptional activator. essential for sexual differentiation and formation of the primary steroidogenic tissues (pubmed:27378692). binds to the ad4 site found in the promoter region of steroidogenic p450 genes such as cyp11a, cyp11b and cyp21b. also regulates the amh/muellerian inhibiting substance gene as well as the ahch and star genes. 5'-ycaaggyc-3' and 5'-rraggtca-3' are the consensus sequences for the recognition by nr5a1 (pubmed:27378692). the sfpq-nono-nr5a1 complex binds to the cyp17 promoter and regulates basal and camp-dependent transcriptional activity. binds phosphatidylcholine (by similarity). binds phospholipids with a phosphatidylinositol (pi) headgroup, in particular pi(3,4)p2 and pi(3,4,5)p3. activated by the phosphorylation of nr5a1 by hipk3 leading to increased steroidogenic gene expression upon camp signaling pathway stimulation. {eco:0000250|uniprotkb:p33242, eco:0000269|pubmed:17210646, eco:0000269|pubmed:27378692, eco:0000269|pubmed:28459839}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00407, eco:0000269|pubmed:11479297, eco:0000269|pubmed:27490115}.","TISSUE SPECIFICITY: High expressed in the adrenal cortex, the ovary, the testis, and the spleen (PubMed:9177385). {ECO:0000269|PubMed:9177385}.","DISEASE: 46,XY sex reversal 3 (SRXY3) [MIM:612965]: A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. {ECO:0000269|PubMed:10369247, ECO:0000269|PubMed:11932325, ECO:0000269|PubMed:17200175, ECO:0000269|PubMed:17694559, ECO:0000269|PubMed:24405868, ECO:0000269|PubMed:27378692, ECO:0000269|PubMed:27490115, ECO:0000269|PubMed:28459839}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XX sex reversal 4 (SRXX4) [MIM:617480]: A condition in which male gonads develop in a genetic female (female to male sex reversal). {ECO:0000269|PubMed:27378692, ECO:0000269|PubMed:27490115, ECO:0000269|PubMed:27610946, ECO:0000269|PubMed:27855412}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adrenal insufficiency, NR5A1-related (AINR) [MIM:612964]: A disorder characterized by adrenal insufficiency, muscular hypotonia, decreased sodium and increased potassium levels, elevated ACTH, salt-wasting crisis, prolonged jaundice, hypoglycemia, and vomiting. {ECO:0000269|PubMed:11038323, ECO:0000269|PubMed:26523528}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Premature ovarian failure 7 (POF7) [MIM:612964]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:19246354}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spermatogenic failure 8 (SPGF8) [MIM:613957]: An infertility disorder characterized by spermatogenesis failure and severe oligozoospermia. {ECO:0000269|PubMed:20887963}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SF1,7536,Hs.502829,ENST00000377390,THC2779582,"GO:0000245(spliceosome assembly)|GO:0000389(nuclear mRNA 3'-splice site recognition)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003676(nucleic acid binding)|GO:0003714(transcription corepressor activity)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0005730(nucleolus)|GO:0005840(ribosome)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0046872(metal ion binding)","Homo sapiens splicing factor 1 (SF1), transcript variant 1, mRNA [NM_004630]",chr11:64532338-64532279,hs|11q13.1,splicing factor 1,TRUE
699_RGPD5_84220,Q99666,ranbp2-like and grip domain-containing protein 5/6 (ran-binding protein 2-like 1/2) (ranbp2-like 1/2) (ranbp2l1) (ranbp2l2) (sperm membrane protein bs-63),RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6,1765,NA,subcellular location: cytoplasm {eco:0000269|pubmed:15710750}.,TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:10101573}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,RGPD5,84220,Hs.469630,ENST00000464730,THC2466286,NA,"Homo sapiens RANBP2-like and GRIP domain containing 5 (RGPD5), transcript variant 1, mRNA [NM_005054]",chr2:110614795-110614854,hs|2q13,RANBP2-like and GRIP domain containing 5,TRUE
7_HDAC10_83933,Q969S8,polyamine deacetylase hdac10 (ec 3.5.1.48) (ec 3.5.1.62) (histone deacetylase 10) (hd10),HDAC10,669,"function: polyamine deacetylase (pdac), which acts preferentially on n(8)-acetylspermidine, and also on acetylcadaverine and acetylputrescine (pubmed:28516954). exhibits attenuated catalytic activity toward n(1),n(8)-diacetylspermidine and very low activity, if any, toward n(1)-acetylspermidine (pubmed:28516954). histone deacetylase activity has been observed in vitro (pubmed:11861901, pubmed:11726666, pubmed:11677242, pubmed:11739383). has also been shown to be involved in msh2 deacetylation (pubmed:26221039). the physiological relevance of protein/histone deacetylase activity is unclear and could be very weak (pubmed:28516954). may play a role in the promotion of late stages of autophagy, possibly autophagosome-lysosome fusion and/or lysosomal exocytosis in neuroblastoma cells (pubmed:23801752, pubmed:29968769). may play a role in homologous recombination (pubmed:21247901). may promote dna mismatch repair (pubmed:26221039). {eco:0000269|pubmed:11677242, eco:0000269|pubmed:11726666, eco:0000269|pubmed:11739383, eco:0000269|pubmed:11861901, eco:0000269|pubmed:21247901, eco:0000269|pubmed:23801752, eco:0000269|pubmed:26221039, eco:0000269|pubmed:28516954, eco:0000269|pubmed:29968769}.","subcellular location: cytoplasm {eco:0000269|pubmed:11677242, eco:0000269|pubmed:11726666, eco:0000269|pubmed:11739383, eco:0000269|pubmed:11861901, eco:0000269|pubmed:23801752}. nucleus {eco:0000269|pubmed:11677242, eco:0000269|pubmed:11726666, eco:0000269|pubmed:11739383, eco:0000269|pubmed:11861901}. note=excluded from nucleoli. {eco:0000269|pubmed:11726666}.","TISSUE SPECIFICITY: Widely expressed with high levels in liver and kidney. {ECO:0000269|PubMed:11677242, ECO:0000269|PubMed:11739383, ECO:0000269|PubMed:11861901}.","DISEASE: Note=In neuroblastoma cells, may promote autophagy in response to chemotherapy-induced DNA damage and efflux of chemotherapeutics via lysosomal exocytosis, hence protecting cells from cytotoxic agents (PubMed:23801752, PubMed:29968769). Expression levels may correlate with survival in neuroblastoma patients, with low levels in the tumor correlating with long-term patient survival and high expression with poor prognosis (PubMed:23801752). Therefore has been proposed as a biomarker to predict neuroblastoma chemoresistance and treatment outcome (PubMed:23801752). {ECO:0000269|PubMed:23801752, ECO:0000269|PubMed:29968769, ECO:0000303|PubMed:23801752}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HDAC10,83933,Hs.26593,ENST00000475965,THC2486522,"GO:0000118(histone deacetylase complex)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0004407(histone deacetylase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006476(protein deacetylation)|GO:0014003(oligodendrocyte development)|GO:0016568(chromatin modification)|GO:0016575(histone deacetylation)|GO:0016787(hydrolase activity)|GO:0019899(enzyme binding)|GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific))|GO:0033558(protein deacetylase activity)|GO:0034739(histone deacetylase activity (H3-K16 specific))|GO:0042826(histone deacetylase binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific))|GO:0046970(NAD-dependent histone deacetylase activity (H4-K16 specific))",histone deacetylase 10 [Source:HGNC Symbol;Acc:18128] [ENST00000475965],chr22:50685744-50685685,hs|22q13.33,histone deacetylase 10,TRUE
70_RPL32_6161,P62910,60s ribosomal protein l32 (large ribosomal subunit protein el32),RPL32 PP9932,135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL32,6161,Hs.265174,ENST00000396953,NP1175331,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L32 (RPL32), transcript variant 3, mRNA [NM_001007074]",chr3:12877621-12877562,hs|3p25.2,ribosomal protein L32,TRUE
700_CBX1_10951,P83916,chromobox protein homolog 1 (hp1hsbeta) (heterochromatin protein 1 homolog beta) (hp1 beta) (heterochromatin protein p25) (m31) (modifier 1 protein) (p25beta),CBX1 CBX,185,"function: component of heterochromatin. recognizes and binds histone h3 tails methylated at 'lys-9', leading to epigenetic repression. interaction with lamin b receptor (lbr) can contribute to the association of the heterochromatin with the inner nuclear membrane. {eco:0000250|uniprotkb:p83917}.","subcellular location: nucleus {eco:0000269|pubmed:10460410, eco:0000269|pubmed:9169582}. note=unassociated with chromosomes during mitosis.",TISSUE SPECIFICITY: Expressed in all adult and embryonic tissues.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CBX1,10951,Hs.77254,ENST00000393408,THC2469660,"GO:0000775(chromosome, centromeric region)|GO:0000785(chromatin)|GO:0001939(female pronucleus)|GO:0001940(male pronucleus)|GO:0003682(chromatin binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005720(nuclear heterochromatin)|GO:0005721(centromeric heterochromatin)|GO:0005819(spindle)|GO:0010369(chromocenter)|GO:0019899(enzyme binding)|GO:0042802(identical protein binding)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens chromobox homolog 1 (CBX1), transcript variant 1, mRNA [NM_006807]",chr17:46147546-46147487,hs|17q21.32,chromobox homolog 1,TRUE
701_ECI1_1632,P42126,"enoyl-coa delta isomerase 1, mitochondrial (ec 5.3.3.8) (3,2-trans-enoyl-coa isomerase) (delta(3),delta(2)-enoyl-coa isomerase) (d3,d2-enoyl-coa isomerase) (dodecenoyl-coa isomerase)",ECI1 DCI,302,function: able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-coa species.,subcellular location: mitochondrion matrix.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ECI1,1632,Hs.403436,ENST00000301729,THC2464894,GO:0004165(dodecenoyl-CoA delta-isomerase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006631(fatty acid metabolic process)|GO:0006635(fatty acid beta-oxidation)|GO:0016860(intramolecular oxidoreductase activity)|GO:0042802(identical protein binding)|GO:0044255(cellular lipid metabolic process),"Homo sapiens enoyl-CoA delta isomerase 1 (ECI1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001919]",chr16:2289997-2289938,hs|16p13.3,enoyl-CoA delta isomerase 1,TRUE
702_ZNF395_55893,Q9H8N7,zinc finger protein 395 (hd-regulating factor 2) (hdrf-2) (huntington disease gene regulatory region-binding protein 2) (hd gene regulatory region-binding protein 2) (hdbp-2) (papillomavirus regulatory factor 1) (prf-1) (papillomavirus-binding factor),ZNF395 HDBP2 PBF,513,function: plays a role in papillomavirus genes transcription.,subcellular location: cytoplasm. nucleus. note=may shuttle between nucleus and cytoplasm.,"TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11853404, ECO:0000269|PubMed:14625278}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF395,55893,Hs.435535,ENST00000521548,THC2462485,"GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 395 (ZNF395), mRNA [NM_018660]",chr8:28205865-28205806,hs|8p21.1,zinc finger protein 395,TRUE
703_THEM5_284486,Q8N1Q8,acyl-coenzyme a thioesterase them5 (acyl-coa thioesterase them5) (ec 3.1.2.2) (acyl-coenzyme a thioesterase 15) (thioesterase superfamily member 5),THEM5 ACOT15,247,"function: has acyl-coa thioesterase activity towards long-chain (c16 and c18) fatty acyl-coa substrates, with a preference for linoleoyl-coa and other unsaturated long-chain fatty acid-coa esters (pubmed:22586271). plays an important role in mitochondrial fatty acid metabolism, and in remodeling of the mitochondrial lipid cardiolipin (pubmed:22586271). required for normal mitochondrial function (pubmed:22586271). {eco:0000269|pubmed:22586271}.",subcellular location: mitochondrion matrix {eco:0000269|pubmed:22586271}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,THEM5,284486,Hs.132648,ENST00000368817,THC2484010,GO:0005739(mitochondrion)|GO:0016787(hydrolase activity),thioesterase superfamily member 5 [Source:HGNC Symbol;Acc:26755] [ENST00000368817],chr1:151819364-151819305,hs|1q21.3,thioesterase superfamily member 5,TRUE
704_XRCC6_2547,P12956,x-ray repair cross-complementing protein 6 (ec 3.6.4.-) (ec 4.2.99.-) (5'-deoxyribose-5-phosphate lyase ku70) (5'-drp lyase ku70) (70 kda subunit of ku antigen) (atp-dependent dna helicase 2 subunit 1) (atp-dependent dna helicase ii 70 kda subunit) (ctc box-binding factor 75 kda subunit) (ctc75) (ctcbf) (dna repair protein xrcc6) (lupus ku autoantigen protein p70) (ku70) (thyroid-lupus autoantigen) (tlaa) (x-ray repair complementing defective repair in chinese hamster cells 6),XRCC6 G22P1,609,"function: single-stranded dna-dependent atp-dependent helicase. has a role in chromosome translocation. the dna helicase ii complex binds preferentially to fork-like ends of double-stranded dna in a cell cycle-dependent manner. it works in the 3'-5' direction. binding to dna may be mediated by xrcc6. involved in dna non-homologous end joining (nhej) required for double-strand break repair and v(d)j recombination. the xrcc5/6 dimer acts as regulatory subunit of the dna-dependent protein kinase complex dna-pk by increasing the affinity of the catalytic subunit prkdc to dna by 100-fold. the xrcc5/6 dimer is probably involved in stabilizing broken dna ends and bringing them together. the assembly of the dna-pk complex to dna ends is required for the nhej ligation step. required for osteocalcin gene expression. probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-drp lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. 5'-drp lyase activity allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. the xrcc5/6 dimer together with apex1 acts as a negative regulator of transcription. plays a role in the regulation of dna virus-mediated innate immune response by assembling into the hdp-rnp complex, a complex that serves as a platform for irf3 phosphorylation and subsequent innate immune response activation through the cgas-sting pathway. {eco:0000269|pubmed:12145306, eco:0000269|pubmed:20383123, eco:0000269|pubmed:20493174, eco:0000269|pubmed:2466842, eco:0000269|pubmed:28712728, eco:0000269|pubmed:7957065, eco:0000269|pubmed:8621488, eco:0000269|pubmed:9742108}.",subcellular location: nucleus {eco:0000269|pubmed:22442688}. chromosome {eco:0000269|pubmed:22442688}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,XRCC6,2547,Hs.292493,ENST00000428575,THC2492168,"GO:0000166(nucleotide binding)|GO:0000723(telomere maintenance)|GO:0000783(nuclear telomere cap complex)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003691(double-stranded telomeric DNA binding)|GO:0004003(ATP-dependent DNA helicase activity)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005694(chromosome)|GO:0005737(cytoplasm)|GO:0005958(DNA-dependent protein kinase-DNA ligase 4 complex)|GO:0006266(DNA ligation)|GO:0006281(DNA repair)|GO:0006302(double-strand break repair)|GO:0006303(double-strand break repair via nonhomologous end joining)|GO:0008022(protein C-terminus binding)|GO:0010212(response to ionizing radiation)|GO:0016032(viral reproduction)|GO:0016787(hydrolase activity)|GO:0016829(lyase activity)|GO:0019047(provirus integration)|GO:0019059(initiation of viral infection)|GO:0033151(V(D)J recombination)|GO:0043564(Ku70:Ku80 complex)|GO:0044212(transcription regulatory region DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0050769(positive regulation of neurogenesis)|GO:0051575(5'-deoxyribose-5-phosphate lyase activity)|GO:0070419(nonhomologous end joining complex)","Homo sapiens X-ray repair complementing defective repair in Chinese hamster cells 6 (XRCC6), mRNA [NM_001469]",chr22:42059942-42060001,hs|22q13.2,X-ray repair complementing defective repair in Chinese hamster cells 6,TRUE
705_TMEM14C_51522,Q9P0S9,transmembrane protein 14c,TMEM14C C6orf53 HSPC194,112,function: required for normal heme biosynthesis. {eco:0000250}.,subcellular location: mitochondrion membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM14C,51522,Hs.519557,ENST00000541412,THC2493842,GO:0005739(mitochondrion)|GO:0006783(heme biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031966(mitochondrial membrane),"Homo sapiens transmembrane protein 14C (TMEM14C), transcript variant 2, mRNA [NM_016462]",chr6:10731156-10731215,hs|6p24.2,transmembrane protein 14C,TRUE
706_CYHR1_50626,Q6ZMK1,cysteine and histidine-rich protein 1,CYHR1 KIAA0496,362,NA,"subcellular location: cytoplasm {eco:0000250}. cytoplasm, perinuclear region {eco:0000250}. note=shows a prominent perinuclear and cytoplasmic localization. {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,CYHR1,50626,Hs.459379,ENST00000306145,THC2497018,GO:0005635(nuclear envelope)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens cysteine/histidine-rich 1 (CYHR1), transcript variant 2, mRNA [NM_032687]",chr8:145689374-145689315,hs|8q24.3,cysteine/histidine-rich 1,TRUE
707_MORF4L1_10933,Q9UBU8,mortality factor 4-like protein 1 (morf-related gene 15 protein) (protein msl3-1) (transcription factor-like protein mrg15),MORF4L1 MRG15 FWP006 HSPC008 HSPC061 PP368,362,"function: component of the nua4 histone acetyltransferase (hat) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones h4 and h2a. this modification may both alter nucleosome - dna interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. this complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and dna repair. the nua4 complex atpase and helicase activities seem to be, at least in part, contributed by the association of ruvbl1 and ruvbl2 with ep400. nua4 may also play a direct role in dna repair when directly recruited to sites of dna damage. also component of the msin3a complex which acts to repress transcription by deacetylation of nucleosomal histones. required for homologous recombination repair (hrr) and resistance to mitomycin c (mmc). involved in the localization of palb2, brca2 and rad51, but not brca1, to dna-damage foci. {eco:0000269|pubmed:14966270, eco:0000269|pubmed:20332121}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MORF4L1,10933,Hs.374503,ENST00000379535,THC2598899,"GO:0000724(double-strand break repair via homologous recombination)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006281(DNA repair)|GO:0006310(DNA recombination)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0016568(chromatin modification)|GO:0016575(histone deacetylation)|GO:0016580(Sin3 complex)|GO:0035267(NuA4 histone acetyltransferase complex)|GO:0040008(regulation of growth)|GO:0043967(histone H4 acetylation)|GO:0043968(histone H2A acetylation)|GO:0047485(protein N-terminus binding)","Homo sapiens mortality factor 4 like 1 (MORF4L1), transcript variant 2, mRNA [NM_206839]",chr15:79189673-79189732,hs|15q25.1,mortality factor 4 like 1,TRUE
708_CYTH1_9267,Q15438,"cytohesin-1 (ph, sec7 and coiled-coil domain-containing protein 1) (sec7 homolog b2-1)",CYTH1 D17S811E PSCD1,398,"function: promotes guanine-nucleotide exchange on arf1, arf5 and arf6. promotes the activation of arf factors through replacement of gdp with gtp. plays an important role in membrane trafficking, during junctional remodeling and epithelial polarization, through regulation of arf6 activity. {eco:0000250|uniprotkb:q9qx11, eco:0000269|pubmed:10652308, eco:0000269|pubmed:29420262, eco:0000269|pubmed:9653114}.","subcellular location: cell membrane {eco:0000269|pubmed:17398095}; peripheral membrane protein {eco:0000269|pubmed:17398095}. cytoplasm, cytosol {eco:0000250|uniprotkb:q9qx11}. cell junction, tight junction {eco:0000250|uniprotkb:q9qx11}. cell junction, adherens junction {eco:0000250|uniprotkb:q9qx11}. note=colocalized with tjp1 during epithelial polarization. {eco:0000250|uniprotkb:q9qx11}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CYTH1,9267,Hs.191215,ENST00000361101,THC2465820,GO:0005086(ARF guanyl-nucleotide exchange factor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0016192(vesicle-mediated transport)|GO:0030155(regulation of cell adhesion)|GO:0032012(regulation of ARF protein signal transduction),"Homo sapiens cytohesin 1 (CYTH1), transcript variant 1, mRNA [NM_004762]",chr17:76670197-76670138,hs|17q25.3,cytohesin 1,TRUE
709_NAMPT_10135,P43490,nicotinamide phosphoribosyltransferase (namprtase) (nampt) (ec 2.4.2.12) (pre-b-cell colony-enhancing factor 1) (pre-b cell-enhancing factor) (visfatin),NAMPT PBEF PBEF1,491,"function: catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of nad. it is the rate limiting component in the mammalian nad biosynthesis pathway. the secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by atp, which has a low level in extracellular space and plasma. plays a role in the modulation of circadian clock function. nampt-dependent oscillatory production of nad regulates oscillation of clock target gene expression by releasing the core clock component: clock-arntl/bmal1 heterodimer from nad-dependent sirt1-mediated suppression (by similarity). {eco:0000250|uniprotkb:q99kq4, eco:0000269|pubmed:24130902}.","subcellular location: nucleus {eco:0000269|pubmed:24130902}. cytoplasm {eco:0000250|uniprotkb:q99kq4}. secreted {eco:0000269|pubmed:21741723}. note=under non-inflammatory conditions, visfatin predominantly exhibits a granular pattern within the nucleus. secreted by endothelial cells upon il-1beta stimulation. abundantly secreted in milk, reaching 100-fold higher concentrations compared to maternal serum. {eco:0000269|pubmed:21741723, eco:0000269|pubmed:24130902}.","TISSUE SPECIFICITY: Expressed in large amounts in bone marrow, liver tissue, and muscle. Also present in heart, placenta, lung, and kidney tissues.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NAMPT,10135,Hs.489615,ENST00000440465,THC2470157,"GO:0004514(nicotinate-nucleotide diphosphorylase (carboxylating) activity)|GO:0004516(nicotinate phosphoribosyltransferase activity)|GO:0005125(cytokine activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006766(vitamin metabolic process)|GO:0006767(water-soluble vitamin metabolic process)|GO:0006769(nicotinamide metabolic process)|GO:0007165(signal transduction)|GO:0007267(cell-cell signaling)|GO:0008284(positive regulation of cell proliferation)|GO:0008286(insulin receptor signaling pathway)|GO:0009435(NAD biosynthetic process)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0019363(pyridine nucleotide biosynthetic process)|GO:0019674(NAD metabolic process)|GO:0047280(nicotinamide phosphoribosyltransferase activity)|GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process)|GO:0060612(adipose tissue development)","Homo sapiens nicotinamide phosphoribosyltransferase (NAMPT), mRNA [NM_005746]",chr7:105890767-105890708,hs|7q22.3,nicotinamide phosphoribosyltransferase,TRUE
71_SERF2_10169,P84101,small edrk-rich factor 2 (gastric cancer-related protein vrg107) (protein 4f5-related) (4f5rel) (h4f5rel),SERF2 FAM2C,59,"function: positive regulator of amyloid protein aggregation and proteotoxicity (pubmed:20723760). induces conformational changes in amyloid proteins, such as htt, driving them into compact formations preceding the formation of aggregates (pubmed:20723760). {eco:0000269|pubmed:20723760}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,SERF2,10169,Hs.424126,ENST00000381359,THC2463118,GO:0003674(molecular_function)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0008150(biological_process),"Homo sapiens small EDRK-rich factor 2 (SERF2), transcript variant 3, mRNA [NM_001018108]",chr15:44086178-44086237,hs|15q15.3,small EDRK-rich factor 2,TRUE
710_GPBP1_65056,Q86WP2,vasculin (gc-rich promoter-binding protein 1) (vascular wall-linked protein),GPBP1 GPBP SSH6,473,function: functions as a gc-rich promoter-specific transactivating transcription factor. {eco:0000250|uniprotkb:q6nxh3}.,"subcellular location: nucleus {eco:0000269|pubmed:14612417}. cytoplasm {eco:0000269|pubmed:12842993}. note=according to pubmed:12842993, it localizes to the cytoplasm. {eco:0000269|pubmed:12842993}.","TISSUE SPECIFICITY: Widely expressed. Some isoforms may be specifically expressed in veins and arteries (at protein level). Isoform 4 is widely expressed. Isoform 1, isoform 2 and isoform 3 may be specifically expressed in vascular smooth muscle cells. {ECO:0000269|PubMed:12842993, ECO:0000269|PubMed:14612417}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,GPBP1,65056,Hs.444279,ENST00000506184,THC2521644,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens GC-rich promoter binding protein 1 (GPBP1), transcript variant 1, mRNA [NM_022913]",chr5:56558753-56558812,hs|5q11.2,GC-rich promoter binding protein 1,TRUE
711_ENY2_56943,Q9NPA8,transcription and mrna export factor eny2 (enhancer of yellow 2 transcription factor homolog),ENY2 DC6,101,"function: involved in mrna export coupled transcription activation by association with both the trex-2 and the saga complexes. the transcription regulatory histone acetylation (hat) complex saga is a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. within the saga complex, participates in a subcomplex that specifically deubiquitinates both histones h2a and h2b. the saga complex is recruited to specific gene promoters by activators such as myc, where it is required for transcription. required for nuclear receptor-mediated transactivation (pubmed:18206972, pubmed:21746879). as a component of the trex-2 complex, involved in the export of mrnas to the cytoplasm through the nuclear pores (pubmed:23591820). {eco:0000269|pubmed:18206972, eco:0000269|pubmed:21746879, eco:0000269|pubmed:23591820}.","subcellular location: nucleus, nucleoplasm {eco:0000255|hamap-rule:mf_03046, eco:0000269|pubmed:22307388}. nucleus, nuclear pore complex {eco:0000255|hamap-rule:mf_03046, eco:0000269|pubmed:22307388, eco:0000269|pubmed:23591820}. note=localization at the nuclear pore complex requires nup153 and tpr. {eco:0000269|pubmed:23591820}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ENY2,56943,Hs.492555,ENST00000517350,THC2694807,"GO:0000124(SAGA complex)|GO:0003713(transcription coactivator activity)|GO:0005634(nucleus)|GO:0006810(transport)|GO:0016568(chromatin modification)|GO:0016578(histone deubiquitination)|GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0051028(mRNA transport)","Homo sapiens enhancer of yellow 2 homolog (Drosophila) (ENY2), transcript variant 1, mRNA [NM_020189]",chr8:110355682-110355741,hs|8q23.1,enhancer of yellow 2 homolog (Drosophila),TRUE
712_HIST1H2AK_8330,P0C0S8,histone h2a type 1 (h2a.1) (histone h2a/ptl),H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2AK,8330,Hs.558421,ENST00000330180,THC2536096,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 1, H2ak (HIST1H2AK), mRNA [NM_003510]",chr6:27805788-27805729,hs|6p22.1,"histone cluster 1, H2ak",TRUE
713_SERBP1_26135,Q8NC51,plasminogen activator inhibitor 1 rna-binding protein (pai1 rna-binding protein 1) (pai-rbp1) (serpine1 mrna-binding protein 1),SERBP1 PAIRBP1 CGI-55,408,"function: may play a role in the regulation of mrna stability. binds to the 3'-most 134 nt of the serpine1/pai1 mrna, a region which confers cyclic nucleotide regulation of message decay. seems to play a role in pml-nuclear bodies formation (pubmed:28695742). {eco:0000269|pubmed:11001948, eco:0000269|pubmed:28695742}.","subcellular location: cytoplasm {eco:0000269|pubmed:12505151, eco:0000269|pubmed:28695742}. nucleus {eco:0000269|pubmed:12505151, eco:0000269|pubmed:28695742}. cytoplasm, perinuclear region {eco:0000269|pubmed:12505151}.","TISSUE SPECIFICITY: Expressed at high level in the heart, skeletal muscle and kidney, and at low levels in placenta, liver and brain. {ECO:0000269|PubMed:12505151}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SERBP1,26135,Hs.730604,ENST00000462814,THC2581085,GO:0003723(RNA binding)|GO:0003730(mRNA 3'-UTR binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0043488(regulation of mRNA stability)|GO:0045767(regulation of anti-apoptosis)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens SERPINE1 mRNA binding protein 1 (SERBP1), transcript variant 1, mRNA [NM_001018067]",chr1:67885693-67880965,hs|1p31.3,SERPINE1 mRNA binding protein 1,TRUE
714_MYH9_4627,P35579,"myosin-9 (cellular myosin heavy chain, type a) (myosin heavy chain 9) (myosin heavy chain, non-muscle iia) (non-muscle myosin heavy chain a) (nmmhc-a) (non-muscle myosin heavy chain iia) (nmmhc ii-a) (nmmhc-iia)",MYH9,1960,"function: cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. during cell spreading, plays an important role in cytoskeleton reorganization, focal contacts formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanically antagonized by myh10. {eco:0000269|pubmed:20052411}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q8vdd5}. cytoplasm, cell cortex {eco:0000250|uniprotkb:q8vdd5}. note=colocalizes with actin filaments at lamellipodia margins and at the leading edge of migrating cells (pubmed:20052411). in retinal pigment epithelial cells, predominantly localized to stress fiber-like structures with some localization to cytoplasmic puncta (pubmed:27331610). {eco:0000269|pubmed:20052411, eco:0000269|pubmed:27331610}.","TISSUE SPECIFICITY: In the kidney, expressed in the glomeruli. Also expressed in leukocytes. {ECO:0000269|PubMed:11752022, ECO:0000269|PubMed:1912569}.","DISEASE: Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]: An autosomal dominant disorder characterized by thrombocytopenia, giant platelets and Dohle body-like inclusions in peripheral blood leukocytes with variable ultrastructural appearance. Some affected individuals lack leukocyte inclusion bodies on classic staining of peripheral blood smears. Alport syndrome-like features of nephritis, hearing loss, and eye abnormalities are present in some patients. {ECO:0000269|PubMed:10973259, ECO:0000269|PubMed:10973260, ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:11752022, ECO:0000269|PubMed:11776386, ECO:0000269|PubMed:11935325, ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12621333, ECO:0000269|PubMed:12649151, ECO:0000269|PubMed:12792306, ECO:0000269|PubMed:16969870}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 17 (DFNA17) [MIM:603622]: A form of deafness characterized by progressive high frequency hearing impairment and cochleosaccular degeneration. {ECO:0000269|PubMed:11023810}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Subjects with mutations in the motor domain of MYH9 present with severe thrombocytopenia and develop nephritis and deafness before the age of 40 years, while those with mutations in the tail domain have a much lower risk of noncongenital complications and significantly higher platelet counts. The clinical course of patients with mutations in the four most frequently affected residues of MYH9 (responsible for 70% of MYH9-related cases) were evaluated. Mutations at residue 1933 do not induce kidney damage or cataracts and cause deafness only in the elderly, those in position 702 result in severe thrombocytopenia and produce nephritis and deafness at a juvenile age, while alterations at residue 1424 or 1841 result in intermediate clinical pictures.; DISEASE: Note=Genetic variations in MYH9 are associated with non-diabetic end stage renal disease (ESRD).",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,MYH9,4627,Hs.474751,ENST00000216181,THC2465306,GO:0000146(microfilament motor activity)|GO:0000166(nucleotide binding)|GO:0000212(meiotic spindle organization)|GO:0000904(cell morphogenesis involved in differentiation)|GO:0000910(cytokinesis)|GO:0001525(angiogenesis)|GO:0001701(in utero embryonic development)|GO:0001725(stress fiber)|GO:0001726(ruffle)|GO:0001768(establishment of T cell polarity)|GO:0001772(immunological synapse)|GO:0001931(uropod)|GO:0003774(motor activity)|GO:0003779(actin binding)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005819(spindle)|GO:0005826(actomyosin contractile ring)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005913(cell-cell adherens junction)|GO:0005938(cell cortex)|GO:0006200(ATP catabolic process)|GO:0006509(membrane protein ectodomain proteolysis)|GO:0007132(meiotic metaphase I)|GO:0007229(integrin-mediated signaling pathway)|GO:0007411(axon guidance)|GO:0007520(myoblast fusion)|GO:0008180(signalosome)|GO:0008305(integrin complex)|GO:0008360(regulation of cell shape)|GO:0015031(protein transport)|GO:0015629(actin cytoskeleton)|GO:0016337(cell-cell adhesion)|GO:0016459(myosin complex)|GO:0016460(myosin II complex)|GO:0016887(ATPase activity)|GO:0030048(actin filament-based movement)|GO:0030220(platelet formation)|GO:0030224(monocyte differentiation)|GO:0030863(cortical cytoskeleton)|GO:0030898(actin-dependent ATPase activity)|GO:0031252(cell leading edge)|GO:0031532(actin cytoskeleton reorganization)|GO:0031594(neuromuscular junction)|GO:0032154(cleavage furrow)|GO:0032796(uropod organization)|GO:0042803(protein homodimerization activity)|GO:0043234(protein complex)|GO:0043495(protein anchor)|GO:0043531(ADP binding)|GO:0043534(blood vessel endothelial cell migration)|GO:0050900(leukocyte migration)|GO:0051015(actin filament binding)|GO:0051295(establishment of meiotic spindle localization),"Homo sapiens myosin, heavy chain 9, non-muscle (MYH9), mRNA [NM_002473]",chr22:36677646-36677587,hs|22q12.3,"myosin, heavy chain 9, non-muscle",TRUE
715_TMEM123_114908,Q8N131,porimin (keratinocytes-associated transmembrane protein 3) (kct-3) (pro-oncosis receptor inducing membrane injury) (transmembrane protein 123),TMEM123 KCT3 PSEC0111 UNQ641/PRO1271,208,"function: implicated in oncotic cell death, characterized by cell swelling, organelle swelling, vacuolization and increased membrane permeability. {eco:0000269|pubmed:11481458}.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Ubiquitous. Not expressed in ovary. Expressed in keratinocytes. {ECO:0000269|PubMed:11481458, ECO:0000269|PubMed:12752121}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM123,114908,Hs.503709,ENST00000398136,THC2536867,GO:0004872(receptor activity)|GO:0009897(external side of plasma membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0070267(oncosis),"Homo sapiens transmembrane protein 123 (TMEM123), mRNA [NM_052932]",chr11:102267545-102267486,hs|11q22.2,transmembrane protein 123,TRUE
716_GTF3C6_112495,Q969F1,general transcription factor 3c polypeptide 6 (transcription factor iiic 35 kda subunit) (tfiiic 35 kda subunit) (tfiiic35) (transcription factor iiic subunit 6),GTF3C6 C6orf51 CDA020 NPD020,213,"function: involved in rna polymerase iii-mediated transcription. integral, tightly associated component of the dna-binding tfiiic2 subcomplex that directly binds trna and virus-associated rna promoters. {eco:0000269|pubmed:17409385}.",subcellular location: nucleus {eco:0000269|pubmed:17409385}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GTF3C6,112495,Hs.418520,ENST00000329970,THC2598016,"GO:0000127(transcription factor TFIIIC complex)|GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006351(transcription, DNA-dependent)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0042791(5S class rRNA transcription from RNA polymerase III type 1 promoter)|GO:0042797(tRNA transcription from RNA polymerase III promoter)","Homo sapiens general transcription factor IIIC, polypeptide 6, alpha 35kDa (GTF3C6), mRNA [NM_138408]",chr6:111288903-111288962,hs|6q21,"general transcription factor IIIC, polypeptide 6, alpha 35kDa",TRUE
717_REEP5_7905,Q00765,receptor expression-enhancing protein 5 (polyposis locus protein 1) (protein tb2),REEP5 C5orf18 DP1 TB2,189,function: may promote functional cell surface expression of olfactory receptors.,subcellular location: membrane {eco:0000255}; multi-pass membrane protein {eco:0000255}. endoplasmic reticulum {eco:0000269|pubmed:23969831}. note=localizes to endoplasmic reticulum tubular network. {eco:0000269|pubmed:23969831}.,TISSUE SPECIFICITY: Expressed in circumvallate papillae and testis. {ECO:0000269|PubMed:16720576}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,REEP5,7905,Hs.429608,ENST00000379638,THC2470188,GO:0003674(molecular_function)|GO:0005515(protein binding)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens receptor accessory protein 5 (REEP5), mRNA [NM_005669]",chr5:112212209-112212150,hs|5q22.2,receptor accessory protein 5,TRUE
718_HIST1H4C_8364,P62805,histone h4,H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4,103,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,"DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6. {ECO:0000269|PubMed:12414651}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H4C,8364,Hs.46423,NA,THC2699129,NA,"Homo sapiens histone cluster 1, H4c (HIST1H4C), mRNA [NM_003542]",chr6:26104468-26104527,hs|6p22.2,"histone cluster 1, H4c",TRUE
719_FAM156A_29057,Q8NDB6,protein fam156a/fam156b (transmembrane protein 29/29b),FAM156A TMEM29 PP12994 PRO0659; FAM156B TMEM29B,213,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,FAM156A,29057,Hs.653131,ENST00000452021,THC2513133,NA,"Homo sapiens family with sequence similarity 156, member A (FAM156A), transcript variant 1, mRNA [NM_014138]",chrX:52976645-52976586,hs|Xp11.22,"family with sequence similarity 156, member A",TRUE
720_SNRPC_6631,P09234,u1 small nuclear ribonucleoprotein c (u1 snrnp c) (u1-c) (u1c),SNRPC,159,"function: component of the spliceosomal u1 snrnp, which is essential for recognition of the pre-mrna 5' splice-site and the subsequent assembly of the spliceosome. snrpc/u1-c is directly involved in initial 5' splice-site recognition for both constitutive and regulated alternative splicing. the interaction with the 5' splice-site seems to precede base-pairing between the pre-mrna and the u1 snrna. stimulates commitment or early (e) complex formation by stabilizing the base pairing of the 5' end of the u1 snrna and the 5' splice-site region. {eco:0000255|hamap-rule:mf_03153, eco:0000269|pubmed:1826349, eco:0000269|pubmed:19325628, eco:0000269|pubmed:2136774, eco:0000269|pubmed:8798632}.","subcellular location: nucleus {eco:0000255|hamap-rule:mf_03153, eco:0000269|pubmed:2136774}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPC,6631,Hs.1063,ENST00000374018,THC2579571,"GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003676(nucleic acid binding)|GO:0003723(RNA binding)|GO:0003727(single-stranded RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005685(U1 snRNP)|GO:0008270(zinc ion binding)|GO:0015030(Cajal body)|GO:0030529(ribonucleoprotein complex)|GO:0030619(U1 snRNA binding)|GO:0042803(protein homodimerization activity)|GO:0046872(metal ion binding)","Homo sapiens small nuclear ribonucleoprotein polypeptide C (SNRPC), transcript variant 1, mRNA [NM_003093]",chr6:34741363-34741422,hs|6p21.31,small nuclear ribonucleoprotein polypeptide C,TRUE
721_HADH_3033,Q99714,3-hydroxyacyl-coa dehydrogenase type-2 (ec 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-hsd 10) (ec 1.1.1.51) (2-methyl-3-hydroxybutyryl-coa dehydrogenase) (mhbd) (3-hydroxy-2-methylbutyryl-coa dehydrogenase) (ec 1.1.1.178) (3-hydroxyacyl-coa dehydrogenase type ii) (endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (mitochondrial ribonuclease p protein 2) (mitochondrial rnase p protein 2) (short chain dehydrogenase/reductase family 5c member 1) (short-chain type dehydrogenase/reductase xh98g2) (type ii hadh),HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2,261,"function: mitochondrial dehydrogenase that catalyzes the beta-oxidation at position 17 of androgens and estrogens and has 3-alpha-hydroxysteroid dehydrogenase activity with androsterone (pubmed:9553139, pubmed:23042678, pubmed:12917011, pubmed:18996107, pubmed:25925575, pubmed:28888424). catalyzes the third step in the beta-oxidation of fatty acids (pubmed:9553139, pubmed:12917011, pubmed:18996107, pubmed:25925575, pubmed:28888424). carries out oxidative conversions of 7-alpha-oh and 7-beta-oh bile acids (pubmed:12917011). also exhibits 20-beta-oh and 21-oh dehydrogenase activities with c21 steroids (pubmed:12917011). by interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with alzheimer disease (ad) (pubmed:9338779). essential for structural and functional integrity of mitochondria (pubmed:20077426). {eco:0000269|pubmed:12917011, eco:0000269|pubmed:18996107, eco:0000269|pubmed:20077426, eco:0000269|pubmed:23042678, eco:0000269|pubmed:25925575, eco:0000269|pubmed:26950678, eco:0000269|pubmed:28888424, eco:0000269|pubmed:9338779, eco:0000269|pubmed:9553139}.; function: in addition to mitochondrial dehydrogenase activity, moonlights as a component of mitochondrial ribonuclease p, a complex that cleaves trna molecules in their 5'-ends (pubmed:18984158, pubmed:24549042, pubmed:25925575, pubmed:26950678, pubmed:28888424). together with hsd17b10/mrpp2, forms a subcomplex of the mitochondrial ribonuclease p, named mrpp1-mrpp2 subcomplex, which displays functions that are independent of the ribonuclease p activity (pubmed:23042678, pubmed:29040705). the mrpp1-mrpp2 subcomplex catalyzes the formation of n(1)-methylguanine and n(1)-methyladenine at position 9 (m1g9 and m1a9, respectively) in trnas; hsd17b10/mrpp2 acting as a non-catalytic subunit (pubmed:23042678, pubmed:25925575, pubmed:28888424). the mrpp1-mrpp2 subcomplex also acts as a trna maturation platform: following 5'-end cleavage by the mitochondrial ribonuclease p complex, the mrpp1-mrpp2 subcomplex enhances the efficiency of 3'-processing catalyzed by elac2, retains the trna product after elac2 processing and presents the nascent trna to the mitochondrial cca trna nucleotidyltransferase trnt1 enzyme (pubmed:29040705). {eco:0000269|pubmed:18984158, eco:0000269|pubmed:23042678, eco:0000269|pubmed:24549042, eco:0000269|pubmed:25925575, eco:0000269|pubmed:26950678, eco:0000269|pubmed:28888424, eco:0000269|pubmed:29040705}.","subcellular location: mitochondrion {eco:0000269|pubmed:12917011, eco:0000269|pubmed:18984158}.",TISSUE SPECIFICITY: Ubiquitously expressed in normal tissues but is overexpressed in neurons affected in AD. {ECO:0000269|PubMed:9338779}.,"DISEASE: HDS10 mitochondrial disease (HSD10MD) [MIM:300438]: An X-linked multisystemic disorder with highly variable severity. Age at onset ranges from the neonatal period to early childhood. Features include progressive neurodegeneration, psychomotor retardation, loss of mental and motor skills, seizures, cardiomyopathy, and visual and hearing impairment. Some patients manifest lactic acidosis and metabolic acidosis. {ECO:0000269|PubMed:12696021, ECO:0000269|PubMed:16148061, ECO:0000269|PubMed:17236142, ECO:0000269|PubMed:18996107, ECO:0000269|PubMed:19706438, ECO:0000269|PubMed:20077426, ECO:0000269|PubMed:22132097, ECO:0000269|PubMed:24549042, ECO:0000269|PubMed:25575635, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HADH,3033,Hs.438289,ENST00000505878,THC2785631,GO:0000166(nucleotide binding)|GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006631(fatty acid metabolic process)|GO:0006635(fatty acid beta-oxidation)|GO:0009725(response to hormone stimulus)|GO:0014823(response to activity)|GO:0016491(oxidoreductase activity)|GO:0032868(response to insulin stimulus)|GO:0042493(response to drug)|GO:0044255(cellular lipid metabolic process)|GO:0046676(negative regulation of insulin secretion)|GO:0050662(coenzyme binding)|GO:0070403(NAD+ binding),"Homo sapiens hydroxyacyl-CoA dehydrogenase (HADH), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_005327]",chr4:108956110-108956169,hs|4q25,hydroxyacyl-CoA dehydrogenase,TRUE
722_NDUFAF3_25915,Q9BU61,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,NDUFAF3 C3orf60,184,function: essential factor for the assembly of mitochondrial nadh:ubiquinone oxidoreductase complex (complex i). {eco:0000269|pubmed:19463981}.,subcellular location: nucleus {eco:0000250}. mitochondrion inner membrane {eco:0000269|pubmed:19463981}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 18 (MC1DN18) [MIM:618240]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN18 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:19463981, ECO:0000269|PubMed:27986404}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFAF3,25915,Hs.31387,ENST00000496152,THC2539654,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0016020(membrane)|GO:0032981(mitochondrial respiratory chain complex I assembly),"Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3 (NDUFAF3), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_199069]",chr3:49060618-49060677,hs|3p21.31,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3",TRUE
723_MRPS21_54460,P82921,"28s ribosomal protein s21, mitochondrial (mrp-s21) (s21mt) (mitochondrial small ribosomal subunit protein bs21m)",MRPS21 RPMS21 MDS016,87,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS21,54460,Hs.405880,ENST00000369084,THC2489422,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005763(mitochondrial small ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein S21 (MRPS21), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_031901]",chr1:150280584-150280643,hs|1q21.2,mitochondrial ribosomal protein S21,TRUE
724_CCT3_7203,P49368,t-complex protein 1 subunit gamma (tcp-1-gamma) (cct-gamma) (htric5),CCT3 CCTG TRIC5,545,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). as part of the tric complex may play a role in the assembly of bbsome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (pubmed:20080638). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:20080638, eco:0000269|pubmed:25467444, eco:0000305}.",subcellular location: cytoplasm {eco:0000305}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CCT3,7203,Hs.491494,ENST00000368261,THC2555909,GO:0000166(nucleotide binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0006457(protein folding)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens chaperonin containing TCP1, subunit 3 (gamma) (CCT3), transcript variant 1, mRNA [NM_005998]",chr1:156280437-156280378,hs|1q22,"chaperonin containing TCP1, subunit 3 (gamma)",TRUE
725_GAA_2548,O43292,glycosylphosphatidylinositol anchor attachment 1 protein (gpi anchor attachment protein 1) (gaa1 protein homolog) (hgaa1),GPAA1 GAA1,621,"function: essential for gpi-anchoring of precursor proteins but not for gpi synthesis. acts before or during formation of the carbonyl intermediate. {eco:0000269|pubmed:29100095, eco:0000269|pubmed:9468317}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:11483512}; multi-pass membrane protein {eco:0000269|pubmed:11483512}.,TISSUE SPECIFICITY: Ubiquitously expressed in fetal and adult tissues. Expressed at higher levels in fetal tissues than adult tissues. {ECO:0000269|PubMed:9468317}.,"DISEASE: Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]: An autosomal recessive disorder characterized by delayed psychomotor development, variable intellectual disability, hypotonia, early-onset seizures in most patients, and cerebellar atrophy, resulting in cerebellar signs including gait ataxia and dysarthria. {ECO:0000269|PubMed:29100095}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GAA,2548,Hs.1437,ENST00000302262,THC2466367,"GO:0000023(maltose metabolic process)|GO:0002026(regulation of the force of heart contraction)|GO:0002086(diaphragm contraction)|GO:0003007(heart morphogenesis)|GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds)|GO:0004558(alpha-glucosidase activity)|GO:0005764(lysosome)|GO:0005765(lysosomal membrane)|GO:0005975(carbohydrate metabolic process)|GO:0005980(glycogen catabolic process)|GO:0005985(sucrose metabolic process)|GO:0006006(glucose metabolic process)|GO:0007040(lysosome organization)|GO:0007517(muscle organ development)|GO:0007626(locomotory behavior)|GO:0009888(tissue development)|GO:0016020(membrane)|GO:0030246(carbohydrate binding)|GO:0032450(maltose alpha-glucosidase activity)|GO:0043181(vacuolar sequestering)|GO:0043587(tongue morphogenesis)|GO:0046716(muscle cell homeostasis)|GO:0050884(neuromuscular process controlling posture)|GO:0050885(neuromuscular process controlling balance)|GO:0055010(ventricular cardiac muscle tissue morphogenesis)|GO:0060048(cardiac muscle contraction)","Homo sapiens glucosidase, alpha; acid (GAA), transcript variant 1, mRNA [NM_000152]",chr17:78093595-78093654,hs|17q25.3,"glucosidase, alpha; acid",TRUE
726_HIPK2_28996,Q9H2X6,homeodomain-interacting protein kinase 2 (hhipk2) (ec 2.7.11.1),HIPK2,1198,"function: serine/threonine-protein kinase involved in transcription regulation, p53/tp53-mediated cellular apoptosis and regulation of the cell cycle. acts as a corepressor of several transcription factors, including smad1 and pou4f1/brn3a and probably nk homeodomain transcription factors. phosphorylates pdx1, atf1, pml, p53/tp53, creb1, ctbp1, cbx4, runx1, ep300, ctnnb1, hmga1 and zbtb4. inhibits cell growth and promotes apoptosis through the activation of p53/tp53 both at the transcription level and at the protein level (by phosphorylation and indirect acetylation). the phosphorylation of p53/tp53 may be mediated by a p53/tp53-hipk2-axin1 complex. involved in the response to hypoxia by acting as a transcriptional co-suppressor of hif1a. mediates transcriptional activation of tp73. in response to tgfb, cooperates with daxx to activate jnk. negative regulator through phosphorylation and subsequent proteasomal degradation of ctnnb1 and the antiapoptotic factor ctbp1. in the wnt/beta-catenin signaling pathway acts as an intermediate kinase between map3k7/tak1 and nlk to promote the proteasomal degradation of myb. phosphorylates cbx4 upon dna damage and promotes its e3 sumo-protein ligase activity. activates creb1 and atf1 transcription factors by phosphorylation in response to genotoxic stress. in response to dna damage, stabilizes pml by phosphorylation. pml, hipk2 and fbxo3 may act synergically to activate p53/tp53-dependent transactivation. promotes angiogenesis, and is involved in erythroid differentiation, especially during fetal liver erythropoiesis. phosphorylation of runx1 and ep300 stimulates ep300 transcription regulation activity. triggers zbtb4 protein degradation in response to dna damage. modulates hmga1 dna-binding affinity. in response to high glucose, triggers phosphorylation-mediated subnuclear localization shifting of pdx1. involved in the regulation of eye size, lens formation and retinal lamination during late embryogenesis. {eco:0000269|pubmed:11740489, eco:0000269|pubmed:11925430, eco:0000269|pubmed:12851404, eco:0000269|pubmed:12874272, eco:0000269|pubmed:14678985, eco:0000269|pubmed:17018294, eco:0000269|pubmed:17960875, eco:0000269|pubmed:18695000, eco:0000269|pubmed:18809579, eco:0000269|pubmed:19015637, eco:0000269|pubmed:19046997, eco:0000269|pubmed:19448668, eco:0000269|pubmed:20307497, eco:0000269|pubmed:20573984, eco:0000269|pubmed:20637728, eco:0000269|pubmed:20980392, eco:0000269|pubmed:21192925, eco:0000269|pubmed:22825850}.","subcellular location: nucleus, pml body {eco:0000269|pubmed:27211601}. cytoplasm. note=concentrated in pml/pod/nd10 nuclear bodies. small amounts are cytoplasmic.","TISSUE SPECIFICITY: Highly expressed in heart, muscle and kidney. Weakly expressed in a ubiquitous way. Down-regulated in several thyroid and breast tumors. {ECO:0000269|PubMed:11267674, ECO:0000269|PubMed:11798164}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,HIPK2,28996,Hs.397465,ENST00000406875,THC2526537,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000166(nucleotide binding)|GO:0001654(eye development)|GO:0003714(transcription corepressor activity)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0006468(protein phosphorylation)|GO:0006915(apoptosis)|GO:0006974(response to DNA damage stimulus)|GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator)|GO:0007224(smoothened signaling pathway)|GO:0007628(adult walking behavior)|GO:0008284(positive regulation of cell proliferation)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0009952(anterior/posterior pattern formation)|GO:0010842(retina layer formation)|GO:0016604(nuclear body)|GO:0016605(PML body)|GO:0019048(virus-host interaction)|GO:0030182(neuron differentiation)|GO:0030218(erythrocyte differentiation)|GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway)|GO:0030514(negative regulation of BMP signaling pathway)|GO:0030578(PML body organization)|GO:0031965(nuclear membrane)|GO:0042771(DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis)|GO:0043388(positive regulation of DNA binding)|GO:0043524(negative regulation of neuron apoptosis)|GO:0045766(positive regulation of angiogenesis)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046330(positive regulation of JNK cascade)|GO:0046332(SMAD binding)|GO:0046790(virion binding)|GO:0048596(embryonic camera-type eye morphogenesis)|GO:0050882(voluntary musculoskeletal movement)|GO:0051726(regulation of cell cycle)|GO:0060059(embryonic retina morphogenesis in camera-type eye)|GO:0060235(lens induction in camera-type eye)|GO:0060395(SMAD protein signal transduction)|GO:0061072(iris morphogenesis)|GO:0071456(cellular response to hypoxia)","Homo sapiens homeodomain interacting protein kinase 2 (HIPK2), transcript variant 1, mRNA [NM_022740]",chr7:139257423-139257364,hs|7q34,homeodomain interacting protein kinase 2,TRUE
727_JUN_3725,P05412,transcription factor ap-1 (activator protein 1) (ap1) (proto-oncogene c-jun) (v-jun avian sarcoma virus 17 oncogene homolog) (p39),JUN,331,"function: transcription factor that recognizes and binds to the enhancer heptamer motif 5'-tga[cg]tca-3' (pubmed:10995748, pubmed:22083952). promotes activity of nr5a1 when phosphorylated by hipk3 leading to increased steroidogenic gene expression upon camp signaling pathway stimulation (pubmed:17210646). involved in activated kras-mediated transcriptional activation of usp28 in colorectal cancer (crc) cells (pubmed:24623306). binds to the usp28 promoter in colorectal cancer (crc) cells (pubmed:24623306). {eco:0000269|pubmed:10995748, eco:0000269|pubmed:17210646, eco:0000269|pubmed:22083952, eco:0000269|pubmed:24623306}.",subcellular location: nucleus.,"TISSUE SPECIFICITY: Expressed in the developing and adult prostate and prostate cancer cells. {ECO:0000269|PubMed:24263171, ECO:0000269|PubMed:24559171}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,JUN,3725,Hs.696684,ENST00000371222,THC2537886,"GO:0000228(nuclear chromosome)|GO:0000790(nuclear chromatin)|GO:0001525(angiogenesis)|GO:0001774(microglial cell activation)|GO:0001836(release of cytochrome c from mitochondria)|GO:0001889(liver development)|GO:0001938(positive regulation of endothelial cell proliferation)|GO:0002224(toll-like receptor signaling pathway)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0003151(outflow tract morphogenesis)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0003713(transcription coactivator activity)|GO:0005100(Rho GTPase activator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005829(cytosol)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0007184(SMAD protein import into nucleus)|GO:0007568(aging)|GO:0007612(learning)|GO:0007623(circadian rhythm)|GO:0008063(Toll signaling pathway)|GO:0008134(transcription factor binding)|GO:0008285(negative regulation of cell proliferation)|GO:0009314(response to radiation)|GO:0009612(response to mechanical stimulus)|GO:0009987(cellular process)|GO:0014070(response to organic cyclic compound)|GO:0017053(transcriptional repressor complex)|GO:0031103(axon regeneration)|GO:0031953(negative regulation of protein autophosphorylation)|GO:0032321(positive regulation of Rho GTPase activity)|GO:0032496(response to lipopolysaccharide)|GO:0034097(response to cytokine stimulus)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0035026(leading edge cell differentiation)|GO:0042493(response to drug)|GO:0042542(response to hydrogen peroxide)|GO:0042803(protein homodimerization activity)|GO:0043392(negative regulation of DNA binding)|GO:0043524(negative regulation of neuron apoptosis)|GO:0043525(positive regulation of neuron apoptosis)|GO:0043565(sequence-specific DNA binding)|GO:0043922(negative regulation by host of viral transcription)|GO:0043923(positive regulation by host of viral transcription)|GO:0044212(transcription regulatory region DNA binding)|GO:0045087(innate immune response)|GO:0045657(positive regulation of monocyte differentiation)|GO:0045740(positive regulation of DNA replication)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048146(positive regulation of fibroblast proliferation)|GO:0048661(positive regulation of smooth muscle cell proliferation)|GO:0051090(regulation of sequence-specific DNA binding transcription factor activity)|GO:0051365(cellular response to potassium ion starvation)|GO:0051403(stress-activated MAPK cascade)|GO:0051591(response to cAMP)|GO:0051726(regulation of cell cycle)|GO:0051899(membrane depolarization)","Homo sapiens jun proto-oncogene (JUN), mRNA [NM_002228]",chr1:59247788-59247729,hs|1p32.1,jun proto-oncogene,TRUE
728_IFITM3_10410,Q01628,interferon-induced transmembrane protein 3 (dispanin subfamily a member 2b) (dspa2b) (interferon-inducible protein 1-8u),IFITM3,133,"function: ifn-induced antiviral protein which disrupts intracellular cholesterol homeostasis. inhibits the entry of viruses to the host cell cytoplasm by preventing viral fusion with cholesterol depleted endosomes. may inactivate new enveloped viruses which buds out of the infected cell, by letting them go out with a cholesterol depleted membrane. active against multiple viruses, including influenza a virus, sars coronavirus (sars-cov), marburg virus (marv) and ebola virus (ebov), dengue virus (dnv), west nile virus (wnv), human immunodeficiency virus type 1 (hiv-1) and vesicular stomatitis virus (vsv). can inhibit: influenza virus hemagglutinin protein-mediated viral entry, marv and ebov gp1,2-mediated viral entry, sars-cov s protein-mediated viral entry and vsv g protein-mediated viral entry. plays a critical role in the structural stability and function of vacuolar atpase (v-atpase). establishes physical contact with the v-atpase of endosomes which is critical for proper clathrin localization and is also required for the function of the v-atpase to lower the ph in phagocytic endosomes thus establishing an antiviral state. {eco:0000269|pubmed:20064371, eco:0000269|pubmed:20534863, eco:0000269|pubmed:20943977, eco:0000269|pubmed:21177806, eco:0000269|pubmed:21253575, eco:0000269|pubmed:22046135, eco:0000269|pubmed:22479637, eco:0000269|pubmed:23601107}.",subcellular location: cell membrane; single-pass type ii membrane protein. late endosome membrane; single-pass type ii membrane protein. lysosome membrane; single-pass type ii membrane protein.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,IFITM3,10410,Hs.374650,ENST00000531688,THC2570992,GO:0005886(plasma membrane)|GO:0006955(immune response)|GO:0009607(response to biotic stimulus)|GO:0009615(response to virus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019221(cytokine-mediated signaling pathway)|GO:0045087(innate immune response)|GO:0060337(type I interferon-mediated signaling pathway),"Homo sapiens interferon induced transmembrane protein 3 (IFITM3), mRNA [NM_021034]",chr11:319914-319855,hs|11p15.5,interferon induced transmembrane protein 3,TRUE
729_HSPA8_3312,P11142,heat shock cognate 71 kda protein (heat shock 70 kda protein 8) (lipopolysaccharide-associated protein 1) (lap-1) (lps-associated protein 1),HSPA8 HSC70 HSP73 HSPA10,646,"function: molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (pubmed:21150129, pubmed:21148293, pubmed:24732912, pubmed:27916661, pubmed:23018488). this is achieved through cycles of atp binding, atp hydrolysis and adp release, mediated by co-chaperones (pubmed:21150129, pubmed:21148293, pubmed:24732912, pubmed:27916661, pubmed:23018488). the co-chaperones have been shown to not only regulate different steps of the atpase cycle of hsp70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (pubmed:21150129, pubmed:21148293, pubmed:24732912, pubmed:27916661, pubmed:23018488). the affinity of hsp70 for polypeptides is regulated by its nucleotide bound state. in the atp-bound form, it has a low affinity for substrate proteins. however, upon hydrolysis of the atp to adp, it undergoes a conformational change that increases its affinity for substrate proteins. hsp70 goes through repeated cycles of atp hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. the hsp70-associated co-chaperones are of three types: j-domain co-chaperones hsp40s (stimulate atpase hydrolysis by hsp70), the nucleotide exchange factors (nef) such as bag1/2/3 (facilitate conversion of hsp70 from the adp-bound to the atp-bound state thereby promoting substrate release), and the tpr domain chaperones such as hopx and stub1 (pubmed:24318877, pubmed:27474739, pubmed:24121476, pubmed:26865365). acts as a repressor of transcriptional activation. inhibits the transcriptional coactivator activity of cited1 on smad-mediated transcription. component of the prp19-cdc5l complex that forms an integral part of the spliceosome and is required for activating pre-mrna splicing. may have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. binds bacterial lipopolysaccharide (lps) and mediates lps-induced inflammatory response, including tnf secretion by monocytes (pubmed:10722728, pubmed:11276205). participates in the er-associated degradation (erad) quality control pathway in conjunction with j domain-containing co-chaperones and the e3 ligase stub1 (pubmed:23990462). interacts with vgf-derived peptide tlqp-21 (pubmed:28934328). {eco:0000269|pubmed:10722728, eco:0000269|pubmed:11276205, eco:0000269|pubmed:21148293, eco:0000269|pubmed:21150129, eco:0000269|pubmed:23018488, eco:0000269|pubmed:23990462, eco:0000269|pubmed:24318877, eco:0000269|pubmed:24732912, eco:0000269|pubmed:27474739, eco:0000269|pubmed:27916661, eco:0000269|pubmed:28934328, eco:0000303|pubmed:24121476, eco:0000303|pubmed:26865365}.","subcellular location: cytoplasm. melanosome. nucleus, nucleolus. cell membrane. note=localized in cytoplasmic mrnp granules containing untranslated mrnas. translocates rapidly from the cytoplasm to the nuclei, and especially to the nucleoli, upon heat shock.",TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11276205}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HSPA8,3312,Hs.180414,ENST00000532091,THC2597343,"GO:0000166(nucleotide binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006457(protein folding)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006950(response to stress)|GO:0006986(response to unfolded protein)|GO:0007268(synaptic transmission)|GO:0007269(neurotransmitter secretion)|GO:0009986(cell surface)|GO:0016044(cellular membrane organization)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0030529(ribonucleoprotein complex)|GO:0042470(melanosome)|GO:0042623(ATPase activity, coupled)|GO:0044419(interspecies interaction between organisms)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0061202(clathrin sculpted gamma-aminobutyric acid transport vesicle membrane)","Homo sapiens heat shock 70kDa protein 8 (HSPA8), transcript variant 1, mRNA [NM_006597]",chr11:122928315-122928256,hs|11q24.1,heat shock 70kDa protein 8,TRUE
73_SORD_6652,Q00796,"sorbitol dehydrogenase (sdh) (ec 1.1.1.-) ((r,r)-butanediol dehydrogenase) (ec 1.1.1.4) (l-iditol 2-dehydrogenase) (ec 1.1.1.14) (polyol dehydrogenase) (ribitol dehydrogenase) (rdh) (ec 1.1.1.56) (xylitol dehydrogenase) (xdh) (ec 1.1.1.9)",SORD,357,"function: polyol dehydrogenase that catalyzes the reversible nad(+)-dependent oxidation of various sugar alcohols. is mostly active with d-sorbitol (d-glucitol), l-threitol, xylitol and ribitol as substrates, leading to the c2-oxidized products d-fructose, l-erythrulose, d-xylulose, and d-ribulose, respectively (pubmed:3365415). is a key enzyme in the polyol pathway that interconverts glucose and fructose via sorbitol, which constitutes an important alternate route for glucose metabolism. the polyol pathway is believed to be involved in the etiology of diabetic complications, such as diabetic neuropathy and retinopathy, induced by hyperglycemia (pubmed:12962626, pubmed:29966615, pubmed:25105142). may play a role in sperm motility by using sorbitol as an alternative energy source for sperm motility (pubmed:16278369). may have a more general function in the metabolism of secondary alcohols since it also catalyzes the stereospecific oxidation of (2r,3r)-2,3-butanediol. to a lesser extent, can also oxidize l-arabinitol, galactitol and d-mannitol and glycerol in vitro. oxidizes neither ethanol nor other primary alcohols. cannot use nadp(+) as the electron acceptor (pubmed:3365415). {eco:0000269|pubmed:16278369, eco:0000269|pubmed:3365415, eco:0000303|pubmed:25105142, eco:0000303|pubmed:29966615, eco:0000305|pubmed:12962626}.","subcellular location: mitochondrion membrane {eco:0000250|uniprotkb:q64442}; peripheral membrane protein {eco:0000250|uniprotkb:q64442}. cell projection, cilium, flagellum {eco:0000250|uniprotkb:q64442}. note=associated with mitochondria of the midpiece and near the plasma membrane in the principal piece of the flagellum. also found in the epididymosome, secreted by the epididymal epithelium and that transfers proteins from the epididymal fluid to the sperm surface. {eco:0000250|uniprotkb:q64442}.","TISSUE SPECIFICITY: Expressed in liver (PubMed:3365415). Expressed in kidney and epithelial cells of both benign and malignant prostate tissue. Expressed in epididymis (at protein level). {ECO:0000269|PubMed:16278369, ECO:0000269|PubMed:19423711, ECO:0000269|PubMed:20372835, ECO:0000269|PubMed:3365415}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,SORD,6652,Hs.878,ENST00000267814,THC2464519,GO:0003939(L-iditol 2-dehydrogenase activity)|GO:0005529(sugar binding)|GO:0005615(extracellular space)|GO:0005624(membrane fraction)|GO:0005625(soluble fraction)|GO:0005739(mitochondrion)|GO:0005929(cilium)|GO:0006006(glucose metabolic process)|GO:0006062(sorbitol catabolic process)|GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0016491(oxidoreductase activity)|GO:0019861(flagellum)|GO:0030317(sperm motility)|GO:0031966(mitochondrial membrane)|GO:0046370(fructose biosynthetic process)|GO:0046872(metal ion binding)|GO:0051160(L-xylitol catabolic process)|GO:0051164(L-xylitol metabolic process)|GO:0051287(NAD binding),"Homo sapiens sorbitol dehydrogenase (SORD), transcript variant 1, mRNA [NM_003104]",chr15:45366874-45366933,hs|15q21.1,sorbitol dehydrogenase,TRUE
730_ACAD9_28976,Q9H845,"complex i assembly factor acad9, mitochondrial (acyl-coa dehydrogenase family member 9) (acad-9) (ec 1.3.8.-)",ACAD9,621,"function: as part of the mcia complex, primarily participates to the assembly of the mitochondrial complex i and therefore plays a role in oxidative phosphorylation (pubmed:20816094, pubmed:24158852). this moonlighting protein has also a dehydrogenase activity toward a broad range of substrates with greater specificity for long-chain unsaturated acyl-coas (pubmed:12359260, pubmed:16020546, pubmed:21237683, pubmed:24158852). however, in vivo, it does not seem to play a primary role in fatty acid oxidation (pubmed:20816094, pubmed:24158852). in addition, the function in complex i assembly is independent of the dehydrogenase activity of the protein (pubmed:24158852). {eco:0000269|pubmed:12359260, eco:0000269|pubmed:16020546, eco:0000269|pubmed:20816094, eco:0000269|pubmed:21237683, eco:0000269|pubmed:24158852}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:16020546, eco:0000269|pubmed:20816094}; peripheral membrane protein {eco:0000269|pubmed:16020546}; matrix side {eco:0000269|pubmed:16020546}. note=essentially associated with membranes. {eco:0000269|pubmed:16020546}.","TISSUE SPECIFICITY: Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver (PubMed:12359260). In the cerebellum uniquely expressed in the granular layer (at protein level) (PubMed:21237683). {ECO:0000269|PubMed:12359260, ECO:0000269|PubMed:21237683}.","DISEASE: Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]: An autosomal recessive metabolic disorder associated with mitochondrial complex I deficiency, resulting in multisystemic and variable manifestations. Clinical features include infantile onset of acute metabolic acidosis, Reye-like episodes (brain edema and vomiting that may rapidly progress to seizures, coma and death), exercise intolerance, hypertrophic cardiomyopathy, liver failure, muscle weakness, and neurologic dysfunction. {ECO:0000269|PubMed:17564966, ECO:0000269|PubMed:20816094, ECO:0000269|PubMed:20929961, ECO:0000269|PubMed:21057504, ECO:0000269|PubMed:22499348, ECO:0000269|PubMed:23836383, ECO:0000269|PubMed:23996478, ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ACAD9,28976,Hs.567482,ENST00000511325,NP073436,GO:0003995(acyl-CoA dehydrogenase activity)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0030425(dendrite)|GO:0050660(flavin adenine dinucleotide binding),"Homo sapiens acyl-CoA dehydrogenase family, member 9 (ACAD9), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_014049]",chr3:128631840-128631899,hs|3q21.3,"acyl-CoA dehydrogenase family, member 9",TRUE
731_F5_2153,P12259,"coagulation factor v (activated protein c cofactor) (proaccelerin, labile factor) [cleaved into: coagulation factor v heavy chain; coagulation factor v light chain]",F5,2224,function: central regulator of hemostasis. it serves as a critical cofactor for the prothrombinase activity of factor xa that results in the activation of prothrombin to thrombin.,subcellular location: secreted {eco:0000250}.,TISSUE SPECIFICITY: Plasma.,"DISEASE: Factor V deficiency (FA5D) [MIM:227400]: A blood coagulation disorder leading to a hemorrhagic diathesis known as parahemophilia. {ECO:0000269|PubMed:10942390, ECO:0000269|PubMed:12393490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]: A hemostatic disorder due to defective degradation of factor V by activated protein C. It is characterized by a poor anticoagulant response to activated protein C resulting in tendency to thrombosis. {ECO:0000269|PubMed:10391209, ECO:0000269|PubMed:10942390, ECO:0000269|PubMed:11435304, ECO:0000269|PubMed:11858490, ECO:0000269|PubMed:14617013, ECO:0000269|PubMed:14695241, ECO:0000269|PubMed:16710414, ECO:0000269|PubMed:8164741, ECO:0000269|PubMed:9454742}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Budd-Chiari syndrome (BDCHS) [MIM:600880]: A syndrome caused by obstruction of hepatic venous outflow involving either the hepatic veins or the terminal segment of the inferior vena cava. Obstructions are generally caused by thrombosis and lead to hepatic congestion and ischemic necrosis. Clinical manifestations observed in the majority of patients include hepatomegaly, right upper quadrant pain and abdominal ascites. Budd-Chiari syndrome is associated with a combination of disease states including primary myeloproliferative syndromes and thrombophilia due to factor V Leiden, protein C deficiency and antithrombin III deficiency. Budd-Chiari syndrome is a rare but typical complication in patients with polycythemia vera. {ECO:0000269|PubMed:9245936}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. {ECO:0000269|PubMed:15534175}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pregnancy loss, recurrent, 1 (RPRGL1) [MIM:614389]: A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. {ECO:0000269|PubMed:11018168}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,F5,2153,Hs.30054,ENST00000367796,THC2787099,GO:0002576(platelet degranulation)|GO:0005507(copper ion binding)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005886(plasma membrane)|GO:0007155(cell adhesion)|GO:0007596(blood coagulation)|GO:0008015(blood circulation)|GO:0030168(platelet activation)|GO:0031093(platelet alpha granule lumen)|GO:0046872(metal ion binding),"Homo sapiens coagulation factor V (proaccelerin, labile factor) (F5), mRNA [NM_000130]",chr1:169483624-169483565,hs|1q24.2,"coagulation factor V (proaccelerin, labile factor)",TRUE
732_NUP62_23636,P37198,nuclear pore glycoprotein p62 (62 kda nucleoporin) (nucleoporin nup62),NUP62,522,"function: essential component of the nuclear pore complex (pubmed:1915414). the n-terminal is probably involved in nucleocytoplasmic transport (pubmed:1915414). the c-terminal is involved in protein-protein interaction probably via coiled-coil formation, promotes its association with centrosomes and may function in anchorage of p62 to the pore complex (pubmed:1915414, pubmed:24107630). plays a role in mitotic cell cycle progression by regulating centrosome segregation, centriole maturation and spindle orientation (pubmed:24107630). it might be involved in protein recruitment to the centrosome after nuclear breakdown (pubmed:24107630). {eco:0000269|pubmed:1915414, eco:0000269|pubmed:24107630}.","subcellular location: nucleus, nuclear pore complex {eco:0000269|pubmed:1915414}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:24107630}. nucleus envelope {eco:0000269|pubmed:24107630}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:24107630}. note=central region of the nuclear pore, within the transporter (pubmed:1915414). during mitotic cell division, it associates with the poles of the mitotic spindle (pubmed:24107630). {eco:0000269|pubmed:1915414, eco:0000269|pubmed:24107630}.",NA,"DISEASE: Infantile striatonigral degeneration (SNDI) [MIM:271930]: Neurological disorder characterized by symmetrical degeneration of the caudate nucleus, putamen, and occasionally the globus pallidus, with little involvement of the rest of the brain. The clinical features include developmental regression, choreoathetosis, dystonia, spasticity, dysphagia, failure to thrive, nystagmus, optic atrophy, and mental retardation. {ECO:0000269|PubMed:16786527}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NUP62,23636,Hs.574492,ENST00000352066,THC2588060,"GO:0000922(spindle pole)|GO:0003682(chromatin binding)|GO:0004674(protein serine/threonine kinase activity)|GO:0005487(nucleocytoplasmic transporter activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005643(nuclear pore)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005975(carbohydrate metabolic process)|GO:0006351(transcription, DNA-dependent)|GO:0006913(nucleocytoplasmic transport)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0007569(cell aging)|GO:0008219(cell death)|GO:0008285(negative regulation of cell proliferation)|GO:0008645(hexose transport)|GO:0009755(hormone-mediated signaling pathway)|GO:0009966(regulation of signal transduction)|GO:0010827(regulation of glucose transport)|GO:0015031(protein transport)|GO:0015758(glucose transport)|GO:0016032(viral reproduction)|GO:0017056(structural constituent of nuclear pore)|GO:0030159(receptor signaling complex scaffold activity)|GO:0030529(ribonucleoprotein complex)|GO:0031074(nucleocytoplasmic shuttling complex)|GO:0031965(nuclear membrane)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042169(SH2 domain binding)|GO:0043066(negative regulation of apoptosis)|GO:0043069(negative regulation of programmed cell death)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0043130(ubiquitin binding)|GO:0043231(intracellular membrane-bounded organelle)|GO:0043407(negative regulation of MAP kinase activity)|GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046578(regulation of Ras protein signal transduction)|GO:0046580(negative regulation of Ras protein signal transduction)|GO:0046930(pore complex)|GO:0046966(thyroid hormone receptor binding)|GO:0051028(mRNA transport)|GO:0051425(PTB domain binding)|GO:0055085(transmembrane transport)","Homo sapiens nucleoporin 62kDa (NUP62), transcript variant 1, mRNA [NM_153719]",chr19:50410195-50410136,hs|19q13.33,nucleoporin 62kDa,TRUE
733_ZSCAN18_65982,Q8TBC5,zinc finger and scan domain-containing protein 18 (zinc finger protein 447),ZSCAN18 ZNF447,510,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000255|prosite-prorule:pru00187}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZSCAN18,65982,Hs.235390,ENST00000240727,THC2510928,GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0008270(zinc ion binding)|GO:0016032(viral reproduction)|GO:0046872(metal ion binding),"Homo sapiens zinc finger and SCAN domain containing 18 (ZSCAN18), transcript variant 3, mRNA [NM_023926]",chr19:58595438-58595379,hs|19q13.43,zinc finger and SCAN domain containing 18,TRUE
734_MRPL51_51258,Q4U2R6,"39s ribosomal protein l51, mitochondrial (l51mt) (mrp-l51) (mitochondrial large ribosomal subunit protein ml51) (bmrp-64) (bmrp64)",MRPL51 MRP64 CDA09 HSPC241,128,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPL51,51258,Hs.55847,ENST00000229238,THC2558350,GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0005762(mitochondrial large ribosomal subunit)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein L51 (MRPL51), nuclear gene encoding mitochondrial protein, mRNA [NM_016497]",chr12:6601595-6601536,hs|12p13.31,mitochondrial ribosomal protein L51,TRUE
735_ATP6V1A_523,P38606,v-type proton atpase catalytic subunit a (v-atpase subunit a) (ec 7.1.2.2) (v-atpase 69 kda subunit) (vacuolar atpase isoform va68) (vacuolar proton pump subunit alpha),ATP6V1A ATP6A1 ATP6V1A1 VPP2,617,"function: catalytic subunit of the peripheral v1 complex of vacuolar atpase. v-atpase vacuolar atpase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. in aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of fe(2+) prolyl hydroxylase (phd) enzymes, and leading to hif1a hydroxylation and subsequent proteasomal degradation (pubmed:28296633). may play a role in neurite development and synaptic connectivity (pubmed:29668857). {eco:0000269|pubmed:28296633, eco:0000269|pubmed:29668857}.",subcellular location: cytoplasm {eco:0000269|pubmed:29668857}.,TISSUE SPECIFICITY: High expression in the skin. {ECO:0000269|PubMed:28065471}.,"DISEASE: Cutis laxa, autosomal recessive, 2D (ARCL2D) [MIM:617403]: A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. Most ARCL2D patients exhibit severe hypotonia as well as cardiovascular and neurologic involvement. {ECO:0000269|PubMed:28065471}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, infantile or early childhood, 3 (IECEE3) [MIM:618012]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE3 is an autosomal dominant form characterized by onset of seizures in the first years of life.The severity of the phenotype is highly variable: some patients may be non-verbal and non-ambulatory with spastic quadriparesis and poor eye contact, whereas others have moderate intellectual disability. {ECO:0000269|PubMed:29668857}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP6V1A,523,Hs.477155,ENST00000273398,THC2529321,"GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0005902(microvillus)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0008286(insulin receptor signaling pathway)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0015992(proton transport)|GO:0016324(apical plasma membrane)|GO:0016469(proton-transporting two-sector ATPase complex)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0033180(proton-transporting V-type ATPase, V1 domain)|GO:0033572(transferrin transport)|GO:0046034(ATP metabolic process)|GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism)|GO:0046961(proton-transporting ATPase activity, rotational mechanism)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A (ATP6V1A), mRNA [NM_001690]",chr3:113530539-113530598,hs|3q13.31,"ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A",TRUE
736_PMPCB_9512,O75439,mitochondrial-processing peptidase subunit beta (ec 3.4.24.64) (beta-mpp) (p-52),PMPCB MPPB,489,"function: catalytic subunit of the essential mitochondrial processing protease (mpp), which is required for maturation of the majority of mitochondrial precursor proteins (pubmed:29576218). most mpp cleavage sites follow an arginine at position -2 (by similarity). {eco:0000250|uniprotkb:p20069, eco:0000269|pubmed:29576218}.",subcellular location: mitochondrion matrix {eco:0000250}.,NA,"DISEASE: Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]: An autosomal recessive, neurodegenerative disorder characterized by basal ganglia lesions, cerebellar atrophy, and neurologic regression in the first year of life. Common features include truncal hypotonia, lack of independent ambulation, poor speech, intellectual disability, and motor abnormalities, such as ataxia, dystonia, and spasticity. {ECO:0000269|PubMed:29576218}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PMPCB,9512,Hs.184211,ENST00000453466,NP1183371,GO:0004222(metalloendopeptidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding),"Homo sapiens peptidase (mitochondrial processing) beta (PMPCB), nuclear gene encoding mitochondrial protein, mRNA [NM_004279]",chr7:102952685-102952744,hs|7q22.1,peptidase (mitochondrial processing) beta,TRUE
737_DDX3X_1654,O00571,"atp-dependent rna helicase ddx3x (ec 3.6.4.13) (dead box protein 3, x-chromosomal) (dead box, x isoform) (helicase-like protein 2) (hlp2)",DDX3X DBX DDX3,662,"function: multifunctional atp-dependent rna helicase. the atpase activity can be stimulated by various ribo- and deoxynucleic acids indicative for a relaxed substrate specificity. in vitro can unwind partially double-stranded dna with a preference for 5'-single-stranded dna overhangs. is involved in several steps of gene expression, such as transcription, mrna maturation, mrna export and translation. however, the exact mechanisms are not known and some functions may be specific for a subset of mrnas. involved in transcriptional regulation. can enhance transcription from the cdkn1a/waf1 promoter in a sp1-dependent manner. found associated with the e-cadherin promoter and can down-regulate transcription from the promoter. involved in regulation of translation initiation. proposed to be involved in positive regulation of translation such as of cyclin e1/ccne1 mrna and specifically of mrnas containing complex secondary structures in their 5'utrs; these functions seem to require rna helicase activity. specifically promotes translation of a subset of viral and cellular mrnas carrying a 5'proximal stem-loop structure in their 5'utrs and cooperates with the eif4f complex. proposed to act prior to 43s ribosomal scanning and to locally destabilize these rna structures to allow recognition of the mrna cap or loading onto the 40s subunit. after association with 40s ribosomal subunits seems to be involved in the functional assembly of 80s ribosomes; the function seems to cover translation of mrnas with structured and non-structured 5'utrs and is independent of rna helicase activity. also proposed to inhibit cap-dependent translation by competetive interaction with eif4e which can block the eif4e:eif4g complex formation. proposed to be involved in stress response and stress granule assembly; the function is independent of rna helicase activity and seems to involve association with eif4e. may be involved in nuclear export of specific mrnas but not in bulk mrna export via interactions with xpo1 and nxf1. also associates with polyadenylated mrnas independently of nxf1. associates with spliced mrnas in an exon junction complex (ejc)-dependent manner and seems not to be directly involved in splicing. may be involved in nuclear mrna export by association with ddx5 and regulating its nuclear location. involved in innate immune signaling promoting the production of type i interferon (ifn-alpha and ifn-beta); proposed to act as viral rna sensor, signaling intermediate and transcriptional coactivator. involved in tbk1 and ikbke-dependent irf3 activation leading to ifnb induction, plays a role of scaffolding adapter that links ikbke and irf3 and coordinates their activation. also found associated with ifnb promoters; the function is independent of irf3. can bind to viral rnas and via association with mavs/ips1 and ddx58/rig-i is thought to induce signaling in early stages of infection. involved in regulation of apoptosis. may be required for activation of the intrinsic but inhibit activation of the extrinsic apoptotic pathway. acts as an antiapoptotic protein through association with gsk3a/b and birc2 in an apoptosis antagonizing signaling complex; activation of death receptors promotes caspase-dependent cleavage of birc2 and ddx3x and relieves the inhibition. may be involved in mitotic chromosome segregation. is an allosteric activator of csnk1e, it stimulates csnk1e-mediated phosphorylation of dvl2 and is involved in the positive regulation of canonical wnt signaling (pubmed:23413191). {eco:0000269|pubmed:16301996, eco:0000269|pubmed:16818630, eco:0000269|pubmed:17357160, eco:0000269|pubmed:17667941, eco:0000269|pubmed:18264132, eco:0000269|pubmed:18583960, eco:0000269|pubmed:18596238, eco:0000269|pubmed:18628297, eco:0000269|pubmed:18636090, eco:0000269|pubmed:18846110, eco:0000269|pubmed:20127681, eco:0000269|pubmed:20375222, eco:0000269|pubmed:20657822, eco:0000269|pubmed:20837705, eco:0000269|pubmed:21170385, eco:0000269|pubmed:21730191, eco:0000269|pubmed:21883093, eco:0000269|pubmed:22034099, eco:0000269|pubmed:22323517, eco:0000269|pubmed:22872150, eco:0000269|pubmed:23413191, eco:0000269|pubmed:23478265}.; function: (microbial infection) appears to be a prime target for viral manipulations. hepatitis b virus (hbv) polymerase and possibly vaccinia virus (vacv) protein k7 inhibit ifnb induction probably by dissociating ddx3x from tbk1 or ikbke. is involved in hepatitis c virus (hcv) replication; the function may involve the association with hcv core protein. hcv core protein inhibits the ips1-dependent function in viral rna sensing and may switch the function from a infb inducing to a hcv replication mode. involved in hiv-1 replication. acts as a cofactor for xpo1-mediated nuclear export of incompletely spliced hiv-1 rev rnas. {eco:0000269|pubmed:10329544, eco:0000269|pubmed:15507209, eco:0000269|pubmed:21589879}.","subcellular location: nucleus speckle. cytoplasm. mitochondrion outer membrane. note=located predominantly in nuclear speckles and, at low levels, throughout the cytoplasm. located to the outer side of nuclear pore complexes (npc). shuttles between the nucleus and the cytoplasm in a xpo1 and may be also in a nfx1-dependent manner. associated with polyadenylated mrnas in the cytoplasm and the nucleus. predominantly located in nucleus during g(0) phase and in the cytoplasm during g1/s phase.",NA,"DISEASE: Mental retardation, X-linked 102 (MRX102) [MIM:300958]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX102 features include mild to severe intellectual disability, hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy. Additionally, patients manifest variable non-neurologic features such as joint hyperlaxity, skin pigmentary abnormalities, cleft lip and/or palate, hearing and visual impairment, and precocious puberty. {ECO:0000269|PubMed:26235985}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DDX3X,1654,Hs.380774,ENST00000457138,THC2489996,GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0004004(ATP-dependent RNA helicase activity)|GO:0004386(helicase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0016607(nuclear speck)|GO:0016787(hydrolase activity)|GO:0044419(interspecies interaction between organisms),"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked (DDX3X), transcript variant 1, mRNA [NM_001356]",chrX:41207012-41207071,hs|Xp11.4,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked",TRUE
738_SPATS2L_26010,Q9NUQ6,spats2-like protein (dna polymerase-transactivated protein 6) (stress granule and nucleolar protein) (sgnp),SPATS2L DNAPTP6 SP1224,558,NA,"subcellular location: cytoplasm {eco:0000269|pubmed:19005571}. nucleus, nucleolus {eco:0000269|pubmed:19005571}. note=during oxidative stress as well as uv irradiation, energy deprivation or heat shock, relocalizes to cytoplasmic stress granules. in the nucleus, found in structures lacking npm1.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,SPATS2L,26010,Hs.120323,ENST00000409988,THC2785158,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm),"Homo sapiens spermatogenesis associated, serine-rich 2-like (SPATS2L), transcript variant 1, mRNA [NM_015535]",chr2:201343028-201343087,hs|2q33.1,"spermatogenesis associated, serine-rich 2-like",TRUE
739_RGS10_6001,O43665,regulator of g-protein signaling 10 (rgs10),RGS10,181,"function: regulates g protein-coupled receptor signaling cascades, including signaling downstream of the muscarinic acetylcholine receptor chrm2. inhibits signal transduction by increasing the gtpase activity of g protein alpha subunits, thereby driving them into their inactive gdp-bound form (pubmed:8774883, pubmed:10608901, pubmed:9353196, pubmed:11443111, pubmed:18434541). modulates the activity of potassium channels that are activated in response to chrm2 signaling (pubmed:11443111). activity on gnaz is inhibited by palmitoylation of the g-protein (pubmed:9353196). {eco:0000269|pubmed:10608901, eco:0000269|pubmed:11443111, eco:0000269|pubmed:18434541, eco:0000269|pubmed:8774883, eco:0000269|pubmed:9353196}.","subcellular location: isoform 1: cytoplasm, cytosol {eco:0000269|pubmed:11443111}. nucleus {eco:0000269|pubmed:11443111}. note=forskolin treatment promotes phosphorylation and translocation to the nucleus. {eco:0000269|pubmed:11443111}.; subcellular location: nucleus {eco:0000269|pubmed:10791963}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RGS10,6001,Hs.501200,ENST00000369103,THC2783455,GO:0004871(signal transducer activity)|GO:0005096(GTPase activator activity)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0009968(negative regulation of signal transduction)|GO:0043547(positive regulation of GTPase activity),"Homo sapiens regulator of G-protein signaling 10 (RGS10), transcript variant 1, mRNA [NM_001005339]",chr10:121259582-121259523,hs|10q26.11,regulator of G-protein signaling 10,TRUE
74_ZNF525_170958,Q8N782,zinc finger protein 525,ZNF525 KIAA1979,197,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF525,170958,Hs.352638,ENST00000475179,THC2508352,"GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 525 (ZNF525), non-coding RNA [NR_003699]",chr19:53889677-53889736,hs|19q13.42,zinc finger protein 525,TRUE
740_PA2G4_5036,Q9UQ80,proliferation-associated protein 2g4 (cell cycle protein p38-2g4 homolog) (hg4-1) (erbb3-binding protein 1),PA2G4 EBP1,394,"function: may play a role in a erbb3-regulated signal transduction pathway. seems be involved in growth regulation. acts a corepressor of the androgen receptor (ar) and is regulated by the erbb3 ligand neuregulin-1/heregulin (hrg). inhibits transcription of some e2f1-regulated promoters, probably by recruiting histone acetylase (hat) activity. binds rna. associates with 28s, 18s and 5.8s mature rrnas, several rrna precursors and probably u3 small nucleolar rna. may be involved in regulation of intermediate and late steps of rrna processing. may be involved in ribosome assembly. mediates cap-independent translation of specific viral iress (internal ribosomal entry site) (by similarity). regulates cell proliferation, differentiation, and survival. isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (by similarity). {eco:0000250|uniprotkb:p50580, eco:0000250|uniprotkb:q6ayd3, eco:0000269|pubmed:11268000, eco:0000269|pubmed:12682367, eco:0000269|pubmed:15064750, eco:0000269|pubmed:15583694, eco:0000269|pubmed:16832058}.","subcellular location: isoform 1: cytoplasm {eco:0000269|pubmed:16832058, eco:0000269|pubmed:19037095}. nucleus, nucleolus {eco:0000269|pubmed:16832058, eco:0000269|pubmed:19037095}. note=translocates to the nucleus upon treatment with hrg. phosphorylation at ser-361 by pkc/prkcd regulates its nucleolar localization. {eco:0000269|pubmed:16832058}.; subcellular location: isoform 2: cytoplasm {eco:0000269|pubmed:16832058, eco:0000269|pubmed:19037095}.","TISSUE SPECIFICITY: Isoform 2 is undetectable whereas isoform 1 is strongly expressed in cancer cells (at protein level). Isoform 1 and isoform 2 are widely expressed, including heart, brain, lung, pancreas, skeletal muscle, kidney, placenta and liver. {ECO:0000269|PubMed:10682683, ECO:0000269|PubMed:15064750, ECO:0000269|PubMed:19037095}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PA2G4,5036,Hs.524498,NA,THC2500770,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006364(rRNA processing)|GO:0006417(regulation of translation)|GO:0007050(cell cycle arrest)|GO:0008283(cell proliferation)|GO:0009987(cellular process)|GO:0030529(ribonucleoprotein complex)|GO:0031625(ubiquitin protein ligase binding)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens proliferation-associated 2G4, 38kDa (PA2G4), mRNA [NM_006191]",chr12:56507592-56507651,hs|12q13.2,"proliferation-associated 2G4, 38kDa",TRUE
741_DDX5_1655,P17844,probable atp-dependent rna helicase ddx5 (ec 3.6.4.13) (dead box protein 5) (rna helicase p68),DDX5 G17P1 HELR HLR1,614,"function: involved in the alternative regulation of pre-mrna splicing; its rna helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a rbm4-dependent manner. binds to the tau pre-mrna in the stem-loop region downstream of exon 10. the rate of atp hydrolysis is highly stimulated by single-stranded rna. involved in transcriptional regulation; the function is independent of the rna helicase activity. transcriptional coactivator for androgen receptor ar but probably not esr1. synergizes with ddx17 and sra1 rna to activate myod1 transcriptional activity and involved in skeletal muscle differentiation. transcriptional coactivator for p53/tp53 and involved in p53/tp53 transcriptional response to dna damage and p53/tp53-dependent apoptosis. transcriptional coactivator for runx2 and involved in regulation of osteoblast differentiation. acts as transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as hdac1. as component of a large per complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as per1 and nr1d1 and the control of the circadian rhythms. {eco:0000269|pubmed:12527917, eco:0000269|pubmed:15298701, eco:0000269|pubmed:15660129, eco:0000269|pubmed:17011493, eco:0000269|pubmed:17960593, eco:0000269|pubmed:18829551, eco:0000269|pubmed:19718048, eco:0000269|pubmed:21343338}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:10837141, eco:0000269|pubmed:1996094}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDX5,1655,Hs.279806,ENST00000225792,THC2592786,"GO:0000166(nucleotide binding)|GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003712(transcription cofactor activity)|GO:0003724(RNA helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0008026(ATP-dependent helicase activity)|GO:0008380(RNA splicing)|GO:0016049(cell growth)|GO:0016787(hydrolase activity)|GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides)|GO:0030529(ribonucleoprotein complex)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 (DDX5), mRNA [NM_004396]",chr17:62496344-62496285,hs|17q23.3,DEAD (Asp-Glu-Ala-Asp) box polypeptide 5,TRUE
742_TSPAN3_10099,O60637,tetraspanin-3 (tspan-3) (tetraspanin tm4-a) (transmembrane 4 superfamily member 8),TSPAN3 TM4SF8,253,"function: regulates the proliferation and migration of oligodendrocytes, a process essential for normal myelination and repair. {eco:0000250}.",subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TSPAN3,10099,Hs.728882,ENST00000346495,NP1208504,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens tetraspanin 3 (TSPAN3), transcript variant 1, mRNA [NM_005724]",chr15:77338573-77338514,hs|15q24.3,tetraspanin 3,TRUE
743_AK4_205,P27144,"adenylate kinase 4, mitochondrial (ak 4) (ec 2.7.4.10) (ec 2.7.4.6) (adenylate kinase 3-like) (gtp:amp phosphotransferase ak4)",AK4 AK3 AK3L1,223,"function: involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates (pubmed:19073142, pubmed:19766732, pubmed:23416111, pubmed:24767988). efficiently phosphorylates amp and damp using atp as phosphate donor, but phosphorylates only amp when using gtp as phosphate donor (pubmed:19073142, pubmed:19766732, pubmed:23416111). also displays broad nucleoside diphosphate kinase activity (pubmed:19073142, pubmed:19766732, pubmed:23416111). plays a role in controlling cellular atp levels by regulating phosphorylation and activation of the energy sensor protein kinase ampk (pubmed:24767988, pubmed:26980435). plays a protective role in the cellular response to oxidative stress (pubmed:19130895, pubmed:23474458, pubmed:26980435). {eco:0000255|hamap-rule:mf_03170, eco:0000269|pubmed:19073142, eco:0000269|pubmed:19130895, eco:0000269|pubmed:19766732, eco:0000269|pubmed:23416111, eco:0000269|pubmed:23474458, eco:0000269|pubmed:24767988, eco:0000269|pubmed:26980435}.","subcellular location: mitochondrion matrix {eco:0000255|hamap-rule:mf_03170, eco:0000269|pubmed:11485571, eco:0000269|pubmed:19766732, eco:0000269|pubmed:26980435}.","TISSUE SPECIFICITY: Highly expressed in kidney, moderately expressed in heart and liver and weakly expressed in brain. {ECO:0000269|PubMed:11485571}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AK4,205,Hs.10862,ENST00000327299,THC2461907,"GO:0000166(nucleotide binding)|GO:0004017(adenylate kinase activity)|GO:0005524(ATP binding)|GO:0005525(GTP binding)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006139(nucleobase, nucleoside, nucleotide and nucleic acid metabolic process)|GO:0016740(transferase activity)","Homo sapiens adenylate kinase 4 (AK4), nuclear gene encoding mitochondrial protein, transcript variant 5, mRNA [NM_001005353]",chr1:65692632-65692691,hs|1p31.3,adenylate kinase 4,TRUE
744_C21orf59_56683,P57076,cilia- and flagella-associated protein 298 (protein kurly homolog),CFAP298 C21orf48 C21orf59,290,"function: plays a role in motile cilium function, possibly by acting on outer dynein arm assembly (pubmed:24094744). seems to be important for initiation rather than maintenance of cilium motility (by similarity). required for correct positioning of the cilium at the apical cell surface, suggesting an additional role in the planar cell polarity (pcp) pathway (by similarity). may suppress canonical wnt signaling activity (by similarity). {eco:0000250|uniprotkb:q6drc3, eco:0000269|pubmed:24094744}.","subcellular location: cytoplasm {eco:0000269|pubmed:29601588}. cytoplasm, cytoskeleton, cilium basal body {eco:0000250|uniprotkb:a0a1l8hck2}. note=partially colocalized with sass6 in cytoplasmic puncta, suggesting a centrosomal localization. {eco:0000250|uniprotkb:q5u3z0}.",NA,"DISEASE: Ciliary dyskinesia, primary, 26 (CILD26) [MIM:615500]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. Patients may exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:24094744}. Note=The disease is caused by mutations affecting the gene represented in this entry. Cilia in nasal epithelia show the absence of both outer and inner dynein-arm components and complete paralysis.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,C21orf59,56683,Hs.5811,ENST00000543202,THC2475633,GO:0005634(nucleus)|GO:0005829(cytosol),"Homo sapiens chromosome 21 open reading frame 59 (C21orf59), transcript variant 1, mRNA [NM_021254]",chr21:33974211-33974152,hs|21q22.11,chromosome 21 open reading frame 59,TRUE
745_DCXR_51181,Q7Z4W1,l-xylulose reductase (xr) (ec 1.1.1.10) (carbonyl reductase ii) (dicarbonyl/l-xylulose reductase) (kidney dicarbonyl reductase) (kidcr) (short chain dehydrogenase/reductase family 20c member 1) (sperm surface protein p34h),DCXR SDR20C1,244,"function: catalyzes the nadph-dependent reduction of several pentoses, tetroses, trioses, alpha-dicarbonyl compounds and l-xylulose. participates in the uronate cycle of glucose metabolism. may play a role in the water absorption and cellular osmoregulation in the proximal renal tubules by producing xylitol, an osmolyte, thereby preventing osmolytic stress from occurring in the renal tubules.",subcellular location: membrane {eco:0000250}; peripheral membrane protein {eco:0000250}. note=probably recruited to membranes via an interaction with phosphatidylinositol. {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in kidney, liver and epididymis. In the epididymis, it is mainly expressed in the proximal and distal sections of the corpus region. Weakly or not expressed in brain, lung, heart, spleen and testis. {ECO:0000269|PubMed:10385429, ECO:0000269|PubMed:11882650}.","DISEASE: Pentosuria (PNTSU) [MIM:260800]: An inborn error of metabolism characterized by excessive urinary excretion of L-xylulose. {ECO:0000269|PubMed:11882650, ECO:0000269|PubMed:22042873, ECO:0000269|PubMed:4392213}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DCXR,51181,Hs.9857,ENST00000306869,THC2497149,"GO:0000166(nucleotide binding)|GO:0005902(microvillus)|GO:0005903(brush border)|GO:0005975(carbohydrate metabolic process)|GO:0005997(xylulose metabolic process)|GO:0006006(glucose metabolic process)|GO:0006739(NADP metabolic process)|GO:0016020(membrane)|GO:0016614(oxidoreductase activity, acting on CH-OH group of donors)|GO:0042732(D-xylose metabolic process)|GO:0050038(L-xylulose reductase (NADP+) activity)|GO:0051289(protein homotetramerization)","Homo sapiens dicarbonyl/L-xylulose reductase (DCXR), transcript variant 1, mRNA [NM_016286]",chr17:79994081-79993895,hs|17q25.3,dicarbonyl/L-xylulose reductase,TRUE
746_S100A10_6281,P60903,protein s100-a10 (calpactin i light chain) (calpactin-1 light chain) (cellular ligand of annexin ii) (s100 calcium-binding protein a10) (p10 protein) (p11),S100A10 ANX2LG CAL1L CLP11,97,"function: because s100a10 induces the dimerization of anxa2/p36, it may function as a regulator of protein phosphorylation in that the anxa2 monomer is the preferred target (in vitro) of tyrosine-specific kinase.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,S100A10,6281,Hs.143873,ENST00000368809,THC2469294,GO:0005102(receptor binding)|GO:0005509(calcium ion binding)|GO:0007165(signal transduction)|GO:0019897(extrinsic to plasma membrane)|GO:0051099(positive regulation of binding)|GO:0071229(cellular response to acid),"Homo sapiens S100 calcium binding protein A10 (S100A10), mRNA [NM_002966]",chr1:151955479-151955420,hs|1q21.3,S100 calcium binding protein A10,TRUE
747_TSPAN8_7103,P19075,tetraspanin-8 (tspan-8) (transmembrane 4 superfamily member 3) (tumor-associated antigen co-029),TSPAN8 TM4SF3,237,NA,subcellular location: membrane; multi-pass membrane protein.,"TISSUE SPECIFICITY: Gastric, colon, rectal, and pancreatic carcinomas.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,TSPAN8,7103,Hs.170563,ENST00000546561,THC2556850,GO:0004871(signal transducer activity)|GO:0005764(lysosome)|GO:0006486(protein glycosylation)|GO:0007165(signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030195(negative regulation of blood coagulation),"Homo sapiens tetraspanin 8 (TSPAN8), mRNA [NM_004616]",chr12:71526574-71526515,hs|12q21.1,tetraspanin 8,TRUE
748_C22orf28_51493,Q9Y3I0,trna-splicing ligase rtcb homolog (ec 6.5.1.3),RTCB C22orf28 HSPC117,505,"function: catalytic subunit of the trna-splicing ligase complex that acts by directly joining spliced trna halves to mature-sized trnas by incorporating the precursor-derived splice junction phosphate into the mature trna as a canonical 3',5'-phosphodiester. may act as an rna ligase with broad substrate specificity, and may function toward other rnas. {eco:0000269|pubmed:21311021, eco:0000269|pubmed:24870230}.","subcellular location: nucleus {eco:0000269|pubmed:24608264}. cytoplasm {eco:0000255|hamap-rule:mf_03144, eco:0000269|pubmed:24608264}. note=enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low. {eco:0000269|pubmed:24608264}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C22orf28,51493,Hs.474643,ENST00000451746,THC2669293,"GO:0000166(nucleotide binding)|GO:0003972(RNA ligase (ATP) activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation)|GO:0007160(cell-matrix adhesion)|GO:0016874(ligase activity)|GO:0017166(vinculin binding)|GO:0034446(substrate adhesion-dependent cell spreading)|GO:0046872(metal ion binding)|GO:0072669(tRNA-splicing ligase complex)","Homo sapiens chromosome 22 open reading frame 28 (C22orf28), mRNA [NM_014306]",chr22:32783739-32783680,hs|22q12.3,chromosome 22 open reading frame 28,TRUE
749_STEAP2_261729,Q8NFT2,metalloreductase steap2 (ec 1.16.1.-) (prostate cancer-associated protein 1) (protein up-regulated in metastatic prostate cancer) (pumpcn) (six-transmembrane epithelial antigen of prostate 2) (sixtransmembrane protein of prostate 1),STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203,490,function: metalloreductase that has the ability to reduce both fe(3+) to fe(2+) and cu(2+) to cu(1+). uses nad(+) as acceptor (by similarity). {eco:0000250}.,subcellular location: endosome membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}. cell membrane {eco:0000269|pubmed:12429817}; multi-pass membrane protein {eco:0000269|pubmed:12429817}.,"TISSUE SPECIFICITY: Expressed at high levels in prostate and at significantly lower levels in heart, brain, kidney, pancreas, and ovary. {ECO:0000269|PubMed:12095985, ECO:0000269|PubMed:12429817, ECO:0000269|PubMed:16609065}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,STEAP2,261729,Hs.489051,ENST00000394622,NP1072232,GO:0000166(nucleotide binding)|GO:0005215(transporter activity)|GO:0005506(iron ion binding)|GO:0005769(early endosome)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006811(ion transport)|GO:0006893(Golgi to plasma membrane transport)|GO:0006897(endocytosis)|GO:0009055(electron carrier activity)|GO:0009725(response to hormone stimulus)|GO:0010008(endosome membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0022900(electron transport chain)|GO:0030140(trans-Golgi network transport vesicle)|GO:0030173(integral to Golgi membrane)|GO:0042598(vesicular fraction)|GO:0045055(regulated secretory pathway)|GO:0046872(metal ion binding)|GO:0050660(flavin adenine dinucleotide binding)|GO:0055072(iron ion homeostasis),"Homo sapiens STEAP family member 2, metalloreductase (STEAP2), transcript variant 1, mRNA [NM_152999]",chr7:89866537-89866596,hs|7q21.13,"STEAP family member 2, metalloreductase",TRUE
75_RPS15A_6210,P62244,40s ribosomal protein s15a (small ribosomal subunit protein us8),RPS15A OK/SW-cl.82,130,"function: structural component of the ribosome (pubmed:23636399). required for proper erythropoiesis (pubmed:27909223). {eco:0000269|pubmed:23636399, eco:0000269|pubmed:27909223}.",NA,NA,"DISEASE: Diamond-Blackfan anemia 20 (DBA20) [MIM:618313]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA20 inheritance is autosomal dominant. {ECO:0000269|PubMed:27909223}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPS15A,6210,Hs.370504,NA,NA,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008284(positive regulation of cell proliferation)|GO:0009615(response to virus)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0045787(positive regulation of cell cycle),"Homo sapiens ribosomal protein S15a, mRNA (cDNA clone MGC:2466 IMAGE:2967511), complete cds. [BC001697]",chr16:18794347-18794288,hs|16p12.3,ribosomal protein S15a,TRUE
750_NACAP1_83955,Q9BZK3,"putative nascent polypeptide-associated complex subunit alpha-like protein (alpha-nac pseudogene 1) (nac-alpha pseudogene 1) (naca family member 4, pseudogene)",NACA4P NACAP1 FKSG17,213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,NACAP1,83955,Hs.567608,ENST00000419462,THC2490918,NA,"Homo sapiens nascent-polypeptide-associated complex alpha polypeptide pseudogene 1 (NACAP1), non-coding RNA [NR_002182]",chr8:102381755-102381814,hs|8q22.3,nascent-polypeptide-associated complex alpha polypeptide pseudogene 1,TRUE
751_TRAM1_23471,Q9Y6Q9,nuclear receptor coactivator 3 (ncoa-3) (ec 2.3.1.48) (actr) (amplified in breast cancer 1 protein) (aib-1) (cbp-interacting protein) (pcip) (class e basic helix-loop-helix protein 42) (bhlhe42) (receptor-associated coactivator 3) (rac-3) (steroid receptor coactivator protein 3) (src-3) (thyroid hormone receptor activator molecule 1) (tram-1),NCOA3 AIB1 BHLHE42 RAC3 TRAM1,1424,"function: nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. involved in the coactivation of different nuclear receptors, such as for steroids (gr and er), retinoids (rars and rxrs), thyroid hormone (trs), vitamin d3 (vdr) and prostanoids (ppars). displays histone acetyltransferase activity. also involved in the coactivation of the nf-kappa-b pathway via its interaction with the nfkb1 subunit.","subcellular location: cytoplasm. nucleus. note=mainly cytoplasmic and weakly nuclear. upon tnf activation and subsequent phosphorylation, it translocates from the cytoplasm to the nucleus.","TISSUE SPECIFICITY: Widely expressed. High expression in heart, skeletal muscle, pancreas and placenta. Low expression in brain, and very low in lung, liver and kidney.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRAM1,23471,Hs.491988,ENST00000262213,THC2719697,GO:0004872(receptor activity)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006613(cotranslational protein targeting to membrane)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens translocation associated membrane protein 1 (TRAM1), mRNA [NM_014294]",chr8:71485966-71485907,hs|8q13.3,translocation associated membrane protein 1,TRUE
752_BCAP31_10134,P51572,b-cell receptor-associated protein 31 (bcr-associated protein 31) (bap31) (6c6-ag tumor-associated antigen) (protein cdm) (p28),BCAP31 BAP31 DXS1357E,246,"function: functions as a chaperone protein. is one of the most abundant endoplasmic reticulum (er) proteins. plays a role in the export of secreted proteins in the er, the recognition of abnormally folded protein and their targeting to the er associated-degradation (erad). also serves as a cargo receptor for the export of transmembrane proteins. may be involved in casp8-mediated apoptosis. {eco:0000269|pubmed:10958671, eco:0000269|pubmed:18287538, eco:0000269|pubmed:9396746}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:9334338, eco:0000269|pubmed:9396746}; multi-pass membrane protein {eco:0000255}. endoplasmic reticulum-golgi intermediate compartment membrane {eco:0000269|pubmed:11042173, eco:0000269|pubmed:9396746}; multi-pass membrane protein {eco:0000255}. note=may shuttle between the er and the intermediate compartment/cis-golgi complex. {eco:0000269|pubmed:9396746}.",TISSUE SPECIFICITY: Ubiquitous. Highly expressed in neurons and discrete endocrine cells. {ECO:0000269|PubMed:11561007}.,"DISEASE: Deafness, dystonia, and cerebral hypomyelination (DDCH) [MIM:300475]: An X-linked recessive mental retardation syndrome characterized by almost no psychomotor development, dysmorphic facial features, sensorineural deafness, dystonia, pyramidal signs, and hypomyelination on brain imaging. {ECO:0000269|PubMed:24011989}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=BCAP31 is deleted in the chromosome Xq28 deletion syndrome which involves BCAP31 and the and the promoter region of ABCD1. {ECO:0000269|PubMed:11992258}.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BCAP31,10134,Hs.522817,ENST00000458587,NP1212363,GO:0000139(Golgi membrane)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005102(receptor binding)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006886(intracellular protein transport)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0006955(immune response)|GO:0007204(elevation of cytosolic calcium ion concentration)|GO:0016192(vesicle-mediated transport)|GO:0032471(reduction of endoplasmic reticulum calcium ion concentration)|GO:0033116(ER-Golgi intermediate compartment membrane)|GO:0035584(calcium-mediated signaling using intracellular calcium source)|GO:0043280(positive regulation of caspase activity)|GO:0051561(elevation of mitochondrial calcium ion concentration)|GO:0071556(integral to lumenal side of endoplasmic reticulum membrane),"Homo sapiens B-cell receptor-associated protein 31 (BCAP31), transcript variant 2, mRNA [NM_005745]",chrX:152966108-152966049,hs|Xq28,B-cell receptor-associated protein 31,TRUE
753_NDUFB3_4709,O43676,nadh dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (complex i-b12) (ci-b12) (nadh-ubiquinone oxidoreductase b12 subunit),NDUFB3,98,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed not to be involved in catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; single-pass membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 25 (MC1DN25) [MIM:618246]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN25 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:22499348, ECO:0000269|PubMed:27091925}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFB3,4709,Hs.109760,ENST00000433898,THC2466672,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa (NDUFB3), nuclear gene encoding mitochondrial protein, mRNA [NM_002491]",chr2:201943743-201950238,hs|2q33.1,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa",TRUE
754_AZGP1_563,P25311,zinc-alpha-2-glycoprotein (zn-alpha-2-gp) (zn-alpha-2-glycoprotein),AZGP1 ZAG ZNGP1,298,function: stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. may bind polyunsaturated fatty acids.,subcellular location: secreted.,"TISSUE SPECIFICITY: Blood plasma, seminal plasma, urine, saliva, sweat, epithelial cells of various human glands, liver.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AZGP1,563,Hs.546239,ENST00000292401,THC2466225,GO:0004540(ribonuclease activity)|GO:0005504(fatty acid binding)|GO:0005576(extracellular region)|GO:0006955(immune response)|GO:0007155(cell adhesion)|GO:0008285(negative regulation of cell proliferation)|GO:0008320(protein transmembrane transporter activity)|GO:0016020(membrane)|GO:0016042(lipid catabolic process)|GO:0019882(antigen processing and presentation)|GO:0042612(MHC class I protein complex),"Homo sapiens alpha-2-glycoprotein 1, zinc-binding (AZGP1), mRNA [NM_001185]",chr7:99564563-99564504,hs|7q22.1,"alpha-2-glycoprotein 1, zinc-binding",TRUE
755_EHF_26298,Q9NZC4,ets homologous factor (hehf) (ets domain-containing transcription factor) (epithelium-specific ets transcription factor 3) (ese-3),EHF ESE3 ESE3B ESEJ,300,"function: transcriptional activator that may play a role in regulating epithelial cell differentiation and proliferation. may act as a repressor for a specific subset of ets/ap-1-responsive genes and as a modulator of the nuclear response to mitogen-activated protein kinase signaling cascades. binds to dna sequences containing the consensus nucleotide core sequence ggaa. involved in regulation of tnfrsf10b/dr5 expression through ets-binding sequences on the tnfrsf10b/dr5 promoter. may contribute to development and carcinogenesis by acting as a tumor suppressor gene or anti-oncogene. {eco:0000269|pubmed:10527851, eco:0000269|pubmed:10644770, eco:0000269|pubmed:11259407, eco:0000269|pubmed:12444029, eco:0000269|pubmed:17027647}.","subcellular location: nucleus {eco:0000255|prosite-prorule:pru00237, eco:0000269|pubmed:11259407, eco:0000269|pubmed:12444029}.","TISSUE SPECIFICITY: Expressed exclusively in tissues with a high content of epithelial cells. Highly expressed in salivary gland, mammary gland, prostate, and lung. Weakly expressed in kidney and colon. Not detected in heart, brain, placenta, liver, skeletal muscle, spleen, thymus, testis, ovary, small intestine or peripheral blood leukocytes. {ECO:0000269|PubMed:10527851, ECO:0000269|PubMed:10644770, ECO:0000269|PubMed:11259407, ECO:0000269|PubMed:12444029}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EHF,26298,Hs.653859,NA,THC2637222,"GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0007275(multicellular organismal development)|GO:0008283(cell proliferation)|GO:0030855(epithelial cell differentiation)|GO:0043565(sequence-specific DNA binding)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens ets homologous factor (EHF), transcript variant 1, mRNA [NM_001206616]",chr11:34684363-34684422,hs|11p13,ets homologous factor,TRUE
756_RNF7_9616,Q9UBF6,ring-box protein 2 (rbx2) (ckii beta-binding protein 1) (ckbbp1) (ring finger protein 7) (regulator of cullins 2) (sensitive to apoptosis gene protein),RNF7 RBX2 ROC2 SAG,113,"function: probable component of the scf (skp1-cul1-f-box protein) e3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle progression, signal transduction and transcription (pubmed:10851089). crls complexes and arih1 collaborate in tandem to mediate ubiquitination of target proteins, arih1 mediating addition of the first ubiquitin on crls targets (by similarity). through the ring-type zinc finger, seems to recruit the e2 ubiquitination enzyme to the complex and brings it into close proximity to the substrate. promotes the neddylation of cul5 via its interaction with ube2f. may play a role in protecting cells from apoptosis induced by redox agents. {eco:0000250|uniprotkb:p62877, eco:0000269|pubmed:10851089}.",subcellular location: cytoplasm {eco:0000269|pubmed:10082581}. nucleus {eco:0000269|pubmed:10082581}.,"TISSUE SPECIFICITY: Expressed in heart, liver, skeletal muscle and pancreas. At very low levels expressed in brain, placenta and lung. {ECO:0000269|PubMed:10512750}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF7,9616,Hs.134623,ENST00000477393,THC2577961,GO:0005507(copper ion binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006916(anti-apoptosis)|GO:0008270(zinc ion binding)|GO:0008631(induction of apoptosis by oxidative stress)|GO:0019788(NEDD8 ligase activity)|GO:0045116(protein neddylation)|GO:0046872(metal ion binding)|GO:0051775(response to redox state),"Homo sapiens ring finger protein 7 (RNF7), transcript variant 1, mRNA [NM_014245]",chr3:141464250-141464309,hs|3q23,ring finger protein 7,TRUE
757_BAG1_573,Q99933,bag family molecular chaperone regulator 1 (bag-1) (bcl-2-associated athanogene 1),BAG1 HAP,345,"function: co-chaperone for hsp70 and hsc70 chaperone proteins. acts as a nucleotide-exchange factor (nef) promoting the release of adp from the hsp70 and hsc70 proteins thereby triggering client/substrate protein release. nucleotide release is mediated via its binding to the nucleotide-binding domain (nbd) of hspa8/hsc70 where as the substrate release is mediated via its binding to the substrate-binding domain (sbd) of hspa8/hsc70 (pubmed:27474739, pubmed:9873016, pubmed:24318877). inhibits the pro-apoptotic function of ppp1r15a, and has anti-apoptotic activity (pubmed:12724406). markedly increases the anti-cell death function of bcl2 induced by various stimuli (pubmed:9305631). {eco:0000269|pubmed:12724406, eco:0000269|pubmed:24318877, eco:0000269|pubmed:27474739, eco:0000269|pubmed:9305631, eco:0000269|pubmed:9873016}.","subcellular location: isoform 1: nucleus. cytoplasm. note=isoform 1 localizes predominantly to the nucleus.; subcellular location: isoform 2: cytoplasm. nucleus. note=isoform 2 localizes to the cytoplasm and shuttles into the nucleus in response to heat shock.; subcellular location: isoform 4: cytoplasm. nucleus. note=isoform 4 localizes predominantly to the cytoplasm. the cellular background in which it is expressed can influence whether it resides primarily in the cytoplasm or is also found in the nucleus. in the presence of bcl2, localizes to intracellular membranes (what appears to be the nuclear envelope and perinuclear membranes) as well as punctate cytosolic structures suggestive of mitochondria.","TISSUE SPECIFICITY: Isoform 4 is the most abundantly expressed isoform. It is ubiquitously expressed throughout most tissues, except the liver, colon, breast and uterine myometrium. Isoform 1 is expressed in the ovary and testis. Isoform 4 is expressed in several types of tumor cell lines, and at consistently high levels in leukemia and lymphoma cell lines. Isoform 1 is expressed in the prostate, breast and leukemia cell lines. Isoform 3 is the least abundant isoform in tumor cell lines (at protein level). {ECO:0000269|PubMed:9679980}.",NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,BAG1,573,Hs.377484,ENST00000379707,THC2494891,GO:0005057(receptor signaling protein activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006916(anti-apoptosis)|GO:0006950(response to stress)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0010226(response to lithium ion)|GO:0035094(response to nicotine)|GO:0042493(response to drug)|GO:0045111(intermediate filament cytoskeleton)|GO:0048471(perinuclear region of cytoplasm)|GO:0051087(chaperone binding)|GO:0070389(chaperone cofactor-dependent protein refolding),"Homo sapiens BCL2-associated athanogene (BAG1), transcript variant 1, mRNA [NM_004323]",chr9:33255124-33255065,hs|9p13.3,BCL2-associated athanogene,TRUE
758_C12orf23_90488,Q8WUH6,transmembrane protein 263,TMEM263 C12orf23,116,NA,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C12orf23,90488,Hs.257664,ENST00000280756,THC2499724,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 12 open reading frame 23 (C12orf23), mRNA [NM_152261]",chr12:107367533-107367592,hs|12q23.3,chromosome 12 open reading frame 23,TRUE
759_PSMD4_5710,P55036,26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit rpn10) (26s proteasome regulatory subunit s5a) (antisecretory factor 1) (af) (asf) (multiubiquitin chain-binding protein),PSMD4 MCB1,377,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair. psmd4 acts as an ubiquitin receptor subunit through ubiquitin-interacting motifs and selects ubiquitin-conjugates for destruction. displays a preferred selectivity for longer polyubiquitin chains. {eco:0000269|pubmed:1317798, eco:0000269|pubmed:15826667}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSMD4,5710,Hs.505059,ENST00000427779,THC2472993,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005515(protein binding)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006281(DNA repair)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008270(zinc ion binding)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (PSMD4), mRNA [NM_002810]",chr1:151239868-151239927,hs|1q21.3,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 4",TRUE
76_RPL30_6156,P62888,60s ribosomal protein l30 (large ribosomal subunit protein el30),RPL30,115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL30,6156,Hs.400295,ENST00000521726,THC2553393,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L30 (RPL30), mRNA [NM_000989]",chr8:99054919-99054066,hs|8q22.2,ribosomal protein L30,TRUE
760_TALDO1_6888,P37837,transaldolase (ec 2.2.1.2),TALDO1 TAL TALDO TALDOR,337,function: transaldolase is important for the balance of metabolites in the pentose-phosphate pathway.,subcellular location: cytoplasm {eco:0000305}.,NA,"DISEASE: Transaldolase deficiency (TALDOD) [MIM:606003]: An inborn error of the pentose phosphate pathway resulting in early-onset multisystem disease. Clinical features include growth retardation, dysmorphic features, cutis laxa, congenital heart disease, hepatosplenomegaly, telangiectases of the skin, pancytopenia, and bleeding tendency. {ECO:0000269|PubMed:11283793}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TALDO1,6888,Hs.438678,ENST00000319006,THC2596774,"GO:0004801(sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0005975(carbohydrate metabolic process)|GO:0005999(xylulose biosynthetic process)|GO:0006002(fructose 6-phosphate metabolic process)|GO:0006098(pentose-phosphate shunt)|GO:0006112(energy reserve metabolic process)|GO:0009052(pentose-phosphate shunt, non-oxidative branch)|GO:0016740(transferase activity)|GO:0019682(glyceraldehyde-3-phosphate metabolic process)|GO:0048029(monosaccharide binding)","Homo sapiens transaldolase 1 (TALDO1), mRNA [NM_006755]",chr11:764914-764973,hs|11p15.5,transaldolase 1,TRUE
761_MCM3_4172,P25205,dna replication licensing factor mcm3 (ec 3.6.4.12) (dna polymerase alpha holoenzyme-associated protein p1) (p1-mcm3) (rlf subunit beta) (p102),MCM3,808,"function: acts as component of the mcm2-7 complex (mcm complex) which is the putative replicative helicase essential for 'once per cell cycle' dna replication initiation and elongation in eukaryotic cells. the active atpase sites in the mcm2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the atp-binding site of the walker a box of the adjacent subunit. the six atpase active sites, however, are likely to contribute differentially to the complex helicase activity. required for dna replication and cell proliferation.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MCM3,4172,Hs.179565,ENST00000340349,THC2641099,GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0003677(DNA binding)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005658(alpha DNA polymerase:primase complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0006260(DNA replication)|GO:0006270(DNA-dependent DNA replication initiation)|GO:0006271(DNA strand elongation involved in DNA replication)|GO:0016787(hydrolase activity)|GO:0042555(MCM complex)|GO:0043231(intracellular membrane-bounded organelle)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens minichromosome maintenance complex component 3 (MCM3), mRNA [NM_002388]",chr6:52128952-52128893,hs|6p12.2,minichromosome maintenance complex component 3,TRUE
762_EIF3K_27335,Q9UBQ5,eukaryotic translation initiation factor 3 subunit k (eif3k) (eukaryotic translation initiation factor 3 subunit 12) (muscle-specific gene m9 protein) (plac-24) (eif-3 p25) (eif-3 p28),EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001,218,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17581632, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17581632). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000255|hamap-rule:mf_03010, eco:0000269|pubmed:17581632, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.","subcellular location: nucleus {eco:0000255|hamap-rule:mf_03010, eco:0000269|pubmed:15327989}. cytoplasm {eco:0000255|hamap-rule:mf_03010, eco:0000269|pubmed:15327989}.","TISSUE SPECIFICITY: Ubiquitous, with the highest levels of expression in brain, testis and kidney. {ECO:0000269|PubMed:14519125}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3K,27335,Hs.314359,ENST00000248342,THC2501270,GO:0003743(translation initiation factor activity)|GO:0005488(binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0010467(gene expression)|GO:0043022(ribosome binding)|GO:0044267(cellular protein metabolic process),"Homo sapiens eukaryotic translation initiation factor 3, subunit K (EIF3K), mRNA [NM_013234]",chr19:39125715-39127544,hs|19q13.2,"eukaryotic translation initiation factor 3, subunit K",TRUE
763_SRP14_6727,P37108,signal recognition particle 14 kda protein (srp14) (18 kda alu rna-binding protein),SRP14,136,"function: signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. srp9 together with srp14 and the alu portion of the srp rna, constitutes the elongation arrest domain of srp. the complex of srp9 and srp14 is required for srp rna binding.",subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRP14,6727,Hs.533732,ENST00000267884,THC2545952,"GO:0003723(RNA binding)|GO:0005737(cytoplasm)|GO:0005786(signal recognition particle, endoplasmic reticulum targeting)|GO:0005829(cytosol)|GO:0006613(cotranslational protein targeting to membrane)|GO:0006614(SRP-dependent cotranslational protein targeting to membrane)|GO:0008312(7S RNA binding)|GO:0030942(endoplasmic reticulum signal peptide binding)|GO:0042493(response to drug)|GO:0045047(protein targeting to ER)|GO:0045900(negative regulation of translational elongation)","Homo sapiens signal recognition particle 14kDa (homologous Alu RNA binding protein) (SRP14), mRNA [NM_003134]",chr15:40328464-40328405,hs|15q15.1,signal recognition particle 14kDa (homologous Alu RNA binding protein),TRUE
764_ATP5J2_9551,P56134,"atp synthase subunit f, mitochondrial (atp synthase membrane subunit f)",ATP5MF ATP5J2 ATP5JL,94,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain. minor subunit located with subunit a in the membrane.",subcellular location: mitochondrion. mitochondrion inner membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5J2,9551,Hs.521056,ENST00000394186,THC2480017,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006754(ATP biosynthetic process)|GO:0006811(ion transport)|GO:0015992(proton transport)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)|GO:0045263(proton-transporting ATP synthase complex, coupling factor F(o))","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 (ATP5J2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004889]",chr7:99057727-99056846,hs|7q22.1,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2",TRUE
765_ANKRD36_375248,Q96IX9,putative ankyrin repeat domain-containing protein 26-like 1 (ankyrin repeat domain-containing protein 36b pseudogene 1),ANKRD36BP1 ANKRD26L1,119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,ANKRD36,375248,Hs.541894,ENST00000377003,THC2548520,NA,"Homo sapiens ankyrin repeat domain 36 (ANKRD36), mRNA [NM_001164315]",chr2:97907163-97909588,hs|2q11.2,ankyrin repeat domain 36,TRUE
766_RPS4Y2_140032,Q8TD47,"40s ribosomal protein s4, y isoform 2 (small ribosomal subunit protein es4)",RPS4Y2 RPS4Y2P,263,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS4Y2,140032,Hs.367761,ENST00000288666,NP518027,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0019843(rRNA binding),"Homo sapiens ribosomal protein S4, Y-linked 2 (RPS4Y2), mRNA [NM_001039567]",chrY:22941435-22941494,hs|Yq11.223,"ribosomal protein S4, Y-linked 2",TRUE
767_DDX50_79009,Q9BQ39,atp-dependent rna helicase ddx50 (ec 3.6.4.13) (dead box protein 50) (gu-beta) (nucleolar protein gu2),DDX50,737,NA,"subcellular location: nucleus, nucleolus {eco:0000269|pubmed:12429849}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,DDX50,79009,Hs.522984,ENST00000541832,THC2571742,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0004386(helicase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005886(plasma membrane)|GO:0008026(ATP-dependent helicase activity)|GO:0016787(hydrolase activity),"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 (DDX50), mRNA [NM_024045]",chr10:70706451-70706510,hs|10q22.1,DEAD (Asp-Glu-Ala-Asp) box polypeptide 50,TRUE
768_NUCKS1_64710,Q9H1E3,nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (p1),NUCKS1 NUCKS JC7,243,NA,subcellular location: nucleus.,"TISSUE SPECIFICITY: Widely expressed, with highest levels in thyroid gland, prostate and uterus and in fetal liver, thymus and lung. {ECO:0000269|PubMed:15381070}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NUCKS1,64710,Hs.213061,ENST00000367142,THC2579831,GO:0005634(nucleus),"Homo sapiens nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1), mRNA [NM_022731]",chr1:205696837-205693060,hs|1q32.1,nuclear casein kinase and cyclin-dependent kinase substrate 1,TRUE
769_PRDX6_9588,P30041,peroxiredoxin-6 (ec 1.11.1.15) (1-cys peroxiredoxin) (1-cys prx) (24 kda protein) (acidic calcium-independent phospholipase a2) (aipla2) (ec 3.1.1.4) (antioxidant protein 2) (liver 2d page spot 40) (non-selenium glutathione peroxidase) (nsgpx) (red blood cells page spot 12),PRDX6 AOP2 KIAA0106,224,"function: thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. can reduce h(2)o(2) and short chain organic, fatty acid, and phospholipid hydroperoxides. also has phospholipase activity, and can therefore either reduce the oxidized sn-2 fatty acyl grup of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity). these activities are dependent on binding to phospholipids at acidic ph and to oxidized phospholipds at cytosolic ph. plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis. {eco:0000269|pubmed:10893423, eco:0000269|pubmed:9497358}.","subcellular location: cytoplasm {eco:0000269|pubmed:16186110, eco:0000269|pubmed:19188445, eco:0000269|pubmed:9497358}. lysosome {eco:0000250|uniprotkb:o35244}. note=also found in lung secretory organelles (lamellar bodies). {eco:0000250|uniprotkb:o35244}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRDX6,9588,Hs.120,ENST00000470017,THC2531006,GO:0004602(glutathione peroxidase activity)|GO:0004623(phospholipase A2 activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0005829(cytosol)|GO:0006979(response to oxidative stress)|GO:0009395(phospholipid catabolic process)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016042(lipid catabolic process)|GO:0016209(antioxidant activity)|GO:0016491(oxidoreductase activity)|GO:0016787(hydrolase activity)|GO:0042744(hydrogen peroxide catabolic process)|GO:0051920(peroxiredoxin activity),"Homo sapiens peroxiredoxin 6 (PRDX6), mRNA [NM_004905]",chr1:173457084-173457143,hs|1q25.1,peroxiredoxin 6,TRUE
77_SP100_6672,P23497,nuclear autoantigen sp-100 (nuclear dot-associated sp100 protein) (speckled 100 kda),SP100,879,"function: together with pml, this tumor suppressor is a major constituent of the pml bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. functions as a transcriptional coactivator of ets1 and ets2 according to pubmed:11909962. under certain conditions, it may also act as a corepressor of ets1 preventing its binding to dna according to pubmed:15247905. through the regulation of ets1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. through interaction with the mrn complex it may be involved in the regulation of telomeres lengthening. may also regulate tp53-mediated transcription and through casp8ap2, regulate fas-mediated apoptosis. also plays a role in infection by viruses, including human cytomegalovirus and epstein-barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {eco:0000269|pubmed:11909962, eco:0000269|pubmed:14647468, eco:0000269|pubmed:15247905, eco:0000269|pubmed:15592518, eco:0000269|pubmed:15767676, eco:0000269|pubmed:16177824, eco:0000269|pubmed:17245429, eco:0000269|pubmed:21274506, eco:0000269|pubmed:21880768}.","subcellular location: nucleus. nucleus, pml body {eco:0000269|pubmed:27211601}. cytoplasm. note=differences in the subnuclear localization of the different isoforms seem to exist and may also be cell cycle- and interferon-dependent. accumulates in the cytoplasm upon fas activation.; subcellular location: isoform sp100-c: nucleus {eco:0000269|pubmed:11313457}. note=forms a reticulate or track-like nuclear pattern with denser concentrations at the nuclear lamina and surrounding the nucleoli, a pattern reminiscent of heterochromatin-rich regions according to pubmed:11313457.","TISSUE SPECIFICITY: Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SP100,6672,Hs.369056,ENST00000264052,THC2477304,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0003713(transcription coactivator activity)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator)|GO:0008134(transcription factor binding)|GO:0016605(PML body)|GO:0019221(cytokine-mediated signaling pathway)|GO:0019900(kinase binding)|GO:0019904(protein domain specific binding)|GO:0032526(response to retinoic acid)|GO:0032897(negative regulation of viral transcription)|GO:0034097(response to cytokine stimulus)|GO:0034340(response to type I interferon)|GO:0034341(response to interferon-gamma)|GO:0034399(nuclear periphery)|GO:0042802(identical protein binding)|GO:0042803(protein homodimerization activity)|GO:0043392(negative regulation of DNA binding)|GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity)|GO:0044419(interspecies interaction between organisms)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0048384(retinoic acid receptor signaling pathway)|GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity)|GO:0051271(negative regulation of cellular component movement)|GO:0060333(interferon-gamma-mediated signaling pathway)|GO:0060337(type I interferon-mediated signaling pathway)|GO:0070087(chromo shadow domain binding)","Homo sapiens SP100 nuclear antigen (SP100), transcript variant 2, mRNA [NM_003113]",chr2:231380490-231380696,hs|2q37.1,SP100 nuclear antigen,TRUE
770_ODC1_4953,P11926,ornithine decarboxylase (odc) (ec 4.1.1.17),ODC1,461,"function: catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine. polyamines are essential for cell proliferation and are implicated in cellular processes, ranging from dna replication to apoptosis. {eco:0000269|pubmed:17900240}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,ODC1,4953,Hs.467701,ENST00000405333,THC2581137,GO:0001822(kidney development)|GO:0004586(ornithine decarboxylase activity)|GO:0005575(cellular_component)|GO:0005829(cytosol)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006595(polyamine metabolic process)|GO:0006596(polyamine biosynthetic process)|GO:0008284(positive regulation of cell proliferation)|GO:0009615(response to virus)|GO:0016829(lyase activity)|GO:0034641(cellular nitrogen compound metabolic process),"Homo sapiens ornithine decarboxylase 1 (ODC1), mRNA [NM_002539]",chr2:10580847-10580788,hs|2p25.1,ornithine decarboxylase 1,TRUE
771_HNRNPR_10236,O43390,heterogeneous nuclear ribonucleoprotein r (hnrnp r),HNRNPR HNRPR,633,"function: component of ribonucleosomes, which are complexes of at least 20 other different heterogeneous nuclear ribonucleoproteins (hnrnp). hnrnp play an important role in processing of precursor mrna in the nucleus.","subcellular location: nucleus {eco:0000250|uniprotkb:q7tmk9}. microsome {eco:0000250|uniprotkb:q7tmk9}. nucleus, nucleoplasm {eco:0000269|pubmed:17289661}. cytoplasm {eco:0000269|pubmed:17289661}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas. the tyrosine phosphorylated form bound to rna is found in microsomes (by similarity). {eco:0000250|uniprotkb:q7tmk9, eco:0000269|pubmed:17289661}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPR,10236,Hs.373763,ENST00000302271,THC2528431,"GO:0000166(nucleotide binding)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003676(nucleic acid binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0030529(ribonucleoprotein complex)|GO:0030530(heterogeneous nuclear ribonucleoprotein complex)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens heterogeneous nuclear ribonucleoprotein R (HNRNPR), transcript variant 2, mRNA [NM_005826]",chr1:23636602-23636543,hs|1p36.12,heterogeneous nuclear ribonucleoprotein R,TRUE
772_MARS_4141,P56192,"methionine--trna ligase, cytoplasmic (ec 6.1.1.10) (methionyl-trna synthetase) (metrs)",MARS,900,"function: catalyzes the specific attachment of an amino acid to its cognate trna in a 2 step reaction: the amino acid (aa) is first activated by atp to form aa-amp and then transferred to the acceptor end of the trna (pubmed:11714285). plays a role in the synthesis of ribosomal rna in the nucleolus (pubmed:10791971). {eco:0000269|pubmed:10791971, eco:0000269|pubmed:11714285}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:10791971, eco:0000269|pubmed:19289464, eco:0000305|pubmed:26472928}. nucleus, nucleolus {eco:0000269|pubmed:10791971}. note=localizes to the nucleolus in proliferative cells but disappears in quiescent cells. {eco:0000269|pubmed:10791971}.",NA,"DISEASE: Interstitial lung and liver disease (ILLD) [MIM:615486]: An autosomal recessive, life-threatening disorder characterized by respiratory insufficiency and progressive liver disease with onset in infancy or early childhood. Clinical features include failure to thrive, hypotonia, intermittent lactic acidosis, aminoaciduria, hypothyroidism, interstitial lung disease, pulmonary alveolar proteinosis, anemia, and liver canalicular cholestasis, steatosis, and iron deposition. {ECO:0000269|PubMed:24103465, ECO:0000269|PubMed:25913036}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2U (CMT2U) [MIM:616280]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2U is a slowly progressive, autosomal dominant form characterized by late-adult onset. {ECO:0000269|PubMed:23729695, ECO:0000269|PubMed:24354524}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MARS,4141,Hs.632707,ENST00000262027,NP1134141,GO:0000049(tRNA binding)|GO:0000166(nucleotide binding)|GO:0004825(methionine-tRNA ligase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006431(methionyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0016874(ligase activity),"Homo sapiens methionyl-tRNA synthetase (MARS), mRNA [NM_004990]",chr12:57910373-57910432,hs|12q13.3,methionyl-tRNA synthetase,TRUE
773_PHF8_23133,Q9UPP1,histone lysine demethylase phf8 (ec 1.14.11.27) (phd finger protein 8),PHF8 KIAA1111 ZNF422,1060,"function: histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rdna transcription and brain development. demethylates mono- and dimethylated histone h3 'lys-9' residue (h3k9me1 and h3k9me2), dimethylated h3 'lys-27' (h3k27me2) and monomethylated histone h4 'lys-20' residue (h4k20me1). acts as a transcription activator as h3k9me1, h3k9me2, h3k27me2 and h4k20me1 are epigenetic repressive marks. involved in cell cycle progression by being required to control g1-s transition. acts as a coactivator of rdna transcription, by activating polymerase i (pol i) mediated transcription of rrna genes. required for brain development, probably by regulating expression of neuron-specific genes. only has activity toward h4k20me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. may also have weak activity toward dimethylated h3 'lys-36' (h3k36me2), however, the relevance of this result remains unsure in vivo. specifically binds trimethylated 'lys-4' of histone h3 (h3k4me3), affecting histone demethylase specificity: has weak activity toward h3k9me2 in absence of h3k4me3, while it has high activity toward h3k9me2 when binding h3k4me3. {eco:0000269|pubmed:19843542, eco:0000269|pubmed:20023638, eco:0000269|pubmed:20101266, eco:0000269|pubmed:20208542, eco:0000269|pubmed:20346720, eco:0000269|pubmed:20421419, eco:0000269|pubmed:20531378, eco:0000269|pubmed:20548336, eco:0000269|pubmed:20622853, eco:0000269|pubmed:20622854}.","subcellular location: nucleus. nucleus, nucleolus. note=recruited to h3k4me3 sites on chromatin during interphase. dissociates from chromatin when cells enter mitosis.",NA,"DISEASE: Mental retardation, X-linked, syndromic, Siderius type (MRXSSD) [MIM:300263]: A syndrome characterized by mild to borderline mental retardation with or without cleft lip/cleft palate. {ECO:0000269|PubMed:16199551, ECO:0000269|PubMed:17661819, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PHF8,23133,Hs.133352,ENST00000396277,THC2461193,"GO:0000082(G1/S transition of mitotic cell cycle)|GO:0003682(chromatin binding)|GO:0005506(iron ion binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0007049(cell cycle)|GO:0007420(brain development)|GO:0008270(zinc ion binding)|GO:0016491(oxidoreductase activity)|GO:0016568(chromatin modification)|GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen)|GO:0016706(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors)|GO:0032452(histone demethylase activity)|GO:0032454(histone demethylase activity (H3-K9 specific))|GO:0033169(histone H3-K9 demethylation)|GO:0035064(methylated histone residue binding)|GO:0035574(histone H4-K20 demethylation)|GO:0035575(histone demethylase activity (H4-K20 specific))|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0045943(positive regulation of transcription from RNA polymerase I promoter)|GO:0046872(metal ion binding)|GO:0051864(histone demethylase activity (H3-K36 specific))|GO:0061188(negative regulation of chromatin silencing at rDNA)|GO:0070544(histone H3-K36 demethylation)|GO:0071557(histone H3-K27 demethylation)|GO:0071558(histone demethylase activity (H3-K27 specific))","Homo sapiens PHD finger protein 8 (PHF8), transcript variant 2, mRNA [NM_015107]",chrX:53963260-53963201,hs|Xp11.22,PHD finger protein 8,TRUE
774_CHCHD8_51287,Q9NYJ1,"cytochrome c oxidase assembly factor 4 homolog, mitochondrial (coiled-coil-helix-coiled-coil-helix domain-containing protein 8) (e2-induced gene 2 protein)",COA4 CHCHD8 E2IG2,87,function: putative cox assembly factor. {eco:0000250}.,subcellular location: mitochondrion {eco:0000269|pubmed:23676665}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CHCHD8,51287,Hs.475387,ENST00000541455,THC2520599,NA,"Homo sapiens coiled-coil-helix-coiled-coil-helix domain containing 8 (CHCHD8), mRNA [NM_016565]",chr11:73583902-73583843,hs|11q13.4,coiled-coil-helix-coiled-coil-helix domain containing 8,TRUE
775_KIAA2013_90231,Q8IYS2,uncharacterized protein kiaa2013,KIAA2013,634,NA,subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,KIAA2013,90231,Hs.520094,ENST00000376572,THC2495518,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens KIAA2013 (KIAA2013), mRNA [NM_138346]",chr1:11979750-11979691,hs|1p36.22,KIAA2013,TRUE
776_PLA2G16_11145,P53816,phospholipase a and acyltransferase 3 (ec 2.3.1.-) (ec 3.1.1.32) (ec 3.1.1.4) (adipose-specific phospholipase a2) (adpla) (group xvi phospholipase a1/a2) (h-rev 107 protein homolog) (h-rev107) (hrev107-1) (hras-like suppressor 1) (hras-like suppressor 3) (hrsl3) (hrev107-3) (renal carcinoma antigen ny-ren-65),PLAAT3 HRASLS3 HREV107 PLA2G16,162,"function: exhibits both phospholipase a1/2 and acyltransferase activities (pubmed:19615464, pubmed:19047760, pubmed:22825852, pubmed:22605381, pubmed:26503625). shows phospholipase a1 (pla1) and a2 (pla2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids (pubmed:19615464, pubmed:19047760, pubmed:22825852, pubmed:22605381, pubmed:22923616). for most substrates, pla1 activity is much higher than pla2 activity (pubmed:19615464). shows o-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid (pubmed:19615464). shows n-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (pc) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (pe), forming n-acylphosphatidylethanolamine (nape), which serves as precursor for n-acylethanolamines (naes) (pubmed:19615464, pubmed:19047760, pubmed:22825852, pubmed:22605381). exhibits high n-acyltransferase activity and low phospholipase a1/2 activity (pubmed:22825852). {eco:0000269|pubmed:19047760, eco:0000269|pubmed:19615464, eco:0000269|pubmed:22605381, eco:0000269|pubmed:22825852, eco:0000269|pubmed:22923616, eco:0000303|pubmed:26503625}.; function: (microbial infection) acts as a host factor for picornaviruses: required during early infection to promote viral genome release into the cytoplasm (pubmed:28077878). may act as a cellular sensor of membrane damage at sites of virus entry, which relocalizes to sites of membrane rupture upon virus unfection (pubmed:28077878). facilitates safe passage of the rna away from lgals8, enabling viral genome translation by host ribosome (pubmed:28077878). may also be involved in initiating pore formation, increasing pore size or in maintaining pores for genome delivery (pubmed:28077878). the lipid-modifying enzyme activity is required for this process (pubmed:28077878). {eco:0000269|pubmed:28077878}.","subcellular location: cell membrane {eco:0000250|uniprotkb:p53817}; single-pass membrane protein {eco:0000255}. cytoplasm {eco:0000269|pubmed:17374643}. cytoplasm, perinuclear region {eco:0000250|uniprotkb:q8r3u1}. peroxisome membrane {eco:0000250|uniprotkb:q8r3u1}.","TISSUE SPECIFICITY: Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. Highly expressed in white adipose tissue (PubMed:19136964). {ECO:0000269|PubMed:11526504, ECO:0000269|PubMed:11973642, ECO:0000269|PubMed:19136964, ECO:0000269|PubMed:19615464, ECO:0000269|PubMed:9771974}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PLA2G16,11145,Hs.502775,ENST00000394613,THC2527206,GO:0003674(molecular_function)|GO:0005515(protein binding)|GO:0005575(cellular_component)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016042(lipid catabolic process)|GO:0016787(hydrolase activity)|GO:0045786(negative regulation of cell cycle)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens phospholipase A2, group XVI (PLA2G16), transcript variant 1, mRNA [NM_007069]",chr11:63342381-63342322,hs|11q12.3,"phospholipase A2, group XVI",TRUE
778_FAM120AOS_158293,Q5T036,uncharacterized protein fam120aos (fam120a opposite strand protein),FAM120AOS C9orf10OS,256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM120AOS,158293,Hs.350364,ENST00000520403,THC2585333,NA,"Homo sapiens family with sequence similarity 120A opposite strand (FAM120AOS), mRNA [NM_198841]",chr9:96208883-96208824,hs|9q22.31,family with sequence similarity 120A opposite strand,TRUE
779_POLR2L_5441,P62875,"dna-directed rna polymerases i, ii, and iii subunit rpabc5 (rna polymerases i, ii, and iii subunit abc5) (dna-directed rna polymerase iii subunit l) (rna polymerase ii 7.6 kda subunit) (rpb7.6) (rpb10 homolog)",POLR2L,67,"function: dna-dependent rna polymerase catalyzes the transcription of dna into rna using the four ribonucleoside triphosphates as substrates. common component of rna polymerases i, ii and iii which synthesize ribosomal rna precursors, mrna precursors and many functional non-coding rnas, and a small rnas, such as 5s rrna and trnas, respectively. pol ii is the central component of the basal rna polymerase ii transcription machinery. pols are composed of mobile elements that move relative to each other. in pol ii, polr2l/rbp10 is part of the core element with the central large cleft (by similarity). {eco:0000250, eco:0000269|pubmed:9852112}.","subcellular location: nucleus {eco:0000269|pubmed:16809778, eco:0000269|pubmed:9852112}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,POLR2L,5441,Hs.441072,ENST00000322028,THC2466205,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003899(DNA-directed RNA polymerase activity)|GO:0004672(protein kinase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005665(DNA-directed RNA polymerase II, core complex)|GO:0006281(DNA repair)|GO:0006283(transcription-coupled nucleotide-excision repair)|GO:0006289(nucleotide-excision repair)|GO:0006356(regulation of transcription from RNA polymerase I promoter)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0006370(mRNA capping)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0006385(transcription elongation from RNA polymerase III promoter)|GO:0006386(termination of RNA polymerase III transcription)|GO:0006468(protein phosphorylation)|GO:0008270(zinc ion binding)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0046872(metal ion binding)|GO:0050434(positive regulation of viral transcription)","Homo sapiens polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (POLR2L), mRNA [NM_021128]",chr11:840281-840222,hs|11p15.5,"polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa",TRUE
78_RPL11_6135,P62913,60s ribosomal protein l11 (cll-associated antigen kw-12) (large ribosomal subunit protein ul5),RPL11,178,"function: component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. the small ribosomal subunit (ssu) binds messenger rnas (mrnas) and translates the encoded message by selecting cognate aminoacyl-transfer rna (trna) molecules. the large subunit (lsu) contains the ribosomal catalytic site termed the peptidyl transferase center (ptc), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by trnas into a polypeptide chain. the nascent polypeptides leave the ribosome through a tunnel in the lsu and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. as part of the 5s rnp/5s ribonucleoprotein particle it is an essential component of the lsu, required for its formation and the maturation of rrnas (pubmed:19061985, pubmed:12962325, pubmed:24120868). it also couples ribosome biogenesis to p53/tp53 activation. as part of the 5s rnp it accumulates in the nucleoplasm and inhibits mdm2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of tp53 (pubmed:24120868). promotes nucleolar location of pml (by similarity). {eco:0000250|uniprotkb:q9cxw4, eco:0000269|pubmed:12962325, eco:0000269|pubmed:19061985, eco:0000269|pubmed:24120868}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:27829214}. cytoplasm {eco:0000250|uniprotkb:q9cxw4}.",NA,"DISEASE: Diamond-Blackfan anemia 7 (DBA7) [MIM:612562]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:19061985, ECO:0000269|PubMed:19191325}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL11,6135,Hs.719951,ENST00000482370,THC2552479,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006364(rRNA processing)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0006605(protein targeting)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0034504(protein localization to nucleus)|GO:0042273(ribosomal large subunit biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L11 (RPL11), transcript variant 1, mRNA [NM_000975]",chr1:24021173-24021232,hs|1p36.11,ribosomal protein L11,TRUE
780_MTRNR2L6_100463482,P0CJ73,humanin-like 6 (hn6) (mt-rnr2-like protein 6),MTRNR2L6,24,function: plays a role as a neuroprotective and antiapoptotic factor. {eco:0000250|uniprotkb:q8ivg9}.,subcellular location: secreted {eco:0000250|uniprotkb:q8ivg9}. cytoplasm {eco:0000250|uniprotkb:q8ivg9}.,TISSUE SPECIFICITY: Expressed in skeletal muscle and testis. {ECO:0000269|PubMed:19477263}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MTRNR2L6,100463482,Hs.727419,ENST00000545075,THC2591743,GO:0005576(extracellular region)|GO:0005737(cytoplasm),"Homo sapiens MT-RNR2-like 6 (MTRNR2L6), mRNA [NM_001190487]",chr7:142375368-142375427,hs|7q34,MT-RNR2-like 6,TRUE
781_ATP1A1_476,P05023,sodium/potassium-transporting atpase subunit alpha-1 (na(+)/k(+) atpase alpha-1 subunit) (ec 7.2.2.13) (sodium pump subunit alpha-1),ATP1A1,1023,"function: this is the catalytic component of the active enzyme, which catalyzes the hydrolysis of atp coupled with the exchange of sodium and potassium ions across the plasma membrane. this action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. {eco:0000269|pubmed:29499166, eco:0000269|pubmed:30388404}.","subcellular location: cell membrane, sarcolemma {eco:0000269|pubmed:7711835}; multi-pass membrane protein {eco:0000255}. melanosome {eco:0000269|pubmed:17081065}. note=identified by mass spectrometry in melanosome fractions from stage i to stage iv. {eco:0000269|pubmed:17081065}.",NA,"DISEASE: Charcot-Marie-Tooth disease 2DD (CMT2DD) [MIM:618036]: A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:29499166}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypomagnesemia, seizures, and mental retardation 2 (HOMGSMR2) [MIM:618314]: An autosomal dominant disease characterized by generalized seizures in infancy, severe hypomagnesemia, and renal magnesium wasting. Seizures persist despite magnesium supplementation and are associated with significant intellectual disability. {ECO:0000269|PubMed:30388404}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP1A1,476,Hs.371889,ENST00000537345,THC2571923,"GO:0000166(nucleotide binding)|GO:0002026(regulation of the force of heart contraction)|GO:0002028(regulation of sodium ion transport)|GO:0003869(4-nitrophenylphosphatase activity)|GO:0005391(sodium:potassium-exchanging ATPase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005624(membrane fraction)|GO:0005792(microsome)|GO:0005886(plasma membrane)|GO:0005890(sodium:potassium-exchanging ATPase complex)|GO:0006754(ATP biosynthetic process)|GO:0006813(potassium ion transport)|GO:0008217(regulation of blood pressure)|GO:0015077(monovalent inorganic cation transmembrane transporter activity)|GO:0015662(ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism)|GO:0016021(integral to membrane)|GO:0016323(basolateral plasma membrane)|GO:0016787(hydrolase activity)|GO:0016820(hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances)|GO:0031947(negative regulation of glucocorticoid biosynthetic process)|GO:0034220(ion transmembrane transport)|GO:0042383(sarcolemma)|GO:0042470(melanosome)|GO:0042493(response to drug)|GO:0045822(negative regulation of heart contraction)|GO:0045823(positive regulation of heart contraction)|GO:0045989(positive regulation of striated muscle contraction)|GO:0046872(metal ion binding)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, Na+/K+ transporting, alpha 1 polypeptide (ATP1A1), transcript variant 1, mRNA [NM_000701]",chr1:116944237-116946524,hs|1p13.1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",TRUE
782_MRPL20_55052,Q9BYC9,"39s ribosomal protein l20, mitochondrial (l20mt) (mrp-l20) (mitochondrial large ribosomal subunit protein bl20m)",MRPL20,149,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:11279069, eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPL20,55052,Hs.730767,ENST00000487659,THC2466903,GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0019843(rRNA binding),"Homo sapiens mitochondrial ribosomal protein L20 (MRPL20), nuclear gene encoding mitochondrial protein, mRNA [NM_017971]",chr1:1337420-1337361,hs|1p36.33,mitochondrial ribosomal protein L20,TRUE
783_RAMP1_10267,O60894,receptor activity-modifying protein 1 (calcitonin-receptor-like receptor activity-modifying protein 1) (crlr activity-modifying protein 1),RAMP1,148,function: transports the calcitonin gene-related peptide type 1 receptor (calcrl) to the plasma membrane. acts as a receptor for calcitonin-gene-related peptide (cgrp) together with calcrl. {eco:0000269|pubmed:9620797}.,subcellular location: membrane; single-pass type i membrane protein.,"TISSUE SPECIFICITY: Expressed in many tissues including the uterus, bladder, brain, pancreas and gastro-intestinal tract. {ECO:0000269|PubMed:9620797}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RAMP1,10267,Hs.471783,ENST00000254661,THC2464432,GO:0004872(receptor activity)|GO:0005615(extracellular space)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006886(intracellular protein transport)|GO:0008277(regulation of G-protein coupled receptor protein signaling pathway)|GO:0008565(protein transporter activity)|GO:0015026(coreceptor activity)|GO:0015031(protein transport),"Homo sapiens receptor (G protein-coupled) activity modifying protein 1 (RAMP1), mRNA [NM_005855]",chr2:238820661-238820720,hs|2q37.3,receptor (G protein-coupled) activity modifying protein 1,TRUE
784_FBL_2091,Q9UKA2,f-box/lrr-repeat protein 4 (f-box and leucine-rich repeat protein 4) (f-box protein fbl4/fbl5),FBXL4 FBL4 FBL5,621,NA,subcellular location: cytoplasm. nucleus. mitochondrion.,"TISSUE SPECIFICITY: Expressed in heart, kidney, liver, lung, pancreas, and placenta, but not in skeletal muscle. {ECO:0000269|PubMed:10531037}.","DISEASE: Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]: An autosomal recessive disorder characterized by early infantile onset of encephalopathy, hypotonia, lactic acidosis, and severe global developmental delay. Cells derived from patient tissues show defects in mitochondrial oxidative phosphorylation and decreased mtDNA content. {ECO:0000269|PubMed:23993193, ECO:0000269|PubMed:23993194, ECO:0000269|PubMed:27182039}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FBL,2091,Hs.299002,ENST00000221801,THC2465274,GO:0001652(granular component)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006364(rRNA processing)|GO:0008033(tRNA processing)|GO:0008168(methyltransferase activity)|GO:0015030(Cajal body)|GO:0016074(snoRNA metabolic process)|GO:0016740(transferase activity)|GO:0030529(ribonucleoprotein complex)|GO:0031428(box C/D snoRNP complex),"Homo sapiens fibrillarin (FBL), mRNA [NM_001436]",chr19:40325192-40325133,hs|19q13.2,fibrillarin,TRUE
785_KRT10_3858,P13645,"keratin, type i cytoskeletal 10 (cytokeratin-10) (ck-10) (keratin-10) (k10)",KRT10 KPP,584,"function: plays a role in the establishment of the epidermal barrier on plantar skin. {eco:0000250|uniprotkb:p02535}.; function: (microbial infection) acts as a mediator of s.aureus adherence to desquamated nasal epithelial cells via clfb, and hence may play a role in nasal colonization. {eco:0000269|pubmed:15385531}.; function: (microbial infection) binds s.pneumoniae psrp, mediating adherence of the bacteria to lung cell lines. reduction of levels of krt10 keratin decrease adherence, overexpression increases adherence. neither protein has to be glycosylated for the interaction to occur. {eco:0000269|pubmed:19627498}.","subcellular location: secreted, extracellular space {eco:0000269|pubmed:12427098}. cell surface {eco:0000269|pubmed:19627498}. note=localized on the surface of desquamated nasal epithelial cells (pubmed:12427098). localized on the surface of lung cell lines (pubmed:19627498). {eco:0000269|pubmed:12427098, eco:0000269|pubmed:19627498}.",TISSUE SPECIFICITY: Seen in all suprabasal cell layers including stratum corneum. Expressed on the surface of lung cell lines (PubMed:19627498). {ECO:0000269|PubMed:19627498}.,"DISEASE: Epidermolytic hyperkeratosis (EHK) [MIM:113800]: An autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop. {ECO:0000269|PubMed:10201536, ECO:0000269|PubMed:1380725, ECO:0000269|PubMed:1381287, ECO:0000269|PubMed:21271994, ECO:0000269|PubMed:7507150, ECO:0000269|PubMed:7507152, ECO:0000269|PubMed:7508181, ECO:0000269|PubMed:7512983, ECO:0000269|PubMed:7526210, ECO:0000269|Ref.7}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis annular epidermolytic (AEI) [MIM:607602]: A skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale, which coalesce to involve most of the body surface and can persist for several weeks or even months. {ECO:0000269|PubMed:9036939, ECO:0000269|PubMed:9856845}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Erythroderma, ichthyosiform, congenital reticular (CRIE) [MIM:609165]: A rare skin condition characterized by slowly enlarging islands of normal skin surrounded by erythematous ichthyotic patches in a reticulated pattern. The condition starts in infancy as a lamellar ichthyosis, with small islands of normal skin resembling confetti appearing in late childhood and at puberty. Histopathologic findings include band-like parakeratosis, psoriasiform acanthosis, and vacuolization of keratinocytes with binucleated cells in the upper epidermis, sometimes associated with amyloid deposition in the dermis. Ultrastructural abnormalities include perinuclear shells formed from a network of fine filaments in the upper epidermis. {ECO:0000269|PubMed:20798280}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KRT10,3858,Hs.99936,ENST00000269576,NP096831,GO:0005198(structural molecule activity)|GO:0005882(intermediate filament)|GO:0008544(epidermis development)|GO:0030280(structural constituent of epidermis)|GO:0030855(epithelial cell differentiation)|GO:0045095(keratin filament)|GO:0071277(cellular response to calcium ion),"Homo sapiens keratin 10 (KRT10), mRNA [NM_000421]",chr17:38974495-38974436,hs|17q21.2,keratin 10,TRUE
786_SNRPD2_6633,P62316,small nuclear ribonucleoprotein sm d2 (sm-d2) (snrnp core protein d2),SNRPD2 SNRPD1,118,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:19325628, pubmed:23333303, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:23333303, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPD2,6633,Hs.515472,ENST00000391932,THC2572583,"GO:0000245(spliceosome assembly)|GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005689(U12-type spliceosomal complex)|GO:0005829(cytosol)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein D2 polypeptide 16.5kDa (SNRPD2), transcript variant 2, mRNA [NM_177542]",chr19:46190933-46190874,hs|19q13.32,small nuclear ribonucleoprotein D2 polypeptide 16.5kDa,TRUE
787_ERRFI1_54206,Q9UJM3,erbb receptor feedback inhibitor 1 (mitogen-inducible gene 6 protein) (mig-6),ERRFI1 MIG6,462,"function: negative regulator of egfr signaling in skin morphogenesis. acts as a negative regulator for several egfr family members, including erbb2, erbb3 and erbb4. inhibits egfr catalytic activity by interfering with its dimerization. inhibits autophosphorylation of egfr, erbb2 and erbb4. important for normal keratinocyte proliferation and differentiation. plays a role in modulating the response to steroid hormones in the uterus. required for normal response to progesterone in the uterus and for fertility. mediates epithelial estrogen responses in the uterus by regulating esr1 levels and activation. important for regulation of endometrium cell proliferation. important for normal prenatal and perinatal lung development (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000269|pubmed:7641805}. cell membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}. nucleus {eco:0000250}. note=associated with the plasma membrane of basal skin keratinocytes. translocates into the nucleus of differentiating suprabasal keratinocytes (by similarity). {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ERRFI1,54206,Hs.605445,ENST00000377482,THC2468875,GO:0005100(Rho GTPase activator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006950(response to stress)|GO:0007175(negative regulation of epidermal growth factor receptor activity)|GO:0019901(protein kinase binding)|GO:0031234(extrinsic to internal side of plasma membrane)|GO:0031953(negative regulation of protein autophosphorylation)|GO:0032321(positive regulation of Rho GTPase activity)|GO:0043589(skin morphogenesis)|GO:0045616(regulation of keratinocyte differentiation)|GO:0048286(lung alveolus development)|GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation)|GO:0060426(lung vasculature development)|GO:0060428(lung epithelium development),"Homo sapiens ERBB receptor feedback inhibitor 1 (ERRFI1), mRNA [NM_018948]",chr1:8072267-8072208,hs|1p36.23,ERBB receptor feedback inhibitor 1,TRUE
788_IVNS1ABP_10625,Q9Y6Y0,influenza virus ns1a-binding protein (ns1-bp) (ns1-binding protein) (aryl hydrocarbon receptor-associated protein 3) (kelch-like protein 39),IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068,642,"function: involved in many cell functions, including pre-mrna splicing, the aryl hydrocarbon receptor (ahr) pathway, f-actin organization and protein ubiquitination. plays a role in the dynamic organization of the actin skeleton as a stabilizer of actin filaments by association with f-actin through kelch repeats (by similarity). protects cells from cell death induced by actin destabilization (by similarity). functions as modifier of the ahr/aryl hydrocarbon receptor pathway increasing the concentration of ahr available to activate transcription (pubmed:16582008). in addition, functions as a negative regulator of bcr(klhl20) e3 ubiquitin ligase complex to prevent ubiquitin-mediated proteolysis of pml and dapk1, two tumor suppressors (pubmed:25619834). inhibits pre-mrna splicing (in vitro) (pubmed:9696811). {eco:0000250|uniprotkb:q920q8, eco:0000269|pubmed:16582008, eco:0000269|pubmed:25619834, eco:0000269|pubmed:9696811}.; function: (microbial infection) involved in the alternative splicing of influenza a virus m1 mrna through interaction with hnrnpk, thereby facilitating the generation of viral m2 protein. {eco:0000269|pubmed:23825951, eco:0000269|pubmed:9696811}.","subcellular location: cytoplasm {eco:0000269|pubmed:9696811}. cytoplasm, cytoskeleton {eco:0000269|pubmed:9696811}. nucleus, nucleoplasm {eco:0000269|pubmed:9696811}. note=associated with actin filaments (by similarity). localization related to speckle domains which correspond to interchromatin granules and are enriched in factors involved in pre-mrna splicing (pubmed:9696811). following influenza a virus infection, redistribution from speckles to a more diffuse distribution in the nucleoplasm (pubmed:9696811). {eco:0000250|uniprotkb:q920q8, eco:0000269|pubmed:9696811}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,IVNS1ABP,10625,Hs.497183,ENST00000475046,THC2508365,GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005667(transcription factor complex)|GO:0005681(spliceosomal complex)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0008380(RNA splicing)|GO:0009615(response to virus)|GO:0044419(interspecies interaction between organisms),"Homo sapiens influenza virus NS1A binding protein (IVNS1ABP), mRNA [NM_006469]",chr1:185267030-185266971,hs|1q25.3,influenza virus NS1A binding protein,TRUE
789_NDUFA6_4700,P56556,nadh dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (complex i-b14) (ci-b14) (lyr motif-containing protein 6) (nadh-ubiquinone oxidoreductase b14 subunit),NDUFA6 LYRM6 NADHB14,128,"function: accessory subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i), that is believed to be not involved in catalysis. required for proper complex i assembly (pubmed:30245030). complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone. {eco:0000269|pubmed:27626371, eco:0000269|pubmed:30245030}.",subcellular location: mitochondrion inner membrane {eco:0000305|pubmed:12611891}; peripheral membrane protein {eco:0000305}; matrix side {eco:0000305}.,NA,"DISEASE: Mitochondrial complex I deficiency, nuclear type 33 (MC1DN33) [MIM:618253]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN33 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:30245030}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NDUFA6,4700,Hs.274416,ENST00000470753,THC2576863,"GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0006979(response to oxidative stress)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0031966(mitochondrial membrane)|GO:0070469(respiratory chain)","Homo sapiens NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa (NDUFA6), nuclear gene encoding mitochondrial protein, mRNA [NM_002490]",chr22:42482197-42482138,hs|22q13.2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa",TRUE
790_STK24_8428,Q9Y6E0,serine/threonine-protein kinase 24 (ec 2.7.11.1) (mammalian ste20-like protein kinase 3) (mst-3) (ste20-like kinase mst3) [cleaved into: serine/threonine-protein kinase 24 36 kda subunit (mammalian ste20-like protein kinase 3 n-terminal) (mst3/n); serine/threonine-protein kinase 24 12 kda subunit (mammalian ste20-like protein kinase 3 c-terminal) (mst3/c)],STK24 MST3 STK3,443,"function: serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. mediates oxidative-stress-induced cell death by modulating phosphorylation of jnk1-jnk2 (mapk8 and mapk9), p38 (mapk11, mapk12, mapk13 and mapk14) during oxidative stress. plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of aifm1 and endog and the dnase activity associated with endog. phosphorylates stk38l on 'thr-442' and stimulates its kinase activity. in association with stk26 negatively regulates golgi reorientation in polarized cell migration upon rho activation (pubmed:27807006). regulates also cellular migration with alteration of ptpn12 activity and pxn phosphorylation: phosphorylates ptpn12 and inhibits its activity and may regulate pxn phosphorylation through ptpn12. may act as a key regulator of axon regeneration in the optic nerve and radial nerve. {eco:0000269|pubmed:16314523, eco:0000269|pubmed:17046825, eco:0000269|pubmed:19604147, eco:0000269|pubmed:19782762, eco:0000269|pubmed:19855390, eco:0000269|pubmed:27807006}.",subcellular location: cytoplasm. nucleus. membrane. note=the truncated form (mst3/n) translocates to the nucleus. colocalizes with stk38l in the membrane.,TISSUE SPECIFICITY: Isoform A is ubiquitous. Isoform B is expressed in brain with high expression in hippocampus and cerebral cortex.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,STK24,8428,Hs.508514,ENST00000376541,THC2579678,GO:0000166(nucleotide binding)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006468(protein phosphorylation)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0007165(signal transduction)|GO:0008631(induction of apoptosis by oxidative stress)|GO:0016020(membrane)|GO:0030336(negative regulation of cell migration)|GO:0046777(protein autophosphorylation)|GO:0046872(metal ion binding)|GO:0048679(regulation of axon regeneration),"Homo sapiens serine/threonine kinase 24 (STK24), transcript variant 2, mRNA [NM_001032296]",chr13:99104638-99104579,hs|13q32.2,serine/threonine kinase 24,TRUE
791_HIST1H2BF_8343,P62807,histone h2b type 1-c/e/f/g/i (histone h2b.1 a) (histone h2b.a) (h2b/a) (histone h2b.g) (h2b/g) (histone h2b.h) (h2b/h) (histone h2b.k) (h2b/k) (histone h2b.l) (h2b/l),H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI,126,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; function: has broad antibacterial activity. may contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2BF,8343,Hs.182137,ENST00000359985,THC2500887,NA,"Homo sapiens histone cluster 1, H2bf (HIST1H2BF), mRNA [NM_003522]",chr6:26200103-26200162,hs|6p22.2,"histone cluster 1, H2bf",TRUE
792_PDDC1_347862,Q8NB37,glutamine amidotransferase-like class 1 domain-containing protein 1 (parkinson disease 7 domain-containing protein 1),GATD1 PDDC1,220,NA,subcellular location: secreted {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,PDDC1,347862,Hs.218362,ENST00000319863,THC2764320,GO:0005576(extracellular region),"Homo sapiens Parkinson disease 7 domain containing 1 (PDDC1), mRNA [NM_182612]",chr11:767293-767234,hs|11p15.5,Parkinson disease 7 domain containing 1,TRUE
793_GNB1_2782,P62873,guanine nucleotide-binding protein g(i)/g(s)/g(t) subunit beta-1 (transducin beta chain 1),GNB1,340,"function: guanine nucleotide-binding proteins (g proteins) are involved as a modulator or transducer in various transmembrane signaling systems. the beta and gamma chains are required for the gtpase activity, for replacement of gdp by gtp, and for g protein-effector interaction.",NA,NA,"DISEASE: Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD42 patients manifest global developmental delay commonly accompanied by hypotonia, seizures of various types, ophthalmological manifestations, and poor growth. {ECO:0000269|PubMed:25485910, ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284, ECO:0000269|PubMed:28087732}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,GNB1,2782,Hs.430425,ENST00000455156,THC2510197,GO:0001664(G-protein-coupled receptor binding)|GO:0001750(photoreceptor outer segment)|GO:0003924(GTPase activity)|GO:0004871(signal transducer activity)|GO:0005834(heterotrimeric G-protein complex)|GO:0005886(plasma membrane)|GO:0006112(energy reserve metabolic process)|GO:0006184(GTP catabolic process)|GO:0007165(signal transduction)|GO:0007200(activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger)|GO:0007204(elevation of cytosolic calcium ion concentration)|GO:0007213(muscarinic acetylcholine receptor signaling pathway)|GO:0007265(Ras protein signal transduction)|GO:0007268(synaptic transmission)|GO:0007596(blood coagulation)|GO:0008283(cell proliferation)|GO:0030168(platelet activation)|GO:0031702(type 1 angiotensin receptor binding)|GO:0050909(sensory perception of taste)|GO:0051020(GTPase binding)|GO:0060041(retina development in camera-type eye)|GO:0071377(cellular response to glucagon stimulus),"Homo sapiens guanine nucleotide binding protein (G protein), beta polypeptide 1 (GNB1), mRNA [NM_002074]",chr1:1717507-1717448,hs|1p36.33,"guanine nucleotide binding protein (G protein), beta polypeptide 1",TRUE
794_BOLA3_388962,Q53S33,bola-like protein 3,BOLA3,107,"function: acts as a mitochondrial iron-sulfur (fe-s) cluster assembly factor that facilitates (fe-s) cluster insertion into a subset of mitochondrial proteins. probably acts together with nfu1 (pubmed:27532772). {eco:0000250|uniprotkb:p39724, eco:0000305|pubmed:27532772}.",subcellular location: mitochondrion {eco:0000269|pubmed:22746225}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:18548201}.,"DISEASE: Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia (MMDS2) [MIM:614299]: A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. Some patients show failure to thrive, pulmonary hypertension, hypotonia and irritability. Biochemical features include severe combined deficiency of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and reduction in activity of mitochondrial respiratory chain complexes. {ECO:0000269|PubMed:21944046, ECO:0000269|PubMed:22562699, ECO:0000269|PubMed:24334290, ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,BOLA3,388962,Hs.61472,ENST00000469676,THC2610330,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005576(extracellular region)|GO:0008150(biological_process),"Homo sapiens bolA homolog 3 (E. coli) (BOLA3), transcript variant 1, mRNA [NM_212552]",chr2:74362689-74362630,hs|2p13.1,bolA homolog 3 (E. coli),TRUE
795_UQCRC2_7385,P22695,"cytochrome b-c1 complex subunit 2, mitochondrial (complex iii subunit 2) (core protein ii) (ubiquinol-cytochrome-c reductase complex core protein 2)",UQCRC2,453,"function: this is a component of the ubiquinol-cytochrome c reductase complex (complex iii or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. the core protein 2 is required for the assembly of the complex.",subcellular location: mitochondrion inner membrane; peripheral membrane protein; matrix side.,NA,"DISEASE: Mitochondrial complex III deficiency, nuclear 5 (MC3DN5) [MIM:615160]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:23281071}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,UQCRC2,7385,Hs.528803,ENST00000268379,NP1212590,GO:0003824(catalytic activity)|GO:0004222(metalloendopeptidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005750(mitochondrial respiratory chain complex III)|GO:0006119(oxidative phosphorylation)|GO:0006508(proteolysis)|GO:0006810(transport)|GO:0008270(zinc ion binding)|GO:0009060(aerobic respiration)|GO:0016020(membrane)|GO:0022904(respiratory electron transport chain)|GO:0032403(protein complex binding)|GO:0046872(metal ion binding)|GO:0070469(respiratory chain),"Homo sapiens ubiquinol-cytochrome c reductase core protein II (UQCRC2), nuclear gene encoding mitochondrial protein, mRNA [NM_003366]",chr16:21994578-21994637,hs|16p12.2,ubiquinol-cytochrome c reductase core protein II,TRUE
796_DVL1_1855,O14640,segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1),DVL1,695,function: participates in wnt signaling by binding to the cytoplasmic c-terminus of frizzled family members and transducing the wnt signal to down-stream effectors. plays a role both in canonical and non-canonical wnt signaling. plays a role in the signal transduction pathways mediated by multiple wnt genes. required for lef1 activation upon wnt1 and wnt3a signaling. dvl1 and pak1 form a ternary complex with musk which is important for musk-dependent regulation of achr clustering during the formation of the neuromuscular junction (nmj).,"subcellular location: cell membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}. cytoplasm, cytosol {eco:0000250}. cytoplasmic vesicle {eco:0000250}. note=localizes at the cell membrane upon interaction with frizzled family members. {eco:0000250}.",NA,"DISEASE: Robinow syndrome, autosomal dominant 2 (DRS2) [MIM:616331]: A rare skeletal dysplasia syndrome characterized by dysmorphic features resembling a fetal face, mesomelic limb shortening, hypoplastic external genitalia in males, costovertebral segmentation defects, and renal anomalies. {ECO:0000269|PubMed:25817014, ECO:0000269|PubMed:25817016}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DVL1,1855,Hs.730615,ENST00000345100,THC2604662,"GO:0001505(regulation of neurotransmitter levels)|GO:0001933(negative regulation of protein phosphorylation)|GO:0003674(molecular_function)|GO:0004871(signal transducer activity)|GO:0005109(frizzled binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005874(microtubule)|GO:0005886(plasma membrane)|GO:0005938(cell cortex)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006469(negative regulation of protein kinase activity)|GO:0007165(signal transduction)|GO:0007269(neurotransmitter secretion)|GO:0007275(multicellular organismal development)|GO:0007411(axon guidance)|GO:0007507(heart development)|GO:0007528(neuromuscular junction development)|GO:0010976(positive regulation of neuron projection development)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0019717(synaptosome)|GO:0019899(enzyme binding)|GO:0019901(protein kinase binding)|GO:0021915(neural tube development)|GO:0022007(convergent extension involved in neural plate elongation)|GO:0030136(clathrin-coated vesicle)|GO:0030177(positive regulation of Wnt receptor signaling pathway)|GO:0030424(axon)|GO:0030425(dendrite)|GO:0030426(growth cone)|GO:0031122(cytoplasmic microtubule organization)|GO:0031410(cytoplasmic vesicle)|GO:0032091(negative regulation of protein binding)|GO:0034504(protein localization to nucleus)|GO:0035176(social behavior)|GO:0035372(protein localization to microtubule)|GO:0035556(intracellular signal transduction)|GO:0042802(identical protein binding)|GO:0043025(neuronal cell body)|GO:0043113(receptor clustering)|GO:0045202(synapse)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0048365(Rac GTPase binding)|GO:0048668(collateral sprouting)|GO:0048675(axon extension)|GO:0048813(dendrite morphogenesis)|GO:0050808(synapse organization)|GO:0060026(convergent extension)|GO:0060070(canonical Wnt receptor signaling pathway)|GO:0060071(Wnt receptor signaling pathway, planar cell polarity pathway)|GO:0060134(prepulse inhibition)|GO:0071340(skeletal muscle nicotinic acetylcholine receptor clustering)|GO:0090103(cochlea morphogenesis)|GO:0090179(planar cell polarity pathway involved in neural tube closure)|GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","Homo sapiens dishevelled, dsh homolog 1 (Drosophila) (DVL1), mRNA [NM_004421]",chr1:1270778-1270719,hs|1p36.33,"dishevelled, dsh homolog 1 (Drosophila)",TRUE
799_MAPRE1_22919,Q15691,microtubule-associated protein rp/eb family member 1 (apc-binding protein eb1) (end-binding protein 1) (eb1),MAPRE1,268,"function: plus-end tracking protein (+tip) that binds to the plus-end of microtubules and regulates the dynamics of the microtubule cytoskeleton (pubmed:12388762, pubmed:16109370, pubmed:19632184, pubmed:21646404, pubmed:28726242, pubmed:28814570). promotes cytoplasmic microtubule nucleation and elongation (pubmed:12388762, pubmed:16109370, pubmed:19632184, pubmed:21646404, pubmed:28726242, pubmed:28814570). may be involved in spindle function by stabilizing microtubules and anchoring them at centrosomes (pubmed:12388762). also acts as a regulator of minus-end microtubule organization: interacts with the complex formed by akap9 and pde4dip, leading to recruit camsap2 to the golgi apparatus, thereby tethering non-centrosomal minus-end microtubules to the golgi, an important step for polarized cell movement (pubmed:28814570). promotes elongation of camsap2-decorated microtubule stretches on the minus-end of microtubules (pubmed:28814570). acts as a regulator of autophagosome transport via interaction with camsap2 (pubmed:28726242). may play a role in cell migration (by similarity). {eco:0000250|uniprotkb:q61166, eco:0000269|pubmed:12388762, eco:0000269|pubmed:16109370, eco:0000269|pubmed:19632184, eco:0000269|pubmed:21646404, eco:0000269|pubmed:28726242, eco:0000269|pubmed:28814570}.","subcellular location: cytoplasm, cytoskeleton {eco:0000269|pubmed:10188731, eco:0000269|pubmed:12388762, eco:0000269|pubmed:21646404, eco:0000269|pubmed:28814570, eco:0000269|pubmed:9724749}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:12388762, eco:0000269|pubmed:14654843}. golgi apparatus {eco:0000269|pubmed:25217626}. note=associated with the microtubule growing distal tips (pubmed:28814570). recruitment to the golgi apparatus requires the presence of pde4dip isoform 13/mmg8/smyle (pubmed:25217626). {eco:0000269|pubmed:25217626, eco:0000269|pubmed:28814570}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10644998}.,NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,MAPRE1,22919,Hs.472437,ENST00000375571,THC2469971,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005813(centrosome)|GO:0005819(spindle)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0005881(cytoplasmic microtubule)|GO:0008022(protein C-terminus binding)|GO:0008283(cell proliferation)|GO:0030981(cortical microtubule cytoskeleton)|GO:0031115(negative regulation of microtubule polymerization)|GO:0031253(cell projection membrane)|GO:0035372(protein localization to microtubule)|GO:0042995(cell projection)|GO:0051010(microtubule plus-end binding)|GO:0051301(cell division),"Homo sapiens microtubule-associated protein, RP/EB family, member 1 (MAPRE1), mRNA [NM_012325]",chr20:31438009-31438068,hs|20q11.21,"microtubule-associated protein, RP/EB family, member 1",TRUE
8_PDZD7_79955,Q9H5P4,pdz domain-containing protein 7,PDZD7 PDZK7,1033,"function: in cochlear developing hair cells, essential in organizing the ush2 complex at stereocilia ankle links. blocks inhibition of adenylate cyclase activity mediated by adgrv1. {eco:0000250|uniprotkb:e9q9w7}.","subcellular location: cell projection, cilium {eco:0000269|pubmed:20440071}. nucleus {eco:0000269|pubmed:20440071}. cell projection, stereocilium {eco:0000250|uniprotkb:e9q9w7}. note=localizes at the ankle region of the stereocilia. {eco:0000250|uniprotkb:e9q9w7}.","TISSUE SPECIFICITY: Weakly expressed in the inner ear. Expressed in the retinal pigment epithelium. {ECO:0000269|PubMed:19028668, ECO:0000269|PubMed:20440071}.","DISEASE: Deafness, autosomal recessive, 57 (DFNB57) [MIM:618003]: A form of non-syndromic, sensorineural deafness characterized by symmetric, bilateral hearing loss with onset in early childhood. Vestibular function is preserved. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB57 severity ranges from moderate to severe. {ECO:0000269|PubMed:19028668, ECO:0000269|PubMed:26416264, ECO:0000269|PubMed:26849169, ECO:0000269|PubMed:29048736}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration disrupting PDZD7 has been found in patients with non-syndromic sensorineural deafness. Translocation t(10;11),t(10;11). {ECO:0000269|PubMed:19028668}.; DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:20440071}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. A PDZD7 mutation has been found in combination with a mutation in ADGRV1 in a patient affected by Usher syndrome, suggesting PDZD7 mutations contribute to digenic Usher syndrome. {ECO:0000269|PubMed:20440071}.; DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:20440071}. Note=The gene represented in this entry acts as a disease modifier.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,PDZD7,79955,Hs.438245,ENST00000370215,THC2474441,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005929(cilium),"Homo sapiens PDZ domain containing 7 (PDZD7), transcript variant 2, mRNA [NM_024895]",chr10:102777238-102777179,hs|10q24.31,PDZ domain containing 7,TRUE
80_RPL27A_6157,P46776,60s ribosomal protein l27a (large ribosomal subunit protein ul15),RPL27A,148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL27A,6157,Hs.523463,ENST00000534599,NP1134701,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L27a (RPL27A), mRNA [NM_000990]",chr11:8707267-8707326,hs|11p15.4,ribosomal protein L27a,TRUE
800_FAM129A_116496,Q9BZQ8,protein niban 1 (cell growth-inhibiting gene 39 protein) (protein fam129a),NIBAN1 C1orf24 FAM129A NIBAN GIG39,928,"function: regulates phosphorylation of a number of proteins involved in translation regulation including eif2a, eif4ebp1 and rps6kb1. may be involved in the endoplasmic reticulum stress response (by similarity). {eco:0000250}.",subcellular location: cytoplasm {eco:0000269|pubmed:16949643}. membrane {eco:0000305}; lipid-anchor {eco:0000305}.,"TISSUE SPECIFICITY: Expressed in various types of thyroid tumor such as papillary thyroid carcinomas and oxyphilic thyroid tumors but not in normal thyroid tissue (at protein level). Strongly expressed in heart, skeletal muscle, pancreas, white blood cells and prostate with moderate expression in colon and spleen. Expressed in renal carcinoma cells but not in normal kidney. {ECO:0000269|PubMed:11011112, ECO:0000269|PubMed:16949643}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM129A,116496,Hs.518662,ENST00000367511,THC2677496,GO:0001933(negative regulation of protein phosphorylation)|GO:0001934(positive regulation of protein phosphorylation)|GO:0003674(molecular_function)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006950(response to stress)|GO:0034976(response to endoplasmic reticulum stress)|GO:0045727(positive regulation of translation),"Homo sapiens family with sequence similarity 129, member A (FAM129A), transcript variant 2, mRNA [NM_052966]",chr1:184760286-184760227,hs|1q25.3,"family with sequence similarity 129, member A",TRUE
801_GRSF1_2926,Q12849,g-rich sequence factor 1 (grsf-1),GRSF1,480,"function: regulator of post-transcriptional mitochondrial gene expression, required for assembly of the mitochondrial ribosome and for recruitment of mrna and lncrna. binds rnas containing the 14 base g-rich element. preferentially binds rnas transcribed from three contiguous genes on the light strand of mtdna, the nd6 mrna, and the long non-coding rnas for mt-cyb and mt-nd5, each of which contains multiple consensus binding sequences (pubmed:23473033, pubmed:23473034, pubmed:29967381). involved in the degradosome-mediated decay of non-coding mitochondrial transcripts (mt-ncrna) and trna-like molecules (pubmed:29967381). acts by unwinding g-quadruplex rna structures in mt-ncrna, thus facilitating their degradation by the degradosome (pubmed:29967381). g-quadruplexes (g4) are non-canonical 4 stranded structures formed by transcripts from the light strand of mtdna (pubmed:29967381). {eco:0000269|pubmed:23473033, eco:0000269|pubmed:23473034, eco:0000269|pubmed:29967381}.","subcellular location: isoform 1: mitochondrion matrix {eco:0000269|pubmed:23473033, eco:0000269|pubmed:23473034, eco:0000269|pubmed:25683715, eco:0000269|pubmed:29967381}. note=localizes to mitochondrial rna granules found in close proximity to the mitochondrial nucleoids. {eco:0000269|pubmed:23473033, eco:0000269|pubmed:23473034, eco:0000269|pubmed:25683715}.; subcellular location: isoform 2: cytoplasm {eco:0000269|pubmed:23473034}.",NA,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GRSF1,2926,Hs.309763,ENST00000540657,THC2475158,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0003729(mRNA binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0006378(mRNA polyadenylation)|GO:0009952(anterior/posterior pattern formation)|GO:0016331(morphogenesis of embryonic epithelium),"Homo sapiens G-rich RNA sequence binding factor 1 (GRSF1), transcript variant 1, mRNA [NM_002092]",chr4:71685628-71685569,hs|4q13.3,G-rich RNA sequence binding factor 1,TRUE
802_CPE_1363,P16870,carboxypeptidase e (cpe) (ec 3.4.17.10) (carboxypeptidase h) (cph) (enkephalin convertase) (prohormone-processing carboxypeptidase),CPE,476,"function: sorting receptor that directs prohormones to the regulated secretory pathway. acts also as a prohormone processing enzyme in neuro/endocrine cells, removing dibasic residues from the c-terminal end of peptide hormone precursors after initial endoprotease cleavage. {eco:0000250|uniprotkb:q00493}.","subcellular location: isoform 1: cytoplasmic vesicle, secretory vesicle {eco:0000250|uniprotkb:q00493}. cytoplasmic vesicle, secretory vesicle membrane {eco:0000250|uniprotkb:p15087}; peripheral membrane protein {eco:0000250|uniprotkb:p15087}. secreted {eco:0000250|uniprotkb:p15087}. note=associated with the secretory granule membrane through direct binding to lipid rafts in intragranular conditions. {eco:0000250|uniprotkb:q00493}.; subcellular location: isoform 2: nucleus {eco:0000269|pubmed:21285511}.","TISSUE SPECIFICITY: Isoform 2, but not isoform 1, is overexpressed in hepatocellular carcinoma (at protein level), as well as in other tumors, including pheochromocytomas and paragangliomas. {ECO:0000269|PubMed:21285511}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CPE,1363,Hs.75360,ENST00000261510,THC2465477,GO:0003214(cardiac left ventricle morphogenesis)|GO:0004180(carboxypeptidase activity)|GO:0004181(metallocarboxypeptidase activity)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006464(protein modification process)|GO:0006508(proteolysis)|GO:0007218(neuropeptide signaling pathway)|GO:0008152(metabolic process)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0008270(zinc ion binding)|GO:0030070(insulin processing)|GO:0030141(stored secretory granule)|GO:0042043(neurexin binding)|GO:0046872(metal ion binding)|GO:0050839(cell adhesion molecule binding)|GO:0072657(protein localization in membrane),"Homo sapiens carboxypeptidase E (CPE), mRNA [NM_001873]",chr4:166419232-166419291,hs|4q32.3,carboxypeptidase E,TRUE
803_LDHA_3939,P00338,l-lactate dehydrogenase a chain (ldh-a) (ec 1.1.1.27) (cell proliferation-inducing gene 19 protein) (ldh muscle subunit) (ldh-m) (renal carcinoma antigen ny-ren-59),LDHA PIG19,332,NA,subcellular location: cytoplasm.,NA,"DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,LDHA,3939,Hs.2795,ENST00000379412,THC2493825,GO:0000166(nucleotide binding)|GO:0004459(L-lactate dehydrogenase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006090(pyruvate metabolic process)|GO:0006096(glycolysis)|GO:0016491(oxidoreductase activity)|GO:0044262(cellular carbohydrate metabolic process),"Homo sapiens lactate dehydrogenase A (LDHA), transcript variant 1, mRNA [NM_005566]",chr11:18429319-18429378,hs|11p15.1,lactate dehydrogenase A,TRUE
804_ANAPC16_119504,Q96DE5,anaphase-promoting complex subunit 16 (apc16) (cyclosome subunit 16),ANAPC16 C10orf104 CENP-27,110,"function: component of the anaphase promoting complex/cyclosome (apc/c), a cell cycle-regulated e3 ubiquitin ligase that controls progression through mitosis and the g1 phase of the cell cycle. the apc/c complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'lys-48'- and 'lys-63'-linked polyubiquitin chains. {eco:0000269|pubmed:20360068}.","subcellular location: cytoplasm {eco:0000269|pubmed:20360068}. nucleus {eco:0000269|pubmed:20360068}. chromosome, centromere, kinetochore {eco:0000269|pubmed:20813266}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ANAPC16,119504,Hs.426296,ENST00000478193,THC2508772,GO:0005634(nucleus)|GO:0005680(anaphase-promoting complex)|GO:0005737(cytoplasm)|GO:0007049(cell cycle)|GO:0007067(mitosis)|GO:0016567(protein ubiquitination)|GO:0051301(cell division),"Homo sapiens anaphase promoting complex subunit 16 (ANAPC16), transcript variant 2, mRNA [NM_173473]",chr10:73992965-73993024,hs|10q22.1,anaphase promoting complex subunit 16,TRUE
805_WSB2_55884,Q9NYS7,wd repeat and socs box-containing protein 2 (wsb-2) (cs box-containing wd protein),WSB2,404,function: may be a substrate-recognition component of a scf-like ecs (elongin-cullin-socs-box protein) e3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,WSB2,55884,Hs.728135,ENST00000315436,THC2705058,GO:0035556(intracellular signal transduction),"Homo sapiens WD repeat and SOCS box containing 2 (WSB2), mRNA [NM_018639]",chr12:118470837-118470778,hs|12q24.23,WD repeat and SOCS box containing 2,TRUE
806_CSDE1_7812,O75534,cold shock domain-containing protein e1 (n-ras upstream gene protein) (protein unr),CSDE1 D1S155E KIAA0885 NRU UNR,798,"function: rna-binding protein. required for internal initiation of translation of human rhinovirus rna. may be involved in translationally coupled mrna turnover. implicated with other rna-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the fos mrna mediated by the major coding-region determinant of instability (mcrd) domain. {eco:0000269|pubmed:11051545, eco:0000269|pubmed:15314026}.",subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CSDE1,7812,Hs.69855,ENST00000534699,THC2526798,"GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008584(male gonad development)","Homo sapiens cold shock domain containing E1, RNA-binding (CSDE1), transcript variant 1, mRNA [NM_001007553]",chr1:115260793-115260734,hs|1p13.2,"cold shock domain containing E1, RNA-binding",TRUE
807_SNRPG_6637,P62308,small nuclear ribonucleoprotein g (snrnp-g) (sm protein g) (sm-g) (smg),SNRPG PBSCG,76,"function: plays role in pre-mrna splicing as core component of the smn-sm complex that mediates spliceosomal snrnp assembly and as component of the spliceosomal u1, u2, u4 and u5 small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome (pubmed:11991638, pubmed:18984161, pubmed:19325628, pubmed:23333303, pubmed:25555158, pubmed:26912367, pubmed:28502770, pubmed:28781166, pubmed:28076346). component of both the pre-catalytic spliceosome b complex and activated spliceosome c complexes (pubmed:11991638, pubmed:28502770, pubmed:28781166, pubmed:28076346). is also a component of the minor u12 spliceosome (pubmed:15146077). as part of the u7 snrnp it is involved in histone 3'-end processing (pubmed:12975319). {eco:0000269|pubmed:11991638, eco:0000269|pubmed:12975319, eco:0000269|pubmed:15146077, eco:0000269|pubmed:18984161, eco:0000269|pubmed:19325628, eco:0000269|pubmed:23333303, eco:0000269|pubmed:25555158, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:18984161}. nucleus {eco:0000269|pubmed:11574479, eco:0000269|pubmed:11991638, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28076346, eco:0000269|pubmed:28502770, eco:0000269|pubmed:28781166}. note=smn-mediated assembly into core snrnps occurs in the cytosol before smn-mediated transport to the nucleus to be included in spliceosomes. {eco:0000305}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SNRPG,6637,Hs.516076,ENST00000429728,THC2650807,"GO:0000245(spliceosome assembly)|GO:0000387(spliceosomal snRNP assembly)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005683(U7 snRNP)|GO:0005689(U12-type spliceosomal complex)|GO:0005829(cytosol)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0008334(histone mRNA metabolic process)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016070(RNA metabolic process)|GO:0030532(small nuclear ribonucleoprotein complex)|GO:0034660(ncRNA metabolic process)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens small nuclear ribonucleoprotein polypeptide G (SNRPG), mRNA [NM_003096]",chr2:70515224-70508782,hs|2p13.3,small nuclear ribonucleoprotein polypeptide G,TRUE
808_NEDD8_4738,Q15843,nedd8 (neddylin) (neural precursor cell expressed developmentally down-regulated protein 8) (nedd-8) (ubiquitin-like protein nedd8),NEDD8,81,"function: ubiquitin-like protein which plays an important role in cell cycle control and embryogenesis. covalent attachment to its substrates requires prior activation by the e1 complex ube1c-appbp1 and linkage to the e2 enzyme ube2m. attachment of nedd8 to cullins activates their associated e3 ubiquitin ligase activity, and thus promotes polyubiquitination and proteasomal degradation of cyclins and other regulatory proteins. {eco:0000269|pubmed:10318914, eco:0000269|pubmed:10597293, eco:0000269|pubmed:11953428}.",subcellular location: nucleus {eco:0000269|pubmed:9353319}. note=mainly nuclear.,"TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle, spleen, thymus, prostate, testis, ovary, colon and leukocytes. {ECO:0000269|PubMed:10597293, ECO:0000269|PubMed:9353319}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEDD8,4738,Hs.531064,ENST00000531430,THC2537939,GO:0005634(nucleus)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0006464(protein modification process)|GO:0006508(proteolysis)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0008104(protein localization)|GO:0009653(anatomical structure morphogenesis)|GO:0014070(response to organic cyclic compound)|GO:0031625(ubiquitin protein ligase binding)|GO:0045116(protein neddylation),"Homo sapiens neural precursor cell expressed, developmentally down-regulated 8 (NEDD8), mRNA [NM_006156]",chr14:24686144-24686085,hs|14q12,"neural precursor cell expressed, developmentally down-regulated 8",TRUE
809_PDS5A_23244,Q29RF7,sister chromatid cohesion protein pds5 homolog a (cell proliferation-inducing gene 54 protein) (sister chromatid cohesion protein 112) (scc-112),PDS5A KIAA0648 PDS5 PIG54,1337,"function: probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. may couple sister chromatid cohesion during mitosis to dna replication. cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in dna repair. {eco:0000269|pubmed:15855230, eco:0000269|pubmed:19907496}.","subcellular location: nucleus {eco:0000269|pubmed:11076961, eco:0000269|pubmed:15019998}. note=associated with chromatin through most of the cell cycle. dissociates from chromatin in late prophase, reassociates during late telophase. {eco:0000269|pubmed:11076961, eco:0000269|pubmed:15019998}.","TISSUE SPECIFICITY: Highest level in colon. Low levels in lung, ovary, breast and kidney. Reduced level in renal tumor tissue. Isoform 2 is expressed in kidney. {ECO:0000269|PubMed:15019998}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PDS5A,23244,Hs.331431,ENST00000303538,THC2467821,GO:0000785(chromatin)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005886(plasma membrane)|GO:0007049(cell cycle)|GO:0007067(mitosis)|GO:0008156(negative regulation of DNA replication)|GO:0051301(cell division),"Homo sapiens PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) (PDS5A), transcript variant 1, mRNA [NM_001100399]",chr4:39826038-39825979,hs|4p14,"PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae)",TRUE
81_RPS8_6202,P62241,40s ribosomal protein s8 (small ribosomal subunit protein es8),RPS8 OK/SW-cl.83,208,NA,subcellular location: cytoplasm {eco:0000269|pubmed:17289661}. membrane {eco:0000305}; lipid-anchor {eco:0000305}. note=localized in cytoplasmic mrnp granules containing untranslated mrnas.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,NA,RPS8,6202,Hs.512675,ENST00000474582,THC2552938,"GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA))|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)","Homo sapiens ribosomal protein S8 (RPS8), mRNA [NM_001012]",chr1:45244296-45244355,hs|1p34.1,ribosomal protein S8,TRUE
810_DDT_1652,P30046,d-dopachrome decarboxylase (ec 4.1.1.84) (d-dopachrome tautomerase) (phenylpyruvate tautomerase ii),DDT,118,"function: tautomerization of d-dopachrome with decarboxylation to give 5,6-dihydroxyindole (dhi).",subcellular location: cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDT,1652,Hs.656723,ENST00000398344,THC2549568,GO:0004167(dopachrome isomerase activity)|GO:0005737(cytoplasm)|GO:0016829(lyase activity)|GO:0033981(D-dopachrome decarboxylase activity)|GO:0042438(melanin biosynthetic process),"Homo sapiens D-dopachrome tautomerase (DDT), transcript variant 1, mRNA [NM_001355]",chr22:24313789-24313730,hs|22q11.23,D-dopachrome tautomerase,TRUE
811_H3F3C_440093,Q6NXT2,histone h3.3c (histone h3.5),H3F3C,135,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. hominid-specific h3.5/h3f3c preferentially colocalizes with euchromatin, and it is associated with actively transcribed genes. {eco:0000269|pubmed:21274551}.",subcellular location: nucleus. chromosome.,TISSUE SPECIFICITY: Specifically expressed in the seminiferous tubules of testis. {ECO:0000269|PubMed:21274551}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,H3F3C,440093,Hs.448697,ENST00000340398,NA,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens H3 histone, family 3C (H3F3C), mRNA [NM_001013699]",chr12:31944484-31944425,hs|12p11.21,"H3 histone, family 3C",TRUE
812_CLTA_1211,P09496,clathrin light chain a (lca),CLTA,248,"function: clathrin is the major protein of the polyhedral coat of coated pits and vesicles. acts as component of the tacc3/ch-tog/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge (pubmed:15858577, pubmed:21297582). {eco:0000305|pubmed:15858577, eco:0000305|pubmed:21297582}.","subcellular location: cytoplasmic vesicle membrane; peripheral membrane protein; cytoplasmic side. membrane, coated pit; peripheral membrane protein; cytoplasmic side. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:21297582, eco:0000305|pubmed:15858577}. note=cytoplasmic face of coated pits and vesicles. in complex with tacc3 and ckap5 (forming the tacc3/ch-tog/clathrin complex) localized to inter-microtubule bridges in mitotic spindles. {eco:0000305}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,CLTA,1211,Hs.522114,ENST00000345519,THC2530471,GO:0003674(molecular_function)|GO:0005198(structural molecule activity)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006886(intracellular protein transport)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0006897(endocytosis)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007411(axon guidance)|GO:0016044(cellular membrane organization)|GO:0030118(clathrin coat)|GO:0030130(clathrin coat of trans-Golgi network vesicle)|GO:0030132(clathrin coat of coated pit)|GO:0030136(clathrin-coated vesicle)|GO:0030659(cytoplasmic vesicle membrane)|GO:0030669(clathrin-coated endocytic vesicle membrane)|GO:0031410(cytoplasmic vesicle)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042277(peptide binding)|GO:0048011(nerve growth factor receptor signaling pathway),"Homo sapiens clathrin, light chain A (CLTA), transcript variant 2, mRNA [NM_007096]",chr9:36211781-36211840,hs|9p13.3,"clathrin, light chain A",TRUE
813_RPS29_6235,P62273,40s ribosomal protein s29 (small ribosomal subunit protein us14),RPS29,56,NA,"subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:25957688}. cytoplasm {eco:0000305|pubmed:23636399, eco:0000305|pubmed:25901680}. rough endoplasmic reticulum {eco:0000250|uniprotkb:q6qap6}. note=detected on cytosolic polysomes (pubmed:25957688). detected in ribosomes that are associated with the rough endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q6qap6, eco:0000269|pubmed:25957688}.",NA,"DISEASE: Diamond-Blackfan anemia 13 (DBA13) [MIM:615909]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:24829207}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,RPS29,6235,Hs.156367,ENST00000557367,THC2589247,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008270(zinc ion binding)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0046872(metal ion binding),"Homo sapiens ribosomal protein S29 (RPS29), transcript variant 1, mRNA [NM_001032]",chr14:50052691-50050358,hs|14q21.3,ribosomal protein S29,TRUE
814_CASP9_842,P55211,caspase-9 (casp-9) (ec 3.4.22.62) (apoptotic protease mch-6) (apoptotic protease-activating factor 3) (apaf-3) (ice-like apoptotic protease 6) (ice-lap6) [cleaved into: caspase-9 subunit p35; caspase-9 subunit p10],CASP9 MCH6,416,function: involved in the activation cascade of caspases responsible for apoptosis execution. binding of caspase-9 to apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. promotes dna damage-induced apoptosis in a abl1/c-abl-dependent manner. proteolytically cleaves poly(adp-ribose) polymerase (parp).; function: isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9.,NA,"TISSUE SPECIFICITY: Ubiquitous, with highest expression in the heart, moderate expression in liver, skeletal muscle, and pancreas. Low levels in all other tissues. Within the heart, specifically expressed in myocytes. {ECO:0000269|PubMed:16857965}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CASP9,842,Hs.329502,ENST00000400777,THC2603847,GO:0004197(cysteine-type endopeptidase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005829(cytosol)|GO:0006508(proteolysis)|GO:0006915(apoptosis)|GO:0006919(activation of caspase activity)|GO:0006974(response to DNA damage stimulus)|GO:0008047(enzyme activator activity)|GO:0008233(peptidase activity)|GO:0008543(fibroblast growth factor receptor signaling pathway)|GO:0008629(induction of apoptosis by intracellular signals)|GO:0008635(activation of caspase activity by cytochrome c)|GO:0009411(response to UV)|GO:0042981(regulation of apoptosis)|GO:0043293(apoptosome)|GO:0043525(positive regulation of neuron apoptosis)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0071549(cellular response to dexamethasone stimulus),"Homo sapiens caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha, mRNA [NM_001229]",chr1:15819038-15818979,hs|1p36.21,"caspase 9, apoptosis-related cysteine peptidase",TRUE
815_C4orf3_401152,Q8WVX3,uncharacterized protein c4orf3 (hepatitis c virus f protein-transactivated protein 1) (hcv f-transactivated protein 1),C4orf3,66,NA,subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C4orf3,401152,Hs.173705,ENST00000399075,THC2510176,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 4 open reading frame 3 (C4orf3), transcript variant 1, mRNA [NM_001170330]",chr4:120218473-120218414,hs|4q26,chromosome 4 open reading frame 3,TRUE
816_ZFAND5_7763,O76080,an1-type zinc finger protein 5 (zinc finger a20 domain-containing protein 2) (zinc finger protein 216),ZFAND5 ZA20D2 ZNF216,213,"function: involved in protein degradation via the ubiquitin-proteasome system. may act by anchoring ubiquitinated proteins to the proteasome. plays a role in ubiquitin-mediated protein degradation during muscle atrophy. plays a role in the regulation of nf-kappa-b activation and apoptosis. inhibits nf-kappa-b activation triggered by overexpression of ripk1 and traf6 but not of rela. inhibits also tumor necrosis factor (tnf), il-1 and tlr4-induced nf-kappa-b activation in a dose-dependent manner. overexpression sensitizes cells to tnf-induced apoptosis. is a potent inhibitory factor for osteoclast differentiation. {eco:0000269|pubmed:14754897}.",subcellular location: cytoplasm {eco:0000250}.,"TISSUE SPECIFICITY: Highly expressed in skeletal muscle. Expressed in fetal cochlea. Also expressed in infant brain, fetal heart, pancreatic islet, melanocyte, pineal gland, placenta, corneal stroma, and parathyroid tumor. Weakly expressed or undetectable in adult brain, heart, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung and peripheral blood leukocytes. Expressed in rhabdomyosarcoma RD cells (at protein level). {ECO:0000269|PubMed:14754897, ECO:0000269|PubMed:9758550}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZFAND5,7763,Hs.406096,ENST00000488164,THC2469722,GO:0001701(in utero embryonic development)|GO:0001944(vasculature development)|GO:0003016(respiratory system process)|GO:0003674(molecular_function)|GO:0003677(DNA binding)|GO:0005575(cellular_component)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0010761(fibroblast migration)|GO:0046872(metal ion binding)|GO:0048008(platelet-derived growth factor receptor signaling pathway)|GO:0048705(skeletal system morphogenesis)|GO:0048745(smooth muscle tissue development)|GO:0060324(face development),"Homo sapiens zinc finger, AN1-type domain 5 (ZFAND5), transcript variant c, mRNA [NM_006007]",chr9:74969825-74969766,hs|9q21.13,"zinc finger, AN1-type domain 5",TRUE
817_KRT19_3880,P08727,"keratin, type i cytoskeletal 19 (cytokeratin-19) (ck-19) (keratin-19) (k19)",KRT19,400,"function: involved in the organization of myofibers. together with krt8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. {eco:0000269|pubmed:16000376}.",NA,"TISSUE SPECIFICITY: Expressed in a defined zone of basal keratinocytes in the deep outer root sheath of hair follicles. Also observed in sweat gland and mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, ectocervical epithelium (at protein level). Expressed in epidermal basal cells, in nipple epidermis and a defined region of the hair follicle. Also seen in a subset of vascular wall cells in both the veins and artery of human umbilical cord, and in umbilical cord vascular smooth muscle. Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma in structures that contain dystrophin and spectrin. {ECO:0000269|PubMed:16000376, ECO:0000269|PubMed:2468493, ECO:0000269|PubMed:2469734}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,KRT19,3880,Hs.654568,ENST00000361566,THC2553201,GO:0005200(structural constituent of cytoskeleton)|GO:0005515(protein binding)|GO:0005882(intermediate filament)|GO:0008307(structural constituent of muscle)|GO:0016010(dystrophin-associated glycoprotein complex)|GO:0030018(Z disc)|GO:0042383(sarcolemma)|GO:0043034(costamere)|GO:0043627(response to estrogen stimulus)|GO:0044419(interspecies interaction between organisms)|GO:0045214(sarcomere organization)|GO:0060706(cell differentiation involved in embryonic placenta development)|GO:0071944(cell periphery),"Homo sapiens keratin 19 (KRT19), mRNA [NM_002276]",chr17:39679977-39679918,hs|17q21.2,keratin 19,TRUE
818_ILF3_3609,Q12906,interleukin enhancer-binding factor 3 (double-stranded rna-binding protein 76) (drbp76) (m-phase phosphoprotein 4) (mpp4) (nuclear factor associated with dsrna) (nfar) (nuclear factor of activated t-cells 90 kda) (nf-at-90) (translational control protein 80) (tcp80),ILF3 DRBF MPHOSPH4 NF90,894,"function: rna-binding protein that plays an essential role in the biogenesis of circular rnas (circrnas) which are produced by back-splicing circularization of pre-mrnas. within the nucleus, promotes circrnas processing by stabilizing the regulatory elements residing in the flanking introns of the circularized exons. plays thereby a role in the back-splicing of a subset of circrnas (pubmed:28625552). as a consequence, participates in a wide range of transcriptional and post-transcriptional processes. binds to poly-u elements and au-rich elements (ares) in the 3'-utr of target mrnas (pubmed:14731398). upon viral infection, ilf3 accumulates in the cytoplasm and participates in the innate antiviral response (pubmed:21123651). mechanistically, ilf3 becomes phosphorylated and activated by the double-stranded rna-activated protein kinase/pkr which releases ilf3 from cellular mature circrnas. in turn, unbound ilf3 molecules are able to interact with and thus inhibit viral mrnas (pubmed:21123651, pubmed:28625552). {eco:0000269|pubmed:14731398, eco:0000269|pubmed:21123651, eco:0000269|pubmed:28625552, eco:0000269|pubmed:9442054}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:26240280}. cytoplasm {eco:0000269|pubmed:28625552}. nucleus {eco:0000269|pubmed:10749851, eco:0000269|pubmed:26240280, eco:0000269|pubmed:28625552}. note=localizes in the cytoplasm in response to viral infection. the unphosphorylated form is retained in the nucleus by ilf2. phosphorylation at thr-188 and thr-315 causes the dissociation of ilf2 from the ilf2-ilf3 complex resulting in a cytoplasmic sequestration of ilf3. localized in cytoplasmic mrnp granules containing untranslated mrnas. {eco:0000269|pubmed:21123651}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ILF3,3609,Hs.465885,ENST00000336059,THC2488428,"GO:0000279(M phase)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003725(double-stranded RNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0030529(ribonucleoprotein complex)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)","Homo sapiens interleukin enhancer binding factor 3, 90kDa (ILF3), transcript variant 1, mRNA [NM_012218]",chr19:10800232-10800291,hs|19p13.2,"interleukin enhancer binding factor 3, 90kDa",TRUE
819_ZFP36_7538,P26651,mrna decay activator protein zfp36 (g0/g1 switch regulatory protein 24) (growth factor-inducible nuclear protein nup475) (tristetraprolin) (zinc finger protein 36) (zfp-36),ZFP36 G0S24 NUP475 RNF162A TIS11A TTP,326,"function: zinc-finger rna-binding protein that destabilizes several cytoplasmic au-rich element (are)-containing mrna transcripts by promoting their poly(a) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (pubmed:9703499, pubmed:10330172, pubmed:10751406, pubmed:11279239, pubmed:12115244, pubmed:12748283, pubmed:15187101, pubmed:15634918, pubmed:17030620, pubmed:16702957, pubmed:20702587, pubmed:20221403, pubmed:21775632, pubmed:27193233, pubmed:23644599, pubmed:25815583). acts as an 3'-untranslated region (utr) are mrna-binding adapter protein to communicate signaling events to the mrna decay machinery (pubmed:15687258, pubmed:23644599). recruits deadenylase cnot7 (and probably the ccr4-not complex) via association with cnot1, and hence promotes are-mediated mrna deadenylation (pubmed:23644599). functions also by recruiting components of the cytoplasmic rna decay machinery to the bound are-containing mrnas (pubmed:11719186, pubmed:12748283, pubmed:15687258, pubmed:16364915). self regulates by destabilizing its own mrna (pubmed:15187101). binds to 3'-utr are of numerous mrnas and of its own mrna (pubmed:10330172, pubmed:10751406, pubmed:12115244, pubmed:15187101, pubmed:15634918, pubmed:17030620, pubmed:16702957, pubmed:19188452, pubmed:20702587, pubmed:20221403, pubmed:21775632, pubmed:25815583). plays a role in anti-inflammatory responses; suppresses tumor necrosis factor (tnf)-alpha production by stimulating are-mediated tnf-alpha mrna decay and several other inflammatory are-containing mrnas in interferon (ifn)- and/or lipopolysaccharide (lps)-induced macrophages (by similarity). plays also a role in the regulation of dendritic cell maturation at the post-transcriptional level, and hence operates as part of a negative feedback loop to limit the inflammatory response (pubmed:18367721). promotes are-mediated mrna decay of hypoxia-inducible factor hif1a mrna during the response of endothelial cells to hypoxia (pubmed:21775632). positively regulates early adipogenesis of preadipocytes by promoting are-mediated mrna decay of immediate early genes (iegs) (by similarity). negatively regulates hematopoietic/erythroid cell differentiation by promoting are-mediated mrna decay of the transcription factor stat5b mrna (pubmed:20702587). plays a role in maintaining skeletal muscle satellite cell quiescence by promoting are-mediated mrna decay of the myogenic determination factor myod1 mrna (by similarity). associates also with and regulates the expression of non-are-containing target mrnas at the post-transcriptional level, such as mhc class i mrnas (pubmed:18367721). participates in association with argonaute risc catalytic components in the are-mediated mrna decay mechanism; assists microrna (mirna) targeting are-containing mrnas (pubmed:15766526). may also play a role in the regulation of cytoplasmic mrna decapping; enhances decapping of are-containing rnas, in vitro (pubmed:16364915). involved in the delivery of target are-mrnas to processing bodies (pbs) (pubmed:17369404). in addition to its cytosolic mrna-decay function, affects nuclear pre-mrna processing (by similarity). negatively regulates nuclear poly(a)-binding protein pabpn1-stimulated polyadenylation activity on are-containing pre-mrna during lps-stimulated macrophages (by similarity). also involved in the regulation of stress granule (sg) and p-body (pb) formation and fusion (by similarity). plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (pubmed:27182009). plays a role as a tumor suppressor by inhibiting cell proliferation in breast cancer cells (pubmed:26926077). {eco:0000250|uniprotkb:p22893, eco:0000269|pubmed:10330172, eco:0000269|pubmed:10751406, eco:0000269|pubmed:11279239, eco:0000269|pubmed:11719186, eco:0000269|pubmed:12115244, eco:0000269|pubmed:12748283, eco:0000269|pubmed:15187101, eco:0000269|pubmed:15634918, eco:0000269|pubmed:15687258, eco:0000269|pubmed:15766526, eco:0000269|pubmed:16364915, eco:0000269|pubmed:16702957, eco:0000269|pubmed:17030620, eco:0000269|pubmed:17369404, eco:0000269|pubmed:18367721, eco:0000269|pubmed:19188452, eco:0000269|pubmed:20221403, eco:0000269|pubmed:20702587, eco:0000269|pubmed:21775632, eco:0000269|pubmed:23644599, eco:0000269|pubmed:25815583, eco:0000269|pubmed:26926077, eco:0000269|pubmed:27182009, eco:0000269|pubmed:27193233, eco:0000269|pubmed:9703499}.; function: (microbial infection) negatively regulates htlv-1 tax-dependent transactivation of viral long terminal repeat (ltr) promoter. {eco:0000269|pubmed:14679154}.","subcellular location: nucleus {eco:0000269|pubmed:15014438, eco:0000269|pubmed:27182009}. cytoplasm {eco:0000269|pubmed:10330172, eco:0000269|pubmed:12115244, eco:0000269|pubmed:14766228, eco:0000269|pubmed:15014438, eco:0000269|pubmed:20221403}. cytoplasmic granule {eco:0000269|pubmed:15014438}. cytoplasm, p-body {eco:0000269|pubmed:17369404}. note=shuttles between nucleus and cytoplasm in a crm1-dependent manner (by similarity). localized predominantly in the cytoplasm in a p38 mapk- and ywhab-dependent manner (by similarity). colocalizes with sh3kbp1 and map3k4 in the cytoplasm (pubmed:20221403). component of cytoplasmic stress granules (sgs) (by similarity). localizes to cytoplasmic stress granules upon energy starvation (pubmed:15014438). localizes in processing bodies (pbs) (pubmed:17369404). excluded from stress granules in a phosphorylation mapkapk2-dependent manner (by similarity). shuttles in and out of both cytoplasmic p-body and sgs (by similarity). {eco:0000250|uniprotkb:p22893, eco:0000269|pubmed:15014438, eco:0000269|pubmed:17369404, eco:0000269|pubmed:20221403}.; subcellular location: nucleus {eco:0000269|pubmed:14679154}. cytoplasm {eco:0000269|pubmed:14679154}. note=(microbial infection) colocalizes with htlv-1 tax in the nucleus and the cytoplasm in a region surrounding the nucleus. {eco:0000269|pubmed:14679154}.","TISSUE SPECIFICITY: Expressed in both basal and suprabasal epidermal layers (PubMed:27182009). Expressed in epidermal keratinocytes (PubMed:27182009). Expressed strongly in mature dendritic cells (PubMed:18367721). Expressed in immature dendritic cells (at protein level) (PubMed:18367721). {ECO:0000269|PubMed:18367721, ECO:0000269|PubMed:27182009}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,ZFP36,7538,Hs.534052,ENST00000248673,THC2469750,GO:0003677(DNA binding)|GO:0003727(single-stranded RNA binding)|GO:0003729(mRNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006402(mRNA catabolic process)|GO:0007243(intracellular protein kinase cascade)|GO:0008270(zinc ion binding)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0017091(AU-rich element binding)|GO:0043488(regulation of mRNA stability)|GO:0045638(negative regulation of myeloid cell differentiation)|GO:0046872(metal ion binding)|GO:0050728(negative regulation of inflammatory response)|GO:0050779(RNA destabilization)|GO:0060213(positive regulation of nuclear-transcribed mRNA poly(A) tail shortening),"Homo sapiens zinc finger protein 36, C3H type, homolog (mouse) (ZFP36), mRNA [NM_003407]",chr19:39899758-39899817,hs|19q13.2,"zinc finger protein 36, C3H type, homolog (mouse)",TRUE
82_RPL10_6134,P27635,60s ribosomal protein l10 (laminin receptor homolog) (large ribosomal subunit protein ul16) (protein qm) (ribosomal protein l10) (tumor suppressor qm),RPL10 DXS648E QM,214,"function: component of the large ribosomal subunit (pubmed:26290468). plays a role in the formation of actively translating ribosomes (pubmed:26290468). may play a role in the embryonic brain development (pubmed:25316788). {eco:0000269|pubmed:25316788, eco:0000269|pubmed:26290468, eco:0000305|pubmed:12962325}.",NA,NA,"DISEASE: Autism, X-linked 5 (AUTSX5) [MIM:300847]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:16940977, ECO:0000269|PubMed:21567917, ECO:0000269|PubMed:25316788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. RPL10 is involved in autism only in rare cases. Two hypomorphic variants affecting the translation process have been found in families with autism spectrum disorders, suggesting that aberrant translation may play a role in disease mechanisms.; DISEASE: Mental retardation, X-linked, syndromic, 35 (MRXS35) [MIM:300998]: A mental retardation syndrome characterized by intellectual deficit, delayed psychomotor development, poor speech, and dysmorphic features. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25316788, ECO:0000269|PubMed:25846674, ECO:0000269|PubMed:26290468}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,RPL10,6134,Hs.534404,ENST00000482732,THC2586632,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L10 (RPL10), transcript variant 1, mRNA [NM_006013]",chrX:153629189-153629249,hs|Xq28,ribosomal protein L10,TRUE
820_MON1B_22879,Q7L1V2,vacuolar fusion protein mon1 homolog b (hsv-1 stimulation-related gene 1 protein) (hsv-i stimulating-related protein),MON1B HSRG1 KIAA0872 SAND2,547,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,MON1B,22879,Hs.513743,ENST00000248248,THC2471155,GO:0005515(protein binding),"Homo sapiens MON1 homolog B (yeast) (MON1B), mRNA [NM_014940]",chr16:77233447-77233506,hs|16q23.1,MON1 homolog B (yeast),TRUE
821_RBM39_9584,Q14498,rna-binding protein 39 (caper alpha) (hepatocellular carcinoma protein 1) (rna-binding motif protein 39) (rna-binding region-containing protein 2) (splicing factor hcc1),RBM39 HCC1 RNPC2,530,"function: transcriptional coactivator for steroid nuclear receptors esr1/er-alpha and esr2/er-beta, and jun/ap-1 (by similarity). may be involved in pre-mrna splicing process. {eco:0000250}.",subcellular location: nucleus speckle. note=concentrated in nuclear speckles. colocalizes with the core spliceosomal snrnp proteins.,"TISSUE SPECIFICITY: Widely expressed. Highly expressed in pancreas, skeletal muscle, lung and brain. Expressed at intermediate level in kidney, liver and heart.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBM39,9584,Hs.282901,ENST00000465158,THC2597934,"GO:0000166(nucleotide binding)|GO:0003676(nucleic acid binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005813(centrosome)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006396(RNA processing)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0015630(microtubule cytoskeleton)|GO:0016607(nuclear speck)","Homo sapiens RNA binding motif protein 39 (RBM39), transcript variant 1, mRNA [NM_184234]",chr20:34292430-34292371,hs|20q11.22,RNA binding motif protein 39,TRUE
822_RPS27L_51065,Q71UM5,40s ribosomal protein s27-like (small ribosomal subunit protein es27-like),RPS27L,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS27L,51065,Hs.108957,ENST00000462430,THC2473897,"GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005840(ribosome)|GO:0006281(DNA repair)|GO:0006412(translation)|GO:0006919(activation of caspase activity)|GO:0006974(response to DNA damage stimulus)|GO:0008494(translation activator activity)|GO:0008656(caspase activator activity)|GO:0031571(mitotic cell cycle G1/S transition DNA damage checkpoint)|GO:0042771(DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis)|GO:0045727(positive regulation of translation)|GO:0045768(positive regulation of anti-apoptosis)|GO:0046872(metal ion binding)","Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920]",chr15:63447925-63447866,hs|15q22.2,ribosomal protein S27-like,TRUE
823_UBE2E3_10477,Q969T4,ubiquitin-conjugating enzyme e2 e3 (ec 2.3.2.23) (e2 ubiquitin-conjugating enzyme e3) (ubch9) (ubiquitin carrier protein e3) (ubiquitin-conjugating enzyme e2-23 kda) (ubiquitin-protein ligase e3),UBE2E3 UBCE4 UBCH9,207,"function: accepts ubiquitin from the e1 complex and catalyzes its covalent attachment to other proteins. in vitro catalyzes 'lys-11'- and 'lys-48'-, as well as 'lys-63'-linked polyubiquitination. participates in the regulation of transepithelial sodium transport in renal cells. may be involved in cell growth arrest. {eco:0000269|pubmed:10343118, eco:0000269|pubmed:20061386}.",subcellular location: nucleus {eco:0000269|pubmed:15545318}. cytoplasm {eco:0000269|pubmed:15545318}. note=shuttles between the nucleus and cytoplasm in a ipo11-dependent manner.,TISSUE SPECIFICITY: Ubiquitously expressed at low levels. Highly expressed in skeletal muscle. {ECO:0000269|PubMed:10343118}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBE2E3,10477,Hs.470804,ENST00000305934,THC2469081,GO:0000166(nucleotide binding)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0040008(regulation of growth)|GO:0070534(protein K63-linked ubiquitination)|GO:0070936(protein K48-linked ubiquitination)|GO:0070979(protein K11-linked ubiquitination),"Homo sapiens ubiquitin-conjugating enzyme E2E 3 (UBE2E3), transcript variant 1, mRNA [NM_006357]",chr2:181928043-181928102,hs|2q31.3,ubiquitin-conjugating enzyme E2E 3,TRUE
824_TCEAL8_90843,Q8IYN2,transcription elongation factor a protein-like 8 (tcea-like protein 8) (transcription elongation factor s-ii protein-like 8),TCEAL8,117,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEAL8,90843,Hs.389734,ENST00000372685,THC2468818,"GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens transcription elongation factor A (SII)-like 8 (TCEAL8), transcript variant 1, mRNA [NM_153333]",chrX:102508057-102507998,hs|Xq22.1,transcription elongation factor A (SII)-like 8,TRUE
825_ENAH_55740,Q8N8S7,protein enabled homolog,ENAH MENA,591,"function: ena/vasp proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. enah induces the formation of f-actin rich outgrowths in fibroblasts. acts synergistically with baiap2-alpha and downstream of ntn1 to promote filipodia formation (by similarity). {eco:0000250, eco:0000269|pubmed:11696321, eco:0000269|pubmed:18158903}.","subcellular location: cytoplasm. cytoplasm, cytoskeleton {eco:0000250}. cell projection, lamellipodium {eco:0000250}. cell projection, filopodium {eco:0000250}. cell junction, synapse {eco:0000250}. cell junction, focal adhesion. note=targeted to the leading edge of lamellipodia and filopodia by mrl family members. colocalizes at filopodial tips with a number of other proteins including vinculin and zyxlin. colocalizes with n-wasp at the leading edge. colocalizes with gphn and pfn at synapses (by similarity). {eco:0000250}.","TISSUE SPECIFICITY: Expressed in myoepithelia of parotid, breast, bronchial glands and sweat glands. Expressed in colon-rectum muscolaris mucosae epithelium, pancreas acinar ductal epithelium, endometrium epithelium, prostate fibromuscolar stroma and placenta vascular media. Overexpressed in a majority of breast cancer cell lines and primary breast tumor lesions. {ECO:0000269|PubMed:15027125}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,ENAH,55740,Hs.497893,ENST00000358675,THC2490107,GO:0001725(stress fiber)|GO:0001843(neural tube closure)|GO:0003779(actin binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0005925(focal adhesion)|GO:0007411(axon guidance)|GO:0008154(actin polymerization or depolymerization)|GO:0017124(SH3 domain binding)|GO:0030027(lamellipodium)|GO:0030036(actin cytoskeleton organization)|GO:0030054(cell junction)|GO:0030175(filopodium)|GO:0045202(synapse)|GO:0046907(intracellular transport)|GO:0050699(WW domain binding)|GO:0050852(T cell receptor signaling pathway)|GO:0051289(protein homotetramerization),"Homo sapiens enabled homolog (Drosophila) (ENAH), transcript variant 1, mRNA [NM_001008493]",chr1:225683355-225683296,hs|1q42.12,enabled homolog (Drosophila),TRUE
826_RSRC2_65117,Q7L4I2,arginine/serine-rich coiled-coil protein 2,RSRC2,434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,RSRC2,65117,Hs.432996,ENST00000532695,THC2605114,NA,"Homo sapiens arginine/serine-rich coiled-coil 2 (RSRC2), transcript variant 1, mRNA [NM_023012]",chr12:122989804-122989745,hs|12q24.31,arginine/serine-rich coiled-coil 2,TRUE
827_PRR11_55771,Q96HE9,proline-rich protein 11,PRR11,360,function: plays a critical role in cell cycle progression. {eco:0000269|pubmed:23246489}.,"subcellular location: cytoplasm {eco:0000269|pubmed:23242552, eco:0000269|pubmed:23246489}. nucleus {eco:0000269|pubmed:23246489}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:23246489}.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PRR11,55771,Hs.631750,NA,THC2755869,NA,"Homo sapiens proline rich 11 (PRR11), mRNA [NM_018304]",chr17:57281935-57281994,hs|17q22,proline rich 11,TRUE
828_HEBP1_50865,Q9NRV9,heme-binding protein 1 (p22hbp),HEBP1 HBP,189,"function: may bind free porphyrinogens that may be present in the cell and thus facilitate removal of these potentially toxic compound. binds with a high affinity to one molecule of heme or porphyrins. it binds metalloporphyrins, free porphyrins and n-methylprotoporphyrin with similar affinities. {eco:0000269|pubmed:12413491}.",subcellular location: cytoplasm {eco:0000269|pubmed:12413491}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HEBP1,50865,Hs.642618,ENST00000014930,THC2749761,GO:0005488(binding)|GO:0005576(extracellular region)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0007623(circadian rhythm)|GO:0020037(heme binding),"Homo sapiens heme binding protein 1 (HEBP1), mRNA [NM_015987]",chr12:13127906-13127847,hs|12p13.1,heme binding protein 1,TRUE
829_RABGGTB_5876,P53611,geranylgeranyl transferase type-2 subunit beta (ec 2.5.1.60) (geranylgeranyl transferase type ii subunit beta) (ggtase-ii-beta) (rab geranyl-geranyltransferase subunit beta) (rab gg transferase beta) (rab ggtase beta) (rab geranylgeranyltransferase subunit beta) (type ii protein geranyl-geranyltransferase subunit beta),RABGGTB GGTB,331,"function: catalyzes the transfer of a geranylgeranyl moiety from geranylgeranyl diphosphate to both cysteines of rab proteins with the c-terminal sequence -xxcc, -xcxc and -ccxx, such as rab1a, rab3a, rab5a and rab7a.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,RABGGTB,5876,Hs.78948,ENST00000535300,THC2499455,GO:0004659(prenyltransferase activity)|GO:0004663(Rab geranylgeranyltransferase activity)|GO:0005515(protein binding)|GO:0006464(protein modification process)|GO:0007601(visual perception)|GO:0016740(transferase activity)|GO:0046872(metal ion binding),"Homo sapiens Rab geranylgeranyltransferase, beta subunit (RABGGTB), mRNA [NM_004582]",chr1:76260225-76260284,hs|1p31.1,"Rab geranylgeranyltransferase, beta subunit",TRUE
830_ZNF664_144348,Q8N3J9,zinc finger protein 664 (zinc finger protein 176) (zinc finger protein from organ of corti),ZNF664 ZFOC1 ZNF176,261,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF664,144348,Hs.524828,ENST00000535937,THC2572425,"GO:0003674(molecular_function)|GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008150(biological_process)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 664 (ZNF664), transcript variant 1, mRNA [NM_152437]",chr12:124499566-124499625,hs|12q24.31,zinc finger protein 664,TRUE
831_CCT7_10574,Q99832,"t-complex protein 1 subunit eta (tcp-1-eta) (cct-eta) (hiv-1 nef-interacting protein) [cleaved into: t-complex protein 1 subunit eta, n-terminally processed]",CCT7 CCTH NIP7-1,543,"function: component of the chaperonin-containing t-complex (tric), a molecular chaperone complex that assists the folding of proteins upon atp hydrolysis (pubmed:25467444). the tric complex mediates the folding of wrap53/tcab1, thereby regulating telomere maintenance (pubmed:25467444). the tric complex plays a role in the folding of actin and tubulin (probable). {eco:0000269|pubmed:25467444, eco:0000305}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:p80313}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CCT7,10574,Hs.368149,ENST00000258091,THC2589623,GO:0000166(nucleotide binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0005832(chaperonin-containing T-complex)|GO:0006457(protein folding)|GO:0042802(identical protein binding)|GO:0044267(cellular protein metabolic process)|GO:0051082(unfolded protein binding)|GO:0051084(de novo' posttranslational protein folding),"Homo sapiens chaperonin containing TCP1, subunit 7 (eta) (CCT7), transcript variant 1, mRNA [NM_006429]",chr2:73479769-73479828,hs|2p13.2,"chaperonin containing TCP1, subunit 7 (eta)",TRUE
832_RPL3_6122,P39023,60s ribosomal protein l3 (hiv-1 tar rna-binding protein b) (tarbp-b) (large ribosomal subunit protein ul3),RPL3 OK/SW-cl.32,403,function: the l3 protein is a component of the large subunit of cytoplasmic ribosomes. {eco:0000305|pubmed:12962325}.,"subcellular location: nucleus, nucleolus {eco:0000269|pubmed:16963496}. cytoplasm {eco:0000269|pubmed:16963496}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPL3,6122,Hs.119598,ENST00000465618,THC2553216,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L3 (RPL3), transcript variant 1, mRNA [NM_000967]",chr22:39710135-39709699,hs|22q13.1,ribosomal protein L3,TRUE
833_ZMPSTE24_10269,O75844,caax prenyl protease 1 homolog (ec 3.4.24.84) (farnesylated proteins-converting enzyme 1) (face-1) (prenyl protein-specific endoprotease 1) (zinc metalloproteinase ste24 homolog),ZMPSTE24 FACE1 STE24,475,function: proteolytically removes the c-terminal three residues of farnesylated proteins. acts on lamin a/c.,subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:23539603}; multi-pass membrane protein {eco:0000269|pubmed:23539603}. nucleus inner membrane {eco:0000269|pubmed:23539603}; multi-pass membrane protein {eco:0000269|pubmed:23539603}.,"TISSUE SPECIFICITY: Widely expressed. High levels in kidney, prostate, testis and ovary.","DISEASE: Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, joint contractures, and generalized lipodystrophy with loss of subcutaneous fat from the extremities, face, neck and trunk. {ECO:0000269|PubMed:12913070, ECO:0000269|PubMed:17152860, ECO:0000269|PubMed:18435794, ECO:0000269|PubMed:20814950}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ZMPSTE24,10269,Hs.132642,ENST00000372759,THC2465855,GO:0000139(Golgi membrane)|GO:0004222(metalloendopeptidase activity)|GO:0005624(membrane fraction)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0006508(proteolysis)|GO:0006998(nuclear envelope organization)|GO:0008233(peptidase activity)|GO:0008235(metalloexopeptidase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030327(prenylated protein catabolic process)|GO:0046872(metal ion binding),"Homo sapiens zinc metallopeptidase (STE24 homolog, S. cerevisiae) (ZMPSTE24), mRNA [NM_005857]",chr1:40759577-40759636,hs|1p34.2,"zinc metallopeptidase (STE24 homolog, S. cerevisiae)",TRUE
834_SRSF4_6429,Q08170,"serine/arginine-rich splicing factor 4 (pre-mrna-splicing factor srp75) (srp001lb) (splicing factor, arginine/serine-rich 4)",SRSF4 SFRS4 SRP75,494,function: plays a role in alternative splice site selection during pre-mrna splicing. represses the splicing of mapt/tau exon 10. {eco:0000269|pubmed:15009664}.,subcellular location: nucleus speckle {eco:0000269|pubmed:14578391}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SRSF4,6429,Hs.469970,ENST00000434636,THC2468005,"GO:0000166(nucleotide binding)|GO:0000375(RNA splicing, via transesterification reactions)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006369(termination of RNA polymerase II transcription)|GO:0006397(mRNA processing)|GO:0006406(mRNA export from nucleus)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016607(nuclear speck)|GO:0031124(mRNA 3'-end processing)|GO:0048025(negative regulation of nuclear mRNA splicing, via spliceosome)","Homo sapiens serine/arginine-rich splicing factor 4 (SRSF4), mRNA [NM_005626]",chr1:29474558-29474499,hs|1p35.3,serine/arginine-rich splicing factor 4,TRUE
835_AFTPH_54812,Q6ULP2,aftiphilin,AFTPH AFTH,936,function: may play a role in membrane trafficking.,subcellular location: cytoplasm {eco:0000269|pubmed:14665628}. note=colocalizes with ap1g1 and clathrin.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AFTPH,54812,Hs.655167,ENST00000422803,THC2468780,GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0015031(protein transport)|GO:0030121(AP-1 adaptor complex)|GO:0030276(clathrin binding)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens aftiphilin (AFTPH), transcript variant 1, mRNA [NM_203437]",chr2:64819947-64820006,hs|2p14,aftiphilin,TRUE
836_TBRG1_84897,Q3YBR2,transforming growth factor beta regulator 1 (nuclear interactor of arf and mdm2),TBRG1 NIAM,411,"function: acts as a growth inhibitor. can activate p53/tp53, causes g1 arrest and collaborates with cdkn2a to restrict proliferation, but does not require either protein to inhibit dna synthesis. redistributes cdkn2a into the nucleoplasm. involved in maintaining chromosomal stability. {eco:0000269|pubmed:17110379}.",subcellular location: nucleus {eco:0000269|pubmed:17110379}.,"TISSUE SPECIFICITY: Widely expressed at low levels in most tissues, with highest levels in pancreas, lung and liver. Expression is decreased in primary tumors including lung, liver, breast, pancreas and kidney carcinomas, chronic lymphocytic leukemia and diffuse large B-cell lymphoma. {ECO:0000269|PubMed:17110379}.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TBRG1,84897,Hs.436410,NA,THC2464396,GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006260(DNA replication)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0008285(negative regulation of cell proliferation)|GO:0032066(nucleolus to nucleoplasm transport)|GO:0050821(protein stabilization),"Homo sapiens transforming growth factor beta regulator 1, mRNA (cDNA clone IMAGE:5212572), complete cds. [BC032312]",chr11:124494039-124494098,hs|11q24.2,transforming growth factor beta regulator 1,TRUE
837_BBX_56987,Q8WY36,hmg box transcription factor bbx (bobby sox homolog) (hmg box-containing protein 2),BBX HBP2,941,function: transcription factor that is necessary for cell cycle progression from g1 to s phase. {eco:0000269|pubmed:11680820}.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,BBX,56987,Hs.124366,ENST00000406780,THC2560151,"GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)","Homo sapiens bobby sox homolog (Drosophila) (BBX), transcript variant 2, mRNA [NM_020235]",chr3:107524534-107524593,hs|3q13.12,bobby sox homolog (Drosophila),TRUE
838_GUSB_2990,P08236,beta-glucuronidase (ec 3.2.1.31) (beta-g1),GUSB,651,function: plays an important role in the degradation of dermatan and keratan sulfates.,subcellular location: lysosome.,NA,"DISEASE: Mucopolysaccharidosis 7 (MPS7) [MIM:253220]: An autosomal recessive lysosomal storage disease characterized by inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment. {ECO:0000269|PubMed:12522561, ECO:0000269|PubMed:12859417, ECO:0000269|PubMed:1702266, ECO:0000269|PubMed:7573038, ECO:0000269|PubMed:7633414, ECO:0000269|PubMed:7680524, ECO:0000269|PubMed:8089138, ECO:0000269|PubMed:8111412, ECO:0000269|PubMed:8111413, ECO:0000269|PubMed:8644704, ECO:0000269|PubMed:8707294, ECO:0000269|PubMed:9099834, ECO:0000269|PubMed:9490302}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GUSB,2990,Hs.255230,ENST00000345660,THC2514402,GO:0004566(beta-glucuronidase activity)|GO:0005529(sugar binding)|GO:0005625(soluble fraction)|GO:0005764(lysosome)|GO:0005792(microsome)|GO:0005975(carbohydrate metabolic process)|GO:0006027(glycosaminoglycan catabolic process)|GO:0043169(cation binding)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens glucuronidase, beta (GUSB), mRNA [NM_000181]",chr7:65425765-65425706,hs|7q11.21,"glucuronidase, beta",TRUE
839_IL13RA1_3597,P78552,interleukin-13 receptor subunit alpha-1 (il-13 receptor subunit alpha-1) (il-13r subunit alpha-1) (il-13r-alpha-1) (il-13ra1) (cancer/testis antigen 19) (ct19) (cd antigen cd213a1),IL13RA1 IL13R IL13RA,427,"function: binds with low affinity to interleukin-13 (il13). together with il4ra can form a functional receptor for il13. also serves as an alternate accessory protein to the common cytokine receptor gamma chain for interleukin-4 (il4) signaling, but cannot replace the function of il2rg in allowing enhanced interleukin-2 (il2) binding activity.",subcellular location: membrane; single-pass type i membrane protein.,"TISSUE SPECIFICITY: Ubiquitous. Highest levels in heart, liver, skeletal muscle and ovary; lowest levels in brain, lung and kidney. Also found in B-cells, T-cells and endothelial cells.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,IL13RA1,3597,Hs.496646,ENST00000371666,THC2525132,GO:0004872(receptor activity)|GO:0004896(cytokine receptor activity)|GO:0005515(protein binding)|GO:0005886(plasma membrane)|GO:0005898(interleukin-13 receptor complex)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens interleukin 13 receptor, alpha 1 (IL13RA1), mRNA [NM_001560]",chrX:117928406-117928465,hs|Xq24,"interleukin 13 receptor, alpha 1",TRUE
84_SAT1_6303,P21673,diamine acetyltransferase 1 (ec 2.3.1.57) (polyamine n-acetyltransferase 1) (putrescine acetyltransferase) (spermidine/spermine n(1)-acetyltransferase 1) (ssat) (ssat-1),SAT1 SAT,171,"function: enzyme which catalyzes the acetylation of polyamines. substrate specificity: norspermidine = spermidine >> spermine > n(1)-acetylspermine > putrescine. this highly regulated enzyme allows a fine attenuation of the intracellular concentration of polyamines. also involved in the regulation of polyamine transport out of cells. acts on 1,3-diaminopropane, 1,5-diaminopentane, putrescine, spermidine (forming n(1)- and n(8)-acetylspermidine), spermine, n(1)-acetylspermidine and n(8)-acetylspermidine. {eco:0000269|pubmed:16455797, eco:0000269|pubmed:17516632}.",subcellular location: cytoplasm.,NA,DISEASE: Note=Overexpression of SAT1 and the consequent putrescine accumulation might play a role in the pathogenesis of keratosis follicularis spinulosa decalvans. {ECO:0000269|PubMed:12215835}.,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SAT1,6303,Hs.28491,ENST00000474223,THC2552940,"GO:0001525(angiogenesis)|GO:0004145(diamine N-acetyltransferase activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005625(soluble fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006595(polyamine metabolic process)|GO:0006596(polyamine biosynthetic process)|GO:0008152(metabolic process)|GO:0016746(transferase activity, transferring acyl groups)|GO:0019809(spermidine binding)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042127(regulation of cell proliferation)","Homo sapiens spermidine/spermine N1-acetyltransferase 1 (SAT1), transcript variant 1, mRNA [NM_002970]",chrX:23804055-23804114,hs|Xp22.11,spermidine/spermine N1-acetyltransferase 1,TRUE
840_HIST1H2AM_8336,P0C0S8,histone h2a type 1 (h2a.1) (histone h2a/ptl),H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST1H2AM,8336,Hs.134999,ENST00000359611,THC2478312,NA,"Homo sapiens histone cluster 1, H2am (HIST1H2AM), mRNA [NM_003514]",chr6:27860636-27860577,hs|6p22.1,"histone cluster 1, H2am",TRUE
841_ASNS_440,P08243,asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (cell cycle control protein ts11) (glutamine-dependent asparagine synthetase),ASNS TS11,561,NA,NA,NA,"DISEASE: Asparagine synthetase deficiency (ASNSD) [MIM:615574]: An inborn error of asparagine biosynthesis that results in a severe neurologic disorder characterized by microcephaly, severely delayed psychomotor development, progressive encephalopathy, cortical atrophy, and seizure or hyperekplexic activity. {ECO:0000269|PubMed:24139043}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,ASNS,440,Hs.489207,ENST00000394308,THC2502767,GO:0000166(nucleotide binding)|GO:0001889(liver development)|GO:0004066(asparagine synthase (glutamine-hydrolyzing) activity)|GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0005829(cytosol)|GO:0006529(asparagine biosynthetic process)|GO:0006541(glutamine metabolic process)|GO:0008152(metabolic process)|GO:0008652(cellular amino acid biosynthetic process)|GO:0009416(response to light stimulus)|GO:0009612(response to mechanical stimulus)|GO:0009636(response to toxin)|GO:0016874(ligase activity)|GO:0031427(response to methotrexate)|GO:0031667(response to nutrient levels)|GO:0032354(response to follicle-stimulating hormone stimulus)|GO:0032870(cellular response to hormone stimulus)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042149(cellular response to glucose starvation)|GO:0042803(protein homodimerization activity)|GO:0043066(negative regulation of apoptosis)|GO:0043200(response to amino acid stimulus)|GO:0045931(positive regulation of mitotic cell cycle)|GO:0048037(cofactor binding),"Homo sapiens asparagine synthetase (glutamine-hydrolyzing) (ASNS), transcript variant 2, mRNA [NM_001673]",chr7:97481520-97481461,hs|7q21.3,asparagine synthetase (glutamine-hydrolyzing),TRUE
842_NEURL1B_54492,A8MQ27,e3 ubiquitin-protein ligase neurl1b (ec 2.3.2.27) (neuralized-2) (neur2) (neuralized-like protein 1b) (neuralized-like protein 3) (ring-type e3 ubiquitin transferase neurl1b),NEURL1B NEURL3,555,function: e3 ubiquitin-protein ligase involved in regulation of the notch pathway through influencing the stability and activity of several notch ligands. {eco:0000269|pubmed:19723503}.,subcellular location: cytoplasm {eco:0000269|pubmed:19723503}.,"TISSUE SPECIFICITY: Highest expression in brain, prostate and small intestine. In the brain the levels are higher in fetal than in adult stage. In the adult brain the highest levels are detected in the olfactory system, cerebellar cortex, optic nerve and the frontal lobe. {ECO:0000269|PubMed:19723503}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NEURL1B,54492,Hs.91521,ENST00000369800,THC2604808,GO:0008270(zinc ion binding)|GO:0016874(ligase activity)|GO:0046872(metal ion binding),"Homo sapiens neuralized homolog 1B (Drosophila) (NEURL1B), mRNA [NM_001142651]",chr5:172118316-172118375,hs|5q35.1,neuralized homolog 1B (Drosophila),TRUE
843_DDB1_1642,Q16531,dna damage-binding protein 1 (ddb p127 subunit) (dna damage-binding protein a) (ddba) (damage-specific dna-binding protein 1) (hbv x-associated protein 1) (xap-1) (uv-damaged dna-binding factor) (uv-damaged dna-binding protein 1) (uv-ddb 1) (xpe-binding factor) (xpe-bf) (xeroderma pigmentosum group e-complementing protein) (xpce),DDB1 XAP1,1140,"function: required for dna repair. binds to ddb2 to form the uv-damaged dna-binding protein complex (the uv-ddb complex). the uv-ddb complex may recognize uv-induced dna damage and recruit proteins of the nucleotide excision repair pathway (the ner pathway) to initiate dna repair. the uv-ddb complex preferentially binds to cyclobutane pyrimidine dimers (cpd), 6-4 photoproducts (6-4 pp), apurinic sites and short mismatches. also appears to function as a component of numerous distinct dcx (ddb1-cul4-x-box) e3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. the functional specificity of the dcx e3 ubiquitin-protein ligase complex is determined by the variable substrate recognition component recruited by ddb1. dcx(ddb2) (also known as ddb1-cul4-roc1, cul4-ddb-roc1 and cul4-ddb-rbx1) may ubiquitinate histone h2a, histone h3 and histone h4 at sites of uv-induced dna damage. the ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent dna repair. dcx(ddb2) also ubiquitinates xpc, which may enhance dna-binding by xpc and promote ner. dcx(dtl) plays a role in pcna-dependent polyubiquitination of cdt1 and mdm2-dependent ubiquitination of tp53 in response to radiation-induced dna damage and during dna replication. dcx(ercc8) (the csa complex) plays a role in transcription-coupled repair (tcr). may also play a role in ubiquitination of cdkn1b/p27kip when associated with cul4 and skp2. the ddb1-cul4a-dtl e3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of cry1 (pubmed:26431207). ddb1-mediated cry1 degradation promotes foxo1 protein stability and foxo1-mediated gluconeogenesis in the liver (by similarity). {eco:0000250|uniprotkb:q3u1j4, eco:0000269|pubmed:12732143, eco:0000269|pubmed:14739464, eco:0000269|pubmed:15448697, eco:0000269|pubmed:15882621, eco:0000269|pubmed:16260596, eco:0000269|pubmed:16407242, eco:0000269|pubmed:16407252, eco:0000269|pubmed:16473935, eco:0000269|pubmed:16482215, eco:0000269|pubmed:16678110, eco:0000269|pubmed:16940174, eco:0000269|pubmed:17041588, eco:0000269|pubmed:17079684, eco:0000269|pubmed:18332868, eco:0000269|pubmed:18381890, eco:0000269|pubmed:18593899, eco:0000269|pubmed:19966799, eco:0000269|pubmed:22118460, eco:0000269|pubmed:25043012, eco:0000269|pubmed:25108355, eco:0000269|pubmed:26431207}.",subcellular location: cytoplasm. nucleus. note=primarily cytoplasmic. translocates to the nucleus following uv irradiation and subsequently accumulates at sites of dna damage.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDB1,1642,Hs.290758,ENST00000545894,THC2755310,"GO:0000075(cell cycle checkpoint)|GO:0000718(nucleotide-excision repair, DNA damage removal)|GO:0003677(DNA binding)|GO:0003684(damaged DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0006281(DNA repair)|GO:0006289(nucleotide-excision repair)|GO:0016055(Wnt receptor signaling pathway)|GO:0031464(Cul4A-RING ubiquitin ligase complex)|GO:0031465(Cul4B-RING ubiquitin ligase complex)|GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0044419(interspecies interaction between organisms)","Homo sapiens damage-specific DNA binding protein 1, 127kDa (DDB1), mRNA [NM_001923]",chr11:61067258-61067199,hs|11q12.2,"damage-specific DNA binding protein 1, 127kDa",TRUE
844_FNBP1L_54874,Q5T0N5,formin-binding protein 1-like (transducer of cdc42-dependent actin assembly protein 1) (toca-1),FNBP1L C1orf39 TOCA1,605,"function: required to coordinate membrane tubulation with reorganization of the actin cytoskeleton during endocytosis. may bind to lipids such as phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and promote membrane invagination and the formation of tubules. also promotes cdc42-induced actin polymerization by activating the wasl/n-wasp-waspip/wip complex, the predominant form of wasl/n-wasp in cells. actin polymerization may promote the fission of membrane tubules to form endocytic vesicles. essential for autophagy of intracellular bacterial pathogens. {eco:0000269|pubmed:15260990, eco:0000269|pubmed:16326391, eco:0000269|pubmed:19342671}.","subcellular location: cytoplasm {eco:0000269|pubmed:16757518}. cytoplasm, cytoskeleton {eco:0000250}. cytoplasm, cell cortex {eco:0000250}. cytoplasmic vesicle {eco:0000250}. cell membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FNBP1L,54874,Hs.134060,ENST00000260506,THC2466802,GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0005938(cell cortex)|GO:0006897(endocytosis)|GO:0008289(lipid binding)|GO:0016023(cytoplasmic membrane-bounded vesicle),"Homo sapiens formin binding protein 1-like (FNBP1L), transcript variant 1, mRNA [NM_001024948]",chr1:94019908-94019967,hs|1p22.1,formin binding protein 1-like,TRUE
845_FAM127B_26071,Q9BWD3,retrotransposon gag-like protein 8a (mammalian retrotransposon derived protein 8a),RTL8A CXX1B FAM127B MAR8A,113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM127B,26071,Hs.460924,ENST00000520964,THC2477942,NA,"Homo sapiens family with sequence similarity 127, member B (FAM127B), transcript variant 1, mRNA [NM_001078172]",chrX:134185072-134185013,hs|Xq26.3,"family with sequence similarity 127, member B",TRUE
846_PHPT1_29085,Q9NRX4,14 kda phosphohistidine phosphatase (ec 3.9.1.3) (phosphohistidine phosphatase 1) (phpt1) (protein histidine phosphatase) (php) (protein janus-a homolog),PHPT1 PHP14 CGI-202 HSPC141,125,"function: exhibits phosphohistidine phosphatase activity. {eco:0000269|pubmed:19836471, eco:0000269|pubmed:25574816}.",subcellular location: cytoplasm {eco:0000250}.,TISSUE SPECIFICITY: Expressed abundantly in heart and skeletal muscle. {ECO:0000269|PubMed:12383260}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PHPT1,29085,Hs.409834,ENST00000492540,THC2559032,GO:0004721(phosphoprotein phosphatase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006470(protein dephosphorylation)|GO:0008969(phosphohistidine phosphatase activity)|GO:0016787(hydrolase activity)|GO:0019855(calcium channel inhibitor activity)|GO:0044325(ion channel binding)|GO:0050860(negative regulation of T cell receptor signaling pathway)|GO:0051350(negative regulation of lyase activity)|GO:2000147(positive regulation of cell motility)|GO:2000249(regulation of actin cytoskeleton reorganization),"Homo sapiens phosphohistidine phosphatase 1 (PHPT1), transcript variant 3, mRNA [NM_014172]",chr9:139745212-139745271,hs|9q34.3,phosphohistidine phosphatase 1,TRUE
847_TMC5_79838,Q6UXY8,transmembrane channel-like protein 5,TMC5 UNQ8238/PRO33604,1006,function: probable ion channel. {eco:0000250}.,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMC5,79838,Hs.115838,ENST00000396229,NP1276461,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane channel-like 5 (TMC5), transcript variant 3, mRNA [NM_024780]",chr16:19509448-19509507,hs|16p12.3,transmembrane channel-like 5,TRUE
848_ITM2B_9445,Q9Y287,"integral membrane protein 2b (immature bri2) (imbri2) (protein e25b) (transmembrane protein bri) (bri) [cleaved into: bri2, membrane form (mature bri2) (mbri2); bri2 intracellular domain (bri2 icd); bri2c, soluble form; bri23 peptide (bri2-23) (abri23) (c-terminal peptide) (p23 peptide)]",ITM2B BRI BRI2,266,function: plays a regulatory role in the processing of the amyloid-beta a4 precursor protein (app) and acts as an inhibitor of the amyloid-beta peptide aggregation and fibrils deposition. plays a role in the induction of neurite outgrowth. functions as a protease inhibitor by blocking access of secretases to app cleavage sites.; function: mature bri2 (mbri2) functions as a modulator of the amyloid-beta a4 precursor protein (app) processing leading to a strong reduction in the secretion of secretase-processed amyloid-beta protein 40 and amyloid-beta protein 42.; function: bri23 peptide prevents aggregation of app amyloid-beta protein 42 into toxic oligomers.,"subcellular location: integral membrane protein 2b: golgi apparatus membrane {eco:0000269|pubmed:14656991, eco:0000269|pubmed:19114711}; single-pass type ii membrane protein {eco:0000269|pubmed:10526337}. note=immature bri2 (imbri2) is cleaved by furin in the golgi into mbri2 and a bri23 peptide. mbri2 is transported to the plasma membrane and bri23 peptide is secreted.; subcellular location: bri2, membrane form: cell membrane {eco:0000269|pubmed:18440095, eco:0000269|pubmed:19748705, eco:0000269|pubmed:21752865}; single-pass type ii membrane protein {eco:0000269|pubmed:10526337}. endosome membrane {eco:0000269|pubmed:19748705}; single-pass type ii membrane protein {eco:0000269|pubmed:10526337}. note=mature bri2 (mbri2) needs to be transported from the endoplasmic reticulum compartment to the cell membrane in order to be able to inhibit app processing. {eco:0000269|pubmed:19748705}.; subcellular location: bri23 peptide: secreted {eco:0000269|pubmed:10526337, eco:0000269|pubmed:14656991, eco:0000269|pubmed:18524908}. note=detected in the cerebral spinal fluid (csf). {eco:0000269|pubmed:18524908}.; subcellular location: bri2c, soluble form: secreted {eco:0000269|pubmed:17965014}.",TISSUE SPECIFICITY: Ubiquitous. Expressed in brain.,"DISEASE: Cerebral amyloid angiopathy, ITM2B-related 1 (CAA-ITM2B1) [MIM:176500]: A disorder characterized by amyloid deposition in the walls of cerebral blood vessels and neurodegeneration in the central nervous system. Cerebral amyloid angiopathy, non-neuritic and perivascular plaques and neurofibrillary tangles are the predominant pathological lesions. Clinical features include progressive mental deterioration, spasticity and muscular rigidity. {ECO:0000269|PubMed:10391242, ECO:0000269|PubMed:10526337, ECO:0000269|PubMed:14656991}. Note=The disease is caused by mutations affecting the gene represented in this entry. A single base substitution at the stop codon of ITM2B generates a 277-residue precursor that is cleaved at the normal furin processing site to generate the ABri amyloidogenic peptide (PubMed:10391242). ABri accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia. ABri peptide variant forms fibrils in vitro (PubMed:10526337). {ECO:0000269|PubMed:10391242, ECO:0000269|PubMed:10526337}.; DISEASE: Cerebral amyloid angiopathy, ITM2B-related 2 (CAA-ITM2B2) [MIM:117300]: A disorder characterized by amyloid deposition in the walls of the blood vessels of the cerebrum, choroid plexus, cerebellum, spinal cord and retina. Plaques and neurofibrillary tangles are observed in the hippocampus. Clinical features include progressive ataxia, dementia, cataracts and deafness. {ECO:0000269|PubMed:10781099, ECO:0000269|PubMed:14656991, ECO:0000269|PubMed:16091362}. Note=The disease is caused by mutations affecting the gene represented in this entry. A decamer duplication in the 3' region of ITM2B results in the production of the ADan amyloidogenic peptide (PubMed:10781099). ADan is generated by cleavage of the mutated precursor at the normal furin processing site. ADan accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia. {ECO:0000269|PubMed:10781099}.; DISEASE: Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities (RDGCA) [MIM:616079]: An autosomal dominant retinal dystrophy characterized by inner retinal dysfunction in association with ganglion cell abnormalities. Clinical features include mild photophobia, progressive loss of central vision, night blindness, and hyperreflectivity of nerve and ganglion cell layers. {ECO:0000269|PubMed:24026677}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ITM2B,9445,Hs.643683,ENST00000378565,NP830451,GO:0000139(Golgi membrane)|GO:0001540(beta-amyloid binding)|GO:0005524(ATP binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005794(Golgi apparatus)|GO:0005886(plasma membrane)|GO:0006915(apoptosis)|GO:0006917(induction of apoptosis)|GO:0007399(nervous system development)|GO:0016021(integral to membrane)|GO:0043231(intracellular membrane-bounded organelle),"Homo sapiens integral membrane protein 2B (ITM2B), mRNA [NM_021999]",chr13:48835913-48835972,hs|13q14.2,integral membrane protein 2B,TRUE
849_BASP1_10409,P80723,brain acid soluble protein 1 (22 kda neuronal tissue-enriched acidic protein) (neuronal axonal membrane protein nap-22),BASP1 NAP22,227,NA,"subcellular location: cell membrane; lipid-anchor. cell projection, growth cone. note=associated with the membranes of growth cones that form the tips of elongating axons.",TISSUE SPECIFICITY: Brain.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,BASP1,10409,Hs.201641,ENST00000322611,THC2503134,"GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0007356(thorax and anterior abdomen determination)|GO:0008180(signalosome)|GO:0008406(gonad development)|GO:0016607(nuclear speck)|GO:0019904(protein domain specific binding)|GO:0030426(growth cone)|GO:0042995(cell projection)|GO:0044212(transcription regulatory region DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0060231(mesenchymal to epithelial transition)|GO:0060421(positive regulation of heart growth)|GO:0060539(diaphragm development)|GO:0072075(metanephric mesenchyme development)|GO:0072112(glomerular visceral epithelial cell differentiation)","Homo sapiens brain abundant, membrane attached signal protein 1 (BASP1), mRNA [NM_006317]",chr5:17276590-17276649,hs|5p15.1,"brain abundant, membrane attached signal protein 1",TRUE
85_RPL38_6169,P63173,60s ribosomal protein l38 (large ribosomal subunit protein el38),RPL38,70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL38,6169,Hs.380953,ENST00000439590,THC2465563,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L38 (RPL38), transcript variant 1, mRNA [NM_000999]",chr17:72205433-72205986,hs|17q25.1,ribosomal protein L38,TRUE
850_IAH1_285148,Q2TAA2,isoamyl acetate-hydrolyzing esterase 1 homolog (ec 3.1.-.-),IAH1,248,function: probable lipase. {eco:0000250}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,IAH1,285148,Hs.570189,ENST00000482918,THC2470361,"GO:0016042(lipid catabolic process)|GO:0016788(hydrolase activity, acting on ester bonds)","Homo sapiens isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae) (IAH1), mRNA [NM_001039613]",chr2:9628439-9628498,hs|2p25.1,isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),TRUE
852_RAI1_10743,Q7Z5J4,retinoic acid-induced protein 1,RAI1 KIAA1820,1906,"function: transcriptional regulator of the circadian clock components: clock, arntl/bmal1, arntl2/bmal2, per1/3, cry1/2, nr1d1/2 and rora/c. positively regulates the transcriptional activity of clock a core component of the circadian clock. regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. may be important for embryonic and postnatal development. may be involved in neuronal differentiation. {eco:0000269|pubmed:22578325}.","subcellular location: cytoplasm. nucleus. note=in neurons, localized to neurites. {eco:0000250}.",TISSUE SPECIFICITY: Expressed in all tissues examined with higher expression in the heart and brain. No expression was seen in the corpus callosum of the brain. {ECO:0000269|PubMed:12837267}.,"DISEASE: Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. {ECO:0000269|PubMed:11404004, ECO:0000269|PubMed:12652298, ECO:0000269|PubMed:24863970}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RAI1,10743,Hs.655395,ENST00000353383,THC2463828,GO:0001501(skeletal system development)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006357(regulation of transcription from RNA polymerase II promoter)|GO:0008270(zinc ion binding)|GO:0040015(negative regulation of multicellular organism growth)|GO:0046872(metal ion binding),"Homo sapiens retinoic acid induced 1 (RAI1), mRNA [NM_030665]",chr17:17714588-17714647,hs|17p11.2,retinoic acid induced 1,TRUE
853_NBR1_4077,Q14596,next to brca1 gene 1 protein (cell migration-inducing gene 19 protein) (membrane component chromosome 17 surface marker 2) (neighbor of brca1 gene 1 protein) (protein 1a1-3b),NBR1 1A13B KIAA0049 M17S2 MIG19,966,function: acts probably as a receptor for selective autophagosomal degradation of ubiquitinated targets. {eco:0000269|pubmed:19250911}.,"subcellular location: cytoplasm {eco:0000269|pubmed:19427866}. cytoplasmic vesicle, autophagosome {eco:0000269|pubmed:19250911}. lysosome {eco:0000269|pubmed:19250911}. cytoplasm, myofibril, sarcomere, m line {eco:0000250|uniprotkb:q501r9}. note=in cardiac muscles localizes to the sarcomeric m line (by similarity). is targeted to lysosomes for degradation (pubmed:19250911). {eco:0000250|uniprotkb:q501r9, eco:0000269|pubmed:19250911}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NBR1,4077,Hs.277721,ENST00000422280,THC2698893,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0005770(late endosome)|GO:0005776(autophagic vacuole)|GO:0005829(cytosol)|GO:0008270(zinc ion binding)|GO:0016236(macroautophagy)|GO:0030500(regulation of bone mineralization)|GO:0031410(cytoplasmic vesicle)|GO:0031430(M band)|GO:0032872(regulation of stress-activated MAPK cascade)|GO:0043130(ubiquitin binding)|GO:0045668(negative regulation of osteoblast differentiation)|GO:0046872(metal ion binding)|GO:0048273(mitogen-activated protein kinase p38 binding)|GO:0051259(protein oligomerization),"Homo sapiens neighbor of BRCA1 gene 1 (NBR1), transcript variant 2, mRNA [NM_031858]",chr17:41363202-41363261,hs|17q21.31,neighbor of BRCA1 gene 1,TRUE
854_SORL1_6653,Q92673,sortilin-related receptor (low-density lipoprotein receptor relative with 11 ligand-binding repeats) (ldlr relative with 11 ligand-binding repeats) (lr11) (sorla-1) (sorting protein-related receptor containing ldlr class a repeats) (sorla),SORL1 C11orf32,2214,"function: sorting receptor that directs several proteins to their correct location within the cell (probable). along with ap-1 complex, involved golgi apparatus - endosome sorting (pubmed:17646382). sorting receptor for app, regulating its intracellular trafficking and processing into amyloidogenic-beta peptides. retains app in the trans-golgi network, hence preventing its transit through late endosomes where amyloid beta peptides abeta40 and abeta42 are generated (pubmed:16174740, pubmed:16407538, pubmed:17855360, pubmed:24523320). may also sort newly produced amyloid-beta peptides to lysosomes for catabolism (pubmed:24523320). does not affect app trafficking from the endoplasmic reticulum to golgi compartments (pubmed:17855360). sorting receptor for the bdnf receptor ntrk2/trkb that facilitates ntrk2 trafficking between synaptic plasma membranes, postsynaptic densities and cell soma, hence positively regulates bdnf signaling by controlling the intracellular location of its receptor (pubmed:23977241). sorting receptor for gdnf that promotes gdnf regulated, but not constitutive secretion (pubmed:21994944). sorting receptor for the gdnf-gfra1 complex, directing it from the cell surface to endosomes. gdnf is then targeted to lysosomes and degraded, while its receptor gfra1 recycles back to the cell membrane, resulting in a gdnf clearance pathway. the sorl1-gfra1 complex further targets ret for endocytosis, but not for degradation, affecting gdnf-induced neurotrophic activities (pubmed:23333276). sorting receptor for erbb2/her2. regulates erbb2 subcellular distribution by promoting its recycling after internalization from endosomes back to the plasma membrane, hence stimulating phosphoinositide 3-kinase (pi3k)-dependent erbb2 signaling. in erbb2-dependent cancer cells, promotes cell proliferation (pubmed:31138794). sorting receptor for lipoprotein lipase lpl. promotes lpl localization to endosomes and later to the lysosomes, leading to degradation of newly synthesized lpl (pubmed:21385844). potential sorting receptor for apoa5, inducing apoa5 internalization to early endosomes, then to late endosomes, wherefrom a portion is sent to lysosomes and degradation, another portion is sorted to the trans-golgi network (pubmed:18603531). sorting receptor for the insulin receptor insr. promotes recycling of internalized insr via the golgi apparatus back to the cell surface, thereby preventing lysosomal insr catabolism, increasing insr cell surface expression and strengthening insulin signal reception in adipose tissue. does not affect insr internalization (pubmed:27322061). plays a role in renal ion homeostasis, controlling the phospho-regulation of slc12a1/nkcc2 by stk39/spak kinase and ppp3cb/calcineurin a beta phosphatase, possibly through intracellular sorting of stk39 and ppp3cb (by similarity). stimulates, via the n-terminal ectodomain, the proliferation and migration of smooth muscle cells, possibly by increasing cell surface expression of the urokinase receptor upar/plaur. this may promote extracellular matrix proteolysis and hence facilitate cell migration (pubmed:14764453). by acting on the migration of intimal smooth muscle cells, may accelerate intimal thickening following vascular injury (pubmed:14764453). promotes adhesion of monocytes (pubmed:23486467). stimulates proliferation and migration of monocytes/macrophages (by similarity). through its action on intimal smooth muscle cells and macrophages, may accelerate intimal thickening and macrophage foam cell formation in the process of atherosclerosis (by similarity). regulates hypoxia-enhanced adhesion of hematopoietic stem and progenitor cells to the bone marrow stromal cells via a plaur-mediated pathway. this function is mediated by the n-terminal ectodomain (pubmed:23486467). metabolic regulator, which functions to maintain the adequate balance between lipid storage and oxidation in response to changing environmental conditions, such as temperature and diet. the n-terminal ectodomain negatively regulates adipose tissue energy expenditure, acting through the inhibition the bmp/smad pathway (by similarity). may regulate signaling by the heterodimeric neurotrophic cytokine clcf1-crlf1 bound to the cntfr receptor by promoting the endocytosis of the tripartite complex clcf1-crlf1-cntfr and lysosomal degradation (pubmed:26858303). may regulate il6 signaling, decreasing cis signaling, possibly by interfering with il6-binding to membrane-bound il6r, while up-regulating trans signaling via soluble il6r (pubmed:28265003). {eco:0000250|uniprotkb:o88307, eco:0000269|pubmed:14764453, eco:0000269|pubmed:16174740, eco:0000269|pubmed:16407538, eco:0000269|pubmed:17646382, eco:0000269|pubmed:17855360, eco:0000269|pubmed:18603531, eco:0000269|pubmed:21385844, eco:0000269|pubmed:21994944, eco:0000269|pubmed:23333276, eco:0000269|pubmed:23486467, eco:0000269|pubmed:23977241, eco:0000269|pubmed:24523320, eco:0000269|pubmed:26858303, eco:0000269|pubmed:27322061, eco:0000269|pubmed:28265003, eco:0000269|pubmed:31138794, eco:0000305}.","subcellular location: golgi apparatus membrane {eco:0000269|pubmed:11294867, eco:0000269|pubmed:16174740, eco:0000269|pubmed:17855360, eco:0000269|pubmed:21385844, eco:0000269|pubmed:21994944}; single-pass type i membrane protein {eco:0000305}. golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:17646382, eco:0000269|pubmed:21385844, eco:0000269|pubmed:23333276}; single-pass type i membrane protein {eco:0000305}. endosome membrane {eco:0000269|pubmed:21385844, eco:0000269|pubmed:23333276}; single-pass type i membrane protein {eco:0000305}. early endosome membrane {eco:0000269|pubmed:16174740, eco:0000269|pubmed:17646382, eco:0000269|pubmed:21385844, eco:0000269|pubmed:31138794}; single-pass type i membrane protein {eco:0000305}. recycling endosome membrane {eco:0000269|pubmed:17855360, eco:0000269|pubmed:31138794}; single-pass type i membrane protein {eco:0000305}. endoplasmic reticulum membrane {eco:0000269|pubmed:17855360, eco:0000269|pubmed:21385844}; single-pass type i membrane protein {eco:0000305}. endosome, multivesicular body membrane {eco:0000269|pubmed:21385844, eco:0000269|pubmed:23333276}; single-pass type i membrane protein {eco:0000305}. cell membrane {eco:0000269|pubmed:11294867, eco:0000269|pubmed:14764453, eco:0000269|pubmed:15053742, eco:0000269|pubmed:17855360, eco:0000269|pubmed:21385844, eco:0000269|pubmed:21994944, eco:0000269|pubmed:31138794}; single-pass type i membrane protein {eco:0000305}. cytoplasmic vesicle, secretory vesicle membrane {eco:0000269|pubmed:21994944}; single-pass type i membrane protein {eco:0000305}. secreted {eco:0000269|pubmed:11082041, eco:0000269|pubmed:14764453, eco:0000269|pubmed:15053742, eco:0000269|pubmed:16393139, eco:0000269|pubmed:16531402}. note=mostly intracellular, predominantly in the trans-golgi network (tgn) and in endosome, as well as in endosome-to-tgn retrograde vesicles; found at low levels on the plasma membrane (pubmed:11294867, pubmed:15053742, pubmed:17855360, pubmed:21994944, pubmed:21385844, pubmed:31138794). at the cell surface, partially subjected to proteolytic shedding that releases the ectodomain (also called soluble sorla, sollr11 or slr11) in the extracellular milieu (pubmed:11082041, pubmed:16393139, pubmed:16531402). the shedding may be catalyzed by adam17/tace (pubmed:16393139). following shedding, psen1/presenilin-1 cleaves the remaining transmembrane fragment and catalyzes the release of a c-terminal fragment in the cytosol and of a soluble n-terminal beta fragment in the extracellular milieu. the c-terminal cytosolic fragment localizes to the nucleus (pubmed:16531402). at the cell surface, the full-length protein undergoes partial clathrin-dependent endocytosis guided by clathrin adapter protein 2 (ap-2) (pubmed:11294867, pubmed:15053742, pubmed:17646382). {eco:0000269|pubmed:11082041, eco:0000269|pubmed:11294867, eco:0000269|pubmed:15053742, eco:0000269|pubmed:16393139, eco:0000269|pubmed:16531402, eco:0000269|pubmed:17646382, eco:0000269|pubmed:17855360, eco:0000269|pubmed:21385844, eco:0000269|pubmed:21994944, eco:0000269|pubmed:31138794}.","TISSUE SPECIFICITY: Highly expressed in brain (at protein level) (PubMed:9157966, PubMed:16174740, PubMed:21147781). Most abundant in the cerebellum, cerebral cortex and occipital pole; low levels in the putamen and thalamus (PubMed:9157966, PubMed:16174740). Expression is significantly reduced in the frontal cortex of patients suffering from Alzheimer disease (PubMed:16174740). Also expressed in spinal cord, spleen, testis, prostate, ovary, tyroid and lymph nodes (PubMed:9157966, PubMed:8940146). {ECO:0000269|PubMed:16174740, ECO:0000269|PubMed:21147781, ECO:0000269|PubMed:8940146, ECO:0000269|PubMed:9157966}.","DISEASE: Alzheimer disease (AD) [MIM:104300]: Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:21220680, ECO:0000269|PubMed:22472873, ECO:0000269|PubMed:23565137, ECO:0000269|PubMed:24523320}. Note=The gene represented in this entry may be involved in disease pathogenesis.",NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SORL1,6653,Hs.368592,ENST00000527649,THC2466317,GO:0004872(receptor activity)|GO:0004888(transmembrane receptor activity)|GO:0005887(integral to plasma membrane)|GO:0006810(transport)|GO:0006869(lipid transport)|GO:0006898(receptor-mediated endocytosis)|GO:0008202(steroid metabolic process)|GO:0008203(cholesterol metabolic process)|GO:0016020(membrane)|GO:0030169(low-density lipoprotein particle binding)|GO:0034362(low-density lipoprotein particle),"Homo sapiens sortilin-related receptor, L(DLR class) A repeats containing (SORL1), mRNA [NM_003105]",chr11:121500247-121500306,hs|11q24.1,"sortilin-related receptor, L(DLR class) A repeats containing",TRUE
855_PDCD4_27250,Q53EL6,programmed cell death protein 4 (neoplastic transformation inhibitor protein) (nuclear antigen h731-like) (protein 197/15a),PDCD4 H731,469,"function: inhibits translation initiation and cap-dependent translation. may excert its function by hindering the interaction between eif4a1 and eif4g. inhibits the helicase activity of eif4a. modulates the activation of jun kinase. down-regulates the expression of map4k1, thus inhibiting events important in driving invasion, namely, mapk85 activation and consequent jun-dependent transcription. may play a role in apoptosis. tumor suppressor. inhibits tumor promoter-induced neoplastic transformation. binds rna (by similarity). {eco:0000250, eco:0000269|pubmed:16357133, eco:0000269|pubmed:16449643, eco:0000269|pubmed:17053147, eco:0000269|pubmed:18296639, eco:0000269|pubmed:19153607, eco:0000269|pubmed:19204291}.","subcellular location: nucleus {eco:0000250|uniprotkb:q61823}. cytoplasm {eco:0000250|uniprotkb:q61823}. note=shuttles between the nucleus and cytoplasm (by similarity). predominantly nuclear under normal growth conditions, and when phosphorylated at ser-457 (pubmed:16357133). {eco:0000269|pubmed:16357133}.","TISSUE SPECIFICITY: Up-regulated in proliferative cells. Highly expressed in epithelial cells of the mammary gland. Reduced expression in lung cancer and colon carcinoma. {ECO:0000269|PubMed:10632927, ECO:0000269|PubMed:12898601, ECO:0000269|PubMed:16449643}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PDCD4,27250,Hs.711490,ENST00000498367,THC2469756,"GO:0003723(RNA binding)|GO:0005488(binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006915(apoptosis)|GO:0007569(cell aging)|GO:0043508(negative regulation of JUN kinase activity)|GO:0045786(negative regulation of cell cycle)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens programmed cell death 4 (neoplastic transformation inhibitor) (PDCD4), transcript variant 2, mRNA [NM_145341]",chr10:112658119-112658178,hs|10q25.2,programmed cell death 4 (neoplastic transformation inhibitor),TRUE
856_HES1_3280,Q14469,transcription factor hes-1 (class b basic helix-loop-helix protein 39) (bhlhb39) (hairy and enhancer of split 1) (hairy homolog) (hairy-like protein) (hhl),HES1 BHLHB39 HL HRY,280,"function: transcriptional repressor of genes that require a bhlh protein for their transcription. may act as a negative regulator of myogenesis by inhibiting the functions of myod1 and ash1. binds dna on n-box motifs: 5'-cacnag-3' with high affinity and on e-box motifs: 5'-canntg-3' with low affinity (by similarity). may play a role in a functional fa core complex response to dna cross-link damage, being required for the stability and nuclear localization of fa core complex proteins, as well as for fancd2 monoubiquitination in response to dna damage. {eco:0000250, eco:0000269|pubmed:18550849}.",subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HES1,3280,Hs.250666,ENST00000232424,NP835010,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity)|GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription)|GO:0001701(in utero embryonic development)|GO:0001889(liver development)|GO:0003151(outflow tract morphogenesis)|GO:0003266(regulation of secondary heart field cardioblast proliferation)|GO:0003281(ventricular septum development)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006461(protein complex assembly)|GO:0007155(cell adhesion)|GO:0007219(Notch signaling pathway)|GO:0007224(smoothened signaling pathway)|GO:0007262(STAT protein import into nucleus)|GO:0007389(pattern specification process)|GO:0007399(nervous system development)|GO:0008134(transcription factor binding)|GO:0008284(positive regulation of cell proliferation)|GO:0016477(cell migration)|GO:0021537(telencephalon development)|GO:0021555(midbrain-hindbrain boundary morphogenesis)|GO:0021557(oculomotor nerve development)|GO:0021558(trochlear nerve development)|GO:0021575(hindbrain morphogenesis)|GO:0021861(forebrain radial glial cell differentiation)|GO:0021915(neural tube development)|GO:0021984(adenohypophysis development)|GO:0030324(lung development)|GO:0030513(positive regulation of BMP signaling pathway)|GO:0030901(midbrain development)|GO:0031018(endocrine pancreas development)|GO:0035019(somatic stem cell maintenance)|GO:0042102(positive regulation of T cell proliferation)|GO:0042517(positive regulation of tyrosine phosphorylation of Stat3 protein)|GO:0042668(auditory receptor cell fate determination)|GO:0042803(protein homodimerization activity)|GO:0042826(histone deacetylase binding)|GO:0043388(positive regulation of DNA binding)|GO:0043565(sequence-specific DNA binding)|GO:0045165(cell fate commitment)|GO:0045598(regulation of fat cell differentiation)|GO:0045608(negative regulation of auditory receptor cell differentiation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046331(lateral inhibition)|GO:0046427(positive regulation of JAK-STAT cascade)|GO:0048469(cell maturation)|GO:0048538(thymus development)|GO:0048667(cell morphogenesis involved in neuron differentiation)|GO:0048711(positive regulation of astrocyte differentiation)|GO:0048715(negative regulation of oligodendrocyte differentiation)|GO:0048844(artery morphogenesis)|GO:0050767(regulation of neurogenesis)|GO:0060037(pharyngeal system development)|GO:0060164(regulation of timing of neuron differentiation)|GO:0060253(negative regulation of glial cell proliferation)|GO:0061009(common bile duct development)|GO:0061106(negative regulation of stomach neuroendocrine cell differentiation)|GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis)|GO:0071820(N-box binding)","Homo sapiens hairy and enhancer of split 1, (Drosophila) (HES1), mRNA [NM_005524]",chr3:193856176-193856235,hs|3q29,"hairy and enhancer of split 1, (Drosophila)",TRUE
857_RPL15_6138,P61313,60s ribosomal protein l15 (large ribosomal subunit protein el15),RPL15 EC45 TCBAP0781,204,NA,subcellular location: membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,"DISEASE: Diamond-Blackfan anemia 12 (DBA12) [MIM:615550]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:23812780}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,NA,RPL15,6138,Hs.381219,ENST00000434031,NP1208607,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein L15 (RPL15), mRNA [NM_002948]",chr3:23960025-23960703,hs|3p24.2,ribosomal protein L15,TRUE
858_LUC7L2_51631,Q9Y383,putative rna-binding protein luc7-like 2,LUC7L2 CGI-59 CGI-74,392,function: may bind to rna via its arg/ser-rich domain.,"subcellular location: nucleus speckle {eco:0000250|uniprotkb:q7tnc4}. nucleus, nucleoplasm {eco:0000250|uniprotkb:q7tnc4}. note=colocalizes with scnm1 and snrnp70 in nuclear speckles. {eco:0000250|uniprotkb:q7tnc4}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,LUC7L2,51631,Hs.728191,ENST00000456182,THC2484667,GO:0019899(enzyme binding)|GO:0046872(metal ion binding),"Homo sapiens LUC7-like 2 (S. cerevisiae) (LUC7L2), transcript variant 1, mRNA [NM_016019]",chr7:139107721-139107780,hs|7q34,LUC7-like 2 (S. cerevisiae),TRUE
859_KIAA1522_57648,Q9P206,uncharacterized protein kiaa1522,KIAA1522,1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,KIAA1522,57648,Hs.591502,ENST00000401073,THC2578126,NA,"Homo sapiens KIAA1522 (KIAA1522), transcript variant 1, mRNA [NM_020888]",chr1:33240353-33240412,hs|1p35.1,KIAA1522,TRUE
86_MCL1_4170,Q07820,induced myeloid leukemia cell differentiation protein mcl-1 (bcl-2-like protein 3) (bcl2-l-3) (bcl-2-related protein eat/mcl1) (mcl1/eat),MCL1 BCL2L3,350,"function: involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. mediates its effects by interactions with a number of other regulators of apoptosis. isoform 1 inhibits apoptosis. isoform 2 promotes apoptosis. {eco:0000269|pubmed:10766760, eco:0000269|pubmed:16543145}.","subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}. cytoplasm. mitochondrion. nucleus, nucleoplasm. note=cytoplasmic, associated with mitochondria.",NA,NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MCL1,4170,Hs.632486,ENST00000369026,THC2576407,GO:0001709(cell fate determination)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005741(mitochondrial outer membrane)|GO:0005759(mitochondrial matrix)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0007275(multicellular organismal development)|GO:0015266(protein channel activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0019725(cellular homeostasis)|GO:0030154(cell differentiation)|GO:0034097(response to cytokine stimulus)|GO:0046982(protein heterodimerization activity)|GO:0051434(BH3 domain binding),"Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_021960]",chr1:150547287-150547228,hs|1q21.3,myeloid cell leukemia sequence 1 (BCL2-related),TRUE
861_PNN_5411,Q9H307,pinin (140 kda nuclear and cell adhesion-related phosphoprotein) (desmosome-associated protein) (domain-rich serine protein) (drs protein) (drsp) (melanoma metastasis clone a protein) (nuclear protein sdk3) (sr-like protein),PNN DRS MEMA,717,"function: transcriptional activator binding to the e-box 1 core sequence of the e-cadherin promoter gene; the core-binding sequence is 5'caggtg-3'. capable of reversing ctbp1-mediated transcription repression. auxiliary component of the splicing-dependent multiprotein exon junction complex (ejc) deposited at splice junction on mrnas. the ejc is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during ejc assembly or during subsequent mrna metabolism. participates in the regulation of alternative pre-mrna splicing. associates to spliced mrna within 60 nt upstream of the 5'-splice sites. component of the psap complex which binds rna in a sequence-independent manner and is proposed to be recruited to the ejc prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. involved in the establishment and maintenance of epithelia cell-cell adhesion. potential tumor suppressor for renal cell carcinoma. {eco:0000269|pubmed:12051732, eco:0000269|pubmed:14517304, eco:0000269|pubmed:15542832, eco:0000269|pubmed:15735603, eco:0000269|pubmed:22388736}.","subcellular location: nucleus speckle. cell junction, desmosome. note=cell-cell contact area, predominantly desmosome of intercellular adherens junction. not a nucleocytoplasmic shuttling protein.","TISSUE SPECIFICITY: Expressed in placenta, lung, liver, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon, heart, epidermis, esophagus, brain and smooth and skeletal muscle. Expressed strongly in melanoma metastasis lesions and advanced primary tumors. {ECO:0000269|PubMed:10095061, ECO:0000269|PubMed:8922384, ECO:0000269|PubMed:9447706}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PNN,5411,Hs.409965,ENST00000216832,THC2528460,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0005198(structural molecule activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005882(intermediate filament)|GO:0005886(plasma membrane)|GO:0005911(cell-cell junction)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007155(cell adhesion)|GO:0008380(RNA splicing)|GO:0016607(nuclear speck)|GO:0030057(desmosome)|GO:0071013(catalytic step 2 spliceosome)","Homo sapiens pinin, desmosome associated protein (PNN), mRNA [NM_002687]",chr14:39651047-39651106,hs|14q21.1,"pinin, desmosome associated protein",TRUE
862_UBE2N_7334,P61088,ubiquitin-conjugating enzyme e2 n (ec 2.3.2.23) (bendless-like ubiquitin-conjugating enzyme) (e2 ubiquitin-conjugating enzyme n) (ubc13) (ubch13) (ubiquitin carrier protein n) (ubiquitin-protein ligase n),UBE2N BLU,152,"function: the ube2v1-ube2n and ube2v2-ube2n heterodimers catalyze the synthesis of non-canonical 'lys-63'-linked polyubiquitin chains. this type of polyubiquitination does not lead to protein degradation by the proteasome. mediates transcriptional activation of target genes. plays a role in the control of progress through the cell cycle and differentiation. plays a role in the error-free dna repair pathway and contributes to the survival of cells after dna damage. acts together with the e3 ligases, hltf and shprh, in the 'lys-63'-linked poly-ubiquitination of pcna upon genotoxic stress, which is required for dna repair. appears to act together with e3 ligase rnf5 in the 'lys-63'-linked polyubiquitination of jkamp thereby regulating jkamp function by decreasing its association with components of the proteasome and erad. promotes trim5 capsid-specific restriction activity and the ube2v1-ube2n heterodimer acts in concert with trim5 to generate 'lys-63'-linked polyubiquitin chains which activate the map3k7/tak1 complex which in turn results in the induction and expression of nf-kappa-b and mapk-responsive inflammatory genes. {eco:0000269|pubmed:10089880, eco:0000269|pubmed:14562038, eco:0000269|pubmed:19269966, eco:0000269|pubmed:20061386, eco:0000269|pubmed:21512573}.",subcellular location: nucleus {eco:0000269|pubmed:19340006}. cytoplasm {eco:0000269|pubmed:19340006}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UBE2N,7334,Hs.524630,ENST00000318066,THC2533462,GO:0000151(ubiquitin ligase complex)|GO:0000166(nucleotide binding)|GO:0000724(double-strand break repair via homologous recombination)|GO:0000729(DNA double-strand break processing)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006282(regulation of DNA repair)|GO:0006301(postreplication repair)|GO:0006464(protein modification process)|GO:0006508(proteolysis)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0008063(Toll signaling pathway)|GO:0016567(protein ubiquitination)|GO:0016574(histone ubiquitination)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0031058(positive regulation of histone modification)|GO:0031372(UBC13-MMS2 complex)|GO:0033182(regulation of histone ubiquitination)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0035370(UBC13-UEV1A complex)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0043130(ubiquitin binding)|GO:0045087(innate immune response)|GO:0045739(positive regulation of DNA repair)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051443(positive regulation of ubiquitin-protein ligase activity)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)|GO:0070534(protein K63-linked ubiquitination),"Homo sapiens ubiquitin-conjugating enzyme E2N (UBE2N), mRNA [NM_003348]",chr12:93803287-93803228,hs|12q22,ubiquitin-conjugating enzyme E2N,TRUE
863_C11orf83_790955,Q6UW78,ubiquinol-cytochrome-c reductase complex assembly factor 3 (assembly factor cbp4 homolog),UQCC3 C11orf83 UNQ655/PRO1286,93,"function: required for the assembly of the ubiquinol-cytochrome c reductase complex (mitochondrial respiratory chain complex iii or cytochrome b-c1 complex), mediating cytochrome b recruitment and probably stabilization within the complex. thereby, plays an important role in atp production by mitochondria. cardiolipin-binding protein, it may also control the cardiolipin composition of mitochondria membranes and their morphology. {eco:0000269|pubmed:25008109, eco:0000269|pubmed:25605331}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:25008109, eco:0000269|pubmed:25605331}; single-pass membrane protein {eco:0000269|pubmed:25008109, eco:0000269|pubmed:25605331}.",NA,"DISEASE: Mitochondrial complex III deficiency, nuclear 9 (MC3DN9) [MIM:616111]: A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. MC3DN9 clinical features include feeding difficulties, hypoglycemia, severe lactic acidosis, and delayed psychomotor development. {ECO:0000269|PubMed:25008109}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,C11orf83,790955,Hs.569009,ENST00000531323,THC2471886,GO:0005576(extracellular region),"Homo sapiens chromosome 11 open reading frame 83 (C11orf83), mRNA [NM_001085372]",chr11:62439796-62439855,hs|11q12.3,chromosome 11 open reading frame 83,TRUE
864_ATP5J_522,P18859,"atp synthase-coupling factor 6, mitochondrial (atpase subunit f6) (atp synthase peripheral stalk subunit f6)",ATP5PF ATP5A ATP5J ATPM,108,"function: mitochondrial membrane atp synthase (f(1)f(0) atp synthase or complex v) produces atp from adp in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. f-type atpases consist of two structural domains, f(1) - containing the extramembraneous catalytic core and f(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. during catalysis, atp synthesis in the catalytic domain of f(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. part of the complex f(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/atp6 static relative to the rotary elements. also involved in the restoration of oligomycin-sensitive atpase activity to depleted f1-f0 complexes.",subcellular location: mitochondrion. mitochondrion inner membrane.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP5J,522,Hs.246310,ENST00000400093,THC2590296,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o))|GO:0005215(transporter activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005753(mitochondrial proton-transporting ATP synthase complex)|GO:0006200(ATP catabolic process)|GO:0006810(transport)|GO:0006811(ion transport)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0016020(membrane)|GO:0016887(ATPase activity)|GO:0022857(transmembrane transporter activity)|GO:0022904(respiratory electron transport chain)|GO:0042776(mitochondrial ATP synthesis coupled proton transport)","Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 (ATP5J), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001003703]",chr21:27101958-27097619,hs|21q21.3,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6",TRUE
865_PSME1_5720,Q06323,proteasome activator complex subunit 1 (11s regulator complex subunit alpha) (reg-alpha) (activator of multicatalytic protease subunit 1) (interferon gamma up-regulated i-5111 protein) (igup i-5111) (proteasome activator 28 subunit alpha) (pa28a) (pa28alpha),PSME1 IFI5111,249,function: implicated in immunoproteasome assembly and required for efficient antigen processing. the pa28 activator complex enhances the generation of class i binding peptides by altering the cleavage pattern of the proteasome.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,PSME1,5720,Hs.75348,ENST00000206451,NP1208249,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008537(proteasome activator complex)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 1, mRNA [NM_006263]",chr14:24607738-24607972,hs|14q12,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",TRUE
866_MYL12A_10627,P19105,"myosin regulatory light chain 12a (epididymis secretory protein li 24) (hel-s-24) (mlc-2b) (myosin rlc) (myosin regulatory light chain 2, nonsarcomeric) (myosin regulatory light chain mrlc3)",MYL12A MLCB MRLC3 RLC,171,"function: myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. implicated in cytokinesis, receptor capping, and cell locomotion (by similarity). {eco:0000250}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MYL12A,10627,Hs.190086,ENST00000536605,THC2501977,GO:0001725(stress fiber)|GO:0005509(calcium ion binding)|GO:0008360(regulation of cell shape)|GO:0016460(myosin II complex)|GO:0030018(Z disc)|GO:0035254(glutamate receptor binding)|GO:0043234(protein complex)|GO:0072661(protein targeting to plasma membrane),"Homo sapiens myosin, light chain 12A, regulatory, non-sarcomeric (MYL12A), mRNA [NM_006471]",chr18:3255981-3256040,hs|18p11.31,"myosin, light chain 12A, regulatory, non-sarcomeric",TRUE
867_KHDRBS1_10657,Q07666,"kh domain-containing, rna-binding, signal transduction-associated protein 1 (gap-associated tyrosine phosphoprotein p62) (src-associated in mitosis 68 kda protein) (sam68) (p21 ras gtpase-activating protein-associated p62) (p68)",KHDRBS1 SAM68,443,"function: recruited and tyrosine phosphorylated by several receptor systems, for example the t-cell, leptin and insulin receptors. once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to sh2 and sh3 domain-containing proteins. role in g2-m progression in the cell cycle. represses cbp-dependent transcriptional activation apparently by competing with other nuclear factors for binding to cbp. also acts as a putative regulator of mrna stability and/or translation rates and mediates mrna nuclear export. positively regulates the association of constitutive transport element (cte)-containing mrna with large polyribosomes and translation initiation. according to some authors, is not involved in the nucleocytoplasmic export of unspliced (cte)-containing rna species according to (pubmed:22253824). rna-binding protein that plays a role in the regulation of alternative splicing and influences mrna splice site selection and exon inclusion. binds to rna containing 5'-[au]uaa-3' as a bipartite motif spaced by more than 15 nucleotides. binds poly(a). can regulate cd44 alternative splicing in a ras pathway-dependent manner (by similarity). in cooperation with hnrnpa1 modulates alternative splicing of bcl2l1 by promoting splicing toward isoform bcl-x(s), and of smn1 (pubmed:17371836, pubmed:20186123). can regulate alternative splicing of nrxn1 and nrxn3 in the laminin g-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (as4) involved in neurexin selective targeting to postsynaptic partners. in a neuronal activity-dependent manner cooperates synergistically with khdrbs2/slim-1 in regulation of nrxn1 exon skipping at as4. the cooperation with khdrbs2/slim-1 is antagonistic for regulation of nxrn3 alternative splicing at as4 (by similarity). {eco:0000250|uniprotkb:q60749, eco:0000269|pubmed:15021911, eco:0000269|pubmed:17371836, eco:0000269|pubmed:20186123, eco:0000269|pubmed:20610388, eco:0000269|pubmed:22253824, eco:0000269|pubmed:26758068}.; function: isoform 3, which is expressed in growth-arrested cells only, inhibits s phase. {eco:0000269|pubmed:9013542}.","subcellular location: nucleus {eco:0000269|pubmed:1374686, eco:0000269|pubmed:29496907}. cytoplasm {eco:0000269|pubmed:29496907}. membrane {eco:0000269|pubmed:1374686}. note=predominantly located in the nucleus but also located partially in the cytoplasm. {eco:0000269|pubmed:29496907}.","TISSUE SPECIFICITY: Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver. {ECO:0000269|PubMed:9013542}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KHDRBS1,10657,Hs.445893,ENST00000355201,THC2743997,"GO:0000086(G2/M transition of mitotic cell cycle)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005070(SH3/SH2 adaptor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006397(mRNA processing)|GO:0007049(cell cycle)|GO:0007050(cell cycle arrest)|GO:0007165(signal transduction)|GO:0007166(cell surface receptor linked signaling pathway)|GO:0008283(cell proliferation)|GO:0016020(membrane)|GO:0017124(SH3 domain binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046831(regulation of RNA export from nucleus)","Homo sapiens KH domain containing, RNA binding, signal transduction associated 1 (KHDRBS1), mRNA [NM_006559]",chr1:32509136-32509195,hs|1p35.1,"KH domain containing, RNA binding, signal transduction associated 1",TRUE
868_MPZL1_9019,O95297,myelin protein zero-like protein 1 (protein zero-related),MPZL1 PZR UNQ849/PRO1787,269,"function: cell surface receptor, which is involved in signal transduction processes. recruits ptpn11/shp-2 to the cell membrane and is a putative substrate of ptpn11/shp-2. is a major receptor for concanavalin-a (cona) and is involved in cellular signaling induced by cona, which probably includes src family tyrosine-protein kinases. isoform 3 seems to have a dominant negative role; it blocks tyrosine phosphorylation of mpzl1 induced by cona. isoform 1, but not isoform 2 and isoform 3, may be involved in regulation of integrin-mediated cell motility. {eco:0000269|pubmed:11751924, eco:0000269|pubmed:12410637}.",subcellular location: membrane {eco:0000305}; single-pass type i membrane protein {eco:0000305}.,"TISSUE SPECIFICITY: Widely expressed with highest levels in heart, placenta, kidney and pancreas. Isoform 3 is relatively abundant in hematopoietic tissues and fetal liver. Isoform 1 and isoform 3 are expressed in CD14- PB monocytes and pre-B cell progenitors. Isoform 3 appears to be the major isoform in CD34- promyelocytic and promonocytic cells. During differentiation in monocytic cells, the expression level of isoform 3 decreases and that of isoform 1 increases. Isoform 1 is prominent in stromal cells and, to a lesser extent, in umbilical vein endothelial cells and erythroid progenitors. Isoform 2 is expressed in a erythroid progenitor cell line. {ECO:0000269|PubMed:12410637, ECO:0000269|PubMed:12684038, ECO:0000269|PubMed:9792637}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,MPZL1,9019,Hs.493919,ENST00000359523,THC2462150,GO:0005198(structural molecule activity)|GO:0005515(protein binding)|GO:0005887(integral to plasma membrane)|GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway)|GO:0007267(cell-cell signaling)|GO:0016020(membrane),"Homo sapiens myelin protein zero-like 1 (MPZL1), transcript variant 1, mRNA [NM_003953]",chr1:167759883-167759942,hs|1q24.2,myelin protein zero-like 1,TRUE
869_COX7B_1349,P24311,"cytochrome c oxidase subunit 7b, mitochondrial (cytochrome c oxidase polypeptide viib)",COX7B,80,"function: this protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport. plays a role in proper central nervous system (cns) development in vertebrates. {eco:0000269|pubmed:23122588}.",subcellular location: mitochondrion inner membrane {eco:0000250}.,NA,"DISEASE: Linear skin defects with multiple congenital anomalies 2 (LSDMCA2) [MIM:300887]: A distinct form of aplasia cutis congenita presenting as multiple linear skin defects on the face and neck associated with poor growth, microcephaly, and facial dysmorphism. Additional features include intellectual disability, nail dystrophy, short stature and cardiac abnormalities. {ECO:0000269|PubMed:23122588}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX7B,1349,Hs.522699,ENST00000373335,THC2693234,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005746(mitochondrial respiratory chain)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIIb (COX7B), nuclear gene encoding mitochondrial protein, mRNA [NM_001866]",chrX:77158204-77158263,hs|Xq21.1,cytochrome c oxidase subunit VIIb,TRUE
87_NBEAL1_65065,Q6ZS30,neurobeachin-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein),NBEAL1 ALS2CR16 ALS2CR17,2694,NA,NA,"TISSUE SPECIFICITY: Highly expressed in brain, kidney, prostate and testis. Weakly expressed in ovary, small intestine, colon and peripheral blood leukocytes. May be correlative to several tumors, such as ovary serous adenocarcinoma and metastasis mammary gland carcinoma breast. {ECO:0000269|PubMed:15193433}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,NBEAL1,65065,Hs.408054,ENST00000460355,THC2507576,GO:0005488(binding),neurobeachin-like 1 [Source:HGNC Symbol;Acc:20681] [ENST00000460355],chr2:204055864-204055923,hs|2q33.2,neurobeachin-like 1,TRUE
870_CBX3_11335,Q13185,chromobox protein homolog 3 (hech) (heterochromatin protein 1 homolog gamma) (hp1 gamma) (modifier 2 protein),CBX3,183,"function: seems to be involved in transcriptional silencing in heterochromatin-like complexes. recognizes and binds histone h3 tails methylated at 'lys-9', leading to epigenetic repression. may contribute to the association of the heterochromatin with the inner nuclear membrane through its interaction with lamin b receptor (lbr). involved in the formation of functional kinetochore through interaction with mis12 complex proteins. contributes to the conversion of local chromatin to a heterochromatin-like repressive state through h3 'lys-9' trimethylation, mediates the recruitment of the methyltransferases suv39h1 and/or suv39h2 by the per complex to the e-box elements of the circadian target genes such as per2 itself or per1. mediates the recruitment of nipbl to sites of dna damage at double-strand breaks (dsbs) (pubmed:28167679). {eco:0000250|uniprotkb:p23198, eco:0000269|pubmed:28167679}.",subcellular location: nucleus {eco:0000305}. note=associates with euchromatin and is largely excluded from constitutive heterochromatin. may be associated with microtubules and mitotic poles during mitosis (potential). {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CBX3,11335,Hs.381189,ENST00000481057,THC2527628,"GO:0000779(condensed chromosome, centromeric region)|GO:0000785(chromatin)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005637(nuclear inner membrane)|GO:0005719(nuclear euchromatin)|GO:0005720(nuclear heterochromatin)|GO:0005819(spindle)|GO:0006338(chromatin remodeling)|GO:0019899(enzyme binding)|GO:0019904(protein domain specific binding)|GO:0031618(nuclear centromeric heterochromatin)|GO:0042802(identical protein binding)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens chromobox homolog 3 (CBX3), transcript variant 2, mRNA [NM_016587]",chr7:26251960-26252019,hs|7p15.2,chromobox homolog 3,TRUE
871_SEC13_6396,P55735,protein sec13 homolog (gator complex protein sec13) (sec13-like protein 1) (sec13-related protein),SEC13 D3S1231E SEC13A SEC13L1 SEC13R,322,"function: functions as a component of the nuclear pore complex (npc) and the copii coat. at the endoplasmic reticulum, sec13 is involved in the biogenesis of copii-coated vesicles (pubmed:8972206). required for the exit of adipsin (cfd/adn), an adipocyte-secreted protein from the endoplasmic reticulum (by similarity). {eco:0000250|uniprotkb:q9d1m0, eco:0000269|pubmed:8972206}.; function: as a component of the gator subcomplex gator2, functions within the amino acid-sensing branch of the torc1 signaling pathway. indirectly activates mtorc1 and the torc1 signaling pathway through the inhibition of the gator1 subcomplex (pubmed:23723238). it is negatively regulated by the upstream amino acid sensors sesn2 and castor1 (pubmed:25457612, pubmed:27487210). {eco:0000269|pubmed:23723238, eco:0000269|pubmed:25457612, eco:0000269|pubmed:27487210}.","subcellular location: cytoplasmic vesicle, copii-coated vesicle membrane {eco:0000269|pubmed:8972206}; peripheral membrane protein {eco:0000269|pubmed:8972206}; cytoplasmic side {eco:0000269|pubmed:8972206}. endoplasmic reticulum membrane {eco:0000269|pubmed:8972206}; peripheral membrane protein {eco:0000269|pubmed:8972206}; cytoplasmic side {eco:0000269|pubmed:8972206}. nucleus, nuclear pore complex {eco:0000269|pubmed:14517296, eco:0000269|pubmed:18160040}. lysosome membrane {eco:0000269|pubmed:28199306}. note=in interphase, localizes at both sides of the npc. {eco:0000269|pubmed:14517296}.",NA,NA,NA,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SEC13,6396,Hs.166924,ENST00000479868,THC2509556,GO:0000087(M phase of mitotic cell cycle)|GO:0000236(mitotic prometaphase)|GO:0000278(mitotic cell cycle)|GO:0000776(kinetochore)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0006888(ER to Golgi vesicle-mediated transport)|GO:0012507(ER to Golgi transport vesicle membrane)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0018279(protein N-linked glycosylation via asparagine)|GO:0031080(Nup107-160 complex)|GO:0031410(cytoplasmic vesicle)|GO:0043687(post-translational protein modification)|GO:0044267(cellular protein metabolic process)|GO:0048208(COPII vesicle coating)|GO:0051028(mRNA transport),"Homo sapiens SEC13 homolog (S. cerevisiae) (SEC13), transcript variant 1, mRNA [NM_183352]",chr3:10342717-10342658,hs|3p25.3,SEC13 homolog (S. cerevisiae),TRUE
872_RASD1_51655,Q9Y272,dexamethasone-induced ras-related protein 1 (activator of g-protein signaling 1),RASD1 AGS1 DEXRAS1,281,function: small gtpase. negatively regulates the transcription regulation activity of the apbb1/fe65-app complex via its interaction with apbb1/fe65 (by similarity). {eco:0000250}.,"subcellular location: cell membrane {eco:0000305}; lipid-anchor {eco:0000305}; cytoplasmic side {eco:0000305}. cytoplasm, perinuclear region {eco:0000250}. nucleus {eco:0000250}.","TISSUE SPECIFICITY: Expressed in a variety of tissues including heart, cardiovascular tissues, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, gastrointestinal and reproductive tissues. {ECO:0000269|PubMed:10673050, ECO:0000269|PubMed:12818426}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RASD1,51655,Hs.25829,ENST00000225688,THC2466358,"GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005625(soluble fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006184(GTP catabolic process)|GO:0007165(signal transduction)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007263(nitric oxide mediated signal transduction)|GO:0007264(small GTPase mediated signal transduction)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048471(perinuclear region of cytoplasm)","Homo sapiens RAS, dexamethasone-induced 1 (RASD1), transcript variant 1, mRNA [NM_016084]",chr17:17397846-17397787,hs|17p11.2,"RAS, dexamethasone-induced 1",TRUE
873_SHROOM3_57619,Q8TF72,protein shroom3 (shroom-related protein) (hshrml),SHROOM3 KIAA1481 SHRML MSTP013,1996,"function: controls cell shape changes in the neuroepithelium during neural tube closure. induces apical constriction in epithelial cells by promoting the apical accumulation of f-actin and myosin ii, and probably by bundling stress fibers (by similarity). induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (by similarity). {eco:0000250|uniprotkb:q27iv2, eco:0000250|uniprotkb:q9qxn0}.","subcellular location: cell junction, adherens junction {eco:0000250|uniprotkb:q9qxn0}. cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q9qxn0}. apical cell membrane {eco:0000250|uniprotkb:q9qxn0}; peripheral membrane protein {eco:0000250|uniprotkb:q9qxn0}. note=colocalizes with f-actin in stress fibers and adherens junctions. {eco:0000250|uniprotkb:q9qxn0}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,SHROOM3,57619,Hs.702168,ENST00000264907,THC2463526,GO:0000902(cell morphogenesis)|GO:0001843(neural tube closure)|GO:0002066(columnar/cuboidal epithelial cell development)|GO:0003779(actin binding)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005874(microtubule)|GO:0005912(adherens junction)|GO:0007389(pattern specification process)|GO:0008360(regulation of cell shape)|GO:0016324(apical plasma membrane)|GO:0030054(cell junction)|GO:0043296(apical junction complex)|GO:0043482(cellular pigment accumulation)|GO:0045176(apical protein localization),"Homo sapiens shroom family member 3 (SHROOM3), mRNA [NM_020859]",chr4:77700819-77700878,hs|4q21.1,shroom family member 3,TRUE
874_C15orf24_56851,Q9NPA0,er membrane protein complex subunit 7,EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926,242,NA,subcellular location: membrane {eco:0000269|pubmed:22119785}; single-pass type i membrane protein {eco:0000269|pubmed:22119785}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,C15orf24,56851,Hs.160565,ENST00000256545,THC2789035,GO:0004180(carboxypeptidase activity)|GO:0005737(cytoplasm)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0017076(purine nucleotide binding)|GO:0030246(carbohydrate binding),"Homo sapiens chromosome 15 open reading frame 24 (C15orf24), mRNA [NM_020154]",chr15:34376399-34376340,hs|15q14,chromosome 15 open reading frame 24,TRUE
875_FNTA_2339,P49354,protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (ec 2.5.1.58) (ec 2.5.1.59) (caax farnesyltransferase subunit alpha) (ftase-alpha) (ras proteins prenyltransferase subunit alpha) (type i protein geranyl-geranyltransferase subunit alpha) (ggtase-i-alpha),FNTA,379,"function: essential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl diphosphate to a cysteine at the fourth position from the c-terminus of several proteins having the c-terminal sequence cys-aliphatic-aliphatic-x. may positively regulate neuromuscular junction development downstream of musk via its function in rac1 prenylation and activation. {eco:0000269|pubmed:12036349, eco:0000269|pubmed:12825937, eco:0000269|pubmed:16893176, eco:0000269|pubmed:19246009, eco:0000269|pubmed:8419339, eco:0000269|pubmed:8494894}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FNTA,2339,Hs.370312,ENST00000525099,THC2491754,GO:0004660(protein farnesyltransferase activity)|GO:0004661(protein geranylgeranyltransferase activity)|GO:0004662(CAAX-protein geranylgeranyltransferase activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005875(microtubule associated complex)|GO:0006915(apoptosis)|GO:0006921(cellular component disassembly involved in apoptosis)|GO:0007179(transforming growth factor beta receptor signaling pathway)|GO:0008017(microtubule binding)|GO:0016740(transferase activity)|GO:0018343(protein farnesylation)|GO:0018344(protein geranylgeranylation)|GO:0043014(alpha-tubulin binding)|GO:0090044(positive regulation of tubulin deacetylation)|GO:0090045(positive regulation of deacetylase activity),"Homo sapiens farnesyltransferase, CAAX box, alpha (FNTA), transcript variant 1, mRNA [NM_002027]",chr8:42940715-42940774,hs|8p11.21,"farnesyltransferase, CAAX box, alpha",TRUE
876_SON_6651,P18583,protein son (bax antagonist selected in saccharomyces 1) (bass1) (negative regulatory element-binding protein) (nre-binding protein) (protein dbp-5) (son3),SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312,2426,"function: rna-binding protein that acts as a mrna splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. specifically promotes splicing of many cell-cycle and dna-repair transcripts that possess weak splice sites, such as tubg1, katnb1, tubgcp2, aurkb, pcnt, akt1, rad23a, and fancg. probably acts by facilitating the interaction between serine/arginine-rich proteins such as srsf2 and the rna polymerase ii. also binds to dna; binds to the consensus dna sequence: 5'-ga[gt]an[cg][ag]cc-3'. may indirectly repress hepatitis b virus (hbv) core promoter activity and transcription of hbv genes and production of hbv virions. essential for correct rna splicing of multiple genes critical for brain development, neuronal migration and metabolism, including tubg1, flna, pnkp, wdr62, psmd3, pck2, pfkl, idh2, and acy1 (pubmed:27545680). {eco:0000269|pubmed:20581448, eco:0000269|pubmed:21504830, eco:0000269|pubmed:27545680}.","subcellular location: nucleus speckle {eco:0000269|pubmed:1424986, eco:0000269|pubmed:21504830}. note=colocalizes with the pre-mrna splicing factor srsf2.","TISSUE SPECIFICITY: Widely expressed, with the higher expression seen in leukocyte and heart.","DISEASE: ZTTK syndrome (ZTTKS) [MIM:617140]: An autosomal dominant syndrome characterized by intellectual disability, developmental delay, malformations of the cerebral cortex, epilepsy, vision problems, musculo-skeletal abnormalities, and congenital malformations. {ECO:0000269|PubMed:25590979, ECO:0000269|PubMed:27256762, ECO:0000269|PubMed:27545676, ECO:0000269|PubMed:27545680}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SON,6651,Hs.517262,ENST00000356577,THC2481508,GO:0000073(spindle pole body separation)|GO:0000226(microtubule cytoskeleton organization)|GO:0000910(cytokinesis)|GO:0003676(nucleic acid binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0003725(double-stranded RNA binding)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006397(mRNA processing)|GO:0006916(anti-apoptosis)|GO:0016607(nuclear speck)|GO:0043484(regulation of RNA splicing)|GO:0050733(RS domain binding)|GO:0051726(regulation of cell cycle),"Homo sapiens SON DNA binding protein (SON), transcript variant f, mRNA [NM_138927]",chr21:34949511-34949570,hs|21q22.11,SON DNA binding protein,TRUE
877_KCTD3_51133,Q9Y597,btb/poz domain-containing protein kctd3 (renal carcinoma antigen ny-ren-45),KCTD3,815,function: accessory subunit of potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 (hcn3) upregulating its cell-surface expression and current density without affecting its voltage dependence and kinetics. {eco:0000250|uniprotkb:q8bfx3}.,subcellular location: cell membrane {eco:0000250|uniprotkb:q8bfx3}.,TISSUE SPECIFICITY: Broadly expressed in normal tissues. {ECO:0000269|PubMed:10508479}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,KCTD3,51133,Hs.335139,ENST00000259154,THC2466101,GO:0005249(voltage-gated potassium channel activity)|GO:0006813(potassium ion transport)|GO:0008076(voltage-gated potassium channel complex)|GO:0016020(membrane),"Homo sapiens potassium channel tetramerisation domain containing 3 (KCTD3), mRNA [NM_016121]",chr1:215794818-215794877,hs|1q41,potassium channel tetramerisation domain containing 3,TRUE
878_FTL_2512,P02792,ferritin light chain (ferritin l subunit),FTL,175,"function: stores iron in a soluble, non-toxic, readily available form. important for iron homeostasis. iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. also plays a role in delivery of iron to cells. mediates iron uptake in capsule cells of the developing kidney (by similarity). {eco:0000250, eco:0000269|pubmed:19923220, eco:0000269|pubmed:20159981}.",NA,NA,"DISEASE: Hyperferritinemia with or without cataract (HRFTC) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. Cataracts may be subclinical in some patients. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. {ECO:0000269|PubMed:23940258}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FTL,2512,Hs.433670,ENST00000397259,THC2501159,GO:0005488(binding)|GO:0005506(iron ion binding)|GO:0005829(cytosol)|GO:0006826(iron ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0006892(post-Golgi vesicle-mediated transport)|GO:0008043(intracellular ferritin complex)|GO:0008199(ferric iron binding)|GO:0008219(cell death)|GO:0016044(cellular membrane organization)|GO:0016491(oxidoreductase activity)|GO:0042802(identical protein binding)|GO:0055072(iron ion homeostasis),"Homo sapiens ferritin, light polypeptide (FTL), mRNA [NM_000146]",chr19:49469856-49469915,hs|19q13.33,"ferritin, light polypeptide",TRUE
879_CREB3L4_148327,Q8TEY5,cyclic amp-responsive element-binding protein 3-like protein 4 (camp-responsive element-binding protein 3-like protein 4) (androgen-induced basic leucine zipper protein) (aibzip) (attaching to cre-like 1) (atce1) (cyclic amp-responsive element-binding protein 4) (creb-4) (camp-responsive element-binding protein 4) (transcript induced in spermiogenesis protein 40) (tisp40) (hjal) [cleaved into: processed cyclic amp-responsive element-binding protein 3-like protein 4],CREB3L4 AIBZIP CREB4 JAL,395,"function: transcriptional activator that may play a role in the unfolded protein response. binds to the upr element (upre) but not to cre element. preferentially binds dna with to the consensus sequence 5'-t[gt]acgt[ga][gt]-3' and has transcriptional activation activity from upre. binds to nf-kappa-b site and has transcriptional activation activity from nf-kappa-b-containing regulatory elements (by similarity). {eco:0000250, eco:0000269|pubmed:16236796}.",subcellular location: endoplasmic reticulum membrane; single-pass type ii membrane protein. golgi apparatus membrane {eco:0000305}; single-pass type ii membrane protein {eco:0000305}. note=may also be located in golgi apparatus.; subcellular location: processed cyclic amp-responsive element-binding protein 3-like protein 4: nucleus. note=under er stress the cleaved n-terminal cytoplasmic domain translocates into the nucleus. {eco:0000250}.,"TISSUE SPECIFICITY: According to PubMed:11830526, exclusively expressed in the prostate. Expressed in breast and prostate cancer cell lines. Expressed in prostatic luminal epithelial cells (at protein level). Expression is significantly more abundant in prostate cancer than in benign prostatic tissue (prostatic hyperplasia). According to PubMed:12111373, also expressed in brain, pancreas and skeletal muscle, and at lower levels in small intestine, testis, leukocyte and thymus. {ECO:0000269|PubMed:11830526, ECO:0000269|PubMed:12111373, ECO:0000269|PubMed:17270658}.",NA,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CREB3L4,148327,Hs.372924,ENST00000368603,THC2602090,GO:0000139(Golgi membrane)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0006986(response to unfolded protein)|GO:0007283(spermatogenesis)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0043565(sequence-specific DNA binding)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046983(protein dimerization activity),"Homo sapiens cAMP responsive element binding protein 3-like 4 (CREB3L4), mRNA [NM_130898]",chr1:153946666-153946725,hs|1q21.3,cAMP responsive element binding protein 3-like 4,TRUE
88_RPL22_6146,P35268,60s ribosomal protein l22 (eber-associated protein) (eap) (epstein-barr virus small rna-associated protein) (heparin-binding protein hbp15) (large ribosomal subunit protein el22),RPL22,128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPL22,6146,Hs.515329,ENST00000234875,THC2576041,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0008201(heparin binding)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022625(cytosolic large ribosomal subunit)|GO:0030529(ribonucleoprotein complex)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0046632(alpha-beta T cell differentiation),"Homo sapiens ribosomal protein L22 (RPL22), mRNA [NM_000983]",chr1:6246415-6246356,hs|1p36.31,ribosomal protein L22,TRUE
880_TMEM205_374882,Q6UW68,transmembrane protein 205,TMEM205 UNQ501/PRO1018,189,"function: in cancer cells, plays a role in resistance to the chemotherapeutic agent cisplatin. {eco:0000269|pubmed:20589834}.","subcellular location: membrane {eco:0000269|pubmed:20589834}; multi-pass membrane protein {eco:0000269|pubmed:20589834}. note=located on cell surface microvilli. in cancer cells, transition in subcellular location from cell surface to intracellular regions correlates the progression of cisplatin resistance.","TISSUE SPECIFICITY: Widely expressed with highest levels in pancreas, followed by adrenal gland, thyroid, liver, mammary gland, prostate, kidney, and retina; lowest levels in skeletal muscle. Overexpressed in cisplatin-resistant cancer cells (at protein level). {ECO:0000269|PubMed:20589834}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TMEM205,374882,Hs.8036,ENST00000354882,THC2495758,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens transmembrane protein 205 (TMEM205), transcript variant 1, mRNA [NM_198536]",chr19:11453529-11453470,hs|19p13.2,transmembrane protein 205,TRUE
881_PYCR1_5831,P32322,"pyrroline-5-carboxylate reductase 1, mitochondrial (p5c reductase 1) (p5cr 1) (ec 1.5.1.2)",PYCR1,319,"function: housekeeping enzyme that catalyzes the last step in proline biosynthesis. can utilize both nad and nadp, but has higher affinity for nad. involved in the cellular response to oxidative stress. {eco:0000269|pubmed:16730026, eco:0000269|pubmed:19648921}.",subcellular location: mitochondrion {eco:0000269|pubmed:19648921}.,NA,"DISEASE: Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]: A disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, a general connective tissue weakness, and varying degrees of growth and developmental delay and neurological abnormalities. Patients do not manifest metabolic abnormalities. {ECO:0000269|PubMed:19576563, ECO:0000269|PubMed:19648921}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cutis laxa, autosomal recessive, 3B (ARCL3B) [MIM:614438]: A disorder characterized by an aged appearance with distinctive facial features, sparse hair, ophthalmologic abnormalities, intrauterine growth retardation, and cutis laxa. {ECO:0000269|PubMed:19648921, ECO:0000269|PubMed:22052856}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PYCR1,5831,Hs.163451,ENST00000329875,THC2499322,"GO:0000166(nucleotide binding)|GO:0004735(pyrroline-5-carboxylate reductase activity)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006561(proline biosynthetic process)|GO:0006950(response to stress)|GO:0008652(cellular amino acid biosynthetic process)|GO:0016491(oxidoreductase activity)|GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)|GO:0034599(cellular response to oxidative stress)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042802(identical protein binding)","Homo sapiens pyrroline-5-carboxylate reductase 1 (PYCR1), transcript variant 1, mRNA [NM_006907]",chr17:79890390-79890331,hs|17q25.3,pyrroline-5-carboxylate reductase 1,TRUE
882_ARL8B_55207,Q9NVJ2,adp-ribosylation factor-like protein 8b (adp-ribosylation factor-like protein 10c) (novel small g protein indispensable for equal chromosome segregation 1),ARL8B ARL10C GIE1,186,"function: plays a role in lysosome motility (pubmed:16537643, pubmed:25898167). in neurons, mediates the anterograde axonal long-range transport of presynaptic lysosome-related vesicles required for presynaptic biogenesis and synaptic function (by similarity). may play a role in chromosome segregation (pubmed:15331635). {eco:0000250|uniprotkb:q9cqw2, eco:0000269|pubmed:15331635, eco:0000269|pubmed:16537643, eco:0000269|pubmed:25898167}.","subcellular location: late endosome membrane {eco:0000269|pubmed:16537643}. lysosome membrane {eco:0000269|pubmed:25898167}. cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:15331635}. cell projection, axon {eco:0000250|uniprotkb:q9cqw2}. cell junction, synapse {eco:0000250|uniprotkb:q9cqw2}. note=localizes with microtubules at the spindle mid-zone during mitosis. {eco:0000269|pubmed:15331635}.",TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:15331635}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ARL8B,55207,Hs.250009,ENST00000438743,THC2470288,GO:0000166(nucleotide binding)|GO:0003924(GTPase activity)|GO:0005525(GTP binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005765(lysosomal membrane)|GO:0005768(endosome)|GO:0005856(cytoskeleton)|GO:0006184(GTP catabolic process)|GO:0007049(cell cycle)|GO:0007059(chromosome segregation)|GO:0007264(small GTPase mediated signal transduction)|GO:0016020(membrane)|GO:0019003(GDP binding)|GO:0030496(midbody)|GO:0031902(late endosome membrane)|GO:0043014(alpha-tubulin binding)|GO:0048487(beta-tubulin binding)|GO:0051233(spindle midzone)|GO:0051301(cell division),"Homo sapiens ADP-ribosylation factor-like 8B (ARL8B), mRNA [NM_018184]",chr3:5222360-5222419,hs|3p26.1,ADP-ribosylation factor-like 8B,TRUE
883_UBE2C_11065,O00762,ubiquitin-conjugating enzyme e2 c (ec 2.3.2.23) ((e3-independent) e2 ubiquitin-conjugating enzyme c) (ec 2.3.2.24) (e2 ubiquitin-conjugating enzyme c) (ubch10) (ubiquitin carrier protein c) (ubiquitin-protein ligase c),UBE2C UBCH10,179,"function: accepts ubiquitin from the e1 complex and catalyzes its covalent attachment to other proteins. in vitro catalyzes 'lys-11'- and 'lys-48'-linked polyubiquitination. acts as an essential factor of the anaphase promoting complex/cyclosome (apc/c), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. acts by initiating 'lys-11'-linked polyubiquitin chains on apc/c substrates, leading to the degradation of apc/c substrates by the proteasome and promoting mitotic exit. {eco:0000269|pubmed:15558010, eco:0000269|pubmed:18485873, eco:0000269|pubmed:19820702, eco:0000269|pubmed:19822757, eco:0000269|pubmed:20061386, eco:0000269|pubmed:27259151}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,UBE2C,11065,Hs.93002,ENST00000405520,THC2609525,GO:0000075(cell cycle checkpoint)|GO:0000166(nucleotide binding)|GO:0000278(mitotic cell cycle)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005654(nucleoplasm)|GO:0005680(anaphase-promoting complex)|GO:0005829(cytosol)|GO:0006511(ubiquitin-dependent protein catabolic process)|GO:0007049(cell cycle)|GO:0007051(spindle organization)|GO:0007067(mitosis)|GO:0007094(mitotic cell cycle spindle assembly checkpoint)|GO:0008054(cyclin catabolic process)|GO:0010458(exit from mitosis)|GO:0010994(free ubiquitin chain polymerization)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0016881(acid-amino acid ligase activity)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0031536(positive regulation of exit from mitosis)|GO:0048015(phosphatidylinositol-mediated signaling)|GO:0051301(cell division)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051488(activation of anaphase-promoting complex activity)|GO:0070936(protein K48-linked ubiquitination)|GO:0070979(protein K11-linked ubiquitination),"Homo sapiens ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 6, mRNA [NM_181803]",chr20:44445525-44445584,hs|20q13.12,ubiquitin-conjugating enzyme E2C,TRUE
884_SAP18_10284,O00422,histone deacetylase complex subunit sap18 (18 kda sin3-associated polypeptide) (2hor0202) (cell growth-inhibiting gene 38 protein) (sin3-associated polypeptide p18),SAP18 GIG38,153,"function: component of the sin3-repressing complex. enhances the ability of sin3-hdac1-mediated transcriptional repression. when tethered to the promoter, it can direct the formation of a repressive complex to core histone proteins. auxiliary component of the splicing-dependent multiprotein exon junction complex (ejc) deposited at splice junction on mrnas. the ejc is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during ejc assembly or during subsequent mrna metabolism. component of the asap and psap complexes which bind rna in a sequence-independent manner and are proposed to be recruited to the ejc prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. the asap complex can inhibit mrna processing during in vitro splicing reactions. the asap complex promotes apoptosis and is disassembled after induction of apoptosis. involved in the splicing modulation of bcl2l1/bcl-x (and probably other apoptotic genes); specifically inhibits the formation of proapoptotic isoforms such as bcl-x(s); the activity is different from the established ejc assembly and function. {eco:0000269|pubmed:12665594, eco:0000269|pubmed:20966198, eco:0000269|pubmed:22203037, eco:0000269|pubmed:9150135}.","subcellular location: nucleus {eco:0000269|pubmed:16314458}. cytoplasm {eco:0000269|pubmed:16314458}. nucleus speckle {eco:0000269|pubmed:20966198}. note=shuttles between the nucleus and the cytoplasm (pubmed:16314458). colocalizes with acin1 and srsf2 in nuclear speckles (pubmed:20966198). {eco:0000269|pubmed:16314458, eco:0000269|pubmed:20966198}.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SAP18,10284,Hs.524899,ENST00000471009,THC2583273,GO:0000118(histone deacetylase complex)|GO:0003714(transcription corepressor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006357(regulation of transcription from RNA polymerase II promoter),"Homo sapiens Sin3A-associated protein, 18kDa (SAP18), mRNA [NM_005870]",chr13:21721365-21721424,hs|13q12.11,"Sin3A-associated protein, 18kDa",TRUE
885_TBCD_6904,Q9BTW9,tubulin-specific chaperone d (beta-tubulin cofactor d) (tfcd) (ssd-1) (tubulin-folding cofactor d),TBCD KIAA0988 SSD1 TFCD PP1096,1192,"function: tubulin-folding protein implicated in the first step of the tubulin folding pathway and required for tubulin complex assembly. involved in the regulation of microtubule polymerization or depolymerization, it modulates microtubule dynamics by capturing gtp-bound beta-tubulin (tubb). its ability to interact with beta tubulin is regulated via its interaction with arl2. acts as a gtpase-activating protein (gap) for arl2. induces microtubule disruption in absence of arl2. increases degradation of beta tubulin, when overexpressed in polarized cells. promotes epithelial cell detachment, a process antagonized by arl2. induces tight adherens and tight junctions disassembly at the lateral cell membrane (pubmed:10722852, pubmed:10831612, pubmed:11847227, pubmed:20740604, pubmed:27666370, pubmed:28158450). required for correct assembly and maintenance of the mitotic spindle, and proper progression of mitosis (pubmed:27666370). involved in neuron morphogenesis (pubmed:27666374). {eco:0000269|pubmed:10722852, eco:0000269|pubmed:10831612, eco:0000269|pubmed:11847227, eco:0000269|pubmed:20740604, eco:0000269|pubmed:27666370, eco:0000269|pubmed:27666374, eco:0000269|pubmed:28158450}.","subcellular location: cell junction, tight junction {eco:0000250|uniprotkb:q28205}. lateral cell membrane {eco:0000250|uniprotkb:q28205}. cytoplasm {eco:0000250|uniprotkb:q28205}. cell junction, adherens junction {eco:0000250|uniprotkb:q28205}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:27666370}. note=localized in cell-cell contacts. {eco:0000250|uniprotkb:q28205}.","TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10231032, ECO:0000269|PubMed:11110777}.","DISEASE: Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]: An autosomal recessive disease with neurodevelopmental and neurodegenerative features. PEBAT is characterized by early-onset cortical atrophy, hypomyelination, microcephaly, thin corpus callosum, delayed psychomotor development, developmental regression, intellectual disability, seizures, optic atrophy, muscle weakness and atrophy, spastic quadriplegia, and respiratory insufficiency due to hypotonia. {ECO:0000269|PubMed:27666370, ECO:0000269|PubMed:27666374, ECO:0000269|PubMed:27807845, ECO:0000269|PubMed:28158450}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TBCD,6904,Hs.464391,ENST00000536182,NP337279,GO:0005096(GTPase activator activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005874(microtubule)|GO:0005886(plasma membrane)|GO:0005912(adherens junction)|GO:0005923(tight junction)|GO:0006457(protein folding)|GO:0007023(post-chaperonin tubulin folding pathway)|GO:0010812(negative regulation of cell-substrate adhesion)|GO:0016328(lateral plasma membrane)|GO:0030054(cell junction)|GO:0031115(negative regulation of microtubule polymerization)|GO:0034333(adherens junction assembly)|GO:0043547(positive regulation of GTPase activity)|GO:0044267(cellular protein metabolic process)|GO:0048487(beta-tubulin binding)|GO:0051084(de novo' posttranslational protein folding)|GO:0051087(chaperone binding)|GO:0070830(tight junction assembly),"Homo sapiens tubulin folding cofactor D (TBCD), mRNA [NM_005993]",chr17:80900511-80900570,hs|17q25.3,tubulin folding cofactor D,TRUE
886_SUN1_23353,O94901,sun domain-containing protein 1 (protein unc-84 homolog a) (sad1/unc-84 protein-like 1),SUN1 KIAA0810 UNC84A,812,"function: as a component of the linc (linker of nucleoskeleton and cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton (pubmed:18039933, pubmed:18396275). the nucleocytoplasmic interactions established by the linc complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning (by similarity). required for interkinetic nuclear migration (inm) and essential for nucleokinesis and centrosome-nucleus coupling during radial neuronal migration in the cerebral cortex and during glial migration (by similarity). involved in telomere attachment to nuclear envelope in the prophase of meiosis implicating a sun1/2:kash5 linc complex in which sun1 and sun2 seem to act at least partial redundantly (by similarity). required for gametogenesis and involved in selective gene expression of coding and non-coding rnas needed for gametogenesis (by similarity). helps to define the distribution of nuclear pore complexes (npcs) (by similarity). required for efficient localization of syne4 in the nuclear envelope (by similarity). may be involved in nuclear remodeling during sperm head formation in spermatogenenis (by similarity). may play a role in dna repair by suppressing non-homologous end joining repair to facilitate the repair of dna cross-links (pubmed:24375709). {eco:0000250|uniprotkb:q9d666, eco:0000269|pubmed:18039933, eco:0000269|pubmed:18396275, eco:0000269|pubmed:24375709}.","subcellular location: nucleus inner membrane {eco:0000269|pubmed:12958361, eco:0000269|pubmed:16445915, eco:0000269|pubmed:17132086, eco:0000269|pubmed:18845190, eco:0000269|pubmed:19933576}; single-pass type ii membrane protein {eco:0000269|pubmed:12958361, eco:0000269|pubmed:16445915, eco:0000269|pubmed:17132086, eco:0000269|pubmed:18845190, eco:0000269|pubmed:19933576}. note=at oocyte mi stage localized around the spindle, at mii stage localized to the spindle poles. {eco:0000250|uniprotkb:q9d666}.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SUN1,23353,Hs.438072,ENST00000413171,THC2566558,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005637(nuclear inner membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031965(nuclear membrane)|GO:0034993(SUN-KASH complex)|GO:0043231(intracellular membrane-bounded organelle)|GO:0090286(cytoskeletal anchoring at nuclear membrane)|GO:0090292(nuclear matrix anchoring at nuclear membrane),"Homo sapiens Sad1 and UNC84 domain containing 1 (SUN1), transcript variant 2, mRNA [NM_025154]",chr7:914243-914302,hs|7p22.3,Sad1 and UNC84 domain containing 1,TRUE
887_DNAJC10_54431,Q8IXB1,dnaj homolog subfamily c member 10 (ec 1.8.4.-) (endoplasmic reticulum dna j domain-containing protein 5) (er-resident protein erdj5) (erdj5) (macrothioredoxin) (mthr),DNAJC10 ERDJ5 UNQ495/PRO1012,793,"function: endoplasmic reticulum disulfide reductase involved both in the correct folding of proteins and degradation of misfolded proteins. required for efficient folding of proteins in the endoplasmic reticulum by catalyzing the removal of non-native disulfide bonds formed during the folding of proteins, such as ldlr. also involved in endoplasmic reticulum-associated degradation (erad) by reducing incorrect disulfide bonds in misfolded glycoproteins recognized by edem1. interaction with hspa5 is required its activity, not for the disulfide reductase activity, but to facilitate the release of dnajc10 from its substrate. promotes apoptotic signaling pathway in response to endoplasmic reticulum stress. {eco:0000269|pubmed:12411443, eco:0000269|pubmed:18400946, eco:0000269|pubmed:19122239, eco:0000269|pubmed:23769672}.","subcellular location: endoplasmic reticulum lumen {eco:0000255|prosite-prorule:pru10138, eco:0000269|pubmed:12411443, eco:0000269|pubmed:23769672}.",NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DNAJC10,54431,Hs.516632,ENST00000264065,THC2485027,GO:0001671(ATPase activator activity)|GO:0001933(negative regulation of protein phosphorylation)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005783(endoplasmic reticulum)|GO:0005788(endoplasmic reticulum lumen)|GO:0005792(microsome)|GO:0006457(protein folding)|GO:0006662(glycerol ether metabolic process)|GO:0009055(electron carrier activity)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0015036(disulfide oxidoreductase activity)|GO:0030433(ER-associated protein catabolic process)|GO:0031072(heat shock protein binding)|GO:0032781(positive regulation of ATPase activity)|GO:0034663(endoplasmic reticulum chaperone complex)|GO:0034976(response to endoplasmic reticulum stress)|GO:0045454(cell redox homeostasis)|GO:0051082(unfolded protein binding)|GO:0051087(chaperone binding)|GO:0051117(ATPase binding)|GO:0051787(misfolded protein binding)|GO:0070059(apoptosis in response to endoplasmic reticulum stress),"Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 10 (DNAJC10), mRNA [NM_018981]",chr2:183643075-183643134,hs|2q32.1,"DnaJ (Hsp40) homolog, subfamily C, member 10",TRUE
888_CKS1B_1163,P61024,cyclin-dependent kinases regulatory subunit 1 (cks-1),CKS1B CKS1 PNAS-143 PNAS-16,79,function: binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,CKS1B,1163,Hs.374378,ENST00000474215,THC2479112,GO:0000079(regulation of cyclin-dependent protein kinase activity)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0005515(protein binding)|GO:0005654(nucleoplasm)|GO:0007049(cell cycle)|GO:0008283(cell proliferation)|GO:0016301(kinase activity)|GO:0016538(cyclin-dependent protein kinase regulator activity)|GO:0051301(cell division),"Homo sapiens CDC28 protein kinase regulatory subunit 1B (CKS1B), transcript variant 1, mRNA [NM_001826]",chr1:154951607-154951666,hs|1q21.3,CDC28 protein kinase regulatory subunit 1B,TRUE
889_CSNK1E_1454,P49674,casein kinase i isoform epsilon (cki-epsilon) (ckie) (ec 2.7.11.1),CSNK1E,416,"function: casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. can phosphorylate a large number of proteins. participates in wnt signaling. phosphorylates dvl1 and dvl2. central component of the circadian clock. in balance with pp1, determines the circadian period length, through the regulation of the speed and rhythmicity of per1 and per2 phosphorylation. controls per1 and per2 nuclear transport and degradation. inhibits cytokine-induced granuloytic differentiation. {eco:0000269|pubmed:12556519, eco:0000269|pubmed:15070676, eco:0000269|pubmed:15917222, eco:0000269|pubmed:16790549, eco:0000269|pubmed:23413191}.",subcellular location: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,"TISSUE SPECIFICITY: Expressed in all tissues examined, including brain, heart, lung, liver, pancreas, kidney, placenta and skeletal muscle. Expressed in monocytes and lymphocytes but not in granulocytes.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CSNK1E,1454,Hs.474833,ENST00000400206,THC2566041,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000278(mitotic cell cycle)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006281(DNA repair)|GO:0006468(protein phosphorylation)|GO:0007165(signal transduction)|GO:0030178(negative regulation of Wnt receptor signaling pathway)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0034613(cellular protein localization)|GO:0090263(positive regulation of canonical Wnt receptor signaling pathway),"Homo sapiens casein kinase 1, epsilon (CSNK1E), transcript variant 1, mRNA [NM_152221]",chr22:38689299-38687924,hs|22q13.1,"casein kinase 1, epsilon",TRUE
89_PTMA_5757,P06454,"prothymosin alpha [cleaved into: prothymosin alpha, n-terminally processed; thymosin alpha-1]",PTMA TMSA,111,function: prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections.,subcellular location: nucleus.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PTMA,5757,Hs.459927,ENST00000358839,THC2556690,"GO:0005634(nucleus)|GO:0006351(transcription, DNA-dependent)","Homo sapiens prothymosin, alpha (PTMA), transcript variant 2, mRNA [NM_002823]",chr2:232577209-232577555,hs|2q37.1,"prothymosin, alpha",TRUE
890_RRAGC_64121,Q9HB90,ras-related gtp-binding protein c (rag c) (ragc) (gtpase-interacting protein 2) (tib929),RRAGC,399,"function: guanine nucleotide-binding protein forming heterodimeric rag complexes required for the amino acid-induced relocalization of mtorc1 to the lysosomes and its subsequent activation by the gtpase rheb. this is a crucial step in the activation of the tor signaling cascade by amino acids. {eco:0000269|pubmed:20381137, eco:0000269|pubmed:27234373}.","subcellular location: cytoplasm {eco:0000269|pubmed:11073942}. nucleus {eco:0000269|pubmed:11073942}. lysosome {eco:0000269|pubmed:20381137}. note=predominantly cytoplasmic. may shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state of associated rraga (pubmed:11073942). {eco:0000269|pubmed:11073942}.",NA,"DISEASE: Note=RRAGC mutations have been found in a patient with idiopathic dilated cardiomyopathy with ventricular dilation and systolic dysfunction, bilateral cataracts, and mild facial dysmorphisms. {ECO:0000269|PubMed:27234373}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RRAGC,64121,Hs.532461,ENST00000373001,THC2704960,"GO:0000166(nucleotide binding)|GO:0000287(magnesium ion binding)|GO:0003924(GTPase activity)|GO:0005515(protein binding)|GO:0005525(GTP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005764(lysosome)|GO:0006184(GTP catabolic process)|GO:0006351(transcription, DNA-dependent)|GO:0006915(apoptosis)|GO:0007264(small GTPase mediated signal transduction)|GO:0008380(RNA splicing)|GO:0016049(cell growth)|GO:0019003(GDP binding)|GO:0032008(positive regulation of TOR signaling cascade)|GO:0034613(cellular protein localization)|GO:0046982(protein heterodimerization activity)|GO:0071230(cellular response to amino acid stimulus)","Homo sapiens Ras-related GTP binding C (RRAGC), mRNA [NM_022157]",chr1:39305074-39305015,hs|1p34.3,Ras-related GTP binding C,TRUE
891_PTPLAD1_51495,Q9P035,very-long-chain (3r)-3-hydroxyacyl-coa dehydratase 3 (ec 4.2.1.134) (3-hydroxyacyl-coa dehydratase 3) (hacd3) (butyrate-induced protein 1) (b-ind1) (hb-ind1) (protein-tyrosine phosphatase-like a domain-containing protein 1),HACD3 BIND1 PTPLAD1,362,"function: catalyzes the third of the four reactions of the long-chain fatty acids elongation cycle. this endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/vlcfas per cycle. this enzyme catalyzes the dehydration of the 3-hydroxyacyl-coa intermediate into trans-2,3-enoyl-coa, within each cycle of fatty acid elongation. thereby, it participates in the production of vlcfas of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. may be involved in rac1-signaling pathways leading to the modulation of gene expression. promotes insulin receptor/insr autophosphorylation and is involved in insr internalization (pubmed:25687571). {eco:0000269|pubmed:10747961, eco:0000269|pubmed:18554506, eco:0000269|pubmed:25687571}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:18554506}; multi-pass membrane protein {eco:0000269|pubmed:18554506}.,"TISSUE SPECIFICITY: Highly expressed in testis, kidney, brain, liver and weakly in skeletal muscle, spleen and heart. No expression detected in leukocytes. {ECO:0000269|PubMed:10747961, ECO:0000269|PubMed:18554506}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PTPLAD1,51495,Hs.512973,ENST00000442729,THC2558184,GO:0005096(GTPase activator activity)|GO:0005575(cellular_component)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006633(fatty acid biosynthetic process)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007257(activation of JUN kinase activity)|GO:0007264(small GTPase mediated signal transduction)|GO:0007266(Rho protein signal transduction)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016601(Rac protein signal transduction)|GO:0016829(lyase activity)|GO:0043547(positive regulation of GTPase activity),"Homo sapiens protein tyrosine phosphatase-like A domain containing 1 (PTPLAD1), mRNA [NM_016395]",chr15:65864606-65864665,hs|15q22.31,protein tyrosine phosphatase-like A domain containing 1,TRUE
892_PPIAL4A_164022,Q9Y536,peptidyl-prolyl cis-trans isomerase a-like 4a (ppiase a-like 4a) (ec 5.2.1.8) (chromosome one-amplified sequence 2) (coas-2) (cyclophilin homolog overexpressed in liver cancer),PPIAL4A COAS2 PPIAL4B,164,function: ppiases accelerate the folding of proteins. it catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (by similarity). {eco:0000250}.,subcellular location: cytoplasm {eco:0000250|uniprotkb:p62937}.,"TISSUE SPECIFICITY: Highly expressed in brain, ovary and mammary gland. Moderately expressed in lung, salivary gland, kidney, skin, adipose tissue, intestine and spleen. Weakly expressed in skeletal muscle, liver and stomach. Expressed in pleiomorphic and undifferentiated liposarcomas, osteosarcomas and breast carcinomas. {ECO:0000269|PubMed:11948409}.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PPIAL4A,164022,Hs.573713,ENST00000419275,THC2487803,NA,"Homo sapiens peptidylprolyl isomerase A (cyclophilin A)-like 4A (PPIAL4A), mRNA [NM_178230]",chr1:147954874-147954815,hs|1q21.2,peptidylprolyl isomerase A (cyclophilin A)-like 4A,TRUE
893_UPF1_5976,Q92900,regulator of nonsense transcripts 1 (ec 3.6.4.-) (atp-dependent helicase rent1) (nonsense mrna reducing factor 1) (norf1) (up-frameshift suppressor 1 homolog) (hupf1),UPF1 KIAA0221 RENT1,1129,"function: rna-dependent helicase and atpase required for nonsense-mediated decay (nmd) of mrnas containing premature stop codons. is recruited to mrnas upon translation termination and undergoes a cycle of phosphorylation and dephosphorylation; its phosphorylation appears to be a key step in nmd. recruited by release factors to stalled ribosomes together with the smg1c protein kinase complex to form the transient surf (smg1-upf1-erf1-erf3) complex. in ejc-dependent nmd, the surf complex associates with the exon junction complex (ejc) (located 50-55 or more nucleotides downstream from the termination codon) through upf2 and allows the formation of an upf1-upf2-upf3 surveillance complex which is believed to activate nmd. phosphorylated upf1 is recognized by est1b/smg5, smg6 and smg7 which are thought to provide a link to the mrna degradation machinery involving exonucleolytic and endonucleolytic pathways, and to serve as adapters to protein phosphatase 2a (pp2a), thereby triggering upf1 dephosphorylation and allowing the recycling of nmd factors. upf1 can also activate nmd without upf2 or upf3, and in the absence of the nmd-enhancing downstream ejc indicative for alternative nmd pathways. plays a role in replication-dependent histone mrna degradation at the end of phase s; the function is independent of upf2. for the recognition of premature termination codons (ptc) and initiation of nmd a competitive interaction between upf1 and pabpc1 with the ribosome-bound release factors is proposed. the atpase activity of upf1 is required for disassembly of mrnps undergoing nmd. essential for embryonic viability. {eco:0000269|pubmed:11163187, eco:0000269|pubmed:16086026, eco:0000269|pubmed:18172165, eco:0000269|pubmed:21145460, eco:0000269|pubmed:21419344, eco:0000269|pubmed:24726324}.","subcellular location: cytoplasm. cytoplasm, p-body. nucleus. note=hyperphosphorylated form is targeted to the p-body, while unphosphorylated protein is distributed throughout the cytoplasm.",TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,UPF1,5976,Hs.515266,ENST00000262803,THC2469041,"GO:0000166(nucleotide binding)|GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)|GO:0000785(chromatin)|GO:0000932(cytoplasmic mRNA processing body)|GO:0003677(DNA binding)|GO:0003682(chromatin binding)|GO:0003723(RNA binding)|GO:0004004(ATP-dependent RNA helicase activity)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006260(DNA replication)|GO:0006281(DNA repair)|GO:0006406(mRNA export from nucleus)|GO:0006449(regulation of translational termination)|GO:0007049(cell cycle)|GO:0008270(zinc ion binding)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016787(hydrolase activity)|GO:0035145(exon-exon junction complex)|GO:0046872(metal ion binding)|GO:0071044(histone mRNA catabolic process)","Homo sapiens UPF1 regulator of nonsense transcripts homolog (yeast) (UPF1), mRNA [NM_002911]",chr19:18978975-18979034,hs|19p13.11,UPF1 regulator of nonsense transcripts homolog (yeast),TRUE
894_PPP1R16A_84988,Q96I34,protein phosphatase 1 regulatory subunit 16a (myosin phosphatase-targeting subunit 3),PPP1R16A MYPT3,528,"function: inhibits protein phosphatase 1 activity toward phosphorylase, myosin light chain and myosin substrates. {eco:0000250}.",subcellular location: cell membrane {eco:0000250}; lipid-anchor {eco:0000250}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PPP1R16A,84988,Hs.521937,ENST00000526183,NA,GO:0005515(protein binding)|GO:0005886(plasma membrane),"Homo sapiens protein phosphatase 1, regulatory subunit 16A (PPP1R16A), mRNA [NM_032902]",chr8:145727444-145727503,hs|8q24.3,"protein phosphatase 1, regulatory subunit 16A",TRUE
895_LOC100170939_100170939,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC100170939,100170939,Hs.652536,NA,THC2544107,NA,"Homo sapiens glucuronidase, beta pseudogene (LOC100170939), non-coding RNA [NR_024054]",chr5:69438247-69438188,hs|5q13.2,"glucuronidase, beta pseudogene",TRUE
896_PTCD3_55037,Q96EY7,"pentatricopeptide repeat domain-containing protein 3, mitochondrial (28s ribosomal protein s39, mitochondrial) (mrp-s39) (mitochondrial small ribosomal subunit protein ms39) (transformation-related gene 15 protein) (trg-15)",PTCD3 MRPS39 TRG15,689,function: mitochondrial rna-binding protein that has a role in mitochondrial translation. {eco:0000269|pubmed:19427859}.,"subcellular location: mitochondrion {eco:0000269|pubmed:19427859, eco:0000269|pubmed:23908630}.","TISSUE SPECIFICITY: Abundant in testes, skeletal muscle and heart tissue. {ECO:0000269|PubMed:19427859}.",NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,PTCD3,55037,Hs.323489,ENST00000254630,THC2531381,GO:0005739(mitochondrion),"Homo sapiens Pentatricopeptide repeat domain 3 (PTCD3), nuclear gene encoding mitochondrial protein, mRNA [NM_017952]",chr2:86365206-86365265,hs|2p11.2,Pentatricopeptide repeat domain 3,TRUE
897_HNRNPA1L2_144983,Q32P51,heterogeneous nuclear ribonucleoprotein a1-like 2 (hnrnp a1-like 2) (hnrnp core protein a1-like 2),HNRNPA1L2 HNRNPA1L,320,"function: involved in the packaging of pre-mrna into hnrnp particles, transport of poly(a) mrna from the nucleus to the cytoplasm and may modulate splice site selection. {eco:0000250}.",subcellular location: nucleus {eco:0000250}. cytoplasm {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HNRNPA1L2,144983,Hs.447506,ENST00000357495,NP1190980,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0005737(cytoplasm)|GO:0006397(mRNA processing)|GO:0006810(transport)|GO:0008380(RNA splicing)|GO:0051028(mRNA transport),"Homo sapiens heterogeneous nuclear ribonucleoprotein A1-like 2 (HNRNPA1L2), transcript variant 1, mRNA [NM_001011724]",chr13:53217750-53217809,hs|13q14.3,heterogeneous nuclear ribonucleoprotein A1-like 2,TRUE
898_FAM36A_116228,Q5RI15,"cytochrome c oxidase assembly protein cox20, mitochondrial",COX20 FAM36A,118,"function: essential for the assembly of the mitochondrial respiratory chain complex iv (civ), also known as cytochrome c oxidase (pubmed:23125284). acts as a chaperone in the early steps of cytochrome c oxidase subunit ii (mt-co2/cox2) maturation, stabilizing the newly synthesized protein and presenting it to metallochaperones sco1/2 which in turn facilitates the incorporation of the mature mt-co2/cox2 into the assembling civ holoenzyme (pubmed:24403053). {eco:0000269|pubmed:23125284, eco:0000269|pubmed:24403053}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:23125284, eco:0000269|pubmed:29154948}; multi-pass membrane protein {eco:0000255}.",NA,"DISEASE: Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and mental retardation. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome. {ECO:0000269|PubMed:23125284, ECO:0000269|PubMed:24202787, ECO:0000269|PubMed:29154948}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM36A,116228,Hs.411490,ENST00000366528,THC2506713,GO:0005739(mitochondrion)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens family with sequence similarity 36, member A (FAM36A), mRNA [NM_198076]",chr1:245005521-245006362,hs|1q44,"family with sequence similarity 36, member A",TRUE
899_RNF103_7844,O00237,e3 ubiquitin-protein ligase rnf103 (ec 2.3.2.27) (kf-1) (hkf-1) (ring finger protein 103) (ring-type e3 ubiquitin transferase rnf103) (zinc finger protein 103 homolog) (zfp-103),RNF103 ZFP103,685,"function: acts as an e2-dependent e3 ubiquitin-protein ligase, probably involved in the er-associated protein degradation pathway. {eco:0000269|pubmed:10500182, eco:0000269|pubmed:18675248}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:18675248}; multi-pass membrane protein {eco:0000269|pubmed:18675248}.,TISSUE SPECIFICITY: Highly expressed in the normal cerebellum but not in the cerebral cortex. {ECO:0000269|PubMed:9070305}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF103,7844,Hs.469199,ENST00000472030,THC2504374,GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0007417(central nervous system development)|GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0030433(ER-associated protein catabolic process)|GO:0046872(metal ion binding),"Homo sapiens ring finger protein 103 (RNF103), transcript variant 1, mRNA [NM_005667]",chr2:86830871-86830812,hs|2p11.2,ring finger protein 103,TRUE
9_RAX2_84839,Q96IS3,retina and anterior neural fold homeobox protein 2 (q50-type retinal homeobox protein) (retina and anterior neural fold homeobox-like protein 1),RAX2 QRX RAXL1,184,function: may be involved in modulating the expression of photoreceptor specific genes. binds to the ret-1 and bat-1 element within the rhodopsin promoter. {eco:0000269|pubmed:15028672}.,subcellular location: nucleus {eco:0000255|prosite-prorule:pru00108}.,NA,"DISEASE: Macular degeneration, age-related, 6 (ARMD6) [MIM:613757]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:15028672}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 11 (CORD11) [MIM:610381]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors. {ECO:0000269|PubMed:15028672}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RAX2,84839,Hs.532691,ENST00000395106,NP340726,GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0007601(visual perception)|GO:0043565(sequence-specific DNA binding)|GO:0050896(response to stimulus),"Homo sapiens retina and anterior neural fold homeobox 2 (RAX2), mRNA [NM_032753]",chr19:3769333-3769274,hs|19p13.3,retina and anterior neural fold homeobox 2,TRUE
90_TXNIP_10628,Q9H3M7,thioredoxin-interacting protein (thioredoxin-binding protein 2) (vitamin d3 up-regulated protein 1),TXNIP VDUP1,391,"function: may act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. interacts with cops5 and restores cops5-induced suppression of cdkn1b stability, blocking the cops5-mediated translocation of cdkn1b from the nucleus to the cytoplasm. functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce g0/g1 cell cycle arrest. required for the maturation of natural killer cells. acts as a suppressor of tumor cell growth. inhibits the proteasomal degradation of ddit4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mtorc1). {eco:0000269|pubmed:12821938, eco:0000269|pubmed:17603038, eco:0000269|pubmed:18541147, eco:0000269|pubmed:21460850}.",subcellular location: cytoplasm {eco:0000250}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TXNIP,10628,Hs.533977,ENST00000475171,THC2555785,"GO:0002218(activation of innate immune response)|GO:0004857(enzyme inhibitor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005758(mitochondrial intermembrane space)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006606(protein import into nucleus)|GO:0006979(response to oxidative stress)|GO:0007049(cell cycle)|GO:0009612(response to mechanical stimulus)|GO:0009749(response to glucose stimulus)|GO:0030216(keratinocyte differentiation)|GO:0031625(ubiquitin protein ligase binding)|GO:0032355(response to estradiol stimulus)|GO:0032570(response to progesterone stimulus)|GO:0042127(regulation of cell proliferation)|GO:0042493(response to drug)|GO:0042542(response to hydrogen peroxide)|GO:0043065(positive regulation of apoptosis)|GO:0045087(innate immune response)|GO:0048008(platelet-derived growth factor receptor signaling pathway)|GO:0051592(response to calcium ion)|GO:0051782(negative regulation of cell division)|GO:0071228(cellular response to tumor cell)","Homo sapiens thioredoxin interacting protein (TXNIP), mRNA [NM_006472]",chr1:145442447-145442506,hs|1q21.1,thioredoxin interacting protein,TRUE
900_EIF4EBP2_1979,Q13542,eukaryotic translation initiation factor 4e-binding protein 2 (4e-bp2) (eif4e-binding protein 2),EIF4EBP2,120,"function: repressor of translation initiation involved in synaptic plasticity, learning and memory formation (by similarity). regulates eif4e activity by preventing its assembly into the eif4f complex: hypophosphorylated form of eif4ebp2 competes with eif4g1/eif4g3 and strongly binds to eif4e, leading to repress translation. in contrast, hyperphosphorylated form dissociates from eif4e, allowing interaction between eif4g1/eif4g3 and eif4e, leading to initiation of translation (pubmed:25533957). eif4ebp2 is enriched in brain and acts as a regulator of synapse activity and neuronal stem cell renewal via its ability to repress translation initiation (by similarity). mediates the regulation of protein translation by hormones, growth factors and other stimuli that signal through the map kinase and mtorc1 pathways (by similarity). {eco:0000250|uniprotkb:p70445, eco:0000269|pubmed:25533957}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF4EBP2,1979,Hs.621200,ENST00000373218,THC2507090,GO:0005515(protein binding)|GO:0006412(translation)|GO:0008190(eukaryotic initiation factor 4E binding)|GO:0008286(insulin receptor signaling pathway)|GO:0019933(cAMP-mediated signaling)|GO:0045947(negative regulation of translational initiation),"Homo sapiens eukaryotic translation initiation factor 4E binding protein 2 (EIF4EBP2), mRNA [NM_004096]",chr10:72183525-72183584,hs|10q22.1,eukaryotic translation initiation factor 4E binding protein 2,TRUE
901_WAC_51322,Q9BTA9,ww domain-containing adapter protein with coiled-coil,WAC KIAA1844,647,"function: acts as a linker between gene transcription and histone h2b monoubiquitination at 'lys-120' (h2bk120ub1) (pubmed:21329877). interacts with the rna polymerase ii transcriptional machinery via its ww domain and with rnf20-rnf40 via its coiled coil region, thereby linking and regulating h2bk120ub1 and gene transcription (pubmed:21329877). regulates the cell-cycle checkpoint activation in response to dna damage (pubmed:21329877). positive regulator of amino acid starvation-induced autophagy (pubmed:22354037). also acts as a negative regulator of basal autophagy (pubmed:26812014). positively regulates mtor activity by promoting, in an energy-dependent manner, the assembly of the ttt complex composed of telo2, tti1 and tti2 and the ruvbl complex composed of ruvbl1 and ruvbl2 into the ttt-ruvbl complex. this leads to the dimerization of the mtorc1 complex and its subsequent activation (pubmed:26812014). may negatively regulate the ubiquitin proteasome pathway (pubmed:21329877). {eco:0000269|pubmed:21329877, eco:0000269|pubmed:22354037, eco:0000269|pubmed:26812014}.",subcellular location: nucleus speckle {eco:0000250|uniprotkb:q924h7}. nucleus {eco:0000269|pubmed:21329877}. note=in distinct nuclear speckles. colocalizes with pre-mrna processing complexes. {eco:0000250|uniprotkb:q924h7}.,NA,"DISEASE: DeSanto-Shinawi syndrome (DESSH) [MIM:616708]: An autosomal dominant syndrome characterized by developmental delay, hypotonia, behavioral problems, eye abnormalities, constipation, feeding difficulties, seizures and sleep problems. Patients exhibit dysmorphic features, including broad/prominent forehead, synophrys and/or bushy eyebrows, depressed nasal bridge and bulbous nasal tip. Additional variable features are posteriorly rotated ears, hirsutism, deep-set eyes, thin upper lip, inverted nipples, hearing loss and branchial cleft anomalies. {ECO:0000269|PubMed:25356899, ECO:0000269|PubMed:26264232}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in WAC are the cause of a form of intellectual disability characterized by hypotonia, behavioral problems and distinctive facial dysmorphisms including a square-shaped face, deep set eyes, long palpebral fissures, and a broad mouth and chin. {ECO:0000269|PubMed:26757981}.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,WAC,51322,Hs.730605,ENST00000338396,THC2469309,"GO:0000075(cell cycle checkpoint)|GO:0000993(RNA polymerase II core binding)|GO:0003682(chromatin binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0006974(response to DNA damage stimulus)|GO:0010390(histone monoubiquitination)|GO:0016568(chromatin modification)|GO:0016607(nuclear speck)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0071894(histone H2B conserved C-terminal lysine ubiquitination)","Homo sapiens WW domain containing adaptor with coiled-coil (WAC), transcript variant 1, mRNA [NM_016628]",chr10:28909391-28909450,hs|10p12.1,WW domain containing adaptor with coiled-coil,TRUE
902_LSS_4047,P48449,"lanosterol synthase (ec 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (oxidosqualene--lanosterol cyclase) (osc) (hosc)",LSS OSC,732,"function: catalyzes the cyclization of (s)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus. through the production of lanosterol may regulate lens protein aggregation and increase transparency. {eco:0000269|pubmed:26200341, eco:0000269|pubmed:7639730}.","subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:14766201, eco:0000269|pubmed:15525992, eco:0000269|pubmed:30401459}; peripheral membrane protein {eco:0000269|pubmed:14766201, eco:0000269|pubmed:15525992}.","TISSUE SPECIFICITY: Widely expressed. Expressed in the hair bulb, the outer root sheath and hair matrix of the hair follicle epithelium. Also detected in dermal papilla, epidermis, sweat glands, sebaceous glands, and blood vessels. {ECO:0000269|PubMed:30401459}.","DISEASE: Cataract 44 (CTRCT44) [MIM:616509]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. {ECO:0000269|PubMed:26200341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypotrichosis 14 (HYPT14) [MIM:618275]: A form of hypotrichosis, a condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The extent of scalp and body hair involvement can be very variable, within as well as between families. HYPT14 is an autosomal recessive form characterized by sparse to absent lanugo-like scalp hair, sparse and brittle eyebrows, and sparse eyelashes and body hair. {ECO:0000269|PubMed:30401459}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,LSS,4047,Hs.596543,ENST00000397728,THC2469337,GO:0000250(lanosterol synthase activity)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005792(microsome)|GO:0006694(steroid biosynthetic process)|GO:0006695(cholesterol biosynthetic process)|GO:0008202(steroid metabolic process)|GO:0016020(membrane)|GO:0016125(sterol metabolic process)|GO:0016866(intramolecular transferase activity),"Homo sapiens lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) (LSS), transcript variant 1, mRNA [NM_002340]",chr21:47609102-47609043,hs|21q22.3,"lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)",TRUE
903_AHSA2_130872,Q719I0,putative activator of 90 kda heat shock protein atpase homolog 2 (activator of hsp90 atpase homolog 2 pseudogene),AHSA2P AHSA2,299,function: co-chaperone that stimulates hsp90 atpase activity. {eco:0000250|uniprotkb:q12449}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,AHSA2,130872,Hs.655602,ENST00000484217,THC2579334,GO:0001671(ATPase activator activity)|GO:0005737(cytoplasm)|GO:0006950(response to stress)|GO:0051087(chaperone binding),"Homo sapiens AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) (AHSA2), mRNA [NM_152392]",chr2:61413626-61413804,hs|2p15,"AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast)",TRUE
904_FAM108C1_58489,Q6PCB6,alpha/beta hydrolase domain-containing protein 17c (abhydrolase domain-containing protein 17c) (ec 3.1.2.22),ABHD17C FAM108C1,329,function: hydrolyzes fatty acids from s-acylated cysteine residues in proteins. has depalmitoylating activity towards nras and dlg4/psd95. {eco:0000269|pubmed:26701913}.,"subcellular location: recycling endosome membrane {eco:0000250|uniprotkb:b5dfk7}; lipid-anchor {eco:0000250|uniprotkb:b5dfk7}; cytoplasmic side {eco:0000250|uniprotkb:b5dfk7}. cell projection, dendritic spine {eco:0000250|uniprotkb:b5dfk7}. cell junction, synapse, postsynaptic density membrane {eco:0000250|uniprotkb:b5dfk7}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM108C1,58489,Hs.459072,ENST00000258884,THC2685168,GO:0016787(hydrolase activity),"Homo sapiens family with sequence similarity 108, member C1 (FAM108C1), mRNA [NM_021214]",chr15:81047885-81047944,hs|15q25.1,"family with sequence similarity 108, member C1",TRUE
905_MKL2_57496,Q9ULH7,myocardin-related transcription factor b (mrtf-b) (mkl/myocardin-like protein 2) (megakaryoblastic leukemia 2),MRTFB KIAA1243 MKL2,1088,function: acts as a transcriptional coactivator of serum response factor (srf). required for skeletal myogenic differentiation. {eco:0000269|pubmed:14565952}.,subcellular location: nucleus {eco:0000250}.,NA,DISEASE: Note=A chromosomal aberration involving C11orf95 is found in 3 chondroid lipomas. Translocation t(11;16)(q13;p13) with C11orf95 produces a C11orf95-MRTFB fusion protein (PubMed:20607705). {ECO:0000269|PubMed:20607705}.,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MKL2,57496,Hs.49143,ENST00000318282,THC2463771,"GO:0003676(nucleic acid binding)|GO:0003713(transcription coactivator activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007275(multicellular organismal development)|GO:0007517(muscle organ development)|GO:0030154(cell differentiation)|GO:0045844(positive regulation of striated muscle tissue development)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","Homo sapiens MKL/myocardin-like 2 (MKL2), mRNA [NM_014048]",chr16:14360546-14360605,hs|16p13.12,MKL/myocardin-like 2,TRUE
906_GTF3A_2971,Q92664,transcription factor iiia (tfiiia),GTF3A,365,"function: involved in ribosomal large subunit biogenesis. binds the approximately 50 base pairs internal control region (icr) of 5s ribosomal rna genes. it is required for their rna polymerase iii-dependent transcription and may also maintain the transcription of other genes (pubmed:24120868). also binds the transcribed 5s rna's (by similarity). {eco:0000250|uniprotkb:p17842, eco:0000269|pubmed:24120868}.",subcellular location: nucleus.,TISSUE SPECIFICITY: Ubiquitous.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GTF3A,2971,Hs.445977,ENST00000470606,NP1175479,"GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0008270(zinc ion binding)|GO:0009303(rRNA transcription)|GO:0046872(metal ion binding)","Homo sapiens general transcription factor IIIA (GTF3A), mRNA [NM_002097]",chr13:28009646-28009705,hs|13q12.2,general transcription factor IIIA,TRUE
907_ACADVL_37,P49748,"very long-chain specific acyl-coa dehydrogenase, mitochondrial (vlcad) (ec 1.3.8.9)",ACADVL VLCAD,655,"function: active toward esters of long-chain and very long chain fatty acids such as palmitoyl-coa, myristoyl-coa and stearoyl-coa. can accommodate substrate acyl chain lengths as long as 24 carbons, but shows little activity for substrates of less than 12 carbons. {eco:0000269|pubmed:18227065}.",subcellular location: mitochondrion inner membrane.,NA,"DISEASE: Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]: An inborn error of mitochondrial fatty acid beta-oxidation which leads to impaired long-chain fatty acid beta-oxidation. It is clinically heterogeneous, with three major phenotypes: a severe childhood form characterized by early onset, high mortality and high incidence of cardiomyopathy; a milder childhood form with later onset, characterized by hypoketotic hypoglycemia, low mortality and rare cardiomyopathy; an adult form, with isolated skeletal muscle involvement, rhabdomyolysis and myoglobinuria, usually triggered by exercise or fasting. {ECO:0000269|PubMed:10077518, ECO:0000269|PubMed:8554073, ECO:0000269|PubMed:9546340}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ACADVL,37,Hs.437178,ENST00000322910,NP1154386,GO:0000062(fatty-acyl-CoA binding)|GO:0001659(temperature homeostasis)|GO:0003995(acyl-CoA dehydrogenase activity)|GO:0004466(long-chain-acyl-CoA dehydrogenase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006631(fatty acid metabolic process)|GO:0006635(fatty acid beta-oxidation)|GO:0015980(energy derivation by oxidation of organic compounds)|GO:0016020(membrane)|GO:0017099(very long-chain-acyl-CoA dehydrogenase activity)|GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase)|GO:0042645(mitochondrial nucleoid)|GO:0042760(very long-chain fatty acid catabolic process)|GO:0044255(cellular lipid metabolic process)|GO:0045717(negative regulation of fatty acid biosynthetic process)|GO:0046322(negative regulation of fatty acid oxidation)|GO:0050660(flavin adenine dinucleotide binding)|GO:0090181(regulation of cholesterol metabolic process),"Homo sapiens acyl-CoA dehydrogenase, very long chain (ACADVL), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_000018]",chr17:7128439-7128498,hs|17p13.1,"acyl-CoA dehydrogenase, very long chain",TRUE
908_LOC152217_152217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC152217,152217,Hs.118820,NA,THC2464079,NA,"Homo sapiens uncharacterized LOC152217 (LOC152217), non-coding RNA [NR_024388]",chr3:196670329-196670388,hs|3q29,uncharacterized LOC152217,TRUE
909_RNF149_284996,Q8NC42,e3 ubiquitin-protein ligase rnf149 (ec 2.3.2.27) (dna polymerase-transactivated protein 2) (ring finger protein 149) (ring-type e3 ubiquitin transferase rnf149),RNF149 DNAPTP2,400,"function: e3 ubiquitin-protein ligase. ubiquitinates braf, inducing its proteasomal degradation. {eco:0000269|pubmed:22628551}.",subcellular location: membrane {eco:0000305}; single-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF149,284996,Hs.142074,ENST00000295317,THC2535057,GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016874(ligase activity)|GO:0046872(metal ion binding),"Homo sapiens ring finger protein 149 (RNF149), mRNA [NM_173647]",chr2:101893115-101893056,hs|2q11.2,ring finger protein 149,TRUE
91_PMEPA1_56937,Q969W9,protein tmepai (prostate transmembrane protein androgen induced 1) (solid tumor-associated 1 protein) (transmembrane prostate androgen-induced protein),PMEPA1 STAG1 TMEPAI,287,"function: functions as a negative regulator of tgf-beta signaling and thereby probably plays a role in cell proliferation, differentiation, apoptosis, motility, extracellular matrix production and immunosuppression. in the canonical tgf-beta pathway, zfyve9/sara recruits the intracellular signal transducer and transcriptional modulators smad2 and smad3 to the tgf-beta receptor. phosphorylated by the receptor, smad2 and smad3 then form a heteromeric complex with smad4 that translocates to the nucleus to regulate transcription. through interaction with smad2 and smad3, ldlrad4 may compete with zfyve9 and smad4 and prevent propagation of the intracellular signal (pubmed:20129061, pubmed:24627487). also involved in down-regulation of the androgen receptor (ar), enhancing ubiquitination and proteasome-mediated degradation of ar, probably by recruiting nedd4 (pubmed:18703514). {eco:0000269|pubmed:18703514, eco:0000269|pubmed:20129061, eco:0000269|pubmed:24627487}.",subcellular location: early endosome membrane; single-pass membrane protein. golgi apparatus membrane; single-pass membrane protein.,TISSUE SPECIFICITY: Highest expression in prostate. Also expressed in ovary.,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PMEPA1,56937,Hs.517155,ENST00000265626,THC2611604,GO:0003674(molecular_function)|GO:0005886(plasma membrane)|GO:0016021(integral to membrane)|GO:0030521(androgen receptor signaling pathway)|GO:0050699(WW domain binding),"Homo sapiens prostate transmembrane protein, androgen induced 1 (PMEPA1), transcript variant 1, mRNA [NM_020182]",chr20:56223548-56223489,hs|20q13.31,"prostate transmembrane protein, androgen induced 1",TRUE
910_KIAA1191_57179,Q96A73,putative monooxygenase p33monox (ec 1.-.-.-) (brain-derived rescue factor p60monox) (flavin monooxygenase motif-containing protein of 33 kda),KIAA1191 P33MONOX,305,"function: potential nadph-dependent oxidoreductase. may be involved in the regulation of neuronal survival, differentiation and axonal outgrowth.",subcellular location: cytoplasm {eco:0000250}.,TISSUE SPECIFICITY: Down-regulated in the occipital lobe of an early stage Alzheimer disease patients. {ECO:0000269|PubMed:17032350}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,KIAA1191,57179,Hs.730636,ENST00000393725,THC2581610,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0008150(biological_process),"Homo sapiens KIAA1191 (KIAA1191), transcript variant 1, mRNA [NM_020444]",chr5:175773286-175773228,hs|5q35.2,KIAA1191,TRUE
911_SRI_6717,P30626,sorcin (22 kda protein) (cp-22) (cp22) (v19),SRI,198,function: calcium-binding protein that modulates excitation-contraction coupling in the heart. contributes to calcium homeostasis in the heart sarcoplasmic reticulum. modulates the activity of ryr2 calcium channels. {eco:0000269|pubmed:17699613}.,subcellular location: cytoplasm. sarcoplasmic reticulum membrane; peripheral membrane protein; cytoplasmic side. note=relocates to the sarcoplasmic reticulum membrane in response to elevated calcium levels.,TISSUE SPECIFICITY: Detected in cardiac myocytes.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SRI,6717,Hs.489040,ENST00000457606,THC2504409,GO:0001508(regulation of action potential)|GO:0005102(receptor binding)|GO:0005246(calcium channel regulator activity)|GO:0005509(calcium ion binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006810(transport)|GO:0006816(calcium ion transport)|GO:0006880(intracellular sequestering of iron ion)|GO:0006942(regulation of striated muscle contraction)|GO:0007165(signal transduction)|GO:0007507(heart development)|GO:0007517(muscle organ development)|GO:0008016(regulation of heart contraction)|GO:0030018(Z disc)|GO:0031982(vesicle)|GO:0033017(sarcoplasmic reticulum membrane),"Homo sapiens sorcin (SRI), transcript variant 1, mRNA [NM_003130]",chr7:87838661-87837829,hs|7q21.12,sorcin,TRUE
912_EIF2B1_1967,Q14232,translation initiation factor eif-2b subunit alpha (eif-2b gdp-gtp exchange factor subunit alpha),EIF2B1 EIF2BA,305,function: catalyzes the exchange of eukaryotic initiation factor 2-bound gdp for gtp.,NA,NA,"DISEASE: Leukodystrophy with vanishing white matter (VWM) [MIM:603896]: A leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. {ECO:0000269|PubMed:11835386, ECO:0000269|PubMed:15776425}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,EIF2B1,1967,Hs.728874,ENST00000424014,THC2720004,GO:0003743(translation initiation factor activity)|GO:0005085(guanyl-nucleotide exchange factor activity)|GO:0005515(protein binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005851(eukaryotic translation initiation factor 2B complex)|GO:0005886(plasma membrane)|GO:0006412(translation)|GO:0006413(translational initiation)|GO:0006446(regulation of translational initiation)|GO:0009408(response to heat)|GO:0009749(response to glucose stimulus)|GO:0010467(gene expression)|GO:0014003(oligodendrocyte development)|GO:0043434(response to peptide hormone stimulus)|GO:0044237(cellular metabolic process)|GO:0044267(cellular protein metabolic process)|GO:0051716(cellular response to stimulus),"Homo sapiens eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa (EIF2B1), mRNA [NM_001414]",chr12:124105818-124105759,hs|12q24.31,"eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa",TRUE
913_NONO_4841,Q15233,"non-pou domain-containing octamer-binding protein (nono protein) (54 kda nuclear rna- and dna-binding protein) (55 kda nuclear protein) (dna-binding p52/p100 complex, 52 kda subunit) (nmt55) (p54(nrb)) (p54nrb)",NONO NRB54,471,"function: dna- and rna binding protein, involved in several nuclear processes. binds the conventional octamer sequence in double-stranded dna. also binds single-stranded dna and rna at a site independent of the duplex site. involved in pre-mrna splicing, probably as a heterodimer with sfpq. interacts with u5 snrna, probably by binding to a purine-rich sequence located on the 3' side of u5 snrna stem 1b. together with pspc1, required for the formation of nuclear paraspeckles. the sfpq-nono heteromer associated with matr3 may play a role in nuclear retention of defective rnas. the sfpq-nono heteromer may be involved in dna unwinding by modulating the function of topoisomerase i/top1. the sfpq-nono heteromer may be involved in dna non-homologous end joining (nhej) required for double-strand break repair and v(d)j recombination and may stabilize paired dna ends. in vitro, the complex strongly stimulates dna end joining, binds directly to the dna substrates and cooperates with the ku70/g22p1-ku80/xrcc5 (ku) dimer to establish a functional preligation complex. nono is involved in transcriptional regulation. the sfpq-nono-nr5a1 complex binds to the cyp17 promoter and regulates basal and camp-dependent transcriptional activity. nono binds to an enhancer element in long terminal repeats of endogenous intracisternal a particles (iaps) and activates transcription. regulates the circadian clock by repressing the transcriptional activator activity of the clock-arntl/bmal1 heterodimer. important for the functional organization of gabaergic synapses. plays a specific and important role in the regulation of synaptic rnas and gphn/gephyrin scaffold structure, through the regulation of gabra2 transcript. plays a role in the regulation of dna virus-mediated innate immune response by assembling into the hdp-rnp complex, a complex that serves as a platform for irf3 phosphorylation and subsequent innate immune response activation through the cgas-sting pathway (pubmed:28712728). {eco:0000250|uniprotkb:q99k48, eco:0000269|pubmed:10858305, eco:0000269|pubmed:11525732, eco:0000269|pubmed:11897684, eco:0000269|pubmed:15590677, eco:0000269|pubmed:22416126, eco:0000269|pubmed:26571461, eco:0000269|pubmed:28712728}.","subcellular location: nucleus. nucleus, nucleolus. nucleus speckle. note=detected in punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles.","TISSUE SPECIFICITY: Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Also found in a number of breast tumor cell lines. {ECO:0000269|PubMed:9341872}.","DISEASE: Note=A chromosomal aberration involving NONO may be a cause of papillary renal cell carcinoma (PRCC). Translocation t(X;X)(p11.2;q13.1) with TFE3. {ECO:0000269|PubMed:9393982}.; DISEASE: Mental retardation, X-linked, syndromic, 34 (MRXS34) [MIM:300967]: A mental retardation syndrome characterized by intellectual deficit, delayed psychomotor development, poor speech, and dysmorphic features. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:26571461}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NONO,4841,Hs.533282,ENST00000472185,THC2522750,"GO:0000166(nucleotide binding)|GO:0003677(DNA binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0006281(DNA repair)|GO:0006310(DNA recombination)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0016363(nuclear matrix)|GO:0042382(paraspeckles)|GO:0042802(identical protein binding)","Homo sapiens non-POU domain containing, octamer-binding (NONO), transcript variant 2, mRNA [NM_007363]",chrX:70520608-70520667,hs|Xq13.1,"non-POU domain containing, octamer-binding",TRUE
914_TXNL4A_10907,P83876,thioredoxin-like protein 4a (dim1 protein homolog) (spliceosomal u5 snrnp-specific 15 kda protein) (thioredoxin-like u5 snrnp protein u5-15kd),TXNL4A DIM1 TXNL4,142,"function: plays role in pre-mrna splicing as component of the u5 snrnp and u4/u6-u5 tri-snrnp complexes that are involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome b complex). {eco:0000269|pubmed:28781166, eco:0000305|pubmed:10610776, eco:0000305|pubmed:26912367}.","subcellular location: nucleus {eco:0000269|pubmed:10610776, eco:0000269|pubmed:11054566, eco:0000269|pubmed:20858735, eco:0000269|pubmed:26912367, eco:0000269|pubmed:28781166}.",NA,"DISEASE: Burn-McKeown syndrome (BMKS) [MIM:608572]: A disease characterized by choanal atresia, sensorineural deafness, cardiac defects, and typical craniofacial dysmorphism consisting of narrow palpebral fissures, coloboma of the lower eyelids, prominent nose with high nasal bridge, short philtrum, cleft lip and/or palate, and large and protruding ears. Intellectual development is normal. {ECO:0000269|PubMed:25434003}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TXNL4A,10907,Hs.465498,ENST00000355491,THC2644962,"GO:0000245(spliceosome assembly)|GO:0000375(RNA splicing, via transesterification reactions)|GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005681(spliceosomal complex)|GO:0005737(cytoplasm)|GO:0007049(cell cycle)|GO:0007067(mitosis)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0051301(cell division)","Homo sapiens thioredoxin-like 4A (TXNL4A), mRNA [NM_006701]",chr18:77733605-77733546,hs|18q23,thioredoxin-like 4A,TRUE
915_SMS_6611,Q86VZ5,phosphatidylcholine:ceramide cholinephosphotransferase 1 (ec 2.7.8.27) (medulla oblongata-derived protein) (protein mob) (sphingomyelin synthase 1) (transmembrane protein 23),SGMS1 MOB SMS1 TMEM23,413,"function: sphingomyelin synthases synthesize the sphingolipid, sphingomyelin, through transfer of the phosphatidyl head group, phosphatidylcholine, on to the primary hydroxyl of ceramide. the reaction is bidirectional depending on the respective levels of the sphingolipid and ceramide. golgi apparatus sms1 directly and specifically recognizes the choline head group on the substrate, requiring two fatty chains on the choline-p donor molecule in order to be recognized efficiently as a substrate. major form in macrophages. required for cell growth in certain cell types such as hela cells. suppresses bax-mediated apoptosis and also prevents cell death in response to stimuli such as hydrogen peroxide, osmotic stress, elevated temperature and exogenously supplied sphingolipids. may protect against cell death by reversing the stress-inducible increase in levels of proapoptotic ceramide. {eco:0000269|pubmed:14685263, eco:0000269|pubmed:17449912}.","subcellular location: golgi apparatus membrane {eco:0000269|pubmed:14685263, eco:0000269|pubmed:17449912, eco:0000269|pubmed:18694848}; multi-pass membrane protein {eco:0000269|pubmed:14685263, eco:0000269|pubmed:17449912, eco:0000269|pubmed:18694848}.","TISSUE SPECIFICITY: Brain, heart, kidney, liver, muscle and stomach. {ECO:0000269|PubMed:11841947, ECO:0000269|PubMed:14685263, ECO:0000269|PubMed:15315829}.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SMS,6611,Hs.727552,ENST00000379404,THC2783686,GO:0004766(spermidine synthase activity)|GO:0005829(cytosol)|GO:0006555(methionine metabolic process)|GO:0006595(polyamine metabolic process)|GO:0006597(spermine biosynthetic process)|GO:0016740(transferase activity)|GO:0016768(spermine synthase activity)|GO:0034641(cellular nitrogen compound metabolic process),"Homo sapiens spermine synthase (SMS), mRNA [NM_004595]",chrX:22010809-22012467,hs|Xp22.11,spermine synthase,TRUE
916_SUMO2_6613,P61956,small ubiquitin-related modifier 2 (sumo-2) (hsmt3) (smt3 homolog 2) (sumo-3) (sentrin-2) (ubiquitin-like protein smt3b) (smt3b),SUMO2 SMT3B SMT3H2,95,"function: ubiquitin-like protein that can be covalently attached to proteins as a monomer or as a lysine-linked polymer. covalent attachment via an isopeptide bond to its substrates requires prior activation by the e1 complex sae1-sae2 and linkage to the e2 enzyme ube2i, and can be promoted by an e3 ligase such as pias1-4, ranbp2, cbx4 or znf451 (pubmed:26524494). this post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, dna replication and repair, mitosis and signal transduction. polymeric sumo2 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins (pubmed:18408734, pubmed:18538659, pubmed:21965678, pubmed:9556629). plays a role in the regulation of sumoylation status of setx (pubmed:24105744). {eco:0000269|pubmed:18408734, eco:0000269|pubmed:18538659, eco:0000269|pubmed:21965678, eco:0000269|pubmed:24105744, eco:0000269|pubmed:26524494, eco:0000269|pubmed:9556629}.","subcellular location: nucleus. nucleus, pml body.",TISSUE SPECIFICITY: Broadly expressed. {ECO:0000269|PubMed:9556629}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SUMO2,6613,Hs.546298,ENST00000420826,THC2528130,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0016925(protein sumoylation)|GO:0031625(ubiquitin protein ligase binding)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process),"Homo sapiens SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) (SUMO2), transcript variant 1, mRNA [NM_006937]",chr17:73164192-73164133,hs|17q25.1,SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae),TRUE
917_VPS37C_55048,A5D8V6,vacuolar protein sorting-associated protein 37c (hvps37c) (escrt-i complex subunit vps37c),VPS37C PML39,355,"function: component of the escrt-i complex, a regulator of vesicular trafficking process. required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. may be involved in cell growth and differentiation. {eco:0000269|pubmed:15509564}.",subcellular location: late endosome membrane {eco:0000305|pubmed:15509564}; peripheral membrane protein {eco:0000305|pubmed:15509564}. note=probably associates with membranes. recruited to the plasma membrane by hiv-1.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VPS37C,55048,Hs.523715,ENST00000301765,THC2464969,GO:0005768(endosome)|GO:0010008(endosome membrane)|GO:0015031(protein transport)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016197(endosome transport)|GO:0031902(late endosome membrane),"Homo sapiens vacuolar protein sorting 37 homolog C (S. cerevisiae) (VPS37C), mRNA [NM_017966]",chr11:60897849-60897790,hs|11q12.2,vacuolar protein sorting 37 homolog C (S. cerevisiae),TRUE
918_MT1G_4495,P13640,metallothionein-1g (mt-1g) (metallothionein-1k) (mt-1k) (metallothionein-ig) (mt-ig),MT1G MT1K MT1M,62,function: metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MT1G,4495,Hs.433391,ENST00000379811,THC2547025,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0030224(monocyte differentiation)|GO:0035924(cellular response to vascular endothelial growth factor stimulus)|GO:0042117(monocyte activation)|GO:0045926(negative regulation of growth)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0071276(cellular response to cadmium ion)|GO:0071280(cellular response to copper ion)|GO:0071294(cellular response to zinc ion),"Homo sapiens metallothionein 1G (MT1G), mRNA [NM_005950]",chr16:56700805-56700746,hs|16q13,metallothionein 1G,TRUE
919_HADHB_3032,P55084,"trifunctional enzyme subunit beta, mitochondrial (tp-beta) [includes: 3-ketoacyl-coa thiolase (ec 2.3.1.155) (ec 2.3.1.16) (acetyl-coa acyltransferase) (beta-ketothiolase)]",HADHB MSTP029,474,"function: mitochondrial trifunctional enzyme catalyzes the last three of the four reactions of the mitochondrial beta-oxidation pathway (pubmed:8135828, pubmed:29915090, pubmed:30850536). the mitochondrial beta-oxidation pathway is the major energy-producing process in tissues and is performed through four consecutive reactions breaking down fatty acids into acetyl-coa (pubmed:29915090). among the enzymes involved in this pathway, the trifunctional enzyme exhibits specificity for long-chain fatty acids (pubmed:30850536). mitochondrial trifunctional enzyme is a heterotetrameric complex composed of two proteins, the trifunctional enzyme subunit alpha/hadha carries the 2,3-enoyl-coa hydratase and the 3-hydroxyacyl-coa dehydrogenase activities, while the trifunctional enzyme subunit beta/hadhb described here bears the 3-ketoacyl-coa thiolase activity (pubmed:8135828, pubmed:29915090, pubmed:30850536). {eco:0000269|pubmed:29915090, eco:0000269|pubmed:30850536, eco:0000269|pubmed:8135828, eco:0000303|pubmed:29915090, eco:0000303|pubmed:30850536}.",subcellular location: mitochondrion {eco:0000269|pubmed:21527675}. mitochondrion inner membrane {eco:0000269|pubmed:21527675}. mitochondrion outer membrane {eco:0000269|pubmed:21527675}. endoplasmic reticulum {eco:0000269|pubmed:21527675}. note=protein stability and association with membranes require hadha. {eco:0000269|pubmed:29915090}.,NA,"DISEASE: Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]: A disease biochemically characterized by loss of all enzyme activities of the mitochondrial trifunctional protein complex. Variable clinical manifestations include hypoglycemia, cardiomyopathy, delayed psychomotor development, sensorimotor axonopathy, generalized weakness, hepatic dysfunction, respiratory failure. Sudden infant death may occur. Most patients die from heart failure. {ECO:0000269|PubMed:12754706, ECO:0000269|PubMed:8651282, ECO:0000269|PubMed:9259266}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HADHB,3032,Hs.515848,ENST00000545822,THC2465205,"GO:0000062(fatty-acyl-CoA binding)|GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity)|GO:0003988(acetyl-CoA C-acyltransferase activity)|GO:0004300(enoyl-CoA hydratase activity)|GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005740(mitochondrial envelope)|GO:0005743(mitochondrial inner membrane)|GO:0005759(mitochondrial matrix)|GO:0006631(fatty acid metabolic process)|GO:0006635(fatty acid beta-oxidation)|GO:0016507(fatty acid beta-oxidation multienzyme complex)|GO:0016508(long-chain-enoyl-CoA hydratase activity)|GO:0016509(long-chain-3-hydroxyacyl-CoA dehydrogenase activity)|GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups)|GO:0042645(mitochondrial nucleoid)|GO:0044255(cellular lipid metabolic process)|GO:0051287(NAD binding)","Homo sapiens hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit (HADHB), nuclear gene encoding mitochondrial protein, mRNA [NM_000183]",chr2:26512913-26512972,hs|2p23.3,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",TRUE
92_WDR45L_56270,Q5MNZ6,wd repeat domain phosphoinositide-interacting protein 3 (wipi-3) (wd repeat-containing protein 45-like) (wdr45-like protein) (wd repeat-containing protein 45b) (wipi49-like protein),WDR45B WDR45L WIPI3,344,"function: component of the autophagy machinery that controls the major intracellular degradation process by which cytoplasmic materials are packaged into autophagosomes and delivered to lysosomes for degradation (pubmed:28561066). binds phosphatidylinositol 3-phosphate (ptdins3p) forming on membranes of the endoplasmic reticulum upon activation of the upstream ulk1 and pi3 kinases and is recruited at phagophore assembly sites where it regulates the elongation of nascent phagophores downstream of wipi2 (pubmed:28561066). in the cellular response to starvation, may also function together with the tsc1-tsc2 complex and rb1cc1 in the inhibition of the mtorc1 signaling pathway (pubmed:28503735). {eco:0000269|pubmed:28503735, eco:0000269|pubmed:28561066}.",subcellular location: preautophagosomal structure {eco:0000269|pubmed:28561066}. lysosome {eco:0000269|pubmed:28561066}.,"TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in heart, skeletal muscle and pancreas. Up-regulated in a variety of tumor tissues including ovarian and uterine cancers. {ECO:0000269|PubMed:15602573}.","DISEASE: Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures (NEDSBAS) [MIM:617977]: An autosomal recessive disorder characterized by profound developmental delay, progressive spastic quadriplegia and contractures, early-onset refractory epilepsy in most patients, and brain malformations. Neuroimaging shows ventriculomegaly, reduced cerebral white matter volume, and thinning of cerebral gray matter. {ECO:0000269|PubMed:28503735}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,WDR45L,56270,Hs.132161,ENST00000392325,THC2509567,"GO:0006914(autophagy)|GO:0031090(organelle membrane)|GO:0042594(response to starvation)|GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","Homo sapiens WDR45-like (WDR45L), mRNA [NM_019613]",chr17:80572621-80572562,hs|17q25.3,WDR45-like,TRUE
920_KRTCAP3_200634,Q53RY4,keratinocyte-associated protein 3 (kcp-3),KRTCAP3 KCP3 UNQ3066/PRO9898,240,NA,subcellular location: membrane; multi-pass membrane protein.,"TISSUE SPECIFICITY: Expressed in skin, pancreas and keratinocytes. {ECO:0000269|PubMed:12752121}.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,KRTCAP3,200634,Hs.59509,ENST00000453171,THC2689023,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens keratinocyte associated protein 3 (KRTCAP3), transcript variant 1, mRNA [NM_001168364]",chr2:27666874-27669169,hs|2p23.3,keratinocyte associated protein 3,TRUE
921_RANBP9_10048,Q96P70,importin-9 (imp9) (ran-binding protein 9) (ranbp9),IPO9 IMP9 KIAA1192 RANBP9 HSPC273,1041,"function: functions in nuclear protein import as nuclear transport receptor (pubmed:11823430). serves as receptor for nuclear localization signals (nls) in cargo substrates (pubmed:11823430). is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (npc) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, ran-dependent mechanism (pubmed:11823430). at the nucleoplasmic side of the npc, ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where gtp hydrolysis releases ran (pubmed:11823430). the directionality of nuclear import is thought to be conferred by an asymmetric distribution of the gtp- and gdp-bound forms of ran between the cytoplasm and nucleus (pubmed:11823430). mediates the nuclear import of rps7, rpl18a, rpl6, histone h2a, histone h2b and histone (pubmed:11823430). prevents the cytoplasmic aggregation of rps7 and rpl18a by shielding exposed basic domains (pubmed:11823430). mediates the nuclear import of actin (by similarity). {eco:0000250|uniprotkb:q91ye6, eco:0000269|pubmed:11823430}.",subcellular location: cytoplasm {eco:0000269|pubmed:11823430}. nucleus {eco:0000269|pubmed:11823430}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RANBP9,10048,Hs.708182,ENST00000011619,THC2466979,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005875(microtubule associated complex)|GO:0006461(protein complex assembly)|GO:0007020(microtubule nucleation)|GO:0007411(axon guidance)|GO:0008536(Ran GTPase binding)|GO:0019899(enzyme binding),"Homo sapiens RAN binding protein 9 (RANBP9), mRNA [NM_005493]",chr6:13622071-13622012,hs|6p23,RAN binding protein 9,TRUE
922_CEP95_90799,Q96GE4,centrosomal protein of 95 kda (cep95) (coiled-coil domain-containing protein 45),CEP95 CCDC45 CEP45,821,NA,"subcellular location: cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843, eco:0000269|pubmed:21399614}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:21399614}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,CEP95,90799,Hs.569713,ENST00000556440,NP1165544,GO:0000922(spindle pole)|GO:0005737(cytoplasm)|GO:0005813(centrosome)|GO:0005856(cytoskeleton),"Homo sapiens centrosomal protein 95kDa (CEP95), mRNA [NM_138363]",chr17:62533931-62533990,hs|17q23.3,centrosomal protein 95kDa,TRUE
923_MRPS6_64968,P82932,"28s ribosomal protein s6, mitochondrial (mrp-s6) (s6mt) (mitochondrial small ribosomal subunit protein bs6m)",MRPS6 C21orf101 RPMS6,125,NA,subcellular location: mitochondrion {eco:0000269|pubmed:25838379}.,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRPS6,64968,Hs.302742,ENST00000483977,THC2623567,GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0006412(translation)|GO:0015935(small ribosomal subunit)|GO:0019843(rRNA binding),"Homo sapiens mitochondrial ribosomal protein S6 (MRPS6), nuclear gene encoding mitochondrial protein, mRNA [NM_032476]",chr21:35515227-35515286,hs|21q22.11,mitochondrial ribosomal protein S6,TRUE
924_IRX3_79191,P78415,iroquois-class homeodomain protein irx-3 (homeodomain protein irxb1) (iroquois homeobox protein 3),IRX3 IRXB1,501,"function: transcription factor involved in shh-dependent neural patterning. together with nkx2-2 and nkx6-1 acts to restrict the generation of motor neurons to the appropriate region of the neural tube. belongs to the class i proteins of neuronal progenitor factors, which are repressed by shh signals. involved in the transcriptional repression of mnx1 in non-motor neuron cells. acts as a regulator of energy metabolism. {eco:0000250|uniprotkb:p81067}.",subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,IRX3,79191,Hs.499205,ENST00000329734,THC2472312,GO:0001656(metanephros development)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0007275(multicellular organismal development)|GO:0007498(mesoderm development)|GO:0043565(sequence-specific DNA binding)|GO:0045665(negative regulation of neuron differentiation)|GO:0045666(positive regulation of neuron differentiation)|GO:0072047(proximal/distal pattern formation involved in nephron development)|GO:0072086(specification of loop of Henle identity),"Homo sapiens iroquois homeobox 3 (IRX3), mRNA [NM_024336]",chr16:54317289-54317230,hs|16q12.2,iroquois homeobox 3,TRUE
925_COX6B1_1340,P14854,cytochrome c oxidase subunit 6b1 (cytochrome c oxidase subunit vib isoform 1) (cox vib-1),COX6B1 COX6B,86,function: connects the two cox monomers into the physiological dimeric form. {eco:0000250}.,subcellular location: mitochondrion intermembrane space {eco:0000250}.,NA,"DISEASE: Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and mental retardation. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome. {ECO:0000269|PubMed:18499082}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COX6B1,1340,Hs.431668,ENST00000392201,THC2662214,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005758(mitochondrial intermembrane space)|GO:0022904(respiratory electron transport chain)|GO:0055114(oxidation-reduction process),"Homo sapiens cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) (COX6B1), nuclear gene encoding mitochondrial protein, mRNA [NM_001863]",chr19:36149509-36149568,hs|19q13.12,cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous),TRUE
926_VPS28_51160,Q9UK41,vacuolar protein sorting-associated protein 28 homolog (h-vps28) (escrt-i complex subunit vps28),VPS28,221,"function: component of the escrt-i complex, a regulator of vesicular trafficking process. {eco:0000269|pubmed:11916981}.",subcellular location: cell membrane {eco:0000269|pubmed:11916981}. late endosome membrane {eco:0000269|pubmed:11916981}; peripheral membrane protein {eco:0000269|pubmed:11916981}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,VPS28,51160,Hs.418175,ENST00000530836,NP1158042,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005768(endosome)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0010008(endosome membrane)|GO:0015031(protein transport)|GO:0016044(cellular membrane organization)|GO:0016197(endosome transport)|GO:0031397(negative regulation of protein ubiquitination)|GO:0031902(late endosome membrane),"Homo sapiens vacuolar protein sorting 28 homolog (S. cerevisiae) (VPS28), transcript variant 2, mRNA [NM_183057]",chr8:145649073-145649014,hs|8q24.3,vacuolar protein sorting 28 homolog (S. cerevisiae),TRUE
927_FKBP9_11328,P68106,peptidyl-prolyl cis-trans isomerase fkbp1b (ppiase fkbp1b) (ec 5.2.1.8) (12.6 kda fk506-binding protein) (12.6 kda fkbp) (fkbp-12.6) (fk506-binding protein 1b) (fkbp-1b) (immunophilin fkbp12.6) (rotamase) (h-fkbp-12),FKBP1B FKBP12.6 FKBP1L FKBP9 OTK4,108,function: has the potential to contribute to the immunosuppressive and toxic effects of fk506 and rapamycin. ppiases accelerate the folding of proteins. it catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.,subcellular location: cytoplasm {eco:0000250}. sarcoplasmic reticulum {eco:0000250}.,TISSUE SPECIFICITY: Detected in heart muscle (at protein level). Isoform 1 and isoform 2 are ubiquitous with highest levels in brain and thymus. {ECO:0000269|PubMed:10830164}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FKBP9,11328,Hs.103934,ENST00000455909,THC2491872,GO:0000413(protein peptidyl-prolyl isomerization)|GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0005509(calcium ion binding)|GO:0005528(FK506 binding)|GO:0005783(endoplasmic reticulum)|GO:0006457(protein folding)|GO:0016020(membrane)|GO:0016853(isomerase activity)|GO:0018208(peptidyl-proline modification),"Homo sapiens FK506 binding protein 9, 63 kDa (FKBP9), mRNA [NM_007270]",chr7:33046439-33046498,hs|7p14.3,"FK506 binding protein 9, 63 kDa",TRUE
928_LOC653061_653061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC653061,653061,Hs.547454,ENST00000450802,THC2504998,NA,"Homo sapiens golgin A8 family, member B pseudogene (LOC653061), non-coding RNA [NR_038843]",chr15:23613391-23613450,hs|15q11.2,"golgin A8 family, member B pseudogene",TRUE
929_SPARCL1_8404,Q14515,sparc-like protein 1 (high endothelial venule protein) (hevin) (mast 9),SPARCL1,664,NA,"subcellular location: secreted, extracellular space, extracellular matrix {eco:0000250}.","TISSUE SPECIFICITY: Highly expressed in lymph node, brain, heart, lung, skeletal muscle, ovary, small intestine, and colon, with lower levels in placenta, pancreas, testis, spleen, and thymus, and no expression in kidney, liver, and peripheral blood leukocytes.",NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,SPARCL1,8404,Hs.62886,ENST00000418378,NP1160816,GO:0005509(calcium ion binding)|GO:0005576(extracellular region)|GO:0005578(proteinaceous extracellular matrix)|GO:0005615(extracellular space)|GO:0007165(signal transduction),"Homo sapiens SPARC-like 1 (hevin) (SPARCL1), transcript variant 2, mRNA [NM_004684]",chr4:88394597-88394538,hs|4q22.1,SPARC-like 1 (hevin),TRUE
93_PABPC3_5042,Q9H361,polyadenylate-binding protein 3 (pabp-3) (poly(a)-binding protein 3) (testis-specific poly(a)-binding protein),PABPC3 PABP3 PABPL3,631,function: binds the poly(a) tail of mrna. may be involved in cytoplasmic regulatory processes of mrna metabolism. binds poly(a) with a slightly lower affinity as compared to pabpc1.,subcellular location: cytoplasm {eco:0000250}.,TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:11328870}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PABPC3,5042,Hs.458280,ENST00000281589,THC2473560,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0005737(cytoplasm)|GO:0008143(poly(A) RNA binding)|GO:0016071(mRNA metabolic process),"Homo sapiens poly(A) binding protein, cytoplasmic 3 (PABPC3), mRNA [NM_030979]",chr13:25672234-25672293,hs|13q12.13,"poly(A) binding protein, cytoplasmic 3",TRUE
930_CEBPB_1051,P17676,ccaat/enhancer-binding protein beta (c/ebp beta) (liver activator protein) (lap) (liver-enriched inhibitory protein) (lip) (nuclear factor nf-il6) (transcription factor 5) (tcf-5),CEBPB TCF5 PP9092,345,"function: important transcription factor regulating the expression of genes involved in immune and inflammatory responses (pubmed:1741402, pubmed:9374525, pubmed:12048245, pubmed:18647749). plays also a significant role in adipogenesis, as well as in the gluconeogenic pathway, liver regeneration, and hematopoiesis. the consensus recognition site is 5'-t[tg]nngnaa[tg]-3'. its functional capacity is governed by protein interactions and post-translational protein modifications. during early embryogenesis, plays essential and redundant functions with cebpa. has a promitotic effect on many cell types such as hepatocytes and adipocytes but has an antiproliferative effect on t-cells by repressing myc expression, facilitating differentiation along the t-helper 2 lineage. binds to regulatory regions of several acute-phase and cytokines genes and plays a role in the regulation of acute-phase reaction and inflammation. plays also a role in intracellular bacteria killing (by similarity). during adipogenesis, is rapidly expressed and, after activation by phosphorylation, induces cebpa and pparg, which turn on the series of adipocyte genes that give rise to the adipocyte phenotype. the delayed transactivation of the cebpa and pparg genes by cebpb appears necessary to allow mitotic clonal expansion and thereby progression of terminal differentiation (pubmed:20829347). essential for female reproduction because of a critical role in ovarian follicle development (by similarity). restricts osteoclastogenesis: together with nfe2l1; represses expression of dspp during odontoblast differentiation (by similarity). {eco:0000250|uniprotkb:p21272, eco:0000250|uniprotkb:p28033, eco:0000269|pubmed:12048245, eco:0000269|pubmed:18647749, eco:0000269|pubmed:20829347, eco:0000269|pubmed:9374525, eco:0000303|pubmed:25451943}.; function: isoform 2: essential for gene expression induction in activated macrophages. plays a major role in immune responses such as cd4(+) t-cell response, granuloma formation and endotoxin shock. not essential for intracellular bacteria killing. {eco:0000250|uniprotkb:p28033}.; function: isoform 3: acts as a dominant negative through heterodimerization with isoform 2 (pubmed:11741938). promotes osteoblast differentiation and osteoclastogenesis (by similarity). {eco:0000250|uniprotkb:p21272, eco:0000250|uniprotkb:p28033, eco:0000269|pubmed:11741938}.","subcellular location: nucleus {eco:0000269|pubmed:20829347}. cytoplasm {eco:0000269|pubmed:9374525}. note=translocates to the nucleus when phosphorylated at ser-288. in t-cells when sumoylated drawn to pericentric heterochromatin thereby allowing proliferation (by similarity). {eco:0000250|uniprotkb:p28033, eco:0000269|pubmed:9374525}.","TISSUE SPECIFICITY: Expressed at low levels in the lung, kidney and spleen.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,CEBPB,1051,Hs.517106,ENST00000303004,THC2511538,"GO:0000790(nuclear chromatin)|GO:0001892(embryonic placenta development)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006916(anti-apoptosis)|GO:0006917(induction of apoptosis)|GO:0006953(acute-phase response)|GO:0006954(inflammatory response)|GO:0006955(immune response)|GO:0008134(transcription factor binding)|GO:0016363(nuclear matrix)|GO:0030182(neuron differentiation)|GO:0032496(response to lipopolysaccharide)|GO:0033598(mammary gland epithelial cell proliferation)|GO:0035259(glucocorticoid receptor binding)|GO:0042803(protein homodimerization activity)|GO:0043565(sequence-specific DNA binding)|GO:0045408(regulation of interleukin-6 biosynthetic process)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046982(protein heterodimerization activity)|GO:0050873(brown fat cell differentiation)|GO:0060644(mammary gland epithelial cell differentiation)|GO:0071230(cellular response to amino acid stimulus)","Homo sapiens CCAAT/enhancer binding protein (C/EBP), beta (CEBPB), mRNA [NM_005194]",chr20:48808989-48809048,hs|20q13.13,"CCAAT/enhancer binding protein (C/EBP), beta",TRUE
931_SPTSSA_171546,Q969W0,serine palmitoyltransferase small subunit a (small subunit of serine palmitoyltransferase a) (ssspta),SPTSSA C14orf147 SSSPTA,71,"function: stimulates the activity of serine palmitoyltransferase (spt). the composition of the serine palmitoyltransferase (spt) complex determines the substrate preference. the sptlc1-sptlc2-sptssa complex shows a strong preference for c16-coa substrate, while the sptlc1-sptlc3-sptssa isozyme uses both c14-coa and c16-coa as substrates, with a slight preference for c14-coa (pubmed:19416851). plays a role in mboat7 location to mitochondria-associated membranes (mams), may me involved in fatty acid remodeling phosphatidylinositol (pi) (pubmed:23510452). {eco:0000269|pubmed:19416851, eco:0000269|pubmed:23510452}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:23510452}; multi-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SPTSSA,171546,Hs.730794,ENST00000298130,THC2468416,GO:0004758(serine C-palmitoyltransferase activity)|GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0017059(serine C-palmitoyltransferase complex)|GO:0030148(sphingolipid biosynthetic process),"Homo sapiens serine palmitoyltransferase, small subunit A (SPTSSA), mRNA [NM_138288]",chr14:34903583-34903524,hs|14q13.1,"serine palmitoyltransferase, small subunit A",TRUE
932_ATP6V0B_533,Q99437,v-type proton atpase 21 kda proteolipid subunit (v-atpase 21 kda proteolipid subunit) (vacuolar proton pump 21 kda proteolipid subunit) (hatpl),ATP6V0B ATP6F,205,function: proton-conducting pore forming subunit of the membrane integral v0 complex of vacuolar atpase. v-atpase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.,subcellular location: vacuole membrane; multi-pass membrane protein.,TISSUE SPECIFICITY: Ubiquitous.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATP6V0B,533,Hs.596514,ENST00000440531,THC2492688,"GO:0005215(transporter activity)|GO:0005773(vacuole)|GO:0005774(vacuolar membrane)|GO:0006811(ion transport)|GO:0006879(cellular iron ion homeostasis)|GO:0008286(insulin receptor signaling pathway)|GO:0010008(endosome membrane)|GO:0015078(hydrogen ion transmembrane transporter activity)|GO:0015991(ATP hydrolysis coupled proton transport)|GO:0015992(proton transport)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0033179(proton-transporting V-type ATPase, V0 domain)|GO:0033572(transferrin transport)|GO:0055085(transmembrane transport)","Homo sapiens ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b (ATP6V0B), transcript variant 1, mRNA [NM_004047]",chr1:44443706-44443765,hs|1p34.1,"ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b",TRUE
933_VCP_7415,P55072,transitional endoplasmic reticulum atpase (ter atpase) (ec 3.6.4.6) (15s mg(2+)-atpase p97 subunit) (valosin-containing protein) (vcp),VCP,806,"function: necessary for the fragmentation of golgi stacks during mitosis and for their reassembly after mitosis. involved in the formation of the transitional endoplasmic reticulum (ter). the transfer of membranes from the endoplasmic reticulum to the golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (ter). vesicle budding from the ter is an atp-dependent process. the ternary complex containing ufd1, vcp and nploc4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the er to the cytoplasm, where they are degraded by the proteasome. the nploc4-ufd1-vcp complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. regulates e3 ubiquitin-protein ligase activity of rnf19a. component of the vcp/p97-amfr/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (erad) of hmgcr. involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (pubmed:26565908). plays a role in the regulation of stress granules (sgs) clearance process upon arsenite-induced response (pubmed:29804830). also involved in dna damage response: recruited to double-strand breaks (dsbs) sites in a rnf8- and rnf168-dependent manner and promotes the recruitment of tp53bp1 at dna damage sites (pubmed:22020440, pubmed:22120668). recruited to stalled replication forks by sprtn: may act by mediating extraction of dna polymerase eta (polh) to prevent excessive translesion dna synthesis and limit the incidence of mutations induced by dna damage (pubmed:23042607, pubmed:23042605). required for cytoplasmic retrotranslocation of stressed/damaged mitochondrial outer-membrane proteins and their subsequent proteasomal degradation (pubmed:16186510, pubmed:21118995). essential for the maturation of ubiquitin-containing autophagosomes and the clearance of ubiquitinated protein by autophagy (pubmed:20104022, pubmed:27753622). acts as a negative regulator of type i interferon production by interacting with ddx58/rig-i: interaction takes place when ddx58/rig-i is ubiquitinated via 'lys-63'-linked ubiquitin on its card domains, leading to recruit rnf125 and promote ubiquitination and degradation of ddx58/rig-i (pubmed:26471729). may play a role in the ubiquitin-dependent sorting of membrane proteins to lysosomes where they undergo degradation (pubmed:21822278). may more particularly play a role in caveolins sorting in cells (pubmed:21822278, pubmed:23335559). by controlling the steady-state expression of the igf1r receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (pubmed:26692333). {eco:0000269|pubmed:15456787, eco:0000269|pubmed:16168377, eco:0000269|pubmed:16186510, eco:0000269|pubmed:20104022, eco:0000269|pubmed:21118995, eco:0000269|pubmed:21822278, eco:0000269|pubmed:22020440, eco:0000269|pubmed:22120668, eco:0000269|pubmed:22607976, eco:0000269|pubmed:23042605, eco:0000269|pubmed:23042607, eco:0000269|pubmed:23335559, eco:0000269|pubmed:26471729, eco:0000269|pubmed:26565908, eco:0000269|pubmed:26692333, eco:0000269|pubmed:27753622, eco:0000269|pubmed:29804830}.","subcellular location: cytoplasm, cytosol {eco:0000269|pubmed:15456787}. endoplasmic reticulum {eco:0000269|pubmed:15215856}. nucleus {eco:0000269|pubmed:23042605, eco:0000269|pubmed:26842564}. cytoplasm, stress granule {eco:0000269|pubmed:29804830}. note=present in the neuronal hyaline inclusion bodies specifically found in motor neurons from amyotrophic lateral sclerosis patients (pubmed:15456787). present in the lewy bodies specifically found in neurons from parkinson disease patients (pubmed:15456787). recruited to the cytoplasmic surface of the endoplasmic reticulum via interaction with amfr/gp78 (pubmed:16168377). following dna double-strand breaks, recruited to the sites of damage (pubmed:22120668). recruited to stalled replication forks via interaction with sprtn (pubmed:23042605). recruited to damaged lysosomes decorated with k48-linked ubiquitin chains (pubmed:27753622). colocalizes with tia1, zfand1 and g3bp1 in cytoplasmic stress granules (sgs) in response to arsenite-induced stress treatment (pubmed:29804830). {eco:0000269|pubmed:15456787, eco:0000269|pubmed:16168377, eco:0000269|pubmed:22120668, eco:0000269|pubmed:23042605, eco:0000269|pubmed:27753622, eco:0000269|pubmed:29804830}.",NA,"DISEASE: Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]: An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance. {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:15732117, ECO:0000269|PubMed:16247064, ECO:0000269|PubMed:16321991, ECO:0000269|PubMed:17935506, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:20335036, ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27209344, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:29804830}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia (ALS14) [MIM:613954]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS14 may develop frontotemporal dementia. {ECO:0000269|PubMed:21145000, ECO:0000269|PubMed:23349634}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2Y (CMT2Y) [MIM:616687]: An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,VCP,7415,Hs.529782,ENST00000493886,THC2621093,"GO:0000166(nucleotide binding)|GO:0000502(proteasome complex)|GO:0005102(receptor binding)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005792(microsome)|GO:0005829(cytosol)|GO:0006200(ATP catabolic process)|GO:0006281(DNA repair)|GO:0006302(double-strand break repair)|GO:0006810(transport)|GO:0006888(ER to Golgi vesicle-mediated transport)|GO:0006919(activation of caspase activity)|GO:0006974(response to DNA damage stimulus)|GO:0008219(cell death)|GO:0008289(lipid binding)|GO:0016567(protein ubiquitination)|GO:0016787(hydrolase activity)|GO:0016887(ATPase activity)|GO:0019903(protein phosphatase binding)|GO:0019904(protein domain specific binding)|GO:0030433(ER-associated protein catabolic process)|GO:0030968(endoplasmic reticulum unfolded protein response)|GO:0030970(retrograde protein transport, ER to cytosol)|GO:0031334(positive regulation of protein complex assembly)|GO:0031593(polyubiquitin binding)|GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)|GO:0042802(identical protein binding)|GO:0042981(regulation of apoptosis)|GO:0043161(proteasomal ubiquitin-dependent protein catabolic process)|GO:0045184(establishment of protein localization)|GO:0045732(positive regulation of protein catabolic process)|GO:0051260(protein homooligomerization)|GO:0070842(aggresome assembly)","Homo sapiens valosin containing protein (VCP), mRNA [NM_007126]",chr9:35057026-35056967,hs|9p13.3,valosin containing protein,TRUE
934_UBB_7314,P0CG47,polyubiquitin-b [cleaved into: ubiquitin],UBB,229,"function: ubiquitin: exists either covalently attached to another protein, or free (unanchored). when covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator met of the ubiquitin (linear polyubiquitin chains). polyubiquitin chains, when attached to a target protein, have different functions depending on the lys residue of the ubiquitin that is linked: lys-6-linked may be involved in dna repair; lys-11-linked is involved in erad (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; lys-29-linked is involved in lysosomal degradation; lys-33-linked is involved in kinase modification; lys-48-linked is involved in protein degradation via the proteasome; lys-63-linked is involved in endocytosis, dna-damage responses as well as in signaling processes leading to activation of the transcription factor nf-kappa-b. linear polymer chains formed via attachment by the initiator met lead to cell signaling. ubiquitin is usually conjugated to lys residues of target proteins, however, in rare cases, conjugation to cys or ser residues has been observed. when polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. {eco:0000269|pubmed:16543144, eco:0000269|pubmed:19754430}.",subcellular location: ubiquitin: cytoplasm {eco:0000250}. nucleus {eco:0000250}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,UBB,7314,Hs.730603,ENST00000302182,THC2583951,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000187(activation of MAPK activity)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002218(activation of innate immune response)|GO:0002224(toll-like receptor signaling pathway)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0002755(MyD88-dependent toll-like receptor signaling pathway)|GO:0002756(MyD88-independent toll-like receptor signaling pathway)|GO:0004842(ubiquitin-protein ligase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005886(plasma membrane)|GO:0006281(DNA repair)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0007173(epidermal growth factor receptor signaling pathway)|GO:0007249(I-kappaB kinase/NF-kappaB cascade)|GO:0007254(JNK cascade)|GO:0008063(Toll signaling pathway)|GO:0008624(induction of apoptosis by extracellular signals)|GO:0010008(endosome membrane)|GO:0016032(viral reproduction)|GO:0016044(cellular membrane organization)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016197(endosome transport)|GO:0030666(endocytic vesicle membrane)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0032480(negative regulation of type I interferon production)|GO:0034130(toll-like receptor 1 signaling pathway)|GO:0034134(toll-like receptor 2 signaling pathway)|GO:0034138(toll-like receptor 3 signaling pathway)|GO:0034142(toll-like receptor 4 signaling pathway)|GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway)|GO:0042981(regulation of apoptosis)|GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade)|GO:0045087(innate immune response)|GO:0048011(nerve growth factor receptor signaling pathway)|GO:0050852(T cell receptor signaling pathway)|GO:0051092(positive regulation of NF-kappaB transcription factor activity)|GO:0051403(stress-activated MAPK cascade)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway)","Homo sapiens ubiquitin B (UBB), mRNA [NM_018955]",chr17:16285505-16285564,hs|17p11.2,ubiquitin B,TRUE
935_HIPK3_10114,Q9H422,homeodomain-interacting protein kinase 3 (ec 2.7.11.1) (androgen receptor-interacting nuclear protein kinase) (anpk) (fas-interacting serine/threonine-protein kinase) (fist) (homolog of protein kinase yak1),HIPK3 DYRK6 FIST3 PKY,1215,"function: serine/threonine-protein kinase involved in transcription regulation, apoptosis and steroidogenic gene expression. phosphorylates jun and runx2. seems to negatively regulate apoptosis by promoting fadd phosphorylation. enhances androgen receptor-mediated transcription. may act as a transcriptional corepressor for nk homeodomain transcription factors. the phosphorylation of nr5a1 activates sf1 leading to increased steroidogenic gene expression upon camp signaling pathway stimulation. in osteoblasts, supports transcription activation: phosphorylates runx2 that synergizes with spen/mint to enhance fgfr2-mediated activation of the osteocalcin fgf-responsive element (ocfre). {eco:0000269|pubmed:14766760, eco:0000269|pubmed:17210646}.",subcellular location: cytoplasm {eco:0000269|pubmed:11034606}. nucleus {eco:0000269|pubmed:11034606}.,"TISSUE SPECIFICITY: Overexpressed in multidrug resistant cells. Highly expressed in heart and skeletal muscle, and at lower levels in placenta, pancreas, brain, spleen, prostate, thymus, testis, small intestine, colon and leukocytes. Not found in liver and lung. {ECO:0000269|PubMed:11034606, ECO:0000269|PubMed:9373137, ECO:0000269|PubMed:9725910}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,HIPK3,10114,Hs.709696,ENST00000303296,THC2497641,"GO:0000166(nucleotide binding)|GO:0004672(protein kinase activity)|GO:0004674(protein serine/threonine kinase activity)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006468(protein phosphorylation)|GO:0006915(apoptosis)|GO:0006916(anti-apoptosis)|GO:0009299(mRNA transcription)|GO:0016605(PML body)|GO:0018105(peptidyl-serine phosphorylation)|GO:0018107(peptidyl-threonine phosphorylation)|GO:0043508(negative regulation of JUN kinase activity)",homeodomain interacting protein kinase 3 [Source:HGNC Symbol;Acc:4915] [ENST00000303296],chr11:33378384-33378443,hs|11p13,homeodomain interacting protein kinase 3,TRUE
936_SESN3_143686,P58005,sestrin-3,SESN3 SEST3,492,"function: may function as an intracellular leucine sensor that negatively regulates the torc1 signaling pathway (pubmed:25263562). may also regulate the insulin-receptor signaling pathway through activation of torc2 (by similarity). this metabolic regulator may also play a role in protection against oxidative and genotoxic stresses (by similarity). {eco:0000250|uniprotkb:p58004, eco:0000250|uniprotkb:q9cyp7, eco:0000269|pubmed:25263562}.",subcellular location: cytoplasm {eco:0000305|pubmed:25263562}.,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:12607115}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SESN3,143686,Hs.120633,ENST00000536441,THC2548286,GO:0005634(nucleus)|GO:0007050(cell cycle arrest),sestrin 3 [Source:HGNC Symbol;Acc:23060] [ENST00000536441],chr11:94898933-94898874,hs|11q21,sestrin 3,TRUE
937_MYL6_4637,P60660,myosin light polypeptide 6 (17 kda myosin light chain) (lc17) (myosin light chain 3) (mlc-3) (myosin light chain alkali 3) (myosin light chain a3) (smooth muscle and nonmuscle myosin light chain alkali 6),MYL6,151,function: regulatory light chain of myosin. does not bind calcium.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,MYL6,4637,Hs.632717,ENST00000550639,THC2505906,GO:0003774(motor activity)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005829(cytosol)|GO:0006936(muscle contraction)|GO:0007411(axon guidance)|GO:0007519(skeletal muscle tissue development)|GO:0008307(structural constituent of muscle)|GO:0016459(myosin complex)|GO:0016461(unconventional myosin complex)|GO:0030049(muscle filament sliding)|GO:0030898(actin-dependent ATPase activity),"Homo sapiens myosin, light chain 6, alkali, smooth muscle and non-muscle (MYL6), transcript variant 2, mRNA [NM_079423]",chr12:56553837-56553896,hs|12q13.2,"myosin, light chain 6, alkali, smooth muscle and non-muscle",TRUE
938_HMGN1_3150,P05114,non-histone chromosomal protein hmg-14 (high mobility group nucleosome-binding domain-containing protein 1),HMGN1 HMG14,100,function: binds to the inner side of the nucleosomal dna thus altering the interaction between the dna and the histone octamer. may be involved in the process which maintains transcribable genes in a unique chromatin conformation. inhibits the phosphorylation of nucleosomal histones h3 and h2a by rps6ka5/msk1 and rps6ka3/rsk2 (by similarity). {eco:0000250}.,subcellular location: nucleus. cytoplasm. note=cytoplasmic enrichment upon phosphorylation. the rna edited version localizes to the nucleus.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HMGN1,3150,Hs.356285,ENST00000436324,THC2501819,"GO:0000785(chromatin)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0032786(positive regulation of transcription elongation, DNA-dependent)","Homo sapiens high mobility group nucleosome binding domain 1 (HMGN1), mRNA [NM_004965]",chr21:40714707-40714648,hs|21q22.2,high mobility group nucleosome binding domain 1,TRUE
939_RNF220_55182,Q5VTB9,e3 ubiquitin-protein ligase rnf220 (ec 2.3.2.27) (ring finger protein 220) (ring-type e3 ubiquitin transferase rnf220),RNF220 C1orf164,566,"function: e3 ubiquitin-protein ligase that promotes the ubiquitination and proteasomal degradation of sin3b (by similarity). independently of its e3 ligase activity, acts as a ctnnb1 stabilizer through usp7-mediated deubiquitination of ctnnb1 promoting wnt signaling (pubmed:25266658). {eco:0000250|uniprotkb:q6pdx6, eco:0000269|pubmed:25266658}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:q6pdx6}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RNF220,55182,Hs.456557,ENST00000480686,THC2501932,GO:0004842(ubiquitin-protein ligase activity)|GO:0005737(cytoplasm)|GO:0008270(zinc ion binding)|GO:0016567(protein ubiquitination)|GO:0016874(ligase activity)|GO:0046872(metal ion binding)|GO:0051865(protein autoubiquitination),"Homo sapiens ring finger protein 220 (RNF220), mRNA [NM_018150]",chr1:45117315-45117374,hs|1p34.1,ring finger protein 220,TRUE
94_SMN1_6606,Q16637,survival motor neuron protein (component of gems 1) (gemin-1),SMN1 SMN SMNT; SMN2 SMNC,294,"function: the smn complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snrnps), the building blocks of the spliceosome. thereby, plays an important role in the splicing of cellular pre-mrnas. most spliceosomal snrnps contain a common set of sm proteins snrpb, snrpd1, snrpd2, snrpd3, snrpe, snrpf and snrpg that assemble in a heptameric protein ring on the sm site of the small nuclear rna to form the core snrnp. in the cytosol, the sm proteins snrpd1, snrpd2, snrpe, snrpf and snrpg are trapped in an inactive 6s picln-sm complex by the chaperone clns1a that controls the assembly of the core snrnp. dissociation by the smn complex of clns1a from the trapped sm proteins and their transfer to an smn-sm complex triggers the assembly of core snrnps and their transport to the nucleus. ensures the correct splicing of u12 intron-containing genes that may be important for normal motor and proprioceptive neurons development. also required for resolving rna-dna hybrids created by rna polymerase ii, that form r-loop in transcription terminal regions, an important step in proper transcription termination. may also play a role in the metabolism of small nucleolar ribonucleoprotein (snornps). {eco:0000269|pubmed:18984161, eco:0000269|pubmed:23063131, eco:0000269|pubmed:26700805, eco:0000269|pubmed:9845364}.","subcellular location: nucleus, gem {eco:0000269|pubmed:11283611, eco:0000269|pubmed:8670859, eco:0000305|pubmed:12067652}. nucleus, cajal body {eco:0000269|pubmed:11283611, eco:0000269|pubmed:21072240, eco:0000305|pubmed:12067652}. cytoplasm {eco:0000269|pubmed:11283611, eco:0000269|pubmed:8670859, eco:0000305|pubmed:12067652}. cytoplasmic granule {eco:0000269|pubmed:14715275}. perikaryon {eco:0000269|pubmed:18093976}. cell projection, neuron projection {eco:0000269|pubmed:18093976}. cell projection, axon {eco:0000250|uniprotkb:p97801}. cytoplasm, myofibril, sarcomere, z line {eco:0000250|uniprotkb:p97801}. note=colocalizes with actin and at the z-line of skeletal muscle (by similarity). under stress conditions colocalizes with rpp20/pop7 in punctuated cytoplasmic granules (pubmed:14715275). colocalized and redistributed with zpr1 from the cytoplasm to nuclear gems (gemini of coiled bodies) and cajal bodies (pubmed:11283611). colocalizes with fmr1 in cytoplasmic granules in the soma and neurite cell processes (pubmed:18093976). {eco:0000250|uniprotkb:p97801, eco:0000269|pubmed:11283611, eco:0000269|pubmed:14715275, eco:0000269|pubmed:18093976}.","TISSUE SPECIFICITY: Expressed in a wide variety of tissues. Expressed at high levels in brain, kidney and liver, moderate levels in skeletal and cardiac muscle, and low levels in fibroblasts and lymphocytes. Also seen at high levels in spinal cord. Present in osteoclasts and mononuclear cells (at protein level). {ECO:0000269|PubMed:11551898, ECO:0000269|PubMed:9259265}.","DISEASE: Spinal muscular atrophy 1 (SMA1) [MIM:253300]: A form of spinal muscular atrophy, a group of neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. Autosomal recessive forms are classified according to the age of onset, the maximum muscular activity achieved, and survivorship. The severity of the disease is mainly determined by the copy number of SMN2, a copy gene which predominantly produces exon 7-skipped transcripts and only low amount of full-length transcripts that encode for a protein identical to SMN1. Only about 4% of SMA patients bear one SMN1 copy with an intragenic mutation. SMA1 is a severe form, with onset before 6 months of age. SMA1 patients never achieve the ability to sit. {ECO:0000269|PubMed:10732817, ECO:0000269|PubMed:14715275, ECO:0000269|PubMed:15249625, ECO:0000269|PubMed:15580564, ECO:0000269|PubMed:21088113, ECO:0000269|PubMed:21389246, ECO:0000269|PubMed:7813012, ECO:0000269|PubMed:9147655}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinal muscular atrophy 2 (SMA2) [MIM:253550]: An autosomal recessive form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. It has intermediate severity, with onset between 6 and 18 months. Patients do not reach the motor milestone of standing, and survive into adulthood. {ECO:0000269|PubMed:10732802, ECO:0000269|PubMed:14715275, ECO:0000269|PubMed:21088113, ECO:0000269|PubMed:9158159, ECO:0000269|PubMed:9837824}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinal muscular atrophy 3 (SMA3) [MIM:253400]: An autosomal recessive form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. Onset is after 18 months. Patients develop ability to stand and walk and survive into adulthood. {ECO:0000269|PubMed:10732817, ECO:0000269|PubMed:14715275, ECO:0000269|PubMed:9158159, ECO:0000269|PubMed:9837824}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinal muscular atrophy 4 (SMA4) [MIM:271150]: An autosomal recessive form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. Onset is in adulthood, disease progression is slow, and patients can stand and walk. {ECO:0000269|PubMed:7658877, ECO:0000269|PubMed:8551862}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SMN1,6606,Hs.535788,ENST00000380707,THC2620559,NA,"Homo sapiens survival of motor neuron 1, telomeric (SMN1), transcript variant d, mRNA [NM_000344]",chr5:70248724-70248783,hs|5q13.2,"survival of motor neuron 1, telomeric",TRUE
940_LIMCH1_22998,Q9UPQ0,lim and calponin homology domains-containing protein 1,LIMCH1 KIAA1102,1083,"function: actin stress fibers-associated protein that activates non-muscle myosin iia. activates the non-muscle myosin iia complex by promoting the phosphorylation of its regulatory subunit mrlc/myl9. through the activation of non-muscle myosin iia, positively regulates actin stress fibers assembly and stabilizes focal adhesions. it therefore negatively regulates cell spreading and cell migration. {eco:0000269|pubmed:28228547}.","subcellular location: cytoplasm, cytoskeleton, stress fiber {eco:0000269|pubmed:28228547}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,LIMCH1,22998,Hs.335163,ENST00000512946,NP1470826,GO:0003779(actin binding)|GO:0008270(zinc ion binding)|GO:0031032(actomyosin structure organization)|GO:0046872(metal ion binding),"Homo sapiens LIM and calponin homology domains 1 (LIMCH1), transcript variant 1, mRNA [NM_014988]",chr4:41700725-41700784,hs|4p13,LIM and calponin homology domains 1,TRUE
941_PSMC1_5700,P62191,26s proteasome regulatory subunit 4 (p26s4) (26s proteasome aaa-atpase subunit rpt2) (proteasome 26s subunit atpase 1),PSMC1,440,"function: component of the 26s proteasome, a multiprotein complex involved in the atp-dependent degradation of ubiquitinated proteins. this complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or dna damage repair. psmc1 belongs to the heterohexameric ring of aaa (atpases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {eco:0000269|pubmed:1317798}.",subcellular location: cytoplasm. nucleus. membrane {eco:0000305}; lipid-anchor {eco:0000305}.,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,PSMC1,5700,Hs.356654,ENST00000261303,THC2492819,"GO:0000075(cell cycle checkpoint)|GO:0000082(G1/S transition of mitotic cell cycle)|GO:0000084(S phase of mitotic cell cycle)|GO:0000166(nucleotide binding)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0000502(proteasome complex)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006200(ATP catabolic process)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0016787(hydrolase activity)|GO:0016887(ATPase activity)|GO:0030163(protein catabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)","Homo sapiens proteasome (prosome, macropain) 26S subunit, ATPase, 1 (PSMC1), mRNA [NM_002802]",chr14:90738839-90738898,hs|14q32.11,"proteasome (prosome, macropain) 26S subunit, ATPase, 1",TRUE
942_DNAJA1_3301,P31689,dnaj homolog subfamily a member 1 (dnaj protein homolog 2) (hsdj) (heat shock 40 kda protein 4) (heat shock protein j2) (hsj-2) (human dnaj protein 2) (hdj-2),DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4,397,"function: co-chaperone for hspa8/hsc70 (pubmed:10816573). stimulates atp hydrolysis, but not the folding of unfolded proteins mediated by hspa1a (in vitro) (pubmed:24318877). plays a role in protein transport into mitochondria via its role as co-chaperone. functions as co-chaperone for hspa1b and negatively regulates the translocation of bax from the cytosol to mitochondria in response to cellular stress, thereby protecting cells against apoptosis (pubmed:14752510). promotes apoptosis in response to cellular stress mediated by exposure to anisomycin or uv (pubmed:24512202). {eco:0000269|pubmed:10816573, eco:0000269|pubmed:14752510, eco:0000269|pubmed:24318877, eco:0000269|pubmed:24512202, eco:0000269|pubmed:9192730}.","subcellular location: membrane {eco:0000305|pubmed:10816573}; lipid-anchor {eco:0000305|pubmed:10816573}. cytoplasm {eco:0000269|pubmed:10816573}. microsome {eco:0000250}. nucleus {eco:0000269|pubmed:10816573}. cytoplasm, perinuclear region {eco:0000269|pubmed:10816573}. mitochondrion {eco:0000250}. note=primarily associated with microsomes. a minor proportion is associated with mitochondria (by similarity). primarily cytoplasmic. a minor proportion is associated with nuclei. {eco:0000250}.","TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is highly expressed in testis and lung, but detected at low levels in thymus, prostate, colon and liver. {ECO:0000269|PubMed:10816573, ECO:0000269|PubMed:15595953}.",NA,NA,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,DNAJA1,3301,Hs.445203,ENST00000539152,THC2469986,"GO:0005524(ATP binding)|GO:0005625(soluble fraction)|GO:0006457(protein folding)|GO:0006986(response to unfolded protein)|GO:0007283(spermatogenesis)|GO:0009408(response to heat)|GO:0016020(membrane)|GO:0030317(sperm motility)|GO:0030521(androgen receptor signaling pathway)|GO:0031072(heat shock protein binding)|GO:0042769(DNA damage response, detection of DNA damage)|GO:0046872(metal ion binding)|GO:0050750(low-density lipoprotein particle receptor binding)|GO:0051082(unfolded protein binding)","Homo sapiens DnaJ (Hsp40) homolog, subfamily A, member 1 (DNAJA1), mRNA [NM_001539]",chr9:33038754-33038813,hs|9p21.1,"DnaJ (Hsp40) homolog, subfamily A, member 1",TRUE
943_CALM1_801,P0DP23,calmodulin-1,CALM1 CALM CAM CAM1,149,"function: calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. together with ccp110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (pubmed:16760425). mediates calcium-dependent inactivation of cacna1c (pubmed:26969752). positively regulates calcium-activated potassium channel activity of kcnn2 (pubmed:27165696). {eco:0000269|pubmed:16760425, eco:0000269|pubmed:23893133, eco:0000269|pubmed:26969752, eco:0000269|pubmed:27165696}.; function: (microbial infection) required for legionella pneumophila sidj glutamylase activity. {eco:0000269|pubmed:31330532}.","subcellular location: cytoplasm, cytoskeleton, spindle {eco:0000269|pubmed:16760425}. cytoplasm, cytoskeleton, spindle pole {eco:0000269|pubmed:16760425}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:14654843}. note=distributed throughout the cell during interphase, but during mitosis becomes dramatically localized to the spindle poles and the spindle microtubules.",NA,"DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT4 inheritance is autosomal dominant. {ECO:0000269|PubMed:23040497, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of CPVT4.; DISEASE: Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24076290, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of LQT14.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,CALM1,801,Hs.282410,ENST00000553630,THC2544384,NA,"Homo sapiens calmodulin 1 (phosphorylase kinase, delta) (CALM1), transcript variant 1, mRNA [NM_006888]",chr14:90871725-90871784,hs|14q32.11,"calmodulin 1 (phosphorylase kinase, delta)",TRUE
944_TXNDC17_84817,Q9BRA2,thioredoxin domain-containing protein 17 (14 kda thioredoxin-related protein) (trp14) (protein 42-9-9) (thioredoxin-like protein 5),TXNDC17 TXNL5,123,"function: disulfide reductase. may participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions. modulates tnf-alpha signaling and nf-kappa-b activation. has peroxidase activity and may contribute to the elimination of cellular hydrogen peroxide. {eco:0000269|pubmed:14607843, eco:0000269|pubmed:14607844}.",subcellular location: cytoplasm {eco:0000269|pubmed:14607844}.,TISSUE SPECIFICITY: Ubiquitously expressed in cell lines. {ECO:0000269|PubMed:14607844}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TXNDC17,84817,Hs.408236,ENST00000250101,THC2679125,GO:0004601(peroxidase activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0009055(electron carrier activity)|GO:0033209(tumor necrosis factor-mediated signaling pathway)|GO:0047134(protein-disulfide reductase activity),"Homo sapiens thioredoxin domain containing 17 (TXNDC17), mRNA [NM_032731]",chr17:6546310-6546369,hs|17p13.1,thioredoxin domain containing 17,TRUE
945_ANKRA2_57763,Q9H9E1,ankyrin repeat family a protein 2 (rfxank-like protein 2),ANKRA2 ANKRA,313,"function: may regulate the interaction between the 3m complex and the histone deacetylases hdac4 and hdac5 (pubmed:25752541). may also regulate lrp2/megalin (by similarity). {eco:0000250|uniprotkb:a2arv4, eco:0000269|pubmed:25752541}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:q99pe2}. membrane {eco:0000250|uniprotkb:q99pe2}; peripheral membrane protein {eco:0000250|uniprotkb:q99pe2}.",NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,ANKRA2,57763,Hs.239154,ENST00000296785,THC2462889,GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0030169(low-density lipoprotein particle binding)|GO:0042826(histone deacetylase binding),"Homo sapiens ankyrin repeat, family A (RFXANK-like), 2 (ANKRA2), mRNA [NM_023039]",chr5:72848323-72848264,hs|5q13.2,"ankyrin repeat, family A (RFXANK-like), 2",TRUE
946_NKTR_4820,P30414,nk-tumor recognition protein (nk-tr protein) (natural-killer cells cyclophilin-related protein) (peptidyl-prolyl cis-trans isomerase nktr) (ppiase) (ec 5.2.1.8) (rotamase),NKTR,1462,"function: ppiase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (pubmed:20676357). component of a putative tumor-recognition complex involved in the function of nk cells (pubmed:8421688). {eco:0000269|pubmed:20676357, eco:0000269|pubmed:8421688}.",subcellular location: cell membrane {eco:0000269|pubmed:8421688}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NKTR,4820,Hs.529509,ENST00000232978,THC2521294,GO:0003755(peptidyl-prolyl cis-trans isomerase activity)|GO:0006457(protein folding)|GO:0016018(cyclosporin A binding)|GO:0016020(membrane)|GO:0016853(isomerase activity),"Homo sapiens natural killer-tumor recognition sequence (NKTR), mRNA [NM_005385]",chr3:42689920-42689979,hs|3p22.1,natural killer-tumor recognition sequence,TRUE
947_HSD17B12_51144,Q53GQ0,very-long-chain 3-oxoacyl-coa reductase (ec 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-hsd 12) (3-ketoacyl-coa reductase) (kar) (estradiol 17-beta-dehydrogenase 12) (ec 1.1.1.62) (short chain dehydrogenase/reductase family 12c member 1),HSD17B12 SDR12C1,312,"function: catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. this endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/vlcfas per cycle. this enzyme has a 3-ketoacyl-coa reductase activity, reducing 3-ketoacyl-coa to 3-hydroxyacyl-coa, within each cycle of fatty acid elongation. thereby, it may participate in the production of vlcfas of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. may also catalyze the transformation of estrone (e1) into estradiol (e2) and play a role in estrogen formation. {eco:0000269|pubmed:12482854, eco:0000269|pubmed:16166196}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12482854}; multi-pass membrane protein {eco:0000269|pubmed:12482854}.,"TISSUE SPECIFICITY: Expressed in most tissues tested. Highly expressed in the ovary and mammary. Expressed in platelets. {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16113833, ECO:0000269|PubMed:16166196}.",NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,HSD17B12,51144,Hs.132513,ENST00000278353,THC2510259,GO:0000166(nucleotide binding)|GO:0001968(fibronectin binding)|GO:0004303(estradiol 17-beta-dehydrogenase activity)|GO:0005518(collagen binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006694(steroid biosynthetic process)|GO:0008201(heparin binding)|GO:0010811(positive regulation of cell-substrate adhesion)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0019432(triglyceride biosynthetic process)|GO:0030198(extracellular matrix organization)|GO:0031012(extracellular matrix)|GO:0035338(long-chain fatty-acyl-CoA biosynthetic process)|GO:0044255(cellular lipid metabolic process),"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12), mRNA [NM_016142]",chr11:43877854-43877913,hs|11p11.2,hydroxysteroid (17-beta) dehydrogenase 12,TRUE
948_IMMT_10989,Q16891,micos complex subunit mic60 (cell proliferation-inducing gene 4/52 protein) (mitochondrial inner membrane protein) (mitofilin) (p87/89),IMMT HMP MIC60 MINOS2 PIG4 PIG52,758,"function: component of the micos complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. plays an important role in the maintenance of the micos complex stability and the mitochondrial cristae morphology (pubmed:22114354, pubmed:25781180). {eco:0000269|pubmed:22114354, eco:0000269|pubmed:25781180}.","subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:25764979, eco:0000269|pubmed:25997101}; single-pass membrane protein {eco:0000255}. mitochondrion {eco:0000269|pubmed:25781180}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,IMMT,10989,Hs.148559,ENST00000398211,THC2470279,GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0008150(biological_process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0031305(integral to mitochondrial inner membrane),"Homo sapiens inner membrane protein, mitochondrial (IMMT), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_006839]",chr2:86371149-86371090,hs|2p11.2,"inner membrane protein, mitochondrial",TRUE
949_DNAJB6_10049,O75190,dnaj homolog subfamily b member 6 (hhdj1) (heat shock protein j2) (hsj-2) (mrj) (msj-1),DNAJB6 HSJ2 MRJ MSJ1,326,"function: plays an indispensable role in the organization of krt8/krt18 filaments. acts as an endogenous molecular chaperone for neuronal proteins including huntingtin. suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins. isoform b but not isoform a inhibits huntingtin aggregation. has a stimulatory effect on the atpase activity of hsp70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of hsp70. also reduces cellular toxicity and caspase-3 activity. {eco:0000269|pubmed:10954706, eco:0000269|pubmed:11896048, eco:0000269|pubmed:20159555, eco:0000269|pubmed:22366786, eco:0000269|pubmed:28233300}.","subcellular location: cytoplasm, perinuclear region {eco:0000269|pubmed:10954706}. nucleus {eco:0000269|pubmed:10954706}. cytoplasm, myofibril, sarcomere, z line {eco:0000269|pubmed:22366786}.","TISSUE SPECIFICITY: Widely expressed. Highest levels in testis and brain, and lower levels in heart, spleen, intestine, ovary, placenta, lung, kidney, pancreas, thymus, prostate, skeletal muscle, liver and leukocytes. In testis, expressed in germ cells in the earlier stages of differentiation pathway as well as in spermatids. In brain, expressed at a higher level in hippocampus and thalamus and a lower level in amygdala, substantia nigra, corpus callosum and caudate nucleus. {ECO:0000269|PubMed:10319584, ECO:0000269|PubMed:11896048, ECO:0000269|PubMed:22366786, ECO:0000269|PubMed:9915854}.","DISEASE: Muscular dystrophy, limb-girdle, autosomal dominant 1 (LGMDD1) [MIM:603511]: An autosomal dominant myopathy characterized by adult onset of proximal muscle weakness, beginning in the hip girdle region and later progressing to the shoulder girdle region. {ECO:0000269|PubMed:22334415, ECO:0000269|PubMed:22366786}. Note=The disease is caused by mutations affecting the gene represented in this entry. There is evidence that LGMDD1 is caused by dysfunction of isoform B (PubMed:22366786). {ECO:0000269|PubMed:22366786}.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DNAJB6,10049,Hs.593923,ENST00000487480,THC2465921,"GO:0001671(ATPase activator activity)|GO:0003677(DNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0006457(protein folding)|GO:0006986(response to unfolded protein)|GO:0031072(heat shock protein binding)|GO:0032781(positive regulation of ATPase activity)|GO:0043154(negative regulation of caspase activity)|GO:0045109(intermediate filament organization)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0048471(perinuclear region of cytoplasm)|GO:0051082(unfolded protein binding)|GO:0051087(chaperone binding)|GO:0060710(chorio-allantoic fusion)","Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 6 (DNAJB6), transcript variant 2, mRNA [NM_005494]",chr7:157178663-157178722,hs|7q36.3,"DnaJ (Hsp40) homolog, subfamily B, member 6",TRUE
95_AHNAK_79026,Q8IVF2,protein ahnak2,AHNAK2 C14orf78 KIAA2019,5795,NA,subcellular location: nucleus {eco:0000250}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,AHNAK,79026,Hs.502756,ENST00000378024,THC2462835,GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0007399(nervous system development),"Homo sapiens AHNAK nucleoprotein (AHNAK), transcript variant 1, mRNA [NM_001620]",chr11:62283459-62283400,hs|11q12.3,AHNAK nucleoprotein,TRUE
950_LOC100287195_100287195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA,LOC100287195,100287195,Hs.528369,NA,NA,NA,"PREDICTED: Homo sapiens 60S ribosomal protein L23a-like (LOC100287195), miscRNA [XR_132905]",chr3:75673786-75673770,hs|3p12.3,60S ribosomal protein L23a-like,TRUE
951_ENTPD6_955,O75354,ectonucleoside triphosphate diphosphohydrolase 6 (ntpdase 6) (ec 3.6.1.6) (cd39 antigen-like 2),ENTPD6 CD39L2 IL6ST2,484,"function: might support glycosylation reactions in the golgi apparatus and, when released from cells, might catalyze the hydrolysis of extracellular nucleotides. hydrolyzes preferentially nucleoside 5'-diphosphates, nucleoside 5'-triphosphates are hydrolyzed only to a minor extent, there is no hydrolysis of nucleoside 5'-monophosphates. the order of activity with different substrates is gdp > idp >> udp = cdp >> adp (by similarity). {eco:0000250}.",subcellular location: golgi apparatus membrane; single-pass type ii membrane protein. secreted. note=but also occurs in a soluble extracellular form.,"TISSUE SPECIFICITY: Expressed in most tissues, but predominantly in heart. {ECO:0000269|PubMed:11041856}.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ENTPD6,955,Hs.500375,ENST00000376641,THC2774650,"GO:0000139(Golgi membrane)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005624(membrane fraction)|GO:0005794(Golgi apparatus)|GO:0008894(guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity)|GO:0009986(cell surface)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0017111(nucleoside-triphosphatase activity)|GO:0032026(response to magnesium ion)|GO:0045134(uridine-diphosphatase activity)|GO:0051592(response to calcium ion)","Homo sapiens ectonucleoside triphosphate diphosphohydrolase 6 (putative) (ENTPD6), transcript variant 1, mRNA [NM_001247]",chr20:25207043-25207102,hs|20p11.21,ectonucleoside triphosphate diphosphohydrolase 6 (putative),TRUE
952_MYEOV2_150678,Q8WXC6,cop9 signalosome complex subunit 9 (csn acidic protein) (csnap) (myeloma-overexpressed gene 2 protein),COPS9 MYEOV2,57,"function: isoform 1: component of the cop9 signalosome complex (csn), a complex involved in various cellular and developmental processes. the csn complex is an essential regulator of the ubiquitin (ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of scf-type e3 ligase complexes, leading to decrease the ubl ligase activity of scf-type complexes such as scf, csa or ddb2. the complex is also involved in phosphorylation of p53/tp53, c-jun/jun, ikappabalpha/nfkbia, itpk1 and irf8/icsbp, possibly via its association with ck2 and pkd kinases. csn-dependent phosphorylation of tp53 and jun promotes and protects degradation by the ubl system, respectively. plays a role in cell proliferation. {eco:0000269|pubmed:26456823}.; function: isoform 2: negatively regulates neddylation of proteins, including ribosoaml protein rpl11. {eco:0000269|pubmed:23776465}.","subcellular location: isoform 1: nucleus {eco:0000269|pubmed:26456823}. cytoplasm {eco:0000269|pubmed:26456823}. nucleus, nucleoplasm {eco:0000269|pubmed:26456823}. note=excluded from the nucleolus. recruited to the nucleoplasm and chromatin following dna damage induction. {eco:0000269|pubmed:26456823}.; subcellular location: isoform 2: nucleus, nucleoplasm {eco:0000269|pubmed:23776465}. note=excluded from the nucleolus. {eco:0000269|pubmed:23776465}.",NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MYEOV2,150678,Hs.293884,ENST00000491765,THC2607559,NA,"Homo sapiens myeloma overexpressed 2 (MYEOV2), transcript variant 2, mRNA [NM_001163424]",chr2:241070356-241070297,hs|2q37.3,myeloma overexpressed 2,TRUE
953_AP3S1_1176,Q92572,"ap-3 complex subunit sigma-1 (ap-3 complex subunit sigma-3a) (adaptor-related protein complex 3 subunit sigma-1) (clathrin-associated/assembly/adaptor protein, small 3) (sigma-3a-adaptin) (sigma3a-adaptin) (sigma-adaptin 3a)",AP3S1 CLAPS3,193,"function: part of the ap-3 complex, an adaptor-related complex which is not clathrin-associated. the complex is associated with the golgi region as well as more peripheral structures. it facilitates the budding of vesicles from the golgi membrane and may be directly involved in trafficking to lysosomes. in concert with the bloc-1 complex, ap-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals.",subcellular location: golgi apparatus. cytoplasmic vesicle membrane; peripheral membrane protein; cytoplasmic side. note=component of the coat surrounding the cytoplasmic face of coated vesicles located at the golgi complex.,"TISSUE SPECIFICITY: Present in all adult tissues examined. {ECO:0000269|PubMed:8697810, ECO:0000269|PubMed:9118953, ECO:0000269|PubMed:9151686}.",NA,NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,AP3S1,1176,Hs.728956,ENST00000395548,THC2492016,GO:0005215(transporter activity)|GO:0005515(protein binding)|GO:0005794(Golgi apparatus)|GO:0006810(transport)|GO:0006886(intracellular protein transport)|GO:0008286(insulin receptor signaling pathway)|GO:0008565(protein transporter activity)|GO:0016020(membrane)|GO:0016192(vesicle-mediated transport)|GO:0030119(AP-type membrane coat adaptor complex)|GO:0030133(transport vesicle)|GO:0030659(cytoplasmic vesicle membrane)|GO:0031410(cytoplasmic vesicle),"Homo sapiens adaptor-related protein complex 3, sigma 1 subunit (AP3S1), mRNA [NM_001284]",chr5:115249541-115249600,hs|5q23.1,"adaptor-related protein complex 3, sigma 1 subunit",TRUE
954_FAM177A1_283635,Q8N128,protein fam177a1,FAM177A1 C14orf24,213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,FAM177A1,283635,Hs.446357,ENST00000382406,THC2529415,NA,"Homo sapiens family with sequence similarity 177, member A1 (FAM177A1), transcript variant 2, mRNA [NM_001079519]",chr14:35546376-35548145,hs|14q13.2,"family with sequence similarity 177, member A1",TRUE
955_TCEA1_6917,P23193,transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o),TCEA1 GTF2S TFIIS,301,"function: necessary for efficient rna polymerase ii transcription elongation past template-encoded arresting sites. the arresting sites in dna have the property of trapping a certain fraction of elongating rna polymerases that pass through, resulting in locked ternary complexes. cleavage of the nascent transcript by s-ii allows the resumption of elongation from the new 3'-terminus.",subcellular location: nucleus.,NA,DISEASE: Note=A chromosomal aberration involving TCEA1 may be a cause of salivary gland pleiomorphic adenomas (PA) [181030]. Pleiomorphic adenomas are the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1. {ECO:0000269|PubMed:10029085}.,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TCEA1,6917,Hs.491745,ENST00000521086,THC2469922,"GO:0003677(DNA binding)|GO:0003746(translation elongation factor activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0006281(DNA repair)|GO:0006283(transcription-coupled nucleotide-excision repair)|GO:0006289(nucleotide-excision repair)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0008270(zinc ion binding)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0030218(erythrocyte differentiation)|GO:0032784(regulation of transcription elongation, DNA-dependent)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0046872(metal ion binding)|GO:0050434(positive regulation of viral transcription)","Homo sapiens transcription elongation factor A (SII), 1 (TCEA1), transcript variant 1, mRNA [NM_006756]",chr8:54879408-54879349,hs|8q11.23,"transcription elongation factor A (SII), 1",TRUE
956_RBM14_10432,Q96PK6,rna-binding protein 14 (paraspeckle protein 2) (psp2) (rna-binding motif protein 14) (rrm-containing coactivator activator/modulator) (synaptotagmin-interacting protein) (syt-interacting protein),RBM14 SIP,669,"function: isoform 1 may function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as ncoa6 and cited1. isoform 2, functions as a transcriptional repressor, modulating transcriptional activities of coactivators including isoform 1, ncoa6 and cited1 (pubmed:11443112). regulates centriole biogenesis by suppressing the formation of aberrant centriolar protein complexes in the cytoplasm and thus preserving mitotic spindle integrity. prevents the formation of the stil-cenpj complex (which can induce the formation of aberrant centriolar protein complexes) by interfering with the interaction of stil with cenpj (pubmed:25385835). plays a role in the regulation of dna virus-mediated innate immune response by assembling into the hdp-rnp complex, a complex that serves as a platform for irf3 phosphorylation and subsequent innate immune response activation through the cgas-sting pathway (pubmed:28712728). {eco:0000269|pubmed:11443112, eco:0000269|pubmed:25385835, eco:0000269|pubmed:28712728}.","subcellular location: nucleus {eco:0000269|pubmed:25385835}. nucleus, nucleolus {eco:0000269|pubmed:11790299}. cytoplasm {eco:0000269|pubmed:25385835}. note=in punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles (pubmed:11790299). cytoplasmic localization is crucial for its function in suppressing the formation of aberrant centriolar protein complexes (pubmed:25385835). {eco:0000269|pubmed:11790299, eco:0000269|pubmed:25385835}.","TISSUE SPECIFICITY: Expressed in all tissues tested, including brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung and peripheral blood lymphocytes.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RBM14,10432,Hs.714949,ENST00000310137,THC2469719,"GO:0000166(nucleotide binding)|GO:0001104(RNA polymerase II transcription cofactor activity)|GO:0003676(nucleic acid binding)|GO:0003723(RNA binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0005730(nucleolus)|GO:0006260(DNA replication)|GO:0006281(DNA repair)|GO:0006310(DNA recombination)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0009725(response to hormone stimulus)|GO:0016575(histone deacetylation)|GO:0016592(mediator complex)|GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity)|GO:0030520(estrogen receptor signaling pathway)|GO:0030529(ribonucleoprotein complex)|GO:0030674(protein binding, bridging)|GO:0042921(glucocorticoid receptor signaling pathway)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","Homo sapiens RNA binding motif protein 14 (RBM14), transcript variant 1, mRNA [NM_006328]",chr11:66394693-66394752,hs|11q13.2,RNA binding motif protein 14,TRUE
957_COPB2_9276,P35606,coatomer subunit beta' (beta'-coat protein) (beta'-cop) (p102),COPB2,906,"function: the coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the er, via the golgi up to the trans golgi network. coatomer complex is required for budding from golgi membranes, and is essential for the retrograde golgi-to-er transport of dilysine-tagged proteins. in mammals, the coatomer can only be recruited by membranes associated to adp-ribosylation factors (arfs), which are small gtp-binding proteins; the complex also influences the golgi structural integrity, as well as the processing, activity, and endocytic recycling of ldl receptors (by similarity). {eco:0000250}.; function: this coatomer complex protein, essential for golgi budding and vesicular trafficking, is a selective binding protein (rack) for protein kinase c, epsilon type. it binds to golgi membranes in a gtp-dependent manner (by similarity). {eco:0000250}.","subcellular location: cytoplasm, cytosol {eco:0000250}. golgi apparatus membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}. cytoplasmic vesicle, copi-coated vesicle membrane {eco:0000250}; peripheral membrane protein {eco:0000250}; cytoplasmic side {eco:0000250}. note=the coatomer is cytoplasmic or polymerized on the cytoplasmic side of the golgi, as well as on the vesicles/buds originating from it. shows only a slight preference for the cis-golgi apparatus, compared with the trans-golgi. {eco:0000250}.",NA,"DISEASE: Microcephaly 19, primary, autosomal recessive (MCPH19) [MIM:617800]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH19 affected individuals manifest severe developmental delay, failure to thrive, cortical blindness, and spasticity. Brain imaging show a simplified gyral pattern, thin corpus callosum, slight ventricular dilation, and delayed myelination. {ECO:0000269|PubMed:29036432}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,COPB2,9276,Hs.75724,ENST00000333188,THC2469778,"GO:0000139(Golgi membrane)|GO:0005198(structural molecule activity)|GO:0005488(binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006886(intracellular protein transport)|GO:0006890(retrograde vesicle-mediated transport, Golgi to ER)|GO:0006891(intra-Golgi vesicle-mediated transport)|GO:0015629(actin cytoskeleton)|GO:0016020(membrane)|GO:0016044(cellular membrane organization)|GO:0016192(vesicle-mediated transport)|GO:0030117(membrane coat)|GO:0030126(COPI vesicle coat)|GO:0031410(cytoplasmic vesicle)|GO:0048205(COPI coating of Golgi vesicle)","Homo sapiens coatomer protein complex, subunit beta 2 (beta prime) (COPB2), transcript variant 1, mRNA [NM_004766]",chr3:139076652-139076593,hs|3q23,"coatomer protein complex, subunit beta 2 (beta prime)",TRUE
958_SAT2_112483,Q96QD8,sodium-coupled neutral amino acid transporter 2 (amino acid transporter a2) (protein 40-9-1) (solute carrier family 38 member 2) (system a amino acid transporter 2) (system a transporter 1) (system n amino acid transporter 2),SLC38A2 ATA2 KIAA1382 SAT2 SNAT2,506,"function: functions as a sodium-dependent amino acid transporter. mediates the saturable, ph-sensitive and electrogenic cotransport of neutral amino acids and sodium ions with a stoichiometry of 1:1. may function in the transport of amino acids at the blood-brain barrier and in the supply of maternal nutrients to the fetus through the placenta. {eco:0000269|pubmed:10930503, eco:0000269|pubmed:15922329}.","subcellular location: cell membrane {eco:0000269|pubmed:15561425, eco:0000269|pubmed:16616430}; multi-pass membrane protein {eco:0000269|pubmed:15561425, eco:0000269|pubmed:16616430}. note=insulin promotes recruitment to the plasma membrane from a pool localized in the trans-golgi network or endosomes (by similarity). enriched in the somatodendritic compartment of neurons, it is also detected at the axonal shaft but excluded from the nerve terminal. {eco:0000250}.","TISSUE SPECIFICITY: Ubiquitously expressed. Widely expressed in the central nervous system with higher concentrations in caudal regions. Expressed by glutamatergic and GABAergic neurons together with astrocytes and other non-neuronal cells in the cerebral cortex (at protein level). {ECO:0000269|PubMed:10930503, ECO:0000269|PubMed:15561425, ECO:0000269|PubMed:16616430}.",NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SAT2,112483,Hs.10846,ENST00000269298,THC2502033,"GO:0004145(diamine N-acetyltransferase activity)|GO:0005737(cytoplasm)|GO:0008152(metabolic process)|GO:0016746(transferase activity, transferring acyl groups)","Homo sapiens spermidine/spermine N1-acetyltransferase family member 2 (SAT2), mRNA [NM_133491]",chr17:7529665-7529606,hs|17p13.1,spermidine/spermine N1-acetyltransferase family member 2,TRUE
959_NCOR2_9612,Q9Y618,"nuclear receptor corepressor 2 (n-cor2) (ctg repeat protein 26) (smap270) (silencing mediator of retinoic acid and thyroid hormone receptor) (smrt) (t3 receptor-associating factor) (trac) (thyroid-, retinoic-acid-receptor-associated corepressor)",NCOR2 CTG26,2514,"function: transcriptional corepressor (pubmed:20812024). mediates the transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access of the basal transcription. isoform 1 and isoform 4 have different affinities for different nuclear receptors. involved in the regulation bcl6-dependent of the germinal center (gc) reactions, mainly through the control of the gc b-cells proliferation and survival. recruited by zbtb7a to the androgen response elements/are on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (pubmed:20812024). {eco:0000269|pubmed:18212045, eco:0000269|pubmed:20812024, eco:0000269|pubmed:23911289}.",subcellular location: nucleus.,"TISSUE SPECIFICITY: Ubiquitous. High levels of expression are detected in lung, spleen and brain.",NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NCOR2,9612,Hs.137510,ENST00000356219,THC2472010,GO:0000118(histone deacetylase complex)|GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0001701(in utero embryonic development)|GO:0003007(heart morphogenesis)|GO:0003682(chromatin binding)|GO:0003714(transcription corepressor activity)|GO:0005112(Notch binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0016604(nuclear body)|GO:0017053(transcriptional repressor complex)|GO:0021537(telencephalon development)|GO:0021846(cell proliferation in forebrain)|GO:0042593(glucose homeostasis)|GO:0042826(histone deacetylase binding)|GO:0043565(sequence-specific DNA binding)|GO:0044255(cellular lipid metabolic process)|GO:0045599(negative regulation of fat cell differentiation)|GO:0047485(protein N-terminus binding)|GO:0050872(white fat cell differentiation)|GO:0072365(regulation of cellular ketone metabolic process by negative regulation of transcription from an RNA polymerase II promoter),"Homo sapiens nuclear receptor corepressor 2 (NCOR2), transcript variant 1, mRNA [NM_006312]",chr12:124809053-124808994,hs|12q24.31,nuclear receptor corepressor 2,TRUE
96_ND1_4535,P03886,nadh-ubiquinone oxidoreductase chain 1 (ec 7.1.1.2) (nadh dehydrogenase subunit 1),MT-ND1 MTND1 NADH1 ND1,318,function: core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase (complex i) that is believed to belong to the minimal assembly required for catalysis. complex i functions in the transfer of electrons from nadh to the respiratory chain. the immediate electron acceptor for the enzyme is believed to be ubiquinone (by similarity). {eco:0000250}.,subcellular location: mitochondrion inner membrane {eco:0000250}; multi-pass membrane protein {eco:0000250}.,NA,"DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. {ECO:0000269|PubMed:1417830, ECO:0000269|PubMed:1674640, ECO:0000269|PubMed:1900003, ECO:0000269|PubMed:1928099, ECO:0000269|PubMed:1959619, ECO:0000269|PubMed:2018041}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]: Genetically heterogeneous disorder, characterized by episodic vomiting, seizures, and recurrent cerebral insults resembling strokes and causing hemiparesis, hemianopsia, or cortical blindness. {ECO:0000269|PubMed:8723687}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alzheimer disease mitochondrial (AD-MT) [MIM:502500]: Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:8104867}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:15265369, ECO:0000269|PubMed:7733935}. Note=The gene represented in this entry may be involved in disease pathogenesis.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ND1,4535,Hs.511386,ENST00000361390,THC2510699,"GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005747(mitochondrial respiratory chain complex I)|GO:0006120(mitochondrial electron transport, NADH to ubiquinone)|GO:0006810(transport)|GO:0006950(response to stress)|GO:0008137(NADH dehydrogenase (ubiquinone) activity)|GO:0014070(response to organic cyclic compound)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016491(oxidoreductase activity)|GO:0022904(respiratory electron transport chain)|GO:0031966(mitochondrial membrane)|GO:0033194(response to hydroperoxide)|GO:0042493(response to drug)|GO:0070469(respiratory chain)",mitochondrially encoded NADH dehydrogenase 1 [Source:HGNC Symbol;Acc:7455] [ENST00000361390],chrM:4181-4240,NA,"NADH dehydrogenase, subunit 1 (complex I)",TRUE
961_GGA1_26088,Q9UJY5,"adp-ribosylation factor-binding protein gga1 (gamma-adaptin-related protein 1) (golgi-localized, gamma ear-containing, arf-binding protein 1)",GGA1,639,"function: plays a role in protein sorting and trafficking between the trans-golgi network (tgn) and endosomes. mediates the arf-dependent recruitment of clathrin to the tgn and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (dxxll) motif (pubmed:11301005, pubmed:15886016). mediates export of the gpcr receptor adra2b to the cell surface (pubmed:27901063). required for targeting pkd1:pkd2 complex from the trans-golgi network to the cilium membrane (by similarity). regulates retrograde transport of proteins such as phosphorylated form of bace1 from endosomes to the trans-golgi network (pubmed:15886016, pubmed:15615712). {eco:0000250|uniprotkb:q8r0h9, eco:0000269|pubmed:11301005, eco:0000269|pubmed:15615712, eco:0000269|pubmed:15886016, eco:0000269|pubmed:27901063}.","subcellular location: golgi apparatus, trans-golgi network membrane {eco:0000269|pubmed:15886016}; peripheral membrane protein. endosome membrane {eco:0000269|pubmed:15886016}; peripheral membrane protein. early endosome membrane {eco:0000269|pubmed:15886016}; peripheral membrane protein {eco:0000305}.",TISSUE SPECIFICITY: Ubiquitously expressed.,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GGA1,26088,Hs.499158,ENST00000406772,THC2514269,GO:0003674(molecular_function)|GO:0005515(protein binding)|GO:0005768(endosome)|GO:0005794(Golgi apparatus)|GO:0006886(intracellular protein transport)|GO:0010008(endosome membrane)|GO:0016020(membrane)|GO:0016192(vesicle-mediated transport)|GO:0030131(clathrin adaptor complex)|GO:0044431(Golgi apparatus part),"Homo sapiens golgi-associated, gamma adaptin ear containing, ARF binding protein 1 (GGA1), transcript variant 2, mRNA [NM_001001560]",chr22:38029480-38029539,hs|22q13.1,"golgi-associated, gamma adaptin ear containing, ARF binding protein 1",TRUE
962_INSIG1_3638,O15503,insulin-induced gene 1 protein (insig-1),INSIG1,277,"function: mediates feedback control of cholesterol synthesis by controlling scap and hmgcr. functions by blocking the processing of sterol regulatory element-binding proteins (srebps). capable of retaining the scap-srebf2 complex in the er thus preventing it from escorting srebps to the golgi. initiates the sterol-mediated ubiquitin-mediated endoplasmic reticulum-associated degradation (erad) of hmgcr via recruitment of the reductase to the ubiquitin ligase, amfr/gp78. may play a role in growth and differentiation of tissues involved in metabolic control. may play a regulatory role during g0/g1 transition of cell growth. {eco:0000269|pubmed:12202038, eco:0000269|pubmed:12535518, eco:0000269|pubmed:16168377, eco:0000269|pubmed:16399501, eco:0000269|pubmed:16606821}.",subcellular location: endoplasmic reticulum membrane {eco:0000269|pubmed:12202038}; multi-pass membrane protein {eco:0000269|pubmed:12202038}.,TISSUE SPECIFICITY: Expressed in all tissues tested with highest expression in the liver. {ECO:0000269|PubMed:12202038}.,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,INSIG1,3638,Hs.520819,ENST00000344756,THC2469739,GO:0005515(protein binding)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0006641(triglyceride metabolic process)|GO:0006695(cholesterol biosynthetic process)|GO:0006991(response to sterol depletion)|GO:0008152(metabolic process)|GO:0008202(steroid metabolic process)|GO:0008283(cell proliferation)|GO:0010894(negative regulation of steroid biosynthetic process)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0030967(ER-nuclear sterol response pathway)|GO:0042472(inner ear morphogenesis)|GO:0042474(middle ear morphogenesis)|GO:0045599(negative regulation of fat cell differentiation)|GO:0045717(negative regulation of fatty acid biosynthetic process)|GO:0060021(palate development)|GO:0060363(cranial suture morphogenesis),"Homo sapiens insulin induced gene 1 (INSIG1), transcript variant 2, mRNA [NM_198336]",chr7:155100071-155100130,hs|7q36.3,insulin induced gene 1,TRUE
963_MUT_4594,P22033,"methylmalonyl-coa mutase, mitochondrial (mcm) (ec 5.4.99.2) (methylmalonyl-coa isomerase)",MMUT MUT,750,"function: involved in the degradation of several amino acids, odd-chain fatty acids and cholesterol via propionyl-coa to the tricarboxylic acid cycle. mcm has different functions in other species.",subcellular location: mitochondrion matrix.,NA,"DISEASE: Methylmalonic aciduria type mut (MMAM) [MIM:251000]: An often fatal disorder of organic acid metabolism. Common clinical features include lethargy, vomiting, failure to thrive, hypotonia, neurological deficit and early death. Two forms of the disease are distinguished by the presence (mut-) or absence (mut0) of residual enzyme activity. Mut0 patients have more severe neurological manifestations of the disease than do MUT- patients. MMAM is unresponsive to vitamin B12 therapy. {ECO:0000269|PubMed:10923046, ECO:0000269|PubMed:11350191, ECO:0000269|PubMed:1346616, ECO:0000269|PubMed:1351030, ECO:0000269|PubMed:15643616, ECO:0000269|PubMed:15781192, ECO:0000269|PubMed:16281286, ECO:0000269|PubMed:1670635, ECO:0000269|PubMed:17113806, ECO:0000269|PubMed:17957493, ECO:0000269|PubMed:19588269, ECO:0000269|PubMed:1977311, ECO:0000269|PubMed:1980486, ECO:0000269|PubMed:22727635, ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:26615597, ECO:0000269|PubMed:27167370, ECO:0000269|PubMed:28101778, ECO:0000269|PubMed:7909321, ECO:0000269|PubMed:7912889, ECO:0000269|PubMed:9285782, ECO:0000269|PubMed:9452100, ECO:0000269|PubMed:9554742}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MUT,4594,Hs.485527,ENST00000274813,THC2612962,GO:0004494(methylmalonyl-CoA mutase activity)|GO:0005739(mitochondrion)|GO:0005759(mitochondrial matrix)|GO:0006635(fatty acid beta-oxidation)|GO:0009791(post-embryonic development)|GO:0031419(cobalamin binding)|GO:0044255(cellular lipid metabolic process)|GO:0046872(metal ion binding),"Homo sapiens methylmalonyl CoA mutase (MUT), nuclear gene encoding mitochondrial protein, mRNA [NM_000255]",chr6:49399349-49399290,hs|6p12.3,methylmalonyl CoA mutase,TRUE
964_C20orf24_55969,Q9BUV8,uncharacterized protein rab5if (rab5-interacting protein) (rip5),RAB5IF C20orf24 PNAS-11,137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,NA,C20orf24,55969,Hs.584985,ENST00000483815,THC2603081,GO:0003674(molecular_function)|GO:0005575(cellular_component)|GO:0005739(mitochondrion)|GO:0008150(biological_process),"Homo sapiens chromosome 20 open reading frame 24 (C20orf24), transcript variant 1, mRNA [NM_018840]",chr20:35240817-35240876,hs|20q11.23,chromosome 20 open reading frame 24,TRUE
965_DAZAP1_26528,Q96EP5,daz-associated protein 1 (deleted in azoospermia-associated protein 1),DAZAP1,407,"function: rna-binding protein, which may be required during spermatogenesis.","subcellular location: cytoplasm {eco:0000269|pubmed:22001406}. nucleus {eco:0000269|pubmed:22001406}. note=predominantly cytoplasmic (by similarity). nuclear at some stages of spermatozoides development. in midpachytene spermatocytes, it is localized in both the cytoplasm and the nuclei and is clearly excluded from the sex vesicles. in round spermatids, it localizes mainly in the nuclei, whereas in elongated spermatids, it localizes to the cytoplasm (by similarity). {eco:0000250}.","TISSUE SPECIFICITY: Mainly expressed in testis. Expressed to a lower level in thymus. Weakly or not expressed in heart, liver, brain, placenta, lung, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:10857750}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DAZAP1,26528,Hs.222510,ENST00000336761,THC2595879,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007275(multicellular organismal development)|GO:0007283(spermatogenesis)|GO:0030154(cell differentiation),"Homo sapiens DAZ associated protein 1 (DAZAP1), transcript variant 1, mRNA [NM_170711]",chr19:1435198-1435257,hs|19p13.3,DAZ associated protein 1,TRUE
966_TARS_6897,P26639,"threonine--trna ligase 1, cytoplasmic (ec 6.1.1.3) (threonyl-trna synthetase) (thrrs) (threonyl-trna synthetase 1)",TARS1 TARS,723,"function: catalyzes the attachment of threonine to trna(thr) in a two-step reaction: threonine is first activated by atp to form thr-amp and then transferred to the acceptor end of trna(thr) (pubmed:25824639). also edits incorrectly charged trna(thr) via its editing domain, at the post-transfer stage (by similarity). {eco:0000250|uniprotkb:q9d0r2, eco:0000269|pubmed:25824639}.",subcellular location: cytoplasm {eco:0000250|uniprotkb:q9d0r2}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TARS,6897,Hs.481860,ENST00000502553,THC2743849,GO:0000166(nucleotide binding)|GO:0004829(threonine-tRNA ligase activity)|GO:0005524(ATP binding)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006418(tRNA aminoacylation for protein translation)|GO:0006435(threonyl-tRNA aminoacylation)|GO:0010467(gene expression)|GO:0015629(actin cytoskeleton)|GO:0016874(ligase activity)|GO:0042803(protein homodimerization activity),"Homo sapiens threonyl-tRNA synthetase (TARS), mRNA [NM_152295]",chr5:33467942-33468001,hs|5p13.3,threonyl-tRNA synthetase,TRUE
967_FAM111A_63901,Q96PZ2,protein fam111a,FAM111A KIAA1895,611,"function: chromatin-associated protein required for pcna loading on replication sites. promotes s-phase entry and dna synthesis (pubmed:24561620). may directly function at replication forks, explaining why simian virus 40 (sv40) interacts with fam111a to overcome host range restriction (pubmed:23093934). {eco:0000269|pubmed:23093934, eco:0000269|pubmed:24561620}.",subcellular location: nucleus. cytoplasm. note=mainly localizes to nucleus: colocalizes with pcna on replication sites. {eco:0000269|pubmed:24561620}.,NA,"DISEASE: Kenny-Caffey syndrome 2 (KCS2) [MIM:127000]: A disorder characterized by impaired skeletal development with small and dense bones, short stature, and primary hypoparathyroidism with hypocalcemia. Clinical features include cortical thickening and medullary stenosis of the tubular bones, delayed closure of fontanels, defective dentition, small eyes with hypermetropia, and frontal bossing with a triangular face. {ECO:0000269|PubMed:23684011, ECO:0000269|PubMed:23996431, ECO:0000269|PubMed:24635597}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gracile bone dysplasia (GCLEB) [MIM:602361]: A perinatally lethal condition characterized by narrowing of the medullary cavity of the long bones and of the skull, gracile bones with thin diaphyses, premature closure of basal cranial sutures, and microphthalmia. Most affected individuals who survive beyond the perinatal period develop hypocalcemia with low parathyroid hormone levels. {ECO:0000269|PubMed:23684011}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FAM111A,63901,Hs.150651,ENST00000420244,THC2648989,GO:0003824(catalytic activity)|GO:0004252(serine-type endopeptidase activity)|GO:0006508(proteolysis),"Homo sapiens family with sequence similarity 111, member A (FAM111A), transcript variant 1, mRNA [NM_022074]",chr11:58922432-58922491,hs|11q12.1,"family with sequence similarity 111, member A",TRUE
968_CXCR4_7852,P61073,c-x-c chemokine receptor type 4 (cxc-r4) (cxcr-4) (fb22) (fusin) (hm89) (lcr1) (leukocyte-derived seven transmembrane domain receptor) (lestr) (lipopolysaccharide-associated protein 3) (lap-3) (lps-associated protein 3) (npyrl) (stromal cell-derived factor 1 receptor) (sdf-1 receptor) (cd antigen cd184),CXCR4,352,"function: receptor for the c-x-c chemokine cxcl12/sdf-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing mapk1/mapk3 activation (pubmed:10452968, pubmed:28978524, pubmed:18799424, pubmed:24912431). involved in the akt signaling cascade (pubmed:24912431). plays a role in regulation of cell migration, e.g. during wound healing (pubmed:28978524). acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular camp levels (pubmed:20228059). binds bacterial lipopolysaccharide (lps) et mediates lps-induced inflammatory response, including tnf secretion by monocytes (pubmed:11276205). involved in hematopoiesis and in cardiac ventricular septum formation. also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. involved in cerebellar development. in the cns, could mediate hippocampal-neuron survival (by similarity). {eco:0000250|uniprotkb:p70658, eco:0000269|pubmed:10074102, eco:0000269|pubmed:10452968, eco:0000269|pubmed:10644702, eco:0000269|pubmed:10825158, eco:0000269|pubmed:11276205, eco:0000269|pubmed:17197449, eco:0000269|pubmed:18799424, eco:0000269|pubmed:20048153, eco:0000269|pubmed:20228059, eco:0000269|pubmed:20505072, eco:0000269|pubmed:24912431, eco:0000269|pubmed:28978524, eco:0000269|pubmed:8752280, eco:0000269|pubmed:8752281}.; function: (microbial infection) acts as a coreceptor (cd4 being the primary receptor) for human immunodeficiency virus-1/hiv-1 x4 isolates and as a primary receptor for some hiv-2 isolates. promotes env-mediated fusion of the virus (pubmed:8849450, pubmed:8929542, pubmed:9427609, pubmed:10074122, pubmed:10756055). {eco:0000269|pubmed:10074122, eco:0000269|pubmed:10756055, eco:0000269|pubmed:8849450, eco:0000269|pubmed:8929542, eco:0000269|pubmed:9427609}.","subcellular location: cell membrane {eco:0000269|pubmed:10452968, eco:0000305|pubmed:20929726}; multi-pass membrane protein {eco:0000269|pubmed:20929726}. cell junction. early endosome. late endosome. lysosome. note=in unstimulated cells, diffuse pattern on plasma membrane. on agonist stimulation, colocalizes with itch at the plasma membrane where it becomes ubiquitinated. in the presence of antigen, distributes to the immunological synapse forming at the t-cell-apc contact area, where it localizes at the peripheral and distal supramolecular activation cluster (smac).","TISSUE SPECIFICITY: Expressed in numerous tissues, such as peripheral blood leukocytes, spleen, thymus, spinal cord, heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, cerebellum, cerebral cortex and medulla (in microglia as well as in astrocytes), brain microvascular, coronary artery and umbilical cord endothelial cells. Isoform 1 is predominant in all tissues tested. {ECO:0000269|PubMed:11276205}.","DISEASE: WHIM syndrome (WHIMS) [MIM:193670]: Immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. {ECO:0000269|PubMed:12692554, ECO:0000269|PubMed:15536153}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=CXCR4 mutations play a role in the pathogenesis of Waldenstroem macroglobulinemia (WM) and influence disease presentation and outcome, as well as response to therapy. WM is a B-cell lymphoma characterized by accumulation of malignant lymphoplasmacytic cells in the bone marrow, lymph nodes and spleen, and hypersecretion of monoclonal immunoglobulin M (IgM). Excess IgM production results in serum hyperviscosity, tissue infiltration, and autoimmune-related pathology. {ECO:0000269|PubMed:24366360, ECO:0000269|PubMed:24553177}.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,CXCR4,7852,Hs.593413,ENST00000241393,THC2468169,GO:0000187(activation of MAPK activity)|GO:0001666(response to hypoxia)|GO:0002407(dendritic cell chemotaxis)|GO:0003779(actin binding)|GO:0004871(signal transducer activity)|GO:0004872(receptor activity)|GO:0004930(G-protein coupled receptor activity)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005886(plasma membrane)|GO:0006915(apoptosis)|GO:0006954(inflammatory response)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007204(elevation of cytosolic calcium ion concentration)|GO:0009615(response to virus)|GO:0009986(cell surface)|GO:0015026(coreceptor activity)|GO:0016021(integral to membrane)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016032(viral reproduction)|GO:0016494(C-X-C chemokine receptor activity)|GO:0019059(initiation of viral infection)|GO:0019722(calcium-mediated signaling)|GO:0030260(entry into host cell)|GO:0031252(cell leading edge)|GO:0031410(cytoplasmic vesicle)|GO:0031625(ubiquitin protein ligase binding)|GO:0032027(myosin light chain binding)|GO:0043130(ubiquitin binding)|GO:0043217(myelin maintenance)|GO:0044419(interspecies interaction between organisms)|GO:0048714(positive regulation of oligodendrocyte differentiation)|GO:0050920(regulation of chemotaxis),"Homo sapiens chemokine (C-X-C motif) receptor 4 (CXCR4), transcript variant 1, mRNA [NM_001008540]",chr2:136872012-136871953,hs|2q22.1,chemokine (C-X-C motif) receptor 4,TRUE
969_C8orf4_56892,Q9NR00,transcriptional and immune response regulator (thyroid cancer protein 1) (tc-1),TCIM C8orf4 TC1,106,"function: seems to be involved in the regulation of cell growth an differentiation, may play different and opposite roles depending on the tissue or cell type. may enhance the wnt-ctnnb1 pathway by relieving antagonistic activity of cby1 (pubmed:16424001, pubmed:16730711). enhances the proliferation of follicular dendritic cells (pubmed:16730711). plays a role in the mitogen-activated mapk2/3 signaling pathway, positively regulates g1-to-s-phase transition of the cell cycle (pubmed:18959821). in endothelial cells, enhances key inflammatory mediators and inflammatory response through the modulation of nf-kappab transcriptional regulatory activity (pubmed:19684084). involved in the regulation of heat shock response, seems to play a positive feedback with hsf1 to modulate heat-shock downstream gene expression (pubmed:17603013). plays a role in the regulation of hematopoiesis even if the mechanisms are unknown (by similarity). in cancers such as thyroid or lung cancer, it has been described as promoter of cell proliferation, g1-to-s-phase transition and inhibitor of apoptosis (pubmed:15087392, pubmed:24941347). however, it negatively regulates self-renewal of liver cancer cells via suppresion of notch2 signaling (pubmed:25985737). {eco:0000250|uniprotkb:q9d915, eco:0000269|pubmed:15087392, eco:0000269|pubmed:16424001, eco:0000269|pubmed:16730711, eco:0000269|pubmed:17603013, eco:0000269|pubmed:18959821, eco:0000269|pubmed:19684084, eco:0000269|pubmed:24941347, eco:0000269|pubmed:25985737, eco:0000305}.","subcellular location: cytoplasm {eco:0000269|pubmed:16424001, eco:0000269|pubmed:25985737}. nucleus, nucleolus {eco:0000269|pubmed:16424001}. nucleus speckle {eco:0000269|pubmed:16424001}. nucleus {eco:0000269|pubmed:16424001}. note=localizes in nucleus speckles in presence of cby1 (pubmed:16424001). translocates to the nucleus upon cellular stress such as h(2)o(2) (pubmed:17603013). {eco:0000269|pubmed:16424001, eco:0000269|pubmed:17603013}.","TISSUE SPECIFICITY: Ubiquitous. Expressed in thyroid papillary carcinoma. Expressed in liver, expression levels decrease in hepatocellular carcinoma (PubMed:25985737). Slightly detected in normal lung, its expression is highly induced in lung cancer cells (at protein level) (PubMed:24941347). {ECO:0000269|PubMed:11056052, ECO:0000269|PubMed:24941347, ECO:0000269|PubMed:25985737}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C8orf4,56892,Hs.591849,ENST00000315792,THC2467189,GO:0006915(apoptosis),"Homo sapiens chromosome 8 open reading frame 4 (C8orf4), mRNA [NM_020130]",chr8:40011967-40012026,hs|8p11.21,chromosome 8 open reading frame 4,TRUE
97_HINT1_3094,P49773,histidine triad nucleotide-binding protein 1 (ec 3.-.-.-) (adenosine 5'-monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c-interacting protein 1) (pkci-1),HINT1 HINT PKCI1 PRKCNH1,126,"function: hydrolyzes purine nucleotide phosphoramidates with a single phosphate group, including adenosine 5'monophosphoramidate (amp-nh2), adenosine 5'monophosphomorpholidate (amp-morpholidate) and guanosine 5'monophosphomorpholidate (gmp-morpholidate). hydrolyzes lysyl-amp (amp-n-epsilon-(n-alpha-acetyl lysine methyl ester)) generated by lysine trna ligase, as well as met-amp, his-amp and asp-amp, lysyl-gmp (gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester)) and amp-n-alanine methyl ester. can also convert adenosine 5'-o-phosphorothioate and guanosine 5'-o-phosphorothioate to the corresponding nucleoside 5'-o-phosphates with concomitant release of hydrogen sulfide. in addition, functions as scaffolding protein that modulates transcriptional activation by the lef1/tcf1-ctnnb1 complex and by the complex formed with mitf and ctnnb1. modulates p53/tp53 levels and p53/tp53-mediated apoptosis. modulates proteasomal degradation of target proteins by the scf (skp2-cul1-f-box protein) e3 ubiquitin-protein ligase complex. {eco:0000269|pubmed:15703176, eco:0000269|pubmed:16014379, eco:0000269|pubmed:16835243, eco:0000269|pubmed:19112177, eco:0000269|pubmed:22329685, eco:0000269|pubmed:22647378, eco:0000269|pubmed:9323207}.",subcellular location: cytoplasm. nucleus. note=interaction with cdk7 leads to a more nuclear localization.,TISSUE SPECIFICITY: Widely expressed.,"DISEASE: Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]: An autosomal recessive neurologic disorder characterized by onset in the first or second decade of a peripheral axonal neuropathy predominantly affecting motor more than sensory nerves. The axonal neuropathy is reminiscent of Charcot-Marie-Tooth disease type 2 and distal hereditary motor neuropathy. Individuals with NMAN also have delayed muscle relaxation and action myotonia associated with neuromyotonic discharges on needle EMG resulting from hyperexcitability of the peripheral nerves. {ECO:0000269|PubMed:16835243, ECO:0000269|PubMed:22961002}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HINT1,3094,Hs.483305,ENST00000513345,THC2492217,GO:0005080(protein kinase C binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005856(cytoskeleton)|GO:0005886(plasma membrane)|GO:0007165(signal transduction)|GO:0016787(hydrolase activity),"Homo sapiens histidine triad nucleotide binding protein 1 (HINT1), transcript variant 1, mRNA [NM_005340]",chr5:130495150-130495091,hs|5q23.3,histidine triad nucleotide binding protein 1,TRUE
970_S100P_6286,P25815,protein s100-p (migration-inducing gene 9 protein) (mig9) (protein s100-e) (s100 calcium-binding protein p),S100P S100E,95,"function: may function as calcium sensor and contribute to cellular calcium signaling. in a calcium-dependent manner, functions by interacting with other proteins, such as ezr and ppp5c, and indirectly plays a role in physiological processes like the formation of microvilli in epithelial cells. may stimulate cell proliferation in an autocrine manner via activation of the receptor for activated glycation end products (rage). {eco:0000269|pubmed:14617629, eco:0000269|pubmed:19111582, eco:0000269|pubmed:22399290}.","subcellular location: nucleus. cytoplasm. cell projection, microvillus membrane. note=colocalizes with s100pbp in the nucleus. colocolizes with ezr in the microvilli in a calcium-dependent manner.","TISSUE SPECIFICITY: Detected in all of the tissues except brain, testis and small intestine, expression level is higher in placenta, heart, lung, skeletal muscle, spleen and leukocyte. Up-regulated in various pancreatic ductal adenocarcinomas and pancreatic intraepithelial neoplasias. {ECO:0000269|PubMed:14672411, ECO:0000269|PubMed:15632002}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,S100P,6286,Hs.2962,ENST00000296370,THC2461598,GO:0000287(magnesium ion binding)|GO:0005509(calcium ion binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0043542(endothelial cell migration)|GO:0048306(calcium-dependent protein binding),"Homo sapiens S100 calcium binding protein P (S100P), mRNA [NM_005980]",chr4:6698819-6698878,hs|4p16.1,S100 calcium binding protein P,TRUE
971_RNH1_6050,O60930,ribonuclease h1 (rnase h1) (ec 3.1.26.4) (ribonuclease h type ii),RNASEH1 RNH1,286,"function: endonuclease that specifically degrades the rna of rna-dna hybrids (pubmed:10497183). plays a role in rna polymerase ii (rnap ii) transcription termination by degrading r-loop rna-dna hybrid formation at g-rich pause sites located downstream of the poly(a) site and behind the elongating rnap ii (pubmed:21700224). {eco:0000269|pubmed:10497183, eco:0000269|pubmed:21700224}.",subcellular location: cytoplasm {eco:0000305}.,TISSUE SPECIFICITY: Ubiquitous.,"DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 (PEOB2) [MIM:616479]: A form of progressive external ophthalmoplegia, a mitochondrial myopathy characterized by progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. PEOB2 patients manifest exercise intolerance, muscle weakness, and signs and symptoms of spinocerebellar ataxia, such as impaired gait and dysarthria. Some patients may have respiratory insufficiency. {ECO:0000269|PubMed:26094573}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,RNH1,6050,Hs.530687,ENST00000354420,NP1194622,GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0006402(mRNA catabolic process)|GO:0008428(ribonuclease inhibitor activity)|GO:0032311(angiogenin-PRI complex)|GO:0045765(regulation of angiogenesis),"Homo sapiens ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 1, mRNA [NM_002939]",chr11:494614-494555,hs|11p15.5,ribonuclease/angiogenin inhibitor 1,TRUE
972_AK2_204,P54819,"adenylate kinase 2, mitochondrial (ak 2) (ec 2.7.4.3) (atp-amp transphosphorylase 2) (atp:amp phosphotransferase) (adenylate monophosphate kinase) [cleaved into: adenylate kinase 2, mitochondrial, n-terminally processed]",AK2 ADK2,239,"function: catalyzes the reversible transfer of the terminal phosphate group between atp and amp. plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. adenylate kinase activity is critical for regulation of the phosphate utilization and the amp de novo biosynthesis pathways. plays a key role in hematopoiesis. {eco:0000255|hamap-rule:mf_03168, eco:0000269|pubmed:19043416}.",subcellular location: mitochondrion intermembrane space {eco:0000255|hamap-rule:mf_03168}.,"TISSUE SPECIFICITY: Present in most tissues. Present at high level in heart, liver and kidney, and at low level in brain, skeletal muscle and skin. Present in thrombocytes but not in erythrocytes, which lack mitochondria. Present in all nucleated cell populations from blood, while AK1 is mostly absent. In spleen and lymph nodes, mononuclear cells lack AK1, whereas AK2 is readily detectable. These results indicate that leukocytes may be susceptible to defects caused by the lack of AK2, as they do not express AK1 in sufficient amounts to compensate for the AK2 functional deficits (at protein level). {ECO:0000269|PubMed:19043417}.","DISEASE: Reticular dysgenesis (RDYS) [MIM:267500]: A fatal form of severe combined immunodeficiency, characterized by absence of granulocytes, almost complete deficiency of lymphocytes in peripheral blood, hypoplasia of the thymus and secondary lymphoid organs, and lack of innate and adaptive humoral and cellular immunity, leading to fatal septicemia within days after birth. In bone marrow of individuals with reticular dysgenesis, myeloid differentiation is blocked at the promyelocytic stage, whereas erythro- and megakaryocytic maturation is generally normal. Inheritance is autosomal recessive. {ECO:0000269|PubMed:19043416, ECO:0000269|PubMed:19043417}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,AK2,204,Hs.470907,ENST00000398192,THC2489684,"GO:0000166(nucleotide binding)|GO:0004017(adenylate kinase activity)|GO:0005524(ATP binding)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005758(mitochondrial intermembrane space)|GO:0015949(nucleobase, nucleoside and nucleotide interconversion)|GO:0016740(transferase activity)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)","Homo sapiens adenylate kinase 2 (AK2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001625]",chr1:33478726-33478667,hs|1p35.1,adenylate kinase 2,TRUE
973_TTC19_54902,Q6DKK2,"tetratricopeptide repeat protein 19, mitochondrial (tpr repeat protein 19)",TTC19,380,"function: required for the preservation of the structural and functional integrity of mitochondrial respiratory complex iii by allowing the physiological turnover of the rieske protein uqcrfs1 (pubmed:21278747, pubmed:28673544). involved in the clearance of uqcrfs1 n-terminal fragments, which are produced upon incorporation of uqcrfs1 into the complex iii and whose presence is detrimental for its catalytic activity (pubmed:28673544). {eco:0000269|pubmed:21278747, eco:0000269|pubmed:28673544}.",subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:21278747}.,NA,"DISEASE: Mitochondrial complex III deficiency, nuclear 2 (MC3DN2) [MIM:615157]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:21278747}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TTC19,54902,Hs.462316,ENST00000555605,THC2513150,GO:0000910(cytokinesis)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0005813(centrosome)|GO:0005856(cytoskeleton)|GO:0007049(cell cycle)|GO:0016020(membrane)|GO:0030496(midbody)|GO:0034551(mitochondrial respiratory chain complex III assembly),"Homo sapiens tetratricopeptide repeat domain 19 (TTC19), transcript variant 1, mRNA [NM_017775]",chr17:15931822-15931881,hs|17p12,tetratricopeptide repeat domain 19,TRUE
974_EIF3L_51386,Q9Y262,eukaryotic translation initiation factor 3 subunit l (eif3l) (eukaryotic translation initiation factor 3 subunit 6-interacting protein) (eukaryotic translation initiation factor 3 subunit e-interacting protein),EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005,564,"function: component of the eukaryotic translation initiation factor 3 (eif-3) complex, which is required for several steps in the initiation of protein synthesis (pubmed:17581632, pubmed:25849773, pubmed:27462815). the eif-3 complex associates with the 40s ribosome and facilitates the recruitment of eif-1, eif-1a, eif-2:gtp:methionyl-trnai and eif-5 to form the 43s pre-initiation complex (43s pic). the eif-3 complex stimulates mrna recruitment to the 43s pic and scanning of the mrna for aug recognition. the eif-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40s and 60s ribosomal subunits prior to initiation (pubmed:17581632). the eif-3 complex specifically targets and initiates translation of a subset of mrnas involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of rna stem-loop binding to exert either translational activation or repression (pubmed:25849773). {eco:0000255|hamap-rule:mf_03011, eco:0000269|pubmed:17581632, eco:0000269|pubmed:25849773, eco:0000269|pubmed:27462815}.; function: (microbial infection) in case of fcv infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of vp2 (pubmed:18056426). {eco:0000269|pubmed:18056426}.",subcellular location: cytoplasm {eco:0000255|hamap-rule:mf_03011}.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EIF3L,51386,Hs.446852,ENST00000477256,THC2574229,GO:0001650(fibrillar center)|GO:0003743(translation initiation factor activity)|GO:0005515(protein binding)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0005852(eukaryotic translation initiation factor 3 complex)|GO:0006413(translational initiation),"Homo sapiens eukaryotic translation initiation factor 3, subunit L (EIF3L), transcript variant 1, mRNA [NM_016091]",chr22:38274156-38282808,hs|22q13.1,"eukaryotic translation initiation factor 3, subunit L",TRUE
975_AGT_183,Q9BYV1,"alanine--glyoxylate aminotransferase 2, mitochondrial (agt 2) (ec 2.6.1.44) ((r)-3-amino-2-methylpropionate--pyruvate transaminase) (ec 2.6.1.40) (beta-alaat ii) (beta-alanine-pyruvate aminotransferase) (d-aibat)",AGXT2 AGT2,514,"function: can metabolize asymmetric dimethylarginine (adma) via transamination to alpha-keto-delta-(nn-dimethylguanidino) valeric acid (dmgv). adma is a potent inhibitor of nitric-oxide (no) synthase, and this activity provides mechanism through which the kidney regulates blood pressure. {eco:0000269|pubmed:20018850, eco:0000269|pubmed:23023372, eco:0000269|pubmed:24586340}.","subcellular location: mitochondrion {eco:0000269|pubmed:20018850, eco:0000269|pubmed:24586340}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,AGT,183,Hs.19383,ENST00000430091,THC2465714,"GO:0001543(ovarian follicle rupture)|GO:0001558(regulation of cell growth)|GO:0001568(blood vessel development)|GO:0001819(positive regulation of cytokine production)|GO:0001822(kidney development)|GO:0001974(blood vessel remodeling)|GO:0001998(angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure)|GO:0001999(renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure)|GO:0002016(regulation of blood volume by renin-angiotensin)|GO:0002018(renin-angiotensin regulation of aldosterone production)|GO:0002019(regulation of renal output by angiotensin)|GO:0002034(regulation of blood vessel size by renin-angiotensin)|GO:0003051(angiotensin-mediated drinking behavior)|GO:0003331(positive regulation of extracellular matrix constituent secretion)|GO:0004867(serine-type endopeptidase inhibitor activity)|GO:0005179(hormone activity)|GO:0005576(extracellular region)|GO:0005615(extracellular space)|GO:0005625(soluble fraction)|GO:0006883(cellular sodium ion homeostasis)|GO:0006917(induction of apoptosis)|GO:0007160(cell-matrix adhesion)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007199(G-protein signaling, coupled to cGMP nucleotide second messenger)|GO:0007200(activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger)|GO:0007263(nitric oxide mediated signal transduction)|GO:0007267(cell-cell signaling)|GO:0007568(aging)|GO:0007588(excretion)|GO:0008065(establishment of blood-nerve barrier)|GO:0008083(growth factor activity)|GO:0008285(negative regulation of cell proliferation)|GO:0009409(response to cold)|GO:0009651(response to salt stress)|GO:0010468(regulation of gene expression)|GO:0010535(positive regulation of activation of JAK2 kinase activity)|GO:0010595(positive regulation of endothelial cell migration)|GO:0010613(positive regulation of cardiac muscle hypertrophy)|GO:0010698(acetyltransferase activator activity)|GO:0010744(positive regulation of macrophage derived foam cell differentiation)|GO:0010873(positive regulation of cholesterol esterification)|GO:0010951(negative regulation of endopeptidase activity)|GO:0014061(regulation of norepinephrine secretion)|GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade)|GO:0014824(artery smooth muscle contraction)|GO:0014873(response to muscle activity involved in regulation of muscle adaptation)|GO:0019229(regulation of vasoconstriction)|GO:0030162(regulation of proteolysis)|GO:0030198(extracellular matrix organization)|GO:0030308(negative regulation of cell growth)|GO:0030432(peristalsis)|GO:0031702(type 1 angiotensin receptor binding)|GO:0031703(type 2 angiotensin receptor binding)|GO:0032270(positive regulation of cellular protein metabolic process)|GO:0032930(positive regulation of superoxide anion generation)|GO:0033864(positive regulation of NAD(P)H oxidase activity)|GO:0034104(negative regulation of tissue remodeling)|GO:0034374(low-density lipoprotein particle remodeling)|GO:0035411(catenin import into nucleus)","Homo sapiens angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (AGT), mRNA [NM_000029]",chr1:230838590-230838531,hs|1q42.2,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",TRUE
976_FOXP1_27086,Q9H334,forkhead box protein p1 (mac-1-regulated forkhead) (mfh),FOXP1 HSPC215,677,"function: transcriptional repressor (pubmed:18347093, pubmed:26647308). can act with ctbp1 to synergistically repress transcription but ctpbp1 is not essential (by similarity). plays an important role in the specification and differentiation of lung epithelium. acts cooperatively with foxp4 to regulate lung secretory epithelial cell fate and regeneration by restricting the goblet cell lineage program; the function may involve regulation of agr2. essential transcriptional regulator of b-cell development. involved in regulation of cardiac muscle cell proliferation. involved in the columnar organization of spinal motor neurons. promotes the formation of the lateral motor neuron column (lmc) and the preganglionic motor column (pgc) and is required for respective appropriate motor axon projections. the segment-appropriate generation of spinal chord motor columns requires cooperation with other hox proteins. can regulate pitx3 promoter activity; may promote midbrain identity in embryonic stem cell-derived dopamine neurons by regulating pitx3. negatively regulates the differentiation of t follicular helper cells t(fh)s. involved in maintenance of hair follicle stem cell quiescence; the function probably involves regulation of fgf18 (by similarity). represses transcription of various pro-apoptotic genes and cooperates with nf-kappa b-signaling in promoting b-cell expansion by inhibition of caspase-dependent apoptosis (pubmed:25267198). binds to csf1r promoter elements and is involved in regulation of monocyte differentiation and macrophage functions; repression of csf1r in monocytes seems to involve ncor2 as corepressor (pubmed:15286807, pubmed:18799727, pubmed:18347093). involved in endothelial cell proliferation, tube formation and migration indicative for a role in angiogenesis; the role in neovascularization seems to implicate suppression of sema5b (pubmed:24023716). can negatively regulate androgen receptor signaling (pubmed:18640093). acts as a transcriptional activator of the fbxl7 promoter; this activity is regulated by aurka (pubmed:28218735). {eco:0000250|uniprotkb:p58462, eco:0000269|pubmed:15286807, eco:0000269|pubmed:18640093, eco:0000269|pubmed:18799727, eco:0000269|pubmed:24023716, eco:0000269|pubmed:25267198, eco:0000269|pubmed:26647308, eco:0000269|pubmed:28218735, eco:0000305|pubmed:18347093, eco:0000305|pubmed:24023716}.; function: isoform 8: involved in transcriptional regulation in embryonic stem cells (escs). stimulates expression of transcription factors that are required for pluripotency and decreases expression of differentiation-associated genes. has distinct dna-binding specifities as compared to the canonical form and preferentially binds dna with the sequence 5'-cgatacaa-3' (or closely related sequences) (pubmed:21924763). promotes esc self-renewal and pluripotency (by similarity). {eco:0000250|uniprotkb:p58462, eco:0000269|pubmed:21924763}.","subcellular location: nucleus {eco:0000269|pubmed:25027557, eco:0000269|pubmed:26647308}. note=not found in the nucleolus. {eco:0000269|pubmed:26647308}.",TISSUE SPECIFICITY: Isoform 8 is specifically expressed in embryonic stem cells. {ECO:0000269|PubMed:21924763}.,"DISEASE: Note=A chromosomal aberration involving FOXP1 is found in acute lymphoblastic leukemia. Translocation t(9;3)(p13;p14.1) with PAX5.; DISEASE: Mental retardation with language impairment and autistic features (MRLIAF) [MIM:613670]: A developmental disorder characterized by mild to moderate mental retardation, language impairment, and autistic features. Patients show global delay, delayed walking, severely delayed speech development, and behavioral abnormalities, including irritability, hyperactivity, aggression, and stereotypical rigid behaviors. {ECO:0000269|PubMed:20950788, ECO:0000269|PubMed:26647308}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FOXP1,27086,Hs.431498,ENST00000498215,NP303072,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0002053(positive regulation of mesenchymal cell proliferation)|GO:0002329(pre-B cell differentiation)|GO:0002639(positive regulation of immunoglobulin production)|GO:0003682(chromatin binding)|GO:0003690(double-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003705(sequence-specific enhancer binding RNA polymerase II transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005667(transcription factor complex)|GO:0005730(nucleolus)|GO:0005737(cytoplasm)|GO:0007389(pattern specification process)|GO:0007507(heart development)|GO:0007519(skeletal muscle tissue development)|GO:0008045(motor axon guidance)|GO:0008134(transcription factor binding)|GO:0008270(zinc ion binding)|GO:0008301(DNA bending activity)|GO:0009790(embryo development)|GO:0021517(ventral spinal cord development)|GO:0030324(lung development)|GO:0033152(immunoglobulin V(D)J recombination)|GO:0042803(protein homodimerization activity)|GO:0043565(sequence-specific DNA binding)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0046982(protein heterodimerization activity)|GO:0048745(smooth muscle tissue development)|GO:0051090(regulation of sequence-specific DNA binding transcription factor activity)|GO:0055007(cardiac muscle cell differentiation)|GO:0060501(positive regulation of epithelial cell proliferation involved in lung morphogenesis)","Homo sapiens forkhead box P1 (FOXP1), transcript variant 1, mRNA [NM_032682]",chr3:71008467-71008408,hs|3p13,forkhead box P1,TRUE
977_SECISBP2_79048,Q96T21,selenocysteine insertion sequence-binding protein 2 (secis-binding protein 2),SECISBP2 SBP2,854,function: binds to the secis element in the 3'-utr of some mrnas encoding selenoproteins. binding is stimulated by selb.,subcellular location: isoform 1: nucleus {eco:0000305}.; subcellular location: isoform 2: mitochondrion {eco:0000269|pubmed:19004874}.,TISSUE SPECIFICITY: Expressed at high levels in testis. {ECO:0000269|PubMed:12095701}.,DISEASE: Abnormal thyroid hormone metabolism (ATHYHM) [MIM:609698]: A disorder associated with a reduction in type II iodothyronine deiodinase activity. {ECO:0000269|PubMed:16228000}. Note=The disease is caused by mutations affecting the gene represented in this entry.,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,SECISBP2,79048,Hs.59804,ENST00000440898,THC2486611,GO:0003723(RNA binding)|GO:0003730(mRNA 3'-UTR binding)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0006412(translation),"Homo sapiens SECIS binding protein 2 (SECISBP2), mRNA [NM_024077]",chr9:91949583-91949642,hs|9q22.2,SECIS binding protein 2,TRUE
978_CHERP_10523,Q8IWX8,calcium homeostasis endoplasmic reticulum protein (erprot 213-21) (sr-related ctd-associated factor 6),CHERP DAN26 SCAF6,916,"function: involved in calcium homeostasis, growth and proliferation. {eco:0000269|pubmed:10794731, eco:0000269|pubmed:12656674}.","subcellular location: cytoplasm {eco:0000269|pubmed:10794731, eco:0000269|pubmed:12656674, eco:0000269|pubmed:8010949}. cytoplasm, perinuclear region {eco:0000269|pubmed:10794731, eco:0000269|pubmed:12656674, eco:0000269|pubmed:8010949}. endoplasmic reticulum {eco:0000269|pubmed:10794731, eco:0000269|pubmed:12656674, eco:0000269|pubmed:8010949}. note=distributed throughout the cytoplasm and also localizes to the perinuclear region of both human erythroleukemia (hel) cells and jurkat cells. colocalizes with itpr1. {eco:0000269|pubmed:10794731, eco:0000269|pubmed:12656674, eco:0000269|pubmed:8010949}.","TISSUE SPECIFICITY: Expressed in brain, placenta, lung, liver, kidney, pancreas, cardiac and skeletal muscle, and in cultured HEL and Dami cells. {ECO:0000269|PubMed:10794731}.",NA,NA,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CHERP,10523,Hs.631627,ENST00000546361,THC2462065,GO:0003674(molecular_function)|GO:0003723(RNA binding)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0006396(RNA processing)|GO:0006874(cellular calcium ion homeostasis)|GO:0007399(nervous system development)|GO:0008285(negative regulation of cell proliferation)|GO:0048471(perinuclear region of cytoplasm),"Homo sapiens calcium homeostasis endoplasmic reticulum protein (CHERP), mRNA [NM_006387]",chr19:16628789-16628730,hs|19p13.11,calcium homeostasis endoplasmic reticulum protein,TRUE
979_RPS2_6187,P15880,40s ribosomal protein s2 (40s ribosomal protein s4) (protein llrep3) (small ribosomal subunit protein us5),RPS2 RPS4,293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,NA,RPS2,6187,Hs.356366,ENST00000531065,THC2498349,GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005515(protein binding)|GO:0005622(intracellular)|GO:0005654(nucleoplasm)|GO:0005730(nucleolus)|GO:0005829(cytosol)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0044267(cellular protein metabolic process)|GO:0048602(fibroblast growth factor 1 binding)|GO:0048604(fibroblast growth factor 3 binding),"Homo sapiens ribosomal protein S2 (RPS2), mRNA [NM_002952]",chr16:2012137-2012081,hs|16p13.3,ribosomal protein S2,TRUE
98_TXN_7295,Q99757,"thioredoxin, mitochondrial (mtrx) (mt-trx) (thioredoxin-2)",TXN2 TRX2,166,"function: important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability. possesses a dithiol-reducing activity. {eco:0000269|pubmed:12032145, eco:0000269|pubmed:12080052, eco:0000269|pubmed:26626369}.","subcellular location: mitochondrion {eco:0000269|pubmed:12032145, eco:0000269|pubmed:12080052}.","TISSUE SPECIFICITY: Widely expressed in adult (at protein level) and fetal tissues. {ECO:0000269|PubMed:12032145, ECO:0000269|PubMed:12080052}.","DISEASE: Combined oxidative phosphorylation deficiency 29 (COXPD29) [MIM:616811]: An autosomal recessive, infantile-onset, neurodegenerative disorder characterized by decreased activities of mitochondrial respiratory complexes I and III, severe cerebellar atrophy, epilepsy, dystonia, optic atrophy, and peripheral neuropathy. {ECO:0000269|PubMed:26626369}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TXN,7295,Hs.435136,ENST00000487892,THC2538504,"GO:0002218(activation of innate immune response)|GO:0005515(protein binding)|GO:0005576(extracellular region)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005829(cytosol)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0006662(glycerol ether metabolic process)|GO:0006810(transport)|GO:0006928(cellular component movement)|GO:0007165(signal transduction)|GO:0007267(cell-cell signaling)|GO:0008283(cell proliferation)|GO:0009055(electron carrier activity)|GO:0009314(response to radiation)|GO:0015035(protein disulfide oxidoreductase activity)|GO:0015037(peptide disulfide oxidoreductase activity)|GO:0015949(nucleobase, nucleoside and nucleotide interconversion)|GO:0022900(electron transport chain)|GO:0033158(regulation of protein import into nucleus, translocation)|GO:0043388(positive regulation of DNA binding)|GO:0045087(innate immune response)|GO:0045454(cell redox homeostasis)|GO:0046826(negative regulation of protein export from nucleus)|GO:0055086(nucleobase, nucleoside and nucleotide metabolic process)|GO:0055114(oxidation-reduction process)","Homo sapiens thioredoxin (TXN), transcript variant 1, mRNA [NM_003329]",chr9:113007066-113006449,hs|9q31.3,thioredoxin,TRUE
980_ZDHHC7_55625,Q9NXF8,palmitoyltransferase zdhhc7 (ec 2.3.1.225) (zinc finger dhhc domain-containing protein 7) (dhhc-7),ZDHHC7,308,"function: palmitoyltransferase with broad specificity (pubmed:22031296, pubmed:28196865). palmitoylates jam3 (pubmed:28196865). palmitoylates snap25 and dlg4/psd95 (by similarity). palmitoylates sex steroid hormone receptors, including esr1, pgr and ar, thereby regulating their targeting to the plasma membrane and their function in rapid intracellular signaling upon binding of sex hormones (pubmed:22031296). may play a role in follicle stimulation hormone (fsh) activation of testicular sertoli cells (by similarity). {eco:0000250|uniprotkb:q91wu6, eco:0000250|uniprotkb:q923g5, eco:0000269|pubmed:22031296, eco:0000269|pubmed:28196865}.",subcellular location: golgi apparatus membrane {eco:0000269|pubmed:22031296}; multi-pass membrane protein {eco:0000255}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ZDHHC7,55625,Hs.461610,ENST00000344861,THC2461043,"GO:0008270(zinc ion binding)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016746(transferase activity, transferring acyl groups)|GO:0046872(metal ion binding)","Homo sapiens zinc finger, DHHC-type containing 7 (ZDHHC7), transcript variant 2, mRNA [NM_017740]",chr16:85008218-85008159,hs|16q24.1,"zinc finger, DHHC-type containing 7",TRUE
981_HIST3H2A_92815,Q7L7L0,histone h2a type 3,HIST3H2A,130,"function: core component of nucleosome. nucleosomes wrap and compact dna into chromatin, limiting dna accessibility to the cellular machineries which require dna as a template. histones thereby play a central role in transcription regulation, dna repair, dna replication and chromosomal stability. dna accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.",subcellular location: nucleus. chromosome.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HIST3H2A,92815,Hs.26331,ENST00000366695,THC2464539,GO:0000786(nucleosome)|GO:0003677(DNA binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006334(nucleosome assembly),"Homo sapiens histone cluster 3, H2a (HIST3H2A), mRNA [NM_033445]",chr1:228645309-228645250,hs|1q42.13,"histone cluster 3, H2a",TRUE
982_MRPL32_64983,Q6P1L8,"39s ribosomal protein l14, mitochondrial (l14mt) (mrp-l14) (39s ribosomal protein l32, mitochondrial) (l32mt) (mrp-l32) (mitochondrial large ribosomal subunit protein ul14m)",MRPL14 MRPL32 RPML32,145,"function: forms part of 2 intersubunit bridges in the assembled ribosome. upon binding to malsu1 intersubunit bridge formation is blocked, preventing ribosome formation and repressing translation (probable). {eco:0000305|pubmed:22829778}.","subcellular location: mitochondrion {eco:0000269|pubmed:11543634, eco:0000269|pubmed:22829778, eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,MRPL32,64983,Hs.50252,ENST00000432845,THC2498310,GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0006412(translation)|GO:0015934(large ribosomal subunit),"Homo sapiens mitochondrial ribosomal protein L32 (MRPL32), nuclear gene encoding mitochondrial protein, mRNA [NM_031903]",chr7:42977128-42977187,hs|7p14.1,mitochondrial ribosomal protein L32,TRUE
983_PURB_5814,Q96QR8,transcriptional activator protein pur-beta (purine-rich element-binding protein b),PURB,312,"function: has capacity to bind repeated elements in single-stranded dna such as the purine-rich single strand of the pur element located upstream of the myc gene. plays a role in the control of vascular smooth muscle (vsm) alpha-actin gene transcription as repressor in myoblasts and fibroblasts. participates in transcriptional and translational regulation of alpha-mhc expression in cardiac myocytes by binding to the purine-rich negative regulatory (pnr) element. modulates constitutive liver galectin-3 gene transcription by binding to its promoter. may play a role in the dendritic transport of a subset of mrnas (by similarity). {eco:0000250, eco:0000269|pubmed:1448097}.",subcellular location: nucleus {eco:0000269|pubmed:1448097}.,TISSUE SPECIFICITY: Expressed in myocardium of heart failure patients. {ECO:0000269|PubMed:12933792}.,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,PURB,5814,Hs.728785,ENST00000395699,THC2556216,"GO:0000900(translation repressor activity, nucleic acid binding)|GO:0003677(DNA binding)|GO:0003690(double-stranded DNA binding)|GO:0003697(single-stranded DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0003729(mRNA binding)|GO:0005634(nucleus)|GO:0005662(DNA replication factor A complex)|GO:0008134(transcription factor binding)|GO:0032422(purine-rich negative regulatory element binding)|GO:0045637(regulation of myeloid cell differentiation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0046332(SMAD binding)","Homo sapiens purine-rich element binding protein B (PURB), mRNA [NM_033224]",chr7:44916101-44916042,hs|7p13,purine-rich element binding protein B,TRUE
984_ATXN2L_11273,Q8WWM7,ataxin-2-like protein (ataxin-2 domain protein) (ataxin-2-related protein),ATXN2L A2D A2LG A2LP A2RP,1075,function: involved in the regulation of stress granule and p-body formation. {eco:0000269|pubmed:23209657}.,"subcellular location: membrane {eco:0000269|pubmed:11784712}; peripheral membrane protein {eco:0000269|pubmed:11784712}. cytoplasm {eco:0000269|pubmed:23209657}. nucleus speckle {eco:0000269|pubmed:23209657}. cytoplasmic granule {eco:0000269|pubmed:23209657}. note=predominantly cytoplasmic but is also detected in nuclear speckles (pubmed:23209657). component of cytoplasmic stress granules (pubmed:23209657). inhibition of methylation alters nuclear localization (pubmed:25748791). methylation does not seem to be required for localization to stress granules under stress conditions (pubmed:25748791). {eco:0000269|pubmed:23209657, eco:0000269|pubmed:25748791}.","TISSUE SPECIFICITY: Expressed at high levels in thymus, lymph node, spleen, fetal kidney and adult testis. Constitutively associated with MPL and EPOR in hematopoietic cells. {ECO:0000269|PubMed:11784712}.",NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,ATXN2L,11273,Hs.460499,ENST00000325215,NP080567,GO:0003674(molecular_function)|GO:0008150(biological_process)|GO:0016020(membrane),"Homo sapiens ataxin 2-like (ATXN2L), transcript variant B, mRNA [NM_145714]",chr16:28848437-28848496,hs|16p11.2,ataxin 2-like,TRUE
985_CALD1_800,Q05682,caldesmon (cdm),CALD1 CAD CDM,793,"function: actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. in muscle tissues, inhibits the actomyosin atpase by binding to f-actin. this inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. also plays an essential role during cellular mitosis and receptor capping. involved in schwann cell migration during peripheral nerve regeneration (by similarity). {eco:0000250, eco:0000269|pubmed:8227296}.","subcellular location: cytoplasm, cytoskeleton {eco:0000250|uniprotkb:p13505}. cytoplasm, myofibril {eco:0000250|uniprotkb:p13505}. cytoplasm, cytoskeleton, stress fiber {eco:0000250|uniprotkb:p13505}. note=on thin filaments in smooth muscle and on stress fibers in fibroblasts (nonmuscle). {eco:0000250|uniprotkb:p13505}.","TISSUE SPECIFICITY: High-molecular-weight caldesmon (isoform 1) is predominantly expressed in smooth muscles, whereas low-molecular-weight caldesmon (isoforms 2, 3, 4 and 5) are widely distributed in non-muscle tissues and cells. Not expressed in skeletal muscle or heart.",NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,CALD1,800,Hs.490203,ENST00000443197,NP1159719,GO:0003779(actin binding)|GO:0005516(calmodulin binding)|GO:0005523(tropomyosin binding)|GO:0005624(membrane fraction)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0005884(actin filament)|GO:0005886(plasma membrane)|GO:0006928(cellular component movement)|GO:0006936(muscle contraction)|GO:0014069(postsynaptic density)|GO:0015629(actin cytoskeleton)|GO:0017022(myosin binding)|GO:0030016(myofibril)|GO:0030478(actin cap)|GO:0032092(positive regulation of protein binding)|GO:0043025(neuronal cell body)|GO:0043197(dendritic spine)|GO:0051017(actin filament bundle assembly),"Homo sapiens caldesmon 1 (CALD1), transcript variant 1, mRNA [NM_033138]",chr7:134655197-134655256,hs|7q33,caldesmon 1,TRUE
986_IFI30_10437,P13284,gamma-interferon-inducible lysosomal thiol reductase (ec 1.8.-.-) (gamma-interferon-inducible protein ip-30) (legumaturain),IFI30 GILT IP30,250,function: lysosomal thiol reductase that can reduce protein disulfide bonds. may facilitate the complete unfolding of proteins destined for lysosomal degradation. plays an important role in antigen processing. facilitates the generation of mhc class ii-restricted epitodes from disulfide bond-containing antigen by the endocytic reduction of disulfide bonds (by similarity). facilitates also mhc class i-restricted recognition of exogenous antigens containing disulfide bonds by cd8+ t-cells or crosspresentation (by similarity). {eco:0000250}.,"subcellular location: secreted {eco:0000269|pubmed:10639150, eco:0000269|pubmed:3136170}. lysosome {eco:0000269|pubmed:10639150, eco:0000269|pubmed:3136170}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,IFI30,10437,Hs.14623,ENST00000407280,THC2482700,"GO:0005576(extracellular region)|GO:0005764(lysosome)|GO:0005886(plasma membrane)|GO:0016667(oxidoreductase activity, acting on a sulfur group of donors)|GO:0019221(cytokine-mediated signaling pathway)|GO:0030054(cell junction)|GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I)|GO:0043202(lysosomal lumen)|GO:0043231(intracellular membrane-bounded organelle)|GO:0060333(interferon-gamma-mediated signaling pathway)","Homo sapiens interferon, gamma-inducible protein 30 (IFI30), mRNA [NM_006332]",chr19:18288840-18288899,hs|19p13.11,"interferon, gamma-inducible protein 30",TRUE
987_DDX47_51202,Q9H0S4,probable atp-dependent rna helicase ddx47 (ec 3.6.4.13) (dead box protein 47),DDX47,455,"function: involved in apoptosis. may have a role in rrna processing and mrna splicing. associates with pre-rrna precursors. {eco:0000269|pubmed:15977068, eco:0000269|pubmed:16963496}.","subcellular location: nucleus, nucleolus {eco:0000269|pubmed:12429849, eco:0000269|pubmed:16963496}. note=localizes in the nucleolar-organizing region during ribosome biogenesis.",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,DDX47,51202,Hs.719938,ENST00000534843,THC2605718,GO:0000166(nucleotide binding)|GO:0003723(RNA binding)|GO:0004386(helicase activity)|GO:0005515(protein binding)|GO:0005524(ATP binding)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006364(rRNA processing)|GO:0006915(apoptosis)|GO:0008026(ATP-dependent helicase activity)|GO:0008380(RNA splicing)|GO:0016787(hydrolase activity),"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 (DDX47), transcript variant 1, mRNA [NM_016355]",chr12:12982717-12982776,hs|12p13.1,DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,TRUE
988_FOLH1B_219595,Q9HBA9,putative n-acetylated-alpha-linked acidic dipeptidase (naaladase) (ec 3.4.-.-) (cell growth-inhibiting gene 26 protein) (prostate-specific membrane antigen-like protein) (putative folate hydrolase 1b),FOLH1B PSMAL GIG26,442,function: has both folate hydrolase and n-acetylated-alpha-linked-acidic dipeptidase (naaladase) activity. {eco:0000250}.; function: exhibits a dipeptidyl-peptidase iv type activity. {eco:0000250}.,subcellular location: cytoplasm {eco:0000305|pubmed:14716746}.,TISSUE SPECIFICITY: Kidney and liver. Not expressed in the prostate. {ECO:0000269|PubMed:14716746}.,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FOLH1B,219595,Hs.645352,ENST00000526379,THC2780880,GO:0005737(cytoplasm)|GO:0006508(proteolysis)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0016805(dipeptidase activity)|GO:0046872(metal ion binding),"Homo sapiens folate hydrolase 1B (FOLH1B), mRNA [NM_153696]",chr11:89424657-89429820,hs|11q14.3,folate hydrolase 1B,TRUE
989_HSD17B4_3295,P51659,"peroxisomal multifunctional enzyme type 2 (mfe-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-hsd 4) (d-bifunctional protein) (dbp) (multifunctional protein 2) (mpf-2) (short chain dehydrogenase/reductase family 8c member 1) [cleaved into: (3r)-hydroxyacyl-coa dehydrogenase (ec 1.1.1.n12); enoyl-coa hydratase 2 (ec 4.2.1.107) (ec 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-coa hydratase)]",HSD17B4 EDH17B4 SDR8C1,736,"function: bifunctional enzyme acting on the peroxisomal beta-oxidation pathway for fatty acids. catalyzes the formation of 3-ketoacyl-coa intermediates from both straight-chain and 2-methyl-branched-chain fatty acids. {eco:0000269|pubmed:8902629, eco:0000269|pubmed:9089413}.",subcellular location: peroxisome.,"TISSUE SPECIFICITY: Present in many tissues with highest concentrations in liver, heart, prostate and testis.","DISEASE: D-bifunctional protein deficiency (DBPD) [MIM:261515]: Disorder of peroxisomal fatty acid beta-oxidation. {ECO:0000269|PubMed:10400999, ECO:0000269|PubMed:10671535, ECO:0000269|PubMed:11743515, ECO:0000269|PubMed:9482850}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Perrault syndrome 1 (PRLTS1) [MIM:233400]: A sex-influenced disorder characterized by sensorineural deafness in both males and females and ovarian dysgenesis in females. Some patients also have neurologic manifestations, including mild mental retardation and cerebellar and peripheral nervous system involvement. {ECO:0000269|PubMed:20673864}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,HSD17B4,3295,Hs.406861,ENST00000522415,THC2745774,"GO:0000038(very long-chain fatty acid metabolic process)|GO:0000166(nucleotide binding)|GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity)|GO:0004303(estradiol 17-beta-dehydrogenase activity)|GO:0005739(mitochondrion)|GO:0005777(peroxisome)|GO:0005782(peroxisomal matrix)|GO:0006699(bile acid biosynthetic process)|GO:0008206(bile acid metabolic process)|GO:0015248(sterol transporter activity)|GO:0015918(sterol transport)|GO:0016491(oxidoreductase activity)|GO:0016508(long-chain-enoyl-CoA hydratase activity)|GO:0016829(lyase activity)|GO:0016853(isomerase activity)|GO:0032934(sterol binding)|GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase)|GO:0033989(3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity)|GO:0043231(intracellular membrane-bounded organelle)|GO:0044255(cellular lipid metabolic process)|GO:0060009(Sertoli cell development)","Homo sapiens hydroxysteroid (17-beta) dehydrogenase 4 (HSD17B4), transcript variant 2, mRNA [NM_000414]",chr5:118867067-118872144,hs|5q23.1,hydroxysteroid (17-beta) dehydrogenase 4,TRUE
99_RPS18_6222,P62269,40s ribosomal protein s18 (ke-3) (ke3) (small ribosomal subunit protein us13),RPS18 D6S218E,152,"function: located at the top of the head of the 40s subunit, it contacts several helices of the 18s rrna. {eco:0000250}.",subcellular location: cytoplasm.,NA,NA,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,RPS18,6222,Hs.627414,ENST00000461584,THC2557981,GO:0003674(molecular_function)|GO:0003723(RNA binding)|GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005840(ribosome)|GO:0006412(translation)|GO:0006414(translational elongation)|GO:0006415(translational termination)|GO:0010467(gene expression)|GO:0015935(small ribosomal subunit)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0019058(viral infectious cycle)|GO:0019083(viral transcription)|GO:0019843(rRNA binding)|GO:0022627(cytosolic small ribosomal subunit)|GO:0031018(endocrine pancreas development)|GO:0042254(ribosome biogenesis)|GO:0044267(cellular protein metabolic process),"Homo sapiens ribosomal protein S18 (RPS18), mRNA [NM_022551]",chr6:33243800-33243968,hs|6p21.32,ribosomal protein S18,TRUE
990_AKAP9_10142,Q99996,a-kinase anchor protein 9 (akap-9) (a-kinase anchor protein 350 kda) (akap 350) (hgakap 350) (a-kinase anchor protein 450 kda) (akap 450) (akap 120-like protein) (centrosome- and golgi-localized pkn-associated protein) (cg-nap) (protein hyperion) (protein kinase a-anchoring protein 9) (prka9) (protein yotiao),AKAP9 AKAP350 AKAP450 KIAA0803,3907,"function: scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and golgi apparatus. required to maintain the integrity of the golgi apparatus (pubmed:10202149, pubmed:15047863). required for microtubule nucleation at the cis-side of the golgi apparatus (pubmed:15047863, pubmed:19242490). required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (pubmed:25657325). in complex with pde4dip isoform 13/mmg8/smyle, recruits camsap2 to the golgi apparatus and tethers non-centrosomal minus-end microtubules to the golgi, an important step for polarized cell movement (pubmed:27666745, pubmed:28814570). in complex with pde4dip isoform 13/mmg8/smyle, eb1/mapre1 and cdk5rap2, contributes to microtubules nucleation and extension also from the centrosome to the cell periphery (pubmed:29162697). {eco:0000269|pubmed:10202149, eco:0000269|pubmed:15047863, eco:0000269|pubmed:19242490, eco:0000269|pubmed:25657325, eco:0000269|pubmed:27666745, eco:0000269|pubmed:28814570, eco:0000269|pubmed:29162697}.; function: isoform 4: associated with the n-methyl-d-aspartate receptor and is specifically found in the neuromuscular junction (nmj) as well as in neuronal synapses, suggesting a role in the organization of postsynaptic specializations. {eco:0000269|pubmed:9482789}.","subcellular location: golgi apparatus {eco:0000269|pubmed:15047863, eco:0000269|pubmed:19242490, eco:0000269|pubmed:25217626, eco:0000269|pubmed:27666745}. cytoplasm {eco:0000269|pubmed:9915845}. cytoplasm, cytoskeleton, microtubule organizing center, centrosome {eco:0000269|pubmed:12270714, eco:0000269|pubmed:14654843, eco:0000269|pubmed:25657325, eco:0000269|pubmed:29162697, eco:0000269|pubmed:9915845}. note=cytoplasmic in parietal cells (pubmed:9915845). recruited to the golgi apparatus by gm130/golga2 (pubmed:25657325). localization at the centrosome versus golgi apparatus may be cell line-dependent. in skbr3 and hek293f cells, exclusively located at the centrosome (pubmed:29162697). in hela, mda-mb231 and rpe-1 cells, detected at the golgi apparatus (pubmed:25217626, pubmed:29162697). in sk-br-3 cells, recruited to the centrosome in the presence of cdk5rap2 (pubmed:29162697). {eco:0000269|pubmed:25217626, eco:0000269|pubmed:25657325, eco:0000269|pubmed:29162697, eco:0000269|pubmed:9915845}.","TISSUE SPECIFICITY: Widely expressed (PubMed:10202149). Isoform 4: Highly expressed in skeletal muscle and in pancreas (PubMed:9482789). {ECO:0000269|PubMed:10202149, ECO:0000269|PubMed:9482789}.","DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,AKAP9,10142,Hs.651221,ENST00000487258,NP076758,GO:0000086(G2/M transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0005102(receptor binding)|GO:0005515(protein binding)|GO:0005737(cytoplasm)|GO:0005794(Golgi apparatus)|GO:0005813(centrosome)|GO:0005829(cytosol)|GO:0005856(cytoskeleton)|GO:0006810(transport)|GO:0007165(signal transduction)|GO:0007268(synaptic transmission)|GO:0016301(kinase activity),"Homo sapiens A kinase (PRKA) anchor protein (yotiao) 9 (AKAP9), transcript variant 2, mRNA [NM_005751]",chr7:91739783-91739842,hs|7q21.2,A kinase (PRKA) anchor protein (yotiao) 9,TRUE
991_TSFM_10102,P43897,"elongation factor ts, mitochondrial (ef-ts) (ef-tsmt)",TSFM,325,"function: associates with the ef-tu.gdp complex and induces the exchange of gdp to gtp. it remains bound to the aminoacyl-trna.ef-tu.gtp complex up to the gtp hydrolysis stage on the ribosome. {eco:0000255|hamap-rule:mf_03135, eco:0000269|pubmed:27677415}.",subcellular location: mitochondrion.,"TISSUE SPECIFICITY: Expressed in all tissues, with the highest levels of expression in skeletal muscle, liver and kidney.","DISEASE: Combined oxidative phosphorylation deficiency 3 (COXPD3) [MIM:610505]: A mitochondrial disease resulting in severe metabolic acidosis with encephalomyopathy or with hypertrophic cardiomyopathy. Patients show a severe defect in mitochondrial translation leading to a failure to assemble adequate amounts of three of the oxidative phosphorylation complexes. {ECO:0000269|PubMed:17033963, ECO:0000269|PubMed:22499341, ECO:0000269|PubMed:27677415}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TSFM,10102,Hs.632704,ENST00000323833,THC2467264,"GO:0003746(translation elongation factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005739(mitochondrion)|GO:0006414(translational elongation)|GO:0032784(regulation of transcription elongation, DNA-dependent)","Homo sapiens Ts translation elongation factor, mitochondrial (TSFM), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_005726]",chr12:58190361-58190420,hs|12q14.1,"Ts translation elongation factor, mitochondrial",TRUE
992_POLR2F_5435,P61218,"dna-directed rna polymerases i, ii, and iii subunit rpabc2 (rna polymerases i, ii, and iii subunit abc2) (dna-directed rna polymerase ii subunit f) (dna-directed rna polymerases i, ii, and iii 14.4 kda polypeptide) (rpabc14.4) (rpb14.4) (rpb6 homolog) (rpc15)",POLR2F POLRF,127,"function: dna-dependent rna polymerases catalyze the transcription of dna into rna using the four ribonucleoside triphosphates as substrates. common component of rna polymerases i, ii, and iii which synthesize ribosomal rna precursors, mrna precursors and many functional non-coding rnas, and small rnas, such as 5s rrna and trnas, respectively. pol ii is the central component of the basal rna polymerase ii transcription machinery. pols are composed of mobile elements that move relative to each other. in pol ii, polr2f/rpb6 is part of the clamp element and together with parts of rpb1 and rpb2 forms a pocket to which the rpb4-rpb7 subcomplex binds (by similarity). {eco:0000250, eco:0000269|pubmed:9852112}.",subcellular location: nucleus {eco:0000269|pubmed:9852112}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,POLR2F,5435,Hs.436578,ENST00000492213,THC2723376,"GO:0000398(nuclear mRNA splicing, via spliceosome)|GO:0003677(DNA binding)|GO:0003899(DNA-directed RNA polymerase activity)|GO:0004672(protein kinase activity)|GO:0005634(nucleus)|GO:0005654(nucleoplasm)|GO:0005665(DNA-directed RNA polymerase II, core complex)|GO:0005730(nucleolus)|GO:0006281(DNA repair)|GO:0006283(transcription-coupled nucleotide-excision repair)|GO:0006289(nucleotide-excision repair)|GO:0006366(transcription from RNA polymerase II promoter)|GO:0006367(transcription initiation from RNA polymerase II promoter)|GO:0006368(transcription elongation from RNA polymerase II promoter)|GO:0006370(mRNA capping)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0006385(transcription elongation from RNA polymerase III promoter)|GO:0006386(termination of RNA polymerase III transcription)|GO:0006468(protein phosphorylation)|GO:0008380(RNA splicing)|GO:0010467(gene expression)|GO:0016032(viral reproduction)|GO:0030880(RNA polymerase complex)|GO:0050434(positive regulation of viral transcription)","Homo sapiens polymerase (RNA) II (DNA directed) polypeptide F (POLR2F), mRNA [NM_021974]",chr22:38363169-38363682,hs|22q13.1,polymerase (RNA) II (DNA directed) polypeptide F,TRUE
993_CAMK2N1_55450,Q7Z7J9,calcium/calmodulin-dependent protein kinase ii inhibitor 1 (camkii inhibitory protein alpha) (camkiin-alpha),CAMK2N1,78,"function: potent and specific inhibitor of cam-kinase ii (camk2). {eco:0000250, eco:0000269|pubmed:18305109}.","subcellular location: cell junction, synapse, synaptosome. cell junction, synapse, postsynaptic density {eco:0000250}.",TISSUE SPECIFICITY: Widely expressed. Nor detected in skeletal muscle. {ECO:0000269|PubMed:18305109}.,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,CAMK2N1,55450,Hs.197922,ENST00000489020,THC2474719,GO:0005886(plasma membrane)|GO:0008427(calcium-dependent protein kinase inhibitor activity)|GO:0014069(postsynaptic density)|GO:0019717(synaptosome)|GO:0019901(protein kinase binding)|GO:0030054(cell junction)|GO:0030425(dendrite)|GO:0043025(neuronal cell body)|GO:0045202(synapse)|GO:0045211(postsynaptic membrane),"Homo sapiens calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1), mRNA [NM_018584]",chr1:20810211-20810152,hs|1p36.12,calcium/calmodulin-dependent protein kinase II inhibitor 1,TRUE
994_GAR1_54433,Q9NY12,h/aca ribonucleoprotein complex subunit 1 (nucleolar protein family a member 1) (snornp protein gar1),GAR1 NOLA1,217,"function: required for ribosome biogenesis and telomere maintenance. part of the h/aca small nucleolar ribonucleoprotein (h/aca snornp) complex, which catalyzes pseudouridylation of rrna. this involves the isomerization of uridine such that the ribose is subsequently attached to c5, instead of the normal n1. each rrna can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rrnas. may also be required for correct processing or intranuclear trafficking of terc, the rna component of the telomerase reverse transcriptase (tert) holoenzyme. {eco:0000269|pubmed:10757788, eco:0000269|pubmed:15044956}.","subcellular location: nucleus, nucleolus. nucleus, cajal body. note=also localized to cajal bodies (coiled bodies).",NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,GAR1,54433,Hs.69851,ENST00000226796,THC2464664,GO:0005261(cation channel activity)|GO:0005634(nucleus)|GO:0005730(nucleolus)|GO:0006364(rRNA processing)|GO:0009982(pseudouridine synthase activity)|GO:0015030(Cajal body)|GO:0030515(snoRNA binding)|GO:0030529(ribonucleoprotein complex)|GO:0031120(snRNA pseudouridine synthesis)|GO:0031429(box H/ACA snoRNP complex),"Homo sapiens GAR1 ribonucleoprotein homolog (yeast) (GAR1), transcript variant 1, mRNA [NM_018983]",chr4:110745600-110745659,hs|4q25,GAR1 ribonucleoprotein homolog (yeast),TRUE
995_EED_8726,O75530,polycomb protein eed (heed) (embryonic ectoderm development protein) (wd protein associating with integrin cytoplasmic tails 1) (wait-1),EED,441,"function: polycomb group (pcg) protein. component of the prc2/eed-ezh2 complex, which methylates 'lys-9' and 'lys-27' of histone h3, leading to transcriptional repression of the affected target gene. also recognizes 'lys-26' trimethylated histone h1 with the effect of inhibiting prc2 complex methyltransferase activity on nucleosomal histone h3 'lys-27', whereas h3 'lys-27' recognition has the opposite effect, enabling the propagation of this repressive mark. the prc2/eed-ezh2 complex may also serve as a recruiting platform for dna methyltransferases, thereby linking two epigenetic repression systems. genes repressed by the prc2/eed-ezh2 complex include hoxc8, hoxa9, myt1 and cdkn2a. {eco:0000269|pubmed:10581039, eco:0000269|pubmed:14532106, eco:0000269|pubmed:15225548, eco:0000269|pubmed:15231737, eco:0000269|pubmed:15385962, eco:0000269|pubmed:16357870, eco:0000269|pubmed:18285464, eco:0000269|pubmed:20974918, eco:0000269|pubmed:28229514, eco:0000269|pubmed:9584199}.",subcellular location: nucleus. chromosome. note=transiently colocalizes with xist at inactive x chromosomes.,"TISSUE SPECIFICITY: Expressed in brain, colon, heart, kidney, liver, lung, muscle, ovary, peripheral blood leukocytes, pancreas, placenta, prostate, spleen, small intestine, testis, thymus and uterus. Appears to be overexpressed in breast and colon cancer. {ECO:0000269|PubMed:15684044, ECO:0000269|PubMed:9584199, ECO:0000269|PubMed:9765275, ECO:0000269|PubMed:9806832, ECO:0000269|PubMed:9880543}.","DISEASE: Cohen-Gibson syndrome (COGIS) [MIM:617561]: An autosomal dominant overgrowth disorder characterized by accelerated osseous maturation, advanced bone age, skeletal abnormalities including flaring of the metaphyses of the long bones, large hands with long fingers and camptodactyly, scoliosis, cervical spine anomalies, dysmorphic facial features, and variable intellectual disability. {ECO:0000269|PubMed:25787343, ECO:0000269|PubMed:27193220, ECO:0000269|PubMed:27868325, ECO:0000269|PubMed:28229514, ECO:0000269|PubMed:28475857}. Note=The disease is caused by mutations affecting the gene represented in this entry.",NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,EED,8726,Hs.503510,ENST00000327320,THC2603594,"GO:0001739(sex chromatin)|GO:0003682(chromatin binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005694(chromosome)|GO:0006349(regulation of gene expression by genetic imprinting)|GO:0016568(chromatin modification)|GO:0016571(histone methylation)|GO:0035098(ESC/E(Z) complex)|GO:0042054(histone methyltransferase activity)|GO:0042802(identical protein binding)|GO:0045120(pronucleus)|GO:0045892(negative regulation of transcription, DNA-dependent)","Homo sapiens embryonic ectoderm development (EED), transcript variant 2, mRNA [NM_152991]",chr11:85989629-85989688,hs|11q14.2,embryonic ectoderm development,TRUE
996_GPR56_9289,Q9Y653,adhesion g-protein coupled receptor g1 (g-protein coupled receptor 56) (protein tm7xn1) [cleaved into: adgrg1 n-terminal fragment (adgrg1 nt) (gpr56 n-terminal fragment) (gpr56 nt) (gpr56(n)) (gpr56 extracellular subunit) (gpr56 subunit alpha); adgrg1 c-terminal fragment (adgrg1 ct) (gpr56 c-terminal fragment) (gpr56 ct) (gpr56(c)) (gpr56 seven-transmembrane subunit) (gpr56 7tm) (gpr56 subunit beta)],ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083,693,"function: receptor involved in cell adhesion and probably in cell-cell interactions. mediates cell matrix adhesion in developing neurons and hematopoietic stem cells. receptor for collagen iii/col3a1 in the developing brain and involved in regulation of cortical development, specifically in maintenance of the pial basement membrane integrity and in cortical lamination (by similarity). binding to the col3a1 ligand inhibits neuronal migration and activates the rhoa pathway by coupling to gna13 and possibly gna12 (pubmed:22238662). plays a role in the maintenance of hematopoietic stem cells and/or leukemia stem cells in bone marrow niche (by similarity). plays a critical role in cancer progression by inhibiting vegfa production threreby inhibiting angiogenesis through a signaling pathway mediated by prkca (pubmed:16757564, pubmed:21724588). plays an essential role in testis development (by similarity). {eco:0000250|uniprotkb:q8k209, eco:0000269|pubmed:16757564, eco:0000269|pubmed:19572147, eco:0000269|pubmed:21708946, eco:0000269|pubmed:21724588, eco:0000269|pubmed:22238662, eco:0000269|pubmed:24531968}.; function: adgrg1 n-terminal fragment: plays a critical role in cancer progression by activating vegfa production and angiogenesis through a signaling pathway mediated by prkca (pubmed:21724588). {eco:0000269|pubmed:21724588}.","subcellular location: cell membrane {eco:0000269|pubmed:21349848, eco:0000269|pubmed:24949629}; multi-pass membrane protein {eco:0000255}.; subcellular location: adgrg1 n-terminal fragment: secreted {eco:0000269|pubmed:21349848}.; subcellular location: adgrg1 c-terminal fragment: membrane raft {eco:0000269|pubmed:24949629}. note=interaction with its ligand col3a1 leads to the release of adgrg1 nt from the membrane and triggers the association of adgrg1 ct with lipid rafts. {eco:0000269|pubmed:24949629}.","TISSUE SPECIFICITY: Widely distributed with highest levels found in thyroid gland, brain and heart. Expressed in a great number of tumor cells. Expression is down-regulated in different tumors from highly metastatic cells. {ECO:0000269|PubMed:16757564}.","DISEASE: Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]: A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination, most severe in the frontoparietal regions. BFPP clinical manifestations include developmental and psychomotor delay, cerebellar and pyramidal signs, truncal ataxia, seizures, hyperreflexia. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. {ECO:0000269|PubMed:15044805, ECO:0000269|PubMed:16240336, ECO:0000269|PubMed:21349848, ECO:0000269|PubMed:21723461, ECO:0000269|PubMed:22238662, ECO:0000269|PubMed:24949629}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polymicrogyria, bilateral perisylvian, autosomal recessive (BPPR) [MIM:615752]: A form of polymicrogyria, a malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. BPPR is characterized by strikingly restricted polymicrogyria limited to the cortex surrounding the Sylvian fissure. Affected individuals have intellectual and language difficulty and seizures, but no motor disability. Polymicrogyria is a heterogeneous disorder, considered to be the result of post-migratory abnormal cortical organization. {ECO:0000269|PubMed:24531968}. Note=The disease is caused by mutations affecting the gene represented in this entry. Homozygous deletion of 1 of 2 tandem 15-bp repeats located 144 bp upstream of the ADGRG1 non-coding exon 1m transcription start site, results in impaired perisylvian ADGRG1 expression and disruption of perisylvian gyri (PubMed:24531968). {ECO:0000269|PubMed:24531968}.",NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,GPR56,9289,Hs.513633,ENST00000379694,THC2472484,GO:0004871(signal transducer activity)|GO:0004872(receptor activity)|GO:0004930(G-protein coupled receptor activity)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0007155(cell adhesion)|GO:0007186(G-protein coupled receptor protein signaling pathway)|GO:0007218(neuropeptide signaling pathway)|GO:0007267(cell-cell signaling)|GO:0007420(brain development)|GO:0016021(integral to membrane),"Homo sapiens G protein-coupled receptor 56 (GPR56), transcript variant 3, mRNA [NM_201525]",chr16:57698776-57698835,hs|16q21,G protein-coupled receptor 56,TRUE
997_ZNF275_10838,Q9NSD4,zinc finger protein 275,ZNF275,429,function: may be involved in transcriptional regulation.,subcellular location: nucleus {eco:0000305}.,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,ZNF275,10838,Hs.348963,ENST00000421401,THC2607766,"GO:0003677(DNA binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding)","Homo sapiens zinc finger protein 275 (ZNF275), mRNA [NM_001080485]",chrX:152616825-152616884,hs|Xq28,zinc finger protein 275,TRUE
998_SLC38A10_124565,Q9HBR0,putative sodium-coupled neutral amino acid transporter 10 (solute carrier family 38 member 10),SLC38A10 PP1744,1119,function: putative sodium-dependent amino acid/proton antiporter. {eco:0000250}.,subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,SLC38A10,124565,Hs.352240,ENST00000539643,THC2462309,GO:0006811(ion transport)|GO:0006814(sodium ion transport)|GO:0006865(amino acid transport)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens solute carrier family 38, member 10 (SLC38A10), transcript variant 1, mRNA [NM_001037984]",chr17:79218895-79218836,hs|17q25.3,"solute carrier family 38, member 10",TRUE
999_MRP63_78988,Q9BQC6,"ribosomal protein 63, mitochondrial (hmrp63) (mitochondrial large ribosomal subunit protein ml63) (mitochondrial ribosomal protein 63) (mitochondrial ribosomal protein l57)",MRPL57 MRP63,102,NA,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,MRP63,78988,Hs.458367,ENST00000309594,THC2516563,GO:0003735(structural constituent of ribosome)|GO:0005739(mitochondrion)|GO:0005761(mitochondrial ribosome)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein 63 (MRP63), nuclear gene encoding mitochondrial protein, mRNA [NM_024026]",chr13:21751305-21751364,hs|13q12.11,mitochondrial ribosomal protein 63,TRUE
1016_C11orf10_746,P61165,transmembrane protein 258 (dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit tmem258) (oligosaccharyl transferase subunit tmem258),TMEM258 C11orf10 HSPC005,79,"subcellular location: membrane {eco:0000305}; multi-pass membrane protein {eco:0000305}. endoplasmic reticulum {eco:0000269|pubmed:26472760, eco:0000269|pubmed:27974209}.",tissue specificity: ubiquitously expressed. {eco:0000269|pubmed:27974209}.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,C11orf10,746,Hs.437779,ENST00000545210,THC2744685,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens chromosome 11 open reading frame 10 (C11orf10), mRNA [NM_014206]",chr11:61557336-61557277,hs|11q12.2,chromosome 11 open reading frame 10,TRUE
1021_VTI1B_10490,Q9UEU0,vesicle transport through interaction with t-snares homolog 1b (vesicle transport v-snare protein vti1-like 1) (vti1-rp1),VTI1B VTI1 VTI1L VTI1L1 VTI2,232,"subcellular location: early endosome membrane {eco:0000269|pubmed:18033301}; single-pass type iv membrane protein {eco:0000255}. late endosome membrane {eco:0000269|pubmed:18033301, eco:0000269|pubmed:23217709}; single-pass type iv membrane protein {eco:0000269|pubmed:23217709}. lysosome membrane {eco:0000269|pubmed:18033301, eco:0000269|pubmed:23217709}. cytoplasmic granule {eco:0000269|pubmed:23217709}. recycling endosome membrane {eco:0000269|pubmed:18033301}; single-pass type iv membrane protein {eco:0000255}.",tissue specificity: expressed in all tissues examined.,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,VTI1B,10490,Hs.728787,ENST00000216456,THC2466967,GO:0006886(intracellular protein transport)|GO:0006904(vesicle docking involved in exocytosis)|GO:0006944(cellular membrane fusion)|GO:0008283(cell proliferation)|GO:0012505(endomembrane system)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport),"Homo sapiens vesicle transport through interaction with t-SNAREs homolog 1B (yeast) (VTI1B), mRNA [NM_006370]",chr14:68118087-68118028,hs|14q24.1,vesicle transport through interaction with t-SNAREs homolog 1B (yeast),TRUE
1234_MRPL33_9553,O75394,"39s ribosomal protein l33, mitochondrial (l33mt) (mrp-l33) (mitochondrial large ribosomal subunit protein bl33m)",MRPL33 C2orf1,65,"subcellular location: mitochondrion {eco:0000269|pubmed:25278503, eco:0000269|pubmed:25838379, eco:0000269|pubmed:28892042}.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,FALSE,MRPL33,9553,Hs.515879,ENST00000476552,THC2520232,GO:0003735(structural constituent of ribosome)|GO:0005622(intracellular)|GO:0005739(mitochondrion)|GO:0005840(ribosome)|GO:0006412(translation),"Homo sapiens mitochondrial ribosomal protein L33 (MRPL33), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_004891]",chr2:28002334-28002393,hs|2p23.2,mitochondrial ribosomal protein L33,TRUE
188_TOMM7_54543,Q9P0U1,mitochondrial import receptor subunit tom7 homolog (translocase of outer membrane 7 kda subunit homolog),TOMM7 TOM7 TOMM07 AD-014,55,subcellular location: mitochondrion outer membrane {eco:0000269|pubmed:12198123}; single-pass membrane protein {eco:0000269|pubmed:12198123}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TOMM7,54543,Hs.112318,ENST00000483581,THC2556657,GO:0005515(protein binding)|GO:0005739(mitochondrion)|GO:0005742(mitochondrial outer membrane translocase complex)|GO:0006626(protein targeting to mitochondrion)|GO:0006886(intracellular protein transport)|GO:0008320(protein transmembrane transporter activity)|GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity)|GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens translocase of outer mitochondrial membrane 7 homolog (yeast) (TOMM7), nuclear gene encoding mitochondrial protein, mRNA [NM_019059]",chr7:22852769-22852710,hs|7p15.3,translocase of outer mitochondrial membrane 7 homolog (yeast),TRUE
426_COX8A_1351,P10176,"cytochrome c oxidase subunit 8a, mitochondrial (cytochrome c oxidase polypeptide viii-liver/heart) (cytochrome c oxidase subunit 8-2)",COX8A COX8 COX8L,69,subcellular location: mitochondrion inner membrane {eco:0000269|pubmed:30030519}; single-pass membrane protein {eco:0000269|pubmed:30030519}.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,COX8A,1351,Hs.433901,ENST00000314133,THC2469787,GO:0004129(cytochrome-c oxidase activity)|GO:0005739(mitochondrion)|GO:0005743(mitochondrial inner membrane)|GO:0006091(generation of precursor metabolites and energy)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0022904(respiratory electron transport chain),"Homo sapiens cytochrome c oxidase subunit VIIIA (ubiquitous) (COX8A), mRNA [NM_004074]",chr11:63743901-63743960,hs|11q13.1,cytochrome c oxidase subunit VIIIA (ubiquitous),TRUE
472_OST4_100128731,P0C6T2,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4,OST4,37,subcellular location: endoplasmic reticulum {eco:0000305|pubmed:23606741}. endoplasmic reticulum membrane; single-pass type iii membrane protein {eco:0000305}. note=the single transmembrane helix has a kink in the middle of the transmembrane span.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,OST4,100128731,Hs.502948,ENST00000429985,THC2654667,GO:0016020(membrane)|GO:0016021(integral to membrane),"Homo sapiens oligosaccharyltransferase 4 homolog (S. cerevisiae) (OST4), mRNA [NM_001134693]",chr2:27293465-27293406,hs|2p23.3,oligosaccharyltransferase 4 homolog (S. cerevisiae),TRUE
505_STRAP_11171,Q9Y3F4,serine-threonine kinase receptor-associated protein (map activator with wd repeats) (unr-interacting protein) (wd-40 repeat protein pt-wd),STRAP MAWD UNRIP,350,subcellular location: cytoplasm. nucleus. note=localized predominantly in the cytoplasm but also found in the nucleus.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,STRAP,11171,Hs.728778,ENST00000541731,THC2524319,GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0005102(receptor binding)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005681(spliceosomal complex)|GO:0005737(cytoplasm)|GO:0005739(mitochondrion)|GO:0005886(plasma membrane)|GO:0006397(mRNA processing)|GO:0008380(RNA splicing)|GO:0030054(cell junction)|GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway),"Homo sapiens serine/threonine kinase receptor associated protein (STRAP), mRNA [NM_007178]",chr12:16056307-16056366,hs|12p12.3,serine/threonine kinase receptor associated protein,TRUE
72_MTRNR2L2_100462981,P0CJ69,humanin-like 2 (hn2) (mt-rnr2-like protein 2),MTRNR2L2,28,subcellular location: secreted {eco:0000250|uniprotkb:q8ivg9}. cytoplasm {eco:0000250|uniprotkb:q8ivg9}.,"tissue specificity: highly expressed in testis. also expressed in kidney, heart, skeletal muscles and brain. {eco:0000269|pubmed:19477263}.",NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,MTRNR2L2,100462981,Hs.666077,ENST00000536684,THC2551340,GO:0005576(extracellular region)|GO:0005737(cytoplasm),"Homo sapiens MT-RNR2-like 2 (MTRNR2L2), mRNA [NM_001190470]",chr5:79946688-79946629,hs|5q14.1,MT-RNR2-like 2,TRUE
